PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Doengi, M; Deitmer, JW; Lohr, C				Doengi, Michael; Deitmer, Joachim W.; Lohr, Christian			New evidence for purinergic signaling in the olfactory bulb: A(2A) and P2Y(1) receptors mediate intracellular calcium release in astrocytes	FASEB JOURNAL			English	Article						neuron-glia interaction; adenosine triphosphate	CULTURED CORTICAL ASTROCYTES; RAT CEREBELLAR ASTROCYTES; RETINAL GLIAL-CELLS; GATED ION CHANNELS; DORSAL SPINAL-CORD; ADENOSINE RECEPTORS; NEURONAL-ACTIVITY; HIPPOCAMPAL ASTROCYTES; SYNAPTIC-TRANSMISSION; GLOMERULAR FORMATION	Purinergic receptors play a key role in neuron-glia and glia-neuron interactions. In the present study, we have recorded cytosolic Ca2+ responses using confocal imaging in astrocytes of acute olfactory bulb slices from mice (postnatal days 3-8). By application of agonists and antagonists, we identified two types of receptors, P2Y(1) and A(2A), that mediated Ca2+ responses attributable to Ca2+ release from intracellular stores in the astrocytes. Both receptor types were activated by application of ATP and ADP; however, when enzymatic ATP degradation was suppressed by the alkaline phosphatase inhibitor levamisole, ATP only activated MRS2179-sensitive P2Y(1) but not ZM241385-sensitive A(2A) receptors. The dose-response curve for A(2A) receptors activated by adenosine revealed an EC50 of 0.3 mu M, one order of magnitude smaller than the EC50 of 5 mu M determined for P2Y(1) receptors activated by ADP. Electrical stimulation of the olfactory nerve in the presence of glutamate receptor blockers to suppress excitation of postsynaptic neurons evoked Ca2+ responses in most of the astrocytes, which were inhibited by blocking both P2Y(1) and A(2A) receptors. Our results indicate that olfactory nerve terminals release not only glutamate, but also ATP, which activates P2Y(1) receptors and, after degradation of ATP to adenosine, A(2A) receptors in astrocytes.	[Doengi, Michael; Deitmer, Joachim W.; Lohr, Christian] Univ Kaiserslautern, Abt Allgemeine Zool, D-67653 Kaiserslautern, Germany	University of Kaiserslautern	Lohr, C (corresponding author), Univ Kaiserslautern, Abt Allgemeine Zool, POB 3049, D-67653 Kaiserslautern, Germany.	clohr@biologie.uni-kl.de	Lohr, Christian/F-2968-2011	Lohr, Christian/0000-0001-6518-6422				Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Alloisio S, 2004, BRIT J PHARMACOL, V141, P935, DOI 10.1038/sj.bjp.0705707; Alloisio S, 2006, MOL PHARMACOL, V69, P1975, DOI 10.1124/mol.105.020164; Amadio S, 2006, NEUROSCIENCE, V141, P1171, DOI 10.1016/j.neuroscience.2006.05.058; Bailey MS, 1999, J COMP NEUROL, V415, P423; Beck A, 2004, CELL CALCIUM, V35, P47, DOI 10.1016/S0143-4160(03)00171-4; Bernstein M, 1998, NEUROPHARMACOLOGY, V37, P169, DOI 10.1016/S0028-3908(98)00012-4; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Butt AM, 2006, GLIA, V54, P666, DOI 10.1002/glia.20424; Dallwig R, 2000, CELL CALCIUM, V28, P247, DOI 10.1054/ceca.2000.0153; Deitmer JW, 2006, CEREBELLUM, V5, P49, DOI 10.1080/14734220500497456; DEITMER JW, 2007, ASTROCYTE P IN PRESS; Fam SR, 2000, J NEUROSCI, V20, P2800; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hartel K, 2007, CELL CALCIUM, V42, P271, DOI 10.1016/j.ceca.2006.12.004; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; JAN DD, 2005, J NEUROSCI, V25, P2917, DOI DOI 10.1523/JNEUR0SCI.5042-04.2005; Johansson B, 1997, NEUROSCIENCE, V80, P1187, DOI 10.1016/S0306-4522(97)00143-7; Jung S, 2000, J PHYSIOL-LONDON, V527, P549, DOI 10.1111/j.1469-7793.2000.00549.x; Kanjhan R, 1999, J COMP NEUROL, V407, P11; Kirischuk S, 1995, J NEUROSCI, V15, P7861; Kozlov AS, 2006, P NATL ACAD SCI USA, V103, P10058, DOI 10.1073/pnas.0603741103; Llaudet E, 2005, ANAL CHEM, V77, P3267, DOI 10.1021/ac048106q; Nasu-Tada K, 2005, GLIA, V52, P98, DOI 10.1002/glia.20224; Newman EA, 2005, J NEUROSCI, V25, P5502, DOI 10.1523/JNEUROSCI.1354-05.2005; Newman EA, 2004, GLIA, V47, P268, DOI 10.1002/glia.20030; Newman EA, 1997, SCIENCE, V275, P844, DOI 10.1126/science.275.5301.844; Pilitsis JG, 1998, BRAIN RES, V798, P294, DOI 10.1016/S0006-8993(98)00430-2; PORTER JT, 1995, J NEUROCHEM, V65, P1515, DOI 10.1046/j.1471-4159.1995.65041515.x; Prediger RDS, 2005, NEUROBIOL AGING, V26, P957, DOI 10.1016/j.neurobiolaging.2004.08.012; Rieger A, 2007, GLIA, V55, P352, DOI 10.1002/glia.20460; Rousse I, 2006, GLIA, V54, P691, DOI 10.1002/glia.20388; SALTER MW, 1994, J NEUROSCI, V14, P1563, DOI 10.1523/JNEUROSCI.14-03-01563.1994; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Simon J, 1997, NEUROPHARMACOLOGY, V36, P1243, DOI 10.1016/S0028-3908(97)00124-X; Singaravelu K, 2006, CELL CALCIUM, V39, P143, DOI 10.1016/j.ceca.2005.10.001; Singaravelu K, 2006, J NEUROSCI, V26, P9579, DOI 10.1523/JNEUROSCI.2604-06.2006; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Treloar HB, 1999, J COMP NEUROL, V413, P289; VENANCE L, 1995, NATURE, V376, P590, DOI 10.1038/376590a0; Volterra A, 2004, GLIA, V47, P249, DOI 10.1002/glia.20080; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Vulchanova L, 1996, P NATL ACAD SCI USA, V93, P8063, DOI 10.1073/pnas.93.15.8063; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; White PJ, 2003, MOL PHARMACOL, V63, P1356, DOI 10.1124/mol.63.6.1356; Yuan Q, 2006, J NEUROPHYSIOL, V95, P3097, DOI 10.1152/jn.00001.2006; Zhang FL, 2002, J PHARMACOL EXP THER, V301, P705, DOI 10.1124/jpet.301.2.705; Zhu YZ, 2001, J NEUROCHEM, V77, P530, DOI 10.1046/j.1471-4159.2001.00241.x; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309	52	47	48	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2008	22	7					2368	2378		10.1096/fj.07-101782	http://dx.doi.org/10.1096/fj.07-101782			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18310463				2022-12-25	WOS:000257292500029
J	Eelen, G; Bempt, IV; Verlinden, L; Drijkoningen, M; Smeets, A; Neven, P; Christiaens, MR; Marchal, K; Bouillon, R; Verstuyf, A				Eelen, G.; Bempt, I. Vanden; Verlinden, L.; Drijkoningen, M.; Smeets, A.; Neven, P.; Christiaens, M. R.; Marchal, K.; Bouillon, R.; Verstuyf, A.			Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy	ONCOGENE			English	Article						Brip1; breast cancer; E2F; vitamin D; high grade; HER-2	FANCONI-ANEMIA; MOLECULAR PORTRAITS; DNA-REPLICATION; HELICASE BRIP1; TARGET GENES; SUSCEPTIBILITY; BACH1; TRANSCRIPTION; CARCINOMAS; MUTATIONS	Mutations in the BRCA1-interacting DEAH helicase Brip1 confer an increased risk of breast cancer. In the present study we aimed to unravel the transcriptional control of Brip1 and to determine its expression levels in a set of 101 primary invasive breast carcinomas. Transcription of Brip1 was found to be cell growth-related and controlled by the E2F/retinoblastoma (Rb) pathway through a conserved E2F-responsive site. Repression of Brip1 expression by the cell growth-inhibiting compound 1 alpha,25-dihydroxyvitamin D(3) depended on this same E2F-responsive site. In spite of its role as a tumor suppressor, both quantitative reverse transcriptase-PCR analyses and immunohistochemical stainings showed significantly elevated Brip1 expression levels in grade 3 tumors as compared to grade 1 or 2 carcinomas. Furthermore, increased Brip1 transcript levels were found in tumors with an estrogen receptor-negative, progesterone receptor-negative or HER-2-positive status. In conclusion, these data show that Brip1 is a genuine target gene for the E2F/Rb pathway and that elevated expression levels of Brip1 are detected in primary invasive breast carcinomas with unfavorable characteristics.	[Eelen, G.; Verlinden, L.; Verstuyf, A.] Katholieke Univ Leuven, LEGENDO, B-3000 Leuven, Belgium; [Bempt, I. Vanden; Drijkoningen, M.] Katholieke Univ Leuven, Univ Hosp, Dept Pathol, B-3000 Leuven, Belgium; [Drijkoningen, M.; Smeets, A.; Neven, P.; Christiaens, M. R.] Katholieke Univ Leuven, Univ Hosp, Multidisciplinary Breast Ctr, B-3000 Leuven, Belgium; [Marchal, K.] Katholieke Univ Leuven, CMPG, ESAT, B-3000 Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven	Verstuyf, A (corresponding author), Katholieke Univ Leuven, LEGENDO, 9th Floor,Bus 902,Herestr 49, B-3000 Leuven, Belgium.	mieke.verstuyf@med.kuleuven.be	Vanden Bempt, Isabelle/AAH-2501-2022; Marchal, Kathleen/B-5001-2013; Vanden Bempt, Isabelle/AFM-0163-2022; Marchal, Kathleen/O-7936-2017; Verlinden, Lieve/E-6517-2011; smeets, ann/AAP-9191-2020	Vanden Bempt, Isabelle/0000-0002-3433-555X; Marchal, Kathleen/0000-0002-2169-4588; Vanden Bempt, Isabelle/0000-0002-3433-555X; Marchal, Kathleen/0000-0002-2169-4588; Verlinden, Lieve/0000-0002-9621-3662; Verstuyf, Annemieke/0000-0003-3193-2698				Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Eelen G, 2007, CURR MED CHEM, V14, P1893; Eelen G, 2004, J STEROID BIOCHEM, V89-90, P405, DOI 10.1016/j.jsbmb.2004.03.008; Eelen G, 2004, J BONE MINER RES, V19, P133, DOI 10.1359/JBMR.0301204; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; ISHIDA R, 1982, CANCER RES, V42, P4000; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Paris PL, 2004, HUM MOL GENET, V13, P1303, DOI 10.1093/hmg/ddh155; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; POLL EHA, 1982, HUM GENET, V61, P228, DOI 10.1007/BF00296447; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Saiz AD, 2002, J PATHOL, V198, P157, DOI 10.1002/path.1185; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sinclair CS, 2003, BREAST CANCER RES TR, V78, P313, DOI 10.1023/A:1023081624133; Sorlie T, 2004, EUR J CANCER, V40, P2667, DOI 10.1016/j.ejca.2004.08.021; Verlinden L, 2005, J BIOL CHEM, V280, P37319, DOI 10.1074/jbc.M503587200; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zacharatos P, 2004, J PATHOL, V203, P744, DOI 10.1002/path.1582; Zhang SY, 2000, CANCER EPIDEM BIOMAR, V9, P395	32	31	32	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2008	27	30					4233	4241		10.1038/onc.2008.51	http://dx.doi.org/10.1038/onc.2008.51			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	324DB	18345034	Green Published			2022-12-25	WOS:000257496800010
J	Nakatsubo, T; Mizutani, M; Suzuki, S; Hattori, T; Umezawa, T				Nakatsubo, Tomoyuki; Mizutani, Masaharu; Suzuki, Shiro; Hattori, Takefumi; Umezawa, Toshiaki			Characterization of Arabidopsis thaliana pinoresinol reductase, a new type of enzyme involved in lignan biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARICIRESINOL REDUCTASES	A lignan, lariciresinol, was isolated from Arabidopsis thaliana, the most widely used model plant in plant bioscience sectors, for the first time. In the A. thaliana genome database, there are two genes (At1g32100 and At4g13660) that are annotated as pinoresinol/lariciresinol reductase (PLR). The recombinant AtPLRs showed strict substrate preference toward pinoresinol but only weak or no activity toward lariciresinol, which is in sharp contrast to conventional PLRs of other plants that can reduce both pinoresinol and lariciresinol efficiently to lariciresinol and secoisolariciresinol, respectively. Therefore, we renamed AtPLRs as A. thaliana pinoresinol reductases (AtPrRs). The recombinant AtPrR2 encoded by At4g13660 reduced only (-)-pinoresinol to (-)-lariciresinol and not (+)-pinoresinol in the presence of NADPH. This enantiomeric selectivity accords with that of other PLRs of other plants so far reported, which can reduce one of the enantiomers selectively, whatever the preferential enantiomer. In sharp contrast, AtPrR1 encoded by At1g32100 reduced both (+)-and (-)-pinoresinols to (+)-and (-)-lariciresinols efficiently with comparative k(cat)/K-m values. Analysis of lignans and spatio-temporal expression of AtPrR1 and AtPrR2 in their functionally deficient A. thaliana mutants and wild type indicated that both genes are involved in lariciresinol biosynthesis. In addition, the analysis of the enantiomeric compositions of lariciresinol isolated from the mutants and wild type showed that PrRs together with a dirigent protein(s) are involved in the enantiomeric control in lignan biosynthesis. Furthermore, it was demonstrated conclusively for the first time that differential expression of PrR isoforms that have distinct selectivities of substrate enantiomers can determine enantiomeric compositions of the product, lariciresinol.	[Mizutani, Masaharu] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Suzuki, Shiro; Umezawa, Toshiaki] Kyoto Univ, Inst Sustainabil Sci, Kyoto 6110011, Japan; [Nakatsubo, Tomoyuki; Hattori, Takefumi; Umezawa, Toshiaki] Kyoto Univ, Res Inst Sustainable Humanosphere, Kyoto 6110011, Japan	Kyoto University; Kyoto University; Kyoto University		tumezawa@rish.kyoto-u.ac.jp	Suzuki, Shiro/P-5830-2019	Mizutani, Masaharu/0000-0002-4321-0644				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Davin Laurence B., 2003, Phytochemistry Reviews, V2, P257, DOI 10.1023/B:PHYT.0000046175.83729.b5; DINCOVAKOSTOVA AT, 1996, J BIOL CHEM, V271, P29473; Fujita M, 1999, J BIOL CHEM, V274, P618, DOI 10.1074/jbc.274.2.618; Hemmati S, 2007, FEBS LETT, V581, P603, DOI 10.1016/j.febslet.2007.01.018; Kai K, 2006, PHYTOCHEMISTRY, V67, P379, DOI 10.1016/j.phytochem.2005.11.006; Li LG, 2001, PLANT CELL, V13, P1567, DOI 10.1105/tpc.13.7.1567; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; MACRAE WD, 1984, PHYTOCHEMISTRY, V23, P1207, DOI 10.1016/S0031-9422(00)80428-8; Moss GP, 2000, PURE APPL CHEM, V72, P1493, DOI 10.1351/pac200072081493; Okunishi T, 2000, J WOOD SCI, V46, P234, DOI 10.1007/BF00776455; Ono E, 2006, P NATL ACAD SCI USA, V103, P10116, DOI 10.1073/pnas.0603865103; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Sakakibara N, 2007, ORG BIOMOL CHEM, V5, P802, DOI 10.1039/b616705e; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Suzuki S, 2007, J WOOD SCI, V53, P273, DOI 10.1007/s10086-007-0892-x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Umezawa T., 2001, Regulation of Plant Growth & Development, V36, P57; Umezawa T., 1997, Wood Research, P62; UMEZAWA T, 1994, BIOSCI BIOTECH BIOCH, V58, P230, DOI 10.1271/bbb.58.230; Umezawa Toshiaki, 2003, Wood Research, P27; Umezawa Toshiaki, 2003, Phytochemistry Reviews, V2, P371, DOI 10.1023/B:PHYT.0000045487.02836.32; von Heimendahl CBI, 2005, PHYTOCHEMISTRY, V66, P1254, DOI 10.1016/j.phytochem.2005.04.026	23	91	96	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					15550	15557		10.1074/jbc.M801131200	http://dx.doi.org/10.1074/jbc.M801131200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18347017	Green Published, hybrid			2022-12-25	WOS:000256332500008
J	Mihelic, M; Dobersek, A; Guncar, G; Turk, D				Mihelic, Marko; Dobersek, Andreja; Guncar, Gregor; Turk, Dusan			Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine ceathepsins in antigen presentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING ENZYME-INHIBITORS; HUMAN CATHEPSIN V; CRYSTAL-STRUCTURE; DENDRITIC CELLS; GENE-PRODUCT; MACROPHAGES; PROTEASE; COMPLEX; PROTEOLYSIS; EXPRESSION	Cysteine cathepsins play an indispensable role in proteolytic processing of the major histocompatibility complex class II-associated invariant chain (Ii) and foreign antigens in a number of antigen presenting cells. Previously it was shown that a fragment of 64 residues present in the p41 form of the Ii (p41 fragment) selectively inhibits the endopeptidase cathepsin L, whereas the activity of cathepsin S remains unaffected. Comparison of structures indicated that the selectivity of interactions between cysteine cathepsins and the p41 fragment is far from being understood and requires further investigation. The p41 fragment has now been shown also to inhibit human cathepsins V, K, and F (also, presumably, O) and mouse cathepsin L with K-i values in the low nanomolar range. These K-i values are sufficiently low to ensure complex formation at physiological concentrations. In addition we have found that the p41 fragment can inhibit cathepsin S too. These findings suggest that regulation of the proteolytic activity of most of the cysteine cathepsins by the p41 fragment is an important and widespread control mechanism of antigen presentation.	[Mihelic, Marko; Dobersek, Andreja; Guncar, Gregor; Turk, Dusan] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, SL-1000 Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Turk, D (corresponding author), Jamova 39, SL-1000 Ljubljana, Slovenia.	dusan.turk@ijs.si		Turk, Dusan/0000-0003-0205-6609; Guncar, Gregor/0000-0003-4500-6951				Antoniou AN, 2000, IMMUNITY, V12, P391, DOI 10.1016/S1074-7613(00)80191-0; ARUNACHALAM B, 1994, INT IMMUNOL, V6, P439, DOI 10.1093/intimm/6.3.439; Bevec T, 1996, J EXP MED, V183, P1331, DOI 10.1084/jem.183.4.1331; Boes M, 2005, EUR J IMMUNOL, V35, P2552, DOI 10.1002/eji.200526323; Bromme D, 1999, BIOCHEMISTRY-US, V38, P2377, DOI 10.1021/bi982175f; Bryant P, 2004, CURR OPIN IMMUNOL, V16, P96, DOI 10.1016/j.coi.2003.11.011; Chapman HA, 2006, CURR OPIN IMMUNOL, V18, P78, DOI 10.1016/j.coi.2005.11.011; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; El-Sukkari D, 2003, J IMMUNOL, V171, P5003, DOI 10.4049/jimmunol.171.10.5003; Fiebiger E, 2002, J EXP MED, V196, P1263, DOI 10.1084/jem.20020762; FINESCHI B, 1995, P NATL ACAD SCI USA, V92, P10257, DOI 10.1073/pnas.92.22.10257; GRECO WR, 1979, J BIOL CHEM, V254, P2104; Guncar G, 1999, EMBO J, V18, P793, DOI 10.1093/emboj/18.4.793; Hsieh CS, 2002, J IMMUNOL, V168, P2618, DOI 10.4049/jimmunol.168.6.2618; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; KAMPGEN E, 1991, P NATL ACAD SCI USA, V88, P3014, DOI 10.1073/pnas.88.8.3014; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Langerholc T, 2005, FEBS J, V272, P1535, DOI 10.1111/j.1742-4658.2005.04594.x; Lennon-Dumenil AM, 2001, EMBO J, V20, P4055, DOI 10.1093/emboj/20.15.4055; McGrath ME, 1997, NAT STRUCT BIOL, V4, P105, DOI 10.1038/nsb0297-105; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mihelic M, 2007, BIOL CHEM, V388, P1123, DOI 10.1515/BC.2007.155; Mihelic M, 2006, FEBS LETT, V580, P4195, DOI 10.1016/j.febslet.2006.06.076; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P105; MUNO D, 1990, EUR J BIOCHEM, V191, P91, DOI 10.1111/j.1432-1033.1990.tb19097.x; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P12648, DOI 10.1021/bi991371z; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Nakagawa TY, 1999, IMMUNOL REV, V172, P121, DOI 10.1111/j.1600-065X.1999.tb01361.x; OGRINC T, 1993, FEBS LETT, V336, P555, DOI 10.1016/0014-5793(93)80875-U; Onishi K, 2004, MICROBES INFECT, V6, P468, DOI 10.1016/j.micinf.2004.01.008; Oorni K, 2004, J BIOL CHEM, V279, P34776, DOI 10.1074/jbc.M310814200; PETERSON M, 1992, NATURE, V357, P596, DOI 10.1038/357596a0; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Riese RJ, 2000, CURR OPIN IMMUNOL, V12, P107, DOI 10.1016/S0952-7915(99)00058-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 2001, MOL CLONING; Shi GP, 2000, J EXP MED, V191, P1177, DOI 10.1084/jem.191.7.1177; Somoza JR, 2002, J MOL BIOL, V322, P559, DOI 10.1016/S0022-2836(02)00780-5; Somoza JR, 2000, BIOCHEMISTRY-US, V39, P12543, DOI 10.1021/bi000951p; STRUBIN M, 1986, EMBO J, V5, P3483, DOI 10.1002/j.1460-2075.1986.tb04673.x; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Tolosa E, 2003, J CLIN INVEST, V112, P517, DOI 10.1172/JCI200318028; Turk B, 2002, CURR PHARM DESIGN, V8, P1623, DOI 10.2174/1381612023394124; Turk D, 2003, ACTA CRYSTALLOGR D, V59, P203, DOI 10.1107/S0907444902021479; Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570; TURK D, 1992, THESIS TU MUENCHEN G; Turk V, 2002, ADV ENZYME REGUL, V42, P285, DOI 10.1016/S0065-2571(01)00034-6; Turkenburg JP, 2002, ACTA CRYSTALLOGR D, V58, P451, DOI 10.1107/S0907444901021825; VELASCO G, 1994, J BIOL CHEM, V269, P27136; Villadangos JA, 2000, IMMUNITY, V12, P233, DOI 10.1016/S1074-7613(00)80176-4; Watts C, 2001, SCIENCE, V294, P1294, DOI 10.1126/science.1066725; Yasuda Y, 2004, J BIOL CHEM, V279, P36761, DOI 10.1074/jbc.M403986200; Zavasnik-Bergant V, 2004, IMMUNOLOGY, V112, P378, DOI 10.1111/j.1365-2567.2004.01879.x	54	71	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14453	14460		10.1074/jbc.M801283200	http://dx.doi.org/10.1074/jbc.M801283200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18362148	hybrid			2022-12-25	WOS:000255941400032
J	Shen, WH; Chen, Z; Shi, S; Chen, HY; Zhu, WQ; Penner, A; Bu, GX; Li, W; Boyle, DW; Rubart, M; Field, LJ; Abraham, R; Liechty, EA; Shou, WN				Shen, Wei-Hua; Chen, Zhuang; Shi, Shu; Chen, Hanying; Zhu, Wuqiang; Penner, Anne; Bu, Guixue; Li, Wei; Boyle, David W.; Rubart, Michael; Field, Loren J.; Abraham, Robert; Liechty, Edward A.; Shou, Weinian			Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mTOR-mediated signaling and cardiac function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; CARDIOMYOCYTE DNA-SYNTHESIS; S6 KINASE; PROTEIN-SYNTHESIS; IN-VIVO; HYPERTROPHY; ACTIVATION; INSULIN; GROWTH; MICE	Mammalian target of rapamycin (mTOR) is a key regulator for cell growth through modulating components of the translation machinery. Previously, numerous pharmacological studies using rapamycin suggested that mTOR has an important role in regulating cardiac hypertrophic growth. To further investigate this assumption, we have generated two lines of cardiac specific mTOR transgenic mice, kinase-dead (kd) mTOR and constitutively active (ca) mTOR, using alpha-myosin heavy chain promoter. alpha-Myosin heavy chain (alpha MHC)-mTOR(kd) mice had a near complete inhibition of p70 S6k and 4E-BP1 phosphorylation, whereas alpha MHC-mTOR(ca) had a significant increase in p70 S6k and 4E-BP1 phosphorylation. Although the cardiac function of alpha MHC-mTOR(kd) mice was significantly altered, the cardiac morphology of these transgenic mice was normal. The cardiac hypertrophic growth in response to physiological and pathological stimuli was not different in alpha MHC-mTOR(kd) and alpha MHC-mTOR(ca) transgenic mice when compared with that of nontransgenic litter-mates. These findings suggest that the mTOR-mediated signaling pathway is not essential to cardiac hypertrophic growth but is involved in regulating cardiac function. Additional analysis of cardiac responses to fasting-refeeding or acute insulin administration indicated that alpha MHC-mTOR(kd) mice had a largely impaired physiological response to nutrient energy supply and insulin stimulation.	[Shen, Wei-Hua; Chen, Zhuang; Shi, Shu; Chen, Hanying; Zhu, Wuqiang; Penner, Anne; Li, Wei; Boyle, David W.; Rubart, Michael; Field, Loren J.; Liechty, Edward A.; Shou, Weinian] Indiana Univ, Sch Med, Dept Pediat,Herman B Wells Ctr Pediat Res, Div Pediat Cardiol & Neonatol, Indianapolis, IN 46202 USA; [Abraham, Robert] Dept Oncol Discovery, Pearl River, NY 10965 USA; [Bu, Guixue] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Liechty, EA (corresponding author), Indiana Univ, Sch Med, Dept Pediat,Herman B Wells Ctr Pediat Res, Div Pediat Cardiol & Neonatol, Indianapolis, IN 46202 USA.	eliecht@iupui.edu; wshou@iupui.edu	Liechty, Edward A/AGN-4710-2022; Bu, Guixue/E-8291-2010; Bu, Guixue/B-1957-2010		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081092, R01HL075165, P01HL085098] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL085098-01A10003, R01 HL081092, P01 HL085098, R01 HL075165-03, R01 HL081092-01A2, R01 HL075165] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Belke DD, 2002, J CLIN INVEST, V109, P629, DOI 10.1172/JCI200213946; Boluyt MO, 1997, CIRC RES, V81, P176, DOI 10.1161/01.RES.81.2.176; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Chen H, 2006, J BIOL CHEM, V281, P27481, DOI 10.1074/jbc.M604818200; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Gerdes A M, 1998, J Card Fail, V4, P343, DOI 10.1016/S1071-9164(98)90240-8; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; GULICK J, 1991, J BIOL CHEM, V266, P9180; Ha TZ, 2005, FREE RADICAL BIO MED, V39, P1570, DOI 10.1016/j.freeradbiomed.2005.08.002; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; SADOSHIMA J, 1995, CIRC RES, V77, P1040, DOI 10.1161/01.RES.77.6.1040; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Sekulic A, 2000, CANCER RES, V60, P3504; Shen WH, 2005, J ENDOCRINOL, V185, P275, DOI 10.1677/joe.1.06080; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Soonpaa MH, 1998, CIRC RES, V83, P15, DOI 10.1161/01.RES.83.1.15; SOONPAA MH, 1994, AM J PHYSIOL, V266, pH1439, DOI 10.1152/ajpheart.1994.266.4.H1439; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; Wang LJ, 2000, AM J PHYSIOL-HEART C, V278, pH1056, DOI 10.1152/ajpheart.2000.278.4.H1056; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	35	52	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13842	13849		10.1074/jbc.M801510200	http://dx.doi.org/10.1074/jbc.M801510200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18326485	hybrid, Green Published			2022-12-25	WOS:000255728200037
J	Barbone, D; Yang, TM; Morgan, JR; Gaudino, G; Broaddus, VC				Barbone, Dario; Yang, Tsung-Ming; Morgan, Jeffrey R.; Gaudino, Giovanni; Broaddus, V. Courtney			Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURVIVAL; IN-VITRO; TUMOR; MTOR; AKT; AKT/PKB; KINASE; PATHWAY; INSULIN; STRESS	When grown as three-dimensional structures, tumor cells can acquire an additional multicellular resistance to apoptosis that may mimic the chemoresistance found in solid tumors. We developed a multicellular spheroid model of malignant mesothelioma to investigate molecular mechanisms of acquired apoptotic resistance. We found that mesothelioma cell lines, when grown as multicellular spheroids, acquired resistance to a variety of apoptotic stimuli, including combinations of tumor necrosis factor-related apoptosis-inducing ligand ( TRAIL), ribotoxic stressors, histone deacetylase, and proteasome inhibitors, that were highly effective against mesothelioma cells when grown as monolayers. Inhibitors of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin ( mTOR) pathway, particularly rapamycin, blocked much of the acquired resistance of the spheroids, suggesting a key role for mTOR. Knockdown by small interference RNA of S6K, a major downstream target of mTOR, reproduced the effect of rapamycin, thereby confirming the role of mTOR and of S6K in the acquired resistance of three-dimensional spheroids. Rapamycin or S6K knockdown increased TRAIL-induced caspase-8 cleavage in spheroids, suggesting initially that mTOR inhibited apoptosis by actions at the death receptor pathway; however, isolation of the apoptotic pathways by means of Bid knockdown ablated this effect showing that mTOR actually controls a step distal to Bid, probably at the level of the mitochondria. In sum, mTOR and S6K contribute to the apoptotic resistance of mesothelioma cells in three-dimensional, not in two-dimensional, cultures. The three-dimensional model may reflect a more clinically relevant in vitro setting in which mTOR exhibits anti-apoptotic properties.	[Barbone, Dario; Yang, Tsung-Ming; Broaddus, V. Courtney] Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, San Francisco, CA 94110 USA; [Gaudino, Giovanni] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci Chim Alimentari Farmaceut & Farm, I-28100 Novara, Italy; [Morgan, Jeffrey R.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Eastern Piedmont Amedeo Avogadro; Brown University	Broaddus, VC (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, 1001 Potrero Ave,Bldg 1,Rm 150, San Francisco, CA 94110 USA.	cbroaddus@medsfgh.ucsf.edu		Morgan, Jeffrey/0000-0002-7546-3443	NCI NIH HHS [R01 CA95671] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA095671] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abayasiriwardana KS, 2007, MOL CANCER THER, V6, P2766, DOI 10.1158/1535-7163.MCT-07-0278; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Altomare DA, 2005, ONCOGENE, V24, P6080, DOI 10.1038/sj.onc.1208744; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Broaddus VC, 2005, J BIOL CHEM, V280, P12486, DOI 10.1074/jbc.M408190200; Broaddus VC, 1996, J CLIN INVEST, V98, P2050, DOI 10.1172/JCI119010; Cacciotti P, 2005, CANCER RES, V65, P5256, DOI 10.1158/0008-5472.CAN-05-0127; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Edinger AL, 2003, CANCER RES, V63, P8451; Emanuele S, 2004, EUR J CANCER, V40, P1441, DOI 10.1016/j.ejca.2004.01.039; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Fennell DA, 2004, LANCET ONCOL, V5, P354, DOI 10.1016/S1470-2045(04)01492-5; Fracasso G, 2000, CRIT REV ONCOL HEMAT, V36, P159, DOI 10.1016/S1040-8428(00)00084-6; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; HARASAWA R, 1993, RES MICROBIOL, V144, P489, DOI 10.1016/0923-2508(93)90057-9; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kim KL, 2005, AM J RESP CELL MOL, V33, P541, DOI 10.1165/rcmb.2004-0355OC; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Liu M, 2005, CANCER RES, V65, P5325, DOI 10.1158/0008-5472.CAN-04-4589; Liu WH, 2001, AM J RESP CELL MOL, V25, P111, DOI 10.1165/ajrcmb.25.1.4472; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MANSBRIDGE JN, 1992, J CELL PHYSIOL, V151, P433, DOI 10.1002/jcp.1041510302; Michael CW, 1997, DIAGN CYTOPATHOL, V17, P272, DOI 10.1002/(SICI)1097-0339(199710)17:4<272::AID-DC7>3.0.CO;2-E; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Napolitano AP, 2007, TISSUE ENG, V13, P2087, DOI 10.1089/ten.2006.0190; Neuzil H, 2004, BIOCHEM BIOPH RES CO, V314, P186, DOI 10.1016/j.bbrc.2003.12.074; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Panner A, 2005, MOL CELL BIOL, V25, P8809, DOI 10.1128/MCB.25.20.8809-8823.2005; Reddy RM, 2007, APOPTOSIS, V12, P55, DOI 10.1007/s10495-006-0484-z; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Santini MT, 1999, PATHOBIOLOGY, V67, P148, DOI 10.1159/000028065; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sartore-Bianchi A, 2007, CLIN CANCER RES, V13, P5942, DOI 10.1158/1078-0432.CCR-07-0536; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Shen CX, 2007, MOL CELL BIOL, V27, P7007, DOI 10.1128/MCB.00290-07; Shi YJ, 2005, MOL CANCER THER, V4, P1533, DOI 10.1158/1535-7163.MCT-05-0068; Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242; Steele JPC, 2005, ANN ONCOL, V16, P345, DOI 10.1093/annonc/mdi094; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; TORRES IP, 1994, P NATL ACAD SCI USA, V91, P2081, DOI 10.1073/pnas.91.6.2081; Vivo C, 2003, J BIOL CHEM, V278, P25461, DOI 10.1074/jbc.M302161200; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Wang XM, 2005, MOL CELL BIOL, V25, P2558, DOI 10.1128/MCB.25.7.2558-2572.2005; Wendel HG, 2006, CANCER RES, V66, P7639, DOI 10.1158/0008-5472.CAN-06-0419; Wendel HG, 2004, CELL CYCLE, V3, P847; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; WHITAKER D, 1977, ACTA CYTOL, V21, P236	65	115	118	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13021	13030		10.1074/jbc.M709698200	http://dx.doi.org/10.1074/jbc.M709698200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18339627	hybrid, Green Published			2022-12-25	WOS:000255499800039
J	Riefler, GM; Dent, SYR; Schumacher, JM				Riefler, Gary M.; Dent, Sharon Y. R.; Schumacher, Jill M.			Tousled-mediated activation of Aurora B kinase does not require Tousled kinase activity in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS EMBRYOS; CHROMATIN ASSEMBLY FACTORS; HISTONE CHAPERONE ASF1; RNA-POLYMERASE-II; CHROMOSOME SEGREGATION; CELL-DIVISION; SERINE/THREONINE KINASE; DNA-DAMAGE; YEAST; PHOSPHORYLATION	The Aurora kinases comprise an evolutionarily conserved protein family that is required for a variety of cell division events, including spindle assembly, chromosome segregation, and cytokinesis. Emerging evidence suggests that once phosphorylated, a subset of Aurora substrates can enhance Aurora kinase activity. Our previous work revealed that the Caenorhabditis elegans Tousled-like kinase TLK-1 is a substrate and activator of the AIR-2 Aurora B kinase in vitro and that partial loss of TLK-1 enhances the mitotic defects of an air-2 mutant. However, given that these experiments were performed in vitro and with partial loss of function alleles in vivo, a necessary step forward in our understanding of the relationship between the Aurora B and Tousled kinases is to prove that TLK-1 expression is sufficient for Aurora B activation in vivo. Here, we report that heterologous expression of wild-type and kinase-inactive forms of TLK-1 suppresses the lethality of temperature-sensitive mutants of the yeast Aurora B kinase Ip11. Moreover, kinase-dead TLK-1 associates with and augments the activity of Ip11 in vivo. Together, these results provide critical and compelling evidence that Tousled has a bona fide kinase-independent role in the activation of Aurora B kinases in vivo.	[Riefler, Gary M.; Schumacher, Jill M.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; [Dent, Sharon Y. R.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Program Genes & Dev, Houston, TX 77030 USA; [Riefler, Gary M.; Dent, Sharon Y. R.; Schumacher, Jill M.] Univ Texas Houston, MD Anderson Canc Ctr, Ctr Excellence Epigenet Res, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Schumacher, JM (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Mol Genet, 1515 Holcombe Blvd,Unit 1006, Houston, TX 77030 USA.	jschumac@mdanderson.org	Dent, Sharon YR/F-1746-2011; Schumacher, Jill/B-2932-2012	Dent, Sharon YR/0000-0002-4824-3269; 	NCI NIH HHS [T32 CA009299 29, CA-16672] Funding Source: Medline; NICHD NIH HHS [T32 HD007325 21] Funding Source: Medline; NIGMS NIH HHS [R01 GM62181-06] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007325] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062181] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Carrera P, 2003, GENE DEV, V17, P2578, DOI 10.1101/gad.276703; CHAN CSM, 1993, GENETICS, V135, P677; Cheetham GMT, 2002, J BIOL CHEM, V277, P42419, DOI 10.1074/jbc.C200426200; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Ehsan H, 2004, PLANT PHYSIOL, V134, P1488, DOI 10.1104/pp.103.038117; Eissenberg JC, 2006, CURR OPIN GENET DEV, V16, P184, DOI 10.1016/j.gde.2006.02.004; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Groth A, 2003, EMBO J, V22, P1676, DOI 10.1093/emboj/cdg151; Hachet V, 2007, DEV CELL, V12, P531, DOI 10.1016/j.devcel.2007.02.015; Han ZB, 2005, CURR BIOL, V15, P894, DOI 10.1016/j.cub.2005.04.019; Han ZB, 2003, CURR BIOL, V13, P1921, DOI 10.1016/j.cub.2003.10.035; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Katayama H, 2001, J BIOL CHEM, V276, P46219, DOI 10.1074/jbc.M107540200; Ke YW, 2003, CELL RES, V13, P69, DOI 10.1038/sj.cr.7290152; KOFF A, 1991, CELL, V66, P1217, DOI 10.1016/0092-8674(91)90044-Y; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Krause DR, 2003, ONCOGENE, V22, P5927, DOI 10.1038/sj.onc.1206691; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; Li JJ, 2006, PHARMACOL THERAPEUT, V111, P974, DOI 10.1016/j.pharmthera.2006.02.006; Li Y, 2001, ONCOGENE, V20, P726, DOI 10.1038/sj.onc.1204147; Li Z, 2007, J CELL SCI, V120, P3883, DOI 10.1242/jcs.007955; Nguyen HG, 2006, J CELL PHYSIOL, V208, P12, DOI 10.1002/jcp.20565; Pascreau G, 2005, J BIOL CHEM, V280, P13415, DOI 10.1074/jbc.M410584200; Petersen J, 2001, J CELL SCI, V114, P4371; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Portier N, 2007, DEV CELL, V12, P515, DOI 10.1016/j.devcel.2007.01.019; Roe JL, 1997, PLANT CELL, V9, P335, DOI 10.1105/tpc.9.3.335; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; Sillje HHW, 1999, EMBO J, V18, P5691, DOI 10.1093/emboj/18.20.5691; Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032; Walter AO, 2000, ONCOGENE, V19, P4906, DOI 10.1038/sj.onc.1203847; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706	46	10	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12763	12768		10.1074/jbc.M709034200	http://dx.doi.org/10.1074/jbc.M709034200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18334486	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000255499800012
J	Chen, H; He, XJ; Wang, Z; Wu, D; Zhang, HY; Xu, CP; He, HB; Cui, LX; Ba, DN; He, W				Chen, Hui; He, Xiaojuan; Wang, Zhun; Wu, Di; Zhang, Huiyuan; Xu, Chunping; He, Hongbin; Cui, Lianxian; Ba, Denian; He, Wei			Identification of human T cell receptor gamma delta-recognized epitopes/proteins via CDR3 delta peptide-based immunobiochemical strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA MISMATCH REPAIR; TUMOR-CELLS; NK CYTOTOXICITY; CANCER; HMSH2; PROTEINS; HEAT-SHOCK-PROTEIN-70; INVOLVEMENT; EXPRESSION; INDUCTION	Human T lymphocytes, bearing T cell receptor (TCR) gamma delta, play an important role in anti-tumor/microbe immune responses. However, few tumor antigens recognized by TCR gamma delta have been defined so far. To investigate antigenic epitopes/proteins recognized by gamma delta T cells, we have established a new immunobiochemical strategy that uses complementarity-determining region 3 of TCR delta chain (CDR3 delta) peptide-mediated epitope/protein-binding assays. CDR3 delta peptides synthesized using the CDR3 region in TCR V delta 2 chain were validated for their binding specificity to target cells or tissues. These CDR3 delta peptides were then employed as probes to pan putative epitopes in a 12-mer random peptide phage-displayed library and to identify putative protein ligands within tumor protein extracts by affinity chromatography and liquid chromatography/electrospray ionizationtandem mass spectrometry analysis. As a result, we have identified nine peptides and two proteins for TCR gamma delta, including human mutS homolog 2 ( hMSH2) and heat shock protein (HSP) 60. All nine tested epitope peptides not only bind to gamma delta T cells but also functionally activate gamma delta T cells in vitro. Identification of HSP60 confirms the validity of this method as HSP60 is an identified ligand for TCR gamma delta. We show that hMSH2 is expressed on the surface of SKOV3 tumor cells, and cytotoxicity of V delta 2 gamma delta T cells to SKOV3 cells was blocked by anti-hMSH2 antibody, suggesting that hMSH2 may be a new ligand for TCR gamma delta. Taken together, our findings provide a novel immunobiochemical strategy to identify epitopes/proteins recognized by gamma delta T cells.	[He, Wei] Peking Union Med Coll, Natl Key Lab Med Mol Biol, Sch Basic Med, Beijing 100005, Peoples R China; Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	He, W (corresponding author), Peking Union Med Coll, Natl Key Lab Med Mol Biol, Sch Basic Med, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	heweiimu@public.bta.net.cn	Zhang, Huiyuan/J-2784-2016					Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Cao W, 2004, IMMUNOBIOLOGY, V209, P283, DOI 10.1016/j.imbio.2004.04.008; Cao W, 2007, J BIOL CHEM, V282, P18922, DOI 10.1074/jbc.M702504200; Chen Y, 2001, CANCER RES, V61, P4112; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Dangles-Marie V, 2003, CANCER RES, V63, P3682; Davies A, 2004, J IMMUNOL, V172, P6828, DOI 10.4049/jimmunol.172.11.6828; Davis MM, 1997, CIBA F SYMP, V204, P94; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Holtmeier Wolfgang, 2005, V86, P151, DOI 10.1159/000086659; Jung CY, 2006, CANCER EPIDEM BIOMAR, V15, P762, DOI 10.1158/1055-9965.EPI-05-0834; Kabelitz D, 2007, CANCER RES, V67, P5, DOI 10.1158/0008-5472.CAN-06-3069; KAKEDA K, 1991, J BIOCHEM, V110, P583, DOI 10.1093/oxfordjournals.jbchem.a123623; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kunzmann V, 2000, BLOOD, V96, P384; Laad AD, 1999, INT J CANCER, V80, P709, DOI 10.1002/(SICI)1097-0215(19990301)80:5<709::AID-IJC14>3.3.CO;2-I; Maeurer MJ, 1996, J EXP MED, V183, P1681, DOI 10.1084/jem.183.4.1681; Mitchell RJ, 2002, AM J EPIDEMIOL, V156, P885, DOI 10.1093/aje/kwf139; Novellino L, 2005, CANCER IMMUNOL IMMUN, V54, P187, DOI 10.1007/s00262-004-0560-6; Rakheja D, 2005, PEDIATR DEVEL PATHOL, V8, P615, DOI 10.1007/s10024-005-0148-y; Samimi G, 2000, CLIN CANCER RES, V6, P1415; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Seifert M, 2006, J MOL HISTOL, V37, P301, DOI 10.1007/s10735-006-9062-5; Spagnoletti I, 2004, ONCOL REP, V11, P845; Srivastava P K, 1991, Semin Immunol, V3, P57; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Thomas ML, 2000, CANCER IMMUNOL IMMUN, V48, P653, DOI 10.1007/s002620050014; Todryk SM, 2003, IMMUNOLOGY, V110, P1, DOI 10.1046/j.1365-2567.2003.01725.x; Viey E, 2005, J IMMUNOL, V174, P1338, DOI 10.4049/jimmunol.174.3.1338; Wei YQ, 1996, CANCER RES, V56, P1104; Xu CP, 2007, MOL IMMUNOL, V44, P302, DOI 10.1016/j.molimm.2006.03.010; Zhang HY, 2005, IMMUNOL INVEST, V34, P453, DOI 10.1080/08820130500265349; Zhao JP, 2006, BIOCHEM BIOPH RES CO, V339, P232, DOI 10.1016/j.bbrc.2005.10.198	36	53	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12528	12537		10.1074/jbc.M708067200	http://dx.doi.org/10.1074/jbc.M708067200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321859	hybrid			2022-12-25	WOS:000255340000069
J	Zhang, B; Dong, YL; Zhang, GH; Moir, RD; Xia, WM; Yue, Y; Tian, M; Culley, DJ; Crosby, G; Tanzi, RE; Xie, ZC				Zhang, Bin; Dong, Yuanlin; Zhang, Guohua; Moir, Robert D.; Xia, Weiming; Yue, Yun; Tian, Ming; Culley, Deborah J.; Crosby, Gregory; Tanzi, Rudolph E.; Xie, Zhongcong			The inhalation anesthetic desflurane induces caspase activation and increases amyloid beta-protein levels under hypoxic conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-DEATH; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; SECRETASE ACTIVITY; APOPTOSIS; PRESENILIN; PEPTIDE; GAMMA; ISOFLURANE; CLEAVAGE	Perioperative factors including hypoxia, hypocapnia, and certain anesthetics have been suggested to contribute to Alzheimer disease (AD) neuropathogenesis. Desflurane is one of the most commonly used inhalation anesthetics. However, the effects of desflurane on AD neuropathogenesis have not been previously determined. Here, we set out to assess the effects of desflurane and hypoxia on caspase activation, amyloid precursor protein (APP) processing, and amyloid beta-protein (A beta) generation in H4 human neuroglioma cells (H4 naive cells) as well as those over-expressing APP (H4-APP cells). Neither 12% desflurane nor hypoxia (18% O-2) alone affected caspase-3 activation, APP-processing, and A beta generation. However, treatment with a combination of 12% desflurane and hypoxia (18% O-2) (desflurane/hypoxia) for 6 h induced caspase-3 activation, altered APP processing, and increased A beta generation in H4-APP cells. Desflurane/hypoxia also increased levels of beta-site APP-cleaving enzyme in H-4-APP cells. In addition, desflurane/hypoxia-induced A beta generation could be reduced by the broad caspase inhibitor benzyloxycarbonyl- VAD. Finally, the A beta aggregation inhibitor clioquinol and gamma-secretase inhibitor L-685,458 attenuated caspase-3 activation induced by desflurane/ hypoxia. In summary, desflurane can induce A beta production and caspase activation, but only in the presence of hypoxia. Pending in vivo confirmation, these data may have profound implications for anesthesia care in elderly patients, and especially those with AD.	[Zhang, Bin; Dong, Yuanlin; Zhang, Guohua; Yue, Yun; Tanzi, Rudolph E.; Xie, Zhongcong] Harvard Univ, Sch Med, Massachusetts Gen Hosp,MassGen Inst Neurodegenera, Genet & Aging Res Unit,Dept Neurol, Charlestown, MA 02129 USA; [Zhang, Bin; Dong, Yuanlin; Zhang, Guohua; Xie, Zhongcong] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA; [Zhang, Bin; Dong, Yuanlin; Zhang, Guohua; Xie, Zhongcong] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Zhang, Bin; Tian, Ming] Capital Med Univ, Dept Anesthesia, Beijing Friendship Hosp, Beijing 100050, Peoples R China; [Zhang, Guohua] China Med Univ, Fac Forens Med, Dept Forens Pathol, Shenyang 110001, Peoples R China; [Xia, Weiming; Culley, Deborah J.; Crosby, Gregory] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Xia, Weiming] Harvard Inst Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Yue, Yun] Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesia, Beijing 100050, Peoples R China; [Culley, Deborah J.; Crosby, Gregory] Brigham & Womens Hosp, Dept Anesthesia, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Capital Medical University; China Medical University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Capital Medical University; Harvard University; Brigham & Women's Hospital	Tanzi, RE (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp,MassGen Inst Neurodegenera, Genet & Aging Res Unit,Dept Neurol, 114 16th St,C3009, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu; zxie@partners.org	Tanzi, Rudolph/AAE-9622-2019; Crosby, Gregory/N-6578-2019; xia, weiming/E-5465-2016; Moir, Robert D./M-7612-2017	Tanzi, Rudolph/0000-0002-7032-1454; xia, weiming/0000-0002-7463-3295; Moir, Robert D./0000-0001-5431-3553; Dong, Yuanlin/0000-0002-4760-0519	NIGMS NIH HHS [R01 GM088801] Funding Source: Medline; NIMH NIH HHS [R37MH60009] Funding Source: Medline; NINDS NIH HHS [K08 NS048140] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048140] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOHNEN N, 1994, INT J NEUROSCI, V77, P181, DOI 10.3109/00207459408986029; BOHNEN NILJ, 1994, J AM GERIATR SOC, V42, P198, DOI 10.1111/j.1532-5415.1994.tb04952.x; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Florent S, 2006, J NEUROCHEM, V96, P385, DOI 10.1111/j.1471-4159.2005.03541.x; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Galli C, 1998, P NATL ACAD SCI USA, V95, P1247, DOI 10.1073/pnas.95.3.1247; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Grace EA, 2002, NEUROSCIENCE, V114, P265, DOI 10.1016/S0306-4522(02)00241-5; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Guo Q, 1997, J NEUROSCI, V17, P4212; Jendroska K, 1997, Ann N Y Acad Sci, V826, P401, DOI 10.1111/j.1749-6632.1997.tb48492.x; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; Kokmen E, 1996, NEUROLOGY, V46, P154, DOI 10.1212/WNL.46.1.154; Kriem B, 2004, FASEB J, V18, P85, DOI 10.1096/fj.04-1807fje; Kvolik S, 2005, LIFE SCI, V77, P2369, DOI 10.1016/j.lfs.2004.12.052; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LeBlanc A, 1995, J NEUROSCI, V15, P7837; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Lee TA, 2005, J ALZHEIMERS DIS, V7, P319; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Loop T, 2005, ANESTHESIOLOGY, V102, P1147, DOI 10.1097/00000542-200506000-00014; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Masliah E, 1998, J NEUROPATH EXP NEUR, V57, P1041, DOI 10.1097/00005072-199811000-00007; Matsuoka H, 2001, ANESTHESIOLOGY, V95, P1467, DOI 10.1097/00000542-200112000-00028; MURAVCHICK S, 1995, ANESTHESIOLOGY, V82, P305, DOI 10.1097/00000542-199501000-00039; Nagy Z, 1997, J NEUROPATH EXP NEUR, V56, P165, DOI 10.1097/00005072-199702000-00007; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Pillot T, 1999, J NEUROCHEM, V73, P1626, DOI 10.1046/j.1471-4159.1999.0731626.x; Raina AK, 2003, PROG NEURO-PSYCHOPH, V27, P251, DOI 10.1016/S0278-5846(03)00020-4; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sodhi CP, 2004, MOL BRAIN RES, V128, P201, DOI 10.1016/j.molbrainres.2004.06.012; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Sponne I, 2003, J BIOL CHEM, V278, P3437, DOI 10.1074/jbc.M206745200; Steiner H, 2002, J BIOL CHEM, V277, P39062, DOI 10.1074/jbc.C200469200; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tesco G, 2003, J BIOL CHEM, V278, P46074, DOI 10.1074/jbc.M307809200; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2005, J MOL NEUROSCI, V25, P67, DOI 10.1385/JMN:25:1:067; Xie ZC, 2005, J BIOL CHEM, V280, P15413, DOI 10.1074/jbc.M414353200; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Xie ZC, 2006, J GERONTOL A-BIOL, V61, P1300, DOI 10.1093/gerona/61.12.1300; Xie ZC, 2004, NEURODEGENER DIS, V1, P29, DOI 10.1159/000076667; Yang FS, 1998, AM J PATHOL, V152, P379; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	58	78	88	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11866	11875		10.1074/jbc.M800199200	http://dx.doi.org/10.1074/jbc.M800199200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326038	Green Published, hybrid			2022-12-25	WOS:000255340000002
J	Cheong, JK; Gunaratnam, L; Hsu, SIH				Cheong, Jit Kong; Gunaratnam, Lakshman; Hsu, Stephen I-Hong			CRM1-mediated nuclear export is required for 26 S proteasome-dependent degradation of the TRIP-Br2 proto-oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; BR FAMILY; IN-VIVO; CYCLIN; SIGNAL; E2F; UBIQUITIN; DOMAIN; LOCALIZATION; PROTEINS	Overexpression of the proto-oncogene TRIP-Br2 (SERTAD2) has been shown to induce E2F activity and promote tumorigenesis, whereas ablation of TRIP-Br2 arrests cell proliferation. Timely degradation of many cell cycle regulators is fundamental to the maintenance of proper cell cycle progression. Here we report novel mechanism(s) that govern the tight regulation of TRIP-Br2 levels during cell cycle progression. TRIP-Br2 was observed to be a short-lived protein in which the expression level peaks at the G(1)/S boundary. TRIP-Br2 accumulated in cells treated with 26 S proteasome inhibitors. Co-immunoprecipitation studies revealed that TRIP-Br2 forms ubiquitin conjugates. In silico analysis identified a putative leucine-rich nuclear export signal (NES) motif that overlaps with the PHD-Bromo interaction domain in the acidic C-terminal transactivation domain (TAD) of TRIP-Br2. This NES motif is highly conserved in widely divergent species and in all TRIP-Br family members. TRIP-Br2 was shown to be stabilized in G(2)/M phase cells through nuclear entrapment, either by deletion of the acidic C-terminal TAD, which includes the NES motif, or by leptomycin B-mediated inhibition of the CRM1-dependent nuclear export machinery. Mutation of leucine residue 238 of this NES motif abolished the interaction between CRM1 and TRIP-Br2, as well as the nuclear export of TRIP- Br2 and its subsequent 26 S proteasome-dependent degradation. These data suggest that CRM1-mediated nuclear export may be required for the proper execution of ubiquitin-proteasome-dependent degradation of TRIP- Br2.	[Cheong, Jit Kong; Hsu, Stephen I-Hong] Univ Florida, Coll Med, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32610 USA; [Cheong, Jit Kong; Gunaratnam, Lakshman; Hsu, Stephen I-Hong] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Cheong, Jit Kong; Gunaratnam, Lakshman; Hsu, Stephen I-Hong] Harvard Univ, Sch Med, Boston, MA 02115 USA	State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hsu, SIH (corresponding author), Univ Florida, Coll Med, Div Nephrol Hypertens & Transplantat, 1600 SW Archer Rd,Rm NG-4A,POB 100224, Gainesville, FL 32610 USA.	Stephen.Hsu@medicine.ufl.edu	Gunaratnam, Lakshman/G-3299-2011	Gunaratnam, Lakshman/0000-0002-8845-1126				BARINAGA M, 1995, SCIENCE, V269, P631, DOI 10.1126/science.7624789; BARRETT AJ, 1992, ANN NY ACAD SCI, V674, P1; Bennetts JS, 2006, GENE, V374, P153, DOI 10.1016/j.gene.2006.01.027; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Calgaro S, 2002, GENETICS, V160, P547; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Craig E, 2002, EMBO J, V21, P31, DOI 10.1093/emboj/21.1.31; Darwish H, 2007, ONCOGENE, V26, P4319, DOI 10.1038/sj.onc.1210195; DYNLACHT BD, 1994, GENE DEV, V8, P1772, DOI 10.1101/gad.8.15.1772; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; GERACE L, 1995, CELL, V82, P341, DOI 10.1016/0092-8674(95)90420-4; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Hayashi R, 2006, J BIOL CHEM, V281, P35633, DOI 10.1074/jbc.M603800200; Heerklotz D, 2001, MOL CELL BIOL, V21, P1759, DOI 10.1128/MCB.21.5.1759-1768.2001; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hsu SIH, 2001, EMBO J, V20, P2273, DOI 10.1093/emboj/20.9.2273; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; Kim FJ, 1996, MOL CELL BIOL, V16, P5147; Kobayashi T, 2001, J VIROL, V75, P3404, DOI 10.1128/JVI.75.7.3404-3412.2001; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Krek W, 1995, CELL, V83, P1149, DOI 10.1016/0092-8674(95)90141-8; Lai IL, 2007, GENE, V388, P102, DOI 10.1016/j.gene.2006.10.008; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Sim KG, 2004, CELL CYCLE, V3, P1296, DOI 10.4161/cc.3.10.1157; Sim KG, 2006, CELL CYCLE, V5, P1111, DOI 10.4161/cc.5.10.2797; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Sugimoto M, 1999, GENE DEV, V13, P3027, DOI 10.1101/gad.13.22.3027; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; Watanabe-Fukunaga R, 2005, GENES CELLS, V10, P851, DOI 10.1111/j.1365-2443.2005.00881.x; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; XU M, 1994, MOL CELL BIOL, V14, P8420, DOI 10.1128/MCB.14.12.8420; Zang ZJ, 2007, CANCER BIOL THER, V6, P712, DOI 10.4161/cbt.6.5.3964	41	9	13	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11661	11676		10.1074/jbc.M708365200	http://dx.doi.org/10.1074/jbc.M708365200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18316374	hybrid			2022-12-25	WOS:000255067400067
J	Deudero, JJP; Caramelo, C; Castellanos, MC; Neria, F; Fernandez-Sanchez, R; Calabia, O; Penate, S; Gonzalez-Pacheco, FR				Deudero, Juan Jose P.; Caramelo, Carlos; Castellanos, Maria Carmen; Neria, Fernando; Fernandez-Sanchez, Ruth; Calabia, Olalla; Penate, Silvia; Gonzalez-Pacheco, Francisco Roman			Induction of hypoxia-inducible factor 1 alpha gene expression by vascular endothelial growth factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE-OXYGEN; NAD(P)H OXIDASE; FACTOR-I; DEPENDENT REGULATION; MAP KINASE; CELLS; PATHWAY; TRANSCRIPTION; ANGIOGENESIS; MODULATION	Transcriptional regulation of vascular endothelial growth factor (VEGF) is critically dependent on hypoxia-inducible factor 1 (HIF-1). However, not only hypoxia, but selected growth factors can induce HIF-1. High levels of both VEGF and HIF-1 coexist in certain conditions, e. g. tumors. Nonetheless, the possibility that the stimulatory relationship between HIF-1 and VEGF may be bi-directional has not been addressed up to date. The present study in endothelial cells analyzed whether HIF-1 is regulated by a product of its own transcriptionally activated genes, namely, VEGF. As a main finding, VEGF-A165 induced the increase of HIF-1 alpha mRNA and HIF-1 alpha protein and nuclear translocation. Autologous endothelial cell VEGF mRNA and protein were also increased upon exposure to exogenous VEGF. The signaling implication of reactive oxygen species was examined by comparison with H2O2 and hypoxanthine/xanthine oxidase and by the superoxide dismutase mimetic, MnTMPyP, the Rac1-NAD(P) H oxidase complex inhibitor, apocynin, transfection of a dominant negative Rac1 mutant, and transfection of a p67phox antisense oligonucleotide. Superoxide anion, largely dependent on Rac1-NAD(P) H oxidase complex activity, was the critical signaling element. The transductional functionality of the pathway was confirmed by means of a reporter gene flanked by a transcription site-related VEGF sequence and by quantitative PCR. In summary, the present results reveal a previously undescribed action of VEGF on the expression of its own transcription factor, HIF-1, and on VEGF itself. This effect is principally mediated by superoxide anion, therefore identifying a new, potentially relevant role of reactive oxygen species in VEGF signaling.	[Deudero, Juan Jose P.; Caramelo, Carlos; Neria, Fernando; Fernandez-Sanchez, Ruth; Calabia, Olalla; Penate, Silvia; Gonzalez-Pacheco, Francisco Roman] Univ Autonoma Madrid, Lab Nefrol Hipertens, Fdn Jimenez Diaz Capio, Madrid 28040, Spain; [Castellanos, Maria Carmen] Univ Autonoma Madrid, Serv Inmunol, Hosp Princesa, Madrid 28040, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Hospital de La Princesa	Gonzalez-Pacheco, FR (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super,Tarry Bldg 4-750-752, Chicago, IL 60611 USA.	fromanglez@gmail.com	Deudero, Juan/E-4345-2010; Gonzalez-Pacheco, Francisco/A-2934-2009	Gonzalez-Pacheco, Francisco/0000-0002-6243-5814; Pena Deudero, Juan Jose/0000-0002-0203-2247				Abdelrahman M, 2005, SHOCK, V23, P107, DOI 10.1097/01.shk.0000151028.15377.f7; Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Al-Shabrawey M, 2005, AM J PATHOL, V167, P599, DOI 10.1016/S0002-9440(10)63001-5; Arroyo MVA, 2002, TRANSPLANTATION, V74, P1618, DOI 10.1097/01.TP.0000041449.31360.16; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Castilla MA, 1999, CIRC RES, V85, P1132; Chatterjee PK, 2005, LANCET, V365, P1890, DOI 10.1016/S0140-6736(05)66622-6; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Feldser D, 1999, CANCER RES, V59, P3915; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fisher JW, 2003, EXP BIOL MED, V228, P1; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gonzalez-Pacheco FR, 2002, NEPHROL DIAL TRANSPL, V17, P392, DOI 10.1093/ndt/17.3.392; Gonzalez-Pacheco FR, 2006, AM J PHYSIOL-HEART C, V291, pH1395, DOI 10.1152/ajpheart.01277.2005; Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lu Q, 2007, J CELL PHYSIOL, V212, P827, DOI 10.1002/jcp.21079; Maulik N, 2002, ANTIOXID REDOX SIGN, V4, P805, DOI 10.1089/152308602760598963; Maxwell P, 2004, CANCER BIOL THER, V3, P29, DOI 10.4161/cbt.3.1.547; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; Millar TM, 2007, FREE RADICAL BIO MED, V42, P1165, DOI 10.1016/j.freeradbiomed.2007.01.015; Monteiro HP, 1996, FREE RADICAL BIO MED, V21, P323, DOI 10.1016/0891-5849(96)00051-2; Naranjo-Suarez S, 2003, J BIOL CHEM, V278, P31895, DOI 10.1074/jbc.M304079200; Richard DE, 2000, J BIOL CHEM, V275, P26765; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; Suda O, 2005, ARTERIOSCL THROM VAS, V25, P506, DOI 10.1161/01.ATV.0000153284.81572.f0; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Tacchini L, 2001, CARCINOGENESIS, V22, P1363, DOI 10.1093/carcin/22.9.1363; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Victoria M, 1998, J AM SOC NEPHROL, V9, P1998; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375, DOI 10.1152/ajpcell.2001.280.6.C1375; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zhong H, 2000, CANCER RES, V60, P1541; Zundel W, 2000, GENE DEV, V14, P391	49	39	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11435	11444		10.1074/jbc.M703875200	http://dx.doi.org/10.1074/jbc.M703875200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18305118	hybrid			2022-12-25	WOS:000255067400041
J	Jean, L; Lee, CF; Shaw, M; Vaux, DJ				Jean, Letitia; Lee, Chiu Fan; Shaw, Michael; Vaux, David J.			Structural Elements Regulating Amyloidogenesis: A Cholinesterase Model System	PLOS ONE			English	Article								Polymerization into amyloid fibrils is a crucial step in the pathogenesis of neurodegenerative syndromes. Amyloid assembly is governed by properties of the sequence backbone and specific side-chain interactions, since fibrils from unrelated sequences possess similar structures and morphologies. Therefore, characterization of the structural determinants driving amyloid aggregation is of fundamental importance. We investigated the forces involved in the amyloid assembly of a model peptide derived from the oligomerization domain of acetylcholinesterase (AChE), AChE(586-599), through the effect of single point mutations on beta-sheet propensity, conformation, fibrilization, surfactant activity, oligomerization and fibril morphology. AChE(586-599) was chosen due to its fibrilization tractability and AChE involvement in Alzheimer's disease. The results revealed how specific regions and residues can control AChE(586-599) assembly. Hydrophobic and/or aromatic residues were crucial for maintaining a high beta-strand propensity, for the conformational transition to beta-sheet, and for the first stage of aggregation. We also demonstrated that positively charged side-chains might be involved in electrostatic interactions, which could control the transition to beta-sheet, the oligomerization and assembly stability. Further interactions were also found to participate in the assembly. We showed that some residues were important for AChE(586-599) surfactant activity and that amyloid assembly might preferentially occur at an air-water interface. Consistently with the experimental observations and assembly models for other amyloid systems, we propose a model for AChE(586-599) assembly in which a steric-zipper formed through specific interactions (hydrophobic, electrostatic, cation-pi, SH-aromatic, metal chelation and polar-polar) would maintain the beta-sheets together. We also propose that the stacking between the strands in the beta-sheets along the fiber axis could be stabilized through pi-pi interactions and metal chelation. The dissection of the specific molecular recognition driving AChE(586-599) amyloid assembly has provided further knowledge on such poorly understood and complicated process, which could be applied to protein folding and the targeting of amyloid diseases.	[Jean, Letitia; Shaw, Michael; Vaux, David J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Lee, Chiu Fan] Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England	University of Oxford; University of Oxford	Jean, L (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	david.vaux@path.ox.ac.uk		Jean, Letitia/0000-0002-6450-7148; Vaux, David/0000-0002-4901-9795; Lee, Chiu Fan/0000-0003-4363-9050	Synaptica Ltd	Synaptica Ltd	This work was supported by a research grant from Synaptica Ltd.	Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2002, PEPTIDES, V23, P1343, DOI 10.1016/S0196-9781(02)00070-0; Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Bemporad F, 2006, PROTEIN SCI, V15, P862, DOI 10.1110/ps.051915806; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Chakkaravarthi S, 2006, POLYMER, V47, P709, DOI 10.1016/j.polymer.2005.11.059; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Claessens CG, 1997, J PHYS ORG CHEM, V10, P254, DOI 10.1002/(SICI)1099-1395(199705)10:5<254::AID-POC875>3.0.CO;2-3; Cottingham MG, 2004, LAB INVEST, V84, P523, DOI 10.1038/labinvest.3700054; Cottingham MG, 2003, BIOCHEMISTRY-US, V42, P10863, DOI 10.1021/bi034768i; Cottingham MG, 2002, BIOCHEMISTRY-US, V41, P13539, DOI 10.1021/bi0260334; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; de la Paz ML, 2005, J MOL BIOL, V349, P583, DOI 10.1016/j.jmb.2005.03.081; Diamant S, 2006, P NATL ACAD SCI USA, V103, P8628, DOI 10.1073/pnas.0602922103; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gillard RE, 1997, CHEM-EUR J, V3, P1933, DOI 10.1002/chem.19970031208; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Jack E, 2006, J AM CHEM SOC, V128, P8098, DOI 10.1021/ja0581898; Jean L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000652; Jones CE, 2004, J BIOL CHEM, V279, P32018, DOI 10.1074/jbc.M403467200; KELLIS JT, 1991, BIO-TECHNOL, V9, P994, DOI 10.1038/nbt1091-994; Klimov DK, 2003, STRUCTURE, V11, P295, DOI 10.1016/S0969-2126(03)00031-5; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Kuner P, 2000, J BIOL CHEM, V275, P1673, DOI 10.1074/jbc.275.3.1673; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lin TY, 1996, PROTEIN SCI, V5, P372; Liu ST, 1999, BIOCHEMISTRY-US, V38, P9373, DOI 10.1021/bi990205o; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Massi F, 2002, PROTEIN SCI, V11, P1639, DOI 10.1110/ps.3150102; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Miura T, 2000, BIOCHEMISTRY-US, V39, P7024, DOI 10.1021/bi0002479; Naito A, 2004, MAGN RESON CHEM, V42, P247, DOI 10.1002/mrc.1323; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Paddock ML, 2005, BIOCHEMISTRY-US, V44, P9619, DOI 10.1021/bi050651d; Pal D, 2001, J BIOMOL STRUCT DYN, V19, P115, DOI 10.1080/07391102.2001.10506725; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Rees Tina M., 2005, Current Alzheimer Research, V2, P291, DOI 10.2174/1567205054367847; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Saez-Valero J, 1999, J NEUROCHEM, V72, P1600, DOI 10.1046/j.1471-4159.1999.721600.x; SALEMME FR, 1981, J MOL BIOL, V146, P101, DOI 10.1016/0022-2836(81)90368-5; Samanta U, 2000, PROTEINS, V38, P288, DOI 10.1002/(SICI)1097-0134(20000215)38:3<288::AID-PROT5>3.3.CO;2-Z; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; Shetty AS, 1996, J AM CHEM SOC, V118, P1019, DOI 10.1021/ja9528893; Sikorski P, 2003, STRUCTURE, V11, P915, DOI 10.1016/S0969-2126(03)00149-7; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; SMITH CK, 1995, SCIENCE, V270, P980, DOI 10.1126/science.270.5238.980; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tarus B, 2005, J MOL BIOL, V345, P1141, DOI 10.1016/j.jmb.2004.11.022; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; WOUTERS MA, 1995, PROTEINS, V22, P119, DOI 10.1002/prot.340220205; Wu C, 2005, BIOPHYS J, V88, P2897, DOI 10.1529/biophysj.104.055574; Yang DS, 2000, EUR J BIOCHEM, V267, P6692, DOI 10.1046/j.1432-1327.2000.01767.x; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Yoshida H, 2000, J BIOCHEM-TOKYO, V128, P271, DOI 10.1093/oxfordjournals.jbchem.a022750; Zahn R, 2003, J MOL BIOL, V334, P477, DOI 10.1016/j.jmb.2003.09.048; Zanuy D, 2004, PHYS BIOL, V1, P89, DOI 10.1088/1478-3967/1/2/005; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334	75	11	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1834	10.1371/journal.pone.0001834	http://dx.doi.org/10.1371/journal.pone.0001834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350169	Green Published, gold, Green Submitted			2022-12-25	WOS:000260762300035
J	Schmidt, RL; Trejo, TR; Plummer, TB; Platt, JL; Tang, AH				Schmidt, Rebecca L.; Trejo, Theodore R.; Plummer, Timothy B.; Platt, Jeffrey L.; Tang, Amy H.			Infection-induced proteolvsis of PGRP-LC controls the IMD activation and melanization cascades in	FASEB JOURNAL			English	Article						innate immunity; host defense; IAM signaling pathway; antimicrobial peptide	PEPTIDOGLYCAN-RECOGNITION PROTEIN; OUTER-MEMBRANE PROTEASE; GRAM-POSITIVE BACTERIA; DROSOPHILA IMMUNE-RESPONSE; TOLL-LIKE RECEPTORS; ESCHERICHIA-COLI; PATTERN-RECOGNITION; HOST-DEFENSE; INNATE IMMUNITY; MATRIX METALLOPROTEINASES	The Drosophila immune deficiency (IMD) pathway, homologous to the mammalian tumor necrosis factor (TNF-alpha) signaling pathway, initiates antimicrobial peptide (AMP) production in response to infection by grain-negative bacteria. A membrane-spanning peptidoglycan recognition protein, PGRP-LC, functions as the receptor for the IMD pathway. This receptor is activated via pattern recognition and binding of monomeric peptidoglycan (DAP-type PGN) through the PGRP ectodomain. In this article, we show that the receptor PGRP-LC is down-regulated in response to Salmonella/Escherichia coli infection but is not affected by Staphylococcus infection in vivo, and an ectodomain-deleted PGRP-LC lacking the PGRP domain is an active receptor. We show that the receptor PGRP-LC regulates and integrates two host defense systems: the AMP production and melanization. A working model is proposed in which pathogen invasion and tissue dairnage may be monitored through the receptor integrity of PGRP-LC after host and pathogen are engaged via pattern recognition. The irreversible cleavage or down-regulation of PGRP-LC may provide an additional cue for the host to distinguish pathogenic microbes from nonpathogenic ones and to subsequently activate multiple host defense systems in Drosophila, thereby effectively combating bacterial infection and initiating tissue repair.-Schmidt, R. L., Trejo, T. R., Plummer, T. B., Platt, J. L., Tang, AH. Infection-induced proteolysis of PGRP-LC controls the IMD activation and melanization cascades in Drosophila.	[Schmidt, Rebecca L.; Tang, Amy H.] Mayo Clin, Coll Med, Mayo Clin Canc Ctr, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Trejo, Theodore R.; Plummer, Timothy B.; Platt, Jeffrey L.; Tang, Amy H.] Mayo Clin, Coll Med, Mayo Clin Canc Ctr, Dept Surg, Rochester, MN 55905 USA; [Platt, Jeffrey L.] Mayo Clin, Coll Med, Mayo Clin Canc Ctr, Dept Immunol, Rochester, MN 55905 USA; [Platt, Jeffrey L.] Mayo Clin, Coll Med, Mayo Clin Canc Ctr, Dept Pediat, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Tang, AH (corresponding author), Mayo Clin, Coll Med, Mayo Clin Canc Ctr, Dept Biochem & Mol Biol, 200 1st St SW,Med Sci 2-85, Rochester, MN 55905 USA.	tang.amy@mayo.edu	Platt, Jeffrey/AHB-0480-2022; Tang, Amy/L-3226-2016	Platt, Jeffrey/0000-0002-4915-0419; Tang, Amy/0000-0002-5772-2878	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069922] Funding Source: NIH RePORTER; NIAID NIH HHS [AI53733] Funding Source: Medline; NIGMS NIH HHS [GM69922] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asha H, 2003, GENETICS, V163, P203; Ashida Masaaki, 1998, P135; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Beg AA, 2002, TRENDS IMMUNOL, V23, P509, DOI 10.1016/S1471-4906(02)02317-7; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bidla G, 2005, DEV COMP IMMUNOL, V29, P669, DOI 10.1016/j.dci.2004.11.007; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; Chaput C, 2007, MICROBES INFECT, V9, P637, DOI 10.1016/j.micinf.2007.01.022; CHASAN R, 1989, CELL, V56, P391, DOI 10.1016/0092-8674(89)90242-0; Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Coughlin SR, 2003, J CLIN INVEST, V111, P25, DOI 10.1172/JCI200317564; Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Dempsey LA, 2000, GLYCOBIOLOGY, V10, P467, DOI 10.1093/glycob/10.5.467; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Garver LS, 2006, P NATL ACAD SCI USA, V103, P660, DOI 10.1073/pnas.0506182103; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Gram H.C, 1884, FORTSCHRITTE MIKROCH, V2, P185; Green C, 2000, GENETICS, V156, P1117; Guina T, 2000, J BACTERIOL, V182, P4077, DOI 10.1128/JB.182.14.4077-4086.2000; Hashimoto C, 2003, DEV CELL, V5, P945, DOI 10.1016/S1534-5807(03)00338-1; Hu XD, 2004, P NATL ACAD SCI USA, V101, P9369, DOI 10.1073/pnas.0307062101; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Johnson GB, 2003, TRENDS IMMUNOL, V24, P19, DOI 10.1016/S1471-4906(02)00014-5; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Kramer RA, 2002, EUR J BIOCHEM, V269, P1746, DOI 10.1046/j.1432-1327.2002.02820.x; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; LACKIE AM, 1988, ADV INSECT PHYSL, V21, P1; Leclerc V, 2004, IMMUNOL REV, V198, P59, DOI 10.1111/j.0105-2896.2004.0130.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; LUNDRIGAN MD, 1992, FEMS MICROBIOL LETT, V97, P51; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McCarter JD, 2004, J BACTERIOL, V186, P5919, DOI 10.1128/JB.186.17.5919-5925.2004; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mellroth P, 2005, P NATL ACAD SCI USA, V102, P6455, DOI 10.1073/pnas.0407559102; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Ryan KJ., 2004, SHERRIS MED MICROBIO; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stumpe S, 1998, J BACTERIOL, V180, P4002, DOI 10.1128/JB.180.15.4002-4006.1998; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; TANG AH, 1995, J BIOL CHEM, V270, P13819, DOI 10.1074/jbc.270.23.13819; Tang AH, 2007, J LEUKOCYTE BIOL, V82, P282, DOI 10.1189/jlb.1206752; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Theopold U, 2002, CELL MOL LIFE SCI, V59, P363, DOI 10.1007/s00018-002-8428-4; Tingvall TO, 2001, EMBO REP, V2, P239; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Ulvatne H, 2002, J ANTIMICROB CHEMOTH, V50, P461, DOI 10.1093/jac/dkf156; Volanakis JE, 1998, HUMAN COMPLEMENT SYS, V20, P9, DOI DOI 10.1201/B14212-3; Wang LH, 2006, EMBO J, V25, P5005, DOI 10.1038/sj.emboj.7601363; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Werner T, 2003, J BIOL CHEM, V278, P26319, DOI 10.1074/jbc.C300184200; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601	85	48	52	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2008	22	3					918	929		10.1096/fj.06-7907com	http://dx.doi.org/10.1096/fj.06-7907com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	276LQ	18308747				2022-12-25	WOS:000254143700030
J	Michalski, CW; Maier, M; Erkan, M; Sauliunaite, D; Bergmann, F; Pacher, P; Batkai, S; Giese, NA; Giese, T; Friess, H; Kleeff, J				Michalski, Christoph W.; Maier, Milena; Erkan, Mert; Sauliunaite, Danguole; Bergmann, Frank; Pacher, Pal; Batkai, Sandor; Giese, Nathalia A.; Giese, Thomas; Friess, Helmut; Kleeff, Joerg			Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells	PLOS ONE			English	Article							MATRIX SYNTHESIS; POTENTIAL ROLE; PAIN; IDENTIFICATION; MECHANISMS; EXPRESSION; RECEPTORS; CYTOKINES; SYSTEM; CANCER	Background: While cannabinoids have been shown to ameliorate liver fibrosis, their effects in chronic pancreatitis and on pancreatic stellate cells (PSC) are unknown. Methodology/Principal Findings: The activity of the endocannabinoid system was evaluated in human chronic pancreatitis (CP) tissues. In vitro, effects of blockade and activation of cannabinoid receptors on pancreatic stellate cells were characterized. In CP, cannabinoid receptors were detected predominantly in areas with inflammatory changes, stellate cells and nerves. Levels of endocannabinoids were decreased compared with normal pancreas. Cannabinoid-receptor-1 antagonism effectuated a small PSC phenotype and a trend toward increased invasiveness. Activation of cannabinoid receptors, however, induced de-activation of PSC and dose-dependently inhibited growth and decreased IL-6 and MCP-1 secretion as well as fibronectin, collagen1 and alphaSMA levels. De-activation of PSC was partially reversible using a combination of cannabinoid-receptor-1 and -2 antagonists. Concomitantly, cannabinoid receptor activation specifically decreased invasiveness of PSC, MMP-2 secretion and led to changes in PSC phenotype accompanied by a reduction of intracellular stress fibres. Conclusions/Significance: Augmentation of the endocannabinoid system via exogenously administered cannabinoid receptor agonists specifically induces a functionally and metabolically quiescent pancreatic stellate cell phenotype and may thus constitute an option to treat inflammation and fibrosis in chronic pancreatitis.	[Michalski, Christoph W.; Erkan, Mert; Sauliunaite, Danguole; Friess, Helmut; Kleeff, Joerg] Tech Univ Munich, Dept Surg, Munich, Germany; [Michalski, Christoph W.; Maier, Milena; Giese, Nathalia A.] Heidelberg Univ, Dept General Surg, Heidelberg, Germany; [Bergmann, Frank] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Pacher, Pal; Batkai, Sandor] NIH, NIAAA, Lab Physiol Stud, Sect Oxidative Stress Tissue Injury, Bethesda, MD USA; [Giese, Thomas] Heidelberg Univ, Inst Immunol, Heidelberg, Germany	Technical University of Munich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Ruprecht Karls University Heidelberg	Michalski, CW (corresponding author), Tech Univ Munich, Dept Surg, Munich, Germany.	christoph.michalski@gmx.de	Kleeff, Jorg/B-2124-2009; Batkai, Sandor/G-3889-2010; Michalski, Christoph/U-9167-2019; Batkai, Sandor/H-7983-2014; Pacher, Pal/B-6378-2008	Kleeff, Jorg/0000-0003-3432-6669; Pacher, Pal/0000-0001-7036-8108	Postdoctoral Research Program, Heidelberg University; Intramural Research Program of the NIH/NIAAA [1Z01AA000375-01]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000375] Funding Source: NIH RePORTER	Postdoctoral Research Program, Heidelberg University; Intramural Research Program of the NIH/NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a Postdoctoral Research Program grant of Heidelberg University (to C.W.M) and in part by the Intramural Research Program of the NIH/NIAAA (#1Z01AA000375-01) to P.P. The funders had no role in the design and conduct of the study; neither did they influence collection, analysis and interpretation of the data or preparation, review or approval of the manuscript.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Apte MV, 2004, DIGEST DIS, V22, P273, DOI 10.1159/000082799; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Apte MV, 2003, PANCREAS, V27, P316, DOI 10.1097/00006676-200311000-00008; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; BOCKMAN DE, 1988, GASTROENTEROLOGY, V94, P1459; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Ceyhan GO, 2007, GUT, V56, P534, DOI 10.1136/gut.2006.105528; Correa F, 2005, MINI-REV MED CHEM, V5, P671, DOI 10.2174/1389557054368790; Di Marzo V, 2007, CHEM BIOL, V14, P741, DOI 10.1016/j.chembiol.2007.05.014; Di Sebastiano P, 2004, DIGEST DIS, V22, P267, DOI 10.1159/000082798; DiMagno MJ, 2006, CURR OPIN GASTROEN, V22, P487; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Esposito I, 2001, ZBL CHIR, V126, P867, DOI 10.1055/s-2001-19158; Friess H, 2003, J GASTROINTEST SURG, V7, P943, DOI 10.1016/j.gassur.2003.10.002; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Hartel M, 2003, LANGENBECK ARCH SURG, V388, P132, DOI 10.1007/s00423-003-0361-y; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Jaster R, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-26; Julien B, 2005, GASTROENTEROLOGY, V128, P742, DOI 10.1053/j.gastro.2004.12.050; Keleg S, 2007, INT J CANCER, V121, P21, DOI 10.1002/ijc.22596; Luttenberger T, 2000, LAB INVEST, V80, P47, DOI 10.1038/labinvest.3780007; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Meng ID, 1998, NATURE, V395, P381, DOI 10.1038/26481; Mews P, 2002, GUT, V50, P535, DOI 10.1136/gut.50.4.535; Michalski CW, 2008, INT J CANCER, V122, P742, DOI 10.1002/ijc.23114; Michalski CW, 2008, AM J PHYSIOL-GASTR L, V294, pG50, DOI 10.1152/ajpgi.00058.2007; Michalski CW, 2007, ANN SURG, V246, P786, DOI 10.1097/SLA.0b013e318070d56e; Michalski CW, 2007, GASTROENTEROLOGY, V132, P1968, DOI 10.1053/j.gastro.2007.02.035; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; PACHER P, 2006, PHARMACOL REV, V58, P1; Pacifici R, 2003, JAMA-J AM MED ASSOC, V289, P1929, DOI 10.1001/jama.289.15.1929-b; Pertwee RG, 2005, AAPS J, V7, pE625, DOI 10.1208/aapsj070364; Phillips PA, 2003, GUT, V52, P677, DOI 10.1136/gut.52.5.677; Phillips PA, 2003, GUT, V52, P275, DOI 10.1136/gut.52.2.275; Popow A, 2006, J PHYSIOL PHARMACOL, V57, P111; Schneider E, 2001, AM J PHYSIOL-CELL PH, V281, pC532, DOI 10.1152/ajpcell.2001.281.2.C532; Schwabe RF, 2005, HEPATOLOGY, V42, P975, DOI 10.1002/hep.20895; Shek FWT, 2002, AM J PATHOL, V160, P1787, DOI 10.1016/S0002-9440(10)61125-X; Shimizu K, 2005, GASTROENTEROLOGY, V128, P2105, DOI 10.1053/j.gastro.2005.03.025; SHIVERS SC, 1994, LIFE SCI, V54, P1281, DOI 10.1016/0024-3205(94)00856-6; Siegmund SV, 2005, HEPATOLOGY, V41, P1085, DOI 10.1002/hep.20667; Talukdar R, 2006, PANCREATOLOGY, V6, P440, DOI 10.1159/000094561; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; van Esch AAJ, 2006, DIGEST LIVER DIS, V38, P518, DOI 10.1016/j.dld.2006.02.002; Wang L, 2003, P NATL ACAD SCI USA, V100, P1393, DOI 10.1073/pnas.0336351100; Whitcomb DC, 2004, NAT CLIN PRACT GASTR, V1, P46, DOI 10.1038/ncpgasthep0025	51	42	45	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1701	10.1371/journal.pone.0001701	http://dx.doi.org/10.1371/journal.pone.0001701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301776	gold, Green Published, Green Submitted			2022-12-25	WOS:000260586500045
J	Neptune, ER; Podowski, M; Calvi, C; Cho, JH; Garcia, JGN; Tuder, R; Linnoila, RI; Tsai, MJ; Dietz, HC				Neptune, Enid R.; Podowski, Megan; Calvi, Carla; Cho, Jang-Hyeon; Garcia, Joe G. N.; Tuder, Rubin; Linnoila, R. Ilona; Tsai, Ming-Jer; Dietz, Harry C.			Targeted disruption of NeuroD, a proneural basic helix-loop-helix factor, impairs distal lung formation and neuroendocrine morphology in the neonatal lung	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROEPITHELIAL BODIES; AIRWAY EPITHELIUM; MOUSE MODEL; DIFFERENTIATION; CELLS; PROLIFERATION; PATHOGENESIS; GROWTH; MICE; LOCALIZATION	Despite the importance of airspace integrity in vertebrate gas exchange, the molecular pathways that instruct distal lung formation are poorly understood. Recently, we found that fibrillin-1 deficiency in mice impairs alveolar formation and recapitulates the pulmonary features of human Marfan syndrome. To further elucidate effectors involved in distal lung formation, we performed expression profiling analysis comparing the fibrillin1-deficient and wild-type developing lung. NeuroD, a basic helix-loop-helix transcription factor, fulfilled the expression criteria for a candidate mediator of distal lung development. We investigated its role in murine lung development using genetically targeted NeuroD-deficient mice. We found that NeuroD deficiency results in both impaired alveolar septation and altered morphology of the pulmonary neuroendocrine cells. NeuroD-deficient mice had enlarged alveoli associated with reduced epithelial proliferation in the airway and airspace compartments during development. Additionally, the neuroendocrine compartment in these mice manifested an increased number of neuroepithelial bodies but a reduced number of solitary pulmonary neuroendocrine cells in the neonatal lung. Overexpression of NeuroD in a murine lung epithelial cell line conferred a neuroendocrine phenotype characterized by the induction of neuroendocrine markers as well as increased proliferation. These results support an unanticipated role for NeuroD in the regulation of pulmonary neuroendocrine and alveolar morphogenesis and suggest an intimate connection between the neuroendocrine compartment and distal lung development.	[Neptune, Enid R.; Podowski, Megan; Calvi, Carla; Garcia, Joe G. N.] Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Neptune, Enid R.; Dietz, Harry C.] Johns Hopkins Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Dietz, Harry C.] Johns Hopkins Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Tuder, Rubin] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Linnoila, R. Ilona] NCI, Ctr Canc Res, Natl Inst Hlth, Bethesda, MD 20892 USA; [Cho, Jang-Hyeon; Tsai, Ming-Jer] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor College of Medicine	Neptune, ER (corresponding author), Johns Hopkins Univ, Sch Med, 1830 E Monument St,Rm 547, Baltimore, MD 21205 USA.	eneptune@jhmi.edu; hdietz@jhmi.edu	Garcia, Joe GN/E-8862-2010		Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [HL 69340, K08 HL 067980, R01 HL 66554, U01 HL 66583] Funding Source: Medline; NIAMS NIH HHS [AR 41135] Funding Source: Medline; NICHD NIH HHS [HD 17379] Funding Source: Medline; NIDDK NIH HHS [DK 45641] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017379, R37HD017379] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIASC000167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066554, K08HL067980, R01HL069340, U01HL066583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045641, R37DK045641] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ball DW, 2004, CANCER LETT, V204, P159, DOI 10.1016/S0304-3835(03)00452-X; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Borges M, 1997, NATURE, V386, P852, DOI 10.1038/386852a0; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Castro CM, 2000, LAB INVEST, V80, P1533, DOI 10.1038/labinvest.3780163; Cho JH, 2006, DEV BIOL, V290, P125, DOI 10.1016/j.ydbio.2005.11.024; Chu K, 2001, RECENT PROG HORM RES, V56, P23, DOI 10.1210/rp.56.1.23; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; CUTZ E, 1982, EXP LUNG RES, V3, P185, DOI 10.3109/01902148209069653; Dakhama A, 2004, CURR OPIN PHARMACOL, V4, P215, DOI 10.1016/j.coph.2004.01.006; DIFIGLIA M, 1989, J NEUROSCI, V9, P4158; EBINA M, 1993, ANAT REC, V236, P226, DOI 10.1002/ar.1092360127; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hiroshima K, 2006, MODERN PATHOL, V19, P1358, DOI 10.1038/modpathol.3800659; HOYT RF, 1991, AM J PHYSIOL, V260, pL234, DOI 10.1152/ajplung.1991.260.4.L234; HOYT RF, 1993, ANAT REC, V236, P15, DOI 10.1002/ar.1092360106; Itkin-Ansari P, 2005, DEV DYNAM, V233, P946, DOI 10.1002/dvdy.20443; Ito T, 2000, DEVELOPMENT, V127, P3913; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Kazanjian A, 2004, CANCER RES, V64, P6874, DOI 10.1158/0008-5472.CAN-04-0633; Kim WY, 2001, DEVELOPMENT, V128, P417; Lawlor DA, 2004, DIABETOLOGIA, V47, P195, DOI 10.1007/s00125-003-1310-6; Linnoila RI, 2007, LAB INVEST, V87, P336, DOI 10.1038/labinvest.3700527; Linnoila RI, 2006, LAB INVEST, V86, P425, DOI 10.1038/labinvest.3700412; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; MCDOWELL EM, 1994, CELL TISSUE RES, V275, P157, DOI 10.1007/BF00305383; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Morrow EM, 1999, DEVELOPMENT, V126, P23; Mutoh H, 1997, P NATL ACAD SCI USA, V94, P3560, DOI 10.1073/pnas.94.8.3560; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Pan J, 2006, AM J RESP CELL MOL, V35, P320, DOI 10.1165/rcmb.2005-0468OC; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Sunday ME, 1998, J CLIN INVEST, V102, P584, DOI 10.1172/JCI2329; SUNDAY ME, 1990, AM J RESP CELL MOL, V3, P199, DOI 10.1165/ajrcmb/3.3.199; Sunday ME, 2000, CONT ENDOCRINOL, P299; Van Lommel A, 2001, Paediatr Respir Rev, V2, P171, DOI 10.1053/prrv.2000.0126; Walter RE, 2003, AM J RESP CRIT CARE, V167, P911, DOI 10.1164/rccm.2203022; WHITE SR, 1993, AM J RESP CELL MOL, V8, P592, DOI 10.1165/ajrcmb/8.6.592; Wuenschell CW, 1996, J HISTOCHEM CYTOCHEM, V44, P113, DOI 10.1177/44.2.8609367; YEI SP, 1994, AM J RESP CELL MOL, V11, P329, DOI 10.1165/ajrcmb.11.3.8086169	45	33	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21160	21169		10.1074/jbc.M708692200	http://dx.doi.org/10.1074/jbc.M708692200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18339630	hybrid, Green Published			2022-12-25	WOS:000257746100058
J	Rohe, M; Carlo, AS; Breyhan, H; Sporbert, A; Militz, D; Schmidt, V; Wozny, C; Harmeier, A; Erdmann, B; Bales, KR; Wolf, S; Kempermann, G; Paul, SM; Schmitz, D; Bayer, TA; Willnow, TE; Andersen, OM				Rohe, Michael; Carlo, Anne-Sophie; Breyhan, Henning; Sporbert, Anje; Militz, Daniel; Schmidt, Vanessa; Wozny, Christian; Harmeier, Anja; Erdmann, Bettina; Bales, Kelly R.; Wolf, Susanne; Kempermann, Gerd; Paul, Steven M.; Schmitz, Dietmar; Bayer, Thomas A.; Willnow, Thomas E.; Andersen, Olav M.			Sortilin-related receptor with A-type repeats (SORLA) affects the amyloid precursor protein-dependent stimulation of ERK signaling and adult neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMER-DISEASE; TRANSGENIC MICE; KINASE; PROLIFERATION; ACTIVATION; CELLS; FORM; PHOSPHORYLATION; DIFFERENTIATION; HIPPOCAMPUS	Sortilin-related receptor with A-type repeats (SORLA) is a sorting receptor that impairs processing of amyloid precursor protein (APP) to soluble (s) APP and to the amyloid beta-peptide in cultured neurons and is poorly expressed in patients with Alzheimer disease (AD). Here, we evaluated the consequences of Sorla gene defects on brain anatomy and function using mouse models of receptor deficiency. In line with a protective role for SORLA in APP metabolism, lack of the receptor results in increased amyloidogenic processing of endogenous APP and in aggravated plaque deposition when introduced into PDAPP mice expressing mutant human APP. Surprisingly, increased levels of sAPP caused by receptor deficiency correlate with profound stimulation of neuronal ERK signaling and with enhanced neurogenesis, providing in vivo support for neurotrophic functions of sAPP. Our data document a role for SORLA not only in control of plaque burden but also in APP-dependent neuronal signaling and suggest a molecular explanation for increased neurogenesis observed in some AD patients.	[Rohe, Michael; Carlo, Anne-Sophie; Sporbert, Anje; Militz, Daniel; Schmidt, Vanessa; Erdmann, Bettina; Wolf, Susanne; Kempermann, Gerd; Willnow, Thomas E.; Andersen, Olav M.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Sporbert, Anje] Free Univ Berlin, Inst Biochem, D-14195 Berlin, Germany; [Breyhan, Henning; Bayer, Thomas A.] Univ Med Ctr, Dept Psychiat, D-37075 Gottingen, Germany; [Wozny, Christian] Charite, Neurosci Res Ctr, D-10117 Berlin, Germany; [Bales, Kelly R.; Paul, Steven M.] Lilly Res Labs, Indianapolis, IN 46285 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eli Lilly	Willnow, TE (corresponding author), Max Delbruck Ctr Mol Med, Robert Roessle Str 10, D-13125 Berlin, Germany.	wilnow@mdc-berlin.de	Paul, Steve/ABE-5400-2020; Wozny, Christian/A-1498-2015; Wolf, Susanne/AAA-6598-2022; Kempermann, Gerd/F-5416-2010; Andersen, Olav/N-2777-2017	Wozny, Christian/0000-0003-4220-2033; Kempermann, Gerd/0000-0002-5304-4061; Wolf, Susanne/0000-0003-0922-8418; Andersen, Olav/0000-0003-4226-3354; Willnow, Thomas/0000-0001-9515-7921; Schmitz, Dietmar/0000-0003-2741-5241				Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cheng GJ, 2002, EXP NEUROL, V175, P407, DOI 10.1006/exnr.2002.7920; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Ferrer I, 2001, BRAIN PATHOL, V11, P144; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GREENBERG SM, 1994, P NATL ACAD SCI USA, V91, P7104, DOI 10.1073/pnas.91.15.7104; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kwak YD, 2006, BIOCHEM BIOPH RES CO, V344, P431, DOI 10.1016/j.bbrc.2006.03.054; Lee JH, 2007, ARCH NEUROL-CHICAGO, V64, P501, DOI 10.1001/archneur.64.4.501; Lopez-Toledano MA, 2004, J NEUROSCI, V24, P5439, DOI 10.1523/JNEUROSCI.0974-04.2004; Luo JJ, 2001, J NEUROSCI RES, V63, P410, DOI 10.1002/1097-4547(20010301)63:5<410::AID-JNR1036>3.3.CO;2-2; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Morwald S, 1997, ARTERIOSCL THROM VAS, V17, P996, DOI 10.1161/01.ATV.17.5.996; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Nagy Z, 2005, J CELL MOL MED, V9, P531, DOI 10.1111/j.1582-4934.2005.tb00485.x; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Perry G, 1999, NEUROREPORT, V10, P2411, DOI 10.1097/00001756-199908020-00035; Persson AI, 2003, MOL CELL NEUROSCI, V23, P360, DOI 10.1016/S1044-7431(03)00061-7; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rueda D, 2002, J BIOL CHEM, V277, P46645, DOI 10.1074/jbc.M206590200; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schmechel A, 2003, J BIOL CHEM, V278, P35317, DOI 10.1074/jbc.M303547200; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Wallace WC, 1997, MOL BRAIN RES, V52, P213, DOI 10.1016/S0169-328X(97)00259-3; Wehner S, 2004, EUR J CELL BIOL, V83, P701, DOI 10.1078/0171-9335-00427; Wen PH, 2002, NEUROBIOL DIS, V10, P8, DOI 10.1006/nbdi.2002.0490; Zhu XW, 2003, J NEUROCHEM, V86, P136, DOI 10.1046/j.1471-4159.2003.01820.x; Zhu XW, 2001, MECH AGEING DEV, V123, P39, DOI 10.1016/S0047-6374(01)00342-6	38	81	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14826	14834		10.1074/jbc.M710574200	http://dx.doi.org/10.1074/jbc.M710574200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18362153	hybrid			2022-12-25	WOS:000255941400070
J	Cadieux, C; Harada, R; Paquet, M; Cote, O; Trudel, M; Nepveu, A; Bouchard, M				Cadieux, Chantal; Harada, Ryoko; Paquet, Marilene; Cote, Olivier; Trudel, Marie; Nepveu, Alain; Bouchard, Maxime			Polycystic kidneys caused by sustained expression of Cux1 isoform p75	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR HINF-D; CCAAT DISPLACEMENT PROTEIN; CELL TYPE SPECIFICATION; CDP/CUX TRANSCRIPTION FACTOR; TRANSGENIC MICE; GENE-TRANSCRIPTION; HISTONE GENE; S-PHASE; CUT HOMEODOMAIN; DNA-BINDING	The transcriptional regulator Cux1 (CDP, Cutl1) is aberrantly expressed in mouse models for polycystic kidney disease. Here we show that p75-Cux1, the shortest isoform of Cux1, transcribed from an alternative promoter within intron 20, is also deregulated in polycystic kidneys derived from Pkd1 mutant embryos. To determine the role of the p75-Cux1 isoform in cystogenesis, we generated transgenic mice expressing p75-CUX1 in the kidneys and other tissues. Strikingly, these animals developed polycystic kidneys at variable penetrance and severity, correlating with transgene expression levels. Histological and marker analysis of p75-CUX1-derived polycystic kidneys revealed renal cysts derived from the tubular nephron, supporting a model of autosomal dominant polycystic kidney disease. Transgenic p75-CUX1 kidneys additionally showed an up-regulation of the protooncogene c-myc and a down-regulation of the cyclin-dependent kinase inhibitor p27. Chromatin affinity purification experiments confirmed the direct interaction of Cux1 with the c-myc and p27 promoters. These molecular alterations were accompanied by an increase in cilia length and in the proliferative index of epithelial cells lining the cysts. Together, these results identify an important role for the short isoform of CUX1 in polycystic kidney disease development.	[Cadieux, Chantal; Nepveu, Alain; Bouchard, Maxime] McGill Univ, McGill Univ Hlth Ctr, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Cadieux, Chantal; Harada, Ryoko; Paquet, Marilene; Nepveu, Alain; Bouchard, Maxime] McGill Univ, McGill Univ Hlth Ctr, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; [Cadieux, Chantal; Harada, Ryoko; Nepveu, Alain] McGill Univ, McGill Univ Hlth Ctr, Mol Oncol Grp, Montreal, PQ H3G 1Y6, Canada; [Cote, Olivier; Trudel, Marie] Univ Montreal, Fac Med, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	McGill University; McGill University; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Bouchard, M (corresponding author), McGill Univ, McGill Univ Hlth Ctr, Dept Biochem, Montreal, PQ H3G 1Y6, Canada.	maxime.bouchard@mcgill.ca	/AAB-8315-2020; Paquet, Marilene/L-3414-2019	Paquet, Marilene/0000-0002-3562-4636; Bouchard, Maxime/0000-0002-7619-9680; Trudel, Marie/0000-0003-0057-2669				BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; BLOCHLINGER K, 1991, GENE DEV, V5, P1124, DOI 10.1101/gad.5.7.1124; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; Brantley JG, 2003, KIDNEY INT, V63, P1240, DOI 10.1046/j.1523-1755.2003.00889.x; Cadieux C, 2006, CANCER RES, V66, P9492, DOI 10.1158/0008-5472.CAN-05-4230; Cai HN, 1997, EMBO J, V16, P1732, DOI 10.1093/emboj/16.7.1732; Coqueret O, 1998, EMBO J, V17, P4680, DOI 10.1093/emboj/17.16.4680; DUFORT D, 1994, MOL CELL BIOL, V14, P4251, DOI 10.1128/MCB.14.6.4251; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2002, CANCER RES, V62, P6625; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Gupta S, 2003, J CELL PHYSIOL, V196, P541, DOI 10.1002/jcp.10335; HARADA R, 1995, MOL CELL BIOL, V15, P129, DOI 10.1128/MCB.15.1.129; Harada R, 2008, NUCLEIC ACIDS RES, V36, P189, DOI 10.1093/nar/gkm970; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Heuvel GBV, 1996, KIDNEY INT, V50, P453, DOI 10.1038/ki.1996.336; HOLTHUIS J, 1990, SCIENCE, V247, P1454, DOI 10.1126/science.2321007; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; JACK J, 1991, DEVELOPMENT, V113, P735; JACK J, 1995, GENETICS, V139, P1689; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Lanoix J, 1996, ONCOGENE, V13, P1153; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Ledford AW, 2002, DEV BIOL, V245, P157, DOI 10.1006/dbio.2002.0636; Li KJ, 2005, KIDNEY INT, V67, P1710, DOI 10.1111/j.1523-1755.2005.00268.x; LIEVENS PMJ, 1995, J BIOL CHEM, V270, P12745, DOI 10.1074/jbc.270.21.12745; LIU S, 1992, DEV BIOL, V150, P133, DOI 10.1016/0012-1606(92)90013-7; LIU S, 1991, GENETICS, V127, P151; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 1999, NAT GENET, V21, P160, DOI 10.1038/5944; Luong MX, 2002, MOL CELL BIOL, V22, P1424, DOI 10.1128/MCB.22.5.1424-1437.2002; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; MODOLELL J, 1983, P NATL ACAD SCI-BIOL, V80, P1678, DOI 10.1073/pnas.80.6.1678; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nepveu A, 2001, GENE, V270, P1, DOI 10.1016/S0378-1119(01)00485-1; Nirodi C, 2001, J BIOL CHEM, V276, P26122, DOI 10.1074/jbc.M102872200; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Pritchard L, 2000, HUM MOL GENET, V9, P2617, DOI 10.1093/hmg/9.18.2617; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Sansregret L, 2006, MOL CELL BIOL, V26, P2441, DOI 10.1128/MCB.26.6.2441-2455.2006; Sharma M, 2005, KIDNEY INT, V67, P432, DOI 10.1111/j.1523-1755.2005.67099.x; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; STOCKLIN E, 1993, J CELL BIOL, V122, P199, DOI 10.1083/jcb.122.1.199; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; TRUDEL M, 1991, KIDNEY INT, V39, P665, DOI 10.1038/ki.1991.80; Truscott M, 2003, MOL CELL BIOL, V23, P3013, DOI 10.1128/MCB.23.8.3013-3028.2003; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Tufarelli C, 1998, DEV BIOL, V200, P69, DOI 10.1006/dbio.1998.8950; VANWIJNEN AJ, 1989, J BIOL CHEM, V264, P15034; vanWijnen AJ, 1996, P NATL ACAD SCI USA, V93, P11516, DOI 10.1073/pnas.93.21.11516; VANWIJNEN AJ, 1991, P NATL ACAD SCI USA, V88, P2573, DOI 10.1073/pnas.88.6.2573; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; WRIGHT KL, 1992, BIOCHEMISTRY-US, V31, P2812, DOI 10.1021/bi00125a023; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zhu Q, 2004, MOL CELL BIOL, V24, P4810, DOI 10.1128/MCB.24.11.4810-4823.2004	63	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13817	13824		10.1074/jbc.M709332200	http://dx.doi.org/10.1074/jbc.M709332200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18356167	hybrid			2022-12-25	WOS:000255728200034
J	Canaff, L; Zhou, X; Hendy, GN				Canaff, Lucie; Zhou, Xiang; Hendy, Geoffrey N.			The proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; AUTOSOMAL-DOMINANT HYPOCALCEMIA; NEONATAL SEVERE HYPERPARATHYROIDISM; PARATHYROID-HORMONE SECRETION; CRITICALLY-ILL; BURN INJURY; CASR; EXPRESSION; MUTATIONS; PROMOTER	Increased expression of the calcium-sensing receptor ( CASR), which controls blood calcium homeostasis, leads to a decrease in the extracellular calcium set-point, thereby reducing parathyroid hormone secretion and renal calcium reabsorption and increasing calcitonin secretion resulting in reduced circulating calcium levels. Critically ill patients with elevated proinflammatory cytokine levels commonly have hypocalcemia, although the mechanism is not known. After intraperitoneal injection of interleukin (IL)-6 in the rat, circulating levels of parathyroid hormone, 1,25-dihydroxyvitamin D, and calcium fell within hours and remained low at 24 h. Expression of CASR ( mRNA and protein) increased within hours in parathyroid, thyroid, and kidney and remained elevated at 24 h. The CASR gene has two promoters (P1 and P2) yielding transcripts having alternative 5'-untranslated regions but encoding the same receptor protein. Activities of P1 and P2 promoter/luciferase reporter constructs were stimulated similar to 2-3-fold by IL-6 in proximal tubule HKC cells and TT thyroid C-cells. Studies with P1 deleted and mutated promoter-reporter and Stat1 and/or Stat3 dominant-negative constructs showed that a Stat1/3 element downstream of the P1 start site accounted for the IL-6 induction. There are no Stat elements in the P2 promoter, but Sp1/3 elements are clustered at the transcription start site. A series of transfection P2 promoter-reporter analyses showed that Sp1 together with Stat1/3 was critical for IL-6 responsiveness of P2. By oligonucleotide precipitation assay, IL-6 rapidly promoted a complex containing both Sp1/3 and Stat1/3 on the Sp1/3 elements. In conclusion, Stat1/3 directly controls promoter P1, and the Stats indirectly regulate promoter P2 via Sp1/3 in response to IL-6. By this mechanism, the cytokine likely contributes to altered extracellular calcium homeostasis.	[Hendy, Geoffrey N.] Royal Victoria Hosp, Calcium Res Lab, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.] Royal Victoria Hosp, Hormones & Canc Res Unit, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Physiol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; McGill University; McGill University; McGill University	Hendy, GN (corresponding author), Royal Victoria Hosp, Calcium Res Lab, Rm H4-67,687 Pine Ave, Montreal, PQ H3A 1A1, Canada.	geoffrey.hendy@mcgill.ca						Caldwell F. T. Jr., 1997, Journal of Burn Care and Rehabilitation, V18, P525, DOI 10.1097/00004630-199711000-00010; Canaff L, 2005, J BIOL CHEM, V280, P14177, DOI 10.1074/jbc.M408587200; Canaff L, 2002, J BIOL CHEM, V277, P30337, DOI 10.1074/jbc.M201804200; Canaff L, 2001, J BIOL CHEM, V276, P4070, DOI 10.1074/jbc.M009317200; Cantwell CA, 1998, MOL CELL BIOL, V18, P2108, DOI 10.1128/MCB.18.4.2108; Carlstedt E, 1999, BIOSCIENCE REP, V19, P35, DOI 10.1023/A:1020146023812; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chikatsu N, 2000, J BIOL CHEM, V275, P7553, DOI 10.1074/jbc.275.11.7553; D'Souza-Li L, 2002, J CLIN ENDOCR METAB, V87, P1309, DOI 10.1210/jc.87.3.1309; D'Souza-Li L, 2001, HUM MUTAT, V18, P411, DOI 10.1002/humu.1212; GARRETT JE, 1995, J BIOL CHEM, V270, P12919, DOI 10.1074/jbc.270.21.12919; GUO Y, 1990, CLIN IMMUNOL IMMUNOP, V54, P361, DOI 10.1016/0090-1229(90)90050-Z; Haan S, 2005, CELL SIGNAL, V17, P1542, DOI 10.1016/j.cellsig.2005.03.010; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hendy GN, 2000, HUM MUTAT, V16, P281, DOI 10.1002/1098-1004(200010)16:4<281::AID-HUMU1>3.0.CO;2-A; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; KLEIN GL, 1995, BONE, V17, P455, DOI 10.1016/8756-3282(95)00279-1; KOWALVERN A, 1994, J AM COLL SURGEONS, V178, P357; Lepage R, 1999, J CLIN ENDOCR METAB, V84, P2654, DOI 10.1210/jc.84.8.2654; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin SB, 2006, MOL ENDOCRINOL, V20, P3376, DOI 10.1210/me.2006-0177; Lind L, 2000, CRIT CARE MED, V28, P93, DOI 10.1097/00003246-200001000-00015; Loeffler S, 2005, INT J CANCER, V115, P202, DOI 10.1002/ijc.20871; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; MOULAND AJ, 1991, ENDOCRINOLOGY, V128, P441, DOI 10.1210/endo-128-1-441; Muller B, 2000, EUR J CLIN INVEST, V30, P823; Murphey ED, 2000, CRIT CARE MED, V28, P3885, DOI 10.1097/00003246-200012000-00024; NIJSTEN MWN, 1991, SURGERY, V109, P761; OHZATO H, 1993, BIOCHEM BIOPH RES CO, V197, P1556, DOI 10.1006/bbrc.1993.2655; Pidasheva S, 2006, HUM MOL GENET, V15, P2200, DOI 10.1093/hmg/ddl145; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Rotheneder H, 1999, J MOL BIOL, V293, P1005, DOI 10.1006/jmbi.1999.3213; SCHLUTER B, 1991, J TRAUMA, V31, P1663, DOI 10.1097/00005373-199112000-00017; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Yamada Y, 1996, BURNS, V22, P587, DOI 10.1016/S0305-4179(96)00052-6; Zivin JR, 2001, AM J KIDNEY DIS, V37, P689, DOI 10.1016/S0272-6386(01)80116-5	39	91	91	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13586	13600		10.1074/jbc.M708087200	http://dx.doi.org/10.1074/jbc.M708087200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348986	hybrid			2022-12-25	WOS:000255728200012
J	Izumi, N; Fumoto, K; Izumi, S; Kikuchi, A				Izumi, Nanae; Fumoto, Katsumi; Izumi, Shunsuke; Kikuchi, Akira			GSK-3 beta regulates proper mitotic spindle formation in cooperation with a component of the gamma-tubulin ring complex, GCP5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ADENOMATOUS POLYPOSIS-COLI; MICROTUBULE NUCLEATION; BICAUDAL-D; BETA-CATENIN; CENTROSOME; PROTEIN; DYNEIN; RECRUITMENT; PHOSPHORYLATION	Glycogen synthase kinase-3 beta (GSK-3 beta) is known to play a role in the regulation of the dynamics of microtubule networks in cells. Here we show the role of GSK-3 beta in the proper formation of the mitotic spindles through an interaction with GCP5, a component of the gamma-tubulin ring complex (gamma TuRC). GCP5 bound directly to GSK-3 beta in vitro, and their interaction was also observed in intact cells at endogenous levels. Depletion of GCP5 dramatically reduced the GCP2 and gamma-tubulin in the gamma TuRC fraction of sucrose density gradients and disrupted gamma-tubulin localization to the spindle poles in mitotic cells. GCP5 appears to be required for the formation or stability of gamma TuRC and the recruitment of gamma-tubulin to the spindle poles. AGSK-3 inhibitor not only led to the accumulation of gamma-tubulin and GCP5 at the spindle poles but also enhanced microtubule nucleation activity at the spindle poles. Depletion of GCP5 rescued this disrupted organization of spindle poles observed in cells treated with the GSK-3 inhibitor. Furthermore, the inhibition of GSK-3 enhanced the binding of gamma TuRC to the centrosome isolated from mitotic cells in vitro. Our findings suggest that GSK-3 beta regulates the localization of gamma TuRC, including GCP5, to the spindle poles, thereby controlling the formation of proper mitotic spindles.	[Izumi, Nanae; Fumoto, Katsumi; Kikuchi, Akira] Hiroshima Univ, Grad Sch Biomed Sci, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan; [Izumi, Shunsuke] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Minami Ku, Hiroshima 7348551, Japan	Hiroshima University; Hiroshima University	Kikuchi, A (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Biochem, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	akikuchi@hiroshima-u.ac.jp						Andoh T, 2000, MOL CELL BIOL, V20, P6712, DOI 10.1128/MCB.20.18.6712-6720.2000; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Geissler S, 1996, EMBO J, V15, P3899, DOI 10.1002/j.1460-2075.1996.tb00764.x; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Hirata Y, 2003, MOL BIOL CELL, V14, P302, DOI 10.1091/mbc.E02-05-0247; Hoogenraad CC, 2001, EMBO J, V20, P4041, DOI 10.1093/emboj/20.15.4041; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Murphy SM, 1998, J CELL BIOL, V141, P663, DOI 10.1083/jcb.141.3.663; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; Tanji C, 2002, J BIOL CHEM, V277, P36955, DOI 10.1074/jbc.M206210200; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Vogt N, 2006, DEVELOPMENT, V133, P3963, DOI 10.1242/dev.02570; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Wiese C, 1999, CURR OPIN STRUC BIOL, V9, P250, DOI 10.1016/S0959-440X(99)80035-9; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Zhang LJ, 2000, J CELL BIOL, V151, P1525, DOI 10.1083/jcb.151.7.1525; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	37	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12981	12991		10.1074/jbc.M710282200	http://dx.doi.org/10.1074/jbc.M710282200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18316369	hybrid			2022-12-25	WOS:000255499800035
J	Loch, S; Klauschies, F; Scholz, C; Verweij, MC; Wiertz, EJHJ; Koch, J; Tampe, R				Loch, Sandra; Klauschies, Florian; Schoelz, Christian; Verweij, Marieke C.; Wiertz, Emmanuel J. H. J.; Koch, Joachim; Tampe, Robert			Signaling of a varicelloviral factor across the endoplasmic reticulum membrane induces destruction of the peptide-loading complex and immune evasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ANTIGEN-PROCESSING TAP; TRANSPORTER TAP; FLUORESCENCE COMPLEMENTATION; GLYCOPROTEIN-M; HOMOLOG GENE; INSECT CELLS; PROTEIN; VIRUS; BINDING	Cytotoxic T lymphocytes eliminate infected cells upon surface display of antigenic peptides on major histocompatibility complex I molecules. To promote immune evasion, UL49.5 of several varicelloviruses interferes with the pathway of major histocompatibility complex I antigen processing. However, the inhibition mechanism has not been elucidated yet. Within the macromolecular peptide-loading complex we identified the transporter associated with antigen processing (TAP1 and TAP2) as the prime target of UL49.5. Moreover, we determined the active oligomeric state and crucial elements of the viral factor. Remarkably, the last two residues of the cytosolic tail of UL49.5 are essential for endoplasmic reticulum (ER)associated proteasomal degradation of TAP. However, this process strictly requires additional signaling of an upstream regulatory element in the ER lumenal domain of UL49.5. Within this new immune evasion mechanism, we show for the first time that additive elements of a small viral factor and their signaling across the ER membrane are essential for targeted degradation of a multi-subunit membrane complex.	[Loch, Sandra; Klauschies, Florian; Schoelz, Christian; Koch, Joachim; Tampe, Robert] Univ Frankfurt, Dept Biochem, Bioctr, D-60438 Frankfurt, Germany; [Verweij, Marieke C.; Wiertz, Emmanuel J. H. J.] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands	Goethe University Frankfurt; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Koch, J (corresponding author), Univ Frankfurt, Dept Biochem, Bioctr, D-60438 Frankfurt, Germany.	joachim.koch@em.uni-frankfurt.de; tampe@em.uni-frankfurt.de	Tampé, Robert/H-2953-2015; Schölz, Christian/K-2855-2014; Schölz, Christian/F-1261-2010	Tampé, Robert/0000-0002-0403-2160; Schölz, Christian/0000-0002-1633-2072; 				Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; BARNETT BC, 1992, J GEN VIROL, V73, P2167, DOI 10.1099/0022-1317-73-8-2167; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Davison AJ, 2002, VET MICROBIOL, V86, P69, DOI 10.1016/S0378-1135(01)00492-8; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; Gewurz BE, 2001, P NATL ACAD SCI USA, V98, P6794, DOI 10.1073/pnas.121172898; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; Hislop AD, 2007, J EXP MED, V204, P1863, DOI 10.1084/jem.20070256; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Koch J, 2006, CELL MOL LIFE SCI, V63, P653, DOI 10.1007/s00018-005-5462-z; Koch J, 2004, J BIOL CHEM, V279, P10142, DOI 10.1074/jbc.M312816200; Koppers-Lalic D, 2005, P NATL ACAD SCI USA, V102, P5144, DOI 10.1073/pnas.0501463102; Koppers-Lalic D, 2003, ARCH VIROL, V148, P2023, DOI 10.1007/s00705-003-0142-5; Kyritsis C, 2001, J BIOL CHEM, V276, P48031, DOI 10.1074/jbc.M108528200; Lauvau G, 1999, J BIOL CHEM, V274, P31349, DOI 10.1074/jbc.274.44.31349; Lehner PJ, 1997, P NATL ACAD SCI USA, V94, P6904, DOI 10.1073/pnas.94.13.6904; LIANG XP, 1995, J VIROL, V69, P3863, DOI 10.1128/JVI.69.6.3863-3867.1995; Liang XP, 1996, J VIROL, V70, P1448, DOI 10.1128/JVI.70.3.1448-1454.1996; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Lipinska AD, 2006, J VIROL, V80, P5822, DOI 10.1128/JVI.02707-05; Loch S, 2005, PFLUG ARCH EUR J PHY, V451, P409, DOI 10.1007/s00424-005-1420-8; Lybarger L, 2005, CURR OPIN IMMUNOL, V17, P71, DOI 10.1016/j.coi.2004.11.009; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; Noriega VM, 2008, J BIOL CHEM, V283, P4031, DOI 10.1074/jbc.M706283200; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Plewnia G, 2007, J MOL BIOL, V369, P95, DOI 10.1016/j.jmb.2007.02.102; Rufer E, 2007, J IMMUNOL, V179, P5717, DOI 10.4049/jimmunol.179.9.5717; Schoenhals GJ, 1999, EMBO J, V18, P743, DOI 10.1093/emboj/18.3.743; Schreiner A, 2007, MOL BIOL CELL, V18, P1272, DOI 10.1091/mbc.E06-07-0637; Schrodt S, 2006, J BIOL CHEM, V281, P6455, DOI 10.1074/jbc.M509784200; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Wolters JC, 2005, J BIOL CHEM, V280, P23631, DOI 10.1074/jbc.M503231200; Wu SX, 1998, J VIROL, V72, P3029, DOI 10.1128/JVI.72.4.3029-3036.1998; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019	40	22	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13428	13436		10.1074/jbc.M800226200	http://dx.doi.org/10.1074/jbc.M800226200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18321854	hybrid			2022-12-25	WOS:000255499800082
J	Belcheva, A; Golemi-Kotra, D				Belcheva, Antoaneta; Golemi-Kotra, Dasantila			A close-up view of the VraSR two-component system - A mediator of staphylococcus aureus response to cell wall damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION SYSTEMS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; HISTIDINE KINASES; ENVELOPE STRESS; PROTEIN-KINASE; BINDING; PHOSPHORYLATION; RESISTANCE; REGULATOR	Staphylococcus aureus remains a clinical scourge. Recent studies have revealed that S. aureus is capable of mounting a response to antibiotics that target cell wall peptidoglycan biosynthesis, such as beta-lactams and vancomycin. A phosphotransfer-mediated signaling pathway composed of a histidine protein kinase, VraS, and a response regulator protein, VraR, has been linked to the coordination of this response. Herein, we report for the first time on the signal transduction mechanism of the VraSR system. We found that VraS is capable of undergoing autophosphorylation in vitro and its phosphoryl group is rapidly transferred to VraR. In addition, phosphorylated VraR undergoes rapid dephosphorylation by VraS. Evidence is presented that VraR has adopted a novel strategy in regulating the output response of the VraSR-mediated signaling pathway. The VraR effector domain inhibits formation of inactive VraR dimers and, in doing so, it holds the regulatory domain into an intermediate active state. Weshow that only phosphorylation induces formation of the biological active VraR-dimer species. Furthermore, we propose that damage inflicted to cell wall peptidoglycan could be the main source of the stimuli that VraR responds to due to the tight control that VraS has on the phosphorylation state of VraR. Our findings provide for the first time insights into the molecular basis for the proposed role of VraSR as a "sentinel" system capable of rapidly sensing cell wall peptidoglycan damage and coordinating a response that enhances the resistance phenotype in S. aureus.	[Belcheva, Antoaneta; Golemi-Kotra, Dasantila] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [Golemi-Kotra, Dasantila] York Univ, Dept Chem, N York, ON M3J 1P3, Canada	York University - Canada; York University - Canada	Golemi-Kotra, D (corresponding author), York Univ, Dept Biol, 4700 Keele St, N York, ON M3J 1P3, Canada.	dgkotra@yorku.ca	/N-6611-2013	/0000-0003-1299-6987; Belcheva, Antoaneta/0000-0001-5061-7533				AIBA H, 1989, J BIOCHEM-TOKYO, V106, P5, DOI 10.1093/oxfordjournals.jbchem.a122817; Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Bergstrom LC, 1998, GENES CELLS, V3, P777, DOI 10.1046/j.1365-2443.1998.00228.x; Birck C, 2002, J MOL BIOL, V321, P447, DOI 10.1016/S0022-2836(02)00651-4; Birkey SM, 1998, MOL MICROBIOL, V30, P943, DOI 10.1046/j.1365-2958.1998.01122.x; Boyle-Vavra S, 2006, FEMS MICROBIOL LETT, V262, P163, DOI 10.1111/j.1574-6968.2006.00384.x; Da Re S, 1999, MOL MICROBIOL, V34, P504, DOI 10.1046/j.1365-2958.1999.01614.x; Darwin AJ, 1996, MOL MICROBIOL, V20, P621, DOI 10.1046/j.1365-2958.1996.5491074.x; Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06; Eldridge AM, 2002, BIOCHEMISTRY-US, V41, P15173, DOI 10.1021/bi026254+; Fan X, 2007, J BIOL CHEM, V282, P35143, DOI 10.1074/jbc.M706296200; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; GALINIER A, 1994, J BIOL CHEM, V269, P23784; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gardete S, 2006, ANTIMICROB AGENTS CH, V50, P3424, DOI 10.1128/AAC.00356-06; Green David W, 2002, Expert Opin Ther Targets, V6, P1, DOI 10.1517/14728222.6.1.1; Janausch IG, 2002, J BIOL CHEM, V277, P39809, DOI 10.1074/jbc.M204482200; Kato Y, 2008, INT J ANTIMICROB AG, V31, P64, DOI 10.1016/j.ijantimicag.2007.08.012; KENNEY LJ, 1995, P NATL ACAD SCI USA, V92, P8866, DOI 10.1073/pnas.92.19.8866; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Kuroda M, 2000, BIOCHEM BIOPH RES CO, V269, P485, DOI 10.1006/bbrc.2000.2277; LUKAT GS, 1993, J CELL BIOCHEM, V51, P41, DOI 10.1002/jcb.240510109; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; Mascher T, 2006, FEMS MICROBIOL LETT, V264, P133, DOI 10.1111/j.1574-6968.2006.00444.x; MCCLEARY WR, 1993, J BACTERIOL, V175, P2793, DOI 10.1128/JB.175.10.2793-2798.1993; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Nathan C, 2004, NATURE, V431, P899, DOI 10.1038/431899a; Okada A, 2007, METHOD ENZYMOL, V422, P386, DOI 10.1016/S0076-6879(06)22019-6; Qin L, 2001, P NATL ACAD SCI USA, V98, P908, DOI 10.1073/pnas.031383098; Raivio TL, 1997, J BACTERIOL, V179, P7724, DOI 10.1128/jb.179.24.7724-7733.1997; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; ROGGIANI M, 1993, J BACTERIOL, V175, P3182, DOI 10.1128/JB.175.10.3182-3187.1993; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Sobral RG, 2007, J BACTERIOL, V189, P2376, DOI 10.1128/JB.01439-06; Stephenson K., 2002, Current Drug Targets - Infectious Disorders, V2, P235, DOI 10.2174/1568005023342443; Stephenson K, 2002, CURR OPIN PHARMACOL, V2, P507, DOI 10.1016/S1471-4892(02)00194-7; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Ulijasz AT, 2000, BIOCHEMISTRY-US, V39, P11417, DOI 10.1021/bi0012888; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; WRIGHT GD, 1993, BIOCHEMISTRY-US, V32, P5057, DOI 10.1021/bi00070a013; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zhang JH, 2003, BIOCHEMISTRY-US, V42, P2552, DOI 10.1021/bi0272205	45	86	94	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12354	12364		10.1074/jbc.M710010200	http://dx.doi.org/10.1074/jbc.M710010200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326495	hybrid			2022-12-25	WOS:000255340000052
J	Carvalho, CML; Chew, EH; Hashemy, SI; Lu, J; Holmgren, A				Carvalho, Cristina M. L.; Chew, Eng-Hui; Hashemy, Seyed Isaac; Lu, Jun; Holmgren, Arne			Inhibition of the human thioredoxin system - A molecular mechanism of mercury toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL MERCURY; NUTRITIONAL FACTORS; HUMAN GLUTAREDOXIN; ESCHERICHIA-COLI; OXIDATIVE STRESS; METHYLMERCURY; REDUCTASE; RAT; GLUTATHIONE; SELENIUM	Mercury toxicity mediated by different forms of mercury is a major health problem; however, the molecular mechanisms underlying toxicity remain elusive. We analyzed the effects of mercuric chloride (HgCl2) and monomethylmercury (MeHg) on the proteins of the mammalian thioredoxin system, thioredoxin reductase (TrxR) and thioredoxin (Trx), and of the glutaredoxin system, glutathione reductase (GR) and glutaredoxin (Grx). HgCl2 and MeHg inhibited recombinant rat TrxR with IC50 values of 7.2 and 19.7 nM, respectively. Fully reduced human Trx1 bound mercury and lost all five free thiols and activity after incubation with HgCl2 or MeHg, but only HgCl2 generated dimers. Mass spectra analysis demonstrated binding of 2.5 mol of Hg2+ and 5 mol of MeHg+/mol of Trx1 with the very strong Hg2+ complexes involving active site and structural disulfides. Inhibition of both TrxR and Trx activity was observed in HeLa and HEK 293 cells treated with HgCl2 or MeHg. GR was inhibited by HgCl2 and MeHg in vitro, but no decrease in GR activity was detected in cell extracts treated with mercurials. Human Grx1 showed similar reactivity as Trx1 with both mercurial compounds, with the loss of all free thiols and Grx dimerization in the presence of HgCl2, but no inhibition of Grx activity was observed in lysates of HeLa cells exposed to mercury. Overall, mercury inhibition was selective toward the thioredoxin system. In particular, the remarkable potency of the mercury compounds to bind to the selenol-thiol in the active site of TrxR should be a major molecular mechanism of mercury toxicity.	[Carvalho, Cristina M. L.; Chew, Eng-Hui; Hashemy, Seyed Isaac; Lu, Jun; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden; [Carvalho, Cristina M. L.] Univ Lisbon, Fac Pharm, P-1649003 Lisbon, Portugal	Karolinska Institutet; Universidade de Lisboa	Holmgren, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden.	arne.holmgren@ki.se	Hashemy, Seyed Isaac/A-2693-2017; Lu, Jun/E-9701-2017; Chew, Eng Hui/D-8975-2016; Carvalho, Cristina/E-3379-2014; iMed.ULisboa, CBT/B-4215-2014	Hashemy, Seyed Isaac/0000-0002-1323-5250; Lu, Jun/0000-0002-1699-8835; Chew, Eng Hui/0000-0002-2615-8987; Carvalho, Cristina/0000-0002-1097-7910; 				Almagro X, 2001, J ORGANOMET CHEM, V623, P137, DOI 10.1016/S0022-328X(00)00672-0; Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; ARNER ESJ, 2000, CURR PROTOCOL TOXI S, V5; Ballatori N, 2002, ENVIRON HEALTH PERSP, V110, P689, DOI 10.1289/ehp.02110s5689; Bando I, 2005, J BIOCHEM MOL TOXIC, V19, P154, DOI 10.1002/jbt.20067; Boelsterli UA, 2003, MECH TOXICOLOGY; BUSHWELLER JH, 1994, J MOL BIOL, V235, P1585, DOI 10.1006/jmbi.1994.1108; CAMPOS EST, 2003, TOXICOL LETT S1, V144, P142; Carvalho CML, 2006, METAL IONS BIOL MED, V9, P381; Cenas N, 2006, J BIOL CHEM, V281, P5593, DOI 10.1074/jbc.M511972200; Chapman L, 2000, ENVIRON HEALTH PERSP, V108, P29, DOI [10.2307/3454631, 10.2307/3454292]; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Clarkson TW, 2002, ENVIRON HEALTH PERSP, V110, P11, DOI 10.1289/ehp.02110s111; Clarkson TW, 2003, J NUTR, V133, p1539S, DOI 10.1093/jn/133.5.1539S; CLARKSON TW, 1993, ANNU REV PHARMACOL, V33, P545, DOI 10.1146/annurev.pa.33.040193.002553; CUVINARALAR MLA, 1991, ECOTOX ENVIRON SAFE, V21, P348, DOI 10.1016/0147-6513(91)90074-Y; DANCE I, 1992, METALLOTHIONEINS, P284; DAVIS LE, 1994, ANN NEUROL, V35, P680, DOI 10.1002/ana.410350608; dos Santos APM, 2007, TOXICOL LETT, V169, P121, DOI 10.1016/j.toxlet.2006.12.007; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Farina M, 2004, TOXICOL LETT, V146, P227, DOI 10.1016/j.toxlet.2003.10.001; Frisk P, 2000, BIOMETALS, V13, P101, DOI 10.1023/A:1009222625616; GANTHER HE, 1972, SCIENCE, V175, P1122, DOI 10.1126/science.175.4026.1122; GHILARDI CA, 1993, J CHEM SOC DALTON, P3117, DOI 10.1039/dt9930003117; Go YM, 2007, AM J PATHOL, V171, P1670, DOI 10.2353/ajpath.2007.070218; Grandjean P, 2005, ENVIRON HEALTH PERSP, V113, P905, DOI 10.1289/ehp.7842; Hansen JM, 2006, FREE RADICAL BIO MED, V40, P138, DOI 10.1016/j.freeradbiomed.2005.09.023; Hashemy SI, 2007, J BIOL CHEM, V282, P14428, DOI 10.1074/jbc.M700927200; Heinz GH, 1998, ENVIRON TOXICOL CHEM, V17, P139; HIROTA Y, 1980, TOXICOL APPL PHARM, V53, P174, DOI 10.1016/0041-008X(80)90394-4; Hoffman DJ, 1998, ENVIRON TOXICOL CHEM, V17, P161, DOI 10.1002/etc.5620170204; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; Hylander LD, 2006, SCI TOTAL ENVIRON, V368, P352, DOI 10.1016/j.scitotenv.2005.11.029; Kaur P, 2007, TOXICOLOGY, V230, P164, DOI 10.1016/j.tox.2006.11.058; KERPER LE, 1992, AM J PHYSIOL, V262, pR761, DOI 10.1152/ajpregu.1992.262.5.R761; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; LUTHMAN M, 1982, J BIOL CHEM, V257, P6686; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Mann RA, 1999, OPER TECHN SPORT MED, V7, P2, DOI 10.1016/S1060-1872(99)80033-1; Naganuma A, 1998, LIFE SCI, V62, pPL157, DOI 10.1016/S0024-3205(98)00037-X; PADILLA CA, 1995, EUR J BIOCHEM, V227, P27, DOI 10.1111/j.1432-1033.1995.tb20356.x; Parran DK, 2001, TOXICOL SCI, V59, P278, DOI 10.1093/toxsci/59.2.278; POTAMITOUFERNAN.A, 2004, ANTIOXID REDOX SIGN, V6, P63; POTTER S, 1974, J NUTR, V104, P638, DOI 10.1093/jn/104.5.638; REN XL, 1993, BIOCHEMISTRY-US, V32, P9701, DOI 10.1021/bi00088a023; Rooney JPK, 2007, TOXICOLOGY, V234, P145, DOI 10.1016/j.tox.2007.02.016; ROZELL B, 1985, EUR J CELL BIOL, V38, P79; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; SARAFIAN T, 1991, INT J DEV NEUROSCI, V9, P147, DOI 10.1016/0736-5748(91)90005-7; Shanker G, 2003, MOL BRAIN RES, V110, P85, DOI 10.1016/S0169-328X(02)00642-3; STEMME S, 1985, BRAIN RES, V359, P140, DOI 10.1016/0006-8993(85)91421-0; VAHTER ME, 1995, TOXICOL APPL PHARM, V134, P273, DOI 10.1006/taap.1995.1193; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; WATAHA JC, 2007, IN PRESS DENTAL MAT; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Who, 2000, AIR QUAL GUID; *WHO, 2003, SUMM CONCL 61 M JECF; WHO World Health Organization, 1989, MERC ENV ASP; Woods JS, 2005, TOXICOL APPL PHARM, V206, P113, DOI 10.1016/j.taap.2004.12.016; WRIGHT JG, 1990, PROG INORG CHEM, V38, P323; Zalups RZ., 2000, MOL BIOL TOXICOLOGY; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897	67	357	367	4	82	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11913	11923		10.1074/jbc.M710133200	http://dx.doi.org/10.1074/jbc.M710133200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321861	hybrid			2022-12-25	WOS:000255340000007
J	Keshwani, MM; Harris, TK				Keshwani, Malik M.; Harris, Thomas K.			Kinetic mechanism of fully activated S6K1 protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; WATER; MTOR; TOR	S6K1 is a member of the AGC subfamily of serine-threonine protein kinases, whereby catalytic activation requires dual phosphorylation of critical residues in the conserved T-loop (Thr-229) and hydrophobic motif (Thr-389). Previously, we described production of the fully activated catalytic kinase domain construct, His6-S6K1 alpha II(Delta AID)-T389E. Now, we report its kinetic mechanism for catalyzing phosphorylation of a model peptide substrate (Tide, RRRLSSLRA). First, two-substrate steady-state kinetics and product inhibition patterns indicated a Steady-State Ordered Bi Bi mechanism, whereby initial high affinity binding of ATP (K-d(ATP) = 5-6 mu M) was followed by low affinity binding of Tide (K-d(Tide) = 180 mu M), and values of K-m(ATP) = 5-6 mu M and K-m(Tide) = 4-5 mu M were expressed in the active ternary complex. Global curve-fitting analysis of ATP, Tide, and ADP titrations of pre-steady-state burst kinetics yielded microscopic rate constants for substrate binding, rapid chemical phosphorylation, and rate-limiting product release. Catalytic trapping experiments confirmed rate-limiting steps involving release of ADP. Pre-steady-state kinetic and catalytic trapping experiments showed osmotic pressure to increase the rate of ADP release; and direct binding experiments showed osmotic pressure to correspondingly weaken the affinity of the enzyme for both ADP and ATP, indicating a less hydrated conformational form of the free enzyme.	[Keshwani, Malik M.; Harris, Thomas K.] Univ Miami, Dept Chem, Coral Gables, FL 33124 USA; [Harris, Thomas K.] Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, Miami, FL 33136 USA	University of Miami; University of Miami	Harris, TK (corresponding author), Univ Miami, Dept Biochem & Mol Biol, Miller Sch Med, POB 016129, Miami, FL 33101 USA.	tkharris@miami.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069868] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM69868] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Aubol BE, 2004, J BIOL CHEM, V279, P30182, DOI 10.1074/jbc.M402797200; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Keshwani MM, 2008, PROTEIN EXPRES PURIF, V58, P32, DOI 10.1016/j.pep.2007.11.003; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LEISER SA, 2005, BIOCHIM BIOPHYS ACTA, V1754, P191; LiCata VJ, 1998, METHOD ENZYMOL, V295, P42; Lieser SA, 2005, J BIOL CHEM, V280, P7769, DOI 10.1074/jbc.M411736200; Martin KA, 2002, ADV CANCER RES, V86, P1, DOI 10.1016/S0065-230X(02)86001-8; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; PARSEGIAN VA, 1994, ADV CHEM SER, V235, P177; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Richardson CJ, 2004, SEMIN CELL DEV BIOL, V15, P147, DOI 10.1016/j.semcdb.2003.12.023; Robinson CR, 1995, METHOD ENZYMOL, V259, P395; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435	21	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11972	11980		10.1074/jbc.M800114200	http://dx.doi.org/10.1074/jbc.M800114200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326039	hybrid, Green Published			2022-12-25	WOS:000255340000013
J	Harrison, BJ; Pujol, J; Ortiz, H; Fornito, A; Pantelis, C; Yucel, M				Harrison, Ben J.; Pujol, Jesus; Ortiz, Hector; Fornito, Alex; Pantelis, Christos; Yucel, Murat			Modulation of Brain Resting-State Networks by Sad Mood Induction	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; FMRI DATA; ALZHEIMERS-DISEASE; NEURAL MECHANISMS; BLIND SEPARATION; LOW-FREQUENCY; MOTOR CORTEX; FLUCTUATIONS	Background: There is growing interest in the nature of slow variations of the blood oxygen level-dependent (BOLD) signal observed in functional MRI resting-state studies. In humans, these slow BOLD variations are thought to reflect an underlying or intrinsic form of brain functional connectivity in discrete neuroanatomical systems. While these 'resting-state networks' may be relatively enduring phenomena, other evidence suggest that dynamic changes in their functional connectivity may also emerge depending on the brain state of subjects during scanning. Methodology/Principal Findings: In this study, we examined healthy subjects (n = 24) with a mood induction paradigm during two continuous fMRI recordings to assess the effects of a change in self-generated mood state (neutral to sad) on the functional connectivity of these resting-state networks (n = 24). Using independent component analysis, we identified five networks that were common to both experimental states, each showing dominant signal fluctuations in the very low frequency domain (similar to 0.04 Hz). Between the two states, we observed apparent increases and decreases in the overall functional connectivity of these networks. Primary findings included increased connectivity strength of a paralimbic network involving the dorsal anterior cingulate and anterior insula cortices with subjects' increasing sadness and decreased functional connectivity of the 'default mode network'. Conclusions/Significance: These findings support recent studies that suggest the functional connectivity of certain resting-state networks may, in part, reflect a dynamic image of the current brain state. In our study, this was linked to changes in subjective mood.	[Harrison, Ben J.; Fornito, Alex; Pantelis, Christos; Yucel, Murat] Univ Melbourne & Melbourne Hlth, Dept Psychiat, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Harrison, Ben J.; Pujol, Jesus; Ortiz, Hector] CRC Corporacio Sanitaria, Inst Alta Tecnol PRBB, Barcelona, Spain; [Yucel, Murat] ORYGEN Res Ctr, Melbourne, Vic, Australia; [Pantelis, Christos] Univ Melbourne, Howard Florey Inst, Melbourne, Vic, Australia	University of Melbourne; Pompeu Fabra University; Orygen, The National Centre of Excellence in Youth Mental Health; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Harrison, BJ (corresponding author), Univ Melbourne & Melbourne Hlth, Dept Psychiat, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia.	habj@unimelb.edu.au	Pantelis, Christos/H-7722-2014; Harrison, Ben J/I-2940-2014; Yucel, Murat/I-3004-2014; Yücel, Murat/AAY-8124-2020; Alex, Fornito/N-8214-2013	Pantelis, Christos/0000-0002-9565-0238; Yucel, Murat/0000-0002-4705-452X; Yücel, Murat/0000-0002-4705-452X; Alex, Fornito/0000-0001-9134-480X; Harrison, Ben/0000-0002-2226-2074	National Health and Medical Research Council (NHMRC) of Australia [236175, 400420, 350241]; Ian Potter Foundation; Clive and Vera Ramaciotti foundations [RA44/07]; Spanish Ministry of Education [AP2006-02869]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ian Potter Foundation; Clive and Vera Ramaciotti foundations; Spanish Ministry of Education(Spanish Government)	This research was supported by a grant from the National Health and Medical Research Council (NHMRC) of Australia (I.D. 236175) and the Ian Potter Foundation. Dr. Harrison is supported by a National Health and Medical Research Council of Australia (NHMRC) Training Award (I.D. 400420) and an establishment grant from the Clive and Vera Ramaciotti foundations (Reference: RA44/07). Dr Yucel is supported by a NHMRC Program Grant (I.D. 350241). Mr. Ortiz is supported by an FPU grant from the Spanish Ministry of Education (AP2006-02869).	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Baker SC, 1997, PSYCHOL MED, V27, P565, DOI 10.1017/S0033291797004856; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Calhoun VD, 2006, IEEE ENG MED BIOL, V25, P79, DOI 10.1109/MEMB.2006.1607672; Calhoun VD, 2004, NEUROPSYCHOPHARMACOL, V29, P2097, DOI 10.1038/sj.npp.1300543; Calhoun VD, 2004, MAGN RESON IMAGING, V22, P1181, DOI 10.1016/j.mri.2004.09.004; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; CLARK DM, 1985, J PERS SOC PSYCHOL, V48, P1595, DOI 10.1037/0022-3514.48.6.1595; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DAMOISEAUX JS, 2007, CEREB CORTEX; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Fukunaga M, 2006, MAGN RESON IMAGING, V24, P979, DOI 10.1016/j.mri.2006.04.018; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Greicius M, 2007, BIOL PSYCHIAT; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hampson M, 2004, NEUROREPORT, V15, P1315, DOI 10.1097/01.wnr.0000129997.95055.15; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2006, NEUROIMAGE, V31, P513, DOI 10.1016/j.neuroimage.2005.12.040; Harrison BJ, 2007, SCHIZOPHR RES, V91, P82, DOI 10.1016/j.schres.2006.12.027; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Kiviniemi V, 2004, MAGN RESON IMAGING, V22, P197, DOI 10.1016/j.mri.2003.09.007; Kiviniemi VJ, 2005, MAGN RESON IMAGING, V23, P531, DOI 10.1016/j.mri.2005.02.009; Lewis PA, 2005, NEUROIMAGE, V25, P1214, DOI 10.1016/j.neuroimage.2004.11.053; LI YO, 2007, HUM BRAIN MAPP; Liotti M, 2000, BIOL PSYCHIAT, V48, P30, DOI 10.1016/S0006-3223(00)00874-X; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Ma LS, 2007, MAGN RESON IMAGING, V25, P47, DOI 10.1016/j.mri.2006.09.032; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; MARTIN M, 1990, CLIN PSYCHOL REV, V10, P669, DOI 10.1016/0272-7358(90)90075-L; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Newton AT, 2007, HUM BRAIN MAPP, V28, P663, DOI 10.1002/hbm.20294; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; PUJOL J, HUMAN BRAIN IN PRESS; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2005, J COMP NEUROL, V493, P167, DOI 10.1002/cne.20752; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajapakse JC, 2006, IEEE ENG MED BIOL, V25, P102, DOI 10.1109/MEMB.2006.1607674; Reiman EM, 1997, J CLIN PSYCHIAT, V58, P4; Sabatinelli D, 2006, PROG BRAIN RES, V156, P93, DOI 10.1016/S0079-6123(06)56005-4; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Segal ZV, 2006, ARCH GEN PSYCHIAT, V63, P749, DOI 10.1001/archpsyc.63.7.749; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Wechsler D., 1999, WECHSLER ABBREVIATED; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5; Yucel M, 2007, ARCH GEN PSYCHIAT, V64, P946, DOI 10.1001/archpsyc.64.8.946; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263	73	159	163	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1794	10.1371/journal.pone.0001794	http://dx.doi.org/10.1371/journal.pone.0001794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370KY	18350136	Green Published, gold			2022-12-25	WOS:000260762300002
J	Ruiz, MIG; Floor, K; Roepman, P; Rodriguez, JA; Meijer, GA; Mooi, WJ; Jassem, E; Niklinski, J; Muley, T; van Zandwijk, N; Smit, EF; Beebe, K; Neckers, L; Ylstra, B; Giaccone, G				Ruiz, Marielle I. Gallegos; Floor, Karijn; Roepman, Paul; Rodriguez, Jose A.; Meijer, Gerrit A.; Mooi, Wolter J.; Jassem, Ewa; Niklinski, Jacek; Muley, Thomas; van Zandwijk, Nico; Smit, Egbert F.; Beebe, Kristin; Neckers, Len; Ylstra, Bauke; Giaccone, Giuseppe			Integration of Gene Dosage and Gene Expression in Non-Small Cell Lung Cancer, Identification of HSP90 as Potential Target	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER ALTERATION; MICROARRAY ANALYSIS; HEAT-SHOCK-PROTEIN-90; ABERRATIONS; REVEALS; GLIOBLASTOMA; ASSOCIATION; MUTATIONS; SIGNATURE	Background: Lung cancer causes approximately 1.2 million deaths per year worldwide, and non-small cell lung cancer (NSCLC) represents 85% of all lung cancers. Understanding the molecular events in non-small cell lung cancer (NSCLC) is essential to improve early diagnosis and treatment for this disease. Methodology and Principal Findings: In an attempt to identify novel NSCLC related genes, we performed a genome-wide screening of chromosomal copy number changes affecting gene expression using microarray based comparative genomic hybridization and gene expression arrays on 32 radically resected tumor samples from stage I and II NSCLC patients. An integrative analysis tool was applied to determine whether chromosomal copy number affects gene expression. We identified a deletion on 14q32.2-33 as a common alteration in NSCLC (44%), which significantly influenced gene expression for HSP90, residing on 14q32. This deletion was correlated with better overall survival (P = 0.008), survival was also longer in patients whose tumors had low expression levels of HSP90. We extended the analysis to three independent validation sets of NSCLC patients, and confirmed low HSP90 expression to be related with longer overall survival (P = 0.003, P = 0.07 and P = 0.04). Furthermore, in vitro treatment with an HSP90 inhibitor had potent antiproliferative activity in NSCLC cell lines. Conclusions: We suggest that targeting HSP90 will have clinical impact for NSCLC patients.	[Ruiz, Marielle I. Gallegos; Floor, Karijn; Rodriguez, Jose A.; Giaccone, Giuseppe] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Roepman, Paul] Agendia BV, Amsterdam, Netherlands; [Meijer, Gerrit A.; Mooi, Wolter J.; Ylstra, Bauke] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Jassem, Ewa] Univ Gdansk, Gdansk, Poland; [Niklinski, Jacek] Univ Bialystok, Bialystok, Poland; [Muley, Thomas] Heidelberg Univ, Thoraxklinik Heidelberg, Heidelberg, Germany; [van Zandwijk, Nico] Netherlands Canc Inst, Amsterdam, Netherlands; [Smit, Egbert F.] Vrije Univ Amsterdam, Med Ctr, Dept Pulmonary Dis, Amsterdam, Netherlands; [Beebe, Kristin; Neckers, Len] NCI, Ctr Canc Res, Urol Oncol Branch, Bethesda, MD USA	Vrije Universiteit Amsterdam; Agendia; Vrije Universiteit Amsterdam; Fahrenheit Universities; University of Gdansk; University of Bialystok; Ruprecht Karls University Heidelberg; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ruiz, MIG (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands.	giacconeg@mail.nih.gov	Giaccone, Giuseppe/E-8297-2017; van Zandwijk, Nico/E-4177-2012; Rodriguez, Jose Antonio/AAA-1125-2019; Ylstra, Bauke/D-2906-2012; Muley, Thomas/AAY-9200-2020	Giaccone, Giuseppe/0000-0002-5023-7562; van Zandwijk, Nico/0000-0002-8405-9688; Rodriguez, Jose Antonio/0000-0002-2823-3733; Ylstra, Bauke/0000-0001-9479-3010; Meijer, Gerrit/0000-0003-0330-3130; Smit, Egbert/0000-0002-7329-6995; Jassem, Ewa/0000-0003-4239-4776	NATIONAL CANCER INSTITUTE [Z01BC011032, Z01SC010074, ZIASC010074, ZIABC011032, Z01BC011051, Z01BC010854, ZIABC010854] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balsara BR, 1997, CANCER RES, V57, P2116; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Braga-Basaria M, 2004, J CLIN ENDOCR METAB, V89, P2982, DOI 10.1210/jc.2003-031767; Burrows F, 2004, CELL CYCLE, V3, P1530, DOI 10.4161/cc.3.12.1277; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Choi JS, 2006, LUNG, V184, P355, DOI 10.1007/s00408-006-0009-0; Cullman SB, 2006, SEMIN ONCOL, V33, P457, DOI 10.1053/j.seminoncol.2006.04.001; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Redon R, 2001, CANCER RES, V61, P4122; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Slamon D, 2001, SEMIN ONCOL, V28, P13, DOI 10.1053/sonc.2001.22812; Tay ST, 2003, CANCER RES, V63, P3309; Thomas CY, 2003, CLIN CANCER RES, V9, p6098S; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; van den IJssel P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni191; van Wieringen WN, 2006, BIOINFORMATICS, V22, P1919, DOI 10.1093/bioinformatics/btl269; Wigle DA, 2002, CANCER RES, V62, P3005; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Yang J, 2001, CANCER RES, V61, P4010; Yang SC, 2006, CANCER RES, V66, P6990, DOI 10.1158/0008-5472.CAN-06-1042; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zsebik B, 2006, IMMUNOL LETT, V104, P146, DOI 10.1016/j.imlet.2005.11.018	36	88	94	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e0001722	10.1371/journal.pone.0001722	http://dx.doi.org/10.1371/journal.pone.0001722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320023	Green Published, gold, Green Submitted			2022-12-25	WOS:000260586600018
J	Chang, WC; Ng, JK; Nguyen, T; Pellissier, L; Claeysen, S; Hsiao, EC; Conklin, BR				Chang, Wei Chun; Ng, Jennifer K.; Nguyen, Trieu; Pellissier, Lucie; Claeysen, Sylvie; Hsiao, Edward C.; Conklin, Bruce R.			Modifying Ligand-Induced and Constitutive Signaling of the Human 5-HT4 Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; 3RD INTRACELLULAR LOOP; FUNCTIONAL SELECTIVITY; WILD-TYPE; EXPRESSION; AGONISTS; G(S); G(I); CONFORMATIONS; DETERMINANTS	G protein-coupled receptors (GPCRs) signal through a limited number of G-protein pathways and play crucial roles in many biological processes. Studies of their in vivo functions have been hampered by the molecular and functional diversity of GPCRs and the paucity of ligands with specific signaling effects. To better compare the effects of activating different G-protein signaling pathways through ligand-induced or constitutive signaling, we developed a new series of RASSLs (receptors activated solely by synthetic ligands) that activate different G-protein signaling pathways. These RASSLs are based on the human 5-HT4b receptor, a GPCR with high constitutive G(s) signaling and strong ligand-induced G-protein activation of the G(s) and G(s/q) pathways. The first receptor in this series, 5-HT4-D(100)A or Rs1 (RASSL serotonin 1), is not activated by its endogenous agonist, serotonin, but is selectively activated by the small synthetic molecules GR113808, GR125487, and RO110-0235. All agonists potently induced G(s) signaling, but only a few (e.g., zacopride) also induced signaling via the G(q) pathway. Zacopride-induced G(q) signaling was enhanced by replacing the C-terminus of Rs1 with the C-terminus of the human 5-HT2C receptor. Additional point mutations (D(66)A and (DN)-N-66) blocked constitutive G(s) signaling and lowered ligand-induced G(q) signaling. Replacing the third intracellular loop of Rs1 with that of human 5-HT1A conferred ligand-mediated G(i) signaling. This G(i)-coupled RASSL, Rs1.3, exhibited no measurable signaling to the G(s) or G(q) pathway. These findings show that the signaling repertoire of Rs1 can be expanded and controlled by receptor engineering and drug selection.	[Chang, Wei Chun; Ng, Jennifer K.; Nguyen, Trieu; Hsiao, Edward C.; Conklin, Bruce R.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA; [Pellissier, Lucie; Claeysen, Sylvie] Univ Montpellier, Inst Genom Fonctionnelle, CNRS, UMR 5203, F-34059 Montpellier, France; [Pellissier, Lucie; Claeysen, Sylvie] INSERM, U661, Montpellier, France; [Chang, Wei Chun] Univ Calif San Francisco, Grad Program Pharmaceut Sci & Pharmacogenom, San Francisco, CA 94143 USA; [Hsiao, Edward C.; Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Conklin, BR (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94143 USA.	bconklin@gladstone.ucsf.edu	Pellissier, Lucie P/L-8239-2014; Claeysen, Sylvie/C-8599-2014; Conklin, Bruce/E-4738-2019	Pellissier, Lucie P/0000-0001-7085-3242; Claeysen, Sylvie/0000-0002-0576-5518; Conklin, Bruce/0000-0003-1463-6061	NIH [HL-60664, 2T32DK07418-26]; American Heart Association Predoctoral Fellowship [0415005Y]; J David Gladstone CIRM Fellowship; Kirschstein NRSA Fellowship [F32A624044-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007418] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); J David Gladstone CIRM Fellowship; Kirschstein NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH grant HL-60664 and American Heart Association Predoctoral Fellowship 0415005Y (to WCC), NIH Fellowship Training Grant 2T32DK07418-26 (to ECH), J David Gladstone CIRM Fellowship (to ECH), and Kirschstein NRSA Fellowship F32A624044-02 (to JKN).	ARMBRUSTER BN, 2007, P NATL ACAD SCI US; Brink CB, 2004, BRIT J CLIN PHARMACO, V57, P373, DOI 10.1111/j.1365-2125.2003.02046.x; Bruysters M, 2005, J BIOL CHEM, V280, P34741, DOI 10.1074/jbc.M504165200; Claeysen S, 2000, MOL PHARMACOL, V58, P136, DOI 10.1124/mol.58.1.136; Claeysen S, 2003, J BIOL CHEM, V278, P699, DOI 10.1074/jbc.C200588200; Claeysen S, 2001, EMBO REP, V2, P61, DOI 10.1093/embo-reports/kve003; Compan Valerie, 2004, Journal de la Societe de Biologie, V198, P37; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Crowell MD, 2005, NEUROGASTROENT MOTIL, V17, P738, DOI 10.1111/j.1365-2982.2005.00681.x; DUMUIS A, 1988, MOL PHARMACOL, V34, P880; EASON MG, 1995, J BIOL CHEM, V270, P24753, DOI 10.1074/jbc.270.42.24753; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gay EA, 2004, MOL PHARMACOL, V66, P97, DOI 10.1124/mol.66.1.97; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Hayataka K, 1998, BIOCHEM CELL BIOL, V76, P657, DOI 10.1139/bcb-76-4-657; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Hsiao EC, 2007, J BONE MINER RES, V22, pS6; Joubert L, 2002, J BIOL CHEM, V277, P25502, DOI 10.1074/jbc.M202539200; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; Kaumann AJ, 2006, PHARMACOL THERAPEUT, V111, P674, DOI 10.1016/j.pharmthera.2005.12.004; Kenakin T, 2003, TRENDS PHARMACOL SCI, V24, P346, DOI 10.1016/S0165-6147(03)00167-6; Kushwaha N, 2006, MOL PHARMACOL, V69, P1518, DOI 10.1124/mol.105.019844; Lefebvre H, 2002, J CLIN ENDOCR METAB, V87, P1211, DOI 10.1210/jc.87.3.1211; Liu YF, 1999, J BIOL CHEM, V274, P16444, DOI 10.1074/jbc.274.23.16444; Malmberg A, 2000, J NEUROCHEM, V75, P1283, DOI 10.1046/j.1471-4159.2000.751283.x; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Orsetti M, 2003, LEARN MEMORY, V10, P420, DOI 10.1101/lm.67303; Ortiz TC, 2000, PHARMACOLOGY, V60, P195, DOI 10.1159/000028369; Pauwels PJ, 2003, TRENDS PHARMACOL SCI, V24, P504, DOI 10.1016/j.tips.2003.08.007; Peng JT, 2006, J BONE MINER RES, V21, pS99; Redfern CH, 1999, NAT BIOTECHNOL, V17, P165, DOI 10.1038/6165; Rivail L, 2004, BRIT J PHARMACOL, V143, P361, DOI 10.1038/sj.bjp.0705950; Ryman-Rasmussen JP, 2007, NEUROPHARMACOLOGY, V52, P562, DOI 10.1016/j.neuropharm.2006.08.028; Saidak Z, 2006, BRIT J PHARMACOL, V147, P671, DOI 10.1038/sj.bjp.0706661; Scearce-Levie K, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-3; Scearce-Levie K, 2001, TRENDS PHARMACOL SCI, V22, P414, DOI 10.1016/S0165-6147(00)01743-0; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Srinivasan S, 2003, ANN NY ACAD SCI, V994, P225, DOI 10.1111/j.1749-6632.2003.tb03184.x; SRINIVASAN S, PLOS ONE IN PRESS; Sweger EJ, 2007, J NEUROSCI, V27, P2309, DOI 10.1523/JNEUROSCI.4565-06.2007; Thiagaraj HV, 2007, NEUROCHEM INT, V50, P109, DOI 10.1016/j.neuint.2006.07.017; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	45	38	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1317	10.1371/journal.pone.0001317	http://dx.doi.org/10.1371/journal.pone.0001317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18338032	Green Published, gold			2022-12-25	WOS:000207459600005
J	Qiu, W; Wu, J; Walsh, EM; Zhang, Y; Chen, CY; Fujita, J; Xiao, ZXJ				Qiu, W.; Wu, J.; Walsh, E. M.; Zhang, Y.; Chen, C-Y; Fujita, J.; Xiao, Z-X J.			Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells	ONCOGENE			English	Article						chemotherapy; gankyrin; MDM2; p53; retinoblastoma protein	TUMOR-SUPPRESSOR; ACIDIC DOMAIN; ONCOPROTEIN MDM2; RB FUNCTION; DEGRADATION; PHOSPHORYLATION; PRB; PATHWAYS; PROMOTES; BINDING	MDM2 is a key ubiquitin E3 ligase for p53 and its activity is critically regulated by a set of modulators, including ARF, p300, YY1 and recently by gankyrin, an oncoprotein frequently overexpressed in human heptocellular carcinomas. We have previously shown that MDM2 binds to and promotes retinoblastoma protein ( Rb) degradation. Here we show that Rb inhibits MDM2 E3 ligase activity resulting in stabilization of p53. In addition, we demonstrated that Rb inhibits MDM2-mediated p53 ubiquitination in a gankyrin-dependent manner and the Rb-gankyrin interaction is critical for Rb-induced p53 stabilization. Furthermore, acute ablation of Rb facilitates gankyrin-mediated p53 destabilization, and desensitizes cancer cells for chemotherapy-induced apoptosis. These results indicate that Rb antagonizes gankyrin to inhibit MDM2-mediate p53 ubiquitination in cancer cells and suggest that the status of both p53 and Rb is important for efficacy of cancer chemotherapy.	[Qiu, W.; Wu, J.; Walsh, E. M.; Xiao, Z-X J.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Qiu, W.; Xiao, Z-X J.] Boston Univ, Sch Med, Dept Med, Grad Program Mol Med, Boston, MA 02118 USA; [Zhang, Y.] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA; [Chen, C-Y] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Fujita, J.] Kyoto Univ, Grad Sch Med, Dept Clin Mol Biol, Sakyo Ku, Kyoto, Japan	Boston University; Boston University; Boston University; Boston University; Kyoto University	Xiao, ZXJ (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St, Boston, MA 02118 USA.	jxiao@bu.edu			NATIONAL CANCER INSTITUTE [R01CA079804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070017] Funding Source: NIH RePORTER; NCI NIH HHS [CA79804] Funding Source: Medline; NIGMS NIH HHS [GM70017] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Argentini M, 2001, ONCOGENE, V20, P1267, DOI 10.1038/sj.onc.1204241; Beroud C, 1998, NUCLEIC ACIDS RES, V26, P200, DOI 10.1093/nar/26.1.200; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; CordonCardo C, 1997, CANCER RES, V57, P1217; Dawson S, 2006, TRENDS CELL BIOL, V16, P229, DOI 10.1016/j.tcb.2006.03.001; de Bruin A, 2003, P NATL ACAD SCI USA, V100, P6546, DOI 10.1073/pnas.1031853100; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; Gotz C, 1999, EUR J BIOCHEM, V266, P493, DOI 10.1046/j.1432-1327.1999.00882.x; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Higashitsuji H, 2005, CANCER CELL, V8, P75, DOI 10.1016/j.ccr.2005.06.006; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Hjerrild M, 2001, BIOCHEM J, V355, P347, DOI 10.1042/0264-6021:3550347; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Kulikov R, 2006, J BIOL CHEM, V281, P28575, DOI 10.1074/jbc.M513311200; Lipinski MM, 2001, EMBO J, V20, P3402, DOI 10.1093/emboj/20.13.3402; Ma JH, 2006, BIOCHEMISTRY-US, V45, P9238, DOI 10.1021/bi060661u; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0; Xu HJ, 1996, CLIN CANCER RES, V2, P1169; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	40	26	29	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 3	2008	27	29					4034	4043		10.1038/onc.2008.43	http://dx.doi.org/10.1038/onc.2008.43			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	321RV	18332869				2022-12-25	WOS:000257325100003
J	Chung, RS; Penkowa, M; Dittmann, J; King, CE; Bartlett, C; Asmussen, JW; Hidalgo, J; Carrasco, J; Leung, YKJ; Walker, AK; Fung, SJ; Dunlop, SA; Fitzgerald, M; Beazley, LD; Chuah, MI; Vickers, JC; West, AK				Chung, Roger S.; Penkowa, Milena; Dittmann, Justin; King, Carolyn E.; Bartlett, Carole; Asmussen, Johanne W.; Hidalgo, Juan; Carrasco, Javier; Leung, Yee Kee J.; Walker, Adam K.; Fung, Samantha J.; Dunlop, Sarah A.; Fitzgerald, Melinda; Beazley, Lyn D.; Chuah, Meng I.; Vickers, James C.; West, Adrian K.			Redefining the role of metallothionein within the injured brain - Extracellular metallothioneins play an important role in the astrocyte-neuron response to injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; II-DEFICIENT MICE; GENE-EXPRESSION; PROTECTIVE ROLE; NEURITE GROWTH; CNS; SURVIVAL; BINDING; DIFFERENTIATION; REGENERATION	A number of intracellular proteins that are protective after brain injury are classically thought to exert their effect within the expressing cell. The astrocytic metallothioneins (MT) are one example and are thought to act via intracellular free radical scavenging and heavy metal regulation, and in particular zinc. Indeed, we have previously established that astrocytic MTs are required for successful brain healing. Here we provide evidence for a fundamentally different mode of action relying upon intercellular transfer from astrocytes to neurons, which in turn leads to uptake-dependent axonal regeneration. First, we show that NIT can be detected within the extracellular fluid of the injured brain, and that cultured astrocytes are capable of actively secreting NIT in a regulatable manner. Second, we identify a receptor, megalin, that mediates NIT transport into neurons. Third, we directly demonstrate for the first time the transfer of NIT from astrocytes to neurons over a specific time course in vitro. Finally, we show that NIT is rapidly internalized via the cell bodies of retinal ganglion cells in vivo and is a powerful promoter of axonal regeneration through the inhibitory environment of the completely severed mature optic nerve. Our work suggests that the protective functions of NIT in the central nervous system should be widened from a purely astrocytic focus to include extracellular and intra-neuronal roles. This unsuspected action of NIT represents a novel paradigm of astrocyte-neuronal interaction after injury and may have implications for the development of MT-based therapeutic agents.	[Chung, Roger S.; Dittmann, Justin; Leung, Yee Kee J.; Walker, Adam K.; Fung, Samantha J.; Chuah, Meng I.; Vickers, James C.; West, Adrian K.] Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Hobart, Tas 7001, Australia; [Penkowa, Milena; Asmussen, Johanne W.] Univ Copenhagen, Fac Hlth Sci, Sect Neuroprotect, DK-2200 Copenhagen, Denmark; [King, Carolyn E.; Bartlett, Carole; Hidalgo, Juan; Carrasco, Javier; Dunlop, Sarah A.; Fitzgerald, Melinda; Beazley, Lyn D.] Univ Western Australia, Sch Anim Biol, Nedlands, WA 6907, Australia; [Hidalgo, Juan; Carrasco, Javier] Autonomous Univ Barcelona, Inst Neurosci, Barcelona 08193, Spain; [Hidalgo, Juan; Carrasco, Javier] Autonomous Univ Barcelona, Fac Sci, Dept Cell Biol Physiol & Immunol, Anim Physiol Unit, Barcelona 08193, Spain	University of Tasmania; Menzies Institute for Medical Research; University of Copenhagen; University of Western Australia; Autonomous University of Barcelona; Autonomous University of Barcelona	Chung, RS (corresponding author), Univ Tasmania, Menzies Res Inst, NeuroRepair Grp, Private Bag 58, Hobart, Tas 7001, Australia.	rschung@utas.edu.au	Dunlop, Sarah A/G-9357-2013; Fitzgerald, Melinda/C-4235-2011; Vickers, James C/J-7464-2014; Walker, Adam Keith/B-7418-2009; Hidalgo, Juan/C-9082-2011; Chuah, Meng Inn/J-7671-2014; West, Adrian/AAR-8857-2021; Chung, Roger/ABF-8395-2020; Fung, Samantha/C-9660-2011; Carrasco, Javier/C-9732-2011	Fitzgerald, Melinda/0000-0002-4823-8179; Vickers, James C/0000-0001-5671-4879; Walker, Adam Keith/0000-0001-7954-5801; Hidalgo, Juan/0000-0003-0921-1122; Carrasco, Javier/0000-0001-6436-0863; King, Carolyn/0000-0001-5097-8064; Chung, Roger/0000-0002-9286-947X; Dunlop, Sarah/0000-0002-1306-3962				Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Campagne MV, 1999, P NATL ACAD SCI USA, V96, P12870; Ceballos D, 2003, CELL MOL LIFE SCI, V60, P1209, DOI 10.1007/s00018-003-3047-2; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chung RS, 2004, J NEUROCHEM, V88, P454, DOI 10.1046/j.1471-4159.2003.02193.x; Chung RS, 2003, J NEUROSCI, V23, P3336; Chung RS, 2002, BIOCHEM J, V365, P323, DOI 10.1042/BJ20011751; Chung RS, 2004, NEUROSCIENCE, V123, P595, DOI 10.1016/j.neuroscience.2003.10.019; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fitzgerald M, 2007, EXP BRAIN RES, V183, P171, DOI 10.1007/s00221-007-1032-y; GASULL T, 1993, J IMMUNOASSAY, V14, P209, DOI 10.1080/15321819308019851; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; HIDALGO J, 1994, CHEM-BIOL INTERACT, V93, P197, DOI 10.1016/0009-2797(94)90020-5; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; KIKUCHI Y, 1993, FEBS LETT, V317, P22, DOI 10.1016/0014-5793(93)81483-G; King CE, 1997, NEUROREPORT, V8, P1663; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; Klassen RB, 2004, AM J PHYSIOL-RENAL, V287, pF393, DOI 10.1152/ajprenal.00233.2003; Kohler LB, 2003, BRAIN RES, V992, P128, DOI 10.1016/j.brainres.2003.08.049; Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; Pedersen MV, 2004, J NEUROSCI RES, V75, P55, DOI 10.1002/jnr.10812; Penkowa M, 2006, J NEUROSCI RES, V83, P974, DOI 10.1002/jnr.20790; Penkowa M, 2001, EXP NEUROL, V170, P1, DOI 10.1006/exnr.2001.7675; Penkowa M, 1999, J NEUROSCI, V19, P2535; Penkowa M, 2001, J NEUROIMMUNOL, V119, P248, DOI 10.1016/S0165-5728(01)00357-5; Puttaparthi K, 2002, J NEUROSCI, V22, P8790; Ronn LCB, 2000, J NEUROSCI METH, V100, P25, DOI 10.1016/S0165-0270(00)00228-4; Schousboe A., 1989, DISSECTION TISSUE CU, P203; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Trayhurn P, 2000, AM J PHYSIOL-REG I, V279, pR2329, DOI 10.1152/ajpregu.2000.279.6.R2329; Trayhurn P, 2000, HORM METAB RES, V32, P542, DOI 10.1055/s-2007-978683; Uchida Y, 2002, J BIOL CHEM, V277, P32353, DOI 10.1074/jbc.M111263200; Vincent AJ, 2005, GLIA, V51, P132, DOI 10.1002/glia.20195; West AK, 2004, REV NEUROSCIENCE, V15, P157; Wolff NA, 2006, J PHARMACOL EXP THER, V318, P782, DOI 10.1124/jpet.106.102574; Xie T, 2004, J NEUROSCI, V24, P7043, DOI 10.1523/JNEUROSCI.1626-04.2004; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	38	121	126	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15349	15358		10.1074/jbc.M708446200	http://dx.doi.org/10.1074/jbc.M708446200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18334482	Green Published, hybrid			2022-12-25	WOS:000256232000053
J	Sakaki, K; Wu, J; Kaufman, RJ				Sakaki, Kenjiro; Wu, Jun; Kaufman, Randal J.			Protein kinase C theta is required for autophagy in response to stress in the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PKC-THETA; ER STRESS; INSULIN-RESISTANCE; CELL-DEATH; ACTIVATION LOOP; APOPTOSIS; SURVIVAL; OBESITY; ROLES; BETA	Autophagy is an evolutionally conserved process for the bulk degradation of cytoplasmic proteins and organelles. Recent observations indicate that autophagy is induced in response to cellular insults that result in the accumulation of misfolded proteins in the lumen of the endoplasmic reticulum (ER). However, the signaling mechanisms that activate autophagy under these conditions are not understood. Here, we report that ER stress-induced autophagy requires the activation of protein kinase C theta (PKC theta), a member of the novel-type PKC family. Induction of ER stress by treatment with either thapsigargin or tunicamycin activated autophagy in immortalized hepatocytes as monitored by the conversion LC3-I to LC3-II, clustering of LC3 into dot-like cytoplasmic structures, and electron microscopic detection of autophago-somes. Pharmacological inhibition of PKC theta or small interfering RNA-mediated knockdown of PKC theta prevented the autophagic response to ER stress. Treatment with ER stressors induced PKC theta phosphorylation within the activation loop and localization of phospho-PKC theta to LC3-containing dot structures in the cytoplasm. However, signaling through the known unfolded protein response sensors was not required for PKC theta activation. PKC theta activation and stress-induced autophagy were blocked by chelation of intracellular Ca2+ with BAPTA-AM. PKC theta was not activated or required for autophagy in response to amino acid starvation. These observations indicate that Ca2+-dependent PKC theta activation is specifically required for autophagy in response to ER stress but not in response to amino acid starvation.	[Kaufman, Randal J.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Sakaki, Kenjiro; Wu, Jun] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kaufman, RJ (corresponding author), Univ Michigan, Sch Med, Howard Hughes Med Inst, 4570 MSRB II,1150 W Med Ctr, Ann Arbor, MI 48109 USA.	kaufmanr@umich.edu			NHLBI NIH HHS [P01 HL 057346, R01 HL 052173] Funding Source: Medline; NIDDK NIH HHS [R01 DK 042934] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173, P01HL057346] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akar U, 2007, MOL CANCER RES, V5, P241, DOI 10.1158/1541-7786.MCR-06-0229; Altman A, 2003, IMMUNOL REV, V192, P53, DOI 10.1034/j.1600-065X.2003.00027.x; Altman A, 2002, J BIOCHEM, V132, P841, DOI 10.1093/oxfordjournals.jbchem.a003295; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; BERRY MN, 1991, ISOLATED HEPATOCYTES, P59; Choi EY, 2007, LIFE SCI, V80, P436, DOI 10.1016/j.lfs.2006.09.044; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Criollo A, 2007, AUTOPHAGY, V3, P350, DOI 10.4161/auto.4077; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Ferrari D, 2002, CELL CALCIUM, V32, P413, DOI 10.1016/S0143416002002014; Fujita M, 2007, J BIOL CHEM, V282, P5736, DOI 10.1074/jbc.M606175200; Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Haasch D, 2006, BIOCHEM BIOPH RES CO, V343, P361, DOI 10.1016/j.bbrc.2006.02.177; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; He CC, 2006, ACS CHEM BIOL, V1, P211, DOI 10.1021/cb600182h; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kitatani K, 2007, J BIOL CHEM, V282, P20647, DOI 10.1074/jbc.M609162200; Klarl BA, 2006, AM J PHYSIOL-CELL PH, V290, pC244, DOI 10.1152/ajpcell.00283.2005; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Lee W, 2005, APOPTOSIS, V10, P407, DOI 10.1007/s10495-005-0814-6; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nagai K, 2006, J NUTR BIOCHEM, V17, P525, DOI 10.1016/j.jnutbio.2005.09.007; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Oakes SA, 2006, CURR MOL MED, V6, P99, DOI 10.2174/156652406775574587; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Sousa M, 1996, MOL HUM REPROD, V2, P967, DOI 10.1093/molehr/2.12.967; Sparatore B, 2003, FEBS LETT, V554, P35, DOI 10.1016/S0014-5793(03)01073-1; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Valverde AM, 2003, DIABETES, V52, P2239, DOI 10.2337/diabetes.52.9.2239; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200	62	144	150	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15370	15380		10.1074/jbc.M710209200	http://dx.doi.org/10.1074/jbc.M710209200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18356160	Green Published, hybrid			2022-12-25	WOS:000256232000055
J	Galmiche, A; Fueller, J; Santel, A; Krohne, G; Wittig, I; Doye, A; Rolando, M; Flatau, G; Lemichez, E; Rapp, UR				Galmiche, Antoine; Fueller, Jochen; Santel, Ansgar; Krohne, Georg; Wittig, Ilka; Doye, Anne; Rolando, Monica; Flatau, Gilles; Lemichez, Emmanuel; Rapp, Ulf R.			Isoform-specific interaction of C-RAF with mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP-KINASE-KINASE; B-RAF; PLASMA-MEMBRANE; A-RAF; LOCALIZATION; PROTEINS; PHOSPHORYLATION; PROLIFERATION; FRAGMENTATION; INACTIVATION	The proteins of the RAF family (A-RAF, B-RAF, and C-RAF) are serine/threonine kinases that play important roles in development, mature cell regulation, and cancer. Although it is widely held that their localization on membranes is an important aspect of their function, there are few data that address this aspect of their mode of action. Here, we report that each member of the RAF family exhibits a specific distribution at the level of cellular membranes and that C-RAF is the only isoform that directly targets mitochondria. We found that the RAF kinases exhibit intrinsic differences in terms of mitochondrial affinity and that C-RAF is the only isoform that binds this organelle efficiently. This affinity is conferred by the C-RAF amino-terminal domain and does not depend on the presence of RAS GTPases on the surface of mitochondria. Finally, we analyzed the consequences of C-RAF activation on mitochondria and observed that this event dramatically changes their morphology and their subcellular distribution. Our observations indicate that: (i) RAF kinases exhibit different localizations at the level of cellular membranes; (ii) C-RAF is the only isoform that directly binds mitochondria; and (iii) through its functional coupling with MEK, C-RAF regulates the shape and the cellular distribution of mitochondria.	[Galmiche, Antoine; Fueller, Jochen; Rapp, Ulf R.] Univ Wurzburg, Inst Med Strahlenkunde & Zellforschung, D-97078 Wurzburg, Germany; [Santel, Ansgar] Silence Therapeut AG, D-13125 Berlin, Germany; [Krohne, Georg] Univ Wurzburg, Bioctr, Div Elect Microscopy, D-97074 Wurzburg, Germany; [Wittig, Ilka] Univ Frankfurt Klinikum, Zentrum Biol Chem Mol Bioenerget, D-60590 Frankfurt, Germany; [Doye, Anne; Rolando, Monica; Flatau, Gilles; Lemichez, Emmanuel] INSERM, U895, Ctr Mediterraneen Med Mol C3M, F-06204 Nice 3, France; [Doye, Anne; Rolando, Monica; Flatau, Gilles; Lemichez, Emmanuel] Univ Nice Sophia Antipolis, UFR Med, F-06204 Nice, France; [Lemichez, Emmanuel] Univ Nice, Ctr Hosp, Serv Bacteriol, Hop Archet 2, F-06204 Nice, France	University of Wurzburg; University of Wurzburg; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur	Galmiche, A (corresponding author), Univ Wurzburg, Inst Med Strahlenkunde & Zellforschung, Versbacher Str 5, D-97078 Wurzburg, Germany.	antoine.galmiche@mail.uni-wuerzburg.de	Lemichez, Emmanuel/G-3559-2013	Lemichez, Emmanuel/0000-0001-9080-7761; Rolando, Monica/0000-0002-3710-0115				Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Baljuls A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702429200; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Carey KD, 2003, J BIOL CHEM, V278, P3185, DOI 10.1074/jbc.M207014200; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Colanzi A, 2003, J CELL BIOL, V161, P27, DOI 10.1083/jcb.200208099; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Galmiche A, 2007, BBA-MOL CELL RES, V1773, P1256, DOI 10.1016/j.bbamcr.2006.10.012; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Gotz R, 2005, NAT NEUROSCI, V8, P1169, DOI 10.1038/nn1524; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hindley A, 2002, J CELL SCI, V115, P1575; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Kerkhoff E, 1997, MOL CELL BIOL, V17, P2576, DOI 10.1128/MCB.17.5.2576; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Plowman SJ, 2005, BBA-MOL CELL RES, V1746, P274, DOI 10.1016/j.bbamcr.2005.06.004; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Santel A, 2006, BBA-MOL CELL RES, V1763, P490, DOI 10.1016/j.bbamcr.2006.02.004; Shaul YD, 2006, J CELL BIOL, V172, P885, DOI 10.1083/jcb.200509063; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; STANCATO LF, 1993, J BIOL CHEM, V268, P21711; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Wang G, 2006, MOL CELL BIOL, V26, P3243, DOI 10.1128/MCB.26.8.3243-3255.2006; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wiese S, 2001, NAT NEUROSCI, V4, P137, DOI 10.1038/83960; Yuryev A, 2000, MOL CELL BIOL, V20, P4870, DOI 10.1128/MCB.20.13.4870-4878.2000	42	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14857	14866		10.1074/jbc.M709098200	http://dx.doi.org/10.1074/jbc.M709098200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18356164	hybrid			2022-12-25	WOS:000255941400073
J	Gomez-Quiroz, LE; Factor, VM; Kaposi-Novak, P; Coulouarn, C; Conner, EA; Thorgeirsson, SS				Gomez-Quiroz, Luis E.; Factor, Valentina M.; Kaposi-Novak, Pal; Coulouarn, Cedric; Conner, Elizabeth A.; Thorgeirsson, Snorri S.			Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FETAL-RAT HEPATOCYTES; NF-KAPPA-B; GROWTH-FACTOR; OXIDATIVE STRESS; REACTIVE OXYGEN; SIGNALING PATHWAY; CELL-DEATH; ACTIVATION; EXPRESSION; PROTECTS	The hepatocyte growth factor and its receptor c-Met direct a pleiotropic signal transduction pathway that controls cell survival. We previously demonstrated that mice lacking c-Met (Met-KO) in hepatocytes were hypersensitive to Fas-induced liver injury. In this study, we used primary hepatocytes isolated from Met-KO and control (Cre-Ctrl) mice to address more directly the protective effects of c-Met signaling. Loss of c-Met function increased sensitivity to Fas-mediated apoptosis. Hepatocyte growth factor suppressed apoptosis in Cre-Ctrl but not Met-KO hepatocytes concurrently with up-regulation of NF-kappa B and major antiapoptotic proteins Bcl-2 and Bcl-xL. Intriguingly, Met-KO hepatocytes exhibited intrinsic activation of NF-kappa B as well as Bcl-2 and Bcl-xL. Furthermore, unchallenged Met-KO cells displayed oxidative stress as evidenced by overproduction of reactive oxygen species, which was associated with greater NADPH and Rac1 activities, was blocked by the known NADPH oxidase inhibitors, and was paralleled by increased lipid peroxidation and reduced glutathione (GSH) content. N-Acetylcysteine, an antioxidant and GSH precursor, significantly reduced Jo2-induced cell death. Conversely, the GSH-depleting agent buthionine sulfoximine completely abolished the protective effects of N-acetylcysteine in Met-KO hepatocytes. In conclusion, genetic inactivation of c-Met in mouse hepatocytes caused defects in redox regulation, which may account for the increased sensitivity to Fas-induced apoptosis and adaptive up-regulation of NF-kappa B survival signaling. These data provide evidence that intact c-Met signaling is a critical factor in the protection against excessive generation of endogenous reactive oxygen species.	[Gomez-Quiroz, Luis E.; Factor, Valentina M.; Kaposi-Novak, Pal; Coulouarn, Cedric; Conner, Elizabeth A.; Thorgeirsson, Snorri S.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Thorgeirsson, SS (corresponding author), 37 Convent Dr,Bldg 37,Rm 4146A, Bethesda, MD 20892 USA.	snorri_s_thorgeirsson@nih.gov	Coulouarn, Cedric/E-5472-2011; Gomez-Quiroz, Luis/L-8415-2013	Coulouarn, Cedric/0000-0002-5692-9586; Gomez-Quiroz, Luis Enrique/0000-0002-5704-5985	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010638] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson ME, 1998, SEMIN LIVER DIS, V18, P415, DOI 10.1055/s-2007-1007174; Arena S, 2007, P NATL ACAD SCI USA, V104, P11412, DOI 10.1073/pnas.0703205104; Buege J A, 1978, Methods Enzymol, V52, P302; Carmona-Cuenca I, 2006, J CELL PHYSIOL, V207, P322, DOI 10.1002/jcp.20568; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Comoglio PM, 2001, NAT CELL BIOL, V3, pE161, DOI 10.1038/35083116; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Devadas S, 2003, FREE RADICAL BIO MED, V35, P648, DOI 10.1016/S0891-5849(03)00391-5; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Fan SJ, 2005, ONCOGENE, V24, P1749, DOI 10.1038/sj.onc.1208327; FARISS MW, 1987, METHOD ENZYMOL, V143, P101; Femandez-Checa JC, 2005, TOXICOL APPL PHARM, V204, P263, DOI 10.1016/j.taap.2004.10.001; Fornoni A, 2001, AM J PATHOL, V158, P275, DOI 10.1016/S0002-9440(10)63966-1; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970; Hatano E, 2001, AM J PHYSIOL-GASTR L, V281, pG1357, DOI 10.1152/ajpgi.2001.281.6.G1357; Herrera B, 2004, FREE RADICAL BIO MED, V36, P16, DOI 10.1016/j.freeradbiomed.2003.09.020; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kannan R, 2004, FREE RADICAL BIO MED, V37, P166, DOI 10.1016/j.freeradbiomed.2004.04.011; Kao CY, 1996, BIOCHEM BIOPH RES CO, V222, P64, DOI 10.1006/bbrc.1996.0698; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Min JK, 2005, CIRC RES, V96, P300, DOI 10.1161/01.RES.0000155330.07887.EE; Morante M, 2005, FREE RADICAL RES, V39, P1127, DOI 10.1080/10715760500193820; Moumen A, 2007, HEPATOLOGY, V45, P1210, DOI 10.1002/hep.21604; Muller M, 2002, MOL CELL BIOL, V22, P1060, DOI 10.1128/MCB.22.4.1060-1072.2002; Nakagawa T, 1996, MUTAT RES-ENVIR MUTA, V360, P181, DOI 10.1016/S0165-1161(96)90015-1; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Ozaki M, 2003, CELL DEATH DIFFER, V10, P508, DOI 10.1038/sj.cdd.4401172; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Sanchez A, 2004, HEPATOLOGY, V40, P590, DOI 10.1002/hep.20363; Sangwan V, 2006, J BIOL CHEM, V281, P221, DOI 10.1074/jbc.M507858200; Santangelo C, 2007, J MOL ENDOCRINOL, V38, P147, DOI 10.1677/jme.1.02133; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schulze-Bergkamen H, 2004, HEPATOLOGY, V39, P645, DOI 10.1002/hep.20138; Shiba D, 1999, FREE RADICAL BIO MED, V27, P1019, DOI 10.1016/S0891-5849(99)00150-1; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Takami T, 2007, CANCER RES, V67, P9844, DOI 10.1158/0008-5472.CAN-07-1905; Tripathi P, 2004, APOPTOSIS, V9, P515, DOI 10.1023/B:APPT.0000038033.14925.02; Tsuboi S, 1999, J BIOCHEM-TOKYO, V126, P815, DOI 10.1093/oxfordjournals.jbchem.a022521; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Wang X, 2002, MOL CELL, V9, P411, DOI 10.1016/S1097-2765(02)00439-2; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898	46	63	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14581	14589		10.1074/jbc.M707733200	http://dx.doi.org/10.1074/jbc.M707733200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18348981	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000255941400046
J	Yamakoshi, Y; Lu, Y; Hu, JCC; Kim, JW; Iwata, T; Kobayashi, K; Nagano, T; Yamakoshi, F; Hu, Y; Fukae, M; Simmer, JP				Yamakoshi, Yasuo; Lu, Yuhe; Hu, Jan C. -C.; Kim, Jung-Wook; Iwata, Takanori; Kobayashi, Kazuyuki; Nagano, Takatoshi; Yamakoshi, Fumiko; Hu, Yuanyuan; Fukae, Makoto; Simmer, James P.			Porcine dentin sialophosphoprotein - Length polymorphisms, glycosylation, phosphorylation, and stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPERFECTA TYPE-II; DENTINOGENESIS IMPERFECTA; SEQUENCE DETERMINATION; MATRIX PROTEINS; IN-VITRO; DSPP; PHOSPHOPROTEIN; PHOSPHOPHORYN; SIALOPROTEIN; GENE	Dentin sialophosphoprotein (DSPP) is critical for proper mineralization of tooth dentin, and mutations in DSPP cause inherited dentin defects. Dentin phosphoprotein (DPP) is the C-terminal cleavage product of DSPP that binds collagen and induces intrafibrillar mineralization. We isolated DPP from individual pigs and determined that its N-terminal and C-terminal domains are glycosylated and that DPP averages 155 phosphates per molecule. Porcine DPP is unstable at low pH and high temperatures, and complexing with collagen improves its stability. Surprisingly, we observed DPP size variations on SDS-PAGE for DPP isolated from individual pigs. These variations are not caused by differences in proteolytic processing or degrees of phosphorylation or glycosylation, but rather to allelic variations in Dspp. Characterization of the DPP coding region identified 4 allelic variants. Among the 4 alleles, 27 sequence variations were identified, including 16 length polymorphisms ranging from 3 to 63 nucleotides. None of the length variations shifted the reading frame, and all localized to the highly redundant region of the DPP code. The 4 alleles encode DPP domains having 551, 575, 589, or 594 amino acids and completely explain the DPP size variations. DPP length variations are polymorphic and are not associated with dentin defects.	[Yamakoshi, Yasuo; Nagano, Takatoshi; Simmer, James P.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48108 USA; [Hu, Yuanyuan] Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48108 USA; [Kim, Jung-Wook] Seoul Natl Univ, Sch Dent, Dept Pediat Dent, Seoul 110768, South Korea; [Kim, Jung-Wook] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul 110768, South Korea; [Nagano, Takatoshi] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan; [Kobayashi, Kazuyuki; Nagano, Takatoshi] Tsurumi Univ, Sch Dent Med, Dept Periodont & Endodont, Yokohama, Kanagawa 2308501, Japan; [Fukae, Makoto] Tsurumi Univ, Sch Dent Med, Dept Biochem, Yokohama, Kanagawa 2308501, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Seoul National University (SNU); Seoul National University (SNU); Tokyo Women's Medical University; Tsurumi University; Tsurumi University	Simmer, JP (corresponding author), Univ Michigan, Dent Res Lab, 1210 Eisenhower Pl, Ann Arbor, MI 48108 USA.	jsimmer@umich.edu	Hu, Jan C-C./F-5679-2015; Iwata, Takanori/AAT-3219-2020	Hu, Jan C-C./0000-0002-9294-0248; Iwata, Takanori/0000-0002-5461-7298	NIDCR NIH HHS [R01 DE011301, DE 15846, R01 DE015846, R01 DE015846-05, R29 DE011301, R56 DE011301, DE 11301] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011301, R01DE011301, R29DE011301] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BUTLER WT, 1983, ARCH BIOCHEM BIOPHYS, V225, P178, DOI 10.1016/0003-9861(83)90021-8; BUTLER WT, 1981, COLLAGEN REL RES, V1, P187; Butler WT, 1998, EUR J ORAL SCI, V106, P204, DOI 10.1111/j.1600-0722.1998.tb02177.x; Chang SR, 1996, CALCIFIED TISSUE INT, V59, P149, DOI 10.1007/s002239900101; Cross KJ, 2005, J PEPT RES, V66, P59, DOI 10.1111/j.1399-3011.2005.00273.x; Dong J, 2005, AM J MED GENET A, V132A, P305, DOI 10.1002/ajmg.a.30460; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Gu K, 2000, EUR J ORAL SCI, V108, P35, DOI 10.1034/j.1600-0722.2000.00765.x; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Hart PS, 2007, CELLS TISSUES ORGANS, V186, P70, DOI 10.1159/000102682; Holappa H, 2006, EUR J ORAL SCI, V114, P381, DOI 10.1111/j.1600-0722.2006.00391.x; Huq NL, 2000, J DENT RES, V79, P1914, DOI 10.1177/00220345000790111701; IBARAKI K, 1991, MATRIX, V11, P115, DOI 10.1016/S0934-8832(11)80215-5; JONSSON M, 1978, J CHROMATOGR, V157, P234; Kim JW, 2007, J DENT RES, V86, P392, DOI 10.1177/154405910708600502; Kim JW, 2005, HUM GENET, V116, P186, DOI 10.1007/s00439-004-1223-6; Kim JW, 2004, HUM GENET, V115, P248, DOI 10.1007/s00439-004-1143-5; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Malmgren B, 2004, HUM GENET, V114, P491, DOI 10.1007/s00439-004-1084-z; Patel PI, 2001, NAT GENET, V27, P129, DOI 10.1038/84728; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2003, EUR J ORAL SCI, V111, P235, DOI 10.1034/j.1600-0722.2003.00043.x; RITCHIE HH, 1994, J BIOL CHEM, V269, P3698; Song YL, 2006, ORAL SURG ORAL MED O, V102, P360, DOI 10.1016/j.tripleo.2005.06.020; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; TERMINE JD, 1980, J BIOL CHEM, V255, P9769; Thomas LJ, 2004, GLYCOBIOLOGY, V14, P883, DOI 10.1093/glycob/cwh112; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamakoshi Y, 2005, J BIOL CHEM, V280, P1552, DOI 10.1074/jbc.M409606200; Yamakoshi Y, 2005, J BIOL CHEM, V280, P17472, DOI 10.1074/jbc.M413220200; Yamakoshi Y, 2003, EUR J ORAL SCI, V111, P60, DOI 10.1034/j.1600-0722.2003.00009.x; YAMAKOSHI Y, 2008, IN PRESS J ORAL BIOS; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Zhang XQ, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-52	34	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14835	14844		10.1074/jbc.M800633200	http://dx.doi.org/10.1074/jbc.M800633200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18359767	Green Published, hybrid			2022-12-25	WOS:000255941400071
J	Saito, T; Nishi, M; Lim, MI; Wu, B; Maeda, T; Hashimoto, H; Takeuchi, T; Roos, DS; Asai, T				Saito, Tomoya; Nishi, Manami; Lim, Muoy I.; Wu, Bo; Maeda, Takuya; Hashimoto, Hisayuki; Takeuchi, Tsutomu; Roos, David S.; Asai, Takashi			A novel GDP-dependent pyruvate kinase isozyme from Toxoplasma gondii localizes to both the apicoplast and the mitochondrion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE PLASMODIUM-FALCIPARUM; NUCLEOSIDE TRIPHOSPHATE HYDROLASE; ESCHERICHIA-COLI; SUBCELLULAR-LOCALIZATION; ALLOSTERIC TRANSITION; REGULATORY PROPERTIES; SIGNAL PEPTIDES; ORTHOLOG GROUPS; CLEAVAGE SITES; METABOLIC MAPS	We previously reported a cytosolic pyruvate kinase (EC 2.7.1.40) from Toxoplasma gondii (TgPyKI) that differs from most eukaryotic pyruvate kinases in being regulated by glucose 6-phosphate rather than fructose 1,6-diphosphate. Another putative pyruvate kinase (TgPyKII) was identified from parasite genome, which exhibits 32% amino acid sequence identity to TgPyKI and retains pyruvate kinase signature motifs and amino acids essential for substrate binding and catalysis. Whereas TgPyKI is most closely related to plant/algal enzymes, phylogenetic analysis suggests a proteobacterial origin for TgPyKII. Enzymatic characterization of recombinant TgPyKII shows a high pH optimum at 8.5, and a preference for GDP as a phosphate recipient. Catalytic activity is independent of K+, and no allosteric or regulatory effects were observed in the presence of fructose 1,6-diphosphate, fructose 2,6-diphosphate, glucose 6-phosphate, ribose 5-phosphate, AMP, or ATP. Unlike TgPyKI, native TgPyKII activity was exclusively associated with the membranous fraction of a T. gondii tachyzoite lysate. TgPyKII possesses a long N-terminal extension containing five putative start codons before the conserved region and localizes to both apicoplast and mitochondrion by immunofluorescence assay using native antibody and fluorescent protein fusion to the N-terminal extension. Further deletional and site-directed mutagenesis suggests that a translation product from 1st Met is responsible for the localization to the apicoplast, whereas one from 3rd Met is for the mitochondrion. This is the first study of a potential mitochondrial pyruvate kinase in any system.	[Saito, Tomoya; Maeda, Takuya; Hashimoto, Hisayuki; Takeuchi, Tsutomu; Asai, Takashi] Keio Univ, Sch Med, Dept Trop Med & Parasitol, Shinjuku Ku, Tokyo 1608582, Japan; [Nishi, Manami; Lim, Muoy I.; Wu, Bo; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Keio University; University of Pennsylvania	Asai, T (corresponding author), Keio Univ, Sch Med, Dept Trop Med & Parasitol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	asait@sc.itc.keio.ac.jp	Hashimoto, Hisayuki/AAS-1938-2020	Hashimoto, Hisayuki/0000-0001-7367-4805; Roos, David Siker/0000-0001-6725-4089; Maeda, Takuya/0000-0003-0912-4643; Saito, Tomoya/0000-0001-6250-4464				ABBE K, 1982, J BACTERIOL, V149, P299, DOI 10.1128/JB.149.1.299-305.1982; ASAI T, 1990, FEMS MICROBIOL LETT, V72, P89, DOI 10.1111/j.1574-6968.1990.tb03867.x; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BOYER PD, 1962, ENZYMES, P95; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Coombs GH, 1997, ADV PARASIT, V39, P141, DOI 10.1016/S0065-308X(08)60046-9; Crawford MJ, 2006, EMBO J, V25, P3214, DOI 10.1038/sj.emboj.7601189; CROW VL, 1982, METHOD ENZYMOL, V90, P165, DOI 10.1016/S0076-6879(82)90122-7; Denton H, 1996, MOL BIOCHEM PARASIT, V76, P23, DOI 10.1016/0166-6851(95)02527-8; Denton H, 1996, FEMS MICROBIOL LETT, V137, P103, DOI 10.1111/j.1574-6968.1996.tb08090.x; Dhanasekaran S, 2004, J BIOL CHEM, V279, P6934, DOI 10.1074/jbc.M311409200; Dubey J., 1993, PARASITIC PROTOZOA, P5; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Esposito S, 2001, PLANTA, V212, P627, DOI 10.1007/s004250000443; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; Fulton J. D., 1960, Experimental Parasitology, V9, P293, DOI 10.1016/0014-4894(60)90037-0; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goodman CD, 2007, CURR DRUG TARGETS, V8, P15, DOI 10.2174/138945007779315579; Hattori J, 1995, BIOCHEM SYST ECOL, V23, P773, DOI 10.1016/0305-1978(95)00061-5; Hoffman SL, 2002, NATURE, V415, P702, DOI 10.1038/415702a; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; IRELAND RJ, 1979, PLANT PHYSIOL, V63, P903, DOI 10.1104/pp.63.5.903; IRELAND RJ, 1980, PLANT PHYSIOL, V65, P1188, DOI 10.1104/pp.65.6.1188; JAULT JM, 1991, J BIOL CHEM, V266, P8073; Jelenska J, 2001, P NATL ACAD SCI USA, V98, P2723, DOI 10.1073/pnas.051629998; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; KAHN A, 1982, METHOD ENZYMOL, V90, P131; KAPOOR R, 1981, BIOCHEM J, V193, P435, DOI 10.1042/bj1930435; Kissinger JC, 2003, NUCLEIC ACIDS RES, V31, P234, DOI 10.1093/nar/gkg072; KROGH A, 1998, P 6 INT C INT SYST M, P122; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033; Laughlin LT, 1997, ARCH BIOCHEM BIOPHYS, V348, P262, DOI 10.1006/abbi.1997.0448; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Maeda T, 2003, PARASITOL RES, V89, P259, DOI 10.1007/s00436-002-0739-8; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; Melo EJL, 2000, J STRUCT BIOL, V130, P27, DOI 10.1006/jsbi.2000.4228; MUIRHEAD H, 1986, EMBO J, V5, P475, DOI 10.1002/j.1460-2075.1986.tb04236.x; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NISHI M, 2006, THESIS U PENNSYLVANI; Olejnik K, 2007, FEBS J, V274, P4877, DOI 10.1111/j.1742-4658.2007.06009.x; Oria-Hernandez J, 2006, J BIOL CHEM, V281, P30717, DOI 10.1074/jbc.M605310200; Peeters N, 2001, BBA-MOL CELL RES, V1541, P54, DOI 10.1016/S0167-4889(01)00146-X; PENG ZY, 1992, MOL BIOCHEM PARASIT, V54, P223, DOI 10.1016/0166-6851(92)90114-Y; Pino P, 2007, PLOS PATHOG, V3, P1092, DOI 10.1371/journal.ppat.0030115; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; PLOWMAN KM, 1965, BIOCHEMISTRY-US, V4, P2809, DOI 10.1021/bi00888a035; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Roos DS, 1999, CURR OPIN MICROBIOL, V2, P426, DOI 10.1016/S1369-5274(99)80075-7; Saavedra E, 2004, EXP PARASITOL, V106, P11, DOI 10.1016/j.exppara.2004.01.009; Saito T, 2002, INT J PARASITOL, V32, P961, DOI 10.1016/S0020-7519(02)00059-0; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SIBLEY LD, 1994, EXP PARASITOL, V79, P301, DOI 10.1006/expr.1994.1093; SIMCOX PD, 1978, PLANT PHYSIOL, V61, P871, DOI 10.1104/pp.61.6.871; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; VANSCHAFTINGEN E, 1992, ADV ENZYME REGUL, V32, P133; Vercesi AE, 1998, J BIOL CHEM, V273, P31040, DOI 10.1074/jbc.273.47.31040; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; WAYGOOD EB, 1974, J BIOL CHEM, V249, P265; WAYGOOD EB, 1975, CAN J BIOCHEM CELL B, V53, P444, DOI 10.1139/o75-061; Wiesner J, 2005, EXPERT OPIN THER TAR, V9, P23, DOI 10.1517/14728222.9.1.23; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449	73	39	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14041	14052		10.1074/jbc.M709015200	http://dx.doi.org/10.1074/jbc.M709015200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18326043	Green Published, hybrid			2022-12-25	WOS:000255728200058
J	Cheng, KT; Liu, XB; Ong, HL; Ambudkar, IS				Cheng, Kwong Tai; Liu, Xibao; Ong, Hwei Ling; Ambudkar, Indu S.			Functional requirement for Orai1 in store-operated TRPC1-STIM1 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CALCIUM-CHANNELS; SALIVARY-GLAND CELLS; CRAC CHANNEL; CA2+ INFLUX; TRPC CHANNELS; PORE SUBUNIT; ENTRY; STIM1; PROTEIN; MICE	Orai1 and TRPC1 have been proposed as core components of store-operated calcium release-activated calcium ( CRAC) and store-operated calcium (SOC) channels, respectively. STIM1, a Ca2+ sensor protein in the endoplasmic reticulum, interacts with and mediates store-dependent regulation of both channels. We have previously reported that dynamic association of Orai1, TRPC1, and STIM1 is involved in activation of store-operated Ca2+ entry ( SOCE) in salivary gland cells. In this study, we have assessed the molecular basis of TRPC1-SOC channels in HEK293 cells. We report that TRPC1+STIM1-dependent SOCE requires functional Orai1. Thapsigargin stimulation of cells expressing Orai1 + STIM1 increased Ca2+ entry and activated typical I-CRAC current. STIM1 alone did not affect SOCE, whereas expression of Orai1 induced a decrease. Expression of TRPC1 induced a small increase in SOCE, which was greatly enhanced by co-expression of STIM1. Thapsigargin stimulation of cells expressing TRPC1 + STIM1 activated a non-selective cation current, I-SOC, that was blocked by 1 mu M Gd3+ and 2-APB. Knockdown of Orai1 decreased endogenous SOCE as well as SOCE with TRPC1 alone. siOrai1 also significantly reduced SOCE and ISOC in cells expressing TRPC1 + STIM1. Expression of R91WOrai1 or E106QOrai1 induced similar attenuation of TRPC1 + STIM1-dependent SOCE and ISOC, whereas expression of Orai1 with TRPC1 + STIM1 resulted in SOCE that was larger than that with Orai1 + STIM1 or TRPC1 + STIM1 but not additive. Additionally, Orai1, E106QOrai1, and R91WOrai1 co-immunoprecipitated with similar levels of TRPC1 and STIM1 from HEK293 cells, and endogenous TRPC1, STIM1, and Orai1 were co-immunoprecipitated from salivary glands. Together, these data demonstrate a functional requirement for Orai1 in TRPC1 + STIM1-dependent SOCE.	[Cheng, Kwong Tai; Liu, Xibao; Ong, Hwei Ling; Ambudkar, Indu S.] NIDCR, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ambudkar, IS (corresponding author), NIDCR, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, NIH, Bldg 10,Rm 1N-113, Bethesda, MD 20892 USA.	indu.ambudkar@nih.gov		Ong, Hwei Ling/0000-0002-7551-6883	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000438] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; Bolotina Victoria M, 2004, Sci STKE, V2004, ppe34, DOI 10.1126/stke.2432004pe34; Brough GH, 2001, FASEB J, V15, P1727, DOI 10.1096/fj.01-0108com; Brownlow SL, 2005, THROMB HAEMOSTASIS, V94, P839, DOI 10.1160/TH05-06-0391; Brueggemann LI, 2006, J PHARMACOL EXP THER, V317, P488, DOI 10.1124/jpet.105.095067; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu X, 2004, J MEMBRANE BIOL, V200, P93, DOI 10.1007/s00232-004-0698-3; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Mori Y, 2001, JPN J PHARMACOL, V87, P245, DOI 10.1254/jjp.87.245; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tseng PH, 2004, BIOCHEMISTRY-US, V43, P11701, DOI 10.1021/bi049349f; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Wissenbach U, 2007, CELL CALCIUM, V42, P439, DOI 10.1016/j.ceca.2007.05.014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200	36	172	179	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12935	12940		10.1074/jbc.C800008200	http://dx.doi.org/10.1074/jbc.C800008200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326500	Green Published, hybrid			2022-12-25	WOS:000255499800030
J	Parker, MD; Musa-Aziz, R; Rojas, JD; Choi, I; Daly, CM; Boron, WF				Parker, Mark D.; Musa-Aziz, Raif; Rojas, Jose D.; Choi, Inyeong; Daly, Christopher M.; Boron, Walter F.			Characterization of human SLC4A10 as an electroneutral Na/HCO3 cotransporter (NBCn2) with Cl- self-exchange activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROGENIC NA+-HCO3-COTRANSPORTER; INTRACELLULAR PH TRANSIENTS; SQUID GIANT-AXONS; FUNCTIONAL-CHARACTERIZATION; XENOPUS OOCYTES; TISSUE DISTRIBUTION; CHLORIDE TRANSPORT; PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; FIBER LOBE	The SLC4A10 gene product, commonly known as NCBE, is highly expressed in rodent brain and has been characterized by others as a Na+-driven Cl-HCO3 exchanger. However, some of the earlier data are not consistent with Na+-driven Cl-HCO3 exchange activity. In the present study, northern blot analysis showed that, also in humans, NCBE transcripts are predominantly expressed in brain. In some human NCBE transcripts, splice cassettes A and/or B, originally reported in rats and mice, are spliced out. In brain cDNA, we found evidence of a unique partial splice of cassette B that is predicted to produce an NCBE protein with a novel C terminus containing a protein kinase C phosphorylation site. We used pH-sensitive microelectrodes to study the molecular physiology of human NCBE expressed in Xenopus oocytes. In agreement with others we found that NCBE mediates the 4,4'-diisothiocyanato-stilbene-2,2'-disulfonic acid-sensitive, Na+-dependent transport of HCO3-. For the first time, we demonstrated that this transport process is electroneutral. Using Cl--sensitive microelectrodes positioned at the oocyte surface, we found that, unlike both human and squid Na+-driven Cl-HCO3 exchangers, human NCBE does not normally couple the net influx of HCO3-to a net efflux of Cl-. Moreover we found that that the Cl-36 efflux from NCBE-expressing oocytes, interpreted by others to be coupled to the influx of Na+ and HCO3-, actually represents a CO2/HCO3-stimulated Cl-self-exchange not coupled to either Na+ or net HCO3-transport. We propose to rename NCBE as the second electroneutral Na/HCO3 cotransporter, NBCn2.	[Parker, Mark D.; Musa-Aziz, Raif; Rojas, Jose D.; Choi, Inyeong; Daly, Christopher M.; Boron, Walter F.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Boron, WF (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	wfb2@case.edu	Musa-Aziz, Raif/F-3434-2013; Boron, Walter/ABI-1564-2020; Parker, Mark/AAH-5575-2020; choi, inyeong/AAM-4826-2021	Musa-Aziz, Raif/0000-0002-0386-4248; Boron, Walter/0000-0003-4741-7287	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018400] Funding Source: NIH RePORTER; NIDDK NIH HHS [R37 DK030344, R37 DK030344-28] Funding Source: Medline; NINDS NIH HHS [NS18400, R01 NS018400-19A2, R01 NS018400] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; BORON WF, 1977, AM J PHYSIOL, V233, pC61, DOI 10.1152/ajpcell.1977.233.3.C61; BORON WF, 1983, J GEN PHYSIOL, V81, P373, DOI 10.1085/jgp.81.3.373; Bourgeois S, 2002, AM J PHYSIOL-RENAL, V282, pF655, DOI 10.1152/ajprenal.00220.2000; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC857, DOI 10.1152/ajpcell.1988.255.6.C857; Chen LM, 2008, NEUROSCIENCE, V151, P374, DOI 10.1016/j.neuroscience.2007.10.015; Choi I, 2002, FASEB J, V16, pA796; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; DALMARK M, 1976, J GEN PHYSIOL, V67, P223, DOI 10.1085/jgp.67.2.223; Doughty JM, 2001, J PHYSIOL-LONDON, V534, P753, DOI 10.1111/j.1469-7793.2001.t01-1-00753.x; Eiden LE, 2004, PFLUG ARCH EUR J PHY, V447, P636, DOI 10.1007/s00424-003-1100-5; Giffard RG, 2003, EUR J NEUROSCI, V18, P2935, DOI 10.1046/j.1460-9568.2003.03053.x; Grichtchenko II, 2001, J BIOL CHEM, V276, P8358, DOI 10.1074/jbc.C000716200; GROVES JD, 1992, J BIOL CHEM, V267, P22163; Hubner CA, 2004, GENE EXPR PATTERNS, V5, P219, DOI 10.1016/j.modgep.2004.08.002; HUMPHREYS BD, 1994, AM J PHYSIOL-CELL PH, V267, pC1295, DOI 10.1152/ajpcell.1994.267.5.C1295; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; JAROLIMEK W, 1990, PFLUG ARCH EUR J PHY, V416, P247, DOI 10.1007/BF00392060; KIETZ D, 1991, BIOCHIM BIOPHYS ACTA, V1064, P81, DOI 10.1016/0005-2736(91)90414-4; Loo DDF, 2000, J BIOL CHEM, V275, P37414, DOI 10.1074/jbc.M007241200; Lu J, 2007, AM J PHYSIOL-CELL PH, V292, pC1787, DOI 10.1152/ajpcell.00267.2006; Odgaard E, 2004, J PHYSIOL-LONDON, V555, P205, DOI 10.1113/jphysiol.2003.046474; OKUBO K, 1994, J BIOL CHEM, V269, P1918; PARKER MD, 2007, SELDIN GIEBISCHS KID, P1481; Pasternack M, 1996, NEUROPHARMACOLOGY, V35, P1279, DOI 10.1016/S0028-3908(96)00075-5; Piermarini PM, 2007, AM J PHYSIOL-CELL PH, V292, pC2032, DOI 10.1152/ajpcell.00544.2006; Praetorius J, 2004, AM J PHYSIOL-CELL PH, V286, pC601, DOI 10.1152/ajpcell.00240.2003; Pushkin A, 1999, J BIOL CHEM, V274, P16569, DOI 10.1074/jbc.274.23.16569; RANSOM BR, 1992, PROG BRAIN RES, V94, P37; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; RUSSELL JM, 1976, NATURE, V264, P73, DOI 10.1038/264073a0; SCHWIENING CJ, 1994, J PHYSIOL-LONDON, V475, P59, DOI 10.1113/jphysiol.1994.sp020049; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; SPRAY DC, 1981, SCIENCE, V211, P712, DOI 10.1126/science.6779379; THOMAS RC, 1977, J PHYSIOL-LONDON, V273, P317, DOI 10.1113/jphysiol.1977.sp012096; Toye AM, 2006, AM J PHYSIOL-CELL PH, V291, pC788, DOI 10.1152/ajpcell.00094.2006; Virkki LV, 2003, AM J PHYSIOL-CELL PH, V285, pC771, DOI 10.1152/ajpcell.00439.2002; Virkki LV, 2002, AM J PHYSIOL-CELL PH, V282, pC1278, DOI 10.1152/ajpcell.00589.2001; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang CZ, 2000, J BIOL CHEM, V275, P35486, DOI 10.1074/jbc.C000456200	43	68	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12777	12788		10.1074/jbc.M707829200	http://dx.doi.org/10.1074/jbc.M707829200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18319254	hybrid, Green Published			2022-12-25	WOS:000255499800014
J	Sheoran, A; Sharma, G; First, EA				Sheoran, Anita; Sharma, Gyanesh; first, Eric A.			Activation of D-tyrosine by Bacillus stearothermophilus tyrosyl-tRNA synthetase - 1. Pre-steady-state kinetic analysis reveals the mechanistic basis for the recognition of D-tyrosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; TRANSITION-STATE; BINDING-ENERGY; GENETIC-CODE; MOBILE LOOP; POSITION 51	Tyrosyl-tRNA synthetase (TyrRS) is able to catalyze the transfer of both L-and D-tyrosine to the 3' end of tRNATyr. Activation of either stereoisomer by ATP results in formation of an enzyme-bound tyrosyl-adenylate intermediate and is accompanied by a blue shift in the intrinsic fluorescence of the protein. Single turnover kinetics for the aminoacylation of tRNATyr by D-tyrosine were monitored using stopped-flow fluorescence spectroscopy. Bacillus stearothermophilus tyrosyl-tRNA synthetase binds D-tyrosine with an 8.5-fold lower affinity than that of L-tyrosine (K-d (D-Tyr) = 102 mu M) and exhibits a 3-fold decrease in the forward rate constant for the activation reaction (k(3)(D-Tyr) = 13 s(-1)). Furthermore, as is the case for L-tyrosine, tyrosyl-tRNA synthetase exhibits "half-of-the-sites" reactivity with respect to the binding and activation of D-tyrosine. Surprisingly, pyrophosphate binds to the TyrRS.D-Tyr-AMP intermediate with a 14-fold higher affinity than it binds to the TyrRS.L-TyrAMP intermediate (K-d(PPi) = 0.043 for TyrRS.D-Tyr-AMP.PPi). tRNATyr binds with a slightly (2.3-fold) lower affinity to the TyrRS.D-Tyr-AMP intermediate than it does to the TyrRS.LTyr-AMP intermediate. The observation that the K-d(Tyr) and k(3) values are similar for L- and D-tyrosine suggests that their side chains bind to tyrosyl-tRNA synthetase in similar orientations and that at least one of the carboxylate oxygen atoms in D-tyrosine is properly positioned for attack on the alpha-phosphate of ATP.	[Sheoran, Anita; Sharma, Gyanesh; first, Eric A.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	First, EA (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.	efirst@lsuhsc.edu	Sharma, Gyanesh/G-1210-2012		NIGMS NIH HHS [GM68070, R01 GM068070] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068070] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Asahara H, 2005, BIOCHEMISTRY-US, V44, P11254, DOI 10.1021/bi050204y; AVIS JM, 1993, BIOCHEMISTRY-US, V32, P5312, DOI 10.1021/bi00071a005; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRICK P, 1987, J MOL BIOL, V194, P287, DOI 10.1016/0022-2836(87)90376-7; CALENDAR R, 1966, BIOCHEMISTRY-US, V5, P1690, DOI 10.1021/bi00869a034; CALENDAR R, 1967, J MOL BIOL, V26, P39, DOI 10.1016/0022-2836(67)90259-8; CLARKE AR, 1996, ENZYMOLOGY LABFAX, P201; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELANO WL, 2002, PYMOL MOL GRAPHICS; DOUBLIE S, 1995, STRUCTURE, V3, P17, DOI 10.1016/S0969-2126(01)00132-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P5, DOI 10.1021/bi00672a002; FERSHT AR, 1985, BIOCHEMISTRY-US, V24, P5858, DOI 10.1021/bi00342a025; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P13, DOI 10.1021/bi00672a003; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P6030, DOI 10.1021/bi00393a013; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13644, DOI 10.1021/bi00212a032; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13651, DOI 10.1021/bi00212a033; FIRST EA, 1995, BIOCHEMISTRY-US, V34, P5030, DOI 10.1021/bi00015a014; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13658, DOI 10.1021/bi00212a034; Gibson T., 1984, THESIS U CAMBRIDGE C; HO CK, 1986, BIOCHEMISTRY-US, V25, P1891, DOI 10.1021/bi00356a009; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JONES DH, 1985, BIOCHEMISTRY-US, V24, P5852, DOI 10.1021/bi00342a024; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002; LIN SX, 1983, BIOCHEMISTRY-US, V22, P681, DOI 10.1021/bi00272a024; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; SANTI DV, 1971, FEBS LETT, V13, P157, DOI 10.1016/0014-5793(71)80224-7; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Sheoran A, 2008, J BIOL CHEM, V283, P12971, DOI 10.1074/jbc.M801650200; Soutourina J, 2000, J BIOL CHEM, V275, P32535, DOI 10.1074/jbc.M005166200; Soutourina J, 2000, J BIOL CHEM, V275, P11626, DOI 10.1074/jbc.275.16.11626; Soutourina O, 2004, J BIOL CHEM, V279, P42560, DOI 10.1074/jbc.M402931200; Thompson D, 2007, J BIOL CHEM, V282, P30856, DOI 10.1074/jbc.M704788200; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Uter NT, 2005, J BIOL CHEM, V280, P23966, DOI 10.1074/jbc.M414259200; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; WELLS TNC, 1986, BIOCHEMISTRY-US, V25, P1881, DOI 10.1021/bi00356a007; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Xin Y, 2000, BIOCHEMISTRY-US, V39, P340, DOI 10.1021/bi991675l	45	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12960	12970		10.1074/jbc.M801649200	http://dx.doi.org/10.1074/jbc.M801649200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18319247	Green Published, hybrid			2022-12-25	WOS:000255499800033
J	Wang, Y; Lee, ATC; Ma, JZI; Wang, JB; Ren, JW; Yang, YC; Tantoso, E; Li, KB; Ooi, LLPJ; Tan, P; Lee, CGL				Wang, Yu; Lee, Alvin T. C.; Ma, Joel Z. I.; Wang, Jingbo; Ren, Jianwei; Yang, Yuchen; Tantoso, Erwin; Li, Kuo-Bin; Ooi, London L. P. J.; Tan, Patrick; Lee, Caroline G. L.			Profiling MicroRNA expression in hepatocellular carcinoma reveals MicroRNA-224 up-regulation and apoptosis inhibitor-5 as a MicroRNA-224-specific target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LUNG CANCERS; IDENTIFICATION; SIGNATURE; AAC-11; GENES; CELLS; PCR; RNA; MYC	Like other cancers, aberrant gene regulation features significantly in hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) were recently found to regulate gene expression at the post-transcriptional/ translational levels. The expression profiles of 157 miRNAs were examined in 19 HCC patients, and 19 up-regulated and 3 down-regulated miRNAs were found to be associated with HCC. Putative gene targets of these 22 miRNAs were predicted in silico and were significantly enriched in 34 biological pathways, most of which are frequently dysregulated during carcinogenesis. Further characterization of microRNA-224 (miR-224), the most significantly upregulated miRNA in HCC patients, revealed that miR-224 increases apoptotic cell death as well as proliferation and targets apoptosis inhibitor-5 (API-5) to inhibit API-5 transcript expression. Significantly, miR-224 expression was found to be inversely correlated with API-5 expression in HCC patients (p < 0.05). Hence, our findings define a true in vivo target of miR-224 and reaffirm the important role of miRNAs in the dysregulation of cellular processes that may ultimately lead to tumorigenesis.	[Lee, Alvin T. C.; Ren, Jianwei; Ooi, London L. P. J.; Lee, Caroline G. L.] Natl Canc Ctr, Div Med Sci, Dept Surg Oncol, Singapore 169610, Singapore; [Wang, Yu; Ma, Joel Z. I.; Wang, Jingbo; Lee, Caroline G. L.] Natl Univ Singapore, Dept Biochem, Singapore 119077, Singapore; [Yang, Yuchen; Tantoso, Erwin; Li, Kuo-Bin] Bioinformat Inst, Singapore 138671, Singapore; [Ooi, London L. P. J.] Singapore Gen Hosp, Dept Surg, Singapore 169608, Singapore; [Tan, Patrick; Lee, Caroline G. L.] Duke NUS Grad Med Sch, Singapore 169547, Singapore	National Cancer Centre Singapore (NCCS); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Singapore General Hospital; National University of Singapore	Lee, CGL (corresponding author), Natl Canc Ctr, Div Med Sci, Dept Surg Oncol, Level 6,Lab 5,11 Hosp Dr, Singapore 169610, Singapore.	bchleec@nus.edu.sg	Yang, Yuchen/GZK-6062-2022; Ooi, London Lucien/AGK-1395-2022; Lee, Caroline G/M-8918-2019	Lee, Caroline G/0000-0002-4323-3635; Tantoso, Erwin/0000-0002-7946-6297; Ma, Joel/0000-0002-0448-6744				Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Allenspach EJ, 2002, CANCER BIOL THER, V1, P466, DOI 10.4161/cbt.1.5.159; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dragan YP, 2001, TOXICOL SCI, V61, P6, DOI 10.1093/toxsci/61.1.6; El-Serag HB, 2001, HEPATOLOGY, V33, P62, DOI 10.1053/jhep.2001.21041; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Kim JW, 2000, LAB INVEST, V80, P587, DOI 10.1038/labinvest.3780063; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Michael MZ, 2003, MOL CANCER RES, V1, P882; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morris EJ, 2006, PLOS GENET, V2, P1834, DOI 10.1371/journal.pgen.0020196; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Myers C, 2002, AM J PATHOL, V161, P2099, DOI 10.1016/S0002-9440(10)64488-4; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Polakis P, 2000, GENE DEV, V14, P1837; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; Seeff LB, 2006, ONCOGENE, V25, P3771, DOI 10.1038/sj.onc.1209560; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Shah S, 1998, CURR BIOL, V8, P1376, DOI 10.1016/S0960-9822(98)00018-9; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tewari M, 1997, CANCER RES, V57, P4063; Thorgeirsson SS, 2006, HEPATOLOGY, V43, pS145, DOI 10.1002/hep.21063; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang ZH, 2005, HUM MOL GENET, V14, P2075, DOI 10.1093/hmg/ddi212; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	54	303	338	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13205	13215		10.1074/jbc.M707629200	http://dx.doi.org/10.1074/jbc.M707629200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18319255	hybrid			2022-12-25	WOS:000255499800060
J	Zaks-Zilberman, M; Harrington, AE; Ishino, T; Chaiken, IM				Zaks-Zilberman, Meirav; Harrington, Adrian E.; Ishino, Tetsuya; Chaiken, Irwin M.			Interleukin-5 receptor subunit oligomerization and rearrangement revealed by fluorescence resonance energy transfer imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; HIGH-AFFINITY BINDING; COMMON BETA-CHAIN; GROWTH-HORMONE RECEPTOR; GM-CSF RECEPTOR; IL-5 RECEPTORS; ALPHA-SUBUNIT; ERYTHROPOIETIN RECEPTOR; EXTRACELLULAR DOMAIN; CYTOKINE RECOGNITION	Interleukin (IL)-5 exerts hematopoietic functions through binding to the IL-5 receptor subunits, alpha and beta c. Specific assembly steps of full-length subunits as they occur in cell membranes, ultimately leading to receptor activation, are not well understood. We tracked the oligomerization of IL-5 receptor subunits using fluorescence resonance energy transfer ( FRET) imaging. Full-length IL-5R alpha and beta c were expressed in Phoenix cells as chimeric proteins fused to enhanced cyan or yellow fluorescent protein (CFP or YFP, respectively). A time-and dose-dependent increase in FRET signal between IL-5R alpha-CFP and beta c-YFP was observed in response to IL-5, indicative of heteromeric receptor alpha-beta c subunit interaction. This response was inhibited by AF17121, a peptide antagonist of IL-5R alpha. Substantial FRET signals with beta c-CFP and beta c-YFP co-expressed in the absence of IL-5R alpha demonstrated that beta c subunits exist as preformed homo-oligomers. IL-5 had no effect on this beta c-alone FRET signal. Interestingly, the addition of IL-5 to cells co-expressing beta c-CFP, beta c-YFP, and nontagged IL-5R alpha led to further increase in FRET efficiency. Observation of preformed beta c oligomers fits with the view that this form can lead to rapid cellular responses upon IL-5 stimulation. The IL-5-induced effects on beta c assembly in the presence of nontagged IL-5R alpha provide direct evidence that IL-5 can cause higher order rearrangements of beta c homo-oligomers. These results suggest that IL-5 and perhaps other beta c cytokines (IL-3 and granulocyte/macrophage colony-stimulating factor) trigger cellular responses by the sequential binding of cytokine ligand to the specificity receptor ( subunit alpha), followed by binding of the ligand-subunit alpha complex to, and consequent rearrangement of, a ground state form of beta c oligomers.	[Zaks-Zilberman, Meirav; Harrington, Adrian E.; Ishino, Tetsuya; Chaiken, Irwin M.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA	Drexel University	Chaiken, IM (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 11102 New Coll Bldg,245 N 15th St, Philadelphia, PA 19102 USA.	ichaiken@drexelmed.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055648] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 40462] Funding Source: Medline; NIGMS NIH HHS [R01 GM55648] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Carr PD, 2006, ACTA CRYSTALLOGR F, V62, P509, DOI 10.1107/S1744309106016812; Carr PD, 2001, CELL, V104, P291, DOI 10.1016/S0092-8674(01)00213-6; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Damjanovich S, 1997, P NATL ACAD SCI USA, V94, P13134, DOI 10.1073/pnas.94.24.13134; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DEVOS R, 1991, EMBO J, V10, P2133, DOI 10.1002/j.1460-2075.1991.tb07747.x; DEVOS R, 1993, J BIOL CHEM, V268, P6581; England BP, 2000, P NATL ACAD SCI USA, V97, P6862, DOI 10.1073/pnas.110053997; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; GOODALL GJ, 1993, GROWTH FACTORS, V8, P87, DOI 10.3109/08977199309046929; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; Hibbs AR, 2004, CONFOCAL MICROSCOPY; Ishino T, 2005, VITAM HORM, V71, P321, DOI 10.1016/S0083-6729(05)71011-6; Ishino T, 2004, J BIOL CHEM, V279, P9547, DOI 10.1074/jbc.M309327200; Ishino T, 2005, J BIOL CHEM, V280, P22951, DOI 10.1074/jbc.M502341200; JOHANSON K, 1995, J BIOL CHEM, V270, P9459, DOI 10.1074/jbc.270.16.9459; Karasawa A, 2005, J BIOL CHEM, V280, P41900, DOI 10.1074/jbc.M510795200; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; Kopf M, 1996, IMMUNITY, V4, P15, DOI 10.1016/S1074-7613(00)80294-0; Kramer JM, 2006, J IMMUNOL, V176, P711, DOI 10.4049/jimmunol.176.2.711; Krause CD, 2006, BIOCHEM BIOPH RES CO, V340, P377, DOI 10.1016/j.bbrc.2005.11.182; Krause CD, 2002, MOL CELL PROTEOMICS, V1, P805, DOI 10.1074/mcp.M200065-MCP200; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Le F, 2000, J BIOL CHEM, V275, P5124, DOI 10.1074/jbc.275.7.5124; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; LOCK P, 1994, P NATL ACAD SCI USA, V91, P252, DOI 10.1073/pnas.91.1.252; LOPEZ AF, 1991, J BIOL CHEM, V266, P24741; LOPEZ AF, 1992, EMBO J, V11, P909, DOI 10.1002/j.1460-2075.1992.tb05129.x; LOPEZ AF, 1992, IMMUNOL TODAY, V13, P495, DOI 10.1016/0167-5699(92)90025-3; Majoul Irina, 2002, J Biotechnol, V82, P267; McClure BJ, 2003, BLOOD, V101, P1308, DOI 10.1182/blood-2002-06-1903; MIGITA M, 1991, CELL IMMUNOL, V133, P484, DOI 10.1016/0008-8749(91)90120-Z; MITA S, 1988, J EXP MED, V168, P863, DOI 10.1084/jem.168.3.863; MURATA Y, 1992, J EXP MED, V175, P341, DOI 10.1084/jem.175.2.341; Murphy JM, 2006, VITAM HORM, V74, P1, DOI 10.1016/S0083-6729(06)74001-8; Murphy JM, 2004, J BIOL CHEM, V279, P26500, DOI 10.1074/jbc.M402705200; Murphy JM, 2003, J BIOL CHEM, V278, P10572, DOI 10.1074/jbc.M211664200; Murray EW, 1996, J BIOL CHEM, V271, P15330, DOI 10.1074/jbc.271.26.15330; Muto A, 1995, J ALLERGY CLIN IMMUN, V96, P1100, DOI 10.1016/S0091-6749(95)70195-8; Muto A, 1996, J EXP MED, V183, P1911, DOI 10.1084/jem.183.4.1911; Ogata N, 1998, BLOOD, V91, P2264, DOI 10.1182/blood.V91.7.2264.2264_2264_2271; PLAETINCK G, 1990, J EXP MED, V172, P683, DOI 10.1084/jem.172.3.683; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Sanderson C J, 2000, Curr Opin Investig Drugs, V1, P435; Scibek JJ, 2002, ANAL BIOCHEM, V307, P258, DOI 10.1016/S0003-2697(02)00043-X; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; SHANAFELT AB, 1991, EMBO J, V10, P4105, DOI 10.1002/j.1460-2075.1991.tb04987.x; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Stirling RG, 2001, AM J RESP CRIT CARE, V164, P1403, DOI 10.1164/ajrccm.164.8.2010002; Stomski FC, 1998, J BIOL CHEM, V273, P1192, DOI 10.1074/jbc.273.2.1192; Stomski FC, 1996, MOL CELL BIOL, V16, P3035; TAVERNIER J, 1992, P NATL ACAD SCI USA, V89, P7041, DOI 10.1073/pnas.89.15.7041; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; TAVERNIER J, 1995, P NATL ACAD SCI USA, V92, P5194, DOI 10.1073/pnas.92.11.5194; Watanabe S, 1996, J BIOL CHEM, V271, P12681, DOI 10.1074/jbc.271.21.12681; WOODCOCK JM, 1994, EMBO J, V13, P5176, DOI 10.1002/j.1460-2075.1994.tb06848.x; Woodcock JM, 1997, BLOOD, V90, P3005, DOI 10.1182/blood.V90.8.3005; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999; Yang XK, 2006, ANAL BIOCHEM, V351, P158, DOI 10.1016/j.ab.2005.12.004; Yi L, 2006, J BIOL CHEM, V281, P35446, DOI 10.1074/jbc.M607302200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	67	23	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13398	13406		10.1074/jbc.M710230200	http://dx.doi.org/10.1074/jbc.M710230200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326494	Green Published, hybrid			2022-12-25	WOS:000255499800079
J	Iriyama, A; Fujiki, R; Inoue, Y; Takahashi, H; Tamaki, Y; Takezawa, S; Takeyama, K; Jang, WD; Kato, S; Yanagi, Y				Iriyama, Aya; Fujiki, Ryoji; Inoue, Yuji; Takahashi, Hidenori; Tamaki, Yasuhiro; Takezawa, Shinichiro; Takeyama, Kenichi; Jang, Woo-Dong; Kato, Shigeaki; Yanagi, Yasuo			A2E, a pigment of the lipofuscin of retinal pigment epithelial cells, is an endogenous ligand for retinoic acid receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; NUCLEAR RECEPTORS; IN-VITRO; ANGIOGENESIS; ACTIVATION; EXPRESSION; VEGF; PATHOGENESIS; INHIBITION	Lipofuscin contains fluorophores, which represent a biomarker for cellular aging. Although it remains unsubstantiated clinically, experimental results support that the accumulation of lipofuscin is related to an increased risk of choroidal neovascularization due to age-related macular degeneration, a leading cause of legal blindness. Here, we report that a major lipofuscin component, A2E, activates the retinoic acid receptor (RAR). In vitro experiments using luciferase reporter assay, competitional binding assay, analysis of target genes, and chromatin immunoprecipitation (ChIP) assay strongly suggest that A2E is a bona fide ligand for RAR and induces sustained activation of RAR target genes. A2E-induced vascular endothelial growth factor (VEGF) expression in a human retinal pigment epithelial cell line (ARPE-19) and RAR antagonist blocked the up-regulation of VEGF. The conditioned medium of A2E-treated ARPE-19 cells induced tube formation in human umbilical vascular endothelial cells, which was blocked by the RAR antagonist and anti-VEGF antibody. These results suggest that A2E accumulation results in the phenotypic alteration of retinal pigment epithelial cells, predisposing the environment to choroidal neovascularization development. This is mediated through the agonistic function of A2E, at least in part. The results of this study provide a novel potential therapeutic target for this incurable condition.	[Iriyama, Aya; Inoue, Yuji; Takahashi, Hidenori; Tamaki, Yasuhiro; Yanagi, Yasuo] Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo 1138655, Japan; [Fujiki, Ryoji; Takezawa, Shinichiro; Takeyama, Kenichi; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Jang, Woo-Dong] Yonsei Univ, Coll Sci, Dept Chem, Seoul 120749, South Korea	University of Tokyo; University of Tokyo; Yonsei University	Yanagi, Y (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.	yanagi-tky@umin.ac.jp	Jang, Woo-Dong/I-7186-2019; Yanagi, Yasuo/AAF-2670-2020; Yanagi, Yasuo/AAA-5441-2022; Takahashi, Hidenori/H-2945-2019	Jang, Woo-Dong/0000-0002-1281-6037; Takahashi, Hidenori/0000-0001-5331-4730; Yanagi, Yasuo/0000-0002-0362-7285				Akiyama H, 2002, INVEST OPHTH VIS SCI, V43, P1367; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; Cideciyan AV, 2004, HUM MOL GENET, V13, P525, DOI 10.1093/hmg/ddh048; Dafer Rima M, 2007, Semin Ophthalmol, V22, P201, DOI 10.1080/08820530701543024; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; ELDRED GE, 1982, SCIENCE, V216, P757, DOI 10.1126/science.7079738; FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Gaetano C, 2001, CIRC RES, V88, pE38; Gillies MC, 2007, NEW ENGL J MED, V356, P748; Kodera Y, 2000, J BIOL CHEM, V275, P33201, DOI 10.1074/jbc.C000517200; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kutty RK, 2001, J BIOL CHEM, V276, P2831, DOI 10.1074/jbc.M007421200; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; MAJEWSKI S, 1993, CANCER LETT, V75, P35, DOI 10.1016/0304-3835(93)90204-M; Moshfeghi AA, 2006, OPHTHALMOLOGY, V113, P2002, DOI 10.1016/j.ophtha.2006.05.070; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; PEPPER MS, 1994, J CELL BIOCHEM, V55, P419, DOI 10.1002/jcb.240550403; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Saito A, 2007, ENDOCRINOLOGY, V148, P1412, DOI 10.1210/en.2006-0900; Samuel W, 2001, J BIOL CHEM, V276, P28744, DOI 10.1074/jbc.M103587200; SARKS SH, 2001, RETINA, P1064; Schwesinger C, 2001, AM J PATHOL, V158, P1161, DOI 10.1016/S0002-9440(10)64063-1; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; WORMALD R, 2000, COCHRANE DB SYST REV, V2; Yanagi Y, 1999, J BIOL CHEM, V274, P12971, DOI 10.1074/jbc.274.19.12971; Yoshida T, 2005, J CLIN INVEST, V115, P2793, DOI 10.1172/JCI24635; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou JL, 2005, EXP EYE RES, V80, P567, DOI 10.1016/j.exer.2004.11.009	34	43	53	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11947	11953		10.1074/jbc.M708989200	http://dx.doi.org/10.1074/jbc.M708989200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326047	hybrid			2022-12-25	WOS:000255340000010
J	Sun, XX; Dai, MS; Lu, H				Sun, Xiao-Xin; Dai, Mu-Shui; Lu, Hua			Mycophenolic acid activation of p53 requires ribosomal proteins l5 and l11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE DEPLETION; INOSINE MONOPHOSPHATE DEHYDROGENASE; CELL-CYCLE ARREST; MULTIPLE-MYELOMA CELLS; IMP DEHYDROGENASE; LEUKEMIA-CELLS; T-LYMPHOCYTES; DNA-SYNTHESIS; INHIBITION; APOPTOSIS	Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid (MPA), is widely used as an immunosuppressive agent. MPA selectively inhibits inosine monophosphate dehydrogenase ( IMPDH), a rate-limiting enzyme for the de novo synthesis of guanine nucleotides, leading to depletion of the guanine nucleotide pool. Its chemotherapeutic effects have been attributed to its ability to induce cell cycle arrest and apoptosis. MPA treatment has also been shown to induce and activate p53. However, the mechanism underlying the p53 activation pathway is still unclear. Here, we show that MPA treatment results in inhibition of pre-rRNA synthesis and disruption of the nucleolus. This treatment enhances the interaction of MDM2 with L5 and L11. Interestingly, knockdown of endogenous L5 or L11 markedly impairs the induction of p53 and G(1) cell cycle arrest induced by MPA. These results suggest that MPA may trigger a nucleolar stress that induces p53 activation via inhibition of MDM2 by ribosomal proteins L5 and L11.	[Sun, Xiao-Xin; Dai, Mu-Shui; Lu, Hua] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Sun, Xiao-Xin; Dai, Mu-Shui; Lu, Hua] Simon Canc Ctr, Indianapolis, IN 46202 USA; [Sun, Xiao-Xin] Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Oregon Health & Science University	Lu, H (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	hualu@iupui.edu			NCI NIH HHS [K99 CA127134-01, R00 CA127134, K99 CA127134] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K99CA127134, R00CA127134] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allison A C, 1977, Ciba Found Symp, P207; Allison AC, 2005, TRANSPLANTATION, V80, pS181, DOI 10.1097/01.tp.0000186390.10150.66; Allison AC, 2005, LUPUS, V14, pS2, DOI 10.1191/0961203305lu2109oa; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; CARR SF, 1993, J BIOL CHEM, V268, P27286; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; DUAN DS, 1988, BIOCHEM J, V255, P1045, DOI 10.1042/bj2551045; GHAREHBAGHI K, 1994, LEUKEMIA, V8, P1257; Gu JJ, 2003, BLOOD, V101, P4958, DOI 10.1182/blood-2002-08-2547; Heinschink A, 2000, CLIN CHIM ACTA, V300, P23, DOI 10.1016/S0009-8981(00)00297-7; Inai K, 1998, ADV EXP MED BIOL, V431, P549; Inai K, 2000, LEUKEMIA RES, V24, P761, DOI 10.1016/S0145-2126(00)00045-X; Ishitsuka K, 2005, ONCOGENE, V24, P5888, DOI 10.1038/sj.onc.1208739; JACKSON RC, 1975, NATURE, V256, P331, DOI 10.1038/256331a0; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Laliberte J, 1998, BLOOD, V91, P2896, DOI 10.1182/blood.V91.8.2896.2896_2896_2904; Li GD, 1998, ENDOCRINOLOGY, V139, P3752, DOI 10.1210/en.139.9.3752; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Messina E, 2005, NEUROSCI LETT, V375, P97, DOI 10.1016/j.neulet.2004.10.076; Messina E, 2004, NUCLEOS NUCLEOT NUCL, V23, P1545, DOI 10.1081/NCN-200027770; Messina E, 2004, INT J CANCER, V108, P812, DOI 10.1002/ijc.11642; NAGAI M, 1991, CANCER RES, V51, P3886; NAGAI M, 1992, CANCER RES, V52, P258; NATSUMEDA Y, 1990, J BIOL CHEM, V265, P5292; NGUYEN BT, 1986, BIOCHEM J, V234, P263, DOI 10.1042/bj2340263; Panic L, 2007, CELL CYCLE, V6, P20, DOI 10.4161/cc.6.1.3666; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Quemeneur L, 2003, J IMMUNOL, V170, P4986, DOI 10.4049/jimmunol.170.10.4986; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Takebe N, 2006, MOL CANCER THER, V5, P457, DOI 10.1158/1535-7163.MCT-05-0340; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weigel G, 2001, CLIN PHARMACOL THER, V69, P137, DOI 10.1067/mcp.2001.114166; WILSON BS, 1989, J IMMUNOL, V143, P259; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	42	82	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12387	12392		10.1074/jbc.M801387200	http://dx.doi.org/10.1074/jbc.M801387200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18305114	Green Published, hybrid			2022-12-25	WOS:000255340000055
J	Ieronimakis, N; Balasundaram, G; Reyes, M				Ieronimakis, Nicholas; Balasundaram, Gayathri; Reyes, Morayma			Direct Isolation, Culture and Transplant of Mouse Skeletal Muscle Derived Endothelial Cells with Angiogenic Potential	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; PROGENITOR CELLS; GROWTH-FACTOR; IN-VIVO; ADHESION MOLECULE-1; ANTIGEN SCA-1; UP-REGULATION; EXPRESSION; DYSFUNCTION; CD34	Background: Although diseases associated with microvascular endothelial dysfunction are among the most prevalent illnesses to date, currently no method exists to isolate pure endothelial cells (EC) from skeletal muscle for in vivo or in vitro study. Methodology: By utilizing multicolor fluorescent-activated cell sorting (FACS), we have isolated a distinct population of Sca-1(+), CD31(+), CD34(dim) and CD45(-) cells from skeletal muscles of C57BL6 mice. Characterization of this population revealed these cells are functional EC that can be expanded several times in culture without losing their phenotype or capabilities to uptake acetylated low-density lipoprotein (ac-LDL), produce nitric oxide (NO) and form vascular tubes. When transplanted subcutaneously or intramuscularly into the tibialis anterior muscle, EC formed microvessels and integrated with existing vasculature. Conclusion: This method, which is highly reproducible, can be used to study the biology and role of EC in diseases such as peripheral vascular disease. In addition this method allows us to isolate large quantities of skeletal muscle derived EC with potential for therapeutic angiogenic applications.	[Ieronimakis, Nicholas; Balasundaram, Gayathri; Reyes, Morayma] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Ieronimakis, N (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	morayma@u.washington.edu			Departments of Pathology and Lab Medicine at the University of Washington; NIH [5R03AR054955]; Jain Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR054955] Funding Source: NIH RePORTER	Departments of Pathology and Lab Medicine at the University of Washington; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jain Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this research has been generously provided by the Departments of Pathology and Lab Medicine at the University of Washington, NIH 5R03AR054955 and the Jain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua RS, 2003, CIRCULATION, V107, P2342, DOI 10.1161/01.CIR.0000066691.52789.BE; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Ceriello A, 1996, DIABETES, V45, P471, DOI 10.2337/diabetes.45.4.471; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Couchman JR, 1999, J CELL SCI, V112, P3415; Crossin KL, 2000, DEV DYNAM, V218, P260, DOI 10.1002/(SICI)1097-0177(200006)218:2<260::AID-DVDY3>3.0.CO;2-9; CURCIO F, 1992, IN VITRO CELL DEV-AN, V28A, P787; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; DeMeyer GRY, 1997, PROG CARDIOVASC DIS, V39, P325, DOI 10.1016/S0033-0620(97)80031-X; Ding SL, 2003, BLOOD, V101, P4816, DOI 10.1182/blood-2002-06-1731; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Donnini D, 2003, BIOCHIMIE, V85, P701, DOI 10.1016/S0300-9084(03)00116-0; Ellis CG, 2005, CRIT CARE, V9, pS3, DOI 10.1186/cc3751; Figarella-Branger D, 2006, J RHEUMATOL, V33, P1623; Ford JW, 1996, J SURG RES, V62, P23, DOI 10.1006/jsre.1996.0167; GRENIER G, 2007, STEM CELLS; Hannum RS, 2001, MICROVASC RES, V61, P287, DOI 10.1006/mvre.2001.2302; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Houzelstein D, 1999, DEVELOPMENT, V126, P2689; Hristov M, 2003, TRENDS CARDIOVAS MED, V13, P201, DOI 10.1016/S1050-1738(03)00077-X; Hurst T, 2006, AM J MED, V119, P560, DOI 10.1016/j.amjmed.2005.07.009; Ingram DA, 2005, BLOOD, V106, P1525, DOI 10.1182/blood-2005-04-1509; Khan SS, 2005, CYTOM PART B-CLIN CY, V64B, P1, DOI 10.1002/cyto.b.20040; Kivela R, 2007, HISTOCHEM CELL BIOL, V127, P31, DOI 10.1007/s00418-006-0226-x; Kotton DN, 2003, AM J PHYSIOL-LUNG C, V284, pL990, DOI 10.1152/ajplung.00415.2002; Kranenburg AR, 2005, THORAX, V60, P106, DOI 10.1136/thx.2004.023986; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Landmesser U, 2007, CURR OPIN CARDIOL, V22, P316, DOI 10.1097/HCO.0b013e3281ca710d; Le Grand F, 2004, EXP CELL RES, V301, P232, DOI 10.1016/j.yexcr.2004.07.028; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Loufrani L, 2004, ARTERIOSCL THROM VAS, V24, P671, DOI 10.1161/01.ATV.0000118683.99628.42; Luna G, 2004, STEM CELLS DEV, V13, P528, DOI 10.1089/scd.2004.13.528; Muller AM, 2002, EXP MOL PATHOL, V72, P221, DOI 10.1006/exmp.2002.2424; Muller-Delp JM, 2006, MICROCIRCULATION, V13, P339, DOI 10.1080/10739680600619023; Nguyen F, 2005, NEUROMUSCULAR DISORD, V15, P154, DOI 10.1016/j.nmd.2004.11.002; Nistri Silvia, 2002, Biological Procedures Online, V4, P32, DOI 10.1251/bpo31; Okaji Y, 2004, J IMMUNOL METHODS, V295, P183, DOI 10.1016/j.jim.2004.10.005; PASSANITI A, 1992, LAB INVEST, V67, P519; Payne GW, 2006, MICROCIRCULATION, V13, P275, DOI 10.1080/10739680600618710; PETERS KG, 1993, P NATL ACAD SCI USA, V90, P8915, DOI 10.1073/pnas.90.19.8915; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; REDDY KG, 1994, J AM COLL CARDIOL, V23, P833, DOI 10.1016/0735-1097(94)90627-0; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Ribatti D, 2007, LEUKEMIA RES, V31, P439, DOI 10.1016/j.leukres.2006.10.014; Rosenkranz AC, 2000, J MOL CELL CARDIOL, V32, P1119, DOI 10.1006/jmcc.2000.1149; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Salomonsson S, 2006, AUTOIMMUNITY, V39, P177, DOI 10.1080/08916930600622256; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; SCHNURCH H, 1993, DEVELOPMENT, V119, P957; Scholz D, 1997, CELL TISSUE RES, V290, P623, DOI 10.1007/s004410050968; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; SWERLICK RA, 1992, J IMMUNOL, V148, P78; Taichman DB, 2003, EXP LUNG RES, V29, P113, DOI 10.1080/01902140303767; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tavian M, 2005, ANN NY ACAD SCI, V1044, P41, DOI 10.1196/annals.1349.006; Thurston G, 2000, MICROCIRCULATION, V7, P67, DOI 10.1038/sj.mn.7300155; Uezumi A, 2006, BIOCHEM BIOPH RES CO, V341, P864, DOI 10.1016/j.bbrc.2006.01.037; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; VANDERIJN M, 1989, P NATL ACAD SCI USA, V86, P4634; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang ZM, 2001, AM J HUM BIOL, V13, P612; WATT SM, 1995, LEUKEMIA LYMPHOMA, V17, P229, DOI 10.3109/10428199509056827; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yamashita JK, 2007, TRENDS CARDIOVAS MED, V17, P59, DOI 10.1016/j.tcm.2007.01.001; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; YOUNG PE, 1995, BLOOD, V85, P96, DOI 10.1182/blood.V85.1.96.bloodjournal85196; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	71	32	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e0001753	10.1371/journal.pone.0001753	http://dx.doi.org/10.1371/journal.pone.0001753			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335025	gold, Green Published, Green Submitted			2022-12-25	WOS:000260723000007
J	Ding, F; Li, HH; Zhang, SW; Solomon, NM; Camper, SA; Cohen, P; Francke, U				Ding, Feng; Li, Hong Hua; Zhang, Shengwen; Solomon, Nicola M.; Camper, Sally A.; Cohen, Pinchas; Francke, Uta			SnoRNA Snord116 (Pwcr1/MBII-85) Deletion Causes Growth Deficiency and Hyperphagia in Mice	PLOS ONE			English	Article								Prader-Willi syndrome (PWS) is the leading genetic cause of obesity. After initial severe hypotonia, PWS children become hyperphagic and morbidly obese, if intake is not restricted. Short stature with abnormal growth hormone secretion, hypogonadism, cognitive impairment, anxiety and behavior problems are other features. PWS is caused by lack of expression of imprinted genes in a similar to 4 mb region of chromosome band 15q11.2. Our previous translocation studies predicted a major role for the C/D box small nucleolar RNA cluster SNORD116 (PWCR1/HBII-85) in PWS. To test this hypothesis, we created similar to 150 kb deletion of the >40 copies of Snord116 (Pwcr1/MBII-85) in C57BL/6 mice. Snord116del mice with paternally derived deletion lack expression of this snoRNA. They have early-onset postnatal growth deficiency, but normal fertility and lifespan. While pituitary structure and somatotrophs are normal, liver Igf1 mRNA is decreased. In cognitive and behavior tests, Snord116del mice are deficient in motor learning and have increased anxiety. Around three months of age, they develop hyperphagia, but stay lean on regular and high-fat diet. On reduced caloric intake, Snord116del mice maintain their weight better than wild-type littermates, excluding increased energy requirement as a cause of hyperphagia. Normal compensatory feeding after fasting, and ability to maintain body temperature in the cold indicate normal energy homeostasis regulation. Metabolic chamber studies reveal that Snord116del mice maintain energy homeostasis by altered fuel usage. Prolonged mealtime and increased circulating ghrelin indicate a defect in meal termination mechanism. Snord116del mice, the first snoRNA deletion animal model, reveal a novel role for a non-coding RNA in growth and feeding regulation.	[Ding, Feng; Li, Hong Hua; Francke, Uta] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Zhang, Shengwen] Stanford Univ, Dept Psychiat & Behavioral Sci, Stanford, CA USA; [Solomon, Nicola M.; Camper, Sally A.] Univ Michigan Ann Arbor, Dept Human Genet, Ann Arbor, MI USA; [Cohen, Pinchas] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA USA; [Francke, Uta] Stanford Univ, Dept Pediat, Stanford, CA USA	Stanford University; Stanford University; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; Stanford University	Ding, F (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	ufrancke@stanford.edu	Ding, Feng/AAH-7335-2019; Ding, Feng/E-5112-2012	Zhang, Shengwen/0000-0001-7318-3870; Camper, Sally/0000-0001-8556-3379	NIH/NICHD; Foundation for Prader-Willi Research	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Foundation for Prader-Willi Research	This work was supported by research grants (to U.F.) from the NIH/NICHD and the Foundation for Prader-Willi Research.	Angulo MA, 2007, AM J MED GENET A, V143A, P1456, DOI 10.1002/ajmg.a.31824; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; BAUMANN G, 1990, ACTA PAEDIATR SCAND, P72; Baumann G., 1990, ACTA PAEDIATR SC   S, V370; Burman P, 2001, ENDOCR REV, V22, P787, DOI 10.1210/er.22.6.787; Butler MG, 1998, AM J MED GENET, V75, P7, DOI 10.1002/(SICI)1096-8628(19980106)75:1<7::AID-AJMG3>3.3.CO;2-B; Cassidy S.B., 2005, MANAGEMENT GENETIC S, P429; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Chamberlain SJ, 2004, HUM MOL GENET, V13, P2971, DOI 10.1093/hmg/ddh314; Choe YH, 2005, J CLIN ENDOCR METAB, V90, P5441, DOI 10.1210/jc.2004-1935; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Cummings DE, 2002, NAT MED, V8, P643, DOI 10.1038/nm0702-643; de los Santos T, 2000, AM J HUM GENET, V67, P1067, DOI 10.1086/303106; DelPparigi A, 2002, J CLIN ENDOCR METAB, V87, P5461, DOI 10.1210/jc.2002-020871; Ding F, 2005, MAMM GENOME, V16, P424, DOI 10.1007/s00335-005-2460-2; EICHER EM, 1976, J HERED, V67, P87, DOI 10.1093/oxfordjournals.jhered.a108682; Fieldstone A, 1998, OBES RES, V6, P29, DOI 10.1002/j.1550-8528.1998.tb00311.x; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Gao Q, 2004, P NATL ACAD SCI USA, V101, P4661, DOI 10.1073/pnas.0303992101; Goldstone AP, 2003, CLIN ENDOCRINOL, V58, P743, DOI 10.1046/j.1365-2265.2003.01788.x; Goldstone AP, 2004, TRENDS ENDOCRIN MET, V15, P12, DOI 10.1016/j.tem.2003.11.003; Haqq AM, 2003, J CLIN ENDOCR METAB, V88, P174, DOI 10.1210/jc.2002-021052; Hinton EC, 2006, INT J OBESITY, V30, P313, DOI 10.1038/sj.ijo.0803128; Holland A, 2003, LANCET, V362, P989, DOI 10.1016/S0140-6736(03)14370-X; HOLLAND AJ, 1993, INT J OBESITY, V17, P527; HOLM VA, 1993, PEDIATRICS, V91, P398; Holsen LM, 2006, OBESITY, V14, P1028, DOI 10.1038/oby.2006.118; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Hwang DL, 2008, GROWTH HORM IGF RES, V18, P65, DOI 10.1016/j.ghir.2007.07.007; I'Allemand D, 2002, HORM RES, V58, P215, DOI 10.1159/000066263; Jordan C, 2006, HUM MOL GENET, V15, P2210, DOI 10.1093/hmg/ddl146; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Le Meur E, 2005, DEV BIOL, V286, P587, DOI 10.1016/j.ydbio.2005.07.030; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Lindgren AC, 2000, J PEDIATR-US, V137, P50, DOI 10.1067/mpd.2000.106563; Meguro M, 2001, HUM MOL GENET, V10, P383, DOI 10.1093/hmg/10.4.383; Miller JL, 2007, J NEUROL NEUROSUR PS, V78, P615, DOI 10.1136/jnnp.2006.099044; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; NICOLOSO M, 1994, MOL CELL BIOL, V14, P5766, DOI 10.1128/MCB.14.9.5766; Pecoraro N, 2006, PROG NEUROBIOL, V79, P247, DOI 10.1016/j.pneurobio.2006.07.004; Reik W, 2003, J PHYSIOL-LONDON, V547, P35, DOI 10.1113/jphysiol.2002.033274; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Runte M, 2005, HUM GENET, V116, P228, DOI 10.1007/s00439-004-1219-2; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schule B, 2007, AM J HUM GENET, V81, P492, DOI 10.1086/520063; Schule B, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-18; Seibler J, 1997, BIOCHEMISTRY-US, V36, P1740, DOI 10.1021/bi962443e; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Silver L.M., 1995, MOUSE GENETICS, p62?75; Stefan M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-157; Stefan M, 2005, ENDOCRINOLOGY, V146, P4377, DOI 10.1210/en.2005-0371; Swaab DF, 1997, ACTA PAEDIATR, V86, P50; Talebizadeh Z, 2004, J AUTISM DEV DISORD, V34, P735, DOI 10.1007/s10803-004-5295-x; Tan TMM, 2004, J CLIN ENDOCR METAB, V89, P4162, DOI 10.1210/jc.2004-0835; TRAYHURN P, 1977, NATURE, V266, P60, DOI 10.1038/266060a0; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Whitman B, 2004, J PEDIATR ENDOCR MET, V17, P591; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; YEN TT, 1974, COMP BIOCHEM PHYSIOL, V49, P377, DOI 10.1016/0300-9629(74)90128-5; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215; ZIPF WB, 1987, AM J CLIN NUTR, V46, P277, DOI 10.1093/ajcn/46.2.277	71	203	210	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1709	10.1371/journal.pone.0001709	http://dx.doi.org/10.1371/journal.pone.0001709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320030	Green Published, gold, Green Submitted			2022-12-25	WOS:000260586600005
J	Hart, ML; Henn, M; Koehler, D; Kloor, D; Mittelbronn, M; Gorzolla, IC; Stahl, GL; Eltzschig, HK				Hart, Melanie L.; Henn, Martina; Koehler, David; Kloor, Doris; Mittelbronn, Michel; Gorzolla, Iris C.; Stahl, Gregory L.; Eltzschig, Holger K.			Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury	FASEB JOURNAL			English	Article						CD73; adenosine receptor; hypoxia; HIF; hypoxia-inducible factor	HYPOXIA-INDUCIBLE FACTOR; ECTO-5'-NUCLEOTIDASE CD73; ADENOSINE RECEPTORS; ISCHEMIA/REPERFUSION INJURY; LYMPHOCYTE BINDING; COMPLEMENT PATHWAY; ENDOTHELIAL-CELLS; ADENYLATE-CYCLASE; TISSUE PROTECTION; EPITHELIA	Extracellular adenosine has been implicated as an innate antiinflammatory metabolite, particularly during conditions of limited oxygen availability such as ischemia. Because extracellular adenosine generation is primarily produced via phosphohydrolysis from its precursor molecule adenosine-monophosphate (AMP) through the enzyme ecto-5 '-nucleotidase (CD73), we examined the contribution of CD73-dependent adenosine production in modulation of intestinal ischemia-reperfusion (IR) injury. Following transcriptional and translational profiling of intestinal tissue that revealed a prominent induction of murine CD73, we next determined the role of CD73 in protection against intestinal IR injury. Interestingly, pharmacological inhibition or targeted gene deletion of CD73 significantly enhanced not only local intestinal injury, but also secondary organ injury, following IR as measured by intestinal and lung myeloperoxidase, aspartate and alanine aminotransferase, interleukin (IL)-1, IL-6, and histological injury. To confirm the role of CD73 in intestinal adenosine production, we measured adenosine tissue levels and found that they were increased with IR injury. In contrast, CD73-deficient (cd73(-/-)) mice had lower adenosine levels at baseline and no increase with IR injury. Finally, reconstitution of cd73(-/-) mice or treatment of wild- type mice with soluble 5 '-nucleotidase was associated with significantly lower levels of injury. These data reveal a previously unrecognized role of CD73 in attenuating intestinal IR-mediated injury.	[Hart, Melanie L.; Henn, Martina; Koehler, David; Gorzolla, Iris C.; Eltzschig, Holger K.] Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Ctr Inflammat & Hypoxia, D-72074 Tubingen, Germany; [Hart, Melanie L.; Stahl, Gregory L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Expt Therapeut & Reperfus Injury,Dept Anesthe, Boston, MA 02115 USA; [Mittelbronn, Michel] Univ Tubingen Hosp, Inst Brain Res, D-72074 Tubingen, Germany; [Kloor, Doris] Univ Tubingen, Dept Pharmacol & Toxicol, Tubingen, Germany; [Eltzschig, Holger K.] Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol, Mucosal Inflammat Program, Denver, CO USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Hart, ML (corresponding author), Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Ctr Inflammat & Hypoxia, Wilhelmstr 56, D-72074 Tubingen, Germany.	melaniehar@googlemail.com; holger.eltzschig@uchsc.edu		Stahl, Gregory/0000-0002-4805-8119; Mittelbronn, Michel/0000-0002-2998-052X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052886, R56HL056086, R01HL056086, R29HL052886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191, R01DE017821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK067782] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL056086, HL-56086, R56 HL056086, HL-52886, R01 HL052886] Funding Source: Medline; NIDCR NIH HHS [DE-16191, P50 DE016191, DE-17821, R01 DE017821] Funding Source: Medline; NIDDK NIH HHS [DK-067782, F32 DK067782] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Airas L, 2000, J IMMUNOL, V165, P5411, DOI 10.4049/jimmunol.165.10.5411; Airas L, 1997, J CELL BIOL, V136, P421, DOI 10.1083/jcb.136.2.421; AIRAS L, 1995, J EXP MED, V182, P1603, DOI 10.1084/jem.182.5.1603; Asfaha S, 2001, AM J PHYSIOL-GASTR L, V281, pG635, DOI 10.1152/ajpgi.2001.281.3.G635; Bourdi M, 2002, BIOCHEM BIOPH RES CO, V294, P225, DOI 10.1016/S0006-291X(02)00466-7; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2004, BRIT MED BULL, V70, P71, DOI 10.1093/bmb/ldh025; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eltzschig HK, 2006, METH MOL B, V341, P73; Freeman SL, 2004, GUT, V53, P214, DOI 10.1136/gut.2003.023895; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; GRISHAM MB, 1989, AM J PHYSIOL, V257, pH1334, DOI 10.1152/ajpheart.1989.257.5.H1334; Guckelberger O, 2004, THROMB HAEMOSTASIS, V91, P576, DOI 10.1160/TH03-06-0373; Hart ML, 2005, J IMMUNOL, V174, P6373, DOI 10.4049/jimmunol.174.10.6373; KAMINSKI PM, 1989, CIRC RES, V65, P426, DOI 10.1161/01.RES.65.2.426; KAMINSKI PM, 1992, CIRC RES, V71, P720, DOI 10.1161/01.RES.71.3.720; KAMINSKI PM, 1990, CIRC RES, V66, P1713, DOI 10.1161/01.RES.66.6.1713; Kolachala V, 2005, J BIOL CHEM, V280, P4048, DOI 10.1074/jbc.M409577200; Koury J, 2004, SHOCK, V22, P270, DOI 10.1097/01.shk.0000135256.67441.3f; Lennon PF, 1998, J EXP MED, V188, P1433, DOI 10.1084/jem.188.8.1433; Linden J, 2005, MOL PHARMACOL, V67, P1385, DOI 10.1124/mol.105.011783; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Luippold G, 1999, J CHROMATOGR B, V724, P231, DOI 10.1016/S0378-4347(98)00580-5; MADARA JL, 1993, J CLIN INVEST, V91, P2320, DOI 10.1172/JCI116462; Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91; Maxwell PH, 2005, EXP PHYSIOL, V90, P791, DOI 10.1113/expphysiol.2005.030924; McCallion K, 2004, CRIT CARE MED, V32, P273, DOI 10.1097/01.CCM.0000098026.12020.45; Naganuma M, 2006, J IMMUNOL, V177, P2765, DOI 10.4049/jimmunol.177.5.2765; Niemela J, 2004, J IMMUNOL, V172, P1646, DOI 10.4049/jimmunol.172.3.1646; Ozacmak VH, 2007, EUR J PHARMACOL, V562, P138, DOI 10.1016/j.ejphar.2007.01.061; PARKOS CA, 1991, J CLIN INVEST, V88, P1605, DOI 10.1172/JCI115473; PARKOS CA, 1994, J AM SOC NEPHROL, V5, P138; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; Sitkovsky MV, 2003, BIOCHEM PHARMACOL, V65, P493, DOI 10.1016/S0006-2952(02)01548-4; Stahl GL, 2003, AM J PATHOL, V162, P449, DOI 10.1016/S0002-9440(10)63839-4; Strohmeier GR, 1997, J CLIN INVEST, V99, P2588, DOI 10.1172/JCI119447; STROHMEIER GR, 1995, J BIOL CHEM, V270, P2387, DOI 10.1074/jbc.270.5.2387; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Tendler David A, 2003, Semin Gastrointest Dis, V14, P66; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; TURNAGE RH, 1994, SHOCK, V1, P408, DOI 10.1097/00024382-199406000-00003; Vakeva AP, 1998, CIRCULATION, V97, P2259, DOI 10.1161/01.CIR.97.22.2259; Zhao H, 2002, J APPL PHYSIOL, V93, P338, DOI 10.1152/japplphysiol.00159.2002	51	83	84	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2008	22	8					2784	2797		10.1096/fj.07-103911	http://dx.doi.org/10.1096/fj.07-103911			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	332NI	18353866	Green Published			2022-12-25	WOS:000258089300019
J	Deshpande, DA; Theriot, BS; Penn, RB; Walker, JKL				Deshpande, Deepak A.; Theriot, Barbara S.; Penn, Raymond B.; Walker, Julia K. L.			beta-arrestins specifically constrain beta 2-adrenergic receptor signaling and function in airway smooth muscle	FASEB JOURNAL			English	Article							PROTEIN-COUPLED RECEPTORS; ADRENERGIC-RECEPTOR; ASTHMA; KINASE; MICE; DESENSITIZATION; SALMETEROL; AGONIST; HYPERREACTIVITY; PHOSPHORYLATION	Chronic use of inhaled beta-agonists by asthmatics is associated with a loss of bronchoprotective effect and deterioration of asthma control. Beta-agonistpromoted desensitization of airway smooth muscle beta-2-adrenergic receptors, mediated by G protein-coupled receptor kinases and arrestins, is presumed to underlie these effects, but such a mechanism has never been demonstrated. Using in vitro, ex vivo, and in vivo murine models, we demonstrate that beta-arrestin-2 gene ablation augments beta-agonist-mediated airway smooth muscle relaxation, while augmenting beta-agonist-stimulated cyclic adenosine monophosphate production. In cultures of human airway smooth muscle, small interfering RNA-mediated knockdown of arrestins also augments beta-agonist-stimulated cyclic adenosine monophosphate production. Interestingly, signaling and function mediated by m2/m3 muscarinic acetylcholine receptors or prostaglandin E-2 receptors were not affected by either beta-arrestin-2 knockout or arrestin knockdown. Thus, arrestins are selective regulators of beta-2-adrenergic receptor signaling and function in airway smooth muscle. These results and our previous findings, which demonstrate a role for arrestins in the development of allergic inflammation in the lung, identify arrestins as potentially important therapeutic targets for obstructive airway diseases.	[Deshpande, Deepak A.; Penn, Raymond B.] WFUHSC, Ctr Human Genom, Winston Salem, NC 27157 USA; [Deshpande, Deepak A.; Penn, Raymond B.] WFUHSC, Dept Internal Med, Winston Salem, NC 27157 USA; [Theriot, Barbara S.; Walker, Julia K. L.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University	Penn, RB (corresponding author), WFUHSC, Ctr Human Genom, Med Ctr Blvd, Winston Salem, NC 27157 USA.	rpenn@wfubmc.edu; walke082@mc.duke.edu	Walker, Julia/R-7585-2017		NHLBI NIH HHS [R01 HL084123, HL-58506, R01 HL093103, R01 HL058506, HL-084123, R29 HL058506, K99 HL-087560, K99 HL087560] Funding Source: Medline; NIAID NIH HHS [R01 AI059755, AI059755] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL058506, R01HL084123, K99HL087560, R01HL058506, R01HL093103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059755] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aaronson DW, 2006, J ALLERGY CLIN IMMUN, V117, P40, DOI 10.1016/j.jaci.2005.08.060; Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; BHAGAT R, 1995, CHEST, V108, P1235, DOI 10.1378/chest.108.5.1235; Billington CK, 2005, BIOCHEMISTRY-US, V44, P14595, DOI 10.1021/bi0510734; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; CHEUNG D, 1992, NEW ENGL J MED, V327, P1198, DOI 10.1056/NEJM199210223271703; Deshpande DA, 2007, FASEB J, V21, P2335, DOI 10.1096/fj.06-8060com; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; GAVETT SH, 1993, AM J PHYSIOL, V265, pL493, DOI 10.1152/ajplung.1993.265.5.L493; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; HOSEY MM, 1995, LIFE SCI, V56, P951; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Jackson CM, 2004, DRUG SAFETY, V27, P243, DOI 10.2165/00002018-200427040-00003; Krueger KM, 1997, J BIOL CHEM, V272, P5; Lee KB, 1998, J BIOL CHEM, V273, P12967, DOI 10.1074/jbc.273.21.12967; LEVITT RC, 1988, FASEB J, V2, P2605, DOI 10.1096/fasebj.2.10.3384240; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2002, J CELL SCI, V115, P455; Mak JCW, 2002, BRIT J PHARMACOL, V135, P987, DOI 10.1038/sj.bjp.0704545; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; PENN RB, 1998, HDB PHYSL, P125; Peters SP, 1999, AM J MED, V107, P283; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SEARS MR, 1990, LANCET, V336, P1391, DOI 10.1016/0140-6736(90)93098-A; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; Struckmann N, 2003, MOL PHARMACOL, V64, P1444, DOI 10.1124/mol.64.6.1444; Taylor DR, 1998, THORAX, V53, P744, DOI 10.1136/thx.53.9.744; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Walker JKL, 1999, AM J PHYSIOL-REG I, V276, pR1214, DOI 10.1152/ajpregu.1999.276.4.R1214; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; WIDDOP S, 1993, AM J RESP CELL MOL, V9, P541, DOI 10.1165/ajrcmb/9.5.541	35	71	74	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2008	22	7					2134	2141		10.1096/fj.07-102459	http://dx.doi.org/10.1096/fj.07-102459			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18337459	Green Accepted			2022-12-25	WOS:000257292500005
J	Membrez, M; Blancher, F; Jaquet, M; Bibiloni, R; Cani, PD; Burcelin, RG; Corthesy, I; Mace, K; Chou, CJ				Membrez, Mathieu; Blancher, Florence; Jaquet, Muriel; Bibiloni, Rodrigo; Cani, Patrice D.; Burcelin, Remy G.; Corthesy, Irene; Mace, Katherine; Chou, Chieh Jason			Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice	FASEB JOURNAL			English	Article						lipopolysaccharide; hepatic steatosis; liver glycogen; TNF-alpha	INDUCED INSULIN-RESISTANCE; TYROSINE KINASE-ACTIVITY; TOLL-LIKE RECEPTORS; MOLECULAR ANALYSIS; OBESITY; DIVERSITY; IMPROVES; ALPHA; OXYTETRACYCLINE; ENDOTOXEMIA	Recent data suggest that the gut microbiota plays a significant role in fat accumulation. However, it is not clear whether gut microbiota is involved in the pathophysiology of type 2 diabetes. To assess this issue, we modulated gut microbiota via antibiotics administration in two different mouse models with insulin resistance. Results from dose-determination studies showed that a combination of norfloxacin and ampicillin, at a dose of 1g/L, maximally suppressed the numbers of cecal aerobic and anaerobic bacteria in ob/ob mice. After a 2-wk intervention with the antibiotic combination, both ob/ob and diet-induced obese and insulin-resistant mice showed a significant improvement in fasting glycemia and oral glucose tolerance. The improved glycemic control was independent of food intake or adiposity because pair-fed ob/ob mice were as glucose intolerant as the control ob/ob mice. Reduced liver triglycerides and increased liver glycogen correlated with improved glucose tolerance in the treated mice. Concomitant reduction of plasma lipopolysaccharides and increase of adiponectin further supported the antidiabetic effects of the antibiotic treatment in ob/ob mice. In summary, modulation of gut microbiota ameliorated glucose tolerance of mice by altering the expression of hepatic and intestinal genes involved in inflammation and metabolism, and by changing the hormonal, inflammatory, and metabolic status of the host.	[Membrez, Mathieu; Blancher, Florence; Jaquet, Muriel; Bibiloni, Rodrigo; Corthesy, Irene; Mace, Katherine; Chou, Chieh Jason] Nestle Res Ctr, CH-1000 Lausanne, Switzerland; [Cani, Patrice D.] Catholic Univ Louvain, Unit Pharmacokinet Metab Nutr & Toxicol, Brussels, Belgium; [Burcelin, Remy G.] INSERM, Inst Mol Med Rangueil 12 MR, U858, IFR31, Toulouse, France	Nestle SA; Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm)	Chou, CJ (corresponding author), Nestle Res Ctr, POB 44, CH-1000 Lausanne, Switzerland.	chieh-jason.chou@rdls.nestle.com	burcelin, remy/M-6013-2014; D., Cani Patrice/M-8055-2016	D., Cani Patrice/0000-0003-2040-2448				Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Begin-Heck N, 1974, Biochem J, V142, P465; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; BLANDIZZI C, 1991, EUR J PHARMACOL, V201, P35, DOI 10.1016/0014-2999(91)90319-L; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chou CJ, 2002, J BIOL CHEM, V277, P24484, DOI 10.1074/jbc.M202449200; DALPESCOTT M, 1982, DIABETES, V31, P53, DOI 10.2337/diabetes.31.1.53; DUBUC PU, 1978, DIABETOLOGIA, V14, P129, DOI 10.1007/BF01263451; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Hill MJ, 1997, EUR J CANCER PREV, V6, pS43, DOI 10.1097/00008469-199703001-00009; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; LEVINE M, 1921, B IOWA STATE COLLEGE, V62; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Scougall KT, 2003, J MOL ENDOCRINOL, V30, P331, DOI 10.1677/jme.0.0300331; Solga SF, 2003, J HEPATOL, V38, P681, DOI 10.1016/S0168-8278(03)00097-7; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; VAN SCHOTHORST M., 1966, ZENTRALBL VETERINARMED REIHE B, V13, P273; VIRKAMAKI A, 1994, ENDOCRINOLOGY, V134, P2072, DOI 10.1210/en.134.5.2072; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zunkler BJ, 2006, TOXICOLOGY, V228, P239, DOI 10.1016/j.tox.2006.09.002	40	363	397	1	61	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2008	22	7					2416	2426		10.1096/fj.07-102723	http://dx.doi.org/10.1096/fj.07-102723			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18326786				2022-12-25	WOS:000257292500033
J	Dillon, TM; Ricci, MS; Vezina, C; Flynn, GC; Liu, YD; Rehder, DS; Plant, M; Henkle, B; Li, Y; Deechongkit, S; Varnum, B; Wypych, J; Balland, A; Bondarenko, PV				Dillon, Thomas M.; Ricci, Margaret Speed; Vezina, Chris; Flynn, Gregory C.; Liu, Yaoqing Diana; Rehder, Douglas S.; Plant, Matthew; Henkle, Brad; Li, Yu; Deechongkit, Songpon; Varnum, Brian; Wypych, Jette; Balland, Alain; Bondarenko, Pavel V.			Structural and functional characterization of disulfide isoforms of the human IgG2 subclass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT ANTIBODIES; SPECTROMETRY METHOD; MASS-SPECTROMETRY; IMMUNOGLOBULIN-G; PROTEINS; PERFORMANCE; STABILITY; HETEROGENEITY; INFECTION; CYTOKINES	In the accompanying report ( Wypych, J., Li, M., Guo, A., Zhang, Z., Martinez, T., Allen, M. J., Fodor, S., Kelner, D. N., Flynn, G. C., Liu, Y. D., Bondarenko, P. V., Ricci, M. S., Dillon, T. M., and Balland, A. (2008) J. Biol. Chem. 283, 16194 -16205), we have identified that the human IgG2 subclass exists as an ensemble of distinct isoforms, designated IgG2-A, -B, and -A/ B, which differ by the disulfide connectivity at the hinge region. In this report, we studied the structural and functional properties of the IgG2 disulfide isoforms and compared them to IgG1. Human monoclonal IgG1 and IgG2 antibodies were designed with identical antigen binding regions, specific to interleukin-1 cell surface receptor type 1. In vitro biological activity measurements showed an increased activity of the IgG1 relative to the IgG2 in blocking interleukin-1 beta ligand from binding to the receptor, suggesting that some of the IgG2 isoforms had lower activity. Under reduction-oxidation conditions, the IgG2 disulfide isoforms converted to IgG2-A when 1M guanidine was used, whereas IgG2-B was enriched in the absence of guanidine. The relative potency of the antibodies in cell-based assays was: IgG1 > IgG2-A > IgG2 >> IgG2-B. This difference correlated with an increased hydrodynamic radius of IgG2-A relative to IgG2-B, as shown by biophysical characterization. The enrichment of disulfide isoforms and activity studies were extended to additional IgG2 monoclonal antibodies with various antigen targets. All IgG2 antibodies displayed the same disulfide conversion, but only a subset showed activity differences between IgG2-A and IgG2-B. Additionally, the distribution of isoforms was influenced by the light chain type, with IgG2 lambda composed mostly of IgG2-A. Based on crystal structure analysis, we propose that IgG2 disulfide exchange is caused by the close proximity of several cysteine residues at the hinge and the reactivity of tandem cysteines within the hinge. Furthermore, the IgG2 isoforms were shown to interconvert in whole blood or a "blood-like" environment, thereby suggesting that the in vivo activity of isoforms.	[Dillon, Thomas M.; Ricci, Margaret Speed; Rehder, Douglas S.; Deechongkit, Songpon; Bondarenko, Pavel V.] Amgen Inc, Dept Pharmaceut, Thousand Oaks, CA 91320 USA; [Vezina, Chris; Plant, Matthew; Henkle, Brad; Li, Yu; Varnum, Brian] Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA 91320 USA; [Flynn, Gregory C.; Liu, Yaoqing Diana; Wypych, Jette; Balland, Alain] Amgen Inc, Dept Analyt Sci, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen	Dillon, TM (corresponding author), Amgen Inc, Dept Pharmaceut, Thousand Oaks, CA 91320 USA.	Tdillon@Amgen.com; Pavel.Bondarenko@Amgen.com	Liu, Y Diana/AAU-4624-2021					Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Banks DD, 2008, J PHARM SCI-US, V97, P775, DOI 10.1002/jps.21014; Beenhouwer DO, 2007, INFECT IMMUN, V75, P1424, DOI 10.1128/IAI.01161-06; BREKKE OH, 1993, MOL IMMUNOL, V30, P1419, DOI 10.1016/0161-5890(93)90103-I; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; BURTON DR, 1985, MOL IMMUNOL, V22, P161, DOI 10.1016/0161-5890(85)90151-8; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Chaderjian WB, 2005, BIOTECHNOL PROGR, V21, P550, DOI 10.1021/bp0497029; CHOWDHURY SK, 1990, J AM CHEM SOC, V112, P9012, DOI 10.1021/ja00180a074; Dillon TM, 2006, J CHROMATOGR A, V1120, P112, DOI 10.1016/j.chroma.2006.01.016; Dillon TM, 2004, J CHROMATOGR A, V1053, P299, DOI 10.1016/j.chroma.2004.08.058; FRANGIONE B, 1969, NATURE, V221, P145, DOI 10.1038/221145a0; Gorgani NN, 1999, J BIOL CHEM, V274, P29633, DOI 10.1074/jbc.274.42.29633; GUERNE PA, 1990, J IMMUNOL, V144, P499; Harris RJ, 2005, DEV BIOLOGICALS, V122, P117; Hildebrandt W, 2002, MECH AGEING DEV, V123, P1269, DOI 10.1016/S0047-6374(02)00013-1; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Jefferis R, 2007, EXPERT OPIN BIOL TH, V7, P1401, DOI 10.1517/14712598.7.9.1401; Lilie H, 1998, CURR OPIN BIOTECH, V9, P497, DOI 10.1016/S0958-1669(98)80035-9; LIU H, 2008, J PHARM SCI IN PRESS; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Mills BJ, 2000, J LAB CLIN MED, V135, P396, DOI 10.1067/mlc.2000.105976; Montano RF, 2002, J IMMUNOL, V168, P224, DOI 10.4049/jimmunol.168.1.224; Naisbitt DJ, 2000, AIDS RES HUM RETROV, V16, P1929, DOI 10.1089/088922200750054657; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; SASSENFELD HM, 2002, Patent No. 02068455; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; SRINIVASAN N, 1990, INT J PEPT PROT RES, V36, P147; Teerinen T, 2006, J MOL BIOL, V361, P687, DOI 10.1016/j.jmb.2006.06.073; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wypych J, 2008, J BIOL CHEM, V283, P16194, DOI 10.1074/jbc.M709987200	35	206	255	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					16206	16215		10.1074/jbc.M709988200	http://dx.doi.org/10.1074/jbc.M709988200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18339626	Green Published, hybrid			2022-12-25	WOS:000256332500079
J	Lee, S; Kim, MH; Kang, BS; Kim, JS; Kim, GH; Kim, YG; Kim, KJ				Lee, Sujin; Kim, Myung Hee; Kang, Beom Sik; Kim, Jeong-Sun; Kim, Ghyung-Hwa; Kim, Yeon-Gil; Kim, Kyung Jin			Crystal structure of Escherichia coli MazG, the regulator of nutritional stress response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; PYROPHOSPHATE SYNTHASE; BACTERIAL; MECHANISM; (P)PPGPP; COMPLEX; MODULE; MODEL; HISE	MazG is a nucleoside triphosphate pyrophosphohydrolase that hydrolyzes all canonical nucleoside triphosphates. The mazG gene located downstream from the chromosomal mazEF "addiction module," that mediated programmed cell death in Escherichia coli. MazG activity is inhibited by the MazEF complex both in vivo and in vitro. Enzymatic activity of MazG in vivo affects the cellular level of guanosine 3', 5'-bispyrophosphate (ppGpp), synthesized by RelA under amino acid starvation. The reduction of ppGpp, caused by MazG, may extend the period of cell survival under nutritional stress. Here we describe the first crystal structure of active MazG from E. coli, which is composed of two similarly folded globular domains in tandem. Among the two putative catalytic domains, only the C-terminal domain has well ordered active sites and exhibits an NTPase activity. The MazG-ATP complex structure and subsequent mutagenesis studies explain the peculiar active site environment accommodating all eight canonical NTPs as substrates. In vivo nutrient starvation experiments show that the C terminus NTPase activity is responsible for the regulation of bacterial cell survival under nutritional stress.	[Lee, Sujin; Kim, Ghyung-Hwa; Kim, Yeon-Gil; Kim, Kyung Jin] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, Kyungbuk, South Korea; [Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Taejon 305600, South Korea; [Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Kim, Jeong-Sun] Chonnam Natl Univ, Dept Chem, Kwangju 500757, South Korea	Pohang University of Science & Technology (POSTECH); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kyungpook National University; Chonnam National University	Kim, KJ (corresponding author), Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, Kyungbuk, South Korea.	kkj@postech.ac.kr						Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang TH, 2006, J BIOL CHEM, V281, P14991, DOI 10.1074/jbc.M512886200; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; GAFNY R, 1988, NUCLEIC ACIDS RES, V16, P61, DOI 10.1093/nar/16.1.61; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; Guo RT, 2004, J BIOL CHEM, V279, P4903, DOI 10.1074/jbc.M310161200; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; Kwon JH, 2000, CAN J MICROBIOL, V46, P848, DOI 10.1139/cjm-46-9-848; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Moroz OV, 2004, J MOL BIOL, V342, P1583, DOI 10.1016/j.jmb.2004.07.050; Moroz OV, 2005, J MOL BIOL, V347, P243, DOI 10.1016/j.jmb.2005.01.030; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters RJ, 2002, P NATL ACAD SCI USA, V99, P580, DOI 10.1073/pnas.022627099; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Robinson A, 2007, MOL MICROBIOL, V66, P610, DOI 10.1111/j.1365-2958.2007.05932.x; SMITH DWE, 1965, J BIOL CHEM, V240, P3056; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Wu BL, 2007, J MOL BIOL, V367, P1405, DOI 10.1016/j.jmb.2007.01.057; YARMOLINSKY MB, 1995, SCIENCE, V267, P836, DOI 10.1126/science.7846528; Zhang JJ, 2002, J BACTERIOL, V184, P5323, DOI 10.1128/JB.184.19.5323-5329.2002; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	34	19	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15232	15240		10.1074/jbc.M800479200	http://dx.doi.org/10.1074/jbc.M800479200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18353782	Green Published, hybrid			2022-12-25	WOS:000256232000041
J	Chen, L; Zhang, JL; Huang, XY				Chen, Lin; Zhang, Jillian; Huang, Xin-Yun			CAMP inhibits cell migration by interfering with Rac-induced lamellipodium formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; LIGHT-CHAIN KINASES; SMOOTH-MUSCLE; PHOSPHORYLATION; CONTRACTION; ACTIVATION; ENA/VASP; MOTILITY; SIGNALS; CSK	Cell migration is critical for animal development and physiological as well as pathological responses. One important step during cell migration is the formation of lamellipodia at the leading edge of migrating cells. Here we report that the second messenger cAMP inhibits the migration of mouse embryonic fibroblast cells and mouse breast tumor cells. cAMP acts downstream of the small GTPase Rac and interferes with the formation of lamellipodia. Moreover, cAMP decreases the phosphorylation of the myosin light chain at the leading edge of cells and increases the phosphorylation of the vasodilator-stimulated phosphoprotein. Together with our previous report of a positive role of another second messenger, cGMP, in lamellipodium formation, our data indicate that cAMP and cGMP play opposite roles in modulating lamellipodium formation.	[Chen, Lin; Zhang, Jillian; Huang, Xin-Yun] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA	Cornell University	Huang, XY (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA.	xyhuang@med.cornell.edu			NATIONAL INSTITUTE ON AGING [R01AG023202] Funding Source: NIH RePORTER; NIA NIH HHS [AG23202] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bakre MM, 2002, NAT MED, V8, P995, DOI 10.1038/nm753; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BUTT E, 1994, J BIOL CHEM, V269, P14509; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Gomez TM, 2004, NEURON, V42, P1, DOI 10.1016/S0896-6273(04)00188-6; Guo DG, 2007, CELL, V128, P341, DOI 10.1016/j.cell.2006.11.048; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Hirakawa M, 2007, J PHARMACOL EXP THER, V321, P1102, DOI 10.1124/jpet.106.118042; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; LAMB NJC, 1988, J CELL BIOL, V106, P1955, DOI 10.1083/jcb.106.6.1955; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lorenowicz MJ, 2007, ARTERIOSCL THROM VAS, V27, P1014, DOI 10.1161/ATVBAHA.106.132282; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; McGarrigle D, 2006, J BIOL CHEM, V281, P10583, DOI 10.1074/jbc.M513002200; NISHIKAWA M, 1984, J BIOL CHEM, V259, P8429; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sandulache VC, 2007, WOUND REPAIR REGEN, V15, P122, DOI 10.1111/j.1524-475X.2006.00193.x; Shan DD, 2006, DEV CELL, V10, P707, DOI 10.1016/j.devcel.2006.03.014; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; SPUDICH JA, 1989, CELL REGUL, V1, P1; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Wang DW, 2006, J BIOL CHEM, V281, P32660, DOI 10.1074/jbc.M604588200; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200	39	42	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13799	13805		10.1074/jbc.M800555200	http://dx.doi.org/10.1074/jbc.M800555200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353776	hybrid, Green Published			2022-12-25	WOS:000255728200032
J	Kim, MK; Kang, MR; Nam, HW; Bae, YS; Kim, YS; Chung, IK				Kim, Mi Kyung; Kang, Mi Ran; Nam, Hyung Wook; Bae, Young-Seuk; Kim, Yu Sam; Chung, In Kwon			Regulation of telomeric repeat binding factor 1 binding to telomeres by casein kinase 2-mediated phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; ATAXIA-TELANGIECTASIA; HUMAN-CELLS; IMMORTAL CELLS; LENGTH CONTROL; TRF1; DNA; DEGRADATION; INHIBITION; END	Telomere maintenance is essential for continued cell proliferation and chromosome stability. Telomeres are maintained by telomerase and a collection of associated proteins. The telomeric protein telomeric repeat binding factor 1 (TRF1) negatively regulates telomere length by inhibiting access of telomerase at telomere termini. Here we report that TRF1 interacts with the beta subunit of casein kinase 2 (CK2) and serves as a substrate for CK2. CK2-mediated phosphorylation is required for the efficient telomere binding of TRF1 in vitro and in vivo. Inhibition of CK2 by the CK2 inhibitor 5,6-dichloro-1-beta-D-ribofuranosyl-benzimidazole decreased the ability of TRF1 to bind telomeric DNA. The resulting telomere-unbound form of TRF1 was then ubiquitinated and degraded by the proteasome. Partial knockdown of CK2 by small interfering RNA resulted in removal of TRF1 from telomeres and subsequent degradation of TRF1. Mapping of the CK2 target site identified threonine 122 as a substrate in TRF1. A threonine to alanine change at this position led to a diminished DNA binding due to reduced dimerization of TRF1. In addition, phosphorylation of threonine 122 seemed critical for TRF1-mediated telomere length control. Our findings suggest that CK2-mediated phosphorylation of TRF1 plays an important role in modulating telomere length homeostasis by determining the levels of TRF1 at telomeres.	[Kim, Mi Kyung; Kang, Mi Ran; Chung, In Kwon] Yonsei Univ, Dept Biol, Seoul 120749, South Korea; [Kim, Mi Kyung; Kang, Mi Ran; Chung, In Kwon] Yonsei Univ, Mol Aging Res Ctr, Seoul 120749, South Korea; [Nam, Hyung Wook; Kim, Yu Sam] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Nam, Hyung Wook; Kim, Yu Sam; Chung, In Kwon] Yonsei Univ, Prot Network Res Ctr, Seoul 120749, South Korea; [Bae, Young-Seuk] Kyungpook Natl Univ, Coll Nat Sci, Dept Biochem, Taegu 702701, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Kyungpook National University	Chung, IK (corresponding author), Yonsei Univ, Dept Biol, 134 Shinchon Dong, Seoul 120749, South Korea.	topoviro@yonsei.ac.kr						Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Cerone MA, 2005, ONCOGENE, V24, P7893, DOI 10.1038/sj.onc.1208934; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; DAYAMAKIN M, 1994, CANCER RES, V54, P2262; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; Fairall L, 2001, MOL CELL, V8, P351, DOI 10.1016/S1097-2765(01)00321-5; Ford HL, 2000, J BIOL CHEM, V275, P22245, DOI 10.1074/jbc.M002446200; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Harrington L, 2005, CHROMOSOME RES, V13, P493, DOI 10.1007/s10577-005-0994-5; Kim JH, 2003, MOL PHARMACOL, V63, P1117, DOI 10.1124/mol.63.5.1117; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kim YS, 2003, J BIOL CHEM, V278, P28462, DOI 10.1074/jbc.M302584200; Kishi S, 2002, J BIOL CHEM, V277, P7420, DOI 10.1074/jbc.M111365200; Kwon C, 2004, J BIOL CHEM, V279, P12812, DOI 10.1074/jbc.M312011200; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lee GE, 2004, J BIOL CHEM, V279, P34750, DOI 10.1074/jbc.M401843200; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Metcalfe JA, 1996, NAT GENET, V13, P350, DOI 10.1038/ng0796-350; Nam HW, 2005, J CHROMATOGR B, V826, P91, DOI 10.1016/j.jchromb.2005.07.039; Nishiyama A, 2006, EMBO J, V25, P575, DOI 10.1038/sj.emboj.7600964; Seimiya H, 2004, MOL CELL BIOL, V24, P1944, DOI 10.1128/MCB.24.5.1944-1955.2004; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1997, TRENDS GENET, V13, P21, DOI 10.1016/S0168-9525(96)10052-4; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Son MY, 1999, BIOCHEM BIOPH RES CO, V263, P743, DOI 10.1006/bbrc.1999.1460; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	48	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14144	14152		10.1074/jbc.M710065200	http://dx.doi.org/10.1074/jbc.M710065200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18347021	hybrid			2022-12-25	WOS:000255728200068
J	Ma, QL; Yang, FS; Calon, F; Ubeda, OJ; Hansen, JE; Weisbart, RH; Beech, W; Frautschy, SA; Cole, GM				Ma, Qiu-Lan; Yang, Fusheng; Calon, Frederic; Ubeda, Oliver J.; Hansen, James E.; Weisbart, Richard H.; Beech, Walter; Frautschy, Sally A.; Cole, Greg M.			p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE MODEL; AMYLOID-BETA OLIGOMERS; LONG-TERM POTENTIATION; IN-VIVO; A-BETA; MENTAL-RETARDATION; RHO-GTPASES; DENDRITIC SPINES; NMDA RECEPTOR; MICE	Defects in dendritic spines and synapses contribute to cognitive deficits in mental retardation syndromes and, potentially, Alzheimer disease. p21-activated kinases (PAKs) regulate actin filaments and morphogenesis of dendritic spines regulated by the Rho family GTPases Rac and Cdc42. We previously reported that active PAK was markedly reduced in Alzheimer disease cytosol, accompanied by downstream loss of the spine actin-regulatory protein Drebrin. beta-Amyloid (A beta) oligomer was implicated in PAK defects. Here we demonstrate that PAK is aberrantly activated and translocated from cytosol to membrane in Alzheimer disease brain and in 22-month-old Tg2576 transgenic mice with Alzheimer disease. This active PAK co-immunoprecipitated with the small GTPase Rac and both translocated to granules. A beta(42) oligomer treatment of cultured hippocampal neurons induced similar effects, accompanied by reduction of dendrites that were protected by kinase-active but not kinase-dead PAK. A beta(42) oligomer treatment also significantly reduced N-methyl-D-aspartic acid receptor subunit NR2B phosphotyrosine labeling. The Src family tyrosine kinase inhibitor PP2 significantly blocked the PAK/Rac translocation but not the loss of p-NR2B in A beta(42) oligomer-treated neurons. Src family kinases are known to phosphorylate the Rac activator Tiam1, which has recently been shown to be A beta-responsive. In addition, anti-oligomer curcumin comparatively suppressed PAK translocation in aged Tg2576 transgenic mice with Alzheimer amyloid pathology and in A beta(42) oligomer-treated cultured hippocampal neurons. Our results implicate aberrant PAK in A beta oligomer-induced signaling and synaptic deficits in Alzheimer disease.	[Ma, Qiu-Lan; Yang, Fusheng; Ubeda, Oliver J.; Hansen, James E.; Weisbart, Richard H.; Beech, Walter; Frautschy, Sally A.; Cole, Greg M.] Vet Affairs Med Ctr, Greater Los Angeles Vet Affairs Healthcare Syst, Geriatr Res & Clin Ctr, North Hills, CA 91343 USA; [Ma, Qiu-Lan; Yang, Fusheng; Ubeda, Oliver J.; Hansen, James E.; Weisbart, Richard H.; Beech, Walter; Frautschy, Sally A.; Cole, Greg M.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Frautschy, Sally A.; Cole, Greg M.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Calon, Frederic] Univ Laval, Med Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ G1V 4G2, Canada; [Calon, Frederic] Univ Laval, Fac Pharm, Quebec City, PQ G1K 7P4, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Laval University; Laval University	Cole, GM (corresponding author), Vet Affairs Med Ctr, Greater Los Angeles Vet Affairs Healthcare Syst, Geriatr Res & Clin Ctr, Alzheimer Res 151,Bldg 7,Rm A102, North Hills, CA 91343 USA.	gmcole@ucla.edu	Calon, Frederic/AAF-4390-2020	Frautschy, Sally A./0000-0003-0194-0363; Calon, Frederic/0000-0002-4203-0887	NCCIH NIH HHS [AT003008, R01 AT003008-03, R01 AT003008, R01 AT003008-02, R01 AT003008-01] Funding Source: Medline; NIA NIH HHS [R01 AG021975-02, P50 AG016570-090005, U01 AG028583-03, R01 AG021975, R01 AG021975-01A2, R01 AG013741-05, P50 AG016570, AG13471, P50 AG016570-060005, AG16570, U01 AG028583, P50 AG016570-070005, R01 AG021975-04, P50 AG016570-080005, P50 AG016570-040001, R01 AG013741-06, AG021975, R01 AG021975-03, R01 AG013741, R01 AG013741-07A2, R01 AG013741-08, P50 AG016570-100005, P50 AG005142] Funding Source: Medline; PHS HHS [U0128583] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT003008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013741, P50AG005142, P50AG016570, R01AG021975, U01AG028583] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Boda B, 2004, J NEUROSCI, V24, P10816, DOI 10.1523/JNEUROSCI.2931-04.2004; Buttini M, 2000, NEUROSCIENCE, V97, P207, DOI 10.1016/S0306-4522(00)00069-5; Buttini M, 2002, J NEUROSCI, V22, P10539; Calon F, 2005, EUR J NEUROSCI, V22, P617, DOI 10.1111/j.1460-9568.2005.04253.x; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; Frasca G, 2008, J NEUROSCI RES, V86, P350, DOI 10.1002/jnr.21487; Hayashi K, 2002, MOL CELL NEUROSCI, V20, P579, DOI 10.1006/mcne.2002.1144; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Lim GP, 2001, NEUROBIOL AGING, V22, P983, DOI 10.1016/S0197-4580(01)00299-8; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Ma QL, 2006, J NEUROSCI RES, V83, P374, DOI 10.1002/jnr.20734; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mendoza-Naranjo A, 2007, J CELL SCI, V120, P279, DOI 10.1242/jcs.03323; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Nguyen TVV, 2008, J NEUROCHEM, V104, P1065, DOI 10.1111/j.1471-4159.2007.05031.x; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	53	93	103	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14132	14143		10.1074/jbc.M708034200	http://dx.doi.org/10.1074/jbc.M708034200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18347024	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000255728200067
J	Eichberger, T; Kaser, A; Pixner, C; Schmid, C; Klingler, S; Winklmayr, M; Hauser-Kronberger, C; Aberger, F; Frischauf, AM				Eichberger, Thomas; Kaser, Alexandra; Pixner, Claudia; Schmid, Carmen; Klingler, Stefan; Winklmayr, Martina; Hauser-Kronberger, Cornelia; Aberger, Fritz; Frischauf, Anna-Maria			GLI2-specific transcriptional activation of the bone morphogenetic protein/activin antagonist follistatin in human epidermal cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIR FOLLICLE DEVELOPMENT; EPITHELIAL STEM-CELLS; SONIC HEDGEHOG; HUMAN KERATINOCYTES; CARCINOMA PROLIFERATION; CUBITUS INTERRUPTUS; SKIN DEVELOPMENT; DNA METHYLATION; BINDING PROTEIN; GENE-EXPRESSION	Hedgehog (HH) signaling in the epidermis is primarily mediated by the zinc finger transcription factors GLI1 and GLI2. Exquisite regulation of HH/GLI signaling is crucial for proper specification of the epidermal lineage and development of its derivatives, whereas dysregulation of HH/GLI signaling disrupts tissue homeostasis and causes basal cell carcinoma (BCC). Similarly, bone morphogenetic proteins (BMPs) and activins have been described as key signaling factors in the complex regulation of epidermal fate decisions, although their precise interplay with HH/GLI is largely elusive. Here we show that, in human epidermal cells, expression of the activin/BMP antagonist follistatin (FST) is predominantly up-regulated by the HH effector GLI2. Consistently, we found strong FST expression in the outer root sheath of human hair follicles and BCC. Detailed promoter analysis showed that two sequences with homology to the GLI consensus binding site are required for GLI2-mediated activation. Interestingly, activation of the FST promoter is highly GLI2-specific, because neither GLI1 nor GLI3 can significantly increase FST transcription. GLI2 specificity requires the presence of a 518-bp fragment in the proximal FST promoter region. On the protein level, sequences C-terminal to the zinc finger are responsible for GLI2-specific activation of FST transcription, pointing to the existence of GLI-interacting cofactors that modulate GLI target specificity. Our results reveal a key role of GLI2 in activation of the activin/BMP antagonist FST in response to HH signaling and provide new evidence for a regulatory interaction between HH and activin/BMP signaling in hair follicle development and BCC.	[Eichberger, Thomas; Kaser, Alexandra; Pixner, Claudia; Schmid, Carmen; Klingler, Stefan; Winklmayr, Martina; Aberger, Fritz; Frischauf, Anna-Maria] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Hauser-Kronberger, Cornelia] Paracelsus Med Univ, St Johanns Hosp, Dept Pathol, A-5020 Salzburg, Austria	Salzburg University; Paracelsus Private Medical University	Frischauf, AM (corresponding author), Salzburg Univ, Dept Mol Biol, Hellbrunnerstr 34, A-5020 Salzburg, Austria.	annemarie.frischauf@sbg.ac.at	Aberger, Fritz/B-6357-2012	Aberger, Fritz/0000-0003-2009-6305; Kaser-Eichberger, Alexandra/0000-0002-6115-5036	Austrian Science Fund FWF [P 16518] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Akimaru H, 1997, NATURE, V386, P735, DOI 10.1038/386735a0; Altaba AR, 2003, CURR OPIN GENET DEV, V13, P513, DOI 10.1016/j.gde.2003.08.005; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Alvarez-Salas LM, 2005, INT J ONCOL, V26, P259; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Callahan CA, 2001, CURR OPIN GENET DEV, V11, P541, DOI 10.1016/S0959-437X(00)00230-6; Chen Y, 2000, MOL CELL BIOL, V20, P1616, DOI 10.1128/MCB.20.5.1616-1625.2000; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Ding Q, 1998, DEVELOPMENT, V125, P2533; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Ghali L, 1999, J INVEST DERMATOL, V113, P595, DOI 10.1046/j.1523-1747.1999.00729.x; Gomes WA, 2001, DEV BIOL, V237, P212, DOI 10.1006/dbio.2001.0344; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Kim Y, 2007, CANCER RES, V67, P3583, DOI 10.1158/0008-5472.CAN-06-3040; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Martin KJ, 2001, P NATL ACAD SCI USA, V98, P2646, DOI 10.1073/pnas.041622398; Matise MP, 1998, DEVELOPMENT, V125, P2759; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Mo R, 1997, DEVELOPMENT, V124, P113; Morita K, 2006, J DERMATOL SCI, V44, P11, DOI 10.1016/j.jdermsci.2006.06.001; Nakamura M, 2003, FASEB J, V17, P497, DOI 10.1096/fj.02-0247fje; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; NUMOTO M, 1993, NUCLEIC ACIDS RES, V21, P3767, DOI 10.1093/nar/21.16.3767; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Ohyama M, 2007, J DERMATOL SCI, V46, P81, DOI 10.1016/j.jdermsci.2006.12.002; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Pardali K, 2005, J CELL PHYSIOL, V204, P260, DOI 10.1002/jcp.20304; Park HL, 2000, DEVELOPMENT, V127, P1593; Patel K, 1999, MECH DEVELOP, V86, P51, DOI 10.1016/S0925-4773(99)00107-0; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Regl G, 2004, ONCOGENE, V23, P1263, DOI 10.1038/sj.onc.1207240; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Seishima M, 1999, J INVEST DERMATOL, V112, P432, DOI 10.1046/j.1523-1747.1999.00558.x; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; So PL, 2006, EXP DERMATOL, V15, P742, DOI 10.1111/j.1600-0625.2006.00465.x; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; SUGINO K, 1993, J BIOL CHEM, V268, P15579; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; Utriainen P, 2006, J ENDOCRINOL, V188, P305, DOI 10.1677/joe.1.06392; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Werner S, 2001, ONCOGENE, V20, P7494, DOI 10.1038/sj.onc.1204937; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Xu XZ, 2004, J INVEST DERMATOL, V123, P1120, DOI 10.1111/j.0022-202X.2004.23492.x; Yoon JW, 1998, J BIOL CHEM, V273, P3496, DOI 10.1074/jbc.273.6.3496	83	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12426	12437		10.1074/jbc.M707117200	http://dx.doi.org/10.1074/jbc.M707117200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319260	Green Published, hybrid			2022-12-25	WOS:000255340000059
J	Fukui, K; Nishida, M; Nakagawa, N; Masui, R; Kuramitsu, S				Fukui, Kenji; Nishida, Masami; Nakagawa, Noriko; Masui, Ryoji; Kuramitsu, Seiki			Bound nucleotide controls the endonuclease activity of mismatch repair enzyme MutL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMUS-THERMOPHILUS; RECA PROTEIN; DNA-REPAIR; GENES; ALPHA; CANCER; ATPASE; TRANSFORMATION; RECOMBINATION; RECOGNITION	DNA mismatch repair corrects mismatched base pairs mainly caused by replication error. Recent studies revealed that human MutL endonuclease, hPMS2, plays an essential role in the repair. However, there has been little biochemical analysis of the MutL endonuclease. In particular, it is unknown for what the MutL utilizes ATP binding and hydrolyzing activity. Here we report the detailed functional analysis of Thermus thermophilus MutL (ttMutL). ttMutL exhibited an endonuclease activity that decreased on alteration of Asp364 in ttMutL to Asn. The biochemical characteristics of ttMutL were significantly affected on ATP binding, which suppressed nonspecific DNA digestion and promoted the mismatch-and MutS-dependent DNA binding. The inactivation of the cysteinyl residues in the C-terminal domain resulted in the perturbation in ATP-dependent regulation of the endonuclease activity, although the ATP-binding motif is located in the N-terminal domain. Complementation experiments revealed that the endonuclease activity of ttMutL and its regulation by ATP binding are necessary for DNA repair in vivo.	[Fukui, Kenji; Nishida, Masami; Nakagawa, Noriko; Masui, Ryoji; Kuramitsu, Seiki] RIKEN, SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan; [Nakagawa, Noriko; Masui, Ryoji; Kuramitsu, Seiki] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan	Japan Synchrotron Radiation Research Institute; RIKEN; Osaka University	Kuramitsu, S (corresponding author), RIKEN, SPring 8 Ctr, Harima Inst, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	kuramitu@bio.sci.osaka-u.ac.jp		Fukui, Kenji/0000-0003-2463-7578				Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; de Grado M, 1999, PLASMID, V42, P241, DOI 10.1006/plas.1999.1427; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; FANG WH, 1993, J BIOL CHEM, V268, P11838; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; Friedberg E. C., 1995, DNA REPAIR MUTAGENES, P1; Fukui K, 2007, NUCLEIC ACIDS RES, V35, P850, DOI 10.1093/nar/gkl735; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Guarne A, 2001, EMBO J, V20, P5521, DOI 10.1093/emboj/20.19.5521; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; Hoseki J, 1999, J BIOCHEM-TOKYO, V126, P951, DOI 10.1093/oxfordjournals.jbchem.a022539; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiang JJ, 2005, MOL CELL, V20, P771, DOI 10.1016/j.molcel.2005.10.014; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kitazono AA, 2002, YEAST, V19, P141, DOI 10.1002/yea.806; KONDO N, 2007, THERMOPHILES, V12, P217; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; KURAMITSU S, 1981, J BIOCHEM-TOKYO, V90, P1033, DOI 10.1093/oxfordjournals.jbchem.a133555; Lee JY, 2005, MOL CELL, V20, P155, DOI 10.1016/j.molcel.2005.08.019; Luria SE, 1943, GENETICS, V28, P491; MODRICH P, 1989, J BIOL CHEM, V264, P6597; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nakagawa N, 1997, J BIOL CHEM, V272, P22703, DOI 10.1074/jbc.272.36.22703; PUGH BF, 1988, J BIOL CHEM, V263, P76; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; SUNG P, 1993, J BIOL CHEM, V268, P26391; Takamatsu S, 1996, NUCLEIC ACIDS RES, V24, P640, DOI 10.1093/nar/24.4.640; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Yang W, 2007, DNA REPAIR, V6, P135, DOI 10.1016/j.dnarep.2006.10.021	35	54	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12136	12145		10.1074/jbc.M800110200	http://dx.doi.org/10.1074/jbc.M800110200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18310077	hybrid			2022-12-25	WOS:000255340000030
J	Zhang, Z; Gameiro, A; Grewer, C				Zhang, Zhou; Gameiro, Armanda; Grewer, Christof			Highly conserved asparagine 82 controls the interaction of Na+ with the sodium-coupled neutral amino acid transporter SNAT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE EXPRESSION PATTERN; PANCREATIC ACINAR-CELLS; SYSTEM N; FUNCTIONAL-CHARACTERISTICS; ELECTROGENIC PROPERTIES; ALANINE COTRANSPORTER; SUBTYPE; CLONING; IDENTIFICATION; METABOLISM	The neutral amino acid transporter 2 (SNAT2), which belongs to the SLC38 family of solute transporters, couples the transport of amino acid to the cotransport of one Na+ ion into the cell. Several polar amino acids are highly conserved within the SLC38 family. Here, we mutated three of these conserved amino acids, Asn(82) in the predicted transmembrane domain 1 (TMD1), Tyr(337) in TMD7, and Arg(374) in TMD8; and we studied the functional consequences of these modifications. The mutation of N82A virtually eliminated the alanine-induced transport current, as well as amino acid uptake by SNAT2. In contrast, the mutations Y337A and R374Q did not abolish amino acid transport. The K-m of SNAT2 for its interaction with Na+, K-Na(+), was dramatically reduced by the N82A mutation, whereas the more conservative mutation N82S resulted in a K-Na(+) that was in between SNAT2(N82A) and SNAT2(WT). These results were interpreted as a reduction of Na+ affinity caused by the Asn(82) mutations, suggesting that these mutations interfere with the interaction of SNAT2 with the sodium ion. As a consequence of this dramatic reduction in Na+ affinity, the apparent K-m of SNAT2(N82A) for alanine was increased 27-fold compared with that of SNAT2(WT). Our results demonstrate a direct or indirect involvement of Asn(82) in Na+ coordination by SNAT2. Therefore, we predict that TMD1 is crucial for the function of SLC38 transporters and that of related families.	[Gameiro, Armanda; Grewer, Christof] SUNY Binghamton, Dept Chem, Binghamton, NY 13902 USA; [Zhang, Zhou; Gameiro, Armanda; Grewer, Christof] Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Zhang, Zhou] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai 200234, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; University of Miami; Shanghai Normal University	Grewer, C (corresponding author), SUNY Binghamton, Dept Chem, 4400 Vestal Pkwy E, Binghamton, NY 13902 USA.	cgrewer@binghamton.edu	Albers, Thomas/A-9082-2012		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049335] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS049335, R01 NS049335-04, R01-NS049335-02] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Bode BP, 2001, J NUTR, V131, p2475S, DOI 10.1093/jn/131.9.2475S; Boll M, 2004, PFLUG ARCH EUR J PHY, V447, P776, DOI 10.1007/s00424-003-1073-4; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; Daikhin Y, 2000, J NUTR, V130, p1026S, DOI 10.1093/jn/130.4.1026S; Fei YJ, 2000, J BIOL CHEM, V275, P23707, DOI 10.1074/jbc.M002282200; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Hatanaka T, 2000, BBA-BIOMEMBRANES, V1467, P1, DOI 10.1016/S0005-2736(00)00252-2; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; JAUCH P, 1986, J MEMBRANE BIOL, V94, P99, DOI 10.1007/BF01871191; JAUCH P, 1986, J MEMBRANE BIOL, V94, P117, DOI 10.1007/BF01871192; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Lu CC, 1999, J GEN PHYSIOL, V114, P445, DOI 10.1085/jgp.114.3.445; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Mackenzie B, 2003, J BIOL CHEM, V278, P23720, DOI 10.1074/jbc.M212718200; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P1343, DOI 10.1006/bbrc.2001.4504; Ortiz-Lopez A, 2000, BBA-BIOMEMBRANES, V1465, P275, DOI 10.1016/S0005-2736(00)00144-9; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Pi J, 2002, J BACTERIOL, V184, P5842, DOI 10.1128/JB.184.21.5842-5847.2002; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Schneider HP, 2007, J BIOL CHEM, V282, P3788, DOI 10.1074/jbc.M609452200; Sugawara M, 2000, BBA-BIOMEMBRANES, V1509, P7, DOI 10.1016/S0005-2736(00)00349-7; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wang HP, 2000, BIOCHEM BIOPH RES CO, V273, P1175, DOI 10.1006/bbrc.2000.3061; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200; Young GB, 1999, BBA-BIOMEMBRANES, V1415, P306, DOI 10.1016/S0005-2736(98)00196-5; Young VR, 2001, J NUTR, V131, p2449S, DOI 10.1093/jn/131.9.2449S; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang Z, 2007, BIOPHYS J, V92, P2621, DOI 10.1529/biophysj.106.100776; Zhou YG, 2005, J BIOL CHEM, V280, P20316, DOI 10.1074/jbc.M412937200	36	22	24	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12284	12292		10.1074/jbc.M706774200	http://dx.doi.org/10.1074/jbc.M706774200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319257	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000255340000045
J	Liu, SB; He, YY; Zhang, Y; Lee, WH; Qian, JQ; Lai, R; Jin, Y				Liu, Shu-Bai; He, Ying-Ying; Zhang, Yun; Lee, Wen-Hui; Qian, Jin-Qiao; Lai, Ren; Jin, Yang			A Novel Non-Lens beta gamma-Crystallin and Trefoil Factor Complex from Amphibian Skin and Its Functional Implications	PLOS ONE			English	Article								Background: In vertebrates, non-lens beta gamma-crystallins are widely expressed in various tissues, but their functions are unknown. The molecular mechanisms of trefoil factors, initiators of mucosal healing and being greatly involved in tumorigenesis, have remained elusive. Principal Findings: A naturally existing 72-kDa complex of non-lens beta gamma-crystallin (alpha-subunit) and trefoil factor (beta-subunit), named beta gamma-CAT, was identified from frog Bombina maxima skin secretions. Its alpha-subunit and beta-subunit (containing three trefoil factor domains), with a non-covalently linked form of alpha beta(2), show significant sequence homology to ep37 proteins, a group of non-lens beta gamma-crystallins identified in newt Cynops pyrrhogaster and mammalian trefoil factors, respectively. beta gamma-CAT showed potent hemolytic activity on mammalian erythrocytes. The specific antiserum against each subunit was able to neutralize its hemolytic activity, indicating that the two subunits are functionally associated. beta gamma-CAT formed membrane pores with a functional diameter about 2.0 nm, leading to K(+) efflux and colloid-osmotic hemolysis. High molecular weight SDS-stable oligomers (>240-kDa) were detected by antibodies against the alpha-subunit with Western blotting. Furthermore, beta gamma-CAT showed multiple cellular effects on human umbilical vein endothelial cells. Low dosages of beta gamma-CAT (25-50 pM) were able to stimulate cell migration and wound healing. At high concentrations, it induced cell detachment (EC(50) 10 nM) and apoptosis. beta gamma-CAT was rapidly endocytosed via intracellular vacuole formation. Under confocal microscope, some of the vacuoles were translocated to nucleus and partially fused with nuclear membrane. Bafilomycin A1 (a specific inhibitor of the vacuolar-type ATPase) and nocodazole (an agent of microtuble depolymerizing), while inhibited beta gamma-CAT induced vacuole formation, significantly inhibited beta gamma-CAT induced cell detachment, suggesting that beta gamma-CAT endocytosis is important for its activities. Conclusions/Significance: These findings illustrate novel cellular functions of non-lens beta gamma-cyrstallins and action mechanism via association with trefoil factors, serving as clues for investigating the possible occurrence of similar molecules and action mechanisms in mammals.	[Liu, Shu-Bai; He, Ying-Ying; Zhang, Yun; Lee, Wen-Hui; Qian, Jin-Qiao; Lai, Ren; Jin, Yang] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming, Yunnan, Peoples R China; [Liu, Shu-Bai; He, Ying-Ying; Qian, Jin-Qiao] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, SB (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Biotoxin Units, Kunming, Yunnan, Peoples R China.	zhangy@mail.kiz.ac.cn	Qian, Jinqiao/Q-7822-2019; liu, tonny/F-1570-2010; Jin, Yang/GXF-7896-2022	Jin, Yang/0000-0002-7996-048X; Zhang, Yun/0000-0002-8636-183X	Chinese National Natural Science Foundation [30630014, 30570359]; Chinese Academy of Sciences [KSCX2-YW-R-088]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from The Chinese National Natural Science Foundation (30630014 and 30570359), and a grant of "Key Research Direction" (KSCX2-YW-R-088) from Chinese Academy of Sciences to Y.Z.	ALLEY MC, 1988, CANCER RES, V48, P589; Baus-Loncar M, 2005, CELL MOL LIFE SCI, V62, P2947, DOI 10.1007/s00018-005-5483-7; BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; Bossenmeyer-Pourie C, 2002, J CELL BIOL, V157, P761, DOI 10.1083/jcb200108056; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Clarke BT, 1997, BIOL REV, V72, P365, DOI 10.1017/S0006323197005045; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; COVER TL, 1991, INFECT IMMUN, V59, P1264, DOI 10.1128/IAI.59.4.1264-1270.1991; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; FOHLMAN J, 1976, EUR J BIOCHEM, V68, P457, DOI 10.1111/j.1432-1033.1976.tb10833.x; FREEDMAN JC, 1979, J GEN PHYSIOL, V74, P157, DOI 10.1085/jgp.74.2.157; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; HAUSER F, 1991, J BIOL CHEM, V266, P21306; HAUSER F, 1992, J BIOL CHEM, V267, P14451; HAUSER F, 1993, P NATL ACAD SCI USA, V90, P6961, DOI 10.1073/pnas.90.15.6961; Hoying JB, 1996, J CELL PHYSIOL, V168, P294, DOI 10.1002/(SICI)1097-4652(199608)168:2<294::AID-JCP8>3.0.CO;2-K; HUNTER SEC, 1992, INFECT IMMUN, V60, P102, DOI 10.1128/IAI.60.1.102-110.1992; INOUYE M, 1979, P NATL ACAD SCI USA, V76, P209, DOI 10.1073/pnas.76.1.209; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Jin LT, 2004, ELECTROPHORESIS, V25, P2494, DOI 10.1002/elps.200306002; Koumanov KS, 2005, ARCH BIOCHEM BIOPHYS, V434, P150, DOI 10.1016/j.abb.2004.10.025; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai R, 2003, COMP BIOCHEM PHYS B, V134, P509, DOI 10.1016/S1096-4959(02)00294-4; Lai R, 2002, PEPTIDES, V23, P427, DOI 10.1016/S0196-9781(01)00641-6; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Ogawa M, 1998, DEV GROWTH DIFFER, V40, P465; Ogawa M, 1997, DEV GENES EVOL, V206, P417, DOI 10.1007/s004270050071; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Ray ME, 1996, ONCOGENE, V12, P2527; Ray ME, 1997, P NATL ACAD SCI USA, V94, P3229, DOI 10.1073/pnas.94.7.3229; SABIROV RZ, 1993, GEN PHYSIOL BIOPHYS, V12, P95; Sands BE, 1996, ANNU REV PHYSIOL, V58, P253, DOI 10.1146/annurev.ph.58.030196.001345; Sandvig K, 2000, EMBO J, V19, P5943, DOI 10.1093/emboj/19.22.5943; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; SCHERRER R, 1971, J BACTERIOL, V107, P718, DOI 10.1128/JB.107.3.718-735.1971; Schiavo G, 2001, NAT REV MOL CELL BIO, V2, P530, DOI 10.1038/35080089; TAKABATAKE T, 1992, DEV GROWTH DIFFER, V34, P277; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Teichmann U, 1998, MAMM GENOME, V9, P715, DOI 10.1007/s003359900852; Thim L, 2005, CELL MOL LIFE SCI, V62, P2956, DOI 10.1007/s00018-005-5484-6; TOMASETTO C, 1990, EMBO J, V9, P407, DOI 10.1002/j.1460-2075.1990.tb08125.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UMATA T, 1990, J BIOL CHEM, V265, P21940; Wang TC, 2002, NAT MED, V8, P1080, DOI 10.1038/nm1002-1080; WISTOW G, 1995, EXP EYE RES, V61, P637, DOI 10.1016/S0014-4835(05)80058-2; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang J, 2005, BIOCHEM BIOPH RES CO, V330, P1027, DOI 10.1016/j.bbrc.2005.03.077	54	45	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1770	10.1371/journal.pone.0001770	http://dx.doi.org/10.1371/journal.pone.0001770			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335045	gold, Green Published, Green Submitted			2022-12-25	WOS:000260723000024
J	Meczes, EL; Gilroy, KL; West, KL; Austin, CA				Meczes, Emma L.; Gilroy, Kathryn L.; West, Katherine L.; Austin, Caroline A.			The Impact of the Human DNA Topoisomerase II C-Terminal Domain on Activity	PLOS ONE			English	Article							IN-VIVO; SACCHAROMYCES-CEREVISIAE; MITOTIC PHOSPHORYLATION; NUCLEAR-LOCALIZATION; THREONINE 1342; ALPHA; BETA; MUTATION; SITE; COMPLEMENTATION	Background: Type II DNA topoisomerases (topos) are essential enzymes needed for the resolution of topological problems that occur during DNA metabolic processes. Topos carry out an ATP-dependent strand passage reaction whereby one double helix is passed through a transient break in another. Humans have two topoII isoforms, alpha and beta, which while enzymatically similar are differentially expressed and regulated, and are thought to have different cellular roles. The C-terminal domain (CTD) of the enzyme has the most diversity, and has been implicated in regulation. We sought to investigate the impact of the CTD domain on activity. Methodology/Principle Findings: We have investigated the role of the human topoII C-terminal domain by creating constructs encoding C-terminally truncated recombinant topoII alpha and beta and topoII alpha+beta-tail and topoII beta+alpha-tail chimeric proteins. We then investigated function in vivo in a yeast system, and in vitro in activity assays. We find that the C-terminal domain of human topoII isoforms is needed for in vivo function of the enzyme, but not needed for cleavage activity. C-terminally truncated enzymes had similar strand passage activity to full length enzymes, but the presence of the opposite C-terminal domain had a large effect, with the topoII alpha-CTD increasing activity, and the topoII beta-CTD decreasing activity. Conclusions/Significance: In vivo complementation data show that the topoII alpha C-terminal domain is needed for growth, but the topoII beta isoform is able to support low levels of growth without a C-terminal domain. This may indicate that topoII beta has an additional localisation signal. In vitro data suggest that, while the lack of any C-terminal domain has little effect on activity, the presence of either the topoII alpha or beta C-terminal domain can affect strand passage activity. Data indicates that the topoII beta-CTD may be a negative regulator. This is the first report of in vitro data with chimeric human topoIIs.	[Meczes, Emma L.; Gilroy, Kathryn L.; Austin, Caroline A.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [West, Katherine L.] Univ Glasgow, Div Canc Sci & Mol Pathol, Glasgow, Lanark, Scotland	Newcastle University - UK; University of Glasgow	Meczes, EL (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	caroline.austin@ncl.ac.uk		Austin, Caroline/0000-0002-1921-5947; West, Katherine/0000-0002-5994-8969; Gilroy, Kathryn/0000-0003-4607-194X	North East Cancer Research Campaign (NECRC); Biotechnology and Biological Sciences Research Council (BBSRC); Newcastle University	North East Cancer Research Campaign (NECRC); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle University	This work was funded by the North East Cancer Research Campaign (NECRC), the Biotechnology and Biological Sciences Research Council (BBSRC), and Newcastle University.	Adachi N, 1997, NUCLEIC ACIDS RES, V25, P3135, DOI 10.1093/nar/25.15.3135; AUSTIN CA, 1995, J BIOL CHEM, V270, P15739, DOI 10.1074/jbc.270.26.15739; Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; CARDENAS ME, 1992, EMBO J, V11, P1785, DOI 10.1002/j.1460-2075.1992.tb05230.x; CARON PR, 1994, MOL CELL BIOL, V14, P3197, DOI 10.1128/MCB.14.5.3197; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Cowell IG, 1998, EXP CELL RES, V243, P232, DOI 10.1006/excr.1998.4150; CRENSHAW DG, 1993, J BIOL CHEM, V268, P21328; Daum JR, 1998, J BIOL CHEM, V273, P30622, DOI 10.1074/jbc.273.46.30622; Dickey JS, 2005, BIOCHEMISTRY-US, V44, P11546, DOI 10.1021/bi050811l; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; Gilroy KL, 2006, NUCLEIC ACIDS RES, V34, P1597, DOI 10.1093/nar/gkl057; GILROY KL, 2007, THESIS; HECK MMS, 1989, J BIOL CHEM, V264, P15161; Ishida R, 2001, CELL STRUCT FUNCT, V26, P215, DOI 10.1247/csf.26.215; Ishida R, 1996, J BIOL CHEM, V271, P30077, DOI 10.1074/jbc.271.47.30077; Isik S, 2003, FEBS LETT, V546, P374, DOI 10.1016/S0014-5793(03)00637-9; Jensen S, 1996, MOL CELL BIOL, V16, P3866; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Leontiou C, 2004, MOL PHARMACOL, V66, P430; Linka RM, 2007, NUCLEIC ACIDS RES, V35, P3810, DOI 10.1093/nar/gkm102; Mao Y, 2000, J BIOL CHEM, V275, P26066, DOI 10.1074/jbc.M001831200; Marsh KL, 1996, BIOCHEM PHARMACOL, V52, P1675, DOI 10.1016/S0006-2952(96)00516-3; McClendon AK, 2005, J BIOL CHEM, V280, P39337, DOI 10.1074/jbc.M503320200; Meczes EL, 1997, CANCER CHEMOTH PHARM, V39, P367, DOI 10.1007/s002800050585; MECZES EL, 1998, THESIS; Mirski SEL, 2003, BIOCHEM BIOPH RES CO, V306, P905, DOI 10.1016/S0006-291X(03)01077-5; Mirski SEL, 1997, EXP CELL RES, V237, P452, DOI 10.1006/excr.1997.3805; Mirski SEL, 1999, EXP CELL RES, V251, P329, DOI 10.1006/excr.1999.4587; Sakaguchi A, 2001, BIOCHEM BIOPH RES CO, V283, P876, DOI 10.1006/bbrc.2001.4856; Sengupta T, 2005, NUCLEIC ACIDS RES, V33, P2364, DOI 10.1093/nar/gki527; SHIOZAKI K, 1992, J CELL BIOL, V119, P1023, DOI 10.1083/jcb.119.5.1023; Takahashi Y, 2006, GENETICS, V172, P783, DOI 10.1534/genetics.105.047167; Turner JG, 2004, J CELL SCI, V117, P3061, DOI 10.1242/jcs.01147; WASSERMAN RA, 1993, CANCER RES, V53, P3591; WELLS NJ, 1995, J BIOL CHEM, V270, P28357; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; Wessel I, 1997, CANCER RES, V57, P4451; West KL, 2002, NUCLEIC ACIDS RES, V30, P5416, DOI 10.1093/nar/gkf677	43	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1754	10.1371/journal.pone.0001754	http://dx.doi.org/10.1371/journal.pone.0001754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335031	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000260723000008
J	Roux, X; Dubuquoy, C; Durand, G; Tran-Tolla, TL; Castagne, N; Bernard, J; Petit-Camurdan, A; Eleouet, JF; Riffault, S				Roux, Xavier; Dubuquoy, Catherine; Durand, Guillaume; Tran-Tolla, Thi-Lan; Castagne, Nathalie; Bernard, Julie; Petit-Camurdan, Agnes; Eleouet, Jean-Francois; Riffault, Sabine			Sub-Nucleocapsid Nanoparticles: A Nasal Vaccine against Respiratory Syncytial Virus	PLOS ONE			English	Article								Background: Bronchiolitis caused by the respiratory syncytial virus (RSV) in infants less than two years old is a growing public health concern worldwide, and there is currently no safe and effective vaccine. A major component of RSV nucleocapsid, the nucleoprotein (N), has been so far poorly explored as a potential vaccine antigen, even though it is a target of protective anti-viral T cell responses and is remarkably conserved between human RSV A and B serotypes. We recently reported a method to produce recombinant N assembling in homogenous rings composed of 10-11 N subunits enclosing a bacterial RNA. These nanoparticles were named sub-nucleocapsid ring structure (N SRS). Methodology and Principal Findings: The vaccine potential of N SRS was evaluated in a well-characterized and widely acknowledged mouse model of RSV infection. BALB/c adult mice were immunized intranasally with N SRS adjuvanted with the detoxified E. coli enterotoxin LT(R192G). Upon RSV challenge, vaccinated mice were largely protected against virus replication in the lungs, with a mild inflammatory lymphocytic and neutrophilic reaction in their airways. Mucosal immunization with N SRS elicited strong local and systemic immunity characterized by high titers of IgG1, IgG2a and IgA anti-N antibodies, antigen-specific CD8(+) T cells and IFN-gamma-producing CD4(+) T cells. Conclusions/Significance: This is the first report of using nanoparticles formed by the recombinant nucleocapsid protein as an efficient and safe intra-nasal vaccine against RSV.	[Roux, Xavier; Dubuquoy, Catherine; Durand, Guillaume; Tran-Tolla, Thi-Lan; Castagne, Nathalie; Bernard, Julie; Petit-Camurdan, Agnes; Eleouet, Jean-Francois; Riffault, Sabine] INRA, Unite Virol & Immunol Mol UR892, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Roux, X (corresponding author), INRA, Unite Virol & Immunol Mol UR892, Jouy En Josas, France.	sabine.riffault@jouy.inra.fr	Eléouët, Jean-François/AAD-1994-2019		INRA Animal Health division; Medical Research Fund [FRM FDT20060607329]	INRA Animal Health division; Medical Research Fund	Xavier Roux was funded during his thesis by the INRA Animal Health division, by the region "Ile de France" and got a fellowship from the Medical Research Fund (FRM FDT20060607329).	BANGHAM CRM, 1986, J IMMUNOL, V137, P3973; Bartholdy C, 2004, J GEN VIROL, V85, P3017, DOI 10.1099/vir.0.80098-0; Bot A, 1998, J VIROL, V72, P6637, DOI 10.1128/JVI.72.8.6637-6645.1998; BOXUS M, 2007, J VIROL; Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; Castagne N, 2004, J GEN VIROL, V85, P1643, DOI 10.1099/vir.0.79830-0; Chavez-Bueno S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-46; CHERRIE AH, 1992, J VIROL, V66, P2102, DOI 10.1128/JVI.66.4.2102-2110.1992; CHIN J, 1969, AM J EPIDEMIOL, V89, P449, DOI 10.1093/oxfordjournals.aje.a120957; Collins Peter L, 2005, Proc Am Thorac Soc, V2, P166, DOI 10.1513/pats.200501-011AW; CONNORS M, 1991, J VIROL, V65, P1634, DOI 10.1128/JVI.65.3.1634-1637.1991; Corthesy B, 2006, J VIROL, V80, P10692, DOI 10.1128/JVI.00927-06; de Haan L, 1998, IMMUNOL CELL BIOL, V76, P270, DOI 10.1046/j.1440-1711.1998.00745.x; DICKINSON BL, 1995, INFECT IMMUN, V63, P1617, DOI 10.1128/IAI.63.5.1617-1623.1995; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Etchart N, 2001, J IMMUNOL, V167, P384, DOI 10.4049/jimmunol.167.1.384; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Goulder PJR, 2000, J VIROL, V74, P7694, DOI 10.1128/JVI.74.16.7694-7697.2000; GRAHAM BS, 1991, J CLIN INVEST, V88, P1026, DOI 10.1172/JCI115362; Hogan RJ, 2001, J EXP MED, V193, P981, DOI 10.1084/jem.193.8.981; Hussell T, 1997, EUR J IMMUNOL, V27, P3341, DOI 10.1002/eji.1830271233; Hussell T, 1998, J IMMUNOL, V161, P6215; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; KING AMQ, 1987, J VIROL, V61, P2885, DOI 10.1128/JVI.61.9.2885-2890.1987; Laine D, 2003, J VIROL, V77, P11332, DOI 10.1128/JVI.77.21.11332-11346.2003; Littel-van den Hurk SV, 2007, REV MED VIROL, V17, P5, DOI 10.1002/rmv.518; LOPEZ JA, 1988, VIRUS RES, V10, P249, DOI 10.1016/0168-1702(88)90020-2; Morris CB, 2000, VACCINE, V18, P1944, DOI 10.1016/S0264-410X(99)00447-8; Nicollier-Jamot A, 2004, VACCINE, V22, P1079, DOI 10.1016/j.vaccine.2003.10.004; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Peebles R Stokes Jr, 2005, Proc Am Thorac Soc, V2, P110, DOI 10.1513/pats.200501-002AW; Plotnicky-Gilquin H, 2002, J VIROL, V76, P10203, DOI 10.1128/JVI.76.20.10203-10210.2002; Riffault S, 2000, J GEN VIROL, V81, P2365, DOI 10.1099/0022-1317-81-10-2365; SAMAL SK, 1991, J GEN VIROL, V72, P1715, DOI 10.1099/0022-1317-72-7-1715; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Simmons CP, 2001, J IMMUNOL, V166, P1106, DOI 10.4049/jimmunol.166.2.1106; Sivasamugham LA, 2006, J MED VIROL, V78, P1096, DOI 10.1002/jmv.20668; Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; TAYLOR G, 1995, J VIROL, V69, P6658, DOI 10.1128/JVI.69.11.6658-6664.1995; Taylor G, 1997, J GEN VIROL, V78, P3195, DOI 10.1099/0022-1317-78-12-3195; Tran TL, 2007, J GEN VIROL, V88, P196, DOI 10.1099/vir.0.82282-0; Tudor D, 2001, VIROLOGY, V286, P197, DOI 10.1006/viro.2001.0957; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; Valarcher JF, 2007, VET RES, V38, P153, DOI 10.1051/vetres:2006053; Vaughan K, 2005, VACCINE, V23, P2928, DOI 10.1016/j.vaccine.2004.10.046; Venter M, 2003, J VIROL, V77, P7319, DOI 10.1128/JVI.77.13.7319-7329.2003; Viuff B, 2002, AM J PATHOL, V161, P2195, DOI 10.1016/S0002-9440(10)64496-3; Williams AE, 2004, J IMMUNOL, V173, P7435, DOI 10.4049/jimmunol.173.12.7435; Yan HM, 2002, J VIROL, V76, P10972, DOI 10.1128/JVI.76.21.10972-10979.2002	52	40	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1766	10.1371/journal.pone.0001766	http://dx.doi.org/10.1371/journal.pone.0001766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335041	gold, Green Published, Green Submitted			2022-12-25	WOS:000260723000020
J	Chen, NKF; Wong, JS; Kee, IHC; Lai, SH; Thng, CH; Ng, WH; Ng, RTH; Tan, SY; Lee, SY; Tan, MEH; Sivalingam, J; Chow, PKH; Kon, OL				Chen, Nelson K. F.; Wong, Jen San; Kee, Irene H. C.; Lai, Siang Hui; Thng, Choon Hua; Ng, Wai Har; Ng, Robert T. H.; Tan, Soo Yong; Lee, Shu Yen; Tan, Mark E. H.; Sivalingam, Jaichandran; Chow, Pierce K. H.; Kon, Oi Lian			Nonvirally Modified Autologous Primary Hepatocytes Correct Diabetes and Prevent Target Organ Injury in a Large Preclinical Model	PLOS ONE			English	Article								Background: Current gene- and cell-based therapies have significant limitations which impede widespread clinical application. Taking diabetes mellitus as a paradigm, we have sought to overcome these limitations by ex vivo electrotransfer of a nonviral insulin expression vector into primary hepatocytes followed by immediate autologous reimplantation in a preclinical model of diabetes. Methods and Results: In a single 3-hour procedure, hepatocytes were isolated from a surgically resected liver wedge, electroporated with an insulin expression plasmid ex vivo and reimplanted intraparenchymally under ultrasonic guidance into the liver in each of 10 streptozotocin-induced diabetic Yorkshire pigs. The vector was comprised of a bifunctional, glucose-responsive promoter linked to human insulin cDNA. Ambient glucose concentrations appropriately altered human insulin mRNA expression and C-peptide secretion within minutes in vitro and in vivo. Treated swine showed correction of hyperglycemia, glucose intolerance, dyslipidemia and other metabolic abnormalities for >= 47 weeks. Metabolic correction correlated significantly with the number of hepatocytes implanted. Importantly, we observed no hypoglycemia even under fasting conditions. Direct intrahepatic implantation of hepatocytes did not alter biochemical indices of liver function or induce abnormal hepatic lobular architecture. About 70% of implanted hepatocytes functionally engrafted, appeared histologically normal, retained vector DNA and expressed human insulin for >= 47 weeks. Based on structural tissue analyses and transcriptome data, we showed that early correction of diabetes attenuated and even prevented pathological changes in the eye, kidney, liver and aorta. Conclusions: We demonstrate that autologous hepatocytes can be efficiently, simply and safely modified by electroporation of a nonviral vector to express, process and secrete insulin durably. This strategy, which achieved significant and sustained therapeutic efficacy in a large preclinical model without adverse effects, warrants consideration for clinical development especially as it could have broader future applications for the treatment of other acquired and inherited diseases for which systemic reconstitution of a specific protein deficiency is critical.	[Wong, Jen San; Chow, Pierce K. H.] Singapore Gen Hosp, Dept Gen Surg, Singapore, Singapore; [Chen, Nelson K. F.; Wong, Jen San; Ng, Wai Har; Tan, Mark E. H.; Sivalingam, Jaichandran; Kon, Oi Lian] Natl Canc Ctr, Div Med Sci, Singapore, Singapore; [Kee, Irene H. C.; Ng, Robert T. H.; Chow, Pierce K. H.] Singapore Gen Hosp, Dept Expt Surg, Singapore, Singapore; [Lai, Siang Hui] Hlth Sci Author, Ctr Forensic Med, Singapore, Singapore; [Thng, Choon Hua] Natl Canc Ctr, Dept Oncol Imag, Singapore, Singapore; [Tan, Soo Yong] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Lee, Shu Yen] Singapore Natl Eye Ctr, Singapore, Singapore	Singapore General Hospital; National Cancer Centre Singapore (NCCS); Singapore General Hospital; Health Sciences Authority (HSA); National Cancer Centre Singapore (NCCS); Singapore General Hospital; Singapore National Eye Center	Chow, PKH (corresponding author), Singapore Gen Hosp, Dept Gen Surg, Singapore, Singapore.	gsupc@sgh.com.sg; dmskol@nccs.com.sg		Chow, Pierce/0000-0003-0584-2584; Sivalingam, Jaichandran/0000-0002-3815-1272; Tan, Soo-Yong/0000-0002-6348-2823; Lai, Siang Hui/0000-0001-6811-7377	National Medical Research Council, Singapore; Biomedical Research Council, Singapore; Juvenile Diabetes Research Foundation, USA; National Cancer Centre, Singapore	National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR)); Juvenile Diabetes Research Foundation, USA(Juvenile Diabetes Research Foundation); National Cancer Centre, Singapore	National Medical Research Council, Singapore; Biomedical Research Council, Singapore, Juvenile Diabetes Research Foundation, USA and National Cancer Centre, Singapore Funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Balamurugan AN, 2006, PANCREAS, V32, P231, DOI 10.1097/01.mpa.0000203961.16630.2f; BARSOUM J, 1990, DNA CELL BIOL, V9, P293, DOI 10.1089/dna.1990.9.293; Beckers GJM, 2006, TRENDS PLANT SCI, V11, P322, DOI 10.1016/j.tplants.2006.05.010; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen NKF, 2005, GENE THER, V12, P655, DOI 10.1038/sj.gt.3302446; Chow PKH, 1997, J SURG RES, V70, P134, DOI 10.1006/jsre.1997.5120; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; Dhawan A, 2004, TRANSPLANTATION, V78, P1812, DOI 10.1097/01.TP.0000146386.77076.47; Dombrowski F, 2006, CANCER RES, V66, P1833, DOI 10.1158/0008-5472.CAN-05-2787; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Fodor A, 2007, DIABETOLOGIA, V50, P121, DOI 10.1007/s00125-006-0509-8; Frank Adam M, 2005, Adv Surg, V39, P137, DOI 10.1016/j.yasu.2005.04.010; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Giannoukakis N, 2005, CURR OPIN MOL THER, V7, P467; Grompe M, 2001, J INHERIT METAB DIS, V24, P231, DOI 10.1023/A:1010375203539; Grompe M, 1999, Hum Cell, V12, P171; GROTH CG, 1977, TRANSPLANT P, V9, P313; Gupta S, 1999, HEPATOLOGY, V29, P509, DOI 10.1002/hep.510290213; HAHN JD, 1993, J ANIM SCI, V71, P3020, DOI 10.2527/1993.71113020x; Halban PA, 2001, DIABETES, V50, P2181, DOI 10.2337/diabetes.50.10.2181; Han J, 2007, MOL THER, V15, P1195, DOI 10.1038/sj.mt.6300117; HIGGINS PJ, 1982, DIABETES, V31, P743, DOI 10.2337/diabetes.31.9.743; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Jones Timothy W, 2003, Pediatr Diabetes, V4, P143, DOI 10.1034/j.1399-5448.2003.00025.x; Kachi S, 2006, GENE THER, V13, P798, DOI 10.1038/sj.gt.3302700; KAY MA, 1992, P NATL ACAD SCI USA, V89, P89, DOI 10.1073/pnas.89.1.89; KINGSTON RE, 1996, CURRENT PROTOCOLS MO; Kjems LL, 2001, DIABETES, V50, P2001, DOI 10.2337/diabetes.50.9.2001; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Korompai FL, 2000, HORM METAB RES, V32, P256, DOI 10.1055/s-2007-978631; MAITRA A, 2005, PATHOLOGIC BASIS DIS, P1155; Meyburg J, 2005, TRANSPLANTATION, V80, pS135, DOI 10.1097/01.tp.0000186905.10088.e5; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mishra R, 2004, AM J PHYSIOL-RENAL, V286, pF913, DOI 10.1152/ajprenal.00323.2003; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; MOSCIONI AD, 1989, GASTROENTEROLOGY, V96, P1546, DOI 10.1016/0016-5085(89)90525-8; Muiesan P, 2007, J HEPATOL, V46, P340, DOI 10.1016/j.jhep.2006.11.006; Muraca M, 2002, TRANSPLANTATION, V73, P890, DOI 10.1097/00007890-200203270-00010; Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145; Picardo A, 1996, J SURG RES, V63, P452, DOI 10.1006/jsre.1996.0291; ROH S, 2004, OPHTHALMOLOGY, P779; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; SCHUTTE JE, 1981, J APPL PHYSIOL, V51, P762, DOI 10.1152/jappl.1981.51.3.762; SEAQUIST ER, 1992, J CLIN INVEST, V89, P1761, DOI 10.1172/JCI115779; Serup P, 2006, DIABETOLOGIA, V49, P2537, DOI 10.1007/s00125-006-0434-x; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Strom SC, 1997, TRANSPLANT P, V29, P2103, DOI 10.1016/S0041-1345(97)00252-2; Tabiin Muhammad T, 2004, J Autoimmune Dis, V1, P3, DOI 10.1186/1740-2557-1-3; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Torbenson M, 2006, AM J SURG PATHOL, V30, P508, DOI 10.1097/00000478-200604000-00012; Towle HC, 2005, TRENDS ENDOCRIN MET, V16, P489, DOI 10.1016/j.tem.2005.10.003; Towle HC, 1997, ANNU REV NUTR, V17, P405, DOI 10.1146/annurev.nutr.17.1.405; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216; Wang Z, 2004, GENE THER, V11, P711, DOI 10.1038/sj.gt.3302213; Wolff JA, 2005, ADV GENET, V54, P3, DOI 10.1016/S0065-2660(05)54001-X; Yechoor V, 2005, GENE THER, V12, P101, DOI 10.1038/sj.gt.3302412; ZHANG H, 1992, J PEDIATR SURG, V27, P312, DOI 10.1016/0022-3468(92)90853-Y	58	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1734	10.1371/journal.pone.0001734	http://dx.doi.org/10.1371/journal.pone.0001734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320053	gold, Green Submitted, Green Published			2022-12-25	WOS:000260586600029
J	Lang, P; van Harmelen, V; Ryden, M; Kaaman, M; Parini, P; Carneheim, C; Cassady, AI; Hume, DA; Andersson, G; Arner, P				Lang, Pernilla; van Harmelen, Vanessa; Ryden, Mikael; Kaaman, Maria; Parini, Paolo; Carneheim, Claes; Cassady, A. Ian; Hume, David A.; Andersson, Goran; Arner, Peter			Monomeric Tartrate Resistant Acid Phosphatase Induces Insulin Sensitive Obesity	PLOS ONE			English	Article							ADIPOSE-CELL-SIZE; CATHEPSIN-K; STEM-CELLS; FAT-CELLS; TRANSCRIPTION FACTORS; TNF-ALPHA; ACP 5; TISSUE; EXPRESSION; ADIPOCYTE	Background: Obesity is associated with macrophage infiltration of adipose tissue, which may link adipose inflammation to insulin resistance. However, the impact of inflammatory cells in the pathophysiology of obesity remains unclear. Tartrate resistant acid phosphatase ( TRAP) is an enzyme expressed by subsets of macrophages and osteoclasts that exists either as an enzymatically inactive monomer or as an active, proteolytically processed dimer. Principal Findings: Using mice over expressing TRAP, we show that over-expression of monomeric, but not the dimeric form in adipose tissue leads to early onset spontaneous hyperplastic obesity i.e. many small fat cells. In vitro, recombinant monomeric, but not proteolytically processed TRAP induced proliferation and differentiation of mouse and human adipocyte precursor cells. In humans, monomeric TRAP was highly expressed in the adipose tissue of obese individuals. In both the mouse model and in the obese humans the source of TRAP in adipose tissue was macrophages. In addition, the obese TRAP over expressing mice exhibited signs of a low-grade inflammatory reaction in adipose tissue without evidence of abnormal adipocyte lipolysis, lipogenesis or insulin sensitivity. Conclusion: Monomeric TRAP, most likely secreted from adipose tissue macrophages, induces hyperplastic obesity with normal adipocyte lipid metabolism and insulin sensitivity.	[Lang, Pernilla; Andersson, Goran] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Pathol, Huddinge, Sweden; [van Harmelen, Vanessa; Ryden, Mikael; Kaaman, Maria; Arner, Peter] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Huddinge, Sweden; [Parini, Paolo] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Clin Chem, Huddinge, Sweden; [Carneheim, Claes] Biovitrum AB, Integrative Pharmacol, Stockholm, Sweden; [Cassady, A. Ian; Hume, David A.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Hume, David A.] Univ Edinburgh, Sch Vet Stud, Roslin Inst, Roslin, Midlothian, Scotland	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Swedish Orphan Biovitrum; University of Queensland; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Lang, P (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Div Pathol, Huddinge, Sweden.	goran.andersson@ki.se; peter.arner@ki.se	Hume, David A/C-7695-2013; Lång, Pernilla/AAA-6660-2019; Cassady, Alan/AAY-2962-2021	Lång, Pernilla/0000-0002-3605-4014; Cassady, Alan/0000-0001-8585-5427; Arner, Peter/0000-0002-6208-6220; Hume, David/0000-0002-2615-1478; van Harmelen, Vanessa/0000-0003-0111-9858	Swedish Research Council; Swedish Heart and Lung Foundation; Novo Nordic Foundation; wedish Diabetes Association; King Gustaf V; Queen Victoria Foundation; European Union [CT-2005-018734]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordic Foundation(Novo Nordisk Foundation); wedish Diabetes Association; King Gustaf V; Queen Victoria Foundation; European Union(European Commission)	This study was supported by grants from Swedish Research Council, Swedish Heart and Lung Foundation, Novo Nordic Foundation, Swedish Diabetes Association and King Gustaf V, Queen Victoria Foundation and the European Union (HEPADIP, LSHM,-CT-2005-018734).	Andersson G, 2003, J BONE MINER RES, V18, P1912, DOI 10.1359/jbmr.2003.18.10.1912; Angel NZ, 2000, J BONE MINER RES, V15, P103, DOI 10.1359/jbmr.2000.15.1.103; Arner P, 2003, TRENDS ENDOCRIN MET, V14, P137, DOI 10.1016/S1043-2760(03)00024-9; BAZER FW, 1991, EXP HEMATOL, V19, P910; BONNET FP, 1979, ACTA PAEDIATR BELG, V32, P17; Bouloumie A, 2005, CURR OPIN CLIN NUTR, V8, P347, DOI 10.1097/01.mco.0000172571.41149.52; BROOK CGD, 1972, BMJ-BRIT MED J, V2, P25, DOI 10.1136/bmj.2.5804.25; BROOK CGD, 1973, ARCH DIS CHILD, V48, P301, DOI 10.1136/adc.48.4.301; Chiellini C, 2003, J CELL PHYSIOL, V195, P309, DOI 10.1002/jcp.10253; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Constant VA, 2006, DIABETOLOGIA, V49, P1402, DOI 10.1007/s00125-006-0253-0; Dahlman I, 2005, J CLIN ENDOCR METAB, V90, P5834, DOI 10.1210/jc.2005-0369; Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029; EkRylander B, 1997, BIOCHEM J, V321, P305, DOI 10.1042/bj3210305; Fajas L, 2003, ANN MED, V35, P79, DOI 10.1080/07853890310009999; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Funicello M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000683; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Halleen JM, 1999, J BIOL CHEM, V274, P22907, DOI 10.1074/jbc.274.33.22907; Hayman AR, 2000, J HISTOCHEM CYTOCHEM, V48, P219, DOI 10.1177/002215540004800207; Hayman AR, 2003, J BONE MINER RES, V18, P1905, DOI 10.1359/jbmr.2003.18.10.1905; Hayman AR, 2001, J HISTOCHEM CYTOCHEM, V49, P675, DOI 10.1177/002215540104900601; HIRSCH J, 1989, MED CLIN N AM, V73, P83, DOI 10.1016/S0025-7125(16)30693-9; Hoffstedt J, 2004, J CLIN ENDOCR METAB, V89, P1391, DOI 10.1210/jc.2003-031458; Hollberg K, 2005, J BONE MINER METAB, V23, P441, DOI 10.1007/s00774-005-0626-3; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Janckila AJ, 2005, J LEUKOCYTE BIOL, V77, P209, DOI 10.1189/jlb.0504287; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Justesen J, 2004, TISSUE ENG, V10, P381, DOI 10.1089/107632704323061744; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim SW, 2005, BIOCHEM BIOPH RES CO, V327, P811, DOI 10.1016/j.bbrc.2004.12.076; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; Kunisch E, 2004, ANN RHEUM DIS, V63, P774, DOI 10.1136/ard.2003.013029; Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687; Lang P, 2005, CELL MOL LIFE SCI, V62, P905, DOI 10.1007/s00018-005-4550-4; Lang P, 2001, J HISTOCHEM CYTOCHEM, V49, P379, DOI 10.1177/002215540104900312; Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200; Ljusberg J, 1999, BIOCHEM J, V343, P63, DOI 10.1042/0264-6021:3430063; Lofgren P, 2005, DIABETOLOGIA, V48, P2334, DOI 10.1007/s00125-005-1961-6; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Partington GA, 2004, BONE, V34, P237, DOI 10.1016/j.bone.2003.11.010; Permana PA, 2006, BIOCHEM BIOPH RES CO, V341, P507, DOI 10.1016/j.bbrc.2006.01.012; Raisanen SR, 2001, BIOCHEM BIOPH RES CO, V288, P142, DOI 10.1006/bbrc.2001.5715; REINHOLT FP, 1990, J BONE MINER RES, V5, P1055; REYNISDOTTIR S, 1994, DIABETOLOGIA, V37, P428, DOI 10.1007/s001250050128; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; SALANS LB, 1973, J CLIN INVEST, V52, P929, DOI 10.1172/JCI107258; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Sheu TJ, 2003, J BIOL CHEM, V278, P438, DOI 10.1074/jbc.M208292200; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; STERN JS, 1972, LANCET, V2, P948; Suzuki K, 1998, J DIABETES COMPLICAT, V12, P176, DOI 10.1016/S1056-8727(97)00107-4; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Vaaraniemi J, 2004, J BONE MINER RES, V19, P1432, DOI 10.1359/JBMR.040603; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; VALET P, 1993, J CLIN INVEST, V91, P2049, DOI 10.1172/JCI116427; van Harmelen V, 2002, DIABETES, V51, P2029, DOI 10.2337/diabetes.51.7.2029; Walsh NC, 2003, GENE, V307, P111, DOI 10.1016/S0378-1119(03)00449-9; Wang YL, 2005, ARCH BIOCHEM BIOPHYS, V435, P147, DOI 10.1016/j.abb.2004.11.029; Wang YL, 2007, ARCH BIOCHEM BIOPHYS, V461, P85, DOI 10.1016/j.abb.2007.01.025; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Winkler G, 2003, EUR J ENDOCRINOL, V149, P129, DOI 10.1530/eje.0.1490129; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xiao Y, 2006, J CLIN ENDOCR METAB, V91, P4520, DOI 10.1210/jc.2005-2486; Zenger S, 2007, BONE, V41, P820, DOI 10.1016/j.bone.2007.07.010	74	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1713	10.1371/journal.pone.0001713	http://dx.doi.org/10.1371/journal.pone.0001713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320034	Green Published, Green Submitted, gold			2022-12-25	WOS:000260586600009
J	Stewart, JP; Kipar, A; Cox, H; Payne, C; Vasiliou, S; Quinn, JP				Stewart, James P.; Kipar, Anja; Cox, Helen; Payne, Catherine; Vasiliou, Sylvia; Quinn, John P.			Induction of Tachykinin Production in Airway Epithelia in Response to Viral Infection	PLOS ONE			English	Article							SUBSTANCE-P RECEPTOR; SYNCYTIAL VIRUS-INFECTION; MARKER-GENE-EXPRESSION; INFLAMMATORY CYTOKINES; IMMUNE-RESPONSE; NEUROPEPTIDES; LYMPHOCYTES; MACROPHAGES; HEMOKININ; CANCER	Background: The tachykinins are implicated in neurogenic inflammation and the neuropeptide substance P in particular has been shown to be a proinflammatory mediator. A role for the tachykinins in host response to lung challenge has been previously demonstrated but has been focused predominantly on the release of the tachykinins from nerves innervating the lung. We have previously demonstrated the most dramatic phenotype described for the substance P encoding gene preprotachykinin-A (PPT-A) to date in controlling the host immune response to the murine gammaherpesvirus 68, in the lung. Methodology/ Principal Findings: In this study we have utilised transgenic mice engineered to co-ordinately express the beta-galactosidase marker gene along with PPT-A to facilitate the tracking of PPT-A expression. Using a combination of these mice and conventional immunohistology we now demonstrate that PPT-A gene expression and substance P peptide are induced in cells of the respiratory tract including tracheal, bronchiolar and alveolar epithelial cells and macrophages after viral infection. This induction was observed 24h post infection, prior to observable inflammation and the expression of pro-inflammatory chemokines in this model. Induced expression of the PPT-A gene and peptide persisted in the lower respiratory tract through day 7 post infection. Conclusions/ Significance: Non-neuronal PPT-A expression early after infection may have important clinical implications for the progression or management of lung disease or infection aside from the well characterised later involvement of the tachykinins during the inflammatory response.	[Stewart, James P.; Cox, Helen] Univ Liverpool, Dept Med Microbiol, Liverpool L69 3BX, Merseyside, England; [Kipar, Anja] Univ Liverpool, Dept Veterinary Pathol, Liverpool, Merseyside, England; [Vasiliou, Sylvia; Quinn, John P.] Univ Liverpool, Div Physiol & Human Anat Cell Biol, Liverpool, Merseyside, England; [Payne, Catherine] Univ Edinburgh, Scottish Ctr Regenerative Med, Edinburgh, Midlothian, Scotland	University of Liverpool; University of Liverpool; University of Liverpool; University of Edinburgh	Stewart, JP (corresponding author), Univ Liverpool, Dept Med Microbiol, POB 147, Liverpool L69 3BX, Merseyside, England.	j.p.stewart@liv.ac.uk; jquinn@liv.ac.uk	Quinn, John P/A-2972-2010; Kipar, Anja/L-7214-2014; Stewart, James/A-6034-2012	Quinn, John P/0000-0003-3551-7803; Kipar, Anja/0000-0001-7289-3459; Stewart, James/0000-0002-8928-2037	BBSRC [NEU15439]; Royal Society (London) University Research Fellowship; Medical Research Council [G0701003] Funding Source: researchfish; MRC [G0701003] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society (London) University Research Fellowship(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by BBSRC grant NEU15439. JPS was supported by a Royal Society (London) University Research Fellowship.	Blum AM, 1999, J IMMUNOL, V162, P6080; Cohen AJ, 1996, CANCER RES, V56, P831; Crimi N, 2003, J ALLERGY CLIN IMMUN, V111, P833, DOI 10.1067/mai.2003.161; D'Agostino B, 2002, CLIN EXP ALLERGY, V32, P472, DOI 10.1046/j.1365-2222.2002.01328.x; Germonpre PR, 1999, EUR RESPIR J, V14, P776, DOI 10.1034/j.1399-3003.1999.14d08.x; GOETZL EJ, 1992, FASEB J, V6, P2646, DOI 10.1096/fasebj.6.9.1612288; Haynes LM, 2002, J VIROL, V76, P6873, DOI 10.1128/JVI.76.14.6873-6881.2002; Ho WZ, 1997, J IMMUNOL, V159, P5654; Joos GF, 2000, ALLERGY, V55, P321, DOI 10.1034/j.1398-9995.2000.00112.x; Kamijo Y, 2001, LIFE SCI, V70, P1, DOI 10.1016/S0024-3205(01)01361-3; Lai JP, 1998, J NEUROIMMUNOL, V86, P80, DOI 10.1016/S0165-5728(98)00025-3; Lambrecht BN, 1999, EUR J IMMUNOL, V29, P3815, DOI 10.1002/(SICI)1521-4141(199912)29:12<3815::AID-IMMU3815>3.0.CO;2-#; LOTZ M, 1988, SCIENCE, V241, P1218, DOI 10.1126/science.2457950; MacKenzie A, 2000, MOL CELL NEUROSCI, V16, P620, DOI 10.1006/mcne.2000.0902; MacKenzie A, 2002, MOL CELL NEUROSCI, V19, P72, DOI 10.1006/mcne.2001.1052; Maggi CA, 1997, REGUL PEPTIDES, V70, P75, DOI 10.1016/S0167-0115(97)00029-3; MCGREGOR GP, 1995, ENDOCRINOLOGY, V136, P2538, DOI 10.1210/en.136.6.2538; Millward-Sadler SJ, 2003, ARTHRITIS RHEUM, V48, P146, DOI 10.1002/art.10711; Morteau O, 2001, NAT IMMUNOL, V2, P1088, DOI 10.1038/ni1201-1088; NOVERAL JP, 1995, AM J PHYSIOL-LUNG C, V269, pL339, DOI 10.1152/ajplung.1995.269.3.L339; Palma C, 1998, J NEUROIMMUNOL, V81, P127, DOI 10.1016/S0165-5728(97)00167-7; Payne CM, 2001, J VIROL, V75, P10467, DOI 10.1128/JVI.75.21.10467-10471.2001; Piedimonte G, 1999, AM J PHYSIOL-LUNG C, V277, pL831, DOI 10.1152/ajplung.1999.277.4.L831; Piedimonte G, 2004, PEDIATR RES, V55, P657, DOI 10.1203/01.PDR.0000112244.72924.26; Piedimonte G, 2003, PEDIATR INFECT DIS J, V22, pS66, DOI 10.1097/00006454-200302001-00010; Prakash A, 2005, J BIOL CHEM, V280, P18651, DOI 10.1074/jbc.M501289200; Sarawar SR, 1996, J VIROL, V70, P3264, DOI 10.1128/JVI.70.5.3264-3268.1996; Sarawar SR, 2002, VIROLOGY, V293, P54, DOI 10.1006/viro.2001.1221; Singh D, 2000, P NATL ACAD SCI USA, V97, P388, DOI 10.1073/pnas.97.1.388; Tripp RA, 2002, J NEUROIMMUNOL, V129, P141, DOI 10.1016/S0165-5728(02)00169-8; Tripp RA, 2000, J VIROL, V74, P1614, DOI 10.1128/JVI.74.4.1614-1622.2000; Veronesi B, 1999, NEUROPEPTIDES, V33, P447, DOI 10.1054/npep.1999.0761; Weinberg JB, 2004, VIRAL IMMUNOL, V17, P69, DOI 10.1089/088282404322875467; Weinberg JB, 2002, J VIROL, V76, P10518, DOI 10.1128/JVI.76.20.10518-10523.2002; Zhang Y, 2000, NAT IMMUNOL, V1, P392, DOI 10.1038/80826; Zhang Y, 2003, BLOOD, V102, P2165, DOI 10.1182/blood-2002-11-3572	36	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1673	10.1371/journal.pone.0001673	http://dx.doi.org/10.1371/journal.pone.0001673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320026	Green Published, Green Submitted, gold			2022-12-25	WOS:000260586600001
J	Huang, J; Chen, J				Huang, J.; Chen, J.			VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation	ONCOGENE			English	Article						VprBP; Merlin; E3 ligase; degradation	CUL4-DDB1 UBIQUITIN LIGASE; NF2 TUMOR-SUPPRESSOR; CELL-CYCLE; NEUROFIBROMATOSIS TYPE-2; PLASMA-MEMBRANE; PROTEIN VPR; ARREST; GROWTH; DDB1; RAC	Inactivation of the neurofibromatosis type 2 ( NF2) tumor suppressor gene function has been observed not only in familial schwannomas and other central nervous system tumors, but also in malignant tumors unrelated to the NF2 syndrome, indicating a broader role of NF2 in human tumorigenesis. The NF2-encoded protein Merlin is closely related to the Ezrin-Radixin-Moesin family of membrane/cytoskeleton linker proteins, and has been demonstrated to suppress tumor growth by inhibiting extracellular signal-regulated kinase ( ERK) and Rac1 activation. Interestingly, serum deprivation has been shown to regulate Merlin at the protein level, however, exactly how such condition affects Merlin remains elusive. In this study, we provide evidence to show that Merlin is regulated in a Roc1-Cullin4A-DDB1-dependent manner. Following serum stimulation, Merlin is recruited to the E3 ligase complex through a direct interaction with the WD40-containing adaptor protein VprBP. Loading of Merlin to the E3 ubiquitin ligase complex resulted in its polyubiquitination, and consequently its proteasome-mediated degradation. Consistently, VprBP depletion abolished the in vivo interaction of Merlin and Roc1-Cullin4A-DDB1, which resulted in Merlin stabilization and inhibited ERK and Rac activation. Together, our data revealed a novel regulatory mechanism for the tumor suppressor function of Merlin.	[Huang, J.; Chen, J.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University	Chen, J (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, Hunter Bldg 213C,333 Cedar St,POB 208040, New Haven, CT 06520 USA.	Junjie.chen@yale.edu	CHEN, JUNJIE/HHM-8428-2022					Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; den Bakker MA, 2000, J NEUROSCI RES, V62, P764, DOI 10.1002/1097-4547(20001215)62:6<764::AID-JNR2>3.0.CO;2-V; Gonzalez-Agosti C, 1999, J BIOL CHEM, V274, P34438, DOI 10.1074/jbc.274.48.34438; Gutmann DH, 1997, NEUROBIOL DIS, V3, P247, DOI 10.1006/nbdi.1997.0128; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; HOFER B, 1994, GENE, V144, P9, DOI 10.1016/0378-1119(94)90196-1; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lee JY, 2006, ONCOGENE, V25, P1143, DOI 10.1038/sj.onc.1209150; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Shaw RJ, 1998, J BIOL CHEM, V273, P7757, DOI 10.1074/jbc.273.13.7757; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Trofatter J A, 1993, Cell, V75, P826; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Xu HM, 1998, J NEUROSCI RES, V51, P403, DOI 10.1002/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7; Zhang SG, 2001, GENE, V263, P131, DOI 10.1016/S0378-1119(00)00583-7	29	52	55	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 3	2008	27	29					4056	4064		10.1038/onc.2008.44	http://dx.doi.org/10.1038/onc.2008.44			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	321RV	18332868				2022-12-25	WOS:000257325100005
J	Sasai, K; Parant, JM; Brandt, ME; Carter, J; Adams, HP; Stass, SA; Killary, AM; Katayama, H; Sen, S				Sasai, K.; Parant, J. M.; Brandt, M. E.; Carter, J.; Adams, H. P.; Stass, S. A.; Killary, A. M.; Katayama, H.; Sen, S.			Targeted disruption of Aurora A causes abnormal mitotic spindle assembly, chromosome misalignment and embryonic lethality	ONCOGENE			English	Article						mouse Aurora kinase A (Aurka) gene; mitotic spindle; chromosome segregation; Cre-LoxP recombination; morula/blastocyst	MAMMALIAN-CELLS; MESSENGER-RNA; PROTEIN; CHECKPOINT; KINASE; MICE; PHOSPHORYLATION; ENTRY; HURP; LOCALIZATION	Aurora A ( also known as STK15/BTAK in humans), a putative oncoprotein naturally overexpressed in many human cancers, is a member of the conserved Aurora protein serine/threonine kinase family that is implicated in the regulation of G(2)-M phases of the cell cycle. In vitro studies utilizing antibody microinjection, siRNA silencing and small molecule inhibitors have indicated that Aurora A functions in early as well as late stages of mitosis. However, due to limitations in specificity of the techniques, exact functional roles of the kinase remain to be clearly elucidated. In order to identify the physiological functions in vivo, we have generated Aurora A null mouse embryos, which show severe defects at 3.5 d.p.c. ( days post-coitus) morula/blastocyst stage and lethality before 8.5 d.p.c. Null embryos at 3.5 d.p.c. reveal growth retardation with cells in mitotic disarray manifesting disorganized spindle, misaligned and lagging chromosomes as well as micronucleated cells. These findings provide the first unequivocal genetic evidence for an essential physiological role of Aurora A in normal mitotic spindle assembly, chromosome alignment segregation and maintenance of viability in mammalian embryos.	[Sasai, K.; Brandt, M. E.; Carter, J.; Katayama, H.; Sen, S.] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77054 USA; [Parant, J. M.; Adams, H. P.; Killary, A. M.] Univ Texas MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77054 USA; [Stass, S. A.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University System of Maryland; University of Maryland Baltimore	Sen, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, 7435 Fannin, Houston, TX 77054 USA.	ssen@mdanderson.org			NATIONAL CANCER INSTITUTE [R01CA089716, P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [CA16672, R01 CA89716] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Conte N, 2003, ONCOGENE, V22, P8102, DOI 10.1038/sj.onc.1206972; Cutts SM, 1999, HUM MOL GENET, V8, P1145, DOI 10.1093/hmg/8.7.1145; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Du J, 2004, P NATL ACAD SCI USA, V101, P8975, DOI 10.1073/pnas.0308484101; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Iwanaga Y, 2007, CANCER RES, V67, P160, DOI 10.1158/0008-5472.CAN-06-3326; Kalitsis P, 1998, P NATL ACAD SCI USA, V95, P1136, DOI 10.1073/pnas.95.3.1136; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Liu Q, 2006, P NATL ACAD SCI USA, V103, P5811, DOI 10.1073/pnas.0601425103; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Ma CQ, 2003, MOL CELL BIOL, V23, P1703, DOI 10.1128/MCB.23.5.1703-1716.2003; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Perera D, 2007, DEV CELL, V13, P566, DOI 10.1016/j.devcel.2007.08.008; Rieder CL, 2005, CHROMOSOMA, V114, P310, DOI 10.1007/s00412-005-0028-2; Satinover DL, 2006, CELL CYCLE, V5, P2268, DOI 10.4161/cc.5.19.3316; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Tay J, 2000, DEV BIOL, V221, P1, DOI 10.1006/dbio.2000.9669; Tulu US, 2006, CURR BIOL, V16, P536, DOI 10.1016/j.cub.2006.01.060; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Wang Q, 2004, BLOOD, V103, P1278, DOI 10.1182/blood-2003-06-2158; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005	32	58	58	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 3	2008	27	29					4122	4127		10.1038/onc.2008.47	http://dx.doi.org/10.1038/onc.2008.47			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	321RV	18345035				2022-12-25	WOS:000257325100012
J	Steelman, LS; Navolanic, PM; Sokolosky, ML; Taylor, JR; Lehmann, BD; Chappell, WH; Abrams, SL; Wong, EWT; Stadelman, KM; Terrian, DM; Leslie, NR; Martelli, AM; Stivala, F; Libra, M; Franklin, RA; McCubrey, JA				Steelman, L. S.; Navolanic, P. M.; Sokolosky, M. L.; Taylor, J. R.; Lehmann, B. D.; Chappell, W. H.; Abrams, S. L.; Wong, E. W. T.; Stadelman, K. M.; Terrian, D. M.; Leslie, N. R.; Martelli, A. M.; Stivala, F.; Libra, M.; Franklin, R. A.; McCubrey, J. A.			Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors	ONCOGENE			English	Article						PTEN; Akt; mTOR; rapamycin; chemotherapeutic drugs	PROTEIN-KINASE-B; INVASIVE DUCTAL CARCINOMA; COWDEN-DISEASE; REDUCED EXPRESSION; MAMMALIAN TARGET; ACTIVATION; GENE; ANGIOGENESIS; TRASTUZUMAB; MUTATIONS	Ectopic expression of mutant forms of phosphatase and tensin homologue deleted on chromosome 10 ( PTEN) lacking lipid ( G129E) or lipid and protein ( C124S) phosphatase activity decreased sensitivity of MCF-7 breast cancer cells, which have wild-type PTEN, to doxorubicin and increased sensitivity to the mammalian target of rapamycin ( mTOR) inhibitor rapamycin. Cells transfected with a mutant PTEN gene lacking both lipid and protein phosphatase activities were more resistant to doxorubicin than cells transfected with the PTEN mutant lacking lipid phosphatase activity indicating that the protein phosphatase activity of PTEN was also important in controlling the sensitivity to doxorubicin, while no difference was observed between the lipid ( G129E) and lipid and protein ( C124S) phosphatase PTEN mutants in terms of sensitivity to rapamycin. A synergistic inhibitory interaction was observed when doxorubicin was combined with rapamycin in the phosphatase-deficient PTEN-transfected cells. Interference with the lipid phosphatase activity of PTEN was sufficient to activate Akt/mTOR/p70S6K signaling. These studies indicate that disruption of the normal activity of the PTEN phosphatase can have dramatic effects on the therapeutic sensitivity of breast cancer cells. Mutations in the key residues which control PTEN lipid and protein phosphatase may act as dominant-negative mutants to suppress endogenous PTEN and alter the sensitivity of breast cancer patients to chemo- and targeted therapies.	[Steelman, L. S.; Navolanic, P. M.; Sokolosky, M. L.; Taylor, J. R.; Chappell, W. H.; Abrams, S. L.; Wong, E. W. T.; Stadelman, K. M.; Franklin, R. A.; McCubrey, J. A.] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA; [Lehmann, B. D.; Terrian, D. M.] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27858 USA; [Terrian, D. M.; Franklin, R. A.; McCubrey, J. A.] E Carolina Univ, Brody Sch Med, Leo Jenkins Canc Ctr, Greenville, NC 27858 USA; [Stivala, F.; Libra, M.] Univ Catania, Dept Biomed Sci, Catania, Italy; [Leslie, N. R.] Univ Dundee, Sch Life Sci, Div Cell Signaling, Dundee, Scotland; [Martelli, A. M.] Univ Bologna, Dept Human Anat Sci, Bologna, Italy; [Martelli, A. M.] IOR, CNR, IGM, Bologna, Italy	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of Catania; University of Dundee; University of Bologna; Consiglio Nazionale delle Ricerche (CNR)	McCubrey, JA (corresponding author), E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA.	mccubreyj@ecu.edu	Lehmann, Brian D./H-8464-2019; Libra, Massimo/ABF-6654-2020; Leslie, Nicholas/D-2699-2009; Libra, Massimo/L-8241-2018	Lehmann, Brian D./0000-0003-0407-5248; Libra, Massimo/0000-0002-7232-7737; Libra, Massimo/0000-0002-7232-7737; McCubrey, James/0000-0001-6027-3156; LESLIE, Nicholas/0000-0001-5131-0541; Franklin, Richard A./0000-0003-0299-9578	NATIONAL CANCER INSTITUTE [R01CA098195] Funding Source: NIH RePORTER; MRC [G9403619] Funding Source: UKRI; Medical Research Council [G9403619] Funding Source: Medline; NCI NIH HHS [R01 CA098195, R01CA098195] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdel-Rahman MH, 2006, J CLIN ONCOL, V24, P288, DOI 10.1200/JCO.2005.02.2418; Agrawal S, 2006, HUM MOL GENET, V15, P777, DOI 10.1093/hmg/ddi492; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bose S, 2002, HUM PATHOL, V33, P405, DOI 10.1053/hupa.2002.124721; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Clark AS, 2002, MOL CANCER THER, V1, P707; Davis JM, 2003, CLIN CANCER RES, V9, P1161; DeGraffenried LA, 2004, CLIN CANCER RES, V10, P8059, DOI 10.1158/1078-0432.CCR-04-0035; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jin J, 2005, ONCOGENE, V24, P5459, DOI 10.1038/sj.onc.1208704; Klos KS, 2006, CANCER RES, V66, P2028, DOI 10.1158/0008-5472.CAN-04-4559; Lee JS, 2004, APPL IMMUNOHISTO M M, V12, P205, DOI 10.1097/00129039-200409000-00004; Lehmann BD, 2007, CELL CYCLE, V6, P595, DOI 10.4161/cc.6.5.3901; Leslie NR, 2000, BIOCHEM J, V346, P827, DOI 10.1042/0264-6021:3460827; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Luo J, 2005, CELL CYCLE, V4, P1309, DOI 10.4161/cc.4.10.2062; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Martelli AM, 2007, CURR MED CHEM, V14, P2009; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Shelton JG, 2005, EXPERT OPIN THER TAR, V9, P1009, DOI 10.1517/14728222.9.5.1009; Shelton JG, 2005, CELL CYCLE, V4, P822, DOI 10.4161/cc.4.6.1724; Singh B, 1998, GENE CHROMOSOME CANC, V21, P166, DOI 10.1002/(SICI)1098-2264(199802)21:2<166::AID-GCC13>3.3.CO;2-V; Steelman LS, 2004, EXPERT OPIN THER TAR, V8, P537, DOI 10.1517/14728222.8.6.537; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Tokunaga Eriko, 2006, Breast Cancer, V13, P137, DOI 10.2325/jbcs.13.137; Tsutsui S, 2005, CANCER-AM CANCER SOC, V104, P2048, DOI 10.1002/cncr.21471; Tsutsui S, 2005, ONCOLOGY-BASEL, V68, P398, DOI 10.1159/000086981; van Nimwegen MJ, 2006, MOL PHARMACOL, V70, P1330, DOI 10.1124/mol.106.026195; Weinstein-Oppenheimer CR, 2001, CLIN CANCER RES, V7, P2898	36	117	131	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 3	2008	27	29					4086	4095		10.1038/onc.2008.49	http://dx.doi.org/10.1038/onc.2008.49			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	321RV	18332865	Green Accepted			2022-12-25	WOS:000257325100008
J	Tai, KY; Shieh, YS; Lee, CS; Shiah, SG; Wu, CW				Tai, K-Y; Shieh, Y-S; Lee, C-S; Shiah, S-G; Wu, C-W			Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappa B and Brg-1	ONCOGENE			English	Article						Axl; Brg-1; ERK; MMP-9; NF-kappa B	RECEPTOR TYROSINE KINASE; TRANSCRIPTIONAL ACTIVATION; DIFFERENTIAL ACTIVATION; ENDOTHELIAL-CELLS; DNA METHYLATION; BREAST-CANCER; EXPRESSION; CARCINOMA; CHROMATIN; PATHWAYS	Activity of the Axl receptor tyrosine kinase is positively correlated with tumor metastasis; however, its detailed role in the mechanism of tumor invasion is still not completely understood. Here, we show that Axl enhances the expression of matrix metalloproteinase 9 ( MMP-9), required for Axl-mediated invasion both in vitro and in vivo. We found that the highly selective MEK1/2 inhibitors U0126 and PD98059, and the expressed dominant-negative form of extracellular signal-regulated kinase ( ERK), completely block Axl-mediated MMP-9 activation. In contrast, the phosphatidylinositol 3-kinase inhibitor LY294002 and wortmannin had little effect on activation. Interestingly, however, the Axl ligand Gas6 is not involved in Axl-mediated MMP-9 activation. Mutation of Glu59(Axl) and Thr77(Axl) dramatically reduced Gas6-Axl binding but continued to induce MMP-9 activation. In addition, overexpression of Axl-activated ERK and enhanced nuclear factor-kappa B (NF-kappa B) transactivation and brahma-related gene-1 ( Brg-1) translocation. Exposure to the NF-kappa B inhibitor silibinin, which inhibits I kappa B alpha kinase activity, or overexpression of the dominant-negative mutant I kappa B and Brg-1 strikingly inhibited Axl-mediated MMP-9 activation. These data indicate that coordination of ERK signaling and NF-kappa B and Brg-1 activation are indispensable to regulation of Axl-dependent MMP-9 gene transcription. Together with previous data, our results provide a plausible mechanism for Axl-mediated tumor invasion and establish a functional link between the Axl and MMP-9 signaling pathways.	[Tai, K-Y; Lee, C-S; Shiah, S-G; Wu, C-W] Natl Hlth Res Inst, Inst Canc Res, Miaoli 350, Miaoli County, Taiwan; [Shieh, Y-S] Natl Defense Med Ctr, Sch Dent, Taipei, Taiwan	National Health Research Institutes - Taiwan; National Defense Medical Center	Shiah, SG (corresponding author), Natl Hlth Res Inst, Inst Canc Res, 35 Keyan Rd,Zhunan Town, Miaoli 350, Miaoli County, Taiwan.	920114@nhri.org.tw; ken@nhri.org.tw	Shiah, Shine-Gwo/D-2087-2010	Shiah, Shine-Gwo/0000-0002-1003-973X; Tai, Kang-Yu/0000-0001-6867-3365				Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Budagian V, 2005, EMBO J, V24, P4260, DOI 10.1038/sj.emboj.7600874; Chung BI, 2003, DNA CELL BIOL, V22, P533, DOI 10.1089/10445490360708946; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; Demarchi F, 2001, J BIOL CHEM, V276, P31738, DOI 10.1074/jbc.M104457200; Dhanalakshmi S, 2002, ONCOGENE, V21, P1759, DOI 10.1038/sj.onc.1205240; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; Genersch E, 2000, J CELL SCI, V113, P4319; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Hasanbasic I, 2004, AM J PHYSIOL-HEART C, V287, pH1207, DOI 10.1152/ajpheart.00020.2004; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Ito T, 1999, THYROID, V9, P563, DOI 10.1089/thy.1999.9.563; Jacob ANK, 1999, CANCER DETECT PREV, V23, P325; Jin S, 2005, J BIOCHEM BIOPH METH, V65, P20, DOI 10.1016/j.jbbm.2005.08.006; Lakka SS, 2002, ONCOGENE, V21, P5601, DOI 10.1038/sj.onc.1205646; Lay JD, 2007, CANCER RES, V67, P3878, DOI 10.1158/0008-5472.CAN-06-3191; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Ma ZD, 2004, MOL CELL BIOL, V24, P5496, DOI 10.1128/MCB.24.12.5496-5509.2004; Melaragno MG, 1999, TRENDS CARDIOVAS MED, V9, P250, DOI 10.1016/S1050-1738(00)00027-X; Meric F, 2002, CLIN CANCER RES, V8, P361; Nakano T, 2003, CLIN EXP METASTAS, V20, P665, DOI 10.1023/A:1027355610603; Nemoto T, 1997, PATHOBIOLOGY, V65, P195, DOI 10.1159/000164123; NEUBAUER A, 1993, SEMIN HEMATOL, V30, P34; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Singh RAK, 2004, J IMMUNOL, V173, P7299, DOI 10.4049/jimmunol.173.12.7299; Sun WS, 2004, ONCOLOGY-BASEL, V66, P450, DOI 10.1159/000079499; Tai KY, 2007, ONCOGENE, V26, P3989, DOI 10.1038/sj.onc.1210176; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; van Ginkel PR, 2004, CANCER RES, V64, P128, DOI 10.1158/0008-5472.CAN-03-0245; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Wu CW, 2002, ANTICANCER RES, V22, P1071; Yao J, 2001, ONCOGENE, V20, P8066, DOI 10.1038/sj.onc.1204944; Zeigler ME, 1999, J CELL PHYSIOL, V180, P271	38	125	150	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 3	2008	27	29					4044	4055		10.1038/onc.2008.57	http://dx.doi.org/10.1038/onc.2008.57			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	321RV	18345028				2022-12-25	WOS:000257325100004
J	Akhmetshina, A; Dees, C; Pileckyte, M; Maurer, B; Axmann, R; Jungel, A; Zwerina, J; Gay, S; Schett, G; Distler, O; Distler, JHW				Akhmetshina, Alfiya; Dees, Clara; Pileckyte, Margarita; Maurer, Britta; Axmann, Roland; Juengel, Astrid; Zwerina, Jochen; Gay, Steffen; Schett, Georg; Distler, Oliver; Distler, Joerg H. W.			Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis	FASEB JOURNAL			English	Article						systemic sclerosis; scleroderma; fibroblasts; TGF beta; translational	CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; BONE-MARROW FIBROSIS; SYSTEMIC-SCLEROSIS; TYROSINE KINASE; TGF-BETA; BCR-ABL; IMATINIB; SRC; PHARMACOKINETICS	Abelson kinase (c-abl) and platelet-derived growth factor (PDGF) are key players in the pathogenesis of systemic sclerosis (SSc). The aim of the present study was to evaluate the antifibrotic potential of dasatinib and nilotinib, 2 novel inhibitors of c-abl and PDGF, which are well tolerated and have recently been approved. Dasatinib and nilotinib dose-dependently reduced the mRNA and protein levels of extracellular matrix proteins in human stimulated dermal fibroblasts from SSc patients (IC50 of 0.5-2.0 nM for dasatinib and 0.8-2.5 nM for nilotinib). In a mouse model of bleomycin-induced dermal fibrosis, dasatinib and nilotinib potently reduced the dermal thickness, the number of myofibroblasts, and the collagen content of the skin in a dose-dependent manner at well-tolerated doses. These data indicate that dasatinib and nilotinib potently inhibit the synthesis of extracellular matrix in vitro and in vivo at biologically relevant concentrations. Thus, we provide the first evidence that dasatinib and nilotinib might be promising drugs for the treatment of patients with SSc.	[Akhmetshina, Alfiya; Dees, Clara; Axmann, Roland; Zwerina, Jochen; Schett, Georg; Distler, Joerg H. W.] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; [Akhmetshina, Alfiya; Dees, Clara; Axmann, Roland; Zwerina, Jochen; Schett, Georg; Distler, Joerg H. W.] Univ Erlangen Nurnberg, Inst Clin Immunol, D-91054 Erlangen, Germany; [Pileckyte, Margarita] Kaunas Med Univ Hosp, Dept Rheumatol, Kaunas, Lithuania; [Maurer, Britta; Juengel, Astrid; Gay, Steffen; Distler, Oliver] Univ Zurich Hosp, Ctr Expt Rheumatol, CH-8091 Zurich, Switzerland; [Maurer, Britta; Juengel, Astrid; Gay, Steffen; Distler, Oliver] Univ Zurich Hosp, Zurich Ctr Integrat Human Physiol, CH-8091 Zurich, Switzerland	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Hospital of Lithuanian University of Health Sciences Kauno Klinikos; Lithuanian University of Health Sciences; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Zurich Center Integrative Human Physiology (ZIHP)	Distler, JHW (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, Univ Str 29, D-91054 Erlangen, Germany.	joerg.distler@uk-erlangen.de	Distler, Oliver/AAE-6225-2019	Distler, Oliver/0000-0002-0546-8310				Abdollahi A, 2005, J EXP MED, V201, P925, DOI 10.1084/jem.20041393; Atallah E, 2007, CLIN LYMPHOMA MYELOM, V7, pS105, DOI 10.3816/CLM.2007.s.010; Beham-Schmid C, 2002, BLOOD, V99, P381, DOI 10.1182/blood.V99.1.381; Bueso-Ramos CE, 2004, CANCER-AM CANCER SOC, V101, P332, DOI 10.1002/cncr.20380; Czochra P, 2006, J HEPATOL, V45, P419, DOI 10.1016/j.jhep.2006.04.010; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Distler JHW, 2005, P NATL ACAD SCI USA, V102, P2892, DOI 10.1073/pnas.0409781102; Distler JHW, 2006, ARTHRITIS RHEUM-US, V54, P214, DOI 10.1002/art.21497; Distler JHW, 2007, ARTHRITIS RHEUM-US, V56, P311, DOI 10.1002/art.22314; Dorey K, 2001, ONCOGENE, V20, P8075, DOI 10.1038/sj.onc.1205017; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Hesselstrand R, 1998, ANN RHEUM DIS, V57, P682, DOI 10.1136/ard.57.11.682; Kamath AV, 2008, CANCER CHEMOTH PHARM, V61, P365, DOI 10.1007/s00280-007-0478-8; Kantarjian H, 2006, NAT REV DRUG DISCOV, V5, P717, DOI 10.1038/nrd2135; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kaur P, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-67; LEROY EC, 1988, J RHEUMATOL, V15, P202; Luo FR, 2006, CLIN CANCER RES, V12, P7180, DOI 10.1158/1078-0432.CCR-06-1112; O'Hare T, 2005, CLIN CANCER RES, V11, P6987, DOI 10.1158/1078-0432.CCR-05-0622; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Santiago B, 2005, J INVEST DERMATOL, V125, P450, DOI 10.1111/j.0022-202X.2005.23859.x; SCHEJA A, 1993, BRIT J RHEUMATOL, V32, P59; SKHIRTLADZE C, 2008, ARTHRITIS R IN PRESS; Sonnylal S, 2007, ARTHRITIS RHEUM-US, V56, P334, DOI 10.1002/art.22328; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Yoshiji H, 2005, AM J PHYSIOL-GASTR L, V288, pG907, DOI 10.1152/ajpgi.00420.2004	29	157	161	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2008	22	7					2214	2222		10.1096/fj.07-105627	http://dx.doi.org/10.1096/fj.07-105627			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18326784				2022-12-25	WOS:000257292500014
J	Logrip, ML; Janak, PH; Ron, D				Logrip, Marian L.; Janak, Patricia H.; Ron, Dorit			Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake	FASEB JOURNAL			English	Article						MAP kinase; alcohol; addiction; TrkB; ERK	MESSENGER-RNA EXPRESSION; NEUROTROPHIC FACTOR EXPRESSION; PRODYNORPHIN SYSTEM ACTIVITY; KAPPA-OPIOID RECEPTORS; NUCLEUS-ACCUMBENS; HOMEOSTATIC PATHWAY; NOR-BINALTORPHIMINE; ALCOHOL-CONSUMPTION; DISCRETE REGIONS; DOPAMINE RELEASE	We recently identified brain-derived neurotrophic factor (BDNF) in the dorsal striatum to be a major component of a homeostatic pathway controlling ethanol consumption (1, 2). We hypothesized that ethanol-mediated activation of the BDNF signaling cascade is required for the ethanol-related function of the neurotrophic factor. Here, we demonstrate that exposure of striatal neurons to ethanol results in the activation of the BDNF receptor TrkB, leading to the activation of the mitogen-activated protein kinase (MAP kinase) signaling pathway and the subsequent increase in the expression of preprodynorphin (Pdyn) via BDNF. Finally, we show that activation of the dynorphin receptor, the kappa opioid receptor (KOR), is required for the BDNF-mediated decrease in ethanol intake, illustrating a function of dynorphin in BDNF's homeostatic control of ethanol consumption. Taken together, these results demonstrate that BDNF regulates ethanol intake by initiation of MAP kinase signaling and the ensuing production of downstream gene products, including Pdyn.	[Logrip, Marian L.; Janak, Patricia H.; Ron, Dorit] Univ Calif San Francisco, Ernest Gallo Res Ctr, Emeryville, CA 94608 USA; [Logrip, Marian L.; Janak, Patricia H.; Ron, Dorit] Univ Calif San Francisco, Neurosci Grad Program, Emeryville, CA 94608 USA; [Janak, Patricia H.; Ron, Dorit] Univ Calif San Francisco, Dept Neurol, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ron, D (corresponding author), Univ Calif San Francisco, Ernest Gallo Res Ctr, 5858 Horton St,Ste 200, Emeryville, CA 94608 USA.	dorit.ron@ucsf.edu		Janak, Patricia/0000-0002-3333-9049; Logrip, Marian L/0000-0001-6602-1283	NIAAA NIH HHS [F31 AA015462] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA015462] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; ALTAR CA, 1994, EUR J NEUROSCI, V6, P1389, DOI 10.1111/j.1460-9568.1994.tb01001.x; Barnea A, 2001, BRAIN RES, V919, P57, DOI 10.1016/S0006-8993(01)02999-7; Beadles-Bohling AS, 2000, NEUROCHEM INT, V37, P463, DOI 10.1016/S0197-0186(00)00056-5; BERHOW MT, 1995, NEUROSCIENCE, V68, P969, DOI 10.1016/0306-4522(95)00207-Y; Blednov YA, 2006, ALCOHOL, V40, P73, DOI 10.1016/j.alcohol.2006.12.002; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; BROADBEAR JH, 1994, PSYCHOPHARMACOLOGY, V115, P311, DOI 10.1007/BF02245071; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; Chefer VI, 2006, EUR J NEUROSCI, V23, P229, DOI 10.1111/j.1460-9568.2005.04525.x; Cowen MS, 2001, ALCOHOL CLIN EXP RES, V25, P1126, DOI 10.1111/j.1530-0277.2001.tb02326.x; CROLL SD, 1994, EUR J NEUROSCI, V6, P1343, DOI 10.1111/j.1460-9568.1994.tb00325.x; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; DICHIARA G, 1985, EUR J PHARMACOL, V115, P131, DOI 10.1016/0014-2999(85)90598-9; DOLE VP, 1985, P NATL ACAD SCI USA, V82, P3469, DOI 10.1073/pnas.82.10.3469; Doyon WM, 2006, NEUROPHARMACOLOGY, V51, P487, DOI 10.1016/j.neuropharm.2006.04.005; Eckardt MJ, 1998, ALCOHOL CLIN EXP RES, V22, P998, DOI 10.1111/j.1530-0277.1998.tb03695.x; ENDOH T, 1992, ARCH INT PHARMACOD T, V316, P30; Fagergren P, 2003, EUR J NEUROSCI, V17, P2212, DOI 10.1046/j.1460-9568.2003.02636.x; Falk T, 2006, J COMP NEUROL, V494, P275, DOI 10.1002/cne.20819; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; GERFEN CR, 1988, BRAIN RES, V460, P161, DOI 10.1016/0006-8993(88)91217-6; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Grimm JW, 2003, J NEUROSCI, V23, P742; GULYA K, 1993, MOL BRAIN RES, V20, P1, DOI 10.1016/0169-328X(93)90105-X; He DY, 2002, MOL PHARMACOL, V62, P272, DOI 10.1124/mol.62.2.272; Hensler JG, 2003, J NEUROCHEM, V85, P1139, DOI 10.1046/j.1471-4159.2003.01748.x; Holter SM, 2000, PSYCHOPHARMACOLOGY, V153, P93, DOI 10.1007/s002130000601; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; HUNT WA, 1979, ALCOHOL CLIN EXP RES, V3, P359, DOI 10.1111/j.1530-0277.1979.tb05336.x; Jamensky NT, 1997, ALCOHOL CLIN EXP RES, V21, P1455; Jeanblanc J, 2006, J NEUROSCI, V26, P1457, DOI 10.1523/JNEUROSCI.3786-05.2006; Kovacs KM, 2005, ALCOHOL CLIN EXP RES, V29, P730, DOI 10.1097/01.ALC.0000164361.62346.D6; Le Foll B, 2005, NEUROREPORT, V16, P175, DOI 10.1097/00001756-200502080-00022; Lindholm S, 2001, BEHAV BRAIN RES, V120, P137, DOI 10.1016/S0166-4328(00)00368-5; Lindholm S, 2000, ALCOHOL, V22, P165, DOI 10.1016/S0741-8329(00)00118-X; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; Marinelli PW, 2006, ALCOHOL CLIN EXP RES, V30, P982, DOI 10.1111/j.1530-0277.2006.00112.x; MARSH HN, 1993, J NEUROSCI, V13, P4281; Mathieu-Kia AM, 1998, MOL BRAIN RES, V54, P141, DOI 10.1016/S0169-328X(97)00338-0; Matsushita S, 2004, ALCOHOL CLIN EXP RES, V28, P1609, DOI 10.1097/01.ALC.0000145697.81741.D2; McGough NNH, 2004, J NEUROSCI, V24, P10542, DOI 10.1523/JNEUROSCI.3714-04.2004; Meredith GE, 2002, BRAIN RES, V949, P218, DOI 10.1016/S0006-8993(02)03160-8; Mitchell JM, 2005, PSYCHOPHARMACOLOGY, V182, P384, DOI 10.1007/s00213-005-0067-7; NAWA H, 1995, EUR J NEUROSCI, V7, P1527, DOI 10.1111/j.1460-9568.1995.tb01148.x; Pandey SC, 2004, J NEUROSCI, V24, P5022, DOI 10.1523/JNEUROSCI.5557-03.2004; Pandey SC, 2006, J NEUROSCI, V26, P8320, DOI 10.1523/JNEUROSCI.4988-05.2006; PANULA P, 1981, BRAIN RES, V219, P202, DOI 10.1016/0006-8993(81)90283-3; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Pierce RC, 2001, REV NEUROSCIENCE, V12, P95; Ploj K, 2000, BRAIN RES BULL, V53, P219, DOI 10.1016/S0361-9230(00)00328-2; POLL G, 1939, ANN SURVEYS TAKEN 19; Przewlocka B, 1997, NEUROSCI LETT, V238, P13, DOI 10.1016/S0304-3940(97)00829-X; Ron D, 2000, FASEB J, V14, P2303, DOI 10.1096/fj.00-0143com; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Saylor AJ, 2006, EXP NEUROL, V199, P362, DOI 10.1016/j.expneurol.2006.01.004; Schlussman SD, 2005, BRAIN RES BULL, V67, P169, DOI 10.1016/j.brainresbull.2005.04.018; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Segal M, 2003, EUR J NEUROSCI, V17, P2573, DOI 10.1046/j.1460-9568.2003.02696.x; SEIZINGER BR, 1983, PHARMACOL BIOCHEM BE, V18, P361, DOI 10.1016/0091-3057(83)90200-9; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Shi X, 2006, NEUROSCIENCE, V138, P1289, DOI 10.1016/j.neuroscience.2005.12.024; SIGNS SA, 1987, NEUROPHARMACOLOGY, V26, P1653, DOI 10.1016/0028-3908(87)90016-5; SMITH AJW, 1994, MOL BRAIN RES, V21, P359, DOI 10.1016/0169-328X(94)90268-2; SPANAGEL R, 1990, J NEUROCHEM, V55, P1734, DOI 10.1111/j.1471-4159.1990.tb04963.x; SPANAGEL R, 1992, P NATL ACAD SCI USA, V89, P2046, DOI 10.1073/pnas.89.6.2046; Spanagel R, 1996, PHARMACOL BIOCHEM BE, V54, P645, DOI 10.1016/0091-3057(95)02288-0; SPANGLER R, 1993, MOL BRAIN RES, V19, P323, DOI 10.1016/0169-328X(93)90133-A; Tapia-Arancibia L, 2001, J NEUROSCI RES, V63, P200, DOI 10.1002/1097-4547(20010115)63:2<200::AID-JNR1012>3.0.CO;2-Q; Thompson AC, 2000, J NEUROSCI, V20, P9333; Turchan J, 1998, NEUROSCIENCE, V85, P1051, DOI 10.1016/S0306-4522(97)00639-8; Uhl GR, 2001, AM J HUM GENET, V69, P1290, DOI 10.1086/324467; Valjent E, 2004, EUR J NEUROSCI, V19, P1826, DOI 10.1111/j.1460-9568.2004.03278.x; Walker BM, 2008, NEUROPSYCHOPHARMACOL, V33, P643, DOI 10.1038/sj.npp.1301438; WANG JQ, 1995, NEUROSCIENCE, V68, P83, DOI 10.1016/0306-4522(95)00100-W; Williams KL, 1998, ALCOHOL CLIN EXP RES, V22, P1634, DOI 10.1111/j.1530-0277.1998.tb03960.x; Xuei X, 2006, MOL PSYCHIATR, V11, P1016, DOI 10.1038/sj.mp.4001882; Yaka R, 2003, J BIOL CHEM, V278, P9630, DOI 10.1074/jbc.M209141200; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; You ZB, 1999, J PHARMACOL EXP THER, V290, P1307; Zapata A, 2006, ALCOHOL CLIN EXP RES, V30, P592, DOI 10.1111/j.1530-0277.2006.00069.x; Zapata A, 2006, NEUROPSYCHOPHARMACOL, V31, P396, DOI 10.1038/sj.npp.1300833; Zhang DS, 2002, J NEUROCHEM, V82, P1453, DOI 10.1046/j.1471-4159.2002.01089.x; Zhang Y, 2004, PSYCHOPHARMACOLOGY, V172, P422, DOI 10.1007/s00213-003-1688-3	90	74	76	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2008	22	7					2393	2404		10.1096/fj.07-099135	http://dx.doi.org/10.1096/fj.07-099135			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18310464				2022-12-25	WOS:000257292500031
J	Wakao, H; Wakao, R; Sakata, S; Iwabuchi, K; Oda, A; Fujita, H				Wakao, Hiroshi; Wakao, Rika; Sakata, Sakura; Iwabuchi, Kazuya; Oda, Atsushi; Fujita, Hiroyoshi			In vitro induction of natural killer T cells from embryonic stem cells prepared using somatic cell nuclear transfer	FASEB JOURNAL			English	Article						adjuvant effect; in vitro differentiation; transplantable lymphocytes; tumor rejection	NKT CELLS; DENDRITIC CELLS; TUMOR-IMMUNITY; IMMUNOREGULATORY AXIS; MICE; LINEAGE; THYMUS; GENERATION; THYMOCYTES; SELECTION	The ectopic expression of the Notch receptor ligand delta-like 1 on stromal cells allows the induction of T cells from embryonic stem cells (ESCs). However, these in vitro-generated T cells are not transplantable because they are too immature to mount an immune response in an immunocompromised animal. We efficiently generated a subset of T cells called invariant natural killer T (iNKT) cells from ESCs derived from peripheral iNKT cells using somatic cell nuclear transfer (ntESCs). These iNKT cells matured autonomously in vivo and exhibited an adjuvant effect accompanying the production of interferon-gamma in an antigen-specific manner. This adjuvant effect culminated in the inhibition of inoculated tumor cell growth. Our results indicate that ntESC-derived iNKT cells are transplantable lymphocytes that will be beneficial for the induction of immune tolerance and the treatment of autoimmune diseases, tumors, and infections.	[Wakao, Hiroshi; Oda, Atsushi; Fujita, Hiroyoshi] Hokkaido Univ, Sch Med, Dept Environm Biol, Sapporo, Hokkaido 0608638, Japan; [Iwabuchi, Kazuya] Hokkaido Univ, Div Immunobiol, Inst Med Genet, Sapporo, Hokkaido 0608638, Japan; [Wakao, Rika] Rikagaku Kenkyusho RIKEN, Res Ctr Allergy & Immunol, Dev Genet Grp, Yokohama, Japan; [Sakata, Sakura] Rikagaku Kenkyusho RIKEN, Res Ctr Allergy & Immunol, Immune Regulat Grp, Yokohama, Japan	Hokkaido University; Hokkaido University; RIKEN; RIKEN	Wakao, H (corresponding author), Hokkaido Univ, Sch Med, Dept Environm Biol, N15W7, Sapporo, Hokkaido 0608638, Japan.	hwakao@med.hokudai.ac.jp	WAKAO, Hiroshi/A-4242-2012					Ambrosino E, 2007, J IMMUNOL, V179, P5126, DOI 10.4049/jimmunol.179.8.5126; Baldwin TA, 2004, J IMMUNOL, V173, P6515, DOI 10.4049/jimmunol.173.11.6515; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; BRADBURY A, 1990, EUR J IMMUNOL, V20, P1831, DOI 10.1002/eji.1830200830; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; Coles MC, 2000, J IMMUNOL, V164, P2412, DOI 10.4049/jimmunol.164.5.2412; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Egawa T, 2005, IMMUNITY, V22, P705, DOI 10.1016/j.immuni.2005.03.011; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kronenberg M, 2005, NATURE, V435, P598, DOI 10.1038/nature03725; Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nakano T, 1995, Semin Immunol, V7, P197, DOI 10.1016/1044-5323(95)90047-0; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; Rothenberg EV, 2002, IMMUNOL REV, V187, P96, DOI 10.1034/j.1600-065X.2002.18709.x; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Shimizu K, 2007, J EXP MED, V204, P2641, DOI 10.1084/jem.20070458; Shimizu K, 2007, J IMMUNOL, V178, P2853, DOI 10.4049/jimmunol.178.5.2853; Smyth MJ, 2002, CURR OPIN IMMUNOL, V14, P165, DOI 10.1016/S0952-7915(02)00316-3; Stewart TJ, 2003, CANCER RES, V63, P3058; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Terabe M, 2007, TRENDS IMMUNOL, V28, P491, DOI 10.1016/j.it.2007.05.008; Wakao H, 2007, J IMMUNOL, V179, P3888, DOI 10.4049/jimmunol.179.6.3888	36	7	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2008	22	7					2223	2231		10.1096/fj.07-104687	http://dx.doi.org/10.1096/fj.07-104687			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18323403				2022-12-25	WOS:000257292500015
J	Yang, KP; Guan, HY; Arany, E; Hill, DJ; Cao, XA				Yang, Kaiping; Guan, Haiyan; Arany, Edith; Hill, David J.; Cao, Xiang			Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor	FASEB JOURNAL			English	Article						obesity; Zucker rat; adipogenesis; 3T3-L1 cells	11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; LOW-PROTEIN-DIET; MESSENGER-RNA; METABOLIC SYNDROME; GENE-EXPRESSION; MOLECULAR PATHWAYS; KINASE ACTIVATION; OBESE-PATIENTS; ADULT DISEASE; BODY-WEIGHT	Neuropeptide Y (NPY) is synthesized in neural tissue of the central and peripheral nervous systems and has a number of important functions besides regulating appetite and energy homeostasis. Here we identify a novel site of NPY biosynthesis and a role for NPY in promoting proliferation of adipocyte precursor cells. We show that NPY mRNA is not only expressed in visceral adipose tissue (VAT) but that its levels are up-regulated 6-fold in our early-life programmed rat model of increased visceral adiposity. This is accompanied by a parallel rise in NPY protein, demonstrating that VAT is a novel peripheral site of NPY biosynthesis. Furthermore, NPY mRNA expression is also elevated > 2-fold in VAT of obese Zucker rats. Importantly, NPY stimulates proliferation of primary rat preadipocytes as well as 3T3-L1 preadipocytes in vitro. This mitogenic effect appears to be mediated by the Y1 receptor and involves the activation of extracellular related kinase 1/2. In addition, insulin and glucocorticoid up-regulate VAT NPY expression in lean but not obese Zucker rats. Taken together, these results suggest that an enhanced local expression of NPY within VAT may be a common feature of and contribute to the molecular mechanisms underlying increased visceral adiposity.	[Yang, Kaiping; Guan, Haiyan; Cao, Xiang] Victoria Res Labs, Childrens Hlth Res Inst, London, ON N6A 4G5, Canada; [Yang, Kaiping; Guan, Haiyan; Cao, Xiang] Univ Western Ontario, Dept Obstet & Gynecol, London, ON, Canada; [Yang, Kaiping; Guan, Haiyan; Arany, Edith; Hill, David J.; Cao, Xiang] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Arany, Edith; Hill, David J.] Univ Western Ontario, Lawson Hlth Res Inst, Dept Med, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Yang, KP (corresponding author), Victoria Res Labs, Childrens Hlth Res Inst, Rm A5-132,Westminster Campus,800 Commissioners R, London, ON N6A 4G5, Canada.	kyang@uwo.ca	Arany, Edith/AAK-2159-2020; Arany, Edith/C-3464-2013; Hill, David J/G-3302-2011	Arany, Edith/0000-0001-9994-8958; Hill, David J/0000-0002-2490-5678				Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; BESTETTI GE, 1990, ENDOCRINOLOGY, V126, P1880, DOI 10.1210/endo-126-4-1880; Bowers RR, 2004, AM J PHYSIOL-REG I, V286, pR1167, DOI 10.1152/ajpregu.00558.2003; Bradley RL, 2005, OBES RES, V13, P653, DOI 10.1038/oby.2005.73; Burns SP, 1997, J CLIN INVEST, V100, P1768, DOI 10.1172/JCI119703; Byrne CD, 2000, J CLIN PATHOL, V53, P822, DOI 10.1136/jcp.53.11.822; Cho YR, 2004, BIOCHEM BIOPH RES CO, V314, P773, DOI 10.1016/j.bbrc.2003.12.170; Chronwall BA, 2004, PEPTIDES, V25, P359, DOI 10.1016/j.peptides.2004.02.013; DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115; Desbriere R, 2006, OBESITY, V14, P794, DOI 10.1038/oby.2006.92; ERICSSON A, 1991, EXP CELL RES, V192, P604, DOI 10.1016/0014-4827(91)90082-6; Fliers E, 2003, J NEUROENDOCRINOL, V15, P1005, DOI 10.1046/j.1365-2826.2003.01096.x; Foster MT, 2006, AM J PHYSIOL-REG I, V291, pR1630, DOI 10.1152/ajpregu.00197.2006; Froguel P, 2001, EXP BIOL MED, V226, P991, DOI 10.1177/153537020122601105; FROST SC, 1985, J BIOL CHEM, V260, P2646; Gomez-Sanchez EP, 2005, AM J PHYSIOL-ENDOC M, V288, pE342, DOI 10.1152/ajpendo.00355.2004; Guan HY, 2005, AM J PHYSIOL-ENDOC M, V288, pE663, DOI 10.1152/ajpendo.00461.2004; Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Heise T, 2007, DIABETES OBES METAB, V9, P648, DOI 10.1111/j.1463-1326.2007.00756.x; HIGUCHI H, 1988, J BIOL CHEM, V263, P6288; Hofbauer K, 2002, INT J OBESITY, V26, pS18, DOI 10.1038/sj.ijo.0802124; Holness MJ, 2000, BIOCHEM J, V349, P657, DOI 10.1042/bj3490657; Joanette EA, 2004, ENDOCRINOLOGY, V145, P3004, DOI 10.1210/en.2003-0796; Julan L, 2005, ENDOCRINOLOGY, V146, P1482, DOI 10.1210/en.2004-1357; KALINYAK JE, 1989, J CLIN INVEST, V84, P1843, DOI 10.1172/JCI114370; Kalra SP, 2004, NEUROPEPTIDES, V38, P201, DOI 10.1016/j.npep.2004.06.003; Keffel S, 1999, J PHARMACOL EXP THER, V291, P1172; Kos K, 2007, AM J PHYSIOL-ENDOC M, V293, pE1335, DOI 10.1152/ajpendo.00333.2007; Kraiczi H, 1997, PEPTIDES, V18, P1597, DOI 10.1016/S0196-9781(97)00248-9; Krysiak R, 2001, J PEPT SCI, V7, P571, DOI 10.1002/psc.354; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Lindsay RS, 2003, J CLIN ENDOCR METAB, V88, P2738, DOI 10.1210/jc.2002-030017; Liu RH, 2002, INT J OBESITY, V26, P318, DOI 10.1038/sj.ijo.0801924; LUNDBERG JM, 1985, BIOCHEM BIOPH RES CO, V133, P30, DOI 10.1016/0006-291X(85)91837-6; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Osmond C, 2000, ENVIRON HEALTH PERSP, V108, P545, DOI 10.1289/ehp.00108s3545; Ozanne SE, 2004, CLIN SCI, V106, P141, DOI 10.1042/CS20030278; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V271, pE1128, DOI 10.1152/ajpendo.1996.271.6.E1128; Ozanne SE, 2001, BRIT MED BULL, V60, P143, DOI 10.1093/bmb/60.1.143; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V270, pE559, DOI 10.1152/ajpendo.1996.270.4.E559; Paulmyer-Lacroix O, 2002, J CLIN ENDOCR METAB, V87, P2701, DOI 10.1210/jc.87.6.2701; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Pellieux C, 2000, P NATL ACAD SCI USA, V97, P1595, DOI 10.1073/pnas.030533197; Petrik J, 1999, ENDOCRINOLOGY, V140, P4861, DOI 10.1210/en.140.10.4861; Petry CJ, 2001, MOL CELL ENDOCRINOL, V185, P81, DOI 10.1016/S0303-7207(01)00627-X; Petry CJ, 1997, CLIN SCI, V93, P147, DOI 10.1042/cs0930147; Pons J, 2003, CAN J PHYSIOL PHARM, V81, P177, DOI 10.1139/Y02-166; Purdy LP, 1996, DIABETOLOGIA, V39, P1126; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Ruscica M, 2006, ENDOCRINOLOGY, V147, P1466, DOI 10.1210/en.2005-0925; Serradeil-Le Gal C, 2000, FEBS LETT, V475, P150, DOI 10.1016/S0014-5793(00)01649-5; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Tomlinson JW, 2002, J CLIN ENDOCR METAB, V87, P5630, DOI 10.1210/jc.2002-020687; Turtzo LC, 2001, P NATL ACAD SCI USA, V98, P12385, DOI 10.1073/pnas.231478898; VALET P, 1990, J CLIN INVEST, V85, P291, DOI 10.1172/JCI114425; Wake DJ, 2003, J CLIN ENDOCR METAB, V88, P3983, DOI 10.1210/jc.2003-030286; Youngstrom TG, 1998, AM J PHYSIOL-REG I, V275, pR1488, DOI 10.1152/ajpregu.1998.275.5.R1488; Zhang T, 2007, J CELL BIOCHEM, V101, P381, DOI 10.1002/jcb.21176; Zukowska-Grojec Z, 1998, REGUL PEPTIDES, V75-6, P231, DOI 10.1016/S0167-0115(98)00073-1	65	123	131	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2008	22	7					2452	2464		10.1096/fj.07-100735	http://dx.doi.org/10.1096/fj.07-100735			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18323405				2022-12-25	WOS:000257292500037
J	Csutora, P; Peter, K; Kilic, H; Park, KM; Zarayskiy, V; Gwozdz, T; Bolotina, VM				Csutora, Peter; Peter, Krisztina; Kilic, Helena; Park, Kristen M.; Zarayskiy, Vladislav; Gwozdz, Tomasz; Bolotina, Victoria M.			Novel role for STIM1 as a trigger for calcium influx factor production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CA2+ ENTRY; CA2+-INDEPENDENT PHOSPHOLIPASE A(2); CRAC CHANNELS; STORE DEPLETION; ACTIVATION; ORAI1; SENSOR; MECHANISM; CURRENTS; CELLS	STIM1 has been recently identified as a Ca2+ sensor in endoplasmic reticulum (ER) and an initiator of the store-operated Ca2+ entry (SOCE) pathway, but the mechanism of SOCE activation remains controversial. Here we focus on the early ER-delimited steps of the SOCE pathway and demonstrate that STIM1 is critically involved in initiating of production of calcium influx factor (CIF), a diffusible messenger that can deliver the signal from the stores to plasma membrane and activate SOCE. We discovered that CIF production is tightly coupled with STIM1 expression and requires functional integrity of its intraluminal sterile alpha-motif (SAM) domain. We demonstrate that 1) molecular knockdown or overexpression of STIM1 results in corresponding impairment or amplification of CIF production and 2) inherent deficiency in the ER-delimited CIF production and SOCE activation in some cell types can be a result of their deficiency in STIM1 protein; expression of a wildtype STIM1 in such cells was sufficient to fully rescue their ability to produce CIF and SOCE. We found that glycosylation sites in the ER-resident SAM domain of STIM1 are essential for initiation of CIF production. We propose that after STIM1 loses Ca2+ from EF hand, its intraluminal SAM domain may change conformation, and via glycosylation sites it can interact with and activate CIF-producing machinery. Thus, CIF production appears to be one of the earliest STIM-dependent events in the ER lumen, and impairment of this process results in impaired SOCE response.	[Csutora, Peter; Peter, Krisztina; Kilic, Helena; Park, Kristen M.; Zarayskiy, Vladislav; Gwozdz, Tomasz; Bolotina, Victoria M.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Bolotina, VM (corresponding author), EBRC, Ion Channel & Calcium Signaling Unit, X-704,650 Albany St, Boston, MA 02118 USA.	bolotina@bu.edu		Bolotina, Victoria/0000-0001-5862-181X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054150, R21HL097569, R01HL071793, T32HL007969, T32HL007224] Funding Source: NIH RePORTER; NHLBI NIH HHS [R21 HL097569, HL 007969, R01 HL 71793, R01 HL 54150, R01 HL054150, R01 HL071793, HL 007224] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Boittin FX, 2006, J CELL SCI, V119, P3733, DOI 10.1242/jcs.03184; Bolotina VM, 2005, TRENDS BIOCHEM SCI, V30, P378, DOI 10.1016/j.tibs.2005.05.009; Bose DD, 2005, BIOCHEM J, V386, P291, DOI 10.1042/BJ20040900; Bystroff Christopher, 2002, Bioinformatics, V18 Suppl 1, pS54; Chen PY, 1998, DIABETES, V47, P874, DOI 10.2337/diabetes.47.6.874; Csutora P, 1999, P NATL ACAD SCI USA, V96, P121, DOI 10.1073/pnas.96.1.121; Csutora P, 2006, J BIOL CHEM, V281, P34926, DOI 10.1074/jbc.M606504200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HISATSUNE C, 2005, SCI STKE, pE53; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; KIM HY, 1995, J BIOL CHEM, V270, P9706, DOI 10.1074/jbc.270.17.9706; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; LO TM, 1993, AM J PHYSIOL, V264, pC641, DOI 10.1152/ajpcell.1993.264.3.C641; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Martinez J, 2005, BIOCHEM PHARMACOL, V70, P733, DOI 10.1016/j.bcp.2005.04.045; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peel SE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-119; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ross K, 2007, J CELL PHYSIOL, V211, P569, DOI 10.1002/jcp.20993; Shin KJ, 2002, TOXICOL APPL PHARM, V178, P37, DOI 10.1006/taap.2001.9317; Shuttleworth TJ, 2007, CELL CALCIUM, V42, P183, DOI 10.1016/j.ceca.2007.01.012; Singaravelu K, 2006, J NEUROSCI, V26, P9579, DOI 10.1523/JNEUROSCI.2604-06.2006; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Smani T, 2003, J BIOL CHEM, V278, P11909, DOI 10.1074/jbc.M210878200; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; THOMAS D, 1995, J BIOL CHEM, V270, P6429, DOI 10.1074/jbc.270.12.6429; Thomas D, 1996, BIOCHEM J, V318, P649, DOI 10.1042/bj3180649; Trepakova ES, 2000, J BIOL CHEM, V275, P26158, DOI 10.1074/jbc.M004666200; Trepakova ES, 2002, BIOL MEMBRANY, V19, P49; Vanden Abeele F, 2004, J BIOL CHEM, V279, P30326, DOI 10.1074/jbc.M400106200; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zablocki K, 2000, ACTA BIOCHIM POL, V47, P591; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	49	58	58	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14524	14531		10.1074/jbc.M709575200	http://dx.doi.org/10.1074/jbc.M709575200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18337241	Green Published, hybrid			2022-12-25	WOS:000255941400040
J	Grou, CP; Carvalho, AF; Pinto, MP; Wiese, S; Piechura, H; Meyer, HE; Warscheid, B; Sa-Miranda, C; Azevedo, JE				Grou, Claudia P.; Carvalho, Andreia F.; Pinto, Manuel P.; Wiese, Sebastian; Piechura, Heike; Meyer, Helmut E.; Warscheid, Bettina; Sa-Miranda, Clara; Azevedo, Jorge E.			Members of the E2D (UbcH5) family mediate the ubiquitination of the conserved cysteine of Pex5p, the peroxisomal import receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYME PEX4P; SIGNAL TYPE-1 RECEPTOR; MATRIX PROTEIN IMPORT; CYCLING RECEPTOR; RAT-LIVER; FUNCTIONAL-CHARACTERIZATION; MASS-SPECTROMETRY; PICHIA-PASTORIS; PTS1 RECEPTOR; IDENTIFICATION	According to current models of peroxisomal biogenesis, newly synthesized peroxisomal matrix proteins are transported into the organelle by Pex5p. Pex5p recognizes these proteins in the cytosol, mediates their membrane translocation, and is exported back into the cytosol in an ATP-dependent manner. We have previously shown that export of Pex5p is preceded by ( and requires) monoubiquitination of a conserved cysteine residue present at its N terminus. In yeasts, and probably also in plants, ubiquitination of Pex5p is mediated by a specialized ubiquitin-conjugating enzyme, Pex4p. In mammals, the identity of this enzyme has remained unknown for many years. Here, we provide evidence suggesting that E2D1/2/3 (UbcH5a/b/c) are the mammalian functional counterparts of yeast/plant Pex4p. The mechanistic implications of these findings are discussed.	[Grou, Claudia P.; Carvalho, Andreia F.; Pinto, Manuel P.; Sa-Miranda, Clara; Azevedo, Jorge E.] Univ Porto, IBMC, P-4150180 Oporto, Portugal; [Grou, Claudia P.; Carvalho, Andreia F.; Pinto, Manuel P.; Azevedo, Jorge E.] Univ Porto, ICBAS, P-4009003 Oporto, Portugal; [Wiese, Sebastian; Piechura, Heike; Meyer, Helmut E.; Warscheid, Bettina] Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany	Universidade do Porto; Universidade do Porto; Ruhr University Bochum	Azevedo, JE (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	jazevedo@ibmc.up.pt	sá Miranda, Maria Clara/K-3920-2013; Carvalho, Andreia/J-9013-2015; Azevedo, Jorge E/A-4113-2008; Lima, Marta T/C-7042-2009; Grou, Claudia P/K-5472-2013; Pinto, Manuel/K-6425-2013	sá Miranda, Maria Clara/0000-0003-0123-5525; Carvalho, Andreia/0000-0001-8781-5680; Azevedo, Jorge E/0000-0001-7714-5302; Grou, Claudia P/0000-0001-5197-2270; Pinto, Manuel/0000-0001-9778-2093; Warscheid, Bettina/0000-0001-5096-1975; Wiese, Heike/0000-0002-8941-3762				Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Azevedo JE, 2004, CELL BIOCHEM BIOPHYS, V41, P451, DOI 10.1385/CBB:41:3:451; Baker A, 2005, CURR OPIN PLANT BIOL, V8, P640, DOI 10.1016/j.pbi.2005.09.009; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Carvalho AF, 2007, BBA-MOL CELL RES, V1773, P1141, DOI 10.1016/j.bbamcr.2007.04.011; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; Costa-Rodrigues J, 2004, J BIOL CHEM, V279, P46573, DOI 10.1074/jbc.M406399200; CRANE DI, 1994, J BIOL CHEM, V269, P21835; Eckert JH, 2003, J CELL SCI, V116, P3623, DOI 10.1242/jcs.00678; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; FRANSEN M, 1995, J BIOL CHEM, V270, P7731, DOI 10.1074/jbc.270.13.7731; Fransen M, 2002, MOL CELL PROTEOMICS, V1, P243, DOI 10.1074/mcp.M100025-MCP200; Gonen H, 1999, J BIOL CHEM, V274, P14823, DOI 10.1074/jbc.274.21.14823; Gouveia AM, 2003, J BIOL CHEM, V278, P226, DOI 10.1074/jbc.M209498200; Gouveia AM, 2003, J BIOL CHEM, V278, P4389, DOI 10.1074/jbc.C200650200; Gouveia AMM, 1999, ANAL BIOCHEM, V274, P270, DOI 10.1006/abio.1999.4281; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; Heiland I, 2005, FEBS J, V272, P2362, DOI 10.1111/j.1742-4658.2005.04690.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Kiel JAKW, 2005, BBA-MOL CELL RES, V1745, P176, DOI 10.1016/j.bbamcr.2005.01.004; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Koller A, 1999, J CELL BIOL, V146, P99, DOI 10.1083/jcb.146.1.99; KOSTER A, 1986, BIOCHEM BIOPH RES CO, V137, P626, DOI 10.1016/0006-291X(86)91124-1; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Okamoto Y, 2003, CANCER RES, V63, P4167; Oliveira ME, 2003, J BIOL CHEM, V278, P39483, DOI 10.1074/jbc.M305089200; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Rajapurohitam V, 2002, AM J PHYSIOL-ENDOC M, V282, pE739, DOI 10.1152/ajpendo.00511.2001; Reguenga C, 2001, J BIOL CHEM, V276, P29935, DOI 10.1074/jbc.M104114200; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Schaefer H, 2004, PROTEOMICS, V4, P2541, DOI 10.1002/pmic.200300801; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schluter A, 2007, NUCLEIC ACIDS RES, V35, pD815, DOI 10.1093/nar/gkl935; van der Klei IJ, 1998, EMBO J, V17, P3608, DOI 10.1093/emboj/17.13.3608; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691	59	96	102	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14190	14197		10.1074/jbc.M800402200	http://dx.doi.org/10.1074/jbc.M800402200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18359941	hybrid			2022-12-25	WOS:000255941400004
J	Jansen, M; Pietiarinen, VM; Polonen, H; Rasilainen, L; Koivusalo, M; Ruotsalainen, U; Jokitalo, E; Ikonen, E				Jansen, Maurice; Pietiarinen, Vilja M.; Polonen, Harri; Rasilainen, Laura; Koivusalo, Mirkka; Ruotsalainen, Ulla; Jokitalo, Eija; Ikonen, Elina			Cholesterol substitution increases the structural heterogeneity of caveolae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ENDOCYTIC TRAFFICKING; LIPID RAFTS; IN-VITRO; CELLS; PROTEIN; KINASE; GLYCOSPHINGOLIPIDS; PHOSPHORYLATION; SIMIAN-VIRUS-40	Caveolin-1 binds cholesterol and caveola formation involves caveolin-1 oligomerization and cholesterol association. The role of cholesterol in caveolae has so far been addressed by methods that compromise membrane integrity and abolish caveolar invaginations. To study the importance of sterol specificity for the structure and function of caveolae, we replaced cholesterol in mammalian cells with its immediate precursor desmosterol by inhibiting 24-dehydrocholesterol reductase. Desmosterol could substitute for cholesterol in maintaining cell growth, membrane integrity, and preserving caveolar invaginations. However, in desmosterol cells the affinity of caveolin-1 for sterol and the stability of caveolin oligomers were decreased. Moreover, caveolar invaginations became more heterogeneous in dimensions and in the number of caveolin-1 molecules per caveola. Despite the altered caveolar structure, caveolar ligand uptake was only moderately inhibited. We found that in desmosterol cells, Src kinase phosphorylated Cav1 at Tyr14 more avidly than in cholesterol cells. Taken the role of Cav1 Tyr14 phosphorylation in caveolar endocytosis, this may help to preserve caveolar uptake in desmosterol cells. We conclude that a sterol C24 double bond interferes with caveolin-sterol interaction and perturbs caveolar morphology but facilitates Cav1 Src phosphorylation and allows caveolar endocytosis. More generally, substitution of cholesterol by a structurally closely related sterol provides a method to selectively modify membrane protein-sterol affinity, structure and function of cholesterol-dependent domains without compromising membrane integrity.	[Jansen, Maurice; Pietiarinen, Vilja M.; Koivusalo, Mirkka; Ikonen, Elina] Univ Helsinki, Inst Biomed Anat, FIN-00140 Helsinki, Finland; [Rasilainen, Laura; Jokitalo, Eija] Univ Helsinki, Inst Biotechnol, FIN-00140 Helsinki, Finland; [Polonen, Harri; Ruotsalainen, Ulla] Tampere Univ Technol, Inst Signal Proc, FIN-33101 Tampere, Finland	University of Helsinki; University of Helsinki; Tampere University	Ikonen, E (corresponding author), Univ Helsinki, Inst Biomed Anat, Haartmaninkatu 8, FIN-00140 Helsinki, Finland.	elina.ikonen@helsinki.fi	Jokitalo, Eija/C-8375-2009; Ruotsalainen, Ulla/J-5678-2014	Jokitalo, Eija/0000-0002-4159-6934; Ruotsalainen, Ulla/0000-0001-7775-3412; Ikonen, Elina/0000-0001-8382-1135; , Harri/0000-0002-3270-2897; Pietiainen, Vilja/0000-0003-3125-2406				Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; BARTLETT EM, 1970, ANAL BIOCHEM, V36, P159, DOI 10.1016/0003-2697(70)90343-X; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom TS, 2003, HUM MOL GENET, V12, P257, DOI 10.1093/hmg/ddg025; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Crameri A, 2006, EMBO J, V25, P432, DOI 10.1038/sj.emboj.7600938; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Gaylor JL, 2002, BIOCHEM BIOPH RES CO, V292, P1139, DOI 10.1006/bbrc.2001.2008; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Holtta-Vuori M, 2000, CURR BIOL, V10, P95, DOI 10.1016/S0960-9822(99)99991-8; KUHRY JG, 1985, BIOCHIM BIOPHYS ACTA, V845, P60, DOI 10.1016/0167-4889(85)90055-2; Lu XL, 2006, ENDOCRINOLOGY, V147, P3123, DOI 10.1210/en.2005-1426; Mirza R, 2006, J INVEST DERMATOL, V126, P638, DOI 10.1038/sj.jid.5700111; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Monier S, 1996, FEBS LETT, V388, P143, DOI 10.1016/0014-5793(96)00519-4; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; NAOI M, 1974, ANAL BIOCHEM, V58, P571, DOI 10.1016/0003-2697(74)90226-7; Nomura R, 1999, MOL BIOL CELL, V10, P975, DOI 10.1091/mbc.10.4.975; Oh P, 1999, J BIOL CHEM, V274, P23144, DOI 10.1074/jbc.274.33.23144; Ortegren U, 2004, EUR J BIOCHEM, V271, P2028, DOI 10.1111/j.1432-1033.2004.04117.x; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Radel C, 2007, BIOCHEM BIOPH RES CO, V358, P626, DOI 10.1016/j.bbrc.2007.04.179; RODBELL M, 1964, J BIOL CHEM, V239, P375; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Ruan BF, 1997, J LIPID RES, V38, P2615; Salonen A, 2003, J VIROL, V77, P1691, DOI 10.1128/JVI.77.3.1691-1702.2003; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Singh RD, 2007, J CELL BIOL, V176, P895, DOI 10.1083/jcb.200609149; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Smart EJ, 2002, METHOD ENZYMOL, V353, P131; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Tohka J, 2007, IEEE T MED IMAGING, V26, P696, DOI 10.1109/TMI.2007.895453; Upla P, 2004, MOL BIOL CELL, V15, P625, DOI 10.1091/mbc.E03-08-0588; Vainio S, 2006, J BIOL CHEM, V281, P348, DOI 10.1074/jbc.M509530200; WEISS JF, 1976, ARCH NEUROL-CHICAGO, V33, P180, DOI 10.1001/archneur.1976.00500030036007	53	33	35	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14610	14618		10.1074/jbc.M710355200	http://dx.doi.org/10.1074/jbc.M710355200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18353778	hybrid			2022-12-25	WOS:000255941400049
J	Mccoy, CE; Carpenter, S; Palsson-McDermott, EM; Gearing, LJ; O'Neill, LAJ				McCoy, Claire E.; Carpenter, Susan; Palsson-McDermott, Eva M.; Gearing, Linden J.; O'Neill, Luke A. J.			Glucocorticoids inhibit IRF3 phosphorylation in response to toll-like receptor-3 and-4 by targeting TBK1 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR-3; DOUBLE-STRANDED-RNA; NF-KAPPA-B; TANK-BINDING KINASE-1; ANTIVIRAL RESPONSE; GENE-EXPRESSION; VIRAL-INFECTION; VIRUS-INFECTION; PROTEIN-KINASE; IKK-EPSILON	Phosphorylation of the transcription factor interferon regulatory factor 3 ( IRF3) is essential for the induction of promoters which contain the interferon-stimulated response element ( ISRE). IRF3 can be activated by Toll-like receptor 3 ( TLR3) in response to the double-stranded RNA mimic poly( I-C) and by TLR4 in response to lipopolysaccharide ( LPS). Here we have analyzed the effect of the glucocorticoid dexamethasone on this response. Dexamethasone inhibited the induction of the ISRE-dependent gene RANTES ( regulated on activation normal T cell expressed and secreted) in both U373-CD14 cells and human peripheral blood mononuclear cells and also an ISRE luciferase construct, activated by either TLR3 or TLR4. It also inhibited increased phosphorylation of IRF3 in its N terminus in response to LPS and in its C terminus on Ser-396 in response to either poly( I-C) or LPS. Several dexamethasone-induced phosphatases were tested for possible involvement in these effects; MKP1 did not appear to be involved, although MKP2 and MKP5 both partially inhibited induction of the ISRE, pointing to their possible involvement in the effect of dexamethasone. Importantly, we found that dexamethasone could inhibit TBK1 kinase activity and TBK1 phosphorylation on Ser-172, both of which are required for IRF3 phosphorylation downstream of TLR3 and TLR4 stimulation. Our study, therefore, demonstrates that TBK1 is a target for dexamethasone, common to both TLR3 and TLR4 signaling.	[McCoy, Claire E.; Carpenter, Susan; Palsson-McDermott, Eva M.; Gearing, Linden J.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Mccoy, CE (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	cmccoy@tcd.ie		O'Neill, Luke/0000-0002-4333-2748; McCoy, Claire/0000-0001-8710-896X; Gearing, Linden/0000-0003-3508-3056				Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chinenov Y, 2007, MOL CELL ENDOCRINOL, V275, P30, DOI 10.1016/j.mce.2007.04.014; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Kang YJ, 2007, J IMMUNOL, V179, P4598, DOI 10.4049/jimmunol.179.7.4598; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lowe EL, 2006, J ENDOTOXIN RES, V12, P337, DOI 10.1179/096805106X118915; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Reily MM, 2006, EMBO J, V25, P108, DOI 10.1038/sj.emboj.7600919; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sing A, 2000, INFECT IMMUN, V68, P1600, DOI 10.1128/IAI.68.3.1600-1607.2000; Solis M, 2007, EUR J IMMUNOL, V37, P528, DOI 10.1002/eji.200636090; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Wietek C, 2003, J BIOL CHEM, V278, P50923, DOI 10.1074/jbc.M308135200; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	34	55	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14277	14285		10.1074/jbc.M709731200	http://dx.doi.org/10.1074/jbc.M709731200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18356163	hybrid, Green Published			2022-12-25	WOS:000255941400014
J	Rogemond, V; Auger, C; Giraudon, P; Becchi, M; Auvergnon, N; Belin, MF; Honnorat, J; Moradi-Ameli, M				Rogemond, Veronique; Auger, Carole; Giraudon, Pascale; Becchi, Michel; Auvergnon, Nathalie; Belin, Marie-Francoise; Honnorat, Jerome; Moradi-Ameli, Mahnaz			Processing and nuclear localization of CRMP2 during brain development induce neurite outgrowth inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE MEDIATOR PROTEIN-2; GROWTH-CONE COLLAPSE; SIGNALING PATHWAYS; MOUSE-BRAIN; RHO-KINASE; NEURONS; PHOSPHORYLATION; RAT; EXPRESSION; COMPLEX	Collapsin response mediator proteins (CRMPs) are believed to play a crucial role in neuronal differentiation and axonal outgrowth. Among them, CRMP2 mediates axonal guidance by collapsing growth cones during development. This activity is correlated with the reorganization of cytoskeletal proteins. CRMP2 is implicated in the regulation of several intracellular signaling pathways. Two subtypes, A and B, and multiple cytosolic isoforms of CRMP2B with apparent masses between 62 and 66 kDa have previously been reported. Here, we show a new short isoform of 58 kDa, expressed during brain development, derived from C-terminal processing of the CRMP2B subtype. Although full-length CRMP2 is restricted to the cytoplasm, using transfection experiments, we demonstrate that a part of the short isoform is found in the nucleus. Interestingly, at the tissue level, this short CRMP2 is also found in a nuclear fraction of brain extract. By mutational analysis, we demonstrate, for the first time, that nuclear translocation occurs via nuclear localization signal (NLS) within residues Arg(471)-Lys(472) in CRMP2 sequence. The NLS may be unmasked after C-terminal processing; thereby, this motif may be surface-exposed. This short CRMP2 induces neurite outgrowth inhibition in neuroblastoma cells and suppressed axonal growth in cultured cortical neurons, whereas full-length CRMP2 promotes neurite elongation. The NLS-mutated short isoform, restricted to the cytoplasm, abrogates both neurite outgrowth and axon growth inhibition, indicating that short nuclear CRMP2 acts as a dominant signal. Therefore, post-transcriptional processing of CRMP2 together with its nuclear localization may be an important key in the regulation of neurite outgrowth in brain development.	[Rogemond, Veronique; Auger, Carole; Giraudon, Pascale; Auvergnon, Nathalie; Belin, Marie-Francoise; Honnorat, Jerome; Moradi-Ameli, Mahnaz] Univ Lyon 1, Fac Med Laennec, INSERM, U Neurooncol & Neuroinflammat 842, F-69372 Lyon, France; [Becchi, Michel] CNRS, UMR 5086, Inst Biol & Chim Proteins, F-69367 Lyon, France; [Rogemond, Veronique; Honnorat, Jerome] Hosp Civil Lyon, F-69677 Bron, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon	Honnorat, J (corresponding author), Univ Lyon 1, Fac Med Laennec, INSERM, U Neurooncol & Neuroinflammat 842, Rue Guilaume Paradin, F-69372 Lyon, France.	jerome.honnorat@chu-layon.fr	Rogemond, Veronique/J-4824-2017; Honnorat, jerome/G-6394-2017	Rogemond, Veronique/0000-0003-2098-920X; Honnorat, jerome/0000-0002-4721-5952				Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bouillot C, 1996, J BIOL CHEM, V271, P7640, DOI 10.1074/jbc.271.13.7640; Bradley KJ, 2007, ONCOGENE, V26, P1213, DOI 10.1038/sj.onc.1209893; Bretin S, 2005, J COMP NEUROL, V486, P1, DOI 10.1002/cne.20465; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brown M, 2004, J NEUROSCI, V24, P8994, DOI 10.1523/JNEUROSCI.3184-04.2004; Buck KB, 2002, J NEUROSCI, V22, P9358; Bulliard C, 1997, BIOCHEM J, V324, P555, DOI 10.1042/bj3240555; Chung MA, 2005, NEUROREPORT, V16, P1647, DOI 10.1097/01.wnr.0000176520.49841.e6; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, BIOCHEMISTRY-US, V39, P4267, DOI 10.1021/bi992323h; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jiang SX, 2007, EUR J NEUROSCI, V26, P801, DOI 10.1111/j.1460-9568.2007.05715.x; Katano T, 2006, PROTEOMICS, V6, P6085, DOI 10.1002/pmic.200600300; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kowara R, 2005, J NEUROCHEM, V95, P466, DOI 10.1111/j.1471-4159.2005.03383.x; Lee S, 2002, J BIOL CHEM, V277, P6542, DOI 10.1074/jbc.M108047200; Liu JF, 2003, NUCLEIC ACIDS RES, V31, P3833, DOI 10.1093/nar/gkg515; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Quach TT, 2004, MOL CELL NEUROSCI, V25, P433, DOI 10.1016/j.mcn.2003.11.006; Ricard D, 2001, J NEUROSCI, V21, P7203, DOI 10.1523/JNEUROSCI.21-18-07203.2001; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Suzuki Y, 2003, J NEUROCHEM, V86, P1042, DOI 10.1046/j.1471-4159.2003.01920.x; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Vincent P, 2005, J IMMUNOL, V175, P7650, DOI 10.4049/jimmunol.175.11.7650; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yuasa-Kawada J, 2003, EUR J NEUROSCI, V17, P2329, DOI 10.1046/j.1460-9568.2003.02664.x; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhou FQ, 2004, J NEUROBIOL, V58, P84, DOI 10.1002/neu.10278	43	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14751	14761		10.1074/jbc.M708480200	http://dx.doi.org/10.1074/jbc.M708480200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18332147	hybrid, Green Submitted			2022-12-25	WOS:000255941400063
J	Kumar, V; Jong, YJI; O'Malley, KL				Kumar, Vikas; Jong, Yuh-Jiin I.; O'Malley, Karen L.			Activated nuclear metabotropic glutamate receptor mGlu5 couples to nuclear G(q/11) proteins to generate inositol 1,4,5-trisphosphate-mediated nuclear Ca2+ release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE PTDINS(4,5)P-2; HETEROTRIMERIC G-PROTEINS; SIGNAL-TRANSDUCTION; LIVING CELLS; NUCLEOPLASMIC RETICULUM; CEREBELLAR PURKINJE; RYANODINE RECEPTORS; FLUORESCENT PROTEIN; CALCIUM TRANSIENTS; CYTOSOLIC CALCIUM	Recently we have shown that the metabotropic glutamate 5 (mGlu5) receptor can be expressed on nuclear membranes of heterologous cells or endogenously on striatal neurons where it can mediate nuclear Ca2+ changes. Here, pharmacological, optical, and genetic techniques were used to show that upon activation, nuclear mGlu5 receptors generate nuclear inositol 1,4,5-trisphosphate (IP3) in situ. Specifically, expression of an mGlu5 F767S mutant in HEK293 cells that blocks G(q/11) coupling or introduction of a dominant negative G alpha(q) construct in striatal neurons prevented nuclear Ca2+ changes following receptor activation. These data indicate that nuclear mGlu5 receptors couple to G(q/11) to mobilize nuclear Ca2+. Nuclear mGlu5-mediated Ca2+ responses could also be blocked by the phospholipase C (PLC) inhibitor, U73122, the phosphatidylinositol (PI) PLC inhibitor 1-O-octadecyl-2-O-methyl-sn-glycero-3- phosphorylcholine (ET-18-OCH3), or by using small interfering RNA targeted against PLC beta 1 demonstrating that PI-PLC is involved. Direct assessment of inositol phosphate production using a PIP2/IP3 "biosensor" revealed for the first time that IP3 can be generated in the nucleus following activation of nuclear mGlu5 receptors. Finally, both IP3 and ryanodine receptor blockers prevented nuclear mGlu5-mediated increases in intranuclear Ca2+. Collectively, this study shows that like plasma membrane receptors, activated nuclear mGlu5 receptors couple to G(q/11) and PLC to generate IP3-mediated release of Ca2+ from Ca2+-release channels in the nucleus. Thus the nucleus can function as an autonomous organelle independent of signals originating in the cytoplasm, and nuclear mGlu5 receptors play a dynamic role in mobilizing Ca2+ in a specific, localized fashion.	[Kumar, Vikas; Jong, Yuh-Jiin I.; O'Malley, Karen L.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	O'Malley, KL (corresponding author), 660 S Euclid Ave, St Louis, MO 63110 USA.	omalleyk@pcg.wustl.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH069646, R01MH057817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER; NIMH NIH HHS [MH69646, MH57817] Funding Source: Medline; NINDS NIH HHS [NS057105] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adebanjo OA, 1999, NAT CELL BIOL, V1, P409, DOI 10.1038/15640; Alonso MT, 2006, CELL CALCIUM, V40, P513, DOI 10.1016/j.ceca.2006.08.013; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Bartlett PJ, 2005, J BIOL CHEM, V280, P21837, DOI 10.1074/jbc.M411843200; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Berridge MJ, 2001, NOVART FDN SYMP, V239, P52; Bhattacharya M, 1999, J BIOL CHEM, V274, P15719, DOI 10.1074/jbc.274.22.15719; Bolsover S, 2001, BIOCHEM J, V356, P345, DOI 10.1042/0264-6021:3560345; Bunce MW, 2006, BBA-MOL CELL BIOL L, V1761, P560, DOI 10.1016/j.bbalip.2006.03.002; Chatterjee TK, 2000, J BIOL CHEM, V275, P24013, DOI 10.1074/jbc.M002082200; D'Santos C, 2000, EUR J HISTOCHEM, V44, P51; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Eder A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-57; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gerasimenko JV, 2003, J CELL BIOL, V163, P271, DOI 10.1083/jcb.200306134; Gerasimenko O, 2005, CELL CALCIUM, V38, P201, DOI 10.1016/j.ceca.2005.06.025; GERASIMENKO OV, 1995, CELL, V80, P439, DOI 10.1016/0092-8674(95)90494-8; Gobeil F, 2002, CIRC RES, V90, P682, DOI 10.1161/01.RES.0000013303.17964.7A; Gobeil F, 2006, CAN J PHYSIOL PHARM, V84, P287, DOI 10.1139/Y05-127; Halet G, 2002, J CELL SCI, V115, P2139; Hardingham GE, 1999, MICROSC RES TECHNIQ, V46, P348, DOI 10.1002/(SICI)1097-0029(19990915)46:6<348::AID-JEMT3>3.3.CO;2-1; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Humbert JP, 1996, J BIOL CHEM, V271, P478, DOI 10.1074/jbc.271.1.478; Ibarra C, 2004, J BIOL CHEM, V279, P7554, DOI 10.1074/jbc.M311604200; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Jong YJI, 2007, J NEUROCHEM, V101, P458, DOI 10.1111/j.1471-4159.2006.04382.x; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kim YH, 2006, J CELL PHYSIOL, V207, P689, DOI 10.1002/jcp.20609; Kingston AE, 2002, NEUROSCI LETT, V330, P127, DOI 10.1016/S0304-3940(02)00751-6; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Lauckner JE, 2005, P NATL ACAD SCI USA, V102, P19144, DOI 10.1073/pnas.0509588102; Limback-Stokin K, 2004, J NEUROSCI, V24, P10858, DOI 10.1523/JNEUROSCI.1022-04.2004; MacMillan D, 2005, J PHYSIOL-LONDON, V569, P533, DOI 10.1113/jphysiol.2005.096529; Marchenko SM, 2006, CEREBELLUM, V5, P36, DOI 10.1080/14734220600554438; Marchenko SM, 2005, J PHYSIOL-LONDON, V565, P897, DOI 10.1113/jphysiol.2004.081299; Marius P, 2006, CELL CALCIUM, V39, P65, DOI 10.1016/j.ceca.2005.09.010; Martelli AM, 2005, HISTOL HISTOPATHOL, V20, P1251, DOI 10.14670/HH-20.1251; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Muhlemann AM, 2005, BRIT J PHARMACOL, V144, P1118, DOI 10.1038/sj.bjp.0706152; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; O'Malley KL, 2003, J BIOL CHEM, V278, P28210, DOI 10.1074/jbc.M300792200; Oka T, 2002, BRIT J PHARMACOL, V135, P1959, DOI 10.1038/sj.bjp.0704662; Power JM, 2002, J NEUROSCI, V22, P3454; Quesada I, 2005, BIOPHYS J, V88, P3946, DOI 10.1529/biophysj.105.061390; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Romano C, 2001, MOL PHARMACOL, V59, P46, DOI 10.1124/mol.59.1.46; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; SORENSEN AM, 1995, J CELL BIOCHEM, V58, P15, DOI 10.1002/jcb.240580104; Spitzer NC, 2000, BIOESSAYS, V22, P811; Stallings JD, 2005, J BIOL CHEM, V280, P22060, DOI 10.1074/jbc.M413813200; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; Ventura C, 2001, CRIT REV EUKAR GENE, V11, P243; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Willard FS, 2000, IMMUNOL CELL BIOL, V78, P387, DOI 10.1046/j.1440-1711.2000.00927.x; Yagisawa H, 2006, J CELL BIOCHEM, V97, P233, DOI 10.1002/jcb.20677; Young KW, 2003, J BIOL CHEM, V278, P20753, DOI 10.1074/jbc.M211555200; Zhu T, 2006, CAN J PHYSIOL PHARM, V84, P377, DOI 10.1139/Y05-147	68	72	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14072	14083		10.1074/jbc.M708551200	http://dx.doi.org/10.1074/jbc.M708551200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18337251	hybrid, Green Published			2022-12-25	WOS:000255728200061
J	Malay, AD; Umehara, T; Matsubara-Malay, K; Padmanabhan, B; Yokoyama, S				Malay, Ali D.; Umehara, Takashi; Matsubara-Malay, Kazuko; Padmanabhan, Balasundaram; Yokoyama, Shigeyuki			Crystal structures of fission yeast histone chaperone Asf1 complexed with the Hip1 B-domain or the Cac2 C terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN; PROTEIN; NUCLEOSOME; IDENTIFICATION; DEPOSITION; REPLICATION; CIA/ASF1; PARTICLE; CAF-1; RAD53	The assembly of core histones onto eukaryotic DNA is modulated by several histone chaperone complexes, including Asf1, CAF-1, and HIRA. Asf1 is a unique histone chaperone that participates in both the replication-dependent and replication-independent pathways. Here we report the crystal structures of the apo-form of fission yeast Asf1/Cia1 (SpAsf1N; residues 1-161) as well as its complexes with the B-domain of the fission yeast HIRA orthologue Hip1 (Hip1B) and the C-terminal region of the Cac2 subunit of CAF-1 (Cac2C). The mode of the fission yeast Asf1N-Hip1B recognition is similar to that of the human Asf1-HIRA recognition, suggesting that Asf1N recognition of Hip1B/HIRA is conserved from yeast to mammals. Interestingly, Hip1B and Cac2C show remarkably similar interaction modes with Asf1. The binding between Asf1N and Hip1B was almost completely abolished by the D37A and L60A/V62A mutations in Asf1N, indicating the critical role of salt bridge and van der Waals contacts in the complex formation. Consistently, both of the aforementioned Asf1 mutations also drastically reduced the binding to Cac2C. These results provide a structural basis for a mutually exclusive Asf1-binding model of CAF-1 and HIRA/Hip1, in which Asf1 and CAF-1 assemble histones H3/H4 (H3.1/H4 in vertebrates) in a replication-dependent pathway, whereas Asf1 and HIRA/Hip1 assemble histones H3/H4 (H3.3/H4 in vertebrates) in a replication-independent pathway.	[Malay, Ali D.; Umehara, Takashi; Matsubara-Malay, Kazuko; Padmanabhan, Balasundaram; Yokoyama, Shigeyuki] RIKEN, Yokohama Inst, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; University of Tokyo	Padmanabhan, B (corresponding author), Aptuit Laurus Private Ltd, ICICI Knowledge Pk, Hyderabad 500078, Andhra Pradesh, India.	paddy.b@aptuitlaurus.com; yokoyama@biochem.s.u-tokyo.ac.jp	Malay, Ali/N-9136-2015; Yokoyama, Shigeyuki/N-6911-2015; Umehara, Takashi/N-5683-2015; Umehara, Takashi/AHB-1730-2022	Malay, Ali/0000-0003-0885-5524; Yokoyama, Shigeyuki/0000-0003-3133-7338; Umehara, Takashi/0000-0003-3464-2960; Umehara, Takashi/0000-0003-3464-2960				Adkins MW, 2004, J BIOL CHEM, V279, P52069, DOI 10.1074/jbc.M406113200; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chimura T, 2002, P NATL ACAD SCI USA, V99, P9334, DOI 10.1073/pnas.142627899; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/j.cub.2003.11.027; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Loyola A, 2004, BBA-GENE STRUCT EXPR, V1677, P3, DOI 10.1016/j.bbaexp.2003.09.012; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Osada S, 2001, GENE DEV, V15, P3155, DOI 10.1101/gad.907201; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padmanabhan B, 2005, J BIOCHEM, V138, P821, DOI 10.1093/jb/mvi182; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; Singer MS, 1998, GENETICS, V150, P613; Sutton A, 2001, GENETICS, V158, P587; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tamburini BA, 2005, EUKARYOT CELL, V4, P1583, DOI 10.1128/EC.4.9.1583-1590.2005; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Umehara T, 2005, ACTA CRYSTALLOGR F, V61, P971, DOI 10.1107/S1744309105030927; Umehara T, 2003, J BIOL CHEM, V278, P35660, DOI 10.1074/jbc.M303549200; Umehara T, 2002, GENES CELLS, V7, P59, DOI 10.1046/j.1356-9597.2001.00493.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019	41	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14022	14031		10.1074/jbc.M800594200	http://dx.doi.org/10.1074/jbc.M800594200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18334479	hybrid			2022-12-25	WOS:000255728200056
J	Arikketh, D; Nelson, R; Vance, JE				Arikketh, Devi; Nelson, Randy; Vance, Jean E.			Defining the importance of phosphatidylserine synthase-1 (PSS1) - Unexpected viability of PSS1-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; PICK C1-DEFICIENT NEURONS; SACCHAROMYCES-CEREVISIAE; LIPOPROTEIN SECRETION; DISTAL AXONS; RAT-LIVER; GENE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPIDS; MEMBRANE	Phosphatidylserine (PS) is a quantitatively minor, but physiologically important, phospholipid in mammalian cells. PS is synthesized by two distinct base-exchange enzymes, PS synthase-1 (PSS1) and PS synthase-2 (PSS2), that are encoded by different genes. PSS1 exchanges serine for choline of phosphatidylcholine, whereas PSS2 exchanges ethanolamine of phosphatidylethanolamine for serine. We previously generated mice lacking PSS2 (Bergo, M. O., Gavino, B. J., Steenbergen, R., Sturbois, B., Parlow, A. F., Sanan, D. A., Skarnes, W. C., Vance, J. E., and Young, S. G. (2002) J. Biol. Chem. 277, 47701-47708) and found that PSS2 is not required for mouse viability. We have now generated PSS1-deficient mice. In light of the markedly impaired survival of Chinese hamster ovary cells lacking PSS1 we were surprised that PSS1-deficient mice were viable, fertile, and had a normal life span. Total serine-exchange activity (contributed by PSS1 and PSS2) in tissues of Pss1(-/-) mice was reduced by up to 85%, but except in liver, the PS content was unaltered. Despite the presumed importance of PS in the nervous system, the rate of axonal extension of PSS1-deficient neurons was normal. Intercrosses of Pss1(-/-) mice and Pss2(-/-) mice yielded mice with three disrupted Pss alleles but no double knockout mice. In Pss1(-/-)/Pss2(-/-) and Pss1(-/-)/Pss2(-/-) mice, serine-exchange activity was reduced by 65-91%, and the tissue content of PS and phosphatidylethanolamine was also decreased. We conclude that (i) elimination of either PSS1 or PSS2, but not both, is compatible with mouse viability, (ii) mice can tolerate as little as 10% of normal total serine-exchange activity, and (iii) mice survive with significantly reduced PS and phosphatidylethanolamine content.	[Arikketh, Devi; Vance, Jean E.] Univ Alberta, Dept Med, Heritage Med Res Ctr 328, Edmonton, AB T6G 2S2, Canada; [Arikketh, Devi; Nelson, Randy; Vance, Jean E.] Univ Alberta, Grp Mol & Cel Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Nelson, Randy] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta; University of Alberta	Vance, JE (corresponding author), Univ Alberta, Dept Med, Heritage Med Res Ctr 328, Edmonton, AB T6G 2S2, Canada.	jean.vance@ualberta.ca	A, Devi/ABE-6011-2021	ARIKKETH, DEVI/0000-0002-8542-3760				ATKINSON K, 1980, J BIOL CHEM, V255, P6653; AXELROD J, 1953, J BIOL CHEM, V204, P903; Bergo MO, 2002, J BIOL CHEM, V277, P47701, DOI 10.1074/jbc.M207734200; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; CAMPENOT RB, 1977, P NATL ACAD SCI USA, V74, P4516, DOI 10.1073/pnas.74.10.4516; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Grandmaison PA, 2004, BBA-MOL CELL BIOL L, V1636, P1, DOI 10.1016/j.bbalip.2003.11.004; Griac P, 1996, J BIOL CHEM, V271, P25692, DOI 10.1074/jbc.271.41.25692; Hayashi H, 2002, NEUROREPORT, V13, P383, DOI 10.1097/00001756-200203250-00004; Hicks AM, 2006, BBA-MOL CELL BIOL L, V1761, P1022, DOI 10.1016/j.bbalip.2006.05.010; Jackson SN, 2007, J AM SOC MASS SPECTR, V18, P17, DOI 10.1016/j.jasms.2006.08.015; Karten B, 2002, J NEUROCHEM, V83, P1154, DOI 10.1046/j.1471-4159.2002.01220.x; Karten B, 2003, J BIOL CHEM, V278, P4168, DOI 10.1074/jbc.M205406200; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; KUGE O, 1986, J BIOL CHEM, V261, P5790; Kuge O, 1997, J BIOL CHEM, V272, P19133, DOI 10.1074/jbc.272.31.19133; Matsuo Y, 2007, EUKARYOT CELL, V6, P2092, DOI 10.1128/EC.00300-07; PERCY AK, 1983, ARCH BIOCHEM BIOPHYS, V223, P484, DOI 10.1016/0003-9861(83)90613-6; PERRY TL, 1975, J NEUROCHEM, V24, P587, DOI 10.1111/j.1471-4159.1975.tb07680.x; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Saito K, 1996, FEBS LETT, V395, P262, DOI 10.1016/0014-5793(96)01049-6; Saito K, 1998, J BIOL CHEM, V273, P17199, DOI 10.1074/jbc.273.27.17199; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Steenbergen R, 2006, BBA-MOL CELL BIOL L, V1761, P313, DOI 10.1016/j.bbalip.2006.03.005; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Stone SJ, 1999, BIOCHEM J, V342, P57, DOI 10.1042/0264-6021:3420057; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; Sturbois-Balcerzak B, 2001, J BIOL CHEM, V276, P8205, DOI 10.1074/jbc.M009776200; VANCE JE, 1986, J BIOL CHEM, V261, P4486; VANCE JE, 1988, J BIOL CHEM, V263, P5898; VANCE JE, 1990, J BIOL CHEM, V265, P7248; VANCE JE, 1988, BIOCHIM BIOPHYS ACTA, V963, P70, DOI 10.1016/0005-2760(88)90339-6; VANCE JE, 2008, IN PRESS J LIPID RES; VANGOLDE LM, 1974, BIOCHIM BIOPHYS ACTA, V360, P179, DOI 10.1016/0005-2760(74)90168-4; VOELKER DR, 1986, J BIOL CHEM, V261, P1002; ZBOROWSKI J, 1983, FEBS LETT, V157, P179, DOI 10.1016/0014-5793(83)81141-7	39	55	59	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12888	12897		10.1074/jbc.M800714200	http://dx.doi.org/10.1074/jbc.M800714200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18343815	hybrid			2022-12-25	WOS:000255499800025
J	Chang, YG; Yan, XZ; Xie, YY; Gao, XC; Song, AX; Zhang, DE; Hu, HY				Chang, Yong-Gang; Yan, Xian-Zhong; Xie, Yuan-Yuan; Gao, Xue-Chao; Song, Ai-Xin; Zhang, Dong-Er; Hu, Hong-Yu			Different roles for two ubiquitin-like domains of ISG15 in protein modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL MOLECULE; STIMULATED GENE-15; HUMAN-CELLS; E3 LIGASE; INTERFERON; CONJUGATION; INFLUENZA; TARGETS; ENZYME; E2	ISG15 (interferon-stimulated gene 15) is a novel ubiquitin-like (UbL) modifier with two UbL domains in its architecture. We investigated different roles for the two UbL domains in protein modification by ISG15 (ISGylation) and the impact of Influenza B virus NS1 protein (NS1B) on regulation of the pathway. The results show that, although the C-terminal domain is sufficient to link ISG15 to UBE1L and UbcH8, the N-terminal domain is dispensable in the activation and transthiolation steps but required for efficient E3-mediated transfer of ISG15 from UbcH8 to its substrates. NS1B specifically binds to the N-terminal domain of ISG15 but does not affect ISG15 linkage via a thioester bond to its activating and conjugating enzymes. However, it does inhibit the formation of cellular ISG15 conjugates upon interferon treatment. We propose that the N-terminal UbL domain of ISG15 mainly functions in the ligation step and NS1B inhibits ISGylation by competing with E3 ligases for binding to the N-terminal domain.	[Chang, Yong-Gang; Xie, Yuan-Yuan; Gao, Xue-Chao; Song, Ai-Xin; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Yan, Xian-Zhong] Natl Ctr Biomed Anal, NMR Lab, Beijing 100850, Peoples R China; [Chang, Yong-Gang; Xie, Yuan-Yuan; Gao, Xue-Chao] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; [Zhang, Dong-Er] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Scripps Research Institute	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China.	hyhu@sibs.ac.cn	Xie, Yuanyuan/F-1974-2017; Hu, Hong-Yu/AAQ-2633-2020					Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Dao CT, 2005, FRONT BIOSCI-LANDMRK, V10, P2701, DOI 10.2741/1730; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; KNIGHT E, 1988, J BIOL CHEM, V263, P4520; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Takeuchi T, 2006, FEBS LETT, V580, P4521, DOI 10.1016/j.febslet.2006.07.032; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	30	42	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13370	13377		10.1074/jbc.M800162200	http://dx.doi.org/10.1074/jbc.M800162200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18356159	hybrid			2022-12-25	WOS:000255499800076
J	Cheung, WD; Hart, GW				Cheung, Win D.; Hart, Gerald W.			AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; GLCNAC MODIFICATION; NUCLEOCYTOPLASMIC PROTEINS; SIGNAL-TRANSDUCTION; NEUROFILAMENT SUBUNIT; ALZHEIMERS-DISEASE; ENERGY-METABOLISM; X-CHROMOSOME; BRAIN-INJURY; PHOSPHORYLATION	We have demonstrated previously that a wide array of stress signals induces O-GlcNAc transferase ( OGT) expression and increases O-GlcNAcylation of many intracellular proteins, a response that is critical for cell survival. Here, we describe a mechanism by which glucose deprivation induces OGT expression and activity in Neuro-2a neuroblastoma cells. Glucose deprivation increases OGT mRNA and protein expression in an AMP-activated protein kinase-dependent manner, whereas OGT enzymatic activity is regulated in a p38 MAPK-dependent manner. OGT is not phosphorylated by p38, but rather it interacts directly with p38 through its C terminus; this interaction increases with p38 activation during glucose deprivation. Surprisingly, the catalytic activity of OGT, as measured toward peptide substrates, is not altered by glucose deprivation. Instead, p38 regulates OGT activity within the cell by recruiting it to specific targets, including neurofilament H. Neurofilament H is O-GlcNAcylated during glucose deprivation in a p38-dependent manner. Interestingly, neurofilament H solubility is increased by glucose deprivation in an O-GlcNAc-dependent manner, suggesting that O-GlcNAcylation of neurofilament H regulates its disassembly from filaments. Not only do these data help to reveal how OGT is regulated by stress, but these findings also describe a possible mechanism by which defective brain glucose metabolism, as found in aging and ischemia, may directly affect axonal structure.	[Cheung, Win D.; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu		Hart, Gerald/0000-0001-7812-4351	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD013563, R01HD013563] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA042486-25, CA42486, R01 CA042486] Funding Source: Medline; NICHD NIH HHS [R37 HD013563-30, R01 HD13563, R37 HD013563] Funding Source: Medline; NIDDK NIH HHS [R01 DK061671] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ackerley S, 2004, MOL CELL NEUROSCI, V26, P354, DOI 10.1016/j.mcn.2004.02.009; Akimoto Yoshihiro, 2005, Medical Molecular Morphology, V38, P84, DOI 10.1007/s00795-004-0264-1; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; BRAIDMAN I, 1974, FEBS LETT, V41, P181, DOI 10.1016/0014-5793(74)81206-8; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Cheng XG, 2000, BIOCHEMISTRY-US, V39, P11609, DOI 10.1021/bi000755i; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Dias WB, 2007, MOL BIOSYST, V3, P766, DOI 10.1039/b704905f; Dong DLY, 1996, J BIOL CHEM, V271, P20845, DOI 10.1074/jbc.271.34.20845; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Elder GA, 1998, J CELL BIOL, V143, P195, DOI 10.1083/jcb.143.1.195; Fehm HL, 2006, PROG BRAIN RES, V153, P129, DOI 10.1016/S0079-6123(06)53007-9; FUKUYAMA H, 1994, J NUCL MED, V35, P1; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Goedert M, 1997, FEBS LETT, V409, P57, DOI 10.1016/S0014-5793(97)00483-3; GOLD PE, 2005, NEUROBIOL AGING S1, V28, P60; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; Hoyer S, 1998, J NEURAL TRANSM-SUPP, P187; Hoyer S, 2004, EUR J PHARMACOL, V490, P115, DOI 10.1016/j.ejphar.2004.02.049; Irving EA, 2002, J CEREBR BLOOD F MET, V22, P631, DOI 10.1097/00004647-200206000-00001; Kamemura K, 2002, J BIOL CHEM, V277, P19229, DOI 10.1074/jbc.M201729200; King CE, 2000, CLIN EXP PHARMACOL P, V27, P548, DOI 10.1046/j.1440-1681.2000.03292.x; Kneass ZT, 2005, J BIOL CHEM, V280, P14579, DOI 10.1074/jbc.M414066200; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; LaManna JC, 1997, NEUROSURG CLIN N AM, V8, P145; Lehmann R, 2000, ELECTROPHORESIS, V21, P3010, DOI 10.1002/1522-2683(20000801)21:14<3010::AID-ELPS3010>3.0.CO;2-C; Leys D, 2000, J NEURAL TRANSM-SUPP, P31; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Ludemann N, 2005, J BIOL CHEM, V280, P31648, DOI 10.1074/jbc.M504395200; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Medina L, 1998, GLYCOBIOLOGY, V8, P383, DOI 10.1093/glycob/8.4.383; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Schurr A, 2002, NEUROCHEM INT, V41, P1, DOI 10.1016/S0197-0186(01)00142-5; SCOTT CW, 1991, J NEUROSCI RES, V30, P154, DOI 10.1002/jnr.490300116; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; SHEA TB, 1994, FEBS LETT, V343, P131, DOI 10.1016/0014-5793(94)80304-8; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Tabakman R, 2005, ANN NY ACAD SCI, V1053, P84, DOI 10.1196/annals.1344.008; TAKMAN R, 2004, J MOL NEUROSCI, V22, P237; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Tomiya N, 2001, ANAL BIOCHEM, V293, P129, DOI 10.1006/abio.2001.5091; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; WATSON DF, 1989, J NEUROCHEM, V53, P1818, DOI 10.1111/j.1471-4159.1989.tb09248.x; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; White L, 2006, ALZ DIS ASSOC DIS, V20, pS79, DOI 10.1097/00002093-200607001-00012; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yun H, 2005, J BIOL CHEM, V280, P9963, DOI 10.1074/jbc.M412994200; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	72	169	175	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13009	13020		10.1074/jbc.M801222200	http://dx.doi.org/10.1074/jbc.M801222200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18353774	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000255499800038
J	Huveneers, S; Arslan, S; van de Water, B; Sonnenberg, A; Danen, EHJ				Huveneers, Stephan; Arslan, Serdar; van de Water, Bob; Sonnenberg, Arnoud; Danen, Erik H. J.			Integrins uncouple src-induced morphological and oncogenic transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SRC; FAMILY KINASES; V-SRC; CELL-TRANSFORMATION; HUMAN-MELANOMA; ACTIVATED SRC; HUMAN CANCER; E-CADHERIN; EXPRESSION; ADHESION	Expression of activated mutants of c-Src in epithelial cells can induce tumorigenicity. In addition to such oncogenic transformation, the cells undergo a dramatic morphological transformation: cell-cell contacts are disrupted, spreading on extracellular matrix proteins is suppressed, actin stress fibers and focal contacts are lost, and podosomes are formed. We have previously shown that integrin alpha v beta 3 strongly supports Src-mediated oncogenic transformation through an interaction at the beta 3 cytoplasmic tail. Our current findings demonstrate that this interaction does not affect Src-mediated morphological alterations, thus separating oncogenic from morphological transformation. Moreover, beta 1 and beta 3 integrins differently affect the various aspects of Src-induced morphological transformation. High levels of beta 3, but not beta 1, integrins can prevent Src-induced cell rounding although stress fiber disassembly and podosome formation still occur. Studies using chimeric integrin subunits demonstrate that this protection requires the beta 3 extracellular domain. Finally, like tumor formation, podosome assembly occurs independent of beta 3 phosphorylation. Instead, phosphorylation of beta 1 is required to suppress Rho-mediated contractility in order to assemble podosomes. Thus, integrins regulate Src-mediated oncogenic transformation and various aspects of morphological transformation through dissociable pathways.	[Huveneers, Stephan; Arslan, Serdar; van de Water, Bob; Danen, Erik H. J.] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Toxicol, NL-2300 RA Leiden, Netherlands; [Huveneers, Stephan; Sonnenberg, Arnoud; Danen, Erik H. J.] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Netherlands Cancer Institute	Danen, EHJ (corresponding author), Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Toxicol, Einsteinweg 55,POB 9502, NL-2300 RA Leiden, Netherlands.	e.danen@lacdr.leidenuniv.nl		Huveneers, Stephan/0000-0002-1091-475X; danen, erik/0000-0002-0491-6345				ALBELDA SM, 1990, CANCER RES, V50, P6757; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Berdeaux RL, 2004, J CELL BIOL, V166, P317, DOI 10.1083/jcb.200312168; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; Danen EHJ, 1996, BIOCHEM BIOPH RES CO, V226, P75, DOI 10.1006/bbrc.1996.1313; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Datta A, 2001, MOL CELL BIOL, V21, P7295, DOI 10.1128/MCB.21.21.7295-7306.2001; Fincham VJ, 1999, J CELL SCI, V112, P947; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Gimond C, 1999, J CELL BIOL, V147, P1325, DOI 10.1083/jcb.147.6.1325; GUY CT, 1994, GENE DEV, V8, P23, DOI 10.1101/gad.8.1.23; Hsu MY, 1998, AM J PATHOL, V153, P1435, DOI 10.1016/S0002-9440(10)65730-6; Huveneers S, 2007, CANCER RES, V67, P2693, DOI 10.1158/0008-5472.CAN-06-3654; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; JOVE R, 1986, J VIROL, V60, P840, DOI 10.1128/JVI.60.3.840-848.1986; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Matsumoto T, 2003, CANCER RES, V63, P4819; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Prathapam T, 2006, P NATL ACAD SCI USA, V103, P2695, DOI 10.1073/pnas.0511186103; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Sakai T, 2001, P NATL ACAD SCI USA, V98, P3808, DOI 10.1073/pnas.240456398; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; WARREN SL, 1987, MOL CELL BIOL, V7, P1326, DOI 10.1128/MCB.7.4.1326; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	34	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13243	13251		10.1074/jbc.M800927200	http://dx.doi.org/10.1074/jbc.M800927200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326486	Green Published, hybrid			2022-12-25	WOS:000255499800064
J	Oliveira, V; Romanow, WJ; Geisen, C; Otterness, DM; Mercurio, F; Wang, HG; Dalton, WS; Abraham, RT				Oliveira, Vasco; Romanow, William J.; Geisen, Christoph; Otterness, Diane M.; Mercurio, Frank; Wang, Hong Gang; Dalton, William S.; Abraham, Robert T.			A protective role for the human SMG-1 kinase against tumor necrosis factor-alpha-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DECAY; INDUCED CELL-DEATH; NF-KAPPA-B; SURVEILLANCE PROTEIN; SIGNALING PATHWAYS; STRESS; UPF1; PHOSPHORYLATION; SUPERFAMILY; ACTIVATION	The human suppressor of morphogenesis in genitalia-1 (hSMG-1) protein kinase plays dual roles in mRNA surveillance and genotoxic stress response pathways in human cells. Here, we report that small interfering RNA-mediated depletion of hSMG-1, but not ATM, ATR, hUpf1, or hUpf2, in human U2OS osteosarcoma cells markedly increases the magnitude and accelerates the rate of apoptosis induced by tumor necrosis factor-alpha(TNF alpha) stimulation. The increase in TNF alpha-mediated cell killing observed in hSMG-1-depleted cells is not related to the suppression of nonsense-mediated mRNA decay or to the inhibition of TNF alpha-induced NF-kappa B activation. Rather, we observed that loss of hSMG-1 accelerates the degradation of the long form of the FLICE-inhibitory protein (FLIPL), an inhibitor of death-inducing signaling complex-mediated caspase-8 activation, in TNF alpha-treated cells. These results suggest that hSMG-1 plays an important role in cell survival during TNF alpha-induced stress.	[Oliveira, Vasco; Wang, Hong Gang; Dalton, William S.] Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Dept Expt Therapeut & Interdisciplinary Oncol, Tampa, FL 33612 USA; [Romanow, William J.; Mercurio, Frank] Signal Pharmaceut LLC, Discovery Biol Grp, San Diego, CA 92121 USA; [Geisen, Christoph] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Otterness, Diane M.] Burnham Inst Med Res, La Jolla, CA 92038 USA	State University System of Florida; University of South Florida; Harvard University; Dana-Farber Cancer Institute; Sanford Burnham Prebys Medical Discovery Institute	Dalton, WS (corresponding author), Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Dept Expt Therapeut & Interdisciplinary Oncol, 12902 Magnolla Dr, Tampa, FL 33612 USA.	william.dalton@moffitt.org		Romanow, William/0000-0002-3808-6482	NATIONAL CANCER INSTITUTE [P30CA076292, R01CA097950] Funding Source: NIH RePORTER; NCI NIH HHS [CA97950, CA2 P30 CA076292-10] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2004, DNA REPAIR, V3, P919, DOI 10.1016/j.dnarep.2004.04.003; Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002; Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Budd RC, 2006, NAT REV IMMUNOL, V6, P196, DOI 10.1038/nri1787; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; LLOBET D, 2007, ONCOGENE; Maquat LE, 2005, J CELL SCI, V118, P1773, DOI 10.1242/jcs.01701; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Park SM, 2005, CURR OPIN CELL BIOL, V17, P610, DOI 10.1016/j.ceb.2005.09.010; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Rodriguez-Gabriel MA, 2006, MOL CELL BIOL, V26, P6347, DOI 10.1128/MCB.00286-06; Saklatvala J, 1996, PHILOS T ROY SOC B, V351, P151, DOI 10.1098/rstb.1996.0011; SECRIST JP, 1991, J BIOL CHEM, V266, P12135; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yamashita A, 2005, BBA-PROTEINS PROTEOM, V1754, P305, DOI 10.1016/j.bbapap.2005.10.002	28	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13174	13184		10.1074/jbc.M708008200	http://dx.doi.org/10.1074/jbc.M708008200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326048	Green Published, hybrid			2022-12-25	WOS:000255499800057
J	Sansom, FM; Riedmaier, P; Newton, HJ; Dunstone, MA; Muller, CE; Stephan, H; Byres, E; Beddoe, T; Rossjohn, J; Cowan, PJ; d'Apice, AJF; Robson, SC; Hartland, EL				Sansom, Fiona M.; Riedmaier, Patrice; Newton, Hayley J.; Dunstone, Michelle A.; Mueller, Christa E.; Stephan, Holger; Byres, Emma; Beddoe, Travis; Rossjohn, Jamie; Cowan, Peter J.; d'Apice, Anthony J. F.; Robson, Simon C.; Hartland, Elizabeth L.			Enzymatic properties of an ecto-nucleoside triphosphate diphosphohydrolase from Legionella pneumophila - Substrate specificity and requirement for virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; E-TYPE ATPASES; ATP-DIPHOSPHOHYDROLASE; SCHISTOSOMA-MANSONI; INTRACELLULAR MULTIPLICATION; BIOCHEMICAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; LEISHMANIA-AMAZONENSIS; ENDOPLASMIC-RETICULUM; TOXOPLASMA-GONDII	Legionella pneumophila is the predominant cause of Legionnaires disease, a severe and potentially fatal form of pneumonia. Recently, we identified an ecto-nucleoside triphosphate diphosphohydrolase ( NTPDase) from L. pneumophila, termed Lpg1905, which enhances intracellular replication of L. pneumophila in eukaryotic cells. Lpg1905 is the first prokaryotic member of the CD39/NTPDase1 family of enzymes, which are characterized by the presence of five apyrase conserved regions and the ability to hydrolyze nucleoside tri- and diphosphates. Here we examined the substrate specificity of Lpg1905 and showed that apart from ATP and ADP, the enzyme catalyzed the hydrolysis of GTP and GDP but had limited activity against CTP, CDP, UTP, and UDP. Based on amino acid residues conserved in the apyrase conserved regions of eukaryotic NTPDases, we generated five site-directed mutants, Lpg1905E159A, R122A, N168A, Q193A, and W384A. Although the mutations E159A, R122A, Q193A, and W384A abrogated activity completely, N168A resulted in decreased activity caused by reduced affinity for nucleotides. When introduced into the lpg1905 mutant strain of L. pneumophila, only N168A partially restored the ability of L. pneumophila to replicate in THP-1 macrophages. Following intratracheal inoculation of A/J mice, none of the Lpg1905 mutants was able to restore virulence to an lpg1905 mutant during lung infection, thereby demonstrating the importance of NTPDase activity to L. pneumophila infection. Overall, the kinetic studies undertaken here demonstrated important differences to mammalian NTPDases and different sensitivities to NTPDase inhibitors that may reflect underlying structural variations.	[Sansom, Fiona M.; Newton, Hayley J.; Hartland, Elizabeth L.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Cowan, Peter J.; d'Apice, Anthony J. F.] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia; [Sansom, Fiona M.; Riedmaier, Patrice; Newton, Hayley J.; Dunstone, Michelle A.; Hartland, Elizabeth L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Dunstone, Michelle A.; Byres, Emma; Beddoe, Travis; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Mueller, Christa E.] Univ Bonn, Inst Pharmacol, D-53121 Bonn, Germany; [Stephan, Holger] Res Ctr Dresden Rossendorf, Inst Radiopharm, D-01314 Dresden, Germany; [d'Apice, Anthony J. F.] St Vincents Hosp, Immunol Res Ctr, Fitzroy, Vic 3065, Australia; [Robson, Simon C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	University of Melbourne; University of Melbourne; Monash University; Monash University; University of Bonn; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); St Vincent's Hospital Melbourne; Harvard University; Beth Israel Deaconess Medical Center	Hartland, EL (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	hartland@unimelb.edu.au	Sansom, Fiona M/W-8445-2019; Cowan, Peter J/B-8730-2013; Beddoe, Travis/F-3415-2014; Rossjohn, Jamie/F-9032-2013; Robson, Simon C./AAA-8537-2021; Cowan, Peter/AAH-7218-2020; Müller, Christa Elisabeth/C-7748-2014; Stephan, Holger/F-9789-2014; Hartland, Elizabeth/O-2569-2014; Dunstone, Michelle/I-2895-2014	Cowan, Peter J/0000-0001-9016-4954; Beddoe, Travis/0000-0003-4550-2277; Rossjohn, Jamie/0000-0002-2020-7522; Müller, Christa Elisabeth/0000-0002-0013-6624; Stephan, Holger/0000-0002-2972-2803; Hartland, Elizabeth/0000-0003-4254-2863; Newton, Hayley/0000-0002-9240-2001; Sansom, Fiona/0000-0002-9433-2545; Dunstone, Michelle/0000-0002-6026-648X	NHLBI NIH HHS [HL63972, HL57307, HL076540] Funding Source: Medline; NIAID NIH HHS [U01 AI066331-01, U01 AI066331-02, U01 AI066331] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076540, R01HL057307, R01HL063972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066331] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASAI T, 1983, J BIOL CHEM, V258, P6816; Asai T, 1998, EXP PARASITOL, V90, P277, DOI 10.1006/expr.1998.4346; ASAI T, 1995, J BIOL CHEM, V270, P11391, DOI 10.1074/jbc.270.19.11391; ASAI T, 1987, ZBL BAKT-INT J MED M, V264, P464; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; BERMUDES D, 1994, J BIOL CHEM, V269, P29252; Berredo-Pinho M, 2001, ARCH BIOCHEM BIOPHYS, V391, P16, DOI 10.1006/abbi.2001.2384; Bokko PB, 2007, MOL BIOL CELL, V18, P1874, DOI 10.1091/mbc.E06-09-0881; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; BRIELAND J, 1994, AM J PATHOL, V145, P1537; Bruggemann H, 2006, CURR OPIN MICROBIOL, V9, P86, DOI 10.1016/j.mib.2005.12.009; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Cambronne ED, 2006, TRAFFIC, V7, P929, DOI 10.1111/j.1600-0854.2006.00446.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen DQ, 2006, MICROBIOL RES, V161, P246, DOI 10.1016/j.micres.2005.09.001; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; de Jesus JB, 2002, Z NATURFORSCH C, V57, P890; Leite MDS, 2007, EXP PARASITOL, V115, P315, DOI 10.1016/j.exppara.2006.09.002; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; DeMarco R, 2003, BIOCHEM BIOPH RES CO, V307, P831, DOI 10.1016/S0006-291X(03)01268-3; Drosopoulos JHF, 2000, BIOCHEMISTRY-US, V39, P6936, DOI 10.1021/bi992581e; Drosopoulos JHF, 2002, ARCH BIOCHEM BIOPHYS, V406, P85, DOI 10.1016/S0003-9861(02)00414-9; ENGLEBERG NC, 1984, INFECT IMMUN, V44, P222, DOI 10.1128/IAI.44.2.222-227.1984; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Esch JSA, 1999, BIOCHEMISTRY-US, V38, P2248, DOI 10.1021/bi982426k; Fairbairn IP, 2001, J IMMUNOL, V167, P3300, DOI 10.4049/jimmunol.167.6.3300; Faria-Pinto P, 2004, PARASITOLOGY, V129, P51, DOI 10.1017/S0031182004005244; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; Ferrari D, 1997, J IMMUNOL, V159, P1451; Fietto JLR, 2004, BIOCHEM BIOPH RES CO, V316, P454, DOI 10.1016/j.bbrc.2004.02.071; Fonseca FV, 2006, EXP PARASITOL, V112, P76, DOI 10.1016/j.exppara.2005.09.005; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Grinthal A, 2000, BIOCHEMISTRY-US, V39, P9, DOI 10.1021/bi991751k; Handa M, 1996, BIOCHEM BIOPH RES CO, V218, P916, DOI 10.1006/bbrc.1996.0162; Hardy CL, 2003, AM J RESP CRIT CARE, V167, P1393, DOI 10.1164/rccm.200209-1002OC; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Jesus JB, 2002, VET PARASITOL, V103, P29, DOI 10.1016/S0304-4017(01)00576-3; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kelly M, 2006, INFECT IMMUN, V74, P2328, DOI 10.1128/IAI.74.4.2328-2337.2006; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kirley TL, 2001, ARCH BIOCHEM BIOPHYS, V395, P94, DOI 10.1006/abbi.2001.2570; Knowles AF, 2006, BIOCHEMISTRY-US, V45, P7323, DOI 10.1021/bi052268e; Kusner DJ, 2001, J IMMUNOL, V167, P3308, DOI 10.4049/jimmunol.167.6.3308; Langston HP, 2003, J IMMUNOL, V170, P2962, DOI 10.4049/jimmunol.170.6.2962; Levano-Garcia J, 2007, BIOCHEM BIOPH RES CO, V352, P384, DOI 10.1016/j.bbrc.2006.11.023; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Matos JAD, 2001, INT J PARASITOL, V31, P770, DOI 10.1016/S0020-7519(01)00191-6; Menze MA, 2005, AM J PHYSIOL-REG I, V288, pR501, DOI 10.1152/ajpregu.00490.2004; Meyer-Fernandes JR, 2004, PARASITOL RES, V93, P567, DOI 10.1007/s00436-003-1066-4; MeyerFernandes JR, 1997, ARCH BIOCHEM BIOPHYS, V341, P40, DOI 10.1006/abbi.1997.9933; Muller CE, 2006, BIOORG MED CHEM LETT, V16, P5943, DOI 10.1016/j.bmcl.2006.09.003; Mundy R, 2003, MOL MICROBIOL, V48, P795, DOI 10.1046/j.1365-2958.2003.03470.x; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Newton HJ, 2007, INFECT IMMUN, V75, P5575, DOI 10.1128/IAI.00443-07; Newton HJ, 2006, INFECT IMMUN, V74, P1683, DOI 10.1128/IAI.74.3.1683-1691.2006; Penido MLO, 2007, EUR J PHARMACOL, V570, P10, DOI 10.1016/j.ejphar.2007.05.028; PINE L, 1986, J CLIN MICROBIOL, V23, P163, DOI 10.1128/JCM.23.1.163-169.1986; Pinheiro CM, 2006, EXP PARASITOL, V114, P16, DOI 10.1016/j.exppara.2006.02.007; Robinson CG, 2006, CELL MICROBIOL, V8, P793, DOI 10.1111/j.1462-5822.2005.00666.x; Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Rossier O, 2004, INFECT IMMUN, V72, P310, DOI 10.1128/IAI.72.1.310-321.2004; Sansom FM, 2007, CELL MICROBIOL, V9, P1922, DOI 10.1111/j.1462-5822.2007.00924.x; Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x; Segal G, 1998, MOL MICROBIOL, V30, P197, DOI 10.1046/j.1365-2958.1998.01054.x; Smith TM, 1999, BIOCHEMISTRY-US, V38, P5849, DOI 10.1021/bi990171k; Smith TM, 1999, BIOCHEMISTRY-US, V38, P321, DOI 10.1021/bi9820457; Stroppolo ME, 2001, CELL MOL LIFE SCI, V58, P1451, DOI 10.1007/PL00000788; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tasca T, 2005, PARASITOLOGY, V131, P71, DOI 10.1017/S0031182005007377; Torres CR, 1998, EUR J BIOCHEM, V251, P516, DOI 10.1046/j.1432-1327.1998.2510516.x; Vasconcelos EG, 1996, J BIOL CHEM, V271, P22139, DOI 10.1074/jbc.271.36.22139; VASCONCELOS EG, 1993, MOL BIOCHEM PARASIT, V58, P205, DOI 10.1016/0166-6851(93)90042-V; Yang F, 2001, BIOCHEMISTRY-US, V40, P3943, DOI 10.1021/bi002711f; Yilmaz O, 2008, CELL MICROBIOL, V10, P863, DOI 10.1111/j.1462-5822.2007.01089.x; Zimmermann H, 2001, DRUG DEVELOP RES, V52, P44, DOI 10.1002/ddr.1097	81	48	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12909	12918		10.1074/jbc.M801006200	http://dx.doi.org/10.1074/jbc.M801006200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337253	Green Published, hybrid			2022-12-25	WOS:000255499800027
J	Wainszelbaum, MJ; Charron, AJ; Kong, C; Kirkpatrick, DS; Srikanth, P; Barbieri, MA; Gygi, SP; Stahl, PD				Wainszelbaum, Marisa J.; Charron, Audra J.; Kong, Chen; Kirkpatrick, Donald S.; Srikanth, Priya; Barbieri, M. Alejandro; Gygi, Steven P.; Stahl, Philip D.			The hominoid-specific oncogene TBC1D3 activates ras and modulates epidermal growth factor receptor signaling and trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASES; LUNG-CANCER; ENDOCYTOSIS; PROTEIN; UBIQUITINATION; UBIQUITYLATION; TRANSDUCTION; MUTATIONS; DOMAIN; RAB5	Hominoid- and human-specific genes may have evolved to modulate signaling pathways of a higher order of complexity. TBC1D3 is a hominoid-specific oncogene encoded by a cluster of eight paralogs on chromosome 17. Initial work indicates that TBC1D3 is widely expressed in human tissues (Hodzic, D., Kong, C., Wainszelbaum, M. J., Charron, A. J., Su, X., and Stahl, P. D. ( 2006) Genomics 88, 731-736). In this study, we show that TBC1D3 expression has a powerful effect on cell proliferation that is further enhanced by epidermal growth factor (EGF) in both human and mouse cell lines. EGF activation of the Erk and protein kinase B/Akt pathways is enhanced, both in amplitude and duration, by TBC1D3 expression, whereas RNA interference silencing of TBC1D3 suppresses the activation. Light microscopy and Western blot experiments demonstrate that increased signaling in response to EGF is coupled with a significant delay in EGF receptor (EGFR) trafficking and degradation, which significantly extends the life span of EGFR. Moreover, TBC1D3 suppresses polyubiquitination of the EGFR and the recruitment of c-Cbl. Using the Ras binding domain of Raf1 to monitor GTP-Ras we show that TBC1D3 expression enhances Ras activation in quiescent cells, which is further increased by EGF treatment. We speculate that TBC1D3 may alter Ras GTP loading. We conclude that the expression of TBC1D3 generates a delay in EGFR degradation, a decrease in ubiquitination, and a failure to recruit adapter proteins that ultimately dysregulate EGFR signal transduction and enhance cell proliferation. Altered growth factor receptor trafficking and GTP-Ras turnover may be sites where recently evolved genes such as TBC1D3 selectively modulate signaling in hominoids and humans.	[Wainszelbaum, Marisa J.; Charron, Audra J.; Kong, Chen; Srikanth, Priya; Barbieri, M. Alejandro; Stahl, Philip D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Kirkpatrick, Donald S.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Washington University (WUSTL); Harvard University; Harvard Medical School	Stahl, PD (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid, St Louis, MO 63110 USA.	pstahl@wustl.edu	Stahl, Philip/D-6315-2012; Barbieri, Marco/J-2597-2014	Kirkpatrick, Donald/0000-0003-3091-2804; Srikanth, Priya/0000-0002-9669-0434	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042259, R01GM067945] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM67945, R01 GM42259] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alwan HAJ, 2007, J BIOL CHEM, V282, P1658, DOI 10.1074/jbc.M604711200; Bizimungu C, 2007, BIOTECHNOL LETT, V29, P1927, DOI 10.1007/s10529-007-9475-6; BOS JL, 1989, CANCER RES, V49, P4682; CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Crosetto N, 2005, FEBS LETT, V579, P3231, DOI 10.1016/j.febslet.2005.03.029; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; FRITTOLI E, 2008, MOL BIOL CELL   0116; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hodzic D, 2006, GENOMICS, V88, P731, DOI 10.1016/j.ygeno.2006.05.009; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Martinu L, 2004, MOL CELL BIOL, V24, P9752, DOI 10.1128/MCB.24.22.9752-9762.2004; Martinu L, 2002, J BIOL CHEM, V277, P50996, DOI 10.1074/jbc.M204869200; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Naviglio S, 1998, EMBO J, V17, P3241, DOI 10.1093/emboj/17.12.3241; Oved S, 2006, J BIOL CHEM, V281, P21640, DOI 10.1074/jbc.M513034200; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pei L, 2002, CANCER RES, V62, P5420; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; SORKIN A, 1991, J BIOL CHEM, V266, P8355; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	37	40	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13233	13242		10.1074/jbc.M800234200	http://dx.doi.org/10.1074/jbc.M800234200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18319245	Green Published, hybrid			2022-12-25	WOS:000255499800063
J	Buffone, MG; Zhuang, T; Ord, TS; Hui, L; Moss, SB; Gerton, GL				Buffone, Mariano G.; Zhuang, Tiangang; Ord, Teri S.; Hui, Ling; Moss, Stuart B.; Gerton, George L.			Recombinant mouse sperm ZP3-binding protein (ZP3R/sp56) forms a high order oligomer that binds eggs and inhibits mouse fertilization in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZONA-PELLUCIDA GLYCOPROTEIN; ACROSOME REACTION; DIFFERENTIAL RELEASE; EXTRACELLULAR-MATRIX; AMINO-ACIDS; SP56; SPERMATOZOA; COMPLEMENT; ACTIVATION; EXOCYTOSIS	Many candidates have been proposed as zona pellucida-binding proteins. Without precluding a role for any of those candidates, we focused on mouse sperm protein ZP3R/sp56, which is localized in the acrosomal matrix. The objective of this study was to analyze the role of ZP3R/sp56 in mouse fertilization. We expressed recombinant ZP3R/sp56 as a secreted protein in HEK293 cells and purified it from serum-free, conditioned medium. In the presence of reducing agents, the recombinant ZP3R/sp56 exhibited a molecular weight similar to that observed for the native ZP3R/sp56. Reminiscent of the native protein, recombinant ZP3R/sp56 formed a high molecular weight, disulfide cross-linked oligomer consisting of six or more monomers under non-reducing conditions. Recombinant ZP3R/sp56 bound to the zona pellucida of unfertilized eggs but not to 2-cell embryos, indicating that the changes that take place in the zona pellucida at fertilization affected the interaction of this protein with the zona pellucida. The extent of in vitro fertilization was reduced in a dose-dependent manner when unfertilized eggs were preincubated with recombinant ZP3R/sp56 (74% drop at the maximum concentrations assayed). Eggs incubated with the recombinant protein showed an absence of or very few sperm in the perivitelline space, suggesting that the reduction in the fertilization rate is caused by the inhibition of sperm binding and/or penetration through the zona pellucida. These results indicate that sperm ZP3R/sp56 is important for sperm-zona interactions during fertilization and support the concept that the acrosomal matrix plays an essential role in mediating the binding of sperm to the zona pellucida.	[Buffone, Mariano G.; Zhuang, Tiangang; Ord, Teri S.; Hui, Ling; Moss, Stuart B.; Gerton, George L.] Univ Penn, Sch Med, Dept Obstet & Gynecol, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Gerton, GL (corresponding author), Univ Penn, Sch Med, Dept Obstet & Gynecol, Ctr Res Reprod & Womens Hlth, 421 Curie Blvd,1311 BRB 2-3, Philadelphia, PA 19104 USA.	gerton@mail.med.upenn.edu	Gerton, George L/A-1039-2007	Gerton, George L/0000-0001-9894-5640	FIC NIH HHS [5D43TW000671] Funding Source: Medline; NICHD NIH HHS [HD-41552] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041552] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000671] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		BABA T, 1994, J BIOL CHEM, V269, P31845; Baibakov B, 2007, DEVELOPMENT, V134, P933, DOI 10.1242/dev.02752; BLEIL JD, 1990, P NATL ACAD SCI USA, V87, P5563, DOI 10.1073/pnas.87.14.5563; BLEIL JD, 1981, DEV BIOL, V86, P189, DOI 10.1016/0012-1606(81)90329-8; BLEIL JD, 1988, P NATL ACAD SCI USA, V85, P6778, DOI 10.1073/pnas.85.18.6778; BLEIL JD, 1983, DEV BIOL, V95, P317, DOI 10.1016/0012-1606(83)90032-5; Blom AM, 2002, BIOCHEM SOC T, V30, P978, DOI 10.1042/bst0300978; Blom AM, 1999, J BIOL CHEM, V274, P19237, DOI 10.1074/jbc.274.27.19237; BOOKBINDER LH, 1995, SCIENCE, V269, P86, DOI 10.1126/science.7604284; BRADEN AWH, 1954, AUST J BIOL SCI, V7, P391, DOI 10.1071/BI9540391; Chemes HE, 2003, HUM REPROD UPDATE, V9, P405, DOI 10.1093/humupd/dmg034; CHENG A, 1994, J CELL BIOL, V125, P867, DOI 10.1083/jcb.125.4.867; Cohen N, 2001, INT J DEV BIOL, V45, P569; Dam AHDM, 2007, HUM REPROD UPDATE, V13, P63, DOI 10.1093/humupd/dml047; Ducibella T, 1996, HUM REPROD UPDATE, V2, P29, DOI 10.1093/humupd/2.1.29; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Foster JA, 1997, J BIOL CHEM, V272, P12714, DOI 10.1074/jbc.272.19.12714; Gao Z, 1998, J BIOL CHEM, V273, P3415, DOI 10.1074/jbc.273.6.3415; Gerton G L., 2002, FERTILIZATION, P265; Kim KS, 2003, DEV BIOL, V264, P141, DOI 10.1016/j.ydbio.2003.08.006; Kim KS, 2001, BIOL REPROD, V64, P148, DOI 10.1095/biolreprod64.1.148; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE MA, 1986, BIOL REPROD, V34, P349, DOI 10.1095/biolreprod34.2.349; Lu QX, 1997, DEVELOPMENT, V124, P4121; MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0; MILLER DJ, 1993, DEVELOPMENT, V118, P1279; Murayama Yoshinobu, 2006, Hum Cell, V19, P119, DOI 10.1111/j.1749-0774.2006.00019.x; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Nixon B, 2001, CELLS TISSUES ORGANS, V168, P46, DOI 10.1159/000016805; PERKINS SJ, 1986, BIOCHEM J, V233, P799, DOI 10.1042/bj2330799; Rockwell PL, 2000, MOL REPROD DEV, V55, P335, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;335::AID-MRD12&gt;3.0.CO;2-5; Rodriguez-Martinez H, 1998, REPROD FERT DEVELOP, V10, P491, DOI 10.1071/RD98111; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHILL WB, 1991, HUM REPROD, V6, P969, DOI 10.1093/oxfordjournals.humrep.a137471; SCHROEDER AC, 1990, BIOL REPROD, V43, P891, DOI 10.1095/biolreprod43.5.891; SOTOMAYOR RE, 1986, BIOL REPROD, V34, P171, DOI 10.1095/biolreprod34.1.171; Summers MC, 2000, HUM REPROD, V15, P1791, DOI 10.1093/humrep/15.8.1791; Tang N, 2004, MASS SPECTROM REV, V23, P34, DOI 10.1002/mas.10066; Tanphaichitr N, 2007, FRONT BIOSCI-LANDMRK, V12, P1748, DOI 10.2741/2186; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; WARD CR, 1994, J BIOL CHEM, V269, P13254; WARD CR, 1992, J BIOL CHEM, V267, P14061; WHITTEN WK, 1968, J REPROD FERTIL, V17, P399, DOI 10.1530/jrf.0.0170399; Williams SA, 2007, J CELL SCI, V120, P1341, DOI 10.1242/jcs.004291; YANAGIMACHI R, 1979, FERTIL STERIL, V31, P562; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	48	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12438	12445		10.1074/jbc.M706421200	http://dx.doi.org/10.1074/jbc.M706421200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18316377	hybrid, Green Published			2022-12-25	WOS:000255340000060
J	Jacquet, S; Nishino, Y; Kumphune, S; Sicard, P; Clark, JE; Kobayashi, KS; Flavell, RA; Eickhoff, J; Cotten, M; Marber, MS				Jacquet, Sebastien; Nishino, Yasuhiro; Kumphune, Sarawut; Sicard, Pierre; Clark, James E.; Kobayashi, Koichi S.; Flavell, Richard A.; Eickhoff, Jan; Cotten, Matt; Marber, Michael S.			The role of RIP2 in p38 MAPK activation in the stressed heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE ACTIVATION; INDEPENDENT ACTIVATION; SIMULATED ISCHEMIA; INHIBITION; P38-ALPHA; MECHANISMS; PATHWAY; BINDING; AUTOPHOSPHORYLATION; EXPRESSION	The activation of p38 MAPK by dual phosphorylation aggravates myocardial ischemic injury and depresses cardiac contractile function. SB203580, an ATP-competitive inhibitor of p38 MAPK and other kinases, prevents this dual phosphorylation during ischemia. Studies in non-cardiac tissue have shown receptor-interacting protein 2 (RIP2) lies upstream of p38 MAPK, is SB203580-sensitive and ischemia-responsive, and aggravates ischemic injury. We therefore examined the RIP2-p38 MAPK signaling axis in the heart. Adenovirus-driven expression of wild-type RIP2 in adult rat ventricular myocytes caused robust, SB203580-sensitive dual phosphorylation of p38 MAPK associated with activation of p38 MAPK kinases MKK3, MKK4, and MKK6. The effect of SB203580 was recapitulated by unrelated inhibitors of RIP2 or the downstream MAPK kinase kinase, TAK1. However, overexpression of wild-type, kinase-dead, caspase recruitment domain-deleted, or kinase-dead and caspase recruitment domain-deleted forms of RIP2 had no effect on the activating dual phosphorylation of p38 MAPK during simulated ischemia. Similarly, p38 MAPK activation and myocardial infarction size in response to true ischemia did not differ between hearts from wild-type and RIP2 null mice. However, both p38 MAPK activation and the contractile depression caused by the endotoxin component muramyl dipeptide were attenuated by SB203580 and in RIP2 null hearts. Although RIP2 can cause myocardial p38 MAPK dual phosphorylation in the heart under some circumstances, it is not responsible for the SB203580-sensitive pattern of activation during ischemia.	[Jacquet, Sebastien; Nishino, Yasuhiro; Kumphune, Sarawut; Sicard, Pierre; Clark, James E.; Marber, Michael S.] Kings Coll London, Rayne Inst, St Thomas Hosp, Div Cardiovasc, London SE1 7EH, England; [Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06520 USA; [Eickhoff, Jan] GBC Biotech, D-82152 Munich, Germany; [Cotten, Matt] MRC Labs, Banjul, Gambia	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Yale University; MRC Laboratory Molecular Biology	Marber, MS (corresponding author), Kings Coll London, Rayne Inst, St Thomas Hosp, Div Cardiovasc, London SE1 7EH, England.	mike.marber@kcl.ac.uk	Sicard, Pierre/N-7310-2018; Sicard, Pierre/B-1637-2010; marber, michael/AAW-7916-2021; Clark, James/H-7786-2019; Kumphune, Sarawut/AAH-9060-2019; KUMPHUNE, SARAWUT/AAA-9278-2021	Sicard, Pierre/0000-0001-5837-3916; Sicard, Pierre/0000-0001-8100-9792; KUMPHUNE, SARAWUT/0000-0003-4940-7103; Cotten, Matthew/0000-0002-3361-3351; Marber, Michael/0000-0002-3463-7128; Clark, James/0000-0001-7574-2162; Kobayashi, Koichi/0000-0003-2930-0114	British Heart Foundation [07/073/23432] Funding Source: Medline; NIDDK NIH HHS [R01 DK074738, R01 DK074738-05] Funding Source: Medline; Wellcome Trust [074653] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074738] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleshin A, 2004, EUR J CARDIO-THORAC, V26, P974, DOI 10.1016/j.ejcts.2004.06.021; Argast GM, 2005, MOL CELL BIOCHEM, V268, P129, DOI 10.1007/s11010-005-3701-0; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Bellahcene M, 2006, J AM COLL CARDIOL, V48, P545, DOI 10.1016/j.jacc.2006.02.072; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Capano M, 2006, BIOCHEM J, V395, P57, DOI 10.1042/BJ20051654; Clanachan AS, 2003, TRANSPLANTATION, V75, P173, DOI 10.1097/01.TP.0000040429.40245.3A; Clark JE, 2007, PHARMACOL THERAPEUT, V116, P192, DOI 10.1016/j.pharmthera.2007.06.013; Dorsch M, 2006, CELL SIGNAL, V18, P2223, DOI 10.1016/j.cellsig.2006.05.005; Eickhoff J, 2004, J BIOL CHEM, V279, P9642, DOI 10.1074/jbc.M312893200; Fiedler B, 2006, J BIOL CHEM, V281, P32831, DOI 10.1074/jbc.M603416200; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Ge BX, 2003, J BIOL CHEM, V278, P2286, DOI 10.1074/jbc.M210918200; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Gorog DA, 2004, CARDIOVASC RES, V61, P123, DOI 10.1016/j.cardiores.2003.09.034; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; House SL, 2005, AM J PHYSIOL-HEART C, V289, pH2167, DOI 10.1152/ajpheart.00392.2005; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Iwanaga Y, 2003, INFLAMM RES, V52, P272, DOI 10.1007/s00011-003-1170-z; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kang YJ, 2006, J BIOL CHEM, V281, P26225, DOI 10.1074/jbc.M606800200; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lau JMC, 2007, MOL CELL BIOL, V27, P1455, DOI 10.1128/MCB.01369-06; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Lu CF, 2005, J BIOL CHEM, V280, P16278, DOI 10.1074/jbc.M410114200; Marber MS, 2000, CIRC RES, V86, P926, DOI 10.1161/01.RES.86.9.926; Maulik N, 1998, AM J PHYSIOL-HEART C, V275, pH1857, DOI 10.1152/ajpheart.1998.275.5.H1857; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; MURCH O, 2008, IN PRESS SHOCK; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Punn A, 2000, BIOCHEM J, V350, P891, DOI 10.1042/0264-6021:3500891; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tanno M, 2003, CIRC RES, V93, P254, DOI 10.1161/01.RES.0000083490.43943.85; Vahebi S, 2007, CIRC RES, V100, P408, DOI 10.1161/01.RES.0000258116.60404.ad; Wang MJ, 2005, ANN THORAC SURG, V80, P2235, DOI 10.1016/j.athoracsur.2005.05.070; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wilson KP, 1996, J BIOL CHEM, V271, P27696, DOI 10.1074/jbc.271.44.27696; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Yada M, 2004, J THORAC CARDIOV SUR, V128, P588, DOI 10.1016/j.jtcvs.2004.02.007; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Zhang JY, 2007, TRENDS PHARMACOL SCI, V28, P286, DOI 10.1016/j.tips.2007.04.008; Zhang WH, 2003, P NATL ACAD SCI USA, V100, P16012, DOI 10.1073/pnas.2534856100	44	28	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11964	11971		10.1074/jbc.M707750200	http://dx.doi.org/10.1074/jbc.M707750200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18310079	Green Published, hybrid			2022-12-25	WOS:000255340000012
J	Nyman, T; Stenmark, P; Flodin, S; Johansson, I; Hammarstrom, M; Nordlund, P				Nyman, Tomas; Stenmark, Pal; Flodin, Susanne; Johansson, Ida; Hammarstroem, Martin; Nordlund, Paer			The crystal structure of the human Toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; TIR-DOMAIN; ADAPTER PROTEIN; BB LOOPS; MYD88; FAMILY; GENE; TRANSDUCTION; DIMERIZATION; INHIBITION	The Toll/interleukin-1 receptor (TIR) domain is a highly conserved signaling domain found in the intracellular regions of Toll-like receptors (TLRs), in interleukin-1 receptors, and in several cytoplasmic adaptor proteins. TIR domains mediate receptor signal transduction through recruitment of adaptor proteins and play critical roles in the innate immune response and inflammation. This work presents the 2.2 angstrom crystal structure of the TIR domain of human TLR10, revealing a symmetric dimer in the asymmetric unit. The dimer interaction surface contains residues from the BB-loop, DD- loop, and alpha C-helix, which have previously been identified as important structural motifs for signaling in homologous TLR receptors. The interaction surface is extensive, containing a central hydrophobic patch surrounded by polar residues. The BB-loop forms a tight interaction, where a range of consecutive residues binds in a pocket formed by the reciprocal BB-loop and alpha C-helix. This pocket appears to be well suited for binding peptide substrates, which is consistent with the notion that peptides and peptide mimetics of the BB-loop are inhibitors for TLR signaling. The TLR10 structure is in good agreement with available biochemical data on TLR receptors and is likely to provide a good model for the physiological dimer.	[Nyman, Tomas; Stenmark, Pal; Flodin, Susanne; Johansson, Ida; Hammarstroem, Martin; Nordlund, Paer] Karolinska Inst, Struct Genom Consortium, S-17177 Stockholm, Sweden; [Nordlund, Paer] Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Nordlund, P (corresponding author), Nobels Vag 5, S-17177 Stockholm, Sweden.	par.nordlund@ki.se		Stenmark, Pal/0000-0003-4777-3417				Bartfai T, 2003, P NATL ACAD SCI USA, V100, P7971, DOI 10.1073/pnas.0932746100; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Heine H, 2003, INT ARCH ALLERGY IMM, V130, P180, DOI 10.1159/000069517; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MEDZHITOV R, 1997, NATURE, V388, P397; MIGUEL RN, 2008, PLOS 1, V2, pE788; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ronni T, 2003, MOL CELL BIOL, V23, P2543, DOI 10.1128/MCB.23.7.2543-2555.2003; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Takeuchi O, 2000, INT IMMUNOL, V12, P113, DOI 10.1093/intimm/12.1.113; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Toshchakov VY, 2007, J IMMUNOL, V178, P2655, DOI 10.4049/jimmunol.178.5.2655; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	33	158	163	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11861	11865		10.1074/jbc.C800001200	http://dx.doi.org/10.1074/jbc.C800001200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18332149	hybrid			2022-12-25	WOS:000255340000001
J	Liu, CC; Lee, SC; Butler, M; Wu, SC				Liu, Chia-Chyi; Lee, Shiang-Chi; Butler, Michael; Wu, Suh-Chin			High Genetic Stability of Dengue Virus Propagated in MRC-5 Cells as Compared to the Virus Propagated in Vero Cells	PLOS ONE			English	Article								This work investigated the replication kinetics of the four dengue virus serotypes (DEN-1 to DEN-4), including dengue virus type 4 (DEN-4) recovered from an infectious cDNA clone, in Vero cells and in MRC-5 cells grown on Cytodex 1 microcarriers. DEN-1 strain Hawaii, DEN-2 strain NGC, DEN-3 strain H-87, and DEN-4 strain H-241, and DEN-4 strain 814669 derived from cloned DNA, were used to infect Vero cells and MRC-5 cells grown in serum-free or serum-containing microcarrier cultures. Serum-free and serum-containing cultures were found to yield comparable titers of these viruses. The cloned DNA-derived DEN-4 started genetically more homogeneous was used to investigate the genetic stability of the virus propagated in Vero cells and MRC-5 cells. Sequence analysis revealed that the DEN-4 propagated in MRC-5 cells maintained a high genetic stability, compared to the virus propagated in Vero cells. Amino acid substitutions of Gly(104)Cys and Phe(108)Ile were detected at 70%, 60%, respectively, in the envelope (E) protein of DEN-4 propagated in Vero cells, whereas a single mutation of Glu(345)Lys was detected at 50% in E of the virus propagated in MRC-5 cells. Sequencing of multiple clones of three separate DNA fragments spanning 40% of the genome also indicated that DEN-4 propagated in Vero cells contained a higher number of mutations than the virus growing in MRC-5 cells. Although Vero cells yielded a peak virus titer approximately 1 to 17 folds higher than MRC-5 cells, cloned DEN-4 from MRC-5 cells maintained a greater stability than the virus from Vero cells. Serum-free microcarrier cultures of MRC-5 cells offer a potentially valuable system for the large-scale production of live-attenuated DEN vaccines.	[Liu, Chia-Chyi; Lee, Shiang-Chi; Wu, Suh-Chin] Natl Tsing Hua Univ, Dept Life Sci, Inst Biotechnol, Hsinchu, Taiwan; [Butler, Michael] Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada	National Tsing Hua University; University of Manitoba	Liu, CC (corresponding author), Natl Tsing Hua Univ, Dept Life Sci, Inst Biotechnol, Hsinchu, Taiwan.	scwu@life.nthu.edu.tw	Wu, Suh-Chin/AAV-6233-2021; Butler, Michael/I-8167-2012; Liu, Chia-Chyi/A-8215-2012	Butler, Michael/0000-0002-4907-3652; Liu, Chia-Chyi/0000-0002-6257-0389	National Health Research Institutes [NHRI-EX95-9534SI]; National Science Council, Taiwan [NSC94-2214-E-007-014, NSC95-2311-B-007-024-MY3]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Health Research Institutes (NHRI-EX95-9534SI) and the National Science Council (NSC94-2214-E-007-014; NSC95-2311-B-007-024-MY3), Taiwan.	Aunins JG, 2000, ENCY CELL TECHNOLOGY, V2, P1182; Bhamarapravati N, 2000, VACCINE, V18, P44, DOI 10.1016/S0264-410X(00)00040-2; Blaney JE, 2002, VIROLOGY, V300, P125, DOI 10.1006/viro.2002.1528; Blaney JE, 2003, VACCINE, V21, P4317, DOI 10.1016/S0264-410X(03)00487-0; Butler M, 2000, BIOTECHNOL PROGR, V16, P854, DOI 10.1021/bp000110+; Chao DY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-72; Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405; Edelman R, 2003, AM J TROP MED HYG, V69, P48, DOI 10.4269/ajtmh.2003.69.48; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000; Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004; Guirakhoo F, 2002, VIROLOGY, V298, P146, DOI 10.1006/viro.2002.1462; Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Huang CYH, 2003, J VIROL, V77, P11436, DOI 10.1128/JVI.77.21.11436-11447.2003; Kanesa-Thasan N, 2003, AM J TROP MED HYG, V69, P17, DOI 10.4269/ajtmh.2003.69.17; KAWANO H, 1993, J VIROL, V67, P6567, DOI 10.1128/JVI.67.11.6567-6575.1993; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Lai CJ, 1998, CLIN DIAGN VIROL, V10, P173, DOI 10.1016/S0928-0197(98)00035-X; LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139; Liu CC, 2004, BIOTECHNOL BIOENG, V85, P482, DOI 10.1002/bit.10918; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Sabchareon A, 2004, PEDIATR INFECT DIS J, V23, P99, DOI 10.1097/01.inf.0000109289.55856.27; Sabchareon A, 2002, AM J TROP MED HYG, V66, P264, DOI 10.4269/ajtmh.2002.66.264; Stinchcomb DT, 2007, 3 AS REG DENG RES NE; Sun W, 2003, AM J TROP MED HYG, V69, P24; Tang WF, 2005, MICROBIOL IMMUNOL, V49, P285, DOI 10.1111/j.1348-0421.2005.tb03719.x; Wang WK, 2002, J VIROL, V76, P4662, DOI 10.1128/JVI.76.9.4662-4665.2002; Whitehead SS, 2003, VACCINE, V21, P4307, DOI 10.1016/S0264-410X(03)00488-2; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Wu SC, 2002, BIOTECHNOL PROGR, V18, P124, DOI 10.1021/bp010120q; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	35	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1810	10.1371/journal.pone.0001810	http://dx.doi.org/10.1371/journal.pone.0001810			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350148	gold, Green Published, Green Submitted			2022-12-25	WOS:000260762300014
J	Nagashima, T; Suzuki, T; Kondo, S; Kuroki, Y; Takahashi, K; Ide, K; Yumoto, N; Hasegawa, A; Toyoda, T; Kojima, T; Konagaya, A; Suzuki, H; Hayashizaki, Y; Sakaki, Y; Hatakeyama, M				Nagashima, Takeshi; Suzuki, Takahiro; Kondo, Shinji; Kuroki, Yoko; Takahashi, Kaoru; Ide, Kaori; Yumoto, Noriko; Hasegawa, Aki; Toyoda, Tetsuro; Kojima, Toshio; Konagaya, Akihiko; Suzuki, Harukazu; Hayashizaki, Yoshihide; Sakaki, Yoshiyuki; Hatakeyama, Mariko			Integrative Genome-Wide Expression Analysis Bears Evidence of Estrogen Receptor-Independent Transcription in Heregulin-Stimulated MCF-7 Cells	PLOS ONE			English	Article								Heregulin beta-1 (HRG) is an extracellular ligand that activates mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI3K)/Akt signaling pathways through ErbB receptors. MAPK and Akt have been shown to phosphorylate the estrogen receptor (ER) at Ser-118 and Ser-167, respectively, thereby mimicking the effects of estrogenic activity such as estrogen responsive element (ERE)-dependent transcription. In the current study, integrative analysis was performed using two tiling array platforms, comprising histone H3 lysine 9 (H3K9) acetylation and RNA mapping, together with array comparative genomic hybridization (CGH) analysis in an effort to identify HRG-regulated genes in ER-positive MCF-7 breast cancer cells. Through application of various threshold settings, 333 (326 up-regulated and 7 down-regulated) HRG-regulated genes were detected. Prediction of upstream transcription factors (TFs) and pathway analysis indicated that 21% of HRG-induced gene regulation may be controlled by the MAPK cascade, while only 0.6% of the gene expression is controlled by ERE. A comparison with previously reported estrogen (E2)-regulated gene expression data revealed that only 12 common genes were identified between the 333 HRG-regulated (3.6%) and 239 E2-regulated (5.0%) gene groups. However, with respect to enriched upstream TFs, 4 common TFs were identified in the 14 HRG-regulated (28.6%) and 13 E2-regulated (30.8%) gene groups. These results indicated that while E2 and HRG may induce common TFs, the regulatory mechanisms that govern HRG- and E2-induced gene expression differ.	[Nagashima, Takeshi; Kuroki, Yoko; Takahashi, Kaoru; Ide, Kaori; Yumoto, Noriko; Toyoda, Tetsuro; Kojima, Toshio; Sakaki, Yoshiyuki; Hatakeyama, Mariko] RIKEN Yokohama Inst, Genom Sci Ctr, Computat & Expt Syst Biol Grp, Yokohama, Kanagawa, Japan; [Suzuki, Takahiro; Kondo, Shinji; Suzuki, Harukazu; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, Genomic Sci Ctr, Genome Explorat Res Grp, Yokohama, Kanagawa, Japan; [Hasegawa, Aki; Konagaya, Akihiko] RIKEN Yokohama Inst, Genomic Sci Ctr, Advanced Genome Informat Technol Res Grp, Yokohama, Kanagawa, Japan; [Suzuki, Takahiro; Hayashizaki, Yoshihide] Yokohama City Univ, Internatl Grad Sch Arts & Sci, Div Genomic Informat Resources, Yokohama, Kanagawa, Japan; [Hayashizaki, Yoshihide] Discovery & Res Inst, Genome Sci Lab, RIKEN Wako Main Campus, Saitama, Japan; [Hayashizaki, Yoshihide] RIKEN Frontier Res Syst, Function RNA Res Program, Saitama, Japan	RIKEN; RIKEN; RIKEN; Yokohama City University; RIKEN; RIKEN	Nagashima, T (corresponding author), RIKEN Yokohama Inst, Genom Sci Ctr, Computat & Expt Syst Biol Grp, Yokohama, Kanagawa, Japan.	marikoh@gsc.riken.jp	Suzuki, Takahiro/AAW-8509-2020; Hayashizaki, Yoshihide/N-6590-2015; Konagaya, Akihiko/F-9302-2014; Okada, Mariko/N-6933-2015; Suzuki, Harukazu/N-9553-2015	Suzuki, Takahiro/0000-0002-0972-6911; Suzuki, Harukazu/0000-0002-8087-0836	RIKEN	RIKEN	All funding for this study was supported by current research expenses in RIKEN.	ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; ARNOLD SF, 1995, J STEROID BIOCHEM, V55, P163, DOI 10.1016/0960-0760(95)00177-2; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; CARRAWAY KL, 1995, J BIOL CHEM, V270, P7111, DOI 10.1074/jbc.270.13.7111; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Driggers PH, 2002, TRENDS ENDOCRIN MET, V13, P422, DOI 10.1016/S1043-2760(02)00634-3; Fann M, 2006, BLOOD, V108, P3363, DOI 10.1182/blood-2006-02-005520; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; GRUNT TW, 1995, INT J CANCER, V63, P560, DOI 10.1002/ijc.2910630417; Hasegawa Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl497; Joel PB, 1998, MOL CELL BIOL, V18, P1978, DOI 10.1128/MCB.18.4.1978; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kojima T, 2006, BIOCHEM BIOPH RES CO, V341, P792, DOI 10.1016/j.bbrc.2006.01.032; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Maass N, 2002, CANCER LETT, V185, P219, DOI 10.1016/S0304-3835(02)00286-0; Martin MB, 2000, ENDOCRINOLOGY, V141, P4503, DOI 10.1210/en.141.12.4503; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Moggs JG, 2001, EMBO REP, V2, P775, DOI 10.1093/embo-reports/kve185; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Nishida H, 2006, CHROMOSOME RES, V14, P203, DOI 10.1007/s10577-006-1036-7; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Proia DA, 2006, J BIOL CHEM, V281, P7089, DOI 10.1074/jbc.M511839200; Ren SR, 2000, ONCOGENE, V19, P1419, DOI 10.1038/sj.onc.1203462; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Tan M, 1999, CANCER RES, V59, P1620; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Toyoda T, 2007, BIOINFORMATICS, V23, P524, DOI 10.1093/bioinformatics/btl523; Weiss FU, 1997, J CELL PHYSIOL, V173, P187, DOI 10.1002/(SICI)1097-4652(199711)173:2<187::AID-JCP19>3.0.CO;2-D; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1803	10.1371/journal.pone.0001803	http://dx.doi.org/10.1371/journal.pone.0001803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350142	gold, Green Published, Green Submitted			2022-12-25	WOS:000260762300008
J	Raoof, M; Nawaz, H; Nusrat, R; Pabaney, AH; Randhawa, AR; Rehman, R; Rizvi, NB; Naqvi, H				Raoof, Mustafa; Nawaz, Haq; Nusrat, Rabeeya; Pabaney, Aqueel Hussain; Randhawa, Ali Raza; Rehman, Rabeea; Rizvi, Nida Butool; Naqvi, Haider			Awareness and Use of Benzodiazepines in Healthy Volunteers and Ambulatory Patients Visiting a Tertiary Care Hospital: A Cross Sectional Survey	PLOS ONE			English	Article							GENERAL-POPULATION; PREVALENCE; PRESCRIPTION; ISSUES; BRAZIL; TERM	Background: Indiscriminate prescription of Benzodiazepines in Pakistan and subsequent availability over-the-counter without prescription is a major public health problem, requiring systematic inquiry through research. Additionally, there is limited data on the awareness and use of Benzodiazepines from developing countries making it impossible to devise meaningful health policies. Methodology/Principal Findings: This was an Observational, Cross-Sectional study. conducted at Aga Khan University. A total of 475 (58.5% males, 41.5% females) people visiting a tertiary care hospital were interviewed by means of a structured questionnaire. The results showed that majority of population was aware of one or more Benzodiazepines (80.4%) and 30.4% had used them at some point in life. 42.4% of the users had been using it for more than a year. Commonest reason for use was sleep disturbance. Frequency of usage was higher for females, married individuals, educated (>Grade12), high socioeconomic status and housewives. More (59%) were prescribed than not and of them most by GP (58.5%). Only 36.5% of them were particularly told about the long-term addiction potential by the use of these drugs. Conclusion: Easy availability, access to re-fills without prescription and self prescription compounded with the lack of understanding of abuse potential of benzodiazepines constitutes a significant problem demanding serious consideration from health policy makers.	[Raoof, Mustafa; Nawaz, Haq; Nusrat, Rabeeya; Pabaney, Aqueel Hussain; Randhawa, Ali Raza; Rehman, Rabeea; Rizvi, Nida Butool] Aga Khan Univ, Coll Med, Karachi, Pakistan; [Naqvi, Haider] Aga Khan Univ, Med Coll, Dept Psychiat, Karachi, Pakistan	Aga Khan University; Aga Khan University	Raoof, M (corresponding author), Aga Khan Univ, Coll Med, Karachi, Pakistan.	mustafaraoof@yahoo.com	Raoof, Mustafa/D-1664-2012					Ahmad K, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-51; Ali B S, 2002, J Pak Med Assoc, V52, P513; de las Cuevas C, 2004, MED SCI MONITOR, V10, pCR288; FUENTEALBA R, 2000, REV PANAM SALUD PUBL, V7, P79; Galduroz JCF, 2005, ADDICT BEHAV, V30, P545, DOI 10.1016/j.addbeh.2004.08.004; Huang BJ, 2006, J CLIN PSYCHIAT, V67, P1062, DOI 10.4088/JCP.v67n0708; Kapczinski F, 2001, SUBST USE MISUSE, V36, P1053, DOI 10.1081/JA-100104489; Khan M M, 1998, J Pak Med Assoc, V48, P293; Khawaja Muhammad Rizwamillah, 2005, JPMA Journal of the Pakistan Medical Association, V55, P259; LADER M, 1984, CURR MED RES OPIN, V8, P120, DOI 10.1185/03007998409109550; LADER M, 1984, PROG NEURO-PSYCHOPH, V8, P85, DOI 10.1016/0278-5846(84)90139-8; LYNDON RW, 1988, AUST NZ J PSYCHIAT, V22, P293, DOI 10.3109/00048678809161210; Magrini N, 1996, EUR J CLIN PHARMACOL, V50, P19, DOI 10.1007/s002280050063; Neutel C Ineke, 2003, Can J Clin Pharmacol, V10, P202; Neutel CI, 2005, INT REV PSYCHIATR, V17, P189, DOI 10.1080/09540260500071863; Ohayon MM, 2002, J CLIN PSYCHIAT, V63, P817, DOI 10.4088/JCP.v63n0912; ROTH T, 1992, J CLIN PSYCHIAT, V53, P14; SWARTZ M, 1991, AM J PUBLIC HEALTH, V81, P592, DOI 10.2105/AJPH.81.5.592; Uchibayashi M, 2007, YAKUGAKU ZASSHI, V127, P217, DOI 10.1248/yakushi.127.217; VOGEL G, 1992, J CLIN PSYCHIAT, V53, P19	20	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1804	10.1371/journal.pone.0001804	http://dx.doi.org/10.1371/journal.pone.0001804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370KY	18350143	gold, Green Published, Green Submitted			2022-12-25	WOS:000260762300009
J	Liew, CG; Shah, NN; Briston, SJ; Shepherd, RM; Khoo, CP; Dunne, MJ; Moore, HD; Cosgrove, KE; Andrews, PW				Liew, Chee Gee; Shah, Nadia N.; Briston, Sarah J.; Shepherd, Ruth M.; Khoo, Cheen Peen; Dunne, Mark J.; Moore, Harry D.; Cosgrove, Karen E.; Andrews, Peter W.			PAX4 Enhances Beta-Cell Differentiation of Human Embryonic Stem Cells	PLOS ONE			English	Article							PANCREATIC MESENCHYME; SURFACE-ANTIGENS; INSULIN; EXPRESSION; GROWTH; GENE; REQUIREMENT; GENERATION; PROGENITOR; RELEASE	Background: Human embryonic stem cells (HESC) readily differentiate into an apparently haphazard array of cell types, corresponding to all three germ layers, when their culture conditions are altered, for example by growth in suspension as aggregates known as embryoid bodies (EBs). However, this diversity of differentiation means that the efficiency of producing any one particular cell type is inevitably low. Although pancreatic differentiation has been reported from HESC, practicable applications for the use of beta-cells derived from HESC to treat diabetes will only be possible once techniques are developed to promote efficient differentiation along the pancreatic lineages. Methods and Findings: Here, we have tested whether the transcription factor, Pax4 can be used to drive the differentiation of HESC to a beta-cell fate in vitro. We constitutively over-expressed Pax4 in HESCs by stable transfection, and used Q-PCR analysis, immunocytochemistry, ELISA, Ca2+ microfluorimetry and cell imaging to assess the role of Pax4 in the differentiation and intracellular Ca2+ homeostasis of beta-cells developing in embryoid bodies produced from such HESC. Cells expressing key beta-cell markers were isolated by fluorescence-activated cell sorting after staining for high zinc content using the vital dye, Newport Green. Conclusion: Constitutive expression of Pax4 in HESC substantially enhances their propensity to form putative beta-cells. Our findings provide a novel foundation to study the mechanism of pancreatic beta-cells differentiation during early human development and to help evaluate strategies for the generation of purified beta-cells for future clinical applications.	[Liew, Chee Gee; Moore, Harry D.; Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Ctrr Stem Cell Biol, Sheffield, S Yorkshire, England; [Liew, Chee Gee; Moore, Harry D.; Andrews, Peter W.] Univ Sheffield, Ctr Stem Cell Biol, Dept Mol Biol & Biotechnol, Sheffield, S Yorkshire, England; [Shah, Nadia N.; Briston, Sarah J.; Shepherd, Ruth M.; Khoo, Cheen Peen; Dunne, Mark J.; Cosgrove, Karen E.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Sheffield; University of Sheffield; University of Manchester	Liew, CG (corresponding author), Univ Sheffield, Dept Biomed Sci, Ctrr Stem Cell Biol, Sheffield, S Yorkshire, England.	karen.e.cosgrove@manchester.ac.uk; p.w.andrews@sheffield.ac.uk		Cosgrove, Karen/0000-0002-5162-0985; BRISTON, SARAH/0000-0001-9772-2007; Andrews, Peter/0000-0001-7215-4410	Juvenile Diabetes Research Foundation; Medical Research Council (UK); Biological and Biotechnical Research Council (UK); Novo Nordisk Research Foundation; Joint MRC/JDRF Career Development Fellowship; MRC [G0300273, G0801059, G113/29, G0700785] Funding Source: UKRI; Medical Research Council [G0700785, G113/29, G0300273, G0801059] Funding Source: researchfish	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biological and Biotechnical Research Council (UK); Novo Nordisk Research Foundation(Novo Nordisk Foundation); Joint MRC/JDRF Career Development Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Juvenile Diabetes Research Foundation (HDM, KEC, MJD, PWA), the Medical Research Council (UK) (KEC, HDM, MJD), the Biological and Biotechnical Research Council (UK) (HDM, PWA) and Novo Nordisk Research Foundation (KEC). KEC is supported by a Joint MRC/JDRF Career Development Fellowship in Stem Cell Research. The authors are grateful to Mark Jones for cell sorting.	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; ANDREWS PW, 1982, INT J CANCER, V29, P523, DOI 10.1002/ijc.2910290507; ANDREWS PW, 1984, HYBRIDOMA, V3, P347, DOI 10.1089/hyb.1984.3.347; Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P323, DOI 10.1111/j.1440-169x.2006.00867.x; Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100; Brun T, 2007, ONCOGENE, V26, P4261, DOI 10.1038/sj.onc.1210205; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Dvash T, 2004, HUM REPROD, V19, P2875, DOI 10.1093/humrep/deh529; Edlund H, 1998, DIABETES, V47, P1817, DOI 10.2337/diabetes.47.12.1817; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Fougerousse F, 2000, HUM MOL GENET, V9, P165, DOI 10.1093/hmg/9.2.165; Gao R, 2003, DIABETES, V52, P2007, DOI 10.2337/diabetes.52.8.2007; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Greenwood AL, 2007, MECH DEVELOP, V124, P97, DOI 10.1016/j.mod.2006.11.002; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Hui HX, 2001, DIABETES, V50, P785, DOI 10.2337/diabetes.50.4.785; Jonasson P, 1996, EUR J BIOCHEM, V236, P656, DOI 10.1111/j.1432-1033.1996.00656.x; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Jung CY, 1996, EXP MOL MED, V28, P153, DOI 10.1038/emm.1996.24; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Khoo MLM, 2005, BIOL REPROD, V73, P1147, DOI 10.1095/biolreprod.104.036673; Lavon N, 2006, STEM CELLS, V24, P1923, DOI 10.1634/stemcells.2005-0397; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Mfopou JK, 2007, STEM CELLS, V25, P1156, DOI 10.1634/stemcells.2006-0720; Namkung Y, 2001, J CLIN INVEST, V108, P1015, DOI 10.1172/JCI13310; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Rajagopal J, 2003, SCIENCE, V299, P363; Segev H, 2004, STEM CELLS, V22, P265, DOI 10.1634/stemcells.22-3-265; Smith SB, 2000, J BIOL CHEM, V275, P36910, DOI 10.1074/jbc.M005202200; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Straub SG, 2001, DIABETES, V50, P329, DOI 10.2337/diabetes.50.2.329; STURGESS NC, 1986, J ENDOCRINOL, V109, P201, DOI 10.1677/joe.0.1090201; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Zhang F, 2006, AM J PHYSIOL-CELL PH, V291, pC466, DOI 10.1152/ajpcell.00418.2005	44	33	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1783	10.1371/journal.pone.0001783	http://dx.doi.org/10.1371/journal.pone.0001783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335054	Green Published, gold, Green Accepted			2022-12-25	WOS:000260723000035
J	Mandel, JT; Ratcliffe, JM; Cerasale, DJ; Winkler, DW				Mandel, James T.; Ratcliffe, John M.; Cerasale, David J.; Winkler, David W.			Laterality and Flight: Concurrent Tests of Side-Bias and Optimality in Flying Tree Swallows	PLOS ONE			English	Article								Behavioural side-bias occurs in many vertebrates, including birds as a result of hemispheric specialization and can be advantageous by improving response times to sudden stimuli and efficiency in multi-tasking. However, behavioural side-bias can lead to morphological asymmetries resulting in reduced performance for specific activities. For flying animals, wing asymmetry is particularly costly and it is unclear if behavioural side-biases will be expressed in flight; the benefits of quick response time afforded by side-biases must be balanced against the costs of less efficient flight due to the morphological asymmetry side-biases may incur. Thus, competing constraints could lead to context-dependent expression or suppression of side-bias in flight. In repeated flight trials through an outdoor tunnel with obstacles, tree swallows (Tachycineta bicolor) preferred larger openings, but we did not detect either individual or population-level side-biases. Thus, while observed behavioural side-biases during substrate-foraging and copulation are common in birds, we did not see such side-bias expressed in obstacle avoidance behaviour in flight. This finding highlights the importance of behavioural context for investigations of side-bias and hemispheric laterality and suggests both proximate and ultimate trade-offs between species-specific cognitive ecology and flight biomechanics.	[Mandel, James T.; Cerasale, David J.; Winkler, David W.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Ratcliffe, John M.] Cornell Univ, Dept Neurobiol & Behavior, Ithaca, NY USA	Cornell University; Cornell University	Mandel, JT (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	jtm39@cornell.edu			NSF [IBN-013437]	NSF(National Science Foundation (NSF))	This project was supported by NSF grant IBN-013437 to DWW. The funders had no role in any aspect of the study.	Adam A, 1998, J NEUROPHYSIOL, V80, P1373, DOI 10.1152/jn.1998.80.3.1373; BALMFORD A, 1993, P ROY SOC B-BIOL SCI, V252, P245, DOI 10.1098/rspb.1993.0072; Bisazza A, 1997, ANIM BEHAV, V54, P1273, DOI 10.1006/anbe.1997.0522; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; Bowlin MS, 2004, AUK, V121, P345, DOI 10.1642/0004-8038(2004)121[0345:NVIFPI]2.0.CO;2; Brown CR, 1998, EVOLUTION, V52, P1461, DOI 10.1111/j.1558-5646.1998.tb02027.x; Buschmann JUF, 2006, BEHAV PROCESS, V73, P62, DOI 10.1016/j.beproc.2006.03.012; Deng C, 1997, BEHAV BRAIN RES, V87, P173, DOI 10.1016/S0166-4328(97)02276-6; Dharmaretnam A, 2005, BEHAV BRAIN RES, V162, P62, DOI 10.1016/j.bbr.2005.03.012; Dukas R, 2004, ANNU REV ECOL EVOL S, V35, P347, DOI 10.1146/annurev.ecolsys.35.112202.130152; GUNTURKUN O, 1987, BEHAV NEUROSCI, V101, P433; Hambly C, 2004, J EXP BIOL, V207, P3977, DOI 10.1242/jeb.01235; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Lippolis G, 2002, LATERALITY, V7, P163, DOI 10.1080/13576500143000221; Malashichev Y. B, 2006, BEHAV MORPHOLOGICAL; Moller A.P., 1997, ASYMMETRY DEV STABIL; Moller AP, 1997, ANIM BEHAV, V54, P1545, DOI 10.1006/anbe.1997.9998; Norberg U., 1990, VERTEBRATE FLIGHT ME; Petersen AD, 2001, ANIM BEHAV, V62, P739, DOI 10.1006/anbe.2001.1791; Prior H, 2004, BEHAV BRAIN RES, V154, P301, DOI 10.1016/j.bbr.2004.02.018; Prior H, 2002, J EXP BIOL, V205, P1795; Pyle P., 1987, IDENTIFICATION GUIDE; ROBERTSON RJ, 1992, BIRDS N AM ONLINE; Robins A, 2006, ANIM BEHAV, V72, P843, DOI 10.1016/j.anbehav.2006.01.022; Rogers LJ, 2000, BRAIN LANG, V73, P236, DOI 10.1006/brln.2000.2305; Rogers LJ, 2004, P ROY SOC B-BIOL SCI, V271, pS420, DOI 10.1098/rsbl.2004.0200; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Swaddle JP, 1997, CAN J ZOOL, V75, P948, DOI 10.1139/z97-114; Teather K, 1996, J AVIAN BIOL, V27, P302, DOI 10.2307/3677261; THOMAS ALR, 1993, P ROY SOC B-BIOL SCI, V254, P181, DOI 10.1098/rspb.1993.0144; Vallortigara G, 1996, BEHAV BRAIN RES, V74, P135, DOI 10.1016/0166-4328(95)00037-2; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2006, DEV PSYCHOBIOL, V48, P418, DOI 10.1002/dev.20166; Ventolini N, 2005, ANIM BEHAV, V69, P1077, DOI 10.1016/j.anbehav.2004.09.003; Winkler David W., 2006, Hornero, V21, P85; [No title captured]	36	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1748	10.1371/journal.pone.0001748	http://dx.doi.org/10.1371/journal.pone.0001748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335028	Green Published, gold, Green Submitted			2022-12-25	WOS:000260723000002
J	Dedek, K; Pandarinath, C; Alam, NM; Wellershaus, K; Schubert, T; Willecke, K; Prusky, GT; Weiler, R; Nirenberg, S				Dedek, Karin; Pandarinath, Chethan; Alam, Nazia M.; Wellershaus, Kerstin; Schubert, Timm; Willecke, Klaus; Prusky, Glen T.; Weiler, Reto; Nirenberg, Sheila			Ganglion Cell Adaptability: Does the Coupling of Horizontal Cells Play a Role?	PLOS ONE			English	Article								Background: The visual system can adjust itself to different visual environments. One of the most well known examples of this is the shift in spatial tuning that occurs in retinal ganglion cells with the change from night to day vision. This shift is thought to be produced by a change in the ganglion cell receptive field surround, mediated by a decrease in the coupling of horizontal cells. Methodology/Principal Findings: To test this hypothesis, we used a transgenic mouse line, a connexin57-deficient line, in which horizontal cell coupling was abolished. Measurements, both at the ganglion cell level and the level of behavioral performance, showed no differences between wild-type retinas and retinas with decoupled horizontal cells from connexin57-deficient mice. Conclusion/Significance: This analysis showed that the coupling and uncoupling of horizontal cells does not play a dominant role in spatial tuning and its adjustability to night and day light conditions. Instead, our data suggest that another mechanism, likely arising in the inner retina, must be responsible.	[Dedek, Karin; Schubert, Timm; Weiler, Reto] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-2900 Oldenburg, Germany; [Pandarinath, Chethan; Nirenberg, Sheila] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY USA; [Alam, Nazia M.; Prusky, Glen T.] Univ Lethbridge, Canadian Ctr Behavioural Neurosci, Lethbridge, AB, Canada; [Wellershaus, Kerstin; Willecke, Klaus] Univ Bonn, Inst Genet, Bonn, Germany	Carl von Ossietzky Universitat Oldenburg; Cornell University; University of Lethbridge; University of Bonn	Dedek, K (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-2900 Oldenburg, Germany.	shn2010@med.cornell.edu	Dedek, Karin/R-6948-2018	Dedek, Karin/0000-0003-1490-0141; Pandarinath, Chethan/0000-0003-1241-1432	National Eye Institute; Deutsche Forschungsgemeinschaft [We 849/14-1, Wi 270/22-5/6]	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the National Eye Institute to S.N. and from the Deutsche Forschungsgemeinschaft to R.W. (We 849/14-1) and K.W. (Wi 270/22-5/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; ATICK JJ, 1992, NEURAL COMPUT, V4, P196, DOI 10.1162/neco.1992.4.2.196; BALDRIDGE WH, 1991, VISUAL NEUROSCI, V7, P441, DOI 10.1017/S0952523800009731; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; BARLOW HB, 1957, J PHYSIOL-LONDON, V137, P338, DOI 10.1113/jphysiol.1957.sp005817; Benedek G, 2003, DOC OPHTHALMOL, V106, P201, DOI 10.1023/A:1022548013313; Bieda MC, 1999, J NEUROPHYSIOL, V81, P3092, DOI 10.1152/jn.1999.81.6.3092; BISTI S, 1977, EXP BRAIN RES, V27, P335; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; CAVONIUS CR, 1973, J PHYSIOL-LONDON, V232, P239, DOI 10.1113/jphysiol.1973.sp010267; Cook PB, 1998, NAT NEUROSCI, V1, P714, DOI 10.1038/3714; CRONER LJ, 1995, VISION RES, V35, P7, DOI 10.1016/0042-6989(94)E0066-T; DeValois RL, 1990, SPATIAL VISION; Dodd R. J., 1998, Technical Digest. Summaries of Papers Presented at the International Quantum Electronics Conference. Conference Edition. 1998 Technical Digest Series, Vol.7 (IEEE Cat. No.98CH36236), P153, DOI 10.1109/IQEC.1998.682738; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P271, DOI 10.1113/jphysiol.1973.sp010308; ENROTHCUGELL C, 1983, J PHYSIOL-LONDON, V341, P279, DOI 10.1113/jphysiol.1983.sp014806; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Fahey PK, 2003, VISUAL NEUROSCI, V20, P1, DOI 10.1017/S0952523803201012; Flores-Herr N, 2001, J NEUROSCI, V21, P4852, DOI 10.1523/JNEUROSCI.21-13-04852.2001; GREENLEE MW, 1991, VISION RES, V31, P223, DOI 10.1016/0042-6989(91)90113-J; HAMPSON ECGM, 1994, P ROY SOC B-BIOL SCI, V255, P67, DOI 10.1098/rspb.1994.0010; He SG, 2000, J COMP NEUROL, V418, P33, DOI 10.1002/(SICI)1096-9861(20000228)418:1<33::AID-CNE3>3.0.CO;2-J; Hombach S, 2004, EUR J NEUROSCI, V19, P2633, DOI 10.1111/j.0953-816X.2004.03360.x; JENSEN RJ, 1984, J NEUROSCI, V4, P2972; JENSEN RJ, 1986, NEUROSCIENCE, V17, P837, DOI 10.1016/0306-4522(86)90049-7; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; MAFFEI L, 1971, J NEUROPHYSIOL, V34, P579, DOI 10.1152/jn.1971.34.4.579; MANGEL SC, 1985, SCIENCE, V229, P1107, DOI 10.1126/science.4035351; MANGEL SC, 1991, J PHYSIOL-LONDON, V442, P211, DOI 10.1113/jphysiol.1991.sp018790; McMahon MJ, 2004, J NEUROSCI, V24, P3736, DOI 10.1523/JNEUROSCI.5252-03.2004; Muller JF, 1997, VISUAL NEUROSCI, V14, P395, DOI 10.1017/S0952523800011512; NAKA K, 1972, J PHYSIOL-LONDON, V223, P449, DOI 10.1113/jphysiol.1972.sp009857; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Packer OS, 2002, J VISION, V2, DOI 10.1167/2.4.1; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; RODIECK RW, 1965, J NEUROPHYSIOL, V28, P833, DOI 10.1152/jn.1965.28.5.833; Roska B, 2000, J NEUROSCI, V20, P1941; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; SHAPLEY R, 1985, ANNU REV NEUROSCI, V8, P547, DOI 10.1146/annurev.ne.08.030185.002555; SHELLEY J, COMMUNICATION; Shelley J, 2006, EUR J NEUROSCI, V23, P3176, DOI 10.1111/j.1460-9568.2006.04848.x; Sinclair JR, 2004, J NEUROSCI, V24, P1459, DOI 10.1523/JNEUROSCI.3959-03.2004; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; SMITH RA, 1973, J PHYSIOL-LONDON, V230, P115, DOI 10.1113/jphysiol.1973.sp010178; SMITH RG, 1995, VISUAL NEUROSCI, V12, P545, DOI 10.1017/S0952523800008440; STONE C, 1993, VISUAL NEUROSCI, V10, P31, DOI 10.1017/S0952523800003205; Taylor WR, 1999, VISUAL NEUROSCI, V16, P285, DOI 10.1017/S0952523899162096; TERANISHI T, 1983, NATURE, V301, P243, DOI 10.1038/301243a0; TORNQVIST K, 1988, J NEUROSCI, V8, P2279; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Urschel S, 2006, J BIOL CHEM, V281, P33163, DOI 10.1074/jbc.M606396200; VANEY DI, 1991, NEUROSCI LETT, V125, P187, DOI 10.1016/0304-3940(91)90024-N; VANHATEREN JH, 1992, BIOL CYBERN, V68, P23, DOI 10.1007/BF00203134; Vigh J, 1999, VISUAL NEUROSCI, V16, P159, DOI 10.1017/S095252389916111X; Wang Y, 1996, P NATL ACAD SCI USA, V93, P4655, DOI 10.1073/pnas.93.10.4655; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WITKOVSKY P, 1991, PROG RETIN RES, V11, P247, DOI 10.1016/0278-4327(91)90031-V; Xia YQ, 2003, VISUAL NEUROSCI, V20, P429, DOI 10.1017/S0952523803204089; Xin DY, 1999, J COMP NEUROL, V405, P75, DOI 10.1002/(SICI)1096-9861(19990301)405:1<75::AID-CNE6>3.0.CO;2-D; YANG XL, 1991, P NATL ACAD SCI USA, V88, P3310, DOI 10.1073/pnas.88.8.3310	69	51	57	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1714	10.1371/journal.pone.0001714	http://dx.doi.org/10.1371/journal.pone.0001714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320035	gold, Green Published			2022-12-25	WOS:000260586600010
J	Jin, QM; Wei, GB; Lin, Z; Sugai, JV; Lynch, SE; Ma, PX; Giannobile, WV				Jin, Qiming; Wei, Guobao; Lin, Zhao; Sugai, James V.; Lynch, Samuel E.; Ma, Peter X.; Giannobile, William V.			Nanofibrous Scaffolds Incorporating PDGF-BB Microspheres Induce Chemokine Expression and Tissue Neogenesis In Vivo	PLOS ONE			English	Article								Platelet-derived growth factor (PDGF) exerts multiple cellular effects that stimulate wound repair in multiple tissues. However, a major obstacle for its successful clinical application is the delivery system, which ultimately controls the in vivo release rate of PDGF. Polylactic-co-glycolic acid (PLGA) microspheres (MS) in nanofibrous scaffolds (NFS) have been shown to control the release of rhPDGF-BB in vitro. In order to investigate the effects of rhPDGF-BB release from MS in NFS on gene expression and enhancement of soft tissue engineering, rhPDGF-BB was incorporated into differing molecular weight (MW) polymeric MS. By controlling the MW of the MS over a range of 6.5 KDa-64 KDa, release rates of PDGF can be regulated over periods of weeks to months in vitro. The NFS-MS scaffolds were divided into multiple groups based on MS release characteristics and PDGF concentration ranging from 2.5-25.0 mg and evaluated in vivo in a soft tissue wound repair model in the dorsa of rats. At 3, 7, 14 and 21 days post-implantation, the scaffold implants were harvested followed by assessments of cell penetration, vasculogenesis and tissue neogenesis. Gene expression profiles using cDNA microarrays were performed on the PDGF-releasing NFS. The percentage of tissue invasion into MS-containing NFS at 7 days was higher in the PDGF groups when compared to controls. Blood vessel number in the HMW groups containing either 2.5 or 25 mg PDGF was increased above those of other groups at 7d (p<0.01). Results from cDNA array showed that PDGF strongly enhanced in vivo gene expression of the CXC chemokine family members such as CXCL1, CXCL2 and CXCL5. Thus, sustained release of rhPDGF-BB, controlled by slow-releasing MS associated with the NFS delivery system, enhanced cell migration and angiogenesis in vivo, and may be related to an induced expression of chemokine-related genes. This approach offers a technology to accurately control growth factor release to promote soft tissue engineering in vivo.	[Jin, Qiming; Lin, Zhao; Sugai, James V.; Giannobile, William V.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Wei, Guobao; Ma, Peter X.] Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI USA; [Lynch, Samuel E.] Biomimetic Therapeutics Inc, Franklin, TN USA; [Ma, Peter X.] Univ Michigan, Sch Dent, Dept Biol & Material Sci, Ann Arbor, MI USA; [Giannobile, William V.] Univ Michigan, Sch Dent, Michigan Ctr Oral Hlth Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jin, QM (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.	wgiannob@umich.edu	X, Peter/E-4895-2011	Giannobile, William/0000-0002-7102-9746	National Institutes of Health [DE15384, DE14755, DE13397]; AO Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015384, R21DE014755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AO Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the National Institutes of Health DE15384 and DE14755 (MPX), and DE13397 and AO Foundation (WVG).	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241; Chandrasekar B, 2003, J BIOL CHEM, V278, P4675, DOI 10.1074/jbc.M207006200; Chin A, 2006, EXP GERONTOL, V41, P63, DOI 10.1016/j.exger.2005.10.012; Cooke JW, 2006, TISSUE ENG, V12, P1441, DOI 10.1089/ten.2006.12.1441; Faisant N, 2002, EUR J PHARM SCI, V15, P355, DOI 10.1016/S0928-0987(02)00023-4; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONAHA.106.639831; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Issa R, 2006, AM J PHYSIOL-LUNG C, V291, pL66, DOI 10.1152/ajplung.00384.2005; Jin QM, 2003, J BIOMED MATER RES A, V67A, P54, DOI 10.1002/jbm.a.10058; Kaigler Darnell, 2006, Expert Opin Drug Deliv, V3, P647, DOI 10.1517/17425247.3.5.647; Kaminski WE, 2001, BLOOD, V97, P1990, DOI 10.1182/blood.V97.7.1990; KAPLAN DR, 1979, BLOOD, V53, P1043; Laing KJ, 2004, DEV COMP IMMUNOL, V28, P443, DOI 10.1016/j.dci.2003.09.006; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lee S, 2006, J MICROENCAPSUL, V23, P741, DOI 10.1080/09687860600945552; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Nirodi CS, 2000, WOUND REPAIR REGEN, V8, P371, DOI 10.1046/j.1524-475x.2000.00371.x; Ostman A, 2001, ADV CANCER RES, V80, P1, DOI 10.1016/S0065-230X(01)80010-5; Ramseier CA, 2006, DENT CLIN N AM, V50, pix; Ramseier Christoph A, 2006, Dent Clin North Am, V50, P245, DOI 10.1016/j.cden.2005.12.001; Rosenkranz S, 1999, GROWTH FACTORS, V16, P201, DOI 10.3109/08977199909002130; RYSECK RP, 1989, EXP CELL RES, V180, P266, DOI 10.1016/0014-4827(89)90230-9; Sarment DP, 2006, J CLIN PERIODONTOL, V33, P135, DOI 10.1111/j.1600-051X.2005.00870.x; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Steed DL, 2006, PLAST RECONSTR SURG, V117, p143S, DOI 10.1097/01.prs.0000222526.21512.4c; Taba M Jr, 2005, Orthod Craniofac Res, V8, P292; Wang WZ, 2006, PLAST RECONSTR SURG, V117, P138, DOI 10.1097/01.prs.0000185610.36051.67; Wang XT, 2006, PLAST RECONSTR SURG, V117, P129, DOI 10.1097/01.prs.0000185609.07293.3e; Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011; Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028; WOOD LD, 1995, NUCLEIC ACIDS RES, V23, P4210, DOI 10.1093/nar/23.20.4210; Zolnik BS, 2006, J CONTROL RELEASE, V112, P293, DOI 10.1016/j.jconrel.2006.02.015; Zymek P, 2006, J AM COLL CARDIOL, V48, P2315, DOI 10.1016/j.jacc.2006.07.060	41	65	81	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1729	10.1371/journal.pone.0001729	http://dx.doi.org/10.1371/journal.pone.0001729			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320048	gold, Green Published, Green Submitted			2022-12-25	WOS:000260586600024
J	Rozen, DE; Habets, MGJL; Handel, A; de Visser, JAGM				Rozen, Daniel E.; Habets, Michelle G. J. L.; Handel, Andreas; de Visser, J. Arjan G. M.			Heterogeneous Adaptive Trajectories of Small Populations on Complex Fitness Landscapes	PLOS ONE			English	Article								Background: Small populations are thought to be adaptively handicapped, not only because they suffer more from deleterious mutations but also because they have limited access to new beneficial mutations, particularly those conferring large benefits. Methodology/Principal Findings: Here, we test this widely held conjecture using both simulations and experiments with small and large bacterial populations evolving in either a simple or a complex nutrient environment. Consistent with expectations, we find that small populations are adaptively constrained in the simple environment; however, in the complex environment small populations not only follow more heterogeneous adaptive trajectories, but can also attain higher fitness than the large populations. Large populations are constrained to near deterministic fixation of rare large-benefit mutations. While such determinism speeds adaptation on the smooth adaptive landscape represented by the simple environment, it can limit the ability of large populations from effectively exploring the underlying topography of rugged adaptive landscapes characterized by complex environments. Conclusions: Our results show that adaptive constraints often faced by small populations can be circumvented during evolution on rugged adaptive landscapes.	[Rozen, Daniel E.; Habets, Michelle G. J. L.; de Visser, J. Arjan G. M.] Wageningen Univ, Dept Genet, Wageningen, Netherlands; [Handel, Andreas] Emory Univ, Dept Biol, Atlanta, GA USA; [Rozen, Daniel E.] Univ Manchester, Manchester, Lancs, England	Wageningen University & Research; Emory University; University of Manchester	Rozen, DE (corresponding author), Wageningen Univ, Dept Genet, Wageningen, Netherlands.	daniel.rozen@manchester.ac.uk	Handel, Andreas/F-6056-2012; Rozen, Daniel/M-9896-2014; de Visser, Arjan/GLU-3870-2022	Handel, Andreas/0000-0002-4622-1146; Rozen, Daniel/0000-0002-7772-0239; 	NWO; US NSF postdoctoral fellowship	NWO(Netherlands Organization for Scientific Research (NWO)); US NSF postdoctoral fellowship	This work was supported by grants to J.A.G.M. de V from NWO and a US NSF postdoctoral fellowship in Microbial Biology to D.E.R. There are no competing interests that would influence conclusions of the authors.	Barrett RDH, 2006, BIOL LETTERS, V2, P236, DOI 10.1098/rsbl.2006.0439; Bergstrom CT, 1999, P NATL ACAD SCI USA, V96, P5095, DOI 10.1073/pnas.96.9.5095; Brockhurst MA, 2005, P ROY SOC B-BIOL SCI, V272, P1385, DOI 10.1098/rspb.2005.3086; Brockhurst MA, 2004, P ROY SOC B-BIOL SCI, V271, P107, DOI 10.1098/rspb.2003.2556; Burch CL, 1999, GENETICS, V151, P921; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0; Colegrave N, 2005, BIOESSAYS, V27, P1167, DOI 10.1002/bies.20292; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cowperthwaite MC, 2006, PLOS COMPUT BIOL, V2, P1292, DOI 10.1371/journal.pcbi.0020141; Coyne JA, 1997, EVOLUTION, V51, P643, DOI [10.2307/2411143, 10.1111/j.1558-5646.1997.tb03650.x]; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; De Visser JAGM, 2005, J EVOLUTION BIOL, V18, P779, DOI 10.1111/j.1420-9101.2005.00879.x; Fisher R. A., 1958, GENETIC THEORY NATUR; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Goodnight CJ, 2006, HEREDITY, V96, P5, DOI 10.1038/sj.hdy.6800746; Habets MGJL, 2006, ECOL LETT, V9, P1041, DOI 10.1111/j.1461-0248.2006.00955.x; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Imhof M, 2001, P NATL ACAD SCI USA, V98, P1113, DOI 10.1073/pnas.98.3.1113; Jain K, 2007, GENETICS, V175, P1275, DOI 10.1534/genetics.106.067165; Kassen R, 2006, NAT GENET, V38, P484, DOI 10.1038/ng1751; KAUFFMAN S, 1987, J THEOR BIOL, V128, P11, DOI 10.1016/S0022-5193(87)80029-2; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; Korona R, 1996, P ROY SOC B-BIOL SCI, V263, P1665, DOI 10.1098/rspb.1996.0243; Lande R, 1998, GENETICA, V102-3, P21, DOI 10.1023/A:1017018405648; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; LYNCH M, 1993, J HERED, V84, P339, DOI 10.1093/oxfordjournals.jhered.a111354; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; MACKEN CA, 1989, P NATL ACAD SCI USA, V86, P6191, DOI 10.1073/pnas.86.16.6191; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Meyer JR, 2007, NATURE, V446, P432, DOI 10.1038/nature05599; Miralles R, 2000, J VIROL, V74, P3566, DOI 10.1128/JVI.74.8.3566-3571.2000; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; MULLER HJ, 1932, AM NAT, V66; Orr HA, 2006, EVOLUTION, V60, P1113; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Pelosi L, 2006, GENETICS, V173, P1851, DOI 10.1534/genetics.105.049619; PERELSON AS, 1995, P NATL ACAD SCI USA, V92, P9657, DOI 10.1073/pnas.92.21.9657; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Reed DH, 2005, CONSERV BIOL, V19, P563, DOI 10.1111/j.1523-1739.2005.00444.x; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; RUBIN LG, 1987, REV INFECT DIS, V9, P488; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1175; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Wilke CO, 2004, GENETICS, V167, P2045, DOI 10.1534/genetics.104.027136; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Wright S, 1932, P 6 INT C GEN, P355; Zeyl C, 2003, SCIENCE, V299, P555, DOI 10.1126/science.1078417	53	69	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1715	10.1371/journal.pone.0001715	http://dx.doi.org/10.1371/journal.pone.0001715			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320036	Green Published, Green Submitted, gold			2022-12-25	WOS:000260586600011
J	Wickramarachchi, T; Devi, YS; Mohmmed, A; Chauhan, VS				Wickramarachchi, Thilan; Devi, Yengkhom S.; Mohmmed, Asif; Chauhan, Virander S.			Identification and Characterization of a Novel Plasmodium falciparum Merozoite Apical Protein Involved in Erythrocyte Binding and Invasion	PLOS ONE			English	Article							MALARIA PARASITES; RHOPTRY PROTEIN; MOVING JUNCTION; ANTIGEN; VIVAX; EXPRESSION; DOMAINS; STAGE; LOCALIZATION; TRANSFECTION	Proteins that coat Plasmodium falciparum merozoite surface and those secreted from its apical secretory organelles are considered promising candidates for the vaccine against malaria. In the present study, we have identified an asparagine rich parasite protein (PfAARP; Gene ID PFD1105w), that harbors a predicted signal sequence, a C-terminal transmembrane region and whose transcription and translation patterns are similar to some well characterized merozoite surface/apical proteins. PfAARP was localized to the apical end of the merozoites by GFP-targeting approach using an inducible, schizont-stage expression system, by immunofluorescence assays using anti-PfAARP antibodies. Immuno-electron microsopic studies showed that PfAARP is localized in the apical ends of the rhoptries in the merozoites. RBC binding assays with PfAARP expressed on COS cells surface showed that it binds to RBCs through its N-terminal region with a receptor on the RBC surface that is sensitive to trypsin and neuraminidase treatments. Sequencing of PfAARP from different P. falciparum strains as well as field isolates showed that the N-terminal region is highly conserved. Recombinant protein corresponding to the N-terminal region of PfAARP (PfAARP-N) was produced in its functional form in E. coli. PfAARP-N showed reactivity with immune sera from individuals residing in P. falciparum endemic area. The anti-PfAARP-N rabbit antibodies significantly inhibited parasite invasion in vitro. Our data on localization, functional assays and invasion inhibition, suggest a role of PfAARP in erythrocyte binding and invasion by the merozoite.	[Wickramarachchi, Thilan; Devi, Yengkhom S.; Mohmmed, Asif; Chauhan, Virander S.] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Wickramarachchi, T (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India.	amohd@icgeb.res.in; virander@icgeb.res.in	Chauhan, Virander S./K-5276-2019		International Post-doctoral research fellowship from ICGEB	International Post-doctoral research fellowship from ICGEB	TW was supported by International Post-doctoral research fellowship from ICGEB.	Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; [Anonymous], 2000, METHODS MALARIA RES; Barale JC, 1997, INFECT IMMUN, V65, P3003, DOI 10.1128/IAI.65.8.3003-3010.1997; Blair PL, 2002, NUCLEIC ACIDS RES, V30, P2224, DOI 10.1093/nar/30.10.2224; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; CLARK JT, 1987, PARASITOL RES, V73, P425, DOI 10.1007/BF00538200; COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crabb BS, 2004, METH MOL B, V270, P263; CREWTHER PE, 1990, EXP PARASITOL, V70, P193, DOI 10.1016/0014-4894(90)90100-Q; Dasaradhi PVN, 2005, BIOCHEM BIOPH RES CO, V336, P1062, DOI 10.1016/j.bbrc.2005.08.213; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; DELPORTILLO HA, 1991, P NATL ACAD SCI USA, V88, P4030, DOI 10.1073/pnas.88.9.4030; Duraisingh MT, 2003, P NATL ACAD SCI USA, V100, P4796, DOI 10.1073/pnas.0730883100; Epstein JE, 2007, CURR OPIN MOL THER, V9, P12; Ghoneim A, 2007, PARASITOL INT, V56, P31, DOI 10.1016/j.parint.2006.11.001; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Hiller NL, 2003, J BIOL CHEM, V278, P48413, DOI 10.1074/jbc.M307266200; Hisaeda H, 2005, INT J BIOCHEM CELL B, V37, P700, DOI 10.1016/j.biocel.2004.10.009; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; Howard RF, 1995, MOL BIOCHEM PARASIT, V74, P43, DOI 10.1016/0166-6851(95)02481-6; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Ling IT, 2004, MOL MICROBIOL, V52, P107, DOI 10.1111/j.1365-2958.2003.03969.x; Mahanty S, 2003, J EXP BIOL, V206, P3781, DOI 10.1242/jeb.00646; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; Meissner M, 2005, P NATL ACAD SCI USA, V102, P2980, DOI 10.1073/pnas.0500112102; Mohmmed A, 2005, PARASITE IMMUNOL, V27, P197, DOI 10.1111/j.1365-3024.2005.00759.x; OEUVRAY C, 1994, BLOOD, V84, P1594; Okoyeh JN, 1999, INFECT IMMUN, V67, P5784, DOI 10.1128/IAI.67.11.5784-5791.1999; Pandey KC, 2002, MOL BIOCHEM PARASIT, V123, P23, DOI 10.1016/S0166-6851(02)00122-6; Pearce JA, 2005, MOL BIOCHEM PARASIT, V139, P141, DOI 10.1016/j.molbiopara.2004.09.012; PROELLOCKS NI, 2007, INT J PARAS IN PRESS; RAJAGOPALAN PK, 1990, INDIAN J MED RES-A, V91, P44; Ramasamy G, 2007, MOL BIOCHEM PARASIT, V152, P139, DOI 10.1016/j.molbiopara.2007.01.002; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Rich SM, 2000, PARASITOL TODAY, V16, P390, DOI 10.1016/S0169-4758(00)01741-5; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rug M, 2004, INFECT IMMUN, V72, P6095, DOI 10.1128/IAI.72.10.6095-6105.2004; Sachdeva S, 2006, VACCINE, V24, P2007, DOI 10.1016/j.vaccine.2005.11.041; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Sato S, 2003, MOL BIOCHEM PARASIT, V130, P155, DOI 10.1016/S0166-6851(03)00166-X; SCHOFIELD L, 1991, PARASITOL TODAY, V7, P99, DOI 10.1016/0169-4758(91)90166-L; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2006, J BIOL CHEM, V281, P31995, DOI 10.1074/jbc.M606717200; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Wickramarachchi T, 2006, INFECT IMMUN, V74, P798, DOI 10.1128/IAI.74.1.798-801.2006; Zhang KY, 1999, PARASITOL RES, V85, P956, DOI 10.1007/s004360050666	60	51	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1732	10.1371/journal.pone.0001732	http://dx.doi.org/10.1371/journal.pone.0001732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320051	Green Published, gold, Green Submitted			2022-12-25	WOS:000260586600027
J	Wolf, DM; Fontaine-Bodin, L; Bischofs, I; Price, G; Keasling, J; Arkin, AP				Wolf, Denise M.; Fontaine-Bodin, Lisa; Bischofs, Ilka; Price, Gavin; Keasling, Jay; Arkin, Adam P.			Memory in Microbes: Quantifying History-Dependent Behavior in a Bacterium	PLOS ONE			English	Article							STABLE-ISOTOPE RATIOS; TIT-FOR-TAT; TRANSCRIPTION FACTOR; BACILLUS-SUBTILIS; POSITIVE FEEDBACK; GENE-EXPRESSION; CELL-CYCLE; IN-VITRO; INFORMATION; SPORULATION	Memory is usually associated with higher organisms rather than bacteria. However, evidence is mounting that many regulatory networks within bacteria are capable of complex dynamics and multi-stable behaviors that have been linked to memory in other systems. Moreover, it is recognized that bacteria that have experienced different environmental histories may respond differently to current conditions. These "memory'' effects may be more than incidental to the regulatory mechanisms controlling acclimation or to the status of the metabolic stores. Rather, they may be regulated by the cell and confer fitness to the organism in the evolutionary game it participates in. Here, we propose that history-dependent behavior is a potentially important manifestation of memory, worth classifying and quantifying. To this end, we develop an information-theory based conceptual framework for measuring both the persistence of memory in microbes and the amount of information about the past encoded in history-dependent dynamics. This method produces a phenomenological measure of cellular memory without regard to the specific cellular mechanisms encoding it. We then apply this framework to a strain of Bacillus subtilis engineered to report on commitment to sporulation and degradative enzyme (AprE) synthesis and estimate the capacity of these systems and growth dynamics to 'remember' 10 distinct cell histories prior to application of a common stressor. The analysis suggests that B. subtilis remembers, both in short and long term, aspects of its cell history, and that this memory is distributed differently among the observables. While this study does not examine the mechanistic bases for memory, it presents a framework for quantifying memory in cellular behaviors and is thus a starting point for studying new questions about cellular regulation and evolutionary strategy.	[Wolf, Denise M.; Fontaine-Bodin, Lisa; Bischofs, Ilka; Price, Gavin; Keasling, Jay; Arkin, Adam P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Fontaine-Bodin, Lisa; Bischofs, Ilka; Price, Gavin; Keasling, Jay; Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA USA; [Keasling, Jay] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wolf, DM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	dmwolf@lbl.gov; aparkin@lbl.gov	Keasling, Jay D/J-9162-2012; Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008	Keasling, Jay D/0000-0003-4170-6088; Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931; Bischofs, Ilka/0000-0001-5905-7106	National Institutes of Health [R01 GM073010-01]; Department of Energy and the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy and the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to acknowledge the National Institutes of Health (R01 GM073010-01), the Department of Energy and the Howard Hughes Medical Institute for support during the period of this project.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Arigoni F, 1996, P NATL ACAD SCI USA, V93, P3238, DOI 10.1073/pnas.93.8.3238; Arkin A, 1998, GENETICS, V149, P1633; Ash R.B., 1990, INFORM THEORY; Aumann R.J., 1995, REPEATED GAMES INCOM; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Basar T., 1995, DYNAMIC NONCOOPERATI; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; BENGTSSON G, 1977, AUTOMATICA, V13, P333, DOI 10.1016/0005-1098(77)90016-4; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Butts DA, 2003, NETWORK-COMP NEURAL, V14, P177, DOI 10.1088/0954-898X/14/2/301; Casadesus J, 2002, BIOESSAYS, V24, P512, DOI 10.1002/bies.10102; Chen I, 2003, FRONT BIOSCI, V8, pS544; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Collins S, 2004, NATURE, V431, P566, DOI 10.1038/nature02945; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; DeWeese MR, 1999, NETWORK-COMP NEURAL, V10, P325, DOI 10.1088/0954-898X/10/4/303; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Entian KD, 1996, ANTON LEEUW INT J G, V69, P109, DOI 10.1007/BF00399416; EWING JA, 1881, P ROY SOC LONDON, V32, P399; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Fujita M, 2002, MOL MICROBIOL, V43, P27, DOI 10.1046/j.1365-2958.2002.02732.x; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GARRITY LF, 1995, PHARMACOL THERAPEUT, V68, P87, DOI 10.1016/0163-7258(95)00027-5; Gawande PV, 2005, J FOOD PROTECT, V68, P1154, DOI 10.4315/0362-028X-68.6.1154; Gazzaniga M. S., 2004, COGNITIVE NEUROSCIEN; Greber D, 2007, J BIOTECHNOL, V130, P329, DOI 10.1016/j.jbiotec.2007.05.014; Grossman AD, 1995, ANNU REV GENET, V29, P477, DOI 10.1146/annurev.ge.29.120195.002401; Hallet B, 2001, CURR OPIN MICROBIOL, V4, P570, DOI 10.1016/S1369-5274(00)00253-8; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hellingwerf KJ, 2005, TRENDS MICROBIOL, V13, P152, DOI 10.1016/j.tim.2005.02.001; Hoffer SM, 2001, J BACTERIOL, V183, P4914, DOI 10.1128/JB.183.16.4914-4917.2001; Holden NJ, 2004, J MED MICROBIOL, V53, P585, DOI 10.1099/jmm.0.05491-0; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Igoshin OA, 2006, MOL MICROBIOL, V61, P165, DOI 10.1111/j.1365-2958.2006.05212.x; Jan J, 2001, APPL MICROBIOL BIOT, V55, P69, DOI 10.1007/s002530000448; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; KOSHLAND DE, 1977, SCIENCE, V196, P1055, DOI 10.1126/science.870969; Krasnoselskij M. A., 1989, SYSTEMS HYSTERESIS; Kreuzer-Martin HW, 2004, J FORENSIC SCI, V49, P961; Kreuzer-Martin HW, 2004, J FORENSIC SCI, V49, P954; KUNST F, 1994, RES MICROBIOL, V145, P393, DOI 10.1016/0923-2508(94)90087-6; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LANDAUER TK, 1986, COGNITIVE SCI, V10, P477, DOI 10.1207/s15516709cog1004_4; LANDE R, 1988, P NATL ACAD SCI USA, V85, P7418, DOI 10.1073/pnas.85.19.7418; Lim HN, 2007, NAT GENET, V39, P269, DOI 10.1038/ng1956; MARAHIEL MA, 1993, MOL MICROBIOL, V7, P631, DOI 10.1111/j.1365-2958.1993.tb01154.x; Maynard Smith J., 1982, pi; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; MORIMOTO BH, 1991, FASEB J, V5, P2061, DOI 10.1096/fasebj.5.7.2010059; Msadek T, 1999, TRENDS MICROBIOL, V7, P201, DOI 10.1016/S0966-842X(99)01479-1; Novak B, 1998, BIOPHYS CHEM, V72, P185, DOI 10.1016/S0301-4622(98)00133-1; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Robinson TP, 1998, INT J FOOD MICROBIOL, V44, P83, DOI 10.1016/S0168-1605(98)00120-2; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rozen Y, 2001, FEMS MICROBIOL REV, V25, P513, DOI 10.1016/S0168-6445(01)00065-1; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Samoilov M, 2001, CHAOS, V11, P108, DOI 10.1063/1.1336499; Sanchez A, 2004, BIOTECHNOL LETT, V26, P403, DOI 10.1023/B:BILE.0000018259.66762.ed; Segel LA, 1998, BIOPHYS CHEM, V72, P223, DOI 10.1016/S0301-4622(98)00136-7; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; SHANNON CE, 1948, BELL SYSTEMS TECHNIC, V27; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Song H, 2006, BIOPHYS J, V90, P2309, DOI 10.1529/biophysj.105.074500; STAHL ML, 1984, J BACTERIOL, V158, P411, DOI 10.1128/JB.158.2.411-418.1984; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; VASTANO JA, 1988, PHYS REV LETT, V60, P1773, DOI 10.1103/PhysRevLett.60.1773; Veening JW, 2005, MOL MICROBIOL, V56, P1481, DOI 10.1111/j.1365-2958.2005.04659.x; VOIGT CA, 2004, B SUBTILIS SIN OPERO; Willeboordse FH, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026207; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X; WOLF DM, 2005, J THEOR BIO IN PRESS	81	81	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1700	10.1371/journal.pone.0001700	http://dx.doi.org/10.1371/journal.pone.0001700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18324309	Green Submitted, gold, Green Published			2022-12-25	WOS:000260586500044
J	Muller, A; Glattard, E; Taleb, O; Kemmel, V; Laux, A; Delalande, F; Roussel, G; Van Dorsselaer, A; Metz-Boutigue, MH; Aunis, D; Goumon, Y				Muller, Arnaud; Glattard, Elise; Taleb, Omar; Kemmel, Veronique; Laux, Alexis; Delalande, Francois; Roussel, Guy; Van Dorsselaer, Alain; Metz-Boutigue, Marie-Helene; Aunis, Dominique; Goumon, Yannick			Endogenous Morphine in SH-SY5Y Cells and the Mouse Cerebellum	PLOS ONE			English	Article								Background: Morphine, the principal active agent in opium, is not restricted to plants, but is also present in different animal tissues and cell types, including the mammalian brain. In fact, its biosynthetic pathway has been elucidated in a human neural cell line. These data suggest a role for morphine in brain physiology (e. g., neurotransmission), but this hypothesis remains a matter of debate. Recently, using the adrenal neuroendocrine chromaffin cell model, we have shown the presence of morphine-6-glucuronide (M6G) in secretory granules and their secretion products, leading us to propose that these endogenous alkaloids might represent new neuroendocrine factors. Here, we investigate the potential function of endogenous alkaloids in the central nervous system. Methodology and Principal Findings: Microscopy, molecular biology, electrophysiology, and proteomic tools were applied to human neuroblastoma SH-SY5Y cells (i) to characterize morphine and M6G, and (ii) to demonstrate the presence of the UDP-glucuronyltransferase 2B7 enzyme, which is responsible for the formation of M6G from morphine. We show that morphine is secreted in response to nicotine stimulation via a Ca2+-dependent mechanism involving specific storage and release mechanisms. We also show that morphine and M6G at concentrations as low as 10 210 M are able to evoke specific naloxone-reversible membrane currents, indicating possible autocrine/paracrine regulation in SH-SY5Y cells. Microscopy and proteomic approaches were employed to detect and quantify endogenous morphine in the mouse brain. Morphine is present in the hippocampus, cortex, olfactory bulb, and cerebellum at concentration ranging from 1.45 to 7.5 pmol/g. In the cerebellum, morphine immunoreactivity is localized to GABA basket cells and their termini, which form close contacts on Purkinje cell bodies. Conclusions/Significance: The presence of morphine in the brain and its localization in particular areas lead us to conclude that it has a specific function in neuromodulation and/or neurotransmission. Furthermore, its presence in cerebellar basket cell termini suggests that morphine has signaling functions in Purkinje cells that remain to be discovered.	[Muller, Arnaud; Glattard, Elise; Taleb, Omar; Kemmel, Veronique; Laux, Alexis; Delalande, Francois; Roussel, Guy; Metz-Boutigue, Marie-Helene; Aunis, Dominique; Goumon, Yannick] INSERM, U575, Physiopathol Syst Nerveux, Strasbourg, France; [Kemmel, Veronique; Roussel, Guy] Inst Chim Biol, Fac Med, Strasbourg, France; [Van Dorsselaer, Alain] Univ Louis Pasteur, LC4 UMR7178, ECPM, CNRS, Lab Spectrom Masse Bio Organ, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Muller, A (corresponding author), INSERM, U575, Physiopathol Syst Nerveux, Strasbourg, France.	yannick.goumon@inserm.u-strasbg.fr	Taleb, Omar/K-1457-2016; Dominique, Aunis/W-1419-2019; Kemmel, Veronique/O-9018-2015; Kemmel, Véronique/V-2590-2019	Taleb, Omar/0000-0003-2407-0380; Kemmel, Veronique/0000-0003-4680-4293; Kemmel, Véronique/0000-0003-4680-4293; Goumon, Yannick/0000-0003-4336-3437; , Elise/0000-0002-4501-9675; Laux-Biehlmann, Alexis/0000-0003-0508-3047; Delalande, Francois/0000-0003-3590-9874	Inserm; University Louis-Pasteur at Strasbourg; Fondation de France; French Ministere delegue a la Recherche et a l'Enseignement Superieur [fellowships]; Fondation Transplantation	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Louis-Pasteur at Strasbourg; Fondation de France(Fondation de France); French Ministere delegue a la Recherche et a l'Enseignement Superieur; Fondation Transplantation	This study was funded by Inserm, the University Louis-Pasteur at Strasbourg, the Fondation de France (to Y.G.), the French Ministere delegue a la Recherche et a l'Enseignement Superieur (Ph.D fellowships to E.G. and A.M.) and the Fondation Transplantation (to Y.G. and D.A.).	Agis-Torres A, 2002, NEUROSCI LETT, V331, P167, DOI 10.1016/S0304-3940(02)00881-9; Aunis D, 1998, INT REV CYTOL, V181, P213, DOI 10.1016/S0074-7696(08)60419-2; Boettcher C, 2005, P NATL ACAD SCI USA, V102, P8495, DOI 10.1073/pnas.0503244102; Brailoiu E, 2004, NEUROSCI LETT, V365, P10, DOI 10.1016/j.neulet.2004.03.092; Brands A, 2000, BIOCHEM PHARMACOL, V59, P1441, DOI 10.1016/S0006-2952(00)00274-4; Bushell T, 2002, BRIT J PHARMACOL, V135, P705, DOI 10.1038/sj.bjp.0704518; Cadet P, 2003, J IMMUNOL, V170, P5118, DOI 10.4049/jimmunol.170.10.5118; Cadet P, 2007, J IMMUNOL, V179, P5839, DOI 10.4049/jimmunol.179.9.5839; Doyle GA, 2007, GENE, V395, P98, DOI 10.1016/j.gene.2007.02.004; Figlewicz DP, 1999, EPILEPSY RES, V37, P203, DOI 10.1016/S0920-1211(99)00072-8; Gasnier C, 2004, PROTEOMICS, V4, P1789, DOI 10.1002/pmic.200300693; GINTZLER AR, 1978, SCIENCE, V199, P447, DOI 10.1126/science.339350; GIUDICI AM, 1992, EUR J CELL BIOL, V58, P383; GOLDSTEIN A, 1985, P NATL ACAD SCI USA, V82, P5203, DOI 10.1073/pnas.82.15.5203; Goodall AR, 1997, J NEUROCHEM, V68, P1542; Goumon Y, 2000, NEUROSCI LETT, V293, P135, DOI 10.1016/S0304-3940(00)01507-X; Goumon Y, 2006, J BIOL CHEM, V281, P8082, DOI 10.1074/jbc.M502298200; Goumon Y, 2004, J BIOL CHEM, V279, P13054, DOI 10.1074/jbc.M308533200; GRANDY DK, 1990, MOL ENDOCRINOL, V4, P1370, DOI 10.1210/mend-4-9-1370; Guarna M, 1998, J NEUROCHEM, V70, P147; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hauser KF, 2000, EUR J NEUROSCI, V12, P1281, DOI 10.1046/j.1460-9568.2000.01015.x; HAZUM E, 1981, SCIENCE, V213, P1010, DOI 10.1126/science.6267691; Hedou G, 2000, J COMP NEUROL, V426, P549, DOI 10.1002/1096-9861(20001030)426:4<549::AID-CNE4>3.0.CO;2-Y; Herbert RB, 2000, NAT PROD REP, V17, P317, DOI 10.1039/a809409h; Heurtaux T, 2006, NEUROPHARMACOLOGY, V50, P317, DOI 10.1016/j.neuropharm.2005.09.007; Horner KA, 2004, BRAIN RES, V1028, P121, DOI 10.1016/j.brainres.2004.07.055; King CD, 1999, ARCH BIOCHEM BIOPHYS, V365, P156, DOI 10.1006/abbi.1999.1155; Kream RM, 2006, MED SCI MONITOR, V12, pRA207; LEE CS, 1991, J PHARMACOL EXP THER, V257, P647; Liu AMF, 2005, NEUROSIGNALS, V14, P136, DOI 10.1159/000086296; Lotsch J, 2005, J PAIN SYMPTOM MANAG, V29, pS10, DOI 10.1016/j.jpainsymman.2005.01.004; Lotsch J, 2001, CLIN PHARMACOKINET, V40, P485; Lugardon K, 2000, J BIOL CHEM, V275, P10745, DOI 10.1074/jbc.275.15.10745; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Martinasevic MK, 1998, DRUG METAB DISPOS, V26, P1039; Meijerink WJHJ, 1999, SHOCK, V12, P165, DOI 10.1097/00024382-199909000-00001; MINAMI M, 1994, NEUROSCI RES, V18, P315, DOI 10.1016/0168-0102(94)90167-8; MOLINA PE, 1995, BIOCHEM BIOPH RES CO, V207, P312, DOI 10.1006/bbrc.1995.1189; Moron JA, 2007, MOL CELL PROTEOMICS, V6, P29, DOI 10.1074/mcp.M600184-MCP200; Mrkusich EM, 2004, DEV BRAIN RES, V148, P213, DOI 10.1016/j.devbrainres.2003.10.013; Nagano E, 2000, LIFE SCI, V67, P2453, DOI 10.1016/S0024-3205(00)00825-0; Ou XM, 1998, INT J MOL MED, V1, P105; PAHLMAN S, 1990, ACTA PHYSIOL SCAND, V140, P25; Pan YX, 2005, DNA CELL BIOL, V24, P736, DOI 10.1089/dna.2005.24.736; Pan YX, 2005, MOL PHARMACOL, V68, P866, DOI 10.1124/mol.105.011858; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Poeaknapo C, 2004, P NATL ACAD SCI USA, V101, P14091, DOI 10.1073/pnas.0405430101; ROSS RA, 1983, J NATL CANCER I, V71, P741; ROZENFELD R, 2007, FASEB J; Stefano GB, 2000, TRENDS NEUROSCI, V23, P436, DOI 10.1016/S0166-2236(00)01611-8; STEFANO GB, 1994, ADV NEUROIMMUNOL, V4, P57, DOI 10.1016/S0960-5428(05)80001-4; Suleman FG, 1998, ARCH BIOCHEM BIOPHYS, V358, P63, DOI 10.1006/abbi.1998.0842; TAGUCHI K, 1989, NEUROPHARMACOLOGY, V28, P235, DOI 10.1016/0028-3908(89)90098-1; Taguchi K, 2000, ACTA PHARMACOL SIN, V21, P877; Tenconi B, 1996, DEV BRAIN RES, V94, P175, DOI 10.1016/0165-3806(96)00047-8; van Dorp ELA, 2006, ANESTH ANALG, V102, P1789, DOI 10.1213/01.ane.0000217197.96784.c3; Vaughan CW, 1997, NATURE, V390, P611, DOI 10.1038/37610; VAUGHAN PFT, 1995, GEN PHARMACOL-VASC S, V26, P1191, DOI 10.1016/0306-3623(94)00312-B; WEITZ CJ, 1986, P NATL ACAD SCI USA, V83, P9784, DOI 10.1073/pnas.83.24.9784; Wu DF, 1997, DRUG METAB DISPOS, V25, P768; Yamada Hideyuki, 2003, J Toxicol Sci, V28, P395, DOI 10.2131/jts.28.395; Yu X, 2003, J PHARMACOL EXP THER, V306, P447, DOI 10.1124/jpet.103.048694; ZADINA JE, 1993, J PHARMACOL EXP THER, V265, P254; Zelcer N, 2005, P NATL ACAD SCI USA, V102, P7274, DOI 10.1073/pnas.0502530102; Zeng YS, 2007, BRAIN RES, V1130, P108, DOI 10.1016/j.brainres.2006.10.079; Zhang YH, 2006, BRAIN RES, V1099, P33, DOI 10.1016/j.brainres.2006.04.133; Zhu W, 2007, INT J IMMUNOPATH PH, V20, P229, DOI 10.1177/039463200702000203; Zhu W, 2006, MED SCI MONITOR, V12, pBR350; Zimmerman G, 2006, CELL TISSUE RES, V326, P655, DOI 10.1007/s00441-006-0239-8	70	30	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2008	3	2							e1641	10.1371/journal.pone.0001641	http://dx.doi.org/10.1371/journal.pone.0001641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XR	18327293	Green Published, Green Submitted, gold			2022-12-25	WOS:000260586400034
J	Hayashi, C; Ono, Y; Doi, N; Kitamura, F; Tagami, M; Mineki, R; Arai, T; Taguchi, H; Yanagida, M; Hirner, S; Labeit, D; Labeit, S; Sorimachi, H				Hayashi, Chikako; Ono, Yasuko; Doi, Naoko; Kitamura, Fujiko; Tagami, Mai; Mineki, Reiko; Arai, Takao; Taguchi, Hayao; Yanagida, Mitsuaki; Hirner, Stephanie; Labeit, Dietmar; Labeit, Siegfried; Sorimachi, Hiroyuki			Multiple molecular interactions implicate the connectin/titin N2A region as a modulating scaffold for p94/calpain 3 activity in skeletal muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN-REPEAT PROTEIN; DYSTROPHY TYPE 2A; MYOGENIC REGULATORY FACTORS; SPINAL MUSCULAR-ATROPHY; IN-VIVO; CONGENITAL MYOPATHY; ELASTIC PROTEIN; CALPAIN SYSTEM; MYOSITIS MDM; TITIN	p94/calpain 3 is a skeletal muscle-specific Ca2+-regulated cysteine protease (calpain), and genetic loss of p94 protease activity causes muscular dystrophy (calpainopathy). In addition, a small in-frame deletion in the N2A region of connectin/titin that impairs p94-connectin interaction causes a severe muscular dystrophy (mdm) in mice. Since p94 via its interaction with the N2A and M-line regions of connectin becomes part of the connectin filament system that serves as a molecular scaffold for the myofibril, it has been proposed that structural and functional integrity of the p94-connectin complex is essential for health and maintenance of myocytes. In this study, we have surveyed the interactions made by p94 and connectin N2A inside COS7 cells. This revealed that p94 binds to connectin at multiple sites, including newly identified loci in the N2A and PEVK regions of connectin. Functionally, p94-N2A interactions suppress p94 autolysis and protected connectin from proteolysis. The connectin N2A region also contains a binding site for the muscle ankyrin repeat proteins (MARPs), a protein family involved in the cellular stress responses. MARP2/Ankrd2 competed with p94 for binding to connectin and was also proteolyzed by p94. Intriguingly, a connectin N2A fragment with the mdm deletion possessed enhanced resistance to proteases, including p94, and its interaction with MARPs was weakened. Our data support a model in which MARP2-p94 signaling converges within the N2A connectin segment and the mdm deletion disrupts their coordination. These results also implicate the dynamic nature of connectin molecule as a regulatory scaffold of p94 functions.	[Hayashi, Chikako; Ono, Yasuko; Doi, Naoko; Kitamura, Fujiko; Tagami, Mai; Sorimachi, Hiroyuki] Tokyo Metropolitan Inst Med Sci, Dept Enzymat Regulat Cell Funct, Calpain Project, Bunkyo Ku, Tokyo 1138613, Japan; [Hayashi, Chikako; Arai, Takao; Taguchi, Hayao] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Chiba 2788570, Japan; [Doi, Naoko] Japan Sci & Technol, CREST, Kawaguchi, Saitama 3320012, Japan; [Mineki, Reiko] Juntendo Univ, Grad Sch Med, Ctr Biomed Res, Chiba 2790021, Japan; [Hirner, Stephanie; Labeit, Dietmar; Labeit, Siegfried] Univ Klinikum Mannheim, Inst Anasthesiol & Operat Intensivmed, D-68167 Mannheim, Germany; [Yanagida, Mitsuaki] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Chiba 2790021, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo University of Science; Japan Science & Technology Agency (JST); Juntendo University; Ruprecht Karls University Heidelberg; Juntendo University	Ono, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Enzymat Regulat Cell Funct, Calpain Project, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.	yakoono@rinshoken.or.jp	Sorimachi, Hiroyuki/C-6448-2009; Sorimachi, Hiroyuki/Q-6956-2017	Sorimachi, Hiroyuki/0000-0001-9509-6727; Sorimachi, Hiroyuki/0000-0001-9509-6727; Taguchi, Hayao/0000-0001-5270-581X				Aihara Y, 2000, HYPERTENSION, V36, P48, DOI 10.1161/01.HYP.36.1.48; Alderton JM, 2000, TRENDS CARDIOVAS MED, V10, P268, DOI 10.1016/S1050-1738(00)00075-X; Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Bassaglia Y, 2005, EXP CELL RES, V302, P221, DOI 10.1016/j.yexcr.2004.08.038; Carson JA, 2001, FASEB J, V15, P207, DOI 10.1096/fj.01-0544fje; Centner T, 2000, ADV EXP MED BIOL, V481, P35; Chen YW, 2002, J PHYSIOL-LONDON, V545, P27, DOI 10.1113/jphysiol.2002.021220; Cohen N, 2006, PROTEOMICS, V6, P6075, DOI 10.1002/pmic.200600199; Dedieu S, 2003, J MOL BIOL, V326, P453, DOI 10.1016/S0022-2836(02)01310-4; Dedieu S, 2004, EXP CELL RES, V292, P187, DOI 10.1016/j.yexcr.2003.08.014; Garvey SM, 2002, GENOMICS, V79, P146, DOI 10.1006/geno.2002.6685; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Heimann P, 1996, CELL TISSUE RES, V283, P435, DOI 10.1007/s004410050554; Helmes M, 1996, CIRC RES, V79, P619, DOI 10.1161/01.RES.79.3.619; Hentzen ER, 2006, J PHYSIOL-LONDON, V570, P157, DOI 10.1113/jphysiol.2005.093005; Herasse M, 1999, MOL CELL BIOL, V19, P4047; Huebsch KA, 2005, HUM MOL GENET, V14, P2801, DOI 10.1093/hmg/ddi313; Ikeda K, 2003, J BIOL CHEM, V278, P3514, DOI 10.1074/jbc.M204563200; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Kinbara K, 1997, ARCH BIOCHEM BIOPHYS, V342, P99, DOI 10.1006/abbi.1997.0108; Kinbara K, 1998, BIOCHEM J, V335, P589, DOI 10.1042/bj3350589; Kojic S, 2004, J MOL BIOL, V339, P313, DOI 10.1016/j.jmb.2004.03.071; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Laval M, 2002, BBA-GEN SUBJECTS, V1570, P121, DOI 10.1016/S0304-4165(02)00184-8; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; MARUYAMA K, 1976, J BIOCHEM-TOKYO, V80, P405, DOI 10.1093/oxfordjournals.jbchem.a131291; Maruyama K, 1997, FASEB J, V11, P341, DOI 10.1096/fasebj.11.5.9141500; Miller MK, 2004, TRENDS CELL BIOL, V14, P119, DOI 10.1016/j.tcb.2004.01.003; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Nakada C, 2004, PATHOBIOLOGY, V71, P43, DOI 10.1159/000072961; Nakada C, 2003, PATHOL INT, V53, P653, DOI 10.1046/j.1440-1827.2003.01541.x; Nakamura K, 2002, PATHOBIOLOGY, V70, P197, DOI 10.1159/000069329; Ojima K, 2007, J BIOL CHEM, V282, P14493, DOI 10.1074/jbc.M610806200; Ono Y, 2004, J BIOL CHEM, V279, P2761, DOI 10.1074/jbc.M308789200; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Y, 2008, FEBS LETT, V582, P691, DOI 10.1016/j.febslet.2008.01.044; Ono Yasuko, 2007, Biotechnology Journal, V2, P565, DOI 10.1002/biot.200700018; Ono Y, 2006, J BIOL CHEM, V281, P18519, DOI 10.1074/jbc.M601029200; Raynaud F, 2005, FEBS J, V272, P2578, DOI 10.1111/j.1742-4658.2005.04683.x; Raynaud F, 2004, EXP CELL RES, V298, P48, DOI 10.1016/j.yexcr.2004.03.053; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Richard I, 2000, J CELL BIOL, V151, P1583, DOI 10.1083/jcb.151.7.1583; Sato N, 2003, MOL CELL BIOL, V23, P6662, DOI 10.1128/MCB.23.18.6662-6671.2003; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Spencer MJ, 2002, HUM MOL GENET, V11, P2645, DOI 10.1093/hmg/11.21.2645; Spencer MJ, 2002, P NATL ACAD SCI USA, V99, P8874, DOI 10.1073/pnas.132269299; SUGITA H, 1980, MUSCLE NERVE, V3, P335, DOI 10.1002/mus.880030410; Suzuki A, 1996, ADV BIOPHYS, V33, P53; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Tagawa K, 2000, HUM MOL GENET, V9, P1393, DOI 10.1093/hmg/9.9.1393; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Taylor RG, 1997, J MUSCLE RES CELL M, V18, P285, DOI 10.1023/A:1018665924412; TOKUYASU KT, 1987, J CELL BIOL, V105, P2795, DOI 10.1083/jcb.105.6.2795; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Tsukamoto Y, 2002, LAB INVEST, V82, P645, DOI 10.1038/labinvest.3780459; Witt SH, 2005, J MUSCLE RES CELL M, V26, P401, DOI 10.1007/s10974-005-9022-9; Wittt CC, 2004, J MOL BIOL, V336, P145, DOI 10.1016/j.jmb.2003.12.021; ZAK R, 1977, J BIOL CHEM, V252, P3430; Zou YM, 1997, DEVELOPMENT, V124, P793	65	84	86	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14801	14814		10.1074/jbc.M708262200	http://dx.doi.org/10.1074/jbc.M708262200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18310072	hybrid			2022-12-25	WOS:000255941400068
J	Kim, SJ; Son, TG; Park, HR; Park, M; Kim, MS; Kim, HS; Chung, HY; Mattson, MP; Lee, J				Kim, So Jung; Son, Tae Gen; Park, Hee Ra; Park, Mikyung; Kim, Min-Sun; Kim, Hyung Sik; Chung, Hae Young; Mattson, Mark P.; Lee, Jaewon			Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC BRAIN-INJURY; DIETARY RESTRICTION; NEUROTROPHIC FACTOR; OXIDATIVE DAMAGE; HEME OXYGENASE-1; DENTATE GYRUS; STEM-CELLS; NEURONS; INCREASES; EXPRESSION	Curcumin is a natural phenolic component of yellow curry spice, which is used in some cultures for the treatment of diseases associated with oxidative stress and inflammation. Curcumin has been reported to be capable of preventing the death of neurons in animal models of neurodegenerative disorders, but its possible effects on developmental and adult neuroplasticity are unknown. In the present study, we investigated the effects of curcumin on mouse multi-potent neural progenitor cells (NPC) and adult hippocampal neurogenesis. Curcumin exerted biphasic effects on cultured NPC; low concentrations stimulated cell proliferation, whereas high concentrations were cytotoxic. Curcumin activated extracellular signal-regulated kinases (ERKs) and p38 kinases, cellular signal transduction pathways known to be involved in the regulation of neuronal plasticity and stress responses. Inhibitors of ERKs and p38 kinases effectively blocked the mitogenic effect of curcumin in NPC. Administration of curcumin to adult mice resulted in a significant increase in the number of newly generated cells in the dentate gyrus of hippocampus, indicating that curcumin enhances adult hippocampal neurogenesis. Our findings suggest that curcumin can stimulate developmental and adult hippocampal neurogenesis, and a biological activity that may enhance neural plasticity and repair.	[Kim, So Jung; Park, Hee Ra; Park, Mikyung; Kim, Min-Sun; Kim, Hyung Sik; Chung, Hae Young; Lee, Jaewon] Pusan Natl Univ, Dept Pharm, Coll Pharm, Pusan 609735, South Korea; [Kim, So Jung; Park, Hee Ra; Park, Mikyung; Kim, Min-Sun; Kim, Hyung Sik; Chung, Hae Young; Lee, Jaewon] Pusan Natl Univ, Res Inst Drug Dev, Longev Life Sci & Technol Inst, Pusan 609735, South Korea; [Son, Tae Gen; Mattson, Mark P.] NIA, Neurosci Lab, NIH, Baltimore, MD 21224 USA	Pusan National University; Pusan National University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lee, J (corresponding author), Pusan Natl Univ, Dept Pharm, Coll Pharm, Pusan 609735, South Korea.	neuron@pusan.ac.kr	Mattson, Mark P/F-6038-2012; Lee, Jaewon/N-9064-2013	Lee, Jaewon/0000-0003-3203-2130	NATIONAL INSTITUTE ON AGING [ZIAAG000312, ZIAAG000331, ZIAAG000324, Z01AG000315, Z01AG000314, Z01AG000324, ZIAAG000315, ZIAAG000314, Z01AG000312] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aggarwal BB, 2007, BIOCHEM PHARMACOL, V73, P1024, DOI 10.1016/j.bcp.2006.12.010; Al-Omar FA, 2006, NEUROCHEM RES, V31, P611, DOI 10.1007/s11064-006-9059-1; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167; Baek OS, 2003, CLIN CHIM ACTA, V338, P135, DOI 10.1016/j.cccn.2003.08.015; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; Calabrese Vittorio, 2003, Ital J Biochem, V52, P177; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Chen H, 1999, ANTICANCER RES, V19, P3675; Cheng AW, 2004, DEV BIOL, V272, P203, DOI 10.1016/j.ydbio.2004.04.031; Cheng AW, 2001, J BIOL CHEM, V276, P43320, DOI 10.1074/jbc.M107698200; Chuang SE, 2000, CARCINOGENESIS, V21, P331, DOI 10.1093/carcin/21.2.331; Duvoix A, 2005, CANCER LETT, V223, P181, DOI 10.1016/j.canlet.2004.09.041; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; HUANG MT, 1991, CANCER RES, V51, P813; Jackson-Guilford J, 2000, NEUROSCI LETT, V293, P91, DOI 10.1016/S0304-3940(00)01502-0; Kalluri HSG, 2007, NEUROSCI LETT, V426, P145, DOI 10.1016/j.neulet.2007.08.047; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lim MS, 2007, BIOCHEM BIOPH RES CO, V357, P903, DOI 10.1016/j.bbrc.2007.04.045; Lin JK, 2007, ADV EXP MED BIOL, V595, P227; Lodha R., 2000, Annals Academy of Medicine Singapore, V29, P37; Mattson MP, 2006, TRENDS NEUROSCI, V29, P632, DOI 10.1016/j.tins.2006.09.001; McNally SJ, 2007, INT J MOL MED, V19, P165; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Niles LP, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-41; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Parent JM, 2007, PROG BRAIN RES, V163, P529, DOI 10.1016/S0079-6123(07)63028-3; Parent JM, 1997, J NEUROSCI, V17, P3727; Piper JT, 1998, INT J BIOCHEM CELL B, V30, P445, DOI 10.1016/S1357-2725(98)00015-6; Rao CV, 1995, ANN NY ACAD SCI, V768, P201, DOI 10.1111/j.1749-6632.1995.tb12122.x; RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J; Salvioli S, 2007, EVID-BASED COMPL ALT, V4, P181, DOI 10.1093/ecam/nem043; Scapagnini G, 2006, ANTIOXID REDOX SIGN, V8, P395, DOI 10.1089/ars.2006.8.395; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Shin HJ, 2007, NEUROSCI LETT, V416, P49, DOI 10.1016/j.neulet.2007.01.060; Shishodia S, 2005, ANN NY ACAD SCI, V1056, P206, DOI 10.1196/annals.1352.010; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Suh HW, 2007, MOL CELL BIOCHEM, V298, P187, DOI 10.1007/s11010-006-9365-6; Sumanont Y, 2006, LIFE SCI, V78, P1884, DOI 10.1016/j.lfs.2005.08.028; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Thiyagarajan M, 2004, LIFE SCI, V74, P969, DOI 10.1016/j.lfs.2003.06.042; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Xiao ZF, 2007, CELL RES, V17, P73, DOI 10.1038/sj.cr.7310126; Xu Y, 2007, BRAIN RES, V1162, P9, DOI 10.1016/j.brainres.2007.05.071; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yang Y, 2006, NEUROREPORT, V17, P235, DOI 10.1097/01.wnr.0000199470.29357.8f; Zbarsky V, 2005, FREE RADICAL RES, V39, P1119, DOI 10.1080/10715760500233113; Zhang M, 2006, INT IMMUNOPHARMACOL, V6, P1233, DOI 10.1016/j.intimp.2006.02.013; Zhu YG, 2004, ACTA PHARMACOL SIN, V25, P1606	60	256	272	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14497	14505		10.1074/jbc.M708373200	http://dx.doi.org/10.1074/jbc.M708373200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18362141	hybrid, Green Published			2022-12-25	WOS:000255941400037
J	Kinderlerer, AR; Ali, F; Johns, M; Lidington, EA; Leung, V; Boyle, JJ; Hamdulay, SS; Evans, PC; Haskard, DO; Mason, JC				Kinderlerer, Anne R.; Ali, Faisal; Johns, Michael; Lidington, Elaine A.; Leung, Viola; Boyle, Joseph J.; Hamdulay, Shahir S.; Evans, Paul C.; Haskard, Dorian O.; Mason, Justin C.			KLF2-dependent, shear stress-induced expression of CD59 - A novel cytoprotective mechanism against complement-mediated injury in the vasculature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DECAY-ACCELERATING FACTOR; NF-KAPPA-B; MEMBRANE-ATTACK COMPLEX; STATIN-INDUCED EXPRESSION; LOW-DENSITY-LIPOPROTEIN; ENDOTHELIAL-CELLS; ADHESION MOLECULES; GENE-EXPRESSION; IN-VITRO; ACTIVATION	Complement activation may predispose to vascular injury and atherogenesis. The atheroprotective actions of unidirectional laminar shear stress led us to explore its influence on endothelial cell expression of complement inhibitory proteins CD59 and decay-accelerating factor. Human umbilical vein and aortic endothelial cells were exposed to laminar shear stress (12 dynes/cm(2)) or disturbed flow (+/-5 dynes/cm(2) at 1Hz) in a parallel plate flow chamber. Laminar shear induced a flow rate-dependent increase in steady-state CD59 mRNA, reaching 4-fold at 12 dynes/cm(2). Following 24-48 h of laminar shear stress, cell surface expression of CD59 was up-regulated by 100%, whereas decay-accelerating factor expression was unchanged. The increase in CD59 following laminar shear was functionally significant, reducing C9 deposition and complement-mediated lysis of flow-conditioned endothelial cells by 50%. Although CD59 induction was independent of PI3-K, ERK1/2 and nitric oxide, an RNA interference approach demonstrated dependence upon an ERK5/KLF2 signaling pathway. In contrast to laminar shear stress, disturbed flow failed to induce endothelial cell CD59 protein expression. Likewise, CD59 expression on vascular endothelium was significantly higher in atheroresistant regions of the murine aorta exposed to unidirectional laminar shear stress, when compared with atheroprone areas exposed to disturbed flow. We propose that up-regulation of CD59 via ERK5/KLF2 activation leads to endothelial resistance to complement-mediated injury and protects from atherogenesis in regions of laminar shear stress.	[Kinderlerer, Anne R.; Ali, Faisal; Johns, Michael; Lidington, Elaine A.; Leung, Viola; Boyle, Joseph J.; Hamdulay, Shahir S.; Evans, Paul C.; Haskard, Dorian O.; Mason, Justin C.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Bywaters Ctr Vasc Inflammat, Natl Heart & Lung Inst, London W12 ONN, England	Imperial College London	Mason, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Bywaters Ctr Vasc Inflammat, Natl Heart & Lung Inst, Du Cane Rd, London W12 ONN, England.	justin.mason@imperial.ac.uk		Mason, Justin/0000-0001-7783-1660; Boyle, Joseph J/0000-0002-4337-3320; Evans, Paul/0000-0001-7975-681X	Arthritis Research UK Funding Source: Medline; British Heart Foundation [FS/13/12/30037] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation)		Accardo-Palumbo A, 2000, DIABETOLOGIA, V43, P1039, DOI 10.1007/s001250051487; Acosta J, 2000, P NATL ACAD SCI USA, V97, P5450, DOI 10.1073/pnas.97.10.5450; Albrecht EA, 2004, AM J PATHOL, V164, P849, DOI 10.1016/S0002-9440(10)63173-2; Ali F, 2007, J THROMB HAEMOST, V5, P2537, DOI 10.1111/j.1538-7836.2007.02787.x; BENZAQUEN LR, 1994, J EXP MED, V179, P985, DOI 10.1084/jem.179.3.985; BHAKDI S, 1995, J EXP MED, V182, P1959, DOI 10.1084/jem.182.6.1959; Bhatia VK, 2007, AM J PATHOL, V170, P416, DOI 10.2353/ajpath.2007.060406; Bongrazio M, 2003, MOL IMMUNOL, V39, P669, DOI 10.1016/S0161-5890(02)00215-8; Chappell DC, 1998, CIRC RES, V82, P532, DOI 10.1161/01.RES.82.5.532; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656, DOI 10.1161/01.ATV.19.3.656; Dimmeler S, 2002, CURR OPIN LIPIDOL, V13, P531, DOI 10.1097/00041433-200210000-00009; Fleming SD, 2004, J IMMUNOL, V173, P7055, DOI 10.4049/jimmunol.173.11.7055; Garin G, 2006, ENDOTHELIUM-J ENDOTH, V13, P375, DOI 10.1080/10623320601061599; Hajra L, 2000, P NATL ACAD SCI USA, V97, P9052, DOI 10.1073/pnas.97.16.9052; HARADA R, 1990, J IMMUNOL, V144, P1823; Hindmarsh EJ, 1998, J IMMUNOL, V160, P6128; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kilgore KS, 1997, AM J PATHOL, V150, P2019; Kinderlerer AR, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2019; Lidington EA, 2005, AM J PHYSIOL-CELL PH, V289, pC1437, DOI 10.1152/ajpcell.00502.2004; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; LOZADA C, 1995, P NATL ACAD SCI USA, V92, P8378, DOI 10.1073/pnas.92.18.8378; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Mason JC, 1999, BLOOD, V94, P1673, DOI 10.1182/blood.V94.5.1673.417a05_1673_1682; Mason JC, 2002, CIRC RES, V91, P696, DOI 10.1161/01.RES.0000038151.57577.19; Navratil JS, 2001, J IMMUNOL, V166, P3231, DOI 10.4049/jimmunol.166.5.3231; Okada N, 1989, Int Immunol, V1, P205, DOI 10.1093/intimm/1.2.205; Orr AW, 2005, J CELL BIOL, V169, P191, DOI 10.1083/jcb.200410073; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Parmar KM, 2005, J BIOL CHEM, V280, P26714, DOI 10.1074/jbc.C500144200; Partridge J, 2007, FASEB J, V21, P3553, DOI 10.1096/fj.06-8059com; Pi XC, 2004, CIRC RES, V94, P362, DOI 10.1161/01.RES.0000112406.27800.6F; Qin XB, 2004, DIABETES, V53, P2653, DOI 10.2337/diabetes.53.10.2653; SAADI S, 1995, J EXP MED, V182, P1807, DOI 10.1084/jem.182.6.1807; SEIFERT PS, 1990, J EXP MED, V172, P547, DOI 10.1084/jem.172.2.547; SEIFERT PS, 1989, LAB INVEST, V60, P747; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Sheikh S, 2003, BLOOD, V102, P2828, DOI 10.1182/blood-2003-01-0080; Sohn SJ, 2005, MOL CELL BIOL, V25, P8553, DOI 10.1128/MCB.25.19.8553-8566.2005; Steinberg R, 2007, J BIOL CHEM, V282, P32288, DOI 10.1074/jbc.M704001200; Tedesco F, 1997, J EXP MED, V185, P1619, DOI 10.1084/jem.185.9.1619; Torzewski J, 1998, ARTERIOSCL THROM VAS, V18, P1386, DOI 10.1161/01.ATV.18.9.1386; Torzewski M, 1997, ARTERIOSCL THROM VAS, V17, P2448, DOI 10.1161/01.ATV.17.11.2448; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Urbich C, 2000, CIRCULATION, V101, P352, DOI 10.1161/01.CIR.101.4.352; VANDENBERG CW, 1994, J IMMUNOL, V152, P4095; Viedt C, 2000, FASEB J, V14, P2370; VLAICU R, 1985, ATHEROSCLEROSIS, V57, P163, DOI 10.1016/0021-9150(85)90030-9; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Yamawaki H, 2003, CIRCULATION, V108, P1619, DOI 10.1161/01.CIR.0000089373.49941.C4	56	43	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14636	14644		10.1074/jbc.M800362200	http://dx.doi.org/10.1074/jbc.M800362200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18362151	hybrid, Green Submitted			2022-12-25	WOS:000255941400052
J	Parsons, JB; Dinesh, SD; Deery, E; Leech, HK; Brindley, AA; Heldt, D; Frank, S; Smales, CM; Lunsdorf, H; Rambach, A; Gass, MH; Bleloch, A; McClean, KJ; Munro, AW; Rigby, SEJ; Warren, MJ; Prentice, MB				Parsons, Joshua B.; Dinesh, Sriramulu D.; Deery, Evelyne; Leech, Helen K.; Brindley, Amanda A.; Heldt, Dana; Frank, Steffanie; Smales, C. Mark; Luensdorf, Heinrich; Rambach, Alain; Gass, Mhairi H.; Bleloch, Andrew; McClean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.; Warren, Martin J.; Prentice, Michael B.			Biochemical and structural insights into bacterial organelle form and biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME B-12-DEPENDENT DEGRADATION; SALMONELLA-ENTERICA; GENOME SEQUENCE; CARBOXYSOMES; TYPHIMURIUM; 1,2-PROPANEDIOL; EVOLUTION; PROTEIN; GENES; SHELL	Many heterotrophic bacteria have the ability to make polyhedral structures containing metabolic enzymes that are bounded by a unilamellar protein shell (metabolosomes or enterosomes). These bacterial organelles contain enzymes associated with a specific metabolic process ( e. g. 1,2-propanediol or ethanolamine utilization). We show that the 21 gene regulon specifying the pdu organelle and propanediol utilization enzymes from Citrobacter freundii is fully functional when cloned in Escherichia coli, both producing metabolosomes and allowing propanediol utilization. Genetic manipulation of the level of specific shell proteins resulted in the formation of aberrantly shaped metabolosomes, providing evidence for their involvement as delimiting entities in the organelle. This is the first demonstration of complete recombinant metabolosome activity transferred in a single step and supports phylogenetic evidence that the pdu genes are readily horizontally transmissible. One of the predicted shell proteins ( PduT) was found to have a novel Fe-S center formed between four protein subunits. The recombinant model will facilitate future experiments establishing the structure and assembly of these multiprotein assemblages and their fate when the specific metabolic function is no longer required.	[Parsons, Joshua B.; Deery, Evelyne; Leech, Helen K.; Brindley, Amanda A.; Heldt, Dana; Frank, Steffanie; Smales, C. Mark; Warren, Martin J.] Univ Kent, Dept Biochem, Prot Sci Grp, Canterbury CT2 7NJ, Kent, England; [Dinesh, Sriramulu D.; Prentice, Michael B.] Natl Univ Ireland Univ Coll Cork, Dept Pathol, Cork, Ireland; [Dinesh, Sriramulu D.; Prentice, Michael B.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Luensdorf, Heinrich] Helmholtz Ctr Infect Res, Dept Vaccinol, D-38124 Braunschweig, Germany; [Rambach, Alain] CHROMagar, F-75006 Paris, France; [Gass, Mhairi H.; Bleloch, Andrew] SERC, Daresbury Lab, SuperSTEM Facil, Warrington WA4 4AD, Cheshire, England; [McClean, Kirsty J.; Munro, Andrew W.] Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, Manchester M1 7DN, Lancs, England; [Rigby, Stephen E. J.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of Kent; University College Cork; University College Cork; Helmholtz Association; Helmholtz-Center for Infection Research; STFC Daresbury Laboratory; University of Manchester; University of London	Warren, MJ (corresponding author), Univ Kent, Dept Biochem, Prot Sci Grp, Canterbury CT2 7NJ, Kent, England.	m.j.warren@kent.ac.uk; m.prentice@ucc.ie	Bleloch, Andrew/A-1350-2009; Prentice, Michael/AAE-7246-2019; Munro, Andrew/G-5639-2019	Prentice, Michael/0000-0003-1117-2388; Munro, Andrew/0000-0002-4642-180X; Parsons, Joshua/0000-0002-0589-3587; Frank, Stefanie/0000-0003-3153-6417; Smales, Christopher Mark/0000-0002-2762-4724; Warren, Martin/0000-0002-6028-6456	BBSRC [BB/E010563/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E010563/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abrescia NGA, 2004, NATURE, V432, P68, DOI 10.1038/nature03056; ALHASHIMI A, 2002, OMICS, V6, P305; ALLEN LN, 1985, J BACTERIOL, V161, P955, DOI 10.1128/JB.161.3.955-962.1985; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Brinsmade SR, 2005, J BACTERIOL, V187, P8039, DOI 10.1128/JB.187.23.8039-8046.2005; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Buchrieser C, 2003, FEMS IMMUNOL MED MIC, V35, P207, DOI 10.1016/S0928-8244(02)00448-0; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Fokine A, 2005, P NATL ACAD SCI USA, V102, P7163, DOI 10.1073/pnas.0502164102; Forouhar Farhad, 2007, Journal of Structural and Functional Genomics, V8, P37, DOI 10.1007/s10969-007-9018-3; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Lawrence JG, 1996, GENETICS, V142, P11; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; Prentice MB, 2003, ADV EXP MED BIOL, V529, P43; Raux E, 1996, J BACTERIOL, V178, P753, DOI 10.1128/jb.178.3.753-767.1996; Sampson EM, 2005, MICROBIOL-SGM, V151, P1169, DOI 10.1099/mic.0.27755-0; Sauvageot N, 2002, FEMS MICROBIOL LETT, V209, P69, DOI 10.1111/j.1574-6968.2002.tb11111.x; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Shively JM, 2001, CURR OPIN MICROBIOL, V4, P301, DOI 10.1016/S1369-5274(00)00207-1; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; TORAYA T, 1979, J BACTERIOL, V139, P39, DOI 10.1128/JB.139.1.39-47.1979; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144	33	109	137	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14366	14375		10.1074/jbc.M709214200	http://dx.doi.org/10.1074/jbc.M709214200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18332146	hybrid			2022-12-25	WOS:000255941400023
J	Schobel, S; Neumann, S; Hertweck, M; Dislich, B; Kuhn, PH; Kremmer, E; Seed, B; Baumeister, R; Haass, C; Lichtenthaler, SF				Schoebel, Susanne; Neumann, Stephanie; Hertweck, Maren; Dislich, Bastian; Kuhn, Peer-Hendrik; Kremmer, Elisabeth; Seed, Brian; Baumeister, Ralf; Haass, Christian; Lichtenthaler, Stefan F.			A novel sorting nexin modulates endocytic trafficking and alpha-secretase cleavage of the amyloid precursor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MARIE-TOOTH DISEASE; ALZHEIMERS-DISEASE; BETA-SECRETASE; GAMMA-SECRETASE; C-ELEGANS; DOMAIN PROTEINS; MUTATION CAUSES; DYNAMIN; ECTODOMAIN	Ectodomain shedding of the amyloid precursor protein (APP) by the two proteases alpha- and beta-secretase is a key regulatory event in the generation of the Alzheimer disease amyloid beta peptide (A beta). beta-Secretase catalyzes the first step in A beta generation, whereas alpha-secretase cleaves within the A beta domain, prevents A beta generation, and generates a secreted form of APP with neuroprotective properties. At present, little is known about the cellular mechanisms that control APP alpha-secretase cleavage and A beta generation. To explore the contributory pathways, we carried out an expression cloning screen. We identified a novel member of the sorting nexin (SNX) family of endosomal trafficking proteins, called SNX33, as a new activator of APP alpha-secretase cleavage. SNX33 is a homolog of SNX9 and was found to be a ubiquitously expressed phosphoprotein. Exogenous expression of SNX33 in cultured cells increased APP alpha-secretase cleavage 4- fold but surprisingly had little effect on beta-secretase cleavage. This effect was similar to the expression of the dominant negative dynamin-1 mutant K44A. SNX33 bound the endocytic GTPase dynamin and reduced the rate of APP endocytosis in a dynamin-dependent manner. This led to an increase of APP at the plasma membrane, where alpha-secretase cleavage mostly occurs. In summary, our study identifies SNX33 as a new endocytic protein, which modulates APP endocytosis and APP alpha-secretase cleavage, and demonstrates that the rate of APP endocytosis is a major control factor for APP alpha-secretase cleavage.	[Schoebel, Susanne; Neumann, Stephanie; Dislich, Bastian; Kuhn, Peer-Hendrik; Haass, Christian; Lichtenthaler, Stefan F.] Univ Munich, Ctr Integrated Prot Sci, D-80336 Munich, Germany; [Schoebel, Susanne; Neumann, Stephanie; Dislich, Bastian; Kuhn, Peer-Hendrik; Haass, Christian; Lichtenthaler, Stefan F.] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Hertweck, Maren; Baumeister, Ralf] Univ Freiburg, Ctr Biochem & Mol Cell Res, ZBMZ, Fac Med,Fac Biol,Inst Biol 3, D-79104 Freiburg, Germany; [Baumeister, Ralf] Univ Freiburg, Ctr Syst Biol, ZBSA, D-79104 Freiburg, Germany; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, D-81377 Munich, Germany; [Seed, Brian] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol, Boston, MA 02114 USA	University of Munich; University of Munich; University of Freiburg; University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lichtenthaler, SF (corresponding author), Univ Munich, Ctr Integrated Prot Sci, Schillerstr 44, D-80336 Munich, Germany.	Stefan.Lichtenthaler@med.uni-muenchen.de	Lichtenthaler, Stefan F/B-6587-2016	Lichtenthaler, Stefan F/0000-0003-2211-2575; Kuhn, Peer-Hendrik/0000-0001-7891-5102				Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Badour K, 2007, P NATL ACAD SCI USA, V104, P1593, DOI 10.1073/pnas.0610543104; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Childress C, 2006, BIOCHEM J, V394, P693, DOI 10.1042/BJ20050576; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fabrizi GM, 2007, NEUROLOGY, V69, P291, DOI 10.1212/01.wnl.0000265820.51075.61; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; Lichtenthaler SF, 2006, NEURODEGENER DIS, V3, P262, DOI 10.1159/000095265; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Neumann S, 2006, J BIOL CHEM, V281, P7583, DOI 10.1074/jbc.M508340200; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Schobel S, 2006, INT J DEV NEUROSCI, V24, P141, DOI 10.1016/j.ijdevneu.2005.11.003; Seet LF, 2006, BBA-MOL CELL BIOL L, V1761, P878, DOI 10.1016/j.bbalip.2006.04.011; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Shin N, 2007, J BIOL CHEM, V282, P28939, DOI 10.1074/jbc.M700283200; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Worby CA, 2001, J BIOL CHEM, V276, P41782, DOI 10.1074/jbc.M107080200; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	55	66	72	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14257	14268		10.1074/jbc.M801531200	http://dx.doi.org/10.1074/jbc.M801531200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18353773	hybrid			2022-12-25	WOS:000255941400012
J	Caughey, GH; Beauchamp, J; Schlatter, D; Raymond, WW; Trivedi, NN; Banner, D; Mauser, H; Fingerle, J				Caughey, George H.; Beauchamp, Jeremy; Schlatter, Daniel; Raymond, Wilfred W.; Trivedi, Neil N.; Banner, David; Mauser, Harald; Fingerle, Juergen			Guinea pig chymase is leucine-specific - A novel example of functional plasticity in the chymase/granzyme family of serine peptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAST-CELL CHYMASE; EXTENDED SUBSTRATE-SPECIFICITY; ANGIOTENSIN-II GENERATION; RODENT ALPHA-CHYMASES; HUMAN CATHEPSIN-G; IN-VIVO; MAMMALIAN EVOLUTION; BETA-CHYMASES; PROTEASE; INHIBITOR	To explore guinea pigs as models of chymase biology, we cloned and expressed the guinea pig ortholog of human chymase. In contrast to rats and mice, guinea pigs appear to express just one chymase, which belongs to the alpha clade, like primate chymases and mouse mast cell protease-5. The guinea pig enzyme autolyzes at Leu residues in the loop where human chymase autolyzes at Phe. In addition, guinea pig alpha-chymase selects P1 Leu in a combinatorial peptide library and cleaves Ala-Ala-Pro-Leu-4-nitroanilide but has negligible activity toward substrates with P1 Phe and does not cleave angiotensin I. This contrasts with human chymase, which cleaves after Phe or Tyr, prefers P1 Phe in peptidyl 4-nitroanilides, and avidly hydrolyzes angiotensin I at Phe(8) to generate bioactive angiotensin II. The guinea pig enzyme also is inactivated more effectively by alpha(1)-antichymotrypsin, which features P1 Leu in the reactive loop. Unlike mouse, rat, and hamster alpha-chymases, guinea pig chymase lacks elastase-like preference for P1 Val or Ala. Partially humanized A216G guinea pig chymase acquires human-like P1 Phe- and angiotensin-cleaving capacity. Molecular models suggest that the wild type active site is crowded by the Ala(216) side chain, which potentially blocks access by bulky P1 aromatic residues. On the other hand, the guinea pig pocket is deeper than in Val-selective chymases, explaining the preference for the longer aliphatic side chain of Leu. These findings are evidence that chymase-like peptidase specificity is sensitive to small changes in structure and provide the first example of a vertebrate Leu-selective peptidase.	[Caughey, George H.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Caughey, George H.] Vet Hlth Res Inst, San Francisco, CA 94121 USA; [Caughey, George H.; Raymond, Wilfred W.; Trivedi, Neil N.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Caughey, George H.; Trivedi, Neil N.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Beauchamp, Jeremy; Schlatter, Daniel; Banner, David; Mauser, Harald; Fingerle, Juergen] F Hoffmann La Roche Ltd, Preclin Pharm Res Basel, CH-4070 Basel, Switzerland	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding	Caughey, GH (corresponding author), Vet Affairs Med Ctr, 111-D,4150 Clement St, San Francisco, CA 94121 USA.	george.caughey@ucsf.edu			NHLBI NIH HHS [P01 HL024136, HL024136] Funding Source: Medline; PHS HHS [T32 07185] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abonia JP, 2005, J IMMUNOL, V174, P7285, DOI 10.4049/jimmunol.174.11.7285; Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Caughey GH, 2006, CURR RESPIR MED REV, V2, P263, DOI 10.2174/157339806778019024; CAUGHEY GH, 1988, J PHARMACOL EXP THER, V244, P133; Caughey GH, 2000, BBA-PROTEIN STRUCT M, V1480, P245, DOI 10.1016/S0167-4838(00)00076-5; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; de Garavilla L, 2005, J BIOL CHEM, V280, P18001, DOI 10.1074/jbc.M501302200; Debela M, 2006, J BIOL CHEM, V281, P25678, DOI 10.1074/jbc.M602372200; DELMAR EG, 1980, BIOCHEMISTRY-US, V19, P468, DOI 10.1021/bi00544a011; DErchia AM, 1996, NATURE, V381, P597, DOI 10.1038/381597a0; Edwards HM, 1999, J BIOL CHEM, V274, P30468, DOI 10.1074/jbc.274.43.30468; Gallwitz M, 2007, IMMUNOGENETICS, V59, P391, DOI 10.1007/s00251-007-0202-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; GRAUR D, 1991, NATURE, V351, P649, DOI 10.1038/351649a0; Greco MN, 2007, J MED CHEM, V50, P1727, DOI 10.1021/jm0700619; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; He SH, 1998, BRIT J PHARMACOL, V125, P1491, DOI 10.1038/sj.bjp.0702223; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; Ju HS, 2001, P NATL ACAD SCI USA, V98, P7469, DOI 10.1073/pnas.131147598; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Karlson L, 2002, J BIOL CHEM, V277, P18579, DOI 10.1074/jbc.M110356200; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Kervinen J, 2008, J BIOL CHEM, V283, P427, DOI 10.1074/jbc.M707157200; Knight PA, 2000, J EXP MED, V192, P1849, DOI 10.1084/jem.192.12.1849; Kunori Y, 2002, EUR J BIOCHEM, V269, P5921, DOI 10.1046/j.1432-1033.2002.03316.x; LETRONG H, 1987, P NATL ACAD SCI USA, V84, P364; Li M, 2004, J CLIN INVEST, V114, P112, DOI 10.1172/JCI200420805; Mellon MB, 2002, J IMMUNOL, V168, P290, DOI 10.4049/jimmunol.168.1.290; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Miyazaki M, 2006, PHARMACOL THERAPEUT, V112, P668, DOI 10.1016/j.pharmthera.2006.05.008; Muilenburg DJ, 2002, BBA-PROTEIN STRUCT M, V1596, P346, DOI 10.1016/S0167-4838(02)00224-8; Nishimoto M, 2001, CIRCULATION, V104, P1274, DOI 10.1161/hc3601.094304; Pemberton AD, 2003, CLIN EXP ALLERGY, V33, P1005, DOI 10.1046/j.1365-2222.2003.01720.x; Pereira PJB, 1999, J MOL BIOL, V286, P163, DOI 10.1006/jmbi.1998.2462; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Plotnick MI, 1997, BIOCHEMISTRY-US, V36, P14601, DOI 10.1021/bi971530j; Polanowska J, 1998, BBA-PROTEIN STRUCT M, V1386, P189, DOI 10.1016/S0167-4838(98)00085-5; POWERS JC, 1985, BIOCHEMISTRY-US, V24, P2048, DOI 10.1021/bi00329a037; Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; Raymond WW, 2003, J BIOL CHEM, V278, P34517, DOI 10.1074/jbc.M304087200; Sakaguchi M, 2004, EUR J PHARMACOL, V493, P173, DOI 10.1016/j.ejphar.2004.04.024; SCHECHTER NM, 1993, J BIOL CHEM, V268, P23626; SMYTH MJ, 1992, J BIOL CHEM, V267, P24418; Smyth MJ, 1996, J IMMUNOL, V156, P4174; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; URATA H, 1990, J BIOL CHEM, V265, P22348; Wang ZM, 1998, BIOL CHEM, V379, P167, DOI 10.1515/bchm.1998.379.2.167; Wolters PJ, 2001, J BIOL CHEM, V276, P18551, DOI 10.1074/jbc.M100223200; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3; YOSHIDA N, 1980, BIOCHEMISTRY-US, V19, P5799, DOI 10.1021/bi00566a021; ZAMOLODCHIKOVA TS, 1995, EUR J BIOCHEM, V227, P866, DOI 10.1111/j.1432-1033.1995.tb20212.x	55	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13943	13951		10.1074/jbc.M710502200	http://dx.doi.org/10.1074/jbc.M710502200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353771	Green Published, hybrid			2022-12-25	WOS:000255728200048
J	Perdomo, G; Martinez-Brocca, MA; Bhatt, BA; Brown, NF; O'Doherty, RM; Garcia-Ocana, A				Perdomo, German; Martinez-Brocca, Maria A.; Bhatt, Bankim A.; Brown, Nicholas F.; O'Doherty, Robert M.; Garcia-Ocana, Adolfo			Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; SATELLITE CELLS; ADIPOSE-TISSUE; C-MET; EXPRESSION; TRANSPORTER; OBESITY; RAT; LOCALIZATION; ADIPOCYTES	Skeletal muscle plays a major role in glucose and lipid metabolism. Active hepatocyte growth factor (HGF) is present in the extracellular matrix in skeletal muscle. However, the effects of HGF on glucose and lipid metabolism in skeletal muscle are completely unknown. We therefore examined the effects of HGF on deoxyglucose uptake (DOGU), glucose utilization, and fatty acid oxidation ( FAO) in skeletal muscle cells. HGF significantly enhanced DOGU in mouse soleus muscles in vitro. Furthermore, HGF significantly increased: (i) DOGU in a time- and dose-dependent manner; (ii) glucose utilization; and (iii) plasma membrane expression of Glut-1 and Glut-4 in the rat skeletal muscle model of L6 myotubes. HGF-mediated effect on DOGU was dependent on the activation of phosphatidylinositol 3-kinase signaling pathway. On the other hand, HGF markedly and significantly decreased FAO in L6 myotubes without affecting the activities of carnitine palmitoyltransferase I and II. Collectively, these results indicate that HGF is a potent activator of glucose transport and metabolism and also a strong inhibitor of FAO in rodent myotubes. HGF, through its ability to stimulate glucose transport and metabolism and to impair FAO, may participate in the regulation of glucose disposal in skeletal muscle.	[Perdomo, German; Martinez-Brocca, Maria A.; Bhatt, Bankim A.; Brown, Nicholas F.; O'Doherty, Robert M.; Garcia-Ocana, Adolfo] Univ Pittsburgh, Div Endocrinol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Garcia-Ocana, A (corresponding author), Univ Pittsburgh, Div Endocrinol, 200 Lothrop St BST E1140, Pittsburgh, PA 15261 USA.	ocana@dom.pitt.edu	Perdomo, German/K-6703-2014	Perdomo, German/0000-0002-2301-0012	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK069363, R01DK067351, R01DK058855] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46204, DK058855, DK069363, DK067351] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bell LN, 2006, AM J PHYSIOL-ENDOC M, V291, pE843, DOI 10.1152/ajpendo.00174.2006; Bertola A, 2007, J BIOL CHEM, V282, P10325, DOI 10.1074/jbc.M611770200; BIRNBAUM MJ, 1987, SCIENCE, V235, P1495, DOI 10.1126/science.3029870; Blaak EE, 2005, BEST PRACT RES CL EN, V19, P391, DOI 10.1016/j.beem.2005.04.001; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BODEN G, 1991, J CLIN INVEST, V88, P960, DOI 10.1172/JCI115399; Brown Nicholas F, 2003, Methods Mol Biol, V228, P281, DOI 10.1385/1-59259-400-X:281; Buettner R, 2000, AM J PHYSIOL-ENDOC M, V278, pE563, DOI 10.1152/ajpendo.2000.278.3.E563; BURANT CF, 1991, RECENT PROG HORM RES, V47, P349; Canto C, 2004, J BIOL CHEM, V279, P12260, DOI 10.1074/jbc.M308554200; Canto C, 2006, J BIOL CHEM, V281, P21690, DOI 10.1074/jbc.M600475200; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Garcia-Ocana A, 2001, DIABETES, V50, P2752, DOI 10.2337/diabetes.50.12.2752; Hayashi T, 1997, AM J PHYSIOL-ENDOC M, V273, pE1039, DOI 10.1152/ajpendo.1997.273.6.E1039; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Hulver MW, 2003, AM J PHYSIOL-ENDOC M, V284, pE741, DOI 10.1152/ajpendo.00514.2002; Kato Y, 1998, J PEDIATR SURG, V33, P13, DOI 10.1016/S0022-3468(98)90351-7; Magnan C, 1996, LIPIDS, V31, P1141, DOI 10.1007/BF02524288; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; MITSUMOTO Y, 1991, BIOCHEM BIOPH RES CO, V175, P652, DOI 10.1016/0006-291X(91)91615-J; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Niu WY, 2003, J BIOL CHEM, V278, P17953, DOI 10.1074/jbc.M211136200; Perdomo G, 2004, J BIOL CHEM, V279, P27177, DOI 10.1074/jbc.M403566200; Rehman J, 2003, J AM COLL CARDIOL, V41, P1408, DOI 10.1016/S0735-1097(03)00231-6; Roccisana J, 2005, DIABETES, V54, P2090, DOI 10.2337/diabetes.54.7.2090; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; Shiota A, 2000, PHARMACOL RES, V42, P443, DOI 10.1006/phrs.2000.0728; Sinha S, 2004, J BIOL CHEM, V279, P41294, DOI 10.1074/jbc.M406514200; Stuart KA, 2000, INT J EXP PATHOL, V81, P17, DOI 10.1046/j.1365-2613.2000.00138.x; Swierczynski J, 2005, OBES SURG, V15, P803, DOI 10.1381/0960892054222678; Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062; Tatsumi R, 2004, MUSCLE NERVE, V30, P654, DOI 10.1002/mus.20114; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; TURINSKY J, 1990, J BIOL CHEM, V265, P7933	36	46	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13700	13706		10.1074/jbc.M707551200	http://dx.doi.org/10.1074/jbc.M707551200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18362143	Green Published, hybrid			2022-12-25	WOS:000255728200021
J	Raychaudhuri, N; Raychaudhuri, S; Thamotharan, M; Devaskar, SU				Raychaudhuri, Nupur; Raychaudhuri, Santanu; Thamotharan, Manikkavasagar; Devaskar, Sherin U.			Histone code modifications repress glucose transporter 4 expression in the intrauterine growth-restricted offspring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER ISOFORM-3 GENE; MEF2 TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; GLUCOSE TRANSPORTERS; DNA METHYLATION; GLUT4; PROTEIN; ENHANCER; DIFFERENTIATION; ACTIVATION	We examined transcriptional and epigenetic mechanism(s) behind diminished skeletal muscle GLUT4 mRNA in intrauterine growth-restricted (IUGR) female rat offspring. An increase in MEF2D (inhibitor) with a decline in MEF2A (activator) and MyoD (co-activator) binding to the glut4 promoter in IUGR versus control was observed. The functional role of MEF2/MyoD-binding sites and neighboring three CpG clusters in glut4 gene transcription was confirmed in C2C12 muscle cells. No differential methylation of these three and other CpG clusters in the glut4 promoter occurred. DNA methyltransferase 1 (DNMT1) in postnatal, DNMT3a, and DNMT3b in adult was differentially recruited with increased MeCP2 ( methyl CpG-binding protein) concentrations to bind the IUGR glut4 gene. Covalent modifications of the histone (H) code consisted of H3.K14 de-acetylation by recruitment of histone deacetylase (HDAC) 1 and enhanced association of HDAC4 enzymes. This set the stage for Suv39H1 methylase-mediated di-methylation of H3.K9 and increased recruitment of heterochromatin protein 1 alpha, which partially inactivates postnatal and adult IUGR glut4 gene transcription. Further increased interactions in the adult IUGR between DNMT3a/DNMT3b and HDAC1 and MEF2D and HDAC1/HDAC4 and decreased association between MyoD and MEF2A existed. We conclude that epigenetic mechanisms consisting of histone code modifications repress skeletal muscle glut4 transcription in the postnatal period and persist in the adult female IUGR offspring.	[Raychaudhuri, Nupur; Raychaudhuri, Santanu; Thamotharan, Manikkavasagar; Devaskar, Sherin U.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Neonatol & Dev Biol, Los Angeles, CA 90095 USA; [Raychaudhuri, Nupur; Raychaudhuri, Santanu; Thamotharan, Manikkavasagar; Devaskar, Sherin U.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Neonatal Res Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Devaskar, SU (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Neonatol & Dev Biol, 10833 Le Conte Ave,MDCC-B2-375, Los Angeles, CA 90095 USA.	sdevaskar@mednet.ucla.edu			NICHD NIH HHS [HD 25024, HD 33997, HD 46979, HD 41230] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD041230] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD025024, R01HD033997, R01HD025024, R01HD046979] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Agote M, 2001, AM J PHYSIOL-ENDOC M, V281, pE1101, DOI 10.1152/ajpendo.2001.281.5.E1101; BALY DL, 1988, BIOCHIM BIOPHYS ACTA, V947, P571, DOI 10.1016/0304-4157(88)90008-1; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Boloker J, 2002, DIABETES, V51, P1499, DOI 10.2337/diabetes.51.5.1499; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGDE GC, 2007, BR J NUTR, V97, P435; Carretero MV, 1998, FEBS LETT, V439, P55, DOI 10.1016/S0014-5793(98)01335-0; Chamson-Reig A, 2006, J ENDOCRINOL, V191, P83, DOI 10.1677/joe.1.06754; Cox DM, 2003, J BIOL CHEM, V278, P15297, DOI 10.1074/jbc.M211312200; Devaskar SU, 2007, PEDIATR RES, V61, p1R, DOI 10.1203/pdr.0b013e31805cdbd8; DEVASKAR SU, 1994, J BIOL CHEM, V269, P8445; Dolinoy DC, 2007, PEDIATR RES, V61, p30R, DOI 10.1203/pdr.0b013e31804575f7; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Fu Yutao, 2005, Genome Inform, V16, P68; Fueger PT, 2005, J PHYSIOL-LONDON, V562, P925, DOI 10.1113/jphysiol.2004.076158; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Garg M, 2006, AM J PHYSIOL-ENDOC M, V290, pE1218, DOI 10.1152/ajpendo.00474.2005; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Holemans K, 1996, J SOC GYNECOL INVEST, V3, P71, DOI 10.1016/1071-5576(95)00046-1; Huang EY, 2000, GENE DEV, V14, P45; KAHN BB, 1992, J CLIN INVEST, V89, P1367, DOI 10.1172/JCI115724; KAUSHAL S, 1994, SCIENCE, V266, P1236, DOI 10.1126/science.7973707; Knight JB, 2003, P NATL ACAD SCI USA, V100, P14725, DOI 10.1073/pnas.2432756100; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Ling JQ, 2007, PEDIATR RES, V61, p11R, DOI 10.1203/pdr.0b013e31804575db; LIU ML, 1994, J BIOL CHEM, V269, P28514; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Martin-Gronert MS, 2007, J INTERN MED, V261, P437, DOI 10.1111/j.1365-2796.2007.01800.x; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; MITSUMOTO Y, 1991, BIOCHEM BIOPH RES CO, V175, P652, DOI 10.1016/0006-291X(91)91615-J; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Moreno H, 2003, J BIOL CHEM, V278, P40557, DOI 10.1074/jbc.M306609200; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; Oak SA, 2006, AM J PHYSIOL-ENDOC M, V290, pE1321, DOI 10.1152/ajpendo.00437.2005; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Pattyn F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-496; Poirier LA, 2001, METABOLISM, V50, P1014, DOI 10.1053/meta.2001.25655; Rajakumar A, 2004, J BIOL CHEM, V279, P26768, DOI 10.1074/jbc.M402735200; Rajakumar RA, 1998, J BIOL CHEM, V273, P27474, DOI 10.1074/jbc.273.42.27474; Rees WD, 2000, J NUTR, V130, P1821, DOI 10.1093/jn/130.7.1821; RICHARDSON JM, 1993, J BIOL CHEM, V268, P21021; Sadiq HF, 1999, BRAIN RES, V823, P96, DOI 10.1016/S0006-8993(99)01145-2; Santalucia T, 2001, J MOL BIOL, V314, P195, DOI 10.1006/jmbi.2001.5091; SANTALUCIA T, 2005, ACTA PHYSL SCAND, V183, P43; Steinmetz KL, 1998, CARCINOGENESIS, V19, P1487, DOI 10.1093/carcin/19.8.1487; TAKAI D, 2003, SILICO BIOL, V2, P35; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Thamotharan M, 2005, AM J PHYSIOL-ENDOC M, V288, pE935, DOI 10.1152/ajpendo.00342.2004; Thamotharan M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1270, DOI 10.1152/ajpendo.00462.2006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wallberg-Henriksson H, 2001, MOL MEMBR BIOL, V18, P205; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Yokomori N, 1999, DIABETES, V48, P685, DOI 10.2337/diabetes.48.4.685; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	68	158	169	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13611	13626		10.1074/jbc.M800128200	http://dx.doi.org/10.1074/jbc.M800128200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18326493	Green Published, hybrid			2022-12-25	WOS:000255728200014
J	He, LS; Hou, ZB; Qi, RZ				He, Lisheng; Hou, Zhibo; Qi, Robert Z.			Calmodulin binding and cdk5 phosphorylation of p35 regulate its effect on microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; NEURONAL-SPECIFIC ACTIVATOR; TARGET RECOGNITION; PROTEIN ACTIVATOR; STOP PROTEINS; TAU; IDENTIFICATION; P25; CLEAVAGE; CALPAIN	In the nervous system, Cdk5 and its neuronal activator p35 are involved in the control of various activities, including neuronal differentiation and migration. Recently, we have reported that p35 is a microtubule-associated protein that regulates microtubule dynamics (Hou, Z., Li, Q., He, L., Lim, H. Y., Fu, X., Cheung, N. S., Qi, D. X., and Qi, R. Z. ( 2007) J. Biol. Chem. 282, 18666 18670). Here we present two regulatory modes of p35 function as a microtubule-associated protein. First, p35 is Ca2+-dependent calmodulin (CaM)-binding protein. The CaM- and microtubule binding domains are localized to overlapping regions at the N terminus of p35. Within the CaM- binding region, Ala substitution for Trp-52 abolishes the CaM- binding activity, corroborating specific CaM- binding of p35. Furthermore, CaM blocks p35 association with microtubules in a Ca2+- specific manner, suggesting that p35 may be involved in the Ca2+/CaM-mediated inhibition of microtubule assembly. Second, p35 phosphorylation by Cdk5 interferes with the microtubule-binding and polymerizing activities of p35. Using a mutational approach, we found that only phosphorylation at Thr-138, one of the two residues primarily phosphorylated in vivo, inhibits the polymerizing activity. In PC12 cells, expression of p35 promotes nerve growth factor-induced neurite outgrowth under a Cdk5 inhibitory condition. Such p35 activity is impaired by the phosphomimetic mutation of Thr-138. These data suggest that Thr-138 phosphorylation plays a critical role in the control of the p35 functions in microtubule assembly and neurite outgrowth.	[He, Lisheng; Hou, Zhibo; Qi, Robert Z.] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Qi, RZ (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.	qirz@ust.hk		Qi, Robert Zhong/0000-0001-5596-8172				BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Bosc C, 2001, J BIOL CHEM, V276, P30904, DOI 10.1074/jbc.M011614200; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fu XR, 2006, J BIOL CHEM, V281, P39014, DOI 10.1074/jbc.M512663200; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hou ZB, 2007, J BIOL CHEM, V282, P18666, DOI 10.1074/jbc.C700052200; Hou ZB, 2007, J BIOL CHEM, V282, P6922, DOI 10.1074/jbc.M607836200; HULEN D, 1991, CELL MOTIL CYTOSKEL, V18, P113, DOI 10.1002/cm.970180206; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Johnson K, 2005, J NEUROCHEM, V93, P538, DOI 10.1111/j.1471-4159.2004.03004.x; Kamei H, 2007, J BIOL CHEM, V282, P1687, DOI 10.1074/jbc.M610541200; KLEE CB, 1977, BIOCHEMISTRY-US, V16, P1017, DOI 10.1021/bi00624a033; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Lee JH, 2004, J NEUROCHEM, V91, P634, DOI 10.1111/j.1471-4159.2004.02770.x; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEE YC, 1984, J BIOL CHEM, V259, P8041; LEE YC, 1982, J BIOL CHEM, V257, P6306; LEE YC, 1984, J BIOL CHEM, V259, P1226; Li CJ, 1999, J CELL SCI, V112, P1567; Lim ACB, 2003, NEUROSIGNALS, V12, P230, DOI 10.1159/000074625; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Paglini G, 1998, J NEUROSCI, V18, P9858; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Pigino G, 1997, J CELL SCI, V110, P257; QI Z, 1995, J BIOL CHEM, V270, P10847, DOI 10.1074/jbc.270.18.10847; Rainaldi M, 2007, J BIOL CHEM, V282, P6031, DOI 10.1074/jbc.M608970200; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; SANCHEZ C, 1995, BIOCHEM J, V306, P481, DOI 10.1042/bj3060481; SOBUE K, 1981, FEBS LETT, V132, P137, DOI 10.1016/0014-5793(81)80447-4; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; TEO TS, 1973, J BIOL CHEM, V248, P5950	44	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13252	13260		10.1074/jbc.M706937200	http://dx.doi.org/10.1074/jbc.M706937200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326489	hybrid			2022-12-25	WOS:000255499800065
J	Kao, YY; Gianni, D; Bohl, B; Taylor, RM; Bokoch, GM				Kao, Yu-Ya; Gianni, Davide; Bohl, Benjamin; Taylor, Ross M.; Bokoch, Gary M.			Identification of a conserved Rac-binding site on NADPH oxidases supports a direct GTPase regulatory mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; RESPIRATORY BURST OXIDASE; MOLECULAR-BASIS; HUMAN-NEUTROPHILS; ACTIVATION; GENERATION; FLAVOCYTOCHROME; P67(PHOX); P47(PHOX); COMPONENT	The NADPH oxidases (Noxs) are a family of superoxide-generating enzymes implicated in a variety of biological processes. Full activity of Nox1, -2, and -3 requires the action of a Rac GTPase. A direct regulatory interaction of Rac with Nox2 has been proposed as part of a two-step mechanism for regulating electron transfer during superoxide formation. Using truncation analysis of Rac binding to the cytoplasmic tail of Nox2, along with peptides derived from this region in cell-free assays, we identify a Rac interaction site within amino acids 419 -430 of Nox2. This region is required for binding Rac2 but not p47(phox) or p67(phox) cytosolic regulatory factors. A cell-permeant version of the peptide encompassing amino acids 419 -430 specifically inhibits NADPH oxidase activation in intact human neutrophils. Mutational analysis of the putative Rac-binding site revealed specific residues, particularly Lys-421, Tyr-425, and Lys-426, individually required for Rac-dependent NADPH oxidase activity that are conserved in the Rac-regulated Nox1, Nox2, and Nox3 enzymes but not in Nox4 or Nox5. Mutation of the conserved residues in the Rac-binding site of Nox1 also result in the loss of Rac-dependent activity. Our data identify a functional Rac interaction site conserved in Rac-dependent Noxs and support a direct regulatory interaction of Rac GTPases to promote activation of these NADPH oxidases.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Scripps Research Institute; Scripps Research Institute; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Bokoch, GM (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Bokoch@scripps.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048008] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL48008] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Burritt JB, 2003, J IMMUNOL, V170, P6082, DOI 10.4049/jimmunol.170.12.6082; Cheng GJ, 2004, J BIOL CHEM, V279, P4737, DOI 10.1074/jbc.M305968200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; CURNUTTE JT, 1987, J BIOL CHEM, V262, P5563; DeLeo FR, 1996, J LEUKOCYTE BIOL, V60, P677, DOI 10.1002/jlb.60.6.677; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Diebold BA, 2004, J BIOL CHEM, V279, P28136, DOI 10.1074/jbc.M313891200; Fortemaison N, 2005, EUR J ENDOCRINOL, V152, P127, DOI 10.1530/eje.1.01815; Freeman JL, 1996, J BIOL CHEM, V271, P22578, DOI 10.1074/jbc.271.37.22578; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; Heyworth PG, 2001, BLOOD CELL MOL DIS, V27, P16, DOI 10.1006/bcmd.2000.0347; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Kamiguti AS, 2005, J IMMUNOL, V175, P8424, DOI 10.4049/jimmunol.175.12.8424; Kaneda M, 1999, BLOOD, V93, P2098, DOI 10.1182/blood.V93.6.2098.406k09_2098_2104; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim C, 2001, J IMMUNOL, V166, P1223, DOI 10.4049/jimmunol.166.2.1223; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; Koshkin V, 1996, J BIOL CHEM, V271, P30326, DOI 10.1074/jbc.271.48.30326; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Martyn KD, 2005, BLOOD, V106, P3962, DOI 10.1182/blood-2005-03-0859; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; Miyano K, 2006, J BIOL CHEM, V281, P21857, DOI 10.1074/jbc.M513665200; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; NAKAMURA M, 1987, BLOOD, V69, P1404; NAKAMURA M, 1988, Acta Paediatrica Hungarica, V29, P179; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; QUINN MT, 1993, J BIOL CHEM, V268, P20983; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Roos D, 1996, IMMUNOL TODAY, V17, P517; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SMITH RM, 1991, BLOOD, V77, P673; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueyama T, 2006, MOL CELL BIOL, V26, P2160, DOI 10.1128/MCB.26.6.2160-2174.2006; Vocero-Akbani A, 2001, METHOD ENZYMOL, V332, P36; Zhao TM, 2003, J CLIN INVEST, V112, P1732, DOI 10.1172/JCI200319108; Zhao XX, 2003, J BIOL CHEM, V278, P40788, DOI 10.1074/jbc.M302208200	54	56	56	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12736	12746		10.1074/jbc.M801010200	http://dx.doi.org/10.1074/jbc.M801010200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18347018	Green Published, hybrid			2022-12-25	WOS:000255499800009
J	Murphy, KL; Zhang, XD; Gainetdinov, RR; Beaulieu, JM; Caron, MG				Murphy, Karen L.; Zhang, Xiaodong; Gainetdinov, Raul R.; Beaulieu, Jean-Martin; Caron, Marc G.			A regulatory domain in the n terminus of tryptophan hydroxylase 2 controls enzyme expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN HYDROXYLASE-2 GENE; ISOFORM TPH2 GENE; TYROSINE-HYDROXYLASE; TRANSMISSION DISEQUILIBRIUM; FUNCTIONAL POLYMORPHISMS; HAPLOTYPE ANALYSIS; SEROTONIN; VARIANTS; PHOSPHORYLATION; ACID	Serotonin is involved in a variety of physiological processes in the central nervous system and the periphery. As the rate-limiting enzyme in serotonin synthesis, tryptophan hydroxylase plays an important role in modulating these processes. Of the two variants of tryptophan hydroxylase, tryptophan hydroxylase 2 (TPH2) is expressed predominantly in the central nervous system, whereas tryptophan hydroxylase 1 (TPH1) is expressed mostly in peripheral tissues. Although the two enzymes share considerable sequence homology, the regulatory domain of TPH2 contains an additional 41 amino acids at the N terminus that TPH1 lacks. Here we show that the extended TPH2 N-terminal domain contains a unique sequence involved in the regulation of enzyme expression. When expressed in cultured mammalian cells, TPH2 is synthesized less efficiently and is also less stable than TPH1. Removal of the unique portion of the N terminus of TPH2 results in expression of the enzyme at a level similar to that of TPH1, whereas protein chimeras containing this fragment are expressed at lower levels than their wild-type counterparts. We identify a region centered on amino acids 10-20 that mediates the bulk of this effect. Wealso demonstrate that phosphorylation of serine 19, a protein kinase A consensus site located in this N-terminal domain, results in increased TPH2 stability and consequent increases in enzyme output in cell culture systems. Because this domain is unique to TPH2, these data provide evidence for selective regulation of brain serotonin synthesis.	[Zhang, Xiaodong; Gainetdinov, Raul R.; Beaulieu, Jean-Martin; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Murphy, Karen L.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3287,487 CARL Bldg, Durham, NC 27710 USA.	m.caron@cellbio.duke.edu	Beaulieu, Jean-Martin/A-7598-2008; Gainetdinov, Raul R/G-5875-2011	Beaulieu, Jean-Martin/0000-0002-0446-7447; Gainetdinov, Raul R/0000-0003-2951-6038; Murphy, Karen/0000-0002-3726-0928	NIMH NIH HHS [MH-40159, MH-79201] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH040159, R01MH079201, P50MH040159] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson GM, 2004, INT J DEV NEUROSCI, V22, P397, DOI 10.1016/j.ijdevneu.2004.06.006; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; Blier P, 2001, J PSYCHIATR NEUROSCI, V26, P37; Breidenthal SE, 2004, PSYCHIAT GENET, V14, P69, DOI 10.1097/01.ypg.0000107929.32051.58; Carkaci-Salli N, 2006, J BIOL CHEM, V281, P28105, DOI 10.1074/jbc.M602817200; Chaube R, 2005, GEN COMP ENDOCR, V141, P116, DOI 10.1016/j.ygcen.2004.12.010; Courtet P, 2005, AM J MED GENET C, V133C, P25, DOI 10.1002/ajmg.c.30043; De Luca V, 2005, PSYCHIAT RES, V134, P195, DOI 10.1016/j.psychres.2005.01.005; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; FERNSTROM JD, 1983, PHYSIOL REV, V63, P484, DOI 10.1152/physrev.1983.63.2.484; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Harvey M, 2004, MOL PSYCHIATR, V9, P980, DOI 10.1038/sj.mp.4001557; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Jiang GCT, 2000, J MOL BIOL, V302, P1005, DOI 10.1006/jmbi.2000.4097; JOHANSEN PA, 1995, J NEUROCHEM, V65, P882; Kinney GG, 2000, MOL NEUROBIOL, V21, P137, DOI 10.1385/MN:21:3:137; Kleppe R, 2004, FEBS LETT, V565, P155, DOI 10.1016/j.febslet.2004.03.092; Kuhn DM, 2007, J NEUROCHEM, V103, P1567, DOI 10.1111/j.1471-4159.2007.04855.x; Kumar GK, 2003, J APPL PHYSIOL, V95, P536, DOI 10.1152/japplphysiol.00186.2003; Kumer SC, 1997, J NEUROCHEM, V69, P1738; Lehmann IT, 2006, J BIOL CHEM, V281, P17644, DOI 10.1074/jbc.M512194200; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Lin YMJ, 2007, ARCH GEN PSYCHIAT, V64, P1015, DOI 10.1001/archpsyc.64.9.1015; Ma FY, 2004, J NEUROCHEM, V90, P431, DOI 10.1111/j.1471-4159.2004.02492.x; Martinez A, 2001, CURR MED CHEM, V8, P1077, DOI 10.2174/0929867013372616; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McKinney J, 2005, J NEUROCHEM, V92, P311, DOI 10.1111/j.1471-4159.2004.02850.x; Mossner R, 2006, INT J NEUROPSYCHOPH, V9, P437, DOI 10.1017/S1461145705005997; Nielsen DA, 2008, BEHAV GENET, V38, P133, DOI 10.1007/s10519-007-9187-7; Patel PD, 2004, BIOL PSYCHIAT, V55, P428, DOI 10.1016/j.biopsych.2003.09.002; Perriquet O, 2003, BIOINFORMATICS, V19, P108, DOI 10.1093/bioinformatics/19.1.108; PICKEL VM, 1977, BRAIN RES, V131, P197, DOI 10.1016/0006-8993(77)90515-7; Sakowski SA, 2006, J NEUROCHEM, V96, P758, DOI 10.1111/j.1471-4159.2005.03604.x; Sheehan K, 2005, MOL PSYCHIATR, V10, P944, DOI 10.1038/sj.mp.4001698; Stenfors C, 2002, J NEURAL TRANSM, V109, P1353, DOI 10.1007/s00702-002-0732-5; Tenner K, 2007, J NEUROCHEM, V102, P1887, DOI 10.1111/j.1471-4159.2007.04664.x; Touzet H, 2004, NUCLEIC ACIDS RES, V32, pW142, DOI 10.1093/nar/gkh415; Walitza S, 2005, MOL PSYCHIATR, V10, P1126, DOI 10.1038/sj.mp.4001734; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Winge I, 2008, BIOCHEM J, V410, P195, DOI 10.1042/BJ20071033; Winge I, 2007, J NEUROCHEM, V100, P1648, DOI 10.1111/j.1471-4159.2006.04290.x; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; Zhang X, 2006, CELL MOL LIFE SCI, V63, P6, DOI 10.1007/s00018-005-5417-4; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zhou ZF, 2005, ARCH GEN PSYCHIAT, V62, P1109, DOI 10.1001/archpsyc.62.10.1109; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525; Zill P, 2004, BIOL PSYCHIAT, V56, P581, DOI 10.1016/j.biopsych.2004.07.015; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	28	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13216	13224		10.1074/jbc.M706749200	http://dx.doi.org/10.1074/jbc.M706749200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18339632	Green Published, hybrid			2022-12-25	WOS:000255499800061
J	Karim, ZA; Choi, WS; Whiteheart, SW				Karim, Zubair A.; Choi, Wangsun; Whiteheart, Sidney W.			Primary platelet signaling cascades and integrin-mediated signaling control ADP-ribosylation factor (Arf) 6-GTP levels during platelet activation and aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; DENSE GRANULE SECRETION; BINDING-PROTEIN; P21-ACTIVATED KINASE; RAP1 ACTIVATION; CELL-ADHESION; THROMBIN; COLLAGEN; GPVI; MECHANISM	Previous studies showed that ADP-ribosylation factor 6 (Arf6) is important for platelet function; however, little is known about which signaling events regulate this small GTP-binding protein. Arf6-GTP was monitored in platelets stimulated with a number of agonists (TRAP, thrombin, convulxin, collagen, PMA, thapsigargin, or A23187) and all led to a time-dependent decrease in Arf6-GTP. ADP and U46619 were without effect. Using inhibitors, it was shown that the decrease of Arf6-GTP is a direct consequence of known signaling cascades. Upon stimulation via PAR receptors, Arf6-GTP loss could be blocked by treatment with U-73122, BAPTA/AM, Ro-31-8220, or Go6976, indicating requirements for phospholipase C, calcium, and protein kinase C (PKC) alpha/beta, respectively. The Arf6-GTP decrease in convulxin- stimulated platelets showed similar requirements and was also sensitive to piceatannol, wortmannin, and LY294002, indicating additional requirements for Syk and phosphatidylinositol 3-kinase. The convulxin- induced decrease was sensitive to both PKC alpha/beta and delta inhibitors. Outside-in signaling, potentially via integrin engagement, caused a second wave of signaling that affected Arf6. Inclusion of RGDS peptides or EGTA, during activation, led to a biphasic response; Arf6-GTP levels partially recovered upon continued incubation. A similar response was seen in beta 3 integrin-null platelets. These data show that Arf6-GTP decreases in response to known signaling pathways associated with PAR and GPVI. They further reveal a second, aggregation-dependent, process that dampens Arf6-GTP recovery. This study demonstrates that the nucleotide state of Arf6 in platelets is regulated during the initial phases of activation and during the later stages of aggregation.	[Karim, Zubair A.; Choi, Wangsun; Whiteheart, Sidney W.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Whiteheart, SW (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, 741 S Limestone,Biomed Biol Sci Res Bldg, Lexington, KY 40536 USA.	whitehe@uky.edu		Whiteheart, Sidney/0000-0001-5577-0473	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091893, R01HL056652] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL056652, HL56652, R01 HL091893] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bertoni A, 2002, J BIOL CHEM, V277, P25715, DOI 10.1074/jbc.M202791200; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Caumont AS, 1998, J BIOL CHEM, V273, P1373, DOI 10.1074/jbc.273.3.1373; Choi W, 2006, BLOOD, V107, P3145, DOI 10.1182/blood-2005-09-3563; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Clough RR, 2002, J BIOL CHEM, V277, P28972, DOI 10.1074/jbc.M201504200; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; Dangelmaier CA, 2005, BLOOD, V105, P3918, DOI 10.1182/blood-2004-09-3689; Danielewski O, 2005, THROMB HAEMOSTASIS, V93, P319, DOI 10.1160/TH04-09-0582; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Elrod JW, 2003, PLATELETS, V14, P247, DOI 10.1080/0953710031000118894; Fitzgerald ML, 1999, BIOCHEM J, V342, P353, DOI 10.1042/0264-6021:3420353; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; HUGHAN SC, 2007, THROMB VASC BIOL, V27, P422; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Jones NP, 2007, MOL CELL BIOL, V27, P5790, DOI 10.1128/MCB.00778-07; Jung SM, 2006, THROMB RES, V118, P509, DOI 10.1016/j.thromres.2005.11.002; KAHN RA, 1992, J BIOL CHEM, V267, P13039; Kawato M, 2008, J BIOL CHEM, V283, P166, DOI 10.1074/jbc.M705340200; Mark BL, 1996, BIOCHEM BIOPH RES CO, V225, P40, DOI 10.1006/bbrc.1996.1128; Murugappan S, 2005, BLOOD, V106, P550, DOI 10.1182/blood-2004-12-4866; Murugappan S, 2004, J BIOL CHEM, V279, P2360, DOI 10.1074/jbc.M306960200; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Paris S, 2003, BIOCHEM J, V372, P391, DOI 10.1042/BJ20030047; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Prevost N, 2005, P NATL ACAD SCI USA, V102, P9820, DOI 10.1073/pnas.0404065102; Prevost N, 2003, J THROMB HAEMOST, V1, P1613, DOI 10.1046/j.1538-7836.2003.00327.x; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; RANDAZZO PA, SCI STKE 2000, pRE1; Riondino S, 2005, J BIOL CHEM, V280, P6504, DOI 10.1074/jbc.M407854200; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Sato H, 2008, BIOCHEM BIOPH RES CO, V368, P157, DOI 10.1016/j.bbrc.2008.01.064; Schwartz MA, 2006, CELL, V125, P1223, DOI 10.1016/j.cell.2006.06.015; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Shirakawa R, 2000, J BIOL CHEM, V275, P33844, DOI 10.1074/jbc.M002834200; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Suzuki-Inoue K, 2001, BLOOD, V98, P3708, DOI 10.1182/blood.V98.13.3708; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; WHITE TE, 1990, P NATL ACAD SCI USA, V87, P758, DOI 10.1073/pnas.87.2.758; Wolthuis RMF, 1998, MOL CELL BIOL, V18, P2486, DOI 10.1128/MCB.18.5.2486; Yang SA, 2004, J BIOL CHEM, V279, P42331, DOI 10.1074/jbc.M404335200; Yoon HY, 2004, CELL SIGNAL, V16, P1033, DOI 10.1016/j.cellsig.2004.02.008	51	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11995	12003		10.1074/jbc.M800146200	http://dx.doi.org/10.1074/jbc.M800146200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326492	Green Published, hybrid			2022-12-25	WOS:000255340000015
J	Kingsbury, JS; Laue, TM; Klimtchuk, ES; Theberge, R; Costello, CE; Connors, LH				Kingsbury, Jonathan S.; Laue, Thomas M.; Klimtchuk, Elena S.; Theberge, Roger; Costello, Catherine E.; Connors, Lawreen H.			The modulation of transthyretin tetramer stability by cysteine 10 adducts and the drug diflunisal - Direct analysis by fluorescence-detected analytical ultracentrifugation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEDIMENTATION-VELOCITY DATA; SENILE SYSTEMIC AMYLOIDOSIS; CLINICAL-SIGNIFICANCE; CARDIAC AMYLOIDOSIS; MASS-SPECTROMETRY; ACIDIC CONDITIONS; SELF-ASSOCIATION; WEIGHT AVERAGE; LAMM EQUATION; NATIVE-STATE	Transthyretin (TTR) is normally a stable plasma protein. However, in cases of familial TTR-related amyloidosis and senile systemic amyloidosis (SSA), TTR is deposited as amyloid fibrils, leading to organ dysfunction and possibly death. The mechanism by which TTR undergoes the transition from stable, soluble precursor to insoluble amyloid fibril and the factors that promote this process are largely undetermined. Most models involve the dissociation of the native TTR tetramer as the initial step. It is largely accepted that the TTR gene mutations associated with TTR-related amyloidosis lead to the expression of variant proteins that are intrinsically unstable and prone to aggregation. It has been suggested that amyloidogenicity may be conferred to wild-type TTR (the form deposited in SSA) by chemical modification of the lone cysteine residue (Cys(10)) through mixed disulfide bonds. S-Sulfonation and S-cysteinylation are prevalent TTR modifications physiologically, and studies have suggested their ability to modulate the structure of TTR under denaturing conditions. In the present study, we have used fluorescence-detected sedimentation velocity to determine the effect of S-sulfonate and S-cysteine on the quaternary structural stability of fluorophore-conjugated recombinant TTR under nondenaturing conditions. We determined that S-sulfonation stabilized TTR tetramer stability by a factor of 7, whereas S-cysteinylation enhanced dissociation by 2-fold with respect to the unmodified form. In addition, we report the direct observation of tetramer stabilization by the potential therapeutic compound diflunisal. Finally, as proof of concept, we report the sedimentation of TTR in serum and the qualitative assessment of the resulting data.	[Kingsbury, Jonathan S.; Costello, Catherine E.; Connors, Lawreen H.] Boston Univ, Sch Med, Amyloid Treatment & Res Program, Dept Biochem, Boston, MA 02118 USA; [Kingsbury, Jonathan S.; Klimtchuk, Elena S.; Theberge, Roger; Costello, Catherine E.; Connors, Lawreen H.] Boston Univ, Sch Med, Alan & Sandra Gerry Amyloid Res Lab, Boston, MA 02118 USA; [Theberge, Roger; Costello, Catherine E.] Boston Univ, Sch Med, Ctr Biol Mass Spectrometry, Boston, MA 02118 USA; [Laue, Thomas M.] Univ New Hampshire, Dept Biochem & Mol Biol, Durham, NH 03824 USA	Boston University; Boston University; Boston University; University System Of New Hampshire; University of New Hampshire	Connors, LH (corresponding author), Boston Univ, Sch Med, Amyloid Treatment & Res Program, Dept Biochem, K-507,715 Albany St, Boston, MA 02118 USA.	lconnors@bu.edu	Laue, Tom/AAI-5136-2020	Laue, Tom/0000-0003-3571-9368; Costello, Catherine/0000-0003-1594-5122; Connors, Lawreen/0000-0002-4672-4296; Kingsbury, Jonathan/0000-0003-1851-3325	NCRR NIH HHS [S10RR020946, S10RR10493, P41 RR10888] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020946, S10RR010493, P41RR010888] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adamski-Werner SL, 2004, J MED CHEM, V47, P355, DOI 10.1021/jm030347n; Almeida MR, 2004, BIOCHEM J, V381, P351, DOI 10.1042/BJ20040011; Benson MD, 1996, AMYLOID, V3, P44, DOI 10.3109/13506129609014354; CANN JR, 1970, INTERACTING MACROMOL, P133; Chiti F, 2001, PROTEIN SCI, V10, P879, DOI 10.1110/ps.42401; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; Correia JJ, 2000, METHOD ENZYMOL, V321, P81; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Damas AM, 2000, J STRUCT BIOL, V130, P290, DOI 10.1006/jsbi.2000.4273; Demeler B, 1998, BIOPHYS J, V74, P444, DOI 10.1016/S0006-3495(98)77802-6; Falk R H, 2000, Adv Intern Med, V45, P107; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; HODKINSON HM, 1977, Q J MED, V46, P381; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; JOHNSTON JP, 1946, T FARADAY SOC, V42, P789, DOI 10.1039/tf9464200789; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kingsbury JS, 2007, PROTEIN EXPRES PURIF, V53, P370, DOI 10.1016/j.pep.2007.01.004; KROE RA, 2005, APPL FLUORESCENCE DE; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; Lim A, 2003, J BIOL CHEM, V278, P49707, DOI 10.1074/jbc.M306748200; Lim A, 2002, ANAL CHEM, V74, P741, DOI 10.1021/ac010780+; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; MANN M, 1989, ANAL CHEM, V61, P1702, DOI 10.1021/ac00190a023; Mason JM, 2003, CURR OPIN STRUC BIOL, V13, P526, DOI 10.1016/S0959-440X(03)00100-3; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Ng B, 2005, ARCH INTERN MED, V165, P1425, DOI 10.1001/archinte.165.12.1425; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Ray SS, 2005, P NATL ACAD SCI USA, V102, P3639, DOI 10.1073/pnas.0408277102; RAZ A, 1969, J BIOL CHEM, V244, P3230; Rivas G, 1999, BIOCHEMISTRY-US, V38, P9379, DOI 10.1021/bi990355z; SCHACHMAN HK, 1959, ULTRACENTRIFUGATION, P157; Schnaible V, 1999, BIOCONJUGATE CHEM, V10, P861, DOI 10.1021/bc990039x; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SMITH TJ, 1984, MAYO CLIN PROC, V59, P547, DOI 10.1016/S0025-6196(12)61493-1; Sontag CA, 2004, BIOPHYS CHEM, V108, P215, DOI 10.1016/j.bpc.2003.10.029; Stafford WF, 2000, METHOD ENZYMOL, V323, P302; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Suhr OB, 1999, AMYLOID, V6, P187, DOI 10.3109/13506129909007325; SVEDBERG T, 1940, ULTRACENTRIFUGE, P28; Teske CA, 2007, BIOTECHNOL BIOENG, V98, P193, DOI 10.1002/bit.21374; Theberge R, 1999, ANAL CHEM, V71, P452, DOI 10.1021/ac980531u; WALLEY VM, 1995, CARDIOVASC PATHOL, V4, P79, DOI 10.1016/1054-8807(95)90411-L; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; WRIGHT JR, 1975, J AM GERIATR SOC, V23, P97, DOI 10.1111/j.1532-5415.1975.tb00968.x; Zhang QH, 2003, BIOCHEMISTRY-US, V42, P8756, DOI 10.1021/bi030077a	51	46	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11887	11896		10.1074/jbc.M709638200	http://dx.doi.org/10.1074/jbc.M709638200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326041	hybrid, Green Published			2022-12-25	WOS:000255340000004
J	Oh, J; Sohn, DH; Ko, M; Chung, H; Jeon, SH; Seong, RH				Oh, Jaehak; Sohn, Dong H.; Ko, Myunggon; Chung, Heekyoung; Jeon, Sung H.; Seong, Rho H.			BAF60a interacts with p53 to recruit the SWI/SNF complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-REMODELING COMPLEX; TUMOR-SUPPRESSOR P53; NUCLEAR RECEPTORS; TRANSCRIPTIONAL REPRESSION; RETINOBLASTOMA PROTEIN; INDUCED APOPTOSIS; BREAST-CANCER; SRG3; BRG1; TRANSACTIVATION	To understand the tumor-suppressing mechanism of the SWI/SNF chromatin remodeling complex, we investigated its molecular relationship with p53. Using the pREP4-luc episomal reporter, we first demonstrated that p53 utilizes the chromatin remodeling activity of the SWI/SNF complex to initiate transcription from the chromatin-structured promoter. Among the components of the SWI/SNF complex, we identified BAF60a as a mediator of the interaction with p53 by the yeast two-hybrid assay. p53 directly interacted only with BAF60a, but not with other components of the SWI/SNF complex, such as BRG1, SRG3, SNF5, or BAF57. We found out that multiple residues at the amino acid 108-150 region of BAF60a were involved in the interaction with the tetramerization domain of p53. The N-terminal fragment of BAF60a containing the p53-interacting region as well as small interfering RNA for baf60a inhibited the SWI/SNF complex-mediated transcriptional activity of p53. The uncoupling of p53 with the SWI/SNF complex resulted in the repression of both p53-dependent apoptosis and cell cycle arrest by the regulation of target genes. These results suggest that the SWI/SNF chromatin remodeling complex is involved in the suppression of tumors by the interaction with p53.	[Oh, Jaehak; Sohn, Dong H.; Ko, Myunggon; Seong, Rho H.] Seoul Natl Univ, Dept Biol Sci, Inst Mol Biol & Genet, Seoul 151742, South Korea; [Oh, Jaehak; Sohn, Dong H.; Ko, Myunggon; Seong, Rho H.] Seoul Natl Univ, Res Ctr Funct Cellulom, Seoul 151742, South Korea; [Chung, Heekyoung] Hanyang Univ, Coll Med, Dept Pathol, Seoul 133791, South Korea; [Jeon, Sung H.] Hallym Univ, Dept Life Sci, Chunchon 200702, South Korea; [Jeon, Sung H.] Hallym Univ, Inst Biosci & Biotechnol, Chunchon 200702, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University; Hallym University; Hallym University	Seong, RH (corresponding author), Seoul Natl Univ, Dept Biol Sci, Inst Mol Biol & Genet Bldg 105, San 56-1, Seoul 151742, South Korea.	rhseong@snu.ac.kr		Ko, Myunggon/0000-0002-6007-2570; Seong, Rho/0000-0001-5699-0718				An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Assmann EM, 2006, J BIOL CHEM, V281, P9869, DOI 10.1074/jbc.M513280200; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Bennett-Lovsey R, 2002, BIOINFORMATICS, V18, P626, DOI 10.1093/bioinformatics/18.4.626; Biegel JA, 1999, CANCER RES, V59, P74; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; CHEN PL, 1990, SCIENCE, V250, P1576, DOI 10.1126/science.2274789; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Chien CY, 2003, FEBS LETT, V543, P55, DOI 10.1016/S0014-5793(03)00401-0; Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200; DRILLER L, 1990, MOL CELL BIOL, V10, P5772; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Han SM, 2001, J IMMUNOL, V167, P805, DOI 10.4049/jimmunol.167.2.805; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Hong CY, 2005, MOL CELL BIOL, V25, P4841, DOI 10.1128/MCB.25.12.4841-4852.2005; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Kim DS, 2002, IMMUNITY, V16, P9, DOI 10.1016/S1074-7613(02)00264-9; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kiskinis E, 2006, BREAST CANCER RES TR, V98, P191, DOI 10.1007/s10549-005-9149-9; Ko M, 2004, J BIOL CHEM, V279, P21916, DOI 10.1074/jbc.M402145200; Koszewski NJ, 2003, J STEROID BIOCHEM, V87, P223, DOI 10.1016/j.jsbmb.2003.09.006; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; MIYASHITA T, 1995, CELL, V80, P293; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Sohn DH, 2007, J BIOL CHEM, V282, P10614, DOI 10.1074/jbc.M610563200; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Trotter KW, 2004, MOL CELL BIOL, V24, P3347, DOI 10.1128/MCB.24.8.3347-3358.2004; van der Vlag J, 2000, J BIOL CHEM, V275, P697, DOI 10.1074/jbc.275.1.697; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; WANG W, 1996, EMBO J, V19, P5370; WANG W, 1996, GENE DEV, V17, P2117; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	45	67	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11924	11934		10.1074/jbc.M705401200	http://dx.doi.org/10.1074/jbc.M705401200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18303029	hybrid, Green Published			2022-12-25	WOS:000255340000008
J	Tavalin, SJ				Tavalin, Steven J.			AKAP79 selectively enhances protein kinase C regulation of GluR1 at a Ca2+-calmodulin-dependent protein kinase II/protein kinase C site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; RECEPTOR UNITARY CONDUCTANCE; GLUR2-LACKING AMPA RECEPTORS; CA1 PYRAMIDAL CELLS; GLUTAMATE-RECEPTOR; ANCHORING PROTEIN; SYNAPTIC-TRANSMISSION; PHOSPHORYLATION SITE; HIPPOCAMPAL-NEURONS; SIGNALING COMPLEXES	Enhancement of AMPA receptor activity in response to synaptic plasticity inducing stimuli may arise, in part, through phosphorylation of the GluR1 AMPA receptor subunit at Ser-831. This site is a substrate for both Ca2+-calmodulin-dependent protein kinase II (CaMKII) and protein kinase C (PKC). However, neuronal protein levels of CaMKII may exceed those of PKC by an order of magnitude. Thus, it is unclear how PKC could effectively regulate this common target site. The multivalent neuronal scaffold A-kinase-anchoring protein 79 (AKAP79) is known to bind PKC and is linked to GluR1 by synapse-associated protein 97 (SAP97). Here, biochemical studies demonstrate that AKAP79 localizes PKC activity near the receptor, thus accelerating Ser-831 phosphorylation. Complementary electrophysiological studies indicate that AKAP79 selectively shifts the dose-dependence for PKC modulation of GluR1 receptor currents similar to 20-fold, such that low concentrations of PKC are as effective as much higher CaMKII concentrations. By boosting PKC activity near a target substrate, AKAP79 provides a mechanism to overcome limitations in kinase abundance thereby ensuring faithful signal propagation and efficient modification of AMPA receptor-mediated responses.	Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Tavalin, SJ (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	stavalin@utmem.edu			NINDS NIH HHS [NS46661, R01 NS046661] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046661] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Carroll RC, 1998, J NEUROPHYSIOL, V80, P2797, DOI 10.1152/jn.1998.80.5.2797; Chung HJ, 2000, J NEUROSCI, V20, P7258; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Faux MC, 1997, J BIOL CHEM, V272, P17038, DOI 10.1074/jbc.272.27.17038; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Gray EE, 2007, J NEUROPHYSIOL, V98, P2488, DOI 10.1152/jn.00473.2007; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Lee HK, 2007, MOL CELL NEUROSCI, V36, P86, DOI 10.1016/j.mcn.2007.06.003; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; LU Y, 2007, EMBO J; Luthi A, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-44; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Palmer MJ, 2004, J NEUROSCI, V24, P4903, DOI 10.1523/JNEUROSCI.0170-04.2004; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Shukla K, 2007, J BIOL CHEM, V282, P18100, DOI 10.1074/jbc.M702906200; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Tsui J, 2006, J BIOL CHEM, V281, P13794, DOI 10.1074/jbc.M600966200; Tsui J, 2005, J BIOL CHEM, V280, P9210, DOI 10.1074/jbc.M407653200; WANG LY, 1994, J PHYSIOL-LONDON, V475, P431, DOI 10.1113/jphysiol.1994.sp020083; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wikstrom MA, 2003, NEUROPHARMACOLOGY, V45, P828, DOI 10.1016/S0028-3908(03)00336-8; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	57	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11445	11452		10.1074/jbc.M709253200	http://dx.doi.org/10.1074/jbc.M709253200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18305116	Green Published, hybrid			2022-12-25	WOS:000255067400042
J	Laiolo, P; Vogeli, M; Serrano, D; Tella, JL				Laiolo, Paola; Vogeli, Matthias; Serrano, David; Tella, Jose L.			Song Diversity Predicts the Viability of Fragmented Bird Populations	PLOS ONE			English	Article								In the global scenario of increasing habitat fragmentation, finding appropriate indicators of population viability is a priority for conservation. We explored the potential of learned behaviours, specifically acoustic signals, to predict the persistence over time of fragmented bird populations. We found an association between male song diversity and the annual rate of population change, population productivity and population size, resulting in birds singing poor repertoires in populations more prone to extinction. This is the first demonstration that population viability can be predicted by a cultural trait ( acquired via social learning). Our results emphasise that cultural attributes can reflect not only individual-level characteristics, but also the emergent population-level properties. This opens the way to the study of animal cultural diversity in the increasingly common human-altered landscapes.	[Laiolo, Paola; Vogeli, Matthias; Serrano, David; Tella, Jose L.] CSIC, Estac Biol Donana, E-41080 Seville, Spain; [Laiolo, Paola] Univ Oviedo, Inst Cantabrico Biodivers, Oviedo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Oviedo	Laiolo, P (corresponding author), CSIC, Estac Biol Donana, E-41080 Seville, Spain.	paola@ebd.csic.es	Tella, José L/I-3707-2015; Laiolo, Paola/Q-3747-2019; Serrano, David/B-5352-2013; Laiolo, Paola/B-6566-2014; Vögeli, Matthias/G-1815-2010; Vögeli, Matthias/M-4269-2019	Tella, José L/0000-0002-3038-7424; Laiolo, Paola/0000-0002-2009-6797; Serrano, David/0000-0001-6205-386X; Laiolo, Paola/0000-0002-2009-6797; Vögeli, Matthias/0000-0002-3408-0972; Vögeli, Matthias/0000-0002-3408-0972	Marie Curie Intra-European Fellowship; Spanish Ministry of Education and Science; Spanish Research Council (CSIC) [I3P pre-doctoral fellowship, I3P post-doctoral contract]; Excellence Project of the Junta the Andalucia	Marie Curie Intra-European Fellowship(European Commission); Spanish Ministry of Education and Science(Spanish Government); Spanish Research Council (CSIC); Excellence Project of the Junta the Andalucia	We were financially supported by a Marie Curie Intra-European Fellowship within the 6th European Framework Program and by a Ramon y Cajal contract of the Spanish Ministry of Education and Science (PL), by an I3P pre-doctoral fellowship from the Spanish Research Council (CSIC) (MV), by an I3P post-doctoral contract from the CSIC (DS), and by an Excellence Project of the Junta the Andalucia to J.L. Tella (PL, MV, DS, JLT).	Ahtiainen JJ, 2004, P ROY SOC B-BIOL SCI, V271, P1839, DOI 10.1098/rspb.2004.2791; Birdlife International, 2000, THREAT BIRDS WORLD; Buchholz R, 2007, TRENDS ECOL EVOL, V22, P401, DOI 10.1016/j.tree.2007.06.002; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Byers BE, 2007, BEHAV ECOL, V18, P130, DOI 10.1093/beheco/arl058; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; Catchpole C.K., 1995, BIRD SONG; Catchpole CK, 1996, TRENDS ECOL EVOL, V11, P358, DOI 10.1016/0169-5347(96)30042-6; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Choquet R., 2005, U CARE 2 2 USERS MAN; Collins Sarah, 2004, P39, DOI 10.1016/B978-012473070-0/50005-0; Cramp S., 1988, BIRDS W PALEARCTIC; Crystal D., 2000, LANGUAGE DEATH; De Leo GA, 2004, ECOL MODEL, V177, P313, DOI 10.1016/j.ecolmodel.2003.11.017; Doutrelant C, 2000, J AVIAN BIOL, V31, P360, DOI 10.1034/j.1600-048X.2000.310312.x; Garamszegi LZ, 2007, ETHOLOGY, V113, P246, DOI 10.1111/j.1439-0310.2007.01337.x; Gerber LR, 2006, FRONT ECOL ENVIRON, V4, P419, DOI 10.1890/1540-9295(2006)4[419:IBDIDM]2.0.CO;2; Gil D, 2000, BEHAV ECOL SOCIOBIOL, V47, P319, DOI 10.1007/s002650050672; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Hultsch Henrike, 2004, P80, DOI 10.1016/B978-012473070-0/50006-2; KRAUSS M, 1992, LANGUAGE, V68, P4, DOI 10.1353/lan.1992.0075; Kroodsma DE, 2001, CONDOR, V103, P855, DOI 10.1650/0010-5422(2001)103[0855:SVACWW]2.0.CO;2; Kroodsma Don, 2004, P108, DOI 10.1016/B978-012473070-0/50007-4; Laiolo P, 2005, J APPL ECOL, V42, P1183, DOI 10.1111/j.1365-2664.2005.01093.x; Laiolo P, 2005, ARDEOLA, V52, P167; Laiolo P, 2007, FRONT ECOL ENVIRON, V5, P68, DOI 10.1890/1540-9295(2007)5[68:EOACIF]2.0.CO;2; Laiolo P, 2007, J AVIAN BIOL, V38, P672, DOI 10.1111/j.2007.0908-8857.04006.x; Laiolo P, 2007, TRENDS ECOL EVOL, V22, P5, DOI 10.1016/j.tree.2006.10.007; Laiolo P, 2006, ENVIRON CONSERV, V33, P223, DOI 10.1017/S0376892906003146; Laiolo P, 2006, ECOLOGY, V87, P1203, DOI 10.1890/0012-9658(2006)87[1203:LBADOT]2.0.CO;2; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Linklater WL, 2004, BIOSCIENCE, V54, P352, DOI 10.1641/0006-3568(2004)054[0352:WFCRBE]2.0.CO;2; Miller PS., 2005, VORTEX STOCHASTIC SI; Penteriani V, 2003, IBIS, V145, pE127, DOI 10.1046/j.1474-919X.2003.00173.x; REED JM, 1993, TRENDS ECOL EVOL, V8, P253, DOI 10.1016/0169-5347(93)90201-Y; RENDEL LE, 2003, P R SOC B, V270, P223; SEARCY WA, 1990, BEHAV ECOL SOCIOBIOL, V27, P123, DOI 10.1007/BF00168455; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP; Tella JL, 2005, ORYX, V39, P90, DOI 10.1017/S0030605305000165; Vaughan C, 2005, BIRD CONSERV INT, V15, P119; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitlock MC, 2000, EVOLUTION, V54, P1855, DOI 10.1111/j.0014-3820.2000.tb01232.x; Yanes M, 1996, CONSERV BIOL, V10, P881, DOI 10.1046/j.1523-1739.1996.10030881.x	45	69	69	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1822	10.1371/journal.pone.0001822	http://dx.doi.org/10.1371/journal.pone.0001822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350158	gold, Green Submitted, Green Published			2022-12-25	WOS:000260762300024
J	Pillai, A				Pillai, Anilkumar			Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; INCREASES CELL-PROLIFERATION; SIGNAL-REGULATED KINASE; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; ATYPICAL ANTIPSYCHOTICS; CHOLINERGIC MARKERS; ABNORMAL EXPRESSION; RECEPTOR; SERUM	Background: Current theories on the pathophysiology of schizophrenia suggest altered brain plasticity such as decreased neural proliferation and migration, delayed myelination, and abnormal synaptic modeling, in the brain of subjects with schizophrenia. Though functional alterations in BDNF, which plays important role in neuroplasticity, are implicated in many abnormalities found in schizophrenia, the regulatory mechanism(s) involved in the abnormal signaling of BDNF in schizophrenia is not clear. The present study investigated whether Sprouty2, a regulator of growth factor signaling, is abnormally expressed in schizophrenia, and is associated with the changes in BDNF mRNA in this disorder. The potential effect of antipsychotic drugs on Sprouty2 expression was tested in adult rats. Methods and Findings: Sprouty2 and BDNF gene expression were analyzed in dorsolateral prefrontal cortex samples from the Stanley Array Collection. Quantitative real-time PCR analysis of RNA in 100 individuals (35 with schizophrenia, 31 with bipolar disorder, and 34 psychiatrically normal controls) showed significantly decreased expression of Sprouty2 and BDNF in both schizophrenia and bipolar disorder. Moreover, a significant correlation between these two genes existed in control, schizophrenia and bipolar subjects. Long-term treatment with antipsychotic drugs, haloperidol and olanzapine, showed differential effects on both Sprouty2 and BDNF mRNA and protein levels in the frontal cortex of rats. Conclusion: These findings demonstrating decreased expression of Sprouty2 associated with changes in BDNF, suggest the possibility that these decreases are secondary to treatment rather than to factors that are significant in the disease process of either schizophrenia and/or bipolar disorder. Further exploration of Sprouty2-related signal transduction pathways may be helpful to design novel treatment strategies for these disorders.	Med Coll Georgia, Dept Psychiat & Hlth Behav, Vet Affairs Med Ctr, Med Res Serv Line, Augusta, GA 30912 USA	University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Pillai, A (corresponding author), Med Coll Georgia, Dept Psychiat & Hlth Behav, Vet Affairs Med Ctr, Med Res Serv Line, Augusta, GA 30912 USA.	apillai@mail.mcg.edu	PILLAI, ANILKUMAR/N-4809-2017					Angelucci F, 2000, INT J NEUROPSYCHOPH, V3, P13, DOI 10.1017/S1461145700001759; Arnold SE, 2005, PROG BRAIN RES, V147, P319, DOI 10.1016/S0079-6123(04)47023-X; Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Browning JL, 2005, BIOL PSYCHIAT, V57, P617, DOI 10.1016/j.biopsych.2004.12.002; Buckley PF, 2007, SCHIZOPHR RES, V94, P1, DOI 10.1016/j.schres.2007.01.025; Buckley PF, 2007, SCHIZOPHR RES, V91, P1, DOI 10.1016/j.schres.2006.12.026; Bunney WE, 2000, BRAIN RES REV, V31, P138, DOI 10.1016/S0165-0173(99)00031-4; Bymaster FP, 1996, PSYCHOPHARMACOLOGY, V124, P87, DOI 10.1007/BF02245608; Cellerino A, 1997, MOL CELL NEUROSCI, V9, P397, DOI 10.1006/mcne.1997.0641; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; De Luca V, 2005, PSYCHOPHARMACOLOGY, V183, P378, DOI 10.1007/s00213-005-0191-4; DIDRIKSEN M, 1995, EUR J PHARMACOL, V281, P241, DOI 10.1016/0014-2999(95)00242-D; Ding W, 2007, J CELL PHYSIOL, V212, P796, DOI 10.1002/jcp.21078; Durany N, 2001, SCHIZOPHR RES, V52, P79, DOI 10.1016/S0920-9964(00)00084-0; Eastwood SL, 2004, INT REV NEUROBIOL, V59, P47; Futamura T, 2002, MOL PSYCHIATR, V7, P673, DOI 10.1038/sj.mp.4001081; Green W, 2006, BRAIN RES, V1070, P242, DOI 10.1016/j.brainres.2005.11.047; Grillo RW, 2007, J PSYCHIAT RES, V41, P31, DOI 10.1016/j.jpsychires.2006.01.005; Gross I, 2007, CELL DEATH DIFFER, V14, P1802, DOI 10.1038/sj.cdd.4402188; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hashimoto K, 2005, PSYCHIAT RES, V135, P257, DOI 10.1016/j.psychres.2003.11.006; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hashimoto T, 2005, J NEUROSCI, V25, P372, DOI 10.1523/JNEUROSCI.4035-04.2005; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Iritani S, 2003, PROG NEURO-PSYCHOPH, V27, P801, DOI 10.1016/S0278-5846(03)00112-X; Jarskog LF, 2007, NEUROPSYCHOPHARMACOL, V32, P95, DOI 10.1038/sj.npp.1301074; Jockers-Scherubl MC, 2004, NEUROSCI LETT, V371, P79, DOI 10.1016/j.neulet.2004.08.045; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kinon BJ, 1996, PSYCHOPHARMACOLOGY, V124, P2, DOI 10.1007/BF02245602; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; Kyosseva SV, 2004, CEREBELLUM, V3, P94, DOI 10.1080/14734220410029164; Manji Husseini K, 2003, Sci STKE, V2003, ppe49; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Merchant JL, 1999, BIOCHEM BIOPH RES CO, V254, P454, DOI 10.1006/bbrc.1998.9964; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Mueller HT, 2004, SCHIZOPHR RES, V71, P361, DOI 10.1016/j.schres.2004.02.016; Pillai A, 2006, SCHIZOPHR RES, V82, P95, DOI 10.1016/j.schres.2005.11.021; PILLAI A, 2007, NEUROPSYCHOPHAR 0905; Pizzorusso T, 1996, CURR OPIN NEUROL, V9, P122, DOI 10.1097/00019052-199604000-00012; Pozzi L, 2003, J NEUROCHEM, V86, P451, DOI 10.1046/j.1471-4159.2003.01851.x; RYLETT RJ, 1994, TRENDS NEUROSCI, V17, P486, DOI 10.1016/0166-2236(94)90138-4; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shimizu E, 2003, NEUROSCI LETT, V351, P111, DOI 10.1016/j.neulet.2003.08.004; Shoval G, 2005, EUR NEUROPSYCHOPHARM, V15, P319, DOI 10.1016/j.euroneuro.2004.12.005; Skarsfeldt T, 1996, PSYCHOPHARMACOLOGY, V124, P126, DOI 10.1007/BF02245612; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Takahashi M, 2000, MOL PSYCHIATR, V5, P293, DOI 10.1038/sj.mp.4000718; Tan YL, 2005, SCHIZOPHR RES, V74, P263, DOI 10.1016/j.schres.2004.08.004; Tefft D, 2002, AM J PHYSIOL-LUNG C, V283, pL700, DOI 10.1152/ajplung.00372.2001; Terry AV, 2002, PSYCHOPHARMACOLOGY, V164, P360, DOI 10.1007/s00213-002-1230-z; Terry AV, 2003, NEUROPSYCHOPHARMACOL, V28, P300, DOI 10.1038/sj.npp.1300039; Torrey EF, 2001, SCHIZOPHR RES, V49, P295, DOI 10.1016/S0920-9964(00)00081-5; Toyooka K, 2002, PSYCHIAT RES, V110, P249, DOI 10.1016/S0165-1781(02)00127-0; Weickert CS, 2003, MOL PSYCHIATR, V8, P592, DOI 10.1038/sj.mp.4001308; Weickert CS, 2005, MOL PSYCHIATR, V10, P637, DOI 10.1038/sj.mp.4001678; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xu B, 2005, PLOS MED, V2, P999, DOI 10.1371/journal.pmed.0020263; Yang BH, 2004, PSYCHIAT CLIN NEUROS, V58, P262, DOI 10.1111/j.1440-1819.2004.01229.x; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	66	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1784	10.1371/journal.pone.0001784	http://dx.doi.org/10.1371/journal.pone.0001784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369VW	18335055	gold, Green Published, Green Submitted			2022-12-25	WOS:000260723000036
J	Sureka, K; Ghosh, B; Dasgupta, A; Basu, J; Kundu, M; Bose, I				Sureka, Kamakshi; Ghosh, Bhaswar; Dasgupta, Arunava; Basu, Joyoti; Kundu, Manikuntala; Bose, Indrani			Positive Feedback and Noise Activate the Stringent Response Regulator Rel in Mycobacteria	PLOS ONE			English	Article							GENE-EXPRESSION; SIGNAL-TRANSDUCTION; STATIONARY-PHASE; TUBERCULOSIS; PERSISTENCE; POLYPHOSPHATE; BISTABILITY; SMEGMATIS; PATHOGEN; STOCHASTICITY	Phenotypic heterogeneity in an isogenic, microbial population enables a subset of the population to persist under stress. In mycobacteria, stresses like nutrient and oxygen deprivation activate the stress response pathway involving the two-component system MprAB and the sigma factor, SigE. SigE in turn activates the expression of the stringent response regulator, rel. The enzyme polyphosphate kinase 1 (PPK1) regulates this pathway by synthesizing polyphosphate required for the activation of MprB. The precise manner in which only a subpopulation of bacterial cells develops persistence, remains unknown. Rel is required for mycobacterial persistence. Here we show that the distribution of rel expression levels in a growing population of mycobacteria is bimodal with two distinct peaks corresponding to low (L) and high (H) expression states, and further establish that a positive feedback loop involving the mprAB operon along with stochastic gene expression are responsible for the phenotypic heterogeneity. Combining single cell analysis by flow cytometry with theoretical modeling, we observe that during growth, noise-driven transitions take a subpopulation of cells from the L to the H state within a "window of opportunity'' in time preceding the stationary phase. It is these cells which adapt to nutrient depletion in the stationary phase via the stringent response. We find evidence of hysteresis in the expression of rel in response to changing concentrations of PPK1. Hysteresis promotes robustness in the maintenance of the induced state. Our results provide, for the first time, evidence that bistability and stochastic gene expression could be important for the development of "heterogeneity with an advantage'' in mycobacteria and suggest strategies for tackling tuberculosis like targeting transitions from the low to the high rel expression state.	[Sureka, Kamakshi; Dasgupta, Arunava; Basu, Joyoti; Kundu, Manikuntala] Bose Inst, Dept Chem, Kolkata, India; [Ghosh, Bhaswar; Bose, Indrani] Bose Inst, Dept Phys, Kolkata, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Sureka, K (corresponding author), Bose Inst, Dept Chem, Kolkata, India.	manikuntala@vsnl.net	Sureka, Kamakshi/ABE-4125-2021	Sureka, Kamakshi/0000-0003-3093-5299	Council of Scientific and Industrial Research, Government of India [fellowship]; Department of Biotechnology, Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	B.G. was supported by a fellowship from the Council of Scientific and Industrial Research, Government of India. This work was supported in part by a grant from the Department of Biotechnology, Government of India.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bishai W, 2000, NATURE, V406, P683, DOI 10.1038/35021159; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Choudhuri BS, 2002, BIOCHEM J, V367, P279, DOI 10.1042/BJ20020615; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; De Voss JJ, 1999, J BACTERIOL, V181, P4443, DOI 10.1128/JB.181.15.4443-4451.1999; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; He HJ, 2005, J BACTERIOL, V187, P202, DOI 10.1128/JB.187.1.202-212.2005; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Leisner M, 2007, MOL MICROBIOL, V63, P1806, DOI 10.1111/j.1365-2958.2007.05628.x; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mahenthiralingam E, 1998, INFECT IMMUN, V66, P3626, DOI 10.1128/IAI.66.8.3626-3634.1998; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Manganelli R, 2007, MOL MICROBIOL, V65, P258, DOI 10.1111/j.1365-2958.2007.05819.x; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; NYKA W, 1974, INFECT IMMUN, V9, P843, DOI 10.1128/IAI.9.5.843-850.1974; Ojha AK, 2000, INFECT IMMUN, V68, P4084, DOI 10.1128/IAI.68.7.4084-4091.2000; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Smeulders MJ, 1999, J BACTERIOL, V181, P270, DOI 10.1128/JB.181.1.270-283.1999; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; WU Q, 2005, J BACTERIOL, V179, P2922; Zahrt TC, 2003, INFECT IMMUN, V71, P6962, DOI 10.1128/IAI.71.12.6962-6970.2003	35	83	92	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1771	10.1371/journal.pone.0001771	http://dx.doi.org/10.1371/journal.pone.0001771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335046	Green Submitted, gold, Green Published			2022-12-25	WOS:000260723000025
J	Wijers, SLJ; Schrauwen, P; Saris, WHM; Lichtenbelt, WDV				Wijers, Sander L. J.; Schrauwen, Patrick; Saris, Wim H. M.; Lichtenbelt, Wouter D. van Marken			Human Skeletal Muscle Mitochondrial Uncoupling Is Associated with Cold Induced Adaptive Thermogenesis	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; ENERGY-EXPENDITURE; PROTEIN-3 CONTENT; MILD COLD; TEMPERATURE; PREVALENCE; OVERWEIGHT; EXPRESSION; RESPONSES; OBESITY	Background: Mild cold exposure and overfeeding are known to elevate energy expenditure in mammals, including humans. This process is called adaptive thermogenesis. In small animals, adaptive thermogenesis is mainly caused by mitochondrial uncoupling in brown adipose tissue and regulated via the sympathetic nervous system. In humans, skeletal muscle is a candidate tissue, known to account for a large part of the epinephrine-induced increase in energy expenditure. However, mitochondrial uncoupling in skeletal muscle has not extensively been studied in relation to adaptive thermogenesis in humans. Therefore we hypothesized that cold-induced adaptive thermogenesis in humans is accompanied by an increase in mitochondrial uncoupling in skeletal muscle. Methodology/Principal Findings: The metabolic response to mild cold exposure in 11 lean, male subjects was measured in a respiration chamber at baseline and mild cold exposure. Skeletal muscle mitochondrial uncoupling (state 4) was measured in muscle biopsies taken at the end of the respiration chamber stays. Mild cold exposure caused a significant increase in 24h energy expenditure of 2.8% (0.32 MJ/day, range of -0.21 to 1.66 MJ/day, p<0.05). The individual increases in energy expenditure correlated to state 4 respiration (p<0.02, R-2 = 0.50). Conclusions/Significance: This study for the first time shows that in humans, skeletal muscle has the intrinsic capacity for cold induced adaptive thermogenesis via mitochondrial uncoupling under physiological conditions. This opens possibilities for mitochondrial uncoupling as an alternative therapeutic target in the treatment of obesity.	[Wijers, Sander L. J.; Schrauwen, Patrick; Saris, Wim H. M.; Lichtenbelt, Wouter D. van Marken] Maastricht Univ, NUTRIM, Dept Human Biol, Maastricht, Netherlands	Maastricht University	Wijers, SLJ (corresponding author), Maastricht Univ, NUTRIM, Dept Human Biol, Maastricht, Netherlands.	S.Wijers@hb.unimaas.nl		Wijers, Sander/0000-0002-2944-4356; schrauwen, patrick/0000-0002-0973-847X				[Anonymous], 2000, WHO TECH REP SER, V894, pi; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; DAVIS TRA, 1960, AM J PHYSIOL, V198, P471, DOI 10.1152/ajplegacy.1960.198.3.471; Harris AM, 2006, J THERM BIOL, V31, P634, DOI 10.1016/j.jtherbio.2006.08.007; Hesselink MKC, 2003, J CLIN INVEST, V111, P479, DOI 10.1172/JCI16653; Himms-Hagen J, 2001, Rev Endocr Metab Disord, V2, P395, DOI 10.1023/A:1011856617047; JEQUIER E, 1983, AM J CLIN NUTR, V38, P989, DOI 10.1093/ajcn/38.6.989; Lebon V, 2001, J CLIN INVEST, V108, P733, DOI 10.1172/JCI11775; Lichtenbelt WDV, 2002, AM J PHYSIOL-ENDOC M, V282, pE1077, DOI 10.1152/ajpendo.00020.2001; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Major GC, 2007, INT J OBESITY, V31, P204, DOI 10.1038/sj.ijo.0803523; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Miranda EJ, 2006, J ANAL TOXICOL, V30, P219, DOI 10.1093/jat/30.3.219; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Sanchis D, 1998, J BIOL CHEM, V273, P34611, DOI 10.1074/jbc.273.51.34611; Schoffelen PFM, 1997, J APPL PHYSIOL, V83, P2064, DOI 10.1152/jappl.1997.83.6.2064; Schokker DF, 2007, OBES REV, V8, P101, DOI 10.1111/j.1467-789X.2006.00273.x; Schrauwen P, 2000, DIABETOLOGIA, V43, P1408, DOI 10.1007/s001250051547; Schrauwen P, 2006, PROG LIPID RES, V45, P17, DOI 10.1016/j.plipres.2005.11.001; Schrauwen P, 2006, J CLIN ENDOCR METAB, V91, P1520, DOI 10.1210/jc.2005-1572; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; SIMONSEN L, 1992, AM J PHYSIOL, V263, pE850, DOI 10.1152/ajpendo.1992.263.5.E850; van Ooijen AMJ, 2004, PHYSIOL BEHAV, V82, P545, DOI 10.1016/j.physbeh.2004.05.001; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; WARWICK PM, 1990, BRIT J NUTR, V63, P481, DOI 10.1079/BJN19900135; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wijers SLJ, 2007, J CLIN ENDOCR METAB, V92, P4299, DOI 10.1210/jc.2007-1065; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002	31	91	95	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1777	10.1371/journal.pone.0001777	http://dx.doi.org/10.1371/journal.pone.0001777			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335051	Green Published, Green Submitted, gold			2022-12-25	WOS:000260723000030
J	Vicario, CM; Pecoraro, P; Turriziani, P; Koch, G; Caltagirone, C; Oliveri, M				Vicario, Carmelo Mario; Pecoraro, Patrizia; Turriziani, Patrizia; Koch, Giacomo; Caltagirone, Carlo; Oliveri, Massimiliano			Relativistic Compression and Expansion of Experiential Time in the Left and Right Space	PLOS ONE			English	Article							MENTAL REPRESENTATION; NEURAL MECHANISMS; NUMBER; DURATION	Time, space and numbers are closely linked in the physical world. However, the relativistic-like effects on time perception of spatial and magnitude factors remain poorly investigated. Here we wanted to investigate whether duration judgments of digit visual stimuli are biased depending on the side of space where the stimuli are presented and on the magnitude of the stimulus itself. Different groups of healthy subjects performed duration judgment tasks on various types of visual stimuli. In the first two experiments visual stimuli were constituted by digit pairs ( 1 and 9), presented in the centre of the screen or in the right and left space. In a third experiment visual stimuli were constituted by black circles. The duration of the reference stimulus was fixed at 300 ms. Subjects had to indicate the relative duration of the test stimulus compared with the reference one. The main results showed that, regardless of digit magnitude, duration of stimuli presented in the left hemispace is underestimated and that of stimuli presented in the right hemispace is overestimated. On the other hand, in midline position, duration judgments are affected by the numerical magnitude of the presented stimulus, with time underestimation of stimuli of low magnitude and time overestimation of stimuli of high magnitude. These results argue for the presence of strict interactions between space, time and magnitude representation on the human brain.	[Vicario, Carmelo Mario] Univ Roma La Sapienza, Dipartimento Psicol, Rome, Italy; [Pecoraro, Patrizia; Turriziani, Patrizia; Oliveri, Massimiliano] Univ Palermo, Dipartimento Psicol, Palermo, Italy; [Koch, Giacomo; Caltagirone, Carlo; Oliveri, Massimiliano] IRCCS, Rome, Italy	Sapienza University Rome; University of Palermo	Vicario, CM (corresponding author), Univ Roma La Sapienza, Dipartimento Psicol, Rome, Italy.	maxoliveri@unipa.it	Caltagirone, Carlo/B-4930-2013; Koch, Giacomo/G-3155-2012; VICARIO, CARMELO/AAR-2521-2021; Oliveri, Massimiliano/HDO-5602-2022	Turriziani, Patrizia/0000-0003-4802-280X; KOch, Giacomo/0000-0001-6155-9439				Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DELONG AJ, 1981, SCIENCE, V213, P681, DOI 10.1126/science.7256273; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Droit-Volet S, 2003, J EXP CHILD PSYCHOL, V84, P63, DOI 10.1016/S0022-0965(02)00180-7; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; MECK WH, 1985, J EXP PSYCHOL ANIM B, V11, P591, DOI 10.1037/0097-7403.11.4.591; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; ROBERTS WA, 1994, J EXP PSYCHOL ANIM B, V20, P66, DOI 10.1037/0097-7403.20.1.66; ROBERTS WA, 1995, CURR DIR PSYCHOL SCI, V4, P47, DOI 10.1111/1467-8721.ep10771008; Roitman JD, 2007, ACTA PSYCHOL, V124, P296, DOI 10.1016/j.actpsy.2006.03.008; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; Vallesi A, 2008, COGNITION, V107, P501, DOI 10.1016/j.cognition.2007.10.011; Vicario C. M., 2007, BRAIN COGNITION, V39, P1317; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002	20	122	126	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1716	10.1371/journal.pone.0001716	http://dx.doi.org/10.1371/journal.pone.0001716			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XT	18320037	Green Submitted, gold, Green Published			2022-12-25	WOS:000260586600012
J	Johansson, BP; Shannon, O; Bjorck, L				Johansson, Bjorn P.; Shannon, Oonagh; Bjorck, Lars			IdeS: A Bacterial Proteolytic Enzyme with Therapeutic Potential	PLOS ONE			English	Article								Background: IdeS, a proteinase from Streptococcus pyogenes, cleaves immunoglobulin (Ig) G antibodies with a unique degree of specificity. Pathogenic IgG antibodies constitute an important clinical problem contributing to the pathogenesis of a number of autoimmune conditions and acute transplant rejection. To be able to effectively remove such antibodies is therefore an important clinical challenge. Methodology/Principal Findings: IdeS was found to specifically and efficiently cleave IgG in human blood in vitro (20 mg of IdeS caused a complete degradation of IgG in one ml of human whole blood in 15 minutes) and to clear IgG from the blood stream of rabbits in vivo (no IgG was detected six hours following an intravenous injection of 5 mg of IdeS) without any side effects. In a mouse model of immune thrombocytopenic purpura (ITP), polyclonal IgG antibodies against platelet surface antigens were used to induce a lethal disease. These profoundly thrombocytopenic animals were treated and cured by a single injection of IdeS. Conclusions/Significance: Novel information is provided concerning the IgG-cleaving activity of IdeS in vitro and in vivo. The highly specific and rapid elimination of IgG in vivo, the dramatic effect in a mouse model of ITP, and the lack of side effects in the treated animals, indicate that IdeS could also be used to treat IgG-driven diseases in humans.	[Johansson, Bjorn P.; Shannon, Oonagh; Bjorck, Lars] Lund Univ, Biomed Ctr, Dept Clin Sci, Div Infect Med, Lund, Sweden	Lund University	Johansson, BP (corresponding author), Lund Univ, Biomed Ctr, Dept Clin Sci, Div Infect Med, Lund, Sweden.	lars.bjorck@med.lu.se		Shannon, Oonagh/0000-0001-8291-8189	Swedish Research Council [project 7480]; Swedish Government Funds for Clinical Research; Foundations of Greta and Johan Kock, Alfred Osterlund, and Torsten and Ragnar Soderberg; Hansa Medical AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Government Funds for Clinical Research; Foundations of Greta and Johan Kock, Alfred Osterlund, and Torsten and Ragnar Soderberg; Hansa Medical AB	This work was supported by the Swedish Research Council (project 7480), the Swedish Government Funds for Clinical Research (ALF), the Foundations of Greta and Johan Kock, Alfred Osterlund, and Torsten and Ragnar Soderberg, and by Hansa Medical AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson P, 2006, INFECT IMMUN, V74, P497, DOI 10.1128/IAI.74.1.497-503.2006; Akesson P, 2004, J INFECT DIS, V189, P797, DOI 10.1086/381982; BERTA E, 1994, INT J ARTIF ORGANS, V17, P603, DOI 10.1177/039139889401701109; BYGREN P, 1985, LANCET, V2, P1295; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; COLLIN M, 2007, P NATL ACAD IN PRESS; Dominguez V, 2003, HAEMATOLOGICA, V88, P679; Eming R, 2006, AUTOIMMUNITY, V39, P609, DOI 10.1080/08916930600972040; Fujimi S, 2006, BLOOD, V107, P4399, DOI 10.1182/blood-2005-09-3776; Lei BF, 2001, NAT MED, V7, P1298, DOI 10.1038/nm1201-1298; Nandakumar KS, 2007, EUR J IMMUNOL, V37, P2973, DOI 10.1002/eji.200737581; Nandakumar KS, 2007, ARTHRITIS RHEUM-US, V56, P3253, DOI 10.1002/art.22930; PALMER A, 1989, LANCET, V1, P10; PALMER A, 1988, LANCET, V2, P272; Stummvoll GH, 2005, ANN RHEUM DIS, V64, P1015, DOI 10.1136/ard.2004.029660; Tomer A, 2005, J THROMB HAEMOST, V3, P74, DOI 10.1111/j.1538-7836.2004.01052.x; Vincents B, 2004, BIOCHEMISTRY-US, V43, P15540, DOI 10.1021/bi048284d; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Wenig K, 2004, P NATL ACAD SCI USA, V101, P17371, DOI 10.1073/pnas.0407965101	19	71	75	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1692	10.1371/journal.pone.0001692	http://dx.doi.org/10.1371/journal.pone.0001692			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301769	gold, Green Published, Green Submitted			2022-12-25	WOS:000260586500036
J	Sekkali, B; Tran, HT; Crabbe, E; De Beule, C; Van Roy, F; Vleminckx, K				Sekkali, Belaid; Tran, Hong Thi; Crabbe, Ellen; De Beule, Christophe; Van Roy, Frans; Vleminckx, Kris			Chicken beta-globin insulator overcomes variegation of transgenes in Xenopus embryos	FASEB JOURNAL			English	Article						transcriptional silencing; heterochromatin; position effect variegation	ENHANCER-BLOCKING ACTIVITY; LOCUS-CONTROL REGIONS; GENE-EXPRESSION; CHROMATIN INSULATOR; LAEVIS EMBRYOS; HETEROCHROMATIN; DROSOPHILA; CELLS; VECTORS; DISEASE	Chromatin structure and gene transcription regulation are intimately linked, and mosaic expression of randomly integrated transgenes into the genome is frequently observed. This variegation of transgene expression is likely due to the genomic integration site, which can affect the behavior of the integrated DNA sequence in a positive or a negative way. Insulators are a class of DNA elements that can protect genes from inappropriate signals emanating from their environment by acting as boundaries that prevent the spreading of nearby condensed chromatin that may otherwise silence expression. Here we show that transgenes escape this silencing in Xenopus laevis and Xenopus tropicalis embryos and that a stable, uniform, and heritable expression pattern is obtained when transgenes are flanked with tandem copies of the chicken beta-globin 5'HS4 insulator. Our data also indicate that the insulator confers copy-number-dependent transgene expression and can increase transgene expression from weak regulatory elements. Hence, it will be an invaluable tool for generating stable lines expressing different levels of a particular coding sequence.	[Sekkali, Belaid; Tran, Hong Thi; Crabbe, Ellen; De Beule, Christophe; Van Roy, Frans; Vleminckx, Kris] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Sekkali, Belaid; Tran, Hong Thi; Crabbe, Ellen; De Beule, Christophe; Van Roy, Frans; Vleminckx, Kris] Univ Ghent, Dept Mol Biol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Vleminckx, K (corresponding author), Univ Ghent VIB, Dept Mol Biomed Res, Technol Pk 927, B-9052 Ghent, Belgium.	kris.vleminckx@dmbr.ugent.be	Vleminckx, Kris/J-5699-2013; van Roy, Frans M/C-6123-2009; Tran, Hong/C-6831-2015	van Roy, Frans M/0000-0003-4358-1039; 				Allen BG, 2005, NAT METHODS, V2, P975, DOI 10.1038/NMETH814; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; BROWN AL, 1986, J BIOL CHEM, V261, P3144; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Dobie K, 1997, TRENDS GENET, V13, P127, DOI 10.1016/S0168-9525(97)01097-4; Festenstein R, 1999, NAT GENET, V23, P457, DOI 10.1038/70579; Gdula DA, 1996, P NATL ACAD SCI USA, V93, P9378, DOI 10.1073/pnas.93.18.9378; Grosveld F, 1998, ANN NY ACAD SCI, V850, P18, DOI 10.1111/j.1749-6632.1998.tb10458.x; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hirsch N, 2002, DEV DYNAM, V225, P522, DOI 10.1002/dvdy.10188; KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; Kleinjan DJ, 1998, HUM MOL GENET, V7, P1611, DOI 10.1093/hmg/7.10.1611; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Milot E, 1996, TRENDS GENET, V12, P123, DOI 10.1016/0168-9525(96)30019-X; MOHUN TJ, 1986, EMBO J, V5, P3185, DOI 10.1002/j.1460-2075.1986.tb04628.x; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Recillas-Targa F, 1999, P NATL ACAD SCI USA, V96, P14354, DOI 10.1073/pnas.96.25.14354; Truffinet W, 2005, IMMUNOL LETT, V96, P303, DOI 10.1016/j.imlet.2004.09.002; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Yannaki E, 2002, MOL THER, V5, P589, DOI 10.1006/mthe.2002.0582	25	17	18	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2008	22	7					2534	2540		10.1096/fj.07-098111	http://dx.doi.org/10.1096/fj.07-098111			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18359926				2022-12-25	WOS:000257292500044
J	Urushitani, M; Abou Ezzi, S; Matsuo, A; Tooyama, I; Julien, JP				Urushitani, Makoto; Abou Ezzi, Samer; Matsuo, Akinori; Tooyama, Ikuo; Julien, Jean-Pierre			The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS	FASEB JOURNAL			English	Article						digitonin; microsome; live imaging; green fluorescent protein; electron immunomicroscopy	AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEATH; CU,ZN-SUPEROXIDE DISMUTASE; RAT-LIVER; SOD1; PROTEINS; MUTATIONS; SECRETION; TOXICITY; DEGENERATION	Mutations in superoxide dismutase 1 (SOD1) are responsible for 20% cases of familial amyotrophic lateral sclerosis (ALS). However, the mechanism of motor neuron degeneration caused by ALS-linked SOD1 mutants is not fully understood. Here, we used novel live cell imaging techniques to demonstrate the subcellular localization of EGFP-fused SOD1 of both wild-type (WT) and ALS-linked mutant forms in the endoplasmic reticulum (ER) and Golgi. The presence of WT and mutant SOD1 species in luminal structures was further confirmed by immunoblotting analysis of microsomal fractions from spinal cord lysates of SOD1 transgenic mice prepared by sucrose density-gradient ultracentrifugation. Chemical cross-linking studies also revealed an age-dependent aggregation of mutant SOD1, but not of WT SOD1, prominently in the microsomal fraction. Cell-free translocation assays provided evidence that monomeric SOD1 is a molecular form that can be translocated into luminal structures in the presence of ATP. Our finding that the ER-Golgi pathway is a predominant cellular site of aggregation of mutant SOD1 suggests that secretion could play a key role in pathogenesis, which is in line with the view that the disease is non-cell autonomous.	[Urushitani, Makoto; Abou Ezzi, Samer; Julien, Jean-Pierre] Univ Laval, Res Ctr CHUQ, Dept Anat & Physiol, Quebec City, PQ G1V 4G2, Canada; [Urushitani, Makoto; Matsuo, Akinori; Tooyama, Ikuo] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga, Japan	Laval University; Shiga University of Medical Science	Julien, JP (corresponding author), Univ Laval, Res Ctr CHUQ, Dept Anat & Physiol, 2705 Boul Laurier, Quebec City, PQ G1V 4G2, Canada.	jean-pierre.julien@crchul.ulaval.ca		Urushitani, Makoto/0000-0003-2773-9836; Tooyama, Ikuo/0000-0001-8054-9666				Bergemalm D, 2006, J NEUROSCI, V26, P4147, DOI 10.1523/JNEUROSCI.5461-05.2006; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; FURUKAWA Y, 2004, J BIOL CHEM, V279, P17266; Furukawa Y., 2005, P NATL ACAD SCI USA, V280, P7148; GELLER BL, 1982, J BIOL CHEM, V257, P8945; Gomes C, 2007, NEUROSCI LETT, V428, P43, DOI 10.1016/j.neulet.2007.09.024; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; JADOT M, 1985, BIOCHEM J, V225, P645, DOI 10.1042/bj2250645; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; LIOU W, 1993, FREE RADICAL BIO MED, V14, P201, DOI 10.1016/0891-5849(93)90011-I; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Martin ME, 2000, J BIOL CHEM, V275, P19050, DOI 10.1074/jbc.275.25.19050; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Miyakawa K, 2003, J BIOL CHEM, V278, P35718, DOI 10.1074/jbc.M300690200; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; RABOUILLE C, 1993, J CELL BIOL, V120, P897, DOI 10.1083/jcb.120.4.897; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Santillo M, 2007, J NEUROCHEM, V102, P679, DOI 10.1111/j.1471-4159.2007.04538.x; Sattler T, 2000, J CELL BIOL, V151, P529, DOI 10.1083/jcb.151.3.529; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Tagaya M, 1996, J BIOL CHEM, V271, P466, DOI 10.1074/jbc.271.1.466; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Zhang FJ, 2006, BBA-GEN SUBJECTS, V1760, P404, DOI 10.1016/j.bbagen.2005.11.024	46	68	72	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2008	22	7					2476	2487		10.1096/fj.07-092783	http://dx.doi.org/10.1096/fj.07-092783			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18337461				2022-12-25	WOS:000257292500039
J	Hillig, T; Engelholm, LH; Ingvarsen, S; Madsen, DH; Gardsvoll, H; Larsen, JK; Ploug, M; Dano, K; Kjoller, L; Behrendt, N				Hillig, Thore; Engelholm, Lars H.; Ingvarsen, Signe; Madsen, Daniel H.; Gardsvoll, Henrik; Larsen, Jorgen K.; Ploug, Michael; Dano, Keld; Kjoller, Lars; Behrendt, Niels			A composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; FUNCTIONAL EPITOPE; LIGAND-BINDING; ADHESION; CANCER; INTEGRIN; IDENTIFICATION; MOTILITY; PROTEIN; GROWTH	The urokinase receptor, urokinase receptor (uPAR), is a glycosylphosphatidylinositol-anchored membrane protein engaged in pericellular proteolysis and cellular adhesion, migration, and modulation of cell morphology. A direct matrix adhesion is mediated through the binding of uPAR to vitronectin, and this event is followed by downstream effects including changes in the cytoskeletal organization. However, it remains unclear whether the adhesion through uPAR-vitronectin is the only event capable of initiating these morphological rearrangements or whether lateral interactions between uPAR and integrins can induce the same response. In this report, we show that both of these triggering mechanisms can be operative and that uPAR-dependent modulation of cell morphology can indeed occur independently of a direct vitronectin binding. Expression of wild-type uPAR on HEK293 cells led to pronounced vitronectin adhesion and cytoskeletal rearrangements, whereas a mutant uPAR, uPAR(W32A) with defective vitronectin binding, failed to induce both phenomena. However, upon saturation of uPAR(W32A) with the protease ligand, pro-uPA, or its receptor-binding domain, the ability to induce cytoskeletal rearrangements was restored, although this did not rescue the uPAR-vitronectin binding and adhesion capability. On the other hand, using other uPAR variants, we could show that uPAR-vitronectin adhesion is indeed capable and sufficient to induce the same morphological rearrangements. This was shown with cells expressing a different single-site mutant, uPAR(Y57A), in the presence of a synthetic uPAR-binding peptide, as well as with wildtype uPAR, which underwent cytoskeletal rearrangements even when cultivated in uPA-deficient serum. Blocking of integrins with an Arg-Gly-Asp-containing peptide counteracted the matrix contacts necessary to initiate the uPAR-dependent cytoskeletal rearrangements, whereas inactivation of the Rac signaling pathway in all cases suppressed the occurrence of the same events.	[Hillig, Thore; Engelholm, Lars H.; Ingvarsen, Signe; Madsen, Daniel H.; Gardsvoll, Henrik; Larsen, Jorgen K.; Ploug, Michael; Dano, Keld; Kjoller, Lars; Behrendt, Niels] Rigshosp, Dept 37 35, Finsen Lab, DK-2200 Copenhagen, Denmark; [Engelholm, Lars H.] Rigshosp, Dept 37 31, Bartholin Inst, DK-2200 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Behrendt, N (corresponding author), Rigshosp, Dept 37 35, Finsen Lab, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	niels.behrendt@finsenlab.dk	Ingvarsen, Signe Ziir/AAT-3296-2020	Ploug, Michael/0000-0003-2215-4265; Ingvarsen, Signe Ziir/0000-0001-7800-6443; Hillig, Thore/0000-0002-2085-5183; Engelholm, Lars/0000-0002-6616-1232; Behrendt, Niels/0000-0003-1833-3922; Madsen, Daniel Hargboel/0000-0002-3183-6201				APPELLA E, 1987, J BIOL CHEM, V262, P4437; AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D; Behrendt N, 2004, BIOL CHEM, V385, P103, DOI 10.1515/BC.2004.031; BEHRENDT N, 1991, J BIOL CHEM, V266, P7842; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Carriero MV, 2002, BIOL CHEM, V383, P107, DOI 10.1515/BC.2002.011; Chapman HA, 2001, THROMB HAEMOSTASIS, V86, P124; Chaurasia P, 2006, J BIOL CHEM, V281, P14852, DOI 10.1074/jbc.M512311200; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Gardsvoll H, 1999, J BIOL CHEM, V274, P37995, DOI 10.1074/jbc.274.53.37995; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Hoyer-Hansen G, 1997, FEBS LETT, V420, P79, DOI 10.1016/S0014-5793(97)01491-9; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Jo MJ, 2003, J BIOL CHEM, V278, P46692, DOI 10.1074/jbc.M308808200; Kanse SM, 1996, EXP CELL RES, V224, P344, DOI 10.1006/excr.1996.0144; Kjoller L, 2002, BIOL CHEM, V383, P5, DOI 10.1515/BC.2002.002; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; MOSER TL, 1995, BIOCHEM J, V307, P867, DOI 10.1042/bj3070867; Nguyen DHD, 1998, J BIOL CHEM, V273, P8502, DOI 10.1074/jbc.273.14.8502; Nielsen BS, 2007, INT J CANCER, V120, P2086, DOI 10.1002/ijc.22340; Ploug M, 2001, BIOCHEMISTRY-US, V40, P12157, DOI 10.1021/bi010662g; Pluskota E, 2003, BLOOD, V101, P1582, DOI 10.1182/blood-2002-06-1842; PYKE C, 1994, HISTOPATHOLOGY, V24, P131, DOI 10.1111/j.1365-2559.1994.tb01291.x; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Romer J, 2001, J INVEST DERMATOL, V116, P353, DOI 10.1046/j.1523-1747.2001.01241.x; WEI Y, 1994, J BIOL CHEM, V269, P32380; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Xue W, 1997, CANCER RES, V57, P1682; XUE W, 1994, J IMMUNOL, V152, P4630; Yuan C, 2007, CELL MOL LIFE SCI, V64, P1033, DOI 10.1007/s00018-007-6498-z	39	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15217	15223		10.1074/jbc.C700214200	http://dx.doi.org/10.1074/jbc.C700214200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18362146	Green Published, hybrid			2022-12-25	WOS:000256232000039
J	Hua, QX; Nakagawa, SH; Jia, W; Huang, K; Phillips, NB; Hu, SQ; Weiss, MA				Hua, Qing-Xin; Nakagawa, Satoe H.; Jia, Wenhua; Huang, Kun; Phillips, Nelson B.; Hu, Shi-quan; Weiss, Michael A.			Design of an active ultrastable single-chain insulin analog - Synthesis, structure, and therapeutic implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DIABETES-ASSOCIATED MUTATIONS; RECEPTOR-BINDING SURFACE; PHOTO-CROSS-LINKING; A-CHAIN; GROWTH-FACTOR; SIDE-CHAIN; BIOLOGICAL-ACTIVITY; CHIRAL MUTAGENESIS; MINI-PROINSULIN; IN-VIVO	Single-chain insulin (SCI) analogs provide insight into the inter-relation of hormone structure, function, and dynamics. Although compatible with wild-type structure, short connecting segments (< 3 residues) prevent induced fit upon receptor binding and so are essentially without biological activity. Substantial but incomplete activity can be regained with increasing linker length. Here, we describe the design, structure, and function of a single-chain insulin analog (SCI-57) containing a 6-residue linker (GGGPRR). Native receptor-binding affinity (130 +/- 8% relative to the wild type) is achieved as hindrance by the linker is offset by favorable substitutions in the insulin moiety. The thermodynamic stability of SCI-57 is markedly increased (Delta Delta G(u) = 0.7 +/- 0.1 kcal/mol relative to the corresponding two-chain analog and 1.9 +/- 0.1 kcal/mol relative to wild-type insulin). Analysis of inter-residue nuclear Overhauser effects demonstrates that a native-like fold is maintained in solution. Surprisingly, the glycine-rich connecting segment folds against the insulin moiety: its central Pro contacts Val(A3) at the edge of the hydrophobic core, whereas the final Arg extends the A1-A8 alpha-helix. Comparison between SCI-57 and its parent two-chain analog reveals striking enhancement of multiple native-like nuclear Overhauser effects within the tethered protein. These contacts are consistent with wild-type crystal structures but are ordinarily attenuated in NMR spectra of two-chain analogs, presumably due to conformational fluctuations. Linker-specific damping of fluctuations provides evidence for the intrinsic flexibility of an insulin monomer. In addition to their biophysical interest, ultrastable SCIs may enhance the safety and efficacy of insulin replacement therapy in the developing world.	[Hua, Qing-Xin; Jia, Wenhua; Huang, Kun; Phillips, Nelson B.; Hu, Shi-quan; Weiss, Michael A.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Nakagawa, Satoe H.] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Case Western Reserve University; University of Chicago	Weiss, MA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Huang, Kun/H-4427-2012		NIDDK NIH HHS [R01 DK040949, DK 040949] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Bassili A, 2001, DIABETES RES CLIN PR, V53, P187, DOI 10.1016/S0168-8227(01)00264-9; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; Bott RF, 2007, DRUG DEV IND PHARM, V33, P393, DOI 10.1080/03639040600975022; BRANDENBURG D, 1973, Z PHYSIOL CHEM, V354, P613; Brange I., 1987, GALENICS INSULIN PHY; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1993, Pharm Biotechnol, V5, P315; BREMS DN, 1991, J BIOL CHEM, V266, P1611; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; BREMS DN, 1992, PROTEIN ENG, V5, P519, DOI 10.1093/protein/5.6.519; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; BRUCH MD, 1991, PROTEINS, V10, P130, DOI 10.1002/prot.340100206; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURKE GT, 1990, BIOCHEM BIOPH RES CO, V173, P982, DOI 10.1016/S0006-291X(05)80882-4; CARA JF, 1990, J BIOL CHEM, V265, P17820; CHAKRABARTTY A, 1995, ADV PROTEIN CHEM, V46, P141, DOI 10.1016/S0065-3233(08)60334-4; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; Chance R. E., 1981, PEPTIDES SYNTHESIS S, P721; Chang SG, 1998, BIOCHEM J, V329, P631, DOI 10.1042/bj3290631; Chang XQ, 1997, BIOCHEMISTRY-US, V36, P9409, DOI 10.1021/bi9631069; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; COSMATOS A, 1978, J BIOL CHEM, V253, P6586; CUTFIELD J, 1981, H-S Z PHYSIOL CHEM, V362, P755, DOI 10.1515/bchm2.1981.362.1.755; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; DOIG AJ, 1995, PROTEIN SCI, V4, P1325, DOI 10.1002/pro.5560040708; Dong J, 2003, J MOL BIOL, V330, P431, DOI 10.1016/S0022-2836(03)00536-9; FREYCHET P, 1974, DIABETOLOGIA, V10, P1, DOI 10.1007/BF00421406; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; GLIEMANN J, 1974, DIABETOLOGIA, V10, P105, DOI 10.1007/BF01219665; GOLDMAN J, 1974, BIOCHEMISTRY-US, V13, P4566, DOI 10.1021/bi00719a015; Guthridge SL, 1996, AUST NZ J PUBL HEAL, V20, P657, DOI 10.1111/j.1467-842X.1996.tb01084.x; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; HUA QX, 1993, BIOCHEMISTRY-US, V32, P1433, DOI 10.1021/bi00057a006; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; HUA QX, 1993, J MOL BIOL, V230, P387, DOI 10.1006/jmbi.1993.1156; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Huang K, 2006, BIOCHEMISTRY-US, V45, P10278, DOI 10.1021/bi060879g; Huang YD, 2001, SCI CHINA SER C, V44, P593, DOI 10.1007/BF02879353; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KANG S, 1991, DIABETES CARE, V14, P571, DOI 10.2337/diacare.14.7.571; Keller Kelley J, 2003, S D J Med, V56, P303; KITAGAWA K, 1984, BIOCHEMISTRY-US, V23, P1405, DOI 10.1021/bi00302a011; Kjeldsen T, 2000, APPL MICROBIOL BIOT, V54, P277, DOI 10.1007/s002530000402; Kjeldsen T, 2002, J BIOL CHEM, V277, P18245, DOI 10.1074/jbc.C200137200; KOBAYASHI M, 1989, DIABETES RES CLIN PR, V7, P25, DOI 10.1016/0168-8227(89)90040-5; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; Kohn WD, 2007, PEPTIDES, V28, P935, DOI 10.1016/j.peptides.2007.01.012; KRISTENSEN C, 1995, BIOCHEM J, V305, P981, DOI 10.1042/bj3050981; Lee HC, 2000, NATURE, V408, P483, DOI 10.1038/35044106; Lefebvre Pierre, 2004, World Hosp Health Serv, V40, P37; LIANG DC, 1994, BIOPHYS CHEM, V50, P63, DOI 10.1016/0301-4622(94)85020-8; LOWMAN HB, 1993, J MOL BIOL, V234, P564, DOI 10.1006/jmbi.1993.1612; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; MARKUSSEN J, 1985, INT J PEPT PROT RES, V25, P431; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; MARKUSSEN J, 1987, PEPTIDES 1986, P189, DOI DOI 10.1002/BIT.260460206; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; NAKAGAWA SH, 1989, J BIOL CHEM, V264, P272; NICHOLSON H, 1991, BIOCHEMISTRY-US, V30, P9816, DOI 10.1021/bi00105a002; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Park YM, 2005, J GENE MED, V7, P621, DOI 10.1002/jgm.708; PEAVY DE, 1985, J BIOL CHEM, V260, P3989; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; PINGEL M, 1972, DIABETES, V21, P805, DOI 10.2337/diab.21.7.805; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; ROY M, 1989, J BIOL CHEM, V264, P19081; SANCHO J, 1992, BIOCHEMISTRY-US, V31, P2253, DOI 10.1021/bi00123a006; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; SELDEN RF, 1987, NEW ENGL J MED, V317, P1067; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; SMITH GD, 1984, P NATL ACAD SCI-BIOL, V81, P7093, DOI 10.1073/pnas.81.22.7093; Sohma Y, 2008, ANGEW CHEM INT EDIT, V47, P1102, DOI 10.1002/anie.200703521; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Steiner DF, 2000, J PEDIATR ENDOCR MET, V13, P229; TIDOR B, 1994, J MOL BIOL, V238, P405, DOI 10.1006/jmbi.1994.1300; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; WEISS MA, 1990, BIOCHEMISTRY-US, V29, P8389, DOI 10.1021/bi00488a028; Weiss MA, 2001, J BIOL CHEM, V276, P40018, DOI 10.1074/jbc.M104634200; WEISS MA, 1987, J MAGN RESON, V72, P324, DOI 10.1016/0022-2364(87)90294-0; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; WEISS MA, 2002, INSULIN RELATED PROT; Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2004, DIABETES, V53, P1599, DOI 10.2337/diabetes.53.6.1599; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377	107	46	64	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14703	14716		10.1074/jbc.M800313200	http://dx.doi.org/10.1074/jbc.M800313200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18332129	Green Published, hybrid			2022-12-25	WOS:000255941400059
J	Xiao, H; Qian, W; Staschke, K; Qian, Y; Cui, G; Deng, L; Ehsani, M; Wang, XL; Qian, YW; Chen, ZJJ; Gilmour, R; Jiang, ZF; Li, XX				Xiao, Hui; Qian, Wen; Staschke, Kirk; Qian, Youcun; Cui, Grace; Deng, Li; Ehsani, Mariam; Wang, Xiliang; Qian, Yue-Wei; Chen, Zhijian J.; Gilmour, Raymond; Jiang, Zhengfan; Li, Xiaoxia			Pellino 3b negatively regulates interleukin-1-induced TAK1-dependent NF kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED KINASE; ADAPTER PROTEIN; IL-1; TAK1; BINDING; TAB2; POLYUBIQUITINATION; FAMILY; TRAF6; IRAK	IL-1 receptor-associated kinase (IRAK) is phosphorylated, ubiquitinated, and degraded upon interleukin-1 (IL-1) stimulation. In this study, we showed that IRAK can be ubiquitinated through both Lys-48- and Lys-63-linked polyubiquitin chains upon IL-1 induction. Pellino 3b is the RING-like motif ubiquitin protein ligase that promotes the Lys-63-linked polyubiquitination on IRAK. Pellino 3b-mediated Lys-63-linked IRAK polyubiquitination competed with Lys-48- linked IRAK polyubiquitination for the same ubiquitination site, Lys-134 of IRAK, thereby blocking IL-1-induced IRAK degradation. Importantly, the negative impact of Pellino 3b on IL-1-induced IRAK degradation correlated with the inhibitory effect of Pellino 3b on the IL-1-induced TAK1-dependent pathway, suggesting that a positive role of IRAK degradation in IL-1 induced TAK1 activation. Taken together, our results suggest that Pellino 3b acts as a negative regulator for IL-1 signaling by regulating IRAK degradation through its ubiquitin protein ligase activity.	[Xiao, Hui; Qian, Wen; Qian, Youcun; Cui, Grace; Li, Xiaoxia] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA; [Staschke, Kirk; Ehsani, Mariam; Wang, Xiliang; Qian, Yue-Wei; Gilmour, Raymond] Lilly Res Labs, Indianapolis, IN 46285 USA; [Deng, Li] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Mol Biol, Dallas, TX 75390 USA	Cleveland Clinic Foundation; Eli Lilly; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jiang, ZF (corresponding author), Peking Univ, Sch Life Sci, Dept Cell Biol & Genet, Beijing 100871, Peoples R China.	jiangzf@pku.edu.cn	Staschke, Kirk/HGC-5664-2022; Chen, Zhijian/C-6039-2012	Staschke, Kirk/0000-0001-8722-9585; Chen, Zhijian/0000-0002-8475-8251	NIGMS NIH HHS [R01 GM 060020-06] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060020] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Butler MP, 2005, J BIOL CHEM, V280, P27759, DOI 10.1074/jbc.M500756200; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jensen LE, 2003, J IMMUNOL, V171, P1500, DOI 10.4049/jimmunol.171.3.1500; Jiang ZF, 2003, J BIOL CHEM, V278, P10952, DOI 10.1074/jbc.M212112200; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Jin G, 2004, P NATL ACAD SCI USA, V101, P2028, DOI 10.1073/pnas.0307314101; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rich T, 2000, IMMUNOGENETICS, V52, P145, DOI 10.1007/s002510000249; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schauvliege R, 2006, FEBS LETT, V580, P4697, DOI 10.1016/j.febslet.2006.07.046; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; XIA ZP, 2005, SCI STKE, V272, pPE7; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Yu KY, 2002, J IMMUNOL, V169, P4075, DOI 10.4049/jimmunol.169.8.4075	31	37	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14654	14664		10.1074/jbc.M706931200	http://dx.doi.org/10.1074/jbc.M706931200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18326498	hybrid, Green Published			2022-12-25	WOS:000255941400054
J	Belmont, PJ; Tadimalla, A; Chen, WQJ; Martindale, JJ; Thuerauf, DJ; Marcinko, M; Gude, N; Sussman, MA; Glembotski, CC				Belmont, Peter J.; Tadimalla, Archana; Chen, Wenqiong J.; Martindale, Joshua J.; Thuerauf, Donna J.; Marcinko, Marie; Gude, Natalie; Sussman, Mark A.; Glembotski, Christopher C.			Coordination of growth and endoplasmic reticulum stress signaling by regulator of calcineurin 1 (RCAN1), a novel ATF6-inducible gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CARDIAC-HYPERTROPHY; CARDIOMYOCYTE APOPTOSIS; MESSENGER-RNA; ER STRESS; TRANSCRIPTION FACTORS; DOWN-SYNDROME; CELL-GROWTH; IN-VITRO; ATF6	Exposing cells to conditions that modulate growth can impair endoplasmic reticulum (ER) protein folding, leading to ER stress and activation of the transcription factor, ATF6. ATF6 binds to ER stress response elements in target genes, inducing expression of proteins that enhance the ER protein folding capacity, which helps overcome the stress and foster survival. To examine the mechanism of ATF6-mediated survival in vivo, we developed a transgenic mouse model that expresses a novel conditionally activated form of ATF6. We previously showed that activating ATF6 protected the hearts of ATF6 transgenic mice from ER stresses. In the present study, transcript profiling identified modulatory calcineurin interacting protein-1 (MCIP1), also known as regulator of calcineurin 1 (RCAN1), as a novel ATF6-inducible gene that encodes a known regulator of calcineurin/nuclear factor of activated T cells (NFAT)mediated growth and development in many tissues. The ability of ATF6 to induce RCAN1 in vivo was replicated in cultured cardiac myocytes, where adenoviral (AdV)-mediated overexpression of activated ATF6 induced the RCAN1 promoter, up-regulated RCAN1 mRNA, inhibited calcineurin phosphatase activity, and exerted a striking growth modulating effect that was inhibited by RCAN1-targeted small interfering RNA. These results demonstrate that RCAN1 is a novel ATF6 target gene that may coordinate growth and ER stress signaling pathways. By modulating growth, RCAN1 may reduce the need for ER protein folding, thus helping to overcome the stress and enhance survival. Moreover, these results suggest that RCAN1 may also be a novel integrator of growth and ER stress signaling in many other tissues that depend on calcineurin/NFAT signaling for optimal growth and development.	San Diego State Univ, Inst Heart, San Diego, CA 92182 USA; San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Glembotski, CC (corresponding author), 5500 Campanile Dr, San Diego, CA 92182 USA.	cglembotski@sciences.sdsu.edu	Sussman, Mark/H-2284-2014	Sussman, Mark/0000-0002-0104-4799	NHLBI NIH HHS [HL-075573, HL-085577] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL085577, R01HL075573] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ardehali H, 2005, CIRC RES, V97, P740, DOI 10.1161/01.RES.0000186277.12336.11; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Blobel G, 2000, BIOSCIENCE REP, V20, P303, DOI 10.1023/A:1010318832604; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; HANFORD DS, 1994, J BIOL CHEM, V269, P26227; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Leahy KP, 2000, ARCH BIOCHEM BIOPHYS, V379, P221, DOI 10.1006/abbi.2000.1897; Leahy KP, 1999, ARCH BIOCHEM BIOPHYS, V368, P67, DOI 10.1006/abbi.1998.1059; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; Paschen W, 2003, J CEREBR BLOOD F MET, V23, P449, DOI 10.1097/01.WCB.0000054216.21675.AC; Pu WT, 2003, CIRC RES, V92, P725, DOI 10.1161/01.RES.0000069211.82346.46; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Rzymski T, 2007, CLIN CANCER RES, V13, P2537, DOI 10.1158/1078-0432.CCR-06-2126; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Shin SY, 2006, FEBS LETT, V580, P5965, DOI 10.1016/j.febslet.2006.09.064; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Taigen T, 2000, P NATL ACAD SCI USA, V97, P1196, DOI 10.1073/pnas.97.3.1196; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Thuerauf DJ, 2001, J BIOL CHEM, V276, P48309, DOI 10.1074/jbc.M107146200; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; van Rooij E, 2004, CIRC RES, V94, pE18, DOI 10.1161/01.RES.0000118597.54416.00; Vega RB, 2003, J BIOL CHEM, V278, P36981, DOI 10.1074/jbc.R300023200; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115	46	79	85	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14012	14021		10.1074/jbc.M709776200	http://dx.doi.org/10.1074/jbc.M709776200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18319259	hybrid, Green Published			2022-12-25	WOS:000255728200055
J	Gong, P; Angelini, DJ; Yang, S; Xia, G; Cross, AS; Mann, D; Bannerman, DD; Vogel, SN; Goldblum, SE				Gong, Ping; Angelini, Daniel J.; Yang, Shiqi; Xia, Guanjun; Cross, Alan S.; Mann, Dean; Bannerman, Douglas D.; Vogel, Stefanie N.; Goldblum, Simeon E.			TLR4 signaling is coupled to SRC family kinase activation, tyrosine phosphorylation of zonula adherens proteins, and opening of the paracellular pathway in human lung microvascular endothelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; FACTOR-KAPPA-B; TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR; P120 CATENIN; C-SRC; BARRIER DYSFUNCTION; CYTOKINE PRODUCTION; ENDOTOXIN RELEASE; BINDING-PROTEIN	Bacterial lipopolysaccharide (LPS) is a key mediator in the vascular leak syndromes associated with Gram-negative bacterial infections. LPS opens the paracellular pathway in pulmonary vascular endothelia through protein tyrosine phosphorylation. We now have identified the protein-tyrosine kinases (PTKs) and their substrates required for LPS-induced protein tyrosine phosphorylation and opening of the paracellular pathway in human lung microvascular endothelial cells (HMVEC-Ls). LPS disrupted barrier integrity in a dose-and time-dependent manner, and prior broad spectrum PTK inhibition was protective. LPS increased tyrosine phosphorylation of zonula adherens proteins, VE-cadherin, gamma-catenin, and p120(ctn). Two SRC family PTK (SFK)-selective inhibitors, PP2 and SU6656, blocked LPS-induced increments in tyrosine phosphorylation of VE-cadherin and p120(ctn) and paracellular permeability. InHMVEC-Ls, c-SRC, YES, FYN, and LYN were expressed at both mRNA and protein levels. Selective small interfering RNA-induced knockdown of c-SRC, FYN, or YES diminished LPS-induced SRC Tyr(416) phosphorylation, tyrosine phosphorylation of VE-cadherin and p120(ctn), and barrier disruption, whereas knockdown of LYN did not. For VE-cadherin phosphorylation, knockdown of either c-SRC or FYN provided total protection, whereas YES knockdown was only partially protective. For p120(ctn) phosphorylation, knockdown of FYN, c-SRC, or YES each provided comparable but partial protection. Toll-like receptor 4 (TLR4) was expressed both on the surface and intracellular compartment of HMVEC-Ls. Prior knockdown of TLR4 blocked both LPS-induced SFK activation and barrier disruption. These data indicate that LPS recognition by TLR4 activates the SFKs, c-SRC, FYN, and YES, which, in turn, contribute to tyrosine phosphorylation of zonula adherens proteins to open the endothelial paracellular pathway.	[Gong, Ping; Angelini, Daniel J.; Yang, Shiqi; Goldblum, Simeon E.] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Gong, Ping; Angelini, Daniel J.; Mann, Dean; Goldblum, Simeon E.] Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA; [Yang, Shiqi; Goldblum, Simeon E.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Vogel, Stefanie N.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Xia, Guanjun] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Cross, Alan S.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Bannerman, Douglas D.] USDA, Bovine Funct Genom Lab, Beltsville, MD 20705 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; United States Department of Agriculture (USDA)	Goldblum, SE (corresponding author), Univ Maryland, Sch Med, Mucosal Biol Res Ctr, 20 Penn St,HSF 2-Rm 351, Baltimore, MD 21201 USA.	sgoldblu@mbrc.umaryland.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070155, R01HL084223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018797, R01AI018797, R56AI018797] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-84223, HL-70155] Funding Source: Medline; NIAID NIH HHS [AI-18797] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHEN MG, 1995, DIFFERENTIATION, V59, P15, DOI 10.1046/j.1432-0436.1995.5910015.x; Adamson RH, 2003, AM J PHYSIOL-HEART C, V285, pH406, DOI 10.1152/ajpheart.00021.2003; Alema S, 2007, BBA-MOL CELL RES, V1773, P47, DOI 10.1016/j.bbamcr.2006.06.001; Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Bannerman DD, 1999, LAB INVEST, V79, P1181; Bannerman DD, 1998, INFECT IMMUN, V66, P1400, DOI 10.1128/IAI.66.4.1400-1407.1998; Bannerman DD, 1997, AM J PHYSIOL-LUNG C, V273, pL217, DOI 10.1152/ajplung.1997.273.1.L217; BEEKHUIZEN H, 1991, J IMMUNOL, V147, P3761; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; BONE RC, 1993, CLIN MICROBIOL REV, V6, P57, DOI 10.1128/CMR.6.1.57-68.1993; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913; BULL HA, 1994, FEBS LETT, V351, P41, DOI 10.1016/0014-5793(94)00814-0; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; CHAOUAT G, 1994, CELL IMMUNOL, V157, P328, DOI 10.1006/cimm.1994.1231; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Cross A, 1996, SHOCK, V6, pS71, DOI 10.1097/00024382-199610001-00013; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; DOFFERHOFF ASM, 1991, SCAND J INFECT DIS, V23, P745, DOI 10.3109/00365549109024303; Dunzendorfer S, 2004, FASEB J, V18, P1117, DOI 10.1096/fj.03-1263fje; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Esser S, 1998, J CELL SCI, V111, P1853; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; FEINGOLD KR, 1995, INFECT IMMUN, V63, P2041, DOI 10.1128/IAI.63.5.2041-2046.1995; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; Funakoshi-Tago M, 2003, EUR J BIOCHEM, V270, P1257, DOI 10.1046/j.1432-1033.2003.03487.x; GEGNER JA, 1995, J BIOL CHEM, V270, P5320, DOI 10.1074/jbc.270.10.5320; GELLER DA, 1993, P NATL ACAD SCI USA, V90, P522, DOI 10.1073/pnas.90.2.522; GOLDBLUM SE, 1993, J CELL PHYSIOL, V157, P13, DOI 10.1002/jcp.1041570103; Goldblum SE, 1999, MOL BIOL CELL, V10, P1537, DOI 10.1091/mbc.10.5.1537; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hamajima Y, 2007, AURIS NASUS LARYNX, V34, P49, DOI 10.1016/j.anl.2006.09.026; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hazeki K, 2003, EUR J IMMUNOL, V33, P740, DOI 10.1002/eji.200323375; HENRICSON BE, 1995, MOL MED, V1, P428, DOI 10.1007/BF03401580; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Jersmann HPA, 2001, INFECT IMMUN, V69, P479, DOI 10.1128/IAI.69.1.479-485.2001; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kanemitsu MY, 1997, J BIOL CHEM, V272, P22824, DOI 10.1074/jbc.272.36.22824; Kang JL, 2005, J TOXICOL ENV HEAL A, V68, P1643, DOI 10.1080/15287390500192114; Kang JL, 2001, AM J RESP CRIT CARE, V164, P2206, DOI 10.1164/ajrccm.164.12.2104017; Kox M, 2007, VASC PHARMACOL, V46, P195, DOI 10.1016/j.vph.2006.10.004; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Lampugnani MG, 1997, CURR OPIN CELL BIOL, V9, P674, DOI 10.1016/S0955-0674(97)80121-4; Lidington D, 2002, J CELL PHYSIOL, V193, P373, DOI 10.1002/jcp.10179; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Loo LWM, 1999, MOL CARCINOGEN, V25, P187, DOI 10.1002/(SICI)1098-2744(199907)25:3<187::AID-MC5>3.3.CO;2-F; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Lu TT, 1997, J BIOL CHEM, V272, P14442, DOI 10.1074/jbc.272.22.14442; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; MCINTIRE FC, 1967, BIOCHEMISTRY-US, V6, P2363, DOI 10.1021/bi00860a011; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Mukundan L, 2004, CELL SIGNAL, V16, P375, DOI 10.1016/j.cellsig.2003.08.008; Napolitani G, 2003, EUR J IMMUNOL, V33, P2832, DOI 10.1002/eji.200324073; Paludan SR, 2000, J LEUKOCYTE BIOL, V67, P18, DOI 10.1002/jlb.67.1.18; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Piedra J, 2003, MOL CELL BIOL, V23, P2287, DOI 10.1128/MCB.23.7.2287-2297.2003; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PRINS JM, 1995, J INFECT DIS, V172, P886, DOI 10.1093/infdis/172.3.886; Puhlmann M, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-37; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Ruetten H, 1997, BRIT J PHARMACOL, V122, P59, DOI 10.1038/sj.bjp.0701345; SCHEIFELE DW, 1985, AM J CLIN PATHOL, V83, P227, DOI 10.1093/ajcp/83.2.227; Schmitz G, 2002, CURR OPIN LIPIDOL, V13, P513, DOI 10.1097/00041433-200210000-00007; Severgnini M, 2005, AM J RESP CRIT CARE, V171, P858, DOI 10.1164/rccm.200407-981OC; Shao MXG, 2003, P NATL ACAD SCI USA, V100, P11618, DOI 10.1073/pnas.1534804100; Shen YM, 1998, AM J PHYSIOL-ENDOC M, V275, pE479, DOI 10.1152/ajpendo.1998.275.3.E479; Spitzer JH, 2002, EUR J IMMUNOL, V32, P1182, DOI 10.1002/1521-4141(200204)32:4<1182::AID-IMMU1182>3.0.CO;2-9; Stief TW, 2007, BLOOD COAGUL FIBRIN, V18, P179, DOI 10.1097/MBC.0b013e328040bf9a; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; ULEVITCH RJ, 1975, J EXP MED, V142, P1570, DOI 10.1084/jem.142.6.1570; Volk T, 2000, INFLAMM RES, V49, P185, DOI 10.1007/s000110050579; VONASMUTH EJU, 1993, IMMUNOLOGY, V80, P78; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang KZQ, 2006, J CELL SCI, V119, P1579, DOI 10.1242/jcs.02889; WU NZ, 1992, AM J PHYSIOL, V262, pH1238; Young BA, 1998, BIOCHEM BIOPH RES CO, V251, P320, DOI 10.1006/bbrc.1998.9475; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; Zhou YQ, 2002, J BIOL CHEM, V277, P38104, DOI 10.1074/jbc.M206167200	91	105	107	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13437	13449		10.1074/jbc.M707986200	http://dx.doi.org/10.1074/jbc.M707986200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326860	Green Published, hybrid			2022-12-25	WOS:000255499800083
J	Lange, A; Mills, RE; Devine, SE; Corbett, AH				Lange, Allison; Mills, Ryan E.; Devine, Scott E.; Corbett, Anita H.			A PY-NLS nuclear targeting signal is required for nuclear localization and function of the Saccharomyces cerevisiae mRNA-binding protein Hrp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORTIN-BETA; PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; YEAST; IDENTIFICATION; RECOGNITION; CYTOPLASM; STRAINS; RANGTP; EXPORT	Proteins destined for import into the nucleus contain nuclear localization signals (NLSs) that are recognized by import receptors termed karyopherins or importins. Until recently, the only nuclear import sequence that had been well defined and characterized was the classical NLS ( cNLS), which is recognized by importin alpha. However, Chook and coworkers ( Lee, B. J., Cansizoglu, A. E., Suel, K. E., Louis, T. H., Zhang, Z., and Chook, Y. M. ( 2006) Cell 126, 543 - 558) have provided new insight into nuclear targeting with their identification of a novel NLS, termed the PY-NLS, that is recognized by the human karyopherin beta 2/transportin (Kap beta 2) receptor. Here, we demonstrate that the PY-NLS is conserved in Saccharomyces cerevisiae and show for the first time that the PY-NLS is a functional nuclear targeting sequence in vivo. The apparent ortholog of Kap beta 2 in yeast, Kap104, has two known cargos, the mRNA-binding proteins Hrp1 and Nab2, which both contain putative PY-NLS- like sequences. We find that the PY-NLS- like sequence within Hrp1, which closely matches the PY-NLS consensus, is both necessary and sufficient for nuclear import and is also required for receptor binding and protein function. In contrast, the PY-NLS- like sequences in Nab2, which vary from the PY-NLS consensus, are not required for proper import or protein function, suggesting that Kap104 may interact with different cargos using multiple mechanisms. Dissection of the PY-NLS consensus reveals that the minimal PY-NLS in yeast consists of the C-terminal portion of the human consensus, R/H/KX2-5PY, with upstream basic or hydrophobic residues enhancing the targeting function. Finally, we apply this analysis to a bioinformatic search of the yeast proteome as a preliminary search for new potential Kap104 cargos.	[Lange, Allison; Mills, Ryan E.; Devine, Scott E.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Corbett, AH (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	acorbe2@emory.edu	Mills, Ryan/F-4225-2010; Corbett, Anita/AAH-6106-2021	Mills, Ryan/0000-0003-3425-6998; Corbett, Anita/0000-0002-0461-6895	NHGRI NIH HHS [R01 HG002898, R01 HG002898-05] Funding Source: Medline; NIGMS NIH HHS [R01 GM058728] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058728] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams A, 1997, METHODS YEAST GENETI; Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Allen TD, 2000, J CELL SCI, V113, P1651; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BONNER WM, 1978, PROTEIN MIGRATION AC; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kessler MM, 1997, GENE DEV, V11, P2545, DOI 10.1101/gad.11.19.2545; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Sambrook J, 2001, MOL CLONING A LAB MA, V3rd; SIKORSKI RS, 1989, GENETICS, V122, P19; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Truant R, 1998, MOL CELL BIOL, V18, P1449, DOI 10.1128/MCB.18.3.1449; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107	32	36	36	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12926	12934		10.1074/jbc.M800898200	http://dx.doi.org/10.1074/jbc.M800898200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18343812	Green Published, hybrid			2022-12-25	WOS:000255499800029
J	Elbaz, Y; Salomon, T; Schuldiner, S				Elbaz, Yael; Salomon, Tal; Schuldiner, Shimon			Identification of a glycine motif required for packing in EmrE, a multidrug transporter from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-BRANCHED RESIDUES; GXXXG MOTIF; BINDING DOMAIN; TOPOLOGY; REVEALS; MUTAGENESIS; ANTIPORTER; PROTEINS; PARALLEL; H+	Glycine residues may play functional and structural roles in membrane proteins. In this work we studied the role of glycine residues in EmrE, a small multidrug transporter from Escherichia coli. EmrE extrudes various drugs across the plasma membrane in exchange with protons and, as a result, confers resistance against their toxic effects. Each of 12 glycine residues was replaced by site-directed mutagenesis. Four of the 12 glycine residues in EmrE are evolutionary conserved within the small multidrug resistance family of multidrug transporters. Our analysis reveals that only two (Gly-67 and Gly-97) of these four highly conserved residues are essential for transporter activity. Moreover, two glycine positions that are less conserved, Gly-17 and Gly-90, demonstrate also a nil phenotype when substituted. Our present results identifying Gly-17 and Gly-67 as irreplaceable reinforce the importance of previously defined functional clusters. Two essential glycine residues, Gly-90 and Gly-97, form a protein motif in which glycine residues are separated by six other residues (GG7). Upon substitution of glycine in these positions, the protein ability to form dimers is impaired as evaluated by cross-linking and pull-down experiments.	[Elbaz, Yael; Salomon, Tal; Schuldiner, Shimon] Hebrew Univ Jerusalem, Alexander A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Schuldiner, S (corresponding author), Hebrew Univ Jerusalem, Alexander A Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	Shimon.Schuldiner@huji.ac.il	Schuldiner, Shimon/F-7628-2012; Elbaz-Alon, Yael/AAW-5332-2021; Elbaz-Alon, Yael/AAB-7044-2019	Schuldiner, Shimon/0000-0002-4874-6237; Elbaz-Alon, Yael/0000-0002-6267-9800; Elbaz-Alon, Yael/0000-0002-6267-9800; Elbaz Alon, Yael/0000-0003-1763-4571	NINDS NIH HHS [NS16708] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adam Y, 2007, P NATL ACAD SCI USA, V104, P17989, DOI 10.1073/pnas.0704425104; Arbely E, 2006, BIOCHEMISTRY-US, V45, P11349, DOI 10.1021/bi060953v; Chang G, 2006, SCIENCE, V314, P1875, DOI 10.1126/science.314.5807.1875b; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Elbaz Y, 2005, BIOCHEMISTRY-US, V44, P7369, DOI 10.1021/bi050356t; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; Han M, 1996, J BIOL CHEM, V271, P32330, DOI 10.1074/jbc.271.50.32330; Han M, 1997, P NATL ACAD SCI USA, V94, P13442, DOI 10.1073/pnas.94.25.13442; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holliday GL, 2007, J MOL BIOL, V372, P1261, DOI 10.1016/j.jmb.2007.07.034; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kim S, 2004, P NATL ACAD SCI USA, V101, P5988, DOI 10.1073/pnas.0308694101; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Kovalenko OV, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-11; LEMMON MA, 1994, Q REV BIOPHYS, V27, P157, DOI 10.1017/S0033583500004522; Li Fusheng, 2002, Methods Mol Biol, V182, P19; LI SC, 1992, FEBS LETT, V311, P217, DOI 10.1016/0014-5793(92)81106-V; Liu Y, 2002, GENOME BIOL, V3; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Ninio S, 2003, J BIOL CHEM, V278, P12000, DOI 10.1074/jbc.M213119200; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rath A, 2006, J BIOL CHEM, V281, P15546, DOI 10.1074/jbc.M600434200; Rotem D, 2001, J BIOL CHEM, V276, P48243, DOI 10.1074/jbc.M108229200; Rotem D, 2006, J BIOL CHEM, V281, P18715, DOI 10.1074/jbc.M602088200; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schuldiner S, 2001, J MOL MICROB BIOTECH, V3, P155; Schuldiner S, 2001, NEWS PHYSIOL SCI, V16, P130; Schuldiner S, 2007, TRENDS BIOCHEM SCI, V32, P252, DOI 10.1016/j.tibs.2007.04.002; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Sharoni M, 2005, J BIOL CHEM, V280, P32849, DOI 10.1074/jbc.M504910200; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Steiner-Mordoch S, 2008, EMBO J, V27, P17, DOI 10.1038/sj.emboj.7601951; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Weinglass AB, 2001, BIOCHEMISTRY-US, V40, P769, DOI 10.1021/bi002171m; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200; Zhou YG, 2005, J BIOL CHEM, V280, P20316, DOI 10.1074/jbc.M412937200	45	31	31	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12276	12283		10.1074/jbc.M710338200	http://dx.doi.org/10.1074/jbc.M710338200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321856	hybrid, Green Published			2022-12-25	WOS:000255340000044
J	Lu, M; Echeverri, F; Kalabat, D; Laita, B; Dahan, DS; Smith, RD; Xu, H; Staszewski, L; Yamamoto, J; Ling, J; Hwang, N; Kimmich, R; Li, P; Patron, E; Keung, W; Patron, A; Moyer, BD				Lu, Min; Echeverri, Fernando; Kalabat, Dalia; Laita, Bianca; Dahan, David S.; Smith, Raymond D.; Xu, Hong; Staszewski, Lena; Yamamoto, Jeff; Ling, Jing; Hwang, Nancy; Kimmich, Rachel; Li, Peter; Patron, Erika; Keung, Walter; Patron, Andrew; Moyer, Bryan D.			Small molecule activator of the human epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFTR CHLORIDE CONDUCTANCE; NA+ SELF-INHIBITION; ALPHA-SUBUNIT; DELTA-SUBUNIT; CYSTIC-FIBROSIS; FUNCTIONAL EXPRESSION; XENOPUS-OOCYTES; PSEUDOHYPOALDOSTERONISM TYPE-1; SURFACE EXPRESSION; GAMMA-SUBUNIT	The epithelial sodium channel (ENaC), a heterotrimeric complex composed of alpha, beta, and gamma subunits, belongs to the ENaC/degenerin family of ion channels and forms the principal route for apical Na+ entry in many reabsorbing epithelia. Although high affinity ENaC blockers, including amiloride and derivatives, have been described, potent and specific small molecule ENaC activators have not been reported. Here we describe compound S3969 that fully and reversibly activates human ENaC (hENaC) in an amiloride-sensitive and dose-dependent manner in heterologous cells. Mechanistically, S3969 increases hENaC open probability through interactions requiring the extracellular domain of the beta subunit. hENaC activation by S3969 did not require cleavage by the furin protease, indicating that nonproteolyzed channels can be opened. Function of alpha beta G37S gamma hENaC, a channel defective in gating that leads to the salt-wasting disease pseudohypoaldosteronism type I, was rescued by S3969. Small molecule activation of hENaC may find application in alleviating human disease, including pseudohypoaldosteronism type I, hypotension, and neonatal respiratory distress syndrome, when improved Na+ flux across epithelial membranes is clinically desirable.	[Lu, Min; Echeverri, Fernando; Kalabat, Dalia; Laita, Bianca; Dahan, David S.; Smith, Raymond D.; Xu, Hong; Staszewski, Lena; Yamamoto, Jeff; Ling, Jing; Hwang, Nancy; Kimmich, Rachel; Li, Peter; Patron, Erika; Keung, Walter; Patron, Andrew; Moyer, Bryan D.] Senomyx Inc, San Diego, CA 92121 USA		Moyer, BD (corresponding author), Senomyx Inc, 4767 Nexus Ctr Dr, San Diego, CA 92121 USA.	bryan.moyer@senomyx.com						Abaffy T, 2006, J NEUROCHEM, V97, P1506, DOI 10.1111/j.1471-4159.2006.03859.x; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Beene DL, 2004, J NEUROSCI, V24, P9097, DOI 10.1523/JNEUROSCI.2429-04.2004; BENOS DJ, 1982, AM J PHYSIOL, V242, pC131, DOI 10.1152/ajpcell.1982.242.3.C131; Bonny O, 2002, PEDIATR NEPHROL, V17, P804, DOI 10.1007/s00467-002-0945-8; Bonny O, 1999, J CLIN INVEST, V104, P967, DOI 10.1172/JCI6821; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CALLAMARAS N, 2002, Patent No. 2002087306; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Chraibi A, 2001, J MEMBRANE BIOL, V183, P15, DOI 10.1007/s00232-001-0049-6; Chraibi A, 1999, J PHARMACOL EXP THER, V290, P341; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; DOGGRELL S, 1994, CLIN EXP PHARMACOL P, V21, P833, DOI 10.1111/j.1440-1681.1994.tb02454.x; DURIEUX ME, 1994, FEBS LETT, V337, P235, DOI 10.1016/0014-5793(94)80198-3; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Giraldez T, 2007, J NEUROCHEM, V102, P1304, DOI 10.1111/j.1471-4159.2007.04622.x; Gribkoff VK, 2003, EXPERT OPIN THER TAR, V7, P737, DOI 10.1517/eott.7.6.737.22569; Gribkoff VK, 2001, NAT MED, V7, P471, DOI 10.1038/86546; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Hewawasam P, 2003, J MED CHEM, V46, P2819, DOI 10.1021/jm030005h; Hirsh AJ, 2006, J MED CHEM, V49, P4098, DOI 10.1021/jm051134w; Horisberger JD., 2004, NEPHRON PHYSIOL, V96, P37, DOI [10.1159/000076406, DOI 10.1159/000076406]; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Ji HL, 2004, J BIOL CHEM, V279, P8428, DOI 10.1074/jbc.M312012200; Kashlan OB, 2005, J BIOL CHEM, V280, P26206, DOI 10.1074/jbc.M503500200; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kelly O, 2003, AM J PHYSIOL-RENAL, V285, pF1279, DOI 10.1152/ajprenal.00094.2003; Kretz O, 1999, J HISTOCHEM CYTOCHEM, V47, P51, DOI 10.1177/002215549904700106; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; MACDONALD RL, 1995, EPILEPSIA, V36, P2; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Palmer LG, 1996, J GEN PHYSIOL, V107, P35, DOI 10.1085/jgp.107.1.35; Papke RL, 2004, NEUROPHARMACOLOGY, V46, P1023, DOI 10.1016/j.neuropharm.2004.01.005; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Poirot O, 2004, J BIOL CHEM, V279, P38448, DOI 10.1074/jbc.M407381200; Randrianarison N, 2007, J PHYSIOL-LONDON, V582, P777, DOI 10.1113/jphysiol.2007.131078; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; Schnizler M, 2003, BBA-BIOMEMBRANES, V1609, P170, DOI 10.1016/S0005-2736(02)00684-3; Schnizler M, 2000, PFLUG ARCH EUR J PHY, V439, P579, DOI 10.1007/s004240050981; SERVANT G, 2005, Patent No. 2005014848; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Swift PA, 2004, ADV RENAL REPLACE TH, V11, P76, DOI 10.1053/j.arrt.2003.10.011; Takahashi A, 1996, AM J PHYSIOL-CELL PH, V271, pC1887, DOI 10.1152/ajpcell.1996.271.6.C1887; Thomas CP, 1998, AM J PHYSIOL-CELL PH, V274, pC1312, DOI 10.1152/ajpcell.1998.274.5.C1312; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Wright T, 1998, HEART FAIL REV, V2, P173; Wu YJ, 2004, J MED CHEM, V47, P2887, DOI 10.1021/jm0305826; Yamamura H, 2005, MOL PHARMACOL, V68, P1142, DOI 10.1124/mol.104.010850; Yamamura H, 2004, J BIOL CHEM, V279, P44483, DOI 10.1074/jbc.M408929200; Yamamura H, 2004, J BIOL CHEM, V279, P12529, DOI 10.1074/jbc.M400274200; Yamamura H, 2006, BIOCHEM BIOPH RES CO, V349, P317, DOI 10.1016/j.bbrc.2006.08.043; Zennaro MC, 2004, TRENDS ENDOCRIN MET, V15, P264, DOI 10.1016/j.tem.2004.06.003	77	44	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11981	11994		10.1074/jbc.M708001200	http://dx.doi.org/10.1074/jbc.M708001200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326490	hybrid			2022-12-25	WOS:000255340000014
J	Tu, CF; Yan, YT; Wu, SY; Djoko, B; Tsai, MT; Cheng, CJ; Yang, RB				Tu, Cheng-Fen; Yan, Yu-Ting; Wu, Szu-Yao; Djoko, Bambang; Tsai, Ming-Tzu; Cheng, Chien-Jui; Yang, Ruey-Bing			Domain and functional analysis of a novel platelet-endothelial cell surface protein, SCUBE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-RELATED GENE; CUB DOMAIN; NEURAL-TUBE; GROWTH; EXPRESSION; RECEPTOR; GLYCOSYLATION; NEURULATION; FAMILY; PAIR	SCUBE1 ((s) under bar ignal peptide-CUB-(E) under bar GF domain-containing protein 1) is a novel, secreted, cell surface glycoprotein expressed during early embryogenesis and found in platelet and endothelial cells. This protein is composed of an N-terminal signal peptide sequence followed by nine tandemly arranged epidermal growth factor (EGF)-like repeats, a spacer region, three cysteinerich repeat motifs, and one CUB domain at the C terminus. However, little is known about its domain and biological function. Here, we generated a comprehensive panel of domain deletion constructs and a new genetic mouse model with targeted disruption of Scube1 (Scube1(Delta cub/Delta cub)) to investigate the domain function and biological significance. A number of cell-based assays were utilized to define the critical role of the spacer region for membrane association and establish that the EGFlike repeats 7-9 are sufficient for the formation of SCUBE1-mediated homophilic adhesions in a calcium-dependent fashion. Biochemical and molecular analyses showed that the C-terminal cysteine-rich motifs and CUB domain could directly bind and antagonize the bone morphogenetic protein activity. Furthermore, genetic ablation of this C-terminal region resulted in brain malformation in the Scube1(Delta cub/Delta cub) embryos. Together, our results support the dual roles of SCUBE1 on brain morphogenesis and cell-cell adhesions through its distinct domain function.	[Tu, Cheng-Fen; Yan, Yu-Ting; Wu, Szu-Yao; Djoko, Bambang; Tsai, Ming-Tzu; Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Cheng, Chien-Jui] Taipei Med Univ Hosp, Coll Med, Grad Inst Clin Med, Taipei 110, Taiwan; [Cheng, Chien-Jui] Taipei Med Univ Hosp, Coll Med, Dept Pathol, Taipei 110, Taiwan; [Yang, Ruey-Bing] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan	Academia Sinica - Taiwan; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; National Yang Ming Chiao Tung University	Yang, RB (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	rbyang@ibms.sinica.edu.tw	Thomson, Axel/A-7893-2013; Yang, Ruey-Bing/O-1494-2018	Yang, Ruey-Bing/0000-0003-3017-3714; Tu, Cheng-Fen/0000-0003-3624-7884				Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Chen GP, 2006, J BIOL CHEM, V281, P27436, DOI 10.1074/jbc.M605525200; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Copp AJ, 2005, J ANAT, V207, P623, DOI 10.1111/j.1469-7580.2005.00476.x; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Franzke CW, 2006, J BIOL CHEM, V281, P30260, DOI 10.1074/jbc.M604464200; Greene NDE, 2005, AM J MED GENET C, V135C, P31, DOI 10.1002/ajmg.c.30051; Grimmond S, 2000, GENOMICS, V70, P74, DOI 10.1006/geno.2000.6370; Grimmond S, 2001, MECH DEVELOP, V102, P209, DOI 10.1016/S0925-4773(00)00586-4; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; Haworth K, 2007, GENE EXPR PATTERNS, V7, P630, DOI 10.1016/j.modgep.2006.12.004; Hollway GE, 2006, DEV BIOL, V294, P104, DOI 10.1016/j.ydbio.2006.02.032; Ishii J, 2002, J BIOL CHEM, V277, P39696, DOI 10.1074/jbc.M206140200; Kannan S, 1997, J BIOL CHEM, V272, P3330, DOI 10.1074/jbc.272.6.3330; Kawakami A, 2005, CURR BIOL, V15, P480, DOI 10.1016/j.cub.2005.02.018; Kristiansen M, 1999, J BIOL CHEM, V274, P20540, DOI 10.1074/jbc.274.29.20540; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Mishra VK, 1996, BIOCHEMISTRY-US, V35, P11210, DOI 10.1021/bi960760f; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Romero A, 1997, NAT STRUCT BIOL, V4, P783, DOI 10.1038/nsb1097-783; Stacey M, 2003, BLOOD, V102, P2916, DOI 10.1182/blood-2002-11-3540; Stottmann RW, 2006, DEV BIOL, V295, P647, DOI 10.1016/j.ydbio.2006.03.051; Su YC, 2007, GENE THER, V14, P565, DOI 10.1038/sj.gt.3302896; Tu CF, 2006, CARDIOVASC RES, V71, P486, DOI 10.1016/j.cardiores.2006.04.010; Werner JM, 2000, J MOL BIOL, V296, P1065, DOI 10.1006/jmbi.1999.3513; Woods IG, 2005, PLOS BIOL, V3, P476, DOI 10.1371/journal.pbio.0030066; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200	35	76	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12478	12488		10.1074/jbc.M705872200	http://dx.doi.org/10.1074/jbc.M705872200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18303018	hybrid			2022-12-25	WOS:000255340000064
J	Grimm, MOW; Grimm, HS; Tomic, I; Beyreuther, K; Hartmann, T; Bergmann, C				Grimm, Marcus O. W.; Grimm, Heike S.; Tomic, Inge; Beyreuther, Konrad; Hartmann, Tobias; Bergmann, Christine			Independent inhibition of Alzheimer disease beta- and gamma-secretase cleavage by lowered cholesterol levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; RAT HIPPOCAMPAL-NEURONS; TRANSGENIC MOUSE MODEL; ENDOPLASMIC-RETICULUM; IN-VITRO; TRANSMEMBRANE DOMAIN; REDUCTASE INHIBITORS; PRIMARY CULTURES; APOLIPOPROTEIN-E; DISTINCT SITES	The major molecular risk factor for Alzheimer disease so far identified is the amyloidogenic peptide A beta(42). In addition, growing evidence suggests a role of cholesterol in Alzheimer disease pathology and A beta generation. However, the cellular mechanism of lipid-dependent A beta production remains unclear. Here we describe that the two enzymatic activities responsible for A beta production, beta-secretase and beta-secretase, are inhibited in parallel by cholesterol reduction. Importantly, our data indicate that cholesterol depletion within the cellular context inhibits both secretases additively and independently from each other. This is unexpected because the beta-secretase beta-site amyloid precursor protein cleaving enzyme and the presenilin-containing gamma-secretase complex are structurally different from each other, and these enzymes are apparently located in different subcellular compartments. The parallel and additive inhibition has obvious consequences for therapeutic research and may indicate an intrinsic cross-talk between Alzheimer disease-related amyloid precursor protein processing, amyloid precursor protein function, and lipid biology.	[Grimm, Marcus O. W.; Grimm, Heike S.; Tomic, Inge; Hartmann, Tobias; Bergmann, Christine] Univ Saarland, Dept Neurol, D-66421 Homburg, Germany; [Grimm, Marcus O. W.; Grimm, Heike S.; Tomic, Inge; Hartmann, Tobias; Bergmann, Christine] Univ Saarland, Dept Neurobiol, D-66421 Homburg, Germany; [Beyreuther, Konrad] Heidelberg Univ, Ctr Mol Biol, D-69120 Heidelberg, Germany; [Bergmann, Christine] Cent Inst Mental Hlth, Div Geriat Psychiat, D-68159 Mannheim, Germany	Saarland University; Saarland University; Ruprecht Karls University Heidelberg; Central Institute of Mental Health	Hartmann, T (corresponding author), Univ Saarland, Dept Neurobiol, Kirrbergerstr,Bldg 90, D-66421 Homburg, Germany.	tobias.hartmann@uniklinikum-saarland.de	Grimm, Marcus O. W./F-8134-2011; Hartmann, Tobias/AAB-8297-2022	Grimm, Marcus O. W./0000-0002-4160-6506; Hartmann, Tobias/0000-0001-7481-6430				BLOOM GS, 1989, J BIOL CHEM, V264, P16083; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bouillot C, 1996, J BIOL CHEM, V271, P7640, DOI 10.1074/jbc.271.13.7640; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bunnell WL, 1998, J BIOL CHEM, V273, P31947, DOI 10.1074/jbc.273.48.31947; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; Cole SL, 2005, J BIOL CHEM, V280, P18755, DOI 10.1074/jbc.M413895200; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; de Hoop MJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P154; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DYRKS T, 1994, FEBS LETT, V349, P210, DOI 10.1016/0014-5793(94)00671-7; DYRKS T, 1992, FEBS LETT, V309, P20, DOI 10.1016/0014-5793(92)80730-5; Evans RM, 2004, NEUROLOGY, V62, P1869, DOI 10.1212/01.WNL.0000125323.15458.3F; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; Gouras GK, 1998, J NEUROCHEM, V71, P1920; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Grimm HS, 2003, J BIOL CHEM, V278, P13077, DOI 10.1074/jbc.M210380200; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Grziwa B, 2003, J BIOL CHEM, V278, P6803, DOI 10.1074/jbc.M210047200; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hardy J, 1996, ACTA NEUROL SCAND, V93, P13; Hartmann T, 1999, EUR ARCH PSY CLIN N, V249, P291, DOI 10.1007/s004060050102; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hoglund K, 2005, DEMENT GERIATR COGN, V19, P256, DOI 10.1159/000084550; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jensen M, 2000, MOL MED, V6, P291, DOI 10.1007/BF03401938; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; LANGAN TJ, 1987, J NEUROCHEM, V49, P513, DOI 10.1111/j.1471-4159.1987.tb02894.x; Lichtenthaler SF, 1997, BIOCHEMISTRY-US, V36, P15396, DOI 10.1021/bi971071m; LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; NAGAMATSU S, 1992, J BIOL CHEM, V267, P467; OLKKONEN VM, 1993, J NEUROSCI RES, V35, P445, DOI 10.1002/jnr.490350412; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Rao S, 1999, P NATL ACAD SCI USA, V96, P7797, DOI 10.1073/pnas.96.14.7797; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Simons M, 1996, J NEUROSCI, V16, P899; SLATER EE, 1988, DRUGS, V36, P72, DOI 10.2165/00003495-198800363-00016; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sudoh S, 1998, J NEUROCHEM, V71, P1535; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Tienari PJ, 1997, P NATL ACAD SCI USA, V94, P4125, DOI 10.1073/pnas.94.8.4125; Turner RS, 1996, J BIOL CHEM, V271, P8966, DOI 10.1074/jbc.271.15.8966; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vaughan CJ, 1999, STROKE, V30, P1969, DOI 10.1161/01.STR.30.9.1969; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Yamazaki T, 2001, J BIOL CHEM, V276, P4454, DOI 10.1074/jbc.M009598200; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303	78	90	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11302	11311		10.1074/jbc.M801520200	http://dx.doi.org/10.1074/jbc.M801520200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18308724	hybrid			2022-12-25	WOS:000255067400026
J	Rondou, P; Haegeman, G; Vanhoenacker, P; Van Craenenbroeck, K				Rondou, Pieter; Haegeman, Guy; Vanhoenacker, Peter; Van Craenenbroeck, Kathleen			BTB protein KLHL12 targets the dopamine D4 receptor for ubiquitination by a Cul3-based E3 ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-PROMOTED UBIQUITINATION; SUBSTRATE ADAPTER PROTEIN; DELTA-OPIOID RECEPTORS; MEDIATES UBIQUITINATION; PROTEASOMAL DEGRADATION; DOWN-REGULATION; PATHWAY; KEAP1; NRF2; POLYMORPHISMS	Dopamine receptors belong to the superfamily of G-protein-coupled receptors and are subdivided into D1-type (D1 and D5) and D2-type (D2, D3, and D4) receptors. The D4 receptor has a remarkable polymorphism in its third intracellular loop, which is under intensive investigation and which has been associated with, among other conditions, attention deficit hyperactivity disorder. Here, we demonstrate that KLHL12, a BTB-Kelch protein, specifically binds to this polymorphic region of the D4 receptor through its Kelch domain. Moreover, we show that KLHL12 also interacts with Cullin3 and thereby functions as an adaptor to target the D4 receptor to an E3 ubiquitin ligase complex. By ubiquitination assays in eukaryotic cells, we further demonstrate that overexpression of KLHL12 strongly promotes ubiquitination of the D4 receptor. In addition, we show that also other dopamine receptor subtypes undergo basal ubiquitination, but this is not affected by KLHL12. These data are the first to show ubiquitination of dopamine receptors and the first to identify a protein specifically interacting with the D4 polymorphism, thereby building up an E3 ligase complex with substrate specificity toward the D4 receptor.	[Rondou, Pieter; Haegeman, Guy; Vanhoenacker, Peter; Van Craenenbroeck, Kathleen] Ghent Univ UGent, Lab Eukaryot Gene Express & Signal Transduct, Dept Mol Biol, B-9000 Ghent, Belgium	Ghent University	Van Craenenbroeck, K (corresponding author), Ghent Univ UGent, Lab Eukaryot Gene Express & Signal Transduct, Dept Mol Biol, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	Kathleen.VanCraenenbroeck@UGent.be						Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Ben Zion IZ, 2006, MOL PSYCHIATR, V11, P782, DOI 10.1038/sj.mp.4001832; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; Cohen BD, 2003, ENDOCRINOLOGY, V144, P4393, DOI 10.1210/en.2002-0063; Cook LB, 2003, MOL ENDOCRINOL, V17, P1777, DOI 10.1210/me.2003-0073; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; De Martelaere K, 2007, CELL SIGNAL, V19, P278, DOI 10.1016/j.cellsig.2006.06.012; DeValck D, 1997, BIOCHEM BIOPH RES CO, V238, P590, DOI 10.1006/bbrc.1997.7343; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Helmeste DM, 2000, JPN J PHARMACOL, V82, P1; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Khan ZU, 1998, J COMP NEUROL, V402, P353, DOI 10.1002/(SICI)1096-9861(19981221)402:3<353::AID-CNE5>3.0.CO;2-4; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Krek W, 2003, NAT CELL BIOL, V5, P950, DOI 10.1038/ncb1103-950; Mai A, 2004, EXP CELL RES, V300, P72, DOI 10.1016/j.yexcr.2004.06.023; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Oak JN, 2000, EUR J PHARMACOL, V405, P303, DOI 10.1016/S0014-2999(00)00562-8; Oldenhof J, 1998, BIOCHEMISTRY-US, V37, P15726, DOI 10.1021/bi981634+; Paterson AD, 1999, NEUROPSYCHOPHARMACOL, V21, P3, DOI 10.1016/S0893-133X(98)00115-8; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Van Craenenbroeck K, 2005, J BIOL CHEM, V280, P19350, DOI 10.1074/jbc.M414043200; VANTOL HHM, 1992, NATURE, V358, P149; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wong AHC, 2000, EUR J PHARMACOL, V410, P183; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	39	62	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11083	11096		10.1074/jbc.M708473200	http://dx.doi.org/10.1074/jbc.M708473200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303015	hybrid, Green Published			2022-12-25	WOS:000255067400004
J	Beard, DA; Vinnakota, KC; Wu, F				Beard, Daniel A.; Vinnakota, Kalyan C.; Wu, Fan			Detailed Enzyme Kinetics in Terms of Biochemical Species: Study of Citrate Synthase	PLOS ONE			English	Article								The compulsory-ordered ternary catalytic mechanism for two-substrate two-product enzymes is analyzed to account for binding of inhibitors to each of the four enzyme states and to maintain the relationship between the kinetic constants and the reaction equilibrium constant. The developed quasi-steady flux expression is applied to the analysis of data from citrate synthase to determine and parameterize a kinetic scheme in terms of biochemical species, in which the effects of pH, ionic strength, and cation binding to biochemical species are explicitly accounted for in the analysis of the data. This analysis provides a mechanistic model that is consistent with the data that have been used support competing hypotheses regarding the catalytic mechanism of this enzyme.	[Beard, Daniel A.; Vinnakota, Kalyan C.; Wu, Fan] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Beard, DA (corresponding author), Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA.	dbeard@mcw.edu	Vinnakota, Kalyan/G-4706-2010	Vinnakota, Kalyan/0000-0003-2185-2213; Wu, Fan/0000-0001-8339-4049	NIH [GM068610, HL072011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grants GM068610 and HL072011	Alberty R. A., 2003, THERMODYNAMICS BIOCH; ALBERTY RA, 1993, BIOPHYS J, V65, P1243, DOI 10.1016/S0006-3495(93)81146-9; Alberty RA, 2006, BIOPHYS CHEM, V124, P11, DOI 10.1016/j.bpc.2006.05.024; Beard DA, 2008, CAMB TEXT BIOMED ENG, P69; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; FRIEDEN C, 1955, J BIOL CHEM, V212, P859; Jamshidi N, 2001, BIOINFORMATICS, V17, P286, DOI 10.1093/bioinformatics/17.3.286; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; Lambeth MJ, 2002, ANN BIOMED ENG, V30, P808, DOI 10.1114/1.1492813; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; MATSUOKA Y, 1973, J BIOL CHEM, V248, P8022; Mulquiney PJ, 1999, BIOCHEM J, V342, P581, DOI 10.1042/0264-6021:3420581; SEGEL IH, 1975, ENZYME KINETICS BEHA, pR22; SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597; SMITH CM, 1971, FEBS LETT, V18, P35, DOI 10.1016/0014-5793(71)80400-3; SRERE PA, 1966, J BIOL CHEM, V241, P2157; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Vinnakota K, 2006, BIOPHYS J, V91, P1264, DOI 10.1529/biophysj.105.073296	18	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1825	10.1371/journal.pone.0001825	http://dx.doi.org/10.1371/journal.pone.0001825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350161	gold, Green Submitted, Green Published			2022-12-25	WOS:000260762300027
J	Moghadas, SM; Bowman, CS; Rost, G; Wu, JH				Moghadas, Seyed M.; Bowman, Christopher S.; Rost, Gergely; Wu, Jianhong			Population-Wide Emergence of Antiviral Resistance during Pandemic Influenza	PLOS ONE			English	Article								Background: The emergence of neuraminidase inhibitor resistance has raised concerns about the prudent use of antiviral drugs in response to the next influenza pandemic. While resistant strains may initially emerge with compromised viral fitness, mutations that largely compensate for this impaired fitness can arise. Understanding the extent to which these mutations affect the spread of disease in the population can have important implications for developing pandemic plans. Methodology/Principal Findings: By employing a deterministic mathematical model, we investigate possible scenarios for the emergence of population-wide resistance in the presence of antiviral drugs. The results show that if the treatment level (the fraction of clinical infections which receives treatment) is maintained constant during the course of the outbreak, there is an optimal level that minimizes the final size of the pandemic. However, aggressive treatment above the optimal level can substantially promote the spread of highly transmissible resistant mutants and increase the total number of infections. We demonstrate that resistant outbreaks can occur more readily when the spread of disease is further delayed by applying other curtailing measures, even if treatment levels are kept modest. However, by changing treatment levels over the course of the pandemic, it is possible to reduce the final size of the pandemic below the minimum achieved at the optimal constant level. This reduction can occur with low treatment levels during the early stages of the pandemic, followed by a sharp increase in drug-use before the virus becomes widely spread. Conclusions/Significance: Our findings suggest that an adaptive antiviral strategy with conservative initial treatment levels, followed by a timely increase in the scale of drug-use, can minimize the final size of a pandemic while preventing large outbreaks of resistant infections.	[Moghadas, Seyed M.; Bowman, Christopher S.] Natl Res Council Canada, Inst Biodiagnost, Winnipeg, MB R3B 1Y6, Canada; [Moghadas, Seyed M.] Univ Winnipeg, Dept Math & Statist, Winnipeg, MB, Canada; [Bowman, Christopher S.] Univ Manitoba, Dept Electrical & Comp Engn, Winnipeg, MB, Canada; [Rost, Gergely] Univ Szeged, Hungarian Acad Sci, Bolyai Inst, Anal & Stochast Res Grp, Szeged, Hungary; [Rost, Gergely; Wu, Jianhong] York Univ, Dept Math & Statist, Toronto, ON, Canada; [Wu, Jianhong] York Univ, York Inst Hlth Res, Ctr Dis Modelling, Toronto, ON, Canada	National Research Council Canada; University of Winnipeg; University of Manitoba; Hungarian Academy of Sciences; Szeged University; York University - Canada; York University - Canada	Moghadas, SM (corresponding author), Natl Res Council Canada, Inst Biodiagnost, 435 Ellice Ave, Winnipeg, MB R3B 1Y6, Canada.	Seyed.Moghadas@nrc-cnrc.gc.ca	Röst, Gergely/B-8622-2008; Rost, Gergely/L-9376-2016; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Rost, Gergely/0000-0001-9476-3284; Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507				Alexander ME, 2008, B MATH BIOL, V70, P382, DOI 10.1007/s11538-007-9257-2; Alexander ME, 2007, P R SOC B, V274, P1675, DOI 10.1098/rspb.2007.0422; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Debarre F, 2007, J R SOC INTERFACE, V4, P893, DOI 10.1098/rsif.2007.1126; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Handel A, 2006, PLOS COMPUT BIOL, V2, P1262, DOI 10.1371/journal.pcbi.0020137; HKISO MH, 2004, LANCET, V364, P759; LIPSITCH M, 2007, PLOS MED; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Rimmelzwaan GF, 2005, J GEN VIROL, V86, P1801, DOI 10.1099/vir.0.80867-0; WARD P, 2005, ANTIMICROB AGENT SS1, V55, pI51; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005	21	58	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1839	10.1371/journal.pone.0001839	http://dx.doi.org/10.1371/journal.pone.0001839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350174	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000260762300040
J	Tubaldi, F; Ansuini, C; Tirindelli, R; Castiello, U				Tubaldi, Federico; Ansuini, Caterina; Tirindelli, Roberto; Castiello, Umberto			The Grasping Side of Odours	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ORBITOFRONTAL CORTEX; RHESUS-MONKEY; HUMAN BRAIN; HAND; PERCEPTION; OBJECTS; VISION; GRIP; EYE	Background: Research on multisensory integration during natural tasks such as reach-to-grasp is still in its infancy. Crossmodal links between vision, proprioception and audition have been identified, but how olfaction contributes to plan and control reach-to-grasp movements has not been decisively shown. We used kinematics to explicitly test the influence of olfactory stimuli on reach-to-grasp movements. Methodology/Principal Findings: Subjects were requested to reach towards and grasp a small or a large visual target (i.e., precision grip, involving the opposition of index finger and thumb for a small size target and a power grip, involving the flexion of all digits around the object for a large target) in the absence or in the presence of an odour evoking either a small or a large object that if grasped would require a precision grip and a whole hand grasp, respectively. When the type of grasp evoked by the odour did not coincide with that for the visual target, interference effects were evident on the kinematics of hand shaping and the level of synergies amongst fingers decreased. When the visual target and the object evoked by the odour required the same type of grasp, facilitation emerged and the intrinsic relations amongst individual fingers were maintained. Conclusions/Significance: This study demonstrates that olfactory information contains highly detailed information able to elicit the planning for a reach-to-grasp movement suited to interact with the evoked object. The findings offer a substantial contribution to the current debate about the multisensory nature of the sensorimotor transformations underlying grasping.	[Tubaldi, Federico; Ansuini, Caterina; Castiello, Umberto] Univ Padua, Dept Gen Psychol, Padua, Italy; [Tirindelli, Roberto] Univ Parma, Dept Neurosci, Parma, Italy; [Castiello, Umberto] Univ London, Royal Holloway, Dept Psychol, Egham, Surrey, England	University of Padua; University of Parma; University of London; Royal Holloway University London	Tubaldi, F (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	umberto.castiello@unipd.it		Castiello, Umberto/0000-0003-0629-1286	University of Padova	University of Padova	This work was supported by a project grant from the University of Padova to UC.	Ansuini C, 2007, EXP BRAIN RES, V180, P85, DOI 10.1007/s00221-006-0840-9; ARBIB MA, 1985, HUM NEUROBIOL, V4, P63; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; BEGLIOMINI C, 2007, PLOS ONE, V10, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bock O, 1999, EXP BRAIN RES, V125, P61, DOI 10.1007/s002210050658; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Castiello U, 1996, J EXP PSYCHOL HUMAN, V22, P582, DOI 10.1037/0096-1523.22.3.582; Castiello U, 1999, TRENDS COGN SCI, V3, P264, DOI 10.1016/S1364-6613(99)01346-7; CASTIELLO U, 1993, EXP BRAIN RES, V94, P163; CASTIELLO U, J PSYCHOPHY IN PRESS; Castiello U, 2006, CHEM SENSES, V31, P665, DOI 10.1093/chemse/bjl007; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; COLEBATCH JG, 1989, BRAIN, V112, P749, DOI 10.1093/brain/112.3.749; DIFRANCO DW, 1997, DSC, V61, P17; Fagg AH, 1998, NEURAL NETWORKS, V11, P1277, DOI 10.1016/S0893-6080(98)00047-1; Frak V, 2001, EXP BRAIN RES, V136, P120, DOI 10.1007/s002210000583; Furr RM, 2003, PSYCHOL METHODS, V8, P275, DOI 10.1037/1082-989X.8.3.275; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Goodwin AW, 1998, J NEUROSCI, V18, P10724; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Grigor J, 1999, CHEM SENSES, V24, P137, DOI 10.1093/chemse/24.2.137; GRIGOR JA, 1995, CHEM SENSES, V20, P163; Guest S, 2002, EXP BRAIN RES, V146, P161, DOI 10.1007/s00221-002-1164-z; Hummel T, 1996, BRAIN RES, V717, P160, DOI 10.1016/0006-8993(96)00094-7; Jenmalm P, 2000, J NEUROPHYSIOL, V84, P2984, DOI 10.1152/jn.2000.84.6.2984; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Klatzky RL, 2000, PRESENCE-TELEOP VIRT, V9, P399, DOI 10.1162/105474600566907; KLATZKY RL, 1987, PSYCHOL LEARN MOTIV, V21, P121; KLATZKY RL, 1987, J EXP PSYCHOL GEN, V116, P356; Lalanne C, 2004, J PHYSIOL-PARIS, V98, P265, DOI 10.1016/j.jphysparis.2004.06.001; Lederman SJ, 2003, 11TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS - HAPTICS 2003, PROCEEDINGS, P151, DOI 10.1109/HAPTIC.2003.1191261; Lederman SJ, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P97, DOI 10.1109/HAPTIC.2002.998946; MacKenzie C. L., 1994, THE GRASPING HAND; MORECRAFT RJ, 1993, J COMP NEUROL, V337, P669, DOI 10.1002/cne.903370411; Osterbauer RA, 2005, J NEUROPHYSIOL, V93, P3434, DOI 10.1152/jn.00555.2004; Patchay S, 2003, PSYCHON B REV, V10, P924, DOI 10.3758/BF03196553; PATCHAY S, 2006, EXP BRAIN RES, V23, P1; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; PRABLANC C, 1979, BIOL CYBERN, V35, P183, DOI 10.1007/BF00337063; ROLLS ET, 1994, J NEUROSCI, V14, P5437; ROSSI S, PLOS ONE IN PRESS; Santello M, 2002, J NEUROSCI, V22, P1426, DOI 10.1523/JNEUROSCI.22-04-01426.2002; Sarfarazi M, 1999, CHEM SENSES, V24, P145, DOI 10.1093/chemse/24.2.145; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; Stein Barry E., 1995, P683; STEIN BE, 1990, ANN NY ACAD SCI, V608, P51, DOI 10.1111/j.1749-6632.1990.tb48891.x; THOMPSON B, 1985, J EXP EDUC, V54, P50, DOI 10.1080/00220973.1985.10806398; Tipper SP, 1998, PHILOS T R SOC B, V353, P1385, DOI 10.1098/rstb.1998.0292; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; Wing A.M., 1996, HAND BRAIN NEUROPHYS; Winges SA, 2003, EXP BRAIN RES, V152, P489, DOI 10.1007/s00221-003-1571-9; Zahariev MA, 2007, EXP BRAIN RES, V180, P69, DOI 10.1007/s00221-006-0845-4	55	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1795	10.1371/journal.pone.0001795	http://dx.doi.org/10.1371/journal.pone.0001795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370KY	18350137	Green Published, gold, Green Submitted			2022-12-25	WOS:000260762300003
J	Achilli, A; Perego, UA; Bravi, CM; Coble, MD; Kong, QP; Woodward, SR; Salas, A; Torroni, A; Bandelt, HJ				Achilli, Alessandro; Perego, Ugo A.; Bravi, Claudio M.; Coble, Michael D.; Kong, Qing-Peng; Woodward, Scott R.; Salas, Antonio; Torroni, Antonio; Bandelt, Hans-Juergen			The Phylogeny of the Four Pan-American MtDNA Haplogroups: Implications for Evolutionary and Disease Studies	PLOS ONE			English	Article								Only a limited number of complete mitochondrial genome sequences belonging to Native American haplogroups were available until recently, which left America as the continent with the least amount of information about sequence variation of entire mitochondrial DNAs. In this study, a comprehensive overview of all available complete mitochondrial DNA (mtDNA) genomes of the four pan-American haplogroups A2, B2, C1, and D1 is provided by revising the information scattered throughout GenBank and the literature, and adding 14 novel mtDNA sequences. The phylogenies of haplogroups A2, B2, C1, and D1 reveal a large number of sub-haplogroups but suggest that the ancestral Beringian population(s) contributed only six (successful) founder haplotypes to these haplogroups. The derived clades are overall starlike with coalescence times ranging from 18,000 to 21,000 years (with one exception) using the conventional calibration. The average of about 19,000 years somewhat contrasts with the corresponding lower age of about 13,500 years that was recently proposed by employing a different calibration and estimation approach. Our estimate indicates a human entry and spread of the pan-American haplogroups into the Americas right after the peak of the Last Glacial Maximum and comfortably agrees with the undisputed ages of the earliest Paleoindians in South America. In addition, the phylogenetic approach also indicates that the pathogenic status proposed for various mtDNA mutations, which actually define branches of Native American haplogroups, was based on insufficient grounds.	[Achilli, Alessandro; Perego, Ugo A.; Torroni, Antonio] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Achilli, Alessandro] Univ degli Studi Perugia, Dipartimento Biol Cell Ambientale, Perugia, Italy; [Perego, Ugo A.; Woodward, Scott R.] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Bravi, Claudio M.] Inst Multidisciplin Biol Celular, Lab Genet Mol Poblac, La Plata, Argentina; [Coble, Michael D.] Armed Forces Inst Pathol, Armed Forces DNA Identificat Lab, Rockville, MD USA; [Kong, Qing-Peng] Chinese Acad Sci, Kunming Inst Zool, Lab Cell & Mol Evolut, & Mol Biol Domestic Animals, Kunming, Peoples R China; [Kong, Qing-Peng] Yunnan Univ, Laboratory for Conservat & Utilizat Bio resource, Kunming, Peoples R China; [Salas, Antonio] Univ Santiago Compostela, Hosp Clin Univ, Inst Med Legal, Grupo Med Xenomica, Unidade Xenetica, Galicia, Spain; [Bandelt, Hans-Juergen] Univ Hamburg, Dept Math, Hamburg, Germany	University of Pavia; United States Department of Defense; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Universidade de Santiago de Compostela; University of Hamburg	Achilli, A (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Palestro 3, I-27100 Pavia, Italy.	torroni@ipvgen.unipv.it	Achilli, Alessandro/I-9236-2012; Salas, Antonio/E-3977-2012; Torroni, Antonio/E-1557-2011; Salas, Antonio/U-2029-2019; Perego, Ugo/AAG-9327-2019; Coble, Michael D/E-7540-2010	Achilli, Alessandro/0000-0001-6871-3451; Salas, Antonio/0000-0002-2336-702X; Torroni, Antonio/0000-0002-4163-4478; Salas, Antonio/0000-0002-2336-702X; Coble, Michael/0000-0003-3687-0342	Progetti Ricerca Interesse Nazionale; Fondazione Cariplo	Progetti Ricerca Interesse Nazionale(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Cariplo(Fondazione Cariplo)	This research received support from Progetti Ricerca Interesse Nazionale 2005 (Italian Ministry of the University) (to AT) and Fondazione Cariplo (to AT). Funding agencies had no role in the design and conduct of the study.	Accetturo M, 2006, HUM MUTAT, V27, P965, DOI 10.1002/humu.20365; Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2008, INT J LEGAL MED, V122, P11, DOI 10.1007/s00414-006-0151-5; Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x; Crispim D, 2005, DIABETIC MED, V22, P1683, DOI 10.1111/j.1464-5491.2005.01702.x; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Forster P, 1996, AM J HUM GENET, V59, P935; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; MITOMAP, HUM MIT GEN DAT; Mix AC, 2001, QUATERNARY SCI REV, V20, P627, DOI 10.1016/S0277-3791(00)00145-1; Monson K.L., 2002, FORENSIC SCI COMMUN, V4, P2; MOSQUERAMIGUEL A, 2008, CANC RES IN PRESS; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; PARSONS TJ, UNPUB; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rocha H, 1999, AM J HUM GENET, V65, P1457, DOI 10.1086/302641; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Schurr TG, 2004, ANNU REV ANTHROPOL, V33, P551, DOI 10.1146/annurev.anthro.33.070203.143932; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Scozzari R, 1997, AM J HUM GENET, V60, P241; Simon DK, 2001, J MED GENET, V38, P58, DOI 10.1136/jmg.38.1.58; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; TORRONI A, 1994, AM J HUM GENET, V54, P303; TORRONI A, 1994, P NATL ACAD SCI USA, V91, P1158, DOI 10.1073/pnas.91.3.1158; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9	50	196	204	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1764	10.1371/journal.pone.0001764	http://dx.doi.org/10.1371/journal.pone.0001764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335039	Green Published, gold			2022-12-25	WOS:000260723000018
J	Liu, BH; Goh, CHK; Ooi, LLPJ; Hui, KM				Liu, B. H.; Goh, C. H. K.; Ooi, L. L. P. J.; Hui, K. M.			Identification of unique and common low abundance tumour-specific transcripts by suppression subtractive hybridization and oligonucleotide probe array analysis	ONCOGENE			English	Article						affymetrix GeneChip arrays; breast cancer; hepatocellular carcinoma; low abundance transcripts; nasopharyngeal carcinoma; suppression subtractive hybridization	GENE-EXPRESSION SIGNATURE; EPSTEIN-BARR-VIRUS; HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; DNA; SURVIVAL	Most human cancers are characterized by genetic aberrations accompanied by altered expression and function of numerous genes. Applying genome-wide, microarray gene expression analysis to identify deregulated genes in different tumour types can provide potential gene candidates as diagnostic and prognostic tools and promising targets for drug development. However, the detection of deregulated genes with low levels of expression remains a major challenge. In this study, we have designed a strategy, termed modified suppression subtractive hybridization ( mSSH), to identify genes encoding rare transcripts. The strategy entails incorporating the T-7-promoter sequence at the 5 ' end of the noncoding cDNA strand during first strand cDNA synthesis to generate unidirectional antisense RNA from the resultant cDNA following conventional SSH. These transcripts are subsequently analysed by Affymetrix oligonucleotide gene arrays. Here, we have used five hepatocellular carcinoma ( HCC), five breast carcinoma and four nasopharyngeal carcinoma ( NPC) biopsies separately as testers and their corresponding normal biopsies as drivers to enrich for low abundance tumour type-specific transcripts. The total detectable number of probe sets following mSSH was reduced almost 10-fold in comparison to those detected for the same resected tumour tissues without undergoing subtraction, thus yielding a subtraction efficacy of over 90%. Using this experimental approach, we have identified 48 HCC-specific, 45 breast carcinoma-specific, and 83 NPC-specific genes. In addition, 115 genes were upregulated in all the three cancer types. When compared to gene-profiling data obtained without mSSH, the majority of these identified transcripts were of low abundance in the original cancer tissues. mSSH can therefore serve as a comprehensive molecular strategy for pursuing functional genomic studies of human cancers.	[Liu, B. H.; Hui, K. M.] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Bek Chai Heah Lab Canc Genom, Singapore 169610, Singapore; [Goh, C. H. K.] Singapore Gen Hosp, Dept Otolaryngol, Singapore 0316, Singapore; [Ooi, L. L. P. J.] Natl Canc Ctr, Div Surg Oncol, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital; National Cancer Centre Singapore (NCCS)	Hui, KM (corresponding author), Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Bek Chai Heah Lab Canc Genom, 11 Hosp Dr, Singapore 169610, Singapore.	cmrhkm@nccs.com.sg	Ooi, London Lucien/AGK-1395-2022; Hui, Kam/C-6186-2011	Hui, Kam/0000-0003-1820-1399				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bonavida B, 2007, ONCOGENE, V26, P3629, DOI 10.1038/sj.onc.1210365; Brentani H, 2003, P NATL ACAD SCI USA, V100, P13418, DOI 10.1073/pnas.1233632100; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Del Rio M, 2007, J CLIN ONCOL, V25, P773, DOI 10.1200/JCO.2006.07.4187; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Kirk GD, 2005, ONCOGENE, V24, P5858, DOI 10.1038/sj.onc.1208732; Lah TT, 2000, CLIN CANCER RES, V6, P578; Lau WM, 2007, ONCOGENE, V26, P6050, DOI 10.1038/sj.onc.1210405; LEE SW, 1991, P NATL ACAD SCI USA, V88, P2825, DOI 10.1073/pnas.88.7.2825; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Qin LX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-23; Russo G, 2003, ONCOGENE, V22, P6497, DOI 10.1038/sj.onc.1206865; Sander C, 2000, SCIENCE, V287, P1977, DOI 10.1126/science.287.5460.1977; Shiota G, 1997, J HEPATOL, V27, P661, DOI 10.1016/S0168-8278(97)80083-9; Thornburg NJ, 2006, ONCOGENE, V25, P288, DOI 10.1038/sj.onc.1209023; Thuerigen O, 2006, J CLIN ONCOL, V24, P1839, DOI 10.1200/JCO.2005.04.7019; Tsopanomichalou M, 1999, LIVER, V19, P305, DOI 10.1111/j.1478-3231.1999.tb00054.x; Wang SM, 2007, CLIN CANCER RES, V13, P6275, DOI 10.1158/1078-0432.CCR-06-2236; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; Yu K, 2006, CLIN CANCER RES, V12, P3288, DOI 10.1158/1078-0432.CCR-05-1530	27	10	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 3	2008	27	29					4128	4136		10.1038/onc.2008.50	http://dx.doi.org/10.1038/onc.2008.50			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	321RV	18332864				2022-12-25	WOS:000257325100013
J	Kimura, Y; Hirano, Y; Yu, LJ; Suzuki, H; Kobayashi, M; Wang, ZY				Kimura, Yukihiro; Hirano, Yu; Yu, Long-Jiang; Suzuki, Hiroaki; Kobayashi, Masayuki; Wang, Zheng-Yu			Calcium ions are involved in the unusual red shift of the light-harvesting 1 Q(y) transition of the core complex in thermophilic purple sulfur bacterium Thermochromatium tepidum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYNTHETIC REACTION-CENTER; BULLFROG SKELETAL-MUSCLE; RHODOBACTER-SPHAEROIDES; RHODOPSEUDOMONAS-VIRIDIS; CIRCULAR-DICHROISM; CRYSTAL-STRUCTURE; HEAT-CAPACITY; CA2+ BINDING; TROPONIN-C	Thermophilic purple sulfur bacterium, Thermochromatium tepidum, can grow at temperatures up to 58 C and exhibits an unusual Q(y) absorption at 915 nm for the core light-harvesting complex (LH1), an similar to 35-nm red shift from those of its mesophilic counterparts. We demonstrate in this study, using a highly purified LH1-reaction center complex, that the LH1 Qy transition is strongly dependent on metal cations and Ca2+ is involved in the unusual red shift. Removal of the Ca2+ resulted in formation of a species with the LH1 Qy absorption at 880 nm, and addition of the Ca2+ to the 880-nm species recovered the native 915-nm form. Interchange between the two forms is fully reversible. Based on spectroscopic and isothermal titration calorimetry analyses, the Ca2+ binding to the LH1 complex was estimated to occur in a stoichiometric ratio of Ca2+/alpha beta-subunit = 1: 1 and the binding constant was in 10(5) M-1 order of magnitude, which is comparable with those for EF-hand Ca2+-binding proteins. Despite the high affinity, conformational changes in the LH1 complex upon Ca2+ binding were small and occurred slowly, with a typical time constant of similar to 6 min. Replacement of the Ca2+ with other metal cations caused blue shifts of the Qy bands depending on the property of the cations, indicating that the binding site is highly selective. Based on the amino acid sequences of the LH1 complex, possible Ca2+-binding sites are proposed that consist of several acidic amino acid residues near the membrane interfaces of the C-terminal region of the alpha-polypeptide and the N-terminal region of the beta-polypeptide.	[Kimura, Yukihiro; Hirano, Yu; Yu, Long-Jiang; Suzuki, Hiroaki; Wang, Zheng-Yu] Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan; [Kobayashi, Masayuki] Ariake Natl Coll Technol, Fukuoka 8368585, Japan	Ibaraki University	Wang, ZY (corresponding author), Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan.	wang@mx.ibaraki.ac.jp	Kimura, Yukihiro/AAI-6300-2020					ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P5730, DOI 10.1073/pnas.84.16.5730; ALLEN JP, 1986, P NATL ACAD SCI USA, V83, P8589, DOI 10.1073/pnas.83.22.8589; CLAYTON RK, 1981, P NATL ACAD SCI-BIOL, V78, P5583, DOI 10.1073/pnas.78.9.5583; Cogdell RJ, 2002, PHOTOSYNTH RES, V74, P135, DOI 10.1023/A:1020995224156; COX JA, 1982, J BIOL CHEM, V257, P694; DEISENHOFER J, 1984, J MOL BIOL, V180, P385, DOI 10.1016/S0022-2836(84)80011-X; Dudev T, 2007, ACCOUNTS CHEM RES, V40, P85, DOI 10.1021/ar068181i; Fathir I, 1998, PHOTOSYNTH RES, V58, P193, DOI 10.1023/A:1006146713751; FOWLER GJS, 1992, NATURE, V355, P848, DOI 10.1038/355848a0; Georgakopoulou S, 2006, J PHYS CHEM B, V110, P3344, DOI 10.1021/jp051794c; Georgakopoulou S, 2006, J PHYS CHEM B, V110, P3354, DOI 10.1021/jp0517955; Glaeser J, 1999, ARCH MICROBIOL, V171, P405, DOI 10.1007/s002030050727; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; IMAIZUMI M, 1987, J BIOL CHEM, V262, P7963; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; KLEE CB, 1977, BIOCHEMISTRY-US, V16, P1017, DOI 10.1021/bi00624a033; Kobayashi M, 2005, BIOSCI BIOTECH BIOCH, V69, P1130, DOI 10.1271/bbb.69.1130; Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9; Kramer H, 1996, PHOTOSYNTH RES, V49, P237, DOI 10.1007/BF00034784; MADIGAN MT, 1984, SCIENCE, V225, P313, DOI 10.1126/science.225.4659.313; Madigan MT, 2003, PHOTOSYNTH RES, V76, P157, DOI 10.1023/A:1024998212684; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; McLuskey K, 2001, BIOCHEMISTRY-US, V40, P8783, DOI 10.1021/bi010309a; MILOS M, 1986, BIOCHEMISTRY-US, V25, P6279, DOI 10.1021/bi00368a067; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; NOZAWA T, 1986, BIOCHIM BIOPHYS ACTA, V852, P191, DOI 10.1016/0005-2728(86)90223-9; OGAWA Y, 1986, J BIOCHEM-TOKYO, V99, P81, DOI 10.1093/oxfordjournals.jbchem.a135482; OGAWA Y, 1984, J BIOCHEM-TOKYO, V95, P19, DOI 10.1093/oxfordjournals.jbchem.a134584; OLSEN JD, 1994, P NATL ACAD SCI USA, V91, P7124, DOI 10.1073/pnas.91.15.7124; Permentier HP, 2001, BIOCHEMISTRY-US, V40, P5573, DOI 10.1021/bi0024308; POTTER JD, 1977, J BIOL CHEM, V252, P2452; Qian P, 2005, J MOL BIOL, V349, P948, DOI 10.1016/j.jmb.2005.04.032; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Scheuring S, 2004, J BIOL CHEM, V279, P3620, DOI 10.1074/jbc.M310050200; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; SCHWARZ FP, 1993, J BIOL CHEM, V268, P7668; STURGIS JN, 1995, BIOCHEMISTRY-US, V34, P517, DOI 10.1021/bi00002a016; Suzuki H, 2007, BBA-BIOENERGETICS, V1767, P1057, DOI 10.1016/j.bbabio.2007.06.002; TANOKURA M, 1993, J BIOL CHEM, V268, P7090; TANOKURA M, 1987, BIOCHEMISTRY-US, V26, P7668, DOI 10.1021/bi00398a020; TANOKURA M, 1986, FEBS LETT, V209, P77, DOI 10.1016/0014-5793(86)81087-0; TANOKURA M, 1984, J BIOCHEM-TOKYO, V95, P643, DOI 10.1093/oxfordjournals.jbchem.a134653; Tuschak C, 2004, PHOTOSYNTH RES, V81, P181, DOI 10.1023/B:PRES.0000035046.91126.bd; Wang ZY, 2003, PHOTOSYNTH RES, V78, P133, DOI 10.1023/B:PRES.0000004328.11219.79; WOLFF DJ, 1977, J BIOL CHEM, V252, P4108; YAMADA K, 1982, J BIOCHEM-TOKYO, V92, P1505, DOI 10.1093/oxfordjournals.jbchem.a134075; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b	49	54	56	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13867	13873		10.1074/jbc.M800256200	http://dx.doi.org/10.1074/jbc.M800256200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18332135	hybrid			2022-12-25	WOS:000255728200040
J	Lee, DW; Ozturk, Y; Osyczka, A; Cooley, JW; Daldal, F				Lee, Dong-Woo; Ozturk, Yavuz; Osyczka, Artur; Cooley, Jason W.; Daldal, Fevzi			Cytochrome bc(1)-c(y) fusion complexes reveal the distance constraints for functional electron transfer between photosynthesis components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATION Q(O) SITE; RHODOBACTER-CAPSULATUS; DOMAIN MOVEMENT; SPHAEROIDES; MEMBRANE; C(Y); SUPERCOMPLEXES; CHAIN; PROTEIN; GROWTH	Photosynthetic (Ps) growth of purple non-sulfur bacteria such as Rhodobacter capsulatus depends on the cyclic electron transfer (ET) between the ubihydroquinone (QH(2)): cytochrome (cyt) c oxidoreductases (cyt bc(1) complex), and the photochemical reaction centers (RC), mediated by either a membrane-bound (cyt c(y)) or a freely diffusible (cyt c(2)) electron carrier. Previously, we constructed a functional cyt bc(1)-c(y) fusion complex that supported Ps growth solely relying on membrane-confined ET (Lee, D.-W., Ozturk, Y., Mamedova, A., Osyczka, A., Cooley, J. W., and Daldal, F. (2006) Biochim. Biophys. Acta 1757, 346 352). In this work, we further characterized this cyt bc1-cy fusion complex, and used its derivatives with shorter cyt c(y) linkers as "molecular rulers" to probe the distances separating the Ps components. Comparison of the physicochemical properties of both membrane-embedded and purified cyt bc(1)-c(y) fusion complexes established that these enzymes were matured and assembled properly. Light-activated, time-resolved kinetic spectroscopy analyses revealed that their variants with shorter cyt c(y) linkers exhibited fast, native-like ET rates to the RC via the cyt bc(1). However, shortening the length of the cyt (c)y linker decreased drastically this electronic coupling between the cyt bc(1)-c(y) fusion complexes and the RC, thereby limiting Ps growth. The shortest and still functional cyt c(y) linker was about 45 amino acids long, showing that the minimal distance allowed between the cyt bc(1)-c(y) fusion complexes and the RC and their surrounding light harvesting proteins was very short. These findings support the notion that membrane-bound Ps components form large, active structural complexes that are "hardwired" for cyclic ET.	[Lee, Dong-Woo; Ozturk, Yavuz; Cooley, Jason W.; Daldal, Fevzi] Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA; [Osyczka, Artur] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Ozturk, Yavuz] TUBITAK Marmara Res Ctr, Genet Engn & Biotechnol Inst, TR-41470 Gebze, Kocaeli, Turkey	University of Pennsylvania; University of Pennsylvania; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)	Daldal, F (corresponding author), Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.	fdaldal@sas.upenn.edu		Osyczka, Artur/0000-0002-1637-2365	NIGMS NIH HHS [GM38237, R01 GM038237] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATTAASAFOADJEI E, 1991, P NATL ACAD SCI USA, V88, P492, DOI 10.1073/pnas.88.2.492; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Cooley JW, 2005, BIOCHEMISTRY-US, V44, P10520, DOI 10.1021/bi050571+; Crofts AR, 2000, TRENDS MICROBIOL, V8, P105, DOI 10.1016/S0966-842X(99)01693-5; CROFTS AR, 1982, BIOCHEM SOC T, V10, P201, DOI 10.1042/bst0100201; DALDAL F, 1986, P NATL ACAD SCI USA, V83, P2012, DOI 10.1073/pnas.83.7.2012; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; Darrouzet E, 2004, PHOTOSYNTH RES, V79, P25, DOI 10.1023/B:PRES.0000011926.47778.4e; Darrouzet E, 2000, BIOCHEMISTRY-US, V39, P15475, DOI 10.1021/bi000750l; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; DONOHUE TJ, 1988, BIOCHEMISTRY-US, V27, P1918, DOI 10.1021/bi00406a018; Dutton P L, 1978, Methods Enzymol, V54, P411; Eubel H, 2003, PLANT PHYSIOL, V133, P274, DOI 10.1104/pp.103.024620; GENNIS RB, 1993, J BIOENERG BIOMEMBR, V25, P195, DOI 10.1007/BF00762582; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P723, DOI 10.1021/bi00169a014; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; JENNEY FE, 1994, BIOCHEMISTRY-US, V33, P2496, DOI 10.1021/bi00175a019; JENNEY FE, 1993, EMBO J, V12, P1283, DOI 10.1002/j.1460-2075.1993.tb05773.x; Jenney FE, 1996, BBA-BIOENERGETICS, V1273, P159, DOI 10.1016/0005-2728(95)00137-9; Joliot P, 2005, BBA-BIOENERGETICS, V1706, P204, DOI 10.1016/j.bbabio.2004.11.002; JOLIOT P, 1989, BIOCHIM BIOPHYS ACTA, V975, P336, DOI 10.1016/S0005-2728(89)80341-X; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DW, 2006, BBA-BIOENERGETICS, V1757, P346, DOI 10.1016/j.bbabio.2006.04.025; Myllykallio H, 1999, P NATL ACAD SCI USA, V96, P4348, DOI 10.1073/pnas.96.8.4348; Myllykallio H, 1998, BIOCHEMISTRY-US, V37, P5501, DOI 10.1021/bi973123d; Myllykallio H, 1997, J BACTERIOL, V179, P2623, DOI 10.1128/jb.179.8.2623-2631.1997; Ozturk Y, 2008, J BIOL CHEM, V283, P13964, DOI 10.1074/jbc.M800090200; ROBERTSON DE, 1993, BIOCHEMISTRY-US, V32, P1310, DOI 10.1021/bi00056a016; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schoepp-Cothenet B, 2001, FEBS LETT, V487, P372, DOI 10.1016/S0014-5793(00)02357-7; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Valkova-Valchanova MB, 1998, BIOCHEMISTRY-US, V37, P16242, DOI 10.1021/bi981651z; Vermeglio A, 1999, TRENDS MICROBIOL, V7, P435, DOI 10.1016/S0966-842X(99)01625-X; ZANNONI D, 1993, ARCH MICROBIOL, V160, P413, DOI 10.1007/BF00245301	38	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13973	13982		10.1074/jbc.M800091200	http://dx.doi.org/10.1074/jbc.M800091200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18343816	Green Published, hybrid			2022-12-25	WOS:000255728200051
J	Radke, S; Chander, H; Schafer, P; Meiss, G; Kruger, R; Schulz, JB; Germain, D				Radke, Susanne; Chander, Harish; Schaefer, Patrick; Meiss, Gregor; Krueger, Rejko; Schulz, Joerg B.; Germain, Doris			Mitochondrial protein quality control by the proteasome involves ubiquitination and the protease Omi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; AAA PROTEASES; DEGRADATION; TRANSPORT; PINK1	We report here that blocking the activity of the 26 S proteasome results in drastic changes in the morphology of the mitochondria and accumulation of intermembrane space (IMS) proteins. Using endonuclease G (endoG) as a model IMS protein, we found that accumulation of wild-type but to a greater extent mutant endoG leads to changes in the morphology of the mitochondria similar to those observed following proteasomal inhibition. Further, we show that wildtype but to a greater extent mutant endoG is a substrate for ubiquitination, suggesting the presence of a protein quality control. Conversely, we also report that wild-type but not mutant endoG is a substrate for the mitochondrial protease Omi but only upon inhibition of the proteasome. These findings suggest that although elimination of mutant IMS proteins is strictly dependent on ubiquitination, elimination of excess or spontaneously misfolded wild-type IMS proteins is monitored by ubiquitination and as a second checkpoint by Omi cleavage when the proteasome function is deficient. One implication of our finding is that in the context of attenuated proteasomal function, accumulation of IMS proteins would contribute to the collapse of the mitochondrial network such as that observed in neurodegenerative diseases. Another implication is that such collapse could be accelerated either by mutations in IMS proteins or by mutations in Omi itself.	[Radke, Susanne; Chander, Harish; Germain, Doris] Mt Sinai Sch Med, Dept Med, Div Hematol Oncol, Inst Biochem, New York, NY 10029 USA; [Schaefer, Patrick; Meiss, Gregor] Univ Giessen, D-35392 Giessen, Germany; Univ Tubingen, Ctr Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Schulz, Joerg B.] Univ Gottingen, Ctr Mol Physiol Brain & Med Neurol, D-37073 Gottingen, Germany	Icahn School of Medicine at Mount Sinai; Justus Liebig University Giessen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Gottingen	Germain, D (corresponding author), Gustave L Levy Pl,Box 1178, New York, NY 10029 USA.	doris.germain@mssm.edu	Schulz, Jörg B/D-9786-2012	Schulz, Jörg B/0000-0002-8903-0593; Krueger, Rejko/0000-0003-4258-6241	NATIONAL CANCER INSTITUTE [R24CA095823, R01CA109482] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA109482, R24 CA095823, 5R24 CA095823-04] Funding Source: Medline; NCRR NIH HHS [1 S10RR0 9145-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Augustin S, 2005, J BIOL CHEM, V280, P2691, DOI 10.1074/jbc.M410609200; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Langer T, 2001, BIOCHEM SOC T, V29, P431, DOI 10.1042/BST0290431; Margineantu DH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001066; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Plemper RK, 1999, MOL BIOL REP, V26, P125, DOI 10.1023/A:1006913215484; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Radke S, 2005, ONCOGENE, V24, P3448, DOI 10.1038/sj.onc.1208328; Rivett AJ, 1998, CURR OPIN IMMUNOL, V10, P110, DOI 10.1016/S0952-7915(98)80040-X; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262	18	128	129	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12681	12685		10.1074/jbc.C800036200	http://dx.doi.org/10.1074/jbc.C800036200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18362145	Green Published, hybrid			2022-12-25	WOS:000255499800002
J	Planque, S; Escobar, MA; Smith, KC; Taguchi, H; Nishiyama, Y; Donnachie, E; Pratt, KP; Paul, S				Planque, Stephanie; Escobar, Miguel A.; Smith, Keri C.; Taguchi, Hiroaki; Nishiyama, Yasuhiro; Donnachie, Elizabeth; Pratt, Kathleen P.; Paul, Sudhir			Covalent inactivation of factor VIII antibodies from hemophilia a patients by an electrophilic FVIII analog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CRYSTAL-STRUCTURE; C2 DOMAIN; INHIBITOR; BINDING; IDENTIFICATION; COMPLEX; EPITOPE; DERIVATIVES; MECHANISMS	The antigen-binding sites of antibodies (Abs) can express enzyme-like nucleophiles that react covalently with electrophilic compounds. We examined the irreversible and specific inactivation of antibodies (Abs) to Factor VIII (FVIII) responsible for failure of FVIII replacement therapy in hemophilia A (HA) patients. Electrophilic analogs of FVIII (E-FVIII) and its C2 domain (E-C2) were prepared by placing the strongly electrophilic phosphonate groups at surface-exposed Lys side chains of diverse antigenic epitopes. IgG Abs to FVIII from HA patients formed stable immune complexes with E-FVIII and E-C2 that were refractory to dissociation by SDS treatment and boiling, procedures that dissociate noncovalent Ab-antigen complexes. The rate-limiting step in the reaction was formation of the initial noncovalent complexes. Conversion of the initial complexes to the irreversible state occurred rapidly. The antigenic epitopes of E-FVIII were largely intact, and most of the Abs were consumed covalently. E-FVIII expressed poor FVIII cofactor activity in clotting factor assays. Nonspecific interference by E-FVIII in clotting factor function was not evident. Treatment with E-FVIII, and to a lesser extent E-C2, irreversibly relieved the FVIII inhibitory effect of HA IgG in clotting factor assays. Small FVIII peptides did not display useful reactivity, highlighting the diverse epitope specificities of the Abs and the conformational character of FVIII epitopes. E-FVIII is a prototype reagent able to attain irreversible and specific inactivation of pathogenic Abs.	[Planque, Stephanie; Escobar, Miguel A.; Smith, Keri C.; Taguchi, Hiroaki; Nishiyama, Yasuhiro; Donnachie, Elizabeth; Paul, Sudhir] Univ Texas Houston, Sch Med, Dept Pathol, Chem Immunol Res Ctr, Houston, TX 77030 USA; [Planque, Stephanie; Escobar, Miguel A.; Smith, Keri C.; Taguchi, Hiroaki; Nishiyama, Yasuhiro; Donnachie, Elizabeth; Paul, Sudhir] Univ Texas Houston, Sch Med, Dept Med, Chem Immunol Res Ctr, Houston, TX 77030 USA; [Planque, Stephanie; Escobar, Miguel A.; Smith, Keri C.; Taguchi, Hiroaki; Nishiyama, Yasuhiro; Donnachie, Elizabeth; Paul, Sudhir] Univ Texas Houston, Sch Med, Gulf States Hemophilia & Thrombophilia Ctr, Houston, TX 77030 USA; [Pratt, Kathleen P.] Univ Washington, Puget Sound Blood Ctr, Seattle, WA 98104 USA; [Pratt, Kathleen P.] Univ Washington, Div Hematol, Seattle, WA 98104 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Puget Sound Blood Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Paul, S (corresponding author), Univ Texas Houston, Sch Med, Dept Pathol, Chem Immunol Res Ctr, 6431 Fannin, Houston, TX 77030 USA.	Sudhir.Paul@uth.tmc.edu	Pratt, Kathleen P/E-9489-2019	Csencsits-Smith, Keri/0000-0002-8477-7903; Pratt, Kathleen/0000-0001-6837-6133	NIAID NIH HHS [AI31268] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031268, R21AI031268] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APPEL SH, 1975, NEW ENGL J MED, V293, P760, DOI 10.1056/NEJM197510092931508; Berntorp E, 2006, SEMIN THROMB HEMOST, V32, P22, DOI 10.1055/s-2006-946911; Bertrand JA, 1996, BIOCHEMISTRY-US, V35, P3147, DOI 10.1021/bi9520996; Bhopale GM, 2003, J BIOSCIENCES, V28, P783, DOI 10.1007/BF02708439; Biemel KM, 2002, J BIOL CHEM, V277, P24907, DOI 10.1074/jbc.M202681200; Brackmann H H, 1984, Prog Clin Biol Res, V150, P181; BRACKMANN HH, 1977, LANCET, V2, P933; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Coopamah MD, 2003, TRANSFUS MED REV, V17, P69, DOI 10.1053/tmrv.2003.50004; Ettingshausen CE, 2006, HAEMOPHILIA, V12, P102, DOI 10.1111/j.1365-2516.2006.01373.x; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gilles JGG, 2004, BLOOD, V103, P2617, DOI 10.1182/blood-2003-07-2207; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HEALEY JF, 1995, J BIOL CHEM, V270, P14505, DOI 10.1074/jbc.270.24.14505; Jones ML, 2003, HAEMOPHILIA, V9, P464, DOI 10.1046/j.1365-2516.2003.00782.x; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P875, DOI 10.1055/s-0038-1651380; Kopecky EM, 2006, J IMMUNOL METHODS, V308, P90, DOI 10.1016/j.jim.2005.10.016; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Lavigne-Lissalde G, 2005, THROMB HAEMOSTASIS, V94, P760, DOI 10.1160/TH05-02-0118; Nishiyama Y, 2005, J MOL RECOGNIT, V18, P295, DOI 10.1002/jmr.734; Nishiyama Y, 2004, J BIOL CHEM, V279, P7877, DOI 10.1074/jbc.M310950200; Nishiyama Y, 2006, J MOL RECOGNIT, V19, P423, DOI 10.1002/jmr.795; Nogami K, 1999, BRIT J HAEMATOL, V107, P196, DOI 10.1046/j.1365-2141.1999.01673.x; Nossal GJV, 1997, CIBA F SYMP, V204, P220; OLEKSYSZYN J, 1994, METHOD ENZYMOL, V244, P423; PAUL S, 1991, J BIOL CHEM, V266, P16128; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; PAUL S, 1992, J BIOL CHEM, V267, P13142; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; PAUL S, 1989, J NEUROIMMUNOL, V23, P133, DOI 10.1016/0165-5728(89)90032-5; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2003, J BIOL CHEM, V278, P20436, DOI 10.1074/jbc.M301468200; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Prescott R, 1997, BLOOD, V89, P3663, DOI 10.1182/blood.V89.10.3663.3663_3663_3671; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Saenko EL, 1996, J BIOL CHEM, V271, P27424, DOI 10.1074/jbc.271.44.27424; Sahud MA, 2007, HAEMOPHILIA, V13, P317, DOI 10.1111/j.1365-2516.2007.01450.x; Scandella D, 1999, VOX SANG, V77, P17, DOI 10.1159/000056708; Schenone M, 2004, CURR OPIN HEMATOL, V11, P272, DOI 10.1097/01.moh.0000130308.37353.d4; Shetty S, 2003, HAEMOPHILIA, V9, P654, DOI 10.1046/j.1365-2516.2003.00810.x; Smith KC, 2007, J IMMUNOL, V178; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; ten Boekel E, 2007, THROMB RES, V121, P361, DOI 10.1016/j.thromres.2007.05.006; Tsao ML, 2005, CHEMBIOCHEM, V6, P2147, DOI 10.1002/cbic.200500314; van Dijk K, 2005, HAEMATOLOGICA, V90, P494; Villard S, 2003, BLOOD, V102, P949, DOI 10.1182/blood-2002-06-1886; Villard S, 2002, J BIOL CHEM, V277, P27232, DOI 10.1074/jbc.M203415200; WALTER J, 1983, H-S Z PHYSIOL CHEM, V364, P949, DOI 10.1515/bchm2.1983.364.2.949; Zhong DG, 1998, BLOOD, V92, P136, DOI 10.1182/blood.V92.1.136.413k35_136_142	50	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					11876	11886		10.1074/jbc.M800589200	http://dx.doi.org/10.1074/jbc.M800589200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18337255	Green Published, hybrid			2022-12-25	WOS:000255340000003
J	Steed, PR; Fillingame, RH				Steed, P. Ryan; Fillingame, Robert H.			Subunit a facilitates aqueous access to a membrane-embedded region of subunit C in Escherichia coli F1F0 ATP synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE PROTEIN COMPONENT; ENERGY-TRANSDUCING SYSTEM; CROSS-LINKING; ROTARY MOTOR; ROTOR RING; CHANNEL; SECTOR; DICYCLOHEXYLCARBODIIMIDE; STOICHIOMETRY; MECHANISM	Rotary catalysis in F1F0 ATP synthase is powered by proton translocation through the membrane-embedded F-0 sector. Proton binding and release occurs in the middle of the membrane at Asp-61 on transmembrane helix 2 of subunit c. Previously, the reactivity of cysteines substituted into F0 subunit a revealed two regions of aqueous access, one extending from the periplasm to the middle of the membrane and a second extending from the middle of the membrane to the cytoplasm. To further characterize aqueous accessibility at the subunit a-c interface, we have substituted Cys for residues on the cytoplasmic side of transmembrane helix 2 of subunit c and probed the accessibility to these substituted positions using thiolate-reactive reagents. The Cys substitutions tested were uniformly inhibited by Ag+ treatment, which suggested widespread aqueous access to this generally hydrophobic region. Sensitivity to N-ethylmaleimide (NEM) and methanethiosulfonate reagents was localized to a membrane-embedded pocket surrounding Asp-61. The cG58C substitution was profoundly inhibited by all the reagents tested, including membrane impermeant methanethiosulfonate reagents. Further studies of the highly reactive cG58C substitution revealed that NEM modification of a single c subunit in the oligomeric c-ring was sufficient to cause complete inhibition. In addition, NEMmodification of subunit c was dependent upon the presence of subunit a. The results described here provide further evidence for an aqueous-accessible region at the interface of subunits a and c extending from the middle of the membrane to the cytoplasm.	[Steed, P. Ryan; Fillingame, Robert H.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1300 Univ Ave, Madison, WI 53706 USA.	rhfillin@wisc.edu		Steed, Ryan/0000-0001-5445-0080	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23105] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; [Anonymous], 1973, CHEM BIOCH SULFHYDRY; Barik S, 1996, Methods Mol Biol, V57, P203; Bell RA, 1999, ENVIRON TOXICOL CHEM, V18, P9, DOI [10.1897/1551-5028(1999)018&lt;0009:SCAGOS&gt;2.3.CO;2, 10.1002/etc.5620180103]; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; FILLINGAME RH, 1976, J BIOL CHEM, V251, P6630; FILLINGAME RH, 1975, J BACTERIOL, V124, P870, DOI 10.1128/JB.124.2.870-883.1975; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; FIMMEL AL, 1983, BIOCHEM J, V213, P451, DOI 10.1042/bj2130451; HERMOLIN J, 1995, J BIOL CHEM, V270, P2815, DOI 10.1074/jbc.270.6.2815; HERMOLIN J, 1989, J BIOL CHEM, V264, P3896; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kwaw I, 2001, BIOCHEMISTRY-US, V40, P10491, DOI 10.1021/bi010866x; Langemeyer L, 2007, BBA-BIOENERGETICS, V1767, P998, DOI 10.1016/j.bbabio.2007.05.007; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; Meier T, 2005, FEBS J, V272, P5474, DOI [10.1111/j.1742-4658.2005.04940.x, 10.1111/j.1742-4685.2005.04940.x]; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; Vincent OD, 2007, J BIOL CHEM, V282, P33788, DOI 10.1074/jbc.M706904200; von Ballmoos C, 2002, EUR J BIOCHEM, V269, P5581, DOI 10.1046/j.1432-1033.2002.03264.x; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	41	35	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12365	12372		10.1074/jbc.M800901200	http://dx.doi.org/10.1074/jbc.M800901200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18332132	Green Published, hybrid			2022-12-25	WOS:000255340000053
J	Miretti, S; Roato, I; Taulli, R; Ponzetto, C; Cilli, M; Olivero, M; Di Renzo, MF; Godio, L; Albini, A; Buracco, P; Ferracini, R				Miretti, Silvia; Roato, Ilaria; Taulli, Riccardo; Ponzetto, Carola; Cilli, Michele; Olivero, Martina; Di Renzo, Maria Flavia; Godio, Laura; Albini, Adriana; Buracco, Paolo; Ferracini, Riccardo			A Mouse Model of Pulmonary Metastasis from Spontaneous Osteosarcoma Monitored In Vivo by Luciferase Imaging	PLOS ONE			English	Article								Background: Osteosarcoma (OSA) is lethal when metastatic after chemotherapy and/or surgical treatment. Thus animal models are necessary to study the OSA metastatic spread and to validate novel therapies able to control the systemic disease. We report the development of a syngeneic (Balb/c) murine OSA model, using a cell line derived from a spontaneous murine tumor. Methodology: The tumorigenic and metastatic ability of OSA cell lines were assayed after orthotopic injection in mice distal femur. Expression profiling was carried out to characterize the parental and metastatic cell lines. Cells from metastases were propagated and engineered to express Luciferase, in order to follow metastases in vivo. Principal Findings: Luciferase bioluminescence allowed to monitor the primary tumor growth and revealed the appearance of spontaneous pulmonary metastases. In vivo assays showed that metastasis is a stable property of metastatic OSA cell lines after both propagation in culture and luciferase trasduction. When compared to parental cell line, both unmodified and genetically marked metastatic cells, showed comparable and stable differential expression of the enpp4, pfn2 and prkcd genes, already associated to the metastatic phenotype in human cancer. Conclusions: This OSA animal model faithfully recapitulates some of the most important features of the human malignancy, such as lung metastatization. Moreover, the non-invasive imaging allows monitoring the tumor progression in living mice. A great asset of this model is the metastatic phenotype, which is a stable property, not modifiable after genetic manipulation.	[Miretti, Silvia] Univ Turin, Sch Vet Med, Dept Morphophysiol, Turin, Italy; [Roato, Ilaria; Taulli, Riccardo; Ponzetto, Carola] Ctr Expt Res & Med Stud, Turin, Italy; [Taulli, Riccardo; Ponzetto, Carola] Univ Turin, Dept Anat, Pharmacol & Forensic Med, Turin, Italy; [Cilli, Michele] Natl Inst Canc Res, Anim Res Facil, Genoa, Italy; [Olivero, Martina; Di Renzo, Maria Flavia] Univ Turin, Sch Med, IRCC, Lab Canc Genet, Turin, Italy; [Godio, Laura] ASO San Giovanni Battista, Dept Pathol, Lab Pathol, Turin, Italy; [Albini, Adriana] IRCCS Multimedica Sci & Technol Pk, Milan, Italy; [Buracco, Paolo] Univ Turin, Sch Vet Med, Dept Anim Pathol, Turin, Italy; [Ferracini, Riccardo] ASO San Giovanni Battista, Dept Orthopaed, Turin, Italy	University of Turin; University of Turin; University of Genoa; IRCCS AOU San Martino IST; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; IRCCS Multimedica; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Miretti, S (corresponding author), Univ Turin, Sch Vet Med, Dept Morphophysiol, Turin, Italy.	silvia.miretti@unito.it	olivero, martina/J-4811-2018; Ferracini, Riccardo/AAL-4622-2020; DI RENZO, Maria Flavia/B-6091-2012; Albini, Adriana/J-3701-2018; TAULLI, Riccardo/J-7347-2018; Buracco, Paolo/J-8251-2014; Cilli, Michele/AAB-8529-2019	olivero, martina/0000-0002-6815-3498; DI RENZO, Maria Flavia/0000-0002-5093-3373; TAULLI, Riccardo/0000-0003-1277-6263; Buracco, Paolo/0000-0002-0181-0887; Cilli, Michele/0000-0003-4083-8986; Roato, Ilaria/0000-0003-3029-4743; Albini, Adriana/0000-0002-9624-5103; MIRETTI, SILVIA/0000-0002-6693-2527	Fondazione Internazionale di Ricerca in Medicina Sperimentale (FIRMS); Compagnia di San Paolo	Fondazione Internazionale di Ricerca in Medicina Sperimentale (FIRMS); Compagnia di San Paolo(Compagnia di San Paolo)	This work was mainly supported by a grant from Fondazione Internazionale di Ricerca in Medicina Sperimentale (FIRMS) and from Compagnia di San Paolo, "Special Project Oncology". Xenogen IVIS imaging system was supported by San Paolo foundation.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; ARESU O, 1991, INVAS METAST, V11, P2; Asai T, 1998, INT J CANCER, V76, P418, DOI 10.1002/(SICI)1097-0215(19980504)76:3<418::AID-IJC21>3.3.CO;2-E; Bell RS, 1997, J BONE JOINT SURG AM, V79A, P1663, DOI 10.2106/00004623-199711000-00008; Cairns RA, 2004, CLIN EXP METASTAS, V21, P275, DOI 10.1023/B:CLIN.0000037729.75981.9e; CANON JR, 2007, CLIN EXP METASTASIS; Choy G, 2003, BIOTECHNIQUES, V35, P1022, DOI 10.2144/03355rr02; Cook SH, 2003, J VIROL, V77, P5333, DOI 10.1128/JVI.77.9.5333-5338.2003; DAVIS AM, 1994, J CLIN ONCOL, V12, P423, DOI 10.1200/JCO.1994.12.2.423; Deroose CM, 2007, J NUCL MED, V48, P295; DORFMAN HD, 1995, CANCER, V75, P203, DOI 10.1002/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Gomes CMF, 2007, EUR J NUCL MED MOL I, V34, P1793, DOI 10.1007/s00259-007-0480-8; GOORIN AM, 1991, J CLIN ONCOL, V9, P600, DOI 10.1200/JCO.1991.9.4.600; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Jia SF, 1999, CLIN EXP METASTAS, V17, P501, DOI 10.1023/A:1006623001465; Kadurugamuwa JL, 2004, ANTIMICROB AGENTS CH, V48, P2283, DOI 10.1128/AAC.48.6.2283-2287.2004; Khanna C, 2001, CANCER RES, V61, P3750; Kruger JS, 2003, MOL CANCER RES, V1, P801; Lee MS, 2005, MOL CELL BIOL, V25, P6921, DOI 10.1128/MCB.25.16.6921-6936.2005; Link M P, 1993, Cancer Treat Res, V62, P383; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Mankin HJ, 2004, CLIN ORTHOP RELAT R, P286, DOI 10.1097/01.blo.0000145991.65770.e6; McClatchey AI, 1999, ONCOGENE, V18, P5334, DOI 10.1038/sj.onc.1203086; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Patane S, 2006, CANCER RES, V66, P4750, DOI 10.1158/0008-5472.CAN-05-4422; SCHMIDT J, 1988, DIFFERENTIATION, V39, P151, DOI 10.1111/j.1432-0436.1988.tb00090.x; Tsuchiya H, 2002, J CLIN ONCOL, V20, P3470, DOI 10.1200/JCO.2002.11.028; WARD WG, 1994, J CLIN ONCOL, V12, P1849, DOI 10.1200/JCO.1994.12.9.1849; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005; Zhang WS, 2003, DRUG METAB DISPOS, V31, P1054, DOI 10.1124/dmd.31.8.1054	34	35	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1828	10.1371/journal.pone.0001828	http://dx.doi.org/10.1371/journal.pone.0001828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350164	gold, Green Published, Green Submitted			2022-12-25	WOS:000260762300030
J	Ji, F; Liu, ZJ; Cao, JP; Li, N; Liu, ZJ; Zuo, JX; Chen, Y; Wang, XZ; Sun, J				Ji, Fang; Liu, Zhanjie; Cao, Jianping; Li, Na; Liu, Zhijian; Zuo, Jinxin; Chen, Yan; Wang, Xinzhi; Sun, Jian			B Cell Response Is Required for Granuloma Formation in the Early Infection of Schistosoma japonicum	PLOS ONE			English	Article								Schistosoma egg-induced liver granuloma is a dynamic inflammatory reaction that results from complex immune responses to the infection. However, the role of B cells in inflammatory granuloma development is not yet fully understood. We report here that B cell function is required for S. japonicum egg-induced granuloma pathology in early infection. Both OBF-1 knockout mice and mu MT mice develop severely reduced hepatic granulomas at five weeks post-infection compared to their wild-type counterparts. In contrast, they display no significant difference in granuloma pathology at eight weeks postinfection. Moreover, we find that B cells and antibodies accumulate in the granulomas of wild-type mice early in the infection, indicating a contribution of the B cell response to the granulomatous inflammation. Furthermore, defects in B cell function markedly reduce liver egg burden. These results suggest an important role for B cells in early granuloma pathology. Surprisingly, we found that the S. japonicum infection destroys the structure of the lymphoid follicles. This disruptive effect is correlated with a severely impaired T cell-dependent antibody response upon challenge with ovalbumin. Thus, these findings reveal a novel aspect of the interaction between Schistosoma and the host immune system.	[Ji, Fang; Li, Na; Chen, Yan; Sun, Jian] Shanghai Jiao Tong Univ, Inst Med Sci, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Liu, Zhanjie; Liu, Zhijian; Zuo, Jinxin; Wang, Xinzhi; Sun, Jian] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Shanghai Inst Biol Sci, Hlth Sci Inst, Shanghai, Peoples R China; [Cao, Jianping] Natl Inst Parasitic Dis, Chinese Ctr Dis Control & Prevent, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Center for Disease Control & Prevention	Sun, J (corresponding author), Shanghai Jiao Tong Univ, Inst Med Sci, Sch Med, Shanghai Inst Immunol, Shanghai 200030, Peoples R China.	jsun@sibs.ac.cn	Cao, Jianping/AFL-5468-2022	Cao, Jianping/0000-0002-1974-0047	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX1-YW-R-45]; Shanghai Science and Technology Committee [074319112]; Shanghai Leading Academic Discipline Project [T0206]	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was partly supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-R-45), Shanghai Science and Technology Committee (074319112), and the Shanghai Leading Academic Discipline Project (T0206).	Bishop GA, 2003, CRIT REV IMMUNOL, V23, P149, DOI 10.1615/CritRevImmunol.v23.i3.10; BOROS DL, 1970, J EXP MED, V132, P488, DOI 10.1084/jem.132.3.488; Davies SJ, 2001, SCIENCE, V294, P1358, DOI 10.1126/science.1064462; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; EPSTEIN MM, 1995, J EXP MED, V182, P915, DOI 10.1084/jem.182.4.915; Fehr T, 2000, INT IMMUNOL, V12, P1275, DOI 10.1093/intimm/12.9.1275; Ferru I, 1998, SCAND J IMMUNOL, V48, P233; Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111; GARB KS, 1981, J IMMUNOL, V127, P115; Hernandez HJ, 1997, J IMMUNOL, V158, P4832; Hoffmann KF, 2000, J IMMUNOL, V164, P6406, DOI 10.4049/jimmunol.164.12.6406; Jankovic D, 1999, J IMMUNOL, V163, P337; Jankovic D, 1998, J EXP MED, V187, P619, DOI 10.1084/jem.187.4.619; Jenkins SJ, 2005, PARASITE IMMUNOL, V27, P385, DOI 10.1111/j.1365-3024.2005.00789.x; Ju ZL, 2007, IMMUNOLOGY, V120, P281, DOI 10.1111/j.1365-2567.2006.02500.x; Kamel OW, 1999, AM J PATHOL, V155, P681, DOI 10.1016/S0002-9440(10)65165-6; Kaplan MH, 1998, J IMMUNOL, V160, P1850; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; King CL, 2001, PARASITE IMMUNOL, V23, P607, DOI 10.1046/j.1365-3024.2001.00420.x; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; Novobrantseva TI, 2005, J CLIN INVEST, V115, P3072, DOI 10.1172/JCI24798; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Peng SL, 2006, CELL MOL IMMUNOL, V3, P87; PULENDRAN B, 1995, NATURE, V375, P331, DOI 10.1038/375331a0; Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Stadecker MJ, 2004, IMMUNOL REV, V201, P168, DOI 10.1111/j.0105-2896.2004.00197.x; Stavitsky AB, 2004, INFECT IMMUN, V72, P1, DOI 10.1128/IAI.72.1.1-12.2004; Sun J, 2003, J IMMUNOL, V170, P1699, DOI 10.4049/jimmunol.170.4.1699; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Wolniak KL, 2004, CRIT REV IMMUNOL, V24, P39, DOI 10.1615/CritRevImmunol.v24.20; Zuo JX, 2007, J AUTOIMMUN, V29, P87, DOI 10.1016/j.jaut.2007.05.001	39	20	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1724	10.1371/journal.pone.0001724	http://dx.doi.org/10.1371/journal.pone.0001724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320044	Green Published, gold, Green Submitted			2022-12-25	WOS:000260586600020
J	Pang, T; Zhang, ZS; Gu, M; Qiu, BY; Yu, LF; Cao, PR; Shao, W; Su, MB; Li, JY; Nan, FJ; Li, J				Pang, Tao; Zhang, Zhen-Shan; Gu, Min; Qiu, Bei-Ying; Yu, Li-Fang; Cao, Peng-Rong; Shao, Wei; Su, Ming-Bo; Li, Jing-Ya; Nan, Fa-Jun; Li, Jia			Small molecule antagonizes autoinhibition and activates AMP-activated protein kinase in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; GAMMA-SUBUNIT ISOFORMS; METABOLIC SYNDROME; CATALYTIC SUBUNIT; UPSTREAM KINASE; GLUCOSE-UPTAKE; RAT-LIVER; METFORMIN; MECHANISM; CASCADE	AMP-activated protein kinase (AMPK) serves as an energy sensor and is considered a promising drug target for treatment of type II diabetes and obesity. A previous report has shown that mammalian AMPK alpha 1 catalytic subunit including autoinhibitory domain was inactive. To test the hypothesis that small molecules can activate AMPK through antagonizing the autoinhibition in alpha subunits, we screened a chemical library with inactive human alpha 1(394) (alpha 1, residues 1-394) and found a novel small-molecule activator, PT1, which dose-dependently activated AMPK alpha 1(394), alpha 1(335), alpha 2(398), and even heterotrimer alpha 1 beta 1 gamma 1. Based on PT1-docked AMPK alpha 1 subunit structure model and different mutations, we found PT1 might interact with Glu-96 and Lys-156 residues near the autoinhibitory domain and directly relieve autoinhibition. Further studies using L6 myotubes showed that the phosphorylation of AMPK and its downstream substrate, acetyl-CoA carboxylase, were dose-dependently and time-dependently increased by PT1 without an increase in cellular AMP: ATP ratio. Moreover, in HeLa cells deficient in LKB1, PT1 enhanced AMPK phosphorylation, which can be inhibited by the calcium/calmodulin-dependent protein kinase kinases inhibitor STO-609 and AMPK inhibitor compound C. PT1 also lowered hepatic lipid content in a dose-dependent manner through AMPK activation in HepG2 cells, and this effect was diminished by compound C. Taken together, these data indicate that this small-molecule activator may directly activate AMPK via antagonizing the autoinhibition in vitro and in cells. This compound highlights the effort to discover novel AMPK activators and can be a useful tool for elucidating the mechanism responsible for conformational change and autoinhibitory regulation of AMPK.	[Pang, Tao; Gu, Min; Qiu, Bei-Ying; Yu, Li-Fang; Cao, Peng-Rong; Shao, Wei; Su, Ming-Bo; Li, Jing-Ya; Nan, Fa-Jun; Li, Jia] Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China; [Zhang, Zhen-Shan] Roche R&D Ctr China Ltd, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Roche Holding	Nan, FJ (corresponding author), Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	fjnan@mail.shcnc.ac.cn; jli@mail.shcnc.ac.cn	Li, Jia/F-9116-2011; Zhang, zs/GXN-3521-2022; li, jia/GVT-7587-2022					BOHM HJ, 1994, J COMPUT AID MOL DES, V8, P243, DOI 10.1007/BF00126743; Carling D, 2004, CURR BIOL, V14, pR220, DOI 10.1016/j.cub.2004.02.048; Cheng Z, 2006, BBA-GEN SUBJECTS, V1760, P1682, DOI 10.1016/j.bbagen.2006.09.007; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dokladda K, 2005, FEBS LETT, V579, P236, DOI 10.1016/j.febslet.2004.11.084; Edelsbrunner H., 1995, Proceedings of the Twenty-Eighth Hawaii International Conference on System Sciences, P256, DOI 10.1109/HICSS.1995.375331; FECHTELER T, 1995, J MOL BIOL, V253, P114, DOI 10.1006/jmbi.1995.0540; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gao G, 1996, J BIOL CHEM, V271, P8675, DOI 10.1074/jbc.271.15.8675; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Hamilton SR, 2002, BIOCHEM BIOPH RES CO, V293, P892, DOI 10.1016/S0006-291X(02)00312-1; Haque MS, 1999, DIABETES, V48, P1706, DOI 10.2337/diabetes.48.9.1706; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kosaka T, 2005, ANAL CHEM, V77, P2050, DOI 10.1021/ac0484631; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Rafaeloff-Phail R, 2004, J BIOL CHEM, V279, P52934, DOI 10.1074/jbc.M409574200; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Villena JA, 2004, DIABETES, V53, P2242, DOI 10.2337/diabetes.53.9.2242; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	56	132	150	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					16051	16060		10.1074/jbc.M710114200	http://dx.doi.org/10.1074/jbc.M710114200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18321858	Green Published, hybrid			2022-12-25	WOS:000256332500063
J	Bentinger, M; Tekle, M; Brismar, K; Chojnacki, T; Swiezewska, E; Dallner, G				Bentinger, Magnus; Tekle, Michael; Brismar, Kerstin; Chojnacki, Tadeusz; Swiezewska, Ewa; Dallner, Gustav			Polyisoprenoid epoxides stimulate the biosynthesis of coenzyme Q and inhibit cholesterol synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-CHAIN DYSFUNCTION; RAT-LIVER; 2,3-OXIDOSQUALENE CYCLASE; DOLICHYL-PHOSPHATE; METABOLISM; UBIQUINONE; Q(10); TISSUES; EPOXYUBIQUINONES; TOCOTRIENOLS	In our search for compounds that up-regulate the biosynthesis of coenzyme Q (CoQ), we discovered that irradiation of CoQ with ultraviolet light results in the formation of a number of compounds that influence the synthesis of mevalonate pathway lipids by HepG2 cells. Among the compounds that potently stimulated CoQ synthesis while inhibiting cholesterol synthesis, derivatives of CoQ containing 1-4 epoxide moieties in their polyisoprenoid side chains were identified. Subsequently, chemical epoxidation of all-trans-polyprenols of different lengths revealed that the shorter farnesol and geranylgeraniol derivatives were without effect, whereas the longer derivatives of solanesol enhanced CoQ and markedly reduced cholesterol biosynthesis. In contrast, none of the modified trans-trans-poly-cis-polyprenols exerted noticeable effects. Tocotrienol epoxides were especially potent in our system; those with one epoxide moiety in the side-chain generally up-regulated CoQ biosynthesis by 200-300%, whereas those with two such moieties also decreased cholesterol synthesis by 50-90%. Prolonged treatment of HepG2 cells with tocotrienol epoxides for 26 days elevated their content of CoQ by 30%. In addition, the levels of mRNA encoding enzymes involved in CoQ biosynthesis were also elevated by the tocotrienol epoxides. The site of inhibition of cholesterol synthesis was shown to be oxidosqualene cyclase. In conclusion, epoxide derivatives of certain all-trans-polyisoprenoids cause pronounced stimulation of CoQ synthesis and, in some cases, simultaneous reduction of cholesterol biosynthesis by HepG2 cells.	[Bentinger, Magnus; Tekle, Michael; Dallner, Gustav] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Bentinger, Magnus; Brismar, Kerstin; Dallner, Gustav] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Swiezewska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Stockholm University; Karolinska Institutet; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Dallner, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.	gustav.dallner@dbb.su.se		Swiezewska, Ewa/0000-0002-3439-8948; Brismar, Kerstin/0000-0002-5241-514X				ABERG F, 1994, CHEM-BIOL INTERACT, V91, P1, DOI 10.1016/0009-2797(94)90002-7; AITHAL HN, 1968, BIOCHIM BIOPHYS ACTA, V162, P66, DOI 10.1016/0005-2728(68)90214-4; Bentinger M, 2003, FREE RADICAL BIO MED, V34, P563, DOI 10.1016/S0891-5849(02)01357-6; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; CATTEL L, 1995, LIPIDS, V30, P235, DOI 10.1007/BF02537827; CHOJNACKI T, 1984, ACTA BIOCHIM POL, V31, P115; Doring F, 2007, IUBMB LIFE, V59, P628, DOI 10.1080/15216540701545991; Downs SM, 2001, BIOL REPROD, V64, P80, DOI 10.1095/biolreprod64.1.80; Duitsman PK, 1999, INT J VITAM NUTR RES, V69, P303, DOI 10.1024/0300-9831.69.5.303; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; EKSTROM TJ, 1984, J BIOL CHEM, V259, P460; ERICSSON J, 1992, J BIOL CHEM, V267, P19730; ERICSSON J, 1993, J BIOL CHEM, V268, P832; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; FAUST JR, 1980, J BIOL CHEM, V255, P6546; ForsmarkAndree P, 1997, FREE RADICAL BIO MED, V22, P391, DOI 10.1016/S0891-5849(96)00330-9; FRIIS P, 1967, BIOCHEMISTRY-US, V6, P3618, DOI 10.1021/bi00863a037; Groneberg DA, 2005, INT J BIOCHEM CELL B, V37, P1208, DOI 10.1016/j.biocel.2004.11.017; Huff MW, 2005, TRENDS PHARMACOL SCI, V26, P335, DOI 10.1016/j.tips.2005.05.004; IKEDA S, 1984, HORM METAB RES, V16, P585, DOI 10.1055/s-2007-1014857; KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072; KELLER RK, 1986, J BIOL CHEM, V261, P2053; Keller RK, 1996, BBA-LIPID LIPID MET, V1303, P169, DOI 10.1016/0005-2760(96)00081-1; Liao JK, 2005, CURR OPIN LIPIDOL, V16, P624, DOI 10.1097/01.mol.0000191913.16321.60; Littarru G. P., 1996, HDB ANTIOXIDANTS, P203; Littarru GP, 2007, MITOCHONDRION, V7, pS168, DOI 10.1016/j.mito.2007.03.002; MANKOWSKI T, 1976, BIOCHEMISTRY-US, V15, P2125, DOI 10.1021/bi00655a015; Mark M, 1996, J LIPID RES, V37, P148; Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892; Morand OH, 1997, J LIPID RES, V38, P373; MORIMOTO H, 1969, LIEBIGS ANN CHEM, V729, P158, DOI 10.1002/jlac.19697290120; Morimoto H, 1970, Justus Liebigs Ann Chem, V735, P65, DOI 10.1002/jlac.19707350111; Nakamura T, 1999, BIOFACTORS, V9, P111, DOI 10.1002/biof.5520090205; Podda M, 1998, FREE RADICAL BIO MED, V24, P55, DOI 10.1016/S0891-5849(97)00142-1; POPJAK G, 1962, J BIOL CHEM, V237, P56; Rotig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9; Rustin P, 2004, METHOD ENZYMOL, V382, P81; Sen CK, 2007, MOL ASPECTS MED, V28, P692, DOI 10.1016/j.mam.2007.03.001; SEN SE, 1995, SYNTHESIS-STUTTGART, P756; Song BL, 2006, J BIOL CHEM, V281, P25054, DOI 10.1074/jbc.M605575200; SOTTOCAS.GL, 1965, BIOCHEMISTRY-US, V4, P305, DOI 10.1021/bi00878a019; Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002; THELIN A, 1994, BBA-LIPID LIPID MET, V1215, P245, DOI 10.1016/0005-2760(94)90049-3; THELIN A, 1992, FEBS LETT, V313, P118, DOI 10.1016/0014-5793(92)81425-L; TRZASKOS JM, 1986, J BIOL CHEM, V261, P6937; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Turunen M, 2000, J MOL BIOL, V297, P607, DOI 10.1006/jmbi.2000.3596; YOSHIDA H, 1992, J LIPID RES, V33, P343	48	28	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14645	14653		10.1074/jbc.M710202200	http://dx.doi.org/10.1074/jbc.M710202200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18353784	hybrid			2022-12-25	WOS:000255941400053
J	Karch, CM; Borchelt, DR				Karch, Celeste M.; Borchelt, David R.			A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC SUPEROXIDE-DISMUTASE; MOLECULAR-WEIGHT COMPLEXES; MOTOR-NEURON DEGENERATION; COPPER-BINDING-SITE; TRANSGENIC MICE; CU,ZN-SUPEROXIDE DISMUTASE; ATOMIC STRUCTURES; ALS; SUPEROXIDE-DISMUTASE-1; MUTATIONS	One of the mechanisms by which mutations in superoxide dismutase 1 (SOD1) cause familial amyotrophic lateral sclerosis (fALS) is proposed to involve the accumulation of detergent-insoluble, disulfide-cross-linked, mutant protein. Recent studies have implicated cysteine residues at positions 6 and 111 as critical in mediating disulfide cross-linking and promoting aggregation. In the present study, we used a panel of experimental and disease-linked mutations at cysteine residues of SOD1 (positions 6, 57, 111, and 146) in cell culture assays for aggregation to demonstrate that extensive disulfide cross-linking is not required for the formation of mutant SOD1 aggregates. Experimental mutants possessing only a single cysteine residue or lacking cysteine entirely were found to retain high potential to aggregate. Furthermore we demonstrate that aggregate structures in symptomatic SOD1-G93A mice can be dissociated such that they no longer sediment upon ultracentrifugation (i.e. appear soluble) under relatively mild conditions that leave disulfide bonds intact. Similar to other recent work, we found that cysteines 6 and 111, particularly the latter, play interesting roles in modulating the aggregation of human SOD1. However, we did not find that extensive disulfide cross-linking via these residues, or any other cysteine, is critical to aggregate structure. Instead we suggest that these residues participate in other features of the protein that, in some manner, modulate aggregation.	[Karch, Celeste M.; Borchelt, David R.] Univ Florida, SantaFe HealthCare Alzheimers Dis Res Ctr, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, SantaFe HealthCare Alzheimers Dis Res Ctr, McKnight Brain Inst, Dept Neurosci, 100 Newell Dr,Rm L1-100,POB 100244, Gainesville, FL 32611 USA.	borchelt@mbi.ufl.edu		Karch, Celeste/0000-0002-6854-5547	NINDS NIH HHS [P01 NS049134] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Guo JT, 2004, PROTEINS, V57, P357, DOI 10.1002/prot.20222; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; KELLER GA, 1991, P NATL ACAD SCI USA, V88, P7381, DOI 10.1073/pnas.88.16.7381; Krishnan U, 2006, MOL CELL BIOCHEM, V287, P201, DOI 10.1007/s11010-005-9112-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lyons TJ, 1999, MET IONS BIOL SYST, V36, P125; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morimoto A, 2002, BIOCHEM BIOPH RES CO, V295, P306, DOI 10.1016/S0006-291X(02)00670-8; Murphy RM, 2002, ANNU REV BIOMED ENG, V4, P155, DOI 10.1146/annurev.bioeng.4.092801.094202; NISHIDA CR, 1994, P NATL ACAD SCI USA, V91, P9906, DOI 10.1073/pnas.91.21.9906; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Ogawa Y, 1997, BIOCHEM BIOPH RES CO, V241, P251, DOI 10.1006/bbrc.1997.7804; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Potter SZ, 2003, J BIOL INORG CHEM, V8, P373, DOI 10.1007/s00775-003-0447-6; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schinina ME, 1996, EUR J BIOCHEM, V237, P433, DOI 10.1111/j.1432-1033.1996.0433k.x; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Stromer T, 2005, MICROSC RES TECHNIQ, V67, P210, DOI 10.1002/jemt.20190; Thakur AK, 2002, P NATL ACAD SCI USA, V99, P17014, DOI 10.1073/pnas.252523899; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Watanabe S, 2007, FREE RADICAL BIO MED, V42, P1534, DOI 10.1016/j.freeradbiomed.2007.02.004; Watanabe Y, 2005, MOL BRAIN RES, V135, P12, DOI 10.1016/j.molbrainres.2004.11.019; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7	48	84	86	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13528	13537		10.1074/jbc.M800564200	http://dx.doi.org/10.1074/jbc.M800564200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18316367	hybrid, Green Published			2022-12-25	WOS:000255728200006
J	Sakasai, R; Tibbetts, R				Sakasai, Ryo; Tibbetts, Randal			RNF8-dependent and RNF8-independent regulation of 53BP1 in response to DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME INHIBITOR PS-341; REPLICATION PROTEIN-A; CELL-CYCLE REGULATION; HISTONE H2AX; INDUCED PHOSPHORYLATION; ATR; REPAIR; MDC1; UBIQUITIN; MEDIATOR	The DNA damage surveillance network orchestrates cellular responses to DNA damage through the recruitment of DNA damage-signaling molecules to DNA damage sites and the concomitant activation of protein phosphorylation cascades controlled by the ATM (ataxia-telangiectasia-mutated) and ATR (ATM-Rad3-related) kinases. Activation of ATM/ATR triggers cell cycle checkpoint activation and adaptive responses to DNA damage. Recent studies suggest that protein ubiquitylation or degradation plays an important role in the DNA damage response. In this study, we examined the potential role of the proteasome in checkpoint activation and ATM/ATR signaling in response to UV light-induced DNA damage. HeLa cells treated with the proteasome inhibitor MG-132 showed delayed phosphorylation of ATM substrates in response to UV light. UV light-induced phosphorylation of 53BP1, as well as its recruitment to DNA damage foci, was strongly suppressed by proteasome inhibition, whereas the recruitment of upstream regulators of 53BP1, including MDC1 and H2AX, was unaffected. The ubiquitin-protein isopeptide ligase RNF8 was critical for 53BP1 focus targeting and phosphorylation in ionizing radiation-damaged cells, whereas UV light-induced 53BP1 phosphorylation and targeting exhibited partial dependence on RNF8 and the ubiquitin-conjugating enzyme UBC13. Suppression of RNF8 or UBC13 also led to subtle defects in UV light-induced G2/M checkpoint activation. These findings are consistent with a model in which RNF8 ubiquitylation pathways are essential for 53BP1 regulation in response to ionizing radiation, whereas RNF8-independent pathways contribute to 53BP1 targeting and phosphorylation in response to UV light and potentially other forms of DNA replication stress.	[Sakasai, Ryo; Tibbetts, Randal] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Tibbetts, R (corresponding author), Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297; Sakasai, Ryo/0000-0002-4495-5437				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Berlanga O, 2000, BLOOD, V96, P2740; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Block WD, 2004, NUCLEIC ACIDS RES, V32, P997, DOI 10.1093/nar/gkh265; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Dodson GE, 2006, J BIOL CHEM, V281, P1692, DOI 10.1074/jbc.M509577200; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hideshima T, 2001, CANCER RES, V61, P3071; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jowsey P, 2007, DNA REPAIR, V6, P1536, DOI 10.1016/j.dnarep.2007.04.011; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Liu QH, 2000, GENE DEV, V14, P1448; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Maki CG, 1996, CANCER RES, V56, P2649; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; O'Connor Owen A, 2004, Curr Treat Options Oncol, V5, P269, DOI 10.1007/s11864-004-0018-2; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Pryde F, 2005, J CELL SCI, V118, P2043, DOI 10.1242/jcs.02336; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Sakasai R, 2006, GENES CELLS, V11, P237, DOI 10.1111/j.1365-2443.2006.00942.x; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Yoo E, 2005, ONCOGENE, V24, P5423, DOI 10.1038/sj.onc.1208710; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029	47	37	38	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13549	13555		10.1074/jbc.M710197200	http://dx.doi.org/10.1074/jbc.M710197200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18337245	hybrid			2022-12-25	WOS:000255728200008
J	Li, Y; Zhang, XW; Polakiewicz, RD; Yao, TP; Comb, MJ				Li, Yu; Zhang, Xiaowu; Polakiewicz, Roberto D.; Yao, Tso-Pang; Comb, Michael J.			HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; ACETYLATION; ACTIVATION; PATHWAY; CANCER; RECEPTOR; APC	Nuclear translocation of beta-catenin is a hallmark of Wnt signaling and is associated with various cancers. In addition to the canonical Wnt pathway activated by Wnt ligands, growth factors such as epidermal growth factor (EGF) also induce beta-catenin dissociation from the adherens junction complex, translocation into the nucleus, and activation of target genes such as c-myc. Here we report that EGF-induced beta-catenin nuclear localization and activation of c-myc are dependent on the deacetylase HDAC6. We show that EGF induces HDAC6 translocation to the caveolae membrane and association with beta-catenin. HDAC6 deacetylates beta-catenin at lysine 49, a site frequently mutated in anaplastic thyroid cancer, and inhibits beta-catenin phosphorylation at serine 45. HDAC6 inactivation blocks EGF-induced beta-catenin nuclear localization and decreases c-Myc expression, leading to inhibition of tumor cell proliferation. These results suggest that EGF-induced nuclear localization of beta-catenin is regulated by HDAC6-dependent deacetylation and provide a new mechanism by which HDAC inhibitors prevent tumor growth.	[Li, Yu; Zhang, Xiaowu; Polakiewicz, Roberto D.; Comb, Michael J.] Cell Signaling Technol, Danvers, MA 01923 USA; [Yao, Tso-Pang] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Comb, MJ (corresponding author), Cell Signaling Technol, 3 Trask La, Danvers, MA 01923 USA.	mcomb@cellsignal.com			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054022] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS054022, R01 NS054022-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; COHEN T, 2004, SCI STKE, pPE42; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; Garcia-Rostan G, 1999, CANCER RES, V59, P1811; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	22	134	143	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12686	12690		10.1074/jbc.C700185200	http://dx.doi.org/10.1074/jbc.C700185200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18356165	Green Published, hybrid			2022-12-25	WOS:000255499800003
J	Archer, CT; Delahodde, A; Gonzalez, F; Johnston, SA; Kodadek, T				Archer, Chase T.; Delahodde, Agnes; Gonzalez, Fernando; Johnston, Stephen Albert; Kodadek, Thomas			Activation domain-dependent monoubiquitylation of gal4 protein is essential for promoter binding in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; REGULATORY PARTICLE; 26S PROTEASOME; IDENTIFICATION; ASSOCIATION; ELONGATION; UBIQUITIN	The Saccharomyces cerevisiae Gal4 protein is a paradigmatic transcriptional activator containing a C-terminal acidic activation domain ( AD) of 34 amino acids. A mutation that results in the truncation of about two-thirds of the Gal4AD (gal4D) results in a crippled protein with only 3% the activity of the wild-type activator. Weshow here that although the Gal4D protein is not intrinsically deficient in DNA binding, it is nonetheless unable to stably occupy GAL promoters in vivo. This is because of the activity of the proteasomal ATPases, including Sug1/Rpt6, which bind to Gal4D via the remainder of the AD and strip it off of DNA. A mutation that suppressed the Gal4D "no growth on galactose" phenotype repressed the stripping activity of the ATPase complex but not other activities. We further demonstrate that Gal4D is hypersensitive to this stripping activity because of its failure to be monoubiquitylated efficiently in vivo and in vitro. Evidence is presented that the piece of the AD that is deleted in Gal4D protein is likely a recognition element for the E3 ubiquitin-protein ligase that modifies Gal4. These data argue that acidic ADs comprise at least two small peptide subdomains, one of which is responsible for activator monou-biquitylation and another that interacts with the proteasomal ATPases, coactivators and other transcription factors. This study validates the physiological importance of Gal4 monoubiquitylation and clarifies its major role as that of protecting the activator from being destabilized by the proteasomal ATPases.	[Archer, Chase T.; Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Div Translat Res, Dallas, TX 75390 USA; [Delahodde, Agnes; Gonzalez, Fernando; Johnston, Stephen Albert; Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kodadek, T (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Thomas.Kodadek@utsouthwestern.edu		Kodadek, Thomas/0000-0003-1930-4795	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071833] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 71833] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Archer CT, 2005, MOL BIOSYST, V1, P366, DOI 10.1039/b510019d; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BHAT KP, 2008, MOL IMMUNOL; Ding WV, 1997, MOL CELL BIOL, V17, P2538, DOI 10.1128/MCB.17.5.2538; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; JOHNSTON SA, 1987, CELL, V50, P143, DOI 10.1016/0092-8674(87)90671-4; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MATSUMOTO K, 1980, J BACTERIOL, V141, P508, DOI 10.1128/JB.141.2.508-527.1980; Russell SJ, 2001, J BIOL CHEM, V276, P9825, DOI 10.1074/jbc.M010889200; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; SALMERON JM, 1990, GENETICS, V125, P21; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x	28	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12614	12623		10.1074/jbc.M801050200	http://dx.doi.org/10.1074/jbc.M801050200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326036	Green Published, hybrid			2022-12-25	WOS:000255340000078
J	Furukawa, Y; Umemoto, E; Jang, MH; Tohya, K; Miyasaka, M; Hirata, T				Furukawa, Yuko; Umemoto, Eiji; Jang, Myoung Ho; Tohya, Kazuo; Miyasaka, Masayuki; Hirata, Takako			Identification of novel isoforms of mouse L-selectin with different carboxyl-terminal tails	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE HOMING RECEPTOR; CYTOPLASMIC DOMAIN; CELL-ADHESION; ENDOTHELIUM; PROTEINS; INFLAMMATION; MECHANISMS; MOLECULE; SEQUENCE; REVEALS	The leukocyte adhesion molecule L-selectin mediates the recruitment of lymphocytes to secondary lymphoid organs and is involved in the accumulation of neutrophils at sites of inflammation. In this study, we report the identification of novel isoforms of the mouse L-selectin gene, termed L-selectin-v1 and L-selectin-v2. Sequence analysis revealed that these isoforms are generated by alternative splicing: the L-selectin-v2 transcript includes a previously unknown exon of 100 bp located between the 7th and 8th exons of the mouse L-selectin gene, while the L-selectin-v1 transcript contains the first 49-bp sequence of this new exon. The insertion of each new sequence adds a downstream reading frame, giving rise to predicted proteins that differ in their carboxyl-terminal tails. These splice variants were found in cells that express conventional L-selectin, termed L-selectin-c, including B and T lymphocytes and granulocytes. Functionally, like L-selectin-c, both L-selectin-v1 and L-selectin-v2 expressed in cultured cells underwent phorbol ester-induced shedding, although L-selectin-v1 and L-selectin-v2 were shed to a greater and lesser degree, respectively, than L-selectin-c. Under flow conditions, both L-selectin-v1 and L-selectin-v2 mediated faster cell rolling than did L-selectin-c. In addition, ligation of L-selectin-c and L-selectin-v1, but not L-selectin-v2, induced p38 mitogen-activated protein kinase phosphorylation. These results suggest that alternative splicing is one mechanism for generating functional diversity in L-selectin.	[Furukawa, Yuko; Hirata, Takako] Osaka Univ, Microbial Dis Res Inst, 21st Century Ctr Excellence Program, Suita, Osaka 5650871, Japan; [Jang, Myoung Ho] Osaka Univ, Microbial Dis Res Inst, WPI Immunol Frontier Res Ctr, Lab Gastrointestinal Immunol, Suita, Osaka 5650871, Japan; [Furukawa, Yuko; Umemoto, Eiji; Miyasaka, Masayuki] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Immunodynam, Suita, Osaka 5650871, Japan; [Tohya, Kazuo] Kansai Univ Hlth Sci, Dept Anat, Osaka 5900482, Japan	Osaka University; Osaka University; Osaka University	Hirata, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, 21st Century Ctr Excellence Program, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	thirata@biken.osaka-u.ac.jp	Jang, Myoung Ho/D-1714-2009; Umemoto, Eiji/AAX-6562-2021; Miyasaka, Masayuki/AAM-6343-2020	Jang, Myoung Ho/0000-0001-8909-4725; Hirata, Takako/0000-0002-1740-6168				Atarashi K, 2005, J IMMUNOL, V174, P1424, DOI 10.4049/jimmunol.174.3.1424; BILLUPS KL, 1995, J LAB CLIN MED, V126, P580; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Crockett-Torabi E, 1998, J LEUKOCYTE BIOL, V63, P1; CYBULSKY MI, 1991, AM J PATHOL, V138, P815; Dwir O, 2001, J CELL BIOL, V155, P145, DOI 10.1083/jcb.200103042; Evans SS, 1999, J IMMUNOL, V162, P3615; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Hafezi-Moghadam A, 2001, J EXP MED, V193, P863, DOI 10.1084/jem.193.7.863; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Ivetic A, 2004, BIOCHEM SOC T, V32, P1118, DOI 10.1042/BST0321118; Ivetic A, 2004, J BIOL CHEM, V279, P33263, DOI 10.1074/jbc.M312212200; JOHNSTON GI, 1990, J BIOL CHEM, V265, P21381; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; KANSAS GS, 1993, J EXP MED, V177, P833, DOI 10.1084/jem.177.3.833; KING PD, 1995, J IMMUNOL, V154, P6080; KIRSCHBAUM NE, 1994, BLOOD, V84, P4028, DOI 10.1182/blood.V84.12.4028.bloodjournal84124028; Kumar A, 1999, CIRCULATION, V99, P1363, DOI 10.1161/01.CIR.99.10.1363; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Matala E, 2001, J IMMUNOL, V167, P1617, DOI 10.4049/jimmunol.167.3.1617; Nandi A, 2000, J BIOL CHEM, V275, P14939, DOI 10.1074/jbc.275.20.14939; PAVALKO FM, 1995, J CELL BIOL, V129, P1155, DOI 10.1083/jcb.129.4.1155; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Smolen JE, 2000, J BIOL CHEM, V275, P15876, DOI 10.1074/jbc.M906232199; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3	34	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12112	12119		10.1074/jbc.M801745200	http://dx.doi.org/10.1074/jbc.M801745200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18332130	hybrid			2022-12-25	WOS:000255340000027
J	Seong, C; Sehorn, MG; Plate, I; Shi, I; Song, B; Chi, P; Mortensen, U; Sung, P; Krejci, L				Seong, Changhyun; Sehorn, Michael G.; Plate, Iben; Shi, Idina; Song, Binwei; Chi, Peter; Mortensen, Uffe; Sung, Patrick; Krejci, Lumir			Molecular anatomy of the recombination mediator function of Saccharomyces cerevisiae Rad52	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; DNA STRAND EXCHANGE; HOMOLOGOUS RECOMBINATION; YEAST RAD51; RAD51-INDEPENDENT RECOMBINATION; BINDING-PROTEIN; REPAIR; BRCA2; COMPLEX; RPA	A helical filament of Rad51 on single-strand DNA (ssDNA), called the presynaptic filament, catalyzes DNA joint formation during homologous recombination. Rad52 facilitates presynaptic filament assembly, and this recombination mediator activity is thought to rely on the interactions of Rad52 with Rad51, the ssDNA-binding protein RPA, and ssDNA. The N-terminal region of Rad52, which has DNA binding activity and an oligomeric structure, is thought to be crucial for mediator activity and recombination. Unexpectedly, we find that the C-terminal region of Rad52 also harbors a DNA binding function. Importantly, the Rad52 C-terminal portion alone can promote Rad51 presynaptic filament assembly. The middle portion of Rad52 associates with DNA-bound RPA and contributes to the recombination mediator activity. Accordingly, expression of a protein species that harbors the middle and C-terminal regions of Rad52 in the rad52 Delta 327 background enhances the association of Rad51 protein with a HO-made DNA double-strand break and partially complements the methyl-methane sulfonate sensitivity of the mutant cells. Our results provide a mechanistic framework for rationalizing the multi-faceted role of Rad52 in recombination and DNA repair.	[Krejci, Lumir] Masaryk Univ, Natl Ctr Biomol Res, Brno 62500, Czech Republic; [Seong, Changhyun; Sehorn, Michael G.; Shi, Idina; Chi, Peter; Sung, Patrick; Krejci, Lumir] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Plate, Iben; Mortensen, Uffe] Tech Univ Denmark, Ctr Microbial Biotechnol, Bioctr, DK-2800 Lyngby, Denmark; [Song, Binwei] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA; [Song, Binwei] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78245 USA	Masaryk University Brno; Yale University; Technical University of Denmark; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Krejci, L (corresponding author), Masaryk Univ, Natl Ctr Biomol Res, Kamenice 5-A4, Brno 62500, Czech Republic.	lkrejci@chemi.muni.cz	Chi, Peter/AAI-1580-2019; Mortensen, Uffe/AAQ-1150-2021; Classen, Scott/AAY-8176-2020; Huang, Wenchi/F-3981-2010; Krejci, Lumir/B-7842-2009	Chi, Peter/0000-0001-9229-8729; Huang, Wenchi/0000-0001-5556-1460; Krejci, Lumir/0000-0002-4732-1405	NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057814] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA92584] Funding Source: Medline; NIEHS NIH HHS [R01ES07061] Funding Source: Medline; NIGMS NIH HHS [R01GM57814] Funding Source: Medline; Wellcome Trust [GR076476] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Asleson EN, 1999, GENETICS, V153, P681; Bianco P R, 1998, Front Biosci, V3, pD570; BOUNDYMILLS KL, 1993, GENETICS, V133, P39; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Cortes-Ledesma F, 2004, GENETICS, V168, P553, DOI 10.1534/genetics.104.030551; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; D'Andrea AD, 2003, GENE DEV, V17, P1933, DOI 10.1101/gad.1128303; Davis AP, 2003, DNA REPAIR, V2, P1127, DOI 10.1016/S1568-7864(03)00121-6; de Mayolo AA, 2006, NUCLEIC ACIDS RES, V34, P2587, DOI 10.1093/nar/gkl280; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Fortin GS, 2002, EMBO J, V21, P3160, DOI 10.1093/emboj/cdf293; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lettier G, 2006, PLOS GENET, V2, P1773, DOI 10.1371/journal.pgen.0020194; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Moynahan ME, 2001, CANCER RES, V61, P4842; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Petukhova G, 1999, J BIOL CHEM, V274, P33839, DOI 10.1074/jbc.274.48.33839; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Stasiak AZ, 2000, CURR BIOL, V10, P337, DOI 10.1016/S0960-9822(00)00385-7; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tsukamoto M, 2003, GENETICS, V165, P1703; Van Komen S, 2002, J BIOL CHEM, V277, P43578, DOI 10.1074/jbc.M205864200; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Wong JMS, 2003, ONCOGENE, V22, P28, DOI 10.1038/sj.onc.1206071; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234	58	41	42	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12166	12174		10.1074/jbc.M800763200	http://dx.doi.org/10.1074/jbc.M800763200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18310075	hybrid, Green Published			2022-12-25	WOS:000255340000033
J	Gill, MB; Edgar, R; May, JS; Stevenson, PG				Gill, Michael B.; Edgar, Rachel; May, Janet S.; Stevenson, Philip G.			A Gamma-Herpesvirus Glycoprotein Complex Manipulates Actin to Promote Viral Spread	PLOS ONE			English	Article								Viruses lack self-propulsion. To move in multi-cellular hosts they must therefore manipulate infected cells. Herpesviruses provide an archetype for many aspects of host manipulation, but only for alpha-herpesviruses in is there much information about they move. Other herpesviruses are not necessarily the same. Here we show that Murine gamma-herpesvirus-68 (MHV-68) induces the outgrowth of long, branched plasma membrane fronds to create an intercellular network for virion traffic. The fronds were actin-based and RhoA-dependent. Time-lapse imaging showed that the infected cell surface became highly motile and that virions moved on the fronds. This plasma membrane remodelling was driven by the cytoplasmic tail of gp48, a MHV-68 glycoprotein previously implicated in intercellular viral spread. The MHV-68 ORF58 was also required, but its role was simply transporting gp48 to the plasma membrane, since a gp48 mutant exported without ORF58 did not require ORF58 to form membrane fronds either. Together, gp48/ORF58 were sufficient to induce fronds in transfected cells, as were the homologous BDLF2/BMRF2 of Epstein-Barr virus. Gp48/ORF58 therefore represents a conserved module by which gamma-herpesviruses rearrange cellular actin to increase intercellular contacts and thereby promote their spread.	[Gill, Michael B.; Edgar, Rachel; May, Janet S.; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	Gill, MB (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	pgs27@cam.ac.uk	Stevenson, Philip g/F-9688-2014; Stevenson, Philip/F-6651-2011	Stevenson, Philip g/0000-0002-3520-5060; Edgar, Rachel/0000-0002-3348-0851	Medical Research Council [G0400427, G9800903]; CR-UK [C19612/A6189]; Wellcome Trust Senior Clinical Fellow [GR076956MA]; MRC [G0400427, G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CR-UK(Cancer Research UK); Wellcome Trust Senior Clinical Fellow(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council grants G0400427 and G9800903, and by CR-UK grant C19612/A6189. PGS is a Wellcome Trust Senior Clinical Fellow (GR076956MA).	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Boname JM, 2005, EUR J IMMUNOL, V35, P171, DOI 10.1002/eji.200425459; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; DINGWELL KS, 1994, J VIROL, V68, P834, DOI 10.1128/JVI.68.2.834-845.1994; Favoreel HW, 2007, TRENDS MICROBIOL, V15, P426, DOI 10.1016/j.tim.2007.08.003; Favoreel HW, 2005, P NATL ACAD SCI USA, V102, P8990, DOI 10.1073/pnas.0409099102; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000705; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; May JS, 2005, TRAFFIC, V6, P780, DOI 10.1111/j.1600-0854.2005.00316.x; May JS, 2005, J VIROL, V79, P5059, DOI 10.1128/JVI.79.8.5059-5068.2005; May JS, 2005, J VIROL, V79, P3459, DOI 10.1128/JVI.79.6.3459-3467.2005; Mettenleiter TC, 2004, VIRUS RES, V106, P167, DOI 10.1016/j.virusres.2004.08.013; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Newsome TP, 2004, SCIENCE, V306, P124, DOI 10.1126/science.1101509; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Smith CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001048; Smith GL, 2003, ANNU REV MICROBIOL, V57, P323, DOI 10.1146/annurev.micro.57.030502.091037; Stevenson PG, 2005, VIRAL IMMUNOL, V18, P445, DOI 10.1089/vim.2005.18.445; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P2347, DOI 10.1099/0022-1317-73-9-2347; THORLEY L, 2001, NAT REV IMMUNOL, V1, P75; Tugizov SM, 2003, NAT MED, V9, P307, DOI 10.1038/nm830; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997	32	34	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1808	10.1371/journal.pone.0001808	http://dx.doi.org/10.1371/journal.pone.0001808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350146	Green Published, gold, Green Submitted			2022-12-25	WOS:000260762300012
J	degli Atti, MLC; Merler, S; Rizzo, C; Ajelli, M; Massari, M; Manfredi, P; Furlanello, C; Tomba, GS; Iannelli, M				degli Atti, Marta Luisa Ciofi; Merler, Stefano; Rizzo, Caterina; Ajelli, Marco; Massari, Marco; Manfredi, Piero; Furlanello, Cesare; Tomba, Gianpaolo Scalia; Iannelli, Mimmo			Mitigation Measures for Pandemic Influenza in Italy: An Individual Based Model Considering Different Scenarios	PLOS ONE			English	Article							SPREAD; STRATEGIES; TRAVEL	Background: Individual-based models can provide the most reliable estimates of the spread of infectious diseases. In the present study, we evaluated the diffusion of pandemic influenza in Italy and the impact of various control measures, coupling a global SEIR model for importation of cases with an individual based model (IBM) describing the Italian epidemic. Methodology/Principal Findings: We co-located the Italian population (57 million inhabitants) to households, schools and workplaces and we assigned travel destinations to match the 2001 census data. We considered different R-0 values (1.4; 1.7; 2), evaluating the impact of control measures (vaccination, antiviral prophylaxis -AVP-, international air travel restrictions and increased social distancing). The administration of two vaccine doses was considered, assuming that first dose would be administered 1-6 months after the first world case, and different values for vaccine effectiveness (VE). With no interventions, importation would occur 37-77 days after the first world case. Air travel restrictions would delay the importation of the pandemic by 7-37 days. With an R-0 of 1.4 or 1.7, the use of combined measures would reduce clinical attack rates (AR) from 21-31% to 0.3-4%. Assuming an R-0 of 2, the AR would decrease from 38% to 8%, yet only if vaccination were started within 2 months of the first world case, in combination with a 90% reduction in international air traffic, closure of schools/workplaces for 4 weeks and AVP of household and school/work close contacts of clinical cases. Varying VE would not substantially affect the results. Conclusions: This IBM, which is based on country-specific demographic data, could be suitable for the real-time evaluation of measures to be undertaken in the event of the emergence of a new pandemic influenza virus. All preventive measures considered should be implemented to mitigate the pandemic.	[degli Atti, Marta Luisa Ciofi; Rizzo, Caterina; Massari, Marco] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, I-00161 Rome, Italy; [Merler, Stefano; Ajelli, Marco; Furlanello, Cesare] Fondazione Bruno Kessler, Trento, Italy; [Rizzo, Caterina] Univ Bari, Dept Pharm Biol, Bari, Italy; [Ajelli, Marco] Univ Trento, Department of Informat Engn & Comp Sci, Trento, Italy; [Manfredi, Piero] Univ Pisa, Dept Stat & Math Appl Ec, Pisa, Italy; [Tomba, Gianpaolo Scalia] Univ Tor Vergata, Dept Math, Rome, Italy; [Iannelli, Mimmo] Univ Trento, Dept Math, Trento, Italy	Istituto Superiore di Sanita (ISS); Fondazione Bruno Kessler; Universita degli Studi di Bari Aldo Moro; University of Trento; University of Pisa; University of Rome Tor Vergata; University of Trento	degli Atti, MLC (corresponding author), Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, Viale Regina Elena 299, I-00161 Rome, Italy.	marta.ciofi@iss.it	merler, stefano/I-3557-2017; Rizzo, Caterina/H-4092-2012; Ajelli, Marco/AAX-1113-2020; degli Atti, Marta Ciofi/K-4650-2018	merler, stefano/0000-0002-5117-0611; Rizzo, Caterina/0000-0002-5583-7508; Ajelli, Marco/0000-0003-1753-4749; degli Atti, Marta Ciofi/0000-0001-6492-4497; Furlanello, Cesare/0000-0002-5384-3605; Iannelli, Mimmo/0000-0002-1637-2234	EPICO Project of the Provincia Autonoma di Trento, Italy	EPICO Project of the Provincia Autonoma di Trento, Italy	This work has been partially funded by the EPICO Project of the Provincia Autonoma di Trento, Italy.	[Anonymous], 2006, Wkly Epidemiol Rec, V81, P249; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; Caley P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000143; Carrat F, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-26; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Demicheli V, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001269.PUB2, 10.1002/14651858.CD001269]; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Flahault A, 2006, VACCINE, V24, P6751, DOI 10.1016/j.vaccine.2006.05.079; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glezen WP, 2006, INT J EPIDEMIOL, V35, P352, DOI 10.1093/ije/dyi293; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; *I NAZ STAT, 2006, STAT TRASP AER ANN; *I NAZ STAT, 2004, 8 CENS IND ART; *I NAZ STAT, 2005, IND MULT FAM STIL VI, P122; *I NAZ STAT, 2006, STRUTT FAM OP FAM FI; *INFL TEAM ECDPAC, 2007, EUR SURVEILL, V12; Istituto Nazionale di Statistica, 2001, 14 CENS GEN POP AB; Jefferson T, 2005, LANCET, V365, P773, DOI 10.1016/S0140-6736(05)17984-7; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; *MIN SAL, 2005, INFL VACC COV; Smith S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub2; Stephenson I, 2006, LANCET INFECT DIS, V6, P71, DOI 10.1016/S1473-3099(06)70364-4; *SWISS INF, 2007, SWITZ ANN STOCKP BIR; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2006, PLOS MED, V3, P2159, DOI 10.1371/journal.pmed.0030503; *WHO, 2006, EMERG INFECT DIS, V81, P42	33	124	125	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1790	10.1371/journal.pone.0001790	http://dx.doi.org/10.1371/journal.pone.0001790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335060	Green Submitted, Green Published, gold			2022-12-25	WOS:000260723000041
J	Fukuda, T; Kondo, Y; Nakagama, H				Fukuda, Tomokazu; Kondo, Yasuyuki; Nakagama, Hitoshi			The Anti-Proliferative Effects of the CHFR Depend on the Forkhead Associated Domain, but not E3 Ligase Activity Mediated by Ring Finger Domain	PLOS ONE			English	Article								The CHFR protein comprises fork head associated- (FHA) and RING-finger (RF) domain and is frequently downregulated in human colon and gastric cancers up to 50%. The loss of CHFR mRNA expression is a consequence of promoter methylation, suggesting a tumor suppressor role for this gene in gastrointestinal carcinogenesis. In terms of the biological functions of CHFR, it has been shown to activate cell cycle checkpoint when cells are treated with microtubule depolymerizing agents. Furthermore, CHFR was reported to have E3 ligase activity and promote ubiquitination and degradation of oncogenic proteins such as Aurora A and polo-like kinase 1. However, molecular pathways involved in the tumor suppressive function of CHFR are not yet clear since the two established roles of this protein are likely to inhibit cell growth. In this study, we have identified that the FHA domain of CHFR protein is critical for growth suppressive properties, whereas the RF and cysteine rich domains (Cys) are not required for this function. In contrast, the RF and Cys domains are essential for E3 ligase activity of CHFR. By the use of a cell cycle checkpoint assay, we also confirmed that the FHA domain of CHFR plays an important role in initiating a cell cycle arrest at G2/M, indicating a functional link exists between the anti-proliferative effects and checkpoint function of this tumor suppressor protein via this domain. Collectively, our data show that the checkpoint function of the FHA domain of CHFR is a core component of anti-proliferative properties against the gastrointestinal carcinogenesis.	[Fukuda, Tomokazu; Kondo, Yasuyuki; Nakagama, Hitoshi] Natl Canc Ctr, Res Inst, Div Biochem, Tokyo 104, Japan	National Cancer Center - Japan	Fukuda, T (corresponding author), Natl Canc Ctr, Res Inst, Div Biochem, Tokyo 104, Japan.	hnakagam@gan2.res.ncc.go.jp	Fukuda, Tomokazu/O-1257-2018	Fukuda, Tomokazu/0000-0001-8456-0483	Ministry of Health, Labour and Welfare of Japan [Grant-in-Aid]; Sankyo Foundation of Life Science [06-016]; Foundation for the Promotion of Cancer Research in Japan [Research Resident Fellowship]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Sankyo Foundation of Life Science; Foundation for the Promotion of Cancer Research in Japan	This work was supported in part by a Grant-in-Aid for Cancer Research for the Third-Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour and Welfare of Japan, and by a Research Grant of the Sankyo Foundation of Life Science (06-016). Y.K. is a recipient of a Research Resident Fellowship from the Foundation for the Promotion of Cancer Research in Japan.	Bertholon J, 2003, ONCOGENE, V22, P8956, DOI 10.1038/sj.onc.1207078; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Brandes JC, 2005, CARCINOGENESIS, V26, P1152, DOI 10.1093/carcin/bgi058; Chaturvedi P, 2002, CANCER RES, V62, P1797; Corn PG, 2003, CARCINOGENESIS, V24, P47, DOI 10.1093/carcin/24.1.47; Crane R, 2004, J CELL SCI, V117, P5975, DOI 10.1242/jcs.01418; Daniels MJ, 2004, NAT STRUCT MOL BIOL, V11, P1114, DOI 10.1038/nsmb837; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Fukuda T, 2005, MOL CELL BIOL, V25, P5270, DOI 10.1128/MCB.25.12.5270-5281.2005; Hamilton JP, 2006, CLIN GASTROENTEROL H, V4, P701, DOI 10.1016/j.cgh.2006.03.007; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Homma N, 2005, VIRCHOWS ARCH, V446, P120, DOI 10.1007/s00428-004-1146-6; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Koga Y, 2006, J GASTROENTEROL, V41, P133, DOI 10.1007/s00535-005-1732-7; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Littlepage LE, 2002, GENE DEV, V16, P2274, DOI 10.1101/gad.1007302; MARTINEZ R, 2007, CARCINOGENESIS; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Matsuda N, 2001, J CELL SCI, V114, P1949; Morioka Y, 2006, ANTICANCER RES, V26, P4267; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ogi K, 2005, CANCER BIOL THER, V4, P773, DOI 10.4161/cbt.4.7.1896; Privette LM, 2007, CANCER RES, V67, P6064, DOI 10.1158/0008-5472.CAN-06-4109; Satoh A, 2003, CANCER RES, V63, P8606; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Summers MK, 2005, ONCOGENE, V24, P2589, DOI 10.1038/sj.onc.1208428; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Takai R, 2002, PLANT J, V30, P447, DOI 10.1046/j.1365-313X.2002.01299.x; Tokunaga E, 2006, BREAST CANCER RES TR, V97, P199, DOI 10.1007/s10549-005-9112-9; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Vahteristo P, 2001, CANCER RES, V61, P5718; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Wim JM, 1997, MOL CELL BIOL, V17, P5016, DOI 10.1128/MCB.17.9.5016; Yanokura M, 2007, ONCOL REP, V17, P41; Yoshida K, 2006, ANTICANCER RES, V26, P49; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	44	24	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1776	10.1371/journal.pone.0001776	http://dx.doi.org/10.1371/journal.pone.0001776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335050	Green Submitted, gold, Green Published			2022-12-25	WOS:000260723000029
J	Santos, AFA; Lengruber, RB; Soares, EA; Jere, A; Sprinz, E; Martinez, AMB; Silveira, J; Sion, FS; Pathak, VK; Soares, MA				Santos, Andre F. A.; Lengruber, Renan B.; Soares, Esmeralda A.; Jere, Abhay; Sprinz, Eduardo; Martinez, Ana M. B.; Silveira, Jussara; Sion, Fernando S.; Pathak, Vinay K.; Soares, Marcelo A.			Conservation Patterns of HIV-1 RT Connection and RNase H Domains: Identification of New Mutations in NRTI-Treated Patients	PLOS ONE			English	Article								Background: Although extensive HIV drug resistance information is available for the first 400 amino acids of its reverse transcriptase, the impact of antiretroviral treatment in C-terminal domains of Pol (thumb, connection and RNase H) is poorly understood. Methods and Findings: We wanted to characterize conserved regions in RT C-terminal domains among HIV-1 group M subtypes and CRF. Additionally, we wished to identify NRTI-related mutations in HIV-1 RT C-terminal domains. We sequenced 118 RNase H domains from clinical viral isolates in Brazil, and analyzed 510 thumb and connection domain and 450 RNase H domain sequences collected from public HIV sequence databases, together with their treatment status and histories. Drug-naive and NRTI-treated datasets were compared for intra- and inter-group conservation, and differences were determined using Fisher's exact tests. One third of RT C-terminal residues were found to be conserved among group M variants. Three mutations were found exclusively in NRTI-treated isolates. Nine mutations in the connection and 6 mutations in the RNase H were associated with NRTI treatment in subtype B. Some of them lay in or close to amino acid residues which contact nucleic acid or near the RNase H active site. Several of the residues pointed out herein have been recently associated to NRTI exposure or increase drug resistance to NRTI. Conclusions: This is the first comprehensive genotypic analysis of a large sequence dataset that describes NRTI-related mutations in HIV-1 RT C-terminal domains in vivo. The findings into the conservation of RT C-terminal domains may pave the way to more rational drug design initiatives targeting those regions.	[Santos, Andre F. A.; Lengruber, Renan B.; Soares, Esmeralda A.; Soares, Marcelo A.] Univ Fed Rio de Janeiro, Dept Genet, Lab Virol Humana, Rio De Janeiro, Brazil; [Jere, Abhay; Pathak, Vinay K.] Natl Canc Inst Frederick, HIV Drug Resistance Program, Frederick, MD USA; [Sprinz, Eduardo] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Martinez, Ana M. B.; Silveira, Jussara] Fundacao Univ Rio Grande, Rio Grande, Brazil; [Sion, Fernando S.] Hosp Univ Gaffree Guinle, Rio De Janeiro, Brazil; [Soares, Marcelo A.] Inst Nacl Canc, Unidade Genet, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Federal do Rio Grande; National Cancer Institute (Inca)	Santos, AFA (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Lab Virol Humana, Rio De Janeiro, Brazil.	masoares@biologia.ufrj.br	sprinz, eduardo/V-7961-2019; Santos, Andre FA/I-5734-2016; Soares, Marcelo A/G-5662-2010	sprinz, eduardo/0000-0003-4343-8304; Pathak, Vinay/0000-0003-2441-8412; Sion, Fernando Samuel/0000-0001-6315-139X	Brazilian Ministry of Science and Technology [403589/2004-5]; Rio de Janeiro State Science Foundation [E-26/171.337/2002]; Brazilian Ministry of Health [322/2005]; NATIONAL CANCER INSTITUTE [ZIABC010532, Z01BC010532] Funding Source: NIH RePORTER	Brazilian Ministry of Science and Technology; Rio de Janeiro State Science Foundation; Brazilian Ministry of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support for this study was from the Brazilian Ministry of Science and Technology (CNPq) grant no. 403589/2004-5, Rio de Janeiro State Science Foundation (FAPERJ) grant no. E-26/171.337/2002 and the Brazilian Ministry of Health (PN-DST/AIDS) grant no. 322/2005. The sponsors had no role in any step of the study design, data analysis or manuscript preparation.	Abram ME, 2005, J VIROL, V79, P11952, DOI 10.1128/JVI.79.18.11952-11961.2005; Arion D, 2002, J BIOL CHEM, V277, P1370, DOI 10.1074/jbc.M110254200; Cane PA, 2007, AIDS, V21, P447, DOI 10.1097/QAD.0b013e3280129964; Ceccherini-Silberstein F, 2005, J VIROL, V79, P10718, DOI 10.1128/JVI.79.16.10718-10729.2005; Ceccherini-Silberstein F, 2004, AIDS, V18, pF11, DOI 10.1097/01.aids.0000131394.76221.02; Coffin J, 1997, RETROVIRUSES; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; DELVIKSFRANKENB.KA, J VIROL, V81, P6837; GOOBARLARSSON L, 1993, VIROLOGY, V196, P731, DOI 10.1006/viro.1993.1530; Hehl EA, 2004, J VIROL, V78, P5056, DOI 10.1128/JVI.78.10.5056-5067.2004; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Johnson Victoria A, 2006, Top HIV Med, V14, P125; Julias JG, 2003, J VIROL, V77, P8548, DOI 10.1128/JVI.77.15.8548-8554.2003; Julias JG, 2002, P NATL ACAD SCI USA, V99, P9515, DOI 10.1073/pnas.142123199; Kane CT, 2001, AIDS RES HUM RETROV, V17, P1211, DOI 10.1089/088922201316912817; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Kuiken Carla, 2003, AIDS Reviews, V5, P52; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; LIGHTFOOTE MM, 1986, J VIROL, V60, P771, DOI 10.1128/JVI.60.2.771-775.1986; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nikolenko GN, 2005, P NATL ACAD SCI USA, V102, P2093, DOI 10.1073/pnas.0409823102; Rhee SY, 2005, J INFECT DIS, V192, P456, DOI 10.1086/431601; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; SMITH JS, 1992, J BIOL CHEM, V267, P15071; Stuyver L, 1997, ANTIMICROB AGENTS CH, V41, P284, DOI 10.1128/AAC.41.2.284; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tippmann HF, 2004, BRIEF BIOINFORM, V5, P82, DOI 10.1093/bib/5.1.82; VOLKMANN S, 1993, BIOCHIMIE, V75, P71, DOI 10.1016/0300-9084(93)90027-P; WOHRL BM, 1990, BIOCHEMISTRY-US, V29, P10141, DOI 10.1021/bi00496a001	32	46	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1781	10.1371/journal.pone.0001781	http://dx.doi.org/10.1371/journal.pone.0001781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335052	Green Submitted, Green Published, gold			2022-12-25	WOS:000260723000033
J	Yang, N; Huang, J; Greshock, J; Liang, S; Barchetti, A; Hasegawa, K; Kim, S; Giannakakis, A; Li, CS; O'Brien-Jenkins, A; Katsaros, D; Butzow, R; Coukos, G; Zhang, L				Yang, Nuo; Huang, Jia; Greshock, Joel; Liang, Shun; Barchetti, Andrea; Hasegawa, Kosei; Kim, Sarah; Giannakakis, Antonis; Li, Chunsheng; O'Brien-Jenkins, Anne; Katsaros, Dionyssios; Butzow, Ralf; Coukos, George; Zhang, Lin			Transcriptional Regulation of PIK3CA Oncogene by NF-kappa B in Ovarian Cancer Microenvironment	PLOS ONE			English	Article								PIK3CA upregulation, amplification and mutation have been widely reported in ovarian cancers and other tumors, which strongly suggests that PIK3CA is a promising therapeutic target. However, to date the mechanisms underlying PIK3CA regulation and activation in vivo is still unclear. During tumorigenesis, host-tumor interactions may play a critical role in editing the tumor. Here, we report a novel mechanism through which the tumor microenvironment activates the PIK3CA oncogene. We show that PIK3CA upregulation occurs in non-proliferating tumor regions in vivo. We identified and characterized the PIK3CA 5' upstream transcriptional regulatory region and confirmed that PIK3CA is transcriptionally regulated through NF-kappa B pathway. These results offer a new mechanism through which the tumor microenvironment directly activates oncogenic pathways in tumor cells.	[Yang, Nuo; Liang, Shun; Barchetti, Andrea; Hasegawa, Kosei; Kim, Sarah; Giannakakis, Antonis; Li, Chunsheng; O'Brien-Jenkins, Anne; Coukos, George; Zhang, Lin] Univ Penn, Sch Med, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA; [Coukos, George; Zhang, Lin] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA USA; [Huang, Jia; Greshock, Joel; Coukos, George] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA USA; [Greshock, Joel] GlaxoSmithKline Inc, Translational Med & Genet, King Of Prussia, PA USA; [Giannakakis, Antonis] Democritus Univ Thrace, Lab Gene Express, Modern Diagnost & Therap Methods, Alexandroupolis, Greece; [Katsaros, Dionyssios] Univ Turin, Dept Obstet & Gynecol, Turin, Italy; [Butzow, Ralf] Univ Helsinki, Dept Obstet, Helsinki, Finland; [Butzow, Ralf] Univ Helsinki, Dept Gynecol, Helsinki, Finland	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; GlaxoSmithKline; Democritus University of Thrace; University of Turin; University of Helsinki; University of Helsinki	Zhang, L (corresponding author), Univ Penn, Sch Med, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA.	linzhang@mail.med.upenn.edu	Giannakakis, Antonis/ABA-2399-2021; Zhang, Lin/K-8478-2012; Li, chunsheng/G-4418-2011; Giannakakis, Antonis/AAN-8329-2021; Coukos, George/ABG-7389-2020	Giannakakis, Antonis/0000-0003-2975-0326; Coukos, George/0000-0001-8813-7367	NCI [P01-CA83638]; Ovarian Cancer Research Fund; Mary Kay Ash Charitable Foundation; American Cancer Society; Hellenic Ministry of Education [predoctoral fellowship]; Italian Association for Cancer Research; NATIONAL CANCER INSTITUTE [P50CA083638] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund; Mary Kay Ash Charitable Foundation; American Cancer Society(American Cancer Society); Hellenic Ministry of Education; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI P01-CA83638 SPORE in Ovarian Cancer (Career Development Award, LZ); the Ovarian Cancer Research Fund (GC and LZ); Mary Kay Ash Charitable Foundation (LZ) and the American Cancer Society (LZ). AG was supported in part by a predoctoral fellowship from the Hellenic Ministry of Education (Program HERACLITOS, EPEAEK). DK was partly supported by the Italian Association for Cancer Research (AIRC).	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Bast Robert C. Jr., 2007, V174, P91; Berchuck A, 2003, GYNECOL ONCOL, V88, pS67, DOI 10.1006/gyno.2002.6687; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu LM, 2002, CANCER RES, V62, P1087; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; KULL FC, 1985, P NATL ACAD SCI USA, V82, P5756, DOI 10.1073/pnas.82.17.5756; Lassus H, 2003, GYNECOL ONCOL, V91, P504, DOI 10.1016/j.ygyno.2003.08.034; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Lin EY, 2004, BRIT J CANCER, V90, P2053, DOI 10.1038/sj.bjc.6601705; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Mok SC, 2007, ADV CANCER RES, V96, P1, DOI 10.1016/S0065-230X(06)96001-1; Nakayama K, 2006, CANCER BIOL THER, V5, P779, DOI 10.4161/cbt.5.7.2751; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Ozols RF, 2000, SEMIN ONCOL, V27, P47; Parsons R, 2005, CLIN CANCER RES, V11, P7965, DOI 10.1158/1078-0432.CCR-05-1681; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; SMITH RA, 1986, J BIOL CHEM, V261, P4871; SUGIMOTO Y, 1984, P NATL ACAD SCI-BIOL, V81, P2117, DOI 10.1073/pnas.81.7.2117; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; VERCAMMEN D, 1995, CYTOKINE, V7, P463, DOI 10.1006/cyto.1995.0063; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wenham RM, 2002, BEST PRACT RES CL OB, V16, P483, DOI 10.1053/beog.2002.0298; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; Zhang L, 2004, CANCER BIOL THER, V3, P1283, DOI 10.4161/cbt.3.12.1388; Zhang L, 2005, CANCER RES, V65, P925; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang L, 2003, CANCER RES, V63, P4225; Zhang L, 2002, AM J PATHOL, V161, P2295, DOI 10.1016/S0002-9440(10)64505-1; Zijlstra A, 2006, BLOOD, V107, P317, DOI 10.1182/blood-2005-04-1458	53	31	32	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1758	10.1371/journal.pone.0001758	http://dx.doi.org/10.1371/journal.pone.0001758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335034	Green Submitted, Green Published, gold			2022-12-25	WOS:000260723000012
J	Paleologou, KE; Schmid, AW; Rospigliosi, CC; Kim, HY; Lamberto, GR; Fredenburg, RA; Lansbury, PT; Fernandez, CO; Eliezer, D; Zweckstetter, M; Lashuel, HA				Paleologou, Katerina E.; Schmid, Adrian W.; Rospigliosi, Carla C.; Kim, Hai-Young; Lamberto, Gonzalo R.; Fredenburg, Ross A.; Lansbury, Peter T., Jr.; Fernandez, Claudio O.; Eliezer, David; Zweckstetter, Markus; Lashuel, Hilal A.			Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED MUTANTS; PARKINSONS-DISEASE; TAU PHOSPHORYLATION; INCLUSION FORMATION; NMR; DYNAMICS; BINDING; SYSTEM	alpha-Synuclein (alpha-syn) phosphorylation at serine 129 is characteristic of Parkinson disease (PD) and related alpha-synulceinopathies. However, whether phosphorylation promotes or inhibits alpha-syn aggregation and neurotoxicity in vivo remains unknown. This understanding is critical for elucidating the role of alpha-syn in the pathogenesis of PD and for development of therapeutic strategies for PD. To better understand the structural and molecular consequences of Ser-129 phosphorylation, we compared the biochemical, structural, and membrane binding properties of wild type alpha-syn to those of the phosphorylation mimics (S129E, S129D) as well as of in vitro phosphorylated alpha-syn using a battery of biophysical techniques. Our results demonstrate that phosphorylation at Ser-129 increases the conformational flexibility of alpha-syn and inhibits its fibrillogenesis in vitro but does not perturb its membrane-bound conformation. In addition, we show that the phosphorylation mimics (S129E/D) do not reproduce the effect of phosphorylation on the structural and aggregation properties of alpha-syn in vitro. Our findings have significant implications for current strategies to elucidate the role of phosphorylation in modulating protein structure and function in health and disease and provide novel insight into the underlying mechanisms that govern alpha-syn aggregation and toxicity in PD and related alpha-synulceinopathies.	[Paleologou, Katerina E.; Schmid, Adrian W.; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Brain Mind Inst, LMNN, CH-1015 Lausanne, Switzerland; [Rospigliosi, Carla C.; Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA; [Rospigliosi, Carla C.; Eliezer, David] Weill Cornell Med, Program Struct Biol, New York, NY 10021 USA; [Kim, Hai-Young; Zweckstetter, Markus] Deutsche Forsch Gemeinschaft Res ctr Mol Physiol, Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Lamberto, Gonzalo R.; Fernandez, Claudio O.] Univ Nacl Rosario, Inst Biol Mol & Celular Rosario, Consejo Nacl Invest Cient & Tecn, RA-2000 Rosario, Argentina; [Fredenburg, Ross A.; Lansbury, Peter T., Jr.] Brigham & Womens Hosp, Ctr Neurol Dis, Harvard Ctr Neurodegenerat & Repair, Cambridge, MA 02139 USA; [Fredenburg, Ross A.; Lansbury, Peter T., Jr.] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02139 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Cornell University; Cornell University; Max Planck Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Harvard University; Brigham & Women's Hospital; Harvard University	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, LMNN, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017; Schmid, Adrien/CAG-1527-2022	Fernandez, Claudio Oscar/0000-0003-0454-7735; Zweckstetter, Markus/0000-0002-2536-6581; Schmid, Adrien W./0000-0001-6671-7950	NIA NIH HHS [R01 AG025440-03, AG019391, R01 AG019391-08, R01 AG019391, R37 AG019391, R01 AG025440] Funding Source: Medline; NIGMS NIH HHS [GM66354] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019391, R01AG025440, R37AG019391] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Frasier M, 2005, EXP NEUROL, V192, P274, DOI 10.1016/j.expneurol.2004.07.016; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hirai Y, 2004, FEBS LETT, V572, P227, DOI 10.1016/j.febslet.2004.07.046; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Kahle PJ, 2002, EMBO REP, V3, P583, DOI 10.1093/embo-reports/kvf109; Kahle PJ, 2000, ANN NY ACAD SCI, V920, P33; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; Klafki HW, 2006, BRAIN, V129, P2840, DOI 10.1093/brain/awl280; KOSEN PA, 1986, BIOCHEMISTRY-US, V25, P2356, DOI 10.1021/bi00357a009; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee G, 2004, J BIOL CHEM, V279, P6834, DOI 10.1074/jbc.M312760200; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Payton JE, 2004, J MOL BIOL, V337, P1001, DOI 10.1016/j.jmb.2004.02.014; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Ryu MY, 2008, J NEUROL SCI, V266, P9, DOI 10.1016/j.jns.2007.08.027; Saha AR, 2004, J CELL SCI, V117, P1017, DOI 10.1242/jcs.00967; Sasakawa H, 2007, BIOCHEM BIOPH RES CO, V363, P795, DOI 10.1016/j.bbrc.2007.09.048; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Takahashi M, 2003, NEUROSCI LETT, V336, P155, DOI 10.1016/S0304-3940(02)01258-2; Tamamizu-Kato S, 2006, BIOCHEMISTRY-US, V45, P10947, DOI 10.1021/bi060939i; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q	44	247	252	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2008	283	24					16895	16905		10.1074/jbc.M800747200	http://dx.doi.org/10.1074/jbc.M800747200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	309YW	18343814	Green Published, hybrid			2022-12-25	WOS:000256497100067
J	Ha, CH; Wang, W; Jhun, BS; Wong, C; Hausser, A; Pfizenmaier, K; McKinsey, TA; Olson, EN; Jin, ZG				Ha, Chang Hoon; Wang, Weiye; Jhun, Bong Sook; Wong, Chelsea; Hausser, Angelika; Pfizenmaier, Klaus; McKinsey, Timothy A.; Olson, Eric N.; Jin, Zheng-Gen			Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; TRANSCRIPTION FACTOR; CARDIAC-HYPERTROPHY; NUR77 EXPRESSION; ACTIVATION; VEGF; CELLS; EMBRYOGENESIS; RECEPTORS; APOPTOSIS	Vascular endothelial growth factor (VEGF) is essential for normal and pathological angiogenesis. However, the signaling pathways linked to gene regulation in VEGF-induced angiogenesis are not fully understood. Here we demonstrate a critical role of protein kinaseD(PKD) and histone deacetylase 5 (HDAC5) in VEGF-induced gene expression and angiogenesis. We found that VEGF stimulated HDAC5 phosphorylation and nuclear export in endothelial cells through a VEGF receptor 2-phospholipase C gamma-protein kinase C-PKD-dependent pathway. We further showed that the PKD-HDAC5 pathway mediated myocyte enhancer factor-2 transcriptional activation and a specific subset of gene expression in response to VEGF, including NR4A1, an orphan nuclear receptor involved in angiogenesis. Specifically, inhibition of PKD by overexpression of the PKD kinase-negative mutant prevents VEGF-induced HDAC5 phosphorylation and nuclear export as well as NR4A1 induction. Moreover, a mutant of HDAC5 specifically deficient in PKD-dependent phosphorylation inhibited VEGF-mediated NR4A1 expression, endothelial cell migration, and in vitro angiogenesis. These findings suggest that the PKD-HDAC5 pathway plays an important role in VEGF regulation of gene transcription and angiogenesis.	[Ha, Chang Hoon; Wang, Weiye; Jhun, Bong Sook; Wong, Chelsea; Jin, Zheng-Gen] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14586 USA; [Ha, Chang Hoon; Wang, Weiye; Jhun, Bong Sook; Wong, Chelsea; Jin, Zheng-Gen] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14586 USA; [Hausser, Angelika; Pfizenmaier, Klaus] Univ Stuttgart, Inst Cell Biol & Immunol, D-70659 Stuttgart, Germany; [McKinsey, Timothy A.] Myogen Inc, Westminster, CO 80021 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Rochester; University of Rochester; University of Stuttgart; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jin, ZG (corresponding author), 211 Bailey Rd,W Henrietta, Rochester, NY 14586 USA.	zheng-gen_jin@urmc.rochester.edu	Hausser, Angelika/AAC-4531-2021; Ha, C/GZL-9046-2022	Ha, Chang Hoon/0000-0001-7606-4340; Jhun, Bong Sook/0000-0001-9916-9962	NHLBI NIH HHS [R01 HL080611-05, R01 HL 080611, R01 HL080611] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080611] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Claesson-Welsh L, 2003, BIOCHEM SOC T, V31, P20, DOI 10.1042/bst0310020; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Hausser A, 2002, J CELL BIOL, V156, P65, DOI 10.1083/jcb.200110047; Jin ZG, 2005, J BIOL CHEM, V280, P12305, DOI 10.1074/jbc.M500294200; Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Lin Q, 1998, DEVELOPMENT, V125, P4565; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Pi XC, 2005, CIRC RES, V96, P1145, DOI 10.1161/01.RES.0000168802.43528.e1; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Sucharov CC, 2006, AM J PHYSIOL-CELL PH, V291, pC1029, DOI 10.1152/ajpcell.00059.2006; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Wong C, 2005, J BIOL CHEM, V280, P33262, DOI 10.1074/jbc.M503198200; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zeng HY, 2006, J EXP MED, V203, P719, DOI 10.1084/jem.20051523; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	32	140	146	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14590	14599		10.1074/jbc.M800264200	http://dx.doi.org/10.1074/jbc.M800264200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18332134	Green Published, hybrid			2022-12-25	WOS:000255941400047
J	Wu, Y; Kantake, N; Sugiyama, T; Kowalczykowski, SC				Wu, Yun; Kantake, Noriko; Sugiyama, Tomohiko; Kowalczykowski, Stephen C.			Rad51 protein controls Rad52-mediated DNA annealing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; RAD51-INDEPENDENT RECOMBINATION; MITOTIC RECOMBINATION; INDUCED REPLICATION; MULTIPLE PATHWAYS; MISMATCH REPAIR; RECA PROTEIN; BINDING	In Saccharomyces cerevisiae, Rad52 protein plays an essential role in the repair of DNA double-stranded breaks (DSBs). Rad52 and its orthologs possess the unique capacity to anneal single-stranded DNA (ssDNA) complexed with its cognate ssDNA-binding protein, RPA. This annealing activity is used in multiple mechanisms of DSB repair: single-stranded annealing, synthesis-dependent strand annealing, and crossover formation. Here we report that the S. cerevisiae DNA strand exchange protein, Rad51, prevents Rad52-mediated annealing of complementary ssDNA. Efficient inhibition is ATP-dependent and involves a specific interaction between Rad51 and Rad52. Free Rad51 can limit DNA annealing by Rad52, but the Rad51 nucleoprotein filament is even more effective. We also discovered that the budding yeast Rad52 paralog, Rad59 protein, partially restores Rad52-dependent DNA annealing in the presence of Rad51, suggesting that Rad52 and Rad59 function coordinately to enhance recombinational DNA repair either by directing the processed DSBs to repair by DNA strand annealing or by promoting second end capture to form a double Holliday junction. This regulation of Rad52-mediated annealing suggests a control function for Rad51 in deciding the recombination path taken for a processed DNA break; the ssDNA can be directed to either Rad51-mediated DNA strand invasion or to Rad52-mediated DNA annealing. This channeling determines the nature of the subsequent repair process and is consistent with the observed competition between these pathways in vivo.	[Wu, Yun; Kowalczykowski, Stephen C.] Univ Calif Davis, Microbiol Sect & Mol & Cellular Biol, Davis, CA 95616 USA; [Kantake, Noriko; Sugiyama, Tomohiko] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	University of California System; University of California Davis; University System of Ohio; Ohio University	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Microbiol Sect & Mol & Cellular Biol, Briggs Hall 1 Shields Ave, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Sugiyama, Tomohiko/0000-0003-2942-3667	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018987] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 18987] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGUILERA A, 1995, CURR GENET, V27, P298, DOI 10.1007/BF00352096; Aylon Y, 2003, MOL CELL BIOL, V23, P1403, DOI 10.1128/MCB.23.4.1403-1417.2003; Bai Y, 1999, GENETICS, V153, P1117; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; BIANCO PR, 1998, FRONT BIOSCI, V570, pD570; BOUNDYMILLS KL, 1993, GENETICS, V133, P39; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Cortes-Ledesma F, 2004, GENETICS, V168, P553, DOI 10.1534/genetics.104.030551; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Davis AP, 2003, DNA REPAIR, V2, P1127, DOI 10.1016/S1568-7864(03)00121-6; Davis AP, 2001, GENETICS, V159, P515; de Jager M, 2001, NUCLEIC ACIDS RES, V29, P1317, DOI 10.1093/nar/29.6.1317; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; IVANOV EL, 1995, MOL CELL BIOL, V15, P2245; Ivanov EL, 1996, GENETICS, V142, P693; Jablonovich Z, 1999, CURR GENET, V36, P13, DOI 10.1007/s002940050467; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kang LE, 2000, MOL CELL BIOL, V20, P9162, DOI 10.1128/MCB.20.24.9162-9172.2000; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kim HK, 2002, GENES CELLS, V7, P1125, DOI 10.1046/j.1365-2443.2002.00588.x; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; LEBOWITZ J, 1985, THESIS J HOPKINS U B; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; MCENTEE K, 1985, BIOCHEMISTRY-US, V24, P4345, DOI 10.1021/bi00337a014; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Mirshad JK, 2003, BIOCHEMISTRY-US, V42, P5937, DOI 10.1021/bi027232q; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Namsaraev EA, 1998, BIOCHEMISTRY-US, V37, P11932, DOI 10.1021/bi9810297; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1997, MOL CELL BIOL, V17, P6765, DOI 10.1128/MCB.17.11.6765; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Petukhova G, 1999, J BIOL CHEM, V274, P33839, DOI 10.1074/jbc.274.48.33839; RATTRAY AJ, 1995, GENETICS, V139, P45; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Spell RM, 2004, GENETICS, V168, P1855, DOI 10.1534/genetics.104.032771; Spell RM, 2003, GENETICS, V165, P1733; Spies M, 2006, MOL CELL, V21, P573, DOI 10.1016/j.molcel.2006.01.007; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Symington LS, 1998, NUCLEIC ACIDS RES, V26, P5589, DOI 10.1093/nar/26.24.5589; Tsukamoto M, 2003, GENETICS, V165, P1703; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; WEINSTOCK GM, 1979, P NATL ACAD SCI USA, V76, P126, DOI 10.1073/pnas.76.1.126; Wu XH, 1997, GENETICS, V147, P399; Wu Y, 2006, J BIOL CHEM, V281, P15441, DOI 10.1074/jbc.M601827200; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907	69	61	62	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14883	14892		10.1074/jbc.M801097200	http://dx.doi.org/10.1074/jbc.M801097200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18337252	Green Published, hybrid			2022-12-25	WOS:000255941400075
J	Barkefors, I; Le Jan, S; Jakobsson, L; Hejll, E; Carlson, G; Johansson, H; Jarvius, J; Park, JW; Jeon, NL; Kreuger, J				Barkefors, Irmeli; Le Jan, Sebastien; Jakobsson, Lars; Hejll, Eduar; Carlson, Gustav; Johansson, Henrik; Jarvius, Jonas; Park, Jeong Won; Jeon, Noo Li; Kreuger, Johan			Endothelial cell migration in stable gradients of vascular endothelial growth factor a and fibroblast growth factor 2 - Effects on chemotaxis and chemokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; FOCAL ADHESIONS; VEGF; ANGIOGENESIS; DIFFUSION; RECEPTOR; DIFFERENTIATION; PROLIFERATION; ACTIVATION; LETHALITY	Gradients of secreted signaling proteins guide growing blood vessels during both normal and pathological angiogenesis. However, the mechanisms by which endothelial cells integrate and respond to graded distributions of chemotactic factors are still poorly understood. We have in this study investigated endothelial cell migration in response to hill-shaped gradients of vascular endothelial growth factor A (VEGFA) and fibroblast growth factor 2 (FGF2) using a novel microfluidic chemotaxis chamber (MCC). Cell migration was scored at the level of individual cells using time-lapse microscopy. A stable gradient of VEGFA165 ranging from 0 to 50 ng/ml over a distance of 400 mu m was shown to strongly induce chemotaxis of endothelial cells of different vascular origin. VEGFA121, unable to bind proteoglycan and neuropilin coreceptors, was also shown to induce chemotaxis in this setup. Furthermore, a gradient of FGF2 was able to attract venular but not arterial endothelial cells, albeit less efficiently than VEGFA165. Notably, constant levels of VEGFA165, but not of FGF2, were shown to efficiently reduce chemokinesis. Systematic exploration of different gradient shapes led to the identification of a minimal gradient steepness required for efficient cell guidance. Finally, analysis of cell migration in different regions of the applied gradients showed that chemotaxis is reduced when cells reach the high end of the gradient. Our findings suggest that chemotactic growth factor gradients may instruct endothelial cells to shift toward a nonmigratory phenotype when approaching the growth factor source.	[Barkefors, Irmeli; Le Jan, Sebastien; Hejll, Eduar; Carlson, Gustav; Kreuger, Johan] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Jakobsson, Lars; Johansson, Henrik; Jarvius, Jonas] Uppsala Univ, Dept Genet & Pathol, SE-75123 Uppsala, Sweden; [Park, Jeong Won; Jeon, Noo Li] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA	Uppsala University; Uppsala University; University of California System; University of California Irvine	Kreuger, J (corresponding author), Husargatan 3,Box 582, SE-75123 Uppsala, Sweden.	Johan.Kreuger@imbim.uu.se	LE JAN, Sébastien/AAH-3952-2019; Kreuger, Johan/HDM-1503-2022; Jakobsson, Lars/B-4200-2011	LE JAN, Sébastien/0000-0003-4027-2855; Jakobsson, Lars/0000-0001-7956-587X				ArrioDupont M, 1996, BIOPHYS J, V70, P2327, DOI 10.1016/S0006-3495(96)79798-9; Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chung BG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-60; Cox CM, 2000, DEV DYNAM, V218, P371, DOI 10.1002/(SICI)1097-0177(200006)218:2<371::AID-DVDY10>3.3.CO;2-Q; Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Filion RJ, 2004, ANN BIOMED ENG, V32, P645, DOI 10.1023/B:ABME.0000030231.88326.78; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hsu S, 2005, BIOCHEM BIOPH RES CO, V337, P401, DOI 10.1016/j.bbrc.2005.08.272; Hufnagel L, 2006, DEV BIOL, V300, P512, DOI 10.1016/j.ydbio.2006.08.076; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Kanda S, 2000, J BIOL CHEM, V275, P10105, DOI 10.1074/jbc.275.14.10105; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Mac Gabhann F, 2006, PLOS COMPUT BIOL, V2, P1107, DOI 10.1371/journal.pcbi.0020127; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pintucci G, 2002, FASEB J, V16, P598, DOI 10.1096/fj.01-0815fje; Poole TJ, 2001, DEV DYNAM, V220, P1, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1087>3.0.CO;2-2; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Senger DR, 1996, AM J PATHOL, V149, P293; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shono T, 2001, EXP CELL RES, V268, P169, DOI 10.1006/excr.2001.5276; Shono T, 2001, EXP CELL RES, V264, P275, DOI 10.1006/excr.2001.5154; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; Vernon RB, 1999, MICROVASC RES, V57, P118, DOI 10.1006/mvre.1998.2122; Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k; Wang SJ, 2004, EXP CELL RES, V300, P180, DOI 10.1016/j.yexcr.2004.06.030; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Yamamoto M, 1999, J BIOACT COMPAT POL, V14, P474, DOI 10.1177/088391159901400603; Yoshida A, 1996, GROWTH FACTORS, V13, P57, DOI 10.3109/08977199609034566; Zhou M, 1998, NAT MED, V4, P201, DOI 10.1038/nm0298-201	38	122	126	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13905	13912		10.1074/jbc.M704917200	http://dx.doi.org/10.1074/jbc.M704917200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18347025	hybrid			2022-12-25	WOS:000255728200044
J	Stallings, JD; Zeng, YX; Narvaez, F; Rebecchi, MJ				Stallings, Jonathan D.; Zeng, Yue X.; Narvaez, Francisco; Rebecchi, Mario J.			Phospholipase C-delta(1) expression is linked to proliferation, DNA synthesis, and cyclin E levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PLECKSTRIN HOMOLOGY DOMAIN; CELL-CYCLE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MAMMALIAN-CELLS; KINASE-ACTIVITY; S-PHASE; C GENE; NUCLEAR; BINDING	We previously reported that phospholipase C-delta(1) (PLC-delta(1)) accumulates in the nucleus at the G(1)/S transition, which is largely dependent on its binding to phosphatidylinositol 4,5-bisphosphate (Stallings, J. D., Tall, E. G., Pentyala, S., and Rebecchi, M. J. (2005) J. Biol. Chem. 280, 22060-22069). Here, using small interfering RNA (siRNA) that specifically targets rat PLC-delta(1), we investigated whether this enzyme plays a role in cell cycle control. Inhibiting expression of PLC-delta(1) significantly decreased proliferation of rat C6 glioma cells and altered S phase progression. [H-3] Thymidine labeling and fluorescence-activated cell sorting analysis indicated that the rates of G(1)/S transition and DNA synthesis were enhanced. On the other hand, knockdown cultures released from the G(1)/S boundary were slower to reach full G(2)/M DNA content, consistent with a delay in S phase. The levels of cyclin E, a key regulator of the G(1)/S transition and DNA synthesis, were elevated in asynchronous cultures as well as those blocked at the G(1)/S boundary. Epifluorescence imaging showed that transient expression of human phospholipase C-delta(1), resistant to these siRNA, suppressed expression of cyclin E at the G(1)/S boundary despite treatment of cultures with rat-specific siRNA. Although whole cell levels of phosphatidylinositol 4,5-bisphosphate were unchanged, suppression of PLC-delta(1) led to a significant rise in the nuclear levels of this phospholipid at the G(1)/S boundary. These results support a role for PLC-delta(1) and nuclear phospholipid metabolism in regulating cell cycle progression.	[Zeng, Yue X.; Narvaez, Francisco; Rebecchi, Mario J.] SUNY Stony Brook, Dept Anesthesiol, Hlth Sci Ctr, Stony Brook, NY 11794 USA; [Stallings, Jonathan D.] Madigan Army Med Ctr, Dept Clin Invest, Tacoma, WA 98431 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Madigan Army Medical Center	Rebecchi, MJ (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Hlth Sci Ctr, Level 4,Rm 075, Stony Brook, NY 11794 USA.	mrebecchi@notes.cc.sunysb.edu	Stallings, Jonathan D/H-7779-2013	Stallings, Jonathan D/0000-0002-6430-5888				Albi E, 2003, J CELL PHYSIOL, V197, P181, DOI 10.1002/jcp.10292; Berridge MJ, 2005, ANNU REV PHYSIOL, V67, P1, DOI 10.1146/annurev.physiol.67.040103.152647; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Brose N, 2004, CURR OPIN NEUROBIOL, V14, P328, DOI 10.1016/j.conb.2004.05.006; Bunce MW, 2006, BBA-MOL CELL BIOL L, V1761, P560, DOI 10.1016/j.bbalip.2006.03.002; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Cocco L, 2006, BBA-MOL CELL BIOL L, V1761, P509, DOI 10.1016/j.bbalip.2006.03.001; Connell-Crowley L, 1998, CURR BIOL, V8, P65, DOI 10.1016/S0960-9822(98)70021-1; Cooper KF, 1999, MOL CELL BIOL, V19, P3338; Downes CP, 2007, ADV ENZYME REGUL, V47, P184, DOI 10.1016/j.advenzreg.2006.12.018; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Faenza I, 2000, J BIOL CHEM, V275, P30520, DOI 10.1074/jbc.M004630200; Faenza I, 2008, FRONT BIOSCI-LANDMRK, V13, P2452, DOI 10.2741/2858; FLICK JS, 1993, MOL CELL BIOL, V13, P5861, DOI 10.1128/MCB.13.9.5861; Flick JS, 1998, GENETICS, V148, P33; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Huppi K, 2005, MOL CELL, V17, P1, DOI 10.1016/j.molcel.2004.12.017; Hwang JI, 2005, BIOCHEM J, V389, P181, DOI 10.1042/BJ20041677; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Ji GS, 1998, MOL BIOL CELL, V9, P749, DOI 10.1091/mbc.9.4.749; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Jones DR, 2004, CURR OPIN GENET DEV, V14, P196, DOI 10.1016/j.gde.2004.02.003; Katan M, 1998, BBA-MOL CELL BIOL L, V1436, P5, DOI 10.1016/S0005-2760(98)00125-8; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Lee H, 2002, MOL VIS, V8, P17; Leone G, 1999, P NATL ACAD SCI USA, V96, P6626, DOI 10.1073/pnas.96.12.6626; Manzoli L, 2005, PROG LIPID RES, V44, P185, DOI 10.1016/j.plipres.2005.04.003; Martelli AM, 2004, PHARMACOL THERAPEUT, V101, P47, DOI 10.1016/j.pharmthera.2003.10.003; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nakahara M, 2005, J BIOL CHEM, V280, P29128, DOI 10.1074/jbc.M503817200; Nakamura Y, 2005, MOL CELL BIOL, V25, P10979, DOI 10.1128/MCB.25.24.10979-10988.2005; Nakamura Y, 2003, EMBO J, V22, P2981, DOI 10.1093/emboj/cdg302; Nakamura Y, 2008, FASEB J, V22, P841, DOI 10.1096/fj.07-9239com; Nebigil CG, 1997, BIOCHEMISTRY-US, V36, P15949, DOI 10.1021/bi971721m; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Osborne SL, 2001, J CELL SCI, V114, P2501; Parrington J, 2002, REPRODUCTION, V123, P31, DOI 10.1530/rep.0.1230031; PAYNE WE, 1993, MOL CELL BIOL, V13, P4351, DOI 10.1128/MCB.13.7.4351; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reed SE, 2004, CANCER RES, V64, P795, DOI 10.1158/0008-5472.CAN-03-3417; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Stallings JD, 2005, J BIOL CHEM, V280, P22060, DOI 10.1074/jbc.M413813200; Tabellini G, 2003, EXP CELL RES, V287, P143, DOI 10.1016/S0014-4827(03)00115-0; TUSCHL T, 2003, RNAI GUIDE GENE SILE, P280; Wang S, 1998, FEBS LETT, V441, P261, DOI 10.1016/S0014-5793(98)01518-X; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Winston JT, 1999, GENE DEV, V13, P2751, DOI 10.1101/gad.13.21.2751; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Yagisawa H, 2006, J CELL BIOCHEM, V97, P233, DOI 10.1002/jcb.20677; Yagisawa H, 1998, J BIOL CHEM, V273, P417, DOI 10.1074/jbc.273.1.417; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; Yu HY, 1998, EUR J BIOCHEM, V251, P281, DOI 10.1046/j.1432-1327.1998.2510281.x; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	60	22	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13992	14001		10.1074/jbc.M800752200	http://dx.doi.org/10.1074/jbc.M800752200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359940	hybrid			2022-12-25	WOS:000255728200053
J	Li, H; Gade, P; Nallar, SC; Raha, A; Roy, SK; Karra, S; Reddy, JK; Reddy, SP; Kalvakolanu, DV				Li, Hui; Gade, Padmaja; Nallar, Shreeram C.; Raha, Abhijit; Roy, Sanjit K.; Karra, Sreenivasu; Reddy, Janardan K.; Reddy, Sekhar P.; Kalvakolanu, Dhananjaya V.			The Med1 subunit of transcriptional mediator plays a central role in regulating CCAAT/enhancer-binding protein-beta-driven transcription in response to interferon-gamma.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; THYROID-HORMONE RECEPTOR; C/EBP-BETA; GENE-EXPRESSION; COACTIVATOR COMPLEX; (PPAR)-BINDING PROTEIN; SIGNAL TRANSDUCER; TRAP220 COMPONENT; NUCLEAR RECEPTORS; PHOSPHORYLATION	Transcription factor CCAAT/enhancer-binding protein (C/EBP)-beta is crucial for regulating transcription of genes involved in a number of diverse cellular processes, including those involved in some cytokine-induced responses. However, the mechanisms that contribute to its diverse transcriptional activity are not yet fully understood. To gain an understanding into its mechanisms of action, we took a proteomic approach and identified cellular proteins that associate with C/EBP-beta in an interferon (IFN)-gamma-dependent manner. Transcriptional mediator ( Mediator) is a multisubunit protein complex that regulates signal-induced cellular gene transcription from enhancer-bound transcription factor(s). Here, we report that the Med1 subunit of the Mediator as a C/EBP-beta-interacting protein. Using gene knock-out cells and mutational and RNA interference approaches, we show that Med1 is critical for IFN-induced expression of certain genes. Med1 associates with C/EBP-beta through a domain located between amino acids 125 and 155 of its N terminus. We also show that the MAPK, ERK1/2, and an ERK phosphorylation site within regulatory domain 2, more specifically the Thr(189) residue, of C/EBP-beta are essential for it to bind to Med1. Last, an ERK- regulated site in Med1 protein is also essential for up-regulating IFN-induced transcription although not critical for binding to C/EBP-beta.	[Li, Hui; Gade, Padmaja; Nallar, Shreeram C.; Raha, Abhijit; Roy, Sanjit K.; Karra, Sreenivasu; Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Greenbaum Canc Ctr, Baltimore, MD 21201 USA; [Reddy, Janardan K.] Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Reddy, Sekhar P.] Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; Northwestern University; Johns Hopkins University	Kalvakolanu, DV (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Greenbaum Canc Ctr, Baltimore, MD 21201 USA.	dkalvako@umaryland.edu			NATIONAL CANCER INSTITUTE [R01CA104578, R01CA078282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023750, R37GM023750] Funding Source: NIH RePORTER; NCI NIH HHS [CA78282, CA104578] Funding Source: Medline; NIEHS NIH HHS [ES011863] Funding Source: Medline; NIGMS NIH HHS [GM23750] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Chen XN, 1997, BLOOD, V90, P156; Crawford SE, 2002, J BIOL CHEM, V277, P3585, DOI 10.1074/jbc.M107995200; Croniger C, 1997, J BIOL CHEM, V272, P26306, DOI 10.1074/jbc.272.42.26306; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Diehl AM, 1998, J BIOL CHEM, V273, P30843, DOI 10.1074/jbc.273.47.30843; Drane P, 1997, ONCOGENE, V15, P3013, DOI 10.1038/sj.onc.1201492; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frade R, 2000, CANCER RES, V60, P6585; Gade P, 2008, MOL CELL BIOL, V28, P2528, DOI 10.1128/MCB.00784-07; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Gordon DF, 2006, MOL ENDOCRINOL, V20, P1073, DOI 10.1210/me.2005-0115; Gorgoni B, 2002, J IMMUNOL, V168, P4055, DOI 10.4049/jimmunol.168.8.4055; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Kalakonda S, 2007, CANCER RES, V67, P6212, DOI 10.1158/0008-5472.CAN-07-0031; Kim TW, 2004, P NATL ACAD SCI USA, V101, P12153, DOI 10.1073/pnas.0401985101; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lau JF, 2003, MOL CELL BIOL, V23, P620, DOI 10.1128/MCB.23.2.620-628.2003; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Malik S, 2002, MOL CELL BIOL, V22, P5626, DOI 10.1128/MCB.22.15.5626-5637.2002; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Minucci S, 1997, MOL CELL BIOL, V17, P644, DOI 10.1128/MCB.17.2.644; Misra P, 2002, J BIOL CHEM, V277, P48745, DOI 10.1074/jbc.M208829200; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; NATSUKA S, 1992, BLOOD, V79, P460; Nevado J, 2004, MOL CELL ENDOCRINOL, V222, P41, DOI 10.1016/j.mce.2004.05.003; Pandey PK, 2005, MOL CELL BIOL, V25, P10695, DOI 10.1128/MCB.25.24.10695-10710.2005; Park JM, 2003, MOL CELL BIOL, V23, P1358, DOI 10.1128/MCB.23.4.1358-1367.2003; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Ren YS, 2000, MOL CELL BIOL, V20, P5433, DOI 10.1128/MCB.20.15.5433-5446.2000; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Roy SK, 2000, J BIOL CHEM, V275, P12626, DOI 10.1074/jbc.275.17.12626; Roy SK, 2002, P NATL ACAD SCI USA, V99, P7945, DOI 10.1073/pnas.122075799; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Shui JW, 2004, GENESIS, V39, P217, DOI 10.1002/gene.20044; Simpson RJ, 2003, PROTEINS PROTEOMICS; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Taatjes DJ, 2004, NAT STRUCT MOL BIOL, V11, P664, DOI 10.1038/nsmb789; Taatjes DJ, 2004, MOL CELL, V14, P675, DOI 10.1016/j.molcel.2004.05.014; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; WILLIAMS SC, 1995, EMBO J, V14, P3170, DOI 10.1002/j.1460-2075.1995.tb07319.x; Xiao WH, 1997, P NATL ACAD SCI USA, V94, P103, DOI 10.1073/pnas.94.1.103; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	61	34	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13077	13086		10.1074/jbc.M800604200	http://dx.doi.org/10.1074/jbc.M800604200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18339625	Green Published, hybrid			2022-12-25	WOS:000255499800046
J	Adan, C; Matsushima, Y; Hernandez-Sierra, R; Marco-Ferreres, R; Fernandez-Moreno, MA; Gonzalez-Vioque, E; Calleja, M; Aragon, JJ; Kaguni, LS; Garesse, R				Adan, Cristina; Matsushima, Yuichi; Hernandez-Sierra, Rosana; Marco-Ferreres, Raquel; Fernandez-Moreno, Miguel Angel; Gonzalez-Vioque, Emiliano; Calleja, Manuel; Aragon, Juan J.; Kaguni, Laurie S.; Garesse, Rafael			Mitochondrial transcription factor B2 is essential for metabolic function in Drosophila melanogaster development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-GAMMA; RNA-POLYMERASE; RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; SCHNEIDER CELLS; GENE-EXPRESSION; SIGMA-FACTORS; COPY NUMBER; SC-MTTFB	Characterization of the basal transcription machinery of mitochondrial DNA (mtDNA) is critical to understand mitochondrial pathophysiology. In mammalian in vitro systems, mtDNA transcription requires mtRNA polymerase, transcription factor A (TFAM), and either transcription factor B1 (TFB1M) or B2 (TFB2M). We have silenced the expression of TFB2M by RNA interference in Drosophila melanogaster. RNA interference knockdown of TF2BM causes lethality by arrest of larval development. Molecular analysis demonstrates that TF2BM is essential for mtDNA transcription during Drosophila development and is not redundant with TFB1M. The impairment of mtDNA transcription causes a dramatic decrease in oxidative phosphorylation and mitochondrial ATP synthesis in the long-lived larvae, and a metabolic shift to glycolysis, which partially restores ATP levels and elicits a compensatory response at the nuclear level that increases mitochondrial mass. At the cellular level, the mitochondrial dysfunction induced by TFB2M knockdown causes a severe reduction in cell proliferation without affecting cell growth, and increases the level of apoptosis. In contrast, cell differentiation and morphogenesis are largely unaffected. Our data demonstrate the essential role of TFB2M in mtDNA transcription in a multicellular organism, and reveal the complex cellular, biochemical, and molecular responses induced by impairment of oxidative phosphorylation during Drosophila development.	[Adan, Cristina; Hernandez-Sierra, Rosana; Marco-Ferreres, Raquel; Fernandez-Moreno, Miguel Angel; Gonzalez-Vioque, Emiliano; Aragon, Juan J.; Garesse, Rafael] Univ Autonoma Madrid, Fac Med, CSIC,Dept Bioquim, CIBERER ISCIII,Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain; [Matsushima, Yuichi; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Calleja, Manuel] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Michigan State University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Garesse, R (corresponding author), Univ Autonoma Madrid, Fac Med, CSIC,Dept Bioquim, CIBERER ISCIII,Inst Invest Biomed Alberto Sols, C Arzobispo Morcillo 4, E-28029 Madrid, Spain.	rafael.garesse@uam.es	Marco-Ferreres, Raquel/J-7122-2012; Fernandez-Moreno, Miguel Angel/K-4425-2017; Garesse, Rafael/F-3836-2012	Fernandez-Moreno, Miguel Angel/0000-0002-3461-0726; Gonzalez Vioque, Emiliano/0000-0001-7279-4311; Garesse, Rafael/0000-0002-0338-2281; Marco-Ferreres, Raquel/0000-0002-6109-3840	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45295] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERTHIER F, 1986, NUCLEIC ACIDS RES, V14, P4519, DOI 10.1093/nar/14.11.4519; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; CLAYTON DA, 1992, J INHERIT METAB DIS, V15, P439, DOI 10.1007/BF01799602; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Cotney J, 2006, J MOL EVOL, V63, P707, DOI 10.1007/s00239-006-0075-1; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; Garesse R, 2005, IUBMB LIFE, V57, P555, DOI 10.1080/15216540500215572; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; GONZALEZMATEOS F, 1993, J BIOL CHEM, V268, P7809; Iyengar B, 1999, GENETICS, V153, P1809; Iyengar B, 2002, P NATL ACAD SCI USA, V99, P4483, DOI 10.1073/pnas.072664899; JANG SH, 1991, J BIOL CHEM, V266, P22671; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lefai E, 2000, MOL GEN GENET, V264, P37, DOI 10.1007/s004380000301; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Marco-Ferreres R, 2005, MECH DEVELOP, V122, P681, DOI 10.1016/j.mod.2004.12.005; Marin MC, 2004, MOL BIOL CELL, V15, P1185, DOI 10.1091/mbc.E03-09-0663; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; PENA P, 1993, BIOCHEM BIOPH RES CO, V195, P785, DOI 10.1006/bbrc.1993.2114; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Pham XH, 2006, J BIOL CHEM, V281, P24647, DOI 10.1074/jbc.M602429200; Reyes A, 2005, J BIOL CHEM, V280, P3242, DOI 10.1074/jbc.M411916200; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SCHINKEL AH, 1988, EMBO J, V7, P3255, DOI 10.1002/j.1460-2075.1988.tb03192.x; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; SHADEL GS, 1995, MOL CELL BIOL, V15, P2101; Shadel GS, 2004, TRENDS GENET, V20, P513, DOI 10.1016/j.tig.2004.08.005; Spinazzola A, 2007, BIOSCIENCE REP, V27, P39, DOI 10.1007/s10540-007-9036-1; Toivonen JM, 2001, GENETICS, V159, P241; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Zordan MA, 2006, GENETICS, V172, P229, DOI 10.1534/genetics.105.049072	45	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12333	12342		10.1074/jbc.M801342200	http://dx.doi.org/10.1074/jbc.M801342200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18308726	hybrid, Green Published			2022-12-25	WOS:000255340000050
J	Abe, T; Hashimoto, Y; Hosaka, H; Tomita-Yokotani, K; Kobayashi, M				Abe, Tomoko; Hashimoto, Yoshiteru; Hosaka, Hideaki; Tomita-Yokotani, Kaori; Kobayashi, Michihiko			Discovery of amide (peptide) bond synthetic activity in Acyl-CoA synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A SYNTHETASE; PSEUDOMONAS-CHLORORAPHIS B23; RHODOCOCCUS-RHODOCHROUS J1; CRYSTAL-STRUCTURE; FIREFLY LUCIFERASE; NITRILE HYDRATASE; ACETYL-COENZYME; TRANSCRIPTIONAL REGULATION; ADENYLATION DOMAINS; STRUCTURAL BASIS	Acyl-CoA synthetase, which is one of the acid-thiol ligases (EC 6.2.1), plays key roles in metabolic and regulatory processes. This enzyme forms a carbon-sulfur bond in the presence of ATP and Mg2+, yielding acyl-CoA thioesters from the corresponding free acids and CoA. This enzyme belongs to the superfamily of adenylate-forming enzymes, whose three-dimensional structures are analogous to one another. We here discovered a new reaction while studying the short-chain acyl-CoA synthetase that we recently reported (Hashimoto, Y., Hosaka, H., Oinuma, K., Goda, M., Higashibata, H., and Kobayashi, M. (2005) J. Biol. Chem. 280, 8660-8667). When L-cysteine was used as a substrate instead of CoA, N-acyl-L-cysteine was surprisingly detected as a reaction product. This finding demonstrated that the enzyme formed a carbon-nitrogen bond (EC 6.3.1 acid-ammonia (or amide) ligase (amide synthase); EC 6.3.2 acid-amino acid ligase (peptide synthase)) comprising the amino group of the cysteine and the carboxyl group of the acid. N-Acyl-D-cysteine, N-acyl-DL-homocysteine, and N-acyl-L-cysteine methyl ester were also synthesized from the corresponding cysteine analog substrates by the enzyme. Furthermore, this unexpected enzyme activity was also observed for acetyl-CoA synthetase and firefly luciferase, indicating the generality of the new reaction in the superfamily of adenylate-forming enzymes.	Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba; University of Tsukuba	Kobayashi, M (corresponding author), 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.							BLACK PN, 1992, J BIOL CHEM, V267, P25513; BRUCKNER H, 1995, J CHROMATOGR A, V711, P201, DOI 10.1016/0021-9673(95)00158-J; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DIXON M, 1964, ENZYMES, P315; Ehmann DE, 2000, P NATL ACAD SCI USA, V97, P2509, DOI 10.1073/pnas.040572897; Endo I, 1999, TRENDS BIOTECHNOL, V17, P244, DOI 10.1016/S0167-7799(99)01303-7; Faergeman NJ, 1997, BIOCHEM J, V323, P1; GOULD SJ, 1988, ANAL BIOCHEM, V175, P5, DOI 10.1016/0003-2697(88)90353-3; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hann EC, 1999, BIOORGAN MED CHEM, V7, P2239, DOI 10.1016/S0968-0896(99)00157-1; Hashimoto Y, 2005, J BIOL CHEM, V280, P8660, DOI 10.1074/jbc.M405686200; Herai S, 2004, P NATL ACAD SCI USA, V101, P14031, DOI 10.1073/pnas.0406058101; HOSAKA K, 1981, METHOD ENZYMOL, V71, P325; Ingram-Smith C, 2006, BIOCHEMISTRY-US, V45, P11482, DOI 10.1021/bi061023e; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Kaneko M, 2003, J BACTERIOL, V185, P20, DOI 10.1128/JB.185.1.20-27.2003; KOBAYASHI M, 1993, P NATL ACAD SCI USA, V90, P247, DOI 10.1073/pnas.90.1.247; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; KOBAYASHI M, 1992, TRENDS BIOTECHNOL, V10, P402, DOI 10.1016/0167-7799(92)90283-2; Komeda H, 1996, P NATL ACAD SCI USA, V93, P4267, DOI 10.1073/pnas.93.9.4267; Komeda H, 1996, P NATL ACAD SCI USA, V93, P10572, DOI 10.1073/pnas.93.20.10572; Komeda H, 1997, P NATL ACAD SCI USA, V94, P36, DOI 10.1073/pnas.94.1.36; Konishi K, 2006, P NATL ACAD SCI USA, V103, P564, DOI 10.1073/pnas.0505412103; Linne U, 2007, FEBS LETT, V581, P905, DOI 10.1016/j.febslet.2007.01.066; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Morgan-Kiss RM, 2004, J BIOL CHEM, V279, P37324, DOI 10.1074/jbc.M405233200; NAGASAWA T, 1987, EUR J BIOCHEM, V162, P691, DOI 10.1111/j.1432-1033.1987.tb10692.x; Nakamura M, 2005, BIOCHEM BIOPH RES CO, V331, P471, DOI 10.1016/j.bbrc.2005.03.202; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Oba Y, 2003, FEBS LETT, V540, P251, DOI 10.1016/S0014-5793(03)00272-2; Oinuma KI, 2003, J BIOL CHEM, V278, P29600, DOI 10.1074/jbc.M211832200; Samanta SK, 2005, MOL MICROBIOL, V55, P1151, DOI 10.1111/j.1365-2958.2004.04452.x; Schneider K, 2003, P NATL ACAD SCI USA, V100, P8601, DOI 10.1073/pnas.1430550100; SHIMIZU S, 1981, BIOCHEM BIOPH RES CO, V103, P1231, DOI 10.1016/0006-291X(81)90254-0; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; TANAKA T, 1979, EUR J BIOCHEM, V98, P165, DOI 10.1111/j.1432-1033.1979.tb13173.x; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953	40	21	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11312	11321		10.1074/jbc.M709654200	http://dx.doi.org/10.1074/jbc.M709654200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18305111	hybrid			2022-12-25	WOS:000255067400027
J	Izumikawa, T; Koike, T; Shiozawa, S; Sugahara, K; Tamura, JI; Kitagawa, H				Izumikawa, Tomomi; Koike, Toshiyasu; Shiozawa, Shoko; Sugahara, Kazuyuki; Tamura, Jun-Ichi; Kitagawa, Hiroshi			Identification of chondroitin sulfate glucuronyltransferase as chondroitin synthase-3 involved in chondroitin polymerization - Chondroitin polymerization is achieved by multiple enzyme complexes consisting of chondroitin synthase family members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; MOLECULAR-CLONING; HEPARAN-SULFATE; N-ACETYLGALACTOSAMINYLTRANSFERASE; DERMATAN SULFATE; GLUCURONIC-ACID; BIOSYNTHESIS; EXPRESSION; PROTEOGLYCANS; ELONGATION	Recently, we demonstrated that chondroitin polymerization is achieved by any two combinations of human chondroitin synthase-1 (ChSy-1), ChSy-2 (chondroitin sulfate synthase 3, CSS3), and chondroitin-polymerizing factor (ChPF). Although an additional ChSy family member, called chondroitin sulfate glucuronyltransferase (CSGlcA-T), has been identified, its involvement in chondroitin polymerization remains unclear because it possesses only glucuronyltransferase II activity responsible for the elongation of chondroitin sulfate (CS) chains. Herein, we report that CSGlcA-T exhibits polymerization activity on alpha-thrombomodulin bearing the truncated linkage region tetrasaccharide through its interaction with ChSy-1, ChSy-2 (CSS3), or ChPF, and the chain length of chondroitin formed by the co-expressed proteins in various combinations is different. In addition, ChSy family members co-expressed in various combinations exhibited distinct but overlapping acceptor substrate specificities toward the two synthetic acceptor substrates, GlcUA beta 1-3Gal beta 1-O-naphthalenemethanol and GlcUA beta 1-3Gal beta 1-O-C2H4NH-benzyloxycarbonyl, both of which share the disaccharide sequence with the glycosaminoglycan-protein linkage region tetrasaccharide. Moreover, overexpression of CSGlcA-T increased the amount of CS in HeLa cells, whereas the RNA interference of CSGlcA-T resulted in a reduction of the amount of CS in the cells. Furthermore, the analysis using the CSGlcA-T mutant that lacks any glycosyltransferase activity but interacts with other ChSy family members showed that the glycosyltransferase activity of CSGlcA-T plays an important role in chondroitin polymerization. Overall, these results suggest that chondroitin polymerization is achieved by multiple combinations of ChSy-1, ChSy-2, CSGlcA-T, and ChPF and that each combination may play a unique role in the biosynthesis of CS. Based on these results, we renamed CSGlcA-T chondroitin synthase-3 (ChSy-3).	[Izumikawa, Tomomi; Koike, Toshiyasu; Shiozawa, Shoko; Sugahara, Kazuyuki; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Tamura, Jun-Ichi] Tottori Univ, Fac Reg Sci, Dept Reg Environm, Tottori 6808551, Japan	Kobe Pharmaceutical University; Tottori University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079				Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fernandez CJ, 1998, J BIOL CHEM, V273, P19030, DOI 10.1074/jbc.273.30.19030; GLEESON PA, 1994, GLYCOCONJUGATE J, V11, P381, DOI 10.1007/BF00731273; Gotoh M, 2002, J BIOL CHEM, V277, P38189, DOI 10.1074/jbc.M203619200; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; Izumikawa T, 2004, J BIOL CHEM, V279, P53755, DOI 10.1074/jbc.M409615200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P531, DOI 10.1093/glycob/7.4.531; Kitagawa H, 1997, GLYCOBIOLOGY, V7, P905, DOI 10.1093/glycob/7.7.905; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; NAWA K, 1990, BIOCHEM BIOPH RES CO, V171, P729, DOI 10.1016/0006-291X(90)91207-9; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Prydz K, 2000, J CELL SCI, V113, P193; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SUGAHARA K, 1995, J BIOL CHEM, V270, P7204, DOI 10.1074/jbc.270.13.7204; SUGAHARA K, 1994, CARBOHYD RES, V255, P145, DOI 10.1016/S0008-6215(00)90976-5; Sugahara K, 2000, CURR OPIN STRUC BIOL, V10, P518, DOI 10.1016/S0959-440X(00)00125-1; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Uyama T, 2003, J BIOL CHEM, V278, P3072, DOI 10.1074/jbc.M209446200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; WATZELE G, 1990, NUCLEIC ACIDS RES, V18, P7174, DOI 10.1093/nar/18.23.7174; WIGGINS S, 1998, P NATL ACAD SCI USA, V95, P7845; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170	35	107	110	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11396	11406		10.1074/jbc.M707549200	http://dx.doi.org/10.1074/jbc.M707549200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18316376	hybrid			2022-12-25	WOS:000255067400037
J	Desrivieres, S; Krause, K; Dyer, A; Frank, J; Blomeyer, D; Lathrop, M; Mann, K; Banaschewski, T; Laucht, M; Schumann, G				Desrivieres, Sylvane; Krause, Kristina; Dyer, Anne; Frank, Josef; Blomeyer, Dorothea; Lathrop, Mark; Mann, Karl; Banaschewski, Tobias; Laucht, Manfred; Schumann, Gunter			Nucleotide Sequence Variation within the PI3K p85 Alpha Gene Associates with Alcohol Risk Drinking Behaviour in Adolescents	PLOS ONE			English	Article								Background: While the phosphatidylinositol 3-kinase (PI3K)-dependent signaling pathway is typically known to regulate cell growth and survival, emerging evidence suggest a role for this pathway in regulating the behavioural responses to addictive drugs. Methodology/Principal Findings: To investigate whether PI3K contributes to patterns of risky alcohol drinking in human, we investigated genetic variations in PIK3R1, encoding the 85 kD regulatory subunit of PIK, in 145 family trios consisting of 15-16 year old adolescents and their parents. Screening for mutations in exons, exon-intron boundaries and regulatory sequences, we identified 14 single nucleotide polymorphisms (SNPs) in the PIK3R1 gene region from exon 1 to the beginning of the 39 untranslated region (UTR). These SNPs defined haplotypes for the respective PIK3R1 region. Four haplotype tagging (ht)SNPs (rs706713, rs2302975, rs171649 and rs1043526), discriminating all haplotypes with a frequency >= 4.5% were identified. These htSNPs were used to genotype adolescents from the "Mannheim Study of Risk Children'' (MARC). Transmission disequilibrium tests in these adolescents and their parents demonstrated sex-specific association of two SNPs, rs2302975 and rs1043526, with patterns of risky alcohol consumption in male adolescents, including lifetime prevalence of drunkenness (p = 0.0019 and 0.0379, respectively) and elevated maximum amount of drinking (p = 0.0020 and 0.0494, respectively), as a measure for binge drinking pattern. Conclusions/Significance: Our findings highlight a previously unknown relevance of PIK3R1 genotypes for alcohol use disorders and might help discriminate individuals at risk for alcoholism.	[Desrivieres, Sylvane; Krause, Kristina; Schumann, Gunter] Kings Coll London, Sect Addict Biol, Interdisciplinary Res Grp Addict, London WC2R 2LS, England; [Krause, Kristina; Frank, Josef; Mann, Karl; Schumann, Gunter] Central Inst Mental Hlth, Dept Addict Med, Mol Genet Lab, Mannheim, Germany; [Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Blomeyer, Dorothea; Banaschewski, Tobias; Laucht, Manfred] Central Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany; [Dyer, Anne] Central Inst Mental Hlth, Dept Psychosomat Med, Mannheim, Germany; [Laucht, Manfred] Univ Potsdam, Dept Psychol, Div Clin Psychol, Potsdam, Germany	University of London; King's College London; Central Institute of Mental Health; CEA; UDICE-French Research Universities; Universite Paris Saclay; Central Institute of Mental Health; Central Institute of Mental Health; University of Potsdam	Desrivieres, S (corresponding author), Kings Coll London, Sect Addict Biol, Interdisciplinary Res Grp Addict, London WC2R 2LS, England.	manfred.laucht@zi-mannheim.de	Schumann, Gunter/H-1013-2013; Banaschewski, Tobias/ABE-5985-2020; Desrivieres, Sylvane/B-7399-2011; Desrivières, Sylvane/ABC-4336-2021	Banaschewski, Tobias/0000-0003-4595-1144; Desrivieres, Sylvane/0000-0002-9120-7060; Desrivières, Sylvane/0000-0002-9120-7060	German Federal Ministry for Education and Research [FKZ EB 01011300]; German National Genome Research Network [FKZ 01GS0117]; UK Department of Health NIHR-Biomedical Research Centre; European Commission [PL 037286]; Medical Research Council [G9817803B] Funding Source: researchfish	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network; UK Department of Health NIHR-Biomedical Research Centre; European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the German Federal Ministry for Education and Research as part of the "Baden-Wuerttemberg Consortium for Addiction Research" (FKZ EB 01011300), the German "National Genome Research Network" (FKZ 01GS0117) as well as the UK Department of Health NIHR-Biomedical Research Centre "Mental Health" and the Framework Programme 6 of the European Commission (Project "IMAGEN" PL 037286). Design and conduct of the study, collection, analysis, interpretation of the data, preparation, review and approval of the manuscript were completely independent of the sponsors of this study.	Backstrom P, 2004, NEUROPSYCHOPHARMACOL, V29, P921, DOI 10.1038/sj.npp.1300381; Bonomo YA, 2004, ADDICTION, V99, P1520, DOI 10.1111/j.1360-0443.2004.00846.x; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; Cowen MS, 2005, J PHARMACOL EXP THER, V315, P590, DOI 10.1124/jpet.105.090449; Crabbe JC, 2002, ANNU REV PSYCHOL, V53, P435, DOI 10.1146/annurev.psych.53.100901.135142; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Daw MI, 2002, NAT NEUROSCI, V5, P835, DOI 10.1038/nn903; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; Dodd PR, 2000, NEUROCHEM INT, V37, P509, DOI 10.1016/S0197-0186(00)00061-9; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Fiskerstrand CE, 1999, FEBS LETT, V458, P171, DOI 10.1016/S0014-5793(99)01150-3; Gong R, 2006, J BIOL CHEM, V281, P18802, DOI 10.1074/jbc.M512524200; Grant BF, 1997, J SUBST ABUSE, V9, P103, DOI 10.1016/S0899-3289(97)90009-2; Higuchi S, 2006, CURR OPIN PSYCHIATR, V19, P253, DOI 10.1097/01.yco.0000218595.54054.7a; Hingson R, 2003, J STUD ALCOHOL, V64, P23, DOI 10.15288/jsa.2003.64.23; Hodge CW, 2006, PSYCHOPHARMACOLOGY, V183, P429, DOI 10.1007/s00213-005-0217-y; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huang CC, 2004, J NEUROCHEM, V89, P217, DOI 10.1111/j.1471-4159.2003.02307.x; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Izzo E, 2002, NAT NEUROSCI, V5, P1263, DOI 10.1038/nn977; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; Laucht M, 2000, J AM ACAD CHILD PSY, V39, P1229, DOI 10.1097/00004583-200010000-00009; Long Fan, 2004, In Silico Biology, V4, P395; MacKenzie A, 1999, P NATL ACAD SCI USA, V96, P15251, DOI 10.1073/pnas.96.26.15251; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; McCarty CA, 2004, PEDIATRICS, V114, P714, DOI 10.1542/peds.2003-0864-L; MULLER R, 1991, CHANGING TRENDS CONS; Nolen-Hoeksema S, 2006, J GEN PSYCHOL, V133, P357, DOI 10.3200/GENP.133.4.357-374; Olive MF, 2005, MOL PHARMACOL, V67, P349, DOI 10.1124/mol.104.003319; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Pincock S, 2003, LANCET, V362, P1126, DOI 10.1016/S0140-6736(03)14502-3; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sanna PP, 2002, J NEUROSCI, V22, P3359; Schroeder JP, 2005, PSYCHOPHARMACOLOGY, V179, P262, DOI 10.1007/s00213-005-2175-9; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Sher KJ, 2005, ANNU REV CLIN PSYCHO, V1, P493, DOI 10.1146/annurev.clinpsy.1.102803.144107; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Tsai GC, 1998, ANNU REV MED, V49, P173; Tyndale RF, 2003, ANN MED, V35, P94, DOI 10.1080/07853890310010014; Uhl GR, 2008, BIOCHEM PHARMACOL, V75, P98, DOI 10.1016/j.bcp.2007.06.042; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; XU K, 2007, PHARMACOGENOMICS J	49	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1769	10.1371/journal.pone.0001769	http://dx.doi.org/10.1371/journal.pone.0001769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335044	gold, Green Published, Green Submitted			2022-12-25	WOS:000260723000023
J	Mohan, S; Ma, PWK; Williams, WP; Luthe, DS				Mohan, Srinidi; Ma, Peter W. K.; Williams, W. Paul; Luthe, Dawn S.			A Naturally Occurring Plant Cysteine Protease Possesses Remarkable Toxicity against Insect Pests and Synergizes Bacillus thuringiensis Toxin	PLOS ONE			English	Article							CORN-BORER LEPIDOPTERA; PERITROPHIC MATRIX; TRANSGENIC PLANTS; INTESTINAL MUCIN; DIAMONDBACK MOTH; RESISTANCE; NOCTUIDAE; PROTEINS; CROPS; DEGRADATION	When caterpillars feed on maize (Zea maize L.) lines with native resistance to several Lepidopteran pests, a defensive cysteine protease, Mir1-CP, rapidly accumulates at the wound site. Mir1-CP has been shown to inhibit caterpillar growth in vivo by attacking and permeabilizing the insect's peritrophic matrix (PM), a structure that surrounds the food bolus, assists in digestion and protects the midgut from microbes and toxins. PM permeabilization weakens the caterpillar defenses by facilitating the movement of other insecticidal proteins in the diet to the midgut microvilli and thereby enhancing their toxicity. To directly determine the toxicity of Mir1-CP, the purified recombinant enzyme was directly tested against four economically significant Lepidopteran pests in bioassays. Mir1-CP LC50 values were 1.8, 3.6, 0.6, and 8.0 ppm for corn earworm, tobacco budworm, fall armyworm and southwestern corn borer, respectively. These values were the same order of magnitude as those determined for the Bacillus thuringiensis toxin Bt-CryIIA. In addition to being directly toxic to the larvae, 60 ppb Mir1-CP synergized sublethal concentrations of Bt-CryIIA in all four species. Permeabilization of the PM by Mir1-CP probably provides ready access to Bt-binding sites on the midgut microvilli and increases its activity. Consequently, Mir1-CP could be used for controlling caterpillar pests in maize using non-transgenic approaches and potentially could be used in other crops either singly or in combination with Bt-toxins.	[Mohan, Srinidi; Ma, Peter W. K.] Mississippi State, Dept Entomol, Starkville, MS USA; [Williams, W. Paul] Mississippi State, USDA ARS, Corn Host Plant Resist Lab, Starkville, MS USA; [Luthe, Dawn S.] Penn State Univ, Dept Crop & Soil Sci, University Pk, PA USA	Mississippi State University; Mississippi State University; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Mohan, S (corresponding author), Mississippi State, Dept Entomol, Starkville, MS USA.	DSL14@psu.edu	GUO, Zhaoyu/AAS-5699-2020		National Science Foundation Awards [IBN-0131328, IOS-0641219]	National Science Foundation Awards(National Science Foundation (NSF))	This research was funded by National Science Foundation Awards IBN-0131328 and IOS-0641219.	Ali MI, 2007, J ECON ENTOMOL, V100, P921, DOI 10.1603/0022-0493(2007)100[921:SOBATB]2.0.CO;2; Ali MI, 2006, J ECON ENTOMOL, V99, P164, DOI 10.1603/0022-0493(2006)099[0164:SOHZAH]2.0.CO;2; BOULTER D, 1993, PHYTOCHEMISTRY, V34, P1453, DOI 10.1016/S0031-9422(00)90828-8; Brookes G., 2005, AgBioForum, V8, P187; Chaufaux J, 2001, J ECON ENTOMOL, V94, P1564, DOI 10.1603/0022-0493-94.6.1564; Chen J, 2007, P NATL ACAD SCI USA, V104, P13901, DOI 10.1073/pnas.0706011104; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; DAVIS FM, 1988, MISS AGR EXP STN TEC, V157, P1; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Ferry N, 2006, TRANSGENIC RES, V15, P13, DOI 10.1007/s11248-005-4803-x; Ferry N, 2004, CURR OPIN BIOTECH, V15, P155, DOI 10.1016/j.copbio.2004.01.008; GATEHOUSE AMR, 1993, PHILOS T R SOC B, V342, P279, DOI 10.1098/rstb.1993.0158; Gould F, 2003, NAT BIOTECHNOL, V21, P1450, DOI 10.1038/nbt1203-1450; HAMA H, 1992, APPL ENTOMOL ZOOL, V27, P355, DOI 10.1303/aez.27.355; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Hoffmann WA, 2002, ANN BOT-LONDON, V90, P37, DOI 10.1093/aob/mcf140; HOFMANN C, 1988, EUR J BIOCHEM, V173, P85, DOI 10.1111/j.1432-1033.1988.tb13970.x; HOFTE H, 1989, MICROBIOL REV, V53, P242; Huesing J., 2004, AgBioForum, V7, P84; James C., 2006, PREVIEW GLOBAL STATU; Jenkins JL, 2000, J BIOL CHEM, V275, P14423, DOI 10.1074/jbc.275.19.14423; KNOWLES BH, 1987, BIOCHIM BIOPHYS ACTA, V924, P509, DOI 10.1016/0304-4165(87)90167-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECADET MM, 1967, J INVERTEBR PATHOL, V9, P310, DOI 10.1016/0022-2011(67)90065-1; Lopez L, 2007, PLANTA, V226, P517, DOI 10.1007/s00425-007-0501-7; LUTHY P, 1981, BACILLUS THURINGIENS; Mohan S, 2006, J INSECT PHYSIOL, V52, P21, DOI 10.1016/j.jinsphys.2005.08.011; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pechan T, 2002, P NATL ACAD SCI USA, V99, P13319, DOI 10.1073/pnas.202224899; PECHAN T, 2000, PLANT CELL, V33; RAWLINGS ND, 1992, BIOL CHEM H-S, V373, P1211, DOI 10.1515/bchm3.1992.373.2.1211; ROBERTSON JL, PESTICIDE BIOASSAYS; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; *SAS I INC, 1998, SAS STAT US GUID VER; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; Tabashnik BE, 2004, J EVOLUTION BIOL, V17, P904, DOI 10.1111/j.1420-9101.2004.00695.x; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; TOJO A, 1983, APPL ENVIRON MICROB, V45, P576, DOI 10.1128/AEM.45.2.576-580.1983; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593; Wang P, 1997, P NATL ACAD SCI USA, V94, P6977, DOI 10.1073/pnas.94.13.6977; Wang P, 1997, J BIOL CHEM, V272, P16663, DOI 10.1074/jbc.272.26.16663; Wang P, 2001, ARCH INSECT BIOCHEM, V47, P110, DOI 10.1002/arch.1041; WI FIJ, 1999, J GEN VIROL, V80, P3289; WILLIAMS WP, 1990, J ECON ENTOMOL, V83, P1578, DOI 10.1093/jee/83.4.1578; Zhao JZ, 2003, NAT BIOTECHNOL, V21, P1493, DOI 10.1038/nbt907	45	47	49	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1786	10.1371/journal.pone.0001786	http://dx.doi.org/10.1371/journal.pone.0001786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335057	gold, Green Published, Green Submitted			2022-12-25	WOS:000260723000038
J	Bouchabke, O; Chang, FQ; Simon, M; Voisin, R; Pelletier, G; Durand-Tardif, M				Bouchabke, Oumaya; Chang, Fengqi; Simon, Matthieu; Voisin, Roger; Pelletier, Georges; Durand-Tardif, Mylene			Natural Variation in Arabidopsis thaliana as a Tool for Highlighting Differential Drought Responses	PLOS ONE			English	Article							CELL-MEMBRANE STABILITY; WATER-USE EFFICIENCY; PLANT-RESPONSES; COMPLEX TRAITS; IDENTIFICATION; EXPRESSION; TOLERANCE; DEFICIT; STRESS; GROWTH	To test whether natural variation in Arabidopsis could be used to dissect out the genetic basis of responses to drought stress, we characterised a number of accessions. Most of the accessions belong to a core collection that was shown to maximise the genetic diversity captured for a given number of individual accessions in Arabidopsis thaliana. We measured total leaf area (TLA), Electrolyte Leakage (EL), Relative Water Content (RWC), and Cut Rosette Water Loss (CRWL) in control and mild water deficit conditions. A Principal Component Analysis revealed which traits explain most of the variation and showed that some accessions behave differently compared to the others in drought conditions, these included Ita-0, Cvi-0 and Shahdara. This study relied on genetic variation found naturally within the species, in which populations are assumed to be adapted to their environment. Overall, Arabidopsis thaliana showed interesting phenotypic variations in response to mild water deficit that can be exploited to identify genes and alleles important for this complex trait.	[Bouchabke, Oumaya; Chang, Fengqi; Simon, Matthieu; Voisin, Roger; Pelletier, Georges; Durand-Tardif, Mylene] INRA, Stn Genet Amelioration plantes, F-78026 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Bouchabke, O (corresponding author), INRA, Stn Genet Amelioration plantes, F-78026 Versailles, France.	durand-t@versailles.inra.fr		Mylene, Durand-Tardif/0000-0003-1568-6941; Bouchabke-Coussa, Oumaya/0000-0003-3311-666X	PRA fellowship [BT02-5]; INRA	PRA fellowship; INRA	Dr. F. Chang has been supported by a PRA fellowship (BT02-5). All the other authors received INRA support.	Aguirrezabal L, 2006, PLANT CELL ENVIRON, V29, P2216, DOI 10.1111/j.1365-3040.2006.01595.x; Alonso-Blanco C, 2000, TRENDS PLANT SCI, V5, P22, DOI 10.1016/S1360-1385(99)01510-1; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Bandurska H, 2001, ACTA PHYSIOL PLANT, V23, P483, DOI 10.1007/s11738-001-0059-0; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Bruce WB, 2002, J EXP BOT, V53, P13, DOI 10.1093/jexbot/53.366.13; Calenge F, 2006, PLANT PHYSIOL, V141, P1630, DOI 10.1104/pp.106.082396; Cornic G, 2002, ANN BOT-LONDON, V89, P887, DOI 10.1093/aob/mcf064; Diaz U, 2006, PLANT CELL PHYSIOL, V47, P74, DOI 10.1093/pcp/pci225; Didier G, 2002, BIOINFORMATICS, V18, P490, DOI 10.1093/bioinformatics/18.3.490; Granier C, 2006, NEW PHYTOL, V169, P623, DOI 10.1111/j.1469-8137.2005.01609.x; HSIAO TC, 1973, ANNU REV PLANT PHYS, V24, P519, DOI 10.1146/annurev.pp.24.060173.002511; Jones HG, 2007, J EXP BOT, V58, P119, DOI 10.1093/jxb/erl118; Juenger TE, 2005, PLANT CELL ENVIRON, V28, P697, DOI 10.1111/j.1365-3040.2004.01313.x; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kliebenstein DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-308; Knight CA, 2006, MOL ECOL, V15, P1229, DOI 10.1111/j.1365-294X.2006.02818.x; KOORNNEEF M, 2004, ANN REV PLANT BIOL, V55; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; Liu L, 2004, EUPHYTICA, V138, P149, DOI 10.1023/B:EUPH.0000046801.27042.14; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; LUDLOW MM, 1989, STRUCTURAL AND FUNCTIONAL RESPONSES TO ENVIRONMENTAL STRESSES : WATER SHORTAGE, P269; McKay JK, 2003, MOL ECOL, V12, P1137, DOI 10.1046/j.1365-294X.2003.01833.x; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Mouille G, 2006, PLANT PHYSIOL, V141, P1035, DOI 10.1104/pp.106.079384; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Paran I, 2003, TRENDS GENET, V19, P303, DOI 10.1016/S0168-9525(03)00117-3; Perchepied L, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000123; Pigliucci M, 1998, TRENDS PLANT SCI, V3, P485, DOI 10.1016/S1360-1385(98)01343-0; PREMACHANDRA GS, 1992, J EXP BOT, V43, P1569, DOI 10.1093/jxb/43.12.1569; Quartacci MF, 2002, J EXP BOT, V53, P2159, DOI 10.1093/jxb/erf076; Reymond M, 2006, PLANT CELL ENVIRON, V29, P115, DOI 10.1111/j.1365-3040.2005.01405.x; Richards LA, 1941, SOIL SCI, V51, P377, DOI 10.1097/00010694-194105000-00005; Richards RA, 1996, PLANT GROWTH REGUL, V20, P157, DOI 10.1007/BF00024012; Richards RA, 2000, J EXP BOT, V51, P447, DOI 10.1093/jexbot/51.suppl_1.447; Scott P, 2000, ANN BOT-LONDON, V85, P159, DOI 10.1006/anbo.1999.1006; Sherrard ME, 2006, EVOLUTION, V60, P2478, DOI 10.1111/j.0014-3820.2006.tb01883.x; Shindo C, 2007, ANN BOT-LONDON, V99, P1043, DOI 10.1093/aob/mcl281; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Zhang JZ, 2004, PLANT PHYSIOL, V135, P615, DOI 10.1104/pp.104.040295	44	99	101	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1705	10.1371/journal.pone.0001705	http://dx.doi.org/10.1371/journal.pone.0001705			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301780	Green Submitted, gold, Green Published			2022-12-25	WOS:000260586500049
J	Popmihajlov, Z; Smith, KA				Popmihajlov, Zoran; Smith, Kendall A.			Negative Feedback Regulation of T Cells via Interleukin-2 and FOXP3 Reciprocity	PLOS ONE			English	Article								As interleukin-2 (IL2) is central to the clonal expansion of antigen-selected T cells, we investigated the relationship between IL2 and the negative regulatory transcription factor FOXP3. We found IL2 to be responsible for T cell antigen receptor (TCR)activated FOXP3 expression by both CD4+ and CD8+ human T cells, and as anticipated, FOXP3 expression restricted TCR-stimulated IL2 expression. However, no evidence could be found that FOXP3+ cells actively suppress IL2 expression by FOXP3-cells. These data are consistent with an IL2/FOXP3- dependent negative feedback loop that normally regulates the T cell immune response. It follows that a defect in this negative feedback loop as a result of a deficiency of either IL2 or FOXP3 will lead to a hyperproliferative autoimmune syndrome, without the necessity of invoking an active suppressive function for FOXP3+ T cells.	[Popmihajlov, Zoran; Smith, Kendall A.] Cornell Univ, Div Immunol, Dept Med, Weill Med Coll, New York, NY 10021 USA	Cornell University	Popmihajlov, Z (corresponding author), Cornell Univ, Div Immunol, Dept Med, Weill Med Coll, New York, NY 10021 USA.	kasmith@med.cornell.edu			NIAID/NIH; Belfer Foundation	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Belfer Foundation	NIAID/NIH, Belfer Foundation. Neither funding source participated in the conduct of the study, in the collection, analysis, intrpretation of the data, or in the preparation, review or approval of the manuscript.	Ahmadzadeh M, 2007, J IMMUNOTHER, V30, P294, DOI 10.1097/CJI.0b013e3180336787; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; BEADLING C, 1994, EMBO J, V13, P5605, DOI 10.1002/j.1460-2075.1994.tb06898.x; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; BLAIR PJ, 1994, J IMMUNOL, V153, P3764; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clark LB, 1999, J IMMUNOL, V162, P2546; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; GARRITY PA, 1994, MOL CELL BIOL, V14, P2159, DOI 10.1128/MCB.14.3.2159; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; GILLIS S, 1978, J IMMUNOL, V120, P2027; GODFREY VL, 1994, AM J PATHOL, V145, P281; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Grant C, 2006, PLOS PATHOG, V2, P303, DOI 10.1371/journal.ppat.0020033; Horak I, 1995, IMMUNOL REV, V148, P35, DOI 10.1111/j.1600-065X.1995.tb00092.x; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Kanangat S, 1996, EUR J IMMUNOL, V26, P161, DOI 10.1002/eji.1830260125; Kelly JA, 2003, J EXP MED, V198, P79, DOI 10.1084/jem.20021548; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Klebb G, 1996, CLIN IMMUNOL IMMUNOP, V81, P282, DOI 10.1006/clin.1996.0190; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Kuroda K, 1996, J IMMUNOL, V157, P1422; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; MARSON A, 2007, NATURE; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; PANDIYAN P, 2007, NAT IMMUNOL     1104, P1; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; RUSSELL WL, 1959, P NATL ACAD SCI USA, V45, P18, DOI 10.1073/pnas.45.1.18; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x; SMITH KA, 1989, ANNU REV CELL BIOL, V5, P397; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; SuriPayer E, 1996, J IMMUNOL, V157, P1799; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng Y., 2007, NATURE; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	64	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2008	3	2							e1581	10.1371/journal.pone.0001581	http://dx.doi.org/10.1371/journal.pone.0001581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367ES	18324310	Green Published, gold, Green Submitted			2022-12-25	WOS:000260535900017
J	Chae, HD; Kim, BM; Yun, UJ; Shin, DY				Chae, H. D.; Kim, B. M.; Yun, U. J.; Shin, D. Y.			Deregulation of Cdk2 causes Bim-mediated apoptosis in p53-deficient tumors following actin damage	ONCOGENE			English	Article						actin; apoptosis; polyploidy; Bim; Cdk2	Y TRANSCRIPTION FACTOR; CDK2-DEPENDENT PHOSPHORYLATION; CELL-DEATH; P53; CHECKPOINT; EXPRESSION; INHIBITORS; ARREST; DNA; REREPLICATION	We previously reported that actin damage by treatment with an actin-depolymerizing agent including pectenotoxin-2 induces Bim-mediated apoptosis in p53-deficient human tumors. In this study, we investigated a molecular mechanism underlying Bim-mediated apoptosis of p53-deficient tumor cells following actin damage. We found that actin inhibitors increased the protein levels of p53 and p21 and thereby inactivated both Cdk2 and Cdc2 kinases. However, p53- or p21-knockout cells fail to induce p21 and hence kept both Cdk2 and Cdc2 kinases active even after treatment with actin inhibitor. The p53- or p21-knockout cells became multinucleate and polyploidy in association with induction of apoptosis. Expression of Bcl-x(L) resulted in accumulation of polyploid cells in association with inhibition of apoptosis. However, expression of a dominant negative mutant ( Cdk2dn) and treatment with chemical inhibitors for Cdk2 suppressed not only accumulation of multinucleated cells, but also induction of Bim expression and apoptosis. Therefore, these results suggest that Bim-mediated apoptosis following actin damage due to deregulation of Cdk2 and the cell cycle by the absence of functional p53.	[Chae, H. D.; Kim, B. M.; Yun, U. J.; Shin, D. Y.] Dankook Univ Coll Med, Dept Microbiol, Natl Res Lab, Cheonan 330714, South Korea; [Chae, H. D.; Kim, B. M.; Yun, U. J.; Shin, D. Y.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea	Dankook University; Seoul National University (SNU)	Shin, DY (corresponding author), Dankook Univ Coll Med, Dept Microbiol, Natl Res Lab, Anseo 29, Cheonan 330714, South Korea.	dreamer@dku.edu	Chae, Hee-Don/D-2620-2011					Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Castedo M, 2006, EMBO J, V25, P2584, DOI 10.1038/sj.emboj.7601127; Chae HD, 2005, ONCOGENE, V24, P4813, DOI 10.1038/sj.onc.1208640; Chae HD, 2004, ONCOGENE, V23, P4084, DOI 10.1038/sj.onc.1207482; Di Leonardo A, 1997, CANCER RES, V57, P1013; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jordan MA, 1996, CANCER RES, V56, P816; JORDAN MA, 1991, CANCER RES, V51, P2212; Jung MS, 2001, ONCOGENE, V20, P5818, DOI 10.1038/sj.onc.1204748; Khan SH, 1998, CANCER RES, V58, P396; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Torres K, 1998, CANCER RES, V58, P3620; Yun JH, 2003, J BIOL CHEM, V278, P36966, DOI 10.1074/jbc.M305178200	26	19	19	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 3	2008	27	29					4115	4121		10.1038/onc.2008.46	http://dx.doi.org/10.1038/onc.2008.46			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	321RV	18345036				2022-12-25	WOS:000257325100011
J	Chen, SY; Pan, CJ; Nandigama, K; Mansfield, BC; Ambudkar, SV; Chou, JY				Chen, Shih-Yin; Pan, Chi-Jiunn; Nandigama, Krishnamachary; Mansfield, Brian C.; Ambudkar, Suresh V.; Chou, Janice Y.			The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic	FASEB JOURNAL			English	Article						proteoliposomes; glucose-6-phosphatase-alpha; endoplasmic reticulum; chorogenic acid; vanadate	ESCHERICHIA-COLI; MICROSOMAL GLUCOSE-6-PHOSPHATASE; GLUCOSE 6-PHOSPHATASE; TRANSMEMBRANE TOPOLOGY; ENZYME-DEFICIENT; CHROMOSOME 11Q23; ANION-EXCHANGE; NON-A; GENE; MUTATIONS	Glycogen storage disease type Ib (GSD-Ib) is caused by deficiencies in the glucose-6-phosphate (G6P) transporter (G6PT) that have been well characterized. Interestingly, deleterious mutations in the G6PT gene were identified in clinical cases of GSD type Ic (GSD-Ic) proposed to be deficient in an inorganic phosphate (P-i) transporter. We hypothesized that G6PT is both the G6P and Pi transporter. Using reconstituted proteoliposomes we show that both G6P and P-i are efficiently taken up into P-i-loaded G6PT-proteoliposomes. The G6P uptake activity decreases as the internal: external P-i ratio decreases and the P-i uptake activity decreases in the presence of external G6P. Moreover, G6P or P-i uptake activity is not detectable in P-i-loaded proteoliposomes containing the p.R28H G6PT null mutant. The G6PT-proteoliposome-mediated G6P or P-i uptake is inhibited by cholorgenic acid and vanadate, both specific G6PT inhibitors. Glucose-6-phosphatase-alpha (G6Pase-alpha), which facilitates microsomal G6P uptake by G6PT, fails to stimulate G6P uptake in P-i-loaded G6PT-proteoliposomes, suggesting that the G6Pase-alpha-mediated stimulation is caused by decreasing G6P and increasing P-i concentrations in microsomes. Taken together, our results suggest that G6PT has a dual role as a G6P and a P-i transporter and that GSD-Ib and GSD-Ic are deficient in the same G6PT gene.	[Chen, Shih-Yin; Pan, Chi-Jiunn; Mansfield, Brian C.; Chou, Janice Y.] NICHHD, Sect Cellular Differentiat, Heritable Disorders Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; [Nandigama, Krishnamachary; Ambudkar, Suresh V.] Natl Canc Inst, Cell Biol Lab, Ctr Canc Res, Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chou, JY (corresponding author), NICHHD, Sect Cellular Differentiat, Heritable Disorders Branch, Natl Inst Hlth, Bldg 10,Rm 9D42,10 Ctr Dr, Bethesda, MD 20892 USA.	chouja@mail.nih.gov	Ambudkar, Suresh V/L-1317-2016	Mansfield, Brian/0000-0002-8533-2789	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000912] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000912] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010030, Z01BC010030] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AMBUDKAR SV, 1986, J BIOL CHEM, V261, P9083; AMBUDKAR SV, 1986, J BIOL CHEM, V261, P79; AMBUDKAR SV, 1984, J BIOL CHEM, V259, P6142; Annabi B, 1998, AM J HUM GENET, V62, P400, DOI 10.1086/301727; ARION WJ, 1980, J BIOL CHEM, V255, P396; ARION WJ, 1972, J BIOL CHEM, V247, P2558; ARION WJ, 1976, J BIOL CHEM, V251, P4901; Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874; BEAUDET AL, 1980, J PEDIATR-US, V97, P906, DOI 10.1016/S0022-3476(80)80418-5; BERTELOOT A, 1991, J BIOL CHEM, V266, P5497; Chen LY, 2000, J BIOL CHEM, V275, P34280, DOI 10.1074/jbc.M006439200; Chen LY, 2002, HUM MOL GENET, V11, P3199, DOI 10.1093/hmg/11.25.3199; Chou Janice Yang, 2002, Current Molecular Medicine (Hilversum), V2, P121, DOI 10.2174/1566524024605798; CHOU JY, 2003, MEMBRANE TRANSPORTER, P191; Davies DR, 2004, FEBS LETT, V577, P315, DOI 10.1016/j.febslet.2004.10.022; Galli L, 1999, FEBS LETT, V459, P255, DOI 10.1016/S0014-5793(99)01248-X; Gerin I, 1997, FEBS LETT, V419, P235, DOI 10.1016/S0014-5793(97)01463-4; Ghosh A, 2002, J BIOL CHEM, V277, P32837, DOI 10.1074/jbc.M201853200; GITZELMANN R, 1993, EUR J PEDIATR, V152, pS33; GOLDRICK D, 1988, J BACTERIOL, V179, P3421; Hiraiwa H, 1999, J BIOL CHEM, V274, P5532, DOI 10.1074/jbc.274.9.5532; Janecke AR, 2000, HUM GENET, V107, P285, DOI 10.1007/s004390000371; LEI KJ, 1994, J CLIN INVEST, V93, P1994, DOI 10.1172/JCI117192; LEI KJ, 1995, J CLIN INVEST, V95, P234, DOI 10.1172/JCI117645; LEI KJ, 1995, AM J HUM GENET, V57, P766; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Lin BC, 1999, HUM GENET, V105, P515, DOI 10.1007/s004390051140; MALONEY PC, 1989, ARCH BIOCHEM BIOPHYS, V269, P1, DOI 10.1016/0003-9861(89)90080-5; MALONEY PC, 1990, MICROBIOL REV, V54, P1; NARISAWA K, 1978, BIOCHEM BIOPH RES CO, V83, P1360, DOI 10.1016/0006-291X(78)91371-2; NILSSON OS, 1978, EUR J BIOCHEM, V82, P627, DOI 10.1111/j.1432-1033.1978.tb12059.x; NORDLIE RC, 1983, J BIOL CHEM, V258, P9739; Pan CJ, 1999, J BIOL CHEM, V274, P13865, DOI 10.1074/jbc.274.20.13865; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SENIOR B, 1968, NEW ENGL J MED, V279, P958, DOI 10.1056/NEJM196810312791802; SHELLY LL, 1993, J BIOL CHEM, V268, P21482; SINGH J, 1981, BIOCHIM BIOPHYS ACTA, V678, P477, DOI 10.1016/0304-4165(81)90129-X; SONNA LA, 1988, J BIOL CHEM, V263, P6625; Veiga-Da-Cunha M, 1999, EUR J HUM GENET, V7, P717, DOI 10.1038/sj.ejhg.5200366; Veiga-da-Cunha M, 1998, AM J HUM GENET, V63, P976, DOI 10.1086/302068; VIANNA AL, 1969, J BIOL CHEM, V244, P4027; VIITANEN P, 1986, METHOD ENZYMOL, V125, P429; WESTON LA, 1987, J BACTERIOL, V169, P3546, DOI 10.1128/jb.169.8.3546-3555.1987	46	39	40	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2008	22	7					2206	2213		10.1096/fj.07-104851	http://dx.doi.org/10.1096/fj.07-104851			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18337460				2022-12-25	WOS:000257292500013
J	Wypych, J; Li, M; Guo, A; Zhang, ZQ; Martinez, T; Allen, MJ; Fodor, S; Kelner, DN; Flynn, GC; Liu, YQD; Bondarenko, PV; Ricci, MS; Dillon, TM; Balland, A				Wypych, Jette; Li, Ming; Guo, Amy; Zhang, Zhongqi; Martinez, Theresa; Allen, Martin J.; Fodor, Szilan; Kelner, Drew N.; Flynn, Gregory C.; Liu, Yaoqing Diana; Bondarenko, Pavel V.; Ricci, Margaret Speed; Dillon, Thomas M.; Balland, Alain			Human IgG2 antibodies display disulfide-mediated structural isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; INDUCED DISSOCIATION SPECTRA; HINGE REGION; DISULPHIDE BRIDGES; IMMUNOGLOBULIN G; SPECTROMETRY METHOD; MASS-SPECTROMETRY; HEAVY CHAIN; PEPTIDES; PREDICTION	In this work, we present studies of the covalent structure of human IgG2 molecules. Detailed analysis showed that recombinant human IgG2 monoclonal antibody could be partially resolved into structurally distinct forms caused by multiple disulfide bond structures. In addition to the presently accepted structure for the human IgG2 subclass, we also found major structures that differ from those documented in the current literature. These novel structural isoforms are defined by the light chain constant domain (CL) and the heavy chain C(H)1 domain covalently linked via disulfide bonds to the hinge region of the molecule. Our results demonstrate the presence of three main types of structures within the human IgG2 subclass, and we have named these structures IgG2-A, -B, and -A/B. IgG2-A is the known classic structure for the IgG2 subclass defined by structurally independent Fab domains and hinge region. IgG2-B is a structure defined by a symmetrical arrangement of a (C(H)1-C-L-hinge) 2 complex with both Fab regions covalently linked to the hinge. IgG2-A/B represents an intermediate form, defined by an asymmetrical arrangement involving one Fab arm covalently linked to the hinge through disulfide bonds. The newly discovered structural isoforms are present in native human IgG2 antibodies isolated from myeloma plasma and from normal serum. Furthermore, the isoforms are present in native human IgG2 with either kappa or lambda light chains, although the ratios differ between the light chain classes. These findings indicate that disulfide structural heterogeneity is a naturally occurring feature of antibodies belonging to the human IgG2 subclass.	[Wypych, Jette; Li, Ming; Guo, Amy; Martinez, Theresa; Fodor, Szilan; Kelner, Drew N.; Flynn, Gregory C.; Liu, Yaoqing Diana; Balland, Alain] Amgen Inc, Dept Analyt Sci, Thousand Oaks, CA 91320 USA; [Zhang, Zhongqi] Amgen Inc, Dept Global Cellular & Analyt Resources, Thousand Oaks, CA 91320 USA; [Allen, Martin J.] Amgen Inc, Dept Cell Sci & Technol, Thousand Oaks, CA 91320 USA; [Bondarenko, Pavel V.; Ricci, Margaret Speed; Dillon, Thomas M.] Amgen Inc, Dept Pharmaceut, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen; Amgen	Wypych, J (corresponding author), 1 Amgen Ctr Dr,Mail Stop 30E-1-C, Thousand Oaks, CA 91320 USA.	jwypych@amgen.com; ballanda@amgen.com	Liu, Y Diana/AAU-4624-2021					Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Bloom JW, 1997, PROTEIN SCI, V6, P407; BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; Buchner J, 2002, J MOL BIOL, V318, P829, DOI 10.1016/S0022-2836(02)00171-7; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Bures EJ, 1998, BIOCHEMISTRY-US, V37, P12172, DOI 10.1021/bi981082v; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Creighton CJ, 2001, J AM CHEM SOC, V123, P12664, DOI 10.1021/ja016505m; Dall'Acqua WF, 2006, J IMMUNOL, V177, P1129, DOI 10.4049/jimmunol.177.2.1129; Dillon TM, 2008, J BIOL CHEM, V283, P16206, DOI 10.1074/jbc.M709988200; Dillon TM, 2006, J CHROMATOGR A, V1120, P112, DOI 10.1016/j.chroma.2006.01.016; Dillon TM, 2004, J CHROMATOGR A, V1053, P299, DOI 10.1016/j.chroma.2004.08.058; DORRINGTON KJ, 1978, CAN J BIOCHEM CELL B, V56, P1087, DOI 10.1139/o78-172; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; FRANGION.B, 1968, BIOCHEM J, V106, P15, DOI 10.1042/bj1060015; FRANGIONE B., 1968, J MOL BIOL, V33, P893, DOI 10.1016/0022-2836(68)90326-4; FRANGIONE B, 1969, NATURE, V221, P145, DOI 10.1038/221145a0; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; LILIE H, 1995, J MOL BIOL, V248, P190, DOI 10.1006/jmbi.1995.0211; LU HS, 1986, MODERN METHODS PROTE, P493; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MILSTEIN C, 1971, BIOCHEM J, V121, P217, DOI 10.1042/bj1210217; PINK JRL, 1967, NATURE, V216, P941, DOI 10.1038/216941a0; PINK JRL, 1967, NATURE, V214, P92, DOI 10.1038/214092a0; Redpath S, 1998, HUM IMMUNOL, V59, P720, DOI 10.1016/S0198-8859(98)00075-5; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; Yang J, 2007, J CHROMATOGR A, V1156, P174, DOI 10.1016/j.chroma.2007.01.140; Yen TY, 2002, J MASS SPECTROM, V37, P15, DOI 10.1002/jms.241; Yoo EM, 2003, J IMMUNOL, V170, P3134, DOI 10.4049/jimmunol.170.6.3134; ZHANG Y, 2003, BIO PROCESS J, V2, P37; Zhang ZQ, 2004, ANAL CHEM, V76, P3908, DOI 10.1021/ac049951b; Zhang ZQ, 2005, ANAL CHEM, V77, P6364, DOI 10.1021/ac050857k; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	37	213	246	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					16194	16205		10.1074/jbc.M709987200	http://dx.doi.org/10.1074/jbc.M709987200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18339624	Green Published, hybrid			2022-12-25	WOS:000256332500078
J	Keller, P; Petrie, JT; De Rose, P; Gerin, I; Wright, WS; Chiang, SH; Nielsen, AR; Fischer, CP; Pedersen, BK; MacDougald, OA				Keller, Pernille; Petrie, John T.; De Rose, Paul; Gerin, Isabelle; Wright, Wendy S.; Chiang, Shian-Huey; Nielsen, Anders R.; Fischer, Christian P.; Pedersen, Bente K.; MacDougald, Ormond A.			Fat-specific protein 27 regulates storage of triacylglycerol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; LIPID DROPLET PROTEIN; GENE-EXPRESSION; ADIPOCYTE LIPOLYSIS; TRIGLYCERIDE LIPASE; LIVER STEATOSIS; RECEPTOR-ALPHA; DEFICIENT MICE; PERILIPIN-A; OBESITY	FSP27 ( fat-specific protein 27) is a member of the cell death-inducing DNA fragmentation factor-alpha-like effector ( CIDE) family. Although Cidea and Cideb were initially characterized as activators of apoptosis, recent studies have demonstrated important metabolic roles for these proteins. In this study, we investigated the function of another member of this family, FSP27 ( Cidec), in apoptosis and adipocyte metabolism. Although overexpression of FSP27 is sufficient to increase apoptosis of 293T and 3T3-L1 cells, more physiological levels of expression stimulate spontaneous lipid accumulation in several cell types without induction of adipocyte genes. Increased triacylglycerol is likely due to decreased beta-oxidation of nonesterified fatty acids. Altered flux of fatty acids into triacylglycerol may be a direct effect of FSP27 function, which is localized to lipid droplets in 293T cells and 3T3-L1 adipocytes. Stable knockdown of FSP27 during adipogenesis of 3T3-L1 cells substantially decreases lipid droplet size, increases mitochondrial and lipid droplet number, and modestly increases glucose uptake and lipolysis. Expression of FSP27 in subcutaneous adipose tissue of a human diabetes cohort decreases with total fat mass but is not associated with measures of insulin resistance ( e. g. homeostasis model assessment). Together, these data indicate that FSP27 binds to lipid droplets and regulates their enlargement.	[Keller, Pernille; Petrie, John T.; De Rose, Paul; Gerin, Isabelle; Wright, Wendy S.; MacDougald, Ormond A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Chiang, Shian-Huey] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Nielsen, Anders R.; Fischer, Christian P.; Pedersen, Bente K.] Univ Copenhagen, Rigshosp, Ctr Inflammat & Metabol, DK-2100 Copenhagen, Denmark	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Rigshospitalet; University of Copenhagen	MacDougald, OA (corresponding author), 7620 Med Sci 2,1301 E Catherine St, Ann Arbor, MI 48109 USA.	macdouga@umich.edu	Pedersen, Bente Klarlund/AGR-3217-2022	Pedersen, Bente Klarlund/0000-0001-6508-6288; Fischer, Christian/0000-0002-0657-9143; MacDougald, Ormond/0000-0001-6907-7960; Rinnov, Anders Rasmussen/0000-0003-3859-3289; Hahn, Wendy/0000-0002-4374-5876	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062876, R01DK062876] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 62876] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adachi J, 2007, MOL CELL PROTEOMICS, V6, P1257, DOI 10.1074/mcp.M600476-MCP200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Ceperuelo-Mallafre V, 2007, J CLIN ENDOCR METAB, V92, P3640, DOI 10.1210/jc.2007-0531; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Chen ZM, 2000, J BIOL CHEM, V275, P22619, DOI 10.1074/jbc.C000207200; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Croce MA, 2007, DIABETES, V56, P2395, DOI 10.2337/db07-0480; Dahlman I, 2005, DIABETES, V54, P3032, DOI 10.2337/diabetes.54.10.3032; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; DANESCH U, 1992, J BIOL CHEM, V267, P7185; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Gummesson A, 2007, J CLIN ENDOCR METAB, V92, P4759, DOI 10.1210/jc.2007-1136; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Imai Y, 2007, GASTROENTEROLOGY, V132, P1947, DOI 10.1053/j.gastro.2007.02.046; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Inohara N, 1999, J BIOL CHEM, V274, P270, DOI 10.1074/jbc.274.1.270; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; KELDER B, 2007, J COMP HEPATOL, V6, P4; Kim JY, 2008, AM J PHYSIOL-ENDOC M, V294, pE654, DOI 10.1152/ajpendo.00104.2007; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Motomura W, 2006, BIOCHEM BIOPH RES CO, V340, P1111, DOI 10.1016/j.bbrc.2005.12.121; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Phillips SA, 2005, OBES RES, V13, P1321, DOI 10.1038/oby.2005.160; Preece A, 1972, MANUAL HIST TECHNICI; Puri V, 2008, ACTA PHYSIOL, V192, P103, DOI 10.1111/j.1748-1716.2007.01786.x; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sato W, 2006, HEPATOL RES, V34, P256, DOI 10.1016/j.hepres.2006.01.003; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Scheele C, 2007, FASEB J, V21, P3653, DOI 10.1096/fj.07-8520com; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Steinberg GR, 2007, AM J PHYSIOL-ENDOC M, V293, pE958, DOI 10.1152/ajpendo.00235.2007; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200; Yu ST, 2001, J BIOL CHEM, V276, P42485, DOI 10.1074/jbc.M106480200; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	52	157	174	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14355	14365		10.1074/jbc.M708323200	http://dx.doi.org/10.1074/jbc.M708323200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18334488	hybrid, Green Published			2022-12-25	WOS:000255941400022
J	El-Yassimi, A; Hichami, A; Besnard, P; Khan, NA				El-Yassimi, Abdelghani; Hichami, Aziz; Besnard, Philippe; Khan, Naim Akhtar			Linoleic acid induces calcium signaling, Src kinase phosphorylation, and neurotransmitter release in mouse CD36-positive gustatory cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TASTE-BUDS; CIRCUMVALLATE PAPILLAE; TYROSINE KINASES; FATTY-ACIDS; TRANSDUCTION; SEROTONIN; CD36; LOCALIZATION; HYDROXYLASE; EXPRESSION	We have recently demonstrated that the cells expressing CD36, localized apically on the taste buds of mouse lingual circumvallate papillae, act as gustatory cells. In the present study we isolated these CD36- positive cells from mouse circumvallate papillae and investigated intracellular signaling events, triggered by a long-chain polyunsaturated fatty acid, i.e. linoleic acid ( LA). LA induced increases in free intracellular calcium concentrations, [ Ca2+](i), by recruiting calcium from endoplasmic reticulum pool via inositol 1,4,5-triphosphate production followed by calcium influx via opening of store-operated calcium (SOC) channels. LA also induced phosphorylation of Src-protein-tyrosine kinases ( Src-PTKs), particularly of Fyn(59) and Yes(62). LA-evoked phosphorylation of Fyn(59) and Yes(62) was implicated in the activation of SOC channels. Reverse transcription-quantitative PCR revealed that the CD36- positive gustatory cells possessed mRNA of enzymes like tryptophan hydroxylase-1, L-aromatic amino acid decarboxylase, tyrosine hydroxylase, and dopamine beta-hydroxylase, involved in the synthesis of monoamine neurotransmitters. Interestingly, the addition of LA to these cells induced the release of 5-hydroxytryptamine and noradrenalin to the extracellular environment. The LA-induced release of these neurotransmitters was curtailed by SOC channel blockers and Src-PTK inhibitors. These results altogether demonstrate that LA binds to mouse CD36- positive gustatory cells, induces Src-PTKs phosphorylation, triggers calcium signaling, and evokes the release of 5-hydroxytryptamine and noradrenalin, which in turn may be implicated in the downstream signaling to the afferent nerve fibers, thus transmitting the output signal from taste buds to the central nervous system.	[El-Yassimi, Abdelghani; Hichami, Aziz; Khan, Naim Akhtar] Fac Life Sci, Equipe Accueil 4183, Unite Propre Enseignment Super Lipides & Signalis, F-21000 Dijon, France; [Besnard, Philippe] Univ Burgundy, INSERM, Ecole Natl Super Biol Appl Nutr & Alimentat, UMR,U866, F-21000 Dijon, France	Universite de Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Khan, NA (corresponding author), Fac Life Sci, Equipe Accueil 4183, Unite Propre Enseignment Super Lipides & Signalis, Gabriel 6, F-21000 Dijon, France.	Naim.Khan@u-bourgogne.fr		hichami, aziz/0000-0003-4331-5152				Babnigg G, 1997, J BIOL CHEM, V272, P29434, DOI 10.1074/jbc.272.47.29434; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; Bernhardt SJ, 1996, J PHYSIOL-LONDON, V490, P325, DOI 10.1113/jphysiol.1996.sp021147; Berridge M, 1999, CURR BIOL, V9, pR157, DOI 10.1016/S0960-9822(99)80101-8; FLEMING I, 1995, CIRC RES, V76, P522, DOI 10.1161/01.RES.76.4.522; Fukuwatari T, 1997, FEBS LETT, V414, P461, DOI 10.1016/S0014-5793(97)01055-7; GAILLARD D, 2007, IN PRESS FASEB J; Ganchrow JR, 2000, PHYSIOL BEHAV, V69, P29, DOI 10.1016/S0031-9384(00)00185-2; Gilbertson TA, 1997, AM J PHYSIOL-CELL PH, V272, pC1203, DOI 10.1152/ajpcell.1997.272.4.C1203; Gousset K, 2004, BBA-BIOMEMBRANES, V1660, P7, DOI 10.1016/j.bbamem.2003.09.009; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; Haskew RE, 2002, J NEUROCHEM, V82, P903, DOI 10.1046/j.1471-4159.2002.01037.x; Herness S, 2002, J PHYSIOL-LONDON, V543, P601, DOI 10.1113/jphysiol.2002.020438; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Huang YJ, 2005, ARCH ITAL BIOL, V143, P87; Izikki M, 2007, AM J PHYSIOL-LUNG C, V293, pL1045, DOI 10.1152/ajplung.00082.2007; Kawai T, 2003, AM J PHYSIOL-REG I, V285, pR447, DOI 10.1152/ajpregu.00729.2002; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Lee KM, 2006, EXP MOL MED, V38, P703, DOI 10.1038/emm.2006.83; Liman E. R., 2007, V179, P287; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Moret F, 2004, J COMP NEUROL, V468, P135, DOI 10.1002/cne.10965; Nagai T, 1996, CHEM SENSES, V21, P353, DOI 10.1093/chemse/21.3.353; NAGATSU T, 1991, NEUROSCI RES, V12, P315, DOI 10.1016/0168-0102(91)90001-F; Ortiz-Alvarado R, 2006, FEBS LETT, V580, P5371, DOI 10.1016/j.febslet.2006.08.078; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Perez CA, 2003, CELL CALCIUM, V33, P541, DOI 10.1016/S0143-4160(03)00059-9; Ren Y, 1999, MOL BRAIN RES, V74, P221, DOI 10.1016/S0169-328X(99)00253-3; RIGGIN RM, 1977, ANAL CHEM, V49, P2109, DOI 10.1021/ac50021a052; RINK TJ, 1980, BIOCHIM BIOPHYS ACTA, V595, P15, DOI 10.1016/0005-2736(80)90243-6; Sclafani A, 2007, AM J PHYSIOL-REG I, V293, pR1504, DOI 10.1152/ajpregu.00364.2007; Seta Y, 2007, HISTOCHEM CELL BIOL, V127, P415, DOI 10.1007/s00418-006-0257-3; TAKEDA M, 1980, CELL TISSUE RES, V210, P71; Vazquez G, 1998, J BIOL CHEM, V273, P33954, DOI 10.1074/jbc.273.51.33954; Wang SJ, 2003, NEUROREPORT, V14, P1519, DOI 10.1097/00001756-200308060-00024; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F	39	138	143	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12949	12959		10.1074/jbc.M707478200	http://dx.doi.org/10.1074/jbc.M707478200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18321850	hybrid			2022-12-25	WOS:000255499800032
J	Hase, M; Yokomizo, T; Shimizu, T; Nakamura, M				Hase, Momoko; Yokomizo, Takehiko; Shimizu, Takao; Nakamura, Motonao			Characterization of an orphan G protein-coupled receptor, GPR20, that constitutively activates G(i) proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; CELL-PROLIFERATION; EXPRESSION; IDENTIFICATION; CYCLASE; EXHIBIT; CLONING; TDAG8; MOTIF; ACID	GPR20 was isolated as an orphan G protein-coupled receptor from genomic DNA by PCR amplification. Although GPR20 was closely related to nucleotide or lipid receptors, the functional role of this receptor, as well as its endogenous ligand, remains unclear. Here we demonstrate that GPR20 is constitutively active in the absence of ligand, leading to continuous activation of its coupled G proteins. When GPR20 was exogenously expressed in HEK293 cells, both the basal level and the prostaglandin E-2-induced production of cAMP were significantly decreased. A remarkable increase in [S-35] guanosine 5'-(gamma-thio) triphosphate (GTP gamma S) binding to membrane preparations was also observed in GPR20-expressing cells. These effects of GPR20 overexpression were diminished in cells treated with pertussis toxin, suggesting that the expression of GPR20 results in the activation of G(i/o) proteins. Involvement of GPR20 in the activation of G(i/o) proteins was also supported by evidence that the disruption of a conserved DRY motif in GPR20 attenuated both [ 35S] GTP gamma S incorporation and inhibition of the prostaglandin E2-induced cAMP production. Knockdown of GPR20 in PC12h cells resulted in an elevation of the basal cAMP level, suggesting that the endogenous GPR20 achieves a constitutively or spontaneously active conformation. Furthermore, enhancement of [H-3] thymidine incorporation was also observed in the GPR20-silencing cells, implying that the GPR20 expression seems to attenuate PC12h cell growth. Taken together, these data indicate that GPR20 constitutively activates G(i) proteins without ligand stimulation. The receptor may be involved in cellular processes, including control of intracellular cAMP levels and mitogenic signaling.	[Hase, Momoko; Yokomizo, Takehiko; Shimizu, Takao; Nakamura, Motonao] Univ Tokyo, Dept Biochem & Mol Biol, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Yokomizo, Takehiko] Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Fukuoka 8128582, Japan	University of Tokyo; Kyushu University	Nakamura, M (corresponding author), Univ Tokyo, Dept Biochem & Mol Biol, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	moto-nakamura@umin.net	Yokomizo, Takehiko/P-5673-2016; Shimizu, Takao/AAV-7052-2021	Yokomizo, Takehiko/0000-0002-5219-1553; 				Allander SV, 2001, CANCER RES, V61, P8624; Ayoub MA, 2007, MOL PHARMACOL, V71, P1329, DOI 10.1124/mol.106.030304; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bates B, 2006, BRAIN RES, V1087, P1, DOI 10.1016/j.brainres.2006.02.123; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN TJ, 2003, Patent No. 0018989; Chen G, 2000, MOL PHARMACOL, V57, P125; Civelli O, 2005, TRENDS PHARMACOL SCI, V26, P15, DOI 10.1016/j.tips.2004.11.005; Dhanasekaran N, 1998, ONCOGENE, V17, P1383, DOI 10.1038/sj.onc.1202242; EGGERICKX D, 1995, BIOCHEM J, V309, P837, DOI 10.1042/bj3090837; HUNT TW, 1994, J BIOL CHEM, V269, P29565; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Jones PG, 2007, BBA-GEN SUBJECTS, V1770, P890, DOI 10.1016/j.bbagen.2007.01.013; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; New David C, 2007, J Mol Signal, V2, P2, DOI 10.1186/1750-2187-2-2; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; ODowd BF, 1997, GENE, V187, P75, DOI 10.1016/S0378-1119(96)00722-6; OKUNO T, 2008, IN PRESS J EXP MED; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SENOGLES SE, 1994, J BIOL CHEM, V269, P23120; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; Wise A, 1997, BIOCHEM J, V321, P721, DOI 10.1042/bj3210721; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	35	21	26	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12747	12755		10.1074/jbc.M709487200	http://dx.doi.org/10.1074/jbc.M709487200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18347022	hybrid			2022-12-25	WOS:000255499800010
J	Pechkovsky, DV; Scaffidi, AK; Hackett, TL; Ballard, J; Shaheen, F; Thompson, PJ; Thannickal, VJ; Knight, DA				Pechkovsky, Dmitri V.; Scaffidi, Amelia K.; Hackett, Tillie L.; Ballard, Joanne; Shaheen, Furquan; Thompson, Philip J.; Thannickal, Victor J.; Knight, Darryl A.			Transforming growth factor beta 1 induces alpha v beta 3 integrin expression in human lung fibroblasts via a beta 3 integrin-, c-Src-, and p38 MAPK-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; FOCAL ADHESION KINASE; EPITHELIAL-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; MESENCHYMAL CELLS; GENE-EXPRESSION; II RECEPTOR; P38 MAPK; ACTIVATION; SP1	In response to transforming growth factor beta 1 ( TGF beta) stimulation, fibroblasts modify their integrin repertoire and adhesive capabilities to certain extracellular matrix proteins. Although TGF beta has been shown to increase the expression of specific alpha v integrins, the mechanisms underlying this are unknown. In this study we demonstrate that TGF beta 1 increased both beta 3 integrin subunit mRNA and protein levels as well as surface expression of alpha v beta 3 in human lung fibroblasts. TGF beta 1-induced alpha v beta 3 expression was strongly adhesion-dependent and associated with increased focal adhesion kinase and c-Src kinase phosphorylation. Inhibition of beta 3 integrin activation by the Arg-Gly-Asp tripeptide motif-specific disintegrin echistatin or alpha v beta 3 blocking antibody prevented the increase in beta 3 but not beta 5 integrin expression. In addition, echistatin inhibited TGF beta 1-induced p38 MAPK but not Smad3 activation. Furthermore, inhibition of the Src family kinases, but not focal adhesion kinase, completely abrogated TGF beta 1-induced expression of alpha v beta 3 and p38 MAPK phosphorylation but not beta 5 integrin expression and Smad3 activation. The TGF beta 1-induced alpha v beta 3 expression was blocked by pharmacologic and genetic inhibition of p38 MAPK- but not Smad2/3-, Sp1-, ERK-, phosphatidylinositol 3-kinase, and NF-kappa B-dependent pathways. Our results demonstrate that TGF beta 1 induces alpha v beta 3 integrin expression via a beta 3 integrin-, c-Src-, and p38 MAPK-dependent pathway. These data identify a novel mechanism for TGF beta 1 signaling in human lung fibroblasts by which they may contribute to normal and pathological wound healing.	[Pechkovsky, Dmitri V.; Shaheen, Furquan; Knight, Darryl A.] Univ British Columbia, James Hogg iCAPTURE Ctr Cardiovasc & Resp Res, Vancouver, BC V6Z 1Y6, Canada; [Hackett, Tillie L.; Knight, Darryl A.] Univ British Columbia, Dept Anaesthesiol Pharmacol & Therapeut, Vancouver, BC V6Z 1Y6, Canada; [Scaffidi, Amelia K.; Ballard, Joanne; Thompson, Philip J.] Univ Western Australia, Lung Inst W Australia, Nedlands, WA 6009, Australia; [Scaffidi, Amelia K.; Ballard, Joanne; Thompson, Philip J.] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Nedlands, WA 6009, Australia; [Thannickal, Victor J.] Univ Michigan, Dept Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA	University of British Columbia; University of British Columbia; University of Western Australia; University of Western Australia; University of Michigan System; University of Michigan	Knight, DA (corresponding author), St Pauls Hosp, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	dknight@mrl.ubc.ca		Pechkovsky, Dmitri/0000-0001-8908-3444				Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Asano Y, 2005, J IMMUNOL, V175, P7708, DOI 10.4049/jimmunol.175.11.7708; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Courter DL, 2005, J BIOL CHEM, V280, P12145, DOI 10.1074/jbc.M412555200; Della Morte R, 2000, EUR J BIOCHEM, V267, P5047, DOI 10.1046/j.1432-1327.2000.01561.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Heidkamp MC, 2002, CIRC RES, V90, P1282, DOI 10.1161/01.RES.0000023201.41774.EA; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IGNOTZ RA, 1987, CELL, V51, P189, DOI 10.1016/0092-8674(87)90146-2; JANAT MF, 1992, J CELL PHYSIOL, V151, P588, DOI 10.1002/jcp.1041510319; Jinnin M, 2004, ONCOGENE, V23, P1656, DOI 10.1038/sj.onc.1207064; Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200; Larouche K, 2000, J BIOL CHEM, V275, P39182, DOI 10.1074/jbc.M002945200; Lu N, 2006, MATRIX BIOL, V25, P118, DOI 10.1016/j.matbio.2005.10.002; Maeda M, 2006, J BIOL CHEM, V281, P59, DOI 10.1074/jbc.M503304200; Marcinkiewicz C, 1997, BLOOD, V90, P1565, DOI 10.1182/blood.V90.4.1565.1565_1565_1575; McHugh KP, 2001, J CELL BIOCHEM, V81, P320, DOI 10.1002/1097-4644(20010501)81:2<320::AID-JCB1047>3.0.CO;2-M; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miyazono K, 2000, J CELL SCI, V113, P1101; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; NEHLS MC, 1993, J CLIN INVEST, V92, P2916, DOI 10.1172/JCI116914; Paine R, 1999, AM J MED, V107, P268, DOI 10.1016/S0002-9343(99)00226-0; Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0; Scaffidi AK, 2004, J BIOL CHEM, V279, P37726, DOI 10.1074/jbc.M403010200; Scaffidi AK, 2001, J CELL SCI, V114, P3507; Schoppet M, 2002, LAB INVEST, V82, P37, DOI 10.1038/labinvest.3780393; Sekimoto H, 2005, MOL ENDOCRINOL, V19, P1859, DOI 10.1210/me.2004-0481; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; SHEPPARD D, 1992, J BIOL CHEM, V267, P17409; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Trusolino L, 1998, J CELL BIOL, V142, P1145, DOI 10.1083/jcb.142.4.1145; Wang A, 1996, AM J RESP CELL MOL, V15, P664, DOI 10.1165/ajrcmb.15.5.8918373; Wilhide CC, 1997, BLOOD, V90, P3951, DOI 10.1182/blood.V90.10.3951; Woods D, 2001, MOL CELL BIOL, V21, P3192, DOI 10.1128/MCB.21.9.3192-3205.2001; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	43	84	91	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12898	12908		10.1074/jbc.M708226200	http://dx.doi.org/10.1074/jbc.M708226200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18353785	hybrid			2022-12-25	WOS:000255499800026
J	Zhang, Q; Guo, RL; Lu, Y; Zhao, L; Zhou, Q; Schwarz, EM; Huang, J; Di, C; Jin, ZG; Boyce, BF; Xing, LP				Zhang, Qian; Guo, Ruolin; Lu, Yan; Zhao, Lan; Zhou, Quan; Schwarz, Edward M.; Huang, Jing; Chen, Di; Jin, Zheng-Gen; Boyce, Brendan F.; Xing, Lianping			VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; COLONY-STIMULATING FACTOR; IN-VIVO; CELL-PROLIFERATION; MATURE OSTEOCLASTS; EXPRESSION; KINASE; MICE; SRC; DIFFERENTIATION	Osteoclasts are bone-resorbing cells, but they also secrete and respond to cytokines. Here, we test the hypothesis that osteoclasts secrete the lymphatic growth factor, VEGF-C, to increase their resorptive activity. Osteoclasts and osteoclast precursors were generated by culturing splenocytes with macrophage colony-stimulating factor and RANKL from wild-type, NF-kappa Bp50(-/-)/p52(-/-), and Src(-/-) mice. Expression of VEGFs was measured by real time reverse transcription-PCR, Western blotting, and immunostaining. The effect of VEGF-C signaling on osteoclast function was determined by osteoclastogenesis and pit assays. RANKL increased the expression of VEGF-C but not of other VEGFs in osteoclasts and their precursors. RANKL-induced VEGF-C expression was reduced in NF-kappa Bp50(-/-)/p52(-/-) precursors or wild- type cells treated with an NF-kappa B inhibitor. VEGF-C directly stimulated RANKL-mediated bone resorption, which was reduced by the VEGF-C-specific receptor blocker, VEGFR3:Fc. Osteoclasts express VEGFR3, and VEGF-C stimulated Src phosphorylation in osteoclasts. VEGF-C-mediated bone resorption was abolished in Src(-/-) osteoclasts or cells treated with an Src inhibitor. We conclude that RANKL stimulates osteoclasts and their precursors to release VEGF-C through an NF-kappa B-dependent mechanism, indicating that VEGF-C is a new RANKL target gene in osteoclasts and functions as an autocrine factor regulating osteoclast activity.	[Zhang, Qian; Guo, Ruolin; Lu, Yan; Zhao, Lan; Boyce, Brendan F.; Xing, Lianping] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Schwarz, Edward M.; Huang, Jing; Chen, Di; Boyce, Brendan F.; Xing, Lianping] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Jin, Zheng-Gen] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Xing, LP (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.	Lianping_xing@urmc.rochester.edu			NHLBI NIH HHS [R01 HL080611-05, R01 HL080611] Funding Source: Medline; NIAMS NIH HHS [R01 AR054465, K02 AR052411, AR43510, R01 AR051189, AR48697, AR53586] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051189, K02AR052411, R01AR043510, R01AR048697, R01AR054465, R21AR053586] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ali N, 2005, J PHARMACOL SCI, V98, P130, DOI 10.1254/jphs.FP0040850; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Boyce BF, 2005, J BONE MINER METAB, V23, P11, DOI 10.1007/BF03026317; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Boyce BF, 2006, CLIN CANCER RES, V12, p6291S, DOI 10.1158/1078-0432.CCR-06-0991; Boyce BF, 2006, CURR OPIN RHEUMATOL, V18, P427, DOI 10.1097/01.bor.0000231913.32364.32; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Cha HS, 2007, J RHEUMATOL, V34, P16; Chilov D, 1997, J BIOL CHEM, V272, P25176, DOI 10.1074/jbc.272.40.25176; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Feng JQ, 2003, J BIOL CHEM, V278, P29130, DOI 10.1074/jbc.M212296200; Hamrah P, 2003, AM J PATHOL, V163, P57, DOI 10.1016/S0002-9440(10)63630-9; Henriksen K, 2003, J BIOL CHEM, V278, P48745, DOI 10.1074/jbc.M309193200; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Kubota K, 2002, J BONE MINER RES, V17, P257, DOI 10.1359/jbmr.2002.17.2.257; Lee SK, 2006, BONE, V38, P678, DOI 10.1016/j.bone.2005.10.011; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Matsumoto Y, 2002, J IMMUNOL, V168, P5824, DOI 10.4049/jimmunol.168.11.5824; Mills BG, 1997, CALCIFIED TISSUE INT, V61, P16, DOI 10.1007/s002239900285; Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Niida S, 2005, P NATL ACAD SCI USA, V102, P14016, DOI 10.1073/pnas.0503544102; Pettit AR, 2006, RHEUMATOLOGY, V45, P1068, DOI 10.1093/rheumatology/kel045; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Salven P, 1998, AM J PATHOL, V153, P103, DOI 10.1016/S0002-9440(10)65550-2; Schwartzberg PL, 1997, GENE DEV, V11, P2835, DOI 10.1101/gad.11.21.2835; Sedivy R, 2004, CANCER DETECT PREV, V29, P8, DOI 10.1016/j.cdp.2004.10.006; Shakespeare WC, 2008, CHEM BIOL DRUG DES, V71, P97, DOI 10.1111/j.1747-0285.2007.00615.x; Su JL, 2007, BRIT J CANCER, V96, P541, DOI 10.1038/sj.bjc.6603487; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tanaka Y, 2007, CLIN CANCER RES, V13, P816, DOI 10.1158/1078-0432.CCR-06-2258; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Tombran-Tink J, 2004, BIOCHEM BIOPH RES CO, V316, P573, DOI 10.1016/j.bbrc.2004.02.076; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200; Xing LP, 2001, GENE DEV, V15, P241, DOI 10.1101/gad.840301; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yao ZQ, 2008, J BIOL CHEM, V283, P9917, DOI 10.1074/jbc.M706415200; Zhang Q, 2005, ARTHRITIS RHEUM-US, V52, P2708, DOI 10.1002/art.21236; Zhang Q, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2326	48	60	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13491	13499		10.1074/jbc.M708055200	http://dx.doi.org/10.1074/jbc.M708055200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18359770	Green Published, hybrid			2022-12-25	WOS:000255499800088
J	Lazebnik, MB; Tussie-Luna, MI; Roy, AL				Lazebnik, Maria B.; Tussie-Luna, Maria Isabel; Roy, Ananda L.			Determination and functional analysis of the consensus binding site for TFII-I family member BEN, implicated in Williams-Beuren Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL TRANSCRIPTION FACTOR-3; GENOMIC ORGANIZATION; CHROMOSOME 7Q11.23; PROMOTER ACTIVITY; EXPRESSION; GTF2IRD1; PROTEIN; IDENTIFICATION; SEQUENCES; RECEPTOR	The ubiquitously expressed TFII-I family of multifunctional transcription factors is involved in gene regulation as well as signaling. Despite the fact that they share significant sequence homology, these factors exhibit varied and distinct functions. The lack of knowledge about its binding sites and physiological target genes makes it more difficult to assign a definitive function for the TFII-I-related protein, BEN. We set out to determine its optimal binding site with the notion of predicting its physiological target genes. Here we report the identification of an optimal binding sequence for BEN by SELEX (systematic evolution of ligands by exponential enrichment) and confirm the relevance of this sequence by functional assays. We further performed a data base search to assign genes that have this consensus site(s) and validate several candidate genes by quantitative PCR upon stable silencing of BEN and by chromatin immunoprecipitation assay upon stable expression of BEN. Given that haploinsufficiency in BEN is causative to Williams-Beuren syndrome, these results may further lead to the identification of a set of physiologically relevant target genes for BEN and may help identify molecular determinants of Williams-Beuren syndrome.	[Lazebnik, Maria B.; Roy, Ananda L.] Tufts Univ, Sch Med, Genet Program, Boston, MA 02111 USA; [Roy, Ananda L.] Tufts Univ, Sch Med, Program Immunol, Boston, MA 02111 USA; [Tussie-Luna, Maria Isabel; Roy, Ananda L.] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University	Roy, AL (corresponding author), Tufts Univ, Sch Med, Genet Program, 150 Harrison Ave, Boston, MA 02111 USA.	ananda.roy@tufts.edu		Tussie-Luna, Maria Isabel/0000-0002-5033-408X	NICHD NIH HHS [HD04603] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bayarsaihan D, 2003, GENE EXPR PATTERNS, V3, P579, DOI 10.1016/S1567-133X(03)00118-2; Bayarsaihan D, 2002, GENOMICS, V79, P137, DOI 10.1006/geno.2001.6674; Bayarsaihan D, 2000, P NATL ACAD SCI USA, V97, P7342, DOI 10.1073/pnas.97.13.7342; BLACKWELL TK, 1995, METHOD ENZYMOL, V254, P604; Burge CB, 1999, RNA WORLD, P525; Calvo S, 2001, MOL CELL BIOL, V21, P8490, DOI 10.1128/MCB.21.24.8490-8503.2001; Chimge NO, 2007, J EXP ZOOL PART B, V308B, P209, DOI 10.1002/jez.b.21129; Desgranges ZP, 2005, MOL CELL BIOL, V25, P10940, DOI 10.1128/MCB.25.24.10940-10952.2005; Franke Y, 1999, CYTOGENET CELL GENET, V86, P296, DOI 10.1159/000015322; Geijsen N, 2001, SCIENCE, V293, P1136, DOI 10.1126/science.1059157; Hakre S, 2006, MOL CELL, V24, P301, DOI 10.1016/j.molcel.2006.09.005; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; Hoppe R, 2003, GENOME RES, V13, P2674, DOI 10.1101/gr.1372203; Ku MC, 2005, MOL CELL BIOL, V25, P7144, DOI 10.1128/MCB.25.16.7144-7157.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Manuel M, 2002, EUR J BIOCHEM, V269, P2527, DOI 10.1046/j.1432-1033.2002.02917.x; McWhirter JR, 1997, DEVELOPMENT, V124, P3221; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; Osborne LR, 1999, GENOMICS, V57, P279, DOI 10.1006/geno.1999.5784; Ring C, 2002, GENE DEV, V16, P820, DOI 10.1101/gad.963802; Schug J, 2003, CURRENT PROTOCOLS BI; Steinberger D, 1998, HUM GENET, V102, P145, DOI 10.1007/s004390050668; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Tantin D, 2004, J BIOL CHEM, V279, P5460, DOI 10.1074/jbc.M311177200; Tassabehji M, 2005, SCIENCE, V310, P1184, DOI 10.1126/science.1116142; Tassabehji M, 1999, EUR J HUM GENET, V7, P737, DOI 10.1038/sj.ejhg.5200396; Tay ESE, 2003, BIOCHEM J, V374, P359, DOI 10.1042/BJ20030189; Tussie-Luna MI, 2001, P NATL ACAD SCI USA, V98, P7789, DOI 10.1073/pnas.141222298; Vullhorst D, 2005, J BIOL CHEM, V280, P31722, DOI 10.1074/jbc.M500593200; Vullhorst D, 2003, J BIOL CHEM, V278, P8370, DOI 10.1074/jbc.M209361200; Yan XM, 2000, BIOCHEM J, V345, P749, DOI 10.1042/0264-6021:3450749	33	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11078	11082		10.1074/jbc.C800049200	http://dx.doi.org/10.1074/jbc.C800049200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18326499	Green Published, hybrid			2022-12-25	WOS:000255067400003
J	Lee, J; Folley, BS; Gore, J; Park, S				Lee, Junghee; Folley, Bradley S.; Gore, John; Park, Sohee			Origins of Spatial Working Memory Deficits in Schizophrenia: An Event-Related fMRI and Near-Infrared Spectroscopy Study	PLOS ONE			English	Article								Abnormal prefrontal functioning plays a central role in the working memory (WM) deficits of schizophrenic patients, but the nature of the relationship between WM and prefrontal activation remains undetermined. Using two functional neuroimaging methods, we investigated the neural correlates of remembering and forgetting in schizophrenic and healthy participants. We focused on the brain activation during WM maintenance phase with event-related functional magnetic resonance imaging (fMRI). We also examined oxygenated hemoglobin changes in relation to memory performance with the near-infrared spectroscopy (NIRS) using the same spatial WM task. Distinct types of correct and error trials were segregated for analysis. fMRI data indicated that prefrontal activation was increased during WM maintenance on correct trials in both schizophrenic and healthy subjects. However, a significant difference was observed in the functional asymmetry of frontal activation pattern. Healthy subjects showed increased activation in the right frontal, temporal and cingulate regions. Schizophrenic patients showed greater activation compared with control subjects in left frontal, temporal and parietal regions as well as in right frontal regions. We also observed increased 'false memory' errors in schizophrenic patients, associated with increased prefrontal activation and resembling the activation pattern observed on the correct trials. NIRS data replicated the fMRI results. Thus, increased frontal activity was correlated with the accuracy of WM in both healthy control and schizophrenic participants. The major difference between the two groups concerned functional asymmetry; healthy subjects recruited right frontal regions during spatial WM maintenance whereas schizophrenic subjects recruited a wider network in both hemispheres to achieve the same level of memory performance. Increased "false memory'' errors and accompanying bilateral prefrontal activation in schizophrenia suggest that the etiology of memory errors must be considered when comparing group performances. Finally, the concordance of fMRI and NIRS data supports NIRS as an alternative functional neuroimaging method for psychiatric research.	[Lee, Junghee; Folley, Bradley S.; Park, Sohee] Vanderbilt Univ, Ctr Integrat & Cognit Neurosci, Dept Psychol, Nashville, TN 37240 USA; [Folley, Bradley S.; Park, Sohee] Vanderbilt Univ, Kennedy Ctr, Nashville, TN USA; [Gore, John] Vanderbilt Univ, Inst Imaging Sci, Dept Radiol, Nashville, TN USA; [Folley, Bradley S.; Park, Sohee] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Lee, J (corresponding author), Vanderbilt Univ, Ctr Integrat & Cognit Neurosci, Dept Psychol, Nashville, TN 37240 USA.	sohee.park@vanderbilt.edu	Lee, Junghee/C-5226-2014; Lee, Junghee/AAX-6124-2021	Lee, Junghee/0000-0001-9567-8700; Lee, Junghee/0000-0001-9567-8700; Park, Sohee/0000-0003-3797-4776	 [MH-073028];  [Discovery Grant]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073028] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported in part by MH-073028 to Sohee Park and the Discovery Grant to Sohee Park and John Gore.	Addington J, 2000, SCHIZOPHR RES, V44, P47, DOI 10.1016/S0920-9964(99)00160-7; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; *AM PSYCH ASS, 1991, DIAGN STAT MAN MENT; Barch DM, 2001, ARCH GEN PSYCHIAT, V58, P280, DOI 10.1001/archpsyc.58.3.280; BILDER RM, 1994, AM J PSYCHIAT, V151, P1437; Brown DW, 2003, PEDIATR RES, V54, P861, DOI 10.1203/01.PDR.0000090928.93045.BE; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1071, DOI 10.1001/archpsyc.62.10.1071; Carter C, 1996, BIOL PSYCHIAT, V40, P930, DOI 10.1016/S0006-3223(96)00350-2; Carter CS, 1998, AM J PSYCHIAT, V155, P1285, DOI 10.1176/ajp.155.9.1285; Chey J, 2002, PSYCHIAT RES, V110, P259, DOI 10.1016/S0165-1781(02)00105-1; Conklin HM, 2000, AM J PSYCHIAT, V157, P275, DOI 10.1176/appi.ajp.157.2.275; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; Crow TJ, 1996, SCHIZOPHR RES, V22, P181, DOI 10.1016/S0920-9964(96)00068-0; Crow TJ, 1997, TRENDS NEUROSCI, V20, P339; DAVID AS, 1994, SCHIZOPHRENIA BULL, V20, P249, DOI 10.1093/schbul/20.2.249; DeLisi LE, 1997, SCHIZOPHRENIA BULL, V23, P255, DOI 10.1093/schbul/23.2.255; Fallgatter AJ, 1998, EUR ARCH PSY CLIN N, V248, P245, DOI 10.1007/s004060050045; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J, 2005, NEUROIMAGE, V26, P215, DOI 10.1016/j.neuroimage.2005.01.055; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glahn DC, 2005, HUM BRAIN MAPP, V25, P60, DOI 10.1002/hbm.20138; Glahn DC, 2003, BIOL PSYCHIAT, V53, P624, DOI 10.1016/S0006-3223(02)01641-4; Gold JM, 2003, J ABNORM PSYCHOL, V112, P61, DOI 10.1037/0021-843X.112.1.61; GOLDMAN R, 1987, HDB PHYSL NERVOUS SY, V5, P373; Green MF, 1996, AM J PSYCHIAT, V153, P321; Heckers S, 2002, PSYCHIAT RES-NEUROIM, V116, P25, DOI 10.1016/S0925-4927(02)00067-7; HOFFMAN RE, 1993, SCHIZOPHRENIA BULL, V19, P119, DOI 10.1093/schbul/19.1.119; HOFFMAN RE, 1994, SCHIZOPHRENIA BULL, V20, P257, DOI 10.1093/schbul/20.2.257; JACOBSEN CF, 1935, COMP PSYCHOL MONOGR, V13, P3; Kennan RP, 2002, HUM BRAIN MAPP, V16, P183, DOI 10.1002/hbm.10039; Klingberg T, 1997, CEREB CORTEX, V7, P465, DOI 10.1093/cercor/7.5.465; Krieger S, 2005, AM J PSYCHIAT, V162, P1206, DOI 10.1176/appi.ajp.162.6.1206; Kubota Y, 2005, SCHIZOPHR RES, V77, P65, DOI 10.1016/j.schres.2005.01.007; Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599; Leung HC, 2002, J COGNITIVE NEUROSCI, V14, P659, DOI 10.1162/08989290260045882; Liddle PF, 2000, ACTA PSYCHIAT SCAND, V101, P11, DOI 10.1111/j.0065-1591.2000.007s021[dash]3.x; Manoach DS, 1999, BIOL PSYCHIAT, V45, P1128, DOI 10.1016/S0006-3223(98)00318-7; Manoach DS, 2000, BIOL PSYCHIAT, V48, P99, DOI 10.1016/S0006-3223(00)00227-4; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; Mehagnoul-Schipper DJ, 2002, HUM BRAIN MAPP, V16, P14, DOI 10.1002/hbm.10026; Millikan GA, 1942, REV SCI INSTRUM, V13, P434, DOI 10.1063/1.1769941; Myles-Worsley M, 2002, AM J MED GENET, V114, P609, DOI 10.1002/ajmg.10644; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nicklin SE, 2003, ARCH DIS CHILD-FETAL, V88, P263; NUECHTERLEIN KH, 1994, NEUROPSYCHOLOGY SCHI; Obrig H, 2000, INT J PSYCHOPHYSIOL, V35, P125, DOI 10.1016/S0167-8760(99)00048-3; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Park S, 1999, BIOL PSYCHIAT, V46, P392, DOI 10.1016/S0006-3223(98)00370-9; PARK S, 1995, J ABNORM PSYCHOL, V104, P355, DOI 10.1037/0021-843X.104.2.355; Park S, 1997, SCHIZOPHR RES, V26, P213, DOI 10.1016/S0920-9964(97)00051-0; Park S, 2003, SCHIZOPHR RES, V59, P261, DOI 10.1016/S0920-9964(02)00209-8; PARK S, 1995, ARCH GEN PSYCHIAT, V52, P821; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Park S.J., 2002, PRINCIPLES EXPT PSYC, P83; Perlstein WM, 2001, AM J PSYCHIAT, V158, P1105, DOI 10.1176/appi.ajp.158.7.1105; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Reilly JL, 2006, ARCH GEN PSYCHIAT, V63, P1189, DOI 10.1001/archpsyc.63.11.1189; Roitman SEL, 2000, SCHIZOPHR RES, V41, P447; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Shinba T, 2004, BIOL PSYCHIAT, V55, P154, DOI 10.1016/S0006-3223(03)00547-X; Silver H, 2003, AM J PSYCHIAT, V160, P1809, DOI 10.1176/appi.ajp.160.10.1809; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Suto T, 2004, BIOL PSYCHIAT, V55, P501, DOI 10.1016/j.biopsych.2003.09.008; Talairach J., 1988, COPLANAR STEREOTAXIC; Tallent KA, 1999, PSYCHIAT RES, V89, P161, DOI 10.1016/S0165-1781(99)00101-8; Tsujimoto S, 2004, CEREB CORTEX, V14, P703, DOI 10.1093/cercor/bhh030; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Walter H, 2003, SCHIZOPHR RES, V61, P175, DOI 10.1016/S0920-9964(02)00225-6; Wilcox T, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852551	79	79	80	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1760	10.1371/journal.pone.0001760	http://dx.doi.org/10.1371/journal.pone.0001760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335036	Green Published, gold, Green Submitted			2022-12-25	WOS:000260723000014
J	Robinson, F; Jackson, RJ; Smith, CWJ				Robinson, Fiona; Jackson, Richard J.; Smith, Christopher W. J.			Expression of Human nPTB Is Limited by Extreme Suboptimal Codon Content	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; HIGH-LEVEL EXPRESSION; TRANSFER-RNA; SECONDARY STRUCTURE; ESCHERICHIA-COLI; MAMMALIAN-CELLS; GENE; OPTIMIZATION; USAGE; PTB	Background: The frequency of synonymous codon usage varies widely between organisms. Suboptimal codon content limits expression of viral, experimental or therapeutic heterologous proteins due to limiting cognate tRNAs. Codon content is therefore often adjusted to match codon bias of the host organism. Codon content also varies between genes within individual mammalian species. However, little attention has been paid to the consequences of codon content upon translation of host proteins. Methodology/Principal Findings: In comparing the splicing repressor activities of transfected human PTB and its two tissue-restricted paralogs-nPTB and ROD1-we found that the three proteins were expressed at widely varying levels. nPTB was expressed at 1-3% the level of PTB despite similar levels of mRNA expression and 74% amino acid identity. The low nPTB expression was due to the high proportion of codons with A or U at the third codon position, which are suboptimal in human mRNAs. Optimization of the nPTB codon content, akin to the "humanization" of foreign ORFs, allowed efficient translation in vivo and in vitro to levels comparable with PTB. We were then able to demonstrate that all three proteins act as splicing repressors. Conclusions/Significance: Our results provide a striking illustration of the importance of mRNA codon content in determining levels of protein expression, even within cells of the natural host species.	[Robinson, Fiona; Jackson, Richard J.; Smith, Christopher W. J.] Univ Cambridge, Dept Biochem, Cambridge, England	University of Cambridge	Robinson, F (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.	cwjs1@cam.ac.uk			Wellcome Trust [059879, 077877]; Canadian Cambridge Trust with Merck Frosst Canada Inc [studentship]; Cambridge Commonwealth Trust; Corpus Christi College	Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Cambridge Trust with Merck Frosst Canada Inc; Cambridge Commonwealth Trust; Corpus Christi College	This work was supported by Wellcome Trust programme grants (059879 & 077877) to CWJS. F.R. was supported by studentship funds from the Canadian Cambridge Trust with Merck Frosst Canada Inc., an Overseas Research Studentship, Cambridge Commonwealth Trust, and Corpus Christi College. None of the funders or sponsors played any role in the research or preparation of the manuscript.	*ACC INC, 2001, WISC; Ali IK, 2001, EMBO J, V20, P4233, DOI 10.1093/emboj/20.15.4233; AOTA S, 1986, NUCLEIC ACIDS RES, V14, P6345, DOI 10.1093/nar/14.16.6345; Ashiya M, 1997, RNA, V3, P996; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; BONEKAMP F, 1988, NUCLEIC ACIDS RES, V16, P3013, DOI 10.1093/nar/16.7.3013; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; CANDELAS GC, 1990, DEV BIOL, V140, P215, DOI 10.1016/0012-1606(90)90069-U; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; Charlet-B N, 2002, MOL CELL, V9, P649, DOI 10.1016/S1097-2765(02)00479-3; CHEVALLIER A, 1979, BIOCHIMIE, V61, P245, DOI 10.1016/S0300-9084(79)80070-X; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; DASSO MC, 1989, NUCLEIC ACIDS RES, V17, P3129, DOI 10.1093/nar/17.8.3129; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Gooding C, 2003, J BIOL CHEM, V278, P15201, DOI 10.1074/jbc.M210131200; Gooding C, 1998, RNA, V4, P85; Gromak N, 2003, RNA, V9, P443, DOI 10.1261/rna.2191903; Guthrie C., 1982, MOL BIOL YEAST SACCH, P487; Hamdan FF, 2002, PARASITOL RES, V88, P583, DOI 10.1007/s00436-001-0585-0; HATFIELD D, 1986, BIOCHEM INT, V13, P835; HOLLER TP, 1993, GENE, V136, P323, DOI 10.1016/0378-1119(93)90488-O; Horvath H, 2000, P NATL ACAD SCI USA, V97, P1914, DOI 10.1073/pnas.030527497; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; Kim CH, 1997, GENE, V199, P293, DOI 10.1016/S0378-1119(97)00384-3; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy JP, 1996, NAT BIOTECHNOL, V14, P610, DOI 10.1038/nbt0596-610; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Massaer M, 2001, INT ARCH ALLERGY IMM, V125, P32, DOI 10.1159/000053794; Narum DL, 2001, INFECT IMMUN, V69, P7250, DOI 10.1128/IAI.69.12.7250-7253.2001; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; OUENZAR B, 1988, BIOCHIM BIOPHYS ACTA, V950, P429, DOI 10.1016/0167-4781(88)90140-6; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Perez I, 1997, RNA, V3, P764; Plotkin JB, 2004, P NATL ACAD SCI USA, V101, P12588, DOI 10.1073/pnas.0404957101; Robinson F, 2006, J BIOL CHEM, V281, P800, DOI 10.1074/jbc.M510578200; Semon M, 2006, MOL BIOL EVOL, V23, P523, DOI 10.1093/molbev/msj053; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; SPELLMAN RH, 2007, MOL CELL, V27; THOMAS LK, 1988, P NATL ACAD SCI USA, V85, P4242, DOI 10.1073/pnas.85.12.4242; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Wollerton MC, 2001, RNA, V7, P819, DOI 10.1017/S1355838201010214; Yamamoto H, 1999, MOL CELL BIOL, V19, P3829; Zhang WQ, 2002, RNA, V8, P671, DOI 10.1017/S1355838202027036; Zhao KN, 2005, MOL CELL BIOL, V25, P8643, DOI 10.1128/MCB.25.19.8643-8655.2005; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	57	22	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1801	10.1371/journal.pone.0001801	http://dx.doi.org/10.1371/journal.pone.0001801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335065	Green Published, Green Submitted, gold			2022-12-25	WOS:000260723000047
J	Tsuchida, R; Das, B; Yeger, H; Koren, G; Shibuya, M; Thorner, P; Baruchel, S; Malkin, D				Tsuchida, R.; Das, B.; Yeger, H.; Koren, G.; Shibuya, M.; Thorner, Ps; Baruchel, S.; Malkin, D.			Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling	ONCOGENE			English	Article						osteosarcoma; cisplatin; tumorigenic SP; VEGF/Flt1 autocrine	ENDOTHELIAL GROWTH-FACTOR; HUMAN OSTEOBLAST CELLS; PROSTATE-CANCER CELLS; HUMAN TUMOR-CELLS; IN-VITRO; VEGF; TRANSFORMATION; PHENOTYPE; CHEMOTHERAPY; INDUCTION	The cellular and molecular mechanisms of tumor progression following chemotherapy are largely unknown. Here, we demonstrate that cisplatin ( CDDP) treatment upregulates VEGF and Flt1 expression leading to the survival and expansion of a highly tumorigenic fraction of side-population (SP) cells in osteosarcoma (HOS), neuroblastoma (SK-N-BE2) and rhabdomyosarcoma (RH-4) cell lines. In all three lines, we show that CDDP treatment increases levels of VEGF and Flt1 expression, and induces enhanced clonogenic capacity and increased expression of the 'stemness'-associated genes Nanog, Bmi-1 and Oct-4 in the SP fraction. In HOS, these changes are associated with the transformation of a non-tumorigenic osteosarcoma SP fraction to a highly tumorigenic phenotype. Inhibition of Flt1 led to complete reduction of tumorigenicity in the HOS SP fraction, and reduction of clonogenic capacity and expression of stemness genes in the SK-N-BE(2) and RH-4 SP fractions. Treatment with U0126, a specific inhibitor of MAPK/ERK1,2 completely downregulates CDDP-induced VEGF and Flt1 expression and induction/expansion of SP fraction in all three cell lines, indicating that these effects are mediated through MAPK/ERK1,2 signaling. In conclusion, we report a novel mechanism of CDDP-induced tumor progression, whereby the activation of VEGF/Flt1 autocrine signaling leads to the survival and expansion of a highly tumorigenic SP fraction.	[Tsuchida, R.; Das, B.; Baruchel, S.; Malkin, D.] Hosp Sick Children, Dept Pediat, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada; [Das, B.; Koren, G.; Baruchel, S.; Malkin, D.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Yeger, H.; Thorner, Ps] Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada; [Yeger, H.; Thorner, Ps] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Shibuya, M.] Univ Tokyo, Inst Med Sci, Dept Genet, Div Genet, Tokyo, Japan; [Baruchel, S.; Malkin, D.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Malkin, D.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Tokyo; University of Toronto; University of Toronto	Malkin, D (corresponding author), Hosp Sick Children, Dept Pediat, Div Hematol Oncol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	david.malkin@sickkids.ca	Malkin, David/AAW-8715-2021; Koren, Gideon/AAG-7726-2019	Koren, Gideon/0000-0002-9234-0875				Bates RC, 2003, CURR BIOL, V13, P1721, DOI 10.1016/j.cub.2003.09.002; Behrends M, 2000, AM J PHYSIOL-HEART C, V279, pH1111, DOI 10.1152/ajpheart.2000.279.3.H1111; Bellamy WT, 2001, BLOOD, V97, P1427, DOI 10.1182/blood.V97.5.1427; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Brozovic A, 2007, CANCER LETT, V251, P1, DOI 10.1016/j.canlet.2006.10.007; Cara S, 2001, ANN ONCOL, V12, P23, DOI 10.1023/A:1008389706725; COLE S, 2004, DRUG RESISTANCE; Cottler-Fox Michele H, 2003, Hematology Am Soc Hematol Educ Program, P419; Das B, 2005, CANCER RES, V65, P7267, DOI 10.1158/0008-5472.CAN-04-4575; Das B, 2003, EUR J CANCER, V39, P2556, DOI 10.1016/j.ejca.2003.07.002; DAS B, 2007, STEM CELLS; Dias S, 2000, J CLIN INVEST, V106, P511, DOI 10.1172/JCI8978; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; GASPARINI G, 1995, J CLIN ONCOL, V13, P765, DOI 10.1200/JCO.1995.13.3.765; Gee MFW, 2005, ONCOGENE, V24, P8025, DOI 10.1038/sj.onc.1208939; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Hirschmann-Jax C, 2005, CELL CYCLE, V4, P203; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; LIN XH, 1994, ENVIRON HEALTH PERSP, V102, P289, DOI 10.2307/3431804; MCALLISTER RM, 1971, CANCER-AM CANCER SOC, V27, P397, DOI 10.1002/1097-0142(197102)27:2<397::AID-CNCR2820270224>3.0.CO;2-X; Mercurio AM, 2004, SEMIN CANCER BIOL, V14, P115, DOI 10.1016/j.semcancer.2003.09.016; Miller AC, 1998, ENVIRON HEALTH PERSP, V106, P465, DOI 10.1289/ehp.98106465; Miller AC, 2001, CARCINOGENESIS, V22, P115, DOI 10.1093/carcin/22.1.115; Miura K, 2005, BIOCHEM CELL BIOL, V83, P36, DOI 10.1139/O04-106; Montanaro F, 2004, EXP CELL RES, V298, P144, DOI 10.1016/j.yexcr.2004.04.010; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Qi L, 2003, ANTICANCER RES, V23, P3917; Ranganathan AC, 2006, CELL CYCLE, V5, P1799, DOI 10.4161/cc.5.16.3109; RICHMAN CM, 1976, BLOOD, V47, P1031; Salnikow K, 1999, CARCINOGENESIS, V20, P1819, DOI 10.1093/carcin/20.9.1819; Setoguchi T, 2004, CELL CYCLE, V3, P414; Soker S, 2001, AM J PATHOL, V159, P651, DOI 10.1016/S0002-9440(10)61736-1; Steiner HH, 2004, J NEURO-ONCOL, V66, P129, DOI 10.1023/B:NEON.0000013495.08168.8f; Strizzi L, 2001, J PATHOL, V193, P468, DOI 10.1002/path.824; Woessmann W, 2002, CANCER CHEMOTH PHARM, V50, P397, DOI 10.1007/s00280-002-0502-y	40	51	53	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2008	27	28					3923	3934		10.1038/onc.2008.38	http://dx.doi.org/10.1038/onc.2008.38			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	318JZ	18332870				2022-12-25	WOS:000257089000004
J	Pavlicek, J; Coon, SL; Ganguly, S; Weller, JL; Hassan, SA; Sackett, DL; Klein, DC				Pavlicek, Jiri; Coon, Steven L.; Ganguly, Surajit; Weller, Joan L.; Hassan, Sergio A.; Sackett, Dan L.; Klein, David C.			Evidence that proline focuses movement of the floppy loop of arylalkylamine N-acetyltransferase (EC 2.3.1.87)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM RESOLUTION; MOLECULAR-DYNAMICS; ENZYME; RHYTHM; SUPERFAMILY; BACKBONE; PROTEINS	Arylalkylamine N-acetyltransferase (AANAT) catalyzes the N-acetylation of serotonin, the penultimate step in the synthesis of melatonin. Pineal AANAT activity increases at night in all vertebrates, resulting in increased melatonin production. This increases circulating levels of melatonin, thereby providing a hormonal signal of darkness. Kinetic and structural analysis of AANAT has determined that one element is floppy. This element, termed Loop 1, is one of three loops that comprise the arylalkylamine binding pocket. During the course of chordate evolution, Loop 1 acquired the tripeptide CPL, and the enzyme became highly active. Here we focused on the functional importance of the CPL tripeptide and found that activity was markedly reduced when it was absent. Moreover, increasing the local flexibility of this tripeptide region by P64G and P64A mutations had the counterintuitive effect of reducing activity and reducing the overall movement of Loop 1, as estimated from Langevin dynamics simulations. Binding studies indicate that these mutations increased the off-rate constant of a model substrate without altering the dissociation constant. The structural kink and local rigidity imposed by Pro-64 may enhance activity by favoring configurations of Loop 1 that facilitate catalysis and do not become immobilized by intramolecular interactions.	[Pavlicek, Jiri; Coon, Steven L.; Ganguly, Surajit; Weller, Joan L.; Klein, David C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Neuroendocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Sackett, Dan L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Cell Biophys, Lab Integrat & Med Biophys, NIH, Bethesda, MD 20892 USA; [Hassan, Sergio A.] NIH, Ctr Mol Modeling, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Klein, DC (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	kleind@mail.nih.gov	Pavlicek, Jiri/G-9927-2014	Ganguly, Surajit/0000-0002-1876-9147; Klein, David/0000-0002-1792-5806	Intramural NIH HHS [Z01 CT000265-11] Funding Source: Medline; CENTER FOR INFORMATION TECHNOLOGY [Z01CT000265] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008836] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arendt J., 1995, MELATONIN MAMMALIAN; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; COON SL, 1995, SCIENCE, V270, P1681, DOI 10.1126/science.270.5242.1681; Coon SL, 2006, MOL CELL ENDOCRINOL, V252, P2, DOI 10.1016/j.mce.2006.03.039; De Angelis J, 1998, J BIOL CHEM, V273, P3045, DOI 10.1074/jbc.273.5.3045; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Ganguly S, 2001, J BIOL CHEM, V276, P47239, DOI 10.1074/jbc.M107222200; Hassan SA, 2000, J PHYS CHEM B, V104, P6478, DOI 10.1021/jp993895e; Hassan SA, 2003, PROTEINS, V51, P109, DOI 10.1002/prot.10330; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hickman AB, 1999, MOL CELL, V3, P23, DOI 10.1016/S1097-2765(00)80171-9; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; Kempf JG, 2007, J MOL BIOL, V368, P131, DOI 10.1016/j.jmb.2007.01.074; Khalil EM, 1998, J AM CHEM SOC, V120, P6195, DOI 10.1021/ja981365a; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; KLEIN DC, 1970, SCIENCE, V169, P1093, DOI 10.1126/science.169.3950.1093; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Klein DC, 2002, BIOCHEM SOC T, V30, P365, DOI 10.1042/bst0300365; KLEIN DC, 1972, SCIENCE, V177, P532, DOI 10.1126/science.177.4048.532; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Nam GH, 2003, BIOCHEM J, V375, P297, DOI 10.1042/BJ20030263; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Pizzitutti F, 2006, J MOL RECOGNIT, V19, P1, DOI 10.1002/jmr.748; Ramaswamy S, 1999, BIOCHEMISTRY-US, V38, P13951, DOI 10.1021/bi991731i; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; Scheibner KA, 2002, J BIOL CHEM, V277, P18118, DOI 10.1074/jbc.M200595200; Shan L, 2007, BIOCHEMISTRY-US, V46, P11504, DOI 10.1021/bi7009794; Sun ZY, 2005, PROTEINS, V61, P870, DOI 10.1002/prot.20686; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wolf E, 2002, J MOL BIOL, V317, P215, DOI 10.1006/jmbi.2001.5371; Yazer MH, 2005, TRANSFUS MED REV, V19, P210, DOI 10.1016/j.tmrv.2005.02.008	36	19	20	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14552	14558		10.1074/jbc.M800593200	http://dx.doi.org/10.1074/jbc.M800593200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18362150	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000255941400043
J	Chelico, L; Sacho, EJ; Erie, DA; Goodman, MF				Chelico, Linda; Sacho, Elizabeth J.; Erie, Dorothy A.; Goodman, Myron F.			A model for oligomeric regulation of APOBEC3G cytosine deaminase-dependent restriction of HIV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SINGLE-STRANDED-DNA; ACTIVATION-INDUCED DEAMINASE; REVERSE TRANSCRIPTION; CYTIDINE DEAMINASE; PROTEIN; DOMAIN; ENDONUCLEASE; AID; HYPERMUTATION	APOBEC3G (A3G) restricts HIV-1 infection by catalyzing processive C -> U deaminations on single-stranded DNA (ssDNA) with marked 3' -> 5' deamination polarity. Here we show that A3G exists in oligomeric states whose composition is dictated primarily by interactions with DNA, with salt playing an important, yet secondary, role. Directional deaminations correlate with the presence of dimers, tetramers, and larger oligomers observed by atomic force microscopy, and random deaminations appear to correlate mainly with monomers. The presence of a 30-nt weakly deaminated "dead" zone located at the 3'-ssDNA end implies the presence of a preferred asymmetric direction for A3G catalysis. Single turnover reaction rates reveal a salt-dependent inhibition of C deamination toward the 3'-ssDNA region, offering a molecular basis underlying A3G deamination polarity. Presteady state analysis demonstrates rapid diffusion-limited A3G-ssDNA binding, a slower salt-dependent conformational change, possibly indicative of DNA wrapping, and long (5-15 min) protein-DNA complex lifetimes. We suggest that diverse A3G oligomerization modes contribute to the human immunodeficiency virus, type 1, proviral DNA mutational bias.	[Chelico, Linda; Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, Los Angeles, CA 90089 USA; [Chelico, Linda; Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; [Sacho, Elizabeth J.; Erie, Dorothy A.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Erie, Dorothy A.] Univ N Carolina, Appl & Mat Sci Curriculum, Chapel Hill, NC 27599 USA	University of Southern California; University of Southern California; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Sect, 1050 Childs Way, Los Angeles, CA 90089 USA.	mgoodman@usc.edu		Sacho, Elizabeth/0000-0002-4499-5869; Chelico, Linda/0000-0003-4673-8978	NIEHS NIH HHS [ES013192] Funding Source: Medline; NIGMS NIH HHS [R37GM21422, R01 GM079480-02, GM79480, R01 GM079480] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013192, R01ES013192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021422, R01GM079480] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Brar SS, 2008, DNA REPAIR, V7, P77, DOI 10.1016/j.dnarep.2007.08.002; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Chen KM, 2007, FEBS LETT, V581, P4761, DOI 10.1016/j.febslet.2007.08.076; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Goddard NL, 2000, PHYS REV LETT, V85, P2400, DOI 10.1103/PhysRevLett.85.2400; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; JACK WE, 1982, P NATL ACAD SCI-BIOL, V79, P4010, DOI 10.1073/pnas.79.13.4010; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Opi S, 2006, J VIROL, V80, P4673, DOI 10.1128/JVI.80.10.4673-4682.2006; Pham P, 2007, DNA REPAIR, V6, P689, DOI 10.1016/j.dnarep.2007.01.001; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Ratcliff GC, 2001, J AM CHEM SOC, V123, P5632, DOI 10.1021/ja005750n; Schlacher K, 2005, MOL CELL, V17, P561, DOI 10.1016/j.molcel.2005.01.006; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Suspene R, 2006, NUCLEIC ACIDS RES, V34, P4677, DOI 10.1093/nar/gkl555; TERRY BJ, 1985, J BIOL CHEM, V260, P3130; Tessmer I, 2005, J MOL BIOL, V350, P254, DOI 10.1016/j.jmb.2005.04.043; Verhoeven EEA, 2002, EMBO J, V21, P4196, DOI 10.1093/emboj/cdf396; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; Xue Y, 2002, BIOCHEMISTRY-US, V41, P2901, DOI 10.1021/bi0157161; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	43	83	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13780	13791		10.1074/jbc.M801004200	http://dx.doi.org/10.1074/jbc.M801004200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18362149	Green Published, hybrid			2022-12-25	WOS:000255728200030
J	Minami, K; Okano, H; Okumachi, A; Seino, S				Minami, Kohtaro; Okano, Hirotoshi; Okumachi, Akinori; Seino, Susumu			Role of cadherin-mediated cell-cell adhesion in pancreatic exocrine-to-endocrine transdifferentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETING CELLS; BETA-CELLS; IN-VITRO; ADHERENS JUNCTIONS; PROGENITOR CELLS; ACINAR-CELLS; HUMAN ISLETS; MDCK CELLS; DIFFERENTIATION; REGENERATION	Although pancreatic exocrine acinar cells have the potential to transdifferentiate into pancreatic endocrine cells, the mechanisms are poorly understood. Here we report that intracellular signaling pathways, including those involving MAPK and phosphatidylinositol 3 (PI3)-kinase, are activated by enzymatic dissociation of pancreatic acinar cells and that spherical cell clusters are formed by cadherin-mediated cell-cell adhesion during transdifferentiation. Inhibition of PI3-kinase by LY294002 prevents spheroid formation by degrading E-cadherin and beta-catenin, blocking transdifferentiation into insulin-secreting cells. In addition, neutralizing antibody against E-cadherin suppresses the induction of genes characteristic of pancreatic beta-cells. We also show that loss of cadherin-mediated cell-cell adhesion induces and maintains a dedifferentiated state in isolated pancreatic acinar cells. Thus, disruption and remodeling of cadherin-mediated cell-cell adhesion is critical in pancreatic exocrine-to-endocrine transdifferentiation, in which the PI3-kinase pathway plays an essential role.	[Minami, Kohtaro; Okano, Hirotoshi; Seino, Susumu] Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 6500017, Japan; [Minami, Kohtaro; Okumachi, Akinori; Seino, Susumu] Kyoto Univ Hosp, Translat Res Ctr, Dept Expt Therapeut, Kyoto 6068507, Japan; [Seino, Susumu] Kobe Univ, Grad Sch Med, Div Endocrinol Diabet & Metab, Dept Internal Med,Chuo Ku, Kobe, Hyogo 6500017, Japan	Kobe University; Kyoto University; Kobe University	Seino, S (corresponding author), Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 6500017, Japan.	seino@med.kobe-u.ac.jp		Minami, Kohtaro/0000-0003-4698-6250				Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Bouwens L, 1998, MICROSC RES TECHNIQ, V43, P332, DOI 10.1002/(SICI)1097-0029(19981115)43:4<332::AID-JEMT7>3.0.CO;2-1; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Dabeva MD, 1997, P NATL ACAD SCI USA, V94, P7356, DOI 10.1073/pnas.94.14.7356; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Echeverri K, 2002, SEMIN CELL DEV BIOL, V13, P353, DOI 10.1016/S1084952102000915; Eguchi G, 1993, CURR OPIN CELL BIOL, V5, P1023, DOI 10.1016/0955-0674(93)90087-7; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Gao R, 2005, DIABETOLOGIA, V48, P2296, DOI 10.1007/s00125-005-1935-8; Gao R, 2003, DIABETES, V52, P2007, DOI 10.2337/diabetes.52.8.2007; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Ito K, 1999, ONCOGENE, V18, P7080, DOI 10.1038/sj.onc.1203191; KANNO Y, 1984, EXP CELL RES, V152, P270, DOI 10.1016/0014-4827(84)90253-2; Kodama A, 1999, ONCOGENE, V18, P3996, DOI 10.1038/sj.onc.1202773; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Okuno M, 2007, AM J PHYSIOL-ENDOC M, V292, pE158, DOI 10.1152/ajpendo.00180.2006; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Potter E, 1999, ENDOCR REV, V20, P207, DOI 10.1210/er.20.2.207; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; RAO MS, 1988, BIOCHEM BIOPH RES CO, V156, P131, DOI 10.1016/S0006-291X(88)80814-3; REDDY JK, 1984, J CELL BIOL, V98, P2082, DOI 10.1083/jcb.98.6.2082; Rooman I, 2000, DIABETOLOGIA, V43, P907, DOI 10.1007/s001250051468; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Slack JMW, 2001, CURR OPIN GENET DEV, V11, P581, DOI 10.1016/S0959-437X(00)00236-7; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Somasiri A, 2000, DIFFERENTIATION, V66, P116, DOI 10.1046/j.1432-0436.2000.660206.x; Strobel O, 2007, P NATL ACAD SCI USA, V104, P4419, DOI 10.1073/pnas.0605248104; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Tosh D, 2002, NAT REV MOL CELL BIO, V3, P187, DOI 10.1038/nrm761; TSONIS PA, 1995, SEMIN CELL BIOL, V6, P127, DOI 10.1006/scel.1995.0018; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; YAMAMOTO H, 1981, NATURE, V294, P284, DOI 10.1038/294284a0; Yatoh S, 2007, DIABETES, V56, P1802, DOI 10.2337/db06-1670; YEUNG RS, 1993, CANCER, V72, P2124, DOI 10.1002/1097-0142(19931001)72:7<2124::AID-CNCR2820720711>3.0.CO;2-C	47	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13753	13761		10.1074/jbc.M710034200	http://dx.doi.org/10.1074/jbc.M710034200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18332139	hybrid			2022-12-25	WOS:000255728200027
J	Wongsiriroj, N; Piantedosi, R; Palczewski, K; Goldberg, IJ; Johnston, TP; Li, E; Blaner, WS				Wongsiriroj, Nuttaporn; Piantedosi, Roseann; Palczewski, Krzysztof; Goldberg, Ira J.; Johnston, Thomas P.; Li, Ellen; Blaner, William S.			The molecular basis of retinoid absorption - A genetic dissection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; RAT-LIVER MICROSOMES; ACYL-COENZYME-A; BINDING-PROTEIN; VITAMIN-A; SMALL-INTESTINE; DIACYLGLYCEROL ACYLTRANSFERASE; ADIPOSE-TISSUE; ESTERIFICATION; LECITHIN	The intestine and other tissues are able to synthesize retinyl esters in an acyl-CoA-dependent manner involving an acyl-CoA: retinol acyltransferase (ARAT). However, the molecular identity of this ARAT has not been established. Recent studies of lecithin: retinol acyltransferase (LRAT)-deficient mice indicate that LRAT is responsible for the preponderance of retinyl ester synthesis in the body, aside from in the intestine and adipose tissue. Our present studies, employing a number of mutant mouse models, identify diacylglycerol acyltransferase 1 (DGAT1) as an important intestinal ARAT in vivo. The contribution that DGAT1 makes to intestinal retinyl ester synthesis becomes greater when a large pharmacologic dose of retinol is administered by gavage to mice. Moreover, when large retinol doses are administered another intestinal enzyme(s) with ARAT activity becomes apparent. Surprisingly, although DGAT1 is expressed in adipose tissue, DGAT1 does not catalyze retinyl ester synthesis in adipose tissue in vivo. Our data also establish that cellular retinol-binding protein, type II (CRBPII), which is expressed solely in the adult intestine, in vivo channels retinol to LRAT for retinyl ester synthesis. Contrary to what has been proposed in the literature based on in vitro studies, CRBPII does not directly prevent retinol from being acted upon by DGAT1 or other intestinal ARATs in vivo.	[Wongsiriroj, Nuttaporn; Piantedosi, Roseann; Goldberg, Ira J.; Blaner, William S.] Columbia Univ, Dept Med, New York, NY 10032 USA; [Wongsiriroj, Nuttaporn; Piantedosi, Roseann; Goldberg, Ira J.; Blaner, William S.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Palczewski, Krzysztof] Case Western Reserve Univ, Case Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Johnston, Thomas P.] Univ Missouri, Sch Pharm, Kansas City, MO 64110 USA; [Li, Ellen] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Columbia University; Columbia University; Case Western Reserve University; University of Missouri System; University of Missouri Kansas City; Washington University (WUSTL)	Blaner, WS (corresponding author), Columbia Univ, Dept Med, Black Bldg,Rm 914, New York, NY 10032 USA.	wsb2@columbia.edu			NEI NIH HHS [R01 EY009339-19S1, R01 EY009339, R01 EY09339, R01 EY08123] Funding Source: Medline; NIDDK NIH HHS [R01 DK079221, R01 DK068437, R01 DK061310, P30 DK052574] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009339, R01EY008123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068437, R01DK079221, P30DK052574, R01DK061310] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BELFRAGE P, 1977, FEBS LETT, V75, P259, DOI 10.1016/0014-5793(77)80099-9; Blaner William S., 1994, P229; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; CROW JA, 1985, P NATL ACAD SCI USA, V82, P4707, DOI 10.1073/pnas.82.14.4707; DEW SE, 1994, BIOCHEMISTRY-US, V33, P12340, DOI 10.1021/bi00206a042; E XP, 2002, J BIOL CHEM, V277, P36617, DOI 10.1074/jbc.M205519200; ECKHOFF C, 1991, TOXICOL APPL PHARM, V111, P116, DOI 10.1016/0041-008X(91)90140-A; ERIKSSON U, 1984, J BIOL CHEM, V259, P3464; GOODMAN DS, 1965, J LIPID RES, V6, P390; Gudas Lorraine J., 1994, P443; HELGERUD P, 1982, J LIPID RES, V23, P609; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; LI E, 1986, P NATL ACAD SCI USA, V83, P5779, DOI 10.1073/pnas.83.16.5779; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; MACDONALD PN, 1988, J BIOL CHEM, V263, P12478; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; MOORE T, 1957, VITAMIN A, P1; NOY N, 1999, HDB EXPT PHARM BIOCH, P3; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; OBYRNE SM, 2005, CAROTENOIDS RETINOID, P1; Ong David E., 1994, P283; ONG DE, 1987, J BIOL CHEM, V262, P2729; Orland MD, 2005, BBA-MOL CELL BIOL L, V1737, P76, DOI 10.1016/j.bbalip.2005.09.003; Palmer WK, 1998, ATHEROSCLEROSIS, V136, P115, DOI 10.1016/S0021-9150(97)00193-7; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; QUICK TC, 1990, BIOCHEMISTRY-US, V29, P11116, DOI 10.1021/bi00502a015; RANDOLPH RK, 1991, ARCH BIOCHEM BIOPHYS, V288, P500, DOI 10.1016/0003-9861(91)90227-A; ROSS AC, 1982, J BIOL CHEM, V257, P2453; ROSS AC, 1982, J LIPID RES, V23, P133; SAARI JC, 1989, J BIOL CHEM, V264, P8636; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; Wasan KM, 2003, J PHARM PHARM SCI, V6, P189; Wei SH, 1997, J BIOL CHEM, V272, P14159, DOI 10.1074/jbc.272.22.14159; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; YEAMAN SJ, 1990, BIOCHIM BIOPHYS ACTA, V1052, P128, DOI 10.1016/0167-4889(90)90067-N; Yen CLE, 2005, J LIPID RES, V46, P2388, DOI 10.1194/jlr.M500168-JLR200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; YOST RW, 1988, J BIOL CHEM, V263, P18693; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; ZOVICH DC, 1992, J BIOL CHEM, V267, P13884	47	87	87	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13510	13519		10.1074/jbc.M800777200	http://dx.doi.org/10.1074/jbc.M800777200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348983	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000255728200004
J	Jacamo, R; Sinnett-Smith, J; Rey, O; Waldron, RT; Rozengurt, E				Jacamo, Rodrigo; Sinnett-Smith, James; Rey, Osvaldo; Waldron, Richard T.; Rozengurt, Enrique			Sequential protein kinase C (PKC)-dependent and PKC-independent protein kinase D catalytic activation via G(q)-coupled receptors - Differential regulation of activation loop Ser(744) and Ser(748) phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; NF-KAPPA-B; SIGNAL-TRANSDUCTION PATHWAY; INTESTINAL EPITHELIAL-CELLS; POTENTIATES DNA-SYNTHESIS; CYSTEINE-RICH MOTIFS; PHORBOL ESTERS; LYSOPHOSPHATIDIC ACID; INTACT-CELLS; IN-VIVO	Protein kinase D (PKD) is a serine/threonine protein kinase rapidly activated by G protein-coupled receptor (GPCR) agonists via a protein kinase C(PKC)-dependent pathway. Recently, PKD has been implicated in the regulation of long term cellular activities, but little is known about the mechanism(s) of sustained PKD activation. Here, we show that cell treatment with the preferential PKC inhibitors GF 109203X or Go 6983 blocked rapid (1 -5-min) PKD activation induced by bombesin stimulation, but this inhibition was greatly diminished at later times of bombesin stimulation (e. g. 45 min). These results imply that GPCR-induced PKD activation is mediated by early PKC-dependent and late PKC-independent mechanisms. Western blot analysis with site-specific antibodies that detect the phosphorylated state of the activation loop residues Ser(744) and Ser(748) revealed striking PKC-independent phosphorylation of Ser748 as well as Ser744 phosphorylation that remained predominantly but not completely PKC-dependent at later times of bombesin or vasopressin stimulation (20-90 min). To determine the mechanisms involved, we examined activation loop phosphorylation in a set of PKD mutants, including kinase-deficient, constitutively activated, and PKD forms in which the activation loop residues were substituted for alanine. Our results show that PKC-dependent phosphorylation of the activation loop Ser744 and Ser748 is the primary mechanism involved in early phase PKD activation, whereas PKD autophosphorylation on Ser748 is a major mechanism contributing to the late phase of PKD activation occurring in cells stimulated by GPCR agonists. The present studies identify a novel mechanism induced by GPCR activation that leads to late, PKC-independent PKD activation.	Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis,CURE Digest Dis Res Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Rozengurt, E (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, 900 Vet Ave,Warren Hall,Rm 11-124, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu	Waldron, Richard Taliesin/ABF-2773-2020	Waldron, Richard Taliesin/0000-0003-3151-6002; Rey, Osvaldo/0000-0003-1575-9864	NATIONAL CANCER INSTITUTE [K22CA128883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK055003, R01DK056930, R21DK071783] Funding Source: NIH RePORTER; NCI NIH HHS [K22 CA 128883] Funding Source: Medline; NIDDK NIH HHS [R0-1 DK56930, P30 DK41301, R21 DK071783, R0-1 DK55003] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abedi H, 1998, FEBS LETT, V427, P209, DOI 10.1016/S0014-5793(98)00427-X; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Buchwald G, 2001, MOL CELL BIOL, V21, P5179, DOI 10.1128/MCB.21.15.5179-5189.2001; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chiu T, 2002, AM J PHYSIOL-CELL PH, V282, pC434, DOI 10.1152/ajpcell.00240.2001; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Chiu T, 2001, FEBS LETT, V489, P101, DOI 10.1016/S0014-5793(01)02076-2; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; Cui J, 2005, J BIOL CHEM, V280, P9913, DOI 10.1074/jbc.M412165200; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Guha S, 2002, CANCER RES, V62, P1632; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; HERGET T, 1995, EUR J BIOCHEM, V233, P448, DOI 10.1111/j.1432-1033.1995.448_2.x; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hurd C, 2002, ONCOGENE, V21, P2154, DOI 10.1038/sj.onc.1205290; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 1998, FEBS LETT, V437, P19, DOI 10.1016/S0014-5793(98)01189-2; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Marais R, 1996, CANCER SURV, V27, P101; Matthews S, 1999, FEBS LETT, V457, P515, DOI 10.1016/S0014-5793(99)01090-X; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Matthews SA, 1997, J BIOL CHEM, V272, P20245, DOI 10.1074/jbc.272.32.20245; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Needham LK, 1998, J BIOL CHEM, V273, P14626, DOI 10.1074/jbc.273.23.14626; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; OLIVER AW, 2007, TRENDS BIOCH SCI; Paolucci L, 2000, AM J PHYSIOL-CELL PH, V278, pC33, DOI 10.1152/ajpcell.2000.278.1.C33; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rey O, 2001, J BIOL CHEM, V276, P49228, DOI 10.1074/jbc.M109395200; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2007, J CELL PHYSIOL, V211, P781, DOI 10.1002/jcp.20984; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Uberall F, 1997, J BIOL CHEM, V272, P4072, DOI 10.1074/jbc.272.7.4072; VALVERDE AM, 1994, P NATL ACAD SCI USA, V91, P8572, DOI 10.1073/pnas.91.18.8572; Van Lint J, 1998, J BIOL CHEM, V273, P7038, DOI 10.1074/jbc.273.12.7038; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Waldron RT, 2007, BIOCHEM BIOPH RES CO, V356, P361, DOI 10.1016/j.bbrc.2007.02.142; Waldron RT, 2000, J BIOL CHEM, V275, P17114, DOI 10.1074/jbc.M908959199; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 2004, J BIOL CHEM, V279, P27482, DOI 10.1074/jbc.M402875200; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang QMJ, 2003, MOL PHARMACOL, V64, P1342, DOI 10.1124/mol.64.6.1342; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Young LH, 2005, CARDIOVASC DRUG REV, V23, P255; Yuan JZ, 2003, J BIOL CHEM, V278, P4882, DOI 10.1074/jbc.M211175200; Yuan JZ, 2002, BIOCHEM BIOPH RES CO, V291, P444, DOI 10.1006/bbrc.2002.6469; Yuan JZ, 2000, J BIOL CHEM, V275, P2157, DOI 10.1074/jbc.275.3.2157; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zhukova E, 2001, J CELL PHYSIOL, V189, P291, DOI 10.1002/jcp.10018; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	86	72	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12877	12887		10.1074/jbc.M800442200	http://dx.doi.org/10.1074/jbc.M800442200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337243	hybrid, Green Published			2022-12-25	WOS:000255499800024
J	Michalska, K; Hernandez-Santoyo, A; Jaskolski, M				Michalska, Karolina; Hernandez-Santoyo, Alejandra; Jaskolski, Mariusz			The mechanism of autocatalytic activation of plant-type L-asparaginases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL NUCLEOPHILE; CRYSTAL-STRUCTURE; STRUCTURAL INSIGHTS; PENICILLIN ACYLASE; REVEALS; ACID; GLYCOSYLASPARAGINASE; CONSTRAINTS; MATURATION; SEQUENCE	Plant L-asparaginases and their bacterial homologs, such as EcAIII found in Escherichia coli, form a subgroup of the N-terminal nucleophile (Ntn)-hydrolase family. In common with all Ntn-hydrolases, they are expressed as inactive precursors that undergo activation in an autocatalytic manner. The maturation process involves intramolecular hydrolysis of a single peptide bond, leading to the formation of two subunits (alpha and beta) folded as one structural domain, with the nucleophilic Thr residue located at the freed N terminus of subunit beta. The mechanism of the autocleavage reaction remains obscure. We have determined the crystal structure of an active site mutant of EcAIII, with the catalytic Thr residue substituted by Ala (T179A). The modification has led to a correctly folded but unprocessed molecule, revealing the geometry and molecular environment of the scissile peptide bond. The autocatalytic reaction is analyzed from the point of view of the Thr179 side chain rotation, identification of a potential general base residue, and the architecture of the oxyanion hole.	[Michalska, Karolina; Hernandez-Santoyo, Alejandra; Jaskolski, Mariusz] Adam Mickiewicz Univ, Fac Chem, Dept Crystallog, PL-60780 Poznan, Poland; [Jaskolski, Mariusz] Polish Acad Sci, Inst Bioorgan Chem, Ctr Biocrystallograph Res, PL-61704 Poznan, Poland	Adam Mickiewicz University; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Jaskolski, M (corresponding author), Adam Mickiewicz Univ, Fac Chem, Dept Crystallog, Grunwaldzka 6, PL-60780 Poznan, Poland.	mariuszj@amu.edu.pl	Hernández-Santoyo, Alejandra H.S./C-7618-2015	Hernández-Santoyo, Alejandra H.S./0000-0001-8045-4157; Jaskolski, Mariusz/0000-0003-1587-6489				Borek D, 2000, ACTA CRYSTALLOGR D, V56, P1505, DOI 10.1107/S0907444900010076; Borek D, 2004, EUR J BIOCHEM, V271, P3215, DOI 10.1111/j.1432-1033.2004.04254.x; Borek D, 2001, ACTA BIOCHIM POL, V48, P893; BRANNIGAN JA, 1995, NATURE, V378, P416, DOI 10.1038/378416a0; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ditzel L, 1998, J MOL BIOL, V279, P1187, DOI 10.1006/jmbi.1998.1818; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans TC, 2002, CHEM REV, V102, P4869, DOI 10.1021/cr9601369; Guan C, 1998, J BIOL CHEM, V273, P9695, DOI 10.1074/jbc.273.16.9695; Guan CD, 1996, J BIOL CHEM, V271, P1732, DOI 10.1074/jbc.271.3.1732; Guo HC, 1998, J BIOL CHEM, V273, P20205, DOI 10.1074/jbc.273.32.20205; Hewitt L, 2000, J MOL BIOL, V302, P887, DOI 10.1006/jmbi.2000.4105; Ignatova Z, 2005, J MOL BIOL, V348, P999, DOI 10.1016/j.jmb.2005.03.005; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Kim JK, 2003, BIOCHEMISTRY-US, V42, P4084, DOI 10.1021/bi027181x; Kim Y, 2000, STRUCTURE, V8, P1059, DOI 10.1016/S0969-2126(00)00505-0; Klabunde T, 1998, NAT STRUCT BIOL, V5, P31, DOI 10.1038/nsb0198-31; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Michalska K, 2005, J BIOL CHEM, V280, P28484, DOI 10.1074/jbc.M504501200; Michalska K, 2006, ACTA BIOCHIM POL, V53, P627, DOI 10.18388/abp.2006_3291; Michalska K, 2008, ACTA CRYSTALLOGR D, V64, P309, DOI 10.1107/S0907444907068072; Michalska K, 2006, J MOL BIOL, V360, P105, DOI 10.1016/j.jmb.2006.04.066; Muller P, 2003, ACTA CRYSTALLOGR D, V59, P32, DOI 10.1107/S0907444902018000; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Oinonen C, 2000, PROTEIN SCI, V9, P2329, DOI 10.1110/ps.9.12.2329; OINONEN C, 1995, NAT STRUCT BIOL, V2, P1102, DOI 10.1038/nsb1295-1102; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; Prahl A, 2004, ACTA CRYSTALLOGR D, V60, P1173, DOI 10.1107/S0907444904003403; Qian XF, 2003, STRUCTURE, V11, P997, DOI 10.1016/S0969-2126(03)00150-3; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Saarela J, 1998, J BIOL CHEM, V273, P25320, DOI 10.1074/jbc.273.39.25320; Saarela J, 2004, BIOCHEM J, V378, P363, DOI 10.1042/BJ20031496; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; Schmitzberger F, 2003, EMBO J, V22, P6193, DOI 10.1093/emboj/cdg575; Seemuller E, 1996, NATURE, V382, P468, DOI 10.1038/382468a0; Suresh CG, 1999, NAT STRUCT BIOL, V6, P414, DOI 10.1038/8213; Tikkanen R, 1996, EMBO J, V15, P2954, DOI 10.1002/j.1460-2075.1996.tb00658.x; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu QA, 1999, CELL, V98, P651, DOI 10.1016/S0092-8674(00)80052-5; Yoon J, 2004, J BIOL CHEM, V279, P341, DOI 10.1074/jbc.M309281200	47	40	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13388	13397		10.1074/jbc.M800746200	http://dx.doi.org/10.1074/jbc.M800746200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18334484	hybrid			2022-12-25	WOS:000255499800078
J	Clawson, ML; Richt, JA; Baron, T; Biacabe, AG; Czub, S; Heaton, MP; Smith, TPL; Laegreid, WW				Clawson, Michael L.; Richt, Juergen A.; Baron, Thierry; Biacabe, Anne-Gaelle; Czub, Stefanie; Heaton, Michael P.; Smith, Timothy P. L.; Laegreid, William W.			Association of a Bovine Prion Gene Haplotype with Atypical BSE	PLOS ONE			English	Article								Background: Atypical bovine spongiform encephalopathies (BSEs) are recently recognized prion diseases of cattle. Atypical BSEs are rare; approximately 30 cases have been identified worldwide. We tested prion gene (PRNP) haplotypes for an association with atypical BSE. Methodology/Principle Findings: Haplotype tagging polymorphisms that characterize PRNP haplotypes from the promoter region through the three prime untranslated region of exon 3 (25.2 kb) were used to determine PRNP haplotypes of six available atypical BSE cases from Canada, France and the United States. One or two copies of a distinct PRNP haplotype were identified in five of the six cases (p = 1.3 x 10(-4), two-tailed Fisher's exact test; CI(95%) 0.263-0.901, difference between proportions). The haplotype spans a portion of PRNP that includes part of intron 2, the entire coding region of exon 3 and part of the three prime untranslated region of exon 3 (13 kb). Conclusions/Significance: This result suggests that a genetic determinant in or near PRNP may influence susceptibility of cattle to atypical BSE.	[Clawson, Michael L.; Heaton, Michael P.; Smith, Timothy P. L.; Laegreid, William W.] USDA ARS, US Meat Anim Res Ctr, Agr Res Serv, Clay Ctr, NE 68933 USA; [Richt, Juergen A.] USDA, ARS, Natl Anim Dis Ctr, Ames, IA USA; [Baron, Thierry; Biacabe, Anne-Gaelle] Unite ATNC, AFSSA, Lyon, France; [Czub, Stefanie] Anim Dis Res Inst Canada, Natl & OIE BSE Reference Lab, Food Inspect Agcy, Lethbridge, AB, Canada	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES)	Clawson, ML (corresponding author), USDA ARS, US Meat Anim Res Ctr, Agr Res Serv, Clay Ctr, NE 68933 USA.	mike.clawson@ars.usda.gov	Richt, Juergen/AAL-3632-2020	Laegreid, William/0000-0002-8694-5229; Clawson, Michael/0000-0002-3355-5390; Heaton, Michael/0000-0003-1386-1208	USDA National Research Initiative [2005-35212-15890]; Agricultural Research Service	USDA National Research Initiative(United States Department of Agriculture (USDA)); Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the USDA National Research Initiative, Competitive Grant No. 2005-35212-15890 and the Agricultural Research Service.	Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; Baron T, 2007, VACCINE, V25, P5625, DOI 10.1016/j.vaccine.2006.10.058; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Brown P, 2006, EMERG INFECT DIS, V12, P1816; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Brunelle BW, 2007, J ANIM SCI, V85, P3142, DOI 10.2527/jas.2007-0208; Clawson ML, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-51; Haase B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-15; Heaton MP, 2005, JAVMA-J AM VET MED A, V226, P1311, DOI 10.2460/javma.2005.226.1311; Heaton MP, 2003, MAMM GENOME, V14, P765, DOI 10.1007/s00335-003-2283-y; Heaton MP, 2001, MAMM GENOME, V12, P219, DOI 10.1007/s003350010269; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Juling K, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-33; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Sander P, 2004, NEUROGENETICS, V5, P19, DOI 10.1007/s10048-003-0171-y; Smith TPL, 2000, BIOTECHNIQUES, V29, P698, DOI 10.2144/00294bm05; Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501	21	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1830	10.1371/journal.pone.0001830	http://dx.doi.org/10.1371/journal.pone.0001830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350166	Green Submitted, gold, Green Published			2022-12-25	WOS:000260762300032
J	Han, SZ; Guthridge, JM; Harley, ITW; Sestak, AL; Kim-Howard, X; Kaufman, KM; Namjou, B; Deshmukh, H; Bruner, G; Espinoza, LR; Gilkeson, GS; Harley, JB; James, JA; Nath, SK				Han, Shizhong; Guthridge, Joel M.; Harley, Isaac T. W.; Sestak, Andrea L.; Kim-Howard, Xana; Kaufman, Kenneth M.; Namjou, Bahram; Deshmukh, Harshal; Bruner, Gail; Espinoza, Luis R.; Gilkeson, Gary S.; Harley, John B.; James, Judith A.; Nath, Swapan K.			Osteopontin and Systemic Lupus Erythematosus Association: A Probable Gene-Gender Interaction	PLOS ONE			English	Article								Osteopontin (SPP1) is an important bone matrix mediator found to have key roles in inflammation and immunity. SPP1 genetic polymorphisms and increased osteopontin protein levels have been reported to be associated with SLE in small patient collections. The present study evaluates association between SPP1 polymorphisms and SLE in a large cohort of 1141 unrelated SLE patients [707 European-American (EA) and 434 African-American (AA)], and 2009 unrelated controls (1309 EA and 700 AA). Population-based case-control association analyses were performed. To control for potential population stratification, admixture adjusted logistic regression, genomic control (GC), structured association (STRAT), and principal components analysis (PCA) were applied. Combined analysis of 2 ethnic groups, showed the minor allele of 2 SNPs (rs1126616T and rs9138C) significantly associated with higher risk of SLE in males (P = 0.0005, OR = 1.73, 95% CI = 1.28-2.33), but not in females. Indeed, significant gene-gender interactions in the 2 SNPs, rs1126772 and rs9138, were detected (P = 0.001 and P = 0.0006, respectively). Further, haplotype analysis identified rs1126616T-rs1126772A-rs9138C which demonstrated significant association with SLE in general (P = 0.02, OR = 1.30, 95% CI 1.08-1.57), especially in males (P = 0.0003, OR = 2.42, 95% CI 1.51-3.89). Subgroup analysis with single SNPs and haplotypes also identified a similar pattern of gender-specific association in AA and EA. GC, STRAT, and PCA results within each group showed consistent associations. Our data suggest SPP1 is associated with SLE, and this association is especially stronger in males. To our knowledge, this report serves as the first association of a specific autosomal gene with human male lupus.	[Han, Shizhong; Guthridge, Joel M.; Harley, Isaac T. W.; Sestak, Andrea L.; Kim-Howard, Xana; Kaufman, Kenneth M.; Namjou, Bahram; Deshmukh, Harshal; Bruner, Gail; Harley, John B.; James, Judith A.; Nath, Swapan K.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Kaufman, Kenneth M.; Harley, John B.] US Dept Vet Affairs Med Ctr, Oklahoma City, OK USA; [Kaufman, Kenneth M.; Harley, John B.; James, Judith A.; Nath, Swapan K.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK USA; [Espinoza, Luis R.] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA; [Gilkeson, Gary S.] Med Univ South Carolina, Charleston, SC USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Medical University of South Carolina	Han, SZ (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	swapan-nath@omrf.ouhsc.edu	Han, Shizhong/E-4084-2010; Han, Shizhong/H-5785-2011	Harley, Isaac/0000-0003-1282-5395; Guthridge, Joel/0000-0002-9308-237X; Han, Shizhong/0000-0002-5114-6742	National Institutes of Health [AR048928, AI063622, RR020143, AR049084, AI24717, AR42460, AR048940, AI053747, AR12253, DE15223, RR01577, RR14467, AI31584]; US Department of Veterans Affairs; The Alliance for Lupus Research; Mary Kirkland Scholar; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR014467, P20RR020143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI053747, R01AI063622, R01AI024717, R01AI031584, R37AI024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR048928, P50AR048940, R01AR042460, P01AR049084, P30AR053483, N01AR012253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); The Alliance for Lupus Research; Mary Kirkland Scholar; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Institutes of Health (AR048928, AI063622, RR020143, AR049084, AI24717, AR42460, AR048940, AI053747, AR12253, DE15223, RR01577, RR14467, and AI31584), the US Department of Veterans Affairs, The Alliance for Lupus Research and a Mary Kirkland Scholar	Arbuckle MR, 2003, LUPUS, V12, P99, DOI 10.1191/0961203303lu334oa; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Chabanon Herve, 2004, Briefings in Functional Genomics & Proteomics, V3, P240; Chiocchetti A, 2004, BLOOD, V103, P1376, DOI 10.1182/blood-2003-05-1748; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Cowley BD, 2001, KIDNEY INT, V60, P2087, DOI 10.1046/j.1523-1755.2001.00065.x; D'Alfonso S, 2005, ARTHRITIS RHEUM, V52, P539, DOI 10.1002/art.20808; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Forton AC, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9025; Graham DSC, 2006, HUM MOL GENET, V15, P3195, DOI 10.1093/hmg/ddl395; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Hieronymus H, 2004, GENE DEV, V18, P2845, DOI 10.1101/gad.1256904; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hur EM, 2007, NAT IMMUNOL, V8, P74, DOI 10.1038/ni1415; KATAGIRI Y, 1995, ANN NY ACAD SCI, V760, P371, DOI 10.1111/j.1749-6632.1995.tb44660.x; Kaufman KM, 2006, ARTHRITIS RHEUM-US, V54, P2533, DOI 10.1002/art.21963; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Martin MM, 2007, J BIOL CHEM, V282, P24262, DOI 10.1074/jbc.M701050200; MATKOVITS T, 1995, ENDOCRINOLOGY, V136, P3971, DOI 10.1210/en.136.9.3971; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Miyazaki T, 2005, EUR J IMMUNOL, V35, P1510, DOI 10.1002/eji.200425672; Mok CC, 1999, LUPUS, V8, P188, DOI 10.1191/096120399678847605; Molina JF, 1996, MEDICINE, V75, P124, DOI 10.1097/00005792-199605000-00002; Nath SK, 2004, CURR OPIN IMMUNOL, V16, P794, DOI 10.1016/j.coi.2004.09.007; O'Regan AW, 2000, IMMUNOL TODAY, V21, P475, DOI 10.1016/S0167-5699(00)01715-1; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Stein CM, 2002, ARTHRITIS RHEUM, V46, P428, DOI 10.1002/art.10105; Sun M, 2005, NUCLEIC ACIDS RES, V33, P5533, DOI 10.1093/nar/gki852; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xing C, 2005, HUM GENET, V118, P309, DOI 10.1007/s00439-005-0061-5; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	40	60	66	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e0001757	10.1371/journal.pone.0001757	http://dx.doi.org/10.1371/journal.pone.0001757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335026	gold, Green Published, Green Submitted			2022-12-25	WOS:000260723000011
J	Campbell, HA; Fraser, KPP; Bishop, CM; Peck, LS; Egginton, S				Campbell, Hamish A.; Fraser, Keiron P. P.; Bishop, Charles M.; Peck, Lloyd S.; Egginton, Stuart			Hibernation in an Antarctic Fish: On Ice for Winter	PLOS ONE			English	Article								Active metabolic suppression in anticipation of winter conditions has been demonstrated in species of mammals, birds, reptiles and amphibians, but not fish. This is because the reduction in metabolic rate in fish is directly proportional to the decrease in water temperature and they appear to be incapable of further suppressing their metabolic rate independently of temperature. However, the Antarctic fish (Notothenia coriiceps) is unusual because it undergoes winter metabolic suppression irrespective of water temperature. We assessed the seasonal ecological strategy by monitoring swimming activity, growth, feeding and heart rate (f(H)) in N. coriiceps as they free-ranged within sub-zero waters. The metabolic rate of wild fish was extrapolated from f(H) recordings, from oxygen consumption calibrations established in the laboratory prior to fish release. Throughout the summer months N. coriiceps spent a considerable proportion of its time foraging, resulting in a growth rate (G(w)) of 0.18 +/- 0.2% day(-1). In contrast, during winter much of the time was spent sedentary within a refuge and fish showed a net loss in Gw (-0.05 +/- 0.05% day(-1)). Whilst inactive during winter, N. coriiceps displayed a very low fH, reduced sensory and motor capabilities, and standard metabolic rate was one third lower than in summer. In a similar manner to other hibernating species, dormancy was interrupted with periodic arousals. These arousals, which lasted a few hours, occurred every 4-12 days. During arousal activity, f(H) and metabolism increased to summer levels. This endogenous suppression and activation of metabolic processes, independent of body temperature, demonstrates that N. coriiceps were effectively 'putting themselves on ice' during winter months until food resources improved. This study demonstrates that at least some fish species can enter a dormant state similar to hibernation that is not temperature driven and presumably provides seasonal energetic benefits.	[Campbell, Hamish A.; Egginton, Stuart] Univ Birmingham, Dept Physiol, Birmingham, W Midlands, England; [Fraser, Keiron P. P.; Peck, Lloyd S.] Natl Env Res Council, British Antarctic Survey, Cambridge, England; [Bishop, Charles M.] Univ Bangor, Dept Biol Sci, Bangor, Gwynedd, Wales	University of Birmingham; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Bangor University	Campbell, HA (corresponding author), Univ Birmingham, Dept Physiol, Birmingham, W Midlands, England.	dr.hamish.campbell@gmail.com		Campbell, Hamish/0000-0003-1428-1686; Egginton, Stuart/0000-0002-3084-9692	NERC (UK) Antarctic Funding Initiative; British Antarctic Survey; Natural Environment Research Council [dml011000] Funding Source: researchfish; NERC [dml011000] Funding Source: UKRI	NERC (UK) Antarctic Funding Initiative(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Antarctic Survey; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was supported by an NERC (UK) Antarctic Funding Initiative Grant in collaboration with the British Antarctic Survey.	AXELSSON M, 1992, J EXP BIOL, V167, P179; Brett J.R., 1979, FISH PHYSL; Brockington S, 2001, MAR BIOL, V139, P127; CAMPBELL HA, 2005, J FISH BIOL, V66, P1; CASAUX C, 1990, ANTARCTICA POLAR BIO, V11, P63; Choi IH, 1998, PHYSIOL ZOOL, V71, P257, DOI 10.1086/515915; CLARKE A, 1988, COMP BIOCHEM PHYS B, V90, P461, DOI 10.1016/0305-0491(88)90285-4; Clarke A, 1996, TRENDS ECOL EVOL, V11, P212, DOI 10.1016/0169-5347(96)10029-X; Cliff A, 1973, SPATIAL AUTOCORRELAT; Coggan R, 1997, J EXP MAR BIOL ECOL, V210, P23, DOI 10.1016/S0022-0981(96)02717-7; Coggan R, 1997, J EXP MAR BIOL ECOL, V213, P215, DOI 10.1016/S0022-0981(96)02731-1; Cooke Steven J., 2003, Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology, V134A, P157, DOI 10.1016/S1095-6433(02)00240-4; Cossins AR, 1996, NATURE, V382, P582, DOI 10.1038/382582a0; CRAWSHAW LI, 1980, ANNU REV PHYSIOL, V42, P473, DOI 10.1146/annurev.ph.42.030180.002353; Dausmann KH, 2004, NATURE, V429, P825, DOI 10.1038/429825a; Desjardins M, 2006, J EXP MAR BIOL ECOL, V335, P142, DOI 10.1016/j.jembe.2006.03.011; Elvert R, 2005, J EXP BIOL, V208, P1373, DOI 10.1242/jeb.01546; Everson I., 1970, Bull. Br. Antarct. Surv., VNo. 23, P25; FARRELL AP, 1992, FISH PHYSL A, V12; GIESER F, 1996, ADAPTATIONS COLD; Grigg Gordon, 1996, P13; JOHNSTON IA, 1991, MAR BIOL, V109, P191, DOI 10.1007/BF01319386; JOHNSTON IA, 1993, MAR BIOL, V115, P7, DOI 10.1007/BF00349380; Kawaguchi K., 1989, P NIPR S POLAR BIOL, V2, P111; Lyman C.P., 1982, HIBERNATION TORPOR M; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; NORTH AW, 1988, CYBIUM, V12, P91; Sayer MDJ, 1996, J FISH BIOL, V49, P41, DOI 10.1111/j.1095-8649.1996.tb00004.x; Targett T.E., 1990, 2 INT S BIOL ANT FIS, P37; White M.G., 1991, P87; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	31	56	56	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1743	10.1371/journal.pone.0001743	http://dx.doi.org/10.1371/journal.pone.0001743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320061	Green Submitted, Green Published, gold			2022-12-25	WOS:000260586600038
J	Hayashi, K; Lopes, SMCD; Kaneda, M; Tang, FC; Hajkova, P; Lao, KQ; O'Carroll, D; Das, PP; Tarakhovsky, A; Miska, EA; Surani, MA				Hayashi, Katsuhiko; Lopes, Susana M. Chuva de Sousa; Kaneda, Masahiro; Tang, Fuchou; Hajkova, Petra; Lao, Kaiqin; O'Carroll, Donal; Das, Partha P.; Tarakhovsky, Alexander; Miska, Eric A.; Surani, M. Azim			MicroRNA Biogenesis Is Required for Mouse Primordial Germ Cell Development and Spermatogenesis	PLOS ONE			English	Article							HUMAN LUNG CANCERS; SMALL RNAS; TRYPANOSOMA-BRUCEI; ENZYME DICER; EXPRESSION; GENE; PROTEIN; PIWI; DIFFERENTIATION; RETROTRANSPOSON	Background: MicroRNAs (miRNAs) are critical regulators of transcriptional and post-transcriptional gene silencing, which are involved in multiple developmental processes in many organisms. Apart from miRNAs, mouse germ cells express another type of small RNA, piwi-interacting RNAs (piRNAs). Although it has been clear that piRNAs play a role in repression of retrotransposons during spermatogenesis, the function of miRNA in mouse germ cells has been unclear. Methodology/Principal Findings: In this study, we first revealed the expression pattern of miRNAs by using a real-time PCR-based 220-plex miRNA expression profiling method. During development of germ cells, miR-17-92 cluster, which is thought to promote cell cycling, and the ES cell-specific cluster encoding miR-290 to -295 (miR-290-295 cluster) were highly expressed in primordial germ cells (PGCs) and spermatogonia. A set of miRNAs was developmentally regulated. We next analysed function of miRNA biogenesis in germ cell development by using conditional Dicer-knockout mice in which Dicer gene was deleted specifically in the germ cells. Dicer-deleted PGCs and spermatogonia exhibited poor proliferation. Retrotransposon activity was unexpectedly suppressed in Dicer-deleted PGCs, but not affected in the spermatogonia. In Dicer-deleted testis, spermatogenesis was retarded at an early stage when proliferation and/or early differentiation. Additionally, we analysed spermatogenesis in conditional Argonaute2-deficient mice. In contrast to Dicer-deficient testis, spermatogenesis in Argonaute2-deficient testis was indistinguishable from that in wild type. Conclusion/Significance: These results illustrate that miRNAs are important for the proliferation of PGCs and spermatogonia, but dispensable for the repression of retrotransposons in developing germ cells. Consistently, miRNAs promoting cell cycling are highly expressed in PGCs and spermatogonia. Furthermore, based on normal spermatogenesis in Argonaute2-deficient testis, the critical function of Dicer in spermatogenesis is independent of Argonaute2.	[Hayashi, Katsuhiko; Lopes, Susana M. Chuva de Sousa; Kaneda, Masahiro; Tang, Fuchou; Hajkova, Petra; Das, Partha P.; Miska, Eric A.; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res United Kingdom Gurdon Ins, Cambridge, England; [Lao, Kaiqin] Appl Biosyst Inc, Advanced Res Technol, Foster City, CA USA; [O'Carroll, Donal; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signal, New York, NY USA	University of Cambridge; Thermo Fisher Scientific; Applied Biosystems; Rockefeller University	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res United Kingdom Gurdon Ins, Cambridge, England.	as10021@mole.bio.cam.ac.uk	Kaneda, Masahiro/E-3117-2010	Kaneda, Masahiro/0000-0003-0660-7156; Das, Partha Pratim/0000-0003-3544-2629; O'Carroll, Donal/0000-0002-8626-2217; Hajkova, Petra/0000-0003-4145-1468; Surani, Azim/0000-0002-8640-4318; Miska, Eric/0000-0002-4450-576X	Wellcome Trust; Japan Society for Promotion of Science; Netherlands Organization for Scientific Research	Wellcome Trust(Wellcome TrustEuropean Commission); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Wellcome Trust, the Japan Society for Promotion of Science, the Netherlands Organization for Scientific Research	Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bourc'his D, 2006, CYTOGENET GENOME RES, V113, P36, DOI 10.1159/000090813; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Costa Y, 2006, HUM MOL GENET, V15, P2324, DOI 10.1093/hmg/ddl158; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Djikeng A, 2001, RNA, V7, P1522; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; Hayashi K, 2002, MECH DEVELOP, V118, P99, DOI 10.1016/S0925-4773(02)00237-X; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lomeli H, 2000, GENESIS, V26, P116, DOI 10.1002/(SICI)1526-968X(200002)26:2<116::AID-GENE4>3.0.CO;2-X; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Moe-Behrens GHG, 2003, MOL ENDOCRINOL, V17, P2630, DOI 10.1210/me.2003-0006; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nolan T, 2005, NUCLEIC ACIDS RES, V33, P1564, DOI 10.1093/nar/gki300; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi HF, 2004, MOL CELL BIOL, V24, P420, DOI 10.1128/MCB.24.1.420-427.2004; Svoboda P, 2004, DEV BIOL, V269, P276, DOI 10.1016/j.ydbio.2004.01.028; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	63	371	403	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1738	10.1371/journal.pone.0001738	http://dx.doi.org/10.1371/journal.pone.0001738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320056	Green Published, gold, Green Submitted			2022-12-25	WOS:000260586600033
J	Iijima, K; Chiang, HC; Hearn, SA; Hakker, I; Gatt, A; Shenton, C; Granger, L; Leung, A; Iijima-Ando, K; Zhong, Y				Iijima, Koichi; Chiang, Hsueh-Cheng; Hearn, Stephen A.; Hakker, Inessa; Gatt, Anthony; Shenton, Christopher; Granger, Linda; Leung, Amy; Iijima-Ando, Kanae; Zhong, Yi			A beta 42 Mutants with Different Aggregation Profiles Induce Distinct Pathologies in Drosophila	PLOS ONE			English	Article								Aggregation of the amyloid-beta-42 (A beta 42) peptide in the brain parenchyma is a pathological hallmark of Alzheimer's disease (AD), and the prevention of Ab aggregation has been proposed as a therapeutic intervention in AD. However, recent reports indicate that Ab can form several different prefibrillar and fibrillar aggregates and that each aggregate may confer different pathogenic effects, suggesting that manipulation of A beta 42 aggregation may not only quantitatively but also qualitatively modify brain pathology. Here, we compare the pathogenicity of human A beta 42 mutants with differing tendencies to aggregate. We examined the aggregation-prone, EOFAD-related (Arc) under bar tic mutation (A beta 42 (arc) under bar) and an (art) under bar ificial mutation (A beta 42 (art) under bar) that is known to suppress aggregation and toxicity of A beta 42 in vitro. In the Drosophila brain, A beta 42Arc formed more oligomers and deposits than did wild type A beta 42, while A beta 42art formed fewer oligomers and deposits. The severity of locomotor dysfunction and premature death positively correlated with the aggregation tendencies of Ab peptides. Surprisingly, however, A beta 42art caused earlier onset of memory defects than A beta 42. More remarkably, each Ab induced qualitatively different pathologies. A beta 42Arc caused greater neuron loss than did A beta 42, while A beta 42art flies showed the strongest neurite degeneration. This pattern of degeneration coincides with the distribution of Thioflavin S-stained Ab aggregates: A beta 42Arc formed large deposits in the cell body, A beta 42art accumulated preferentially in the neurites, while A beta 42 accumulated in both locations. Our results demonstrate that manipulation of the aggregation propensity of A beta 42 does not simply change the level of toxicity, but can also result in qualitative shifts in the pathology induced in vivo.	[Iijima, Koichi; Chiang, Hsueh-Cheng; Hearn, Stephen A.; Hakker, Inessa; Leung, Amy; Iijima-Ando, Kanae; Zhong, Yi] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Iijima, Koichi; Gatt, Anthony; Granger, Linda] Thomas Jefferson Univ Hosp, Farber Inst Neurosci, Lab Neurodegenerative Dis Gene Discovery, Philadelphia, PA USA; [Shenton, Christopher; Granger, Linda; Iijima-Ando, Kanae] Thomas Jefferson Univ Hosp, Farber Inst Neurosci, Lab Neurogenet & Protein Misfolding Dis, Philadelphia, PA USA; [Iijima, Koichi; Iijima-Ando, Kanae] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA USA; [Chiang, Hsueh-Cheng] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY USA	Cold Spring Harbor Laboratory; Jefferson University; Jefferson University; Jefferson University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Iijima, K (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	Koichi.Iijima@jefferson.edu; zhongyi@cshl.edu		Zhong, Yi/0000-0001-7810-9899; Hearn, Stephen/0000-0002-2489-2424; Zhong, Yi/0000-0002-7927-5976	Alzheimer's Association; Pilot Research Award from Thomas Jefferson University; Hereditary Disease Foundation; Farber Institute for Neurosciences; National Institutes of Health	Alzheimer's Association(Alzheimer's Association); Pilot Research Award from Thomas Jefferson University; Hereditary Disease Foundation; Farber Institute for Neurosciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the Alzheimer's Association (to K.I.), Pilot Research Award from Thomas Jefferson University (to K.I.), the Hereditary Disease Foundation (to K.I.-A.), the start-up funds from Farber Institute for Neurosciences (to K.I. and K. I.-A. ), and the National Institutes of Health (to Y.Z.).	BRAND AH, 1993, DEVELOPMENT, V118, P401; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; Cummings JL, 2000, NEUROBIOL AGING, V21, P845, DOI 10.1016/S0197-4580(00)00183-4; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Fay DS, 1998, J NEUROCHEM, V71, P1616; GANETZKY B, 1978, EXP GERONTOL, V13, P189, DOI 10.1016/0531-5565(78)90012-8; Gestwicki JE, 2004, SCIENCE, V306, P865, DOI 10.1126/science.1101262; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Johansson AS, 2006, FEBS J, V273, P2618, DOI 10.1111/j.1742-4658.2006.05263.x; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelly JW, 2005, NEW ENGL J MED, V352, P722, DOI 10.1056/NEJMcibr044231; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Ryman Davis, 2006, Current Alzheimer Research, V3, P465, DOI 10.2174/156720506779025198; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Slow EJ, 2006, TRENDS GENET, V22, P408, DOI 10.1016/j.tig.2006.05.008; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; THAL DR, 2006, SCI AGING KNOWLEDGE, pRE1, DOI DOI 10.1126/SAGEKE.2006.6.RE1; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Whalen BM, 2005, NEUROBIOL DIS, V20, P254, DOI 10.1016/j.nbd.2005.03.007; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201	43	127	139	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1703	10.1371/journal.pone.0001703	http://dx.doi.org/10.1371/journal.pone.0001703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301778	Green Submitted, Green Published, gold			2022-12-25	WOS:000260586500047
J	Arias-Moreno, X; Arolas, JL; Aviles, FX; Sancho, J; Ventura, S				Arias-Moreno, Xabier; Arolas, Joan L.; Aviles, Francesc X.; Sancho, Javier; Ventura, Salvador			Scrambled isomers as key intermediates in the oxidative folding of ligand binding module 5 of the low density lipoprotein receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS; CYSTEINE-RICH REPEAT; LDL-A MODULE; DISULFIDE-BOND; 3-DIMENSIONAL STRUCTURE; MOLECULAR-BASIS; PROTEINS; CALCIUM; MECHANISM; DETERMINANTS	The ligand binding module five (LA5) of the low density lipoprotein receptor is a small, single-domain protein of 40 residues and three disulfide bonds with a calcium binding motif that is essential for its structure and function. Several mutations in LA5 have been reported to cause familial hypercholesterolemia by impairing a proper folding of the module. The current study reports the oxidative folding and reductive unfolding pathways of wild type and mutant LA5 modules through kinetic and structural analysis of the trapped intermediates. Wild type LA5 folding involves an initial phase of nonspecific packing where the sequential oxidation of its cysteines gives rise to complex equilibrated populations of intermediates. In the presence of calcium, the attainment of a coordination-competent conformation becomes the rate-limiting step of folding while binding of the ion funnels both thermodynamically and kinetically the folding reaction toward the native state. In the absence of calcium, a scrambled isomer (termed Xa) constitutes the global free energy minimum of the folding process. Xa and the native form are stable, inter-convertible species whose relative populations at equilibrium appear displaced in disease-linked mutants toward the scrambled form. Because stable scrambled isomers such as Xa avoid the exposition of reactive cysteines in misfolded modules, they might constitute a strategy to prevent wrong interactions with other domains during folding of the receptor. Comparison of the folding pathways of wild type and mutant LA5 provides the molecular basis to understand how LA modules fold into a functional conformation or upon mutation misfold and lead to disease.	[Arolas, Joan L.; Aviles, Francesc X.; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotechnol & Biomed, E-08193 Barcelona, Spain; [Arolas, Joan L.; Aviles, Francesc X.; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Arias-Moreno, Xabier; Sancho, Javier] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain; [Arias-Moreno, Xabier; Sancho, Javier] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, E-50009 Zaragoza, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Zaragoza; University of Zaragoza	Ventura, S (corresponding author), Univ Autonoma Barcelona, Inst Biotechnol & Biomed, E-08193 Barcelona, Spain.	Salvador.Ventura@uab.es	MORENO, XABIER ARIAS/AAA-1176-2021; Sancho, javier/AAA-1225-2019; Ventura, Salvador/AAY-3170-2021; Aviles, Francesc Xavier/F-3482-2019; Ventura, Salvador/C-7021-2008; Avilés, Francesc Xavier/A-2664-2015	MORENO, XABIER ARIAS/0000-0001-8601-9092; Sancho, javier/0000-0002-2879-9200; Ventura, Salvador/0000-0002-9652-6351; Aviles, Francesc Xavier/0000-0002-1399-6789; Ventura, Salvador/0000-0002-9652-6351; Avilés, Francesc Xavier/0000-0002-1399-6789; Lopez Arolas, Joan/0000-0002-4198-5016				Abdul-Aziz D, 2005, BIOCHEMISTRY-US, V44, P5075, DOI 10.1021/bi047575j; Arolas JL, 2006, J BIOL CHEM, V281, P22906, DOI 10.1074/jbc.M602301200; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; Chang JY, 2008, ANTIOXID REDOX SIGN, V10, P171, DOI 10.1089/ars.2007.1873; Chang JY, 2000, J BIOL CHEM, V275, P8287, DOI 10.1074/jbc.275.12.8287; Chang JY, 1997, J BIOL CHEM, V272, P69; Creighton TE, 1997, BIOL CHEM, V378, P731; Cuesta-Lopez S, 2007, PROTEINS, V66, P87, DOI 10.1002/prot.21181; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; English BP, 2002, J AM CHEM SOC, V124, P4995, DOI 10.1021/ja012634r; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Gent J, 2004, CELL MOL LIFE SCI, V61, P2461, DOI 10.1007/s00018-004-4090-3; Guo Y, 2004, J BIOL CHEM, V279, P16629, DOI 10.1074/jbc.M400157200; HOBBS HH, 1990, ANNU REV GENET, V24, P133, DOI 10.1146/annurev.ge.24.120190.001025; Iwaoka M, 1998, BIOCHEMISTRY-US, V37, P4490, DOI 10.1021/bi9725327; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Koduri V, 2001, BIOCHEMISTRY-US, V40, P12801, DOI 10.1021/bi011344k; Lu BY, 2005, BIOCHEMISTRY-US, V44, P15032, DOI 10.1021/bi051399c; North CL, 2000, BIOCHEMISTRY-US, V39, P13127, DOI 10.1021/bi0015156; North CL, 1999, BIOCHEMISTRY-US, V38, P3926, DOI 10.1021/bi9821622; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; Singh RR, 2004, BIOCHEM J, V377, P685, DOI 10.1042/BJ20030968; van den Berg P, 1999, EMBO J, V18, P4794, DOI 10.1093/emboj/18.17.4794; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Welker E, 2001, BIOCHEMISTRY-US, V40, P9059, DOI 10.1021/bi010409g; Welker E, 2001, P NATL ACAD SCI USA, V98, P2312, DOI 10.1073/pnas.041615798	38	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13627	13637		10.1074/jbc.M800755200	http://dx.doi.org/10.1074/jbc.M800755200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18343813	hybrid			2022-12-25	WOS:000255728200015
J	Wang, XH; Urvalek, AM; Liu, JS; Zhao, JH				Wang, Xianhui; Urvalek, Alison M.; Liu, Jinsong; Zhao, Jihe			Activation of KLF8 transcription by focal adhesion kinase in human ovarian epithelial and cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-8; GENE-EXPRESSION; ONCOGENIC TRANSFORMATION; CYCLE PROGRESSION; RECEPTOR GENE; GROWTH-FACTOR; SP1; FAK; INVASION; PROTEIN	KLF8 (Kruppel-like factor 8) is a transcription factor downstream of focal adhesion kinase (FAK) important in the regulation of the cell cycle and also plays a critical role in oncogenic transformation and epithelial to mesenchymal transition. Here we report the mechanisms by which FAK regulates KLF8 expression in human ovarian epithelial and cancer cells. We show that the overexpression of both KLF8 and FAK in the human ovarian cancer cells as compared with the normal human ovarian surface epithelial cells is critical for cell growth. Using promoter luciferase reporter assays, we demonstrate that exogenous FAK strongly promotes the activity of the KLF8 promoter, and knockdown of FAK inhibits it. KLF8 promoter activity and mRNA levels are induced by expression of constitutively active (CA) phosphatidylinositol 3-kinase (PI3K) or CA-Akt but are repressed by dominant negative Akt or the PI3K inhibitor LY294002. Disruption of an Sp1 binding site in the KLF8 promoter abolishes the FAK- or Sp1-mediated promoter activation. Sp1 knockdown prevents the KLF8 promoter from being activated by Sp1 or CA-Akt, and expression of CA-Akt enhances Sp1 expression in SKOV3ip1 cells. Chromatin immunoprecipitation and oligonucleotide precipitation results show that Sp1 binds to the KLF8 promoter. Taken together, our data suggest that FAK induces KLF8 expression in human ovarian cancer cells by activating the PI3K-Akt signaling pathway, leading to the activation of KLF8 promoter by Sp1.	[Wang, Xianhui; Urvalek, Alison M.; Zhao, Jihe] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Liu, Jinsong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Albany Medical College; University of Texas System; UTMD Anderson Cancer Center	Zhao, JH (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, MS338,47 New Scotland Ave,MC-165, Albany, NY 12208 USA.	zhaojh@mail.amc.edu			NATIONAL CANCER INSTITUTE [R01CA131183, P50CA083639] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA083639, R01 CA131183] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allgayer H, 1999, J BIOL CHEM, V274, P18428, DOI 10.1074/jbc.274.26.18428; Bae IH, 2006, CANCER RES, V66, P4991, DOI 10.1158/0008-5472.CAN-05-4254; Benlimame N, 2005, J CELL BIOL, V171, P505, DOI 10.1083/jcb.200504124; Bennudez Y, 2007, GYNECOL ONCOL, V106, P526, DOI 10.1016/j.ygyno.2007.05.005; Bilsland AE, 2006, CANCER RES, V66, P1363, DOI 10.1158/0008-5472.CAN-05-1941; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Buczek-Thomas JA, 1998, CELL SIGNAL, V10, P55, DOI 10.1016/S0898-6568(97)00074-0; Chen CS, 2004, GENE, V330, P133, DOI 10.1016/j.gene.2004.01.014; Cheng JQ, 2002, DRUG RESIST UPDATE, V5, P131, DOI 10.1016/S1368-7646(02)00003-1; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Ding Q, 2005, J BIOL CHEM, V280, P6802, DOI 10.1074/jbc.M409180200; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Grisaru-Granovsky S, 2005, INT J CANCER, V113, P372, DOI 10.1002/ijc.20607; Honda H, 2006, J BIOL CHEM, V281, P21433, DOI 10.1074/jbc.M603767200; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Judson PL, 1999, CANCER, V86, P1551, DOI 10.1002/(SICI)1097-0142(19991015)86:6<1551::AID-CNCR23>3.0.CO;2-P; Kruk PA, 1999, GYNECOL ONCOL, V73, P229, DOI 10.1006/gyno.1999.5348; Kuo LY, 2006, J CELL PHYSIOL, V207, P729, DOI 10.1002/jcp.20616; Lark AL, 2005, MODERN PATHOL, V18, P1289, DOI 10.1038/modpathol.3800424; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; MAINESBANDIERA SL, 1992, AM J OBSTET GYNECOL, V167, P729, DOI 10.1016/S0002-9378(11)91579-8; Maor S, 2007, HORM METAB RES, V39, P179, DOI 10.1055/s-2007-970415; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; Mitra SK, 2006, ONCOGENE, V25, P4429, DOI 10.1038/sj.onc.1209482; Nicosia SV, 2003, HEMATOL ONCOL CLIN N, V17, P927, DOI 10.1016/S0889-8588(03)00056-X; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Qureshi HY, 2007, CELL SIGNAL, V19, P1643, DOI 10.1016/j.cellsig.2007.02.007; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHILDER RJ, 1990, INT J CANCER, V45, P416, DOI 10.1002/ijc.2910450306; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sood AK, 2004, AM J PATHOL, V165, P1087, DOI 10.1016/S0002-9440(10)63370-6; Sroka IC, 2007, NEOPLASIA, V9, P406, DOI 10.1593/neo.07193; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tomassetti A, 2003, CANCER RES, V63, P696; van Nimwegen MJ, 2005, CANCER RES, V65, P4698, DOI 10.1158/0008-5472.CAN-04-4126; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Volberg T, 2001, J CELL SCI, V114, P2279; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; YU DH, 1993, CANCER RES, V53, P891; Zhao JH, 2000, J CELL SCI, V113, P3063; Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5	50	69	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13934	13942		10.1074/jbc.M709300200	http://dx.doi.org/10.1074/jbc.M709300200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353772	hybrid			2022-12-25	WOS:000255728200047
J	Lemaire, S; Fuda, C; Van Bambeke, F; Tulkens, PM; Mobashery, S				Lemaire, Sandrine; Fuda, Cosimo; Van Bambeke, Francoise; Tulkens, Paul M.; Mobashery, Shahriar			Restoration of susceptibility of methicillin-resistant Staphylococcus aureus to beta-lactam antibiotics by acidic pH - Role of penicillin-binding protein PBP 2a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PNEUMONIAE; INTRACELLULAR ACTIVITIES; VANCOMYCIN-INTERMEDIATE; THP-1 MACROPHAGES; MECHANISTIC BASIS; PREVALENCE; MRSA; IDENTIFICATION; PATHOGEN; ANIMALS	Methicillin-resistant Staphylococcus aureus (MRSA) is a global scourge, and treatment options are becoming limited. The MRSA phenotype reverts to that of beta-lactam-sensitive S. aureus when bacteria are grown at pH 5.0 in broth and, more importantly from a medical perspective (protracted, relapsing infections), after phagocytosis by macrophages, where the bacteria thrive in the acidic environment of phagolysosomes. The central factor for the MRSA phenotype is the function of the penicillin-binding protein (PBP) 2a, which maintains transpeptidase activity while being poorly inhibited by beta-lactams because of a closed conformation of its active site. We document herein by binding, acylation/deacylation kinetics, and circular dichroism spectroscopy with purified PBP 2a that at acidic pH (i) beta-lactams interact with PBP 2a more avidly; (ii) the non-covalent pre-acylation complex exhibits a lower dissociation constant and an increased rate of acyl-enzyme formation (first-order rate constant) without change in hydrolytic deacylation rate; and (iii) PBP 2a undergoes a conformational change in the presence of the antibiotic consistent with the opening of the active site from the closed conformation. These observations argue that PBP 2a most likely evolved for its physiological function at pH 7 or higher by adopting a closed conformation, which is not maintained at acidic pH. Although at the organism level the effect of acidic pH on other biological processes in MRSA could not be discounted, our report should provide the impetus for closer examination of the properties of PBP 2a at low pH and thereby identifying novel points of intervention in combating this problematic organism.	[Lemaire, Sandrine; Van Bambeke, Francoise; Tulkens, Paul M.] Catholic Univ Louvain, Unite Pharmacol Cellulaire & Mol, B-1200 Brussels, Belgium; [Fuda, Cosimo; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Universite Catholique Louvain; University of Notre Dame	Lemaire, S (corresponding author), Catholic Univ Louvain, Unite Pharmacol Cellulaire & Mol, 73-70 Ave E Mounier 73, B-1200 Brussels, Belgium.	sandrine.lemaire@facm.ucl.ac.be	Van Bambeke, Françoise/H-5934-2019; Tulkens, Paul/B-2087-2015	Van Bambeke, Françoise/0000-0002-0052-7991; Tulkens, Paul/0000-0002-7121-3623	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061629] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33170] Funding Source: Medline; NIGMS NIH HHS [GM61629] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P1047, DOI 10.1086/520731; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P16, DOI 10.1111/j.1469-0691.2006.01344.x; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P3, DOI 10.1111/j.1469-0691.2006.01402.x; Barcia-Macay M, 2006, ANTIMICROB AGENTS CH, V50, P841, DOI 10.1128/AAC.50.3.841-851.2006; Barcia-Macay M, 2006, J ANTIMICROB CHEMOTH, V58, P1177, DOI 10.1093/jac/dkl424; Barrett D, 2005, J BACTERIOL, V187, P2215, DOI 10.1128/JB.187.6.2215-2217.2005; BERGERBACHI B, 1986, EUR J CLIN MICROBIOL, V5, P697, DOI 10.1007/BF02013308; CHAMBERS HF, 1992, ANTIMICROB AGENTS CH, V36, P656, DOI 10.1128/AAC.36.3.656; Davies TA, 2007, ANTIMICROB AGENTS CH, V51, P2621, DOI 10.1128/AAC.00029-07; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; File Jr TM, 2007, CLEV CLIN J MED, V74, P6, DOI [DOI 10.3949/CCJM.74.SUPPL_4.S6, 10.3949/ccjm.74.Suppl_4.S6]; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fuda C, 2006, J BIOL CHEM, V281, P10035, DOI 10.1074/jbc.M508846200; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; Gee KR, 2001, ELECTROPHORESIS, V22, P960, DOI 10.1002/1522-2683()22:5<960::AID-ELPS960>3.0.CO;2-9; GEORGOPAPADAKOU NH, 1982, ANTIMICROB AGENTS CH, V22, P172, DOI 10.1128/AAC.22.1.172; Gould IM, 2006, INT J ANTIMICROB AG, V28, P379, DOI 10.1016/j.ijantimicag.2006.09.001; Guignard B, 2005, CURR OPIN PHARMACOL, V5, P479, DOI 10.1016/j.coph.2005.06.002; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lee JH, 2003, APPL ENVIRON MICROB, V69, P6489, DOI 10.1128/AEM.69.11.6489-6494.2003; Lemaire S, 2007, ANTIMICROB AGENTS CH, V51, P1627, DOI 10.1128/AAC.01192-06; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Loveland-Cherry CJ, 2006, J FAM NURS, V12, P4, DOI 10.1177/1074840705285209; Lovering AL, 2006, PROTEIN SCI, V15, P1701, DOI 10.1110/ps.062112106; Lowy FD, 2000, TRENDS MICROBIOL, V8, P341, DOI 10.1016/S0966-842X(00)01803-5; Macheboeuf P, 2007, NAT CHEM BIOL, V3, P565, DOI 10.1038/nchembio.2007.21; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; MOELLERING RC, 2007, PRINCIPLES PRACTICE; Mouz N, 1998, P NATL ACAD SCI USA, V95, P13403, DOI 10.1073/pnas.95.23.13403; Normanno G, 2007, INT J FOOD MICROBIOL, V117, P219, DOI 10.1016/j.ijfoodmicro.2007.04.006; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Page MGP, 2007, EXPERT OPIN EMERG DR, V12, P511, DOI 10.1517/14728214.12.4.511; Pantosti A, 2007, FUTURE MICROBIOL, V2, P323, DOI 10.2217/17460913.2.3.323; Pinho MG, 2001, J BACTERIOL, V183, P6525, DOI 10.1128/JB.183.22.6525-6531.2001; PRESTON DA, 1990, ANTIMICROB AGENTS CH, V34, P718, DOI 10.1128/AAC.34.5.718; SABATH LD, 1972, ANTIMICROB AGENTS CH, V22, P350, DOI 10.1128/AAC.2.5.350; Weese JS, 2005, J AM ANIM HOSP ASSOC, V41, P150, DOI 10.5326/0410150; Wijaya L, 2006, ANN ACAD MED SINGAP, V35, P479; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	45	30	31	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12769	12776		10.1074/jbc.M800079200	http://dx.doi.org/10.1074/jbc.M800079200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337244	hybrid, Green Published			2022-12-25	WOS:000255499800013
J	Mao, C; Patterson, NM; Cherian, MT; Aninye, IO; Zhang, C; Montoya, JB; Cheng, J; Putt, KS; Hergenrother, PJ; Wilson, EM; Nardulli, AM; Nordeen, SK; Shapiro, DJ				Mao, Chengjian; Patterson, Nicole M.; Cherian, Milu T.; Aninye, Irene O.; Zhang, Chen; Montoya, Jamie Boney; Cheng, Jingwei; Putt, Karson S.; Hergenrother, Paul J.; Wilson, Elizabeth M.; Nardulli, Ann M.; Nordeen, Steven K.; Shapiro, David J.			A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; PROTEIN INTERACTIONS; ANDROGEN RECEPTOR; ENDOCRINE THERAPY; TARGET GENE; DNA-BINDING; IN-VIVO; EXPRESSION; MECHANISMS; PROTEINASE-INHIBITOR-9	Estrogen receptor alpha(ER alpha) plays an important role in several human cancers. Most current ER alpha antagonists bind in the receptor ligand binding pocket and compete for binding with estrogenic ligands. Instead of the traditional approach of targeting estrogen binding to ER, we describe a strategy using a high throughput fluorescence anisotropy microplate assay to identify small molecule inhibitors of ER alpha binding to consensus estrogen response element (cERE) DNA. We identified small molecule inhibitors of ER alpha binding to the fluorescein-labeled (fl)cERE and evaluated their specificity, potency, and efficacy. One small molecule, theophylline, 8-[(benzylthio) methyl]-(7CI, 8CI) (TPBM), inhibited ER alpha binding to the flcERE (IC50 similar to 3 mu M) and inhibited ER alpha-mediated transcription of a stably transfected ERE-containing reporter gene. Inhibition by TPBM was ER-specific, because progesterone and glucocorticoid receptor transcriptional activity were not significantly inhibited. In tamoxifen resistant breast cancer cells that overexpress ER alpha, TPBM inhibited 17 beta-estradiol (E-2)-ER alpha (IC50 9 mu M) and 4-hydroxytamoxifen ER alpha-mediated gene expression. Chromatin immunoprecipitation showed TPBM reduced E-2.ER alpha recruitment to an endogenous estrogen-responsive gene. TPBM inhibited E-2-dependent growth of ER alpha-positive cancer cells (IC50 of 5 mu M). TPBM is not toxic to cells and does not affect estrogen-independent cell growth. TPBM acts outside of the ER ligand binding pocket, does not act by chelating the zinc in ER zinc fingers, and differs from known ER alpha inhibitors. Using a simple high throughput screen for inhibitors of ER alpha binding to the cERE, a small molecule inhibitor has been identified that selectively inhibits ER alpha-mediated gene expression and estrogen-dependent growth of cancer cells.	[Mao, Chengjian; Patterson, Nicole M.; Zhang, Chen; Cheng, Jingwei; Shapiro, David J.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cherian, Milu T.; Aninye, Irene O.; Montoya, Jamie Boney; Nardulli, Ann M.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Putt, Karson S.; Hergenrother, Paul J.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; Univ N Carolina, Labs Reprod Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ Colorado, Dept Pathol, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO 80045 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Anschutz Medical Campus	Shapiro, DJ (corresponding author), Univ Illinois, Dept Biochem, 600 S Mathews Ave, Urbana, IL 61801 USA.	djshapir@uiuc.edu	Zhang, Chen/K-3978-2014	Aninye, Irene/0000-0002-1747-9148	NICHD NIH HHS [HD16910] Funding Source: Medline; NIDDK NIH HHS [R01 DK053884-11, R01 DK053884, R01 DK-071909, R01 DK 53884, R01 DK071909] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016910, R37HD016910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071909, R01DK053884] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Arnold LA, 2005, J BIOL CHEM, V280, P43048, DOI 10.1074/jbc.M506693200; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Baldwin WS, 1998, IN VITRO CELL DEV-AN, V34, P649; BOCCARDO F, 2004, CLIN BREAST CANC  S1, V1, P13; Boonyaratanakornkit V, 2004, ESSAYS BIOCHEM, V40, P105, DOI 10.1042/bse0400105; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Cheng JW, 2007, J BIOL CHEM, V282, P30535, DOI 10.1074/jbc.M704829200; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Cunningham TD, 2007, CELL IMMUNOL, V245, P32, DOI 10.1016/j.cellimm.2007.03.004; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; DIETZ AJ, 1966, J MED CHEM, V9, P500, DOI 10.1021/jm00322a013; DIETZ AJ, 1966, J MED CHEM, V9, P160, DOI 10.1021/jm00319a044; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Fowler AM, 2006, MOL ENDOCRINOL, V20, P291, DOI 10.1210/me.2005-0288; Fowler AM, 2004, FASEB J, V18, P81, DOI 10.1096/fj.03-0038com; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Gradishar WJ, 2006, JAMA-J AM MED ASSOC, V295, P2784, DOI 10.1001/jama.295.23.jed60037; Hergenrother PJ, 2006, CURR OPIN CHEM BIOL, V10, P213, DOI 10.1016/j.cbpa.2006.04.005; Jiang X, 2007, ONCOGENE, V26, P4106, DOI 10.1038/sj.onc.1210197; Jiang XG, 2006, ENDOCRINOLOGY, V147, P1419, DOI 10.1210/en.2005-0996; Jordan VC, 2001, ANN NY ACAD SCI, V949, P72; Katzenellenbogen BS, 2000, J SOC GYNECOL INVEST, V7, pS33, DOI 10.1177/1071557600007001S10; Katzenellenbogen BS, 1997, BREAST CANCER RES TR, V44, P23, DOI 10.1023/A:1005835428423; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Krieg AJ, 2004, J BIOL CHEM, V279, P5025, DOI 10.1074/jbc.M307076200; Krieg SA, 2001, MOL ENDOCRINOL, V15, P1971, DOI 10.1210/me.15.11.1971; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Mao CJ, 2006, ANAL BIOCHEM, V350, P222, DOI 10.1016/j.ab.2005.12.010; Mattick S, 1997, J STEROID BIOCHEM, V60, P285, DOI 10.1016/S0960-0760(96)00198-7; Medema JP, 1999, J EXP MED, V190, P1033, DOI 10.1084/jem.190.7.1033; Melvin VS, 2001, METH MOL B, V176, P39; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Naughton C, 2007, MOL ENDOCRINOL, V21, P2615, DOI 10.1210/me.2007-0110; NORDEEN SK, 1989, MOL ENDOCRINOL, V3, P1270, DOI 10.1210/mend-3-8-1270; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; Pandey Kaushal Raj, 2007, BMJ, V334, P925, DOI 10.1136/bmj.39202.548588.DB; Putt KS, 2006, NAT CHEM BIOL, V2, P543, DOI 10.1038/nchembio814; Putt KS, 2004, ANAL BIOCHEM, V326, P78, DOI 10.1016/j.ab.2003.11.015; Rishi V, 2005, ANAL BIOCHEM, V340, P259, DOI 10.1016/j.ab.2005.02.012; Schultz-Norton JR, 2007, MOL ENDOCRINOL, V21, P1569, DOI 10.1210/me.2006-0519; Schultz-Norton JR, 2006, MOL ENDOCRINOL, V20, P1982, DOI 10.1210/me.2006-0006; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Smyth JF, 2007, CLIN CANCER RES, V13, P3617, DOI 10.1158/1078-0432.CCR-06-2878; ten Berge RL, 2002, BLOOD, V99, P4540, DOI 10.1182/blood.V99.12.4540; van Houdt IS, 2005, CLIN CANCER RES, V11, P6400, DOI 10.1158/1078-0432.CCR-05-0306; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Wang LH, 2004, NAT MED, V10, P40, DOI 10.1038/nm969; Wang LH, 2006, CANCER CELL, V10, P487, DOI 10.1016/j.ccr.2006.09.015; Wang S, 2007, J BIOL CHEM, V282, P2765, DOI 10.1074/jbc.M607531200; Wang SY, 2004, BIOTECHNIQUES, V37, P807, DOI 10.2144/04375RR01; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Winer EP, 2005, J CLIN ONCOL, V23, P1609, DOI 10.1200/JCO.2005.01.005; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	60	46	49	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12819	12830		10.1074/jbc.M709936200	http://dx.doi.org/10.1074/jbc.M709936200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337247	Green Published, hybrid			2022-12-25	WOS:000255499800018
J	Ogo, Y; Kobayashi, T; Itai, RN; Nakanishi, H; Kakei, Y; Takahashi, M; Toki, S; Mori, S; Nishizawa, NK				Ogo, Yuko; Kobayashi, Takanori; Itai, Reiko Nakanishi; Nakanishi, Hiromi; Kakei, Yusuke; Takahashi, Michiko; Toki, Seiichi; Mori, Satoshi; Nishizawa, Naoko K.			A novel NAC transcription factor, IDEF2, that recognizes the iron deficiency-responsive element 2 regulates the genes involved in iron homeostasis in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTIANAMINE SYNTHASE GENES; MOLECULAR CHARACTERIZATION; RICE; PROTEIN; EXPRESSION; CLONING; ROOT; PHYTOSIDEROPHORES; ACQUISITION; BARLEY	Iron is essential for most living organisms, and thus iron deficiency poses a major abiotic stress in crop production. Plants induce iron utilization systems under conditions of low iron availability, but the molecular mechanisms of gene regulation under iron deficiency remain largely unknown. We identified a novel transcription factor of rice and barley, IDEF2, which specifically binds to the iron deficiency-responsive cis-acting element 2 (IDE2) by yeast one-hybrid screening. IDEF2 belongs to an uncharacterized branch of the NAC transcription factor family and exhibits novel properties of sequence recognition. An electrophoretic mobility shift assay and cyclic amplification and selection of targets experiment revealed that IDEF2 predominantly recognized CA(A/C) G(T/C)(T/C/A)(T/C/A) within IDE2 as the core-binding site. IDEF2 transcripts are constitutively present in rice roots and leaves. Repression of the function of IDEF2 by the RNA interference (RNAi) technique and chimeric repressor gene-silencing technology (CRES-T) caused aberrant iron homeostasis in rice. Several genes up-regulated by iron deficiency, including the Fe(II)-nicotianamine transporter gene OsYSL2, were less induced by iron deficiency in the RNAi rice of IDEF2, suggesting that IDEF2 is involved in the regulation of these genes. Many genes with repressed expression in IDEF2 RNAi rice possessed the IDEF2-binding core sites in their promoters, and the flanking sequences were also highly homologous to IDE2. IDEF2 bound to OsYSL2 promoter region containing the binding core site, suggesting direct regulation of OsYSL2 expression. These results reveal novel cis-element/trans-factor interactions functionally associated with iron homeostasis.	[Ogo, Yuko; Kobayashi, Takanori; Itai, Reiko Nakanishi; Kakei, Yusuke; Takahashi, Michiko; Nishizawa, Naoko K.] Univ Tokyo, Plant Biotechnol Lab, Bunkyo Ku, Tokyo 1138657, Japan; [Mori, Satoshi] Univ Tokyo, Lab Plant Physiol, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Toki, Seiichi] Natl Inst Agrobiol Sci, Plant Genet Engn Res Unit, Div Plant Sci, Tsukuba, Ibaraki 3058602, Japan	University of Tokyo; University of Tokyo; National Institute of Agrobiological Sciences - Japan	Nishizawa, NK (corresponding author), Univ Tokyo, Plant Biotechnol Lab, Bunkyo Ku, 1-1 Yayoi, Tokyo 1138657, Japan.	annaoko@mail.ecc.u-tokyo.ac.jp	Toki, Seiichi/AAR-1889-2021; Kakei, Yusuke/AAF-7408-2020; Nakanishi, Hiromi/C-6461-2015	Nakanishi, Hiromi/0000-0001-5556-5058				Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; BECKER R, 1995, PLANT PHYSIOL, V108, P269, DOI 10.1104/pp.108.1.269; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Delessert C, 2005, PLANT J, V43, P745, DOI 10.1111/j.1365-313X.2005.02488.x; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Hegedus D, 2003, PLANT MOL BIOL, V53, P383, DOI 10.1023/B:PLAN.0000006944.61384.11; Herbik A, 1999, EUR J BIOCHEM, V265, P231, DOI 10.1046/j.1432-1327.1999.00717.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Higuchi K, 2001, PLANT J, V25, P159, DOI 10.1046/j.1365-313x.2001.00951.x; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Inoue H, 2006, PLANT CELL PHYSIOL, V47, pS231; Inoue H, 2003, PLANT J, V36, P366, DOI 10.1046/j.1365-313X.2003.01878.x; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; IZAWA T, 1993, J MOL BIOL, V230, P1131, DOI 10.1006/jmbi.1993.1230; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; KATAGIRI F, 1989, NATURE, V340, P727, DOI 10.1038/340727a0; Kobayashi T, 2004, SOIL SCI PLANT NUTR, V50, P1167, DOI 10.1080/00380768.2004.10408590; Kobayashi T, 2005, J EXP BOT, V56, P1305, DOI 10.1093/jxb/eri131; Kobayashi T, 2003, PLANT J, V36, P780, DOI 10.1046/j.1365-313X.2003.01920.x; Kobayashi T, 2007, P NATL ACAD SCI USA, V104, P19150, DOI 10.1073/pnas.0707010104; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; Ling HQ, 2002, P NATL ACAD SCI USA, V99, P13938, DOI 10.1073/pnas.212448699; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Mizuno D, 2003, PLANT PHYSIOL, V132, P1989, DOI 10.1104/pp.102.019869; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; NAKANISHI H, 1993, PLANT CELL PHYSIOL, V34, P401; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Ogo Y, 2006, J EXP BOT, V57, P2867, DOI 10.1093/jxb/erl054; OKUMURA N, 1994, PLANT MOL BIOL, V25, P705, DOI 10.1007/BF00029608; Olsen AN, 2005, PLANT SCI, V169, P785, DOI 10.1016/j.plantsci.2005.05.035; Pich A, 1996, J EXP BOT, V47, P41, DOI 10.1093/jxb/47.1.41; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; STEPHAN UW, 1994, PLANT SOIL, V165, P181, DOI 10.1007/BF00008060; TAKAGI SI, 1976, SOIL SCI PLANT NUTR, V22, P423, DOI 10.1080/00380768.1976.10433004; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Vorwieger A, 2007, PLANTA, V226, P147, DOI 10.1007/s00425-006-0476-9; Yi Y, 1996, PLANT J, V10, P835, DOI 10.1046/j.1365-313X.1996.10050835.x	47	156	171	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13407	13417		10.1074/jbc.M708732200	http://dx.doi.org/10.1074/jbc.M708732200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308732	hybrid			2022-12-25	WOS:000255499800080
J	Martin, AM; Kuhlmann, C; Trossbach, S; Jaeger, S; Waldron, E; Roebroek, A; Luhmann, HJ; Laatsch, A; Weggen, S; Lessmann, V; Pietrzik, CU				Martin, Anne M.; Kuhlmann, Christoph; Trossbach, Svenja; Jaeger, Sebastian; Waldron, Elaine; Roebroek, Anton; Luhmann, Heiko J.; Laatsch, Alexander; Weggen, Sascha; Lessmann, Volkmar; Pietrzik, Claus U.			The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CYTOPLASMIC DOMAIN; ALZHEIMERS; MODULATION; CLEARANCE; FAMILY	The low density lipoprotein receptor-related protein 1 (LRP1) emerges to play fundamental roles in cellular signaling pathways in the brain. One of its prominent ligands is the serine proteinase tissue-type plasminogen activator (tPA), which has been shown to act as a key activator of neuronal mitogen-activated protein kinase pathways via the N-methyl-D-aspartate (NMDA) receptor. However, here we set out to examine whether LRP1 and the NMDA receptor might eventually act in a combined fashion to mediate tPA downstream signaling. By blocking tPA from binding to LRP1 using the receptor-associated protein, we were able to completely inhibit NMDA receptor activation. Additionally, inhibition of NMDA receptor calcium influx with MK-801 resulted in dramatic reduction of tPA-mediated downstream signaling. This indicates a functional interaction between the two receptors, since both experimental approaches resulted in strongly reduced calcium influx and Erk1/2 phosphorylation. Additionally, we were able to inhibit Erk1/2 activation by competing for the LRP1 C-terminal binding motif with a truncated PSD95 construct resembling its PDZ III domain. Furthermore, we identified the distal NPXY amino acid motif in the C terminus of LRP1 as the crucial element for LRP1-NMDA receptor interaction via the adaptor protein PSD95. These results provide new insights into the mechanism of a tPA-induced, LRP1-mediated gating mechanism for NMDA receptors.	[Martin, Anne M.; Trossbach, Svenja; Jaeger, Sebastian; Waldron, Elaine; Pietrzik, Claus U.] Johannes Gutenberg Univ Mainz, Inst Physiol Chem & Pathobiochem, D-55099 Mainz, Germany; [Kuhlmann, Christoph; Luhmann, Heiko J.] Johannes Gutenberg Univ Mainz, Inst Physiol, D-55099 Mainz, Germany; [Roebroek, Anton] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Roebroek, Anton] Flanders Inst Biotechnol, B-3000 Louvain, Belgium; [Laatsch, Alexander] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol Mol Cell Biol 2, D-20246 Hamburg, Germany; [Weggen, Sascha] Univ Med Ctr Heinrich Heine Univ, Dept Mol Neuropathol, Inst Neuropathol, D-40225 Dusseldorf, Germany; [Lessmann, Volkmar] Otto Von Guericke Univ, Inst Physiol, D-39120 Magdeburg, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; KU Leuven; Flanders Institute for Biotechnology (VIB); University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Otto von Guericke University	Pietrzik, CU (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol Chem & Pathobiochem, Duesbergweg 6, D-55099 Mainz, Germany.	pietrzik@uni-mainz.de	Luhmann, Heiko J./N-8797-2019; Leßmann, Volkmar/E-8125-2013	Luhmann, Heiko J./0000-0002-7934-8661; Leßmann, Volkmar/0000-0002-6863-323X				Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Barnes H, 2003, ONCOGENE, V22, P3589, DOI 10.1038/sj.onc.1206504; Boucher P, 2004, TRENDS CARDIOVAS MED, V14, P55, DOI 10.1016/j.tcm.2003.12.001; Bu GJ, 2006, ANN NY ACAD SCI, V1086, P35, DOI 10.1196/annals.1377.005; Cao J, 2005, J CELL BIOL, V168, P117, DOI 10.1083/jcb.200407024; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Eugenin EA, 2007, P NATL ACAD SCI USA, V104, P3438, DOI 10.1073/pnas.0611699104; Fernandez-Monreal M, 2004, J BIOL CHEM, V279, P50850, DOI 10.1074/jbc.M407069200; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Harris-White M. E., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P469, DOI 10.2174/156800705774322102; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kanterewicz BI, 1998, J NEUROCHEM, V70, P1009; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Laatsch A, 2004, EUR J CELL BIOL, V83, P113, DOI 10.1078/0171-9335-00364; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Medina MG, 2005, EMBO J, V24, P1706, DOI 10.1038/sj.emboj.7600650; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Pang PT, 2004, AGEING RES REV, V3, P407, DOI 10.1016/j.arr.2004.07.002; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; Roebroek AJM, 2006, MOL CELL BIOL, V26, P605, DOI 10.1128/MCB.26.2.605-616.2006; Sambrook J, 2001, MOL CLONING LAB MANU; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; Strickland DK, 2003, J THROMB HAEMOST, V1, P1663, DOI 10.1046/j.1538-7836.2003.00330.x; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Waldron E, 2006, NEURODEGENER DIS, V3, P233, DOI 10.1159/000095261; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	35	83	86	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12004	12013		10.1074/jbc.M707607200	http://dx.doi.org/10.1074/jbc.M707607200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321860	hybrid			2022-12-25	WOS:000255340000016
J	Liu, X; Spicarova, Z; Rydholm, S; Li, J; Brismar, H; Aperia, A				Liu, Xiao; Spicarova, Zuzana; Rydholm, Susanna; Li, Juan; Brismar, Hjalmar; Aperia, Anita			Ankyrin B modulates the function of Na, K-ATPase/inositol 1,4,5-trisphosphate receptor signaling microdomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM OSCILLATIONS; CARDIAC-ARRHYTHMIA; CATALYTIC SUBUNIT; SERUM DEPRIVATION; BINDING DOMAIN; IP3 RECEPTOR; NA,K-ATPASE; ATPASE; IDENTIFICATION; HOMEOSTASIS	Na, K-ATPase and inositol 1,4,5-trisphosphate (IP3) receptor (IP3R) can form a signaling microdomain that in the presence of ouabain triggers highly regular calcium oscillations. Downstream effects include NF-kappa B activation. Here we report that ankyrin B (Ank-B), expressed in most mammalian cells, plays a pivotal role in the function of the Na, K-ATPase/ IP3R signaling microdomain. In studies performed on a monkey kidney cell line, we show that Ank-B co-precipitates with both Na, K-ATPase and IP3R. We identify the N terminus tail of the Na, K-ATPase catalytic subunit and the N-terminal portion 1-604 of the IP3R as novel binding sites for Ank-B. Knockdown of Ank-B with small interfering RNA reduced the expression of Ank-B to 15-30%. This down-regulation of Ank-B attenuated the interaction between Na, K-ATPase and IP3R, reduced the number of cells responding to pM doses of ouabain with calcium oscillations, altered the calcium oscillatory pattern, and abolished the ouabain effect on NF-kappa B. In contrast, Ank-B down-regulation had no effect on the ion transporting function of Na, K-ATPase and no effect on the distribution and apparent mobility of Na, K-ATPase in the plasma membrane.	[Liu, Xiao; Spicarova, Zuzana; Li, Juan; Brismar, Hjalmar; Aperia, Anita] Astrid Lindgren Childrens Hosp, Karolinska Inst, Dept Woman & Child Hlth, SE-17176 Stockholm, Sweden; [Rydholm, Susanna; Brismar, Hjalmar] AlbaNova Univ Ctr, Royal Inst Technol, Dept Cell Phys, S-10691 Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology	Aperia, A (corresponding author), Astrid Lindgren Childrens Hosp, Karolinska Inst, Dept Woman & Child Hlth, Q2 09, SE-17176 Stockholm, Sweden.	anita.aperia@ki.se	Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003				Aizman O, 2001, P NATL ACAD SCI USA, V98, P13420, DOI 10.1073/pnas.221315298; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; BOURGUIGNON LYW, 1995, J BIOL CHEM, V270, P7257, DOI 10.1074/jbc.270.13.7257; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC893, DOI 10.1152/ajpcell.1997.273.3.C893; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Haas M, 2000, J BIOL CHEM, V275, P27832; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Li JA, 2006, J AM SOC NEPHROL, V17, P1848, DOI 10.1681/ASN.2005080894; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liu XL, 2007, NEUROREPORT, V18, P597, DOI 10.1097/WNR.0b013e3280b07bc9; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; Mogi M, 2004, BONE, V35, P507, DOI 10.1016/j.bone.2004.03.003; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Mohler PJ, 2002, J CELL SCI, V115, P1565; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Pressley TA, 1996, AM J PHYSIOL-CELL PH, V271, pC825, DOI 10.1152/ajpcell.1996.271.3.C825; Schoner W, 2007, AM J CARDIOVASC DRUG, V7, P173, DOI 10.2165/00129784-200707030-00004; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Scott L, 2006, P NATL ACAD SCI USA, V103, P762, DOI 10.1073/pnas.0505557103; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tuvia S, 1999, J CELL BIOL, V147, P995, DOI 10.1083/jcb.147.5.995; Woroniecki R, 2003, AM J PHYSIOL-RENAL, V284, pF358, DOI 10.1152/ajprenal.00100.2002; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200; Zhang ZS, 1998, J BIOL CHEM, V273, P18681, DOI 10.1074/jbc.273.30.18681	33	39	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11461	11468		10.1074/jbc.M706942200	http://dx.doi.org/10.1074/jbc.M706942200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303017	hybrid			2022-12-25	WOS:000255067400044
J	Inoue, K; Negishi, M				Inoue, Kaoru; Negishi, Masahiko			Nuclear receptor CAR requires early growth response 1 to activate the human cytochrome P4502B6 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR; SYNERGISTIC ACTIVATION; FACTOR 4-ALPHA; TARGET GENES; HEPG2 CELLS; CROSS-TALK; P450 GENE; EXPRESSION; FACTOR-4-ALPHA	The nuclear receptor CAR (constitutive active/androstane receptor) is a drug-sensing transcription factor, regulating the hepatic genes that encode various drug-metabolizing enzymes. We have now characterized the novel regulatory mechanism by which the signal molecule EGR1 (early growth response 1) determines CAR-mediated activation of the human CYP2B6 (cytochrome P450 2B6) gene. The CYP2B6 enzyme metabolizes commonly used therapeutics and also activates pro-drugs. The CAR directly binds to the distal enhancer element of the CYP2B6 promoter, which is essential in converging to its drug-sensing function onto promoter activity. However, this binding alone is not sufficient to activate the CYP2B6 promoter; the promoter requires EGR1 to enable CAR to activate the CYP2B6 promoter. Upon stimulation by protein kinase C, EGR1 directly binds to the proximal promoter and coordinates the nearby HNF4 alpha (hepatocyte-enriched nuclear factor 4 alpha) with CAR at the distal enhancer element to activate the promoter. Thus, synergy of drug activation and the stimulation of cellular signal are necessary for CAR to activate the CYP2B6 gene.	[Inoue, Kaoru; Negishi, Masahiko] NIEHS, NIH, Reprod & Dev Toxicol Lab, Pharmacogenet Sect, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040, Z01ES080040] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barbier O, 2005, MOL PHARMACOL, V67, P241, DOI 10.1124/mol.104.003863; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; CAO XM, 1993, J BIOL CHEM, V268, P16949; CAO XM, 1992, J BIOL CHEM, V267, P12991; Chen YP, 2005, J PHARMACOL EXP THER, V314, P1125, DOI 10.1124/jpet.105.087072; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Hosseinpour F, 2007, FEBS LETT, V581, P4937, DOI 10.1016/j.febslet.2007.09.024; Hung HL, 1996, J BIOL CHEM, V271, P2323, DOI 10.1074/jbc.271.4.2323; Inoue K, 2006, BIOCHEM J, V398, P125, DOI 10.1042/BJ20060109; Kamiya A, 2003, HEPATOLOGY, V37, P1375, DOI 10.1053/jhep.2003.50212; Kamiyama Y, 2007, DRUG METAB PHARMACOK, V22, P287, DOI 10.2133/dmpk.22.287; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004; Koike C, 2007, MOL PHARMACOL, V71, P1217, DOI 10.1124/mol.107.034538; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; Meester-Smoor MA, 2007, J MOL ENDOCRINOL, V38, P113, DOI 10.1677/jme.1.02110; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; Saborowski M, 2006, J PHARMACOL EXP THER, V317, P778, DOI 10.1124/jpet.105.099929; Schwartz PS, 2003, CANCER GENE THER, V10, P571, DOI 10.1038/sj.cgt.7700601; Silva PNG, 2006, BIOCHEM J, V398, P83, DOI 10.1042/BJ20060509; Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Swales K, 2005, J BIOL CHEM, V280, P3458, DOI 10.1074/jbc.M411318200; Tarumi T, 2002, J BIOL CHEM, V277, P18510, DOI 10.1074/jbc.M201886200; Tegude H, 2007, DRUG METAB DISPOS, V35, P946, DOI 10.1124/dmd.106.013565; Wong WK, 2002, J BIOL CHEM, V277, P22222, DOI 10.1074/jbc.M202844200; Worden B, 2005, CANCER RES, V65, P7071, DOI 10.1158/0008-5472.CAN-04-0989	30	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10425	10432		10.1074/jbc.M800729200	http://dx.doi.org/10.1074/jbc.M800729200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18303024	hybrid, Green Published			2022-12-25	WOS:000254894700023
J	Bistue, AJCS; Birshan, D; Tomaras, AP; Dandekar, M; Tran, T; Newmark, J; Bui, D; Gupta, N; Hernandez, K; Sarno, R; Zorreguieta, A; Actis, LA; Tolmasky, ME				Bistue, Alfonso J. C. Soler; Birshan, Daniel; Tomaras, Andrew P.; Dandekar, Manisha; Tran, Tung; Newmark, Jason; Bui, Duyen; Gupta, Nisha; Hernandez, Keziah; Sarno, Renee; Zorreguieta, Angeles; Actis, Luis A.; Tolmasky, Marcelo E.			Klebsiella pneumoniae Multiresistance Plasmid pMET1: Similarity with the Yersinia pestis Plasmid pCRY and Integrative Conjugative Elements	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; AMIKACIN RESISTANCE; RECOMBINATION SITES; BACTERIAL PLASMIDS; ESCHERICHIA-COLI; PROTEIN; SYSTEM; SEGREGATION; PARG; BIOSYNTHESIS	Background: Dissemination of antimicrobial resistance genes has become an important public health and biodefense threat. Plasmids are important contributors to the rapid acquisition of antibiotic resistance by pathogenic bacteria. Principal Findings: The nucleotide sequence of the Klebsiella pneumoniae multiresistance plasmid pMET1 comprises 41,723 bp and includes Tn1331.2, a transposon that carries the bla(TEM-1) gene and a perfect duplication of a 3-kbp region including the aac(6')-Ib, aadA1, and bla(OXA-9) genes. The replication region of pMET1 has been identified. Replication is independent of DNA polymerase I, and the replication region is highly related to that of the cryptic Yersinia pestis 91001 plasmid pCRY. The potential partition region has the general organization known as the parFG locus. The self-transmissible pMET1 plasmid includes a type IV secretion system consisting of proteins that make up the mating pair formation complex (Mpf) and the DNA transfer (Dtr) system. The Mpf is highly related to those in the plasmid pCRY, the mobilizable high-pathogenicity island from E. coli ECOR31 (HPIECOR31), which has been proposed to be an integrative conjugative element (ICE) progenitor of high-pathogenicity islands in other Enterobacteriaceae including Yersinia species, and ICEKp1, an ICE found in a K. pneumoniae strain causing primary liver abscess. The Dtr MobB and MobC proteins are highly related to those of pCRY, but the endonuclease is related to that of plasmid pK245 and has no significant homology with the protein of similar function in pCRY. The region upstream of mobB includes the putative oriT and shares 90% identity with the same region in the HPIECOR31. Conclusions: The comparative analyses of pMET1 with pCRY, HPIECOR31, and ICEKp1 show a very active rate of genetic exchanges between Enterobacteriaceae including Yersinia species, which represents a high public health and biodefense threat due to transfer of multiple resistance genes to pathogenic Yersinia strains.	[Bistue, Alfonso J. C. Soler; Birshan, Daniel; Dandekar, Manisha; Tran, Tung; Newmark, Jason; Bui, Duyen; Gupta, Nisha; Hernandez, Keziah; Sarno, Renee; Zorreguieta, Angeles; Tolmasky, Marcelo E.] Calif State Univ Fullerton, Ctr Appl Biotechnol Studies, Dept Biol Sci, Coll Nat Sci & Math, Fullerton, CA 92634 USA; [Tomaras, Andrew P.; Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH USA	California State University System; California State University Fullerton; University System of Ohio; Miami University	Bistue, AJCS (corresponding author), Calif State Univ Fullerton, Ctr Appl Biotechnol Studies, Dept Biol Sci, Coll Nat Sci & Math, Fullerton, CA 92634 USA.	mtolmasky@fullerton.edu	Tolmasky, Marcelo/AAC-5316-2020; Soler-Bistué, Alfonso/AAV-3123-2021	Tolmasky, Marcelo/0000-0002-6298-7811; Soler-Bistué, Alfonso/0000-0002-3917-0002	Public Health Service [2R15AI047115]; National Institutes of Health; National Science Foundation [0420479]; LA Basin Minority Health; Health Disparities International Research Training Program (MHIRT) [5T37MD001368-09]; Howell-CSUPERB Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI047115] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [T37MD001368] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); LA Basin Minority Health; Health Disparities International Research Training Program (MHIRT); Howell-CSUPERB Scholar Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by Public Health Service grant 2R15AI047115 (to M.E.T.) from the National Institutes of Health and National Science Foundation grant 0420479 (to L.A.A.). J.N. and D.B. were supported in part by LA Basin Minority Health and Health Disparities International Research Training Program (MHIRT) 5T37MD001368-09 (National Center on Minority Health and Health Disparities). T.T. was the recipient of a Howell-CSUPERB Scholar Award.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avila P, 1996, J MOL BIOL, V261, P135, DOI 10.1006/jmbi.1996.0447; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Barilla D, 2003, MOL MICROBIOL, V49, P487, DOI 10.1046/j.1365-2958.2003.03564.x; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; Belogurov AA, 2000, J MOL BIOL, V296, P969, DOI 10.1006/jmbi.1999.3493; BHATTACHARJEE M, 1992, J BACTERIOL, V174, P6659, DOI 10.1128/JB.174.20.6659-6665.1992; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Bui DY, 2006, J BACTERIOL, V188, P2812, DOI 10.1128/JB.188.8.2812-2820.2006; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; Chen YT, 2006, ANTIMICROB AGENTS CH, V50, P3861, DOI 10.1128/AAC.00456-06; COHEN SN, 1993, GENE, V135, P67, DOI 10.1016/0378-1119(93)90050-D; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ding ZY, 2003, TRENDS MICROBIOL, V11, P527, DOI 10.1016/j.tim.2003.09.004; Ebringer A, 2007, CLIN RHEUMATOL, V26, P289, DOI 10.1007/s10067-006-0391-2; Fluit AC, 2004, CLIN MICROBIOL INFEC, V10, P272, DOI 10.1111/j.1198-743X.2004.00858.x; Golovanov AP, 2003, MOL MICROBIOL, V50, P1141, DOI 10.1046/j.1365-2958.2003.03750.x; Gupta A, 2002, SEMIN PERINATOL, V26, P340, DOI 10.1053/sper.2002.36267; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; IRIARTE M, 2006, YERSINIA ENTEROCOLIT; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; LEONG SA, 1982, J BIOL CHEM, V257, P8724; Lin TL, 2008, J BACTERIOL, V190, P515, DOI 10.1128/JB.01219-07; Lutkenhaus J, 2003, MOL MICROBIOL, V48, P295, DOI 10.1046/j.1365-2958.2003.03427.x; McGhee GC, 2000, APPL ENVIRON MICROB, V66, P4897, DOI 10.1128/AEM.66.11.4897-4907.2000; Moller-Jensen J, 2000, TRENDS MICROBIOL, V8, P313, DOI 10.1016/S0966-842X(00)01787-X; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; Nunez B, 2001, MOL MICROBIOL, V39, P1088, DOI 10.1046/j.1365-2958.2001.02308.x; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; PETERSON BC, 1985, J BACTERIOL, V164, P1359, DOI 10.1128/JB.164.3.1359-1361.1985; PETERSON BC, 1985, J BACTERIOL, V161, P1042, DOI 10.1128/JB.161.3.1042-1048.1985; PETERSON BC, 1983, J BACTERIOL, V156, P177, DOI 10.1128/JB.156.1.177-185.1983; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P2889, DOI 10.1128/AAC.00398-06; Prentice MB, 2001, J BACTERIOL, V183, P2586, DOI 10.1128/JB.183.8.2586-2594.2001; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; REISH O, 1993, J HOSP INFECT, V25, P287, DOI 10.1016/0195-6701(93)90115-G; Rice LB, 2008, ENZYME-MEDIATED RESISTANCE TO ANTIBIOTICS: MECHANISMS, DISSEMINATION, AND PROSPECTS FOR INHIBITION, P271; Sarno R, 2002, ANTIMICROB AGENTS CH, V46, P3422, DOI 10.1128/AAC.46.11.3422-3427.2002; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001; Schubert S, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03870.x; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Strauch E, 2003, MICROBIOL-SGM, V149, P2829, DOI 10.1099/mic.0.26418-0; Taylor DE, 2004, PLASMID BIOLOGY, P473; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolmasky ME, 2008, ENZYME-MEDIATED RESISTANCE TO ANTIBIOTICS: MECHANISMS, DISSEMINATION, AND PROSPECTS FOR INHIBITION, P35; TOLMASKY ME, 1990, PLASMID, V24, P218, DOI 10.1016/0147-619X(90)90005-W; TOLMASKY ME, 1987, ANTIMICROB AGENTS CH, V31, P1955, DOI 10.1128/AAC.31.12.1955; TOLMASKY ME, 1988, ANTIMICROB AGENTS CH, V32, P1416, DOI 10.1128/AAC.32.9.1416; TOLMASKY ME, 1993, PLASMID, V29, P31, DOI 10.1006/plas.1993.1004; van't Veen A, 2005, J CLIN MICROBIOL, V43, P4961, DOI 10.1128/JCM.43.10.4961-4967.2005; vanHam RCHJ, 1997, J BACTERIOL, V179, P4768, DOI 10.1128/jb.179.15.4768-4777.1997; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Walsh TR, 2006, CURR OPIN MICROBIOL, V9, P476, DOI 10.1016/j.mib.2006.08.009; Waters Virginia L., 2007, P285; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; WOLOJ M, 1986, ANTIMICROB AGENTS CH, V29, P315, DOI 10.1128/AAC.29.2.315	61	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1800	10.1371/journal.pone.0001800	http://dx.doi.org/10.1371/journal.pone.0001800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350140	Green Published, Green Submitted, gold			2022-12-25	WOS:000260762300006
J	Groenenberg, DSJ; Beintema, AJ; Dekker, RWRJ; Gittenberger, E				Groenenberg, Dick S. J.; Beintema, Albert J.; Dekker, Rene W. R. J.; Gittenberger, Edmund			Ancient DNA Elucidates the Controversy about the Flightless Island Hens (Gallinula sp.) of Tristan da Cunha	PLOS ONE			English	Article								A persistent controversy surrounds the flightless island hen of Tristan da Cunha, Gallinula nesiotis. Some believe that it became extinct by the end of the 19th century. Others suppose that it still inhabits Tristan. There is no consensus about Gallinula comeri, the name introduced for the flightless moorhen from the nearby island of Gough. On the basis of DNA sequencing of both recently collected and historical material, we conclude that G. nesiotis and G. comeri are different taxa, that G. nesiotis indeed became extinct, and that G. comeri now inhabits both islands. This study confirms that among gallinules seemingly radical adaptations (such as the loss of flight) can readily evolve in parallel on different islands, while conspicuous changes in other morphological characters fail to occur.	[Groenenberg, Dick S. J.; Dekker, Rene W. R. J.; Gittenberger, Edmund] Natl Museum Nat Hist Naturalis, Leiden, Netherlands; [Beintema, Albert J.] Biowrite, Gorssel, Netherlands; [Gittenberger, Edmund] Leiden Univ, Inst Biol, Leiden, Netherlands	Naturalis Biodiversity Center; Leiden University; Leiden University - Excl LUMC	Groenenberg, DSJ (corresponding author), Natl Museum Nat Hist Naturalis, Leiden, Netherlands.	groenenberg@naturalis.nl						Allen JA, 1892, B AM MUS NAT HIST, V4, P57; Austin JJ, 2003, MOL ECOL, V12, P1415, DOI 10.1046/j.1365-294X.2003.01842.x; Beintema A.J., 1972, Bulletin Br Orn Club, V92, P106; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; Broekhuysen G. V., 1949, Ardea Leiden, V37, P97; Casane D, 1997, J MOL EVOL, V45, P216, DOI 10.1007/PL00006223; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Dickinson EC., 2003, HOWARD MOORE COMPLET; Eber G., 1962, Bonner Zoologische Beitraege, V12, P247; Eldridge MDB, 1999, CONSERV BIOL, V13, P531, DOI 10.1046/j.1523-1739.1999.98115.x; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; Knox A.G., 1994, BRIT ORNITHOLOGISTS; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kolokotronis SO, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-67; Maddison WP, 2005, MACCLADE ANAL PHYLOG; MILNER J, 1869, CRUISE HMS GLATEA CA; MUSE SV, 1992, GENETICS, V132, P269; Nicoll MJ, 1908, 3 VOYAGES NATURALIST; NICOLL MJ, 1906, BIRDS COLLECTED OBSE, V8, P666; NYLANDER J.A.A., 2004, MRMODELTEST 2 2 PROG; Orlando L, 2003, MOL PHYLOGENET EVOL, V28, P485, DOI 10.1016/S1055-7903(03)00023-X; Perna NT, 1996, CURR BIOL, V6, P128, DOI 10.1016/S0960-9822(02)00441-4; POND SLK, 2005, HYPHY HYPOTHESIS TES, P676; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quinn TW, 1992, MOL ECOL, V1, P105, DOI 10.1111/j.1365-294X.1992.tb00162.x; Richardson M.E., 1984, Cormorant, V12, P123; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCLATER PL, 1861, P ZOOL SOC LOND, P260; Slikas B, 2002, J AVIAN BIOL, V33, P5, DOI 10.1034/j.1600-048X.2002.330103.x; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; SPERLING RM, 1872, IBIS, V3, P74; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TAYLOR B, 1998, RAILS GUIDE RAILS CO	37	9	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1835	10.1371/journal.pone.0001835	http://dx.doi.org/10.1371/journal.pone.0001835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350170	Green Published, gold			2022-12-25	WOS:000260762300036
J	Muller, IB; Knockel, J; Groves, MR; Jordanova, R; Ealick, SE; Walter, RD; Wrenger, C				Mueller, Ingrid B.; Knoeckel, Julia; Groves, Matthew R.; Jordanova, Rositsa; Ealick, Steven E.; Walter, Rolf D.; Wrenger, Carsten			The Assembly of the Plasmodial PLP Synthase Complex Follows a Defined Course	PLOS ONE			English	Article								Background: Plants, fungi, bacteria and the apicomplexan parasite Plasmodium falciparum are able to synthesize vitamin B6 de novo, whereas mammals depend upon the uptake of this essential nutrient from their diet. The active form of vitamin B6 is pyridoxal 5-phosphate (PLP). For its synthesis two enzymes, Pdx1 and Pdx2, act together, forming a multimeric complex consisting of 12 Pdx1 and 12 Pdx2 protomers. Methodology/Principal Findings: Here we report amino acid residues responsible for stabilization of the structural and enzymatic integrity of the plasmodial PLP synthase, identified by using distinct mutational analysis and biochemical approaches. Residues R85, H88 and E91 (RHE) are located at the Pdx1: Pdx1 interface and play an important role in Pdx1 complex assembly. Mutation of these residues to alanine impedes both Pdx1 activity and Pdx2 binding. Furthermore, changing D26, K83 and K151 (DKK), amino acids from the active site of Pdx1, to alanine obstructs not only enzyme activity but also formation of the complex. In contrast to the monomeric appearance of the RHE mutant, alteration of the DKK residues results in a hexameric assembly, and does not affect Pdx2 binding or its activity. While the modelled position of K151 is distal to the Pdx1: Pdx1 interface, it affects the assembly of hexameric Pdx1 into a functional dodecamer, which is crucial for PLP synthesis. Conclusions/Significance: Taken together, our data suggest that the assembly of a functional Pdx1: Pdx2 complex follows a defined pathway and that inhibition of this assembly results in an inactive holoenzyme.	[Mueller, Ingrid B.; Knoeckel, Julia; Walter, Rolf D.; Wrenger, Carsten] Bernhard Nocht Inst Trop Med, Dept Biochem, Hamburg, Germany; [Groves, Matthew R.; Jordanova, Rositsa] European Mol Biol Lab Hamburg Outstation, Hamburg, Germany; [Ealick, Steven E.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA	Bernhard Nocht Institut fur Tropenmedizin; European Molecular Biology Laboratory (EMBL); Cornell University	Muller, IB (corresponding author), Bernhard Nocht Inst Trop Med, Dept Biochem, Hamburg, Germany.	wrenger@bni-hamburg.de	Wrenger, Carsten/E-4110-2013	Wrenger, Carsten/0000-0001-5987-1749; Vivian, Julia/0000-0001-6688-7714; Groves, Matthew/0000-0001-9859-5177	Deutsche Forschungsgemeinschaft [WA 395/15]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant WA 395/15.	Bauer JA, 2004, J BIOL CHEM, V279, P2704, DOI 10.1074/jbc.M310311200; Belitsky BR, 2004, J BACTERIOL, V186, P1191, DOI 10.1128/JB.186.4.1191-1196.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Dong YX, 2004, EUR J BIOCHEM, V271, P745, DOI 10.1111/j.1432-1033.2003.03973.x; Ehrenshaft M, 1998, MOL CELL, V1, P603, DOI 10.1016/S1097-2765(00)80060-X; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; Geerlof A, 2006, ACTA CRYSTALLOGR D, V62, P1125, DOI 10.1107/S0907444906030307; Gengenbacher M, 2006, J BIOL CHEM, V281, P3633, DOI 10.1074/jbc.M508696200; Hill RE, 1996, J BIOL CHEM, V271, P30426, DOI 10.1074/jbc.271.48.30426; KERRY JA, 1986, EUR J BIOCHEM, V158, P581, DOI 10.1111/j.1432-1033.1986.tb09794.x; Knockel J, 2007, MOL BIOCHEM PARASIT, V152, P108, DOI 10.1016/j.molbiopara.2006.12.005; LAM HM, 1992, J BACTERIOL, V174, P6033, DOI 10.1128/JB.174.19.6033-6045.1992; LAM HM, 1992, J BACTERIOL, V174, P1554, DOI 10.1128/jb.174.5.1554-1567.1992; Newton P, 1999, ANNU REV MED, V50, P179, DOI 10.1146/annurev.med.50.1.179; Osmani AH, 1999, J BIOL CHEM, V274, P23565, DOI 10.1074/jbc.274.33.23565; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; PFLUG W, 1983, H-S Z PHYSIOL CHEM, V364, P1627, DOI 10.1515/bchm2.1983.364.2.1627; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; Raschle T, 2007, J BIOL CHEM, V282, P6098, DOI 10.1074/jbc.M610614200; ROA BB, 1989, J BACTERIOL, V171, P4767, DOI 10.1128/jb.171.9.4767-4777.1989; Sambrook J., 2002, MOL CLONING LAB MANU; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Stolz J, 2003, J BIOL CHEM, V278, P18990, DOI 10.1074/jbc.M300949200; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Tambasco-Studart M, 2005, P NATL ACAD SCI USA, V102, P13687, DOI 10.1073/pnas.0506228102; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wrenger C, 2005, J BIOL CHEM, V280, P5242, DOI 10.1074/jbc.M412475200; Wrenger C, 2001, J BIOL CHEM, V276, P29651, DOI 10.1074/jbc.M100578200; Zein F, 2006, BIOCHEMISTRY-US, V45, P14609, DOI 10.1021/bi061464y; Zhu JH, 2005, J BIOL CHEM, V280, P27914, DOI 10.1074/jbc.M503642200	31	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1815	10.1371/journal.pone.0001815	http://dx.doi.org/10.1371/journal.pone.0001815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350152	Green Submitted, Green Published, gold			2022-12-25	WOS:000260762300018
J	Zen, K; Liu, DQ; Guo, YL; Wang, C; Shan, J; Fang, M; Zhang, CY; Liu, Y				Zen, Ke; Liu, Dan-Qing; Guo, Ya-Lan; Wang, Chen; Shan, Jun; Fang, Ming; Zhang, Chen-Yu; Liu, Yuan			CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration	PLOS ONE			English	Article								Background: Endothelial E-selectin has been shown to play a pivotal role in mediating cell-cell interactions between breast cancer cells and endothelial monolayers during tumor cell metastasis. However, the counterreceptor for E-selectin and its role in mediating breast cancer cell transendothelial migration remain unknown. Methodology/Principal Findings: By assessing migration of various breast cancer cells across TNF-alpha pre-activated human umbilical vein endothelial cells (HUVECs), we found that breast cancer cells migrated across HUVEC monolayers differentially and that transmigration was E-selectin dependent. Cell surface labeling with the E-selectin extracellular domain/Fc chimera (exE-selectin/Fc) showed that the transmigration capacity of breast cancer cells was correlated to both the expression level and localization pattern of E-selectin binding protein(s) on the tumor cell surface. The exE-selectin/Fc strongly bound to metastatic MDA-MB-231, MDA-MB-435 and MDA-MB-468 cells, but not non-metastatic MCF-7 and T47D cells. Binding of exE-selectin/Fc was abolished by removal of tumor cell surface sialyl lewis x (sLe(x)) moieties. Employing an exE-selectin/Fc affinity column, we further purified the counterreceptor of E-selectin from metastatic breast cancer cells. The N-terminal protein sequence and cDNA sequence identified this E-selectin ligand as a similar to 170 kD human CD44 variant 4 (CD44v4). Purified CD44v4 showed a high affinity for E-selectin via sLe(x) moieties and, as expected, MDA-MB-231 cell adhesion to and migration across HUVEC monolayers were significantly reduced by down-regulation of tumor cell CD44v4 via CD44v4-specific siRNA. Conclusions/Significance: We demonstrated, for the first time, that breast cancer cell CD44v4 is a major E-selectin ligand in facilitating tumor cell migration across endothelial monolayers. This finding offers new insights into the molecular basis of E-selectin-dependent adhesive interactions that mediate breast cancer cell transendothelial metastasis.	[Zen, Ke; Liu, Dan-Qing; Guo, Ya-Lan; Wang, Chen; Shan, Jun; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Zen, Ke] Jiangsu CDC Nanjing Univ Joint Inst Virol, Nanjing, Peoples R China; [Fang, Ming; Liu, Yuan] Georgia State Univ, Dept Biol, Program Cell & Mol Biol, Atlanta, GA USA	Nanjing University; University System of Georgia; Georgia State University	Zen, K (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	kzen@nju.edu.cn	wang, chen/GWM-9481-2022		American Heart Association; Nanjing University; China Basic Science 973 program [2006CB503909]	American Heart Association(American Heart Association); Nanjing University(Nanjing University); China Basic Science 973 program(National Basic Research Program of China)	First-aid grant from the American Heart Association (Yuan Liu), Research grant from Nanjing University (111 Project) (Ke Zen), China Basic Science 973 program (2006CB503909)(C.Y. Zhang, and K. Zen)	Bajorath J, 2000, PROTEINS, V39, P103, DOI 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.3.CO;2-7; Bouker KB, 2005, CARCINOGENESIS, V26, P1527, DOI 10.1093/carcin/bgi113; Diaz LK, 2005, CLIN CANCER RES, V11, P3309, DOI 10.1158/1078-0432.CCR-04-2184; Dimitroff CJ, 2005, CANCER RES, V65, P5750, DOI 10.1158/0008-5472.CAN-04-4653; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Edberg DD, 2005, J BIOL CHEM, V280, P8961, DOI 10.1074/jbc.M407348200; Edwards DR, 1998, NATURE, V394, P527, DOI 10.1038/28961; Fanning A, 2005, INT IMMUNOL, V17, P449, DOI 10.1093/intimm/dxh225; Fujimoto T, 2001, INT IMMUNOL, V13, P359, DOI 10.1093/intimm/13.3.359; Fujisaki T, 1999, CANCER RES, V59, P4427; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; GUO YJ, 1994, CANCER RES, V54, P1561; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Herrera-Gayol A, 1999, EXP MOL PATHOL, V66, P99, DOI 10.1006/exmp.1999.2236; HESSION C, 1990, P NATL ACAD SCI USA, V87, P1673, DOI 10.1073/pnas.87.5.1673; Hibino S, 2005, CANCER RES, V65, P10494, DOI 10.1158/0008-5472.CAN-05-0314; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Jensen PV, 2004, HISTOCHEM CELL BIOL, V121, P361, DOI 10.1007/s00418-004-0648-2; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Koike T, 2004, P NATL ACAD SCI USA, V101, P8132, DOI 10.1073/pnas.0402088101; Krop I, 2005, CANCER RES, V65, P11326, DOI 10.1158/0008-5472.CAN-05-1523; Laferriere J, 2001, J BIOL CHEM, V276, P33762, DOI 10.1074/jbc.M008564200; Laferriere J, 2002, ANN NY ACAD SCI, V973, P562, DOI 10.1111/j.1749-6632.2002.tb04702.x; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P14321, DOI 10.1074/jbc.M212246200; Lechertier T, 2004, ANTICANCER RES, V24, P4011; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Marhaba R, 2004, J MOL HISTOL, V35, P211; McEver RP, 2002, THROMB HAEMOSTASIS, V87, P364; Mine S, 2003, EXP CELL RES, V288, P189, DOI 10.1016/S0014-4827(03)00184-8; Moss MA, 2000, ANTICANCER RES, V20, P1425; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Nubel T, 2004, FASEB J, V18, P140, DOI 10.1096/fj.03-0261fje; Price EA, 1996, INT J CANCER, V65, P513, DOI 10.1002/(SICI)1097-0215(19960208)65:4<513::AID-IJC20>3.0.CO;2-9; Roetger A, 1998, AM J PATHOL, V153, P1797, DOI 10.1016/S0002-9440(10)65694-5; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; Ryu JW, 2004, ARTERIOSCL THROM VAS, V24, P864, DOI 10.1161/01.ATV.0000125705.28058.eb; SEITER S, 1993, J EXP MED, V177, P443, DOI 10.1084/jem.177.2.443; Spessotto P, 2002, J CELL BIOL, V158, P1133, DOI 10.1083/jcb.200202120; Tozawa K, 2005, KIDNEY INT, V67, P1391, DOI 10.1111/j.1523-1755.2005.00216.x; TOZEREN A, 1995, INT J CANCER, V60, P426; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Tzircotis G, 2006, ONCOGENE, V25, P7401, DOI 10.1038/sj.onc.1209724; Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629; UNDERHILL C, 1992, J CELL SCI, V103, P293; Wallach-Dayan SB, 2001, J CELL SCI, V114, P3463; Wang HS, 2005, EXP CELL RES, V304, P116, DOI 10.1016/j.yexcr.2004.10.015; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; ZAHALKA MA, 1995, J IMMUNOL, V154, P5345; Zen K, 2004, MOL BIOL CELL, V15, P3926, DOI 10.1091/mbc.E04-04-0317; Zen K, 2002, J IMMUNOL, V169, P5270, DOI 10.4049/jimmunol.169.9.5270	53	93	94	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1826	10.1371/journal.pone.0001826	http://dx.doi.org/10.1371/journal.pone.0001826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350162	gold, Green Published, Green Submitted			2022-12-25	WOS:000260762300028
J	Dale, R; Roche, J; Snyder, K; McCall, R				Dale, Rick; Roche, Jennifer; Snyder, Kristy; McCall, Ryan			Exploring Action Dynamics as an Index of Paired-Associate Learning	PLOS ONE			English	Article							MENTAL CHRONOMETRY; FIELD-THEORY; TIME; DECISION; MOVEMENTS; ATTENTION; SELECTION; SYSTEM	Much evidence exists supporting a richer interaction between cognition and action than commonly assumed. Such findings demonstrate that short-timescale processes, such as motor execution, may relate in systematic ways to longer-timescale cognitive processes, such as learning. We further substantiate one direction of this interaction: the flow of cognition into action systems. Two experiments explored match-to-sample paired-associate learning, in which participants learned randomized pairs of unfamiliar symbols. During the experiments, their hand movements were continuously tracked using the Nintendo Wiimote. Across learning, participant arm movements are initiated and completed more quickly, exhibit lower fluctuation, and exert more perturbation on the Wiimote during the button press. A second experiment demonstrated that action dynamics index novel learning scenarios, and not simply acclimatization to the Wiimote interface. Results support a graded and systematic covariation between cognition and action, and recommend ways in which this theoretical perspective may contribute to applied learning contexts.	[Dale, Rick; Roche, Jennifer; Snyder, Kristy; McCall, Ryan] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA	University of Memphis	Dale, R (corresponding author), Univ Memphis, Dept Psychol, Memphis, TN 38152 USA.	radale@memphis.edu	Tapp, Kristy/D-8880-2012; Snyder, Kristy/C-2822-2014; Dale, Rick/F-4660-2010	Snyder, Kristy/0000-0002-0063-3620; Dale, Rick/0000-0001-7865-474X	NSF [BCS-0720322]; Direct For Social, Behav & Economic Scie [1216638] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was partly supported by NSF Grant BCS-0720322 to the first author.	ABRAMS RA, 1991, PSYCHOL SCI, V2, P153, DOI 10.1111/j.1467-9280.1991.tb00123.x; Anderson JR, 2002, COGNITIVE SCI, V26, P85, DOI 10.1207/s15516709cog2601_3; Azevedo R., 2006, HDB ED PSYCHOL, V2, P803; BALOTA DA, 1995, J EXP PSYCHOL LEARN, V21, P1289, DOI 10.1037/0278-7393.21.5.1289; BALOTA DA, 1989, J MEM LANG, V28, P14, DOI 10.1016/0749-596X(89)90026-0; CACIOPPO JT, 1993, J PERS SOC PSYCHOL, V65, P5; Caminiti R, 1998, CURR OPIN NEUROBIOL, V8, P753, DOI 10.1016/S0959-4388(98)80118-9; Castiello U, 1996, J EXP PSYCHOL HUMAN, V22, P582, DOI 10.1037/0096-1523.22.3.582; Castiello U, 2003, J EXP PSYCHOL HUMAN, V29, P416, DOI 10.1037/0096-1523.29.2.416; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Dale R, 2007, MEM COGNITION, V35, P15, DOI 10.3758/BF03195938; Davidson PR, 2003, CURR OPIN NEUROBIOL, V13, P232, DOI 10.1016/S0959-4388(03)00038-2; Dixon JA, 2007, CURR DIR PSYCHOL SCI, V16, P111, DOI 10.1111/j.1467-8721.2007.00486.x; Doyle D, 2001, EXP BRAIN RES, V139, P333, DOI 10.1007/s002210100742; EKMAN P, 1991, AM PSYCHOL, V46, P913, DOI 10.1037/0003-066X.46.9.913; Erlhagen W, 2002, PSYCHOL REV, V109, P545, DOI 10.1037//0033-295X.109.3.545; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; Fodor J. A, 1983, MODULARITY MIND; Fu WT, 2001, BEHAV RES METH INS C, V33, P149, DOI 10.3758/BF03195360; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Goldin-Meadow S, 2001, PSYCHOL SCI, V12, P516, DOI 10.1111/1467-9280.00395; GORDON AM, 1984, B PSYCHONOMIC SOC, V22, P214; Jeannerod M., 2006, MOTOR COGNITION; John B. E., 2004, P SIGCHI C HUM FACT, P455, DOI DOI 10.1145/985692.985750; Keith TZ, 2005, MULTIPLE REGRESSION; Magill R. A., 2006, MOTOR LEARNING CONTR; Markman AB, 2005, PSYCHOL SCI, V16, P6, DOI 10.1111/j.0956-7976.2005.00772.x; Mattes S, 2002, VIS COGN, V9, P477, DOI 10.1080/13506280143000548; McKinstry C, 2008, PSYCHOL SCI, V19, P22, DOI 10.1111/j.1467-9280.2008.02041.x; Newell A., 1990, UNIFIED THEORIES COG; Newell KM, 2001, PSYCHOL REV, V108, P57, DOI 10.1037//0033-295X.108.1.57; OSMAN A, 1986, J EXP PSYCHOL HUMAN, V12, P243, DOI 10.1037/0096-1523.12.3.243; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rosenbaum D. A., 2002, STEVENS HDB EXPT PSY, V1, P315; Rosenbaum DA, 2004, J MOTOR BEHAV, V36, P390, DOI 10.1080/00222895.2004.11008003; Rosenbaum DA, 2005, AM PSYCHOL, V60, P308, DOI 10.1037/0003-066X.60.4.308; ROSENBAUM DA, 1991, PSYCHOL SCI, V2, P86, DOI 10.1111/j.1467-9280.1991.tb00106.x; SALVUCCI DD, 1999, THESIS DPT CARN MEL; Schutte AR, 2007, MOTOR CONTROL, V11, P166, DOI 10.1123/mcj.11.2.166; Sheliga BM, 1997, EXP BRAIN RES, V114, P339, DOI 10.1007/PL00005642; Spivey M., 2006, CONTINUITY MIND; Spivey MJ, 2006, CURR DIR PSYCHOL SCI, V15, P207, DOI 10.1111/j.1467-8721.2006.00437.x; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; STEPHEN DG, 2006, DYNAMICS REPRE UNPUB; THOMAS LE, 2006, J VIS, V6, P871; Tipper SP, 1997, VIS COGN, V4, P1, DOI 10.1080/713756749; Ulrich R, 1999, ACTA PSYCHOL, V102, P43, DOI 10.1016/S0001-6918(99)00019-0; Wells P, 2007, J LANG SOC PSYCHOL, V26, P321, DOI 10.1177/0261927X07306978	52	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1728	10.1371/journal.pone.0001728	http://dx.doi.org/10.1371/journal.pone.0001728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XT	18320047	Green Published, gold, Green Submitted			2022-12-25	WOS:000260586600023
J	Oleksyk, TK; Zhao, K; De La Vega, FM; Gilbert, DA; O'Brien, SJ; Smith, MW				Oleksyk, Taras K.; Zhao, Kai; De La Vega, Francisco M.; Gilbert, Dennis A.; O'Brien, Stephen J.; Smith, Michael W.			Identifying Selected Regions from Heterozygosity and Divergence Using a Light-Coverage Genomic Dataset from Two Human Populations	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; NATURAL-SELECTION; LINKAGE DISEQUILIBRIUM; HAPLOTYPE MAP; SIGNATURES; DIVERSITY; SCANS	When a selective sweep occurs in the chromosomal region around a target gene in two populations that have recently separated, it produces three dramatic genomic consequences: 1) decreased multi-locus heterozygosity in the region; 2) elevated or diminished genetic divergence (F-ST) of multiple polymorphic variants adjacent to the selected locus between the divergent populations, due to the alternative fixation of alleles; and 3) a consequent regional increase in the variance of FST ((SFST)-F-2) for the same clustered variants, due to the increased alternative fixation of alleles in the loci surrounding the selection target. In the first part of our study, to search for potential targets of directional selection, we developed and validated a resampling-based computational approach; we then scanned an array of 31 different-sized moving windows of SNP variants (5-65 SNPs) across the human genome in a set of European and African American population samples with 183,997 SNP loci after correcting for the recombination rate variation. The analysis revealed 180 regions of recent selection with very strong evidence in either population or both. In the second part of our study, we compared the newly discovered putative regions to those sites previously postulated in the literature, using methods based on inspecting patterns of linkage disequilibrium, population divergence and other methodologies. The newly found regions were cross-validated with those found in nine other studies that have searched for selection signals. Our study was replicated especially well in those regions confirmed by three or more studies. These validated regions were independently verified, using a combination of different methods and different databases in other studies, and should include fewer false positives. The main strength of our analysis method compared to others is that it does not require dense genotyping and therefore can be used with data from population-based genome SNP scans from smaller studies of humans or other species.	[Oleksyk, Taras K.; Zhao, Kai; O'Brien, Stephen J.; Smith, Michael W.] NCI, Lab Genom Div, Frederick, MD 21701 USA; [Oleksyk, Taras K.; Smith, Michael W.] NCI, SAIC Frederick, Inc, Basic Res Prog, Frederick, MD USA; [De La Vega, Francisco M.; Gilbert, Dennis A.] Appl Biosyst Inc, Foster City, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Thermo Fisher Scientific; Applied Biosystems	Oleksyk, TK (corresponding author), NCI, Lab Genom Div, Frederick, MD 21701 USA.	oleksyk@ncifcrf.gov	Smith, Michael/B-5341-2012; Taras, Oleksyk/J-8805-2013; De La Vega, Francisco/H-3832-2011; OBRIEN, STEPHEN/ABD-1346-2020	Taras, Oleksyk/0000-0002-8148-3918; OBRIEN, STEPHEN/0000-0001-7857-0757	National Cancer Institute, National Institutes of Health [N01-CO-12400]; NATIONAL CANCER INSTITUTE [Z01BC005800, Z01BC010270] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; BERRY A, 1993, GENETICS, V134, P869; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Cavalli-Sforza LL., 2000, GENES PEOPLES LANGUA; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; De La Vega FA, 2005, MUTAT RES-FUND MOL M, V573, P111, DOI 10.1016/j.mrfmmm.2005.01.008; De La Vega FM, 2002, BIOTECHNIQUES, P48; Dove A, 2005, NAT METHODS, V2, P989, DOI 10.1038/nmeth1205-989; Engle LJ, 2006, ONCOGENE, V25, P1594, DOI 10.1038/sj.onc.1209368; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Huttley GA, 1999, GENETICS, V152, P1711; KARL SA, 1992, SCIENCE, V256, P100, DOI 10.1126/science.1348870; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; LEWONTIN RC, 1973, GENETICS, V74, P175; NEI M, 1974, GENETICS, V76, P379; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Olson S, 2002, SCIENCE, V298, P1324, DOI 10.1126/science.298.5597.1324; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Spencer CCA, 2004, BIOINFORMATICS, V20, P3673, DOI 10.1093/bioinformatics/bth417; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; TAYLOR MFJ, 1995, SCIENCE, V270, P1497, DOI 10.1126/science.270.5241.1497; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WRIGHT S, 1951, ANN EUGENIC, V15, P323	43	41	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1712	10.1371/journal.pone.0001712	http://dx.doi.org/10.1371/journal.pone.0001712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320033	Green Submitted, Green Published, gold			2022-12-25	WOS:000260586600008
J	Schneider, H; Wang, HY; Raab, M; Valk, E; Smith, X; Lovatt, M; Wu, ZL; Maqueira-Iglesias, B; Strebhardt, K; Rudd, CE				Schneider, Helga; Wang, Hongyan; Raab, Monika; Valk, Elke; Smith, Xin; Lovatt, Matt; Wu, Zhonglin; Maqueira-Iglesias, Braudel; Strebhardt, Klaus; Rudd, Christopher E.			Adaptor SKAP-55 Binds p21(ras) Activating Exchange Factor RasGRP1 and Negatively Regulates the p21(ras)-ERK Pathway in T-Cells	PLOS ONE			English	Article							ANTIGEN RECEPTOR; RAS ACTIVATION; PROTEIN; SKAP55; STIMULATION; COSTIMULATION; EXPRESSION; ADHESION; P21RAS; DOMAIN	While the adaptor SKAP-55 mediates LFA-1 adhesion on T-cells, it is not known whether the adaptor regulates other aspects of signaling. SKAP-55 could potentially act as a node to coordinate the modulation of adhesion with downstream signaling. In this regard, the GTPase p21(ras) and the extracellular signal-regulated kinase (ERK) pathway play central roles in T-cell function. In this study, we report that SKAP-55 has opposing effects on adhesion and the activation of the p21(ras)-ERK pathway in T-cells. SKAP-55 deficient primary T-cells showed a defect in LFA-1 adhesion concurrent with the hyperactivation of the ERK pathway relative to wild-type cells. RNAi knock down (KD) of SKAP-55 in T-cell lines also showed an increase in p21(ras) activation, while over-expression of SKAP-55 inhibited activation of ERK and its transcriptional target ELK. Three observations implicated the p21(ras) activating exchange factor RasGRP1 in the process. Firstly, SKAP-55 bound to RasGRP1 via its C-terminus, while secondly, the loss of binding abrogated SKAP-55 inhibition of ERK and ELK activation. Thirdly, SKAP-55-/- primary T-cells showed an increased presence of RasGRP1 in the trans-Golgi network (TGN) following TCR activation, the site where p21(ras) becomes activated. Our findings indicate that SKAP-55 has a dual role in regulating p21(ras)-ERK pathway via RasGRP1, as a possible mechanism to restrict activation during T-cell adhesion.	[Schneider, Helga; Valk, Elke; Wu, Zhonglin; Maqueira-Iglesias, Braudel; Rudd, Christopher E.] Univ Cambridge, Dept Pathol, Cell Signalling Sect, Cambridge CB2 1QP, England; [Schneider, Helga; Wang, Hongyan; Raab, Monika; Valk, Elke; Lovatt, Matt; Wu, Zhonglin; Rudd, Christopher E.] Hammersmith Hosp, Imperial Coll London, Fac Med, Div Investigative Sci, Mol Immunol Sect, London, England; [Wang, Hongyan; Smith, Xin; Rudd, Christopher E.] Cambridge Inst Med Res, Cambridge, England; [Raab, Monika; Strebhardt, Klaus] Goethe Univ Frankfurt, Med Sch, Dept Gynecol & Obstet, Frankfurt, Germany	University of Cambridge; Imperial College London; University of Cambridge; Goethe University Frankfurt	Schneider, H (corresponding author), Univ Cambridge, Dept Pathol, Cell Signalling Sect, Tennis Court Rd, Cambridge CB2 1QP, England.	cer51@cam.ac.uk	Rudd, Christopher E/GOH-2021-2022; Strebhardt, Klaus/E-8765-2011; hongyan, wang/GWQ-6360-2022; Rudd, Christopher E/ABF-7259-2021	Rudd, Christopher E/0000-0001-5295-9019; Strebhardt, Klaus/0000-0003-2173-9763	Wellcome Trust; BBSRC	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Wellcome Trust, BBSRC	Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; Duke-Cohan JS, 2006, J BIOL CHEM, V281, P13743, DOI 10.1074/jbc.M508774200; Dustin ML, 1999, SCIENCE, V283, P649, DOI 10.1126/science.283.5402.649; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; Fields PE, 1996, SCIENCE, V271, P1276, DOI 10.1126/science.271.5253.1276; Guilbault B, 2004, J BIOL CHEM, V279, P19523, DOI 10.1074/jbc.M314273200; IZQUIERDO M, 1992, MOL CELL BIOL, V12, P3305, DOI 10.1128/MCB.12.7.3305; Jo EK, 2005, J EXP MED, V201, P1733, DOI 10.1084/jem.20042577; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; Koretzky GA, 2006, NAT REV IMMUNOL, V6, P67, DOI 10.1038/nri1750; Kosco KA, 2008, MOL IMMUNOL, V45, P510, DOI 10.1016/j.molimm.2007.05.024; Kupfer A, 2003, SEMIN IMMUNOL, V15, P295, DOI 10.1016/j.smim.2003.09.001; Layer K, 2003, IMMUNITY, V19, P243, DOI 10.1016/S1074-7613(03)00209-7; Liu J, 1998, P NATL ACAD SCI USA, V95, P8779, DOI 10.1073/pnas.95.15.8779; MACLEOD K, 1992, TRENDS BIOCHEM SCI, V17, P251, DOI 10.1016/0968-0004(92)90404-W; Marie-Cardine A, 1998, J BIOL CHEM, V273, P25789, DOI 10.1074/jbc.273.40.25789; MarieCardine A, 1997, J BIOL CHEM, V272, P16077, DOI 10.1074/jbc.272.26.16077; McGilvray ID, 1997, J BIOL CHEM, V272, P10287; Medeiros RB, 2007, SCIENCE, V316, P754, DOI 10.1126/science.1137895; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Reedquist KA, 1998, J BIOL CHEM, V273, P4944, DOI 10.1074/jbc.273.9.4944; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Smith JA, 1997, J EXP MED, V185, P1413, DOI 10.1084/jem.185.8.1413; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; Valk E, 2006, IMMUNITY, V25, P807, DOI 10.1016/j.immuni.2006.08.024; Wang H, 2007, MOL CELL BIOL, V27, P6863, DOI 10.1128/MCB.00556-07; Wang HY, 2004, J EXP MED, V200, P1063, DOI 10.1084/jem.20040780; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Wu LT, 2002, MOL CELL BIOL, V22, P2673, DOI 10.1128/MCB.22.8.2673-2686.2002	41	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1718	10.1371/journal.pone.0001718	http://dx.doi.org/10.1371/journal.pone.0001718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320039	Green Submitted, Green Published, gold			2022-12-25	WOS:000260586600014
J	Vacher, C; Piou, D; Desprez-Loustau, ML				Vacher, Corinne; Piou, Dominique; Desprez-Loustau, Marie-Laure			Architecture of an Antagonistic Tree/Fungus Network: The Asymmetric Influence of Past Evolutionary History	PLOS ONE			English	Article							SPECIES ABUNDANCE; PARASITIC FUNGI; PLANT; SPECIALIZATION; COMPARTMENTS; NESTEDNESS; PATHOGENS; ANGIOSPERMS; PATTERNS; TREES	Background: Compartmentalization and nestedness are common patterns in ecological networks. The aim of this study was to elucidate some of the processes shaping these patterns in a well resolved network of host/pathogen interactions. Methology/Principal Findings: Based on a long-term (1972-2005) survey of forest health at the regional scale (all French forests; 15 million ha), we uncovered an almost fully connected network of 51 tree taxa and 157 parasitic fungal species. Our analyses revealed that the compartmentalization of the network maps out the ancient evolutionary history of seed plants, but not the ancient evolutionary history of fungal species. The very early divergence of the major fungal phyla may account for this asymmetric influence of past evolutionary history. Unlike compartmentalization, nestedness did not reflect any consistent phylogenetic signal. Instead, it seemed to reflect the ecological features of the current species, such as the relative abundance of tree species and the life-history strategies of fungal pathogens. We discussed how the evolution of host range in fungal species may account for the observed nested patterns. Conclusion/Significance: Overall, our analyses emphasized how the current complexity of ecological networks results from the diversification of the species and their interactions over evolutionary times. They confirmed that the current architecture of ecological networks is not only dependant on recent ecological processes.	[Vacher, Corinne; Piou, Dominique; Desprez-Loustau, Marie-Laure] INRA, Inst Sci Rech Agron, UMR Biodivers Genes & Communautes 1202, Villenave Dornon, France; [Piou, Dominique] Ministere Agr Peche, Dept Sante Forets, Cenon, France	INRAE	Vacher, C (corresponding author), INRA, Inst Sci Rech Agron, UMR Biodivers Genes & Communautes 1202, Villenave Dornon, France.	cvacher@bordeaux.inra.fr	Vacher, Corinne/ABG-8163-2020; Vacher, Corinne/Q-3182-2019; Vacher, Corinne/J-1777-2012	Vacher, Corinne/0000-0003-3023-6113; Vacher, Corinne/0000-0003-3023-6113	INRA	INRA	This study was funded by the INRA.	ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2006, SFI S SCI C, P143; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Berbee ML, 2001, MYCOTA, V7, P229; Berbee ML, 2001, PHYSIOL MOL PLANT P, V59, P165, DOI 10.1006/pmpp.2001.0355; Brandle M, 2006, OIKOS, V113, P296, DOI 10.1111/j.2006.0030-1299.14418.x; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brandle M, 2003, EVOL ECOL RES, V5, P941; Brasier C. M., 2001, Biological Invasions, V3, P223, DOI 10.1023/A:1015248819864; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Combes Claude., 2001, PARASITISM ECOLOGY E; Csardi G., 2005, IGRAPH ROUTINES NETW; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Dicks LV, 2002, J ANIM ECOL, V71, P32, DOI 10.1046/j.0021-8790.2001.00572.x; Fonseca CR, 1996, J ANIM ECOL, V65, P339, DOI 10.2307/5880; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Garcia-Guzman G, 2007, ECOLOGY, V88, P589, DOI 10.1890/05-1174; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimaraes PR, 2007, BIOL LETTERS, V3, P51, DOI 10.1098/rsbl.2006.0562; Guimaraes PR, 2006, P ROY SOC B-BIOL SCI, V273, P2041, DOI 10.1098/rspb.2006.3548; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Ives AR, 2006, AM NAT, V168, pE1, DOI 10.1086/505157; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; Mielke P. W., 2001, PERMUTATION METHODS; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nielsen A, 2007, J ECOL, V95, P1134, DOI 10.1111/j.1365-2745.2007.01271.x; Oksanen J., 2006, VEGAN COMMUNITY ECOL; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Ollerton J, 2007, P ROY SOC B-BIOL SCI, V274, P591, DOI 10.1098/rspb.2006.3758; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paradis E., 2006, APE ANAL PHYLOGENETI; Parker IM, 2004, ANNU REV ECOL EVOL S, V35, P675, DOI 10.1146/annurev.ecolsys.34.011802.132339; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Phillips D.H., 1982, DIS FOREST ORNAMENTA; Prado PI, 2004, J ANIM ECOL, V73, P1168, DOI 10.1111/j.0021-8790.2004.00891.x; R Development Core Team, 2006, R LANG ENV STAT COMP; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Roy BA, 2001, EVOLUTION, V55, P41, DOI 10.1111/j.0014-3820.2001.tb01271.x; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Selosse MA, 1998, TRENDS ECOL EVOL, V13, P15, DOI 10.1016/S0169-5347(97)01230-5; Stevens P.F., 2006, ANGIOSPERM PHYLOGENY; Taylor TN, 1999, NATURE, V399, P648, DOI 10.1038/21349; Thomas PA, 2003, J ECOL, V91, P489, DOI 10.1046/j.1365-2745.2003.00783.x; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2005, J ANIM ECOL, V74, P946, DOI 10.1111/j.1365-2656.2005.00992.x; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	55	71	71	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1740	10.1371/journal.pone.0001740	http://dx.doi.org/10.1371/journal.pone.0001740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320058	Green Published, gold, Green Submitted			2022-12-25	WOS:000260586600035
J	Boulanger, P; Jacquot, P; Plancon, L; Chami, M; Engel, A; Parquet, C; Herbeuval, C; Letellier, L				Boulanger, Pascale; Jacquot, Pierre; Plancon, Laure; Chami, Mohamed; Engel, Andreas; Parquet, Claudine; Herbeuval, Chantal; Letellier, Lucienne			Phage T5 straight tail fiber is a multifunctional protein acting as a tape measure and carrying fusogenic and muralytic activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; OUTER-MEMBRANE PROTEIN; BACTERIOPHAGE-LAMBDA; ESCHERICHIA-COLI; IRREVERSIBLE BINDING; LENGTH DETERMINATION; SECONDARY STRUCTURE; DNA; FHUA; INJECTION	We report a bioinformatic and functional characterization of Pb2, a 121-kDa multimeric protein that forms phage T5 straight fiber and is implicated in DNA transfer into the host. Pb2 was predicted to consist of three domains. Region I ( residues 1-1030) was mainly organized in coiled coil and shared features of tape measure proteins. Region II ( residues 1030-1076) contained two alpha-helical transmembrane segments. Region III ( residues 1135-1148) included a metallopeptidase motif. A truncated version of Pb2 (Pb2-Cterm, residues 964-1148) was expressed and purified. Pb2-Cterm shared common features with fusogenic membrane polypeptides. It formed oligomeric structures and inserted into liposomes triggering their fusion. Pb2-Cterm caused beta-galactosidase release from Escherichia coli cells and in vitro peptidoglycan hydrolysis. Based on these multifunctional properties, we propose that binding of phage T5 to its receptor triggers large conformational changes in Pb2. The coiled coil region would serve as a sensor for triggering the opening of the head-tail connector. The C-terminal region would gain access to the host envelope, permitting the local degradation of the peptidoglycan and the formation of the DNA pore by fusion of the two membranes.	[Boulanger, Pascale; Jacquot, Pierre; Plancon, Laure; Parquet, Claudine; Herbeuval, Chantal; Letellier, Lucienne] Univ Paris Sud, IBBMC, F-91405 Orsay, France; [Boulanger, Pascale; Jacquot, Pierre; Plancon, Laure; Parquet, Claudine; Herbeuval, Chantal; Letellier, Lucienne] CNRS, UMR 8619, F-91405 Orsay, France; [Chami, Mohamed; Engel, Andreas] Univ Basel, ME Muller Inst, CH-4056 Basel, Switzerland	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); University of Basel	Letellier, L (corresponding author), Univ Paris Sud, IBBMC, Bat 430, F-91405 Orsay, France.	lucienne.letellier@u-psud.fr						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9; Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673; BOULANGER P, 1992, J BIOL CHEM, V267, P3168; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Del Angel VD, 2002, BIOCHEM BIOPH RES CO, V293, P1153; Edmonds L, 2007, J MOL BIOL, V365, P175, DOI 10.1016/j.jmb.2006.09.068; Effantin G, 2006, J MOL BIOL, V361, P993, DOI 10.1016/j.jmb.2006.06.081; FEUCHT A, 1989, FEBS LETT, V255, P435, DOI 10.1016/0014-5793(89)81140-8; FEUCHT A, 1990, J BIOL CHEM, V265, P18561; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Goldberg Edward, 1994, P347; Gonzalez-Huici V, 2004, MOL MICROBIOL, V52, P529, DOI 10.1111/j.1365-2958.2004.03993.x; Grayson P, 2007, P NATL ACAD SCI USA, V104, P14652, DOI 10.1073/pnas.0703274104; GUIHARD G, 1992, J BIOL CHEM, V267, P3173; HELLER KJ, 1992, ARCH MICROBIOL, V158, P235, DOI 10.1007/BF00245239; HELLER KJ, 1985, J BACTERIOL, V162, P621, DOI 10.1128/JB.162.2.621-625.1985; Hendrix RW, 2003, CURR OPIN MICROBIOL, V6, P506, DOI 10.1016/j.mib.2003.09.004; HENDRIX RW, 1988, CURR TOP MICROBIOL, V136, P21; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; HEUSTERSPREUTE M, 1987, GENE, V52, P155, DOI 10.1016/0378-1119(87)90042-4; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Inamdar MM, 2006, BIOPHYS J, V91, P411, DOI 10.1529/biophysj.105.070532; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Katsura I, 1990, Adv Biophys, V26, P1, DOI 10.1016/0065-227X(90)90004-D; KATSURA I, 1975, J MOL BIOL, V91, P257, DOI 10.1016/0022-2836(75)90379-4; KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8; LABEDAN B, 1979, P NATL ACAD SCI USA, V76, P4669, DOI 10.1073/pnas.76.9.4669; Lambert O, 1998, MOL MICROBIOL, V30, P761, DOI 10.1046/j.1365-2958.1998.01107.x; Lambert O, 2000, P NATL ACAD SCI USA, V97, P7248, DOI 10.1073/pnas.130187297; LANNI YT, 1960, VIROLOGY, V10, P501, DOI 10.1016/0042-6822(60)90132-X; LANNI YT, 1968, BACTERIOL REV, V32, P227, DOI 10.1128/MMBR.32.3.227-242.1968; LEMAIRE M, 1989, ANAL BIOCHEM, V177, P50, DOI 10.1016/0003-2697(89)90012-2; Letellier L, 2004, FRONT BIOSCI-LANDMRK, V9, P1228, DOI 10.2741/1333; Letellier L, 2003, RES MICROBIOL, V154, P283, DOI 10.1016/S0923-2508(03)00072-X; LETELLIER L, 1998, LIPID PROTEIN TRAFFI, V106, P267; Letellier Lucienne, 2007, P209; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mangenot S, 2005, CURR BIOL, V15, P430, DOI 10.1016/j.cub.2004.12.080; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; MCCORQUODALE DJ, 1977, J VIROL, V22, P480, DOI 10.1128/JVI.22.2.480-488.1977; MCCORQUODALE JD, 1988, VIRUSES, V1, P439; Moak M, 2004, MOL MICROBIOL, V51, P1169, DOI 10.1046/j.1365-2958.2003.03894.x; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Olia AS, 2007, NAT STRUCT MOL BIOL, V14, P1221, DOI 10.1038/nsmb1317; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Plancon L, 2002, J MOL BIOL, V318, P557, DOI 10.1016/S0022-2836(02)00089-X; Plancon L, 1997, J BIOL CHEM, V272, P16868, DOI 10.1074/jbc.272.27.16868; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; RHOADES M, 1972, J MOL BIOL, V69, P187, DOI 10.1016/0022-2836(72)90224-0; Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848; ROESSNER CA, 1983, J BACTERIOL, V153, P1528, DOI 10.1128/JB.153.3.1528-1534.1983; ROESSNER CA, 1983, J BIOL CHEM, V258, P643; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SNYDER CE, 1981, J VIROL, V40, P248, DOI 10.1128/JVI.40.1.248-257.1981; Stojkovic EA, 2007, J MOL BIOL, V366, P406, DOI 10.1016/j.jmb.2006.11.028; Wang JB, 2005, VIROLOGY, V332, P45, DOI 10.1016/j.virol.2004.10.049; ZWEIG M, 1973, J MOL BIOL, V80, P505, DOI 10.1016/0022-2836(73)90418-X; ZWEIG M, 1973, VIROLOGY, V51, P443, DOI 10.1016/0042-6822(73)90443-1	64	61	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13556	13564		10.1074/jbc.M800052200	http://dx.doi.org/10.1074/jbc.M800052200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348984	hybrid			2022-12-25	WOS:000255728200009
J	Nabavi, S; Nazar, RN				Nabavi, Sadeq; Nazar, Ross N.			Nonpolyadenylated RNA polymerase II termination is induced by transcript cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-RNA; 3'-END FORMATION; PAC1 RIBONUCLEASE; YEAST SNORNA; PROTEIN; PLASMIDS; SNRNA; DNA	Although the termination of transcription and 3' RNA processing of the eukaryotic mRNA has been linked to a polyadenylation signal and a transcript cleavage process, much less is known about the termination or processing of nonpolyadenylated RNA polymerase II transcripts. An efficiently expressed plasmid-based expression system was used to study the termination and processing of Schizosaccharomyces pombe U3 small nucleolar RNA ( snoRNA) transcripts in vivo. The termination assay was linked to cell transformation, and restriction fragment length polymorphism was used to determine levels of plasmid-derived U3 snoRNA. Mutation analyses in vivo indicate that the maturation of the 3' end is not directly dependent on an external cis-acting sequence or structure; rather, it is dependent on a transcript cleavage that can occur hundreds or even thousands of nucleotides downstream of the mature U3 snoRNA sequence. Similarly, termination is dependent on the same transcript cleavage that is localized in a hairpin structure that normally follows the 3' end of the U3 snoRNA but that also can be moved hundreds or thousands of nucleotides downstream. Both processes, however, can be induced simultaneously and equally efficiently with a single unrelated Pac1 endonuclease-labile structure. The results support a "reversed torpedoes" model in which a single cleavage allows exonucleases and/or other protein factors access to the transcript leading to transcription termination in one direction and RNA maturation in the other direction.	[Nabavi, Sadeq; Nazar, Ross N.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Nazar, RN (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rnnazar@uoguelph.ca		Nabavi, Sadegh/0000-0002-3940-1210				ABOUELELA S, 1998, EMBO J, V13, P3738; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; CHACONAS G, 1980, METHOD ENZYMOL, V1, P75; Chanfreau G, 1997, GENE DEV, V11, P2741, DOI 10.1101/gad.11.20.2741; Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237; Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004; Dheur S, 2003, EMBO J, V22, P2831, DOI 10.1093/emboj/cdg253; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Gutz H, 1974, HDB GENETICS, P395, DOI 10.1007/978-1-4899-1710-2_25; Hitchcock RA, 2004, FEMS MICROBIOL LETT, V236, P73, DOI 10.1016/j.femsle.2004.05.020; Hitchen J, 1997, J MOL BIOL, V274, P481, DOI 10.1006/jmbi.1997.1376; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Ivakine E, 2003, NUCLEIC ACIDS RES, V31, P7110, DOI 10.1093/nar/gkg932; Kessler MM, 1996, J BIOL CHEM, V271, P27167, DOI 10.1074/jbc.271.43.27167; Kienzle N, 1996, BIOTECHNIQUES, V20, P612; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; Kufel J, 2003, NUCLEIC ACIDS RES, V31, P6788, DOI 10.1093/nar/gkg904; Lalev AI, 1999, NUCLEIC ACIDS RES, V27, P3071, DOI 10.1093/nar/27.15.3071; LANG WH, 1993, MOL CELL BIOL, V13, P649, DOI 10.1128/MCB.13.1.649; Lee Y, 1997, J BIOL CHEM, V272, P15206, DOI 10.1074/jbc.272.24.15206; LOSSON R, 1983, CELL, V32, P371, DOI 10.1016/0092-8674(83)90456-7; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MinvielleSebastia L, 1997, P NATL ACAD SCI USA, V94, P7897, DOI 10.1073/pnas.94.15.7897; Morlando M, 2002, MOL CELL BIOL, V22, P1379, DOI 10.1128/MCB.22.5.1379-1389.2002; Nabavi S, 2005, ANAL BIOCHEM, V345, P346, DOI 10.1016/j.ab.2005.06.033; NAZAR RN, 1991, J BIOL CHEM, V266, P4562; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Reeder RH, 1997, TRENDS BIOCHEM SCI, V22, P473, DOI 10.1016/S0968-0004(97)01133-X; Reeder RH, 1999, MOL CELL BIOL, V19, P7369; Rose M. D., 1990, METHODS YEAST GENETI, P140; Rotondo G, 1996, NUCLEIC ACIDS RES, V24, P2377, DOI 10.1093/nar/24.12.2377; Rotondo G, 1997, RNA, V3, P1182; Sambrook J, 2001, MOL CLONING LAB MANU; Seipelt RL, 1999, NUCLEIC ACIDS RES, V27, P587, DOI 10.1093/nar/27.2.587; SELINGER DA, 1992, MOL BIOL EVOL, V9, P297; Spasov K, 2002, MOL CELL, V9, P433, DOI 10.1016/S1097-2765(02)00461-6; STEELE WJ, 1965, J BIOL CHEM, V240, P1742; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Steinmetz EJ, 2006, MOL CELL BIOL, V26, P2688, DOI 10.1128/MCB.26.7.2688-2696.2006; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Zhou DW, 1999, RNA, V5, P1083, DOI 10.1017/S1355838299990726	53	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13601	13610		10.1074/jbc.M710125200	http://dx.doi.org/10.1074/jbc.M710125200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18321857	hybrid			2022-12-25	WOS:000255728200013
J	Sjostrand, D; Ibanez, CF				Sjostrand, Dan; Ibanez, Carlos F.			Insights into GFR alpha 1 regulation of neural cell adhesion molecule (NCAM) function from structure-function analysis of the NCAM/GFR alpha 1 receptor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; P75 NEUROTROPHIN RECEPTOR; HOMOPHILIC ADHESION; LIGAND-BINDING; NGF BINDING; GDNF; ACTIVATION; DOMAINS; TRK; PROTOONCOGENE	The neural cell adhesion molecule NCAM binds glial cell line-derived neurotrophic factor (GDNF) through specific determinants located in its third immunoglobulin (Ig) domain. However, high affinity GDNF binding and downstream signaling depend upon NCAM co-expression with the GDNF co-receptor GFR alpha 1. GFR alpha 1 promotes high affinity GDNF binding to NCAM and down-regulates NCAM-mediated homophilic cell adhesion, but the mechanisms underlying these effects are unknown. NCAM and GFR alpha 1 interact at the plasma membrane, but the molecular determinants involved have not been characterized nor is it clear whether their interaction is required for GFR alpha 1 regulation of NCAM function. We have investigated the structure-function relationships underlying GFR alpha 1 binding to NCAM in intact cells. The fourth Ig domain of NCAM was both necessary and sufficient for the interaction of NCAM with GFR alpha 1. Moreover, although the N-terminal domain of GFR alpha 1 had previously been shown to be dispensable for GDNF binding, we found that it was both necessary and sufficient for the efficient interaction of this receptor with NCAM. GFR alpha 1 lacking its N-terminal domain was still able to potentiate GDNF binding to NCAM and assemble into a tripartite receptor complex but showed a reduced capacity to attenuate NCAM-mediated cell adhesion. On its own, the GFR alpha 1 N-terminal domain was sufficient to decrease NCAM-mediated cell adhesion. These results indicate that direct receptor-receptor interactions are not required for high affinity GDNF binding to NCAM but play an important role in the regulation of NCAM-mediated cell adhesion by GFR alpha 1.	[Sjostrand, Dan; Ibanez, Carlos F.] Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, S-17177 Stockholm, Sweden	Karolinska Institutet	Ibanez, CF (corresponding author), Karolinska Inst, Dept Neurosci, Div Mol Neurobiol, S-17177 Stockholm, Sweden.	carlos.ibanez@ki.se						Atkins AR, 2004, J BIOL CHEM, V279, P49633, DOI 10.1074/jbc.M409159200; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; Cik M, 2000, J BIOL CHEM, V275, P27505; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; HALL AK, 1987, J CELL BIOL, V104, P1579, DOI 10.1083/jcb.104.6.1579; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Ryden M, 1997, J BIOL CHEM, V272, P16322, DOI 10.1074/jbc.272.26.16322; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Scott RP, 2001, J BIOL CHEM, V276, P1450, DOI 10.1074/jbc.M006157200; Sjostrand D, 2007, J BIOL CHEM, V282, P12734, DOI 10.1074/jbc.M701588200; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Trupp M, 1998, MOL CELL NEUROSCI, V11, P47, DOI 10.1006/mcne.1998.0667; Wang XQ, 2006, STRUCTURE, V14, P1083, DOI 10.1016/j.str.2006.05.010; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wieland JA, 2005, J BIOL CHEM, V280, P41037, DOI 10.1074/jbc.M503975200	24	17	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13792	13798		10.1074/jbc.M800283200	http://dx.doi.org/10.1074/jbc.M800283200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353777	hybrid			2022-12-25	WOS:000255728200031
J	Abu-Hamad, S; Zaid, H; Israelson, A; Nahon, E; Shoshan-Barmatz, V				Abu-Hamad, Salah; Zaid, Hilal; Israelson, Adrian; Nahon, Edna; Shoshan-Barmatz, Varda			Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1 - Mapping the site of binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER MITOCHONDRIAL-MEMBRANE; RAT-BRAIN HEXOKINASE; SARCOPLASMIC-RETICULUM; CONFORMATIONAL-CHANGES; HEPATOMA MITOCHONDRIA; MAMMALIAN HEXOKINASE; GLUCOSE CATABOLISM; BOUND HEXOKINASE; CANCER-CELLS; VDAC	In brain and tumor cells, the hexokinase isoforms HK-I and HK-II bind to the voltage-dependent anion channel ( VDAC) in the outer mitochondrial membrane. We have previously shown that HK-I decreases murine VDAC1 (mVDAC1) channel conductance, inhibits cytochrome c release, and protects against apoptotic cell death. Now, we define mVDAC1 residues, found in two cytoplasmic domains, involved in the interaction with HK-I. Protection against cell death by HK-I, as induced by overexpression of native or mutated mVDAC1, served to identify the mVDAC1 amino acids required for interaction with HK-I. HK-I binding to mVDAC1 either in isolated mitochondria or reconstituted in a bilayer was inhibited upon mutation of specific VDAC1 residues. HK-I anti-apoptotic activity was also diminished upon mutation of these amino acids. HK-I-mediated inhibition of cytochrome c release induced by staurosporine was also diminished in cells expressing VDAC1 mutants. Our results thus offer new insights into the mechanism by which HK-I promotes tumor cell survival via inhibition of cytochrome c release through HK-I binding to VDAC1. These results, moreover, point to VDAC1 as a key player in mitochondrially mediated apoptosis and implicate an HK-I-VDAC1 interaction in the regulation of apoptosis. Finally, these findings suggest that interference with the binding of HK-I to mitochondria by VDAC1-derived peptides may offer a novel strategy by which to potentiate the efficacy of conventional chemotherapeutic agents.	[Abu-Hamad, Salah; Nahon, Edna; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Zaid, Hilal] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Israelson, Adrian] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA	Ben Gurion University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ludwig Institute for Cancer Research; University of California System; University of California San Diego	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il		Israelson, Adrian/0000-0002-8289-7653				Abu-Hamad S, 2006, P NATL ACAD SCI USA, V103, P5787, DOI 10.1073/pnas.0600103103; AUBERTFOUCHER E, 1984, ARCH BIOCHEM BIOPHYS, V232, P391, DOI 10.1016/0003-9861(84)90554-X; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Bryson JM, 2002, J BIOL CHEM, V277, P11392, DOI 10.1074/jbc.M110927200; Castagna A, 2004, PROTEOMICS, V4, P3246, DOI 10.1002/pmic.200400835; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Cullen KJ, 2007, J BIOENERG BIOMEMBR, V39, P43, DOI 10.1007/s10863-006-9059-5; De Pinto Vito, 2003, Ital J Biochem, V52, P17; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; DEPINTO V, 1993, J BIOL CHEM, V268, P12977; FANCIULLI M, 1994, ONCOL RES, V6, P405; FELGNER PL, 1977, ARCH BIOCHEM BIOPHYS, V182, P282, DOI 10.1016/0003-9861(77)90309-5; Gardner Colin R, 2004, Expert Rev Anticancer Ther, V4, P1157, DOI 10.1586/14737140.4.6.1157; GELB BD, 1992, P NATL ACAD SCI USA, V89, P202, DOI 10.1073/pnas.89.1.202; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Hashimoto M, 2000, ARCH BIOCHEM BIOPHYS, V384, P163, DOI 10.1006/abbi.2000.2085; Israelson A, 2008, CELL CALCIUM, V43, P196, DOI 10.1016/j.ceca.2007.05.006; Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954; MATHUPALA SP, 1995, J BIOL CHEM, V270, P16918, DOI 10.1074/jbc.270.28.16918; MCENERY MW, 1992, J BIOENERG BIOMEMBR, V24, P63, DOI 10.1007/BF00769532; NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010; NAKASHIMA RA, 1988, CANCER RES, V48, P913; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Oudard Stephane, 2004, Bull Cancer, V91, pE184; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Pedersen PL, 2002, BBA-BIOENERGETICS, V1555, P14, DOI 10.1016/S0005-2728(02)00248-7; POLAKIS PG, 1985, ARCH BIOCHEM BIOPHYS, V236, P328, DOI 10.1016/0003-9861(85)90633-2; Preston TJ, 2001, ADV DRUG DELIVER REV, V49, P45, DOI 10.1016/S0169-409X(01)00127-2; Rempel A, 1996, CANCER RES, V56, P2468; REMPEL A, 1994, BBA-GENE STRUCT EXPR, V1219, P660, DOI 10.1016/0167-4781(94)90225-9; REYMANN S, 1995, BIOCHEM MOL MED, V54, P75, DOI 10.1006/bmme.1995.1011; Roman I, 2006, BBA-BIOMEMBRANES, V1758, P479, DOI 10.1016/j.bbamem.2006.03.019; Sade H, 2004, EUR J IMMUNOL, V34, P119, DOI 10.1002/eji.200324650; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Shafir I, 1998, EUR J BIOCHEM, V253, P627, DOI 10.1046/j.1432-1327.1998.2530627.x; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; ShoshanBarmatz V, 1996, FEBS LETT, V386, P205, DOI 10.1016/0014-5793(96)00442-5; Song JM, 1998, BIOPHYS J, V74, P2926, DOI 10.1016/S0006-3495(98)78000-2; Sui DX, 1997, ARCH BIOCHEM BIOPHYS, V345, P111, DOI 10.1006/abbi.1997.0241; THOMAS L, 1993, P NATL ACAD SCI USA, V90, P5446, DOI 10.1073/pnas.90.12.5446; Vyssokikh MY, 2003, ACTA BIOCHIM POL, V50, P389; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wilson JE, 1997, J BIOENERG BIOMEMBR, V29, P97, DOI 10.1023/A:1022472124746; Yang ZJ, 2006, CLIN CANCER RES, V12, P5817, DOI 10.1158/1078-0432.CCR-06-1037; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599	50	197	202	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13482	13490		10.1074/jbc.M708216200	http://dx.doi.org/10.1074/jbc.M708216200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308720	hybrid			2022-12-25	WOS:000255499800087
J	Matitau, AE; Scheid, MP				Matitau, Adi E.; Scheid, Michael P.			Phosphorylation of MEKK3 at threonine 294 promotes 14-3-3 association to inhibit nuclear factor kappa B activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; KINASE-ACTIVITY; IN-VIVO; RAF-1; PROTEINS; 14-3-3-PROTEINS; DOMAIN	The protein kinase MEKK3 is essential for tumor necrosis factor alpha(TNF alpha)- and lipopolysaccharide-induced activation of nuclear factor kappa B, although the mechanism by which TNF receptor 1 and Toll-like receptors regulate MEKK3 is largely unknown. In this study we have identified MEKK3 Thr(294) as a novel site of phosphorylation that regulates MEKK3 binding with 14-3-3. Phosphorylation of MEKK3 at Thr(294) was observed for both endogenous and ectopically expressed MEKK3. Mutation of Thr(294) to alanine abolished 14-3-3-MEKK3 association and incubation with phosphorylated peptides mimicking Thr(P)(294) competed for 14-3-3 binding. Mutation of Thr(294) did not alter Ser(526) phosphorylation within the activation loop. However, expression of T294A MEKK3 elevated TNF alpha-stimulated NF-kappa B transcriptional activity, suggesting that Thr(294) phosphorylation and 14-3-3 binding negatively regulate MEKK3. Stimulation with TNF alpha or lipopolysaccharide caused a rapid decrease in Thr(294) phosphorylation of endogenous MEKK3 and subsequent loss of 14-3-3 association. Thus, this study identifies a potentially important regulatory step in MEKK3 signaling via dephosphorylation of Thr(294), which reduces 14-3-3 binding correlating with MEKK3 pathway activation.	[Matitau, Adi E.; Scheid, Michael P.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	York University - Canada	Scheid, MP (corresponding author), York Univ, Dept Biol, Farquharson Bldg,Rm 236, Toronto, ON M3J 1P3, Canada.	mscheid@yorku.ca						Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; Fritz A, 2006, J BIOL CHEM, V281, P6236, DOI 10.1074/jbc.M509249200; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913	18	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13261	13268		10.1074/jbc.M801474200	http://dx.doi.org/10.1074/jbc.M801474200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308725	hybrid			2022-12-25	WOS:000255499800066
J	Winton, MJ; Igaz, LM; Wong, MM; Kwong, LK; Trojanowski, JQ; Lee, VMY				Winton, Matthew J.; Igaz, Lionel M.; Wong, Margaret M.; Kwong, Linda K.; Trojanowski, John Q.; Lee, Virginia M. -Y.			Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; UBIQUITIN-POSITIVE INCLUSIONS; DEMENTIA; EXPORT; LOCALIZATION; MUTATIONS; PATHOLOGY; SIGNAL; RCC1	TAR DNA-binding protein 43 (TDP- 43) is the disease protein in frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS). Although normal TDP- 43 is a nuclear protein, pathological TDP- 43 is redistributed and sequestered as insoluble aggregates in neuronal nuclei, perikarya, and neurites. Here we recapitulate these pathological phenotypes in cultured cells by altering endogenous TDP-43 nuclear trafficking and by expressing mutants with defective nuclear localization (TDP-43-Delta NLS) or nuclear export signals (TDP-43-Delta NES). Restricting endogenous cytoplasmic TDP- 43 from entering the nucleus or preventing its exit out of the nucleus resulted in TDP- 43 aggregate formation. TDP-43-Delta NLS accumulates as insoluble cytoplasmic aggregates and sequesters endogenous TDP-43, thereby depleting normal nuclear TDP-43, whereas TDP-43-Delta NES forms insoluble nuclear aggregates with endogenous TDP-43. Mutant forms of TDP-43 also replicate the biochemical profile of pathological TDP-43 in FTLD-U/ALS. Thus, FTLD-U/ALS pathogenesis may be linked mechanistically to deleterious perturbations of nuclear trafficking and solubility of TDP-43.	[Winton, Matthew J.; Igaz, Lionel M.; Wong, Margaret M.; Kwong, Linda K.; Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res,HUP, Philadelphia, PA 19104 USA; [Trojanowski, John Q.; Lee, Virginia M. -Y.] Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res,HUP, Maloney Bldg,3rd Floor,3600 Spruce St, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu	Igaz, Lionel/AAP-3059-2020	Igaz, Lionel Muller/0000-0001-9988-3242	NIA NIH HHS [AG17586, AG10124] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG010124, P01AG017586] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; BANKER G, 1998, CULTURING NERVE CELL, P398; Boche I, 1997, J CELL BIOL, V139, P313, DOI 10.1083/jcb.139.2.313; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; DREYFUSS G, 1984, J CELL BIOL, V99, pA233, DOI 10.1083/jcb.99.6.1997; GEISERT EE, 1990, P NATL ACAD SCI USA, V87, P3967, DOI 10.1073/pnas.87.10.3967; Grossman M, 2002, J INT NEUROPSYCH SOC, V8, P566, DOI 10.1017/S1355617702814357; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P177, DOI 10.1097/01.jnen.0000248554.45456.58; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; PEEPLES ME, 1988, VIROLOGY, V162, P255, DOI 10.1016/0042-6822(88)90418-7; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; Seelaar H, 2007, BRAIN, V130, P1375, DOI 10.1093/brain/awm024; Tan CF, 2007, ACTA NEUROPATHOL, V113, P535, DOI 10.1007/s00401-007-0206-9; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3	22	416	427	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13302	13309		10.1074/jbc.M800342200	http://dx.doi.org/10.1074/jbc.M800342200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18305110	Green Published, hybrid			2022-12-25	WOS:000255499800070
J	Zheng, J; Shen, WH; Lu, TJ; Zhou, Y; Chen, Q; Wang, Z; Xiang, T; Zhu, YC; Zhang, C; Duan, SM; Xiong, ZQ				Zheng, Jing; Shen, Wan-Hua; Lu, Ting-Jia; Zhou, Yang; Chen, Qian; Wang, Zi; Xiang, Ting; Zhu, Yong-Chuan; Zhang, Chi; Duan, Shumin; Xiong, Zhi-Qi			Clathrin-dependent endocytosis is required for TrkB-dependent Akt-mediated neuronal protection and dendritic growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; RECEPTOR INTERNALIZATION; IN-VITRO; SURVIVAL; EXPRESSION; KINASE; CELLS; BDNF; NGF	Endocytosis of Trk ((t) under bar ropomyosin-(r) under bar elated (k) under bar inase) receptors is critical for neurotrophin signal transduction and biological functions. However, the mechanism governing endocytosis of TrkB ((t) under bar ropomyosin-(r) under bar elated (k) under bar inase (B) under bar) and the specific contributions of TrkB endocytosis to downstream signaling are unknown. In this study, we report that blocking clathrin, dynamin, or AP2 in cultured neurons of the central nervous system inhibited brain-derived neurotrophic factor (BDNF)-induced activation of Akt but not ERK. Treating neurons with the clathrin inhibitor monodansylcadaverine or a peptide that blocks dynamin function specifically abrogated Akt pathway activation in response to BDNF but did not affect the response of other downstream effectors or the up-regulation of immediate early genes neuropeptide Y and activity-regulated cytoskeleton-associated protein. Similar effects were found in neurons expressing small interfering RNA to silence AP2 or a dominant negative form of dynamin that inhibits clathrin-mediated endocytosis. In PC12 cells, ERK but not Akt activation required TrkA endocytosis following stimulation with nerve growth factor, whereas the opposite was true when TrkA-expressing neurons were stimulated with nerve growth factor in the central nervous system. Thus, the specific effects of internalized Trk receptors probably depend on the presence of cell type-specific modulators of neurotrophin signaling and not on differences inherent to Trk receptors themselves. Endocytosis-dependent activation of Akt in neurons was found to be critical for BDNF-supported survival and dendrite outgrowth. Together, these results demonstrate the functional requirement of clathrin-and dynamin-dependent endocytosis in generating the full intracellular response of neurons to BDNF in the central nervous system.	[Xiong, Zhi-Qi] Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xiong, ZQ (corresponding author), Chinese Acad Sci, Inst Neurosci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	xiongzhiqi@ion.ac.cn	Chen, Qian/B-7405-2013; Zhang, Chi/ABB-1176-2021; Shen, Wanhua/B-5554-2011	Zhang, Chi/0000-0003-4866-1441; Shen, Wanhua/0000-0002-5178-9561				Alder J, 2003, J NEUROSCI, V23, P10800; Alderson RF, 2000, BRAIN RES, V871, P210, DOI 10.1016/S0006-8993(00)02428-8; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Baxter GT, 1997, J NEUROSCI, V17, P2683; Beattie EC, 2000, J NEUROSCI, V20, P7325; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Eide FF, 1996, J NEUROSCI, V16, P3123; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Grimes ML, 1996, J NEUROSCI, V16, P7950; Haapasalo A, 1999, ONCOGENE, V18, P1285, DOI 10.1038/sj.onc.1202401; Hapner SJ, 1998, DEV BIOL, V201, P90, DOI 10.1006/dbio.1998.8970; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; IP NY, 1993, J NEUROSCI, V13, P3394; Je HS, 2005, J NEUROSCI, V25, P11719, DOI 10.1523/JNEUROSCI.4087-05.2005; KAHLE P, 1994, J NEUROSCI RES, V38, P599, DOI 10.1002/jnr.490380512; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; LINDHOLM D, 1993, EUR J NEUROSCI, V5, P1455, DOI 10.1111/j.1460-9568.1993.tb00213.x; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MacInnis BL, 2002, SCIENCE, V295, P1536, DOI 10.1126/science.1064913; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ninkina N, 1996, EMBO J, V15, P6385, DOI 10.1002/j.1460-2075.1996.tb01029.x; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; SOTRONIEW MV, 2001, ANNU REV NEUROSCI, V24, P1217; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	37	89	91	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13280	13288		10.1074/jbc.M709930200	http://dx.doi.org/10.1074/jbc.M709930200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18353779	hybrid			2022-12-25	WOS:000255499800068
J	Dominy, JE; Hwang, J; Guo, S; Hirschberger, LL; Zhang, S; Stipanuk, MH				Dominy, John E.; Hwang, Jesse; Guo, Stephanie; Hirschberger, Lawrence L.; Zhang, Sheng; Stipanuk, Martha H.			Synthesis of amino acid cofactor in cysteine dioxygenase is regulated by substrate and represents a novel post-translational regulation of activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSE-OXIDASE; INTRACELLULAR CYSTEINE; PROTEASOME SYSTEM; CRYSTAL-STRUCTURE; GLYOXAL OXIDASE; RAT; PURIFICATION; BIOGENESIS; EXPRESSION; MECHANISM	Cysteine dioxygenase (CDO) catalyzes the conversion of cysteine to cysteinesulfinic acid and is important in the regulation of intracellular cysteine levels in mammals and in the provision of oxidized cysteine metabolites such as sulfate and taurine. Several crystal structure studies of mammalian CDO have shown that there is a cross-linked cofactor present in the active site of the enzyme. The cofactor consists of a thioether bond between the gamma-sulfur of residue cysteine 93 and the aromatic side chain of residue tyrosine 157. The exact requirements for cofactor synthesis and the contribution of the cofactor to the catalytic activity of the enzyme have yet to be fully described. In this study, therefore, we explored the factors necessary for cofactor biogenesis in vitro and in vivo and examined what effect cofactor formation had on activity in vitro. Like other cross-linked cofactor-containing enzymes, formation of the Cys-Tyr cofactor in CDO required a transition metal cofactor (Fe2+) and O-2. Unlike other enzymes, however, biogenesis was also strictly dependent upon the presence of substrate. Cofactor formation was also appreciably slower than the rates reported for other enzymes and, indeed, took hundreds of catalytic turnover cycles to occur. In the absence of the Cys-Tyr cofactor, CDO possessed appreciable catalytic activity, suggesting that the cofactor was not essential for catalysis. Nevertheless, at physiologically relevant cysteine concentrations, cofactor formation increased CDO catalytic efficiency by similar to 10-fold. Overall, the regulation of Cys-Tyr cofactor formation in CDO by ambient cysteine levels represents an unusual form of substrate-mediated feed-forward activation of enzyme activity with important physiological consequences.	[Dominy, John E.; Hwang, Jesse; Guo, Stephanie; Hirschberger, Lawrence L.; Stipanuk, Martha H.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Zhang, Sheng] Cornell Univ, Life Sci Core Labs Ctr, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stipanuk, MH (corresponding author), Cornell Univ, Div Nutr Sci, 227 Savage Hall, Ithaca, NY 14853 USA.	mhs6@cornell.edu						BAGLEY PJ, 1994, J NUTR, V124, P2410, DOI 10.1093/jn/124.12.2410; BAGLEY PJ, 1995, J NUTR, V125, P933; Bella DL, 1999, AM J PHYSIOL-ENDOC M, V277, pE144, DOI 10.1152/ajpendo.1999.277.1.E144; Chai SC, 2005, J BIOL CHEM, V280, P9865, DOI 10.1074/jbc.M413733200; Chai SC, 2006, J BIOL CHEM, V281, P15774, DOI 10.1074/jbc.M601269200; Davidson VL, 2007, BIOCHEMISTRY-US, V46, P5283, DOI 10.1021/bi700468t; DEVILLEBONNE D, 1991, BIOCHEMISTRY-US, V30, P5750, DOI 10.1021/bi00237a017; Dominy JE, 2006, BIOCHEM J, V394, P267, DOI 10.1042/BJ20051510; Dominy JE, 2007, AM J PHYSIOL-ENDOC M, V293, pE62, DOI 10.1152/ajpendo.00053.2007; Dominy JE, 2006, J BACTERIOL, V188, P5561, DOI 10.1128/JB.00291-06; Dooley DM, 1999, J BIOL INORG CHEM, V4, P1, DOI 10.1007/s007750050283; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Klinman JP, 2001, P NATL ACAD SCI USA, V98, P14766, DOI 10.1073/pnas.011602498; Lee JI, 2004, J NUTR BIOCHEM, V15, P112, DOI 10.1016/j.jnutbio.2003.10.005; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; Okeley NM, 2000, CHEM BIOL, V7, pR159, DOI 10.1016/S1074-5521(00)00140-X; Pierce BS, 2007, BIOCHEMISTRY-US, V46, P8569, DOI 10.1021/bi700662d; PRATT ML, 1979, J BIOL CHEM, V254, P7191; Rogers MS, 2000, J AM CHEM SOC, V122, P990, DOI 10.1021/ja993385y; Ruggiero CE, 1997, BIOCHEMISTRY-US, V36, P1953, DOI 10.1021/bi9628836; Schnell R, 2005, J BIOL CHEM, V280, P27319, DOI 10.1074/jbc.M502560200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; Simmons CR, 2006, PROTEIN EXPRES PURIF, V47, P74, DOI 10.1016/j.pep.2005.10.025; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Stipanuk MH, 2004, AM J PHYSIOL-ENDOC M, V286, pE439, DOI 10.1152/ajpendo.00336.2003; Stipanuk MH, 2004, AMINO ACIDS, V26, P99, DOI 10.1007/s00726-003-0001-4; Whittaker MM, 1999, J BIOL CHEM, V274, P36226, DOI 10.1074/jbc.274.51.36226; Whittaker MM, 2003, J BIOL CHEM, V278, P22090, DOI 10.1074/jbc.M300112200; Whittaker MM, 1996, J BIOL CHEM, V271, P681, DOI 10.1074/jbc.271.2.681; YAMAGUCHI K, 1978, J BIOCHEM-TOKYO, V83, P479, DOI 10.1093/oxfordjournals.jbchem.a131935; Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200	32	87	90	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12188	12201		10.1074/jbc.M800044200	http://dx.doi.org/10.1074/jbc.M800044200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18308719	Green Published, hybrid			2022-12-25	WOS:000255340000035
J	Yan, G; Huang, J; Jarbadan, NR; Jiang, YX; Cheng, H				Yan, Guang; Huang, Jiannan; Jarbadan, Nancy Ruth; Jiang, Yixing; Cheng, Hua			Sequestration of NF-kappa B signaling complexes in lipid rafts contributes to repression of NF-kappa B in T lymphocytes under hyperthermia stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-THETA; RECEPTOR-MEDIATED APOPTOSIS; HUMAN DNAJ PROTEIN; INHIBITS APOPTOSIS; APAF-1 APOPTOSOME; SENSITIZES CELLS; MEMBRANE RAFTS; PKC-THETA; ACTIVATION; RECRUITMENT	Sepsis causes extensive apoptosis of lymphocytes, a pathological condition that is frequently associated with hyperthermia. Heat stress has been implicated to repress the activation of an inflammatory mediator, nuclear factor of kappa B (NF-kappa B), which sensitizes cells to apoptosis mediated by inflammatory cytokine, tumor necrosis factor alpha. However, the molecular mechanism of hyperthermia-associated loss of T cells remains unclear. We show that hyperthermia causes rapid translocation of I kappa B kinase (IKK) and NF-kappa B complexes into the plasma membrane-associated lipid rafts in T cells. Heat stress induces aggregation of Carma1 in lipid rafts, which in turn recruits protein kinase C theta (PKC theta) and Bcl10 to the microdomains, causing subsequent membrane translocation of the IKK and NF-kappa B signalosomes. Depletion of Carma1 and inhibition of PKC theta impair accumulation of NF-kappa B complexes in lipid rafts. Heat stress prohibits I kappa B kinase activity by sequestrating the IKK and NF-kappa B complexes in lipid rafts and by segregating the chaperone protein Hsp90, an essential cofactor for IKK, from the IKK complex. This process ultimately results in functional deficiency of NF-kappa B and renders T cells resistant to tumor necrosis factor alpha-induced activation of IKK, thereby contributing to the apoptotic loss of T lymphocytes in sepsis-associated hyperthermia.	[Yan, Guang; Huang, Jiannan; Jarbadan, Nancy Ruth; Jiang, Yixing; Cheng, Hua] Penn State Univ, Coll Med, Penn State Canc Inst, Hershey, PA 17033 USA; [Yan, Guang; Huang, Jiannan; Jiang, Yixing; Cheng, Hua] Penn State Univ, Coll Med, Dept Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cheng, H (corresponding author), Penn State Univ, Coll Med, Penn State Canc Inst, Oncol Room 6818,500 Univ Dr, Hershey, PA 17033 USA.	hcheng@hmc.psu.edu						Abboushi N, 2004, J IMMUNOL, V173, P3193, DOI 10.4049/jimmunol.173.5.3193; Aghdassi A, 2007, CANCER RES, V67, P616, DOI 10.1158/0008-5472.CAN-06-1567; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen GQ, 2002, MOL CELL, V9, P401, DOI 10.1016/S1097-2765(02)00450-1; Cheng H, 2005, NEOPLASIA, V7, P1065, DOI 10.1593/neo.05553; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Cheng H, 2001, CURR BIOL, V11, P1771, DOI 10.1016/S0960-9822(01)00540-1; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Clemons NJ, 2006, CELL STRESS CHAPERON, V11, P343, DOI 10.1379/CSC-206.1; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Drevot P, 2002, EMBO J, V21, P1899, DOI 10.1093/emboj/21.8.1899; Feng XL, 2006, MOL CELL BIOL, V26, P9244, DOI 10.1128/MCB.01538-06; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Guzhova I, 2006, INT REV CYTOL, V254, P101, DOI 10.1016/S0074-7696(06)54003-3; Hara H, 2004, J EXP MED, V200, P1167, DOI 10.1084/jem.20032246; He KL, 2002, MOL CELL BIOL, V22, P6034, DOI 10.1128/MCB.22.17.6034-6045.2002; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Jiang YX, 2007, LEUKEMIA RES, V31, P541, DOI 10.1016/j.leukres.2006.07.010; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kabouridis PS, 2006, MOL MEMBR BIOL, V23, P49, DOI 10.1080/09687860500453673; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; LAIRMORE MD, 1992, INT J CANCER, V50, P124, DOI 10.1002/ijc.2910500125; Manicassamy S, 2006, CELL MOL IMMUNOL, V3, P263; Nakashima H, 2006, CANCER RES, V66, P7041, DOI 10.1158/0008-5472.CAN-05-4588; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Rouquette-Jazdanian AK, 2006, CELL SIGNAL, V18, P105, DOI 10.1016/j.cellsig.2005.03.024; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; Schilling B, 1998, VIROLOGY, V247, P74, DOI 10.1006/viro.1998.9220; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Sebald A, 2005, EUR J IMMUNOL, V35, P318, DOI 10.1002/eji.200425024; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Sweeney C, 2004, CLIN CANCER RES, V10, P5501, DOI 10.1158/1078-0432.CCR-0571-03; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Tani-ichi S, 2005, INT IMMUNOL, V17, P749, DOI 10.1093/intimm/dxh257; Tran SEF, 2003, CELL DEATH DIFFER, V10, P1137, DOI 10.1038/sj.cdd.4401278; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; WANG SD, 1994, J IMMUNOL, V152, P5014; Yenari MA, 2005, ANN NY ACAD SCI, V1053, P74, DOI 10.1196/annals.1344.007; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	52	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12489	12500		10.1074/jbc.M707988200	http://dx.doi.org/10.1074/jbc.M707988200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18316375	hybrid			2022-12-25	WOS:000255340000065
J	Mao, T; O'Connor, DH; Scheuss, V; Nakai, J; Svoboda, K				Mao, Tianyi; O'Connor, Daniel H.; Scheuss, Volker; Nakai, Junichi; Svoboda, Karel			Characterization and Subcellular Targeting of GCaMP-Type Genetically-Encoded Calcium Indicators	PLOS ONE			English	Article								Genetically-encoded calcium indicators (GECIs) hold the promise of monitoring [Ca2+] in selected populations of neurons and in specific cellular compartments. Relating GECI fluorescence to neuronal activity requires quantitative characterization. We have characterized a promising new genetically-encoded calcium indicator-GCaMP2- in mammalian pyramidal neurons. Fluorescence changes in response to single action potentials (17 +/- 10% Delta F/F [mean +/- SD]) could be detected in some, but not all, neurons. Trains of high-frequency action potentials yielded robust responses (302 +/- 50% for trains of 40 action potentials at 83 Hz). Responses were similar in acute brain slices from in utero electroporated mice, indicating that long-term expression did not interfere with GCaMP2 function. Membrane-targeted versions of GCaMP2 did not yield larger signals than their non-targeted counterparts. We further targeted GCaMP2 to dendritic spines to monitor Ca2+ accumulations evoked by activation of synaptic NMDA receptors. We observed robust DF/F responses (range: 37%-264%) to single spine uncaging stimuli that were correlated with NMDA receptor currents measured through a somatic patch pipette. One major drawback of GCaMP2 was its low baseline fluorescence. Our results show that GCaMP2 is improved from the previous versions of GCaMP and may be suited to detect bursts of high-frequency action potentials and synaptic currents in vivo.	[Mao, Tianyi; O'Connor, Daniel H.; Scheuss, Volker; Svoboda, Karel] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Mao, Tianyi; O'Connor, Daniel H.; Scheuss, Volker; Svoboda, Karel] Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA; [Nakai, Junichi] RIKEN Brain Sci Inst, Lab Memory & Learn, Saitama, Japan	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; RIKEN	Mao, T (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	svobodak@janelia.hhmi.org	Nakai, Junichi/GQZ-6415-2022; Volker, Scheuss/G-7846-2015	Scheuss, Volker/0000-0002-0659-3228; Mao, Tianyi/0000-0002-3532-8319	HHMI; NIH	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHMI, NIH. Funders had no role in the design and conduct, analysis or reporting of the study.	CALLAWAY JC, 1995, J NEUROPHYSIOL, V74, P1395, DOI 10.1152/jn.1995.74.4.1395; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Diez-Garcia J, 2007, NEUROIMAGE, V34, P859, DOI 10.1016/j.neuroimage.2006.10.021; Emmanouilidou E, 1999, CURR BIOL, V9, P915, DOI 10.1016/S0960-9822(99)80398-4; GRAY NW, 2006, PLOS BIOL, P4; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Heim N, 2004, J BIOL CHEM, V279, P14280, DOI 10.1074/jbc.M312751200; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Knopfel T, 2006, TRENDS NEUROSCI, V29, P160, DOI 10.1016/j.tins.2006.01.004; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Kotlikoff MI, 2007, J PHYSIOL-LONDON, V578, P55, DOI 10.1113/jphysiol.2006.120212; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Lee MY, 2006, P NATL ACAD SCI USA, V103, P13232, DOI 10.1073/pnas.0605757103; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; MANK M, 2005, BIOPHYS J; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; PALMER AE, 2006, CHEM BIOL IN PRESS; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Scheuss V, 2006, J NEUROSCI, V26, P8183, DOI 10.1523/JNEUROSCI.1962-06.2006; SHANER NC, 2004, NAT BIOTECHNOL; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; Tsai PS, 2003, NEURON, V39, P27, DOI 10.1016/S0896-6273(03)00370-2; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Yuste R, 1999, J NEUROSCI, V19, P1976; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	52	118	124	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1796	10.1371/journal.pone.0001796	http://dx.doi.org/10.1371/journal.pone.0001796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350138	gold, Green Published, Green Accepted			2022-12-25	WOS:000260762300004
J	Roberts, M; Zimin, AV; Hayes, W; Hunt, BR; Ustun, C; White, JR; Havlak, P; Yorke, J				Roberts, Michael; Zimin, Aleksey V.; Hayes, Wayne; Hunt, Brian R.; Ustun, Cevat; White, James R.; Havlak, Paul; Yorke, James			Improving Phrap-Based Assembly of the Rat Using "Reliable" Overlaps	PLOS ONE			English	Article							GENOME	The assembly methods used for whole-genome shotgun (WGS) data have a major impact on the quality of resulting draft genomes. We present a novel algorithm to generate a set of "reliable'' overlaps based on identifying repeat k-mers. To demonstrate the benefits of using reliable overlaps, we have created a version of the Phrap assembly program that uses only overlaps from a specific list. We call this version PhrapUMD. Integrating PhrapUMD and our "reliable-overlap'' algorithm with the Baylor College of Medicine assembler, Atlas, we assemble the BACs from the Rattus norvegicus genome project. Starting with the same data as the Nov. 2002 Atlas assembly, we compare our results and the Atlas assembly to the 4.3 Mb of rat sequence in the 21 BACs that have been finished. Our version of the draft assembly of the 21 BACs increases the coverage of finished sequence from 93.4% to 96.3%, while simultaneously reducing the base error rate from 4.5 to 1.1 errors per 10,000 bases. There are a number of ways of assessing the relative merits of assemblies when the finished sequence is available. If one views the overall quality of an assembly as proportional to the inverse of the product of the error rate and sequence missed, then the assembly presented here is seven times better. The UMD Overlapper with options for reliable overlaps is available from the authors at http://www.genome.umd.edu. We also provide the changes to the Phrap source code enabling it to use only the reliable overlaps.	[Roberts, Michael; Zimin, Aleksey V.; Hayes, Wayne; Hunt, Brian R.; Ustun, Cevat; White, James R.; Yorke, James] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Havlak, Paul] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX USA	University System of Maryland; University of Maryland College Park; Baylor College of Medicine	Roberts, M (corresponding author), Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA.	alekseyz@ipst.umd.edu	Hunt, Brian/J-6895-2012	Hayes, Wayne B./0000-0002-3310-6042	NSF [DMS0616585]; NIH [1R01HG0294501]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002945] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported under NSF grant DMS0616585 and under NIH grant 1R01HG0294501.	Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Green P, 1996, PHRAP DOCUMENTATION; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Roberts M, 2004, J COMPUT BIOL, V11, P734; SALZBERG SL, 2005, BIOINFORMATICS, V21, P133; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]	15	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1836	10.1371/journal.pone.0001836	http://dx.doi.org/10.1371/journal.pone.0001836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350171	Green Published, gold, Green Accepted			2022-12-25	WOS:000260762300037
J	Yu, JZ; Poulton, J; Huang, YC; Deng, WM				Yu, Jianzhong; Poulton, John; Huang, Yi-Chun; Deng, Wu-Min			The Hippo Pathway Promotes Notch Signaling in Regulation of Cell Differentiation, Proliferation, and Oocyte Polarity	PLOS ONE			English	Article								Specification of the anterior-posterior axis in Drosophila oocytes requires proper communication between the germ-line cells and the somatically derived follicular epithelial cells. Multiple signaling pathways, including Notch, contribute to oocyte polarity formation by controlling the temporal and spatial pattern of follicle cell differentiation and proliferation. Here we show that the newly identified Hippo tumor-suppressor pathway plays a crucial role in the posterior follicle cells in the regulation of oocyte polarity. Disruption of the Hippo pathway, including major components Hippo, Salvador, and Warts, results in aberrant follicle-cell differentiation and proliferation and dramatic disruption of the oocyte anterior-posterior axis. These phenotypes are related to defective Notch signaling in follicle cells, because misexpression of a constitutively active form of Notch alleviates the oocyte polarity defects. We also find that follicle cells defective in Hippo signaling accumulate the Notch receptor and display defects in endocytosis markers. Our findings suggest that the interaction between Hippo and classic developmental pathways such as Notch is critical to spatial and temporal regulation of differentiation and proliferation and is essential for development of the body axes in Drosophila.	[Yu, Jianzhong; Poulton, John; Huang, Yi-Chun; Deng, Wu-Min] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Yu, JZ (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	wumin@bio.fsu.edu	Yu, Jianzhong/F-6050-2010		American Heart Association [Scientist Development Grant]; National Institutes of Health [R01 GM072562]; FSU College of Arts and Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072562] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FSU College of Arts and Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	WMD is supported by a Scientist Development Grant from the American Heart Association, Florida/Puerto Rico affiliate; National Institutes of Health Grant R01 GM072562; and the FSU College of Arts and Sciences set-up fund.	Beccari S, 2002, MECH DEVELOP, V111, P115, DOI 10.1016/S0925-4773(01)00615-3; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Cox DN, 2001, P NATL ACAD SCI USA, V98, P14475, DOI 10.1073/pnas.261565198; de Celis JF, 1998, DEVELOPMENT, V125, P4617; Deng WM, 1998, INT J DEV BIOL, V42, P541; Deng WM, 2001, DEVELOPMENT, V128, P4737; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Frydman HM, 2001, DEVELOPMENT, V128, P3209; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Ghiglione C, 2002, DEVELOPMENT, V129, P5437, DOI 10.1242/dev.00116; Gonzalez-Reyes A, 1998, DEVELOPMENT, V125, P2837; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hariharan IK, 2006, CURR BIOL, V16, pR1037, DOI 10.1016/j.cub.2006.11.012; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; MacDougall N, 2001, DEVELOPMENT, V128, P665; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Morimoto AM, 1996, DEVELOPMENT, V122, P3745; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Pellock BJ, 2007, DEV BIOL, V304, P102, DOI 10.1016/j.ydbio.2006.12.021; Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049; Poulton JS, 2007, DEV BIOL, V311, P1, DOI 10.1016/j.ydbio.2007.08.030; Poulton JS, 2006, P NATL ACAD SCI USA, V103, P12775, DOI 10.1073/pnas.0603817103; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Rawls AS, 2002, CURR BIOL, V12, P1021, DOI 10.1016/S0960-9822(02)00893-X; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; SPRADLING AC, 1993, CELL, V72, P649, DOI 10.1016/0092-8674(93)90393-5; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Sun JJ, 2007, DEV CELL, V12, P431, DOI 10.1016/j.devcel.2007.02.003; Sun JJ, 2005, DEVELOPMENT, V132, P4299, DOI 10.1242/dev.02015; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Twombly V, 1996, DEVELOPMENT, V122, P1555; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Wei X, 2007, EMBO J, V26, P1772, DOI 10.1038/sj.emboj.7601630; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xi RW, 2003, DEV CELL, V4, P167, DOI 10.1016/S1534-5807(02)00412-4; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053	74	87	92	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1761	10.1371/journal.pone.0001761	http://dx.doi.org/10.1371/journal.pone.0001761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335037	Green Published, Green Submitted, gold			2022-12-25	WOS:000260723000015
J	Mount, AM; Smith, CM; Kupresanin, F; Stoermer, K; Heath, WR; Belz, GT				Mount, Adele M.; Smith, Christopher M.; Kupresanin, Fiona; Stoermer, Kristina; Heath, William R.; Belz, Gabrielle T.			Multiple Dendritic Cell Populations Activate CD4(+) T Cells after Viral Stimulation	PLOS ONE			English	Article								Dendritic cells (DC) are a heterogeneous cell population that bridge the innate and adaptive immune systems. CD8a DC play a prominent, and sometimes exclusive, role in driving amplification of CD8(+) T cells during a viral infection. Whether this reliance on a single subset of DC also applies for CD4(+) T cell activation is unknown. We used a direct ex vivo antigen presentation assay to probe the capacity of flow cytometrically purified DC populations to drive amplification of CD4(+) and CD8(+) T cells following infection with influenza virus by different routes. This study examined the contributions of non-CD8 alpha DC populations in the amplification of CD8(+) and CD4(+) T cells in cutaneous and systemic influenza viral infections. We confirmed that in vivo, effective immune responses for CD8(+) T cells are dominated by presentation of antigen by CD8a DC but can involve non-CD8a DC. In contrast, CD4(+) T cell responses relied more heavily on the contributions of dermal DC migrating from peripheral lymphoid tissues following cutaneous infection, and CD4 DC in the spleen after systemic infection. CD4(+) T cell priming by DC subsets that is dependent upon the route of administration raises the possibility that vaccination approaches could be tailored to prime helper T cell immunity.	[Mount, Adele M.; Smith, Christopher M.; Kupresanin, Fiona; Stoermer, Kristina; Heath, William R.; Belz, Gabrielle T.] Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Mount, AM (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia.	belz@wehi.edu.au	Belz, Gabrielle T/C-9350-2013	Belz, Gabrielle T/0000-0002-9660-9587; Heath, William/0000-0001-9670-259X	National Health and Medical Research Council of Australia; University of Melbourne Research Scholarship; NHMRC CJ Martin Fellowship; Wellcome Trust Senior Overseas Fellowship; Viertel Fellowship; Howard Hughes Medical Institute International Fellowships	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne Research Scholarship(University of Melbourne); NHMRC CJ Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust Senior Overseas Fellowship(Wellcome Trust); Viertel Fellowship; Howard Hughes Medical Institute International Fellowships	This work was funded by the National Health and Medical Research Council of Australia, a University of Melbourne Research Scholarship (A.M.M. and C.M.S.) and an NHMRC CJ Martin Fellowship (C.M.S), a Wellcome Trust Senior Overseas Fellowship (G.T.B.), Viertel Fellowship (G.T.B.) and Howard Hughes Medical Institute International Fellowships (G.T.B. and W.R. H)	Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Belz GT, 2007, NAT IMMUNOL, V8, P1060, DOI 10.1038/ni1505; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; Belz GT, 2004, J IMMUNOL, V172, P1996, DOI 10.4049/jimmunol.172.4.1996; Belz GT, 2002, J EXP MED, V196, P1099, DOI 10.1084/jem.20020861; Blaney JE, 1998, J VIROL, V72, P9567, DOI 10.1128/JVI.72.12.9567-9574.1998; BORROW P, 1995, J VIROL, V69, P1059, DOI 10.1128/JVI.69.2.1059-1070.1995; Carter RW, 2006, J IMMUNOL, V177, P2276, DOI 10.4049/jimmunol.177.4.2276; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Filippi C, 2003, J EXP MED, V198, P201, DOI 10.1084/jem.20021893; He YK, 2006, IMMUNITY, V24, P643, DOI 10.1016/j.immuni.2006.03.014; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Ingulli E, 2002, J IMMUNOL, V169, P2247, DOI 10.4049/jimmunol.169.5.2247; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kerksiek KM, 2005, BLOOD, V105, P742, DOI 10.1182/blood-2004-05-1891; Lemos MP, 2004, J EXP MED, V199, P725, DOI 10.1084/jem.20030795; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Manickasingham S, 2000, J IMMUNOL, V165, P5027, DOI 10.4049/jimmunol.165.9.5027; Morgan DJ, 1996, J IMMUNOL, V157, P978; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Perry JA, 2004, J IMMUNOL, V172, P475, DOI 10.4049/jimmunol.172.1.475; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Smith CM, 2003, J IMMUNOL, V170, P4437, DOI 10.4049/jimmunol.170.9.4437; Valdez Y, 2002, J EXP MED, V195, P683, DOI 10.1084/jem.20010898; Veeraswamy RK, 2003, J IMMUNOL, V170, P5367, DOI 10.4049/jimmunol.170.11.5367; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	37	45	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1691	10.1371/journal.pone.0001691	http://dx.doi.org/10.1371/journal.pone.0001691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301768	Green Published, gold			2022-12-25	WOS:000260586500035
J	Qi, W; Shakalya, K; Stejskal, A; Goldman, A; Beeck, S; Cooke, L; Mahadevan, D				Qi, W.; Shakalya, K.; Stejskal, A.; Goldman, A.; Beeck, S.; Cooke, L.; Mahadevan, D.			NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells	ONCOGENE			English	Article						nucleophosmin; small molecular inhibitor; NSC348884; p53; apoptosis	TUMOR-SUPPRESSOR PROTEIN; TRANSCRIPTIONAL ACTIVITY; CENTROSOME DUPLICATION; NUCLEOLAR PROTEIN-B23; DNA-DAMAGE; B23; P53; IDENTIFICATION; NUCLEAR; GROWTH	Nucleophosmin (NPM), a multifunctional nucleolar phosphoprotein is dysregulated in human malignancies leadingto anti-apoptosis and inhibition of differentiation. We evaluated the precise three-dimensional structure of NPM based on the highly conserved structure of Xenopus NO38 and its requirement to form dimers and pentamers via its N-terminal domain (residues, 1-107). We hypothesized that a small molecular inhibitor (SMI) that could disrupt the formation of dimers would inhibit aberrant NPM function(s) in cancer cells. Molecular modeling, pharmacophore design, in silico screening and interactive docking identified NSC348884 as a putative NPM SMI that disrupts a defined hydrophobic pocket required for oligomerization. NSC348884 inhibited cell proliferation at an IC50 of 1.7-4.0 mu M in distinct cancer cell lines and disrupted NPM oligomer formation by native polyacrylamide gel electrophoresis assay. Treatment of several different cancer cell types with NSC348884 upregulated p53 (increased Ser15 phosphorylation) and induced apoptosis in a dose-dependent manner that correlated with apoptotic markers: H2AX phosphorylation, poly(ADP-ribose) polymerase cleavage and Annexin V labeling. Further, NSC348884 synergized doxorubicin cytotoxicity on cancer cell viability. The data together show that NSC348884 is an SMI of NPM oligomer formation, upregulates p53, induces apoptosis and synergizes with chemotherapy. Hence, an SMI to NPM may be a useful approach to anticancer therapy.	[Qi, W.; Shakalya, K.; Stejskal, A.; Goldman, A.; Beeck, S.; Cooke, L.; Mahadevan, D.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA	Arizona Center Cancer Care; University of Arizona	Qi, W (corresponding author), Univ Arizona, Arizona Canc Ctr, 1515 N Campbell Ave, Tucson, AZ 85724 USA.	wenqing@email.arizona.edu; dmahadevan@azcc.arizona						Ahn JY, 2005, MOL CELL, V18, P435, DOI 10.1016/j.molcel.2005.04.010; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Chan HJ, 2005, BIOCHEM BIOPH RES CO, V333, P396, DOI 10.1016/j.bbrc.2005.04.176; CHAN WY, 1989, BIOCHEMISTRY-US, V28, P1033, DOI 10.1021/bi00429a017; CHOU YH, 1995, BIOCHEM BIOPH RES CO, V217, P313, DOI 10.1006/bbrc.1995.2779; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; FANKHAUSER C, 1991, MOL CELL BIOL, V11, P2567, DOI 10.1128/MCB.11.5.2567; FEUERSTEIN N, 1988, J BIOL CHEM, V263, P10608; Gjerset RA, 2006, J MOL HISTOL, V37, P239, DOI 10.1007/s10735-006-9040-y; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Herrera JE, 1996, BIOCHEMISTRY-US, V35, P2668, DOI 10.1021/bi9523320; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Lee C, 2005, CANCER RES, V65, P9834, DOI 10.1158/0008-5472.CAN-05-1759; Li J, 2005, LEUKEMIA RES, V29, P1415, DOI 10.1016/j.leukres.2005.05.005; Li J, 2004, J BIOL CHEM, V279, P41275, DOI 10.1074/jbc.C400297200; Li YP, 1996, EUR J BIOCHEM, V237, P153, DOI 10.1111/j.1432-1033.1996.0153n.x; Lim MJ, 2006, CANCER DETECT PREV, V30, P481, DOI 10.1016/j.cdp.2006.10.008; Liu Y, 2007, CANCER RES, V67, P2685, DOI 10.1158/0008-5472.CAN-06-3497; Maiguel DA, 2004, MOL CELL BIOL, V24, P3703, DOI 10.1128/MCB.24.9.3703-3711.2004; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Naoe T, 2006, CANCER SCI, V97, P963, DOI 10.1111/j.1349-7006.2006.00270.x; Nozawa Y, 1996, J PATHOL, V178, P48; Okuda M, 2002, ONCOGENE, V21, P6170, DOI 10.1038/sj.onc.1205708; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; PATTERSON SD, 1995, J BIOL CHEM, V270, P9429, DOI 10.1074/jbc.270.16.9429; Qi WQ, 2003, RADIAT RES, V160, P217, DOI 10.1667/RR3038; Shields LBE, 1997, J SOC GYNECOL INVEST, V4, P298, DOI 10.1016/S1071-5576(97)00068-3; Subong ENP, 1999, PROSTATE, V39, P298; Takemura M, 1999, J BIOCHEM-TOKYO, V125, P904, DOI 10.1093/oxfordjournals.jbchem.a022367; TANAKA M, 1992, CANCER RES, V52, P3372; VALDEZ BC, 1994, J BIOL CHEM, V269, P23776; VanBelzen N, 1995, EUR J BIOCHEM, V234, P843; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; WANG DR, 1993, CELL MOL BIOL RES, V39, P33; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Ye KQ, 2005, CANCER BIOL THER, V4, P918, DOI 10.4161/cbt.4.9.2072; Yeh CW, 2006, MOL PHARMACOL, V70, P1443, DOI 10.1124/mol.106.024810; YUNG BY, 1990, CANCER RES, V50, P5987; Zhang YP, 2004, CELL CYCLE, V3, P259	49	83	90	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2008	27	30					4210	4220		10.1038/onc.2008.54	http://dx.doi.org/10.1038/onc.2008.54			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	324DB	18345031				2022-12-25	WOS:000257496800008
J	Wang, IC; Meliton, L; Tretiakova, M; Costa, RH; Kalinichenko, VV; Kalin, TV				Wang, I-C; Meliton, L.; Tretiakova, M.; Costa, R. H.; Kalinichenko, V. V.; Kalin, T. V.			Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors	ONCOGENE			English	Article						winged helix DNA-binding domain; forkhead transcription factor; Foxm1; non-small cell lung cancer; lung epithelial cells; cellular proliferation	GENE-EXPRESSION; CYCLOOXYGENASE-2 EXPRESSION; HEPATOCELLULAR-CARCINOMA; FOXM1; PROGRESSION; CELLS; IDENTIFICATION; PROLIFERATION; PATHWAYS; NETWORK	The forkhead box m1 (Foxm1 or Foxm1b) protein (previously called HFH-11B, Trident, Win or MPP2) is abundantly expressed in human non-small cell lung cancers where it transcriptionally induces expression of genes essential for proliferation of tumor cells. In this study, we used Rosa26-Foxm1 transgenic mice, in which the Rosa26 promoter drives ubiquitous expression of Foxm1 transgene, to identify new signaling pathways regulated by Foxm1. Lung tumors were induced in Rosa26-Foxm1 mice using the 3-methylcholanthrene (MCA)/butylated hydroxytoluene (BHT) lung tumor initiation/promotion protocol. Tumors from MCA/BHT-treated Rosa26-Foxm1 mice displayed a significant increase in the number, size and DNA replication compared to wild-type mice. Elevated tumor formation in Rosa26-Foxm1 transgenic lungs was associated with persistent pulmonary inflammation, macrophage infiltration and increased expression of cyclooxygenase-2 (Cox-2), Cdc25C phosphatase, cyclin E2, chemokine ligands CXCL5, CXCL1 and CCL3, cathepsins and matrix metalloprotease-12. Cell culture experiments with A549 human lung adenocarcinoma cells demonstrated that depletion of Foxm1 by either short interfering RNA transfection or treatment with Foxm1-inhibiting ARF 26-44 peptide significantly reduced Cox-2 expression. In co-transfection experiments, Foxm1 protein-induced Cox-2 promoter activity and directly bound to the -2566/- 2580 bp region of human Cox-2 promoter.	[Wang, I-C; Kalinichenko, V. V.; Kalin, T. V.] Cincinnati Childrens Hosp Res Fdn, Div Pulm Biol, Cincinnati, OH 45229 USA; [Meliton, L.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Tretiakova, M.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Costa, R. H.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kalin, TV (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Pulm Biol, 3333 Burnet Ave,MLC 7009, Cincinnati, OH 45229 USA.	kal4ti@cchmc.org	Tretiakova, Maria/U-3320-2019	Wang, I-Ching/0000-0003-4398-2975	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054687] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Acuff HB, 2006, CANCER RES, V66, P7968, DOI 10.1158/0008-5472.CAN-05-4279; Blaine SA, 2005, CARCINOGENESIS, V26, P209, DOI 10.1093/carcin/bgh302; Bratt T, 2000, BBA-PROTEIN STRUCT M, V1482, P318, DOI 10.1016/S0167-4838(00)00154-0; Chang MS, 2005, CELL SIGNAL, V17, P299, DOI 10.1016/j.cellsig.2004.07.008; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; Costa RH, 2005, CURR OPIN GENET DEV, V15, P42, DOI 10.1016/j.gde.2004.12.007; Giaccone G, 1996, CHEST, V109, pS130, DOI 10.1378/chest.109.5_Supplement.130S; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2003, J BIOL CHEM, V278, P37888, DOI 10.1074/jbc.M305555200; Kalinichenko VV, 2001, DEV BIOL, V235, P489, DOI 10.1006/dbio.2001.0322; Kalinichenko VV, 2001, AM J PHYSIOL-LUNG C, V280, pL695, DOI 10.1152/ajplung.2001.280.4.L695; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kim IM, 2005, J BIOL CHEM, V280, P37908, DOI 10.1074/jbc.M506531200; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Kulbe H, 2004, INT J DEV BIOL, V48, P489, DOI 10.1387/ijdb.041814hk; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Malkinson AM, 1998, EXP LUNG RES, V24, P541, DOI 10.3109/01902149809087385; Malkinson AM, 1997, CANCER RES, V57, P2832; McCormick Frank, 1999, Trends in Cell Biology, V9, pM53, DOI 10.1016/S0962-8924(99)01668-2; Mitsuuchi Y, 2002, AM J MED GENET, V115, P183, DOI 10.1002/ajmg.10692; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Obama K, 2005, HEPATOLOGY, V41, P1339, DOI 10.1002/hep.20718; Park HJ, 2008, ONCOGENE, V27, P1696, DOI 10.1038/sj.onc.1210814; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Riedl K, 2004, DRUG RESIST UPDATE, V7, P169, DOI 10.1016/j.drup.2004.04.003; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Teh MT, 2002, CANCER RES, V62, P4773; Toloza EM, 2006, J CELL BIOCHEM, V99, P1, DOI 10.1002/jcb.20851; Tong M, 2006, CARCINOGENESIS, V27, P2170, DOI 10.1093/carcin/bgl053; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wolters P J, 2000, Respir Res, V1, P170, DOI 10.1186/rr29; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154	46	64	70	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2008	27	30					4137	4149		10.1038/onc.2008.60	http://dx.doi.org/10.1038/onc.2008.60			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	324DB	18345025				2022-12-25	WOS:000257496800001
J	Dhawan, P; Su, YJ; Thu, YM; Yu, YC; Baugher, P; Ellis, DL; Sobolik-Delmaire, T; Kelley, M; Cheung, TC; Ware, CF; Richmond, A				Dhawan, Punita; Su, Yingjun; Thu, Yee Mon; Yu, Yingchun; Baugher, Paige; Ellis, Darrel L.; Sobolik-Delmaire, Tammy; Kelley, Mark; Cheung, Timothy C.; Ware, Carl F.; Richmond, Ann			The lymphotoxin-beta receptor is an upstream activator of NF-kappa B-mediated transcription in melanoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; IN-VIVO; KINASE; NUCLEAR; ALPHA; ALYMPHOPLASIA; INHIBITOR; PATHWAY; TNF; PHOSPHORYLATION	The pleiotropic transcription factor nuclear factor-kappa B (NF-kappa B (p50/p65)) regulates the transcription of genes involved in the modulation of cell proliferation, apoptosis, and oncogenesis. Furthermore, a host of solid and hematopoietic tumor types exhibit constitutive activation of NF-kappa B (Basseres, D. S., and Baldwin, A. S. (2006) 25,6817-6830). However, the mechanism for this constitutive activation of NF-kappa B has not been elucidated in the tumors. We have previously shown that NF-kappa B-inducing kinase (NIK) protein and its association with Inhibitor of kappa B kinase alpha beta are elevated in melanoma cells compared with their normal counterpart, leading to constitutive activation of NF-kappa B. Moreover, expression of dominant negative NIK blocked this base-line NF-kappa B activity in melanoma cells. Of the three receptors that require NIK for activation of NF-kappa B only the lymphotoxin-beta receptor (LT beta-R) is expressed in melanoma. We show in this manuscript that for melanoma there is a strong relationship between expression of the LT beta-R and constitutive NF-kappa B transcriptional activity. Moreover, we show that activation of the LT beta-R can drive NF-kappa B. activity to regulate gene expression that leads to enhanced cell growth. The inhibition by LT beta-R shRNA resulted in decreased NF-kappa B promoter activity, decreased growth, and decreased invasiveness as compared with control. These results indicate that the LT beta-R constitutively induces NF-kappa B activation, and this event maybe associated with autonomous growth of melanoma cells.	[Richmond, Ann] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Dhawan, Punita; Su, Yingjun; Thu, Yee Mon; Yu, Yingchun; Baugher, Paige; Sobolik-Delmaire, Tammy; Richmond, Ann] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Dhawan, Punita; Kelley, Mark] Vanderbilt Univ, Med Ctr, Surg Oncol Res Labs, Dept Surg, Nashville, TN 37232 USA; [Ellis, Darrel L.] Vanderbilt Univ, Med Ctr, Div Dermatol, Dept Med, Nashville, TN 37232 USA; [Cheung, Timothy C.; Ware, Carl F.] La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; La Jolla Institute for Immunology	Richmond, A (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, 23rd Ave S Pierce,PRB 432, Nashville, TN 37232 USA.	ann.richmond@vanderbilt.edu	Richmond, Ann/A-3048-2014	RICHMOND, ANN/0000-0002-9580-900X	NCI NIH HHS [P30 CA068485, CA 098807, R01 CA098807-03, CA 68485, CA 56704, R01 CA098807] Funding Source: Medline; NHLBI NIH HHS [T30 HL 07751, T32 HL007751] Funding Source: Medline; NIAMS NIH HHS [SP30 AR 1943] Funding Source: Medline; BLRD VA [IK6 BX005225] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA056704, R01CA098807] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001943] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); BLRD VA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Birbach A, 2004, J CELL SCI, V117, P3615, DOI 10.1242/jcs.01224; Chang YH, 2002, EXP CELL RES, V278, P166, DOI 10.1006/excr.2002.5573; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Dhawan P, 2002, CANCER RES, V62, P7335; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 2007, CANCER CELL, V12, P95, DOI 10.1016/j.ccr.2007.07.010; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karrer U, 2000, EUR J IMMUNOL, V30, P2799, DOI 10.1002/1521-4141(200010)30:10<2799::AID-IMMU2799>3.0.CO;2-2; Kim S, 2004, J BIOL CHEM, V279, P4285, DOI 10.1074/jbc.M308383200; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Lukashev M, 2006, CANCER RES, V66, P9617, DOI 10.1158/0008-5472.CAN-06-0217; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Marsters SA, 1997, J BIOL CHEM, V272, P14029, DOI 10.1074/jbc.272.22.14029; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Mortarini R, 2005, CANCER RES, V65, P3428, DOI 10.1158/0008-5472.CAN-04-3239; Nemoto S, 1998, MOL CELL BIOL, V18, P7336, DOI 10.1128/MCB.18.12.7336; Rangaswami H, 2004, J BIOL CHEM, V279, P38921, DOI 10.1074/jbc.M404674200; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stahl JM, 2003, CANCER RES, V63, P2881; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamada T, 2000, J IMMUNOL, V165, P804, DOI 10.4049/jimmunol.165.2.804; Yang JM, 2007, CANCER RES, V67, P3127, DOI 10.1158/0008-5472.CAN-06-3547; Yang JM, 2006, CLIN CANCER RES, V12, P950, DOI 10.1158/1078-0432.CCR-05-1220; Yang JM, 2001, CANCER RES, V61, P4901; Zhai YF, 1998, J CLIN INVEST, V102, P1142, DOI 10.1172/JCI3492	36	33	36	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15399	15408		10.1074/jbc.M708272200	http://dx.doi.org/10.1074/jbc.M708272200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18347013	Green Published, hybrid			2022-12-25	WOS:000256232000058
J	Ito, K; Nakanishi, M; Lee, WC; Zhi, Y; Sasaki, H; Zenno, S; Saigo, K; Kitade, Y; Tanokura, M				Ito, Kosuke; Nakanishi, Masayuki; Lee, Woo-Cheol; Zhi, Yuehua; Sasaki, Hiroshi; Zenno, Shuhei; Saigo, Kaoru; Kitade, Yukio; Tanokura, Masaru			Expansion of substrate specificity and catalytic mechanism of azoreductase by X-ray crystallography and site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GENOME SEQUENCE; REDUCTASE; FLAVIN; ENZYME; PURIFICATION; DEGRADATION; NAD(P)H; PROGRAM; BINDING	AzoR is an FMN-dependent NADH-azoreductase isolated from Escherichia coli as a protein responsible for the degradation of azo compounds. We previously reported the crystal structure of the enzyme in the oxidized form. In the present study, different structures of AzoR were determined under several conditions to obtain clues to the reaction mechanism of the enzyme. AzoR in its reduced form revealed a twisted butterfly bend of the isoalloxazine ring of the FMN cofactor and a rearrangement of solvent molecules. The crystal structure of oxidized AzoR in a different space group and the structure of the enzyme in complex with the inhibitor dicoumarol were also determined. These structures indicate that the formation of a hydrophobic part around the isoalloxazine ring is important for substrate binding and an electrostatic interaction between Arg-59 and the carboxyl group of the azo compound causes a substrate preference for methyl red over p-methyl red. The substitution of Arg-59 with Ala enhanced the V-max value for p-methyl red 27-fold with a 3.8-fold increase of the K-m value. This result indicates that Arg-59 decides the substrate specificity of AzoR. The V-max value for the p-methyl red reduction of the R59A mutant is comparable with that for the methyl red reduction of the wild-type enzyme, whereas the activity toward methyl red was retained. These findings indicate the expansion of AzoR substrate specificity by a single amino acid substitution. Furthermore, we built an authentic model of the AzoR-methyl red complex based on the results of the study.	[Ito, Kosuke; Lee, Woo-Cheol; Zhi, Yuehua; Sasaki, Hiroshi; Tanokura, Masaru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Nakanishi, Masayuki; Kitade, Yukio] Gifu Univ, Fac Engn, Dept Biomol Sci, Gifu 5011193, Japan; [Zenno, Shuhei; Saigo, Kaoru] Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan	University of Tokyo; Gifu University; University of Tokyo	Tanokura, M (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amtanok@mail.ecc.u-tokyo.ac.jp		Tanokura, Masaru/0000-0001-5072-2480				Asher G, 2006, BIOCHEMISTRY-US, V45, P6372, DOI 10.1021/bi0600087; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEINERT WD, 1985, EUR J BIOCHEM, V152, P573, DOI 10.1111/j.1432-1033.1985.tb09234.x; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng Z, 1999, NAT STRUCT BIOL, V6, P847; DIXON DA, 1979, BIOCHEMISTRY-US, V18, P5770, DOI 10.1021/bi00593a004; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Faig M, 2000, P NATL ACAD SCI USA, V97, P3177, DOI 10.1073/pnas.050585797; Foster CE, 1999, BIOCHEMISTRY-US, V38, P9881, DOI 10.1021/bi990799v; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; Ghosh Dilip K., 1993, Indian Journal of Experimental Biology, V31, P951; GHOSH DK, 1992, FEMS MICROBIOL LETT, V98, P229, DOI 10.1016/0378-1097(92)90161-G; Harrison A, 2005, J BACTERIOL, V187, P4627, DOI 10.1128/JB.187.13.4627-4636.2005; HUANG MT, 1979, J BIOL CHEM, V254, P3930; Ito K, 2005, ACTA CRYSTALLOGR F, V61, P399, DOI 10.1107/S1744309105007918; Ito K, 2006, J BIOL CHEM, V281, P20567, DOI 10.1074/jbc.M513345200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Khan H, 2002, J BIOL CHEM, V277, P21906, DOI 10.1074/jbc.M200637200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LI RB, 1995, P NATL ACAD SCI USA, V92, P8846, DOI 10.1073/pnas.92.19.8846; Liger D, 2004, J BIOL CHEM, V279, P34890, DOI 10.1074/jbc.M405404200; Maier J, 2004, APPL ENVIRON MICROB, V70, P837, DOI 10.1128/AEM.70.2.837-844.2004; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Moutaouakkil A, 2003, ARCH BIOCHEM BIOPHYS, V413, P139, DOI 10.1016/S0003-9861(03)00096-1; Muller F, 1991, CHEM BIOCH FLAVOENZY, V1, P1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai S, 1999, THEOR CHEM ACC, V103, P109, DOI 10.1007/s002140050521; Nakanishi M, 2001, J BIOL CHEM, V276, P46394, DOI 10.1074/jbc.M104483200; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; RAFII F, 1993, APPL ENVIRON MICROB, V59, P1731, DOI 10.1128/AEM.59.6.1731-1734.1993; Ramalho PA, 2005, APPL ENVIRON MICROB, V71, P3882, DOI 10.1128/AEM.71.7.3882-3888.2005; Suzuki Y, 2001, J BIOL CHEM, V276, P9059, DOI 10.1074/jbc.M008083200; TRUS BL, 1969, ACTA CRYSTALL B-STRU, VB 25, P1911, DOI 10.1107/S0567740869004900; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zheng YJ, 1996, J AM CHEM SOC, V118, P9402, DOI 10.1021/ja9608151; ZIMMERMANN T, 1984, ARCH MICROBIOL, V138, P37, DOI 10.1007/BF00425404; ZIMMERMANN T, 1982, EUR J BIOCHEM, V129, P197, DOI 10.1111/j.1432-1033.1982.tb07040.x	43	45	50	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13889	13896		10.1074/jbc.M710070200	http://dx.doi.org/10.1074/jbc.M710070200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18337254	hybrid			2022-12-25	WOS:000255728200042
J	Papakostas, K; Georgopoulou, E; Frillingos, S				Papakostas, Konstantinos; Georgopoulou, Ekaterini; Frillingos, Stathis			Cysteine-scanning analysis of putative helix XII in the YgfO xanthine permease - Ile-432 and Asn-430 are important	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ASPERGILLUS-NIDULANS; PURINE TRANSPORTERS; LACTOSE PERMEASE; FUNCTIONAL-CHARACTERIZATION; NUCLEOBASE TRANSPORTERS; MEMBRANE-PROTEINS; CARRIER PROTEIN; SIGNATURE MOTIF; NAT/NCS2 FAMILY	Transmembrane helix XII of UapA, the major fungal homolog of the nucleobase-ascorbate transporter (NAT/NCS2) family, has been proposed to contain an aromatic residue acting as a purine-selectivity filter, distinct from the binding site. To analyze the role of helix XII more systematically, we employed Cys-scanning mutagenesis of the Escherichia coli xanthine-specific homolog YgfO. Using a functional mutant devoid of Cys residues (C-less), each amino acid residue in sequence (419)ILPASIYVLVENPICAGGLTAILLNIILPGGY(450) ( the putative helix XII is underlined) was replaced individually with Cys. Of the 32 single-Cys mutants, 25 accumulate xanthine to 80-130% of the steady state observed with C-less YgfO, six (P421C, S423C, I424C, Y425C, L427C, G436C) accumulate to low levels (15-40%), and I432C is inactive. Immunoblot analysis shows that P421C and I432C display low expression in the membrane. Extensive mutagenesis reveals that replacement of Ile-432 with equally or more bulky side chains abolishes active transport without affecting expression, whereas replacement with smaller side chains allows activity but impairs affinity for the analogues 1-methyl and 6-thioxanthine. Only three of the single-Cys mutants of helix XII (V426C, N430C, and N443C) are sensitive to inactivation by N-ethylmaleimide. N430C is highly sensitive, with an IC50 of 10 mu M, and is completely protected against inactivation in the presence of 2-thioxanthine, a high affinity substrate analogue. Other xanthine analogues are poorly bound by N430C, whereas replacement of Asn-430 with Thr inactivates the permease. The findings suggest that Ile-432 and Asn-430 of helix XII are crucial for purine uptake and affinity, and Asn-430 is probably at the vicinity of the binding site.	[Papakostas, Konstantinos; Georgopoulou, Ekaterini; Frillingos, Stathis] Univ Loannina Med Sch, Biol Chem Lab, Loannina 45110, Greece		Frillingos, S (corresponding author), Univ Loannina Med Sch, Biol Chem Lab, Loannina 45110, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021					Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Amillis S, 2001, J MOL BIOL, V313, P765, DOI 10.1006/jmbi.2001.5087; Argyrou E, 2001, PLANT CELL, V13, P953, DOI 10.1105/tpc.13.4.953; CARRASCO N, 1984, P NATL ACAD SCI-BIOL, V81, P4672, DOI 10.1073/pnas.81.15.4672; de Koning H, 2000, MOL MEMBR BIOL, V17, P75; Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; DIALLINAS G, 1989, GENETICS, V122, P341; FRILLINGOS S, 1994, BIOCHEMISTRY-US, V33, P8074, DOI 10.1021/bi00192a012; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Goudela S, 2005, MOL MEMBR BIOL, V22, P263, DOI 10.1080/09687860500093016; Goudela S, 2008, FUNGAL GENET BIOL, V45, P459, DOI 10.1016/j.fgb.2007.08.001; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Liang WJ, 2001, MOL MEMBR BIOL, V18, P87, DOI 10.1080/09687680120706; Meintanis C, 2000, MOL MEMBR BIOL, V17, P47; Pantazopoulou A, 2007, FEMS MICROBIOL REV, V31, P657, DOI 10.1111/j.1574-6976.2007.00083.x; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Vlanti A, 2006, J MOL BIOL, V357, P808, DOI 10.1016/j.jmb.2005.12.070	24	25	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13666	13678		10.1074/jbc.M800261200	http://dx.doi.org/10.1074/jbc.M800261200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359771	hybrid			2022-12-25	WOS:000255728200018
J	Pavon, LR; Lundh, F; Lundin, B; Mishra, A; Persson, BL; Spetea, C				Pavon, Lorena Ruiz; Lundh, Fredrik; Lundin, Bjoern; Mishra, Arti; Persson, Bengt L.; Spetea, Cornelia			Arabidopsis ANTR1 is a thylakoid Na+-dependent phosphate transporter - Functional characterization in escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED-CHLOROPLASTS; INORGANIC-PHOSPHATE; IN-VIVO; EXPRESSION; MEMBRANE; ENVELOPE; PROTEIN; CARRIER; CDNA; COTRANSPORTERS	In this study, the putative anion transporter 1 (ANTR1) from Arabidopsis thaliana was shown to be localized to the chloroplast thylakoid membrane by Western blotting with two different peptide-specific antibodies. ANTR1 is homologous to the type I of mammalian Na+-dependent inorganic phosphate ( Pi) transporters. The function of ANTR1 as a Na+-dependent Pi transporter was demonstrated by heterologous expression and uptake of radioactive Pi into Escherichia coli cells. The expression of ANTR1 conferred increased growth rates to the transformed cells and stimulated Pi uptake in a pH- and Na+-dependent manner as compared with the control cells. Among various tested effectors, Pi was the preferred substrate. Although it competed with the uptake of Pi, glutamate was not transported by ANTR1 into E. coli. In relation to its function as a Pi transporter, several physiological roles for ANTR1 in the thylakoid membrane are proposed, such as export of Pi produced during nucleotide metabolism in the thylakoid lumen back to the chloroplast stroma and balance of the trans-thylakoid H+ electrochemical gradient storage.	[Pavon, Lorena Ruiz; Lundin, Bjoern; Mishra, Arti; Spetea, Cornelia] Linkoping Univ, Dept Phys Chem & Biol, Div Mol Genet, SE-58183 Linkoping, Sweden; [Lundh, Fredrik; Persson, Bengt L.] Kalmar Univ, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden	Linkoping University; Linnaeus University; University of Kalmar	Persson, BL (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Div Mol Genet, SE-58183 Linkoping, Sweden.	corsp@ifm.liu.se	Wiklund, Cornelia Spetea/S-3635-2019	Mishra, Arti/0000-0002-5214-0676				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bottger P, 2006, AM J PHYSIOL-CELL PH, V291, pC1377, DOI 10.1152/ajpcell.00015.2006; Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741; DEGUCHI Y, 1990, J BIOL CHEM, V265, P21704; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Flugge UI, 1999, ANNU REV PLANT PHYS, V50, P27, DOI 10.1146/annurev.arplant.50.1.27; Harris RM, 2001, J BACTERIOL, V183, P5008, DOI 10.1128/JB.183.17.5008-5014.2001; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Kanazawa A, 2002, P NATL ACAD SCI USA, V99, P12789, DOI 10.1073/pnas.182427499; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; Lebens M, 2002, J BACTERIOL, V184, P4466, DOI 10.1128/JB.184.16.4466-4474.2002; Lemieux MJ, 2007, MOL MEMBR BIOL, V24, P333, DOI 10.1080/09687680701496507; LOLKEMA JS, 1994, BBA-BIOENERGETICS, V1187, P211, DOI 10.1016/0005-2728(94)90113-9; MIYAMOTO KI, 1995, BIOCHEM J, V305, P81, DOI 10.1042/bj3050081; RAO NN, 1990, MOL MICROBIOL, V4, P1083, DOI 10.1111/j.1365-2958.1990.tb00682.x; Rausch C, 2002, PLANTA, V216, P23, DOI 10.1007/s00425-002-0921-3; Reid RJ, 2000, PLANT CELL ENVIRON, V23, P223, DOI 10.1046/j.1365-3040.2000.00524.x; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; ROBINSON SP, 1987, AUST J PLANT PHYSIOL, V14, P451, DOI 10.1071/PP9870451; ROBINSON SP, 1983, PLANT PHYSIOL, V73, P238, DOI 10.1104/pp.73.2.238; Rolland N, 2003, PHOTOSYNTH RES, V78, P205, DOI 10.1023/B:PRES.0000006891.12416.6c; Roth C, 2004, PLANTA, V218, P406, DOI 10.1007/s00425-003-1121-5; Rubio L, 2005, J EXP BOT, V56, P613, DOI 10.1093/jxb/eri053; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; SHARKEY TD, 1989, PLANT PHYSIOL, V91, P679, DOI 10.1104/pp.91.2.679; Spetea C, 2004, P NATL ACAD SCI USA, V101, P1409, DOI 10.1073/pnas.0308164100; Takizawa K, 2008, PLANT CELL ENVIRON, V31, P235, DOI 10.1111/j.1365-3040.2007.01753.x; Thuswaldner S, 2007, J BIOL CHEM, V282, P8848, DOI 10.1074/jbc.M609130200; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Weber APM, 2005, ANNU REV PLANT BIOL, V56, P133, DOI 10.1146/annurev.arplant.56.032604.144228; Werner A, 1998, J EXP BIOL, V201, P3135; WERNER A, 1991, P NATL ACAD SCI USA, V88, P9608, DOI 10.1073/pnas.88.21.9608; Zimmermann P, 2005, TRENDS PLANT SCI, V10, P407, DOI 10.1016/j.tplants.2005.07.003	35	47	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13520	13527		10.1074/jbc.M709371200	http://dx.doi.org/10.1074/jbc.M709371200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353780	hybrid			2022-12-25	WOS:000255728200005
J	Drew, ME; Banerjee, R; Uffman, EW; Gilbertson, S; Rosenthal, PJ; Goldberg, DE				Drew, Mark E.; Banerjee, Ritu; Uffman, Eric W.; Gilbertson, Scott; Rosenthal, Philip J.; Goldberg, Daniel E.			Plasmodium food vacuole plasmepsins are activated by falcipains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEASES; HEMOGLOBIN DEGRADATION; ASPARTIC PROTEASES; EXPRESSION; ROLES; BIOSYNTHESIS; TRAFFICKING; PROTEINASE; INVASION	Intraerythrocytic malaria parasites use host hemoglobin as a major nutrient source. Aspartic proteases (plasmepsins) and cysteine proteases (falcipains) function in the early steps of the hemoglobin degradation pathway. There is extensive functional redundancy within and between these protease families. Plasmepsins are synthesized as integral membrane proenzymes that are activated by cleavage from the membrane. This cleavage is mediated by a maturase activity whose identity has been elusive. We have used a combination of cell biology, chemical biology, and enzymology approaches to analyze this processing event. These studies reveal that plasmepsin processing occurs primarily via the falcipains; however, if falcipain activity is blocked, autoprocessing can take place, serving as an alternate activation system. These results establish a further level of redundancy between the protease families involved in Plasmodium hemoglobin degradation.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med, St Louis, MO 63110 USA; [Drew, Mark E.; Goldberg, Daniel E.] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA; [Banerjee, Ritu] Univ Calif San Francisco, Div Infect Dis, Dept Pediat, San Francisco, CA 94143 USA; [Uffman, Eric W.] Chemir Anal Serv, St Louis, MO 63043 USA; [Gilbertson, Scott] Univ Texas Galveston, Med Branch, Dept Pharmacol & Toxicol, Chem Biol Program, Galveston, TX 77555 USA; [Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); University of California System; University of California San Francisco; University of Texas System; University of Texas Medical Branch Galveston; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	goldberg@borcim.wustl.edu	Drew, Mark/E-2993-2011		Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [AI-035800, AI-47798] Funding Source: Medline; NICHD NIH HHS [T32 HD044331] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD044331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035800, R56AI035800, R01AI047798, R29AI035800] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Banerjee R, 2003, MOL BIOCHEM PARASIT, V129, P157, DOI 10.1016/S0166-6851(03)00119-1; Bonilla JA, 2007, INT J PARASITOL, V37, P317, DOI 10.1016/j.ijpara.2006.11.008; Bonilla JA, 2007, MOL MICROBIOL, V65, P64, DOI 10.1111/j.1365-2958.2007.05768.x; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Dahl EL, 2005, MOL BIOCHEM PARASIT, V139, P205, DOI 10.1016/j.molbiopara.2004.11.009; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; GLUZMAN IY, 1994, J CLIN INVEST, V93, P1602, DOI 10.1172/JCI117140; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; HILL J, 1994, FEBS LETT, V352, P155, DOI 10.1016/0014-5793(94)00940-6; Kim YM, 2006, J BIOCHEM, V139, P189, DOI 10.1093/jb/mvj018; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Klemba M, 2002, ANNU REV BIOCHEM, V71, P275, DOI 10.1146/annurev.biochem.71.090501.145453; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Luker KE, 1996, MOL BIOCHEM PARASIT, V79, P71, DOI 10.1016/0166-6851(96)02651-5; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; Ramjee MK, 2006, BIOCHEM J, V399, P47, DOI 10.1042/BJ20060422; ROSENTHAL PJ, 1988, J CLIN INVEST, V82, P1560, DOI 10.1172/JCI113766; Shenai BR, 2000, J BIOL CHEM, V275, P29000, DOI 10.1074/jbc.M004459200; Sijwali PS, 2001, BIOCHEM J, V360, P481, DOI 10.1042/0264-6021:3600481; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Singh N, 2006, EXP PARASITOL, V112, P187, DOI 10.1016/j.exppara.2005.10.007; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Subramanian S, 2007, J BIOL CHEM, V282, P24961, DOI 10.1074/jbc.M703316200	27	90	91	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12870	12876		10.1074/jbc.M708949200	http://dx.doi.org/10.1074/jbc.M708949200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308731	Green Published, hybrid			2022-12-25	WOS:000255499800023
J	Liu, L; Srikakulam, R; Winkelmann, DA				Liu, Li; Srikakulam, Rajani; Winkelmann, Donald A.			Unc45 activates hsp90-dependent folding of the myosin motor domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONE; RETICULOCYTE LYSATE; STRIATED-MUSCLE; UNC-45; PROTEIN; HSP90; SKELETAL; RNG3P; COLOCALIZES	Myosin folding and assembly in striated muscle are mediated by the general chaperones Hsc70 and Hsp90 and involve a myosin-specific co-chaperone related to the Caenorhabditis elegans gene unc-45. Two unc-45 genes are found in vertebrates, a general cell isoform, unc45a, and a striated muscle-specific isoform, unc45b. We have investigated the role of both isoforms of mouse Unc45 in myosin folding using an in vitro synthesis and folding assay. A smooth muscle myosin motor domain ( MD) fused to green fluorescent protein (GFP) ( MD:: GFP) was used as substrate, and folding was measured by native gel electrophoresis and functional assays. In the absence of Unc45, the MD:: GFP chimera folds poorly. Addition of either Unc45a or Unc45b dramatically enhances the folding in a reaction that is dependent on Hsp90 ATPase activity. Unc45a is more effective than Unc45b with a higher apparent affinity and greater extent of folding. The Unc45- Hsp90 chaperone complex acts late in the folding pathway and promotes motor domain maturation after release from the ribosome. Unc45a behaves kinetically as an activator of the folding reaction by stimulating the rate of the Hsp90-dependent folding by > 20-fold with an apparent K-act of 33 nM. This analysis of vertebrate Unc45 isoforms clearly demonstrates a direct role for Unc45 in Hsp90-mediated myosin motor domain folding and highlights major differences between the isoforms in substrate specificity and mechanism.	[Liu, Li; Srikakulam, Rajani; Winkelmann, Donald A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Winkelmann, DA (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA.	daw@pleiad.umdnj.edu			NIAMS NIH HHS [AR38454] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038454, R29AR038454] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Berteaux-Lecellier V, 1998, EMBO J, V17, P1248, DOI 10.1093/emboj/17.5.1248; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Chadli A, 2006, MOL CELL BIOL, V26, P1722, DOI 10.1128/MCB.26.5.1722-1730.2006; Chow D, 2002, J BIOL CHEM, V277, P36799, DOI 10.1074/jbc.M204101200; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Kachur T, 2004, J CELL SCI, V117, P5313, DOI 10.1242/jcs.01389; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Lord M, 2004, J CELL BIOL, V167, P315, DOI 10.1083/jcb.200404045; Mishra M, 2005, EUKARYOT CELL, V4, P567, DOI 10.1128/EC.4.3.567-576.2005; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Srikakulam R, 1999, J BIOL CHEM, V274, P27265, DOI 10.1074/jbc.274.38.27265; SRIKAKULAM R, 2008, IN PTRDD PLOS ONE; VENOLIA L, 1990, GENETICS, V126, P345; Wesche S, 2003, CURR BIOL, V13, P715, DOI 10.1016/S0960-9822(03)00264-1; WINKELMANN DA, 1986, J MOL BIOL, V188, P595, DOI 10.1016/S0022-2836(86)80009-2; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Wong KCY, 2000, J CELL SCI, V113, P2421; Zhao RM, 2007, ADV EXP MED BIOL, V594, P27	33	59	62	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13185	13193		10.1074/jbc.M800757200	http://dx.doi.org/10.1074/jbc.M800757200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326487	Green Published, hybrid			2022-12-25	WOS:000255499800058
J	Son, M; Leary, SC; Romain, N; Pierrel, F; Winge, DR; Haller, RG; Elliott, JL				Son, Marjatta; Leary, Scot C.; Romain, Nadine; Pierrel, Fabien; Winge, Dennis R.; Haller, Ronald G.; Elliott, Jeffrey L.			Isolated cytochrome C oxidase deficiency in G93A SOD1 mice overexpressing CCS protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; OXIDATIVE-PHOSPHORYLATION; TRANSGENIC MICE; CELL-DEATH; HEME-A; HYPERTROPHIC CARDIOMYOPATHY; MITOCHONDRIAL DYSFUNCTION; NATIVE-ELECTROPHORESIS; BIOSYNTHETIC-PATHWAY	G93A SOD1 transgenic mice overexpressing CCS protein develop an accelerated disease course that is associated with enhanced mitochondrial pathology and increased mitochondrial localization of mutant SOD1. Because these results suggest an effect of mutant SOD1 on mitochondrial function, we assessed the enzymatic activities of mitochondrial respiratory chain complexes in the spinal cords of CCS/G93A SOD1 and control mice. CCS/G93A SOD1 mouse spinal cord demonstrates a 55% loss of complex IV (cytochrome c oxidase) activity compared with spinal cord from age-matched non-transgenic or G93A SOD1 mice. In contrast, CCS/G93A SOD1 spinal cord shows no reduction in the activities of complex I, II, or III. Blue native gel analysis further demonstrates a marked reduction in the levels of complex IV but not of complex I, II, III, or V in spinal cords of CCS/G93A SOD1 mice compared with non-transgenic, G93A SOD1, or CCS/WT SOD1 controls. With SDS-PAGE analysis, spinal cords from CCS/G93A SOD1 mice showed significant decreases in the levels of two structural subunits of cytochrome c oxidase, COX1 and COX5b, relative to controls. In contrast, CCS/G93A SOD1 mouse spinal cord showed no reduction in levels of selected subunits from complexes I, II, III, or V. Heme A analyses of spinal cord further support the existence of cytochrome c oxidase deficiency in CCS/G93A SOD1 mice. Collectively, these results establish that CCS/G93A SOD1 mice manifest an isolated complex IV deficiency which may underlie a substantial part of mutant SOD1-induced mitochondrial cytopathy.	[Son, Marjatta; Haller, Ronald G.; Elliott, Jeffrey L.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Leary, Scot C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Haller, Ronald G.] Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA; [Romain, Nadine; Haller, Ronald G.] Inst Exercise & Environm Med, Dallas, TX 75232 USA; [Pierrel, Fabien; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Pierrel, Fabien; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; McGill University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Elliott, JL (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	elliott@utsouthwestern.edu	PIERREL, Fabien/M-6016-2014; Winge, Dennis/G-3611-2010; Leary, Scot/B-3036-2012	PIERREL, Fabien/0000-0003-2083-3002; Romain, Nadine/0000-0003-2492-549X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055315] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM083292] Funding Source: Medline; NINDS NIH HHS [NS055315] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038; Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Barros MH, 2002, FEBS LETT, V516, P119, DOI 10.1016/S0014-5793(02)02514-0; Barros MH, 2001, FEBS LETT, V492, P133, DOI 10.1016/S0014-5793(01)02249-9; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Bertamini M, 2002, EUR J NEUROSCI, V16, P2291, DOI 10.1046/j.1460-9568.2002.02299.x; Borisov VB, 2002, MOL ASPECTS MED, V23, P385, DOI 10.1016/S0098-2997(02)00013-4; Bosetti F, 2002, NEUROBIOL AGING, V23, P371, DOI 10.1016/S0197-4580(01)00314-1; Browne SE, 1998, J NEUROCHEM, V71, P281; Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546; Bugiani M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029926; Campos Y, 2001, ANN NEUROL, V50, P409, DOI 10.1002/ana.1141; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kirkinezos IG, 2005, J NEUROSCI, V25, P164, DOI 10.1523/JNEUROSCI.3829-04.2005; KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523; Leary SC, 2004, HUM MOL GENET, V13, P1839, DOI 10.1093/hmg/ddh197; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Moraes CT, 2004, BBA-BIOENERGETICS, V1659, P153, DOI 10.1016/j.bbabio.2004.09.002; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Papadopoulou LC, 1999, NAT GENET, V23, P333; Puttaparthi K, 2002, J NEUROSCI, V22, P8790; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rubio-Gozalbo ME, 1999, NEUROLOGY, V52, P383, DOI 10.1212/WNL.52.2.383; Sasaki S, 2004, ACTA NEUROPATHOL, V107, P461, DOI 10.1007/s00401-004-0837-z; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Son M, 2003, J BIOL CHEM, V278, P14331, DOI 10.1074/jbc.M211698200; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Stiburek L, 2005, BIOCHEM J, V392, P625, DOI 10.1042/BJ20050807; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050; Takahashi Y, 2002, MOL CELL BIOL, V22, P7614, DOI 10.1128/MCB.22.21.7614-7621.2002; Takeuchi H, 2002, J BIOL CHEM, V277, P50966, DOI 10.1074/jbc.M209356200; Thierbach R, 2005, HUM MOL GENET, V14, P3857, DOI 10.1093/hmg/ddi410; Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Valnot I, 2000, AM J HUM GENET, V67, P1104; Vesela K, 2004, ACTA PAEDIATR, V93, P1312, DOI 10.1080/08035250410031341; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7	57	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12267	12275		10.1074/jbc.M708523200	http://dx.doi.org/10.1074/jbc.M708523200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18334481	Green Published, hybrid			2022-12-25	WOS:000255340000043
J	Fan, CG; Bobik, TA				Fan, Chenguang; Bobik, Thomas A.			The PduX enzyme of Salmonella enterica is an L-threonine kinase used for coenzyme B-12 synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; VITAMIN-B12 BIOSYNTHETIC GENES; SEROVAR TYPHIMURIUM LT2; ESCHERICHIA-COLI; COBALAMIN BIOSYNTHESIS; PROTEIN; INTERMEDIATE; TRANSPORT	Here, the PduX enzyme of Salmonella enterica is shown to be an L-threonine kinase used for the de novo synthesis of coenzyme B-12 and the assimilation of cobyric acid (Cby). PduX with a C-terminal His tag (PduX-His(6)) was produced at high levels in Escherichia coli, purified by nickel affinity chromatography, and partially characterized. P-31 NMR spectroscopy established that purified PduX-His(6) catalyzed the conversion of L-threonine and ATP to L-threonine-O-3-phosphate and ADP. Enzyme assays showed that ATP was the preferred substrate compared with GTP, CTP, or UTP. PduX displayed Michaelis-Menten kinetics with respect to both ATP and L-threonine and nonlinear regression was used to determine the following kinetic constants: V-max = 62.1 +/- 3.6 nmol min(-1) mg of protein(-1); K-m,K-ATP = 54.7 +/- 5.7 mu M and K-m,K-Thr = 146.1 +/- 8.4 mu M. Growth studies showed that pduX mutants were impaired for the synthesis of coenzyme B-12 de novo and from Cby, but not from cobinamide, which was the expected phenotype for an L-threonine kinase mutant. The defect in Cby assimilation was corrected by ectopic expression of pduX or by supplementation of growth medium with L-threonine-O-3-phosphate, providing further support that PduX is an L-threonine kinase. In addition, a bioassay showed that a pduX mutant was impaired for the de novo synthesis of coenzyme B-12 as expected. Collectively, the genetic and biochemical studies presented here show that PduX is an L-threonine kinase used for AdoCbl synthesis. To our knowledge, PduX is the first enzyme shown to phosphorylate free L-threonine and the first L-threonine kinase shown to function in coenzyme B-12 synthesis.	[Fan, Chenguang; Bobik, Thomas A.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Iowa City, IA 50011 USA	Iowa State University	Bobik, TA (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Iowa City, IA 50011 USA.	bobik@iastate.edu	Fan, Cheguang/O-9709-2016	Fan, Cheguang/0000-0003-0662-1185				AILION M, 1993, J BACTERIOL, V175, P7200, DOI 10.1128/JB.175.22.7200-7208.1993; Banerjee R., 1999, CHEM BIOCH B 12; BATTERSBY AR, 1994, SCIENCE, V264, P1551, DOI 10.1126/science.8202709; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; BORK P, 1993, PROTEIN SCI, V2, P31; Brushaber KR, 1998, J BIOL CHEM, V273, P2684, DOI 10.1074/jbc.273.5.2684; CAUTHEN SE, 1966, BIOCHEM J, V98, P630, DOI 10.1042/bj0980630; DEVEAUX LC, 1986, J BACTERIOL, V167, P920, DOI 10.1128/jb.167.3.920-927.1986; Escalante-Semerena JC, 2007, J BACTERIOL, V189, P4555, DOI 10.1128/JB.00503-07; ESCALANTESEMERENA JC, 1990, J BACTERIOL, V172, P273, DOI 10.1128/JB.172.1.273-280.1990; FUJII K, 1974, J BIOL CHEM, V249, P6745; GRABAU C, 1992, J BACTERIOL, V174, P2138, DOI 10.1128/JB.174.7.2138-2144.1992; HELLER K, 1985, J BACTERIOL, V161, P904, DOI 10.1128/JB.161.3.904-908.1985; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; JETER RM, 1990, J GEN MICROBIOL, V136, P887, DOI 10.1099/00221287-136-5-887; JETER RM, 1984, J BACTERIOL, V159, P206, DOI 10.1128/JB.159.1.206-213.1984; JETER RM, 1987, J BACTERIOL, V169, P3189, DOI 10.1128/jb.169.7.3189-3198.1987; Johnson CLV, 2001, J BACTERIOL, V183, P1577, DOI 10.1128/JB.183.5.1577-1584.2001; Krautler B, 2005, BIOCHEM SOC T, V33, P806; Liu Y, 2007, J BACTERIOL, V189, P1589, DOI 10.1128/JB.01151-06; Matthews R. G., 1999, Chemistry and biochemistry of B12., P681; NEUHARD J, 1987, ESCHERICHIA COLI SAL, P447; OTOOLE GA, 1995, J BIOL CHEM, V270, P23560, DOI 10.1074/jbc.270.40.23560; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Roessner CA, 2006, J BACTERIOL, V188, P7331, DOI 10.1128/JB.00918-06; RONDON MR, 1992, J BACTERIOL, V174, P2267, DOI 10.1128/JB.174.7.2267-2272.1992; ROOF DM, 1988, J BACTERIOL, V170, P3855, DOI 10.1128/jb.170.9.3855-3863.1988; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schneider Z., 1987, COMPREHENSIVE B12 CH; Scott AI, 2003, J ORG CHEM, V68, P2529, DOI 10.1021/jo020728t; Van Bibber M, 1999, J BACTERIOL, V181, P5539, DOI 10.1128/JB.181.17.5539-5541.1999; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Zayas CL, 2007, J BACTERIOL, V189, P2210, DOI 10.1128/JB.01665-06	36	39	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11322	11329		10.1074/jbc.M800287200	http://dx.doi.org/10.1074/jbc.M800287200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18308727	hybrid			2022-12-25	WOS:000255067400028
J	Mariappan, M; Gande, SL; Radhakrishnan, K; Schmidt, B; Dierks, T; von Figura, K				Mariappan, Malaiyalam; Gande, Santosh Lakshmi; Radhakrishnan, Karthikeyan; Schmidt, Bernhard; Dierks, Thomas; von Figura, Kurt			The non-catalytic N-terminal extension of formylglycine-generating enzyme is required for its biological activity and retention in the endoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SULFATASE DEFICIENCY; PROTEIN MODIFICATION; MODIFYING FACTOR-1; OXIDASE ERV2P; MUTATIONS; CYSTEINE; PARALOG; ERP44; GENE; DETERMINANTS	Formylglycine-generating enzyme (FGE) catalyzes the oxidation of a specific cysteine residue in nascent sulfatase polypeptides to formylglycine (FGly). This FGly is part of the active site of all sulfatases and is required for their catalytic activity. Here we demonstrate that residues 34-68 constitute an N-terminal extension of the FGE catalytic core that is dispensable for in vitro enzymatic activity of FGE but is required for its in vivo activity in the endoplasmic reticulum (ER), i.e. for generation of FGly residues in nascent sulfatases. In addition, this extension is needed for the retention of FGE in the ER. Fusing a KDEL retention signal to the C terminus of FGE is sufficient to mediate retention of an N-terminally truncated FGE but not sufficient to restore its biological activity. Fusion of FGE residues 1-88 to secretory proteins resulted in ER retention of the fusion protein. Moreover, when fused to the paralog of FGE (pFGE), which itself lacks FGly-generating activity, the FGE extension ( residues 34-88) of this hybrid construct led to partial restoration of the biological activity of co-expressed N-terminally truncated FGE. Within the FGE N-terminal extension cysteine 52 is critical for the biological activity. We postulate that this N-terminal region of FGE mediates the interaction with an ER component to be identified and that this interaction is required for both the generation of FGly residues in nascent sulfatase polypeptides and for retention of FGE in the ER.	[Mariappan, Malaiyalam; Gande, Santosh Lakshmi; Schmidt, Bernhard; von Figura, Kurt] Univ Gottingen, Biochem Abt 2, Zentrum Biochem & Mol Zellbiol, D-37073 Gottingen, Germany; [Radhakrishnan, Karthikeyan; Dierks, Thomas] Univ Bielefeld, Fac Chem, D-33615 Bielefeld, Germany	University of Gottingen; University of Bielefeld	von Figura, K (corresponding author), Univ Gottingen, Biochem Abt 2, Zentrum Biochem & Mol Zellbiol, Heinrich Duker Weg 12, D-37073 Gottingen, Germany.	kurt.figura@zvw.uni-goettingen.de	mariappan, malaiyalam/K-9024-2012; Dierks, Thomas/A-3596-2012	Dierks, Thomas/0000-0001-6426-1339; Radhakrishnan, Karthikeyan/0000-0003-1731-7410				Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844; Annunziata Ida, 2007, Hum Mutat, V28, P928, DOI 10.1002/humu.9504; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Cosma MP, 2004, HUM MUTAT, V23, P576, DOI 10.1002/humu.20040; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Dickmanns A, 2005, J BIOL CHEM, V280, P15180, DOI 10.1074/jbc.M414317200; Dierks T, 1997, P NATL ACAD SCI USA, V94, P11963, DOI 10.1073/pnas.94.22.11963; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; Dierks T, 1999, EMBO J, V18, P2084, DOI 10.1093/emboj/18.8.2084; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Gande SL, 2008, FEBS J, V275, P1118, DOI 10.1111/j.1742-4658.2008.06271.x; GIESELMANN V, 1992, J BIOL CHEM, V267, P13262; GLOSSL J, 1978, CLIN CHIM ACTA, V88, P111, DOI 10.1016/0009-8981(78)90157-2; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; Mariappan M, 2005, J BIOL CHEM, V280, P15173, DOI 10.1074/jbc.M413698200; Mariappan M, 2008, J BIOL CHEM, V283, P6375, DOI 10.1074/jbc.M709171200; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Roeser D, 2006, P NATL ACAD SCI USA, V103, P81, DOI 10.1073/pnas.0507592102; ROMMERSKIRCH W, 1992, P NATL ACAD SCI USA, V89, P2561, DOI 10.1073/pnas.89.7.2561; Schlotawa Lars, 2008, Hum Mutat, V29, P205, DOI 10.1002/humu.9515; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vala A, 2005, J MOL BIOL, V354, P952, DOI 10.1016/j.jmb.2005.09.076; von Figura K, 1998, BIOESSAYS, V20, P505, DOI 10.1002/(SICI)1521-1878(199806)20:6<505::AID-BIES9>3.0.CO;2-K; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; ZHANG RM, 1989, J BIOL CHEM, V264, P18472; Zito E, 2005, EMBO REP, V6, P655, DOI 10.1038/sj.embor.7400454; Zito E, 2007, EMBO J, V26, P2443, DOI 10.1038/sj.emboj.7601695	32	14	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11556	11564		10.1074/jbc.M707858200	http://dx.doi.org/10.1074/jbc.M707858200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18305113	hybrid			2022-12-25	WOS:000255067400056
J	Bourret, TJ; Porwollik, S; McClelland, M; Zhao, R; Greco, T; Ischiropoulos, H; Vazquez-Torres, A				Bourret, Travis J.; Porwollik, Steffen; McClelland, Michael; Zhao, Rui; Greco, Todd; Ischiropoulos, Harry; Vazquez-Torres, Andres			Nitric Oxide Antagonizes the Acid Tolerance Response that Protects Salmonella against Innate Gastric Defenses	PLOS ONE			English	Article								Background: Reactive nitrogen species (RNS) derived from dietary and salivary inorganic nitrogen oxides foment innate host defenses associated with the acidity of the stomach. The mechanisms by which these reactive species exert antimicrobial activity in the gastric lumen are, however, poorly understood. Methodology/Principal Findings: The genetically tractable acid tolerance response (ATR) that enables enteropathogens to survive harsh acidity was screened for signaling pathways responsive to RNS. The nitric oxide ( NO) donor spermine NONOate derepressed the Fur regulon that controls secondary lines of resistance against organic acids. Despite inducing a Fur-mediated adaptive response, acidified RNS largely repressed oral virulence as demonstrated by the fact that Salmonella bacteria exposed to NO donors during mildly acidic conditions were shed in low amounts in feces and exhibited ameliorated oral virulence. NO prevented Salmonella from mounting a de novo ATR, but was unable to suppress an already functional protective response, suggesting that RNS target regulatory cascades but not their effectors. Transcriptional and translational analyses revealed that the PhoPQ signaling cascade is a critical ATR target of NO in rapidly growing Salmonella. Inhibition of PhoPQ signaling appears to contribute to most of the NO-mediated abrogation of the ATR in log phase bacteria, because the augmented acid sensitivity of phoQ-deficient Salmonella was not further enhanced after RNS treatment. Conclusions/Significance: Since PhoPQ-regulated acid resistance is widespread in enteric pathogens, the RNS-mediated inhibition of the Salmonella ATR described herein may represent a common component of innate host defenses.	[Bourret, Travis J.; Vazquez-Torres, Andres] Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Aurora, CO USA; [Porwollik, Steffen; McClelland, Michael] Sidney Kimmel Canc Ctr, San Diego, CA USA; [Zhao, Rui] Univ Colorado, Hlth Sci Ctr, Dept Biomol Structure, Aurora, CO USA; [Greco, Todd; Ischiropoulos, Harry] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA USA; [Greco, Todd] Univ Penn, Childrens Hosp Philadelphia, Dept Pharmacol, Philadelphia, PA USA; [Ischiropoulos, Harry] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Bourret, TJ (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Aurora, CO USA.	andres.vazquez-torres@uchsc.edu	McClelland, Michael/A-8583-2011; Bourret, Travis/J-4673-2019	McClelland, Michael/0000-0003-1788-9347; Bourret, Travis/0000-0002-4154-929X	National Institutes of Health [AI54959, T32 AI52066]; Burroughs Wellcome Fund; Schweppe Foundation; NIEHS Center of Excellence in Environmental Toxicology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054959, R56AI054959, T32AI052066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Schweppe Foundation; NIEHS Center of Excellence in Environmental Toxicology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support of this work was provided by the National Institutes of Health (AI54959 and T32 AI52066), the Burroughs Wellcome Fund, the Schweppe Foundation and the NIEHS Center of Excellence in Environmental Toxicology.	Adams P, 2001, PROTEOMICS, V1, P597, DOI 10.1002/1615-9861(200104)1:4<597::AID-PROT597>3.0.CO;2-P; Aiso T, 2003, GENES CELLS, V8, P179, DOI 10.1046/j.1365-2443.2003.00624.x; Bacon RT, 2003, J FOOD PROTECT, V66, P732, DOI 10.4315/0362-028X-66.5.732; Bang IS, 2000, J BACTERIOL, V182, P2245, DOI 10.1128/JB.182.8.2245-2252.2000; Baumler AJ, 1996, GENE, V183, P207, DOI 10.1016/S0378-1119(96)00560-4; Bearson BL, 1998, J BACTERIOL, V180, P2409, DOI 10.1128/JB.180.9.2409-2417.1998; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Bjorne H, 2006, FREE RADICAL BIO MED, V41, P1404, DOI 10.1016/j.freeradbiomed.2006.07.020; BUCHIN PJ, 1980, J CLIN GASTROENTEROL, V2, P133, DOI 10.1097/00004836-198006000-00005; Butler CS, 1997, BIOCHEMISTRY-US, V36, P16259, DOI 10.1021/bi971481a; Canani RB, 2006, PEDIATRICS, V117, pE817, DOI 10.1542/peds.2005-1655; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; COOK GC, 1985, SCAND J GASTROENTERO, V20, P17, DOI 10.3109/00365528509093751; Cunningham R, 2003, J HOSP INFECT, V54, P243, DOI 10.1016/S0195-6701(03)00088-4; D'Autreaux B, 2002, P NATL ACAD SCI USA, V99, P16619, DOI 10.1073/pnas.252591299; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; DORMAN CJ, 1989, INFECT IMMUN, V57, P2136, DOI 10.1128/IAI.57.7.2136-2140.1989; DRESSMAN JB, 1990, PHARMACEUT RES, V7, P756, DOI 10.1023/A:1015827908309; DUNCAN C, 1995, NAT MED, V1, P546, DOI 10.1038/nm0695-546; Dykhuizen RS, 1996, ANTIMICROB AGENTS CH, V40, P1422, DOI 10.1128/AAC.40.6.1422; Eichelberg K, 1999, INFECT IMMUN, V67, P4099, DOI 10.1128/IAI.67.8.4099-4105.1999; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; Fite A, 2004, ANTIMICROB AGENTS CH, V48, P655, DOI 10.1128/AAC.48.2.655-658.2004; FOSTER JW, 1991, J BACTERIOL, V173, P5129, DOI 10.1128/jb.173.16.5129-5135.1991; FOSTER JW, 1990, J BACTERIOL, V172, P771, DOI 10.1128/jb.172.2.771-778.1990; FOSTER JW, 1993, J BACTERIOL, V175, P1981, DOI 10.1128/JB.175.7.1981-1987.1993; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; GIANNELLA RA, 1972, GUT, V13, P251, DOI 10.1136/gut.13.4.251; Golubeva YA, 2006, J BACTERIOL, V188, P7853, DOI 10.1128/JB.00706-06; GROISMAN EA, 1992, P NATL ACAD SCI USA, V89, P11939, DOI 10.1073/pnas.89.24.11939; Hall HK, 1996, J BACTERIOL, V178, P5683, DOI 10.1128/jb.178.19.5683-5691.1996; HOLT P, 1985, PRACTITIONER, V229, P1027; Hori H, 1996, J BIOL CHEM, V271, P9254, DOI 10.1074/jbc.271.16.9254; Hung CR, 2004, EUR J PHARMACOL, V491, P61, DOI 10.1016/j.ejphar.2004.03.029; HUSAIN M, 2008, J BIOL CHEM IN PRESS; Klose KE, 1997, INFECT IMMUN, V65, P587, DOI 10.1128/IAI.65.2.587-596.1997; LEE IS, 1995, MOL MICROBIOL, V17, P155; Lee YH, 2007, J BACTERIOL, V189, P2417, DOI 10.1128/JB.01277-06; LEYER GJ, 1993, APPL ENVIRON MICROB, V59, P1842, DOI 10.1128/AEM.59.6.1842-1847.1993; Llama-Palacios A, 2003, MOL MICROBIOL, V49, P347, DOI 10.1046/j.1365-2958.2003.03583.x; McCollister BD, 2005, J EXP MED, V202, P625, DOI 10.1084/jem.20050246; McCollister BD, 2007, IMMUNOBIOLOGY, V212, P759, DOI 10.1016/j.imbio.2007.09.019; Miller JH., 1972, EXPT MOL GENETICS; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Monsieurs P, 2005, J MOL EVOL, V60, P462, DOI 10.1007/s00239-004-0212-7; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Porwollik S, 2003, NUCLEIC ACIDS RES, V31, P1869, DOI 10.1093/nar/gkg298; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Puzniak L, 2004, INFECT CONT HOSP EP, V25, P628, DOI 10.1086/502452; REYNAERT H, 1995, J GASTROENTEROL, V30, P775, DOI 10.1007/BF02349646; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; SPIEGELHALDER B, 1976, FOOD COSMET TOXICOL, V14, P545, DOI 10.1016/S0015-6264(76)80005-3; STOCKBRUEGGER RW, 1985, SCAND J GASTROENTERO, V20, P7, DOI 10.3109/00365528509093749; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; TANNENBAUM SR, 1976, FOOD COSMET TOXICOL, V14, P549, DOI 10.1016/S0015-6264(76)80006-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; van der Velden AWM, 1998, INFECT IMMUN, V66, P2803, DOI 10.1128/IAI.66.6.2803-2808.1998; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; Xu J, 2001, J APPL MICROBIOL, V90, P523, DOI 10.1046/j.1365-2672.2001.01278.x; Zhou DG, 1999, INFECT IMMUN, V67, P1974; Zhou DS, 2005, FEMS MICROBIOL LETT, V250, P85, DOI 10.1016/j.femsle.2005.06.053; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	71	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1833	10.1371/journal.pone.0001833	http://dx.doi.org/10.1371/journal.pone.0001833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350168	gold, Green Published			2022-12-25	WOS:000260762300034
J	Chiara, F; Castellaro, D; Marin, O; Petronilli, V; Brusilow, WS; Juhaszova, M; Sollott, SJ; Forte, M; Bernardi, P; Rasola, A				Chiara, Federica; Castellaro, Diego; Marin, Oriano; Petronilli, Valeria; Brusilow, William S.; Juhaszova, Magdalena; Sollott, Steven J.; Forte, Michael; Bernardi, Paolo; Rasola, Andrea			Hexokinase II Detachment from Mitochondria Triggers Apoptosis through the Permeability Transition Pore Independent of Voltage-Dependent Anion Channels	PLOS ONE			English	Article								Type II hexokinase is overexpressed in most neoplastic cells, and it mainly localizes on the outer mitochondrial membrane. Hexokinase II dissociation from mitochondria triggers apoptosis. The prevailing model postulates that hexokinase II release from its mitochondrial interactor, the voltage-dependent anion channel, prompts outer mitochondrial membrane permeabilization and the ensuing release of apoptogenic proteins, and that these events are inhibited by growth factor signalling. Here we show that a hexokinase II N-terminal peptide selectively detaches hexokinase II from mitochondria and activates apoptosis. These events are abrogated by inhibiting two established permeability transition pore modulators, the adenine nucleotide translocator or cyclophilin D, or in cyclophilin D knock-out cells. Conversely, insulin stimulation or genetic ablation of the voltage-dependent anion channel do not affect cell death induction by the hexokinase II peptide. Therefore, hexokinase II detachment from mitochondria transduces a permeability transition pore opening signal that results in cell death and does not require the voltage-dependent anion channel. These findings have profound implications for our understanding of the pathways of outer mitochondrial membrane permeabilization and their inactivation in tumors.	[Chiara, Federica; Castellaro, Diego; Petronilli, Valeria; Bernardi, Paolo; Rasola, Andrea] Univ Padua, CNR, Inst Neurosci, Dept Biomed Sci, Padua, Italy; [Marin, Oriano] Univ Padua, Venetian Inst Mol Med, Dept Biol Chem, Padua, Italy; [Brusilow, William S.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA; [Juhaszova, Magdalena; Sollott, Steven J.] NIH, Natl Inst Aging, Gerontol Res Ctr, Lab Cardiovascul Sci, Baltimore, MD USA; [Forte, Michael] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR USA	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; Veneto Institute Molecular Medicine; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Oregon Health & Science University	Chiara, F (corresponding author), Univ Padua, CNR, Inst Neurosci, Dept Biomed Sci, Padua, Italy.	bernardi@bio.unipd.it; rasola@bio.unipd.it	Bernardi, Paolo/C-3656-2008; Petronilli, Valeria/C-3558-2015	Bernardi, Paolo/0000-0001-9187-3736; Petronilli, Valeria/0000-0003-4026-6404; chiara, federica/0000-0003-2396-3080; Rasola, Andrea/0000-0003-4522-3008	Progetti di Ricerca di Interesse Nazionale del Ministero dell Universita e della Ricerca; USA NIH-PHS [GM69883]; Intramural Research Program, National Institute on Aging, NIH; AIRC; Progetti di Ateneo dell Universita di Padova; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000823] Funding Source: NIH RePORTER	Progetti di Ricerca di Interesse Nazionale del Ministero dell Universita e della Ricerca; USA NIH-PHS; Intramural Research Program, National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AIRC(Fondazione AIRC per la ricerca sul cancro); Progetti di Ateneo dell Universita di Padova; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was made possible by grants from the Progetti di Ricerca di Interesse Nazionale del Ministero dell Universita e della Ricerca (MIUR-PRIN, to P.B.), from the USA NIH-PHS (Grant GM69883 to M.F and P.B.), from the Intramural Research Program, National Institute on Aging, NIH (to M.J. and S.J.S.), from AIRC (to P.B.), and from Progetti di Ateneo dell Universita di Padova (to A.R.).	Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Belzacq AS, 2002, BIOCHIMIE, V84, P167, DOI 10.1016/S0300-9084(02)01366-4; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; BLACHLYDYSON E, 1993, J BIOL CHEM, V268, P1835; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Gramaglia D, 2004, CELL DEATH DIFFER, V11, P342, DOI 10.1038/sj.cdd.4401326; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; JUHASZOVA M, 2008, ANN N Y ACA IN PRESS; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; POSTIC C, 1994, AM J PHYSIOL, V266, pE548, DOI 10.1152/ajpendo.1994.266.4.E548; Rasola A, 2001, CYTOMETRY, V45, P151, DOI 10.1002/1097-0320(20011001)45:2<151::AID-CYTO1157>3.0.CO;2-I; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Vyssokikh M, 2004, MOL CELL BIOCHEM, V256, P117, DOI 10.1023/B:MCBI.0000009863.69249.d9; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wu SL, 1999, BBA-MOL CELL RES, V1452, P68, DOI 10.1016/S0167-4889(99)00120-2; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zhou H, 2005, EXP CELL RES, V309, P316, DOI 10.1016/j.yexcr.2005.06.014; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	42	214	221	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1852	10.1371/journal.pone.0001852	http://dx.doi.org/10.1371/journal.pone.0001852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350175	Green Published, Green Submitted, gold			2022-12-25	WOS:000260762300041
J	Bluteau, J; Coquillart, S; Payan, Y; Gentaz, E				Bluteau, Jeremy; Coquillart, Sabine; Payan, Yohan; Gentaz, Edouard			Haptic Guidance Improves the Visuo-Manual Tracking of Trajectories	PLOS ONE			English	Article							INTERNAL-MODELS; MOVEMENT	Background: Learning to perform new movements is usually achieved by following visual demonstrations. Haptic guidance by a force feedback device is a recent and original technology which provides additional proprioceptive cues during visuo-motor learning tasks. The effects of two types of haptic guidances-control in position (HGP) or in force (HGF)-on visuo-manual tracking ("following") of trajectories are still under debate. Methodology/Principals Findings: Three training techniques of haptic guidance (HGP, HGF or control condition, NHG, without haptic guidance) were evaluated in two experiments. Movements produced by adults were assessed in terms of shapes (dynamic time warping) and kinematics criteria (number of velocity peaks and mean velocity) before and after the training sessions. Trajectories consisted of two Arabic and two Japanese-inspired letters in Experiment 1 and ellipses in Experiment 2. We observed that the use of HGF globally improves the fluency of the visuo-manual tracking of trajectories while no significant improvement was found for HGP or NHG. Conclusion/Significance: These results show that the addition of haptic information, probably encoded in force coordinates, play a crucial role on the visuo-manual tracking of new trajectories.	[Bluteau, Jeremy; Coquillart, Sabine] Inst Natl Rech Informat & Automat, LIG, Grenoble, France; [Bluteau, Jeremy; Payan, Yohan] Univ Joseph Fourier, CNRS, TIMC IMAG, Grenoble, France; [Bluteau, Jeremy; Gentaz, Edouard] Univ Pierre Mendes France, CNRS, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Bluteau, J (corresponding author), Inst Natl Rech Informat & Automat, LIG, Grenoble, France.	edouard.gentaz@upmf-grenoble.fr	Payan, Yohan/N-3980-2019; PAYAN, Yohan/E-3993-2013	Payan, Yohan/0000-0002-6012-4123; PAYAN, Yohan/0000-0002-6012-4123; Gentaz, Edouard/0000-0003-0574-5557	Region Rhone-Alpes	Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	We thank "Region Rhone-Alpes", especially the Cluster ISLE-II and the PPF "Interactions Multimodales" for the partial funding of this research.	Bartletti R, 2007, SPORT BIOMECH, V6, P224, DOI 10.1080/14763140701322994; CONTI F, 2003, EUROHAPTICS 03; Feygin D, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P40, DOI 10.1109/HAPTIC.2002.998939; GILLESPIE PTC, 1998, ASME INT MECH ENG C, V64, P171; Henmi K, 1998, IEEE INT CONF ROBOT, P1275, DOI 10.1109/ROBOT.1998.677278; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Liu J, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-20; Morris D, 2007, WORLD HAPTICS 2007: SECOND JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P21; Niels R., 2004, THESIS RADBOUD U NIJ; PALLUELGERMAIN R, 2007, P IEEE WORLD HAPT 20, V2007, P72; SCHMIDT RA, 1987, MOTOR CONTROL LEARNI; Solis J, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P255, DOI 10.1109/HAPTIC.2002.998966; Srimathveeravalli G, 2005, WORLD HAPTICS CONFERENCE: FIRST JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRUTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P452; Teo CL, 2002, 10TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P335, DOI 10.1109/HAPTIC.2002.998977; VIVIANI P, 1982, NEUROSCIENCE, V7, P431, DOI 10.1016/0306-4522(82)90277-9; VIVIANI P, 1991, J EXP PSYCHOL HUMAN, V17, P198, DOI 10.1037/0096-1523.17.1.198; Yokokohji Y, 1996, P IEEE VIRT REAL ANN, P46, DOI 10.1109/VRAIS.1996.490509	19	91	91	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1775	10.1371/journal.pone.0001775	http://dx.doi.org/10.1371/journal.pone.0001775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335049	gold, Green Submitted, Green Published			2022-12-25	WOS:000260723000028
J	Ha, BH; Ahn, HC; Kang, SH; Tanaka, K; Chung, CH; Kim, EE				Ha, Byung Hak; Ahn, Hee-Chul; Kang, Sung Hwan; Tanaka, Keiji; Chung, Chin Ha; Kim, Eunice EunKyeong			Structural basis for Ufm1 processing by UfSP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYME; CONJUGATING ENZYME; CRYSTAL-STRUCTURE; HUMAN ATG4B; UBIQUITIN; SYSTEM; PROTEINS; PATHWAY; COMPLEX; UCH-L3	Ubiquitin-fold modifier 1 (Ufm1) is a newly identified ubiquitin-like protein. Like ubiquitin and other ubiquitin-like proteins, Ufm1 is synthesized as a precursor that needs to be processed to expose the conserved C-terminal glycine prior to its conjugation to target proteins. Two novel proteases, named UfSP1 and UfSP2, have been shown to be responsible for the release of Ufm1 from Ufm1-conjugated cellular proteins as well as for the processing of its precursor. They show no sequence homology with known proteases. Here, we describe the 1.7 angstrom resolution crystal structure of mouse UfSP1, consisting of 217 amino acids. The structure reveals that it is a novel cysteine protease having a papain-like fold, with Cys(53), Asp(175), and His(177) that form a catalytic triad, and Tyr(41) that participates in the formation of the oxyanion hole. This differs from the canonical catalytic triad of papain-like proteases in that the aspartate and the histidine residues are from the "Asp-Pro-His" box. The Asp-Pro-His configuration seen in UfSP1, together with Atg4B and M48(USP), seem to form a new subfamily of the cysteine protease superfamily. The mutagenesis study of the active site residues confirms structural basis for catalysis. The interaction between UfSP1 and Ufm1 appears quite substantial, since the K-D value was estimated to be 1.6 mu M by the isothermal titration calorimetry analysis. Furthermore, the NMR data shows that the loop between beta 3 and alpha 2 in addition to the C-terminal region of Ufm1 plays a role in binding to UfSP1.	[Ha, Byung Hak; Kang, Sung Hwan; Chung, Chin Ha] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Ha, Byung Hak; Ahn, Hee-Chul; Kim, Eunice EunKyeong] Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea; [Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138613, Japan	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Tokyo Metropolitan Institute of Medical Science	Chung, CH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	chchung@snu.ac.kr; eunice@kist.re.kr						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Sasakawa H, 2006, BIOCHEM BIOPH RES CO, V343, P21, DOI 10.1016/j.bbrc.2006.02.107; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Schwartz AL, 1999, ANNU REV MED, V50, P57; Shen LN, 2006, NAT STRUCT MOL BIOL, V13, P1069, DOI 10.1038/nsmb1172; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; VIJAYKUMAR S, 1987, J BIOL CHEM, V262, P6396; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700	36	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14893	14900		10.1074/jbc.M708756200	http://dx.doi.org/10.1074/jbc.M708756200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18321862	hybrid			2022-12-25	WOS:000255941400076
J	Navarro, MVAS; Oliveira, CC; Zanchin, NIT; Guimaraes, BG				Navarro, Marcos V. A. S.; Oliveira, Carla C.; Zanchin, Nilson I. T.; Guimaraes, Beatriz G.			Insights into the mechanism of progressive RNA degradation by the archaeal exosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST EXOSOME; RIBOSOMAL-RNA; NUCLEAR SURVEILLANCE; STRUCTURAL BASIS; QUALITY CONTROL; MESSENGER-RNAS; COMPLEX; PROTEIN; PATHWAY; POLYMERASE	Initially identified in yeast, the exosome has emerged as a central component of the RNA maturation and degradation machinery both in Archaea and eukaryotes. Here we describe a series of high-resolution structures of the RNase PH ring from the Pyrococcus abyssi exosome, one of them containing three 10-mer RNA strands within the exosome catalytic chamber, and report additional nucleotide interactions involving positions N5 and N7. Residues from all three Rrp41-Rrp42 heterodimers interact with a single RNA molecule, providing evidence for the functional relevance of exosome ring-like assembly in RNA processivity. Furthermore, an ADP-bound structure showed a rearrangement of nucleotide interactions at site N1, suggesting a rationale for the elimination of nucleoside diphosphate after catalysis. In combination with RNA degradation assays performed with mutants of key amino acid residues, the structural data presented here provide support for a model of exosome-mediated RNA degradation that integrates the events involving catalytic cleavage, product elimination, and RNA translocation. Finally, comparisons between the archaeal and human exosome structures provide a possible explanation for the eukaryotic exosome inability to catalyze phosphate-dependent RNA degradation.	[Navarro, Marcos V. A. S.; Zanchin, Nilson I. T.; Guimaraes, Beatriz G.] Brazilian Synchrotron Light Lab, BR-13083970 Campinas, SP, Brazil; [Oliveira, Carla C.] Univ Sao Paulo, Dept Biochem, Inst Chem, BR-05508900 Sao Paulo, Brazil	Laboratorio Nacional de Luz Sincrotron (LNLS); Universidade de Sao Paulo	Navarro, MVAS (corresponding author), Cornell Univ, Vet Med Ctr C4 173, Ithaca, NY 14853 USA.	mn372@cornell.edu; beatriz@lnls.br	Oliveira, Carla C/F-2323-2011; Zanchin, Nilson Ivo Tonin/AAB-4907-2019; Navarro, Marcos VAS/C-9141-2013; Guimarães, Beatriz G/D-3858-2014; Guimarães, Beatriz Gomes/Z-6242-2019	Oliveira, Carla C/0000-0002-1098-9241; Zanchin, Nilson Ivo Tonin/0000-0002-1153-0694; Guimarães, Beatriz Gomes/0000-0002-8546-2460; Navarro, Marcos/0000-0002-2461-0431				Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brakoulias A, 2004, PROTEINS, V56, P250, DOI 10.1002/prot.20123; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Chekanova JA, 2000, J BIOL CHEM, V275, P33158, DOI 10.1074/jbc.M005493200; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Evguenieva-Hackenberg E, 2003, EMBO REP, V4, P889, DOI 10.1038/sj.embor.embor929; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Jiang TJ, 2002, P NATL ACAD SCI USA, V99, P5295, DOI 10.1073/pnas.072083699; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; LANDAU M, 2003, BIOINFORMATICS, V19, P163; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu QS, 2007, CELL, V131, P188, DOI 10.1016/j.cell.2007.09.019; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Lorentzen E, 2007, EMBO REP, V8, P470, DOI 10.1038/sj.embor.7400945; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Mitchell P, 2003, MOL CELL, V11, P1405, DOI 10.1016/S1097-2765(03)00190-4; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oddone A, 2007, EMBO REP, V8, P63, DOI 10.1038/sj.embor.7400856; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Ramos CRR, 2006, J BIOL CHEM, V281, P6751, DOI 10.1074/jbc.M512495200; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Wahle E, 2007, NAT STRUCT MOL BIOL, V14, P5, DOI 10.1038/nsmb0107-5; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	45	45	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14120	14131		10.1074/jbc.M801005200	http://dx.doi.org/10.1074/jbc.M801005200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353775	hybrid			2022-12-25	WOS:000255728200066
J	Qian, P; Bullough, PA; Hunter, CN				Qian, Pu; Bullough, Per A.; Hunter, C. Neil			Three-dimensional reconstruction of a membrane-bending complex - The RC-LH1-PufX core dimer of Rhodobacter sphaeroides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; PIGMENT PROTEIN COMPLEXES; RHODOSPIRILLUM-RUBRUM; PHOTOSYNTHETIC APPARATUS; CRYSTAL-STRUCTURE; PROJECTION STRUCTURE; STRUCTURAL-ANALYSIS; CHARGE SEPARATION; REACTION CENTERS; ANTENNA COMPLEX	A three-dimensional model of the dimeric reaction center-light harvesting I-PufX (RC-LH1-PufX) complex from Rhodobacter sphaeroides, calculated from electron microscope single particle analysis of negatively stained complexes, shows that the two halves of the dimer molecule incline toward each other on the periplasmic side, creating a remarkable V-shaped structure. The distribution of negative stain is consistent with loose packing of the LH1 ring near the 14th LH1 alpha/beta pair, which could facilitate the migration of quinone and quinol molecules across the LH1 boundary. The three-dimensional model encloses a space near the reaction center Q(B) site and the 14th LH1 alpha/beta pair, which is similar to 20 angstrom in diameter, sufficient to sequester a quinone pool. Helical arrays of dimers were used to construct a three-dimensional membrane model, which matches the packing lattice deduced from electron microscope analysis of the tubular dimer-only membranes found in mutants of Rba. sphaeroides lacking the LH2 complex. The intrinsic curvature of the dimer explains the shape and similar to 70-nm diameter of these membrane tubules, and at least partially accounts for the spherical membrane invaginations found in wild-type Rba. sphaeroides. A model of dimer aggregation and membrane curvature in these spherical membrane invaginations is presented.	[Qian, Pu; Bullough, Per A.; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biochem, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Hunter, CN (corresponding author), Univ Sheffield, Dept Mol Biol & Biochem, Sheffield S10 2TN, S Yorkshire, England.	c.n.hunter@sheffield.ac.uk	Qian, Pu/GZM-2400-2022	Bullough, Per/0000-0001-8147-1127	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abresch EC, 2005, PHOTOSYNTH RES, V86, P61, DOI 10.1007/s11120-005-5106-z; [Anonymous], 2002, PHOTOSYNTHETICA; Bahatyrova S, 2004, J BIOL CHEM, V279, P21327, DOI 10.1074/jbc.M313039200; Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Boekema EJ, 1999, NATURE, V401, P37, DOI 10.1038/43369; Busselez J, 2007, STRUCTURE, V15, P1674, DOI 10.1016/j.str.2007.09.026; Chaban Y, 2002, EMBO REP, V3, P982, DOI 10.1093/embo-reports/kvf196; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Cogdell R. J., 1995, ANOXYGENIC PHOTOSYNT, P315; Comayras R, 2005, J BIOL CHEM, V280, P11203, DOI 10.1074/jbc.M412088200; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V726, P149, DOI 10.1016/0304-4173(83)90004-6; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Darrouzet E, 2004, PHOTOSYNTH RES, V79, P25, DOI 10.1023/B:PRES.0000011926.47778.4e; Dezi M, 2007, BBA-BIOENERGETICS, V1767, P1041, DOI 10.1016/j.bbabio.2007.05.006; Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065; FARCHAUS JW, 1990, J BACTERIOL, V172, P977, DOI 10.1128/jb.172.2.977-985.1990; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200; Francia F, 1999, BIOCHEMISTRY-US, V38, P6834, DOI 10.1021/bi982891h; Francia F, 2004, BIOCHEMISTRY-US, V43, P14199, DOI 10.1021/bi048629s; Francia F, 2002, EUR J BIOCHEM, V269, P1877, DOI 10.1046/j.1432-1033.2002.02834.x; Frese RN, 2008, BIOPHYS J, V94, P640, DOI 10.1529/biophysj.107.116913; Frese RN, 2004, P NATL ACAD SCI USA, V101, P17994, DOI 10.1073/pnas.0407295102; HUNTER CN, 1988, BIOCHEMISTRY-US, V27, P3459, DOI 10.1021/bi00409a050; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7; Jones MR, 2007, PROG LIPID RES, V46, P56, DOI 10.1016/j.plipres.2006.06.001; JONES MR, 1992, MOL MICROBIOL, V6, P1173, DOI 10.1111/j.1365-2958.1992.tb01556.x; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; KILEY PJ, 1988, J BACTERIOL, V170, P1103, DOI 10.1128/jb.170.3.1103-1115.1988; Koepke J, 1996, STRUCTURE, V4, P581, DOI 10.1016/S0969-2126(96)00063-9; Loach P. A., 1995, ANOXYGENIC PHOTOSYNT, P437; MacKinnon R, 2004, SCIENCE, V306, P1304, DOI 10.1126/science.1105528; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MILLER KR, 1982, NATURE, V300, P53, DOI 10.1038/300053a0; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; OELZE J, 1972, BIOCHIM BIOPHYS ACTA, V265, P209, DOI 10.1016/0304-4157(72)90003-2; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qian P, 2005, J MOL BIOL, V349, P948, DOI 10.1016/j.jmb.2005.04.032; Qian P, 2003, J BIOL CHEM, V278, P23678, DOI 10.1074/jbc.M302753200; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Scheuring S, 2004, J BIOL CHEM, V279, P3620, DOI 10.1074/jbc.M310050200; Scheuring S, 2004, P NATL ACAD SCI USA, V101, P11293, DOI 10.1073/pnas.0404350101; Scheuring S, 2005, J BIOL CHEM, V280, P1426, DOI 10.1074/jbc.M411334200; Sener MK, 2007, P NATL ACAD SCI USA, V104, P15723, DOI 10.1073/pnas.0706861104; Siebert CA, 2004, EMBO J, V23, P690, DOI 10.1038/sj.emboj.7600092; STARK W, 1984, EMBO J, V3, P777, DOI 10.1002/j.1460-2075.1984.tb01884.x; Tunnicliffe RB, 2006, FEBS LETT, V580, P6967, DOI 10.1016/j.febslet.2006.11.065; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; VANGRONDELLE R, 1994, BBA-BIOENERGETICS, V1187, P1, DOI 10.1016/0005-2728(94)90166-X; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; VANHEEL M, 1985, EMBO J, V4, P2389, DOI 10.1002/j.1460-2075.1985.tb03944.x; VANHEEL M, 1981, ULTRAMICROSCOPY, V7, P113, DOI 10.1016/0304-3991(81)90001-2; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050; WANG DN, 1994, EMBO J, V13, P3230, DOI 10.1002/j.1460-2075.1994.tb06624.x; Westerhuis WHJ, 2002, BIOCHEMISTRY-US, V41, P8698, DOI 10.1021/bi011663b	65	82	84	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14002	14011		10.1074/jbc.M800625200	http://dx.doi.org/10.1074/jbc.M800625200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18326046	hybrid			2022-12-25	WOS:000255728200054
J	Taghbalout, A; Rothfield, L				Taghbalout, Aziz; Rothfield, Lawrence			RNaseE and RNA helicase B play central roles in the cytoskeletal organization of the RNA degradosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; RIBONUCLEASE-E; BACTERIAL CYTOSKELETON; CHROMOSOMAL GENES; CELL-SHAPE; COMPLEXES; PROTEINS; MINE; MREB	The RNA degradosome of Escherichia coli is a multiprotein complex that plays an essential role in normal RNA processing and decay. It was recently shown that the major degradosome constituents are organized in a coiled cytoskeletal-like structure that extends along the length of the cell. Here we show that the endoribonuclease E (RNaseE) and RNA helicase B (RhlB) components of the degradosome can each independently form coiled structures in the absence of the other degradosome proteins. In contrast, the cytoskeletal organization of the other degradosome proteins required the presence of the RNaseE or RhlB coiled elements. Although the RNaseE and RhlB structures were equally competent to support the helical organization of polynucleotide phosphorylase, the cytoskeletal-like organization of enolase occurred only in the presence of the RNaseE coiled structure. The results indicate that the RNA degradosome proteins are components of the bacterial cytoskeleton rather than existing as randomly distributed multiprotein complexes within the cell and suggest a model for the cellular organization of the components within the helical degradosomal structure.	[Taghbalout, Aziz; Rothfield, Lawrence] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Farmington, CT 06032 USA	University of Connecticut	Taghbalout, A (corresponding author), Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, 263 Farmington Ave, Farmington, CT 06032 USA.	taghbalout@neuron.uchc.edu	Taghbalout, Aziz/A-7516-2009		NIGMS NIH HHS [GM R37-06032] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; CARPOUSIS AJ, 1994, CELL, V76, P889, DOI 10.1016/0092-8674(94)90363-8; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; Divakaruni AV, 2005, P NATL ACAD SCI USA, V102, P18602, DOI 10.1073/pnas.0507937102; Dye NA, 2005, P NATL ACAD SCI USA, V102, P18608, DOI 10.1073/pnas.0507708102; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; GHORA BK, 1978, CELL, V15, P1055, DOI 10.1016/0092-8674(78)90289-1; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Lin PH, 2005, P NATL ACAD SCI USA, V102, P16590, DOI 10.1073/pnas.0500994102; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Maniatis T., 1982, MOL CLONING LAB MANU; MICZAK A, 1991, MOL MICROBIOL, V5, P1801, DOI 10.1111/j.1365-2958.1991.tb01929.x; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Miller J. H., 1992, SHORT COURSE BACTERI, P263; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Ow MC, 2002, GENE DEV, V16, P1102, DOI 10.1101/gad.983502; PY B, 1994, MOL MICROBIOL, V14, P717, DOI 10.1111/j.1365-2958.1994.tb01309.x; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Shih YL, 2005, MOL MICROBIOL, V58, P917, DOI 10.1111/j.1365-2958.2005.04841.x; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770	36	43	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13850	13855		10.1074/jbc.M709118200	http://dx.doi.org/10.1074/jbc.M709118200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18337249	hybrid, Green Published			2022-12-25	WOS:000255728200038
J	Bhamidi, S; Scherman, MS; Rithner, CD; Prenni, JE; Chatterjee, D; Khoo, KH; McNeil, MR				Bhamidi, Suresh; Scherman, Michael S.; Rithner, Christopher D.; Prenni, Jessica E.; Chatterjee, Delphi; Khoo, Kay-Hooi; McNeil, Michael R.			The identification and location of succinyl residues and the characterization of the interior arabinan region allow for a model of the complete primary structure of Mycobacterium tuberculosis mycolyl arabinogalactan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL ARABINOGALACTAN; MASS-SPECTROMETRY; LIPOARABINOMANNAN; BIOSYNTHESIS; SMEGMATIS; CORYNEBACTERIANEAE; PEPTIDOGLYCAN; SPECTROSCOPY; FRAGMENTS; FEATURES	The complex cell wall of Mycobacterium tuberculosis is the hallmark of acid fast bacteria and is responsible for much of its physiological characteristics. Hence, much effort has been made to determine its primary structure. Such studies have been hampered by its extreme complexity. Also, its insolubility leads to difficulties determining the presence or absence of base labile groups. We have used an endogenous arabinase to solubilize the arabinan region of the cell wall and have shown using mass spectrometry and NMR that succinyl esters are present on O2 of the inner-branched 1,3,5-alpha-D-arabinofuranosyl residues. In addition, an inner arabinan region of 14 linear alpha-1,5 arabinofuranosyl residues has been identified. These and earlier results now allow the presentation of a model of the entire primary structure of the mycobacterial mycolyl arabinogalactan highlighted by three arabinan chains of 31 residues each.	[Bhamidi, Suresh; Scherman, Michael S.; Chatterjee, Delphi; McNeil, Michael R.] Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA; [Rithner, Christopher D.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA; [Prenni, Jessica E.] Colorado State Univ, Proteom & Metab Facil, Ft Collins, CO 80523 USA; [Khoo, Kay-Hooi] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan; [Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan	Colorado State University; Colorado State University; Colorado State University; National Taiwan University; Academia Sinica - Taiwan	McNeil, MR (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	mmcneil@colostate.edu	Khoo, Kay-Hooi/E-1989-2019; McNeil, Michael/G-3325-2019	Khoo, Kay-Hooi/0000-0003-2906-406X; Prenni, Jessica/0000-0002-0337-8450	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI037139, R01AI033706, R01AI037139] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-37139, AI-33706] Funding Source: Medline; PHS HHS [NSC96-2628-B-001-014] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; AMARNACASCH C, 1970, B SOC CHIM BIOL, V52, P145; AZUMA I, 1969, J BACTERIOL, V98, P331, DOI 10.1128/JB.98.1.331-333.1969; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; BESRA GS, 1995, BIOCHEMISTRY-US, V34, P4257, DOI 10.1021/bi00013a015; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234; CHATTERJEE D, 1991, J BIOL CHEM, V266, P9652; DAFFE M, 1990, J BIOL CHEM, V265, P6734; Delmas C, 1997, GLYCOBIOLOGY, V7, P811, DOI 10.1093/glycob/7.6.811; Dmitriev BA, 2000, INT J MED MICROBIOL, V290, P251; Dong X, 2006, APPL ENVIRON MICROB, V72, P2601, DOI 10.1128/AEM.72.4.2601-2605.2006; Draper P, 1997, BIOCHEM J, V327, P519, DOI 10.1042/bj3270519; Escuyer VE, 2001, J BIOL CHEM, V276, P48854, DOI 10.1074/jbc.M102272200; KANETSUN.F, 1968, BIOCHIM BIOPHYS ACTA, V158, P130, DOI 10.1016/0304-4165(68)90080-9; KOTANI S, 1971, BIKEN J, V14, P379; Lee A, 2006, BIOCHEMISTRY-US, V45, P15817, DOI 10.1021/bi060688d; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; Mahapatra S, 2005, J BACTERIOL, V187, P2747, DOI 10.1128/JB.187.8.2747-2757.2005; MCNEIL M, 1990, J BIOL CHEM, V265, P18200; McNeil M, 1999, GENETICS OF BACTERIALS POLYSACCHARIDES, P207; MCNEIL M, 1991, J BIOL CHEM, V266, P13217; McNeil M., 1996, TUBERCULOSIS, P171; MCNEIL MR, 1994, GLYCOBIOLOGY, V4, P165, DOI 10.1093/glycob/4.2.165; MCNEIL MR, 1991, RES MICROBIOL, V142, P451, DOI 10.1016/0923-2508(91)90120-Y; MINNIKIN DE, 1982, BIOL MYCOBACTERIA, V1, P95; MISAKI A, 1974, J BIOCHEM-TOKYO, V76, P15, DOI 10.1093/oxfordjournals.jbchem.a130540; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; Shi LB, 2006, J BIOL CHEM, V281, P19512, DOI 10.1074/jbc.M513846200; STOTT K, 1995, J AM CHEM SOC, V117, P4199, DOI 10.1021/ja00119a048; Torrelles JB, 2004, J BIOL CHEM, V279, P41227, DOI 10.1074/jbc.M405180200; VILKAS E, 1973, BIOCHIM BIOPHYS ACTA, V297, P423, DOI 10.1016/0304-4165(73)90089-5; WIETZERBIN J, 1974, BIOCHEMISTRY-US, V13, P3471, DOI 10.1021/bi00714a008; Zhang N, 2003, MOL MICROBIOL, V50, P69, DOI 10.1046/j.1365-2958.2003.03681.x	34	72	74	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12992	13000		10.1074/jbc.M800222200	http://dx.doi.org/10.1074/jbc.M800222200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18303028	Green Published, hybrid			2022-12-25	WOS:000255499800036
J	Ferber, EC; Kajita, M; Wadlow, A; Tobiansky, L; Niessen, C; Ariga, H; Daniel, J; Fujita, Y				Ferber, Emma C.; Kajita, Mihoko; Wadlow, Anthony; Tobiansky, Lara; Niessen, Carien; Ariga, Hiroyoshi; Daniel, Juliet; Fujita, Yasuyuki			A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED TRANSCRIPTIONAL REPRESSION; C-TERMINAL FRAGMENT; CELL-CELL CONTACTS; BETA-CATENIN; P120 CATENIN; INTRACELLULAR DOMAIN; ADHERENS JUNCTIONS; N-CADHERIN; GAMMA-PROTOCADHERINS; PROTEOLYTIC RELEASE	Cell-cell contacts play a vital role in intracellular signaling, although the molecular mechanisms of these signaling pathways are not fully understood. E-cadherin, an important mediator of cell-cell adhesions, has been shown to be cleaved by gamma-secretase. This cleavage releases a fragment of E-cadherin, E-cadherin C-terminal fragment 2 (E-cad/CTF2), into the cytosol. Here, we study the fate and function of this fragment. First, we show that coexpression of the cadherin-binding protein, p120 catenin (p120), enhances the nuclear translocation of E-cad/CTF2. By knocking down p120 with short interfering RNA, we also demonstrate that p120 is necessary for the nuclear localization of E-cad/CTF2. Furthermore, p120 enhances and is required for the specific binding of E-cad/CTF2 to DNA. Finally, we show that E-cad/CTF2 can regulate the p120-Kaiso-mediated signaling pathway in the nucleus. These data indicate a novel role for cleaved E-cadherin in the nucleus.	[Ferber, Emma C.; Kajita, Mihoko; Wadlow, Anthony; Tobiansky, Lara; Fujita, Yasuyuki] UCL, MRC Cell Biol Unit, MRC Lab Mol Cell Biol, London WC1E 6BT, England; [Fujita, Yasuyuki] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Niessen, Carien] Univ Cologne, Dept Dermatol, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Daniel, Juliet] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; University of Cologne; Hokkaido University; McMaster University	Fujita, Y (corresponding author), UCL, MRC Cell Biol Unit, MRC Lab Mol Cell Biol, London WC1E 6BT, England.	y.fujita@ucl.ac.uk	Ariga, Hiroyoshi/B-5895-2013; Fujita, Yasuyuki/A-4324-2012	Ariga, Hiroyoshi/0000-0001-7384-2143; Niessen, Carien M./0000-0002-4892-9391	Medical Research Council [MC_U122669938] Funding Source: Medline; MRC [MC_U122669938] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gao YH, 2001, P NATL ACAD SCI USA, V98, P14979, DOI 10.1073/pnas.261463298; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Haas IG, 2005, J BIOL CHEM, V280, P9313, DOI 10.1074/jbc.M412909200; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Hosking CR, 2007, MOL BIOL CELL, V18, P1918, DOI 10.1091/mbc.E06-10-0941; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Kelly KF, 2004, J CELL SCI, V117, P2675, DOI 10.1242/jcs.01101; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Larue L, 1996, DEVELOPMENT, V122, P3185; Lochter A, 1997, J CELL BIOL, V139, P1861, DOI 10.1083/jcb.139.7.1861; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Roczniak-Ferguson A, 2003, J CELL SCI, V116, P4201, DOI 10.1242/jcs.00724; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shcherbik N, 2004, J CELL BIOCHEM, V93, P11, DOI 10.1002/jcb.20130; Shoval I, 2007, DEVELOPMENT, V134, P491, DOI 10.1242/dev.02742; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Tricaud N, 2005, J NEUROSCI, V25, P3259, DOI 10.1523/JNEUROSCI.5168-04.2005; Uemura K, 2006, BIOCHEM BIOPH RES CO, V345, P951, DOI 10.1016/j.bbrc.2006.04.157; van Hengel J, 1999, P NATL ACAD SCI USA, V96, P7980, DOI 10.1073/pnas.96.14.7980; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wu SG, 2007, J CELL SCI, V120, P1944, DOI 10.1242/jcs.03455; Yagi T, 2000, GENE DEV, V14, P1169; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200	52	113	117	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12691	12700		10.1074/jbc.M708887200	http://dx.doi.org/10.1074/jbc.M708887200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18356166	Green Published, hybrid			2022-12-25	WOS:000255499800004
J	Ishida, N; Sugiura, M; Rappaport, F; Lai, TL; Rutherford, AW; Boussac, A				Ishida, Naoko; Sugiura, Miwa; Rappaport, Fabrice; Lai, Thanh-Lan; Rutherford, A. William; Boussac, Alain			Biosynthetic exchange of bromide for chloride and strontium for calcium in the photosystem II oxygen-evolving enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC WATER OXIDATION; S-STATE TRANSITION; THERMOSYNECHOCOCCUS-ELONGATUS; THERMOPHILIC CYANOBACTERIUM; SYNECHOCOCCUS-ELONGATUS; TEMPERATURE-DEPENDENCE; CA2+/SR2+ EXCHANGE; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; PSII MEMBRANES	The active site for water oxidation in photosystem II goes through five sequential oxidation states (S-0 to S-4) before O-2 is evolved. It consists of a Mn4Ca cluster close to a redox-active tyrosine residue (Tyr(Z)). Cl- is also required for enzyme activity. To study the role of Ca2+ and Cl- in PSII, these ions were biosynthetically substituted by Sr2+ and Br-, respectively, in the thermophilic cyanobacterium Thermosynechococcus elongatus. Irrespective of the combination of the non-native ions used (Ca/Br, Sr/Cl, Sr/Br), the enzyme could be isolated in a state that was fully intact but kinetically limited. The electron transfer steps affected by the exchanges were identified and then investigated by using time-resolved UV-visible absorption spectroscopy, time-resolved O-2 polarography, and thermoluminescence spectroscopy. The effect of the Ca2+/Sr2+ and Cl-/Br- exchanges was additive, and the magnitude of the effect varied in the following order: Ca/Cl < Ca/Br < Sr/Cl < Sr/Br. In all cases, the rate of O-2 release was similar to that of the S(3)Tyr(Z)(center dot) to S(0)Tyr(Z) transition, with the slowest kinetics (i.e. the Sr/Br enzyme) being approximate to 6-7 slower than in the native Ca/Cl enzyme. This slowdown in the kinetics was reflected in a decrease in the free energy level of the S-3 state as manifest by thermoluminescence. These observations indicate that Cl- is involved in the water oxidation mechanism. The possibility that Cl- is close to the active site is discussed in terms of recent structural models.	[Ishida, Naoko; Lai, Thanh-Lan; Rutherford, A. William; Boussac, Alain] Inst Biol & Technol Saclay, Commissariat Energie Atom Saclay, CNRS, URA 2096, F-91191 Gif Sur Yvette, France; [Sugiura, Miwa] Osaka Prefecture Univ, Sch Life Sci & Environm Sci, Dept Plant Biosci, Naka Ku, Sakai, Osaka 5998531, Japan; [Rappaport, Fabrice] Univ Paris 06, CNRS, UMR7141, Inst Biol Physicochim, F-75005 Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); Osaka Metropolitan University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Boussac, A (corresponding author), Inst Biol & Technol Saclay, Commissariat Energie Atom Saclay, CNRS, URA 2096, F-91191 Gif Sur Yvette, France.	alain.boussac@cea.fr	Rutherford, Alfred W/A-7831-2019	Rutherford, Alfred W/0000-0002-3124-154X; Rappaport, Fabrice/0000-0001-9377-4934				Ananyev GM, 2001, BBA-BIOENERGETICS, V1503, P52, DOI 10.1016/S0005-2728(00)00215-2; Barber J, 2004, PHYS CHEM CHEM PHYS, V6, P4737, DOI 10.1039/b407981g; BAUMGARTEN M, 1990, BIOCHEMISTRY-US, V29, P10814, DOI 10.1021/bi00500a014; Betley TA, 2008, PHILOS T R SOC B, V363, P1293, DOI 10.1098/rstb.2007.2226; Boussac A, 2000, BIOCHEMISTRY-US, V39, P13788, DOI 10.1021/bi001159r; BOUSSAC A, 1992, BIOCHEMISTRY-US, V31, P1224, DOI 10.1021/bi00119a036; Boussac A, 2004, J BIOL CHEM, V279, P22809, DOI 10.1074/jbc.M401677200; BOUSSAC A, 1989, BIOCHEMISTRY-US, V28, P8984, DOI 10.1021/bi00449a005; BOUSSAC A, 1988, BIOCHEMISTRY-US, V27, P3476, DOI 10.1021/bi00409a052; BOUSSAC A, 1988, FEBS LETT, V236, P432, DOI 10.1016/0014-5793(88)80071-1; BOUSSAC A, 1995, CHEM PHYS, V194, P409, DOI 10.1016/0301-0104(94)00419-B; Boussac A, 2008, PHILOS T R SOC B, V363, P1203, DOI 10.1098/rstb.2007.2216; CHEN CG, 1995, BIOCHEMISTRY-US, V34, P13511, DOI 10.1021/bi00041a031; Christen G, 1999, BIOCHEMISTRY-US, V38, P2068, DOI 10.1021/bi982188t; Cinco RM, 2004, BIOCHEMISTRY-US, V43, P13271, DOI 10.1021/bi036308v; Clausen J, 2005, BIOCHEMISTRY-US, V44, P12775, DOI 10.1021/bi051183a; Clausen J, 2004, NATURE, V430, P480, DOI 10.1038/nature02676; Danielsson R, 2004, BBA-BIOENERGETICS, V1608, P53, DOI 10.1016/j.bbabio.2003.10.005; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; DEVAULT D, 1990, PHOTOSYNTH RES, V24, P175, DOI 10.1007/BF00032597; Diner BA, 2001, BIOCHEMISTRY-US, V40, P9265, DOI 10.1021/bi010121r; DUCRUET JM, 1992, PHOTOSYNTH RES, V33, P15, DOI 10.1007/BF00032979; Fernandez C, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P1399; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fufezan C, 2005, BIOCHEMISTRY-US, V44, P12780, DOI 10.1021/bi051000k; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Groot ML, 2005, P NATL ACAD SCI USA, V102, P13087, DOI 10.1073/pnas.0503483102; Hasegawa K, 2002, BIOCHEMISTRY-US, V41, P13839, DOI 10.1021/bi026595n; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Haumann M, 2006, BIOCHEMISTRY-US, V45, P13101, DOI 10.1021/bi061308r; Hendry G, 2003, BIOCHEMISTRY-US, V42, P6209, DOI 10.1021/bi034279i; Hillier W, 2004, PHYS CHEM CHEM PHYS, V6, P4882, DOI 10.1039/b407269c; Holzwarth AR, 2006, P NATL ACAD SCI USA, V103, P6895, DOI 10.1073/pnas.0505371103; Homann PH, 2002, PHOTOSYNTH RES, V73, P169, DOI 10.1023/A:1020486729283; HOMANN PH, 1986, ION INTERACTIONS ENE, P291; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kargul J, 2007, BBA-BIOENERGETICS, V1767, P404, DOI 10.1016/j.bbabio.2007.01.007; Kimura Y, 2005, PHOTOSYNTH RES, V84, P245, DOI 10.1007/s11120-005-0412-z; KOIKE H, 1987, BIOCHIM BIOPHYS ACTA, V893, P524, DOI 10.1016/0005-2728(87)90104-6; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kos PB, 2008, BBA-BIOENERGETICS, V1777, P74, DOI 10.1016/j.bbabio.2007.10.015; KRIEGER A, 1995, BBA-BIOENERGETICS, V1229, P193, DOI 10.1016/0005-2728(95)00002-Z; LAVERGNE J, 1991, BIOCHIM BIOPHYS ACTA, V1060, P175, DOI 10.1016/S0005-2728(09)91005-2; LAVOREL J, 1992, BIOCHIM BIOPHYS ACTA, V1101, P33, DOI 10.1016/0167-4838(92)90463-N; LINDBERG K, 1993, PHOTOSYNTH RES, V38, P401, DOI 10.1007/BF00046767; Lindberg K, 1996, BIOCHEMISTRY-US, V35, P14259, DOI 10.1021/bi961244s; LINDBERG K, 1990, FEBS LETT, V264, P153, DOI 10.1016/0014-5793(90)80788-K; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; McEvoy JP, 2004, PHYS CHEM CHEM PHYS, V6, P4754, DOI 10.1039/b407500e; Meelich K, 2008, PHILOS T R SOC B, V363, P1271, DOI 10.1098/rstb.2007.2224; Messinger J, 2004, PHYS CHEM CHEM PHYS, V6, P4764, DOI 10.1039/b406437b; MIYAO M, 1991, BIOCHEMISTRY-US, V30, P5379, DOI 10.1021/bi00236a008; Olesen K, 2003, BIOCHEMISTRY-US, V42, P2025, DOI 10.1021/bi026175y; ONO T, 1986, BIOCHIM BIOPHYS ACTA, V851, P193, DOI 10.1016/0005-2728(86)90125-8; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; Rappaport F, 2005, BIOPHYS J, V88, P1948, DOI 10.1529/biophysj.104.050237; RAPPAPORT F, 1994, BBA-BIOENERGETICS, V1184, P178, DOI 10.1016/0005-2728(94)90222-4; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Razeghifard MR, 1999, BIOCHEMISTRY-US, V38, P1252, DOI 10.1021/bi9811765; Renger G, 2007, PHOTOSYNTH RES, V92, P407, DOI 10.1007/s11120-007-9185-x; RUTHERFORD AW, 1984, BIOCHIM BIOPHYS ACTA, V767, P548, DOI 10.1016/0005-2728(84)90054-9; Rutherford AW, 2004, SCIENCE, V303, P1782, DOI 10.1126/science.1096767; RUTHERFORD AW, 1982, BIOCHIM BIOPHYS ACTA, V682, P457, DOI 10.1016/0005-2728(82)90061-5; Schilstra MJ, 1998, BIOCHEMISTRY-US, V37, P3974, DOI 10.1021/bi9713815; Siegbahn PEM, 2008, PHILOS T R SOC B, V363, P1221, DOI 10.1098/rstb.2007.2218; Sproviero EM, 2008, PHILOS T R SOC B, V363, P1149, DOI 10.1098/rstb.2007.2210; Sproviero EM, 2007, CURR OPIN STRUC BIOL, V17, P173, DOI 10.1016/j.sbi.2007.03.015; Strickler MA, 2005, BIOCHEMISTRY-US, V44, P8571, DOI 10.1021/bi050653y; STYRING S, 1987, BIOCHEMISTRY-US, V26, P2401, DOI 10.1021/bi00383a001; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219, DOI 10.1093/oxfordjournals.pcp.a029510; Sugiura M, 2004, BIOCHEMISTRY-US, V43, P13549, DOI 10.1021/bi048732h; Sugiura M, 2008, BBA-BIOENERGETICS, V1777, P331, DOI 10.1016/j.bbabio.2008.01.007; Suzuki H, 2006, BIOCHEMISTRY-US, V45, P13454, DOI 10.1021/bi061232z; Tang XS, 1996, J AM CHEM SOC, V118, P7638, DOI 10.1021/ja9610592; Un S, 2007, BIOCHEMISTRY-US, V46, P3138, DOI 10.1021/bi062084f; vanVliet P, 1996, BIOCHEMISTRY-US, V35, P1829, DOI 10.1021/bi9514471; Vass I, 2003, PHOTOSYNTH RES, V76, P303, DOI 10.1023/A:1024989519054; VOS MH, 1991, BIOCHIM BIOPHYS ACTA, V1056, P27, DOI 10.1016/S0005-2728(05)80069-6; Vrettos JS, 2002, PHILOS T R SOC B, V357, P1395, DOI 10.1098/rstb.2002.1136; Westphal KL, 2000, BIOCHEMISTRY-US, V39, P16220, DOI 10.1021/bi0018077; Wincencjusz H, 1998, BIOCHEMISTRY-US, V37, P8595, DOI 10.1021/bi972660v; Wincencjusz H, 1999, BIOCHEMISTRY-US, V38, P3719, DOI 10.1021/bi982295n; Wincencjusz H, 1997, BIOCHEMISTRY-US, V36, P3663, DOI 10.1021/bi9626719; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	90	56	56	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13330	13340		10.1074/jbc.M710583200	http://dx.doi.org/10.1074/jbc.M710583200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18332136	hybrid			2022-12-25	WOS:000255499800073
J	Potapova, IA; Brink, PR; Cohen, IS; Doronin, SV				Potapova, Irina A.; Brink, Peter R.; Cohen, Ira S.; Doronin, Sergey V.			Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MARROW; CHEMOKINE RECEPTORS; IN-VITRO; PROMOTING MIGRATION; HIV-1 ENTRY; TRANSPLANTATION; INDUCTION; MATRIX; BLOOD; MICE	Culture-expanded human mesenchymal stem cells (hMSCs) are increasingly used in a variety of preclinical and clinical studies. However, these cells have a low rate of engraftment to bone marrow or damaged tissues. Several laboratories have shown that during isolation and subculturing mesenchymal stem cells quickly lose the expression of CXCR4, the key receptor responsible for lymphocytes and hematopoietic stem cell homing. Here we show that culturing of hMSCs as three-dimensional aggregates (hMSC spheroids) restores CXCR4 functional expression. Expression of CXCR4 inversely correlates with the secretion of SDF-1 by hMSCs. Cells from hMSC spheroids up-regulate expression of CD49b, the alpha 2 integrin subunit, and suppress the expression of CD49d, the alpha 4 integrin subunit. Transfer of cells from the spheroids back to a monolayer suppresses the expression of CXCR4 and CD49b and restores the expression of CD49d. Treatment of cells from the spheroids with SDF-1 leads to CXCR4 internalization and activation of ERK-1,2. Adhesion of hMSCs to human umbilical vein endothelial cells ( HUVECs) was investigated. SDF-1, AMD-3100, or exposure of HUVECs to hypoxia did not affect adhesion of hMSCs from a monolayer to HUVECs. Adhesion of cells from hMSC spheroids to HUVECs was stimulated by SDF-1, AMD-3100, or by exposure of HUVECs to hypoxia. Stimulatory effects of hypoxia and addition of SDF-1 or AMD- 3100 were not additive. Overall, our data indicate that the expression of CXCR4 by hMSCs regulates hMSC adhesion to endothelial cells.	[Potapova, Irina A.; Brink, Peter R.; Cohen, Ira S.; Doronin, Sergey V.] SUNY Stony Brook, Dept Physiol & Biophys, Inst Mol Cardiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Doronin, SV (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Inst Mol Cardiol, BST-6,Rm 124, Stony Brook, NY 11794 USA.	sdoronin@notes.cc.sunysb.edu			NHLBI NIH HHS [HL67101, HL28958] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067101, P01HL028958] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allers C, 2004, TRANSPLANTATION, V78, P503, DOI 10.1097/01.TP.0000128334.93343.B3; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; BHAKTA S, 2006, J INTERFERON CYTOKIN, V27, P53; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Chute JP, 2006, CURR OPIN HEMATOL, V13, P399, DOI 10.1097/01.moh.0000245698.62511.3d; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Croitoru-Lamoury J, 2007, J INTERF CYTOK RES, V27, P53, DOI 10.1089/jir.2006.0037; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Feil C, 1998, BIOCHEM BIOPH RES CO, V247, P38, DOI 10.1006/bbrc.1998.8499; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; FRIEDL P, 1995, J IMMUNOL, V154, P4973; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Geminder H, 2001, J IMMUNOL, V167, P4747, DOI 10.4049/jimmunol.167.8.4747; Glodek AM, 2007, LEUKEMIA, V21, P1723, DOI 10.1038/sj.leu.2404769; Hesselgesser J, 1997, CURR BIOL, V7, P112, DOI 10.1016/S0960-9822(06)00055-8; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jori FP, 2005, J CELL BIOCHEM, V94, P645, DOI 10.1002/jcb.20315; Kemp KC, 2005, LEUKEMIA LYMPHOMA, V46, P1531, DOI 10.1080/10428190500215076; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; Le Blanc K, 2005, TRANSPLANTATION, V79, P1607, DOI 10.1097/01.TP.0000159029.48678.93; Le Y, 2005, J IMMUNOL, V174, P2582, DOI 10.4049/jimmunol.174.5.2582; Li Y, 2007, BIOCHEM BIOPH RES CO, V356, P780, DOI 10.1016/j.bbrc.2007.03.049; Lisignoli G, 2006, J CELL PHYSIOL, V207, P364, DOI 10.1002/jcp.20572; Lisignoli G, 2003, Chir Organi Mov, V88, P363; Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Potapova IA, 2007, STEM CELLS, V25, P1761, DOI 10.1634/stemcells.2007-0022; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shield Kristy, 2007, J Carcinog, V6, P11, DOI 10.1186/1477-3163-6-11; Sixt M, 2006, CURR OPIN CELL BIOL, V18, P482, DOI 10.1016/j.ceb.2006.08.007; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; van Buul JD, 2003, J BIOL CHEM, V278, P30302, DOI 10.1074/jbc.M304764200; Von Luttichau I, 2005, STEM CELLS DEV, V14, P329, DOI 10.1089/scd.2005.14.329; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Wang Lei, 2002, Hematology, V7, P113; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	53	140	146	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13100	13107		10.1074/jbc.M800184200	http://dx.doi.org/10.1074/jbc.M800184200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18334485	Green Published, hybrid			2022-12-25	WOS:000255499800048
J	Rand, KD; Andersen, MD; Olsen, OH; Jorgensen, TJD; Ostergaard, H; Jensen, ON; Stennicke, HR; Persson, E				Rand, Kasper D.; Andersen, Mette D.; Olsen, Ole H.; Jorgensen, Thomas J. D.; Ostergaard, Henrik; Jensen, Ole N.; Stennicke, Henning R.; Persson, Egon			The origins of enhanced activity in factor VIIa analogs and the interplay between key allosteric sites revealed by hydrogen exchange mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR VIIA; RECOMBINANT FACTOR VIIA; TISSUE FACTOR-BINDING; BLOOD-COAGULATION; PROTEASE DOMAIN; CRYSTAL-STRUCTURE; INTRINSIC ACTIVITY; CATALYTIC-ACTIVITY; AFFINITY; IDENTIFICATION	Factor VIIa (FVIIa) circulates in the blood in a zymogen-like state. Only upon association with membrane-bound tissue factor (TF) at the site of vascular injury does FVIIa become active and able to initiate blood coagulation. Here we used hydrogen exchange monitored by mass spectrometry to investigate the conformational effects of site-directed mutagenesis at key positions in FVIIa and the origins of enhanced intrinsic activity of FVIIa analogs. The differences in hydrogen exchange of two highly active variants, FVIIa(DVQ) and FVIIa(VEAY), imply that enhanced catalytic efficiency was attained by two different mechanisms. Regions protected from exchange in FVIIaDVQ include the N-terminal tail and the activation pocket, which is a subset of the regions of FVIIa protected from exchange upon TF binding. FVIIaDVQ appeared to adopt an intermediate conformation between the free (zymogen-like) and TF-bound ( active) form of FVIIa and to attain enhanced activity by partial mimicry of TF-induced activation. In contrast, exchange-protected regions in FVIIaVEAY were confined to the vicinity of the active site of FVIIa. Thus, the changes in FVIIaVEAY appeared to optimize the active site region rather than imitate the TF-induced effect. Hydrogen exchange analysis of the FVIIa(M306D) variant, which was unresponsive to stimulation by TF, correlated widespread reductions in exchange to the single mutation in the TF-binding region. These results reveal the delicate interplay between key allosteric sites necessary to achieve the transition of FVIIa into the active form.	[Rand, Kasper D.; Andersen, Mette D.; Olsen, Ole H.; Ostergaard, Henrik; Stennicke, Henning R.; Persson, Egon] Novo Nordisk AS, Dept Haemostasis Biochem, DK-2760 Malov, Denmark; [Rand, Kasper D.; Jorgensen, Thomas J. D.; Jensen, Ole N.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark	Novo Nordisk; University of Southern Denmark	Rand, KD (corresponding author), Novo Nordisk AS, Dept Haemostasis Biochem, Novo Nordisk Pk, DK-2760 Malov, Denmark.	kasperd@bmb.sdu.dk; egpe@novonordisk.com	Rand, Kasper/ABG-7446-2021; Jensen, Ole N/J-1763-2012	Jensen, Ole N/0000-0003-1862-8528; Jorgensen, Thomas J.D./0000-0002-7149-316X; Rand, Kasper/0000-0002-6337-5489				Allen GA, 2007, ARTERIOSCL THROM VAS, V27, P683, DOI 10.1161/01.ATV.0000257204.82396.2b; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; BODE W, 1975, FEBS LETT, V56, P139, DOI 10.1016/0014-5793(75)80128-1; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Dickinson CD, 1997, J BIOL CHEM, V272, P19875, DOI 10.1074/jbc.272.32.19875; Dickinson CD, 1996, P NATL ACAD SCI USA, V93, P14379, DOI 10.1073/pnas.93.25.14379; Englander SW, 2001, NAT STRUCT BIOL, V8, P741, DOI 10.1038/nsb0901-741; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; HIGASHI S, 1994, J BIOL CHEM, V269, P18891; Higashi S, 1996, J BIOL CHEM, V271, P26569, DOI 10.1074/jbc.271.43.26569; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Kemball-Cook G, 1999, J STRUCT BIOL, V127, P213, DOI 10.1006/jsbi.1999.4158; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Martinowitz U, 2001, J TRAUMA, V51, P431, DOI 10.1097/00005373-200109000-00002; Monroe DM, 1997, BRIT J HAEMATOL, V99, P542, DOI 10.1046/j.1365-2141.1997.4463256.x; Olsen OH, 2007, PROTEIN SCI, V16, P671, DOI 10.1110/ps.062504907; Persson E, 2006, BIOCHEM BIOPH RES CO, V341, P28, DOI 10.1016/j.bbrc.2005.12.146; Persson E, 2004, BIOCHEM J, V379, P497, DOI 10.1042/BJ20031596; Persson E, 2001, BIOCHEMISTRY-US, V40, P3251, DOI 10.1021/bi001612z; Persson E, 2001, P NATL ACAD SCI USA, V98, P13583, DOI 10.1073/pnas.241339498; Petersen LC, 2000, PROTEIN SCI, V9, P859, DOI 10.1110/ps.9.5.859; Petrovan RJ, 2000, BIOCHEMISTRY-US, V39, P14457, DOI 10.1021/bi0009486; Petrovan RJ, 2002, BIOCHEMISTRY-US, V41, P9302, DOI 10.1021/bi0202169; Pike ACW, 1999, P NATL ACAD SCI USA, V96, P8925, DOI 10.1073/pnas.96.16.8925; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; REZAIE AR, 1994, J BIOL CHEM, V269, P21495; Roberts HR, 2004, BLOOD, V104, P3858, DOI 10.1182/blood-2004-06-2223; Ruf W, 1998, TRENDS CARDIOVAS MED, V8, P350, DOI 10.1016/S1050-1738(98)00031-0; SABHARWAL AK, 1995, J BIOL CHEM, V270, P15523, DOI 10.1074/jbc.270.26.15523; Soejima K, 2002, J BIOL CHEM, V277, P49027, DOI 10.1074/jbc.M203091200; Sorensen BB, 1997, J BIOL CHEM, V272, P11863, DOI 10.1074/jbc.272.18.11863; Sorensen B, 2007, BRIT J HAEMATOL, V137, P158, DOI 10.1111/j.1365-2141.2007.06534.x; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; WILDGOOSE P, 1993, BIOCHEMISTRY-US, V32, P114, DOI 10.1021/bi00052a016	37	29	31	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13378	13387		10.1074/jbc.M709716200	http://dx.doi.org/10.1074/jbc.M709716200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18343822	hybrid			2022-12-25	WOS:000255499800077
J	Sheoran, A; First, EA				Sheoran, Anita; First, Eric A.			Activation of D-tyrosine by Bacillus stearothermophilus tyrosyl-tRNA synthetase - 2. Cooperative binding of atp is limited to the initial turnover of the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						6	SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; CATALYSIS; KINETICS; SEQUENCE; BACTERIORHODOPSIN; DISSOCIATION; SUBUNITS; MUTATION; MUTANTS	The activation of D-tyrosine by tyrosyl-tRNA synthetase has been investigated using single and multiple turnover kinetic methods. In the presence of saturating concentrations of D-tyrosine, the activation reaction displays sigmoidal kinetics with respect to ATP concentration under single turnover conditions. In contrast, when the kinetics for the activation reaction are monitored using a steady-state ( multiple turnover) pyrophosphate exchange assay, Michaelis-Menten kinetics are observed. Previous investigations indicated that activation of L-tyrosine by the K233A variant of Bacillus stearothermophilus tyrosyl-tRNA synthetase displays sigmoidal kinetics similar to those observed for activation of D-tyrosine by the wild-type enzyme. Kinetic analyses indicate that the sigmoidal behavior of the D-tyrosine activation reaction is not enhanced when Lys-233 is replaced by alanine. This supports the hypothesis that the mechanistic basis for the sigmoidal behavior is the same for both D-tyrosine activation by wild-type tyrosyl-tRNA synthetase and activation of L-tyrosine by the K233A variant. The observed sigmoidal behavior presents a paradox, as tyrosyl-tRNA synthetase displays an extreme form of negative cooperativity, known as "half-of-the-sites reactivity," with respect to tyrosine binding and tyrosyl-adenylate formation. We propose that the binding of D-tyrosine weakens the affinity with which ATP binds to the functional subunit in tyrosyl-tRNA synthetase. This allows ATP to bind initially to the nonfunctional subunit, inducing a conformational change in the enzyme that enhances the affinity of the functional subunit for ATP. The observation that sigmoidal kinetics are observed only under single turnover conditions suggests that this conformational change is stable over multiple rounds of catalysis.	[Sheoran, Anita; First, Eric A.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	First, EA (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.	efirst@lsuhsc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068070] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM68070, R01 GM068070] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adair GS, 1925, J BIOL CHEM, V63, P529; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Austin J, 2002, J BIOL CHEM, V277, P20243, DOI 10.1074/jbc.M201923200; Austin J, 2002, J BIOL CHEM, V277, P14812, DOI 10.1074/jbc.M103396200; AVIS JM, 1993, BIOCHEMISTRY-US, V32, P5312, DOI 10.1021/bi00071a005; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; CALENDAR R, 1966, BIOCHEMISTRY-US, V5, P1690, DOI 10.1021/bi00869a034; CALENDAR R, 1967, J MOL BIOL, V26, P39, DOI 10.1016/0022-2836(67)90259-8; CLARKE AR, 1996, ENZYMOLOGY LABFAX, P201; Eadie GS, 1942, J BIOL CHEM, V146, P85; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P5, DOI 10.1021/bi00672a002; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P13, DOI 10.1021/bi00672a003; FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13651, DOI 10.1021/bi00212a033; Hill A.V., 1910, J PHYSIOL-LONDON, V40, piv; HO CK, 1986, BIOCHEMISTRY-US, V25, P1891, DOI 10.1021/bi00356a009; HOFSTEE BHJ, 1959, NATURE, V184, P1296, DOI 10.1038/1841296b0; JONES DH, 1985, BIOCHEMISTRY-US, V24, P5852, DOI 10.1021/bi00342a024; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; Kollbach G, 1998, BIOCHEMISTRY-US, V37, P8227, DOI 10.1021/bi972268h; LLOYD AJ, 1995, NUCLEIC ACIDS RES, V23, P2886, DOI 10.1093/nar/23.15.2886; MATSUOKA I, 1982, J BIOCHEM-TOKYO, V92, P1383, DOI 10.1093/oxfordjournals.jbchem.a134062; Michaelis L, 1913, BIOCHEM Z, V49, P333; Prigent V, 2005, BIOINFORMATICS, V21, P1437, DOI 10.1093/bioinformatics/bti218; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Sheoran A, 2008, J BIOL CHEM, V283, P12960, DOI 10.1074/jbc.M801649200; WELLS TNC, 1991, BIOCHEMISTRY-US, V30, P5151, DOI 10.1021/bi00235a006; WELLS TNC, 1986, BIOCHEMISTRY-US, V25, P1881, DOI 10.1021/bi00356a007; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; Xin Y, 2000, BIOCHEMISTRY-US, V39, P340, DOI 10.1021/bi991675l; Yamaguchi S, 2000, J BIOCHEM-TOKYO, V127, P861, DOI 10.1093/oxfordjournals.jbchem.a022680	32	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12971	12980		10.1074/jbc.M801650200	http://dx.doi.org/10.1074/jbc.M801650200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18319246	hybrid, Green Published			2022-12-25	WOS:000255499800034
J	Shim, SY; Samuels, BA; Wang, J; Neumayer, G; Belzil, C; Ayala, R; Shi, Y; Shi, YJ; Tsai, LH; Nguyen, MD				Shim, Su Yeon; Samuels, Benjamin Adam; Wang, Jian; Neumayer, Gernot; Belzil, Camille; Ayala, Ramses; Shi, Yang; Shi, Yujiang; Tsai, Li-Huei; Nguyen, Minh Dang			Ndel1 controls the dynein-mediated transport of vimentin during neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT NETWORKS; AMYOTROPHIC-LATERAL-SCLEROSIS; MARIE-TOOTH-DISEASE; CYTOPLASMIC DYNEIN; NEURONAL MIGRATION; VESICLE-TRAFFICKING; MOTILE PROPERTIES; CEREBRAL-CORTEX; LIS1; NUDEL	Ndel1, the mammalian homologue of the Aspergillus nidulans NudE, is emergently viewed as an integrator of the cytoskeleton. By regulating the dynamics of microtubules and assembly of neuronal intermediate filaments (IFs), Ndel1 promotes neurite outgrowth, neuronal migration, and cell integrity (1-6). To further understand the roles of Ndel1 in cytoskeletal dynamics, we performed a tandem affinity purification of Ndel1-interacting proteins. We isolated a novel Ndel1 molecular complex composed of the IF vimentin, the molecular motor dynein, the lissencephaly protein Lis1, and the cis-Golgi-associated protein alpha COP. Ndel1 promotes the interaction between Lis1, alpha COP, and the vimentin-dynein complex. The functional result of this complex is activation of dynein-mediated transport of vimentin. A loss of Ndel1 functions by RNA interference fails to incorporate Lis1/alpha COP in the complex, reduces the transport of vimentin, and culminates in IF accumulations and altered neuritogenesis. Our findings reveal a novel regulatory mechanism of vimentin transport during neurite extension that may have implications in diseases featuring transport/trafficking defects and impaired regeneration.	[Shim, Su Yeon; Wang, Jian; Neumayer, Gernot; Belzil, Camille; Nguyen, Minh Dang] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Shim, Su Yeon; Wang, Jian; Neumayer, Gernot; Belzil, Camille; Nguyen, Minh Dang] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Wang, Jian; Neumayer, Gernot; Belzil, Camille; Nguyen, Minh Dang] Univ Calgary, Hotchkiss Brain Inst, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Samuels, Benjamin Adam; Ayala, Ramses; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Shi, Yang; Shi, Yujiang] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Calgary; University of Calgary; University of Calgary; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Harvard Medical School	Nguyen, MD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, 3330 Hosp Dr NW,Heritage Med Res Bldg,Room 151, Calgary, AB T2N 4N1, Canada.	mdnguyen@ucalgary.ca			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Boyne LJ, 1996, INT J DEV NEUROSCI, V14, P739, DOI 10.1016/S0736-5748(96)00053-6; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Chen JL, 2005, J CELL BIOL, V169, P383, DOI 10.1083/jcb.200501157; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; De Jonghe P, 2001, ANN NEUROL, V49, P245, DOI 10.1002/1531-8249(20010201)49:2<245::AID-ANA45>3.0.CO;2-A; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; DePianto D, 2004, EXP CELL RES, V301, P68, DOI 10.1016/j.yexcr.2004.08.007; Dubey M, 2004, J NEUROSCI RES, V78, P245, DOI 10.1002/jnr.20146; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Helfand BT, 2002, J CELL BIOL, V157, P795, DOI 10.1083/jcb.200202027; Helfand BT, 2004, J CELL SCI, V117, P133, DOI 10.1242/jcs.00936; Helfand BT, 2003, ANNU REV CELL DEV BI, V19, P445, DOI 10.1146/annurev.cellbio.19.111401.092306; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2006, HUM MOL GENET, V15, P3313, DOI 10.1093/hmg/ddl407; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058; Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345; LO NC, 1997, HUM MOL GENET, V6, P157; Mackie S, 2007, CURR OPIN NEUROBIOL, V17, P95, DOI 10.1016/j.conb.2007.01.007; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Mesngon MT, 2006, J NEUROSCI, V26, P2132, DOI 10.1523/JNEUROSCI.5095-05.2006; Mori D, 2007, MOL CELL BIOL, V27, P352, DOI 10.1128/MCB.00878-06; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Munch C, 2005, ANN NEUROL, V58, P777, DOI 10.1002/ana.20631; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2001, Prog Brain Res, V132, P23; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Perrin FE, 2005, HUM MOL GENET, V14, P3309, DOI 10.1093/hmg/ddi357; Perrin FE, 2006, J NEUROCHEM, V98, P1959, DOI 10.1111/j.1471-4159.2006.04024.x; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Qi YP, 1997, J NEUROSCI, V17, P1217; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Shah JV, 2000, MOL BIOL CELL, V11, P3495, DOI 10.1091/mbc.11.10.3495; SHEA TB, 1993, J NEUROSCI RES, V36, P66, DOI 10.1002/jnr.490360108; Sheen VL, 2004, NAT GENET, V36, P69, DOI 10.1038/ng1276; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tai CY, 2002, J CELL BIOL, V156, P959, DOI 10.1083/jcb.200109046; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008; Wang L, 2001, MOL BIOL CELL, V12, P3257, DOI 10.1091/mbc.12.10.3257; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Yan YP, 2005, J NEUROSCI, V25, P7014, DOI 10.1523/JNEUROSCI.2001-05.2005; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	61	35	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12232	12240		10.1074/jbc.M710200200	http://dx.doi.org/10.1074/jbc.M710200200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18303022	hybrid			2022-12-25	WOS:000255340000039
J	Tanemoto, M; Toyohara, T; Abe, T; Ito, S				Tanemoto, Masayuki; Toyohara, Takafumi; Abe, Takaaki; Ito, Sadayoshi			MAGI-1a functions as a scaffolding protein for the distal renal tubular basolateral K+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED PHOSPHORYLATION; HUMAN HYPERTENSION; BETA-CATENIN; PDZ-BINDING; RAT-KIDNEY; MEMBRANE; CELLS; KIR4.1; PREVALENCE; KINASE	As the K+ recycling pathway for renal Na+ reabsorption, renal tubular K+ channels participate in the fluid and electrolyte homeostasis. Previously, we showed that the Kir5.1/Kir4.1 heteromer, which is a heteromeric assembly of two inwardly rectifying K+ channels, composes the principal basolateral K+ channels in distal renal tubules and that two motifs in the carboxyl-terminal portion of the Kir4.1 subunit regulate its functional expression. In this study, by using yeast two-hybrid screening, we identified a new isoform of membrane-associated guanylate kinase with inverted domain structure 1 (MAGI-1a-long) as a scaffolding protein for the basolateral K+ channels. MAGI-1a-long interacted with the PSD-95/Dlg/ZO-1 (PDZ)binding motif of Kir4.1 by its fifth PDZ domain, and a high salt diet, which could suppress mineralocorticoid secretion, facilitated the interaction. The phosphorylation of serine 377 in the PDZ-binding motif disrupted the interaction, and the disruption of the interaction altered the intracellular localization of the channels from the basolateral side to perinuclear components. These results demonstrate that the phosphorylation-dependent scaffolding of the basolateral K+ channels by MAGI-1a-long participates in the renal regulation of the fluid and electrolyte homeostasis.	[Tanemoto, Masayuki; Toyohara, Takafumi; Abe, Takaaki; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Dept Med, Div Nephrol Hypertens & Endocrinol,Aoba Ku, Sendai, Miyagi 9808574, Japan	Tohoku University	Tanemoto, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med, Div Nephrol Hypertens & Endocrinol,Aoba Ku, 1-1 Seiryo Cho, Sendai, Miyagi 9808574, Japan.	mtanemoto-tky@umin.ac.jp	Ito, Sadayoshi/A-3933-2015	Ito, Sadayoshi/0000-0002-5092-3626				Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Brown D, 2000, KIDNEY INT, V57, P816, DOI 10.1046/j.1523-1755.2000.00920.x; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; de la Rosa DA, 2003, J PHYSIOL-LONDON, V551, P455, DOI 10.1113/jphysiol.2003.042903; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Giebisch G, 2001, KIDNEY INT, V60, P436, DOI 10.1046/j.1523-1755.2001.060002436.x; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Hou JH, 2002, J AM SOC NEPHROL, V13, P1190, DOI 10.1097/01.ASN.0000013702.73570.3B; Ito M, 1996, FEBS LETT, V388, P11, DOI 10.1016/0014-5793(96)00502-9; Kachinsky AM, 1999, J CELL BIOL, V145, P391, DOI 10.1083/jcb.145.2.391; Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002; Laura RP, 2002, EXP CELL RES, V275, P155, DOI 10.1006/excr.2002.5475; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Loh NY, 2000, J CELL SCI, V113, P2715; Lourdel S, 2002, J PHYSIOL-LONDON, V538, P391, DOI 10.1113/jphysiol.2001.012961; Meneton P, 2004, AM J PHYSIOL-RENAL, V287, pF593, DOI 10.1152/ajprenal.00454.2003; Nishimura W, 2000, J CELL PHYSIOL, V185, P358, DOI 10.1002/1097-4652(200012)185:3<358::AID-JCP6>3.3.CO;2-R; Patrie KM, 2001, J AM SOC NEPHROL, V12, P667, DOI 10.1681/ASN.V124667; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Psaltopoulou T, 2004, INT J EPIDEMIOL, V33, P1345, DOI 10.1093/ije/dyh249; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Tanemoto M, 2005, J AM SOC NEPHROL, V16, P2608, DOI 10.1681/ASN.2005030266; Tanemoto M, 2004, AM J PHYSIOL-RENAL, V287, pF1148, DOI 10.1152/ajprenal.00203.2004; Tanemoto M, 2002, NEURON, V34, P387, DOI 10.1016/S0896-6273(02)00675-X; Tanemoto M, 2000, J PHYSIOL-LONDON, V525, P587, DOI 10.1111/j.1469-7793.2000.00587.x; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844	34	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12241	12247		10.1074/jbc.M707738200	http://dx.doi.org/10.1074/jbc.M707738200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18303016	hybrid			2022-12-25	WOS:000255340000040
J	Strathdee, D; Whitelaw, CBA; Clark, AJ				Strathdee, Douglas; Whitelaw, C. Bruce A.; Clark, A. John			Distal transgene insertion affects CpG island maintenance during differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIGENETIC GENE INACTIVATION; EMBRYONIC STEM-CELLS; BETA-ACTIN LOCUS; DNA METHYLATION; EXPRESSION; PROMOTER; SP1; EVOLUTION; METHYLTRANSFERASES; SEQUENCES	About half of all genes have a CpG island surrounding the promoter and transcription start site. Most promoter CpG islands are normally unmethylated in all tissues, irrespective of the expression level of the associated gene. Establishment of the appropriate patterns of DNA methylation in the genome is essential for normal development and patterns of gene expression. Aberrant methylation of CpG islands and silencing of the associated genes is frequently observed in cancer. One gene with a 5'-CpG island is cytoplasmic beta-actin, which is an abundantly expressed protein and a major component of microfilaments. Inserting a beta geo cassette into the 3'-untranslated region of beta-actin gene led to widespread but not ubiquitous lacZ expression in mice heterozygous for the modified beta-actin allele. Surprisingly, embryos homozygous for this insertion died at mid-gestation. The modified beta-actin allele was expressed in undifferentiated embryonic stem cells but was turned off as these cells differentiate in vitro and in vivo. We demonstrate that the insertion affects the maintenance of the methylation status of the CpG island of the modified beta-actin allele in differentiated but not in undifferentiated embryonic cells. These data suggest that there is a two-step process to defining a CpG island, requiring both embryonic establishment and a signal that maintains the CpG island in differentiated cells. Furthermore, they indicate that features built into the CpG island are not sufficient to direct CpG island maintenance during differentiation.	[Strathdee, Douglas; Whitelaw, C. Bruce A.; Clark, A. John] Roslin Inst, Div Gene Funct & Dev, Roslin EH25 9PS, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute	Strathdee, D (corresponding author), Wellcome Trust Sanger Inst, Genome Campus, Hinxton Cambridge CB10 1SA, Cambs, England.	ds10@sanger.ac.uk		Whitelaw, Bruce/0000-0002-2918-1605	BBSRC [BBS/E/D/05251442, BBS/E/D/05251445, BBS/E/D/05251443, BBS/E/D/05251444] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05251444, BBS/E/D/05251445, Cad04943, BBS/E/D/05251443, BBS/E/D/05251442] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Antequera F, 2003, CELL MOL LIFE SCI, V60, P1647, DOI 10.1007/s00018-003-3088-6; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; BRANDEIS M, 1993, BIOESSAYS, V15, P709, DOI 10.1002/bies.950151103; CROSS SH, 1995, CURR OPIN GENET DEV, V5, P309, DOI 10.1016/0959-437X(95)80044-1; ELDER PK, 1988, MOL CELL BIOL, V8, P480, DOI 10.1128/MCB.8.1.480; ERBA HP, 1988, MOL CELL BIOL, V8, P1775, DOI 10.1128/MCB.8.4.1775; FRANK D, 1991, NATURE, V351, P239, DOI 10.1038/351239a0; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GRUENBAUM Y, 1981, FEBS LETT, V124, P67, DOI 10.1016/0014-5793(81)80055-5; Hattori N, 2004, GENOME RES, V14, P1733, DOI 10.1101/gr.2431504; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lei H, 1996, DEVELOPMENT, V122, P3195; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Macleod D, 1998, MOL CELL BIOL, V18, P4433, DOI 10.1128/MCB.18.8.4433; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; MUMMANENI P, 1995, J BIOL CHEM, V270, P788, DOI 10.1074/jbc.270.2.788; Mummaneni P, 1998, NUCLEIC ACIDS RES, V26, P5163, DOI 10.1093/nar/26.22.5163; NG SY, 1985, MOL CELL BIOL, V5, P2720, DOI 10.1128/MCB.5.10.2720; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; Robertson KD, 2001, ONCOGENE, V20, P3139, DOI 10.1038/sj.onc.1204341; Selbert S, 1998, TRANSGENIC RES, V7, P387, DOI 10.1023/A:1008848304391; Shawlot W, 1998, TRANSGENIC RES, V7, P95, DOI 10.1023/A:1008816308171; Shmerling D, 2005, GENESIS, V42, P229, DOI 10.1002/gene.20135; Small JV, 2005, CURR OPIN CELL BIOL, V17, P517, DOI 10.1016/j.ceb.2005.08.004; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Wallace H, 2000, NUCLEIC ACIDS RES, V28, P1455, DOI 10.1093/nar/28.6.1455; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yates PA, 1999, J BIOL CHEM, V274, P36357, DOI 10.1074/jbc.274.51.36357	37	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11509	11515		10.1074/jbc.M709805200	http://dx.doi.org/10.1074/jbc.M709805200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18308728	hybrid			2022-12-25	WOS:000255067400050
J	Boily, G; Seifert, EL; Bevilacqua, L; He, XH; Sabourin, G; Estey, C; Moffat, C; Crawford, S; Saliba, S; Jardine, K; Xuan, J; Evans, M; Harper, ME; McBurney, MW				Boily, Gino; Seifert, Erin L.; Bevilacqua, Lisa; He, Xiao Hong; Sabourin, Guillaume; Estey, Carmen; Moffat, Cynthia; Crawford, Sean; Saliba, Sarah; Jardine, Karen; Xuan, Jian; Evans, Meredith; Harper, Mary-Ellen; McBurney, Michael W.			SirT1 Regulates Energy Metabolism and Response to Caloric Restriction in Mice	PLOS ONE			English	Article								The yeast sir2 gene and its orthologues in Drosophila and C. elegans have well-established roles in lifespan determination and response to caloric restriction. We have studied mice carrying two null alleles for SirT1, the mammalian orthologue of sir2, and found that these animals inefficiently utilize ingested food. These mice are hypermetabolic, contain inefficient liver mitochondria, and have elevated rates of lipid oxidation. When challenged with a 40% reduction in caloric intake, normal mice maintained their metabolic rate and increased their physical activity while the metabolic rate of SirT1-null mice dropped and their activity did not increase. Moreover, CR did not extend lifespan of SirT1-null mice. Thus, SirT1 is an important regulator of energy metabolism and, like its orthologues from simpler eukaryotes, the SirT1 protein appears to be required for a normal response to caloric restriction.	[Boily, Gino; He, Xiao Hong; Sabourin, Guillaume; Moffat, Cynthia; Crawford, Sean; Saliba, Sarah; Jardine, Karen; McBurney, Michael W.] Univ Ottawa, Dept Med, Ctr Canc Therapeut, Hlth Res Inst, Ottawa, ON, Canada; [Seifert, Erin L.; Bevilacqua, Lisa; Estey, Carmen; Xuan, Jian; Evans, Meredith; Harper, Mary-Ellen; McBurney, Michael W.] Univ Ottawa, Dept Biochem, Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Boily, G (corresponding author), Univ Ottawa, Dept Med, Ctr Canc Therapeut, Hlth Res Inst, Ottawa, ON, Canada.	mmcburney@ohri.ca		Harper, Mary-Ellen/0000-0003-3864-5886; Crawford, Sean/0000-0002-0665-4772	Canadian Institutes of Health Research; Fonds de Recherche en Sante du Quebec [fellowship]; Canadian Diabetes Association [fellowship]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Diabetes Association	This project was funded by the Canadian Institutes of Health Research (CIHR; MM and MEH). GB and ES are recipients of fellowships from the Fonds de Recherche en Sante du Quebec (FRSQ) and the Canadian Diabetes Association (CDA), respectively.	Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003; Bezaire V, 2001, AM J PHYSIOL-ENDOC M, V281, pE975, DOI 10.1152/ajpendo.2001.281.5.E975; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; CHAPPELL JB, 1954, NATURE, V173, P1094, DOI 10.1038/1731094a0; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Zhang J, 2007, J BIOL CHEM, V282, P34356, DOI 10.1074/jbc.M706644200	40	354	365	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1759	10.1371/journal.pone.0001759	http://dx.doi.org/10.1371/journal.pone.0001759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335035	Green Published, gold, Green Submitted			2022-12-25	WOS:000260723000013
J	Kola, B; Farkas, I; Christ-Crain, M; Wittmann, G; Lolli, F; Amin, F; Harvey-White, J; Liposits, Z; Kunos, G; Grossman, AB; Fekete, C; Korbonits, M				Kola, Blerina; Farkas, Imre; Christ-Crain, Mirjam; Wittmann, Gabor; Lolli, Francesca; Amin, Faisal; Harvey-White, Judith; Liposits, Zsolt; Kunos, George; Grossman, Ashley B.; Fekete, Csaba; Korbonits, Marta			The Orexigenic Effect of Ghrelin Is Mediated through Central Activation of the Endogenous Cannabinoid System	PLOS ONE			English	Article							RECEPTOR ANTAGONIST SR141716; CB1 RECEPTOR; FOOD-INTAKE; ENDOCANNABINOID RELEASE; NEUROPEPTIDE-Y; KNOCKOUT MICE; PROTEIN; HYPOTHALAMUS; METABOLISM; NUTRIENT	Introduction: Ghrelin and cannabinoids stimulate appetite, this effect possibly being mediated by the activation of hypothalamic AMP-activated protein kinase (AMPK), a key enzyme in appetite and metabolism regulation. The cannabinoid receptor type 1 (CB1) antagonist rimonabant can block the orexigenic effect of ghrelin. In this study, we have elucidated the mechanism of the putative ghrelin-cannabinoid interaction. Methods: The effects of ghrelin and CB1 antagonist rimonabant in wild-type mice, and the effect of ghrelin in CB1-knockout animals, were studied on food intake, hypothalamic AMPK activity and endogenous cannabinoid content. In patch-clamp electrophysiology experiments the effect of ghrelin was assessed on the synaptic inputs in parvocellular neurons of the hypothalamic paraventricular nucleus, with or without the pre-administration of a CB1 antagonist or of cannabinoid synthesis inhibitors. Results and Conclusions: Ghrelin did not induce an orexigenic effect in CB1-knockout mice. Correspondingly, both the genetic lack of CB1 and the pharmacological blockade of CB1 inhibited the effect of ghrelin on AMPK activity. Ghrelin increased the endocannabinoid content of the hypothalamus in wild-type mice and this effect was abolished by rimonabant pre-treatment, while no effect was observed in CB1-KO animals. Electrophysiology studies showed that ghrelin can inhibit the excitatory inputs on the parvocellular neurons of the paraventricular nucleus, and that this effect is abolished by administration of a CB1 antagonist or an inhibitor of the DAG lipase, the enzyme responsible for 2-AG synthesis. The effect is also lost in the presence of BAPTA, an intracellular calcium chelator, which inhibits endocannabinoid synthesis in the recorded parvocellular neuron and therefore blocks the retrograde signaling exerted by endocannabinoids. In summary, an intact cannabinoid signaling pathway is necessary for the stimulatory effects of ghrelin on AMPK activity and food intake, and for the inhibitory effect of ghrelin on paraventricular neurons.	[Farkas, Imre; Wittmann, Gabor; Liposits, Zsolt; Fekete, Csaba] Hungarian Acad Sci, Inst Expt Med, Dept Endocrine Neurobiol, Budapest, Hungary; [Kola, Blerina; Christ-Crain, Mirjam; Lolli, Francesca; Amin, Faisal; Grossman, Ashley B.; Korbonits, Marta] Univ London, Barts & London Sch Med & Dentist, Dept Endocrinol, London, England; [Harvey-White, Judith; Kunos, George] NIH, NIAAA, Lab Physiol Stud, Bethesda, MD USA; [Fekete, Csaba] Tufts-New England Med Ctr, Dept Med, Tupper Res Inst, Div Endocrinol, Diabetes, Metabol & Mol Med, Boston, MA USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; University of London; Queen Mary University London; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Tufts Medical Center	Fekete, C (corresponding author), Hungarian Acad Sci, Inst Expt Med, Dept Endocrine Neurobiol, Budapest, Hungary.	Feketecs@koki.hu; m.korbonits@qmul.ac.uk	Liposits, Zsolt/K-8145-2019	Fekete, Csaba/0000-0002-8206-562X; Liposits, Zsolt/0000-0002-3508-2750; Christ-Crain, Mirjam/0000-0002-6336-0965; Korbonits, Marta/0000-0002-4101-9432	Wellcome Trust [319/2006]; ETT; Sixth EU Research Framework Programme [LSHM-CT-2003-503041]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000350, Z01AA000350] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); ETT; Sixth EU Research Framework Programme(European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by a Wellcome Trust Project Grant, by ETT (319/2006) and the Sixth EU Research Framework Programme (contact LSHM-CT-2003-503041). The funders did not have a role in this manuscript.	Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Batkai S, 2004, AM J PHYSIOL-HEART C, V287, pH595, DOI 10.1152/ajpheart.00184.2004; Bequet F, 2007, EUR J NEUROSCI, V26, P3458, DOI 10.1111/j.1460-9568.2007.05900.x; CRESPO I, 2007, NEUROPHARMACOLOGY; Di Marzo V, 2000, J NEUROCHEM, V75, P2434, DOI 10.1046/j.1471-4159.2000.0752434.x; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di S, 2005, ENDOCRINOLOGY, V146, P4292, DOI 10.1210/en.2005-0610; Di S, 2003, J NEUROSCI, V23, P4850; Fekete C, 2004, ENDOCRINOLOGY, V145, P4816, DOI 10.1210/en.2004-0476; Fride E, 2003, EUR J PHARMACOL, V461, P27, DOI 10.1016/S0014-2999(03)01295-0; Gamber KM, 2005, NEUROPHARMACOLOGY, V49, P646, DOI 10.1016/j.neuropharm.2005.04.017; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Higgins SC, 2007, ANN MED, V39, P116, DOI 10.1080/07853890601149179; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Kola B, 2006, TRENDS ENDOCRIN MET, V17, P205, DOI 10.1016/j.tem.2006.05.006; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Matias I, 2008, NEUROPHARMACOLOGY, V54, P206, DOI 10.1016/j.neuropharm.2007.06.011; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Poncelet M, 2003, NEUROSCI LETT, V343, P216, DOI 10.1016/S0304-3940(03)00397-5; Rigamonti AE, 2006, EUR J PHARMACOL, V542, P116, DOI 10.1016/j.ejphar.2006.05.028; Tucci SA, 2004, BRIT J PHARMACOL, V143, P520, DOI 10.1038/sj.bjp.0705968; Turu G, 2007, J BIOL CHEM, V282, P7753, DOI 10.1074/jbc.C600318200; Verty ANA, 2004, ENDOCRINOLOGY, V145, P3224, DOI 10.1210/en.2004-0059; Wang L, 2003, P NATL ACAD SCI USA, V100, P1393, DOI 10.1073/pnas.0336351100; Wittmann G, 2007, J COMP NEUROL, V503, P270, DOI 10.1002/cne.21383; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217	34	227	232	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1797	10.1371/journal.pone.0001797	http://dx.doi.org/10.1371/journal.pone.0001797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335063	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000260723000045
J	Waibler, Z; Sender, LY; Merten, C; Hartig, R; Kliche, S; Gunzer, M; Reichardt, P; Kalinke, U; Schraven, B				Waibler, Zoe; Sender, Linda Y.; Merten, Camilla; Hartig, Roland; Kliche, Stefanie; Gunzer, Matthias; Reichardt, Peter; Kalinke, Ulrich; Schraven, Burkhart			Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies	PLOS ONE			English	Article								Superagonistic CD28 antibodies (CD28SAs) activate T lymphocytes without concomitant perturbation of the TCR/CD3-complex. In rodents these reagents induce the preferential expansion of regulatory T cells and can be used for the treatment of autoimmune diseases. Unexpectedly, the humanized CD28 superagonist TGN1412 caused severe and life threatening adverse effects during a recently conducted phase I clinical trail. The underlying molecular mechanisms are as yet unclear. We show that TGN1412 as well as the commercially available CD28 superagonist ANC28.1 induce a delayed but extremely sustained calcium response in human naive and memory CD4+ T cells but not in cynomolgus T lymphocytes. The sustained Ca++-signal was associated with the activation of multiple intracellular signaling pathways and together these events culminated in the rapid de novo synthesis of high amounts of pro-inflammatory cytokines, most notably IFN-gamma and TNF-alpha. Importantly, sustained transmembranous calcium flux, activation of Src-kinases as well as activation of PI3K were found to be absolutely required for CD28SA-mediated production of IFN-gamma and IL-2. Collectively, our data suggest a molecular basis for the severe side effects caused by TGN1412 and impinge upon the relevance of non-human primates as preclinical models for reagents that are supposed to modify the function of human T cells.	[Waibler, Zoe; Sender, Linda Y.; Kalinke, Ulrich] Paul Ehrlich Inst, D-6070 Langen, Germany; [Merten, Camilla; Hartig, Roland; Kliche, Stefanie; Gunzer, Matthias; Reichardt, Peter; Schraven, Burkhart] Otto von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany	Paul Ehrlich Institute; Otto von Guericke University	Waibler, Z (corresponding author), Paul Ehrlich Inst, D-6070 Langen, Germany.	kalul@pei.de; Burkhart.Schraven@med.ovgu.de	Gunzer, Matthias/AAW-7026-2021	Gunzer, Matthias/0000-0002-5534-6055; Hartig, Roland/0000-0002-3706-7458; Kalinke, Ulrich/0000-0003-0503-9564	German Research Foundation [SFB432, B15]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG) to B.S. and to U.K. (SFB432, B15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE R, 1995, J IMMUNOL, V154, P985; Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Beyersdorf N, 2006, AUTOIMMUN REV, V5, P40, DOI 10.1016/j.autrev.2005.06.001; Beyersdorf N, 2005, ANN RHEUM DIS, V64, P91, DOI 10.1136/ard.2005.042564; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Beyersdorf N, 2006, IMMUNOLOGY, V119, P441, DOI 10.1111/j.1365-2567.2006.02455.x; Bischof A, 2000, EUR J IMMUNOL, V30, P876, DOI 10.1002/1521-4141(200003)30:3<876::AID-IMMU876>3.0.CO;2-M; Dennehy KM, 2007, J IMMUNOL, V178, P1363, DOI 10.4049/jimmunol.178.3.1363; Dennehy KM, 2003, INT IMMUNOL, V15, P655, DOI 10.1093/intimm/dxg063; Expert Scientific Group, 2006, EXP SCI GROUP PHAS O; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hanke T, 2006, LANCET, V368, P1569, DOI 10.1016/S0140-6736(06)69651-7; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; Hunig T, 2005, IMMUNOL LETT, V100, P21, DOI 10.1016/j.imlet.2005.06.012; Ibegbu C, 2001, J MED PRIMATOL, V30, P291, DOI 10.1034/j.1600-0684.2001.300601.x; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Kenter MJH, 2006, LANCET, V368, P1387, DOI 10.1016/S0140-6736(06)69562-7; Kirchgessner H, 2001, J EXP MED, V193, P1269, DOI 10.1084/jem.193.11.1269; LEDBETTER JA, 1990, BLOOD, V75, P1531; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lin CH, 2003, EUR J IMMUNOL, V33, P626, DOI 10.1002/eji.200323570; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; Michel F, 2001, IMMUNITY, V15, P935, DOI 10.1016/S1074-7613(01)00244-8; Nguyen DH, 2006, P NATL ACAD SCI USA, V103, P7765, DOI 10.1073/pnas.0510484103; NUNES J, 1991, MOL IMMUNOL, V28, P427, DOI 10.1016/0161-5890(91)90156-E; Okkenhaug K, 2001, NAT IMMUNOL, V2, P325, DOI 10.1038/86327; PANTALEO G, 1986, EUR J IMMUNOL, V16, P1639, DOI 10.1002/eji.1830161228; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Rodriguez-Palmero M, 2006, J RHEUMATOL, V33, P110; Rodriguez-Palmero M, 1999, EUR J IMMUNOL, V29, P3914; ROSS SE, 1994, BIOCHEM BIOPH RES CO, V198, P88, DOI 10.1006/bbrc.1994.1013; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; SAEZRODRIGUEZ J, 2007, COMPREHENSIVE UNPUB; Schmidt J, 2003, J NEUROIMMUNOL, V140, P143, DOI 10.1016/S0165-5728(03)00182-6; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Sester U, 2007, EUR J IMMUNOL, V37, P2881, DOI 10.1002/eji.200737206; Sharpe AH, 2006, NEW ENGL J MED, V355, P973, DOI 10.1056/NEJMp068087; Siefken R, 1998, J IMMUNOL, V161, P1645; Sopper S, 1997, CYTOMETRY, V29, P351; Stebbings R, 2007, J IMMUNOL, V179, P3325, DOI 10.4049/jimmunol.179.5.3325; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tacke M, 1997, EUR J IMMUNOL, V27, P239, DOI 10.1002/eji.1830270136; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	46	68	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1708	10.1371/journal.pone.0001708	http://dx.doi.org/10.1371/journal.pone.0001708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320029	Green Published, Green Submitted, gold			2022-12-25	WOS:000260586600004
J	Fu, J; Fong, K; Bellacosa, A; Ross, E; Apostolou, S; Bassi, DE; Jin, F; Zhang, J; Cairns, P; Ibanez de Caceres, I; Braunewell, KH; Klein-Szanto, AJ				Fu, Jian; Fong, Kathryn; Bellacosa, Alfonso; Ross, Eric; Apostolou, Sinoula; Bassi, Daniel E.; Jin, Fang; Zhang, Jirong; Cairns, Paul; Ibanez de Caceres, Immaculada; Braunewell, Karl-Heinz; Klein-Szanto, Andres J.			VILIP-1 Downregulation in Non-Small Cell Lung Carcinomas: Mechanisms and Prediction of Survival	PLOS ONE			English	Article								VILIP-1, a member of the neuronal Ca++ sensor protein family, acts as a tumor suppressor gene in an experimental animal model by inhibiting cell proliferation, adhesion and invasiveness of squamous cell carcinoma cells. Western Blot analysis of human tumor cells showed that VILIP-1 expression was undetectable in several types of human tumor cells, including 11 out of 12 non-small cell lung carcinoma (NSCLC) cell lines. The down-regulation of VILIP-1 was due to loss of VILIP-1 mRNA transcripts. Rearrangements, large gene deletions or mutations were not found. Hypermethylation of the VILIP-1 promoter played an important role in gene silencing. In most VILIP-1-silent cells the VILIP-1 promoter was methylated. In vitro methylation of the VILIP-1 promoter reduced its activity in a promoter-reporter assay. Transcriptional activity of endogenous VILIP-1 promoter was recovered by treatment with 59-aza-29-deoxycytidine (5'-Aza-dC). Trichostatin A (TSA), a histone deacetylase inhibitor, potently induced VILIP-1 expression, indicating that histone deacetylation is an additional mechanism of VILIP-1 silencing. TSA increased histone H3 and H4 acetylation in the region of the VILIP-1 promoter. Furthermore, statistical analysis of expression and promoter methylation (n = 150 primary NSCLC samples) showed a significant relationship between promoter methylation and protein expression downregulation as well as between survival and decreased or absent VILIP-1 expression in lung cancer tissues (p < 0.0001). VILIP-1 expression is silenced by promoter hypermethylation and histone deacetylation in aggressive NSCLC cell lines and primary tumors and its clinical evaluation could have a role as a predictor of short-term survival in lung cancer patients.	[Fu, Jian; Fong, Kathryn; Bassi, Daniel E.; Jin, Fang; Zhang, Jirong; Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Bellacosa, Alfonso] Fox Chase Canc Ctr, Human Genet Program, Philadelphia, PA USA; [Ross, Eric] Fox Chase Canc Ctr, Biomathematics & Biostat, Philadelphia, PA USA; [Apostolou, Sinoula] Fox Chase Canc Ctr, Bioinformat Facility, Philadelphia, PA USA; [Cairns, Paul; Ibanez de Caceres, Immaculada] Fox Chase Canc Ctr, Surg Oncol, Philadelphia, PA USA; [Braunewell, Karl-Heinz] Humboldt Univ, Neurosci Res Ctr Charite, Fac Med, Berlin, Germany	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Fu, J (corresponding author), Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA.	aj_klein-szanto@fccc.edu			National Institutes of Health [CA107257, CA06927]; Commonwealth of Pennsylvania; Pennsylvania Department of Health; Deutsche Krebshilfe; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA107257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Pennsylvania Department of Health; Deutsche Krebshilfe(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health CA107257, CA06927, by an appropriation from the Commonwealth of Pennsylvania, and by a grant from the Pennsylvania Department of Health. The Department specifically disclaims responsibility for any analyses, interpretations or conclusions. K.-H. B was supported by a grant from Deutsche Krebshilfe.	Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Belinsky SA, 2005, CARCINOGENESIS, V26, P1481, DOI 10.1093/carcin/bgi020; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Cairns P, 2001, CLIN CANCER RES, V7, P2727; Chang YS, 2004, ONCOGENE, V23, P6569, DOI 10.1038/sj.onc.1207882; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Deng XY, 2005, ACTA BIOCH BIOPH SIN, V37, P241, DOI 10.1111/j.1745-7270.2005.00034.x; Fan JQ, 2005, P NATL ACAD SCI USA, V102, P17751, DOI 10.1073/pnas.0509175102; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gierke P, 2004, BIOCHEM BIOPH RES CO, V323, P38, DOI 10.1016/j.bbrc.2004.08.055; Guerrico AMG, 2005, ONCOGENE, V24, P2307, DOI 10.1038/sj.onc.1208476; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Liu T, 2006, CANCER TREAT REV, V32, P157, DOI 10.1016/j.ctrv.2005.12.006; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Mahloogi H, 2003, CANCER RES, V63, P4997; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Osada H, 2002, ONCOGENE, V21, P7421, DOI 10.1038/sj.onc.1205802; Osada H, 2001, CANCER RES, V61, P8331; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Santos-Rosa H, 2005, EUR J CANCER, V41, P2381, DOI 10.1016/j.ejca.2005.08.010; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Tani M, 2004, GENE CHROMOSOME CANC, V40, P146, DOI 10.1002/gcc.20027; Toyooka S, 2003, CLIN CANCER RES, V9, P3034; Wickborn C, 2006, MOL CARCINOGEN, V45, P572, DOI 10.1002/mc.20201; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041; Zhu WG, 2001, CANCER RES, V61, P1327	37	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1698	10.1371/journal.pone.0001698	http://dx.doi.org/10.1371/journal.pone.0001698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301774	gold, Green Published, Green Submitted			2022-12-25	WOS:000260586500042
J	Wallace, RG; Fitch, WM				Wallace, Robert G.; Fitch, Walter M.			Influenza A H5N1 Immigration Is Filtered Out at Some International Borders	PLOS ONE			English	Article							PHYLOGENETIC STRUCTURE; STATISTICAL PHYLOGEOGRAPHY; GEOGRAPHICAL-DISTRIBUTION; CLADISTIC-ANALYSIS; GENE FLOW; EVOLUTION; VIRUS; AFRICA; SPREAD; HAPLOTYPES	Background: Geographic spread of highly pathogenic influenza A H5N1, the bird flu strain, appears a necessary condition for accelerating the evolution of a related human-to-human infection. As H5N1 spreads the virus diversifies in response to the variety of socioecological environments encountered, increasing the chance a human infection emerges. Genetic phylogenies have for the most part provided only qualitative evidence that localities differ in H5N1 diversity. For the first time H5N1 variation is quantified across geographic space. Methodology and Principal Findings: We constructed a statistical phylogeography of 481 H5N1 hemagglutinin genetic sequences from samples collected across 28 Eurasian and African localities through 2006. The MigraPhyla protocol showed southern China was a source of multiple H5N1 strains. Nested clade analysis indicated H5N1 was widely dispersed across southern China by both limited dispersal and long distance colonization. The UniFrac metric, a measure of shared phylogenetic history, grouped H5N1 from Indonesia, Japan, Thailand and Vietnam with those from southeastern Chinese provinces engaged in intensive international trade. Finally, H5N1's accumulative phylogenetic diversity was greatest in southern China and declined beyond. The gradient was interrupted by areas of greater and lesser phylogenetic dispersion, indicating H5N1 migration was restricted at some geopolitical borders. Thailand and Vietnam, just south of China, showed significant phylogenetic clustering, suggesting newly invasive H5N1 strains have been repeatedly filtered out at their northern borders even as both countries suffered recurring outbreaks of endemic strains. In contrast, Japan, while successful in controlling outbreaks, has been subjected to multiple introductions of the virus. Conclusions: The analysis demonstrates phylogenies can provide local health officials with more than hypotheses about relatedness. Pathogen dispersal, the functional relationships among disease ecologies across localities, and the efficacy of control efforts can also be inferred, all from viral genetic sequences alone.	[Wallace, Robert G.; Fitch, Walter M.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Wallace, RG (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	rwallace@uci.edu			National Institutes of Health NIAID [1R21AI063275-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI063275] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health NIAID grant 1R21AI063275-01.	Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; CASTELLOE J, 1994, MOL PHYLOGENET EVOL, V3, P102, DOI 10.1006/mpev.1994.1013; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chutinimitkul S, 2007, EMERG INFECT DIS, V13, P506, DOI 10.3201/eid1303.061103; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CLIFF A, 1986, SPATIAL ASPECTS INFL; CRANDALL KA, 1993, GENETICS, V134, P959; CRANDALL KA, 1999, STAT MOL BIOL GENETI, P186; Ducatez MF, 2007, J GEN VIROL, V88, P2297, DOI 10.1099/vir.0.82939-0; Ducatez MF, 2006, NATURE, V442, P37, DOI 10.1038/442037a; Epperson B. K., 2003, GEOGRAPHICAL GENETIC; Fasina FO, 2007, LANCET INFECT DIS, V7, P696, DOI 10.1016/S1473-3099(07)70244-X; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270; Flint PL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-132; Gibson CC, 2000, ECOL ECON, V32, P217, DOI 10.1016/S0921-8009(99)00092-0; GILBERT M, 2007, GLOBAL ENV CHANGE IN; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2003, ECOLOGY, V84, P532, DOI 10.1890/0012-9658(2003)084[0532:SAINMA]2.0.CO;2; Gould SJ, 2002, STRUCTURE EVOLUTIONA; HoDac H., 2007, MIGRAPHYLA STAT ANAL; Janies D, 2007, SYST BIOL, V56, P321, DOI 10.1080/10635150701266848; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Keller W, 2007, REV DEV ECON, V11, P107, DOI 10.1111/j.1467-9361.2007.00359.x; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Legendre P, 2004, AUST NZ J STAT, V46, P615, DOI 10.1111/j.1467-842X.2004.00357.x; LEGENDRE P, 2001, CONGRUENCE DISTANCE; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Macken C, 2001, INT CONGR SER, V1219, P103, DOI 10.1016/S0531-5131(01)00330-2; MADDISON WP, 2006, MESQUITE MODULAR SYS; Mase M, 2005, VIROLOGY, V339, P101, DOI 10.1016/j.virol.2005.05.010; MIYAMOTO MM, 1995, SYST BIOL, V44, P64, DOI 10.2307/2413483; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Oyana TJ, 2006, AVIAN DIS, V50, P508, DOI 10.1637/7597-040506.1; Pennington RT, 2006, NEW PHYTOL, V172, P605, DOI 10.1111/j.1469-8137.2006.01902.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; Posada D, 2006, MOL ECOL NOTES, V6, P590, DOI 10.1111/j.1471-8286.2006.01368.x; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Rweyemamu M, 2000, ANN NY ACAD SCI, V916, P61, DOI 10.1111/j.1749-6632.2000.tb05275.x; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; SLATKIN M, 1989, GENETICS, V123, P603; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Songserm T, 2006, EMERG INFECT DIS, V12, P575, DOI 10.3201/eid1204.051614; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TEMPLETON AR, 1995, GENETICS, V140, P767; Templeton AR, 2004, MOL ECOL, V13, P789, DOI 10.1046/j.1365-294X.2003.02041.x; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; TEMPLETON AR, 1992, GENETICS, V132, P619; WALLACE R, 1995, ENVIRON PLANN A, V27, P1085, DOI 10.1068/a271085; Wallace RG, 2007, P NATL ACAD SCI USA, V104, P4473, DOI 10.1073/pnas.0700435104; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Webb CO, 2007, PHYLOCOM SOFTWARE AN; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34; Yang Y, 2007, EMERG INFECT DIS, V13, P1348, DOI 10.3201/eid1309.070111; Yuen K. Y., 2005, Hong Kong Medical Journal, V11, P189; Zwickl D., 2006, GARLI GENETIC ALGORI	68	45	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1697	10.1371/journal.pone.0001697	http://dx.doi.org/10.1371/journal.pone.0001697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301773	Green Published, Green Submitted, gold			2022-12-25	WOS:000260586500041
J	Besaratinia, A; Kim, SI; Pfeifer, GP				Besaratinia, Ahmad; Kim, Sang-in; Pfeifer, Gerd P.			Rapid repair of UVA-induced oxidized purines and persistence of UVB-induced dipyrimidine lesions determine the mutagenicity of sunlight in mouse cells	FASEB JOURNAL			English	Review						DNA damage; mutations; skin cancer; ultraviolet radiation	CYCLOBUTANE PYRIMIDINE DIMERS; OXIDATIVE DNA-DAMAGE; CUTANEOUS MALIGNANT-MELANOMA; NUCLEOTIDE EXCISION-REPAIR; HUMAN SKIN CELLS; DEFICIENT XERODERMA-PIGMENTOSUM; CANCER MUTATIONAL HOTSPOTS; ULTRAVIOLET-A RADIATION; TO-T TRANSVERSIONS; MAMMALIAN-CELLS	Despite the predominance of ultraviolet A (UVA) relative to UVB in terrestrial sunlight, solar mutagenesis in humans and rodents is characterized by mutations specific for UVB. We have investigated the kinetics of repair of UVA- and UVB-induced DNA lesions in relation to mutagenicity in transgenic mouse fibroblasts irradiated with equilethal doses of UVA and UVB in comparison to simulated-sunlight UV(SSL). We have also analyzed mutagenesis-derived carcinogenesis in sunlight-associated human skin cancers by compiling the published data on mutation types found in crucial genes in nonmelanoma and melanoma skin cancers. Here, we demonstrate a resistance to repair of UVB-induced cis-syn cyclobutane pyrimidine-dimers (CPDs) together with rapid removal of UVA- induced oxidized purines in the genome overall and in the cII transgene of SSL-irradiated cells. The spectra of mutation induced by both UVB and SSL irradiation in this experimental system are characterized by significant increases in relative frequency of C -> T transitions at dipyrimidines, which are the established signature mutation of CPDs. This type of mutation is also the predominant mutation found in human nonmelanoma and melanoma tumor samples in the TP53, CDKN2, PTCH, and protein kinase genes. The prevailing role of UVB over UVA in solar mutagenesis in our test system can be ascribed to different kinetics of repair for lesions induced by the respective UV irradiation.	[Besaratinia, Ahmad; Kim, Sang-in; Pfeifer, Gerd P.] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Besaratinia, A (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, 1450 E Duarte Rd, Duarte, CA 91010 USA.	ania@coh.org		Besaratinia, Ahmad/0000-0001-7231-228X	NIEHS NIH HHS [ES06070, R37 ES006070-16, R01 ES006070, R37 ES006070] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES006070, R01ES006070] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADAMS WT, 1987, J MOL BIOL, V194, P391, DOI 10.1016/0022-2836(87)90669-3; Agar NS, 2004, P NATL ACAD SCI USA, V101, P4954, DOI 10.1073/pnas.0401141101; Ananthaswamy HN, 1998, PHOTOCHEM PHOTOBIOL, V67, P227, DOI 10.1562/0031-8655(1998)067<0227:MIHSHM>2.3.CO;2; Avery AM, 1999, NUCLEIC ACIDS RES, V27, P2256, DOI 10.1093/nar/27.11.2256; Besaratinia A, 2005, P NATL ACAD SCI USA, V102, P10058, DOI 10.1073/pnas.0502311102; Besaratinia A, 2004, BIOCHEMISTRY-US, V43, P15557, DOI 10.1021/bi048717c; Besaratinia A, 2004, BIOCHEMISTRY-US, V43, P8169, DOI 10.1021/bi049761v; Besaratinia A, 2002, CANCER RES, V62, P4331; Besaratinia A, 2007, P NATL ACAD SCI USA, V104, P5953, DOI 10.1073/pnas.0610534104; Besaratinia A, 2006, CARCINOGENESIS, V27, P1526, DOI 10.1093/carcin/bgi311; BOITEUX S, 1987, EMBO J, V6, P3177, DOI 10.1002/j.1460-2075.1987.tb02629.x; BRASH DE, 1987, P NATL ACAD SCI USA, V84, P3782, DOI 10.1073/pnas.84.11.3782; Busuttil RA, 2006, DNA REPAIR, V5, P52, DOI 10.1016/j.dnarep.2005.07.006; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Buterin T, 2002, CANCER RES, V62, P4229; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Cadet J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1219, DOI 10.1562/2006-06-09-IR-914; Castellano M, 1997, CANCER RES, V57, P4868; Courdavault S, 2005, DNA REPAIR, V4, P836, DOI 10.1016/j.dnarep.2005.05.001; Courdavault S, 2004, MUTAT RES-FUND MOL M, V556, P135, DOI 10.1016/j.mrfmmm.2004.07.011; Courdavault S, 2004, PHOTOCHEM PHOTOBIOL, V79, P145, DOI 10.1562/0031-8655(2004)079<0145:UCPDDN>2.0.CO;2; D'Errico M, 2000, ONCOGENE, V19, P463, DOI 10.1038/sj.onc.1203313; D'Errico M, 2006, EMBO J, V25, P4305, DOI 10.1038/sj.emboj.7601277; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Gruijl FR, 2002, SKIN PHARMACOL APPL, V15, P316, DOI 10.1159/000064535; DEGRUIJL FR, 1993, CANCER RES, V53, P53; DEMARINI DM, 1995, MUTAT RES-FUND MOL M, V327, P131, DOI 10.1016/0027-5107(94)00179-9; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Douki T, 2003, BIOCHEMISTRY-US, V42, P9221, DOI 10.1021/bi034593c; DROBETSKY EA, 1995, P NATL ACAD SCI USA, V92, P2350, DOI 10.1073/pnas.92.6.2350; DUMAZ N, 1993, P NATL ACAD SCI USA, V90, P10529, DOI 10.1073/pnas.90.22.10529; Dutt A, 2006, CLIN CANCER RES, V12, p4396S, DOI 10.1158/1078-0432.CCR-06-0414; Emmert S, 2000, P NATL ACAD SCI USA, V97, P2151, DOI 10.1073/pnas.040559697; Evans T, 2000, HUM MUTAT, V16, P43, DOI 10.1002/1098-1004(200007)16:1<43::AID-HUMU8>3.3.CO;2-Z; Feng ZH, 2002, J NATL CANCER I, V94, P1527; Flores JF, 1996, CANCER RES, V56, P5023; FORD JM, 1994, MOL CARCINOGEN, V10, P105, DOI 10.1002/mc.2940100208; FRANKLIN WA, 1985, NUCLEIC ACIDS RES, V13, P5317, DOI 10.1093/nar/13.14.5317; Fujimoto A, 1999, ONCOGENE, V18, P2527, DOI 10.1038/sj.onc.1202803; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; GALE JM, 1990, PHOTOCHEM PHOTOBIOL, V51, P411, DOI 10.1111/j.1751-1097.1990.tb01732.x; Green A, 2007, INT J CANCER, V120, P1116, DOI 10.1002/ijc.22453; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grishko VI, 1997, MUTAT RES-DNA REPAIR, V384, P73, DOI 10.1016/S0921-8777(97)00017-7; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Heitzer E, 2007, J INVEST DERMATOL, V127, P2872, DOI 10.1038/sj.jid.5700923; Herbst RA, 1997, J INVEST DERMATOL, V108, P950, DOI 10.1111/1523-1747.ep12296624; Hollenbach S, 1999, CARCINOGENESIS, V20, P1863, DOI 10.1093/carcin/20.9.1863; Ikehata H, 2003, MUTAGENESIS, V18, P511, DOI 10.1093/mutage/geg030; IZUMIZAWA Y, 2000, NUCL ACIDS S SER, V73; Jakubczak JL, 1996, P NATL ACAD SCI USA, V93, P9073, DOI 10.1073/pnas.93.17.9073; KANJILAL S, 1993, CANCER RES, V53, P2961; Kanno S, 1999, NUCLEIC ACIDS RES, V27, P3096, DOI 10.1093/nar/27.15.3096; Kappes UP, 2006, J INVEST DERMATOL, V126, P667, DOI 10.1038/sj.jid.5700093; Kappes UP, 2005, RADIAT RES, V164, P440, DOI 10.1667/RR3434.1; KELFKENS G, 1990, PHOTOCHEM PHOTOBIOL, V52, P819, DOI 10.1111/j.1751-1097.1990.tb08687.x; Kim SI, 2007, CANCER RES, V67, P11640, DOI 10.1158/0008-5472.CAN-07-2528; Kim SI, 2007, MUTAT RES-FUND MOL M, V617, P71, DOI 10.1016/j.mrfmmm.2006.12.003; Kim SH, 2002, DYES PIGMENTS, V53, P1, DOI 10.1016/S0143-7208(02)00015-3; Kobayashi T, 1998, NUCLEIC ACIDS RES, V26, P4662, DOI 10.1093/nar/26.20.4662; Koehler DR, 1996, J BACTERIOL, V178, P1347, DOI 10.1128/jb.178.5.1347-1350.1996; Kozmin S, 2005, P NATL ACAD SCI USA, V102, P13538, DOI 10.1073/pnas.0504497102; Kumar R, 1998, INT J CANCER, V75, P193, DOI 10.1002/(SICI)1097-0215(19980119)75:2<193::AID-IJC5>3.3.CO;2-5; Lambert LB, 2005, MUTAT RES-REV MUTAT, V590, P1, DOI 10.1016/j.mrrev.2005.04.002; Lamperska K, 2002, ACTA BIOCHIM POL, V49, P369; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Ley RD, 1997, CANCER RES, V57, P3682; LOMMEL L, 1993, MOL CELL BIOL, V13, P970, DOI 10.1128/MCB.13.2.970; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Mathonnet R, 2003, P NATL ACAD SCI USA, V100, P7219, DOI 10.1073/pnas.123216100; MITCHELL DL, 1990, NUCLEIC ACIDS RES, V18, P963, DOI 10.1093/nar/18.4.963; MITCHELL DL, 1990, J BIOL CHEM, V265, P5353; Mitchell DL, 2001, J INVEST DERMATOL, V116, P209, DOI 10.1046/j.1523-1747.2001.01192.x; MORIYA M, 1993, P NATL ACAD SCI USA, V90, P1122, DOI 10.1073/pnas.90.3.1122; Mouret S, 2006, P NATL ACAD SCI USA, V103, P13765, DOI 10.1073/pnas.0604213103; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Otoshi E, 2000, CANCER RES, V60, P1729; Palmer CM, 1997, PHOTOCHEM PHOTOBIOL, V65, P543, DOI 10.1111/j.1751-1097.1997.tb08602.x; Pascucci B, 1997, J MOL BIOL, V273, P417, DOI 10.1006/jmbi.1997.1268; PEARLMAN DA, 1985, SCIENCE, V227, P1304, DOI 10.1126/science.3975615; Perdiz D, 2000, J BIOL CHEM, V275, P26732; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; PFLAUM M, 1994, CARCINOGENESIS, V15, P297, DOI 10.1093/carcin/15.2.297; Piccinin S, 1997, INT J CANCER, V74, P26, DOI 10.1002/(SICI)1097-0215(19970220)74:1<26::AID-IJC5>3.0.CO;2-2; Platz A, 1996, BRIT J CANCER, V73, P344, DOI 10.1038/bjc.1996.59; Pollock PM, 1996, GENE CHROMOSOME CANC, V15, P77, DOI 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0; RAO SN, 1985, PHOTOCHEM PHOTOBIOL, V42, P465, DOI 10.1111/j.1751-1097.1985.tb01596.x; Ratner D, 2001, J AM ACAD DERMATOL, V44, P293, DOI 10.1067/mjd.2001.112361; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Riou L, 2004, CANCER RES, V64, P889, DOI 10.1158/0008-5472.CAN-03-2070; Robert C, 1996, J INVEST DERMATOL, V106, P721, DOI 10.1111/1523-1747.ep12345616; Rochette PJ, 2003, NUCLEIC ACIDS RES, V31, P2786, DOI 10.1093/nar/gkg402; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Ruiz A, 1998, INT J CANCER, V76, P312, DOI 10.1002/(SICI)1097-0215(19980504)76:3<312::AID-IJC4>3.3.CO;2-B; RUVEN HJT, 1994, ONCOGENE, V9, P3427; Sage E, 1996, P NATL ACAD SCI USA, V93, P176, DOI 10.1073/pnas.93.1.176; SETLOW RB, 1993, P NATL ACAD SCI USA, V90, P6666, DOI 10.1073/pnas.90.14.6666; SETLOW RB, 1974, P NATL ACAD SCI USA, V71, P3363, DOI 10.1073/pnas.71.9.3363; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Smith LE, 2000, JNCI-J NATL CANCER I, V92, P803, DOI 10.1093/jnci/92.10.803; SmithSorensen B, 1996, HUM MUTAT, V7, P294, DOI 10.1002/(SICI)1098-1004(1996)7:4<294::AID-HUMU2>3.0.CO;2-9; Spencer JPE, 1996, BIOCHEM BIOPH RES CO, V224, P17, DOI 10.1006/bbrc.1996.0977; SZYMKOWSKI DE, 1993, P NATL ACAD SCI USA, V90, P9823, DOI 10.1073/pnas.90.21.9823; Therrien JP, 1999, P NATL ACAD SCI USA, V96, P15038, DOI 10.1073/pnas.96.26.15038; THOMAS DC, 1989, J BIOL CHEM, V264, P18005; Tommasi S, 1997, CANCER RES, V57, P4727; Tu YQ, 1997, J BIOL CHEM, V272, P20747, DOI 10.1074/jbc.272.33.20747; Tung BS, 1996, MUTAT RES-DNA REPAIR, V362, P65, DOI 10.1016/0921-8777(95)00034-8; Unden AB, 1996, CANCER RES, V56, P4562; van der Wees CGC, 2003, DNA REPAIR, V2, P1297, DOI 10.1016/j.dnarep.2003.06.001; vanElsas A, 1996, AM J PATHOL, V149, P883; VANHOFFEN A, 1995, EMBO J, V14, P360, DOI 10.1002/j.1460-2075.1995.tb07010.x; VREESWIJK MPG, 1994, J BIOL CHEM, V269, P31858; Walker GJ, 1998, GENE CHROMOSOME CANC, V22, P157, DOI 10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N; WANG YC, 1993, MOL CELL BIOL, V13, P4276, DOI 10.1128/MCB.13.7.4276; Wolter M, 1997, CANCER RES, V57, P2581; Woodhead A D, 1999, J Epidemiol, V9, pS102; Woollons A, 1999, BRIT J DERMATOL, V140, P1023; Xie JW, 1997, CANCER RES, V57, P2369; YAJIMA H, 1995, EMBO J, V14, P2393, DOI 10.1002/j.1460-2075.1995.tb07234.x; Yoon JH, 2004, CANCER RES, V64, P7321, DOI 10.1158/0008-5472.CAN-04-1094; Yoon JH, 2001, CANCER RES, V61, P7110; Zhang H, 2001, AM J PATHOL, V158, P381, DOI 10.1016/S0002-9440(10)63980-6	123	55	56	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2008	22	7					2379	2392		10.1096/fj.07-105437	http://dx.doi.org/10.1096/fj.07-105437			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18326785	Green Accepted			2022-12-25	WOS:000257292500030
J	Leung, JY; Ehmann, GL; Giangrande, PH; Nevins, JR				Leung, J. Y.; Ehmann, G. L.; Giangrande, P. H.; Nevins, J. R.			A role for Myc in facilitating transcription activation by E2F1	ONCOGENE			English	Article						E2F1; Myc; promoter; transcription activation	C-MYC; DROSOPHILA-MYC; CELL-CYCLE; S-PHASE; GENE; BINDING; IDENTIFICATION; SPECIFICITY; EXPRESSION; INDUCTION	Previous work has demonstrated that E2F proteins regulate the expression of various genes encoding proteins essential for DNA replication and cell-cycle progression. E2F1 in particular is required for the initial entry to the cell cycle from a quiescent state and is required for the activation of other E2F genes. Other work has demonstrated a role for the Myc transcription factor in the activation of a large number of genes associated with cell growth, including E2F genes. We now show that Myc is required to allow the interaction of the E2F1 protein with the E2F gene promoters. As such, Myc thus provides a link between the development of a growth-competent state during the initial stage of G1 and the activation of genes essential for DNA replication at G1/S.	[Leung, J. Y.; Ehmann, G. L.; Giangrande, P. H.; Nevins, J. R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Duke Inst Genome Sci & Policy, Durham, NC 27710 USA	Duke University	Nevins, JR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Duke Inst Genome Sci & Policy, Box 3382, Durham, NC 27710 USA.	j.nevins@duke.edu						Adams MR, 2000, MOL CELL BIOL, V20, P3633, DOI 10.1128/MCB.20.10.3633-3639.2000; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Giangrande PH, 2004, EMBO J, V23, P1336, DOI 10.1038/sj.emboj.7600134; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Lin WC, 2001, GENE DEV, V15, P1833; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Takahashi Y, 2000, GENE DEV, V14, P804; Walker W, 2005, J CELL BIOL, V169, P405, DOI 10.1083/jcb.200411013; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	24	68	71	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2008	27	30					4172	4179		10.1038/onc.2008.55	http://dx.doi.org/10.1038/onc.2008.55			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	324DB	18345030				2022-12-25	WOS:000257496800004
J	Nakamura, H; Tanimoto, K; Hiyama, K; Yunokawa, M; Kawamoto, T; Kato, Y; Yoshiga, K; Poellinger, L; Hiyama, E; Nishiyama, M				Nakamura, H.; Tanimoto, K.; Hiyama, K.; Yunokawa, M.; Kawamoto, T.; Kato, Y.; Yoshiga, K.; Poellinger, L.; Hiyama, E.; Nishiyama, M.			Human mismatch repair gene, MLH1, is transcriptionally repressed by the hypoxia-inducible transcription factors, DEC1 and DEC2	ONCOGENE			English	Article						MLH1; DEC1; DEC2; hypoxia; HIF-1	TUMOR-SUPPRESSOR PROTEIN; MAMMALIAN-CELLS; DOWN-REGULATION; CANCER-THERAPY; EXPRESSION; LOOP; MICROENVIRONMENT; DEC1/STRA13; INSTABILITY; MECHANISMS	Tumor hypoxia has been reported to cause a functional loss in DNA mismatch repair (MMR) system as a result of downregulation of MMR genes, although the precise molecular mechanisms remain unclear. In this study, we focused on the downregulation of a key MMR gene, MLH1, and demonstrated that hypoxia-inducible transcription repressors, differentiated embryo chondrocytes (DEC1 and 2), participated in its transcriptional regulation via their bindings to E-box-like motif(s) in MLH1 promoter region. In all cancer cell lines examined, hypoxia increased expression of DEC1 and 2, known as hypoxia-inducible genes, but decreased MLH1 expression in an exposure time-dependent manner at both the mRNA and protein levels. Co-transfection reporter assay revealed that DEC1 and, to greater extent, DEC2 as well as hypoxia-repressed MLH1 promoter activity. We further found that the action was remarkably inhibited by trichostatin A, and identified a possible DEC-response element in the MLH1 promoter. In vitro electrophoretic gel mobility shift and chromatin immunoprecipitation assays demonstrated that DEC1 or 2 directly bounds to the suggested element, and transient transfection assay revealed that overexpression of DEC2 repressed endogenous MLH1 expression in the cells. Hypoxia-induced DEC may impair MMR function through repression of MLH1 expression, possibly via the histone deacethylase-mediated mechanism in cancer cells.	[Nakamura, H.; Tanimoto, K.; Hiyama, K.; Yunokawa, M.; Nishiyama, M.] Hiroshima Univ, Dept Translat Canc Res, Res Inst Radiat Biol & Med, Minami Ku, Hiroshima 7348551, Japan; [Kawamoto, T.; Kato, Y.] Hiroshima Univ, Dept Dent & Med Biochem, Hiroshima 7348551, Japan; [Yoshiga, K.] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Oral Med & Maxillofacial Surg, Hiroshima 7348551, Japan; [Poellinger, L.] Karolinska Inst, Med Noble Inst, Stockholm, Sweden; [Nakamura, H.; Hiyama, E.] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima 7348551, Japan; [Nishiyama, M.] Saitama Med Univ, Int Med Ctr, Saitama, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Karolinska Institutet; Hiroshima University; Saitama Medical University	Tanimoto, K (corresponding author), Hiroshima Univ, Dept Translat Canc Res, Res Inst Radiat Biol & Med, Minami Ku, Kasumi 1-2-3, Hiroshima 7348551, Japan.	ktanimo@hiroshima-u.ac.jp	, 河本健/D-7938-2015; Hiyama, Eiso/A-2013-2019; Keiji, Tanimoto/U-1839-2019	, 河本健/0000-0003-3337-1775; Hiyama, Eiso/0000-0001-9179-5037; Keiji, Tanimoto/0000-0003-4912-4197				Bindra RS, 2007, CANCER LETT, V252, P93, DOI 10.1016/j.canlet.2006.12.011; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Bindra RS, 2004, MOL CELL BIOL, V24, P8504, DOI 10.1128/MCB.24.19.8504-8518.2004; BINDRA RS, 2006, ONCOGENE, V26, P1; Brown JM, 1998, CANCER RES, V58, P1408; Cairns R, 2006, MOL CANCER RES, V4, P61, DOI 10.1158/1541-7786.MCR-06-0002; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Fujimoto K, 2001, BIOCHEM BIOPH RES CO, V280, P164, DOI 10.1006/bbrc.2000.4133; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Ivanova AV, 2001, J BIOL CHEM, V276, P15306, DOI 10.1074/jbc.M010516200; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; Mihaylova VT, 2003, MOL CELL BIOL, V23, P3265, DOI 10.1128/MCB.23.9.3265-3273.2003; Miyazaki K, 2002, J BIOL CHEM, V277, P47014, DOI 10.1074/jbc.M204938200; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; Poellinger L, 2004, CURR OPIN GENET DEV, V14, P81, DOI 10.1016/j.gde.2003.12.006; Reynolds TY, 1996, CANCER RES, V56, P5754; Sato F, 2004, EUR J BIOCHEM, V271, P4409, DOI 10.1111/j.1432-1033.2004.04379.x; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen M, 1997, BIOCHEM BIOPH RES CO, V236, P294, DOI 10.1006/bbrc.1997.6960; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tanimoto K, 2003, CARCINOGENESIS, V24, P1779, DOI 10.1093/carcin/bgg132; TEICHER BA, 1994, CANCER METAST REV, V13, P139, DOI 10.1007/BF00689633; Yuan JL, 2000, CANCER RES, V60, P4372; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4	30	71	73	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2008	27	30					4200	4209		10.1038/onc.2008.58	http://dx.doi.org/10.1038/onc.2008.58			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	324DB	18345027	Green Submitted			2022-12-25	WOS:000257496800007
J	Shin, DM; Jeon, JH; Kim, CW; Cho, SY; Lee, HJ; Jang, GY; Jeong, EM; Lee, DS; Kang, JH; Melino, G; Park, SC; Kim, IG				Shin, Dong-Myung; Jeon, Ju-Hong; Kim, Chai-Wan; Cho, Sung-Yup; Lee, Hye-Jin; Jang, Gi-Yong; Jeong, Eui Man; Lee, Dong-Sup; Kang, Ja-Heon; Melino, Gerry; Park, Sang-Chul; Kim, In-Gyu			TGF beta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation	FASEB JOURNAL			English	Article						aging; cataract; protein modification	GROWTH-FACTOR-BETA; CROSS-LINKING ENZYMES; TRANSFORMING GROWTH-FACTOR-BETA-1; SIGNALING PATHWAY; SMAD PROTEINS; CELL-DEATH; CATARACT; INHIBITION; DISRUPTION; MECHANISMS	Transglutaminase 2 (TGase2) is a ubiquitously expressed enzyme that catalyzes irreversible post-translational modification of protein, forming cross-linked protein aggregates. We previously reported that intracellular TGase2 is activated by oxidative stress. To elucidate the functional role of TGase2 activation in cells under the oxidatively stressed condition, we identified the mediator that activates TGase2. In this study, we showed that low levels of oxidative stress trigger the release of TGF beta, which subsequently activates TGase2 through the nuclear translocation of Smad3. Analysis of substrate proteins reveals that TGase2-mediated protein modification results in a decrease of protein solubility and a collapse of intermediate filament network, which leads to aggregation of proteins. We confirm these results using lens tissues from TGase2-deficient mice. Among several antioxidants tried, only N-acetylcysteine effectively inhibits TGF beta-mediated activation of TGase2. These results indicate that TGF beta mediates oxidative stress-induced protein aggregation through activation of TGase2 and suggest that the formation of protein aggregation may not be a passive process of self-assembly of oxidatively damaged proteins but may be an active cellular response to oxidative stress. Therefore, TGF beta-TGase2 pathway may have implications for both the pathogenesis of age-related degenerative diseases and the development of pharmaceutics.	[Shin, Dong-Myung; Kim, Chai-Wan; Cho, Sung-Yup; Lee, Hye-Jin; Jang, Gi-Yong; Jeong, Eui Man; Park, Sang-Chul; Kim, In-Gyu] Seoul Natl Univ, Coll Med, AARC, Dept Biochem & Mol Biol, Seoul 110799, South Korea; [Jeon, Ju-Hong] Seoul Natl Univ, Coll Med, Dept Physiol & Biophys, Seoul 110799, South Korea; [Lee, Hye-Jin] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110799, South Korea; [Kang, Ja-Heon] Kyung Hee Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Melino, Gerry] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; University of Rome Tor Vergata	Kim, IG (corresponding author), Seoul Natl Univ, Coll Med, AARC, Dept Biochem & Mol Biol, 28 Yongon Dong, Seoul 110799, South Korea.	igkim@plaza.snu.ac.kr	Jeon, Ju-Hong/D-5740-2012; Lee, Dong-Sup/J-2777-2012; Kim, In-Gyu/J-2747-2012	Jeon, Ju-Hong/0000-0002-5603-2955; Kim, Chai-Wan/0000-0001-5105-2829; Jeong, Eui Man/0000-0003-0692-2033	MRC [MC_U132670600] Funding Source: UKRI; Medical Research Council [MC_U132670600] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bissell DM, 2001, EXP MOL MED, V33, P179, DOI 10.1038/emm.2001.31; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; CARCAMO J, 1995, MOL CELL BIOL, V15, P1573; Chiarelli F, 2000, HORM RES, V53, P53, DOI 10.1159/000023515; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Guh JY, 2003, KIDNEY INT, V64, P2041, DOI 10.1046/j.1523-1755.2003.00330.x; Haddad JJ, 2002, BIOCHEM BIOPH RES CO, V296, P847, DOI 10.1016/S0006-291X(02)00947-6; Hagiwara S, 2000, AM J RESP CRIT CARE, V162, P225, DOI 10.1164/ajrccm.162.1.9903129; HALES AM, 1995, INVEST OPHTH VIS SCI, V36, P1709; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Hoehenwarter W, 2006, AMINO ACIDS, V30, P369, DOI 10.1007/s00726-005-0283-9; Ichinose A, 2001, THROMB HAEMOSTASIS, V86, P57; Jeon JH, 2004, EXP MOL MED, V36, P576, DOI 10.1038/emm.2004.74; Jeon JH, 2003, EMBO J, V22, P5273, DOI 10.1093/emboj/cdg495; Kawabata M, 1998, EMBO J, V17, P4056, DOI 10.1093/emboj/17.14.4056; Lee DK, 2002, J BIOL CHEM, V277, P33766, DOI 10.1074/jbc.M200150200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Menko AS, 2002, EXP EYE RES, V75, P485, DOI 10.1006/exer.2002.2057; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; MUKHERJEE DC, 1983, SCIENCE, V219, P989, DOI 10.1126/science.6130601; O'Brian CA, 2005, FREE RADICAL RES, V39, P471, DOI 10.1080/10715760500073931; Park BJ, 2000, CANCER RES, V60, P3031; Robman L, 2005, EYE, V19, P1074, DOI 10.1038/sj.eye.6701964; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Sanderson J, 2000, INVEST OPHTH VIS SCI, V41, P2255; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shin Joo-Ho, 2004, Proteome Sci, V2, P2, DOI 10.1186/1477-5956-2-2; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Srinivasan Y, 1998, J CLIN INVEST, V101, P625, DOI 10.1172/JCI1360; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003	41	52	52	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2008	22	7					2498	2507		10.1096/fj.07-095455	http://dx.doi.org/10.1096/fj.07-095455			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18353867				2022-12-25	WOS:000257292500041
J	Fukuhara, N; Howitt, JA; Hussain, SA; Hohenester, E				Fukuhara, Noemi; Howitt, Jason A.; Hussain, Sadaf-Ahmahni; Hohenester, Erhard			Structural and functional analysis of Slit and heparin binding to immunoglobulin-like domains 1 and 2 of Drosophila Robo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; REPELLENT SLIT; GUIDANCE; SULFATE; LIGAND; INDUCTION; MOLECULES; MECHANISM; NETRIN-1; COMPLEX	Recognition of the secreted protein Slit by transmembrane receptors of the Robo family provides important signals in the development of the nervous system and other organs, as well as in tumor metastasis and angiogenesis. Heparan sulfate (HS) proteoglycans serve as essential co-receptors in Slit-Robo signaling. Previous studies have shown that the second leucine-rich repeat domain of Slit, D2, binds to the N-terminal immunoglobulin-like domains of Robo, IG1-2. Here we present two crystal structures of Drosophila Robo IG1-2, one of which contains a bound heparin-derived oligosaccharide. Using structure-based mutagenesis of a Robo IG1-5 construct we identified key Slit binding residues (Thr-74, Phe-114, Arg-117) forming a conserved patch on the surface of IG1; mutation of similarly conserved residues in IG2 had no effect on Slit binding. Mutation of conserved basic residues in IG1 (Lys-69, Arg-117, Lys-122, Lys-123), but not in IG2, reduced binding of Robo IG1-5 to heparin, in full agreement with the Robo-heparin co-crystal structure. Our collective results, together with a recent crystal structure of a minimal human Slit-Robo complex (Morlot, C., Thielens, N. M., Ravelli, R. B., Hemrika, W., Romijn, R. A., Gros, P., Cusack, S., and McCarthy, A. A. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 14923 -14928), reveal a contiguous HS/ heparin binding surface extending across the Slit-Robo interface. Based on the size of this composite binding site, we predict that at least five HS disaccharide units are required to support Slit-Robo signaling.	[Fukuhara, Noemi; Howitt, Jason A.; Hussain, Sadaf-Ahmahni; Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Biophys Sect, Blackett Lab, Dept Life Sci, London SW7 2AZ, England	Imperial College London	Hohenester, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Biophys Sect, Blackett Lab, Dept Life Sci, London SW7 2AZ, England.	e.hohenester@imperial.ac.uk	Xiao, Yang/B-5668-2012	Howitt, Jason/0000-0001-9922-7931	BBSRC [BB/D524840/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBD5248401, BB/D524840/1] Funding Source: Medline; Wellcome Trust [054334] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chedotal A, 2005, CELL DEATH DIFFER, V12, P1044, DOI 10.1038/sj.cdd.4401707; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Hussain SA, 2006, J BIOL CHEM, V281, P39693, DOI 10.1074/jbc.M609384200; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jen JC, 2004, SCIENCE, V304, P1509, DOI 10.1126/science.1096437; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lietha D, 2001, EMBO J, V20, P5543, DOI 10.1093/emboj/20.20.5543; Liu Z, 2004, MOL CELL NEUROSCI, V26, P232, DOI 10.1016/j.mcn.2004.01.002; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stiegler AL, 2006, J MOL BIOL, V364, P424, DOI 10.1016/j.jmb.2006.09.019; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strickland P, 2006, DEVELOPMENT, V133, P823, DOI 10.1242/dev.02261; Tan K, 2008, J BIOL CHEM, V283, P3932, DOI 10.1074/jbc.M705203200; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Xian J, 2001, P NATL ACAD SCI USA, V98, P15062, DOI 10.1073/pnas.251407098	40	62	66	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					16226	16234		10.1074/jbc.M800688200	http://dx.doi.org/10.1074/jbc.M800688200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18359766	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000256332500081
J	Marchand, A; Winther, AML; Holm, PJ; Olesen, C; Montigny, C; Arnou, B; Champeil, P; Clausen, JD; Vilsen, B; Andersen, JP; Nissen, P; Jaxel, C; Moller, JV; Le Maire, M				Marchand, Alexandre; Winther, Anne-Marie Lund; Holm, Peter Joakim; Olesen, Claus; Montigny, Cedric; Arnou, Bertrand; Champeil, Philippe; Clausen, Johannes D.; Vilsen, Bente; Andersen, Jens Peter; Nissen, Poul; Jaxel, Christine; Moller, Jesper Vuust; Le Maire, Marc			Crystal structure of D351A and P312A mutant forms of the mammalian sarcoplasmic reticulum Ca2+-ATPase reveals key events in phosphorylation and Ca2+ release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4TH TRANSMEMBRANE SEGMENT; CALCIUM-PUMP; ATP-BINDING; CONFORMATIONAL-CHANGES; FUNCTIONAL CONSEQUENCES; SERCA1A CA2+-ATPASE; INORGANIC-PHOSPHATE; MEMBRANE-PROTEINS; SITE; TRANSPORT	In recent years crystal structures of the sarcoplasmic reticulum Ca2+-ATPase (SERCA1a), stabilized in various conformations with nucleotide and phosphate analogs, have been obtained. However, structural analysis of mutant forms would also be valuable to address key mechanistic aspects. We have worked out a procedure for affinity purification of SERCA1a heterologously expressed in yeast cells, producing sufficient amounts for crystallization and biophysical studies. We present here the crystal structures of two mutant forms, D351A and P312A, to address the issue whether the profound functional changes seen for these mutants are caused by major structural changes. We find that the structure of P312A with ADP and AlF4- bound (3.5-angstrom resolution) and D351A with AMPPCP or ATP bound (3.4- and 3.7-angstrom resolution, respectively) deviate only slightly from the complexes formed with that of wild-type ATPase. ATP affinity of the D351A mutant was very high, whereas the affinity for cytosolic Ca2+ was similar to that of the wild type. We conclude from an analysis of data that the extraordinary affinity of the D351A mutant for ATP is caused by the electrostatic effects of charge removal and not by a conformational change. P312A exhibits a profound slowing of the Ca2+-translocating Ca(2)E1P -> E2P transition, which seems to be due to a stabilization of Ca(2)E1P rather than a destabilization of E2P. This can be accounted for by the strain that the Pro residue induces in the straight M4 helix of the wild type, which is removed upon the replacement of Pro(312) with alanine in P312A.	[Winther, Anne-Marie Lund; Holm, Peter Joakim; Nissen, Poul] Univ Aarhus, Dept Mol Biol, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-2800 Aarhus, Denmark; [Olesen, Claus; Clausen, Johannes D.; Andersen, Jens Peter; Moller, Jesper Vuust] Univ Aarhus, Inst Physiol & Biophys, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-2800 Aarhus, Denmark; [Marchand, Alexandre; Olesen, Claus; Montigny, Cedric; Arnou, Bertrand; Jaxel, Christine; Le Maire, Marc] 17V Univ Paris Sud, Lab Rech Assoc, URA CNRS 2096, Inst Biol & Technol Saclay,SB SM 2,CEA, F-91191 Gif Sur Yvette, France	Aarhus University; Danmarks Grundforskningsfond; Aarhus University; Danmarks Grundforskningsfond; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Nissen, P (corresponding author), Univ Aarhus, Dept Mol Biol, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-2800 Aarhus, Denmark.	pn@mb.au.dk; chrisstine.jaxel@cea.fr; jvm@biophys.au.dk; marc.lemaire@cea.fr	Nissen, Poul/D-5774-2014	Nissen, Poul/0000-0003-0948-6628; Vilsen, Bente/0000-0002-4727-9382; Andersen, Jens Peter/0000-0003-0654-4300; Olesen, Claus/0000-0002-0462-1686; Lund Winther, Anne-Marie/0000-0002-5776-0989; JAXEL, CHRISTINE/0000-0002-1387-4458				Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; ANDERSEN JP, 1983, EUR J BIOCHEM, V134, P205, DOI 10.1111/j.1432-1033.1983.tb07552.x; BEIL FU, 1977, EUR J BIOCHEM, V81, P151, DOI 10.1111/j.1432-1033.1977.tb11936.x; Bright JN, 2002, BIOPOLYMERS, V64, P303, DOI 10.1002/bip.10197; CHAMPEIL P, 1985, BIOCHEMISTRY-US, V24, P69, DOI 10.1021/bi00322a012; CHAMPEIL P, 1983, J BIOL CHEM, V258, P4453; Champeil P, 2000, J BIOL CHEM, V275, P18623, DOI 10.1074/jbc.M000470200; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; COMBETTES L, 1993, CELL CALCIUM, V14, P279, DOI 10.1016/0143-4160(93)90049-C; Counillon L, 1997, BIOCHEMISTRY-US, V36, P2951, DOI 10.1021/bi9615405; DEFORESTA B, 1994, EUR J BIOCHEM, V223, P359; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DUPONT Y, 1980, FEBS LETT, V115, P247, DOI 10.1016/0014-5793(80)81179-3; EBASHI F, 1962, NATURE, V194, P378, DOI 10.1038/194378a0; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GUILLAIN F, 1982, J BIOL CHEM, V257, P7366; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Jidenko M, 2006, PROTEIN EXPRES PURIF, V48, P32, DOI 10.1016/j.pep.2006.03.001; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LACAPERE JJ, 1990, J BIOL CHEM, V265, P348; LACAPERE JJ, 1993, EUR J BIOCHEM, V211, P117, DOI 10.1111/j.1432-1033.1993.tb19877.x; Lee AG, 2001, BIOCHEM J, V356, P665, DOI 10.1042/0264-6021:3560665; Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8; Lenoir G, 2006, BIOCHEMISTRY-US, V45, P5261, DOI 10.1021/bi0522091; Lenoir G, 2004, J BIOL CHEM, V279, P32125, DOI 10.1074/jbc.M402934200; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ma HL, 2003, J BIOL CHEM, V278, P28938, DOI 10.1074/jbc.M304120200; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; MOLLER JV, 1993, J BIOL CHEM, V268, P18659; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pedersen PA, 1996, BIOCHEMISTRY-US, V35, P16085, DOI 10.1021/bi961614c; Picard M, 2006, BIOCHEMISTRY-US, V45, P1861, DOI 10.1021/bi051954a; Picard M, 2005, J BIOL CHEM, V280, P18745, DOI 10.1074/jbc.M501596200; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; PUNZENGRUBER C, 1978, EUR J BIOCHEM, V92, P349, DOI 10.1111/j.1432-1033.1978.tb12754.x; Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848; Sorensen TLM, 2006, J BIOTECHNOL, V124, P704, DOI 10.1016/j.jbiotec.2006.02.004; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Soulie S, 1999, BIOCHEMISTRY-US, V38, P5813, DOI 10.1021/bi983039d; Stokes DL, 2003, ANNU REV BIOPH BIOM, V32, P445, DOI 10.1146/annurev.biophys.32.110601.142433; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Touret N, 2001, BIOCHEMISTRY-US, V40, P5095, DOI 10.1021/bi0025464; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; VILSEN B, 1991, J BIOL CHEM, V266, P16157; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; VILSEN B, 1989, J BIOL CHEM, V264, P21024; Yohannan S, 2004, P NATL ACAD SCI USA, V101, P959, DOI 10.1073/pnas.0306077101; ZHANG Z, 1995, J BIOL CHEM, V270, P16283	70	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14867	14882		10.1074/jbc.M710165200	http://dx.doi.org/10.1074/jbc.M710165200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18356161	hybrid, Green Published			2022-12-25	WOS:000255941400074
J	Briggs, LC; Baldwin, GS; Miyata, N; Kondo, HS; Zhang, XD; Freemont, PS				Briggs, Louise C.; Baldwin, Geoff S.; Miyata, Non; Kondo, Hisao; Zhang, Xiaodong; Freemont, Paul S.			Analysis of nucleotide binding to p97 reveals the properties of a tandem AAA hexameric ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE FUSION PROTEIN; CONFORMATIONAL-CHANGES; P97/VALOSIN-CONTAINING PROTEIN; CRYSTAL-STRUCTURE; MEMBRANE-FUSION; DOMAIN; P97/VCP; HYDROLYSIS; HSP104; CYCLE	p97, an essential chaperone in endoplasmic reticulum-associated degradation and organelle biogenesis, contains two AAA domains (D1 and D2) and assembles as a stable hexamer. We present a quantitative analysis of nucleotide binding to both D1 and D2 domains of p97, the first detailed study of nucleotide binding to both AAA domains for this type of AAA+ ATPase. We report that adenosine 5'-O-(thiotriphosphate) (ATP gamma S) binds with similar affinity to D1 and D2, but ADP binds with higher affinity to D1 than D2, offering an explanation for the higher ATPase activity in D2. Stoichiometric measurements suggest that although both ADP and ATP gamma S can saturate all 6 nucleotide binding sites in D1, only 3-4 of the 6 D2 sites can bind ATP gamma S simultaneously. ATP gamma S binding triggers a downstream cooperative conformational change of at least three monomers, which involves conserved arginine fingers and is necessary for ATP hydrolysis.	[Briggs, Louise C.; Baldwin, Geoff S.; Zhang, Xiaodong; Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Miyata, Non; Kondo, Hisao] Kyushi Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128582, Japan	Imperial College London; Kyushu University	Freemont, PS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Rm 502, London SW7 2AZ, England.	p.freemont@imperial.ac.uk		Baldwin, Geoffrey/0000-0003-4800-023X; Zhang, Xiaodong/0000-0001-9786-7038; Freemont, Paul/0000-0002-5658-8486	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Beuron F, 2003, J MOL BIOL, V327, P619, DOI 10.1016/S0022-2836(03)00178-5; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Dreveny I, 2004, BIOCHEM SOC T, V32, P715, DOI 10.1042/BST0320715; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hattendorf DA, 2002, P NATL ACAD SCI USA, V99, P2732, DOI 10.1073/pnas.261693199; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Matveeva EA, 1997, J BIOL CHEM, V272, P26413, DOI 10.1074/jbc.272.42.26413; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Paro S, 2007, J BIOL CHEM, V282, P5217, DOI 10.1074/jbc.M609042200; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Rouiller I, 2000, MOL CELL, V6, P1485, DOI 10.1016/S1097-2765(00)00144-1; Shcherbik N, 2007, MOL CELL, V25, P385, DOI 10.1016/j.molcel.2007.01.024; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Smith GR, 2004, J STRUCT BIOL, V146, P189, DOI 10.1016/j.jsb.2003.11.022; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; SUMIDA M, 1994, J BIOL CHEM, V269, P20636; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Wang Q, 2003, J BIOL CHEM, V278, P32784, DOI 10.1074/jbc.M303869200; Wang Q, 2003, BIOCHEM BIOPH RES CO, V300, P253, DOI 10.1016/S0006-291X(02)02840-1; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zalk R, 2003, BIOCHEM J, V374, P473, DOI 10.1042/BJ20030219; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	41	63	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13745	13752		10.1074/jbc.M709632200	http://dx.doi.org/10.1074/jbc.M709632200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18332143	Green Published, hybrid			2022-12-25	WOS:000255728200026
J	Chen, C; Lewis, RE; White, MA				Chen, Chiyuan; Lewis, Robert E.; White, Michael A.			IMP modulates KSR1-dependent multivalent complex formation to specify ERK1/2 pathway activation and response thresholds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN MAP KINASE; B-RAF; SIGNAL PROPAGATION; SCAFFOLD; KSR; HETERODIMERIZATION; ERK/MAPK; MECHANISMS; CANCER; CELLS	The Ras effector and ubiquitin-protein isopeptide ligase family member IMP acts as a steady-state resistor within the Raf-MEK- ERK kinase module. IMP concentrations are regulated by Ras through induction of autodegradation and can modulate signal/response thresholds by directly limiting the assembly of functional KSR1-dependent Raf.MEK complexes. Here, we show that the capacity of IMP to inhibit signal propagation through Raf to MEK is a consequence of disrupting KSR1 homo-oligomerization and B-Raf/c-Raf hetero-oligomerization. This impairs both the recruitment of MEK to activated Raf family members and the contribution of Raf oligomers to c-Raf kinase activation. Our observations indicate that human KSR1 proteins promote assembly of multivalent Raf.MEK complexes that are required for c-Raf kinase activation and functional coupling of active kinases to downstream substrates. This property is engaged by IMP for modulation of signal amplitude.	[Chen, Chiyuan; White, Michael A.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Lewis, Robert E.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Pathol, Omaha, NE 68198 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Nebraska System; University of Nebraska Medical Center	White, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	michael.white@utsouthwestern.edu	Lewis, Robert E./H-3404-2019		NATIONAL CANCER INSTITUTE [R01CA071443] Funding Source: NIH RePORTER; NCI NIH HHS [CA71443] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anselmo AN, 2002, J BIOL CHEM, V277, P5940, DOI 10.1074/jbc.M110498200; Bumeister R, 2004, CURR BIOL, V14, P439, DOI 10.1016/j.cub.2004.02.037; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Douziech M, 2006, GENE DEV, V20, P807, DOI 10.1101/gad.1390406; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Joneson T, 1998, J BIOL CHEM, V273, P7743, DOI 10.1074/jbc.273.13.7743; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Morrison DK, 2001, J CELL SCI, V114, P1609; Muller J, 2001, MOL CELL, V8, P983, DOI 10.1016/S1097-2765(01)00383-5; Ory S, 2004, CURR BIOL, V14, pR277, DOI 10.1016/j.cub.2004.03.023; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697	26	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12789	12796		10.1074/jbc.M709305200	http://dx.doi.org/10.1074/jbc.M709305200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18332145	Green Published, hybrid			2022-12-25	WOS:000255499800015
J	Eckford, PDW; Sharom, FJ				Eckford, Paul D. W.; Sharom, Frances J.			Functional characterization of Escherichia coli MsbA - Interaction with nucleotides and substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN MULTIDRUG TRANSPORTER; TEMPERATURE REQUIREMENT GENE; P-GLYCOPROTEIN; ABC TRANSPORTER; HTRB GENE; NULL MUTATIONS; MULTICOPY SUPPRESSOR; ATP BINDING; FLIPPASE; PROTEIN	The Escherichia coli MsbA protein is a 65-kDa member of the ATP-binding cassette superfamily. It is thought to function as an ATP-dependent lipid translocase that transports lipid A from the inner to the outer leaflet of the cytoplasmic membrane. MsbA with high ATPase activity was isolated and found to be homodimeric in detergent solution. The protein ATPase activity was inhibited by vanadate and showed variable patterns of stimulation and inhibition by lipid A and other compounds. The intrinsic tryptophan fluorescence of the protein was characterized, and dynamic quenching using acrylamide showed that a conformational change took place on binding of lipid A. Fluorescence quenching was used to characterize the interactions of MsbA with nucleotides and various putative substrates, including lipids, lipid-like compounds, and drugs. MsbA had an apparent binding affinity for ATP of similar to 2 mM and also bound nonhydrolyzable ATP analogs and fluorescent ATP derivatives. The putative substrate lipid A interacted with the protein with an affinity of 6.4 mu M. Drugs that are known to be substrates for ABC multidrug transporters also interacted with MsbA with affinities in the range 0.25-50 mu M. This study represents the first use of fluorescence approaches to estimate MsbA binding affinities for nucleotides and putative transport substrates.	[Eckford, Paul D. W.; Sharom, Frances J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Sharom, FJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	fsharom@uoguelph.ca	Eckford, Paul/ABE-9189-2021; Sharom, Frances/A-1613-2010	Sharom, Frances/0000-0002-9521-5367				Buchaklian AH, 2004, BIOCHEMISTRY-US, V43, P8600, DOI 10.1021/bi0497751; Chang G, 2006, SCIENCE, V314, P1875, DOI 10.1126/science.314.5807.1875b; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Eckford PDW, 2006, BIOCHEM CELL BIOL, V84, P1022, DOI 10.1139/O06-196; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Huang ZH, 2004, BBA-BIOMEMBRANES, V1660, P155, DOI 10.1016/j.bbamem.2003.11.010; Huijbregts RPH, 2000, BBA-REV BIOMEMBRANES, V1469, P43, DOI 10.1016/S0304-4157(99)00014-3; KAROW M, 1992, J BACTERIOL, V174, P702, DOI 10.1128/jb.174.3.702-710.1992; KAROW M, 1993, MOL MICROBIOL, V7, P69, DOI 10.1111/j.1365-2958.1993.tb01098.x; KAROW M, 1991, MOL MICROBIOL, V5, P2285, DOI 10.1111/j.1365-2958.1991.tb02159.x; KAROW M, 1991, J BACTERIOL, V173, P741, DOI 10.1128/jb.173.2.741-750.1991; KAROW M, 1992, J BACTERIOL, V174, P7407, DOI 10.1128/jb.174.22.7407-7418.1992; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Liu RH, 2000, BIOCHEMISTRY-US, V39, P14927, DOI 10.1021/bi0018786; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; Russell PL, 2006, BIOCHEM J, V399, P315, DOI 10.1042/BJ20060015; Sharom FJ, 2006, BIOCHEM CELL BIOL, V84, P979, DOI 10.1139/O06-199; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005	31	77	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12840	12850		10.1074/jbc.M708274200	http://dx.doi.org/10.1074/jbc.M708274200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18344567	hybrid			2022-12-25	WOS:000255499800020
J	Lee, SG; Su, ZZ; Emdad, L; Gupta, P; Sarkar, D; Borjabad, A; Volsky, DJ; Fisher, PB				Lee, Seok-Geun; Su, Zhao-Zhong; Emdad, Luni; Gupta, Pankaj; Sarkar, Devanand; Borjabad, Alejandra; Volsky, David J.; Fisher, Paul B.			Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NF-KAPPA-B; ELEVATED GENE-1; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTION FACTOR; CEREBROSPINAL-FLUID; EAAT2; PATHWAYS; DISEASE; NEUROTRANSMITTER	Glutamate is an essential neurotransmitter regulating brain functions. Excitatory amino acid transporter ( EAAT)-2 is one of the major glutamate transporters primarily expressed in astroglial cells. Dysfunction of EAAT2 is implicated in acute and chronic neurological disorders, including stroke/ischemia, temporal lobe epilepsy, amyotrophic lateral sclerosis, Alzheimer disease, human immunodeficiency virus 1-associated dementia, and growth of malignant gliomas. Ceftriaxone, one of the beta-lactam antibiotics, is a stimulator of EAAT2 expression with neuroprotective effects in both in vitro and in vivo models based in part on its ability to inhibit neuronal cell death by glutamate excitotoxicity. Based on this consideration and its lack of toxicity, ceftriaxone has potential to manipulate glutamate transmission and ameliorate neurotoxicity. We investigated the mechanism by which ceftriaxone enhances EAAT2 expression in primary human fetal astrocytes (PHFA). Ceftriaxone elevated EAAT2 transcription in PHFA through the nuclear factor-kappa B (NF-kappa B) signaling pathway. The antibiotic promoted nuclear translocation of p65 and activation of NF-kappa B. The specific NF-kappa B binding site at the -272 position of the EAAT2 promoter was responsible for ceftriaxone-mediated EAAT2 induction. In addition, ceftriaxone increased glutamate uptake, a primary function of EAAT2, and EAAT2 small interference RNA completely inhibited ceftriaxone-induced glutamate uptake activity in PHFA. Taken together, our data indicate that ceftriaxone is a potent modulator of glutamate transport in PHFA through NF-kappa-Bmediated EAAT2 promoter activation. These findings suggest a mechanism for ceftriaxone modulation of glutamate transport and for its potential effects on ameliorating specific neurodegenerative diseases through modulation of extracellular glutamate.	[Lee, Seok-Geun; Su, Zhao-Zhong; Emdad, Luni; Sarkar, Devanand; Fisher, Paul B.] Virginia Commonwealth Univ, VCU Inst Mol Med, Massey Canc Ctr, Dept Human & Mol Genet,Sch Med, Richmond, VA 23298 USA; [Lee, Seok-Geun; Su, Zhao-Zhong; Emdad, Luni; Gupta, Pankaj; Sarkar, Devanand; Fisher, Paul B.] Columbia Univ, Coll Phys & Surg, Med Ctr, Herbert Irving Comprehens Canc Ctr,Dept Urol, New York, NY 10032 USA; [Emdad, Luni; Fisher, Paul B.] Columbia Univ, Coll Phys & Surg, Med Ctr, Herbert Irving Comprehens Canc Ctr,Dept Neurosurg, New York, NY 10032 USA; [Borjabad, Alejandra; Volsky, David J.; Fisher, Paul B.] Columbia Univ, Coll Phys & Surg, Med Ctr, Herbert Irving Comprehens Canc Ctr,Dept Pathol, New York, NY 10032 USA; [Borjabad, Alejandra; Volsky, David J.] St Lukes Roosevelt Hosp, Div Mol Virol, New York, NY 10019 USA	Virginia Commonwealth University; Columbia University; Columbia University; Columbia University; Mount Sinai St. Luke's; Mount Sinai West	Fisher, PB (corresponding author), Virginia Commonwealth Univ, VCU Inst Mol Med, Massey Canc Ctr, Dept Human & Mol Genet,Sch Med, 1101 E Marshall St,Sanger Hall Bldg, Richmond, VA 23298 USA.	pbfisher@vcu.edu	Lee, Seok-Geun/B-3408-2011	Lee, Seok-Geun/0000-0002-0060-5777	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031492] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS031492, P01 NS31492] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson CM, 2000, GLIA, V32, P1; Blei AT, 1999, J HEPATOL, V31, P771, DOI 10.1016/S0168-8278(99)80361-4; Boston-Howes W, 2006, J BIOL CHEM, V281, P14076, DOI 10.1074/jbc.M600653200; Brown J.H., 2001, GOODMAN GILMANS PHAR, V10th ed., P10; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Chan H, 1999, NEUROCHEM RES, V24, P1397, DOI 10.1023/A:1022532623281; CHANDRASEKAR PH, 1984, J ANTIMICROB CHEMOTH, V14, P427, DOI 10.1093/jac/14.4.427; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; COURATIER P, 1993, LANCET, V341, P265, DOI 10.1016/0140-6736(93)92615-Z; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; HEADLEY PM, 1990, TRENDS PHARMACOL SCI, V11, P205, DOI 10.1016/0165-6147(90)90116-P; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Li S, 1997, J NEUROPATH EXP NEUR, V56, P901, DOI 10.1097/00005072-199708000-00008; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Martin LJ, 1997, ANN NEUROL, V42, P335, DOI 10.1002/ana.410420310; Massa PT, 2006, J NEUROCHEM, V97, P607, DOI 10.1111/j.1471-4159.2006.03810.x; Mathern GW, 1999, NEUROLOGY, V52, P453, DOI 10.1212/WNL.52.3.453; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; NAU R, 1993, ANTIMICROB AGENTS CH, V37, P1518, DOI 10.1128/AAC.37.7.1518; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pappas TC, 1998, J NEUROVIROL, V4, P69, DOI 10.3109/13550289809113483; PLAITAKIS A, 1987, ANN NEUROL, V22, P575, DOI 10.1002/ana.410220503; Rawls SM, 2007, BRIT J PHARMACOL, V151, P1095, DOI 10.1038/sj.bjp.0707309; Robinson MB, 1998, NEUROCHEM INT, V33, P479, DOI 10.1016/S0197-0186(98)00055-2; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Rumbaugh JA, 2007, J NEUROVIROL, V13, P168, DOI 10.1080/13550280601178218; Schlag BD, 1998, MOL PHARMACOL, V53, P355, DOI 10.1124/mol.53.3.355; Sitcheran R, 2005, EMBO J, V24, P510, DOI 10.1038/sj.emboj.7600555; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Su ZZ, 2003, P NATL ACAD SCI USA, V100, P1955, DOI 10.1073/pnas.0136555100; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tian GL, 2007, J BIOL CHEM, V282, P1727, DOI 10.1074/jbc.M609822200; TORP R, 1995, EXP BRAIN RES, V103, P51; Trotti D, 2001, J BIOL CHEM, V276, P576, DOI 10.1074/jbc.M003779200; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; Wang ZY, 2003, VIROLOGY, V312, P60, DOI 10.1016/S0042-6822(03)00181-8; Waxman EA, 2007, J BIOL CHEM, V282, P17594, DOI 10.1074/jbc.M702278200; Zelenaia O, 2000, MOL PHARMACOL, V57, P667, DOI 10.1124/mol.57.4.667	50	234	245	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13116	13123		10.1074/jbc.M707697200	http://dx.doi.org/10.1074/jbc.M707697200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326497	Green Published, hybrid			2022-12-25	WOS:000255499800050
J	Vercauteren, K; Gleyzer, N; Scarpulla, RC				Vercauteren, Kristel; Gleyzer, Natalie; Scarpulla, Richard C.			PGC-1-related coactivator complexes with HCF-1 and NRF-2 beta in mediating NRF-2(GABP)-dependent respiratory gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL TRANSCRIPTION FACTOR; CYTOCHROME-C PROMOTER; DNA COPY NUMBER; INDUCIBLE COACTIVATOR; PGC-1 FAMILY; FACTOR GABP; BIOGENESIS; ACTIVATION; GROWTH; ALPHA	The PGC-1 family of regulated coactivators (PGC-1 alpha, PGC-1 beta, and PRC) plays an important role in directing respiratory gene expression in response to environmental signals. Here, we show that PRC and PGC-1 alpha differ in their interactions with nuclear hormone receptors but are highly similar in their direct binding to several nuclear transcription factors implicated in the expression of the respiratory chain. Surprisingly, neither coactivator binds NRF-2(GABP), a multisubunit transcriptional activator associated with the expression of many respiratory genes. However, the NRF-2 subunits and PRC are co-immuno-precipitated from cell extracts indicating that the two proteins exist in a complex in vivo. Several lines of evidence indicate that HCF-1(host cell factor 1), a major chromatin component, mediates the association between PRC and NRF-2. Both PRC and NRF-2 beta bind HCF-1 in vitro, and the molecular determinants required for the interactions of each with HCF-1 are also required for PRC trans-activation through promoter-bound NRF-2. These determinants include a consensus HCF-1 binding site on PRC and the NRF-2 activation domain. In addition, PRC and NRF-2 beta can complex with HCF-1 in vivo, and all three associate with NRF-2-dependent nuclear genes that direct the expression of the mitochondrial transcription factors, TFB1M and TFB2M. Finally, short hairpin RNA-mediated knock down of PRC protein levels leads to reduced expression of TFB2M mRNA and mitochondrial transcripts for cytochrome oxidase II (COXII) and cytochrome b. These changes in gene expression coincide with a marked reduction in cytochrome oxidase activity. The results are consistent with a pathway whereby PRC regulates NRF-2-dependent genes through a multiprotein complex involving HCF-1.	[Vercauteren, Kristel; Gleyzer, Natalie; Scarpulla, Richard C.] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University	Scarpulla, RC (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	rsc248@northwestern.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM032525, R01GM032525] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32525-25] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; GUGNEJA S, 1995, MOL CELL BIOL, V15, P102, DOI 10.1128/MCB.15.1.102; Gugneja S, 1996, MOL CELL BIOL, V16, P5708; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Huo L, 2001, MOL CELL BIOL, V21, P644, DOI 10.1128/MCB.21.2.644-654.2001; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KRISTIE TM, 1990, GENE DEV, V4, P2383, DOI 10.1101/gad.4.12b.2383; LAMARCO KL, 1989, GENE DEV, V3, P1372, DOI 10.1101/gad.3.9.1372; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushima Y, 2005, J BIOL CHEM, V280, P16815, DOI 10.1074/jbc.M500569200; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321; SCARPULLA RC, 2004, MED INTELL UNIT, P28; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; VIRBASIUS JV, 1993, GENE DEV, V7, P380, DOI 10.1101/gad.7.3.380; Vogel JL, 2000, P NATL ACAD SCI USA, V97, P9425, DOI 10.1073/pnas.160266697; Vogel JL, 2000, EMBO J, V19, P683, DOI 10.1093/emboj/19.4.683; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Winkles JA, 1998, PROG NUCLEIC ACID RE, V58, P41; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548	47	57	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12102	12111		10.1074/jbc.M710150200	http://dx.doi.org/10.1074/jbc.M710150200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18343819	Green Published, hybrid			2022-12-25	WOS:000255340000026
J	Pan, MR; Hou, MF; Chang, HC; Hung, WC				Pan, Mei-Ren; Hou, Ming-Feng; Chang, Hui-Chiu; Hung, Wen-Chun			Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGNOSTIC-SIGNIFICANCE; LUNG ADENOCARCINOMA; NODE METASTASIS; DENDRITIC CELLS; EXPRESSION; MECHANISM; GROWTH; ANGIOGENESIS; INVOLVEMENT; ACTIVATION	Recent studies demonstrate that cyclooxygenase-2 (COX-2) expression is frequently associated with lymph node metastasis. However, the mechanism by which COX-2 increases the invasion of cancer cells to lymph node is unclear. CCR7 is a chemokine receptor that plays important roles in the mediation of migration of leukocytes and dendritic cells toward lymphatic endothelial cells (LECs) that express receptor ligand CCL21. We found that treatment of prostaglandin E-2 or ectopic expression of COX-2 in MCF-7 cells up-regulated CCR7 expression. On the contrary, knockdown of COX-2 by small hairpin RNA reduced CCR7 in COX-2-overexpressing MDA-MB-231 cells. Interaction of CCR7 and CCL21 was important for the migration of breast cancer cells toward LECs because antibodies against these two molecules inhibited the migration. We also found that COX-2 increased CCR7 expression via the EP2 and EP4 receptor in breast cancer cells. EP2 and EP4 agonists stimulated CCR7 in MCF- 7 cells, whereas antagonists or small hairpin RNA of EP2 and EP4 attenuated CCR7 in MDA-MB-231 cells. Protein kinase A and AKT kinase were involved in COX-2-induced CCR7. Pathological analysis demonstrated that COX-2 overexpression was associated with CCR7, EP2, and EP4 expressions in breast tumor tissues. In addition, CCR7 expression in COX-2 overexpressing tumors was significantly correlated with lymph node metastasis. Collectively, we suggest that CCR7 is a downstream target for COX-2 to enhance the migration of breast cancer cells toward LECs and to promote lymphatic invasion.	[Hung, Wen-Chun] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 804, Taiwan; [Pan, Mei-Ren; Chang, Hui-Chiu] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 807, Taiwan; [Hou, Ming-Feng] Kaohsiung Med Univ, Dept Surg, Kaohsiung 807, Taiwan; [Hou, Ming-Feng; Chang, Hui-Chiu; Hung, Wen-Chun] Kaohsiung Med Univ Joint Res Ctr, Natl Sun Yat Sen Univ, Fukuoka 804, Taiwan; [Hung, Wen-Chun] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 701, Taiwan	National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; National Cheng Kung University	Hung, WC (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, 70 Lien Hai Rd, Kaohsiung 804, Taiwan.	hung1228@ms10.hinet.net	Pan, Mei-Ren/I-2021-2013; Hou, Ming-Feng/D-5506-2009; Hung, Wen-Chun/F-4846-2011	Hou, Ming-Feng/0000-0001-6030-9702				Achiwa H, 1999, CLIN CANCER RES, V5, P1001; Barnes NLP, 2007, BRIT J CANCER, V96, P575, DOI 10.1038/sj.bjc.6603593; Berahovich RD, 2006, J IMMUNOL, V177, P7833, DOI 10.4049/jimmunol.177.11.7833; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Chan G, 1999, CANCER RES, V59, P991; Chang HC, 2001, ONCOL REP, V8, P1321; Chang HC, 2006, CANCER RES, V66, P8413, DOI 10.1158/0008-5472.CAN-06-0685; Costa C, 2002, J CLIN PATHOL, V55, P429, DOI 10.1136/jcp.55.6.429; Denkert C, 2003, CANCER-AM CANCER SOC, V97, P2978, DOI 10.1002/cncr.11437; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Gately S, 2000, CANCER METAST REV, V19, P19, DOI 10.1023/A:1026575610124; Hegde S, 2004, FASEB J, V18, P1439, DOI 10.1096/fj.03-0969fje; Hida T, 1998, CANCER RES, V58, P3761; Huang M, 1996, J IMMUNOL, V157, P5512; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; Lin MT, 2001, J BIOL CHEM, V276, P48997, DOI 10.1074/jbc.M107829200; Liu LT, 2003, CANCER RES, V63, P3069; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Mutoh M, 2002, CANCER RES, V62, P28; Ohd JF, 2003, GASTROENTEROLOGY, V124, P57, DOI 10.1053/gast.2003.50011; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Ristimaki A, 2002, CANCER RES, V62, P632; Saeki H, 1999, J IMMUNOL, V162, P2472; SANO H, 1995, CANCER RES, V55, P3785; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sorokin A, 2004, CURR PHARM DESIGN, V10, P647, DOI 10.2174/1381612043453117; Su JL, 2004, CANCER RES, V64, P554, DOI 10.1158/0008-5472.CAN-03-1301; Taichman RS, 2002, CANCER RES, V62, P1832; Timoshenko AV, 2006, BRIT J CANCER, V94, P1154, DOI 10.1038/sj.bjc.6603067; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Tucker ON, 1999, CANCER RES, V59, P987; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev	36	86	98	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11155	11163		10.1074/jbc.M710038200	http://dx.doi.org/10.1074/jbc.M710038200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18319253	hybrid			2022-12-25	WOS:000255067400011
J	Zhao, S; Ammanamanchi, S; Brattain, M; Cao, L; Thangasamy, A; Wang, J; Freeman, JW				Zhao, Shujie; Ammanamanchi, Sudhakar; Brattain, Michael; Cao, Lin; Thangasamy, Amalraj; Wang, Jing; Freeman, James W.			Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MACROPHAGE-STIMULATING PROTEIN; TRANSFORMING GROWTH-FACTOR-BETA-1; MESENCHYMAL TRANSITION; EPITHELIAL-CELLS; BONE METASTASIS; EXPRESSION; PROGRESSION; GENE; DPC4	Transforming growth factor beta(TGF-beta) signals through Smad-dependent and Smad-independent pathways. However, Smad signaling is altered by allelic deletion or intragenic mutation of the Smad4 gene in more than half of pancreatic ductal adenocarcinomas. We show here that loss of Smad4-dependent signaling leads to aberrant expression of RON, a phosphotyrosine kinase receptor, and that signaling by RON cooperates with Smad4-independent TGF-beta signaling to promote cell motility and invasion. Restoring Smad4 expression in a pancreatic ductal adenocarcinoma cell line that is deficient in Smad4 repressed RON expression. Conversely, small interference RNA knock down of Smad4 or blocking TGF-beta signaling with a TGF-beta type I receptor kinase inhibitor in Smad4-intact cell lines induced RON expression. TGF-beta-induced motility and invasion were inhibited in cells that express Smad4 and that have low levels of RON compared with isogenically matched cells that were deficient in Smad4. Furthermore, knocking down RON expression in Smad4-deficient cells suppressed TGF-beta-mediated motility and invasion. We further determined that Smad4-dependent signaling regulated RON expression at the transcriptional level by real-time reverse transcription PCR and RON promoter luciferase reporter assays. Functional inactivation by site-directed mutations of two Smad binding sites on the RON promoter inhibited TGF-beta-mediated repression of RON promoter activity. These studies indicate that loss of Smad4 contributes to aberrant RON expression and that cross-talk of Smad4-independent TGF-beta signaling and the RON pathway promotes an invasive phenotype.	[Zhao, Shujie; Ammanamanchi, Sudhakar; Cao, Lin; Thangasamy, Amalraj; Freeman, James W.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Med Oncol, San Antonio, TX 78229 USA; [Brattain, Michael; Wang, Jing] Univ Nebraska, Med Ctr, Eppley Inst, Omaha, NE 68198 USA; [Freeman, James W.] Audie Murphy Vet Adm Hosop, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Nebraska System; University of Nebraska Medical Center	Freeman, JW (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Med Oncol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	freemanjw@uthscsa.edu			NCI NIH HHS [CA96122] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmed MM, 2002, J BIOL CHEM, V277, P2234, DOI 10.1074/jbc.M110168200; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Camp ER, 2007, CANCER-AM CANCER SOC, V109, P1030, DOI 10.1002/cncr.22490; Camp ER, 2005, ANN SURG ONCOL, V12, P273, DOI 10.1245/ASO.2005.08.013; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; DELGATTO F, 1995, BBA-GENE STRUCT EXPR, V1263, P93, DOI 10.1016/0167-4781(95)00082-R; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fralix KD, 2000, CANCER, V88, P2010, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2010::AID-CNCR5>3.0.CO;2-5; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Freeman JW, 2004, FRONT BIOSCI-LANDMRK, V9, P1889, DOI 10.2741/1388; Germano S, 2006, J BIOL CHEM, V281, P21710, DOI 10.1074/jbc.M602014200; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Hua Z, 2003, WORLD J GASTROENTERO, V9, P2764; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Matsuzaki S, 2005, FERTIL STERIL, V84, P1180, DOI 10.1016/j.fertnstert.2005.04.041; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Ozawa F, 2001, TERATOGEN CARCIN MUT, V21, P27, DOI 10.1002/1520-6866(2001)21:1<27::AID-TCM4>3.0.CO;2-9; PIERCE DF, 1995, P NATL ACAD SCI USA, V92, P4254, DOI 10.1073/pnas.92.10.4254; RONSIN C, 1993, ONCOGENE, V8, P1195; Schutte M, 1996, CANCER RES, V56, P2527; SENTONROGERS SE, 2004, P NATL ACAD SCI USA, V101, P1257; Sieg DJ, 1999, J CELL SCI, V112, P2677; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Thomas RM, 2007, CANCER RES, V67, P6075, DOI 10.1158/0008-5472.CAN-06-4128; Tian F, 2003, CANCER RES, V63, P8284; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; Venkatasubbarao K, 2005, CANCER RES, V65, P2861, DOI 10.1158/0008-5472.CAN-04-2396; Venkatasubbarao K, 1998, GENE CHROMOSOME CANC, V22, P138, DOI 10.1002/(SICI)1098-2264(199806)22:2<138::AID-GCC8>3.0.CO;2-Y; Wang D, 2005, CARCINOGENESIS, V26, P27, DOI 10.1093/carcin/bgh284; Wang D, 2004, ONCOGENE, V23, P1668, DOI 10.1038/sj.onc.1207282; Wilentz RE, 2000, CANCER RES, V60, P2002; Wilkins-Port C. E., 2007, J BIOMED BIOTECHNOL, V2007, P1, DOI DOI 10.1155/2007/85208; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Zhao SJ, 2003, CANCER RES, V63, P2624; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075	45	40	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11293	11301		10.1074/jbc.M800154200	http://dx.doi.org/10.1074/jbc.M800154200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18310076	hybrid, Green Published			2022-12-25	WOS:000255067400025
J	Creighton, CJ				Creighton, Chad J.			Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors	PLOS ONE			English	Article							CELLS IN-VITRO; GENE-EXPRESSION; HUMAN BREAST; CANCER; IDENTIFICATION; MICROARRAYS; ACTIVATION; ESTROGEN; RECEPTOR; REVEALS	Background: Gene transcription patterns associated with activation of oncogenes Myc, c-Src, beta-catenin, E2F3, H-Ras, HER2, EGFR, MEK, Raf, MAPK, Akt, and cyclin D1, as well as of the cell cycle and of androgen signaling have been generated in previous studies using experimental models. It was not clear whether genes in these "oncogenic signatures'' would show coordinate expression patterns in human prostate tumors, particularly as most of the signatures were derived from cell types other than prostate. Principal Findings: The above oncogenic pathway signatures were examined in four different gene expression profile datasets of human prostate tumors (representing similar to 250 patients in all), using both Q1-Q2 and one-sided Fisher's exact enrichment analysis methods. A significant fraction (similar to 5%) of genes up-regulated experimentally by Myc, c-Src, HER2, Akt, or androgen were co-expressed in human tumors with the oncogene or biomarker corresponding to the pathway signature. Genes down-regulated experimentally, however, did not show anticipated patterns of anti-enrichment in the human tumors. Conclusions: Significant subsets of the genes in these experimentally-derived oncogenic signatures are relevant to the study of human prostate cancer. Both molecular biologists and clinical researchers could focus attention on the relatively small number of genes identified here as having coordinate patterns that arise from both the experimental system and the human disease system.			Creighton, CJ (corresponding author), Baylor Coll Med, Div Biostat, Dept Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	creighto@bcm.edu			NIH [P30 CA125123]; Dan L. Duncan Cancer Center at Baylor College of Medicine; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dan L. Duncan Cancer Center at Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CJC was supported in part by NIH grant P30 CA125123, and the Dan L. Duncan Cancer Center at Baylor College of Medicine. No funding source played any role in the design and conduct of the study, in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Creighton CJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r28; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Deeb KK, 2007, CANCER RES, V67, P8065, DOI 10.1158/0008-5472.CAN-07-1515; Dehm SM, 2004, BIOCHEM CELL BIOL, V82, P263, DOI 10.1139/o03-077; DePrimo SE, 2002, GENOME BIOL, V3; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hughes C, 2005, J CLIN PATHOL, V58, P673, DOI 10.1136/jcp.2002.003954; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Paronetto MP, 2004, AM J PATHOL, V164, P1243, DOI 10.1016/S0002-9440(10)63212-9; Rhodes DR, 2002, CANCER RES, V62, P4427; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	27	43	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1816	10.1371/journal.pone.0001816	http://dx.doi.org/10.1371/journal.pone.0001816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350153	Green Submitted, gold, Green Published			2022-12-25	WOS:000260762300019
J	Deng, JM; Li, T; Wang, GX; Liu, J; Yu, ZL; Zhao, CM; Ji, MF; Zhang, Q; Liu, JQ				Deng, Jian-Ming; Li, Tao; Wang, Gen-Xuan; Liu, Jing; Yu, Ze-Long; Zhao, Chang-Ming; Ji, Ming-Fei; Zhang, Qiang; Liu, Jian-quan			Trade-Offs between the Metabolic Rate and Population Density of Plants	PLOS ONE			English	Article								The energetic equivalence rule, which is based on a combination of metabolic theory and the self-thinning rule, is one of the fundamental laws of nature. However, there is a progressively increasing body of evidence that scaling relationships of metabolic rate vs. body mass and population density vs. body mass are variable and deviate from their respective theoretical values of 3/4 and -3/4 or -2/3. These findings questioned the previous hypotheses of energetic equivalence rule in plants. Here we examined the allometric relationships between photosynthetic mass (M-p) or leaf mass (M-L) vs. body mass (beta); population density vs. body mass (d); and leaf mass vs. population density, for desert shrubs, trees, and herbaceous plants, respectively. As expected, the allometric relationships for both photosynthetic mass (i.e. metabolic rate) and population density varied with the environmental conditions. However, the ratio between the two exponents was -1 (i.e. beta/delta = -1) and followed the trade-off principle when local resources were limited. Our results demonstrate for the first time that the energetic equivalence rule of plants is based on trade-offs between the variable metabolic rate and population density rather than their constant allometric exponents.	[Deng, Jian-Ming; Li, Tao; Yu, Ze-Long; Zhao, Chang-Ming; Ji, Ming-Fei; Zhang, Qiang; Liu, Jian-quan] Lanzhou Univ, MOE Key Lab Arid & Grassland, Sch Life Sci, Lanzhou 730000, Peoples R China; [Wang, Gen-Xuan] Zhejiang Univ, Coll Life Sci, Inst Agroecol & Ecoengn, Hangzhou, Peoples R China; [Liu, Jing] Chinese Acad Sci, Inst Modern Phys, Lanzhou, Peoples R China	Lanzhou University; Zhejiang University; Chinese Academy of Sciences; Institute of Modern Physics, CAS	Deng, JM (corresponding author), Lanzhou Univ, MOE Key Lab Arid & Grassland, Sch Life Sci, Lanzhou 730000, Peoples R China.	wanggx@zju.edu.cn; Liujq@nwipb.ac.cn			Natural Science Foundation of China [30730020, 30430560]; 863 Program of China [2006AA100202]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Program of China(National High Technology Research and Development Program of China)	This study was supported by the Natural Science Foundation of China (Grant 30730020 and 30430560) and the hi-tech research and development program (863 Program) of China (Grant 2006AA100202).	Anderson KJ, 2005, ECOL LETT, V8, P310, DOI 10.1111/j.1461-0248.2005.00723.x; Banavar JR, 2002, P NATL ACAD SCI USA, V99, P10506, DOI 10.1073/pnas.162216899; Begon M., 1996, ECOLOGY; Bi HQ, 2000, ECOLOGY, V81, P1477, DOI 10.1890/0012-9658(2000)081[1477:ETSTBL]2.0.CO;2; Bokma F, 2004, FUNCT ECOL, V18, P184, DOI 10.1111/j.0269-8463.2004.00817.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chen BM, 2007, J INTEGR PLANT BIOL, V49, P1537, DOI 10.1111/j.1774-7909.2007.00531.x; CRY H, 2004, ECOLOGY, V85, P1802; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; Deng JM, 2006, J ECOL, V94, P953, DOI 10.1111/j.1365-2745.2006.01141.x; DENG JM, 2006, ACTA ECOLPGICA SINAC, V26, P2282; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Duncan RP, 2007, ECOLOGY, V88, P324, DOI 10.1890/0012-9658(2007)88[324:TTMTOE]2.0.CO;2; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 1999, NATURE, V398, P573, DOI 10.1038/19219; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; ENQUIST BJ, 2003, SCALING MACROECOLOGI; Gong CM, 2006, PAK J BOT, V38, P647; HUTCHINGS M, 1983, NEW SCI, V98, P765; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Kleiman D, 2007, J ECOL, V95, P376, DOI 10.1111/j.1365-2745.2006.01205.x; Kozlowski J, 2005, FUNCT ECOL, V19, P739, DOI 10.1111/j.1365-2435.2005.01021.x; Kozlowski J, 2004, FUNCT ECOL, V18, P283, DOI 10.1111/j.0269-8463.2004.00830.x; Li HT, 2006, J INTEGR PLANT BIOL, V48, P268, DOI 10.1111/j.1744-7909.2006.00222.x; Liu J, 2006, J INTEGR PLANT BIOL, V48, P415, DOI 10.1111/j.1744-7909.2006.00240.x; Loeuille N, 2006, ECOL LETT, V9, P171, DOI 10.1111/j.1461-0248.2005.00861.x; LONG JN, 1984, FOREST ECOL MANAG, V7, P191, DOI 10.1016/0378-1127(84)90067-7; LONSDALE WM, 1990, ECOLOGY, V71, P1373, DOI 10.2307/1938275; LUO TX, 1996, PATTERNS BIOL PRODUC, P50; LYSHEDE OB, 1979, BOT J LINN SOC, V78, P85, DOI 10.1111/j.1095-8339.1979.tb02187.x; Morris EC, 2002, ECOL RES, V17, P17, DOI 10.1046/j.1440-1703.2002.00459.x; Niklas KJ, 2003, EVOL ECOL RES, V5, P459; Niklas KJ, 2002, AM J BOT, V89, P812, DOI 10.3732/ajb.89.5.812; Niklas KJ, 2002, AM NAT, V159, P482, DOI 10.1086/339459; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; O'Connor MP, 2007, OIKOS, V116, P1058, DOI 10.1111/j.2006.0030-1299.15534.x; OSAWA A, 1993, ECOLOGY, V74, P1020, DOI 10.2307/1940472; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Pretzsch H, 2006, OECOLOGIA, V146, P572, DOI 10.1007/s00442-005-0126-0; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; Reich PB, 2006, NATURE, V439, P457, DOI 10.1038/nature04282; Reynolds JH, 2005, J ECOL, V93, P362, DOI 10.1111/j.1365-2745.2005.00976.x; RICHARDS RA, 1991, FIELD CROP RES, V26, P141, DOI 10.1016/0378-4290(91)90033-R; Ricklefs RE, 2003, FUNCT ECOL, V17, P384, DOI 10.1046/j.1365-2435.2003.00745.x; Roderick ML, 2004, FUNCT ECOL, V18, P197, DOI 10.1111/j.0269-8463.2004.00832.x; Wang G, 2004, B MATH BIOL, V66, P1875, DOI 10.1016/j.bulm.2004.04.005; WANG G, 1996, INTRASPECIFIC COMPET, P28; WELLER DE, 1991, ECOLOGY, V72, P747, DOI 10.2307/2937216; WELLER DE, 1987, ECOLOGY, V68, P813, DOI 10.2307/1938352; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2007, ECOLOGY, V88, P315, DOI 10.1890/05-1883; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; White J., 1980, Demography and evolution in plant populations., P21; YODA KYOJI, 1963, J BIOL OSAKA CITY UNIV, V14, P107; Zhang DY, 1999, FIELD CROP RES, V61, P179, DOI 10.1016/S0378-4290(98)00156-7	60	34	43	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1799	10.1371/journal.pone.0001799	http://dx.doi.org/10.1371/journal.pone.0001799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350139	Green Published, Green Submitted, gold			2022-12-25	WOS:000260762300005
J	Mao, Y; Kerr, M; Freeman, M				Mao, Yanlan; Kerr, Martin; Freeman, Matthew			Modulation of Drosophila Retinal Epithelial Integrity by the Adhesion Proteins Capricious and Tartan	PLOS ONE			English	Article								Background: The development of the Drosophila eye imaginal disc requires complex epithelial rearrangements. Cells of the morphogenetic furrow are apically constricted and this leads to a physical indentation in the epithelium. Posterior to the furrow, cells start to rearrange into distinct clusters and eventually form a precisely patterned array of ommatidia. These morphogenetic processes include regulated changes of adhesion between cells. Methodology/Principal Findings: Here, we show that two transmembrane adhesion proteins, Capricious and Tartan, have dynamic and complementary expression patterns in the eye imaginal disc. We also describe novel null mutations in capricious and double null mutations in capricious and tartan. We report that they have redundant functions in regulating the architecture of the morphogenetic furrow and ommatidial spacing. Conclusions/Significance: We conclude that Capricious and Tartan contribute to the adhesive properties of the cells in the morphogenetic furrow and that this regulated adhesion participates in the control of spacing ommatidial clusters.	[Mao, Yanlan; Kerr, Martin; Freeman, Matthew] MRC Lab Mol Biol, Cambridge, England	MRC Laboratory Molecular Biology	Mao, Y (corresponding author), MRC Lab Mol Biol, Cambridge, England.	mf1@mrc-lmb.cam.ac.uk		Freeman, Matthew/0000-0003-0410-5451	Core MRC; Medical Research Council [MC_U105178780] Funding Source: researchfish; MRC [MC_U105178780] Funding Source: UKRI	Core MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Core MRC support	BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; Brown KE, 2006, DEV BIOL, V300, P710, DOI 10.1016/j.ydbio.2006.08.003; CHANG Z, 1993, DEV BIOL, V160, P315, DOI 10.1006/dbio.1993.1310; Escudero LM, 2007, DEV CELL, V13, P717, DOI 10.1016/j.devcel.2007.09.002; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; Milan M, 2005, DEV DYNAM, V233, P804, DOI 10.1002/dvdy.20384; Milan M, 2003, DEVELOPMENT, V130, P553, DOI 10.1242/dev.00276; Milan M, 2002, DEV CELL, V2, P797, DOI 10.1016/S1534-5807(02)00169-7; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Preston CR, 1996, GENETICS, V144, P1623; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Sakurai KT, 2007, DEV BIOL, V309, P126, DOI 10.1016/j.ydbio.2007.07.001; Salzberg A, 1997, GENETICS, V147, P1723; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; Taniguchi H, 2000, J NEUROBIOL, V42, P104, DOI 10.1002/(SICI)1097-4695(200001)42:1<104::AID-NEU10>3.0.CO;2-V; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; XU T, 1993, DEVELOPMENT, V117, P1223	26	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1827	10.1371/journal.pone.0001827	http://dx.doi.org/10.1371/journal.pone.0001827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350163	Green Published, Green Submitted, gold			2022-12-25	WOS:000260762300029
J	Yimer, G; Aderaye, G; Amogne, W; Makonnen, E; Aklillu, E; Lindquist, L; Yamuah, L; Feleke, B; Aseffa, A				Yimer, Getnet; Aderaye, Getachew; Amogne, Wondwossen; Makonnen, Eyasu; Aklillu, Eleni; Lindquist, Lars; Yamuah, Lawrence; Feleke, Beniyam; Aseffa, Abraham			Anti-Tuberculosis Therapy-Induced Hepatotoxicity among Ethiopian HIV-Positive and Negative Patients	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; PREVALENCE; GENOTYPE; DRUGS	Background: To assess and compare the prevalence, severity and prognosis of anti-TB drug induced hepatotoxicity (DIH) in HIV positive and HIV negative tuberculosis (TB) patients in Ethiopia. Methodology/Principal Findings: In this study, 103 HIV positive and 94 HIV negative TB patients were enrolled. All patients were evaluated for different risk factors and monitored biochemically and clinically for development of DIH. Sub-clinical hepatotoxicity was observed in 17.3% of the patients and 8 out of the 197 (4.1%) developed clinical hepatotoxicity. Seven of the 8 were HIV positive and 2 were positive for HBsAg. Conclusions/Significance: Sub-clinical hepatotoxicity was significantly associated with HIV co-infection (p = 0.002), concomitant drug intake (p = 0.008), and decrease in CD4 count (p = 0.001). Stepwise restarting of anti TB treatment was also successful in almost all the patients who developed clinical DIH. We therefore conclude that anti-TB DIH is a major problem in HIV-associated TB with a decline in immune status and that there is a need for a regular biochemical and clinical follow up for those patients who are at risk.	[Yimer, Getnet; Yamuah, Lawrence; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Yimer, Getnet; Aderaye, Getachew; Amogne, Wondwossen; Makonnen, Eyasu] Addis Ababa Univ, Med Fac, Addis Ababa, Ethiopia; [Aklillu, Eleni] Karolinska Inst, Dept Clin Pharmacol, Stockholm, Sweden; [Lindquist, Lars] Karolinska Inst, Dept Internal Med, Infect Dis Unit, Stockholm, Sweden; [Feleke, Beniyam] St Peters TB Specialized Hosp, Addis Ababa, Ethiopia	Addis Ababa University; Karolinska Institutet; Karolinska Institutet	Yimer, G (corresponding author), Armauer Hansen Res Inst, Addis Ababa, Ethiopia.	getadera@yahoo.com	Aklillu, Eleni/ABG-3461-2021; Aseffa, Abraham/J-3248-2016; Degu, Wondwossen Amogne/GON-3590-2022; Yimer, Getnet/A-9436-2015	Aseffa, Abraham/0000-0002-8028-1150; Aklillu, Eleni/0000-0002-9788-0790; Yimer, Getnet/0000-0002-1469-837X; Makonnen, Eyasu/0000-0002-9259-5288	AHRI; Sida/SAREC [HIV-2006-031]	AHRI; Sida/SAREC	The study done in Ethiopia was fully funded by AHRI, with part of the study done in Sweden funded by Sida/SAREC grant HIV-2006-031.	Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x; Ali J, 1996, POSTGRAD MED, V99, P217, DOI 10.1080/00325481.1996.11946128; Anand A C, 2006, Med J Armed Forces India, V62, P45, DOI 10.1016/S0377-1237(06)80155-3; BARNES PF, 1993, ANN INTERN MED, V119, P400, DOI 10.7326/0003-4819-119-5-199309010-00009; Bassey EB, 2005, PUBLIC HEALTH, V119, P405, DOI 10.1016/j.puhe.2004.05.012; Brewer TF, 2004, J EPIDEMIOL COMMUN H, V58, P822, DOI 10.1136/jech.2003.008664; Bruchfeld J, 2000, T ROY SOC TROP MED H, V94, P677, DOI 10.1016/S0035-9203(00)90230-X; Campos-Franco J, 2004, Eur J Intern Med, V15, P396, DOI 10.1016/j.ejim.2004.07.005; CHEUKMING T, 2002, MONITORING HEPATOTOX; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; *FOC DIS WATCH, 2004, NATURE REV MICROBIOL, V2, P930; GOOZE L, 2003, TUBERCULOSIS HIV; Gross M, 1999, CANCER EPIDEM BIOMAR, V8, P683; HOFFMANN C, 2006, HIV MED, P395; Huang YS, 2003, HEPATOLOGY, V37, P924, DOI 10.1053/jhep.2003.50144; Kimmoun Elisabeth, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS408, DOI 10.1046/j.1440-1746.17.s3.36.x; KOJU D, 2005, KATHMANDU J SCI ENG, V1; Lee BH, 2005, CHEST, V127, P1304, DOI 10.1378/chest.127.4.1304; Mahmood K, 2007, PAK J MED SCI, V23, P33; OZICK LA, 1995, AM J GASTROENTEROL, V90, P1978; Pan L, 2005, WORLD J GASTROENTERO, V11, P2518, DOI 10.3748/wjg.v11.i16.2518; Pedral-Sampaio Diana B., 2004, Braz J Infect Dis, V8, P211, DOI 10.1590/S1413-86702004000300004; Pol S, 2004, CLIN INFECT DIS, V38, pS65, DOI 10.1086/381499; SHAKYA R, 2006, KATHMANDU U J SCI EN, V2, P1; Sharma SK, 2002, AM J RESP CRIT CARE, V166, P916, DOI 10.1164/rccm.2108091; Sturgill MG, 1997, CLIN CHEM, V43, P1512; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; World Health Organization, 2004, TB HIV CLIN MAN, V2nd; World Health Organization, 2006, ANT THER HIV INF AD; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC; Yepes JF, 2004, ORAL SURG ORAL MED O, V98, P267, DOI 10.1016/j.tripleo.2004.05.012	31	43	44	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1809	10.1371/journal.pone.0001809	http://dx.doi.org/10.1371/journal.pone.0001809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350147	Green Published, gold, Green Submitted			2022-12-25	WOS:000260762300013
J	Strom, K; Hansson, O; Lucas, S; Nevsten, P; Fernandez, C; Klint, C; Moverare-Skrtic, S; Sundler, F; Ohlsson, C; Holm, C				Strom, Kristoffer; Hansson, Ola; Lucas, Stephanie; Nevsten, Pernilla; Fernandez, Celine; Klint, Cecilia; Moverare-Skrtic, Sofia; Sundler, Frank; Ohlsson, Claes; Holm, Cecilia			Attainment of Brown Adipocyte Features in White Adipocytes of Hormone-Sensitive Lipase Null Mice	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; RECEPTOR COREPRESSOR RIP140; ADIPOSE-TISSUE; GENE-EXPRESSION; RETINOBLASTOMA PROTEIN; RETINOIC ACID; FAT-CELLS; IN-VIVO; DIFFERENTIATION; DEFICIENCY	Background: Hormone-sensitive lipase (HSL) is expressed predominantly in adipose tissue, where it plays an important role in catecholamine-stimulated hydrolysis of stored tri- and diglycerides, thus mobilizing fatty acids. HSL exhibits broad substrate specificity and besides acylglycerides it hydrolyzes cholesteryl esters, retinyl esters and lipoidal esters. Despite its role in fatty acid mobilization, HSL null mice have been shown to be resistant to diet-induced obesity. Methodology/Principal Findings: Following a high-fat diet (HFD) regimen, energy expenditure, measured using indirect calorimetry, was increased in HSL null mice. White adipose tissue of HSL null mice was characterized by reduced mass and reduced protein expression of PPAR gamma, a key transcription factor in adipogenesis, and stearoyl-CoA desaturase 1, the expression of which is known to be positively correlated to the differentiation state of the adipocyte. The protein expression of uncoupling protein-1 (UCP-1), the highly specific marker of brown adipocytes, was increased 7-fold in white adipose tissue of HSL null mice compared to wildtype littermates. Transmission electron microscopy revealed an increase in the size of mitochondria of white adipocytes of HSL null mice. The mRNA expression of pRb and RIP140 was decreased in isolated white adipocytes, while the expression of UCP-1 and CPT1 was increased in HSL null mice compared to wildtype littermates. Basal oxygen consumption was increased almost 3-fold in white adipose tissue of HSL null mice and was accompanied by increased uncoupling activity. Conclusions: These data suggest that HSL is involved in the determination of white versus brown adipocytes during adipocyte differentiation The exact mechanism(s) underlying this novel role of HSL remains to be elucidated, but it seems clear that HSL is required to sustain normal expression levels of pRb and RIP140, which both promote differentiation into the white, rather than the brown, adipocyte lineage.	[Strom, Kristoffer; Hansson, Ola; Lucas, Stephanie; Fernandez, Celine; Klint, Cecilia; Sundler, Frank; Holm, Cecilia] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Nevsten, Pernilla] Lund Univ, Natl Ctr High Resolut Electron Microscopy, Lund, Sweden; [Moverare-Skrtic, Sofia; Ohlsson, Claes] Gothenburg Univ, Sahlgrenska Acad, Res Ctr Endocrinol & Metabolism, Gothenburg, Sweden	Lund University; Lund University; University of Gothenburg	Strom, K (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	kristoffer.strom@med.lu.se	Fernandez, Celine/ABH-9332-2020; Ohlsson, Claes/AGP-3544-2022; Skrtic, Sofia/AAQ-1585-2020; Hansson, Ola/F-1793-2011	Fernandez, Celine/0000-0003-1290-4982; Ohlsson, Claes/0000-0002-9633-2805; Hansson, Ola/0000-0002-7394-7639; LUCAS, Stephanie/0000-0001-7530-7486	Swedish Research Council [11284, 621-2203-300]; Juvenile Diabetes Foundation, USA [Center of Excellence Grant]; Knut and Alice Wallenberg Foundation, Sweden; Swedish Diabetes Association; Novo Nordisk; Swedish Foundation for Strategic Research; Foundation of Tage Blucher for Medical Research; Swedish Research School of Genomics and Bioinformatics	Swedish Research Council(Swedish Research CouncilEuropean Commission); Juvenile Diabetes Foundation, USA; Knut and Alice Wallenberg Foundation, Sweden(Knut & Alice Wallenberg Foundation); Swedish Diabetes Association; Novo Nordisk(Novo Nordisk); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Foundation of Tage Blucher for Medical Research; Swedish Research School of Genomics and Bioinformatics	Financial support was provided by the Swedish Research Council (project no 11284 to C.H. and project no 621-2203-300 to Reine Wallenberg at HREM), a Center of Excellence Grant from the Juvenile Diabetes Foundation, USA, and Knut and Alice Wallenberg Foundation, Sweden, the Swedish Diabetes Association, and the following foundations: Novo Nordisk, A. Pahlsson, Salubrin/Druvan, and Torsten and Ragnar Soderberg. O.H. was supported by the Cell Factory for Functional Genomics, a program funded by the Swedish Foundation for Strategic Research, S.L was supported by the Foundation of Tage Blucher for Medical Research and C.F. was supported by the Swedish Research School of Genomics and Bioinformatics. The funding agencies did not take any part in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Antinozzi PA, 1998, J BIOL CHEM, V273, P16146, DOI 10.1074/jbc.273.26.16146; Brown NF, 1997, BIOCHEM J, V327, P225, DOI 10.1042/bj3270225; Cannon B, 2001, Methods Mol Biol, V155, P295; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005; Christian M, 2006, TRENDS ENDOCRIN MET, V17, P243, DOI 10.1016/j.tem.2006.06.008; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Fex M, 2004, ENDOCRINOLOGY, V145, P3746, DOI 10.1210/en.2003-1673; Fortier M, 2004, AM J PHYSIOL-ENDOC M, V287, pE282, DOI 10.1152/ajpendo.00203.2003; FREDRIKSON G, 1981, J BIOL CHEM, V256, P6311; Glass CK, 1997, CURR OPIN CELL BIOL, V9, P222, DOI 10.1016/S0955-0674(97)80066-X; Grober J, 2003, J BIOL CHEM, V278, P6510, DOI 10.1074/jbc.M208513200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Hansson O, 2005, J LIPID RES, V46, P2614, DOI 10.1194/jlr.M500028-JLR200; Hansson O, 2006, J PROTEOME RES, V5, P1701, DOI 10.1021/pr060101h; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Kerley JS, 2001, BIOCHEM BIOPH RES CO, V285, P969, DOI 10.1006/bbrc.2001.5274; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Mulder H, 2003, J BIOL CHEM, V278, P36380, DOI 10.1074/jbc.M213032200; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Park SY, 2005, AM J PHYSIOL-ENDOC M, V289, pE30, DOI 10.1152/ajpendo.00251.2004; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Ribot J, 2005, BBA-MOL BASIS DIS, V1740, P249, DOI 10.1016/j.bbadis.2004.10.013; RODBELL M, 1964, J BIOL CHEM, V239, P375; Roduit R, 2001, DIABETES, V50, P1970, DOI 10.2337/diabetes.50.9.1970; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sekiya M, 2004, J BIOL CHEM, V279, P15084, DOI 10.1074/jbc.M310985200; Soloveva V, 1997, MOL ENDOCRINOL, V11, P27, DOI 10.1210/me.11.1.27; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Voshol PJ, 2003, ENDOCRINOLOGY, V144, P3456, DOI 10.1210/en.2002-0036; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; Wei SH, 1997, J BIOL CHEM, V272, P14159, DOI 10.1074/jbc.272.22.14159; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; Yeaman SJ, 2004, BIOCHEM J, V379, P11, DOI 10.1042/BJ20031811; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zimmermann R, 2003, J LIPID RES, V44, P2089, DOI 10.1194/jlr.M300190-JLR200	48	49	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1793	10.1371/journal.pone.0001793	http://dx.doi.org/10.1371/journal.pone.0001793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335062	gold, Green Submitted, Green Published			2022-12-25	WOS:000260723000044
J	Risueno, RM; Schamel, WWA; Alarcon, B				Risueno, Ruth M.; Schamel, Wolfgang W. A.; Alarcon, Balbino			T Cell Receptor Engagement Triggers Its CD3 epsilon and CD3 zeta Subunits to Adopt a Compact, Locked Conformation	PLOS ONE			English	Article								How the T cell antigen receptor (TCR) discriminates between molecularly related peptide/Major Histocompatibility Complex (pMHC) ligands and converts this information into different possible signaling outcomes is still not understood. One current model proposes that strong pMHC ligands, but not weak ones, induce a conformational change in the TCR. Evidence supporting this comes from a pull-down assay that detects ligand-induced binding of the TCR to the N-terminal SH3 domain of the adapter protein Nck, and also from studies with a neoepitope-specific antibody. Both methods rely on the exposure of a polyproline sequence in the CD3 epsilon subunit of the TCR, and neither indicates whether the conformational change is transmitted to other CD3 subunits. Using a protease-sensitivity assay, we now show that the cytoplasmic tails of CD3 epsilon and CD3 zeta subunits become fully protected from degradation upon TCR triggering. These results suggest that the TCR conformational change is transmitted to the tails of CD3 epsilon and CD3 zeta, and perhaps all CD3 subunits. Furthermore, the resistance to protease digestion suggests that CD3 cytoplasmic tails adopt a compact structure in the triggered TCR. These results are consistent with a model in which transduction of the conformational change induced upon TCR triggering promotes condensation and shielding of the CD3 cytoplasmic tails.	[Risueno, Ruth M.; Alarcon, Balbino] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Schamel, Wolfgang W. A.] Max Planck Inst Immunobiol, Freiburg, Germany	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Max Planck Society	Risueno, RM (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	balarcon@cbm.uam.es	Risueño, Ruth Muñoz/G-9969-2015; Alarcon, Balbino/N-9648-2016	Risueño, Ruth Muñoz/0000-0003-4048-9536; Alarcon, Balbino/0000-0001-7820-1070	CICYT [SAF2006-01391]; Comunidad de Madrid [SAL-0159/2006]; EU [LSHC-CT-2005-018914]; Emmy Noether Fellowship from DFG [SCHA976/1, SFB620]	CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Comunidad de Madrid(Comunidad de Madrid); EU(European Commission); Emmy Noether Fellowship from DFG(German Research Foundation (DFG))	This work was supported by grants SAF2006-01391 from CICYT, SAL-0159/2006 from the Comunidad de Madrid, and LSHC-CT-2005-018914 from the EU (to B.A.), and by an Emmy Noether Fellowship from the DFG (SCHA976/1) and SFB620 (to W.W.S). The institutional support of Fundacion Ramon Areces to the CBMSO is also acknowledged.	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; Alarcon B, 2003, IMMUNOL REV, V191, P38, DOI 10.1034/j.1600-065X.2003.00017.x; ALARCON B, 1991, EMBO J, V10, P903, DOI 10.1002/j.1460-2075.1991.tb08023.x; Bachmann MF, 1999, IMMUNOL TODAY, V20, P568, DOI 10.1016/S0167-5699(99)01543-1; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Borroto A, 1998, J BIOL CHEM, V273, P12807, DOI 10.1074/jbc.273.21.12807; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; Chan FKM, 2001, CYTOMETRY, V44, P361, DOI 10.1002/1097-0320(20010801)44:4<361::AID-CYTO1128>3.0.CO;2-3; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gil D, 2005, J EXP MED, V201, P517, DOI 10.1084/jem.20042036; GILBERT JM, 1995, J VIROL, V69, P7410, DOI 10.1128/JVI.69.12.7410-7415.1995; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Huo XW, 1999, BIOCHEMISTRY-US, V38, P16941, DOI 10.1021/bi9919448; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; Jose ES, 1998, EUR J IMMUNOL, V28, P12; KAPPLER J, 1983, CELL, V34, P727, DOI 10.1016/0092-8674(83)90529-9; KAYE J, 1984, J IMMUNOL, V133, P1339; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Laczko I, 1998, BIOCHEM BIOPH RES CO, V242, P474, DOI 10.1006/bbrc.1997.7989; Lin J, 2001, J CELL SCI, V114, P243; Malissen B, 2003, IMMUNOL REV, V191, P7, DOI 10.1034/j.1600-065X.2003.00016.x; MEUER SC, 1983, J EXP MED, V158, P988, DOI 10.1084/jem.158.3.988; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Pitcher LA, 2003, IMMUNOL REV, V191, P47, DOI 10.1034/j.1600-065X.2003.00003.x; Qi SY, 2006, P NATL ACAD SCI USA, V103, P4416, DOI 10.1073/pnas.0510991103; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Risueno RM, 2005, BLOOD, V106, P601, DOI 10.1182/blood-2004-12-4763; Risueno RM, 2006, P NATL ACAD SCI USA, V103, P9625, DOI 10.1073/pnas.0601785103; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Sahuquillo AG, 1998, J EXP MED, V187, P1179, DOI 10.1084/jem.187.8.1179; Schamel WWA, 2006, TRENDS IMMUNOL, V27, P176, DOI 10.1016/j.it.2006.02.005; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Sigalov A, 2004, BIOCHEMISTRY-US, V43, P2049, DOI 10.1021/bi035900h; Stones JD, 2006, J IMMUNOL, V176, P1498, DOI 10.4049/jimmunol.176.3.1498; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Wess J, 1997, LIFE SCI, V60, P1007, DOI 10.1016/S0024-3205(97)00041-6; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; YOON ST, 1994, IMMUNITY, V1, P563	49	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1747	10.1371/journal.pone.0001747	http://dx.doi.org/10.1371/journal.pone.0001747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320063	Green Published, gold, Green Submitted			2022-12-25	WOS:000260586600041
J	Gehen, SC; Staversky, RJ; Bambara, RA; Keng, PC; O'Reilly, MA				Gehen, S. C.; Staversky, R. J.; Bambara, R. A.; Keng, P. C.; O'Reilly, M. A.			hSMG-1 and ATM sequentially and independently regulate the G(1) checkpoint during oxidative stress	ONCOGENE			English	Article						cell cycle; DNA damage; p53; reactive oxygen species	DAMAGE-INDUCED PHOSPHORYLATION; RNA SURVEILLANCE PROTEIN; DOUBLE-STRAND BREAKS; DNA-DAMAGE; IONIZING-RADIATION; DEPENDENT PHOSPHORYLATION; HUMAN SMG-1; KINASE; P53; UBIQUITINATION	Genotoxic stress activates the phosphatidylinositol 3-kinase-like kinases ( PIKKs) that phosphorylate proteins involved in cell cycle arrest, DNA repair and apoptosis. Previous work showed that the PIKK ataxia telangiectasia mutated ( ATM) but not ATM and Rad3 related phosphorylates p53 ( Ser15) during hyperoxia, a model of prolonged oxidative stress and DNA damage. Here, we show hSMG-1 is responsible for the rapid and early phosphorylation of p53 ( Ser15) and that ATM helps maintain phosphorylation after 24 h. Despite reduced p53 phosphorylation and abundance in cells depleted of hSMG-1 or ATM, levels of the p53 target p21 were still elevated and the G(1) checkpoint remained intact. Conditional overexpression of p21 in p53-deficient cells revealed that hyperoxia also stimulates wortmannin-sensitive degradation of p21. siRNA depletion of hSMG-1 or ATM restored p21 stability and the G(1) checkpoint during hyperoxia. These findings establish hSMG-1 as a proximal regulator of DNA damage signaling and reveal that the G1 checkpoint is tightly regulated during prolonged oxidative stress by both PIKK-dependent synthesis and proteolysis of p21.	[Staversky, R. J.; O'Reilly, M. A.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Gehen, S. C.] Univ Rochester, Dept Environm Med, Rochester, NY 14642 USA; [Bambara, R. A.] Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Keng, P. C.] Univ Rochester, Dept Radiat Oncol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	O'Reilly, MA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pediat, 601 Elmwood Ave,Box 850, Rochester, NY 14642 USA.	michael_oreilly@urmc.rochester.edu			NHLBI NIH HHS [HL-67392, R01 HL067392, R01 HL067392-06] Funding Source: Medline; NIEHS NIH HHS [T32 ES007026-21, P30 ES001247, ES-07026, P30 ES001247-349022, T32 ES007026, ES-01247, R01 ES007026] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007026, T32ES007026, P30ES001247] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abraham RT, 2005, SCIENCE, V308, P510, DOI 10.1126/science.1112069; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Blagosklonny MV, 1996, BIOCHEM BIOPH RES CO, V227, P564, DOI 10.1006/bbrc.1996.1546; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Chen MJ, 2001, J BIOL CHEM, V276, P16580, DOI 10.1074/jbc.M008871200; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Das KC, 2004, AM J PHYSIOL-LUNG C, V286, pL87, DOI 10.1152/ajplung.00203.2002; Denning G, 2001, J BIOL CHEM, V276, P22709, DOI 10.1074/jbc.C100144200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Engel FB, 2003, MOL CELL BIOL, V23, P555, DOI 10.1128/MCB.23.2.555-565.2003; Gehen SC, 2007, AM J PHYSIOL-LUNG C, V292, pL716, DOI 10.1152/ajplung.00135.2006; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Helt CE, 2004, AM J PHYSIOL-LUNG C, V286, pL506, DOI 10.1152/ajplung.00243.2003; Helt CE, 2005, J BIOL CHEM, V280, P1186, DOI 10.1074/jbc.M410873200; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; O'Reilly MA, 2001, AM J RESP CELL MOL, V24, P703, DOI 10.1165/ajrcmb.24.6.4355; OConnor PM, 1997, CANCER SURV, V29, P151; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P8869, DOI 10.1021/bi00027a039; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Suzuki K, 1999, J BIOL CHEM, V274, P25571, DOI 10.1074/jbc.274.36.25571; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Vitiello PF, 2006, AM J PATHOL, V168, P1838, DOI 10.2353/ajpath.2006.051162; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134	36	41	41	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 3	2008	27	29					4065	4074		10.1038/onc.2008.48	http://dx.doi.org/10.1038/onc.2008.48			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	321RV	18332866	Green Accepted			2022-12-25	WOS:000257325100006
J	Toscano, F; El Fajoui, Z; Gay, F; Lalaoui, N; Parmentier, B; Chayvialle, JA; Scoazec, JY; Micheau, O; Abello, J; Saurin, JC				Toscano, F.; El Fajoui, Z.; Gay, F.; Lalaoui, N.; Parmentier, B.; Chayvialle, J-A; Scoazec, J-Y; Micheau, O.; Abello, J.; Saurin, J-C			p53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells	ONCOGENE			English	Article						oxaliplatin; TRAIL; antagonism; p53; DcR1; colon cancer	TRAIL-INDUCED APOPTOSIS; DECOY RECEPTORS; CHEMOTHERAPEUTIC-AGENTS; COLORECTAL-CANCER; DEATH RECEPTORS; TARGETING DEATH; IN-VITRO; C-FLIP; LIGAND; P53	Oxaliplatin hasemerged as a major chemotherapeutic drug in the treatment of advanced colorectal cancer, yet like most conventional cancer therapeutics, its efficacy is often compromised due to p53 mutations. Unlike oxaliplatin, tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in a p53-independent manner, and chemotherapy is known to overcome tumour resistance to TRAIL-induced cell death in most cancer cells. Using a panel of colon cancer cell lines, we assessed the ability of oxaliplatin to sensitize to TRAIL-induced apoptosis. We demonstrate that while both drugs additively or synergistically induced apoptosis in almost all cell lines tested, p53 wild-type colon cancer cells such as HCT116, LS513 or LS174T remained resistant. Impaired TRAIL-induced cell death resulted from a strong p53 dependent, oxaliplatin-mediated, DcR1 receptor expression increase. According to our finding, downregulation of DcR1 using siRNA, in p53 wild-type colon cancer cells, restored oxaliplatin/TRAIL synergistic apoptotic activity. On the contrary, exogenous DcR1 overexpression in SW480, a p53-mutated cell line, abolished the synergy between the two drugs. Altogether we demonstrate for the first time that p53 negatively regulates oxaliplatin-mediated TRAIL-induced apoptotic activity through DcR1 upregulation. Our findings could have important implications for future therapeutic strategies, and suggest that the association oxaliplatin/TRAIL should be restricted to patients harbouring a non-functional p53 protein.	[Toscano, F.; El Fajoui, Z.; Gay, F.; Parmentier, B.; Chayvialle, J-A; Scoazec, J-Y; Abello, J.; Saurin, J-C] Fac Med Laennec, INSERM, Unite 865, Inst Fed Rech Lyon Est, F-69372 Lyon 08, France; [Toscano, F.; El Fajoui, Z.; Gay, F.; Parmentier, B.; Chayvialle, J-A; Scoazec, J-Y; Abello, J.; Saurin, J-C] Univ Lyon 1, Fac Laennec, F-69008 Lyon, France; [Lalaoui, N.; Micheau, O.] Univ Bourgogne, INSERM, U866, F-21079 Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Abello, J (corresponding author), Fac Med Laennec, INSERM, Unite 865, Inst Fed Rech Lyon Est, 7 Rue G Paradin, F-69372 Lyon 08, France.	abello@lyon.inserm.fr	saurin, jean christophe/AAB-4077-2020; Lalaoui, Najoua/C-1410-2014; micheau, olivier/C-3574-2011	Lalaoui, Najoua/0000-0002-0165-3324; micheau, olivier/0000-0001-8499-7984				Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bouralexis S, 2003, BRIT J CANCER, V89, P206, DOI 10.1038/sj.bjc.6601021; Bouralexis S, 2005, APOPTOSIS, V10, P35, DOI 10.1007/s10495-005-6060-0; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Davidovich IA, 2004, CANCER LETT, V211, P189, DOI 10.1016/j.canlet.2004.03.026; de Almodovar CR, 2004, J BIOL CHEM, V279, P4093, DOI 10.1074/jbc.M311243200; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Gayet J, 2001, ONCOGENE, V20, P5025, DOI 10.1038/sj.onc.1204611; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Gramont Aimery de, 2005, Semin Oncol, V32, P11, DOI 10.1053/j.seminoncol.2005.06.004; He Q, 2004, ONCOGENE, V23, P2554, DOI 10.1038/sj.onc.1207351; Jang SH, 2004, INT J MOL MED, V13, P181; Jin H, 2004, CANCER RES, V64, P4900, DOI 10.1158/0008-5472.CAN-04-0408; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kim YH, 2004, CARCINOGENESIS, V25, P1813, DOI 10.1093/carcin/bgh188; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Liu XG, 2005, CANCER RES, V65, P9169, DOI 10.1158/0008-5472.CAN-05-0939; Merino D, 2007, EXPERT OPIN THER TAR, V11, P1299, DOI 10.1517/14728222.11.10.1299; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 1999, J BIOL CHEM, V274, P7987, DOI 10.1074/jbc.274.12.7987; Mita MM, 2006, ANN ONCOL, V17, P313, DOI 10.1093/annonc/mdj067; Motoki K, 2005, CLIN CANCER RES, V11, P3126, DOI 10.1158/1078-0432.CCR-04-1867; Nagane M, 2000, CANCER RES, V60, P847; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pukac L, 2005, BRIT J CANCER, V92, P1430, DOI 10.1038/sj.bjc.6602487; Scaffidi C, 1999, J BIOL CHEM, V274, P22532, DOI 10.1074/jbc.274.32.22532; Shankar S, 2004, DRUG RESIST UPDATE, V7, P139, DOI 10.1016/j.drup.2004.03.002; Sheikh MS, 2000, LEUKEMIA, V14, P1509, DOI 10.1038/sj.leu.2401865; STEEL GG, 1979, INT J RADIAT ONCOL, V5, P85; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Toscano F, 2007, BIOCHEM PHARMACOL, V74, P392, DOI 10.1016/j.bcp.2007.05.001; van Geelen CM, 2006, J CLIN ONCOL, V24, P4998, DOI 10.1200/JCO.2006.06.8809; Vignati S, 2002, EUR J CANCER, V38, P177, DOI 10.1016/S0959-8049(01)00345-8; Wajant H, 2005, CYTOKINE GROWTH F R, V16, P55, DOI 10.1016/j.cytogfr.2004.12.001; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Yamanaka T, 2000, HEPATOLOGY, V32, P482, DOI 10.1053/jhep.2000.16266	39	35	38	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2008	27	30					4161	4171		10.1038/onc.2008.52	http://dx.doi.org/10.1038/onc.2008.52			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	324DB	18345033				2022-12-25	WOS:000257496800003
J	Cheng, GZ; Zhang, W; Sun, M; Wang, Q; Coppola, D; Mansour, M; Xu, L; Costanzo, C; Cheng, JQ; Wang, LH				Cheng, George Z.; Zhang, WeiZhou; Sun, Mei; Wang, Qi; Coppola, Domenico; Mansour, Mena; Xu, Limei; Costanzo, Carliann; Cheng, Jin Q.; Wang, Lu-Hai			Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EPIDERMAL-GROWTH-FACTOR; CANCER-CELLS; CONSTITUTIVE ACTIVATION; SIGNALING PATHWAY; UP-REGULATION; E-CADHERIN; EXPRESSION; PROTEIN; GENE	To explore the basis of metastasis, we compared the human breast cancer lines MCF-7 and MDA-MB453, which have low invasive ability, with their sublines MCF7-I4 and MDA-MB453-I4 with high invasive ability for gene expression and signaling pathways. We previously showed that the I4 lines had dramatically elevated levels of Twist compared with their parental lines. In this study, we observed significantly increased STAT3 Tyr(705) phosphorylation, but not the STAT3 protein levels, in the I4 lines. Activation of STAT3 by interleukin-6 or expression of activated Src induced Twist expression at protein and mRNA levels. Inhibiting STAT3 by a small molecule inhibitor, JSI-124, STAT3 small hairpin RNAs, or dominant negative STAT3 resulted in significant reduction of Twist protein and mRNA expression. STAT3 directly bound to the second proximal STAT3-binding site on the human Twist promoter and activated its transcriptional activity. Inhibition of STAT3 reduced migration, invasion, and colony formation of the I4 cells. Ectopic expression of Twist significantly rescued those phenotypes. Ten normal and 46 tumor specimens of breast tissues were examined for activation of STAT3 and expression of Twist. There was a strong correlation between Tyr(705) p-STAT3 and Twist level in the late stage tumor tissues. Our results indicate that activated STAT3 transcriptionally induces Twist, which plays an important role in promoting migration, invasion, and anchorage-independent growth. Together with our previous observation that Twist transcriptionally induces AKT2 to mediate Twist-promoted oncogenic functions, we conclude that STAT3, Twist, and AKT2 form a functional signaling axis to regulate pivotal oncogenic properties of cancer cells.	[Cheng, George Z.; Zhang, WeiZhou; Mansour, Mena; Xu, Limei; Costanzo, Carliann; Wang, Lu-Hai] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Sun, Mei; Wang, Qi; Coppola, Domenico; Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA	Icahn School of Medicine at Mount Sinai; H Lee Moffitt Cancer Center & Research Institute	Wang, LH (corresponding author), Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl,Box 1124, New York, NY 10029 USA.	lu-hai.wang@mssm.edu	Mansour, Mena/K-6632-2019; Wang, Lu-Hai/E-3986-2010	Mansour, Mena/0000-0003-1358-1062; 	NCI NIH HHS [CA 29339] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA029339] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Buettner R, 2002, CLIN CANCER RES, V8, P945; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Castanon I, 2001, DEVELOPMENT, V128, P3145; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; El Ghouzzi V, 2000, HUM MOL GENET, V9, P813, DOI 10.1093/hmg/9.5.813; Fernandes A, 1999, INT J CANCER, V83, P564, DOI 10.1002/(SICI)1097-0215(19991112)83:4<564::AID-IJC20>3.0.CO;2-Q; Garcia R, 1997, CELL GROWTH DIFFER, V8, P1267; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Kira M, 2002, J BIOL CHEM, V277, P12931, DOI 10.1074/jbc.M110795200; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; McLoughlin RM, 2005, P NATL ACAD SCI USA, V102, P9589, DOI 10.1073/pnas.0501794102; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Mitchell TJ, 2005, IMMUNOLOGY, V114, P301, DOI 10.1111/j.1365-2567.2005.02091.x; Ohuchida K, 2007, INT J CANCER, V120, P1634, DOI 10.1002/ijc.22295; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Pedranzini L, 2004, J CLIN INVEST, V114, P619, DOI 10.1172/JCI200422800; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Spiekermann K, 2002, EXP HEMATOL, V30, P262, DOI 10.1016/S0301-472X(01)00787-1; Wang SM, 1997, GENE, V187, P83, DOI 10.1016/S0378-1119(96)00727-5; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yuen HF, 2007, J CLIN PATHOL, V60, P510, DOI 10.1136/jcp.2006.039099; Zhang F, 2003, ONCOGENE, V22, P894, DOI 10.1038/sj.onc.1206158; Zhang Z, 2007, HUM PATHOL, V38, P598, DOI 10.1016/j.humpath.2006.10.004; Zong CS, 1998, J BIOL CHEM, V273, P28065, DOI 10.1074/jbc.273.43.28065	44	221	236	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14665	14673		10.1074/jbc.M707429200	http://dx.doi.org/10.1074/jbc.M707429200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18353781	Green Published, hybrid			2022-12-25	WOS:000255941400055
J	Hanawa, N; Shinohara, M; Saberi, B; Gaarde, WA; Han, D; Kaplowitz, N				Hanawa, Naoko; Shinohara, Mie; Saberi, Behnam; Gaarde, William A.; Han, Derick; Kaplowitz, Neil			Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-INDUCED APOPTOSIS; N-TERMINAL KINASE; C-JUN; CELL-DEATH; GLUTATHIONE DEPLETION; HYDROGEN-PEROXIDE; SUPEROXIDE ANION; PERMEABILITY TRANSITION; INTERMEMBRANE SPACE; MOUSE HEPATOCYTES	Previously, we demonstrated JNK plays a central role in acetaminophen (APAP)-induced liver injury (Gunawan, B. K., Liu, Z. X., Han, D., Hanawa, N., Gaarde, W. A., and Kaplowitz, N. ( 2006) Gastroenterology 131, 165-178). In this study, we examine the mechanism involved in activating JNK and explore the downstream targets of JNK important in promoting APAP-induced liver injury in vivo. JNK inhibitor (SP600125) was observed to significantly protect against APAP-induced liver injury. Increased mitochondria-derived reactive oxygen species were implicated in APAP-induced JNK activation based on the following: 1) mitochondrial GSH depletion (maximal at 2 h) caused increased H2O2 release from mitochondria, which preceded JNK activation ( maximal at 4 h); 2) treatment of isolated hepatocytes with H2O2 or inhibitors ( e. g. antimycin) that cause increased H2O2 release from mitochondria-activated JNK. An important downstream target of JNK following activation was mitochondria based on the following: 1) JNK translocated to mitochondria following activation; 2) JNK inhibitor treatment partially protected against a decline in mitochondria respiration caused by APAP treatment; and 3) addition of purified active JNK to mitochondria isolated from mice treated with APAP plus JNK inhibitor ( mitochondria with severe GSH depletion, covalent binding) directly inhibited respiration. Cyclosporin A blocked the inhibitory effect of JNK on mitochondria respiration, suggesting JNK was directly inducing mitochondrial permeability transition in isolated mitochondria from mice treated with APAP plus JNK inhibitor. Addition of JNK to mitochondria isolated from control mice did not affect respiration. Our results suggests that APAP-induced liver injury involves JNK activation, due to increased reactive oxygen species generated by GSH-depleted mitochondria, and translocation of activated JNK to mitochondria where JNK induces mitochondrial permeability transition and inhibits mitochondria bioenergetics.	[Hanawa, Naoko; Shinohara, Mie; Saberi, Behnam; Han, Derick; Kaplowitz, Neil] Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, Los Angeles, CA 90089 USA; [Gaarde, William A.] ISIS Pharmaceut, Carlsbad, CA 92008 USA	University of Southern California; Isis Pharmaceuticals Inc	Kaplowitz, N (corresponding author), Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, 2011 Zonol Ave,HMR 101, Los Angeles, CA 90089 USA.	kaplowit@usc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067215, P30DK048522] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK048522, R01 DK067215, DK48522, DK067215] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Armstrong JS, 2006, MITOCHONDRION, V6, P225, DOI 10.1016/j.mito.2006.07.006; Bajt ML, 2008, J PHARMACOL EXP THER, V324, P8, DOI 10.1124/jpet.107.129445; Bradham CA, 1997, HEPATOLOGY, V25, P1128, DOI 10.1002/hep.510250514; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; BURCHAM PC, 1991, J BIOL CHEM, V266, P5049; Chauhan D, 2003, J BIOL CHEM, V278, P17593, DOI 10.1074/jbc.C300076200; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327; Deak JC, 1998, P NATL ACAD SCI USA, V95, P5595, DOI 10.1073/pnas.95.10.5595; Dorion S, 2002, J BIOL CHEM, V277, P30792, DOI 10.1074/jbc.M203642200; El-Hassan H, 2003, TOXICOL APPL PHARM, V191, P118, DOI 10.1016/S0041-008X(03)00240-0; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Femandez-Checa JC, 2005, TOXICOL APPL PHARM, V204, P263, DOI 10.1016/j.taap.2004.10.001; Gujral JS, 2002, TOXICOL SCI, V67, P322, DOI 10.1093/toxsci/67.2.322; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Han D, 2003, MOL PHARMACOL, V64, P1136, DOI 10.1124/mol.64.5.1136; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Han D, 2002, METHOD ENZYMOL, V349, P271, DOI 10.1016/S0076-6879(02)49341-X; Han D, 2006, FREE RADICAL BIO MED, V41, P627, DOI 10.1016/j.freeradbiomed.2006.05.002; Han D, 2006, AM J PHYSIOL-GASTR L, V291, pG1, DOI 10.1152/ajpgi.00001.2006; Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372; Jaeschke H, 2006, LIFE SCI, V78, P1670, DOI 10.1016/j.lfs.2005.07.003; Jaeschke H, 2003, TOXICOL LETT, V144, P279, DOI 10.1016/S0378-4274(03)00239-X; JEFFERY EH, 1988, TOXICOL APPL PHARM, V93, P452, DOI 10.1016/0041-008X(88)90048-8; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Kaplowitz N, 2002, SEMIN LIVER DIS, V22, P137, DOI 10.1055/s-2002-30100; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Latchoumycandane C, 2007, HEPATOLOGY, V45, P412, DOI 10.1002/hep.21475; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Matsumaru K, 2003, HEPATOLOGY, V37, P1425, DOI 10.1053/jhep.2003.50230; Meyer S, 1999, ANAL BIOCHEM, V271, P43, DOI 10.1006/abio.1999.4119; MEYERS LL, 1988, TOXICOL APPL PHARM, V93, P378, DOI 10.1016/0041-008X(88)90040-3; Nemoto S, 2000, MOL CELL BIOL, V20, P7311, DOI 10.1128/MCB.20.19.7311-7318.2000; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; PARK YJ, 1988, TOXICOLOGY, V52, P165, DOI 10.1016/0300-483X(88)90202-8; Pumford NR, 1997, ANNU REV PHARMACOL, V37, P91, DOI 10.1146/annurev.pharmtox.37.1.91; RASHED MS, 1990, DRUG METAB DISPOS, V18, P765; RASHED MS, 1989, CHEM RES TOXICOL, V2, P41, DOI 10.1021/tx00007a007; Reilly TP, 2001, CHEM RES TOXICOL, V14, P1620, DOI 10.1021/tx0155505; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schattenberg JM, 2006, HEPATOLOGY, V43, P163, DOI 10.1002/hep.20999; Schroeter H, 2003, BIOCHEM J, V372, P359, DOI 10.1042/BJ20030201; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwabe RF, 2006, GASTROENTEROLOGY, V131, P314, DOI 10.1053/j.gastro.2006.05.029; Singh R, 2007, J GASTROEN HEPATOL, V22, pS45, DOI 10.1111/j.1440-1746.2006.04646.x; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wicovsky A, 2007, J BIOL CHEM, V282, P2174, DOI 10.1074/jbc.M606167200; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x	57	373	376	4	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13565	13577		10.1074/jbc.M708916200	http://dx.doi.org/10.1074/jbc.M708916200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18337250	Green Published, hybrid			2022-12-25	WOS:000255728200010
J	Phillips, MJ; Calero, G; Chan, B; Ramachandran, S; Cerione, RA				Phillips, Matthew J.; Calero, Guillermo; Chan, Britton; Ramachandran, Sekar; Cerione, Richard A.			Effector proteins exert an important influence on the signaling-active state of the small GTPase Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-DISSOCIATION INHIBITOR; BINDING DOMAIN; CRYSTAL-STRUCTURE; ACTIVATING PROTEIN; NUCLEOTIDE-BINDING; H-RAS; FAMILY; RHO; COMPLEX; SWITCH	GTP-binding (G) proteins regulate the flow of information in cellular signaling pathways by alternating between a GTP-bound "active" state and a GDP-bound "inactive" state. Cdc42, a member of the Rho family of Ras-related small G-proteins, plays key roles in the regulation of cell shape, motility, and growth. Here we describe the high resolution x-ray crystal structure for Cdc42 bound to the GTP analog guanylyl beta,gamma-methylene-diphosphonate (GMP-PCP) (i.e. the presumed signaling-active state) and show that it is virtually identical to the structures for the signaling-inactive, GDP-bound form of the protein, contrary to what has been reported for Ras and other G-proteins. Especially surprising was that the GMP-PCP- and GDP-bound forms of Cdc42 did not show detectable differences in their Switch I and Switch II loops. Fluorescence studies using a Cdc42 mutant in which a tryptophan residue was introduced at position 32 of Switch I also showed that there was little difference in the Switch I conformation between the GDP- and GMP-PCP-bound states (i.e. < 10%), which again differed from Ras where much larger changes in Trp-32 fluorescence were observed when comparing these two nucleotide-bound states (> 30%). However, the binding of an effector protein induced significant changes in the Trp-32 emission specifically from GMP-PCP-bound Cdc42, as well as in the phosphate resonances for GTP bound to this G-protein as indicated in NMR studies. An examination of the available structures for Cdc42 complexed to different effector proteins, versus the x-ray crystal structure for GMP-PCP-bound Cdc42, provides a possible explanation for how effectors can distinguish between the GTP- and GDP-bound forms of this G-protein and ensure that the necessary conformational changes for signal propagation occur.	[Phillips, Matthew J.; Chan, Britton; Ramachandran, Sekar; Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Calero, Guillermo] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Cornell University; Cornell University; Stanford University	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA.	rac1@cornell.edu	Ramachandran, Sekar/AAP-2287-2020	Ramachandran, Sekar/0000-0002-2243-1368	NIGMS NIH HHS [GM40654, GM47458, R01 GM047458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654, R01GM047458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; Dias SMG, 2007, BIOCHEMISTRY-US, V46, P6547, DOI 10.1021/bi700035p; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Feltham JL, 1997, BIOCHEMISTRY-US, V36, P8755, DOI 10.1021/bi970694x; Garrard SM, 2003, EMBO J, V22, P1125, DOI 10.1093/emboj/cdg110; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Gizachew D, 2000, BIOCHEMISTRY-US, V39, P3963, DOI 10.1021/bi992646d; Gladfelter AS, 2001, MOL BIOL CELL, V12, P1239, DOI 10.1091/mbc.12.5.1239; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; HART MJ, 1991, J BIOL CHEM, V266, P20840; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Loh AP, 1999, BIOCHEMISTRY-US, V38, P12547, DOI 10.1021/bi9913707; Majumdar S, 2006, J BIOL CHEM, V281, P9219, DOI 10.1074/jbc.M513837200; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; RESLAND H, 1995, BIOCHEMISTRY-US, V34, P593; Rudolph MG, 1999, PROTEIN SCI, V8, P778; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Spoerner M, 2005, BIOCHEMISTRY-US, V44, P2225, DOI 10.1021/bi0488000; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Stumber M, 2002, J MOL BIOL, V323, P899, DOI 10.1016/S0022-2836(02)01010-0; Sydor JR, 1998, BIOCHEMISTRY-US, V37, P14292, DOI 10.1021/bi980764f; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Whitehead IP, 1997, BIOCHIM BIOPHYS ACTA, V1332, P1; Wilson KF, 2000, J BIOL CHEM, V275, P37307, DOI 10.1074/jbc.C000482200; Wittinghofer A, 1996, TRENDS BIOCHEM SCI, V21, P488, DOI 10.1016/S0968-0004(96)10064-5; Ye M, 2005, J BIOL CHEM, V280, P31267, DOI 10.1074/jbc.M505503200	50	39	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14153	14164		10.1074/jbc.M706271200	http://dx.doi.org/10.1074/jbc.M706271200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348980	Green Published, hybrid			2022-12-25	WOS:000255728200069
J	Paulsen, FP; Woon, CW; Varoga, D; Jansen, A; Garreis, F; Jager, K; Amm, M; Podolsky, DK; Steven, P; Barker, NP; Sel, S				Paulsen, Friedrich P.; Woon, Chee-Wai; Varoga, Deike; Jansen, Anne; Garreis, Fabian; Jaeger, Kristin; Amm, Marita; Podolsky, Daniel K.; Steven, Philipp; Barker, Nicholas P.; Sel, Saadettin			Intestinal trefoil factor/TFF3 promotes re-epithelialization of corneal wounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; EPITHELIAL-CELLS; TFF PEPTIDES; IMMUNE-RESPONSE; MIGRATION; MAINTENANCE; RESTITUTION	Disorders of wound healing characterized by impaired or delayed re-epithelialization are a serious medical problem. These conditions affect many tissues, are painful, and are difficult to treat. In this study using cornea as a model, we demonstrate the importance of trefoil factor 3 (TFF3, also known as intestinal trefoil factor) in re-epithelialization of wounds. In two different models of corneal wound healing, alkali- and laser-induced corneal wounding, we analyzed the wound healing process in in vivo as well as in combined in vivo/in vitro model in wild type (Tff3(+/+)) and Tff3-deficient (Tff3(-/-)) mice. Furthermore, we topically applied different concentrations of recombinant human TFF3 (rTFF3) peptide on the wounded cornea to determine the efficacy of rTFF3 on corneal wound healing. We found that Tff3 peptide is not expressed in intact corneal epithelium, but its expression is extensively up-regulated after epithelial injury. Re-epithelialization of corneal wounds in Tff3(-/-) mice is significantly prolonged in comparison to Tff3(-/-) mice. In addition, exogenous application of rTFF3 to the alkali- induced corneal wounds accelerates significantly in in vivo and in combined in vivo/in vitro model wound healing in Tff3(+/+) and Tff3(-/-) mice. These findings reveal a pivotal role for Tff3 in corneal wound healing mechanism and have broad implications for developing novel therapeutic strategies for treating nonhealing wounds.	[Paulsen, Friedrich P.; Garreis, Fabian; Jaeger, Kristin] Univ Halle Wittenberg, Dept Anat & Cell Biol, D-06097 Halle, Germany; [Varoga, Deike; Jansen, Anne] Univ Kiel, Inst Anat, D-24098 Kiel, Germany; [Woon, Chee-Wai; Barker, Nicholas P.] Gl Co Inc, Framingham, MA 01701 USA; [Podolsky, Daniel K.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Steven, Philipp] Med Univ Lubeck, Dept Ophthalmol, D-23538 Lubeck, Germany	Martin Luther University Halle Wittenberg; University of Kiel; Harvard University; Massachusetts General Hospital; University of Lubeck	Paulsen, FP (corresponding author), Univ Halle Wittenberg, Dept Anat & Cell Biol, Grosse Steinstr 52, D-06097 Halle, Germany.	friedrich.paulsen@medizin.uni-halle.de		Steven, Philipp/0000-0001-6892-3619; Paulsen, Friedrich/0000-0002-0527-0953; Sel, Prof. Dr. med. Saadettin/0000-0003-3307-3305	NIDDK NIH HHS [DK46906] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046906] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P489, DOI 10.1053/gast.1996.v110.pm8566596; Baus-Loncar M, 2005, CELL MOL LIFE SCI, V62, P2947, DOI 10.1007/s00018-005-5483-7; Blin N, 2005, CELL MOL LIFE SCI, V62, P2907, DOI 10.1007/s00018-005-5477-5; BREITSCHOPF H, 1992, ACTA NEUROPATHOL, V84, P581; Chwieralski CE, 2004, AM J RESP CELL MOL, V31, P528, DOI 10.1165/rcmb.2003-0433OC; Cook GA, 1999, FEBS LETT, V456, P155, DOI 10.1016/S0014-5793(99)00940-0; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Durer U, 2007, CELL PHYSIOL BIOCHEM, V20, P329, DOI 10.1159/000107519; Emami S, 2001, FASEB J, V15, P351, DOI 10.1096/fj.00-0355com; Goke MN, 2001, EXP CELL RES, V264, P337, DOI 10.1006/excr.2000.5116; Hoffmann W, 2005, CELL MOL LIFE SCI, V62, P2932, DOI 10.1007/s00018-005-5481-9; Ihanamaki T, 2004, PROG RETIN EYE RES, V23, P403, DOI 10.1016/j.preteyeres.2004.04.002; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Kinoshita S, 2001, PROG RETIN EYE RES, V20, P639, DOI 10.1016/S1350-9462(01)00007-6; Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008; Krachmer JH, 1997, CORNEA; Kuo Irene C, 2004, Curr Opin Ophthalmol, V15, P311, DOI 10.1097/00055735-200408000-00006; Lalani EN, 1999, LAB INVEST, V79, P537; Langer G, 1999, INVEST OPHTH VIS SCI, V40, P2220; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; Matsumoto K, 2005, CORNEA, V24, pS43, DOI 10.1097/01.ico.0000178737.35297.d4; Oertel M, 2001, AM J RESP CELL MOL, V25, P418, DOI 10.1165/ajrcmb.25.4.4429; Otto W, 2005, CELL MOL LIFE SCI, V62, P2939, DOI 10.1007/s00018-005-5482-8; Paulsen FP, 2002, INVEST OPHTH VIS SCI, V43, P3359; Paulsen FP, 2006, PROG HISTOCHEM CYTO, V41, P1, DOI 10.1016/j.proghi.2006.03.001; Steven P, 2004, PEPTIDES, V25, P819, DOI 10.1016/j.peptides.2004.01.023; Taupin DR, 2000, P NATL ACAD SCI USA, V97, P799, DOI 10.1073/pnas.97.2.799; Thim L, 2002, EUR J CLIN INVEST, V32, P519, DOI 10.1046/j.1365-2362.2002.01014.x; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Williams GR, 1997, VIRCHOWS ARCH, V431, P299, DOI 10.1007/s004280050102; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8	31	54	57	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13418	13427		10.1074/jbc.M800177200	http://dx.doi.org/10.1074/jbc.M800177200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326859	Green Published, hybrid			2022-12-25	WOS:000255499800081
J	Zhang, Y; Yuan, F; Wang, D; Gu, L; Li, GM				Zhang, Yanbin; Yuan, Fenghua; Wang, Daojing; Gu, Liya; Li, Guo-Min			Identification of regulatory factor X as a novel mismatch repair stimulatory factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARE LYMPHOCYTE SYNDROME; HUMAN EXONUCLEASE-I; SYSTEM; DEFICIENCY; COMPLEX; RECONSTITUTION; RECOMBINATION; EXPRESSION; EXCISION; CELLS	This report describes the identification and purification of a novel mismatch repair stimulatory factor from HeLa cell extracts. This activity copurifies with a proliferating cell nuclear antigen-dependent 5' --> 33' DNA excision activity during several purification steps but is resolved from the excision activity during gel filtration chromatography using Sephacryl S-300. After purification to near homogeneity, the stimulatory factor is associated with three polypeptides with apparent molecular masses of 68, 36, and 30 kDa. Peptide sequencing analysis by tandem mass spectrometry identified the stimulatory factor as the heterotrimeric regulatory factor X (RFX) complex, which regulates transcription of the class II major histocompatibility complex by facilitating histone acetylation and is defective in the human hereditary immunodeficiency syndrome called bare lymphocyte syndrome. This conclusion was confirmed by the facts that purified recombinant RFX stimulates mismatch repair in an in vitro reconstituted mismatch repair system and that depletion of RFX from nuclear extracts or RFX knockdown in cells reduces mismatch repair activity. As expected, RFX knockdown cells display instability in microsatellite sequences. The possible role of RFX in human MMR repair is discussed.	[Zhang, Yanbin; Yuan, Fenghua; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Dept Toxicol, Lexington, KY 40536 USA; [Wang, Daojing] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	University of Kentucky; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Li, GM (corresponding author), Univ Kentucky, Coll Med, Dept Toxicol, 1095 VA Dr, Lexington, KY 40536 USA.	gmli@uky.edu	Zhang, Yanbin/F-2998-2011; Yuan, Fenghua/F-8736-2011; Li, Guo-Min/I-5016-2014	Zhang, Yanbin/0000-0002-7263-5510; Li, Guo-Min/0000-0002-9842-4578	NATIONAL CANCER INSTITUTE [R01CA115942, R01CA104333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072756] Funding Source: NIH RePORTER; NCI NIH HHS [CA115942, CA104333] Funding Source: Medline; NIGMS NIH HHS [GM072756] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Carmell MA, 2003, NAT STRUCT BIOL, V10, P91, DOI 10.1038/nsb896; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; DeSandro A, 1999, AM J HUM GENET, V65, P279, DOI 10.1086/302519; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Elhasid R, 1996, BLOOD REV, V10, P242, DOI 10.1016/S0268-960X(96)90008-9; Garvie CW, 2007, BIOCHEMISTRY-US, V46, P1597, DOI 10.1021/bi6023868; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Gu LY, 2002, NUCLEIC ACIDS RES, V30, P2758, DOI 10.1093/nar/gkf410; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Mudhasani R, 2005, MOL IMMUNOL, V42, P673, DOI 10.1016/j.molimm.2004.09.021; Nagarajan UM, 1999, IMMUNITY, V10, P153, DOI 10.1016/S1074-7613(00)80016-3; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Schmutte C, 1998, CANCER RES, V58, P4537; Tishkoff DX, 1998, CANCER RES, V58, P5027; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	27	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12730	12735		10.1074/jbc.M800460200	http://dx.doi.org/10.1074/jbc.M800460200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18319249	Green Published, hybrid			2022-12-25	WOS:000255499800008
J	Jeon, D; Song, I; Guido, W; Kim, K; Kim, E; Oh, U; Shin, HS				Jeon, Daejong; Song, Inseon; Guido, William; Kim, Karam; Kim, Eunjoon; Oh, Uhtaek; Shin, Hee-Sup			Ablation of Ca2+ channel beta 3 subunit leads to enhanced N-methyl-D-aspartate receptor-dependent long term potentiation and improved long term memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; SYNAPTIC PLASTICITY; MICE LACKING; SIGNAL-TRANSDUCTION; SPATIAL MEMORY; MUTANT MICE; RAT-BRAIN; EXPRESSION; PROTEIN; DOMAIN	The beta subunits of voltage-dependent Ca2+ channels (VDCCs) have marked effects on the properties of the pore-forming alpha(1) subunits of VDCCs, including surface expression of channel complexes and modification of voltage-dependent kinetics. Among the four different beta subunits, the beta 3 subunit (Ca-v beta 3) is abundantly expressed in the hippocampus. However, the role of Ca-v beta 3 in hippocampal physiology and function in vivo has never been examined. Here, we investigated Ca-v beta 3-deficient mice for hippocampus-dependent learning and memory and synaptic plasticity at hippocampal CA3-CA1 synapses. Interestingly, the mutant mice exhibited enhanced performance in several hippocampus-dependent learning and memory tasks. However, electrophysiological studies revealed no alteration in the Ca2+ current density, the frequency and amplitude of miniature excitatory postsynaptic currents, and the basal synaptic transmission in the mutant hippocampus. On the other hand, however, N-methyl-D-aspartate receptor (NMDAR)-mediated synaptic currents and NMDAR-dependent long term potentiation were significantly increased in the mutant. Protein blot analysis showed a slight increase in the level of NMDAR-2B in the mutant hippocampus. Our results suggest a possibility that, unrelated to VDCCs regulation, Ca-v beta 3 negatively regulates the NMDAR activity in the hippocampus and thus activity-dependent synaptic plasticity and cognitive behaviors in the mouse.	[Jeon, Daejong; Oh, Uhtaek] Seoul Natl Univ, Natl Creat Res Initiat Ctr Sensory Res, Coll Pharm, Seoul 151742, South Korea; [Jeon, Daejong; Song, Inseon; Shin, Hee-Sup] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 136791, South Korea; [Guido, William] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Kim, Karam; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Virginia Commonwealth University; Korea Advanced Institute of Science & Technology (KAIST)	Oh, U (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr Sensory Res, Coll Pharm, Seoul 151742, South Korea.	utoh@plaza.snu.ac.kr; shin@kist.re.kr	Jeon, Daejong/C-1814-2011; Kim, Eunjoon/C-1566-2011; Kim, Karam/K-1412-2018	Kim, Karam/0000-0002-1886-5163; Jeon, Daejong/0000-0002-6998-7603	NATIONAL EYE INSTITUTE [R01EY012716] Funding Source: NIH RePORTER; NEI NIH HHS [EY12716, R01 EY012716] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Berggren PO, 2004, CELL, V119, P273, DOI 10.1016/j.cell.2004.09.033; BERROW NS, 1995, J PHYSIOL-LONDON, V482, P481, DOI 10.1113/jphysiol.1995.sp020534; Bichet D, 2000, BIOCHEM BIOPH RES CO, V277, P729, DOI 10.1006/bbrc.2000.3750; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bunsey M, 1995, HIPPOCAMPUS, V5, P546, DOI 10.1002/hipo.450050606; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cavus I, 1996, J NEUROPHYSIOL, V76, P3038, DOI 10.1152/jn.1996.76.5.3038; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Faber ESL, 2003, NEUROSCIENTIST, V9, P181, DOI 10.1177/1073858403009003011; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; Jeon D, 2007, GENES BRAIN BEHAV, V6, P375, DOI 10.1111/j.1601-183X.2006.00267.x; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; JEON D, 2007, IN PRESS CELL CALCIU; Kang YS, 2002, MOL CELLS, V14, P361; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Lu YM, 1997, J NEUROSCI, V17, P5196; Ludwig A, 1997, J NEUROSCI, V17, P1339; Mansuy IM, 1998, NEURON, V21, P257, DOI 10.1016/S0896-6273(00)80533-4; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Murakami M, 2002, J BIOL CHEM, V277, P40342, DOI 10.1074/jbc.M203425200; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Namkung Y, 1998, P NATL ACAD SCI USA, V95, P12010, DOI 10.1073/pnas.95.20.12010; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; Podhorna J, 2002, GENES BRAIN BEHAV, V1, P96, DOI 10.1034/j.1601-183X.2002.10205.x; REGEHR WG, 1994, J NEUROSCI, V14, P523; Restituito S, 2001, BIOPHYS J, V81, P89, DOI 10.1016/S0006-3495(01)75682-2; ROUSSET M, 2005, SCI STKE 2005; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Sheng M, 2000, J CELL SCI, V113, P1851; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shiraiwa T, 2007, BIOCHEM BIOPH RES CO, V355, P1019, DOI 10.1016/j.bbrc.2007.02.063; Song I, 2004, J NEUROSCI, V24, P5249, DOI 10.1523/JNEUROSCI.5546-03.2004; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vance CL, 1998, J BIOL CHEM, V273, P14495, DOI 10.1074/jbc.273.23.14495; Vnek N, 1996, J NEUROSCI, V16, P2780; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	57	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12093	12101		10.1074/jbc.M800816200	http://dx.doi.org/10.1074/jbc.M800816200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18339621	Green Published, hybrid			2022-12-25	WOS:000255340000025
J	Warthmann, N; Chen, H; Ossowski, S; Weigel, D; Herve, P				Warthmann, Norman; Chen, Hao; Ossowski, Stephan; Weigel, Detlef; Herve, Philippe			Highly Specific Gene Silencing by Artificial miRNAs in Rice	PLOS ONE			English	Article							CYTOCHROME-P450 MONOOXYGENASE; GREEN-REVOLUTION; MESSENGER-RNAS; MICRORNAS; EXPRESSION; ENCODES; INTERFERENCE; SUPPRESSION; EFFICIENT; CLEAVAGE	Background: Endogenous microRNAs (miRNAs) are potent negative regulators of gene expression in plants and animals. Artificial miRNAs (amiRNAs)-designed to target one or several genes of interest-provide a new and highly specific approach for effective post-transcriptional gene silencing (PTGS) in plants. Methodology: We devised an amiRNA-based strategy for both japonica and indica type strains of cultivated rice, Oryza sativa. Using an endogenous rice miRNA precursor and customized 21mers, we designed amiRNA constructs targeting three different genes (Pds, Spl11, and Eui1/CYP714D1). Upon constitutive expression of these amiRNAs in the varieties Nipponbare (japonica) and IR64 (indica), the targeted genes are down-regulated by amiRNA-guided cleavage of the transcripts, resulting in the expected mutant phenotypes. The effects are highly specific to the target gene, the transgenes are stably inherited and they remain effective in the progeny. Conclusion/Significance: Our results not only show that amiRNAs can efficiently trigger gene silencing in a monocot crop, but also that amiRNAs can effectively modulate agronomically important traits in varieties used in modern breeding programs. We provide all software tools and a protocol for the design of rice amiRNA constructs, which can be easily adapted to other crops. The approach is suited for candidate gene validation, comparative functional genomics between different varieties, and for improvement of agronomic performance and nutritional value.	[Warthmann, Norman; Ossowski, Stephan; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Chen, Hao; Herve, Philippe] Internatl Rice Res Inst IRRI, Manila, Philippines	Max Planck Society; CGIAR; International Rice Research Institute (IRRI)	Warthmann, N (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany.	norman@warthmann.com; p.herve@cgiar.org	Warthmann, Norman/E-1069-2011; Ding, Cheng-Qiang/B-6287-2011; Weigel, Detlef/C-1418-2008; Ossowski, Stephan/E-2139-2011; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022	Warthmann, Norman/0000-0002-1178-8409; Weigel, Detlef/0000-0002-2114-7963; Ossowski, Stephan/0000-0002-7416-9568; Weigel, Detlef/0000-0002-2114-7963	Max Planck Society; European Community FP6 IP SIROCCO [LSHG-CT-2006-037900]; USAID	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Community FP6 IP SIROCCO(European Commission); USAID(United States Agency for International Development (USAID))	This work was supported by the Max Planck Society, of which D.W. is a director, by European Community FP6 IP SIROCCO (contract LSHG-CT-2006-037900), and by the USAID-funded project entitled Development of rice biotechnology products for Asia: technical and pre-regulatory components at the International Rice Research Institute (IRRI) coordinated by P.H. and Gerard Barry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Asano K, 2007, BREEDING SCI, V57, P53, DOI 10.1270/jsbbs.57.53; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Harushima Y, 2002, GENETICS, V160, P313; Herve P, 2006, METH MOL B, V343, P213; Hiei Y, 2006, PLANT CELL TISS ORG, V85, P271, DOI 10.1007/s11240-005-9069-8; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kusaba M, 2004, CURR OPIN BIOTECH, V15, P139, DOI 10.1016/j.copbio.2004.02.004; Leshem Y, 2006, P NATL ACAD SCI USA, V103, P18008, DOI 10.1073/pnas.0604421103; Liu B, 2005, PLANT PHYSIOL, V139, P296, DOI 10.1104/pp.105.063420; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Luo AD, 2006, PLANT CELL PHYSIOL, V47, P181, DOI 10.1093/pcp/pci233; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Muckstein U, 2006, BIOINFORMATICS, V22, P1177, DOI 10.1093/bioinformatics/btl024; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu J, 2007, J VIROL, V81, P6690, DOI 10.1128/JVI.02457-06; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutger JN, 2005, CROP SCI, V45, P433, DOI 10.2135/cropsci2005.0433; Sallaud C, 2004, PLANT J, V39, P450, DOI 10.1111/j.1365-313X.2004.02145.x; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Sen GL, 2006, FASEB J, V20, P1293, DOI 10.1096/fj.06-6014rev; SINGH K, 1995, RICE GENET NEWSL, V12, P192; Small I, 2007, CURR OPIN BIOTECH, V18, P148, DOI 10.1016/j.copbio.2007.01.012; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Tang GL, 2007, METABOLOMICS, V3, P357, DOI 10.1007/s11306-007-0073-3; Watson JM, 2005, FEBS LETT, V579, P5982, DOI 10.1016/j.febslet.2005.08.014; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Xu P, 2006, PLANT PHYSIOL, V142, P429, DOI 10.1104/pp.106.083295; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	46	235	268	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1829	10.1371/journal.pone.0001829	http://dx.doi.org/10.1371/journal.pone.0001829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350165	gold, Green Published, Green Submitted			2022-12-25	WOS:000260762300031
J	Le Tortorec, A; Le Grand, R; Denis, H; Satie, AP; Mannioui, K; Roques, P; Maillard, A; Daniels, S; Jegou, B; Dejucq-Rainsford, N				Le Tortorec, Anna; Le Grand, Roger; Denis, Helene; Satie, Anne-Pascale; Mannioui, Karim; Roques, Pierre; Maillard, Anne; Daniels, Sylvanne; Jegou, Bernard; Dejucq-Rainsford, Nathalie			Infection of Semen-Producing Organs by SIV during the Acute and Chronic Stages of the Disease	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE-CHAIN-REACTION; MESSENGER-RNA EXPRESSION; MALE GENITAL-TRACT; WHITE BLOOD-CELLS; MEMORY T-CELLS; REVERSE-TRANSCRIPTASE; DRUG-RESISTANCE; SEMINAL PLASMA; IN-SITU	Background: Although indirect evidence suggests the male genital tract as a possible source of persistent HIV shedding in semen during antiretroviral therapy, this phenomenon is poorly understood due to the difficulty of sampling semen-producing organs in HIV+ asymptomatic individuals. Methodology/Principal Findings: Using a range of molecular and cell biological techniques, this study investigates SIV infection within reproductive organs of macaques during the acute and chronic stages of the disease. We demonstrate for the first time the presence of SIV in the testes, epididymides, prostate and seminal vesicles as early as 14 days post-inoculation. This infection persists throughout the chronic stage and positively correlates with blood viremia. The prostate and seminal vesicles appear to be the most efficiently infected reproductive organs, followed by the epididymides and testes. Within the male genital tract, mostly T lymphocytes and a small number of germ cells harbour SIV antigens and RNA. In contrast to the other organs studied, the testis does not display an immune response to the infection. Testosteronemia is transiently increased during the early phase of the infection but spermatogenesis remains unaffected. Conclusions/Significance: The present study reveals that SIV infection of the macaque male genital tract is an early event and that semen-producing organs display differential infection levels and immune responses. These results help elucidate the origin of HIV in semen and constitute an essential base to improving the design of antiretroviral therapies to eradicate virus from semen.	[Le Tortorec, Anna; Denis, Helene; Satie, Anne-Pascale; Daniels, Sylvanne; Jegou, Bernard; Dejucq-Rainsford, Nathalie] Univ Rennes 1, INSERM, U625, Grp Etud Reprod Chez Homme & Mammiferes,IFR 140, Rennes, France; [Le Grand, Roger; Mannioui, Karim; Roques, Pierre] DSV iMETI, Serv Immuno Virol, CEA, Fontenay Aux Roses, France; [Maillard, Anne] Ctr Hosp Univ Regional Pontchaillou, Unite Retrovirol, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CEA; CHU Rennes	Le Tortorec, A (corresponding author), Univ Rennes 1, INSERM, U625, Grp Etud Reprod Chez Homme & Mammiferes,IFR 140, Campus Beaulieu, Rennes, France.	nathalie.dejucq-rainsford@rennes.inserm.fr	Le Tortorec, Anna/J-5291-2015; DEJUCQ-RAINSFORD, Nathalie/I-2571-2015; Roques, Pierre/M-2212-2013; Jégou, Bernard/I-4742-2015	Roques, Pierre/0000-0003-1825-1054; JEGOU, Bernard/0000-0003-0623-3609; Daniels, Sylvanne/0000-0003-4300-5672; Dejucq-Rainsford, Nathalie/0000-0002-1788-2690	INSERM; ANRS; Sidaction; Region Bretagne; Ministere de l'Enseignement Superieur et de la Recherche; Organon stipend; European Microbicides Project	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANRS(ANRSFrench National Research Agency (ANR)); Sidaction; Region Bretagne(Region Bretagne); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Organon stipend; European Microbicides Project	Sources of support: INSERM, ANRS, Sidaction, Region Bretagne, Ministere de l'Enseignement Superieur et de la Recherche. Anna Le Tortorec has been successively a recipient of an Organon and an ANRS stipend. Helene Denis is supported by ANRS and Sidaction. Karim Mannioui is financed by the European Microbicides Project.	Abel K, 2005, J VIROL, V79, P12164, DOI 10.1128/JVI.79.19.12164-12172.2005; Abel K, 2001, CYTOKINE, V16, P191, DOI 10.1006/cyto.2001.0961; Alexander RB, 1998, UROLOGY, V52, P744, DOI 10.1016/S0090-4295(98)00390-2; Anderson DJ, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1647, DOI 10.1016/B978-012491543-5/50100-5; ANDERSON DJ, 1991, LANCET, V338, P573, DOI 10.1016/0140-6736(91)91139-L; ANDERSON RM, 1988, J ACQ IMMUN DEF SYND, V1, P241; ARANEO BA, 1991, BLOOD, V78, P688, DOI 10.1182/blood.V78.3.688.688; BEHRE HM, 1997, ANDROLOGY MALE REPRO, P163; Benlhassan-Chahour K, 2003, J VIROL, V77, P12479, DOI 10.1128/JVI.77.23.12479-12493.2003; Benveniste O, 1996, P NATL ACAD SCI USA, V93, P3658, DOI 10.1073/pnas.93.8.3658; Bladergroen BA, 2001, J IMMUNOL, V166, P3218, DOI 10.4049/jimmunol.166.5.3218; Bomsel M, 2003, NAT REV MOL CELL BIO, V4, P57, DOI 10.1038/nrm1005; Bourlet T, 2001, AIDS, V15, P284, DOI 10.1097/00002030-200101260-00025; BROGI A, 1995, J SUBMICR CYTOL PATH, V27, P565; Bujan L, 2004, AIDS, V18, P757, DOI 10.1097/00002030-200403260-00006; Bujan L, 2007, J ANDROL, V28, P444, DOI 10.2164/jandrol.106.001529; Byrn RA, 1997, LANCET, V350, P1141, DOI 10.1016/S0140-6736(97)24042-0; Castrillon DH, 2000, P NATL ACAD SCI USA, V97, P9585, DOI 10.1073/pnas.160274797; CHAKRABARTI L, 1991, AM J PATHOL, V139, P1273; Cheret A, 1996, AIDS RES HUM RETROV, V12, P1263, DOI 10.1089/aid.1996.12.1263; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Dai ZH, 2005, J IMMUNOL, V174, P1165, DOI 10.4049/jimmunol.174.3.1165; DASILVA M, 1990, AM J CLIN PATHOL, V93, P196, DOI 10.1093/ajcp/93.2.196; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; DECESARIS P, 1992, BIOCHEM BIOPH RES CO, V186, P1639; Decrion AZ, 2005, CURR HIV RES, V3, P243, DOI 10.2174/1570162054368057; Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001; Dejucq-Rainsford N, 2004, CURR PHARM DESIGN, V10, P557, DOI 10.2174/1381612043453225; Delezay O, 1997, AIDS, V11, P1311, DOI 10.1097/00002030-199711000-00004; Delwart EL, 1998, J VIROL, V72, P617, DOI 10.1128/JVI.72.1.617-623.1998; Dioszeghy V, 2006, J VIROL, V80, P236, DOI 10.1128/JVI.80.1.236-245.2006; ELDEMIRY MIM, 1985, BRIT J UROL, V57, P769, DOI 10.1111/j.1464-410X.1985.tb07051.x; Eron JJ, 1998, AIDS, V12, pF181, DOI 10.1097/00002030-199815000-00003; Eyre R C, 2000, Urology, V55, P591, DOI 10.1016/S0090-4295(99)00592-0; FANTINI J, 1993, P NATL ACAD SCI USA, V90, P2700, DOI 10.1073/pnas.90.7.2700; Filippini A, 2001, HUM REPROD UPDATE, V7, P444, DOI 10.1093/humupd/7.5.444; Garrido N, 2005, HUM REPROD, V20, P1028, DOI 10.1093/humrep/deh699; Ghosn J, 2004, AIDS, V18, P447, DOI 10.1097/00002030-200402200-00011; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Graziosi C, 1996, P NATL ACAD SCI USA, V93, P4386, DOI 10.1073/pnas.93.9.4386; Greenier JL, 2001, J VIROL, V75, P3753, DOI 10.1128/JVI.75.8.3753-3765.2001; Gupta P, 2000, J INFECT DIS, V182, P79, DOI 10.1086/315644; Haigwood NL, 2004, AIDS REV, V6, P187; Hales DB, 2002, J REPROD IMMUNOL, V57, P3, DOI 10.1016/S0165-0378(02)00020-7; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; Hofmann-Lehmann R, 2002, AIDS RES HUM RETROV, V18, P627, DOI 10.1089/088922202760019329; Hu LH, 2004, WORLD J GASTROENTERO, V10, P3514; Karlsson I, 2007, J VIROL, V81, P13456, DOI 10.1128/JVI.01619-07; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Kiessling AA, 1998, AIDS RES HUM RETROV, V14, pS33; Krieger JN, 1998, J UROLOGY, V159, P820, DOI 10.1016/S0022-5347(01)63742-X; KROODSMA KL, 1994, J INFECT DIS, V170, P1292, DOI 10.1093/infdis/170.5.1292; Lafeuillade Alain, 2002, HIV Clin Trials, V3, P27; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Liu XA, 2003, J VIROL, V77, P3470, DOI 10.1128/JVI.77.6.3470-3476.2003; Markowitz M, 2005, LANCET, V365, P1031, DOI 10.1016/S0140-6736(05)74227-6; Mayer KH, 1999, CLIN INFECT DIS, V28, P1252, DOI 10.1086/514775; MILLER CJ, 1994, LAB INVEST, V70, P255; Miller LJ, 2002, J UROLOGY, V167, P753, DOI 10.1016/S0022-5347(01)69139-0; Miyake A, 2006, J GEN VIROL, V87, P1311, DOI 10.1099/vir.0.81307-0; Moniuszko M, 2005, VIROLOGY, V333, P159, DOI 10.1016/j.virol.2005.01.003; Muciaccia B, 1998, FASEB J, V12, P151, DOI 10.1096/fasebj.12.2.151; Naito M, 2008, AM J REPROD IMMUNOL, V59, P55, DOI 10.1111/j.1600-0897.2007.00556.x; Nasr IW, 2005, J IMMUNOL, V174, P6161, DOI 10.4049/jimmunol.174.10.6161; Nicopoullos JDM, 2004, HUM REPROD, V19, P2289, DOI 10.1093/humrep/deh426; Nilsson J, 2007, AIDS, V21, P565, DOI 10.1097/QAD.0b013e3280117204; NUOVO GJ, 1994, AM J PATHOL, V144, P1142; O'Bryan MK, 2005, AM J PHYSIOL-REG I, V288, pR1744, DOI 10.1152/ajpregu.00651.2004; Paranjpe S, 2002, AIDS RES HUM RETROV, V18, P1271, DOI 10.1089/088922202320886316; Paulis Gianni, 2003, Arch Ital Urol Androl, V75, P179; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; Ping LH, 2000, J VIROL, V74, P8946, DOI 10.1128/JVI.74.19.8946-8952.2000; POLLANEN P, 1990, J REPROD IMMUNOL, V18, P51, DOI 10.1016/0165-0378(90)90024-Z; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puaux AL, 2004, VACCINE, V22, P3535, DOI 10.1016/j.vaccine.2004.03.044; PUDNEY J, 1991, AM J PATHOL, V139, P149; Pudney J, 1998, J REPROD IMMUNOL, V41, P105, DOI 10.1016/S0165-0378(98)00052-7; Pullium JK, 2001, J INFECT DIS, V183, P1023, DOI 10.1086/319293; Quayle AJ, 1997, J INFECT DIS, V176, P960, DOI 10.1086/516541; RIVENSON A, 1981, CELL MOL BIOL, V27, P49; Roulet V, 2006, HUM REPROD, V21, P1564, DOI 10.1093/humrep/del018; Roulet V, 2006, AM J PATHOL, V169, P2094, DOI 10.2353/ajpath.2006.060191; SETCHELL BP, 1988, ANATOMY VASCULATURE, P753; Shehu-Xhilaga M, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-7; Shevchuk MM, 1998, J REPROD IMMUNOL, V41, P69, DOI 10.1016/S0165-0378(98)00049-7; Shiboski SC, 1998, J ACQ IMMUN DEF SYND, V19, P527, DOI 10.1097/00042560-199812150-00013; Smith DM, 2004, AIDS, V18, P1600, DOI 10.1097/01.aids.0000131364.60081.01; Solas C, 2003, ANTIMICROB AGENTS CH, V47, P238, DOI 10.1128/AAC.47.1.238-243.2003; Staprans SI, 1999, J VIROL, V73, P4829, DOI 10.1128/JVI.73.6.4829-4839.1999; STREILEIN JW, 1995, SCIENCE, V270, P1158, DOI 10.1126/science.270.5239.1158; Suarez-Pinzon W, 2000, DIABETES, V49, P1810, DOI 10.2337/diabetes.49.11.1810; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Tachet A, 1999, AIDS, V13, P823, DOI 10.1097/00002030-199905070-00012; TERASAWA E, 1987, ENDOCRINOLOGY, V120, P2265, DOI 10.1210/endo-120-6-2265; Thiebot H, 2005, BLOOD, V105, P2403, DOI 10.1182/blood-2004-01-0025; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VERNAZZA PL, 1994, AIDS, V8, P1325, DOI 10.1097/00002030-199409000-00017; VICENZI E, 1994, CHEM-BIOL INTERACT, V91, P101, DOI 10.1016/0009-2797(94)90030-2; VIVIER E, 1993, J EXP MED, V178, P2023, DOI 10.1084/jem.178.6.2023; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Willey S, 2003, AIDS, V17, P183, DOI 10.1097/00002030-200301240-00007; WOLFF H, 1995, FERTIL STERIL, V63, P1143; WOLFF H, 1988, FERTIL STERIL, V49, P497; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502; Zhu TF, 1996, J VIROL, V70, P3098, DOI 10.1128/JVI.70.5.3098-3107.1996	109	45	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1792	10.1371/journal.pone.0001792	http://dx.doi.org/10.1371/journal.pone.0001792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18347738	Green Published, gold			2022-12-25	WOS:000260723000043
J	Song, XY; Li, F; Zhang, FH; Zhong, JH; Zhou, XF				Song, Xing-Yun; Li, Fang; Zhang, Feng-He; Zhong, Jin-Hua; Zhou, Xin-Fu			Peripherally-Derived BDNF Promotes Regeneration of Ascending Sensory Neurons after Spinal Cord Injury	PLOS ONE			English	Article								Background: The blood brain barrier (BBB) and truncated trkB receptor on astrocytes prevent the penetration of brain derived neurotrophic factor (BDNF) applied into the peripheral (PNS) and central nervous system (CNS) thus restrict its application in the treatment of nervous diseases. As BDNF is anterogradely transported by axons, we propose that peripherally derived and/or applied BDNF may act on the regeneration of central axons of ascending sensory neurons. Methodology/Principal Findings: The present study aimed to test the hypothesis by using conditioning lesion of the sciatic nerve as a model to increase the expression of endogenous BDNF in sensory neurons and by injecting exogenous BDNF into the peripheral nerve or tissues. Here we showed that most of regenerating sensory neurons expressed BDNF and p-CREB but not p75NTR. Conditioning-lesion induced regeneration of ascending sensory neuron and the increase in the number of p-Erk positive and GAP-43 positive neurons was blocked by the injection of the BDNF antiserum in the periphery. Enhanced neurite outgrowth of dorsal root ganglia (DRG) neurons in vitro by conditioning lesion was also inhibited by the neutralization with the BDNF antiserum. The delivery of exogenous BDNF into the sciatic nerve or the footpad significantly increased the number of regenerating DRG neurons and regenerating sensory axons in the injured spinal cord. In a contusion injury model, an injection of BDNF into the footpad promoted recovery of motor functions. Conclusions/Significance: Our data suggest that endogenous BDNF in DRG and spinal cord is required for the enhanced regeneration of ascending sensory neurons after conditioning lesion of sciatic nerve and peripherally applied BDNF may have therapeutic effects on the spinal cord injury.	[Song, Xing-Yun; Li, Fang; Zhang, Feng-He; Zhong, Jin-Hua; Zhou, Xin-Fu] Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia; [Li, Fang] Central South Univ, Xiangya Sch Med, Dept Anat & Neurobiol, Changsha, Peoples R China	Flinders University South Australia; Central South University	Song, XY (corresponding author), Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia.	xin-fu.zhou@flinders.edu.au	Zhou, Xiaofang/C-6169-2013; zhou, xin-fu/G-6643-2011; zhou, xin-fu/F-4119-2013	Zhou, Xiaofang/0000-0001-6343-1455; zhou, xin-fu/0000-0002-8687-0175	NHMRC [375109]; Postgraduate Scholarship from Flinders University	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Postgraduate Scholarship from Flinders University	This work was supported by NHMRC grant (375109). XYS is supported by Postgraduate Scholarship from Flinders University. All authors claim no financial conflict of interest.	ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Andersen LB, 1999, EXP NEUROL, V155, P157, DOI 10.1006/exnr.1998.6903; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BIFFO S, 1995, DEVELOPMENT, V121, P2461; Blesch A, 2007, J NEUROSCI, V27, P10535, DOI 10.1523/JNEUROSCI.1903-07.2007; Bradbury EJ, 1998, EUR J NEUROSCI, V10, P3058, DOI 10.1046/j.1460-9568.1998.00307.x; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; Bradbury EJ, 2000, TRENDS PHARMACOL SCI, V21, P389, DOI 10.1016/S0165-6147(00)01536-4; Butowt R, 2005, MOL CELL NEUROSCI, V29, P11, DOI 10.1016/j.mcn.2005.02.004; Cafferty WBJ, 2001, J NEUROSCI, V21, P7161, DOI 10.1523/JNEUROSCI.21-18-07161.2001; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; Cao ZX, 2006, J NEUROSCI, V26, P5565, DOI 10.1523/JNEUROSCI.0815-06.2006; CHONG MS, 1994, J NEUROSCI, V14, P4375; Curtis R, 1998, MOL CELL NEUROSCI, V12, P105, DOI 10.1006/mcne.1998.0704; Deng YS, 1999, NEUROTOX RES, V1, P311, DOI 10.1007/BF03033260; Deng YS, 2000, EXP NEUROL, V164, P344, DOI 10.1006/exnr.2000.7432; Farhadi HF, 2000, J NEUROSCI, V20, P4059; FOSTER E, 1994, BRAIN RES, V659, P267, DOI 10.1016/0006-8993(94)90891-5; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gao Y, 2003, J NEUROSCI, V23, P11770; Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298; Hennigan A, 2007, BIOCHEM SOC T, V35, P424, DOI 10.1042/BST0350424; Hu P, 2003, J NEUROSCI, V23, P10559; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ibanez CF, 2007, NEURON, V54, P673, DOI 10.1016/j.neuron.2007.05.023; Jin Y, 2000, NEUROREHAB NEURAL RE, V14, P311, DOI 10.1177/154596830001400407; KODA M, EUROPEAN SPINE J; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Lee SE, 1998, BRAIN RES, V796, P99, DOI 10.1016/S0006-8993(98)00335-7; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Lever IJ, 2001, J NEUROSCI, V21, P4469, DOI 10.1523/JNEUROSCI.21-12-04469.2001; Li L, 2006, NEUROTOX RES, V9, P269, DOI 10.1007/BF03033317; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Liu Y, 1999, J NEUROSCI, V19, P4370; MCQUARRIE IG, 1973, ARCH NEUROL-CHICAGO, V29, P53, DOI 10.1001/archneur.1973.00490250071008; MCQUARRIE IG, 1978, BRAIN RES, V141, P21, DOI 10.1016/0006-8993(78)90614-5; Menei P, 1998, EUR J NEUROSCI, V10, P607, DOI 10.1046/j.1460-9568.1998.00071.x; Michael GJ, 1999, EUR J NEUROSCI, V11, P3539, DOI 10.1046/j.1460-9568.1999.00767.x; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Mu JS, 1999, BRAIN RES, V835, P259, DOI 10.1016/S0006-8993(99)01592-9; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Obata K, 2003, J NEUROSCI, V23, P4117, DOI 10.1523/jneurosci.23-10-04117.2003; Pezet S, 2004, EXPERT OPIN THER TAR, V8, P391, DOI 10.1517/14728222.8.5.391; Puigdellivol-Sanchez A, 2002, J NEUROSCI METH, V115, P115, DOI 10.1016/S0165-0270(01)00532-5; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Ramer LM, 2007, J NEUROSCI, V27, P5812, DOI 10.1523/JNEUROSCI.0491-07.2007; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RICHARDSON PM, 1986, J NEUROCYTOL, V15, P585, DOI 10.1007/BF01611859; RICHARDSON PM, 1987, BRAIN RES, V411, P406, DOI 10.1016/0006-8993(87)91096-1; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Sasaki M, 2006, GLIA, V53, P352, DOI 10.1002/glia.20285; SCHREYER DJ, 1991, J NEUROSCI, V11, P3738; SEBERT ME, 1993, J NEUROSCI RES, V36, P357, DOI 10.1002/jnr.490360402; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Spencer T, 2003, CURR OPIN NEUROBIOL, V13, P133, DOI 10.1016/S0959-4388(03)00012-6; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Tomita K, 2007, GLIA, V55, P1199, DOI 10.1002/glia.20533; Tonra JR, 1998, J NEUROSCI, V18, P4374; von Bartheld CS, 2004, J NEUROBIOL, V58, P295, DOI 10.1002/neu.10315; Wang H, 2006, EUR J NEUROSCI, V24, P2444, DOI 10.1111/j.1460-9568.2006.05138.x; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Young KM, 2007, J NEUROSCI, V27, P5146, DOI 10.1523/JNEUROSCI.0654-07.2007; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x; Zhang SH, 1999, J NEUROSCI METH, V89, P69, DOI 10.1016/S0165-0270(99)00038-2; Zhou XF, 2005, NEUROSCIENCE, V132, P591, DOI 10.1016/j.neuroscience.2004.12.034; Zhou XF, 1999, NEUROSCIENCE, V92, P841, DOI 10.1016/S0306-4522(99)00027-5; Zhou XF, 2000, EUR J NEUROSCI, V12, P100, DOI 10.1046/j.1460-9568.2000.00884.x; Zhou XF, 1996, J NEUROSCI, V16, P2901; Zhou XF, 1996, NEUROSCIENCE, V74, P945, DOI 10.1016/S0306-4522(96)00237-0; Zhou XF, 2007, J NEUROSCI RES, V85, P1601, DOI 10.1002/jnr.21220	78	79	84	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1707	10.1371/journal.pone.0001707	http://dx.doi.org/10.1371/journal.pone.0001707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320028	Green Published, gold, Green Submitted			2022-12-25	WOS:000260586600003
J	Van der Velden, J; Zheng, Y; Patullo, BW; Macmillan, DL				Van der Velden, Joanne; Zheng, Ying; Patullo, Blair W.; Macmillan, David L.			Crayfish Recognize the Faces of Fight Opponents	PLOS ONE			English	Article								The capacity to associate stimuli underlies many cognitive abilities, including recognition, in humans and other animals. Vertebrates process different categories of information separately and then reassemble the distilled information for unique identification, storage and recall. Invertebrates have fewer neural networks and fewer neural processing options so study of their behavior may reveal underlying mechanisms still not fully understood for any animal. Some invertebrates form complex social colonies and are capable of visual memory-bees and wasps, for example. This ability would not be predicted in species that interact in random pairs without strong social cohesion; for example, crayfish. They have chemical memory but the extent to which they remember visual features is unknown. Here we demonstrate that the crayfish Cherax destructor is capable of visual recognition of individuals. The simplicity of their interactions allowed us to examine the behavior and some characteristics of the visual features involved. We showed that facial features are learned during face-to-face fights, that highly variable cues are used, that the type of variability is important, and that the learning is context-dependent. We also tested whether it is possible to engineer false identifications and for animals to distinguish between twin opponents.	[Van der Velden, Joanne; Zheng, Ying; Patullo, Blair W.; Macmillan, David L.] Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia	University of Melbourne	Van der Velden, J (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic 3010, Australia.	b.patullo@zoology.unimelb.edu.au			Australian Research Council	Australian Research Council(Australian Research Council)	Funding support was from the Australian Research Council discovery project scheme to D.L.M.	Atema Jelle, 1995, P313, DOI 10.1016/B978-012247570-2/50035-9; Barrett L, 2007, PHILOS T R SOC B, V362, P561, DOI 10.1098/rstb.2006.1995; Basil J, 2000, ETHOLOGY, V106, P247, DOI 10.1046/j.1439-0310.2000.00524.x; BERRILL M, 1975, B MAR SCI, V25, P515; BOVBJERG RV, 1953, PHYSIOL ZOOL, V26, P173, DOI 10.1086/physzool.26.2.30154514; BREITHAUPT T, 1993, BIOL BULL, V185, P318, DOI 10.1086/BBLv185n2p318; Breithaupt T, 2002, J EXP BIOL, V205, P1221; BRUSKI CA, 1987, BEHAVIOUR, V103, P83, DOI 10.1163/156853987X00288; CALDWELL RL, 1985, ANIM BEHAV, V33, P101, DOI 10.1016/S0003-3472(85)80123-8; Chiao CC, 2000, BRAIN BEHAV EVOLUT, V56, P107, DOI 10.1159/000006681; COURCHESNE E, 1971, Z VERGL PHYSIOL, V74, P32; Crook R, 2004, MAR FRESHW BEHAV PHY, V37, P271, DOI 10.1080/10236240400016595; Daws AG, 2002, MAR FRESHW BEHAV PHY, V35, P139, DOI 10.1080/1023624021000014725; Detto T, 2006, P ROY SOC B-BIOL SCI, V273, P1661, DOI 10.1098/rspb.2006.3503; Diaz ER, 2004, BIOL BULL-US, V206, P134, DOI 10.2307/1543637; DUNHAM DW, 1978, MAR BEHAV PHYSIOL, V5, P137, DOI 10.1080/10236247809378529; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; Fisher J., 1954, P71; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gherardi F, 2005, ETHOLOGY, V111, P271, DOI 10.1111/j.1439-0310.2004.01060.x; Gherardi F, 2004, BEHAV ECOL SOCIOBIOL, V55, P524, DOI 10.1007/s00265-003-0734-9; Gherardi F, 2003, CAN J ZOOL, V81, P1269, DOI 10.1139/Z03-107; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Goessmann C, 2000, BEHAV ECOL SOCIOBIOL, V48, P418, DOI 10.1007/s002650000222; Griffiths SW, 2004, P ROY SOC B-BIOL SCI, V271, P695, DOI 10.1098/rspb.2003.2648; HAZLETT BA, 1972, ANIM BEHAV, V20, P101, DOI 10.1016/S0003-3472(72)80178-7; HAZLETT BA, 1969, NATURE, V222, P268, DOI 10.1038/222268a0; Hazlett BA, 2007, MAR FRESHW BEHAV PHY, V40, P257, DOI 10.1080/10236240701562412; HEMSWORTH R, 2007, BIOL B IN PRESS; Herath P, 2001, HUM BRAIN MAPP, V12, P110, DOI 10.1002/1097-0193(200102)12:2<110::AID-HBM1008>3.0.CO;2-0; HERRNKIN.W, 1969, SCIENCE, V164, P1425, DOI 10.1126/science.164.3886.1425; HILL H, 1995, P ROY SOC B-BIOL SCI, V261, P367, DOI 10.1098/rspb.1995.0161; Horridge A, 2005, PHYSIOL ENTOMOL, V30, P2, DOI 10.1111/j.0307-6962.2005.00425.x; JOHNSON VR, 1977, ANIM BEHAV, V25, P418, DOI 10.1016/0003-3472(77)90017-3; Kaczer L, 2007, NEUROBIOL LEARN MEM, V87, P140, DOI 10.1016/j.nlm.2006.08.002; Karavanich C, 1998, ANIM BEHAV, V56, P1553, DOI 10.1006/anbe.1998.0914; Kelly S, 1999, MAR FRESHWATER RES, V50, P409, DOI 10.1071/MF98126; KENNEDY D, 1961, J GEN PHYSIOL, V44, P1089, DOI 10.1085/jgp.44.6.1089; Kilner R, 1998, ANIM BEHAV, V56, P705, DOI 10.1006/anbe.1998.0785; Lake P.S., 1986, 87 AUSTR WAT RES COU; Marshall NJ, 1996, J COMP PHYSIOL A, V179, P473; Muller CA, 2007, P ROY SOC B-BIOL SCI, V274, P959, DOI 10.1098/rspb.2006.0222; Pavey CR, 1996, J ZOOL, V238, P445, DOI 10.1111/j.1469-7998.1996.tb05405.x; Riesenhuber M, 2004, P ROY SOC B-BIOL SCI, V271, pS448, DOI 10.1098/rsbl.2004.0216; Rufino MM, 2001, J CRUSTACEAN BIOL, V21, P388, DOI 10.1651/0278-0372(2001)021[0388:BIRILD]2.0.CO;2; Schneider RAZ, 2001, BEHAVIOUR, V138, P137, DOI 10.1163/15685390151074348; SEIBT U, 1972, NATURWISSENSCHAFTEN, V59, P40, DOI 10.1007/BF00594633; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Sokal RR, 1995, BIOMETRY; SPANIER E, 1992, J EXP MAR BIOL ECOL, V164, P103, DOI 10.1016/0022-0981(92)90139-2; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tibbetts EA, 2002, P ROY SOC B-BIOL SCI, V269, P1423, DOI 10.1098/rspb.2002.2031; VANNINI M, 1981, MAR BEHAV PHYSIOL, V8, P13, DOI 10.1080/10236248109386999; Ward J, 2004, MAR FRESHW BEHAV PHY, V37, P35, DOI 10.1080/1023624042000199908; WINSTON ML, 1978, ANIM BEHAV, V26, P184, DOI 10.1016/0003-3472(78)90018-0; YDENBERG RC, 1988, ANIM BEHAV, V36, P343, DOI 10.1016/S0003-3472(88)80004-6; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103; ZIMMERFAUST RK, 1987, J EXP MAR BIOL ECOL, V105, P57, DOI 10.1016/S0022-0981(87)80029-1	60	54	54	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1695	10.1371/journal.pone.0001695	http://dx.doi.org/10.1371/journal.pone.0001695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18305823	Green Published, Green Submitted, gold			2022-12-25	WOS:000260586500039
J	Deep, G; Oberlies, NH; Kroll, DJ; Agarwal, R				Deep, G.; Oberlies, N. H.; Kroll, D. J.; Agarwal, R.			Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway	ONCOGENE			English	Article						androgen receptor; prostate specific antigen; prostate cancer; isosilybin B	CANCER CELLS; FLAVONOID ANTIOXIDANT; INDUCED APOPTOSIS; SILYBUM-MARIANUM; P53 ACTIVATION; MILK THISTLE; G(1) ARREST; IN-VIVO; SILYMARIN; GROWTH	The identification and development of novel nontoxic phytochemicals that target androgen and androgen receptor (AR) signaling remains a priority for prostate cancer (PCA) control. In the present study, we assessed the antiandrogenic efficacy of isosilybin B employing human PCA LNCaP ( mutated AR), 22Rv1 ( mutated AR) and LAPC4 ( wild-type AR) cells. Isosilybin B (10-90 mu M) treatment decreased the AR and prostate specific antigen (PSA) levels in LNCaP, 22Rv1 and LAPC4 cells, but not in non-neoplastic human prostate epithelial PWR-1E cells. Isosilybin B treatment also inhibited synthetic androgen R1881-induced nuclear localization of AR, PSA expression and cell growth, and caused G(1) arrest. In mechanistic studies identifying AR degradation, isosilybin B caused increased phosphorylation of Akt (Ser-473 and Thr-308) and Mdm2 (Ser-166), which was linked with AR degradation as pretreatment with PI3K inhibitor (LY294002)-restored AR level. Further, overexpression of kinase-dead Akt largely reversed isosilybin B mediated-AR degradation suggesting a critical role of Akt in AR degradation. Antibody pull-down results also indicated that isosilybin B treatment enhances the formation of complex between Akt, Mdm2 and AR, which promotes phosphorylation-dependent AR ubiquitination and its degradation by proteasome. Together, present findings identify a novel mechanism for isosilybin B-mediated anticancer effects in human PCA cells.	[Deep, G.; Agarwal, R.] Univ Colorado, Sch Pharm, Dept Pharmaceut Sci, Denver, CO 80262 USA; [Oberlies, N. H.; Kroll, D. J.] Ctr Organ & Med Chem, Nat Prod Lab, Res Triangle Pk, NC USA; [Agarwal, R.] Univ Colorado, Ctr Canc, Denver, CO 80262 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver	Agarwal, R (corresponding author), Univ Colorado, Sch Pharm, Dept Pharmaceut Sci, 4200 E 9th St,Box C238, Denver, CO 80262 USA.	Rajesh.Agarwal@uchsc.edu	Deep, Gagan/H-1853-2012; Oberlies, Nicholas/D-8162-2011	Oberlies, Nicholas/0000-0002-0354-8464	NCI NIH HHS [R01 CA104286] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA104286] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bernard D, 2003, J CLIN INVEST, V112, P1724; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Cinar B, 2005, CANCER RES, V65, P2547, DOI 10.1158/0008-5472.CAN-04-3411; Davis-Searles PR, 2005, CANCER RES, V65, P4448, DOI 10.1158/0008-5472.CAN-04-4662; Deep G, 2006, ONCOGENE, V25, P1053, DOI 10.1038/sj.onc.1209146; Deep G, 2007, CARCINOGENESIS, V28, P1533, DOI 10.1093/carcin/bgm069; Dhanalakshmi S, 2005, J BIOL CHEM, V280, P20375, DOI 10.1074/jbc.M414640200; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kim NC, 2003, ORG BIOMOL CHEM, V1, P1684, DOI 10.1039/b300099k; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Lee DK, 2003, J CLIN ENDOCR METAB, V88, P4043, DOI 10.1210/jc.2003-030261; Lee HJ, 2003, CELL MOL LIFE SCI, V60, P1613, DOI 10.1007/s00018-003-2309-3; Liao ZM, 2005, PROSTATE, V64, P186, DOI 10.1002/pros.20224; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Mendoza N, 2002, CANCER RES, V62, P5485; Miyamoto H, 2005, MOL CARCINOGEN, V44, P1, DOI 10.1002/mc.20121; MULLER MM, 1989, NUCLEIC ACIDS RES, V17, P6420, DOI 10.1093/nar/17.15.6420; Nagabhushan M, 1996, CANCER RES, V56, P3042; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Paajarvi G, 2004, FASEB J, V18, P476, DOI 10.1096/fj.04-2745fje; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Pliskova M, 2005, TOXICOLOGY, V215, P80, DOI 10.1016/j.tox.2005.06.020; Reddy GPV, 2006, J CELL BIOCHEM, V98, P1408, DOI 10.1002/jcb.20927; Seidlova-Wuttke D, 2003, J STEROID BIOCHEM, V86, P179, DOI 10.1016/S0960-0760(03)00270-X; Sharifi Nima, 2006, Am J Ther, V13, P166, DOI 10.1097/00045391-200603000-00013; Singh RP, 2006, MOL CARCINOGEN, V45, P436, DOI 10.1002/mc.20223; Singh RP, 2002, ANTIOXID REDOX SIGN, V4, P655, DOI 10.1089/15230860260220166; Tong QS, 2003, CHINESE MED J-PEKING, V116, P1515; Wang L, 2004, J BIOL CHEM, V279, P32444, DOI 10.1074/jbc.M313963200; Wellington K, 2001, BIODRUGS, V15, P465, DOI 10.2165/00063030-200115070-00005; Wen Y, 2000, CANCER RES, V60, P6841; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zi XL, 1998, CLIN CANCER RES, V4, P1055; Zi ZL, 1999, P NATL ACAD SCI USA, V96, P7490, DOI 10.1073/pnas.96.13.7490	42	47	48	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2008	27	28					3986	3998		10.1038/onc.2008.45	http://dx.doi.org/10.1038/onc.2008.45			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	318JZ	18332867				2022-12-25	WOS:000257089000010
J	Bijli, KM; Fazal, F; Minhajuddin, M; Rahman, A				Bijli, Kaiser M.; Fazal, Fabeha; Minhajuddin, Mohd; Rahman, Arshad			Activation of Syk by protein kinase C-delta regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via tyrosine phosphorylation of RelA/p65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GENE-EXPRESSION; P65 SUBUNIT; ICAM-1 EXPRESSION; ALPHA KINASE; TNF-ALPHA; SRC; BETA; TRANSCRIPTION; ANTISENSE	Protein kinase C-delta (PKC-delta) plays a pivotal role in mediating thrombin-induced NF-kappa B activation and ICAM-1 expression in endothelial cells. However, the downstream mechanisms mediating its function are unclear. In this study, we show that PKC-delta-mediated activation of protein-tyrosine kinase Syk plays an important role in thrombin signaling of NF-kappa B activation and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells. Stimulation of human vascular endothelial cells with thrombin resulted in a time-dependent phosphorylation of Syk on tyrosine 525 and 526, an indication of Syk activation. Inhibition of PKC-delta by pharmacological and genetic approaches prevented Syk activation by thrombin. These results place Syk downstream of PKC-delta in transmitting thrombin-activated signaling in endothelial cells. Consistent with this, thrombin-induced NF-kappa B activity and ICAM-1 expression were prevented by the expression of a kinase-defective mutant or RNA interference knockdown of Syk. Similarly, inhibiting Syk also impaired NF-kappa B activity and ICAM-1 expression induced by a constitutively active mutant of PKC-delta. Analysis of the NF-kappa B pathway showed that Syk contributes to thrombin-induced NF-kappa B activation by controlling its transactivation potential and that this response is associated with tyrosine phosphorylation of RelA/p65. Thus, these data unveil a novel pathway in which Syk signals downstream of PKC-delta to mediate thrombin-induced ICAM-1 expression in endothelial cells by increasing transcriptional capacity of NF-kappa B via a mechanism that relies on tyrosine phosphorylation of RelA/p65.	Univ Rochester, Sch Med, Dept Pediat Neonatol, Lung Biol & Dis Program, Rochester, NY 14642 USA	University of Rochester	Rahman, A (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pediat, Box 850 601 Elmwood Ave, Rochester, NY 14642 USA.	arshad_rahman@urmc.rochester.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001247] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 67424] Funding Source: Medline; NIEHS NIH HHS [ES 01247] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Amos S, 2005, J BIOL CHEM, V280, P7729, DOI 10.1074/jbc.M409056200; Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Ashikawa K, 2002, J IMMUNOL, V169, P6490, DOI 10.4049/jimmunol.169.11.6490; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; BIJLI KM, 2007, AM J PHYSIOL, V292, P396; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen CC, 1998, J IMMUNOL, V161, P6206; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; COLLETT MS, 1979, J VIROL, V29, P770, DOI 10.1128/JVI.29.2.770-781.1979; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; DICKNEITE G, 1993, THROMB HAEMOSTASIS, V69, P98; DOERSCHUK CM, 2002, AM J RESP CELL MOL B, V23, P133; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Fan CG, 2003, J BIOL CHEM, V278, P2072, DOI 10.1074/jbc.M206718200; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Fenton J W 2nd, 1981, Ann N Y Acad Sci, V370, P468, DOI 10.1111/j.1749-6632.1981.tb29757.x; Fernandez R, 1998, J IMMUNOL, V160, P5154; Funakoshi-Tago M, 2005, J BIOCHEM, V137, P189, DOI 10.1093/jb/mvi018; GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huang WC, 2003, J IMMUNOL, V170, P4767, DOI 10.4049/jimmunol.170.9.4767; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Inatome R, 2001, BIOCHEM BIOPH RES CO, V286, P195, DOI 10.1006/bbrc.2001.5355; Kasper B, 2006, BLOOD, V107, P1768, DOI 10.1182/blood-2005-06-2501; Kettritz R, 2004, J BIOL CHEM, V279, P2657, DOI 10.1074/jbc.M309778200; Lin CH, 2006, J IMMUNOL, V177, P3427, DOI 10.4049/jimmunol.177.5.3427; Mahabeleshwar GH, 2003, J BIOL CHEM, V278, P52598, DOI 10.1074/jbc.M308941200; Mayo MW, 2001, METHOD ENZYMOL, V333, P73; Miah SMS, 2004, MOL CELL BIOL, V24, P71, DOI 10.1128/MCB.24.1.71-83.2004; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; MOYERS JS, 1993, MOL CELL BIOL, V13, P2391, DOI 10.1128/MCB.13.4.2391; Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681; Rahman A, 2004, AM J PHYSIOL-LUNG C, V287, pL1017, DOI 10.1152/ajplung.00072.2004; Rahman A, 1999, J IMMUNOL, V162, P5466; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Schymeinsky P, 2005, J CELL PHYSIOL, V204, P614, DOI 10.1002/jcp.20323; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHENOY S, 1992, P NATL ACAD SCI USA, V89, P7237, DOI 10.1073/pnas.89.15.7237; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Soh JW, 1999, MOL CELL BIOL, V19, P1313; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stenton GR, 2002, J IMMUNOL, V169, P1028, DOI 10.4049/jimmunol.169.2.1028; Stenton GR, 2000, J IMMUNOL, V164, P3790, DOI 10.4049/jimmunol.164.7.3790; Takada Y, 2004, J IMMUNOL, V173, P1066, DOI 10.4049/jimmunol.173.2.1066; Takada Y, 2003, J BIOL CHEM, V278, P24233, DOI 10.1074/jbc.M212389200; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Ulanova M, 2005, AM J PHYSIOL-LUNG C, V288, pL497, DOI 10.1152/ajplung.00246.2004; Vancurova I, 2001, J BIOL CHEM, V276, P19746, DOI 10.1074/jbc.M100234200; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Wang QD, 2003, J BIOL CHEM, V278, P51091, DOI 10.1074/jbc.M306541200; Waris G, 2003, J BIOL CHEM, V278, P40778, DOI 10.1074/jbc.M303248200; Wu SQ, 2005, AM J PHYSIOL-HEART C, V289, pH873, DOI 10.1152/ajpheart.00993.2004; Xu B, 2004, J BIOL CHEM, V279, P15954, DOI 10.1074/jbc.M400413200; Yanagi S, 2001, BLOOD, V98, P2869, DOI 10.1182/blood.V98.9.2869; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	68	43	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14674	14684		10.1074/jbc.M802094200	http://dx.doi.org/10.1074/jbc.M802094200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18362147	Green Published, hybrid			2022-12-25	WOS:000255941400056
J	Xu, Y; Ravid, K; Smith, BD				Xu, Yong; Ravid, Katya; Smith, Barbara D.			Major histocompatibility class II transactivator expression in smooth muscle cells from A2b adenosine receptor knock-out mice - Cross-talk between the adenosine and interferon-gamma signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN COL1A2 TRANSCRIPTION; CYCLIC-AMP; PROTEIN-KINASE; GENE-EXPRESSION; IFN-GAMMA; REGULATORY FACTOR; A(2B) ADENOSINE; BLOOD-PRESSURE; CIITA; INFLAMMATION	Atherosclerosis characterized by sustained inflammation and aberrant extracellular matrix alterations. Our previous investigation has defined major histocompatibility class II transactivator ( CIITA) as a key factor in mediating these two processes in smooth muscle cells. Here, we demonstrate that CIITA and major histocompatibility class II expression are elevated in interferon-gamma (IFN-gamma)-treated smooth muscle cells from A2b adenosine receptor ( A2bAR(-/-)) knock- out mice, as compared with wild type cells. An A2-type adenosine receptor agonist suppresses these effects of IFN-gamma in wild type cells, which can be blocked by an A2bAR-specific antagonist. We further identify that increased cellular cAMP levels are responsible for the down-regulation of CIITA expression and, hence, reduced IFN-gamma response as evidenced by the following data: 1) direct activation of adenylyl cyclase activity is both necessary and sufficient to suppress the IFN-gamma response; 2) inhibition of phosphodiesterase activity attenuates IFN-gamma induced transcription events; and 3) direct treatment with cAMP analog abrogates CIITA activation and IFN-gamma response. Therefore, our data establish possible crosstalk between the adenosine signaling through cAMP and IFN-gamma during regulation of CIITA expression.	[Xu, Yong; Ravid, Katya; Smith, Barbara D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Smith, BD (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St, Boston, MA 02118 USA.	smith@biochem.bumc.bu.edu		Ravid, Katya/0000-0002-9918-3024; Smith, Barbara/0000-0002-5375-7627	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068094, P01HL013262] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 68094, HL 013262-31] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKUTAGAWA H, 1994, HEMATOL PATHOL, V8, P85; Awad AS, 2006, AM J PHYSIOL-RENAL, V290, pF828, DOI 10.1152/ajprenal.00310.2005; BOUILLON M, 1992, INT J CANCER, V50, P281, DOI 10.1002/ijc.2910500219; Braun M, 1997, ARTERIOSCL THROM VAS, V17, P2568, DOI 10.1161/01.ATV.17.11.2568; Buttice G, 2006, CIRC RES, V98, P472, DOI 10.1161/01.RES.0000204725.46332.97; Chunn JL, 2006, AM J PHYSIOL-LUNG C, V290, pL579, DOI 10.1152/ajplung.00258.2005; DALY JW, 1983, CELL MOL NEUROBIOL, V3, P69, DOI 10.1007/BF00734999; Day YJ, 2005, J IMMUNOL, V174, P5040, DOI 10.4049/jimmunol.174.8.5040; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dubey RK, 2000, HYPERTENSION, V35, P267, DOI 10.1161/01.HYP.35.1.267; Emala CW, 1997, AM J PHYSIOL-LUNG C, V272, pL644, DOI 10.1152/ajplung.1997.272.4.L644; Fozard JR, 2002, EUR J PHARMACOL, V438, P183, DOI 10.1016/S0014-2999(02)01305-5; Gao ZH, 1999, J BIOL CHEM, V274, P5972, DOI 10.1074/jbc.274.9.5972; Giroux M, 2003, J IMMUNOL, V171, P4187, DOI 10.4049/jimmunol.171.8.4187; Hilaire CS, 2008, J CELL BIOCHEM, V103, P1962, DOI 10.1002/jcb.21586; Hofmann CS, 2005, J BIOL CHEM, V280, P7694, DOI 10.1074/jbc.M412501200; Hofmann CS, 2004, ARTERIOSCL THROM VAS, V24, P1608, DOI 10.1161/01.ATV.0000139010.71779.f3; Ivashkiv LB, 1996, J IMMUNOL, V157, P1415; Kalk P, 2007, BRIT J PHARMACOL, V151, P1025, DOI 10.1038/sj.bjp.0707319; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Krawczyk M, 2006, TISSUE ANTIGENS, V67, P183, DOI 10.1111/j.1399-0039.2006.00557.x; Lange-Sperandio B, 2005, NEPHRON EXP NEPHROL, V100, pE113, DOI 10.1159/000085057; Li GX, 2001, MOL CELL BIOL, V21, P4626, DOI 10.1128/MCB.21.14.4626-4635.2001; Lin HY, 1998, J IMMUNOL, V161, P843; Lochamy J, 2007, MOL IMMUNOL, V44, P837, DOI 10.1016/j.molimm.2006.04.004; LONDOS C, 1980, P NATL ACAD SCI-BIOL, V77, P2551, DOI 10.1073/pnas.77.5.2551; McPherson JA, 2001, ARTERIOSCL THROM VAS, V21, P791, DOI 10.1161/01.ATV.21.5.791; Mead JR, 2003, J BIOL CHEM, V278, P17741, DOI 10.1074/jbc.M301602200; Mohsenin A, 2007, AM J PHYSIOL-LUNG C, V293, pL753, DOI 10.1152/ajplung.00187.2007; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nikodemova M, 2007, J BIOL CHEM, V282, P15208, DOI 10.1074/jbc.M611907200; Odashima M, 2005, GASTROENTEROLOGY, V129, P26, DOI 10.1053/j.gastro.2005.05.032; Peirce SM, 2001, AM J PHYSIOL-HEART C, V281, pH67, DOI 10.1152/ajpheart.2001.281.1.H67; Ravid K, 1999, J CELL BIOCHEM, V75, P177, DOI 10.1002/(SICI)1097-4644(19991001)75:1<177::AID-JCB18>3.3.CO;2-N; Schulte G, 2003, EXP CELL RES, V290, P168, DOI 10.1016/S0014-4827(03)00324-0; STEIMLE V, 1995, GENE DEV, V9, P1021, DOI 10.1101/gad.9.9.1021; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Tosi G, 2002, EMBO J, V21, P5467, DOI 10.1093/emboj/cdf557; VANCALKER D, 1979, J NEUROCHEM, V33, P999, DOI 10.1111/j.1471-4159.1979.tb05236.x; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960; Xu Y, 2004, J BIOL CHEM, V279, P41319, DOI 10.1074/jbc.M404174200; Xu Y, 2003, J BIOL CHEM, V278, P49134, DOI 10.1074/jbc.M309003200; Xu Y, 2008, J BIOL CHEM, V283, P1243, DOI 10.1074/jbc.M707180200; Xu Y, 2007, J BIOL CHEM, V282, P26046, DOI 10.1074/jbc.M703652200; Xu Y, 2007, MOL IMMUNOL, V44, P1709, DOI 10.1016/j.molimm.2006.07.294; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933; Zhao ZH, 2000, BBA-MOL BASIS DIS, V1500, P280, DOI 10.1016/S0925-4439(99)00111-8; Zhu XS, 2001, MOL CELL BIOL, V21, P7078, DOI 10.1128/MCB.21.20.7078-7088.2001	48	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14213	14220		10.1074/jbc.M708657200	http://dx.doi.org/10.1074/jbc.M708657200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18359773	Green Published, hybrid			2022-12-25	WOS:000255941400007
J	Ammendola, S; Pasquali, P; Pacello, F; Rotilio, G; Castor, M; Libby, SJ; Figueroa-Bossi, N; Bossi, L; Fang, FC; Battistoni, A				Ammendola, Serena; Pasquali, Paolo; Pacello, Francesca; Rotilio, Giuseppe; Castor, Margaret; Libby, Stephen J.; Figueroa-Bossi, Nara; Bossi, Lionello; Fang, Ferric C.; Battistoni, Andrea			Regulatory and structural differences in the Cu, Zn-superoxide dismutases of Salmonella enterica and their significance for virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ESCHERICHIA-COLI; SEROVAR TYPHIMURIUM; MYCOBACTERIUM-TUBERCULOSIS; PERIPLASMIC COPPER; HYDROGEN-PEROXIDE; CHROMOSOMAL GENES; STATIONARY-PHASE; OXIDATIVE BURST; ZINC UPTAKE	Many of the most virulent strains of Salmonella enterica produce two distinct Cu, Zn-superoxide dismutases (SodCI and SodCII). The bacteriophage-encoded SodCI enzyme makes the greater contribution to Salmonella virulence. We have performed a detailed comparison of the functional, structural, and regulatory properties of the Salmonella SodC enzymes. Here we demonstrate that SodCI and SodCII differ with regard to specific activity, protease resistance, metal affinity, and peroxidative activity, with dimeric SodCI exhibiting superior stability and activity. In particular, monomeric SodCII is unable to retain its catalytic copper ion in the absence of zinc. We have also found that SodCI and SodCII are differentially affected by oxygen, zinc availability, and the transcriptional regulator FNR. SodCII is strongly down-regulated under anaerobic conditions and dependent on the high affinity ZnuABC zinc transport system, whereas SodCI accumulation in vitro and within macrophages is FNR-dependent. We have confirmed earlier findings that SodCII accumulation in intracellular Salmonella is negligible, whereas SodCI is strongly up-regulated in macrophages. Our observations demonstrate that differences in expression, activity, and stability help to account for the unique contribution of the bacteriophage-encoded SodCI enzyme to Salmonella virulence.	[Ammendola, Serena; Pacello, Francesca; Rotilio, Giuseppe; Battistoni, Andrea] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Pasquali, Paolo] Ist Super Sanita, Dipartimento Sanita Alimentare & Anim, I-00161 Rome, Italy; [Rotilio, Giuseppe] IRCCS San Raffaele La Pisana, Ctr Ric, I-00163 Rome, Italy; [Castor, Margaret; Libby, Stephen J.; Fang, Ferric C.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Castor, Margaret; Libby, Stephen J.; Fang, Ferric C.] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Bossi, Lionello; Fang, Ferric C.] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; [Battistoni, Andrea] Consorzio Interuniv, Ist Nazl Biostrutture & Biosistemi, I-00136 Rome, Italy	University of Rome Tor Vergata; Istituto Superiore di Sanita (ISS); IRCCS San Raffaele Pisana; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Battistoni, A (corresponding author), Univ Roma Tor Vergata, Dept Biol, Via Della Ricerca Sci, I-00133 Rome, Italy.	andrea.battistoni@uniroma2.it	Battistoni, Andrea/A-4778-2016; Pasquali, Paolo/C-1111-2008	Battistoni, Andrea/0000-0003-4085-7917; Pasquali, Paolo/0000-0003-4704-0731; AMMENDOLA, Serena/0000-0003-1436-0608; Fang, Ferric/0000-0002-3243-110X	NIAID NIH HHS [AI50660, AI039557] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039557, R01AI039557, R01AI050660] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ammendola S, 2005, MICROBES INFECT, V7, P698, DOI 10.1016/j.micinf.2005.01.005; Ammendola S, 2007, INFECT IMMUN, V75, P5867, DOI 10.1128/IAI.00559-07; BANNISTER JV, 1987, CRC CR REV BIOCH MOL, V22, P111, DOI 10.3109/10409238709083738; Battistoni A, 1998, BIOCHEM BIOPH RES CO, V243, P804, DOI 10.1006/bbrc.1998.8182; Battistoni A, 1996, BIOCHEM J, V320, P713, DOI 10.1042/bj3200713; Battistoni A, 2000, INFECT IMMUN, V68, P30, DOI 10.1128/IAI.68.1.30-37.2000; Battistoni A, 1998, J BIOL CHEM, V273, P5655, DOI 10.1074/jbc.273.10.5655; Battistoni A, 2003, BIOCHEM SOC T, V31, P1326; Battistoni A, 2004, INT J IMMUNOPATH PH, V17, P71, DOI 10.1177/039463200401700110; BENOV LT, 1994, J BIOL CHEM, V269, P25310; Berducci G, 2004, FEBS LETT, V569, P289, DOI 10.1016/j.febslet.2004.06.008; BORDO D, 2001, HDB METALLOPROTEINS, P1284; Campoy S, 2002, INFECT IMMUN, V70, P4721, DOI 10.1128/IAI.70.8.4721-4725.2002; Chen CY, 1996, INFECT IMMUN, V64, P4739, DOI 10.1128/IAI.64.11.4739-4743.1996; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; D'Orazio M, 2000, BIOCHEM BIOPH RES CO, V272, P81, DOI 10.1006/bbrc.2000.2730; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; di Patti MCB, 2002, METHOD ENZYMOL, V349, P49; Dunn KLR, 2003, INFECT IMMUN, V71, P1604, DOI 10.1128/IAI.71.3.1604-1607.2003; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Falconi M, 2002, PROTEINS, V47, P513, DOI 10.1002/prot.10094; Fang FC, 1999, P NATL ACAD SCI USA, V96, P7502, DOI 10.1073/pnas.96.13.7502; FANG FC, 1992, P NATL ACAD SCI USA, V89, P11978, DOI 10.1073/pnas.89.24.11978; Farrant JL, 1997, MOL MICROBIOL, V25, P785, DOI 10.1046/j.1365-2958.1997.5151877.x; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Figueroa-Bossi N, 2006, MICROBES INFECT, V8, P1569, DOI 10.1016/j.micinf.2006.01.015; Fink RC, 2007, J BACTERIOL, V189, P2262, DOI 10.1128/JB.00726-06; Gabbianelli R, 2004, BIOL CHEM, V385, P749, DOI 10.1515/BC.2004.091; Gee JM, 2005, INFECT IMMUN, V73, P2873, DOI 10.1128/IAI.73.5.2873-2880.2005; Golubeva YA, 2006, J BACTERIOL, V188, P7853, DOI 10.1128/JB.00706-06; Gort AS, 1999, MOL MICROBIOL, V32, P179, DOI 10.1046/j.1365-2958.1999.01343.x; Ho TD, 2001, J BACTERIOL, V183, P611, DOI 10.1128/JB.183.2.611-620.2001; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010; Korshunov S, 2006, J BACTERIOL, V188, P6326, DOI 10.1128/JB.00554-06; Krishnakumar R, 2004, J BACTERIOL, V186, P5230, DOI 10.1128/JB.186.16.5230-5238.2004; Krishnakumar R, 2007, J BACTERIOL, V189, P4343, DOI 10.1128/JB.00010-07; Liochev SI, 1999, FREE RADICAL BIO MED, V27, P1444, DOI 10.1016/S0891-5849(99)00190-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynch M, 2000, MICROBES INFECT, V2, P1245, DOI 10.1016/S1286-4579(00)01278-8; Maloy S.R., 1996, GENETIC ANAL PATHOGE, P473; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MESSING J, 1977, P NATL ACAD SCI USA, V74, P3642, DOI 10.1073/pnas.74.9.3642; Miller J.H., 1972, EXPT MOL GENETICS; NAKASHIMA K, 1995, NEUROLOGY, V45, P1019, DOI 10.1212/WNL.45.5.1019-a; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Pacello F, 2008, BBA-GEN SUBJECTS, V1780, P226, DOI 10.1016/j.bbagen.2007.12.001; PANTOLIANO MW, 1982, J INORG BIOCHEM, V17, P325, DOI 10.1016/S0162-0134(00)80093-8; Pesce A, 2000, J MOL BIOL, V302, P465, DOI 10.1006/jmbi.2000.4074; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; POLTICELLI F, 1995, BIOCHEMISTRY-US, V34, P6043, DOI 10.1021/bi00018a006; San Mateo LR, 1999, INFECT IMMUN, V67, P5345, DOI 10.1128/IAI.67.10.5345-5351.1999; Sansone A, 2002, MICROBIOL-SGM, V148, P719, DOI 10.1099/00221287-148-3-719; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Sly LM, 2002, INFECT IMMUN, V70, P5312, DOI 10.1128/IAI.70.9.5312-5315.2002; STRAUCH KL, 1985, J BACTERIOL, V161, P673, DOI 10.1128/JB.161.2.673-680.1985; Stroppolo ME, 2001, J MOL BIOL, V308, P555, DOI 10.1006/jmbi.2001.4606; SUN Y, 1988, FREE RADICAL RES COM, V5, P67, DOI 10.3109/10715768809066913; Sutton A, 2000, J BACTERIOL, V182, P4375, DOI 10.1128/JB.182.16.4375-4379.2000; Sutton VR, 2004, BIOCHEMISTRY-US, V43, P791, DOI 10.1021/bi0357053; Uzzau S, 2002, MOL MICROBIOL, V46, P147, DOI 10.1046/j.1365-2958.2002.03145.x; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Visick JE, 1997, J BACTERIOL, V179, P4158, DOI 10.1128/jb.179.13.4158-4163.1997; Watanabe Y, 2001, NEUROPATHOLOGY, V21, P61, DOI 10.1046/j.1440-1789.2001.00360.x; Wilks KE, 1998, INFECT IMMUN, V66, P213, DOI 10.1128/IAI.66.1.213-217.1998	70	50	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13688	13699		10.1074/jbc.M710499200	http://dx.doi.org/10.1074/jbc.M710499200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18362154	Green Published, hybrid			2022-12-25	WOS:000255728200020
J	Helland, R; Fjellbirkeland, A; Karlsen, OA; Ve, T; Lillehaug, JR; Jensen, HB				Helland, Ronny; Fjellbirkeland, Anne; Karlsen, Odd Andre; Ve, Thomas; Lillehaug, Johan R.; Jensen, Harald B.			An oxidized tryptophan facilitates copper binding in Methylococcus capsulatus-secreted protein MopE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATION; METAL SITES; RESIDUES; BATH; TRYPTOPHYLQUINONE; IDENTIFICATION; METHANOTROPH; HOMEOSTASIS; REFINEMENT; COMPLEXES	Proteins can coordinate metal ions with endogenous nitrogen and oxygen ligands through backbone amino and carbonyl groups, but the amino acid side chains coordinating metals do not include tryptophan. Here we show for the first time the involvement of the tryptophan metabolite kynurenine in a protein metal-binding site. The crystal structure to 1.35 angstrom of MopE* from the methane-oxidizing Methylococcus capsulatus (Bath) provided detailed information about its structure and mononuclear copper-binding site. MopE* contains a novel protein fold of which only one-third of the structure displays similarities to other known folds. The geometry around the copper ion is distorted tetrahedral with one oxygen ligand from a water molecule, two histidine imidazoles (His-132 and His-203), and at the fourth distorted tetrahedral position, the N1 atom of the kynurenine, an oxidation product of Trp-130. Trp-130 was not oxidized to kynurenine in MopE* heterologously expressed in Escherichia coli, nor did this protein bind copper. Our findings indicate that the modification of tryptophan to kynurenine and its involvement in copper binding is an innate property of M. capsulatus MopE*.	[Fjellbirkeland, Anne; Karlsen, Odd Andre; Ve, Thomas; Lillehaug, Johan R.; Jensen, Harald B.] Univ Bergen, Dept Mol Biol, HIB, N-5020 Bergen, Norway; [Helland, Ronny] Univ Tromso, Fac Sci, Norwegian Struct Biol Ctr, N-9073 Tromso, Norway	University of Bergen; UiT The Arctic University of Tromso	Jensen, HB (corresponding author), Univ Bergen, Dept Mol Biol, HIB, Thormohlensgate 55, N-5020 Bergen, Norway.	jensen@mbi.uib.no	Ve, Thomas/AEK-1006-2022; Ve, Thomas/F-9820-2011	Ve, Thomas/0000-0002-0113-1905; 				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Anderson LB, 2002, P NATL ACAD SCI USA, V99, P14676, DOI 10.1073/pnas.232591599; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ball LJ, 2004, ORG BIOMOL CHEM, V2, P1872, DOI 10.1039/b402722a; Berson O, 1997, FEMS MICROBIOL LETT, V148, P169, DOI 10.1016/S0378-1097(97)00029-3; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Fjellbirkeland A, 1997, ARCH MICROBIOL, V168, P128, DOI 10.1007/s002030050478; Fjellbirkeland A, 2001, ARCH MICROBIOL, V176, P197, DOI 10.1007/s002030100307; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Hakemian AS, 2007, ANNU REV BIOCHEM, V76, P223, DOI 10.1146/annurev.biochem.76.061505.175355; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung D, 2004, CHEM BIOL, V11, P949, DOI 10.1016/j.chembiol.2004.04.020; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaminskaia NV, 2001, INORG CHEM, V40, P2368, DOI 10.1021/ic0014033; Karlsen OA, 2005, FEBS J, V272, P6324, DOI 10.1111/j.1742-4658.2005.05020.x; Karlsen OA, 2003, APPL ENVIRON MICROB, V69, P2386, DOI 10.1128/AEM.69.4.2386-2388.2003; Kim HJ, 2004, SCIENCE, V305, P1612, DOI 10.1126/science.1098322; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Manzanares D, 2007, BIOCHEMISTRY-US, V46, P5604, DOI 10.1021/bi062304p; MCINTIRE WS, 1991, SCIENCE, V252, P817, DOI 10.1126/science.2028257; Moller IM, 2006, FREE RADICAL BIO MED, V40, P430, DOI 10.1016/j.freeradbiomed.2005.08.036; Murrell JC, 2000, TRENDS MICROBIOL, V8, P221, DOI 10.1016/S0966-842X(00)01739-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Pearson AR, 2004, BIOCHEMISTRY-US, V43, P5494, DOI 10.1021/bi049863l; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Takani M, 2006, INORG CHEM, V45, P5938, DOI 10.1021/ic060595k; Taylor SW, 2003, J BIOL CHEM, V278, P19587, DOI 10.1074/jbc.C300135200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang ZM, 2000, ACTA CRYSTALLOGR C, V56, P786, DOI 10.1107/S0108270100004984; Xiao ZG, 2004, J AM CHEM SOC, V126, P3081, DOI 10.1021/ja0390350; Yang CY, 1999, BIOCHEMISTRY-US, V38, P15903, DOI 10.1021/bi991464g; Zhang H, 2004, FREE RADICAL BIO MED, V37, P2018, DOI 10.1016/j.freeradbiomed.2004.08.026	45	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13897	13904		10.1074/jbc.M800340200	http://dx.doi.org/10.1074/jbc.M800340200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348978	hybrid			2022-12-25	WOS:000255728200043
J	Lindemann, MJ; Hu, ZH; Benczik, M; Liu, KD; Gaffen, SL				Lindemann, Matthew J.; Hu, Zihua; Benczik, Marta; Liu, Kathleen D.; Gaffen, Sarah L.			Differential regulation of the IL-17 receptor by gamma c cytokines - Inhibitory signaling by the phosphatidylinositol 3-kinase pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-ACTIVATION; BETA-CHAIN; INTERLEUKIN-2 RECEPTOR; PROTEIN-KINASE; TYROSINE RESIDUES; ALPHA SUBUNIT; TARGET GENES; TRANSDUCTION; FAMILY; PROLIFERATION	The gamma c-family cytokine IL-2 activates signaling events that contribute to cell survival and proliferation, the best-studied of which are the STAT-5 and phosphatidylinositol 3-kinase (PI3K) pathways. The starting point of this study was to define genes regulated by the IL-2R-mediated PI3K pathway in T cells. Accordingly, we used an erythropoietin (EPO) receptor chimeric receptor system in which IL-2-dependent HT-2 T cells expressed a mutant EPO-IL-2R beta construct where Tyr-338 is mutated to Phe. Cells expressing this mutant IL-2R beta chain fail to induce phosphorylation of PI3K-p85 alpha/beta or activate Akt, but mediate normal IL-2-dependent proliferation and activation of JAK1 and STAT-5A/B. Microarray analyses revealed differential regulation of numerous genes compared with cells expressing a wild-type IL-2R beta, including up-regulation of the IL-17 receptor subunit IL-17RA. Blockade of the PI3K pathway but not p70(S6K) led to up-regulation of IL-17RA, and constitutive Akt activation was associated with suppressed IL-17RA expression. Moreover, similar to the mutant EPO-IL-2R beta chimera, IL-15 and IL-21 induced IL-17RA preferentially compared with IL-2, and IL-2 but not IL-15 or IL-21 mediated prolonged activation of the PI3K p85 regulatory subunit. Thus, there are intrinsic signaling differences between IL-2 and IL-15 that can be attributed to differences in activation of the PI3K pathway.	[Lindemann, Matthew J.; Benczik, Marta; Gaffen, Sarah L.] SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA; [Gaffen, Sarah L.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14214 USA; [Hu, Zihua] SUNY Buffalo, Dept Biostat, Buffalo, NY 14214 USA; [Hu, Zihua] SUNY Buffalo, Ctr Excellence Bioinformat, Buffalo, NY 14214 USA; [Liu, Kathleen D.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California San Francisco	Gaffen, SL (corresponding author), 36 Foster Hall,3435 Main St, Buffalo, NY 14214 USA.	sgaffen@buffalo.edu	Gaffen, Sarah L/B-1560-2009	Gaffen, Sarah L/0000-0001-8511-2041; Liu, Kathleen/0000-0003-4891-8649	NIAID NIH HHS [AI05439] Funding Source: Medline; NIAMS NIH HHS [AR050458] Funding Source: Medline; NIDCR NIH HHS [DE007034] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR050458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R43DE007034] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Bauer JH, 1998, J BIOL CHEM, V273, P9255, DOI 10.1074/jbc.273.15.9255; Chu CL, 1999, J IMMUNOL, V162, P1896; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; Cua DJ, 2006, NAT IMMUNOL, V7, P557, DOI 10.1038/ni0606-557; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; Gaffen SL, 2006, VITAM HORM, V74, P255, DOI 10.1016/S0083-6729(06)74010-9; Gaffen Sarah L., 1998, P73; Gaffen SL, 1999, BLOOD, V94, P74, DOI 10.1182/blood.V94.1.74.413k36_74_86; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; Gaffen SL, 1996, J BIOL CHEM, V271, P21381, DOI 10.1074/jbc.271.35.21381; GAFFEN SL, 1995, P NATL ACAD SCI USA, V92, P7192, DOI 10.1073/pnas.92.16.7192; GOLDSMITH MA, 1995, J BIOL CHEM, V270, P21729, DOI 10.1074/jbc.270.37.21729; Ha CT, 2005, J LEUKOCYTE BIOL, V77, P948, DOI 10.1189/jlb.0804453; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; HATAKEYAMA M, 1992, P NATL ACAD SCI USA, V89, P2022, DOI 10.1073/pnas.89.6.2022; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; Hur EM, 2003, J EXP MED, V198, P1463, DOI 10.1084/jem.20030232; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; KARNITZ LM, 1995, MOL CELL BIOL, V15, P3049; Kikly K, 2006, CURR OPIN IMMUNOL, V18, P670, DOI 10.1016/j.coi.2006.09.008; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kovanen PE, 2003, J BIOL CHEM, V278, P5205, DOI 10.1074/jbc.M209015200; Lai SY, 1996, EMBO J, V15, P4506, DOI 10.1002/j.1460-2075.1996.tb00828.x; Lai SY, 1997, J CLIN INVEST, V99, P169, DOI 10.1172/JCI119144; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lindemann MJ, 2003, J BIOL CHEM, V278, P10239, DOI 10.1074/jbc.M209471200; Liu KD, 1998, CURR OPIN IMMUNOL, V10, P271, DOI 10.1016/S0952-7915(98)80165-9; Lord JD, 1998, J IMMUNOL, V161, P4627; MA A, 2000, MOD ASP IMMUNOBIOL, V1, P102; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Nelson BH, 1996, MOL CELL BIOL, V16, P309; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; Sato N, 2007, P NATL ACAD SCI USA, V104, P588, DOI 10.1073/pnas.0610115104; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Shindoh M, 2004, CANCER LETT, V216, P1, DOI 10.1016/j.canlet.2004.07.020; Tagaya Y, 2006, BLOOD, V108, P409, DOI 10.1182/blood-2006-05-019463; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Yu JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P170, DOI 10.2741/2667; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	60	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14100	14108		10.1074/jbc.M801357200	http://dx.doi.org/10.1074/jbc.M801357200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348982	hybrid, Green Published			2022-12-25	WOS:000255728200064
J	Ozturk, Y; Lee, DW; Mandaci, S; Osyczka, A; Prince, RC; Daldal, F				Ozturk, Yavuz; Lee, Dong-Woo; Mandaci, Sevnur; Osyczka, Artur; Prince, Roger C.; Daldal, Fevzi			Soluble variants of Rhodobacter capsulatus membrane-anchored cytochrome c(y) are efficient photosynthetic electron carriers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHAEROIDES REACTION-CENTER; RHODOPSEUDOMONAS-CAPSULATA; BC(1) COMPLEX; PARACOCCUS-DENITRIFICANS; C-OXIDASE; C(2); GROWTH; RESPIRATION; DOMAIN; EXPRESSION	Photosynthetic (Ps) electron transport pathways often contain multiple electron carriers with overlapping functions. Here we focus on two c-type cytochromes (cyt) in facultative phototrophic bacteria of the Rhodobacter genus: the diffusible cyt c(2) and the membrane-anchored cyt c(y). In species like R. capsulatus, cyt c(y) functions in both Ps and respiratory electron transport chains, whereas in other species like R. sphaeroides, it does so only in respiration. The molecular bases of this difference was investigated by producing a soluble variant of cyt c(y) (S-c(y)), by fusing genetically the cyt c(2) signal sequence to the cyt c domain of cyt c(y). This novel electron carrier was unable to support the Ps growth of R. capsulatus. However, strains harboring cyt S-c(y) regained Ps growth ability by acquiring mutations in its cyt c domain. They produced cyt S-c(y) variants at amounts comparable with that of cyt c(2), and conferred Ps growth. Chemical titration indicated that the redox midpoint potential of cyt S-c(y) was about 340 mV, similar to that of cyts c(2) or c(y). Remarkably, electron transfer kinetics from the cyt bc(1) complex to the photochemical reaction center (RC) mediated by cyt S-c(y) was distinct from those seen with the cyt c(2) or cyt c(y). The kinetics exhibited a pronounced slow phase, suggesting that cyt S-c(y) interacted with the RC less tightly than cyt c(2). Comparison of structural models of cyts c(2) and S-c(y) revealed that several of the amino acid residues implicated in long-range electrostatic interactions promoting binding of cyt c(2) to the RC are not conserved in cyt c(y), whereas those supporting short-range hydrophobic interactions are conserved. These findings indicated that attaching electron carrier cytochromes to the membrane allowed them to weaken their interactions with their partners so that they could accommodate more rapid multiple turnovers.	[Ozturk, Yavuz; Lee, Dong-Woo; Daldal, Fevzi] Univ Penn, Johnson Res Fdn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA; [Osyczka, Artur] Univ Penn, Johnson Res Fdn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Ozturk, Yavuz; Mandaci, Sevnur] TUBITAK Marmara Res Ctr, Genet Engn & Biotechnol Inst, TR-41470 Kocaeli, Turkey; [Prince, Roger C.] Exxon Mobil Biomed Sci Inc, Annandale, NJ 08801 USA	University of Pennsylvania; University of Pennsylvania; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Exxon Mobil Corporation	Daldal, F (corresponding author), Univ Penn, Johnson Res Fdn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.	fdaldal@sas.upenn.edu		Osyczka, Artur/0000-0002-1637-2365	NIGMS NIH HHS [R01 GM038237, GM 38237] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Axelrod HL, 2002, J MOL BIOL, V319, P501, DOI 10.1016/S0022-2836(02)00168-7; Baymann F, 2003, FEBS LETT, V539, P91, DOI 10.1016/S0014-5793(03)00206-0; BLANKENSHIP R, 1995, ANOXYGENIC PHOTOSYNT, P747; CAFFREY MS, 1992, J BIOL CHEM, V267, P6317; DALDAL F, 1986, P NATL ACAD SCI USA, V83, P2012, DOI 10.1073/pnas.83.7.2012; DALDAL F, 1988, J BACTERIOL, V170, P2388, DOI 10.1128/jb.170.5.2388-2391.1988; Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567; DITTA G, 1985, PLASMID, V13, P149, DOI 10.1016/0147-619X(85)90068-X; DONOHUE TJ, 1986, J BACTERIOL, V168, P962, DOI 10.1128/jb.168.2.962-972.1986; Drepper F, 1997, BIOCHEMISTRY-US, V36, P1418, DOI 10.1021/bi961350u; Drepper F, 1997, BIOCHEMISTRY-US, V36, P1428, DOI 10.1021/bi961351m; Dutton P L, 1978, Methods Enzymol, V54, P411; GRAY KA, 1994, BIOCHEMISTRY-US, V33, P3120, DOI 10.1021/bi00176a047; Harrenga A, 2000, J MOL BIOL, V295, P667, DOI 10.1006/jmbi.1999.3382; HOCHKOEPPLER A, 1995, J BACTERIOL, V177, P608, DOI 10.1128/jb.177.3.608-613.1995; Hunte C, 2002, BBA-BIOENERGETICS, V1555, P21, DOI 10.1016/S0005-2728(02)00249-9; HUNTER N, 2008, PURPLE PHOTOSYNTHETI; JENNEY FE, 1994, BIOCHEMISTRY-US, V33, P2496, DOI 10.1021/bi00175a019; JENNEY FE, 1993, EMBO J, V12, P1283, DOI 10.1002/j.1460-2075.1993.tb05773.x; Jenney FE, 1996, BBA-BIOENERGETICS, V1273, P159, DOI 10.1016/0005-2728(95)00137-9; LAMONICA RF, 1976, BIOCHIM BIOPHYS ACTA, V423, P431, DOI 10.1016/0005-2728(76)90198-5; Lee DW, 2008, J BIOL CHEM, V283, P13973, DOI 10.1074/jbc.M800091200; Lee DW, 2006, BBA-BIOENERGETICS, V1757, P346, DOI 10.1016/j.bbabio.2006.04.025; LONG JE, 1989, BIOCHEMISTRY-US, V28, P6970, DOI 10.1021/bi00443a029; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Merchant S, 2005, PLANT CELL, V17, P648, DOI 10.1105/tpc.105.030676; MOSER CC, 1988, BIOCHEMISTRY-US, V27, P2450, DOI 10.1021/bi00407a031; Myllykallio H, 1999, P NATL ACAD SCI USA, V96, P4348, DOI 10.1073/pnas.96.8.4348; Myllykallio H, 1998, BIOCHEMISTRY-US, V37, P5501, DOI 10.1021/bi973123d; Myllykallio H, 2000, TRENDS MICROBIOL, V8, P493, DOI 10.1016/S0966-842X(00)01831-X; Myllykallio H, 1997, J BACTERIOL, V179, P2623, DOI 10.1128/jb.179.8.2623-2631.1997; OVERFIELD RE, 1979, FEBS LETT, V105, P137, DOI 10.1016/0014-5793(79)80903-5; PRINCE RC, 1975, BIOCHIM BIOPHYS ACTA, V387, P212, DOI 10.1016/0005-2728(75)90104-8; PRINCE RC, 1986, BIOCHEMISTRY-US, V25, P5208, DOI 10.1021/bi00366a034; PRINCE RC, 1990, BACTERIA, V12, P111; Reincke B, 2001, BIOCHEMISTRY-US, V40, P12312, DOI 10.1021/bi010615o; ROBERTSON DE, 1986, J BIOL CHEM, V261, P584; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427; SISTROM WR, 1960, J GEN MICROBIOL, V22, P778, DOI 10.1099/00221287-22-3-778; Tetreault M, 2002, BIOCHEMISTRY-US, V41, P5807, DOI 10.1021/bi012053e; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; TIEDE DM, 1993, BIOCHEMISTRY-US, V32, P4515, DOI 10.1021/bi00068a006; Vermeglio A, 2002, BBA-BIOENERGETICS, V1555, P60, DOI 10.1016/S0005-2728(02)00255-4; ZANNONI D, 1993, ARCH MICROBIOL, V160, P413, DOI 10.1007/BF00245301; ZANNONI D, 1976, BIOCHIM BIOPHYS ACTA, V423, P413, DOI 10.1016/0005-2728(76)90197-3	47	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13964	13972		10.1074/jbc.M800090200	http://dx.doi.org/10.1074/jbc.M800090200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18343817	Green Published, hybrid			2022-12-25	WOS:000255728200050
J	Sengle, G; Charbonneau, NL; Ono, RN; Sasaki, T; Alvarez, J; Keene, DR; Bachinger, HP; Sakai, LY				Sengle, Gerhard; Charbonneau, Noe L.; Ono, Robert N.; Sasaki, Takako; Alvarez, Jennifer; Keene, Douglas R.; Bachinger, Hans Peter; Sakai, Lynn Y.			Targeting of bone morphogenetic protein growth factor complexes to fibrillin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-BINDING PROTEIN-1; TGF-BETA; PRODOMAIN; CALCIUM; IDENTIFICATION; PURIFICATION; MICROFIBRILS; DEGRADATION; EXPRESSION; PROPEPTIDE	Both latent transforming growth factor-beta (TGF-beta)-binding proteins fibrillins are components of microfibril networks, and both interact with members of the TGF-beta family of growth factors. Interactions between latent TGF-beta-binding protein-1 and TGF-beta and between fibrillin-1 and bone morphogenetic protein-7 (BMP-7) are mediated by the prodomain of growth factor complexes. To extend this information, investigations were performed to test whether stable complexes are formed by additional selected TGF-beta family members. Using velocity sedimentation in sucrose gradients as an assay, complex formation was demonstrated for BMP-7 and growth and differentiation factor-8 (GDF-8), which are known to exist in prodomain/growth factor complexes. Comparison of these results with complex formation by BMP-2, BMP-4 (full-length and shortened propeptides), BMP-10, and GDF-5 allowed us to conclude that all, except for BMP-2 and the short BMP-4 propeptides, formed complexes with their growth factors. Using surface plasmon resonance, binding affinities between fibrillin and all propeptides were determined. Binding studies revealed that the N-terminal end of fibrillin-1 serves as a universal high affinity docking site for the propeptides of BMP-2, -4, -7, and -10 and GDF-5, but not GDF-8, and located the BMP/GDF binding site within the N-terminal domain in fibrillin-1. Rotary shadowing electron microscopy of molecules of BMP-7 complex bound to fibrillin-1 confirmed these findings and also showed that prodomain binding targets the growth factor to fibrillin. Immunolocalization of BMP-4 demonstrated fibrillar staining limited to certain tissues, indicating tissue-specific targeting of BMP-4. These data implicate the fibrillin microfibril network in the extracellular control of BMP signaling and demonstrate differences in how prodomains target their growth factors to the extracellular space.	[Sengle, Gerhard; Charbonneau, Noe L.; Ono, Robert N.; Sasaki, Takako; Alvarez, Jennifer; Keene, Douglas R.; Bachinger, Hans Peter; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97239 USA; [Sengle, Gerhard; Sasaki, Takako; Bachinger, Hans Peter; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Sakai, LY (corresponding author), Oregon Hlth & Sci Univ, Shriners Hosp Children, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lys@shcc.org			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698, R01AR046811] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01AR46811, P01 AR049698] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Cui YZ, 2001, GENE DEV, V15, P2797; De Crescenzo G, 2001, J BIOL CHEM, V276, P29632, DOI 10.1074/jbc.M009765200; Degnin C, 2004, MOL BIOL CELL, V15, P5012, DOI 10.1091/mbc.E04-08-0673; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Gleizes PE, 1996, J BIOL CHEM, V271, P29891, DOI 10.1074/jbc.271.47.29891; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; HOLLISTER DW, 1990, NEW ENGL J MED, V323, P152, DOI 10.1056/NEJM199007193230303; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Israel DI, 1992, GROWTH FACTORS, V7, P139, DOI 10.3109/08977199209046403; Keene DR, 1997, J HISTOCHEM CYTOCHEM, V45, P1069, DOI 10.1177/002215549704500805; Kodaira K, 2006, BIOCHEM BIOPH RES CO, V345, P1224, DOI 10.1016/j.bbrc.2006.05.045; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Kuo CL, 2007, J BIOL CHEM, V282, P4007, DOI 10.1074/jbc.M606370200; MAYER U, 1995, FEBS LETT, V365, P129, DOI 10.1016/0014-5793(95)00438-F; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Reinhardt DP, 2000, J BIOL CHEM, V275, P2205, DOI 10.1074/jbc.275.3.2205; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691; Schmid B, 2000, DEVELOPMENT, V127, P957; Thies RS, 2001, GROWTH FACTORS, V18, P251; Yuan XM, 1997, EMBO J, V16, P6659, DOI 10.1093/emboj/16.22.6659	33	168	172	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13874	13888		10.1074/jbc.M707820200	http://dx.doi.org/10.1074/jbc.M707820200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18339631	hybrid, Green Published			2022-12-25	WOS:000255728200041
J	Snider, JL; Allison, C; Bellaire, BH; Ferrero, RL; Cardelli, JA				Snider, Jared L.; Allison, Cody; Bellaire, Bryan H.; Ferrero, Richard L.; Cardelli, James A.			The beta(1) integrin activates JNK independent of CagA, and JNK activation is required for Helicobacter pylori CagA(+)-induced motility of gastric cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; N-TERMINAL KINASE; JUN NH2-TERMINAL KINASE; TYROSINE PHOSPHORYLATION; IV SECRETION; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; UP-REGULATION; IN-VITRO; KAPPA-B	The Helicobacter pylori CagA protein is translocated into gastric epithelial cells through a type IV secretion system (TFSS), and published studies suggest CagA is critical for H. pylori-associated carcinogenesis. CagA is thought to be necessary and sufficient to induce the motogenic response observed in response to CagA(+) strains, as CagA interacts with proteins involved in adhesion and motility. We report that H. pylori strain 60190 stimulated AGS cell motility through a CagA- and TFSS-dependent mechanism, because strains 60190 Delta cagA or 60190 Delta cagE (TFSS-defective) did not increase motility. The JNK pathway is critical for H. pylori-dependent cell motility, as inhibition using SP600125 (JNK1/2/3 inhibitor) or a JNK2/3-specific inhibitor blocked motility. JNK mediates H. pylori-induced cell motility by activating paxillin, because JNK inhibition blocked paxillin(Tyr-118) phosphorylation, and paxillin expression knockdown completely abrogated bacteria-induced motility. Furthermore, JNK and paxillinTyr-118 were activated by 60190 Delta cagA but not 60190 Delta cagE, demonstrating CagA-independent signaling critical for cell motility. A beta(1) integrin-blocking antibody significantly inhibited JNK and paxillinTyr-118 phosphorylation and cell scattering, demonstrating that CagA-independent signaling required for cell motility occurs through beta(1). The requirement of both Src and focal adhesion kinase for signaling and motility further suggests the importance of integrin signaling in H. pylori-induced cell motility. Finally, we show that JNK activation occurs independent of known upstream kinases and signaling molecules, including Nod1, Cdc42, Rac1, MKK4, and MKK7, which demonstrates novel signaling leading to JNK activation. We report for the first time that H. pylori mediates CagA-independent signaling that promotes cell motility through the beta(1) integrin pathway.	[Snider, Jared L.; Cardelli, James A.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA 71130 USA; [Snider, Jared L.; Cardelli, James A.] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA; [Allison, Cody; Ferrero, Richard L.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Bellaire, Bryan H.] Iowa State Univ Sci & Technol, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Monash University; Iowa State University	Cardelli, JA (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, 1501 Kings Highway, Shreveport, LA 71130 USA.	jcarde@lsuhsc.edu	Bellaire, Bryan/GNP-5200-2022; Ferrero, Richard/U-1332-2017	Bellaire, Bryan/0000-0002-4034-6482; Ferrero, Richard/0000-0001-6817-6211	NCI NIH HHS [CA104242] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA104242] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Ghoul L, 2004, BIOCHEM BIOPH RES CO, V322, P860, DOI 10.1016/j.bbrc.2004.07.199; Almeida EAC, 2000, J CELL BIOL, V149, P741, DOI 10.1083/jcb.149.3.741; Altan ZM, 2004, BIOCHEM BIOPH RES CO, V322, P56, DOI 10.1016/j.bbrc.2004.07.079; Amagasaki K, 2006, J BIOL CHEM, V281, P22173, DOI 10.1074/jbc.M513307200; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Backert S, 2001, PROTEOMICS, V1, P608, DOI 10.1002/1615-9861(200104)1:4<608::AID-PROT608>3.3.CO;2-7; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BLASER MJ, 1995, CANCER RES, V55, P2111; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Chang YJ, 2005, J IMMUNOL, V175, P8242, DOI 10.4049/jimmunol.175.12.8242; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Churin Y, 2001, MOL MICROBIOL, V40, P815, DOI 10.1046/j.1365-2958.2001.02443.x; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; FORMAN D, 1993, LANCET, V341, P1359; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Hatakeyama M, 2005, CANCER SCI, V96, P835, DOI 10.1111/j.1349-7006.2005.00130.x; Higashi H, 2004, J BIOL CHEM, V279, P17205, DOI 10.1074/jbc.M309964200; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hirata Y, 2001, INFECT IMMUN, V69, P3965, DOI 10.1128/IAI.69.6.3965-3971.2001; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang C, 2004, CELL CYCLE, V3, P4, DOI 10.4161/cc.3.1.601; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Kufer TA, 2008, CELL MICROBIOL, V10, P477, DOI 10.1111/j.1462-5822.2007.01062.x; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Maeda S, 2001, J BIOL CHEM, V276, P44856, DOI 10.1074/jbc.M105381200; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moese S, 2004, INFECT IMMUN, V72, P3646, DOI 10.1128/IAI.72.6.3646-3649.2004; Moese S, 2002, INFECT IMMUN, V70, P4687, DOI 10.1128/IAI.70.8.4687-4691.2002; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Oktay M, 1999, J CELL BIOL, V145, P1461, DOI 10.1083/jcb.145.7.1461; Oliveira MJ, 2006, J BIOL CHEM, V281, P34888, DOI 10.1074/jbc.M607067200; Opitz B, 2006, J IMMUNOL, V176, P484, DOI 10.4049/jimmunol.176.1.484; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Scott WN, 2000, ANAL BIOCHEM, V287, P343, DOI 10.1006/abio.2000.4866; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2003, EMBO J, V22, P515, DOI 10.1093/emboj/cdg050; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Selbach M, 2002, INFECT IMMUN, V70, P665, DOI 10.1128/IAI.70.2.665-671.2002; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Takino T, 2005, J BIOL CHEM, V280, P37772, DOI 10.1074/jbc.M505241200; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Taylor JM, 2001, MOL CELL BIOL, V21, P1565, DOI 10.1128/MCB.21.5.1565-1572.2001; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Wroblewski LE, 2003, J CELL SCI, V116, P3017, DOI 10.1242/jcs.00518; Yamauchi J, 2000, J BIOL CHEM, V275, P7633, DOI 10.1074/jbc.275.11.7633; Yamauchi J, 2006, EXP CELL RES, V312, P2954, DOI 10.1016/j.yexcr.2006.05.016; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004	64	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13952	13963		10.1074/jbc.M800289200	http://dx.doi.org/10.1074/jbc.M800289200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18356158	Green Published, hybrid			2022-12-25	WOS:000255728200049
J	Gusarov, I; Starodubtseva, M; Wang, ZQ; McQuade, L; Lippard, SJ; Stuehr, DJ; Nudler, E				Gusarov, Ivan; Starodubtseva, Marina; Wang, Zhi-Qiang; McQuade, Lindsey; Lippard, Stephen J.; Stuehr, Dennis J.; Nudler, Evgeny			Bacterial nitric-oxide Synthases operate without a dedicated redox partner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; NITROSATIVE STRESS; SIGNALING MOLECULE; OXIDATIVE STRESS; GENE-EXPRESSION; PROTEIN; ADAPTATION; MECHANISM	Bacterial nitric-oxide (NO) synthases (bNOSs) are smaller than their mammalian counterparts. They lack an essential reductase domain that supplies electrons during NO biosynthesis. This and other structural peculiarities have raised doubts about whether bNOSs were capable of producing NO in vivo. Here we demonstrate that bNOS enzymes from Bacillus subtilis and Bacillus anthracis do indeed produce NO in living cells and accomplish this task by hijacking available cellular redox partners that are not normally committed to NO production. These "promiscuous" bacterial reductases also support NO synthesis by the oxygenase domain of mammalian NOS expressed in Escherichia coli. Our results suggest that bNOS is an early precursor of eukaryotic NOS and that it acquired its dedicated reductase domain later in evolution. This work also suggests that alternatively spliced forms of mammalian NOSs lacking their reductase domains could still be functional in vivo. On a practical side, bNOS-containing probiotic bacteria offer a unique advantage over conventional chemical NO donors in generating continuous, readily controllable physiological levels of NO, suggesting a possibility of utilizing such live NO donors for research and clinical needs.	[Gusarov, Ivan; Starodubtseva, Marina; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Wang, Zhi-Qiang] Kent State Univ Tuscarawas, Dept Chem, New Philadelphia, PA USA; [McQuade, Lindsey; Lippard, Stephen J.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stuehr, Dennis J.] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA	New York University; Massachusetts Institute of Technology (MIT); Cleveland Clinic Foundation	Nudler, E (corresponding author), 550 1st Ave,MSB359, New York, NY 10016 USA.	evgeny.nudler@med.nyu.edu	Gusarov, Ivan/AAJ-6282-2020	Nudler, Evgeny/0000-0002-8811-3071	NIH HHS [DP1 OD000799] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000799] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adak S, 2002, J BIOL CHEM, V277, P16167, DOI 10.1074/jbc.M201136200; Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Bang IS, 2006, J BIOL CHEM, V281, P28039, DOI 10.1074/jbc.M605174200; Bird LE, 2002, STRUCTURE, V10, P1687, DOI 10.1016/S0969-2126(02)00911-5; CHEN L, 1995, P NATL ACAD SCI USA, V92, P8190, DOI 10.1073/pnas.92.18.8190; CHEN YJ, 1994, BIOCHEM BIOPH RES CO, V203, P1251, DOI 10.1006/bbrc.1994.2317; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Fang F.C., 1999, NITRIC OXIDE INFECT; Gardner AM, 2002, J BIOL CHEM, V277, P8166, DOI 10.1074/jbc.M110470200; Gautier C, 2006, NITRIC OXIDE-BIOL CH, V15, P312, DOI 10.1016/j.niox.2006.03.010; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Ignarro LJ, 1999, BIOSCIENCE REP, V19, P51, DOI 10.1023/A:1020150124721; Inaoka T, 1999, J BACTERIOL, V181, P1939, DOI 10.1128/JB.181.6.1939-1943.1999; Johnson EG, 2008, CHEM BIOL, V15, P43, DOI 10.1016/j.chembiol.2007.11.014; KERWIN JF, 1995, J MED CHEM, V38, P4343, DOI 10.1021/jm00022a001; Korneev S, 2002, MOL BIOL EVOL, V19, P1228, DOI 10.1093/oxfordjournals.molbev.a004183; Larsson B, 1998, BIOCHEM BIOPH RES CO, V251, P898, DOI 10.1006/bbrc.1998.9578; Lei L, 2004, P NATL ACAD SCI USA, V101, P494, DOI 10.1073/pnas.2435922100; Lim MH, 2006, J AM CHEM SOC, V128, P14364, DOI 10.1021/ja064955e; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; Miller JH., 1972, EXPT MOL GENETICS; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moore CM, 2004, J BACTERIOL, V186, P4655, DOI 10.1128/JB.186.14.4655-4664.2004; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; Nakano MM, 2002, J BACTERIOL, V184, P1783, DOI 10.1128/JB.184.6.1783-1787.2002; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Okuda S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-48; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Rafikova O, 2002, P NATL ACAD SCI USA, V99, P5913, DOI 10.1073/pnas.092048999; Rogstam A, 2007, J BACTERIOL, V189, P3063, DOI 10.1128/JB.01782-06; Salard I, 2006, J INORG BIOCHEM, V100, P2024, DOI 10.1016/j.jinorgbio.2006.09.017; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Stasiv Y, 2004, GENE DEV, V18, P1812, DOI 10.1101/gad.298004; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Wang ZQ, 2007, J BIOL CHEM, V282, P2196, DOI 10.1074/jbc.M608206200; Wang ZQ, 2004, J BIOL CHEM, V279, P19018, DOI 10.1074/jbc.M311663200; Watmough NJ, 1999, BBA-BIOENERGETICS, V1411, P456, DOI 10.1016/S0005-2728(99)00032-8	45	117	121	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13140	13147		10.1074/jbc.M710178200	http://dx.doi.org/10.1074/jbc.M710178200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18316370	hybrid, Green Published			2022-12-25	WOS:000255499800053
J	Rabionet, M; van der Spoel, AC; Chuang, CC; von Tumpling-Radosta, B; Litjens, M; Bouwmeester, D; Hellbusch, CC; Korner, C; Wiegandt, H; Gorgas, K; Platt, FM; Grone, HJ; Sandhoff, R				Rabionet, Mariona; van der Spoel, Aarnoud C.; Chuang, Chia-Chen; von Tuempling-Radosta, Benita; Litjens, Manja; Bouwmeester, Diane; Hellbusch, Christina C.; Koerner, Christian; Wiegandt, Herbert; Gorgas, Karin; Platt, Frances M.; Groene, Hermann Josef; Sandhoff, Roger			Male germ cells require polyenoic sphingolipids with complex glycosylation for completion of meiosis - A link to ceramide synthase-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; SEMINIFEROUS EPITHELIUM; DEFICIENT MICE; FAMILY-MEMBERS; SPERMATOGENESIS; TESTIS; MOUSE; GENE; GLUCOSYLCERAMIDE; GANGLIOSIDES	Previously, it was found that a novel class of neutral fucosylated glycosphingolipids (GSLs) is required for male fertility. These lipids contain very long-chain (C26-C32) polyunsaturated (4-6 double bonds) fatty acid residues (VLC-PUFAs). To assess the role of these complex GSLs in spermatogenesis, we have now investigated with which of the testicular cell types these lipids are associated. During postnatal development, complex glycosylated and simple VLC-PUFA sphingolipids were first detectable at day 15, when the most advanced germ cells are pachytene spermatocytes. Their synthesis is most likely driven by ceramide synthase-3. This enzyme is encoded by the Cers3/Lass3 gene (longevity assurance genes), and out of six members of this gene family, only Cers3 mRNA expression was limited to germ cells, where it was up-regulated more than 700-fold during postnatal testicular maturation. Increasing levels of neutral complex VLC-PUFA GSLs also correlated with the progression of spermatogenesis in a series of male sterile mutants with arrests at different stages of spermatogenesis. Remarkably, fucosylation of the complex VLC-PUFA GSLs was not essential for spermatogenesis, as fucosylation- deficient mice produced nonfucosylated versions of the complex testicular VLC-PUFA GSLs, had complete spermatogenesis, and were fertile. Nevertheless, sterile Galgt1(-/-) mice, with a defective meiotic cytokinesis and a subsequent block in spermiogenesis, lacked complex but contained simple VLC-PUFA GSLs, as well as VLC-PUFA ceramides and sphingomyelins, indicating that the latter lipids are not sufficient for completion of spermatogenesis. Thus, our data imply that both glycans and the particular acyl chains of germinal sphingolipids are relevant for proper completion of meiosis.	[van der Spoel, Aarnoud C.; Chuang, Chia-Chen; Litjens, Manja; Bouwmeester, Diane; Wiegandt, Herbert; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Rabionet, Mariona; von Tuempling-Radosta, Benita; Wiegandt, Herbert; Groene, Hermann Josef; Sandhoff, Roger] German Canc Res Ctr, Dept Cellular & Mol Pathol, INF 280, D-69120 Heidelberg, Germany; [Hellbusch, Christina C.; Koerner, Christian] Univ Childrens Hosp, Div Inborn Metab Dis, Dept Pediat, INF 153, D-69120 Heidelberg, Germany; [Gorgas, Karin] Heidelberg Univ, Dept Anat & Cell Biol 2, INF 307, D-69120 Heidelberg, Germany	University of Oxford; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg	van der Spoel, AC (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	aarnoud.vanderspoel@pharm.ox.ac.uk; r.sandhoff@dkfz-heidelberg.de	Platt, Frances/G-1004-2010	Platt, Frances/0000-0001-7614-0403; van der Spoel, Aarnoud/0000-0002-2338-5316	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD045861] Funding Source: NIH RePORTER; NICHD NIH HHS [1 U01 HD45861] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adams J, 2005, AM J PATHOL, V167, P285, DOI 10.1016/S0002-9440(10)62973-2; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; BURGOS MH, 1970, TESTIS, P551; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Fujimoto H, 2000, J BIOL CHEM, V275, P22623, DOI 10.1074/jbc.C000200200; Furland NE, 2007, J BIOL CHEM, V282, P18151, DOI 10.1074/jbc.M700709200; Furland NE, 2007, J BIOL CHEM, V282, P18141, DOI 10.1074/jbc.M700708200; GORGAS K, 1989, J LIPID RES, V30, P1859; GROGAN WM, 1982, LIPIDS, V17, P605, DOI 10.1007/BF02535366; Hellbusch CC, 2007, J BIOL CHEM, V282, P10762, DOI 10.1074/jbc.M700314200; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; ISHIZUKA I, 1973, J BIOCHEM-TOKYO, V73, P77; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; Jennemann R, 2005, P NATL ACAD SCI USA, V102, P12459, DOI 10.1073/pnas.0500893102; Jennemann R, 2007, J BIOL CHEM, V282, P3083, DOI 10.1074/jbc.M610304200; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kolter T, 1999, ANGEW CHEM INT EDIT, V38, P1532, DOI 10.1002/(SICI)1521-3773(19990601)38:11<1532::AID-ANIE1532>3.0.CO;2-U; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lee NPY, 2007, J ENDOCRINOL, V192, P17, DOI 10.1677/JOE-06-0002; Liu YJ, 1999, J CLIN INVEST, V103, P497, DOI 10.1172/JCI5542; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; NEBEL BR, 1961, SCIENCE, V134, P832, DOI 10.1126/science.134.3482.832; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Ohta H, 2000, DEVELOPMENT, V127, P2125; Popko B, 2000, GLIA, V29, P149, DOI 10.1002/(SICI)1098-1136(20000115)29:2<149::AID-GLIA8>3.0.CO;2-4; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; RUSSELL LD, 1980, GAMETE RES, V3, P179, DOI 10.1002/mrd.1120030209; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Sandhoff R, 2005, J BIOL CHEM, V280, P27310, DOI 10.1074/jbc.M502775200; Sandhoff R, 2002, J BIOL CHEM, V277, P20386, DOI 10.1074/jbc.M110641200; Susuki K, 2007, GLIA, V55, P746, DOI 10.1002/glia.20503; SUTCLIFFE MJ, 1989, DEVELOPMENT, V107, P373; SUZUKI A, 1973, JPN J EXP MED, V43, P435; SVENNERHOLM L, 1994, PROG BRAIN RES, V101, pR11; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; Walden CM, 2007, J BIOL CHEM, V282, P32655, DOI 10.1074/jbc.M702387200; WardBailey PF, 1996, MAMM GENOME, V7, P793, DOI 10.1007/s003359900239; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Zhang YL, 2005, GLYCOBIOLOGY, V15, P649, DOI 10.1093/glycob/cwi043	46	79	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13357	13369		10.1074/jbc.M800870200	http://dx.doi.org/10.1074/jbc.M800870200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308723	hybrid, Green Published			2022-12-25	WOS:000255499800075
J	Koga, T; Lim, JH; Jono, H; Ha, UH; Xu, HD; Ishinaga, H; Morino, S; Xu, XB; Yan, C; Kai, H; Li, JD				Koga, Tomoaki; Lim, Jae Hyang; Jono, Hirofumi; Ha, Un Hwan; Xu, Haidong; Ishinaga, Hajime; Morino, Saori; Xu, Xiangbin; Yan, Chen; Kai, Hirofumi; Li, Jian-Dong			Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; DEUBIQUITINATING ENZYME CYLD; KAPPA-B ACTIVATION; T-CELL DEVELOPMENT; EPITHELIAL-CELLS; NUCLEAR-FACTOR; IKK-BETA; PNEUMOLYSIN; KINASE; EXPRESSION	Gram-positive bacterium Streptococcus pneumoniae is an important human pathogen that colonizes the upper respiratory tract and is also the major cause of morbidity and mortality worldwide. S. pneumoniae causes invasive diseases such as pneumonia, meningitis, and otitis media. Despite the importance of pneumococcal diseases, little is known about the molecular mechanisms by which S. pneumoniae-induced inflammation is regulated, especially the negative regulatory mechanisms. Here we show that S. pneumoniae activates nuclear factor of activated T cells ( NFAT) signaling pathway and the subsequent up-regulation of inflammatory mediators via a key pneumococcal virulence factor, pneumolysin. We also demonstrate that S. pneumoniae activates NFAT transcription factor independently of Toll-like receptors 2 and 4. Moreover, S. pneumoniae induces NFAT activation via both Ca2(+)-calcineurin and transforming growth factor-beta-activated kinase 1 (TAK1)-mitogen-activated protein kinase kinase (MKK) 3/6-p38 alpha/beta-dependent signaling pathways. Interestingly, we found for the first time that tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for S. pneumoniae-induced NFAT signaling pathway via a deubiquitination-dependent mechanism. Finally, we showed that CYLD interacts with and deubiquitinates TAK1 to negatively regulate the activation of the downstream MKK3/6p38 alpha/beta pathway. Our studies thus bring new insights into the molecular pathogenesis of S. pneumoniae infections through the NFAT-dependent mechanism and further identify CYLD as a negative regulator for NFAT signaling, thereby opening up new therapeutic targets for these diseases.	[Koga, Tomoaki; Lim, Jae Hyang; Jono, Hirofumi; Ha, Un Hwan; Xu, Haidong; Ishinaga, Hajime; Xu, Xiangbin; Li, Jian-Dong] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Yan, Chen] Univ Rochester, Med Ctr, Cardiovasc Res Inst, Rochester, NY 14642 USA; [Morino, Saori; Kai, Hirofumi] Kumamoto Univ, Dept Mol Med, Kumamoto 8620973, Japan	University of Rochester; University of Rochester; Kumamoto University	Li, JD (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Box 672,601 Elmwood Ave, Rochester, NY 14642 USA.	Jian-Dong_Li@URMC.Rochester.edu	Ha, Un-Hwan/ABH-8017-2020	Yan, Chen/0000-0002-1397-6358; Lim, Jae Hyang/0000-0003-0972-9271; Li, Jian-Dong/0000-0002-5593-050X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077789, R01HL088400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562, R01DC005843] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL088400, P01 HL077789] Funding Source: Medline; NIDCD NIH HHS [DC004562, DC005843] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Amory-Rivier CF, 2000, CRIT CARE MED, V28, P3249, DOI 10.1097/00003246-200009000-00021; Arnold KE, 1996, J PEDIATR-US, V128, P757, DOI 10.1016/S0022-3476(96)70326-8; BENTON KA, 1995, INFECT IMMUN, V63, P448, DOI 10.1128/IAI.63.2.448-455.1995; BERRY AM, 1989, INFECT IMMUN, V57, P2037, DOI 10.1128/IAI.57.7.2037-2042.1989; Braun JS, 2002, J CLIN INVEST, V109, P19; COURTOIS G, 2008, CELL MOL LIFE SCI; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; DUCHIN JS, 1995, PEDIATR INFECT DIS J, V14, P745, DOI 10.1097/00006454-199509000-00004; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Ha U, 2007, J IMMUNOL, V178, P1736, DOI 10.4049/jimmunol.178.3.1736; Iliev AI, 2007, P NATL ACAD SCI USA, V104, P2897, DOI 10.1073/pnas.0608213104; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Jin W, 2007, J BIOL CHEM, V282, P15884, DOI 10.1074/jbc.M609952200; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Klugman KP, 2001, CURR OPIN INFECT DIS, V14, P173, DOI 10.1097/00001432-200104000-00011; Koga T, 2005, BIOCHEM BIOPH RES CO, V337, P1319, DOI 10.1016/j.bbrc.2005.09.184; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Koga T, 2005, FEBS LETT, V579, P2811, DOI 10.1016/j.febslet.2005.04.015; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Krutzik SR, 2001, CURR OPIN IMMUNOL, V13, P104, DOI 10.1016/S0952-7915(00)00189-8; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Kweon SM, 2006, BIOCHEM BIOPH RES CO, V351, P368, DOI 10.1016/j.bbrc.2006.10.052; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ratner AJ, 2006, J BIOL CHEM, V281, P12994, DOI 10.1074/jbc.M511431200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Sakai A, 2007, FEBS J, V274, P3655, DOI 10.1111/j.1742-4658.2007.05899.x; Schmeck B, 2006, AM J PHYSIOL-LUNG C, V290, pL730, DOI 10.1152/ajplung.00271.2005; Shapiro VS, 1996, J EXP MED, V184, P1663, DOI 10.1084/jem.184.5.1663; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; van Rossum AMC, 2005, INFECT IMMUN, V73, P7718, DOI 10.1128/IAI.73.11.7718-7726.2005; Wheeler J, 1999, J MED MICROBIOL, V48, P863, DOI 10.1099/00222615-48-9-863; Xia Y, 2002, J BIOL CHEM, V277, P24601, DOI 10.1074/jbc.M201369200; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	44	42	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12546	12554		10.1074/jbc.M710518200	http://dx.doi.org/10.1074/jbc.M710518200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18332137	hybrid, Green Published			2022-12-25	WOS:000255340000071
J	Sam, KA; Fairhurst, SA; Thorneley, RNF; Allen, JWA; Ferguson, SJ				Sam, Katharine A.; Fairhurst, Shirley A.; Thorneley, Roger N. F.; Allen, James W. A.; Ferguson, Stuart J.			Pseudoazurin dramatically enhances the reaction profile of nitrite reduction by Paracoccus pantotrophus cytochrome cd(1) and facilitates release of product nitric oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; THIOSPHAERA-PANTOTROPHA; ELECTRON-TRANSFER; D(1) HEME; INTERMEDIATE; SPECTROSCOPY; BINDING; ENZYME; DENITRIFICANS; REDUCTASES	Cytochrome cd(1) is a respiratory nitrite reductase found in the periplasm of denitrifying bacteria. When fully reduced Paracoccus pantotrophus cytochrome cd1 is mixed with nitrite in a stopped-flow apparatus in the absence of excess reductant, a kinetically stable complex of enzyme and product forms, assigned as a mixture of cFe(II) d(1)Fe(II)-NO+ and cFe(III)d1Fe(II)-NO (cd(1)-X). However, in order for the enzyme to achieve steady-state turnover, product (NO) release must occur. In this work, we have investigated the effect of a physiological electron donor to cytochrome cd(1), the copper protein pseudoazurin, on the mechanism of nitrite reduction by the enzyme. Our data clearly show that initially oxidized pseudoazurin causes rapid further turnover by the enzyme to give a final product that we assign as all-ferric cytochrome cd(1) with nitrite bound to the d(1) heme (i.e. from which NO had dissociated). Pseudoazurin catalyzed this effect even when present at only one-tenth the stoichiometry of cytochrome cd(1). In contrast, redox-inert zinc pseudoazurin did not affect cd(1)-X, indicating a crucial role for electron movement between monomers or individual enzyme dimers rather than simply a protein-protein interaction. Furthermore, formation of cd(1)-X was, remarkably, accelerated by the presence of pseudoazurin, such that it occurred at a rate consistent with cd(1)-X being an intermediate in the catalytic cycle. It is clear that cytochrome cd1 functions significantly differently in the presence of its two substrates, nitrite and electron donor protein, than in the presence of nitrite alone.	[Sam, Katharine A.; Allen, James W. A.; Ferguson, Stuart J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Fairhurst, Shirley A.; Thorneley, Roger N. F.] John Innes Inst, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England	University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Ferguson, SJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	stuart.ferguson@bioch.ox.ac.uk			Biotechnology and Biological Sciences Research Council [C19430, BB/D019753/1] Funding Source: Medline; BBSRC [BB/D019753/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; Allen JWA, 2000, NAT STRUCT BIOL, V7, P885; Allen JWA, 2003, PHILOS T ROY SOC B, V358, P255, DOI 10.1098/rstb.2002.1192; Allen JWA, 2002, BIOCHEM J, V366, P883, DOI 10.1042/BJ20020795; Allen JWA, 2000, BIOCHEM BIOPH RES CO, V279, P674, DOI 10.1006/bbrc.2000.4009; Allen JWA, 2001, HDB METALLOPROTEINS; Capaldi AP, 1999, J MOL BIOL, V286, P1621, DOI 10.1006/jmbi.1998.2588; Cheesman MR, 1997, BIOCHEMISTRY-US, V36, P16267, DOI 10.1021/bi971677a; COYNE MS, 1990, J BACTERIOL, V172, P2558, DOI 10.1128/jb.172.5.2558-2562.1990; Cutruzzola F, 2001, P NATL ACAD SCI USA, V98, P2232, DOI 10.1073/pnas.041365298; Fry HC, 2003, J AM CHEM SOC, V125, P11866, DOI 10.1021/ja034911v; FULOP V, 1995, CELL, V81, P369, DOI 10.1016/0092-8674(95)90390-9; George SJ, 2000, J BIOL CHEM, V275, P33231, DOI 10.1074/jbc.M005033200; Gordon EHJ, 2003, J BIOL CHEM, V278, P11773, DOI 10.1074/jbc.M211886200; Jafferji A, 2000, J BIOL CHEM, V275, P25089, DOI 10.1074/jbc.M001377200; JOHNSON MK, 1980, BIOCHEM J, V189, P285, DOI 10.1042/bj1890285; Kobayashi K, 1997, BIOCHEMISTRY-US, V36, P13611, DOI 10.1021/bi971045o; Koppenhofer A, 2000, BIOCHEMISTRY-US, V39, P4028, DOI 10.1021/bi991912k; Koppenhofer A, 2000, BIOCHEMISTRY-US, V39, P4243, DOI 10.1021/bi000192a; Leung YC, 1997, BIOCHEM J, V321, P699, DOI 10.1042/bj3210699; MOIR JWB, 1993, EUR J BIOCHEM, V212, P377, DOI 10.1111/j.1432-1033.1993.tb17672.x; Pearson IV, 2003, J BACTERIOL, V185, P6308, DOI 10.1128/JB.185.21.6308-6315.2003; Richter CD, 2002, J BIOL CHEM, V277, P3093, DOI 10.1074/jbc.M108944200; Rinaldo S, 2007, BIOCHEM BIOPH RES CO, V363, P662, DOI 10.1016/j.bbrc.2007.09.036; Rinaldo S, 2007, J BIOL CHEM, V282, P14761, DOI 10.1074/jbc.M700933200; SAM KA, 2007, THESIS U OXFORD; SILVESTRINI MC, 1992, BIOCHEM J, V285, P661, DOI 10.1042/bj2850661; Stevens JM, 2004, ACCOUNTS CHEM RES, V37, P999, DOI 10.1021/ar030266l; TIMKOVICH R, 1982, ARCH BIOCHEM BIOPHYS, V215, P47, DOI 10.1016/0003-9861(82)90277-6; Wang YN, 1996, J AM CHEM SOC, V118, P3972, DOI 10.1021/ja9538647; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; WILLIAMS PA, 1995, NAT STRUCT BIOL, V2, P975, DOI 10.1038/nsb1195-975; WU WS, 1987, J AM CHEM SOC, V109, P3149, DOI 10.1021/ja00244a050; Zajicek RS, 2005, J BIOL CHEM, V280, P26073, DOI 10.1074/jbc.M501890200; ZENNARO E, 1993, FEMS MICROBIOL LETT, V109, P243, DOI 10.1016/0378-1097(93)90027-Y; ZUMFT WG, 1988, ARCH MICROBIOL, V149, P492, DOI 10.1007/BF00446750	36	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12555	12563		10.1074/jbc.M800954200	http://dx.doi.org/10.1074/jbc.M800954200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18310770	hybrid			2022-12-25	WOS:000255340000072
J	Boyle, JG; Logan, PJ; Ewart, MA; Reihill, JA; Ritchie, SA; Connell, JMC; Cleland, SJ; Salt, IP				Boyle, James G.; Logan, Pamela J.; Ewart, Marie-Ann; Reihill, James A.; Ritchie, Stuart A.; Connell, John M. C.; Cleland, Stephen J.; Salt, Ian P.			Rosiglitazone stimulates nitric oxide synthesis in human aortic endothelial cells via AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; UPSTREAM KINASE; SKELETAL-MUSCLE; PPAR-GAMMA; RAT-LIVER; PHOSPHORYLATION; LKB1; SYNTHASE; GLUCOSE; BETA	The thiazolidinedione anti-diabetic drugs increase activation of endothelial nitric-oxide (NO) synthase by phosphorylation at Ser-1177 and increase NO bioavailability, yet the molecular mechanisms that underlie this remain poorly characterized. Several protein kinases, including AMP-activated protein kinase, have been demonstrated to phosphorylate endothelial NO synthase at Ser-1177. In the current study we determined the role of AMP-activated protein kinase in rosiglitazone-stimulated NO synthesis. Stimulation of human aortic endothelial cells with rosiglitazone resulted in the time- and dose-dependent stimulation of AMP-activated protein kinase activity and NO production with concomitant phosphorylation of endothelial NO synthase at Ser-1177. Rosiglitazone stimulated an increase in the ADP/ATP ratio in endothelial cells, and LKB1 was essential for rosiglitazone-stimulated AMPK activity in HeLa cells. Infection of endothelial cells with a virus encoding a dominant negative AMP-activated protein kinase mutant abrogated rosiglitazone-stimulated Ser-1177 phosphorylation and NO production. Furthermore, the stimulation of AMP-activated protein kinase and NO synthesis by rosiglitazone was unaffected by the peroxisome proliferator-activated receptor-gamma inhibitor GW9662. These studies demonstrate that rosiglitazone is able to acutely stimulate NO synthesis in cultured endothelial cells by an AMP-activated protein kinase-dependent mechanism, likely to be mediated by LKB1.	[Boyle, James G.; Logan, Pamela J.; Ewart, Marie-Ann; Reihill, James A.; Ritchie, Stuart A.; Salt, Ian P.] Univ Glasgow, Henry Wellcome Lab Cell Biol, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Boyle, James G.; Ritchie, Stuart A.; Connell, John M. C.; Cleland, Stephen J.] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow Cardiovasc Res Ctr, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Salt, IP (corresponding author), Univ Glasgow, Henry Wellcome Lab Cell Biol, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	i.salt@bio.gla.ac.uk		Salt, Ian/0000-0003-0055-3724; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Reihill, James/0000-0001-8599-5198; s, hema/0000-0002-3440-9475	MRC [G84/6589, G0400874] Funding Source: UKRI; British Heart Foundation Funding Source: Medline; Medical Research Council [G84/6589, G0400874] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altarejos JY, 2005, J BIOL CHEM, V280, P183, DOI 10.1074/jbc.M411810200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calnek DS, 2003, ARTERIOSCL THROM VAS, V23, P52, DOI 10.1161/01.ATV.0000044461.01844.C9; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cho DH, 2004, J BIOL CHEM, V279, P2499, DOI 10.1074/jbc.M309451200; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hetzel J, 2005, ARTERIOSCL THROM VAS, V25, P1804, DOI 10.1161/01.ATV.0000176192.16951.9a; Ignarro Louis J, 2005, Curr Diab Rep, V5, P17, DOI 10.1007/s11892-005-0062-8; Kim KA, 2004, BIOMED CHROMATOGR, V18, P613, DOI 10.1002/bmc.410; Kim KY, 2006, J BIOL CHEM, V281, P13503, DOI 10.1074/jbc.M510357200; Konrad D, 2005, DIABETOLOGIA, V48, P954, DOI 10.1007/s00125-005-1713-7; Kurebayashi S, 2005, ATHEROSCLEROSIS, V182, P71, DOI 10.1016/j.atherosclerosis.2005.02.004; Laight DW, 2000, CARDIOVASC RES, V47, P457, DOI 10.1016/S0008-6363(00)00054-7; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Natali A, 2004, DIABETES CARE, V27, P1349, DOI 10.2337/diacare.27.6.1349; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Pistrosch F, 2004, DIABETES CARE, V27, P484, DOI 10.2337/diacare.27.2.484; Polikandriotis JA, 2005, ARTERIOSCL THROM VAS, V25, P1810, DOI 10.1161/01.ATV.0000177805.65864.d4; REDDY KG, 1994, J AM COLL CARDIOL, V23, P833, DOI 10.1016/0735-1097(94)90627-0; Reihill JA, 2007, BIOCHEM BIOPH RES CO, V354, P1084, DOI 10.1016/j.bbrc.2007.01.110; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sapkota GP, 2002, BIOCHEM J, V368, P507, DOI 10.1042/BJ20021284; Satoh N, 2003, DIABETES CARE, V26, P2493, DOI 10.2337/diacare.26.9.2493; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Ting HH, 1996, J CLIN INVEST, V97, P22, DOI 10.1172/JCI118394; Uesugi T, 1997, J CHROMATOGR B, V703, P63, DOI 10.1016/S0378-4347(97)00430-1; Wang TD, 2004, AM J CARDIOL, V93, P362, DOI 10.1016/j.amjcard.2003.10.022; WILLIAMS SB, 1996, J AM COLL CARDIOL, V27, P564; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005	46	77	83	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11210	11217		10.1074/jbc.M710048200	http://dx.doi.org/10.1074/jbc.M710048200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303014	hybrid			2022-12-25	WOS:000255067400016
J	Soerensen, J; Jakupoglu, C; Beck, H; Forster, H; Schmidt, J; Schmahl, W; Schweizer, U; Conrad, M; Brielmeier, M				Soerensen, Jonna; Jakupoglu, Cemile; Beck, Heike; Foerster, Heidi; Schmidt, Joerg; Schmahl, Wolfgang; Schweizer, Ulrich; Conrad, Marcus; Brielmeier, Markus			The Role of Thioredoxin Reductases in Brain Development	PLOS ONE			English	Article								The thioredoxin-dependent system is an essential regulator of cellular redox balance. Since oxidative stress has been linked with neurodegenerative disease, we studied the roles of thioredoxin reductases in brain using mice with nervous system (NS)-specific deletion of cytosolic (Txnrd1) and mitochondrial (Txnrd2) thioredoxin reductase. While NS-specific Txnrd2 null mice develop normally, mice lacking Txnrd1 in the NS were significantly smaller and displayed ataxia and tremor. A striking patterned cerebellar hypoplasia was observed. Proliferation of the external granular layer (EGL) was strongly reduced and fissure formation and laminar organisation of the cerebellar cortex was impaired in the rostral portion of the cerebellum. Purkinje cells were ectopically located and their dendrites stunted. The Bergmann glial network was disorganized and showed a pronounced reduction in fiber strength. Cerebellar hypoplasia did not result from increased apoptosis, but from decreased proliferation of granule cell precursors within the EGL. Of note, neuron-specific inactivation of Txnrd1 did not result in cerebellar hypoplasia, suggesting a vital role for Txnrd1 in Bergmann glia or neuronal precursor cells.	[Soerensen, Jonna; Jakupoglu, Cemile; Schmidt, Joerg; Brielmeier, Markus] Helmholtz Zentrum Munchen German Res Ctr Environm, Dept Comparat Med, Neuherberg, Germany; [Foerster, Heidi; Conrad, Marcus] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Clin Mol Biol & Tumour Genet, Munich, Germany; [Schweizer, Ulrich] Charite, Neurosci Res Ctr, Inst Experiment Endocrinol, AG Neurobiology of Selenium, Berlin, Germany; [Schmahl, Wolfgang] Ludwig Maximilians Univ Munchen, Inst Vet Pathol, Chair General Pathol & Neuropathol, Munich, Germany; [Beck, Heike] Ludwig Maximilians Univ Munchen, Walter Brendel Ctr, Inst Physiol, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; University of Munich	Soerensen, J (corresponding author), Helmholtz Zentrum Munchen German Res Ctr Environm, Dept Comparat Med, Neuherberg, Germany.	Brielmeier@helmholtz-muenchen.de	Brielmeier, Markus/M-7352-2014; Schweizer, Ulrich/E-8105-2013; Conrad, Marcus/E-8792-2015	Brielmeier, Markus/0000-0002-8715-869X; Conrad, Marcus/0000-0003-1140-5612; Schweizer, Ulrich/0000-0003-1380-4780	Deutsche Forschungsgemeinschaft Priority Programme 1087	Deutsche Forschungsgemeinschaft Priority Programme 1087	This work was supported by the Deutsche Forschungsgemeinschaft Priority Programme 1087 "Selenoproteins" to MC, MB and US. The supporting foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Akterin S, 2006, CELL DEATH DIFFER, V13, P1454, DOI 10.1038/sj.cdd.4401818; Altman J, 1997, DEV CEREBELLAR SYSTE; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; Berggren M, 1996, ANTICANCER RES, V16, P3459; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Cho JH, 2006, DEV BIOL, V290, P125, DOI 10.1016/j.ydbio.2005.11.024; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Coppola V, 2004, DEVELOPMENT, V131, P5185, DOI 10.1242/dev.01383; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; DETALAMONI NT, 1993, P NATL ACAD SCI USA, V90, P11949, DOI 10.1073/pnas.90.24.11949; Fernagut PO, 2003, NEUROSCIENCE, V116, P1123, DOI 10.1016/S0306-4522(02)00778-9; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Gasdaska JR, 1999, J BIOL CHEM, V274, P25379, DOI 10.1074/jbc.274.36.25379; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gladyshev VN, 1996, P NATL ACAD SCI USA, V93, P6146, DOI 10.1073/pnas.93.12.6146; GLOSTER A, 1994, J NEUROSCI, V14, P7319; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HATTEN ME, 1981, J CELL BIOL, V90, P622, DOI 10.1083/jcb.90.3.622; Hattori I, 2004, ANTIOXID REDOX SIGN, V6, P81, DOI 10.1089/152308604771978372; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huard JMT, 1999, DEVELOPMENT, V126, P1927; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lincoln DT, 2003, ANTICANCER RES, V23, P2425; Lind D, 2005, J NEUROSCI RES, V79, P295, DOI 10.1002/jnr.20354; Lovell MA, 2000, FREE RADICAL BIO MED, V28, P418, DOI 10.1016/S0891-5849(99)00258-0; Malynn BA, 2000, GENE DEV, V14, P1390; MARES V, 1970, BRAIN RES, V23, P343, DOI 10.1016/0006-8993(70)90061-2; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; MOORE EC, 1964, J BIOL CHEM, V239, P3453; Nalvarte I, 2004, J BIOL CHEM, V279, P54510, DOI 10.1074/jbc.M408494200; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; ROSS ME, 1990, P NATL ACAD SCI USA, V87, P4189, DOI 10.1073/pnas.87.11.4189; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schomburg L, 2006, ENDOCRINOLOGY, V147, P1306, DOI 10.1210/en.2005-1089; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; SCHWEIZER U, 2006, SELENIUM ITS MOL BIO, pCH23; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Sun QA, 2001, J BIOL CHEM, V276, P3106, DOI 10.1074/jbc.M004750200; Takagi Y, 1999, P NATL ACAD SCI USA, V96, P4131, DOI 10.1073/pnas.96.7.4131; Takagi Y, 2000, J CEREBR BLOOD F MET, V20, P829, DOI 10.1097/00004647-200005000-00009; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; TOHYAMA T, 1992, LAB INVEST, V66, P303; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; WAHLSTEN D, 1991, BRAIN RES, V557, P184, DOI 10.1016/0006-8993(91)90133-G; WAKASUGI N, 1990, P NATL ACAD SCI USA, V87, P8282, DOI 10.1073/pnas.87.21.8282	55	82	87	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1813	10.1371/journal.pone.0001813	http://dx.doi.org/10.1371/journal.pone.0001813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350150	Green Published, Green Submitted, gold			2022-12-25	WOS:000260762300016
J	Feenders, G; Liedvogel, M; Rivas, M; Zapka, M; Horita, H; Hara, E; Wada, K; Mouritsen, H; Jarvis, ED				Feenders, Gesa; Liedvogel, Miriam; Rivas, Miriam; Zapka, Manuela; Horita, Haruhito; Hara, Erina; Wada, Kazuhiro; Mouritsen, Henrik; Jarvis, Erich D.			Molecular Mapping of Movement-Associated Areas in the Avian Brain: A Motor Theory for Vocal Learning Origin	PLOS ONE			English	Article							DRIVEN GENE-EXPRESSION; IMMEDIATE-EARLY GENE; SONG SYSTEM; AUDITORY RESPONSES; NEURAL PATHWAYS; ZEBRA FINCHES; ANTERIOR FOREBRAIN; MIGRATORY BIRDS; PASSERINE BIRDS; NUCLEUS BASALIS	Vocal learning is a critical behavioral substrate for spoken human language. It is a rare trait found in three distantly related groups of birds-songbirds, hummingbirds, and parrots. These avian groups have remarkably similar systems of cerebral vocal nuclei for the control of learned vocalizations that are not found in their more closely related vocal non-learning relatives. These findings led to the hypothesis that brain pathways for vocal learning in different groups evolved independently from a common ancestor but under pre-existing constraints. Here, we suggest one constraint, a pre-existing system for movement control. Using behavioral molecular mapping, we discovered that in songbirds, parrots, and hummingbirds, all cerebral vocal learning nuclei are adjacent to discrete brain areas active during limb and body movements. Similar to the relationships between vocal nuclei activation and singing, activation in the adjacent areas correlated with the amount of movement performed and was independent of auditory and visual input. These same movement-associated brain areas were also present in female songbirds that do not learn vocalizations and have atrophied cerebral vocal nuclei, and in ring doves that are vocal non-learners and do not have cerebral vocal nuclei. A compilation of previous neural tracing experiments in songbirds suggests that the movement-associated areas are connected in a network that is in parallel with the adjacent vocal learning system. This study is the first global mapping that we are aware for movement-associated areas of the avian cerebrum and it indicates that brain systems that control vocal learning in distantly related birds are directly adjacent to brain systems involved in movement control. Based upon these findings, we propose a motor theory for the origin of vocal learning, this being that the brain areas specialized for vocal learning in vocal learners evolved as a specialization of a pre-existing motor pathway that controls movement.	[Feenders, Gesa; Liedvogel, Miriam; Zapka, Manuela; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Inst Biol Umweltwissenschaften, Volkswagen Nachwuchsgruppe Animal Navigat, Oldenburg, Germany; [Rivas, Miriam; Horita, Haruhito; Hara, Erina; Wada, Kazuhiro; Jarvis, Erich D.] Duke Univ Med Ctr, Dept Neurobiol, Durham, NC USA	Carl von Ossietzky Universitat Oldenburg; Volkswagen; Duke University	Mouritsen, H (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol Umweltwissenschaften, Volkswagen Nachwuchsgruppe Animal Navigat, Oldenburg, Germany.	henrik.mouritsen@uni-oldenburg.de; jarvis@neuro.duke.edu	Liedvogel, Miriam/HDM-7933-2022; Liedvogel, Miriam/S-8341-2019; Wada, Kazuhiro/A-6548-2012; Mouritsen, Henrik/A-5401-2010; Liedvogel, Miriam/D-5418-2015; Jarvis, Erich D/A-2319-2008	Mouritsen, Henrik/0000-0001-7082-4839; Liedvogel, Miriam/0000-0002-8372-8560; Jarvis, Erich D/0000-0001-8931-5049; Wada, Kazuhiro/0000-0001-8137-9144	NSF Alan T. Waterman Award; NIH Director's Pioneer Award; DFG; Volkswagen Stiftung Nachwuchsgruppe and Lichtenberg Professorships; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000448] Funding Source: NIH RePORTER	NSF Alan T. Waterman Award; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); Volkswagen Stiftung Nachwuchsgruppe and Lichtenberg Professorships; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a NSF Alan T. Waterman Award and a NIH Director's Pioneer Award to E.D.J. and by the DFG, Volkswagen Stiftung Nachwuchsgruppe and Lichtenberg Professorship grants to H.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allott R., 1992, LANGUAGE ORIGIN MULT, P105, DOI DOI 10.1007/978-94-017-2039-7_7; Altshuler DL, 2006, AM NAT, V167, P216, DOI 10.1086/498622; Bailey DJ, 2006, NEUROSCI LETT, V401, P86, DOI 10.1016/j.neulet.2006.02.076; BAPTISTA LF, 1990, ETHOLOGY, V84, P15; Boiko V P, 1985, Neurosci Behav Physiol, V15, P265, DOI 10.1007/BF01182997; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bottjer SW, 2000, J COMP NEUROL, V420, P244; Cardin JA, 2005, J NEUROPHYSIOL, V93, P2157, DOI 10.1152/jn.01001.2004; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Coleman MJ, 2004, J NEUROSCI, V24, P7251, DOI 10.1523/JNEUROSCI.0947-04.2004; Cooper BG, 2004, SCIENCE, V303, P544, DOI 10.1126/science.1091099; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; DUBBELDAM JL, 1994, EUR J MORPHOL, V32, P127; Dubbeldam JL, 1998, ACTA ANAT, V163, P157; Durand SE, 1997, J COMP NEUROL, V377, P179, DOI 10.1002/(SICI)1096-9861(19970113)377:2<179::AID-CNE3>3.0.CO;2-0; Edelman DB, 2005, CONSCIOUS COGN, V14, P169, DOI 10.1016/j.concog.2004.09.001; EMLEN ST, 1966, AUK, V83, P361, DOI 10.2307/4083048; Farabaugh SM, 1997, BRAIN RES, V747, P18, DOI 10.1016/S0006-8993(96)01143-2; Farabaugh Susan M., 1992, Bioacoustics, V4, P111; Farries MA, 2004, ANN NY ACAD SCI, V1016, P61, DOI 10.1196/annals.1298.007; Farries MA, 2001, BRAIN BEHAV EVOLUT, V58, P80, DOI 10.1159/000047263; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; Fitch WT, 2005, COGNITION, V97, P179, DOI 10.1016/j.cognition.2005.02.005; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Foster EF, 1997, J COMP NEUROL, V382, P364, DOI 10.1002/cne.903820305; Frost BJ, 2006, CURR OPIN NEUROBIOL, V16, P481, DOI 10.1016/j.conb.2006.06.005; FUNKE K, 1989, EXP BRAIN RES, V76, P620, DOI 10.1007/BF00248918; Gahr M, 2000, J COMP NEUROL, V426, P182; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Ghysen A, 2003, INT J DEV BIOL, V47, P555; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HEIL P, 1986, J COMP NEUROL, V252, P279, DOI 10.1002/cne.902520302; Hessler NA, 1999, J NEUROSCI, V19, P10461; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Ito H, 2007, BRAIN BEHAV EVOLUT, V69, P76, DOI 10.1159/000095196; Iwaniuk AN, 2006, BRAIN BEHAV EVOLUT, V67, P53, DOI 10.1159/00089120; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P40, DOI 10.1159/000081110; Iyengar S, 1999, J NEUROSCI, V19, P6037, DOI 10.1523/JNEUROSCI.19-14-06037.1999; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; JARVIS ED, 1995, LEARN MEMORY, V2, P62, DOI 10.1101/lm.2.2.62; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2000, NATURE, V406, P628, DOI 10.1038/35020570; Jarvis ED, 2000, J COMP NEUROL, V419, P1, DOI 10.1002/(SICI)1096-9861(20000327)419:1<1::AID-CNE1>3.0.CO;2-M; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; JOHNSON F, 1995, J COMP NEUROL, V358, P260, DOI 10.1002/cne.903580208; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; KONISHI MASAKAZU, 1964, CONDOR, V66, P85, DOI 10.2307/1365388; Kroner S, 1999, J COMP NEUROL, V407, P228, DOI 10.1002/(SICI)1096-9861(19990503)407:2<228::AID-CNE6>3.0.CO;2-2; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; KRUEGER K, 1982, Comparative Biochemistry and Physiology A, V73, P679; Kubikova L, 2007, EUR J NEUROSCI, V25, P2145, DOI 10.1111/j.1460-9568.2007.05368.x; LEWALD J, 1990, EXP BRAIN RES, V82, P423; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Manger PR, 2002, EUR J NEUROSCI, V16, P743, DOI 10.1046/j.1460-9568.2002.02119.x; MARGOLIASH D, 1994, BRAIN BEHAV EVOLUT, V44, P247, DOI 10.1159/000113580; Medina L, 2000, TRENDS NEUROSCI, V23, P1, DOI 10.1016/S0166-2236(99)01486-1; MELLO C, 1995, J NEUROSCI, V15, P6919; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mello CV, 1998, J COMP NEUROL, V395, P137; MELLO CV, 1995, J NEUROBIOL, V26, P145, DOI 10.1002/neu.480260112; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; MILLER SJ, 1983, ANIM BEHAV, V31, P689, DOI 10.1016/S0003-3472(83)80224-3; Mouritsen H, 1998, ANIM BEHAV, V55, P1311, DOI 10.1006/anbe.1997.0696; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2004, CURR BIOL, V14, P1946, DOI 10.1016/j.cub.2004.10.025; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Necker R, 2001, J COMP NEUROL, V429, P403; Nelson RJ, 1996, CURR OPIN NEUROBIOL, V6, P801, DOI 10.1016/S0959-4388(96)80031-6; Nguyen AP, 2004, J NEUROSCI, V24, P4962, DOI 10.1523/JNEUROSCI.0146-04.2004; NixdorfBergweiler BE, 1996, J COMP NEUROL, V375, P445, DOI 10.1002/(SICI)1096-9861(19961118)375:3<445::AID-CNE7>3.0.CO;2-2; NOTTEBOHM F, 1971, ANIM BEHAV, V19, P313, DOI 10.1016/S0003-3472(71)80012-X; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1972, AM NAT, V106, P116, DOI 10.1086/282756; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Nottebohm F., 1980, PROGR PSYCHOBIOLOGY, V9, P85; Okanoya K, 2007, CURR OPIN NEUROBIOL, V17, P271, DOI 10.1016/j.conb.2007.03.011; PATON JA, 1981, J NEUROSCI, V1, P1279; Perkel DJ, 2004, ANN NY ACAD SCI, V1016, P736, DOI 10.1196/annals.1298.039; Petrides M, 2005, NATURE, V435, P1235, DOI 10.1038/nature03628; Pika S, 2005, AM J PRIMATOL, V65, P39, DOI 10.1002/ajp.20096; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Plummer TK, 2000, J NEUROBIOL, V42, P79, DOI 10.1002/(SICI)1097-4695(200001)42:1<79::AID-NEU8>3.0.CO;2-W; Pollick AS, 2007, P NATL ACAD SCI USA, V104, P8184, DOI 10.1073/pnas.0702624104; Poole JH, 2005, NATURE, V434, P455, DOI 10.1038/434455a; Prum RO, 1998, ANIM BEHAV, V55, P977, DOI 10.1006/anbe.1997.0647; Purves D, 2001, NEUROSCIENCE, V2nd edition; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Reiner A, 2004, J COMP NEUROL, V469, P239, DOI 10.1002/cne.11012; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rendell L, 2001, BEHAV BRAIN SCI, V24, P324, DOI DOI 10.1017/S0140525X0100396X; Sanvito S, 2007, ETHOLOGY, V113, P137, DOI 10.1111/j.1439-0310.2006.01306.x; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Shimizu Toru, 1993, P103; SHOLOMENKO GN, 1991, EXP BRAIN RES, V85, P659, DOI 10.1007/BF00231752; Sibley CG, 1990, PHYLOGENY CLASSIFICA; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; STRIEDTER GF, 1994, J COMP NEUROL, V343, P35, DOI 10.1002/cne.903430104; van Schie HT, 2006, CORTEX, V42, P495, DOI 10.1016/S0010-9452(08)70385-X; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; VEENMAN CL, 1995, J COMP NEUROL, V354, P87, DOI 10.1002/cne.903540108; Wada K, 2004, J COMP NEUROL, V476, P44, DOI 10.1002/cne.20201; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; WEIDNER C, 1985, BRAIN RES, V340, P99, DOI 10.1016/0006-8993(85)90778-4; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A; Wild JM, 1997, BRAIN RES, V759, P122, DOI 10.1016/S0006-8993(97)00253-9; Wild JM, 2000, NEUROSCIENCE, V96, P333, DOI 10.1016/S0306-4522(99)00546-1; Wild JM, 1999, J COMP NEUROL, V413, P520, DOI 10.1002/(SICI)1096-9861(19991101)413:4<520::AID-CNE3>3.0.CO;2-B; Wild JM, 1996, J COMP NEUROL, V365, P306, DOI 10.1002/(SICI)1096-9861(19960205)365:2<306::AID-CNE8>3.0.CO;2-9; Wild JM, 2001, BRAIN BEHAV EVOLUT, V57, P39, DOI 10.1159/000047225; Wild JM, 2000, J COMP NEUROL, V416, P429; Wild JM, 1997, BRAIN RES, V755, P137, DOI 10.1016/S0006-8993(97)00026-7; WILLIAMS H, 1985, SCIENCE, V229, P279, DOI 10.1126/science.4012321; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; ZEIER H, 1971, BRAIN RES, V31, P313, DOI 10.1016/0006-8993(71)90185-5; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1002/AJPA.10171; [No title captured]; [No title captured]; [No title captured]; [No title captured]	131	187	190	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1768	10.1371/journal.pone.0001768	http://dx.doi.org/10.1371/journal.pone.0001768			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369VW	18335043	gold, Green Published, Green Submitted			2022-12-25	WOS:000260723000022
J	Finocchietto, P; Barreyro, F; Holod, S; Peralta, J; Franco, MC; Mendez, C; Converso, DP; Estevez, A; Carreras, MC; Poderoso, JJ				Finocchietto, Paola; Barreyro, Fernando; Holod, Silvia; Peralta, Jorge; Franco, Maria C.; Mendez, Carlos; Converso, Daniela P.; Estevez, Alvaro; Carreras, Maria C.; Poderoso, Juan J.			Control of Muscle Mitochondria by Insulin Entails Activation of Akt2-mtNOS Pathway: Implications for the Metabolic Syndrome	PLOS ONE			English	Article								Background: In the metabolic syndrome with hyperinsulinemia, mitochondrial inhibition facilitates muscle fat and glycogen accumulation and accelerates its progression. In the last decade, nitric oxide (NO) emerged as a typical mitochondrial modulator by reversibly inhibiting citochrome oxidase and oxygen utilization. We wondered whether insulin-operated signaling pathways modulate mitochondrial respiration via NO, to alternatively release complete glucose oxidation to CO(2) and H(2)O or to drive glucose storage to glycogen. Methodology/Principal Findings: We illustrate here that NO produced by translocated nNOS (mtNOS) is the insulin-signaling molecule that controls mitochondrial oxygen utilization. We evoke a hyperinsulinemic-normoglycemic non-invasive clamp by subcutaneously injecting adult male rats with long-lasting human insulin glargine that remains stable in plasma by several hours. At a precise concentration, insulin increased phospho-Akt2 that translocates to mitochondria and determines in situ phosphorylation and substantial cooperative mtNOS activation (+4-8 fold, P<.05), high NO, and a lowering of mitochondrial oxygen uptake and resting metabolic rate (-25 to -60%, P<.05). Comparing in vivo insulin metabolic effects on gastrocnemius muscles by direct electroporation of siRNA nNOS or empty vector in the two legs of the same animal, confirmed that in the silenced muscles disrupted mtNOS allows higher oxygen uptake and complete (U-(14)C)-glucose utilization respect to normal mtNOS in the vector-treated ones (respectively 37 +/- 3 vs 10 +/- 1 mu molO(2)/h. g tissue and 13 +/- 61 vs 7.2 +/- 1 mmol (3)H(2)O/h.g tissue, P<.05), which reciprocally restricted glycogen-synthesis by a half. Conclusions/Significance: These evidences show that after energy replenishment, insulin depresses mitochondrial respiration in skeletal muscle via NO which permits substrates to be deposited as macromolecules; at discrete hyperinsulinemia, persistent mtNOS activation could contribute to mitochondrial dysfunction with insulin resistance and obesity and therefore, to the progression of the metabolic syndrome.	[Finocchietto, Paola; Barreyro, Fernando; Holod, Silvia; Peralta, Jorge; Franco, Maria C.; Converso, Daniela P.; Carreras, Maria C.; Poderoso, Juan J.] Univ Hosp, Lab Oxygen Metab, Buenos Aires, DF, Argentina; [Holod, Silvia; Carreras, Maria C.] Univ Buenos Aires, Univ Hosp, Sch Pharm & Biochem, Dept Clin Biochem, Buenos Aires, DF, Argentina; [Finocchietto, Paola; Barreyro, Fernando; Peralta, Jorge; Poderoso, Juan J.] Univ Buenos Aires, Univ Hosp, Dept Med, Buenos Aires, DF, Argentina; [Mendez, Carlos] Univ Buenos Aires, Sch Med, Dept Human Biochem, Buenos Aires, DF, Argentina; [Estevez, Alvaro] Cornell Univ, Burke Med Res Inst, Ithaca, NY USA	University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; Cornell University	Finocchietto, P (corresponding author), Univ Hosp, Lab Oxygen Metab, Buenos Aires, DF, Argentina.	jpoderos@fmed.uba.ar	Franco, Maria/O-7862-2015	Mendez, Carlos Fernando/0000-0002-9659-1866	Agencia Nacional para la Promocion Cientifica Tecnologica [PICT 8468, PICT 14199]; University of Buenos Aires [Ubacyt M063]; CONICET [PIP 5495]; Fundacion Perez Companc; Fundacion Florencio Fiorini; Fundacion Qualitas; Asociacion Cooperadora del Hospital de Clinicas, Buenos Aires, Argentina	Agencia Nacional para la Promocion Cientifica Tecnologica; University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Perez Companc; Fundacion Florencio Fiorini; Fundacion Qualitas; Asociacion Cooperadora del Hospital de Clinicas, Buenos Aires, Argentina	This work was supported with research grants from the Agencia Nacional para la Promocion Cientifica Tecnologica (FONCYT; PICT 8468 and PICT 14199), Ubacyt M063 (University of Buenos Aires), CONICET (PIP 5495), Fundacion Perez Companc, Fundacion Florencio Fiorini, Fundacion Qualitas, and Asociacion Cooperadora del Hospital de Clinicas, Buenos Aires, Argentina.	Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Auwerx J, 2006, NAT MED, V12, P44, DOI 10.1038/nm0106-44; Barreyro FJ, 2006, HEPATOLOGY, V44, p662A; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; BOVERIS A, 2000, NITRIC OXIDE BIOL PA, P355; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Carreras MC, 2007, AM J PHYSIOL-CELL PH, V292, pC1569, DOI 10.1152/ajpcell.00248.2006; Carreras MC, 2004, HEPATOLOGY, V40, P157, DOI 10.1002/hep.20255; CHO H, 2001, SCIENCE, V242, P1228; CUENDET GS, 1976, J CLIN INVEST, V58, P1078, DOI 10.1172/JCI108559; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; Derave W, 2000, AM J PHYSIOL-ENDOC M, V279, pE947, DOI 10.1152/ajpendo.2000.279.5.E947; Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200; Franco MC, 2006, J BIOL CHEM, V281, P4779, DOI 10.1074/jbc.M512080200; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; Golzio M, 2005, GENE THER, V12, P246, DOI 10.1038/sj.gt.3302405; Hargreaves M, 2004, P NUTR SOC, V63, P217, DOI 10.1079/PNS2004344; Hofmann T, 2002, INT J TOXICOL, V21, P181, DOI 10.1080/10915810290096315; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; Kim YI, 2006, DIABETES, V55, P2311, DOI 10.2337/db05-1606; Korotchkina LG, 2006, J BIOL CHEM, V281, P9688, DOI 10.1074/jbc.M511481200; LELOIR LF, 1960, J BIOL CHEM, V235, P919; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; McKeage K, 2001, DRUGS, V61, P1599, DOI 10.2165/00003495-200161110-00007; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE986, DOI 10.1152/ajpendo.00399.2006; Peralta JG, 2003, AM J PHYSIOL-HEART C, V284, pH2375, DOI 10.1152/ajpheart.00785.2002; Persichini T, 2005, NEUROSCI LETT, V384, P254, DOI 10.1016/j.neulet.2005.04.085; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146; Poderoso JJ, 1999, J BIOL CHEM, V274, P37709, DOI 10.1074/jbc.274.53.37709; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Reinhart L, 2002, AM J HEALTH-SYST PH, V59, P643, DOI 10.1093/ajhp/59.7.643; Riobo NA, 2001, BIOCHEM J, V359, P139, DOI 10.1042/0264-6021:3590139; Sasaoka T, 2004, J BIOL CHEM, V279, P14835, DOI 10.1074/jbc.M311534200; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Trimmer BA, 2001, SCIENCE, V292, P2486, DOI 10.1126/science.1059833; Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2; Turko IV, 2003, J BIOL CHEM, V278, P33972, DOI 10.1074/jbc.M303734200; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zaobornyj T, 2005, J APPL PHYSIOL, V98, P2370, DOI 10.1152/japplphysiol.00986.2004	49	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1749	10.1371/journal.pone.0001749	http://dx.doi.org/10.1371/journal.pone.0001749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335029	gold, Green Submitted, Green Published			2022-12-25	WOS:000260723000003
J	Nakakuki, T; Yumoto, N; Naka, T; Shirouzu, M; Yokoyama, S; Hatakeyama, M				Nakakuki, Takashi; Yumoto, Noriko; Naka, Takashi; Shirouzu, Mikako; Yokoyama, Shigeyuki; Hatakeyama, Mariko			Topological Analysis of MAPK Cascade for Kinetic ErbB Signaling	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR-RECEPTOR; B-RAF; PHOSPHORYLATION SITES; KINASE CASCADE; IN-VIVO; IDENTIFICATION; ACTIVATION; ERK; NETWORK	Ligand-induced homo-and hetero-dimer formation of ErbB receptors results in different biological outcomes irrespective of recruitment and activation of similar effector proteins. Earlier experimental research indicated that cells expressing both EGFR (epidermal growth factor receptor) and the ErbB4 receptor (E1/4 cells) induced E1/4 cell-specific B-Raf activation and higher extracellular signal-regulated kinase (ERK) activation, followed by cellular transformation, than cells solely expressing EGFR (E1 cells) in Chinese hamster ovary (CHO) cells. Since our experimental data revealed the presence of positive feedback by ERK on upstream pathways, it was estimated that the cross-talk/feedback pathway structure of the Raf-MEK-ERK cascade might affect ERK activation dynamics in our cell system. To uncover the regulatory mechanism concerning the ERK dynamics, we used topological models and performed parameter estimation for all candidate structures that possessed ERK-mediated positive feedback regulation of Raf. The structure that reliably reproduced a series of experimental data regarding signal amplitude and duration of the signaling molecules was selected as a solution. We found that the pathway structure is characterized by ERK-mediated positive feedback regulation of B-Raf and B-Raf-mediated negative regulation of Raf-1. Steady-state analysis of the estimated structure indicated that the amplitude of Ras activity might critically affect ERK activity through ERK-B-Raf positive feedback coordination with sustained B-Raf activation in E1/4 cells. However, Rap1 that positively regulates B-Raf activity might be less effective concerning ERK and B-Raf activity. Furthermore, we investigated how such Ras activity in E1/4 cells can be regulated by EGFR/ErbB4 heterodimer-mediated signaling. From a sensitivity analysis of the detailed upstream model for Ras activation, we concluded that Ras activation dynamics is dominated by heterodimer-mediated signaling coordination with a large initial speed of dimerization when the concentration of the ErbB4 receptor is considerably high. Such characteristics of the signaling cause the preferential binding of the Grb2-SOS complex to heterodimer-mediated signaling molecules.	[Nakakuki, Takashi; Yumoto, Noriko; Hatakeyama, Mariko] RIKEN Genom Sci Ctr, Computat & Expt Syst Biol Grp, Cellular Syst Biol Team, Tsurumi Ku, Kanagawa, Japan; [Naka, Takashi] Kyushu Sangyo Univ, Fac Informat Sci, Dept Intelligent Informat, Fukuoka, Japan; [Shirouzu, Mikako; Yokoyama, Shigeyuki] RIKEN Genom Sci Ctr, Protein Res Group, Kanagawa, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo, Japan	RIKEN; RIKEN; University of Tokyo	Nakakuki, T (corresponding author), RIKEN Genom Sci Ctr, Computat & Expt Syst Biol Grp, Cellular Syst Biol Team, Tsurumi Ku, Kanagawa, Japan.	marikoh@gsc.riken.jp	Yokoyama, Shigeyuki/N-6911-2015; Okada, Mariko/N-6933-2015; Shirouzu, Mikako/A-6521-2016	Yokoyama, Shigeyuki/0000-0003-3133-7338; 				Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Baulida J, 1996, J BIOL CHEM, V271, P5251; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185; CAMPA MJ, 1991, BIOCHEM BIOPH RES CO, V174, P1, DOI 10.1016/0006-291X(91)90475-M; Chen D, 1996, J BIOL CHEM, V271, P6328, DOI 10.1074/jbc.271.11.6328; Cohen BD, 1996, J BIOL CHEM, V271, P30897, DOI 10.1074/jbc.271.48.30897; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Hatakeyama M, 2004, ONCOGENE, V23, P5023, DOI 10.1038/sj.onc.1207664; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Holt KH, 1996, J BIOL CHEM, V271, P8300, DOI 10.1074/jbc.271.14.8300; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kim JH, 2002, EUR J BIOCHEM, V269, P2323, DOI 10.1046/j.1432-1033.2002.02877.x; Kimura S, 2003, IEEE SYS MAN CYBERN, P335; Klinghoffer RA, 2001, MOL CELL, V7, P343, DOI 10.1016/S1097-2765(01)00182-4; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MARUTA H, 1994, BIOESSAYS, V16, P489, DOI 10.1002/bies.950160708; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Reusch HP, 2001, J BIOL CHEM, V276, P33630, DOI 10.1074/jbc.M105322200; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wiseman SM, 2005, CANCER-AM CANCER SOC, V103, P1770, DOI 10.1002/cncr.20970; Xia WY, 1999, CLIN CANCER RES, V5, P4164; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yumoto N, 2006, MOL CELL BIOCHEM, V285, P165, DOI 10.1007/s11010-005-9075-5; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	49	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1782	10.1371/journal.pone.0001782	http://dx.doi.org/10.1371/journal.pone.0001782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335053	gold, Green Published, Green Submitted			2022-12-25	WOS:000260723000034
J	Lopman, B; Gregson, S				Lopman, Ben; Gregson, Simon			When Did HIV Incidence Peak in Harare, Zimbabwe? Back-Calculation from Mortality Statistics	PLOS ONE			English	Article							INFECTION; AIDS; AFRICA; SPREAD; IMPACT; TIME	HIV prevalence has recently begun to decline in Zimbabwe, a result of both high levels of AIDS mortality and a reduction in incident infections. An important component in understanding the dynamics in HIV prevalence is knowledge of past trends in incidence, such as when incidence peaked and at what level. However, empirical measurements of incidence over an extended time period are not available from Zimbabwe or elsewhere in sub-Saharan Africa. Using mortality data, we use a back-calculation technique to reconstruct historic trends in incidence. From AIDS mortality data, extracted from death registration in Harare, together with an estimate of survival post-infection, HIV incidence trends were reconstructed that would give rise to the observed patterns of AIDS mortality. Models were fitted assuming three parametric forms of the incidence curve and under nine different assumptions regarding combinations of trends in non-AIDS mortality and patterns of survival post-infection with HIV. HIV prevalence was forward-projected from the fitted incidence and mortality curves. Models that constrained the incidence pattern to a cubic spline function were flexible and produced well-fitting, realistic patterns of incidence. In models assuming constant levels of non-AIDS mortality, annual incidence peaked between 4 and 5% between 1988 and 1990. Under other assumptions the peak level ranged from 3 to 8% per annum. However, scenarios assuming increasing levels of non-AIDS mortality resulted in implausibly low estimates of peak prevalence (11%), whereas models with decreasing underlying crude mortality could be consistent with the prevalence and mortality data. HIV incidence is most likely to have peaked in Harare between 1988 and 1990, which may have preceded the peak elsewhere in Zimbabwe. This finding, considered alongside the timing and location of HIV prevention activities, will give insight into the decline of HIV prevalence in Zimbabwe.	[Lopman, Ben; Gregson, Simon] Imperial Coll London, Dept Infect Dis Epidemiol, London, England; [Gregson, Simon] Biomed Res & Training Inst, Harare, Zimbabwe	Imperial College London; Biomedical Research Training Institute	Lopman, B (corresponding author), Imperial Coll London, Dept Infect Dis Epidemiol, London, England.	Ben.Lopman@hpa.org.uk		Gregson, Simon/0000-0003-2707-0714	Wellcome Trust; UNAIDS	Wellcome Trust(Wellcome Trust); UNAIDS	This work was supported by the Wellcome Trust and UNAIDS. The funders had no influence in the collection, analysis, and interpretation of the data, or in the preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; [Anonymous], WORLD POP PROSP 2004; BROOKMEYER R, 1991, SCIENCE, V253, P37, DOI 10.1126/science.2063206; Brookmeyer R., 1994, AIDS EPIDEMIOLOGY QU; *CASCASE COLL, LANCET, V355, P1131; Feeney G, 2001, POPUL DEV REV, V27, P771, DOI 10.1111/j.1728-4457.2001.00771.x; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2005, AIDS CARE, V17, P785, DOI 10.1080/09540120500258029; Gregson S, 1998, AIDS, V12, P2049, DOI 10.1097/00002030-199815000-00017; HOWDEN D, 2006, INDEPENDENT, P8; ISHAM V, 1989, PHILOS T ROY SOC B, V325, P113, DOI 10.1098/rstb.1989.0076; Machekano R., 1998, Central African Journal of Medicine, V44, P98; Mbizvo M. T., 1997, Central African Journal of Medicine, V43, P135; Mbizvo M T, 2001, Cent Afr J Med, V47, P115; *MEAS DHS ZIMB CEN, 2006, ZIMB DEM HLTH SURV 2; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; MOTULKSKY H, 2004, FITTING MODELS BIOL; OSULLIVAN F, STAT SCI, V1, P502; POTTS D, 1990, J S AFR STUD, V16, P677, DOI 10.1080/03057079008708256; Sonnenberg P, 2004, AIDS, V18, P657, DOI 10.1097/00002030-200403050-00010; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; *UN POP DIV, 2004, POP DAT; *UNAIDS, 2004, REP GLOB AIDS EP; *UNAIDS, 2005, EV HIV DECL ZIMB COM; *UNAIDS ZIMB MIN H, 2005, ZIMB NAT HIV AIDS ES; Wasserheit JN, 1996, J INFECT DIS, V174, pS201, DOI 10.1093/infdis/174.Supplement_2.S201	27	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1711	10.1371/journal.pone.0001711	http://dx.doi.org/10.1371/journal.pone.0001711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320032	Green Published, Green Submitted, gold			2022-12-25	WOS:000260586600007
J	Ye, WB; Lv, Q; Wong, CKA; Hu, S; Fu, C; Hua, Z; Cai, GP; Li, GX; Yang, BB; Zhang, Y				Ye, Wenbin; Lv, Qing; Wong, Chung-Kwun Amy; Hu, Sean; Fu, Chao; Hua, Zhong; Cai, Guoping; Li, Guoxi; Yang, Burton B.; Zhang, Yaou			The Effect of Central Loops in miRNA:MRE Duplexes on the Efficiency of miRNA-Mediated Gene Regulation	PLOS ONE			English	Article							CELL-PROLIFERATION; MICRORNA EXPRESSION; MESSENGER-RNAS; TARGETS; PREDICTION; DIFFERENTIATION; IDENTIFICATION; SPECIFICITY; BIOGENESIS; SEQUENCE	MicroRNAs (miRNAs) guide posttranscriptional repression of mRNAs. Hundreds of miRNAs have been identified but the target identification of mammalian mRNAs is still a difficult task due to a poor understanding of the interaction between miRNAs and the miRNA recognizing element (MRE). In recent research, the importance of the 59 end of the miRNA:MRE duplex has been emphasized and the effect of the tail region addressed, but the role of the central loop has largely remained unexplored. Here we examined the effect of the loop region in miRNA: MRE duplexes and found that the location of the central loop is one of the important factors affecting the efficiency of gene regulation mediated by miRNAs. It was further determined that the addition of a loop score combining both location and size as a new criterion for predicting MREs and their cognate miRNAs significantly decreased the false positive rates and increased the specificity of MRE prediction.	[Wong, Chung-Kwun Amy; Yang, Burton B.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Dept Lab Med & Pathol, Toronto, ON, Canada; [Ye, Wenbin; Lv, Qing; Fu, Chao] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing, Peoples R China; [Ye, Wenbin; Lv, Qing; Fu, Chao; Hua, Zhong; Cai, Guoping; Zhang, Yaou] Tsinghua Univ, Grad Sch, Div Life Sci, Shenzhen, Peoples R China; [Hu, Sean; Li, Guoxi] Shenzhen Beike Biotechnol Co Ltd, Shenzhen, Peoples R China	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Yang, BB (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Dept Lab Med & Pathol, Toronto, ON, Canada.	byang@sri.utoronto.ca; zhangyo@sz.tsinghua.edu.cn	Hua, Zhong/J-8149-2014; Lyu, Qing/AAF-5181-2021; Lyu, Qing/AAP-8387-2020	Lyu, Qing/0000-0002-1325-6828; 	Canadian Institutes of Health Research [MOP-62729]; National Natural Science Foundation of China [30611120519]; Shenzhen Bureau of Science Technology & Information [387 2005-k2-046]; Heart and Stroke Foundation of Ontario [CI 5958]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Bureau of Science Technology & Information; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by a China-Canada Joint Health Research Grant (from Canadian Institutes of Health Research and the National Natural Science Foundation of China to Burton B. Yang and Yaou Zhang), Grant MOP-62729 from Canadian Institutes of Health Research to Burton B. Yang, Grant 30611120519 from the National Natural Science Foundation of China to Yaou Zhang, and Grant 387 2005-k2-046 from the Shenzhen Bureau of Science Technology & Information to Yaou Zhang. Burton B. Yang is the recipient of a Career Investigator Award (CI 5958) from the Heart and Stroke Foundation of Ontario.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Enright AJ, 2004, GENOME BIOL, V5; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Makunin IV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001133; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; MARTIN MM, 2006, J BIOL CHEM; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sandmann T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001265; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sheng Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000946; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	65	117	121	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1719	10.1371/journal.pone.0001719	http://dx.doi.org/10.1371/journal.pone.0001719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320040	Green Published, gold, Green Submitted			2022-12-25	WOS:000260586600015
J	Perel, P; Miranda, JJ; Ortiz, Z; Casas, JP				Perel, Pablo; Miranda, J. Jaime; Ortiz, Zulma; Casas, Juan Pablo			Relation between the Global Burden of Disease and Randomized Clinical Trials Conducted in Latin America Published in the Five Leading Medical Journals	PLOS ONE			English	Article							COUNTRIES; AFRICA	Background: Since 1990 non communicable diseases and injuries account for the majority of death and disability-adjusted life years in Latin America. We analyzed the relationship between the global burden of disease and Randomized Clinical Trials (RCTs) conducted in Latin America that were published in the five leading medical journals. Methodology/Principal Findings: We included all RCTs in humans, exclusively conducted in Latin American countries, and published in any of the following journals: Annals of Internal Medicine, British Medical Journal, Journal of the American Medical Association, Lancet, and New England Journal of Medicine. We described the trials and reported the number of RCTs according to the main categories of the global burden of disease. Sixty-six RCTs were identified. Communicable diseases accounted for 38 (57%) reports. Maternal, perinatal, and nutritional conditions accounted for 19 (29%) trials. Non-communicable diseases represent 48% of the global burden of disease but only 14% of reported trials. No trial addressed injuries despite its 18% contribution to the burden of disease in 2000. Conclusions/Significance: A poor correlation between the burden of disease and RCTs publications was found. Non communicable diseases and injuries account for up to two thirds of the burden of disease in Latin America but these topics are seldom addressed in published RCTs in the selected sample of journals. Funding bodies of health research and editors should be aware of the increasing burden of non communicable diseases and injuries occurring in Latin America to ensure that this growing epidemic is not neglected in the research agenda and not affected by publication bias.	[Perel, Pablo; Miranda, J. Jaime; Casas, Juan Pablo] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Miranda, J. Jaime] Univ Peruana Cayetano Heredia, Sch Publ Hlth, Lima, Peru; [Ortiz, Zulma] Natl Acad Med, Epidemiol Res Inst, Buenos Aires, DF, Argentina	University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia; Buenos Aires National Academy of Medicine; IIE - Instituto de Investigaciones Epidemiologicas	Perel, P (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	jaime.miranda@lshtm.ac.uk	Miranda, J. Jaime/A-8482-2008	Miranda, J. Jaime/0000-0002-4738-5468; /0000-0002-2342-301X	Wellcome Trust Research Training Fellowship [GR074833MA]	Wellcome Trust Research Training Fellowship(Wellcome Trust)	JJM is supported by a Wellcome Trust Research Training Fellowship (GR074833MA). The authors have no additional support or funding to report.	[Anonymous], 2006, LANCET, V368, P619; [Anonymous], 1996, GLOBAL BURDEN DIS CO; BAKKE P, 1985, SCIENTOMETRICS, V1, P11; Bruzzi P, 2008, BMJ-BRIT MED J, V336, P1, DOI 10.1136/bmj.39416.559942.BE; Doval HC, 2005, BMJ-BRIT MED J, V331, P425, DOI 10.1136/bmj.38516.398067.E0; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Glanville JM, 2006, J MED LIBR ASSOC, V94, P130; *GLOB FOR HLTH RES, 2002, 1090 GLOB FOR HLTH R; Gulmezoglu AM, 2005, LANCET, V365, P1829, DOI 10.1016/S0140-6736(05)66589-0; HIGGINS JPT, 2005, COCHRANE LIB, V1; Horton R, 2003, LANCET, V361, P712, DOI 10.1016/S0140-6736(03)12665-7; Horton R, 2000, LANCET, V355, P2231, DOI 10.1016/S0140-6736(00)02414-4; Isaakidis P, 2002, BRIT MED J, V324, P702, DOI 10.1136/bmj.324.7339.702; Keiser J, 2004, BMJ-BRIT MED J, V328, P1229, DOI 10.1136/bmj.38069.518137.F6; Kenyon S, 2002, BJOG-INT J OBSTET GY, V109, P1341; Langer A, 2004, B WORLD HEALTH ORGAN, V82, P802; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; OBUAYA CC, 2002, EURO SCI EDIT, V28, P72; Perel P, 2006, PLOS MED, V3, P1448, DOI 10.1371/journal.pmed.0030344; Reveiz L, 2006, REV PANAM SALUD PUBL, V19, P417, DOI 10.1590/S1020-49892006000600014; Rochon PA, 2004, CAN MED ASSOC J, V170, P1673, DOI 10.1503/cmaj.1031006; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Siegfried N, 2005, BRIT MED J, V331, P742, DOI 10.1136/bmj.331.7519.742; Sumathipala Athula, 2004, BMC Med Ethics, V5, pE5	25	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1696	10.1371/journal.pone.0001696	http://dx.doi.org/10.1371/journal.pone.0001696			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301772	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000260586500040
J	Horn, S; Bergholz, U; Jucker, M; McCubrey, JA; Trumper, L; Stocking, C; Basecke, J				Horn, S.; Bergholz, U.; Juecker, M.; McCubrey, J. A.; Truemper, L.; Stocking, C.; Baesecke, J.			Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells	ONCOGENE			English	Article						leukemia; oncogenic transformation; phosphoinositide 3-kinase; signal transduction	ACUTE MYELOID-LEUKEMIA; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; ACUTE MYELOGENOUS LEUKEMIA; PIK3CA GENE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; HUMAN CANCER; IN-VIVO; C-MYC; CONSTITUTIVE PHOSPHORYLATION	Constitutive activation of the phosphoinositide 3-kinase ( PI3K)-AKT pathway is observed in up to 70% of acute myelogenous leukemia. To investigate the relevance of an intrinsic PI3K-AKT pathway activation in hematopoietic malignancies, we analysed the effect of point mutations in the catalytic ( p110 alpha) and regulatory ( p85 alpha) subunit of class IA PI3K. We demonstrated that mutations in the helical ( E542K, E545A) and kinase domain ( H1047R) of p110 alpha constitutively activate the PI3K-AKT pathway and lead to factor-independent growth of early hematopoietic cells. Proliferation and survival of the cells were inhibited in a time- and dose-dependent manner using either PI3K or AKT inhibitors. The mammalian target of rapamycin ( mTOR) was demonstrated to be important for mitogenic, but not antiapoptotic signaling of mutant p110a. In a syngenic mouse model, hematopoietic cells expressing mutated p110 alpha induced a leukemia-like disease characterized by anemia, neoplastic infiltration of hematopoietic organs and 90% mortality within 5 weeks, whereas activated mutants of the receptor tyrosine kinase c-KIT led to 100% mortality within 10 days. Our data show that point mutations in the p110 alpha subunit of class IA PI3K confer factor independence to hematopoietic cells in vitro and leukemogenic potential in vivo, but have lower transforming activity than a deregulated class III receptor tyrosine kinase.	[Horn, S.; Truemper, L.; Baesecke, J.] Univ Gottingen, Dept Hematol & Oncol, D-37075 Gottingen, Germany; [Bergholz, U.; Stocking, C.] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, Program Area Cellular Dysregulat, Mol Pathol Grp, D-2000 Hamburg, Germany; [Juecker, M.] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol Cellular Signal Transduct, Hamburg, Germany; [McCubrey, J. A.] Univ Greenville, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC USA	University of Gottingen; Heinrich Pette Institute; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Basecke, J (corresponding author), Univ Gottingen, Dept Hematol & Oncol, Robert Koch Str 40, D-37075 Gottingen, Germany.	jbaesec@gwdg.de		McCubrey, James/0000-0001-6027-3156				Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Billottet C, 2006, ONCOGENE, V25, P6648, DOI 10.1038/sj.onc.1209670; Borlado LR, 2000, FASEB J, V14, P895; Bouchard C, 2004, EMBO J, V23, P2830, DOI 10.1038/sj.emboj.7600279; Bousquet M, 2005, BRIT J HAEMATOL, V131, P411, DOI 10.1111/j.1365-2141.2005.05784.x; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Cammenga J, 2005, BLOOD, V106, P3958, DOI 10.1182/blood-2005-02-0583; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Dutton A, 2005, J PATHOL, V205, P498, DOI 10.1002/path.1725; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; Gilliland DG, 2002, CURR OPIN HEMATOL, V9, P274, DOI 10.1097/00062752-200207000-00003; Grandage VL, 2005, LEUKEMIA, V19, P586, DOI 10.1038/sj.leu.2403653; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hashimoto K, 2003, BLOOD, V101, P1094, DOI 10.1182/blood-2002-01-0177; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Hummerdal P, 2006, EUR J HAEMATOL, V77, P86, DOI 10.1111/j.0902-4441.2006.t01-1-EJH2605.x; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Jucker M, 2002, LEUKEMIA, V16, P894, DOI 10.1038/sj.leu.2402484; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Kornblau SM, 2006, BLOOD, V108, P2358, DOI 10.1182/blood-2006-02-003475; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Li VSW, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-29; Luo JM, 2003, LEUKEMIA, V17, P1, DOI 10.1038/sj.leu.2402725; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Min YH, 2004, CANCER RES, V64, P5225, DOI 10.1158/0008-5472.CAN-04-0174; Min YH, 2003, LEUKEMIA, V17, P995, DOI 10.1038/sj.leu.2402874; Muller CI, 2007, LEUKEMIA RES, V31, P27, DOI 10.1016/j.leukres.2006.04.011; Nyakern M, 2006, LEUKEMIA, V20, P230, DOI 10.1038/sj.leu.2404057; Philp AJ, 2001, CANCER RES, V61, P7426; Recher C, 2005, BLOOD, V105, P2527, DOI 10.1182/blood-2004-06-2494; RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x; Rudelius M, 2006, BLOOD, V108, P1668, DOI 10.1182/blood-2006-04-015586; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schade AE, 2006, BLOOD, V107, P4834, DOI 10.1182/blood-2005-08-3076; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Shelton JG, 2004, CELL CYCLE, V3, P503; Shivakrupa R, 2003, CANCER RES, V63, P4412; STOCKING C, 1993, GROWTH FACTORS, V8, P197, DOI 10.3109/08977199309011023; Sujobert P, 2005, BLOOD, V106, P1063, DOI 10.1182/blood-2004-08-3225; Uddin S, 2006, BLOOD, V108, P4178, DOI 10.1182/blood-2006-04-016907; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wick MJ, 2003, J BIOL CHEM, V278, P42913, DOI 10.1074/jbc.M304172200; Xu Q, 2003, BLOOD, V102, P972, DOI 10.1182/blood-2002-11-3429; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhao S, 2004, LEUKEMIA, V18, P267, DOI 10.1038/sj.leu.2403220	53	40	40	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 3	2008	27	29					4096	4106		10.1038/onc.2008.40	http://dx.doi.org/10.1038/onc.2008.40			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	321RV	18317450				2022-12-25	WOS:000257325100009
J	Bahassi, EM; Ovesen, JL; Riesenberg, AL; Bernstein, WZ; Hasty, PE; Stambrook, PJ				Bahassi, E. M.; Ovesen, J. L.; Riesenberg, A. L.; Bernstein, W. Z.; Hasty, P. E.; Stambrook, P. J.			The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage	ONCOGENE			English	Article						Rad51; DNA damage; homologous recombination; phosphorylation	CANCER SUSCEPTIBILITY GENE; HOMOLOGOUS RECOMBINATION; HUMAN BRCA2; BREAST; PROTEIN; REPAIR; HYPERSENSITIVITY; INSTABILITY; EXCHANGE; REPEATS	The cellular response to the introduction of double strand DNA breaks involves complexes of protein interactions that govern cell cycle checkpoint arrest and repair of the DNA lesions. The checkpoint kinases Chk1 and Chk2 phosphorylate the carboxy-terminal domain of hBRCA2, a protein involved in recombination-mediated DNA repair (HRR) and replication fork maintenance. Cells deficient in hBRCA2 are hypersensitive to DNA damaging agents. Phosphorylation of the residue in hBRCA2 targeted by the Chk1 and Chk2 kinases regulates its interaction with Rad51. Furthermore, the cell line lex1/lex2, which lacks the carboxy-terminal domain containing the phosphorylated residue, does not support localization of Rad51 to nuclear foci after exposure to UV or treatment with ionizing radiation (IR). The data show that either phosphorylation of Rad51 by Chk1 or phosphorylation of the carboxy-terminal domain of hBRCA2 by Chk1 or Chk2 plays a critical role in the binding of Rad51 to hBRCA2 and the subsequent recruitment of Rad51 to sites of DNA damage. While depletion of Chk1 from cells leads to loss of Rad51 localization to nuclear foci in response to replication arrest, cells lacking Chk2 also show a defect in Rad51 localization, but only in presence of double strand DNA breaks, indicating that each of these kinases may contribute somewhat differently to the formation of Rad51 nucleoprotein. laments depending on the type of DNA damage incurred by the cells.	[Bahassi, E. M.; Ovesen, J. L.; Riesenberg, A. L.; Bernstein, W. Z.; Stambrook, P. J.] Univ Cincinnati, Coll Med, Dept Cell & Canc Biol, Cincinnati, OH 45267 USA; [Hasty, P. E.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78229 USA	University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Health San Antonio	Stambrook, PJ (corresponding author), Univ Cincinnati, Coll Med, Dept Cell & Canc Biol, 3125 Eden Ave, Cincinnati, OH 45267 USA.	peter.stambrook@uc.edu		Hasty, Paul/0000-0003-3046-0131	NCI NIH HHS [CA 90934] Funding Source: Medline; NIEHS NIH HHS [P39-ES06096, U02 ES011038, P30-ES06096] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011038, P30ES006096] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bahassi EM, 2007, MUTAT RES-FUND MOL M, V616, P201, DOI 10.1016/j.mrfmmm.2006.11.025; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bork P, 1996, NAT GENET, V13, P22, DOI 10.1038/ng0596-22; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Donoho G, 2003, GENE CHROMOSOME CANC, V36, P317, DOI 10.1002/gcc.10148; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Mizuta R, 1997, P NATL ACAD SCI USA, V94, P6927, DOI 10.1073/pnas.94.13.6927; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shivji MKK, 2006, NUCLEIC ACIDS RES, V34, P4000, DOI 10.1093/nar/gkl505; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Venkitaraman AR, 2000, PHILOS T R SOC B, V355, P191, DOI 10.1098/rstb.2000.0558; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yu VPCC, 2000, GENE DEV, V14, P1400	19	120	130	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2008	27	28					3977	3985		10.1038/onc.2008.17	http://dx.doi.org/10.1038/onc.2008.17			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	318JZ	18317453				2022-12-25	WOS:000257089000009
J	Khan, AA; Hanada, T; Mohseni, M; Jeong, JJ; Zeng, LX; Gaetani, M; Li, DH; Reed, BC; Speicher, DW; Chishti, AH				Khan, Anwar A.; Hanada, Toshihiko; Mohseni, Morvarid; Jeong, Jong-Jin; Zeng, Lixiao; Gaetani, Massimiliano; Li, Donghai; Reed, Brent C.; Speicher, David W.; Chishti, Athar H.			Dematin and adducin provide a novel link between the spectrin cytoskeleton and human erythrocyte membrane by directly interacting with glucose transporter-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELL; GLUCOSE-TRANSPORTER GLUT1; ACTIN-BINDING DOMAIN; GLYCOPHORIN-C; BETA-ADDUCIN; PROTEIN 4.1; SKELETAL PROTEIN-4.1; DEFICIENCY SYNDROME; STABILITY; COMPLEX	Dematin and adducin are actin-binding proteins located at the spectrin-actin junctions, also called the junctional complex, in the erythrocyte membrane. Here we propose a new model whereby dematin and adducin link the junctional complex to human erythrocyte plasma membrane. Using a combination of surface labeling, immunoprecipitation, and vesicle proteomics approaches, we have identified glucose transporter-1 as the receptor for dematin and adducin in the human erythrocyte membrane. This finding is the first description of a transmembrane protein that binds to dematin and adducin, thus providing a rationale for the attachment of the junctional complex to the lipid bilayer. Because homologues of dematin, adducin, and glucose transporter-1 exist in many non-erythroid cells, we propose that a conserved mechanism may exist that couples sugar and other related transporters to the actin cytoskeleton.	[Khan, Anwar A.; Hanada, Toshihiko; Mohseni, Morvarid; Jeong, Jong-Jin; Zeng, Lixiao; Chishti, Athar H.] Univ Illinois, Ctr Canc, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [Gaetani, Massimiliano; Li, Donghai; Speicher, David W.] Wistar Inst Anat & Biol, Syst Biol Div, Philadelphia, PA 19104 USA; [Reed, Brent C.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; The Wistar Institute; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Chishti, AH (corresponding author), Univ Illinois, Ctr Canc, Dept Pharmacol, Coll Med, MC-704,909 S Wolcott Ave, Chicago, IL 60612 USA.	chishti@uic.edu	Gaetani, Massimiliano/Z-1252-2019	Gaetani, Massimiliano/0000-0001-5610-0797	NHLBI NIH HHS [HL 38794, HL 051445, R01 HL038794] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL051445, R01HL051445, R01HL038794] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AZIM AC, 1995, J BIOL CHEM, V270, P17407, DOI 10.1074/jbc.270.29.17407; BALDWIN SA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P17, DOI 10.1016/0304-4157(93)90015-G; BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; Boukharov AA, 1998, BIOCHEM J, V330, P1391, DOI 10.1042/bj3301391; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Chang SH, 2001, J BIOL CHEM, V276, P22223, DOI 10.1074/jbc.M100604200; CHASIS JA, 1992, BLOOD, V80, P1869; Chen HQ, 2007, J BIOL CHEM, V282, P4124, DOI 10.1074/jbc.M610231200; Chishti A H, 1998, Curr Opin Hematol, V5, P116; CHISHTI AH, 1988, NATURE, V334, P718; CONBOY JG, 1993, SEMIN HEMATOL, V30, P58; DAS AK, 1994, EUR J BIOCHEM, V224, P575, DOI 10.1111/j.1432-1033.1994.00575.x; DERICK LH, 1992, EUR J CELL BIOL, V57, P317; DISCHER D, 1993, J BIOL CHEM, V268, P7186; DISCHER DE, 1995, J CELL BIOL, V130, P897, DOI 10.1083/jcb.130.4.897; Gilligan DM, 1999, P NATL ACAD SCI USA, V96, P10717, DOI 10.1073/pnas.96.19.10717; GILLIGAN DM, 1993, SEMIN HEMATOL, V30, P74; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; Heilig C, 2003, AM J PATHOL, V163, P1873, DOI 10.1016/S0002-9440(10)63546-8; HEMMING NJ, 1994, BIOCHEM J, V299, P191, DOI 10.1042/bj2990191; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Huang S, 2001, EUR J CLIN INVEST, V31, P907, DOI 10.1046/j.1365-2362.2001.00892.x; IZUMO A, 1989, PARASITOLOGY, V98, P371, DOI 10.1017/S0031182000061448; JARVIS SM, 1988, BIOCHEM J, V249, P383, DOI 10.1042/bj2490383; Kakhniashvili DG, 2004, MOL CELL PROTEOMICS, V3, P501, DOI 10.1074/mcp.M300132-MCP200; Khanna R, 2002, P NATL ACAD SCI USA, V99, P6637, DOI 10.1073/pnas.052155999; Klepper J, 2005, BIOCHEMISTRY-US, V44, P12621, DOI 10.1021/bi051079t; Klepper J, 2002, EUR J PEDIATR, V161, P295, DOI 10.1007/s00431-002-0939-3; Klepper J, 1999, J CLIN LAB ANAL, V13, P116, DOI 10.1002/(SICI)1098-2825(1999)13:3<116::AID-JCLA5>3.0.CO;2-C; Klepper J, 2007, DEV MED CHILD NEUROL, V49, P707, DOI 10.1111/j.1469-8749.2007.00707.x; KONDO T, 1980, J CLIN INVEST, V65, P1, DOI 10.1172/JCI109638; LARIS PC, 1958, J CELL COMPAR PHYSL, V51, P273, DOI 10.1002/jcp.1030510212; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Lux SE, 1995, BLOOD PRINCIPLES PRA, P1701; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; MARFATIA SM, 1994, J BIOL CHEM, V269, P8631; MARFATIA SM, 1995, J BIOL CHEM, V270, P715, DOI 10.1074/jbc.270.2.715; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Muro AF, 2000, BLOOD, V95, P3978; OHANIAN V, 1984, BIOCHEMISTRY-US, V23, P4416, DOI 10.1021/bi00314a027; Pascual JM, 2004, REV NEUROLOGIA, V38, P860, DOI 10.33588/rn.3809.2003609; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; PINDER JC, 1993, BLOOD, V82, P3482; Rabenstein RL, 2005, J NEUROSCI, V25, P2138, DOI 10.1523/JNEUROSCI.3530-04.2005; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; STAUFENBIEL M, 1986, P NATL ACAD SCI USA, V83, P318, DOI 10.1073/pnas.83.2.318; Steck T L, 1974, Methods Enzymol, V31, P172; TAKAKUWA Y, 1990, BIORHEOLOGY, V27, P357; TAKAKUWA Y, 1986, J CLIN INVEST, V78, P80, DOI 10.1172/JCI112577; Wang D, 2006, HUM MOL GENET, V15, P1169, DOI 10.1093/hmg/ddl032; WIDDAS WF, 1955, J PHYSIOL-LONDON, V127, P318, DOI 10.1113/jphysiol.1955.sp005259; WINARDI R, 1993, BLOOD, V81, P2799; Zhang JZ, 1999, ARCH BIOCHEM BIOPHYS, V372, P173, DOI 10.1006/abbi.1999.1489; Zhang JZ, 2001, AM J PHYSIOL-CELL PH, V280, pC1277, DOI 10.1152/ajpcell.2001.280.5.C1277	55	68	72	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14600	14609		10.1074/jbc.M707818200	http://dx.doi.org/10.1074/jbc.M707818200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18347014	hybrid, Green Published			2022-12-25	WOS:000255941400048
J	Litherland, GJ; Dixon, C; Lakey, RL; Robson, T; Jones, D; Young, DA; Cawston, TE; Rowan, AD				Litherland, Gary J.; Dixon, Craig; Lakey, Rachel L.; Robson, Timothy; Jones, Debra; Young, David A.; Cawston, Tim E.; Rowan, Andrew D.			Synergistic collagenase expression and cartilage collagenolysis are phosphatidylinositol 3-kinase/Akt signaling-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ARTHRITIS SYNOVIAL FIBROBLASTS; MATRIX METALLOPROTEINASE-13 EXPRESSION; HUMAN ARTICULAR CHONDROCYTES; LINKED-IMMUNOSORBENT-ASSAY; ACTIVATED PROTEIN-KINASE; BOVINE NASAL CARTILAGE; T-CELL-ACTIVATION; ONCOSTATIN-M; RHEUMATOID-ARTHRITIS	The phosphatidylinositol 3-kinase (PI3K) signaling pathway has emerged as a major regulator of cellular functions and has been implicated in several pathologies involving remodeling of extracellular matrix ( ECM). The end stage of inflammatory joint diseases is characterized by excessive ECM catabolism, and in this study we assess the role of PI3K signaling in the induction of collagenolytic matrix metalloproteinases ( MMPs) in human chondrocytes. We used the most potent cytokine stimulus reported to promote cartilage ECM catabolism, namely interleu-kin-1 ( IL-1) in combination with oncostatin M( OSM). Both OSM and IL-6 ( in the presence of its soluble receptor), but not IL-1 nor leukemia inhibitory factor, induced Akt phosphorylation in human chondrocytes. Inhibition of PI3K signaling using LY294002 blocked IL-1 + OSM-mediated Akt phosphorylation, induction of MMP-1 and MMP-13, and cartilage collagenolysis. To further explore the role of downstream substrates within the PI3K pathway, complementary use of small molecule inhibitors and specific small interfering RNAs demonstrated that the PI3K subunit p110 alpha and Akt1 were required for MMP-1 mRNA induction. MMP-13 induction was also reduced by loss of function of these molecules and by a lack of p110 delta, 3-phosphoinositide-dependent kinase-1 or Akt3. We therefore propose that the activities of specific elements of the PI3K signaling pathway, including Akt, are necessary for the synergistic induction of MMP-1 and MMP- 13 and the cartilage breakdown stimulated by IL-1 + OSM. Our data provide new insight into the mechanism of synergy between IL-1 and OSM and highlight new therapeutic targets for inflammatory joint diseases that aim to repress the expression of collagenases.	[Litherland, Gary J.; Dixon, Craig; Lakey, Rachel L.; Robson, Timothy; Jones, Debra; Young, David A.; Cawston, Tim E.; Rowan, Andrew D.] Univ Newcastle, Inst Cellular Med, Cell Signalling Injury & Repair Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Rowan, AD (corresponding author), Univ Newcastle, Inst Cellular Med, Cell Signalling Injury & Repair Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	a.d.rowan@ncl.ac.uk	Young, David/H-2023-2014; Litherland, Gary J/K-9755-2015; Young, David/GOV-5677-2022	Young, David/0000-0002-7547-3246; Young, David/0000-0002-7078-6745; Litherland, Gary/0000-0001-5264-0219	Arthritis Research UK Funding Source: Medline	Arthritis Research UK(Versus Arthritis)		Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P540, DOI 10.1002/art.21574; BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Catterall JB, 2006, RHEUMATOLOGY, V45, P1101, DOI 10.1093/rheumatology/kel060; Catterall JB, 2001, ARTHRITIS RHEUM-US, V44, P2296, DOI 10.1002/1529-0131(200110)44:10<2296::AID-ART392>3.0.CO;2-9; Cawston TE, 1998, ARTHRITIS RHEUM-US, V41, P1760, DOI 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M; Chrysis D, 2005, ENDOCRINOLOGY, V146, P1391, DOI 10.1210/en.2004-1152; CLARK IM, 1992, MATRIX, V12, P475, DOI 10.1016/S0934-8832(11)80092-2; CLARK IM, 1991, MATRIX, V11, P76, DOI 10.1016/S0934-8832(11)80211-8; Cleaver CS, 2001, ANN RHEUM DIS, V60, P150, DOI 10.1136/ard.60.2.150; El Mabrouk M, 2007, BBA-MOL CELL RES, V1773, P309, DOI 10.1016/j.bbamcr.2006.11.018; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Fukaya Y, 2005, ONCOL REP, V14, P847; Godoy-Tundidor S, 2005, PROSTATE, V64, P209, DOI 10.1002/pros.20235; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; GUERNE PA, 1990, J IMMUNOL, V144, P499; GUERNE PA, 1989, J CLIN INVEST, V83, P585, DOI 10.1172/JCI113921; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hsieh YS, 2007, J RHEUMATOL, V34, P785; Hui W, 2003, ARTHRITIS RHEUM-US, V48, P3404, DOI 10.1002/art.11333; Hui W, 2003, ANN RHEUM DIS, V62, P172, DOI 10.1136/ard.62.2.172; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jacques C, 2007, OSTEOARTHR CARTILAGE, V15, P138, DOI 10.1016/j.joca.2006.07.003; Johansen JS, 1999, RHEUMATOLOGY, V38, P618, DOI 10.1093/rheumatology/38.7.618; JUBB RW, 1980, J PATHOL, V130, P159, DOI 10.1002/path.1711300304; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim G, 2002, ARTHRITIS RHEUM-US, V46, P1504, DOI 10.1002/art.10314; Koenders MI, 2006, ANN RHEUM DIS, V65, P29, DOI 10.1136/ard.2006.058529; Koshy PJ, 2002, ANN RHEUM DIS, V61, P704, DOI 10.1136/ard.61.8.704; Koshy PJT, 1999, ANAL BIOCHEM, V275, P202, DOI 10.1006/abio.1999.4310; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Kumar R, 2005, CANCER RES, V65, P2511, DOI 10.1158/0008-5472.CAN-05-0189; Ling H, 2004, BIOCHEM J, V380, P651, DOI 10.1042/BJ20040099; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Morgan TG, 2006, ANN RHEUM DIS, V65, P184, DOI 10.1136/ard.2004.033480; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Oh CD, 2003, J BIOL CHEM, V278, P36563, DOI 10.1074/jbc.M304857200; Oh H, 1998, J BIOL CHEM, V273, P9703, DOI 10.1074/jbc.273.16.9703; Okamoto H, 1997, ARTHRITIS RHEUM, V40, P1096, DOI 10.1002/art.1780400614; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parry RV, 2007, TRENDS IMMUNOL, V28, P161, DOI 10.1016/j.it.2007.02.004; Priore R, 2006, J CELL PHYSIOL, V207, P800, DOI 10.1002/jcp.20620; Qureshi HY, 2007, CELL SIGNAL, V19, P1643, DOI 10.1016/j.cellsig.2007.02.007; Reuveni H, 2002, BIOCHEMISTRY-US, V41, P10304, DOI 10.1021/bi0202530; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Rowan AD, 2003, AM J PATHOL, V162, P1975, DOI 10.1016/S0002-9440(10)64330-1; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Scrivo R, 2007, ANN NY ACAD SCI, V1108, P312, DOI 10.1196/annals.1422.033; Shingleton WD, 2006, RHEUMATOLOGY, V45, P958, DOI 10.1093/rheumatology/kel024; Shingleton WD, 2000, J CELL BIOCHEM, V79, P519, DOI 10.1002/1097-4644(20001215)79:4<519::AID-JCB10>3.0.CO;2-U; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; Tetlow LC, 1998, BRIT J RHEUMATOL, V37, P64; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Volck B, 1999, SCAND J RHEUMATOL, V28, P171; Yart A, 2002, BBA-MOL CELL BIOL L, V1582, P107, DOI 10.1016/S1388-1981(02)00144-0; Zhang HG, 2001, ARTHRITIS RHEUM-US, V44, P1555, DOI 10.1002/1529-0131(200107)44:7<1555::AID-ART279>3.0.CO;2-M	66	43	44	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14221	14229		10.1074/jbc.M710136200	http://dx.doi.org/10.1074/jbc.M710136200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18332138	hybrid			2022-12-25	WOS:000255941400008
J	Paun, A; Reinert, JT; Jiang, Z; Medin, C; Balkhi, MY; Fitzgerald, KA; Pitha, PM				Paun, Andrea; Reinert, Jorgen T.; Jiang, Zhaozhao; Medin, Carey; Balkhi, Mumtaz Yaseen; Fitzgerald, Katherine A.; Pitha, Paula M.			Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR; TOLL-LIKE RECEPTORS; DOUBLE-STRANDED-RNA; NF-KAPPA-B; GENE INDUCTION-PROGRAM; RIG-I; VIRAL-INFECTION; ALPHA GENES; TRANSCRIPTIONAL ACTIVITY; VIRUS-INFECTION	Although the role of human IRF-5 in antiviral and inflammatory responses in vitro has been well characterized, much remains to be elucidated about murine IRF-5. Murine IRF-5, unlike the heavily spliced human gene, is primarily expressed as a full-length transcript, with only a single splice variant that was detected in very low levels in the bone marrow of C57BL/6J mice. This bone marrow variant contains a 288-nucleotide deletion from exons 4-6 and exhibits impaired transcriptional activity. The murine IRF-5 can be activated by both TBK1 and MyD88 to form homodimers and bind to and activate transcription of type I interferon and inflammatory cytokine genes. The importance of IRF-5 in the antiviral and inflammatory response in vivo is highlighted by marked reductions in serum levels of type I interferon and tumor necrosis factor alpha (TNF alpha) in Newcastle disease virus-infected Irf5(-/-) mice. IRF- 5 is critical for TLR3-, TLR4-, and TLR9-dependent induction of TNF alpha in CD11c(+) dendritic cells. In contrast, TLR9, but not TLR3/4-mediated induction of type I IFN transcription, is dependent on IRF- 5 in these cells. In addition, IRF- 5 regulates TNF alpha but not type I interferon gene transcription in Newcastle disease virus-infected peritoneal macrophages. Altogether, these data reveal the cell type-specific importance of IRF- 5 in MyD88-mediated antiviral pathways and the widespread role of IRF- 5 in the regulation of inflammatory cytokines.	[Paun, Andrea; Reinert, Jorgen T.; Balkhi, Mumtaz Yaseen; Pitha, Paula M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Pitha, Paula M.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21231 USA; [Pitha, Paula M.] Johns Hopkins Univ, Sch Med, Dept Biol, Baltimore, MD 21231 USA; [Jiang, Zhaozhao; Fitzgerald, Katherine A.] Univ Massachusetts, Med Ctr, Div Infect Dis & Immunol, Worcester, MA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; University of Massachusetts System; University of Massachusetts Worcester	Pitha, PM (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St, Baltimore, MD 21231 USA.	parowe@jhmi.edu	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X; Medin, Carey/0000-0002-9346-6760; Reinert, Thomas/0000-0003-4835-4804	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067497, R37AI067497, R01AI067497, R01AI067632] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 067632, AI 067497] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Au WC, 2001, J BIOL CHEM, V276, P41629, DOI 10.1074/jbc.M105121200; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2003, J BIOL CHEM, V278, P16630, DOI 10.1074/jbc.M212609200; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Cheng TF, 2006, J IMMUNOL, V176, P7462, DOI 10.4049/jimmunol.176.12.7462; CHEUNG SC, 1991, J IMMUNOL, V146, P121; COUZINET A, 2008, NATL ACAD SCI US, V105, P2556; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dragan AI, 2007, NUCLEIC ACIDS RES, V35, P3525, DOI 10.1093/nar/gkm142; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; HARADA H, 1994, ONCOGENE, V9, P3313; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; Karpova AY, 2001, MOL CELL BIOL, V21, P4169, DOI 10.1128/MCB.21.13.4169-4176.2001; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 2005, J BIOL CHEM, V280, P3088, DOI 10.1074/jbc.M408452200; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Negishi H, 2006, P NATL ACAD SCI USA, V103, P15136, DOI 10.1073/pnas.0607181103; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Paun A, 2007, ADV VIRUS RES, V69, P1, DOI 10.1016/S0065-3527(06)69001-5; Ronco LV, 1998, GENE DEV, V12, P2061, DOI 10.1101/gad.12.13.2061; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; YANAI H, 2007, NATL ACAD SCI US, V104, P3402; Yasuda K, 2007, J IMMUNOL, V178, P6876, DOI 10.4049/jimmunol.178.11.6876; Yeow WS, 2000, J BIOL CHEM, V275, P6313, DOI 10.1074/jbc.275.9.6313; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748	64	98	99	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14295	14308		10.1074/jbc.M800501200	http://dx.doi.org/10.1074/jbc.M800501200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18332133	hybrid, Green Published			2022-12-25	WOS:000255941400016
J	Bandyopadhyay, S; Naik, SG; O'Carroll, IP; Huynh, BH; Dean, DR; Johnson, MK; Dos Santos, PC				Bandyopadhyay, Sibali; Naik, Sunil G.; O'Carroll, Ina P.; Huynh, Boi-Hanh; Dean, Dennis R.; Johnson, Michael K.; Dos Santos, Patricia C.			A proposed role for the Azotobacter vinelandii NfuA protein as an intermediate iron-sulfur cluster carrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAFFOLD PROTEIN; ESCHERICHIA-COLI; 4FE-4S CLUSTERS; CONTROLLED EXPRESSION; GENE-CLUSTER; NIFU; FERREDOXIN; ISCA; NITROGENASE; ACONITASE	Iron-sulfur clusters ([Fe-S] clusters) are assembled on molecular scaffolds and subsequently used for maturation of proteins that require [Fe-S] clusters for their functions. Previous studies have shown that Azotobacter vinelandii produces at least two [Fe-S] cluster assembly scaffolds: NifU, required for the maturation of nitrogenase, and IscU, required for the general maturation of other [Fe-S] proteins. A. vinelandii also encodes a protein designated NfuA, which shares amino acid sequence similarity with the C-terminal region of NifU. The activity of aconitase, a [4Fe-4S] cluster-containing enzyme, is markedly diminished in a strain containing an inactivated nfuA gene. This inactivation also results in a null-growth phenotype when the strain is cultivated under elevated oxygen concentrations. NifU has a limited ability to serve the function of NfuA, as its expression at high levels corrects the defect of the nfuA-disrupted strain. Spectroscopic and analytical studies indicate that one [4Fe-4S] cluster can be assembled in vitro within a dimeric form of NfuA. The resultant [4Fe-4S] cluster-loaded form of NfuA is competent for rapid in vitro activation of apo-aconitase. Based on these results a model is proposed where NfuA could represent a class of intermediate [Fe-S] cluster carriers involved in [Fe-S] protein maturation.	[O'Carroll, Ina P.; Dean, Dennis R.; Dos Santos, Patricia C.] Virginia Tech, Fralin Biotech Ctr 108, Dept Biochem, Blacksburg, VA 24061 USA; [Bandyopadhyay, Sibali; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Naik, Sunil G.; Huynh, Boi-Hanh] Emory Univ, Dept Phys, Atlanta, GA 30322 USA	Virginia Polytechnic Institute & State University; University System of Georgia; University of Georgia; Emory University	Dos Santos, PC (corresponding author), Virginia Tech, Fralin Biotech Ctr 108, Dept Biochem, W Campus Dr, Blacksburg, VA 24061 USA.	pdossant@vt.edu	O'Carroll, Ina Puleri/GZH-1001-2022	O'Carroll, Ina Puleri/0000-0002-1331-9155; Dos Santos, Patricia/0000-0002-3364-0931	NIGMS NIH HHS [GM62524, GM47295, R01 GM062524, R01 GM062524-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062524, R37GM062524, R01GM047295] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Agar JN, 2000, J BIOL INORG CHEM, V5, P167, DOI 10.1007/s007750050361; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Angelini S, 2008, J BIOL CHEM, V283, P14084, DOI 10.1074/jbc.M709405200; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Brereton PS, 1999, BIOCHEMISTRY-US, V38, P10594, DOI 10.1021/bi990671d; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Cosper MM, 2004, BIOCHEMISTRY-US, V43, P2007, DOI 10.1021/bi0356653; CRIBBS R, 1964, GENETICS, V49, P95; CZERNUSZEWICZ RS, 1987, J AM CHEM SOC, V109, P7178, DOI 10.1021/ja00257a045; Ding H, 2004, J BIOL CHEM, V279, P37499, DOI 10.1074/jbc.M404533200; Dos Santos PC, 2007, J BACTERIOL, V189, P2854, DOI 10.1128/JB.01734-06; Dos Santos PC, 2004, J BIOL CHEM, V279, P19705, DOI 10.1074/jbc.M400278200; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Johnson DC, 2005, BIOCHEM SOC T, V33, P90, DOI 10.1042/BST0330090; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Johnson DC, 2006, J BACTERIOL, V188, P7551, DOI 10.1128/JB.00596-06; KENNEDY MC, 1988, J BIOL CHEM, V263, P8194; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; Morimoto K, 2006, J MOL BIOL, V360, P117, DOI 10.1016/j.jmb.2006.04.067; Nishio K, 2000, J BIOL CHEM, V275, P22615, DOI 10.1074/jbc.C000279200; Ollagnier-de-Choudens S, 2004, J BIOL INORG CHEM, V9, P828, DOI 10.1007/s00775-004-0581-9; Ollagnier-de-Choudens S, 2001, J BIOL CHEM, V276, P22604, DOI 10.1074/jbc.M102902200; ONATE YA, 1993, BIOCHIM BIOPHYS ACTA, V1164, P113, DOI 10.1016/0167-4838(93)90237-L; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Que Jr L., 2000, PHYS METHODS BIOINOR, P233; RAVI N, 1994, J AM CHEM SOC, V116, P8007, DOI 10.1021/ja00097a007; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Saas J, 2000, J BIOL CHEM, V275, P2745, DOI 10.1074/jbc.275.4.2745; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Sen S, 2004, BIOCHEMISTRY-US, V43, P1787, DOI 10.1021/bi0358465; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Spiro T. G., 1988, BIOL APPLICATIONS RA, P523; STRANDBERG GW, 1968, CAN J MICROBIOL, V14, P25, DOI 10.1139/m68-005; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	45	88	91	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14092	14099		10.1074/jbc.M709161200	http://dx.doi.org/10.1074/jbc.M709161200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18339629	Green Published, hybrid			2022-12-25	WOS:000255728200063
J	Ammar, H; Closset, JL				Ammar, Hayet; Closset, Jean L.			Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; NECROSIS-FACTOR-ALPHA; CLUSTERIN/APOLIPOPROTEIN-J; EPITHELIAL-CELLS; APOLIPOPROTEIN-J; SULFATED GLYCOPROTEIN-2; ANDROGEN-ABLATION; NUCLEAR CLUSTERIN; OXIDATIVE STRESS; MESSENGER-RNA	Clusterin is, in its major form, a secreted heterodimeric disulfide-linked glycoprotein (75-80 kDa). It was first linked to cell death in the rat ventral prostate after androgen deprivation. Recent studies have demonstrated that overexpression of clusterin in prostatic cells protects them against tumor necrosis factor alpha (TNF alpha)-induced apoptosis. However the details of this survival mechanism remain undefined. Here, we investigate how clusterin prevents cells from undergoing TNF alpha-induced apoptosis. We established a double-stable prostatic cell line for inducible clusterin by using the Tet-On gene expression system. We demonstrated that 50% of the cells overexpressing clusterin escaped from TNF alpha- and actinomycin D-induced cell death. Moreover we demonstrated that the incubation of MLL cells with conditioned medium containing the secreted clusterin or the supplementation of purified clusterin in the extracellular medium decreased the TNF alpha-induced apoptosis significantly. This extracellular action implicates megalin, the putative membrane receptor for clusterin to mediate survival. Indeed clusterin overexpression up-regulated the expression of megalin and induced its phosphorylation in a dose-dependent manner. We interestingly showed that clusterin overexpression is associated with the up-regulation of the phosphorylation of Akt. Activated Akt induced the phosphorylation of Bad and caused a decrease of cytochrome c release. These results enable us to pinpoint one mechanism by which secreted clusterin favors survival in androgen-independent prostate cancer cells, implicating its receptor megalin and Akt survival pathway.	[Ammar, Hayet; Closset, Jean L.] Univ Liege, Dept Biochem, Inst Pathol B23, Liege 4000, Belgium	University of Liege	Closset, JL (corresponding author), Univ Liege, Dept Biochem, Inst Pathol B23, Ave Hop 3, Liege 4000, Belgium.	jclosset@ulg.ac.be						Bartl MM, 2001, EXP CELL RES, V271, P130, DOI 10.1006/excr.2001.5358; BETTUZZI S, 1989, BIOCHEM J, V257, P293, DOI 10.1042/bj2570293; BURSCH W, 1995, ARCH TOXICOL, V69, P253, DOI 10.1007/s002040050167; Caccamo AE, 2006, J CELL PHYSIOL, V207, P208, DOI 10.1002/jcp.20561; Caccamo AE, 2003, ANN NY ACAD SCI, V1010, P514, DOI 10.1196/annals.1299.095; Carnevali S, 2006, AM J RESP CRIT CARE, V174, P393, DOI 10.1164/rccm.200512-1835OC; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; FRENCH LE, 1992, J CLIN INVEST, V90, P1919, DOI 10.1172/JCI116069; Gasparian AV, 2002, J CELL SCI, V115, P141; Girton RA, 2002, AM J PHYSIOL-RENAL, V282, pF703, DOI 10.1152/ajprenal.00060.2001; Gleave M, 2005, ANN NY ACAD SCI, V1058, P1, DOI 10.1196/annals.1359.001; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Hammad SM, 1997, J BIOL CHEM, V272, P18644, DOI 10.1074/jbc.272.30.18644; Hermo L, 1999, MOL REPROD DEV, V53, P282, DOI 10.1002/(SICI)1098-2795(199907)53:3&lt;282::AID-MRD4&gt;3.0.CO;2-A; Herz J, 2000, CURR OPIN LIPIDOL, V11, P161, DOI 10.1097/00041433-200004000-00009; Ho SM, 1998, AM J PATHOL, V153, P131, DOI 10.1016/S0002-9440(10)65553-8; July LV, 2002, PROSTATE, V50, P179, DOI 10.1002/pros.10047; Kurahashi T, 2005, BJU INT, V96, P895, DOI 10.1111/j.1464-410X.2005.05733.x; KYPRIANOU N, 1990, CANCER RES, V50, P3748; KYPRIANOU N, 1991, CANCER RES, V51, P162; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; LEE C, 1990, BIOL REPROD, V43, P1079, DOI 10.1095/biolreprod43.6.1079; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Lourda M, 2007, INT J CANCER, V120, P611, DOI 10.1002/ijc.22327; May Petra, 2003, Sci STKE, V2003, pPE12, DOI 10.1126/stke.2003.176.pe12; Miyake H, 2000, CLIN CANCER RES, V6, P1655; Miyake H, 2000, CANCER RES, V60, P2547; Miyake H, 2000, CANCER RES, V60, P170; Miyake H, 2005, ONCOL REP, V14, P1371; Morales CR, 1996, BIOL REPROD, V55, P676, DOI 10.1095/biolreprod55.3.676; Nesterov A, 2001, J BIOL CHEM, V276, P10767, DOI 10.1074/jbc.M005196200; Pfeil K, 2004, PROSTATE, V58, P259, DOI 10.1002/pros.10332; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; Scaltriti M, 2004, CANCER RES, V64, P6174, DOI 10.1158/0008-5472.CAN-04-0920; SCUDIERO DA, 1988, CANCER RES, V48, P4827; SENSIBAR JA, 1995, CANCER RES, V55, P2431; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; SHUKLA S, 2005, PROSTATE; Sintich SM, 1999, PROSTATE, V39, P87; Trougakos IP, 2005, FREE RADICAL BIO MED, V38, P436, DOI 10.1016/j.freeradbiomed.2004.10.038; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Yang CC, 2003, J BIOL CHEM, V278, P25872, DOI 10.1074/jbc.M301744200; Yang CR, 2000, P NATL ACAD SCI USA, V97, P5907, DOI 10.1073/pnas.97.11.5907; You KH, 2003, Z NATURFORSCH C, V58, P148; Zellweger T, 2002, CLIN CANCER RES, V8, P3276; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zlokovic BV, 1996, P NATL ACAD SCI USA, V93, P4229, DOI 10.1073/pnas.93.9.4229	51	104	107	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12851	12861		10.1074/jbc.M800403200	http://dx.doi.org/10.1074/jbc.M800403200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18321852	hybrid			2022-12-25	WOS:000255499800021
J	Itoh, Y; Ito, N; Nagase, H; Seiki, M				Itoh, Yoshifumi; Ito, Noriko; Nagase, Hideaki; Seiki, Motoharu			The second dimer interface of MT1-MMP, the transmembrane domain, is essential for ProMMP-2 activation on the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; 3-DIMENSIONAL EXTRACELLULAR-MATRIX; GELATINASE-A; TISSUE INHIBITOR; TUMOR-GROWTH; MEMBRANE; MIGRATION; INVASION; EXPRESSION; HEMOPEXIN	Activation of proMMP-2 and cell surface collagenolysis are important activities of membrane-type 1 matrix metalloproteinase (MT1-MMP) to promote cell migration in tissue, and these activities are regulated by homodimerization of MT1-MMP on the cell surface. In this study, we have identified the transmembrane domain as a second dimer interface of MT1-MMP in addition to the previously identified hemopexin domain. Our analyses indicate that these two modes of dimerization have different roles; transmembrane-dependent dimerization is critical forproMMP-2activation, whereas hemopexin-dependent dimerization is important for degradation of collagen on the cell surface. Our finding provides new insight into the potential molecular arrangement of MT1-MMP contributing to its function on the cell surface.	[Itoh, Yoshifumi; Ito, Noriko; Nagase, Hideaki] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Rheumatol, Kennedy Inst,Dept Matrix Biol, London W6 8LH, England; [Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Tokyo 1088639, Japan	Imperial College London; University of Oxford; University of Tokyo	Itoh, Y (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Rheumatol, Kennedy Inst,Dept Matrix Biol, 65 Aspenlea Rd, London W6 8LH, England.	y.itoh@imperial.ac.uk	Seiki, Motoharu/K-9443-2015	Itoh, Yoshifumi/0000-0002-2128-2823	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER; Arthritis Research UK Funding Source: Medline; Cancer Research UK [C1507/A5541] Funding Source: Medline; NIAMS NIH HHS [AR40994, R01 AR040994, R01 AR040994-15A1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Research UK(Versus Arthritis); Cancer Research UK(Cancer Research UK); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Atkinson JJ, 2005, DEV DYNAM, V232, P1079, DOI 10.1002/dvdy.20267; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Fosang AJ, 1998, FEBS LETT, V430, P186, DOI 10.1016/S0014-5793(98)00667-X; Gingras D, 2001, FEBS LETT, V507, P231, DOI 10.1016/S0014-5793(01)02985-4; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Honda S, 2001, CLIN EXP IMMUNOL, V126, P131, DOI 10.1046/j.1365-2249.2001.01624.x; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Huber O, 1999, J CELL SCI, V112, P4415; Itoh Y, 2004, TRENDS BIOCHEM SCI, V29, P285, DOI 10.1016/j.tibs.2004.04.001; Itoh Y, 1999, J BIOL CHEM, V274, P34260, DOI 10.1074/jbc.274.48.34260; Itoh Y, 1998, J BIOL CHEM, V273, P24360, DOI 10.1074/jbc.273.38.24360; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; KANUPER V, 1996, J BIOL CHEM, V271, P17124; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Lehti K, 2002, J BIOL CHEM, V277, P8440, DOI 10.1074/jbc.M109128200; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Morrison CJ, 2006, J BIOL CHEM, V281, P26528, DOI 10.1074/jbc.M603331200; Nakada M, 2003, CANCER RES, V63, P3364; Nakada M, 2001, CANCER RES, V61, P8896; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Okada A, 1997, J CELL BIOL, V137, P67, DOI 10.1083/jcb.137.1.67; Rajavashisth TB, 1999, CIRCULATION, V99, P3103, DOI 10.1161/01.CIR.99.24.3103; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 1996, FEBS LETT, V385, P238, DOI 10.1016/0014-5793(96)00389-4; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Sato T, 1997, J CELL SCI, V110, P589; Stanton H, 1998, J CELL SCI, V111, P2789; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Takino T, 2003, BIOCHEM BIOPH RES CO, V304, P160, DOI 10.1016/S0006-291X(03)00544-8; Taniwaki K, 2007, CANCER RES, V67, P4311, DOI 10.1158/0008-5472.CAN-06-4761; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang P, 2004, J BIOL CHEM, V279, P51148, DOI 10.1074/jbc.M409074200; Wang X, 2004, J BIOL CHEM, V279, P9331, DOI 10.1074/jbc.M312369200; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	62	52	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13053	13062		10.1074/jbc.M709327200	http://dx.doi.org/10.1074/jbc.M709327200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337248	Green Published, hybrid			2022-12-25	WOS:000255499800043
J	Sarker, KP; Kataoka, H; Chan, A; Netherton, SJ; Pot, I; Huynh, MA; Feng, XL; Bonni, A; Riabowol, K; Bonni, S				Sarker, Krishna P.; Kataoka, Hiromi; Chan, Angela; Netherton, Stuart J.; Pot, Isabelle; Huynh, Mai Anh; Feng, Xiaolan; Bonni, Azad; Riabowol, Karl; Bonni, Shirin			ING2 as a novel mediator of transforming growth factor-beta-dependent responses in epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDATE TUMOR-SUPPRESSOR; REPRESSES TRANSCRIPTION; AXONAL MORPHOGENESIS; PLANT HOMEODOMAIN; RECEPTOR COMPLEX; PHD FINGER; PROTEINS; CANCER; FAMILY; SNON	Members of the ING(inhibitor of growth) family of chromatin modifying proteins (ING1-ING5) have emerged as critical regulators of gene expression and cellular responses, suggesting that the ING proteins may impinge on specific signal transduction pathways and their mediated effects. Here, we demonstrate a role for the protein ING2 in mediating responses by the transforming growth factor (TGF)-beta-Smad signaling pathway. We show that ING2 promotes TGF-beta-induced transcription. Both gain-of-function and RNA interference-mediated knockdown of endogenous ING2 reveal that ING2 couples TGF-beta signals to the induction of transcription and cell cycle arrest. We also find that the Smad-interacting transcriptional modulator SnoN interacts with ING2 and promotes the assembly of a protein complex containing SnoN, ING2, and Smad2. Knockdown of endogenous SnoN blocks the ability of ING2 to promote TGF beta-dependent transcription, and conversely expression of SnoN augments ING2 enhancement of the TGF-beta response. Collectively, our data suggest that ING2 collaborates with SnoN to mediate TGF-beta-induced Smad-dependent transcription and cellular responses.	[Sarker, Krishna P.; Kataoka, Hiromi; Chan, Angela; Netherton, Stuart J.; Pot, Isabelle; Feng, Xiaolan; Riabowol, Karl; Bonni, Shirin] Univ Calgary, So Alberta Canc Res Inst, Calgary, AB T2N 1N4, Canada; [Sarker, Krishna P.; Kataoka, Hiromi; Chan, Angela; Netherton, Stuart J.; Pot, Isabelle; Feng, Xiaolan; Riabowol, Karl; Bonni, Shirin] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada; [Riabowol, Karl] Univ Calgary, Fac Med, Dept Oncol, Calgary, AB T2N 1N4, Canada; [Huynh, Mai Anh; Bonni, Azad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Calgary; University of Calgary; University of Calgary; Harvard University; Harvard Medical School	Bonni, S (corresponding author), Univ Calgary, So Alberta Canc Res Inst, 3330 Hosp Dr NW, Calgary, AB T2N 1N4, Canada.	sbonni@ucalgary.ca	Feng, Xiaolan/J-9997-2019	Feng, Xiaolan/0000-0002-7333-8198	NIGMS NIH HHS [GM077226, T32 GM007753] Funding Source: Medline; NINDS NIH HHS [NS051255] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM077226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051255] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Chen LS, 2001, CANCER RES, V61, P4345; Coles AH, 2007, CANCER RES, V67, P2054, DOI 10.1158/0008-5472.CAN-06-3558; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Feng XL, 2006, MOL CELL BIOL, V26, P9244, DOI 10.1128/MCB.01538-06; Feng XL, 2002, TRENDS CELL BIOL, V12, P532, DOI 10.1016/S0962-8924(02)02391-7; Garkavtsev I, 2004, NATURE, V428, P328, DOI 10.1038/nature02329; Gasparri F, 2004, J BIOMOL SCREEN, V9, P232, DOI 10.1177/1087057103262836; Gong W, 2005, INT J BIOCHEM CELL B, V37, P1054, DOI 10.1016/j.biocel.2004.09.008; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Helbing CC, 1997, CANCER RES, V57, P1255; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jones DR, 2006, MOL CELL, V23, P685, DOI 10.1016/j.molcel.2006.07.014; Kaadige MR, 2006, J BIOL CHEM, V281, P28831, DOI 10.1074/jbc.M605624200; Kameyama K, 2003, CLIN CANCER RES, V9, P4926; Kataoka H, 2003, CANCER RES, V63, P5785; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Pedeux R, 2005, MOL CELL BIOL, V25, P6639, DOI 10.1128/MCB.25.15.6639-6648.2005; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; POT I, 2008, IN PRESS CURR MOL ME; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; Russell M, 2006, EXP CELL RES, V312, P951, DOI 10.1016/j.yexcr.2006.01.020; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Stegmuller J, 2008, J NEUROSCI, V28, P1961, DOI 10.1523/JNEUROSCI.3061-07.2008; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; STROSCHEIN SL, 2001, GENES DEV, V15; Takaesu NT, 2006, GENETICS, V174, P1299, DOI 10.1534/genetics.106.064956; Toyama T, 1999, ONCOGENE, V18, P5187, DOI 10.1038/sj.onc.1202905; Vieyra D, 2002, J BIOL CHEM, V277, P29832, DOI 10.1074/jbc.M200197200; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	51	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13269	13279		10.1074/jbc.M708834200	http://dx.doi.org/10.1074/jbc.M708834200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18334480	hybrid, Green Published			2022-12-25	WOS:000255499800067
J	Romantsov, T; Stalker, L; Culham, DE; Wood, JM				Romantsov, Tatyana; Stalker, Leanne; Culham, Doreen E.; Wood, Janet M.			Cardiolipin controls the osmotic stress response and the subcellular location of transporter ProP in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL; LISTERIA-MONOCYTOGENES; BETAINE TRANSPORTER; MEMBRANE-PROTEINS; DOMAIN FORMATION; OSMOSENSOR PROP; ACRIDINE-ORANGE; IN-VIVO; ANTIPARALLEL; MODEL	The phospholipid composition of the membrane and transporter structure control the subcellular location and function of osmosensory transporter ProP in Escherichia coli. Growth in media of increasing osmolality increases, and entry to stationary phase decreases, the proportion of phosphatidate in anionic lipids (phosphatidylglycerol (PG) plus cardiolipin (CL)). Both treatments increase the CL: PG ratio. Transporters ProP and LacY are concentrated with CL (and not PG) near cell poles and septa. The polar concentration of ProP is CL-dependent. Here we show that the polar concentration of LacY is CL-independent. The osmotic activation threshold of ProP was directly proportional to the CL content of wild type bacteria, the PG content of CL-deficient bacteria, and the anionic lipid content of cells and proteoliposomes. CL was effective at a lower concentration in cells than in proteoliposomes, and at a much lower concentration than PG in either system. Thus, in wild type bacteria, osmotic induction of CL synthesis and concentration of ProP with CL at the cell poles adjust the osmotic activation threshold of ProP to match ambient conditions. ProP proteins linked by homodimeric, C-terminal coiled-coils are known to activate at lower osmolalities than those without such structures and coiled-coil disrupting mutations raise the osmotic activation threshold. Here we show that these mutations also prevent polar concentration of ProP. Stabilization of the C-terminal coiled-coil by covalent cross-linking of introduced Cys reverses the impact of increasing CL on the osmotic activation of ProP. Association of ProP C termini with the CL-rich membrane at cell poles may raise the osmotic activation threshold by blocking coiled-coil formation. Mutations that block coiled-coil formation may also block association of the C termini with the CL-rich membrane.	[Romantsov, Tatyana; Stalker, Leanne; Culham, Doreen E.; Wood, Janet M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Wood, JM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jwood@uoguelph.ca						Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Binenbaum Z, 1999, MOL MICROBIOL, V32, P1173, DOI 10.1046/j.1365-2958.1999.01426.x; Bolen D W, 2001, Methods Mol Biol, V168, P17; BROWN ED, 1992, J BIOL CHEM, V267, P13086; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Culham DE, 2000, J MOL RECOGNIT, V13, P309, DOI 10.1002/1099-1352(200009/10)13:5<309::AID-JMR505>3.3.CO;2-I; CULHAM DE, 1993, J MOL BIOL, V229, P268, DOI 10.1006/jmbi.1993.1030; Culham DE, 2003, BIOCHEMISTRY-US, V42, P11815, DOI 10.1021/bi034939j; Culham DE, 2003, BIOCHEMISTRY-US, V42, P410, DOI 10.1021/bi0264364; Cullen PJ, 2004, GENE DEV, V18, P1695, DOI 10.1101/gad.1178604; Fiske CH, 1925, J BIOL CHEM, V66, P375; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harold FM, 2002, FUNGAL GENET BIOL, V37, P271, DOI 10.1016/S1087-1845(02)00528-5; Hillar A, 2005, BIOCHEMISTRY-US, V44, P10170, DOI 10.1021/bi050774y; Hillar A, 2003, BIOCHEMISTRY-US, V42, P15170, DOI 10.1021/bi035122t; HOUSSIN C, 1991, BIOCHIM BIOPHYS ACTA, V1056, P76, DOI 10.1016/S0005-2728(05)80075-1; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Kentner D, 2006, CURR OPIN MICROBIOL, V9, P619, DOI 10.1016/j.mib.2006.10.012; Koppelman CM, 2001, J BACTERIOL, V183, P6144, DOI 10.1128/JB.183.20.6144-6147.2001; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lai EM, 2004, MOL MICROBIOL, V52, P1029, DOI 10.1111/j.1365-2958.2004.04040.x; Liu F, 2007, BIOCHEMISTRY-US, V46, P5647, DOI 10.1021/bi062198r; MacMillan SV, 1999, BBA-BIOMEMBRANES, V1420, P30, DOI 10.1016/S0005-2736(99)00085-1; MANGOLD HK, 1961, J AM OIL CHEM SOC, V38, P708, DOI 10.1007/BF02633061; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E, 2001, FEBS LETT, V507, P187, DOI 10.1016/S0014-5793(01)02948-9; MORGAN, 1967, J BACTERIOL, V93, P1987, DOI 10.1128/JB.93.6.1987-2002.1967; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NORRIS V, 1995, MOL MICROBIOL, V16, P1051, DOI 10.1111/j.1365-2958.1995.tb02330.x; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Poolman B, 2004, BBA-BIOMEMBRANES, V1666, P88, DOI 10.1016/j.bbamem.2004.06.013; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; Racher KI, 2001, BIOCHEMISTRY-US, V40, P7324, DOI 10.1021/bi002331u; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; Sambrook J, 2001, MOL CLONING LAB MANU; Sleator RD, 2003, J BACTERIOL, V185, P7140, DOI 10.1128/JB.185.24.7140-7144.2003; Sleator RD, 2003, APPL ENVIRON MICROB, V69, P1, DOI 10.1128/AEM.69.1.1-9.2003; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Thiem S, 2007, EMBO J, V26, P1615, DOI 10.1038/sj.emboj.7601610; Tsatskis Y, 2005, J BIOL CHEM, V280, P41387, DOI 10.1074/jbc.M508362200; Tsatskis Y, 2008, BIOCHEMISTRY-US, V47, P60, DOI 10.1021/bi7018173; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Wood JM, 2005, BIOCHEMISTRY-US, V44, P5634, DOI 10.1021/bi047383o; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Zakharyan E, 2001, FEMS MICROBIOL LETT, V204, P61, DOI 10.1111/j.1574-6968.2001.tb10863.x; Zoetewey DL, 2003, J MOL BIOL, V334, P1063, DOI 10.1016/j.jmb.2003.10.020	53	59	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12314	12323		10.1074/jbc.M709871200	http://dx.doi.org/10.1074/jbc.M709871200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326496	hybrid			2022-12-25	WOS:000255340000048
J	Song, XM; Hresko, RC; Mueckler, M				Song, Xiao Mei; Hresko, Richard C.; Mueckler, Mike			Identification of amino acid residues within the C terminus of the glut4 glucose transporter that are essential for insulin-stimulated redistribution to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SKELETAL-MUSCLE; INTRACELLULAR SEQUESTRATION; TARGETING MOTIF; ADIPOSE-CELLS; REGULATED TRANSPORT; NH2 TERMINUS; TRANSLOCATION; VESICLES; PROTEIN; SIGNAL	The Glut4 glucose transporter undergoes complex insulinregulated subcellular trafficking in adipocytes. Much effort has been expended in an attempt to identify targeting motifs within Glut4 that direct its subcellular trafficking, but an amino acid motif responsible for the targeting of the transporter to insulin-responsive intracellular compartments in the basal state or that is directly responsible for its insulin-stimulated redistribution to the plasma membrane has not yet been delineated. In this study we define amino acid residues within the C-terminal cytoplasmic tail of Glut4 that are essential for its insulin-stimulated translocation to the plasma membrane. The residues were identified based on sequence similarity (LXXLXPDEXD) between cytoplasmic domains of Glut4 and the insulin-responsive aminopeptidase ( IRAP). Alteration of this putative targeting motif (IRM, insulin-responsive motif) resulted in the targeting of the bulk of the mutant Glut4 molecules to dispersed membrane vesicles that lacked detectable levels of wild-type Glut4 in either the basal or insulin-stimulated states and completely abolished the insulin-stimulated translocation of the mutant Glut4 to the plasma membrane in 3T3L1 adipocytes. The bulk of the dispersed membrane vesicles containing the IRM mutant did not contain detectable levels of any subcellular marker tested. A fraction of the total IRM mutant was also detected in a wild-type Glut4/Syntaxin 6-containing perinuclear compartment. Interestingly, mutation of the IRM sequence did not appreciably alter the subcellular trafficking of IRAP. We conclude that residues within the IRM are critical for the targeting of Glut4, but not of IRAP, to insulin-responsive intracellular membrane compartments in 3T3-L1 adipocytes.	[Song, Xiao Mei; Hresko, Richard C.; Mueckler, Mike] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Mueckler, M (corresponding author), Washington Univ, Sch Med, Dept Cell Biol, 660 Euclid Ave,Campus Box 8228, St Louis, MO 63110 USA.	mmueckler@wustl.edu	Mueckler, Mike M/F-6115-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043695, R01DK067229, P30DK056341] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK043695, P30 DK056341-08, R01 DK067229, P30 DK056341, P30 DK056341-07] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Hasani H, 2002, J CELL SCI, V115, P131; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Cope DL, 2000, FEBS LETT, V481, P261, DOI 10.1016/S0014-5793(00)02021-4; CORVERA S, 1994, J CELL BIOL, V126, P979, DOI 10.1083/jcb.126.4.979; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; CZECH MP, 1993, J CELL BIOL, V123, P127, DOI 10.1083/jcb.123.1.127; DUDEK RW, 1994, FEBS LETT, V339, P205, DOI 10.1016/0014-5793(94)80416-8; GARIPPA RJ, 1994, J CELL BIOL, V124, P705, DOI 10.1083/jcb.124.5.705; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; HANEY PM, 1991, J CELL BIOL, V114, P689, DOI 10.1083/jcb.114.4.689; HANEY PM, 1995, J CELL BIOL, V129, P641, DOI 10.1083/jcb.129.3.641; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Holman GD, 2001, TRENDS CELL BIOL, V11, P173, DOI 10.1016/S0962-8924(01)01953-5; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KANDROR KV, 1994, J BIOL CHEM, V269, P30777; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Keller SR, 2003, FRONT BIOSCI-LANDMRK, V8, pS410, DOI 10.2741/1078; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; LAWRENCE JC, 1990, J BIOL CHEM, V265, P2324; Malide D, 2000, J CELL SCI, V113, P4203; MARETTE A, 1992, DIABETES, V41, P1562, DOI 10.2337/diabetes.41.12.1562; MARSH BJ, 1995, J CELL BIOL, V130, P1081, DOI 10.1083/jcb.130.5.1081; MARSHALL BA, 1993, J BIOL CHEM, V268, P26193; Martin OJ, 2006, J BIOL CHEM, V281, P484, DOI 10.1074/jbc.M505944200; Martinez-Arca S, 2000, J CELL SCI, V113, P1705; MUECKLER MM, 1995, NEWS PHYSIOL SCI, V10, P22; PIPER RC, 1992, J CELL BIOL, V117, P729, DOI 10.1083/jcb.117.4.729; PIPER RC, 1993, J CELL BIOL, V121, P1221, DOI 10.1083/jcb.121.6.1221; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; ROTHMAN DL, 1992, J CLIN INVEST, V89, P1069, DOI 10.1172/JCI115686; Shewan AM, 2000, BIOCHEM J, V350, P99, DOI 10.1042/0264-6021:3500099; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; VERHEY KJ, 1995, J CELL BIOL, V130, P1071, DOI 10.1083/jcb.130.5.1071; VERHEY KJ, 1994, J BIOL CHEM, V269, P2353; Wang WC, 1996, J CELL BIOL, V135, P415, DOI 10.1083/jcb.135.2.415; Xu Z, 2006, MOL ENDOCRINOL, V20, P2890, DOI 10.1210/me.2006-0193; Zeigerer A, 2002, MOL BIOL CELL, V13, P2421, DOI 10.1091/mbc.E02-02-0071	48	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12571	12585		10.1074/jbc.M800838200	http://dx.doi.org/10.1074/jbc.M800838200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18305115	Green Published, hybrid			2022-12-25	WOS:000255340000074
J	Su, NY; Ouni, I; Papagiannis, CV; Kaiser, P				Su, Ning-Yuan; Ouni, Ikram; Papagiannis, Christie V.; Kaiser, Peter			A dominant suppressor mutation of the met30 cell cycle defect suggests regulation of the Saccharomyces cerevisiae Met4-Cbf1 transcription complex by Met32	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR MET4; POLYUBIQUITINATED MET4; SULFUR METABOLISM; UBIQUITIN LIGASES; YEAST; DEGRADATION; BINDING; PROTEIN; SCFMET30; CADMIUM	Met30 is the substrate recognition subunit of the essential ubiquitin ligase SCFMet30. The essential function of Met30 is the inactivation of the Saccharomyces cerevisiae transcription factor Met4, because fully activated Met4 induces a cell cycle arrest. Met4 regulates expression of genes involved in the sulfur assimilation pathway and coordinates the transcriptional program and cell cycle progression in response to cadmium and arsenic stress. Met4 lacks DNA binding activity and requires either Cbf1 or one of the two homologous proteins Met31 and Met32 for promoter association. Accordingly, met4 mutants, cbf1 mutants, and met31 met32 double mutants are methionine auxotroph. We isolated a truncated version of Met32 (Met32(Delta 145-192)) as a dominant suppressor of the cell cycle defect of met30 mutants. Expression of Met32(Delta 145-192) significantly reduced induction of Met4-regulated genes. Interestingly, both Cbf1- and Met31/32-dependent genes were affected by Met32(Delta 145-192). Mechanistically, Met32(Delta 145-192) prevented recruitment of Met4 to both Cbf1 and Met31/32-dependent promoters. We further demonstrated that Met32 is part of the Cbf1-Met4 complex bound to Cbf1- recruiting promoter elements and that Met31/32 are required for formation of a stable Met4-Cbf1 transcription complex. These results suggest a regulatory role of Met32 as part of the Cbf1-Met4 complex and provide molecular insight into coordination of cell cycle response and modulation of gene expression programs.	[Su, Ning-Yuan; Ouni, Ikram; Papagiannis, Christie V.; Kaiser, Peter] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Kaiser, P (corresponding author), 240D Med Sci 1, Irvine, CA 92697 USA.	pkaiser@uci.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066164, R01GM066164] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM066164, GM66164] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbey R, 2005, EMBO J, V24, P521, DOI 10.1038/sj.emboj.7600556; Baudouin-Cornu P, 2006, BIOCHIMIE, V88, P1673, DOI 10.1016/j.biochi.2006.03.001; Blaiseau PL, 1998, EMBO J, V17, P6327, DOI 10.1093/emboj/17.21.6327; Blaiseau PL, 1997, MOL CELL BIOL, V17, P3640, DOI 10.1128/MCB.17.7.3640; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; Chandrasekaran S, 2006, MOL CELL, V24, P689, DOI 10.1016/j.molcel.2006.10.028; Dormer UH, 2000, J BIOL CHEM, V275, P32611, DOI 10.1074/jbc.M004167200; Fauchon M, 2002, MOL CELL, V9, P713, DOI 10.1016/S1097-2765(02)00500-2; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; Flick K, 2006, NAT CELL BIOL, V8, P509, DOI 10.1038/ncb1402; Guthrie C, 1991, GUIDE YEAST GENETICS; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kaiser P, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-16; Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0; Kuras L, 1997, EMBO J, V16, P2441, DOI 10.1093/emboj/16.9.2441; Kuras L, 1996, EMBO J, V15, P2519, DOI 10.1002/j.1460-2075.1996.tb00609.x; Leroy C, 2006, MOL CELL BIOL, V26, P3149, DOI 10.1128/MCB.26.8.3149-3163.2006; Menant A, 2006, J BIOL CHEM, V281, P11744, DOI 10.1074/jbc.M600037200; Patton EE, 2000, EMBO J, V19, P1613, DOI 10.1093/emboj/19.7.1613; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Su NY, 2005, MOL CELL BIOL, V25, P3875, DOI 10.1128/MCB.25.10.3875-3885.2005; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1995, MOL CELL BIOL, V15, P6526; THOMAS D, 1992, MOL CELL BIOL, V12, P1719, DOI 10.1128/MCB.12.4.1719; Yen JL, 2005, MOL BIOL CELL, V16, P1872, DOI 10.1091/mbc.E04-12-1130	27	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11615	11624		10.1074/jbc.M708230200	http://dx.doi.org/10.1074/jbc.M708230200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18308733	Green Published, hybrid			2022-12-25	WOS:000255067400062
J	Jupiter, DC; VanBuren, V				Jupiter, Daniel C.; VanBuren, Vincent			A Visual Data Mining Tool that Facilitates Reconstruction of Transcription Regulatory Networks	PLOS ONE			English	Article							GENE; EXPRESSION; INFERENCE; INFORMATION; MODELS	Background: Although the use of microarray technology has seen exponential growth, analysis of microarray data remains a challenge to many investigators. One difficulty lies in the interpretation of a list of differentially expressed genes, or in how to plan new experiments given that knowledge. Clustering methods can be used to identify groups of genes with similar expression patterns, and genes with unknown function can be provisionally annotated based on the concept of "guilt by association'', where function is tentatively inferred from the known functions of genes with similar expression patterns. These methods frequently suffer from two limitations: ( 1) visualization usually only gives access to group membership, rather than specific information about nearest neighbors, and ( 2) the resolution or quality of the relationships are not easily inferred. Methodology/Principal Findings: We have addressed these issues by improving the precision of similarity detection over that of a single experiment and by creating a tool to visualize tractable association networks: we ( 1) performed meta-analysis computation of correlation coefficients for all gene pairs in a heterogeneous data set collected from 2,145 publicly available micorarray samples in mouse, ( 2) filtered the resulting distribution of over 130 million correlation coefficients to build new, more tractable distributions from the strongest correlations, and ( 3) designed and implemented a new Web based tool (StarNet, http://vanburenlab.medicine.tamhsc.edu/starnet.html) for visualization of sub-networks of the correlation coefficients built according to user specified parameters. Conclusions/Significance: Correlations were calculated across a heterogeneous collection of publicly available microarray data. Users can access this analysis using a new freely available Web-based application for visualizing tractable correlation networks that are flexibly specified by the user. This new resource enables rapid hypothesis development for transcription regulatory relationships.	[Jupiter, Daniel C.; VanBuren, Vincent] Texas A&M Univ, Coll Med, Texas A&M Hlth Sci Ctr, Dept Syst Biol & Translat Med, Temple, TX 76508 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Jupiter, DC (corresponding author), Texas A&M Univ, Coll Med, Texas A&M Hlth Sci Ctr, Dept Syst Biol & Translat Med, Temple, TX 76508 USA.	vanburen@tamu.edu			American Heart Association [0630263N]; Department of Systems Biology and Translational Medicine and the Dean of the College of Medicine, Texas A & M Health Science Center	American Heart Association(American Heart Association); Department of Systems Biology and Translational Medicine and the Dean of the College of Medicine, Texas A & M Health Science Center	This work was funded by a Scientist Development Grant from the American Heart Association (Grant ID: 0630263N), and by start-up funds from the Department of Systems Biology and Translational Medicine and the Dean of the College of Medicine, Texas A & M Health Science Center. The project funders had no role in the design and conduct of the study, no role in the collection, analysis, and interpretation of the data, and no role in the preparation, review, or approval of the manuscript.	Angello JC, 2006, DEV DYNAM, V235, P2122, DOI 10.1002/dvdy.20863; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Bolstad B, 2005, BIOINFORMATICS COMPU; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Duselis AR, 2007, HUM MOL GENET, V16, P808, DOI 10.1093/hmg/ddm025; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Hastie T, 2001, GENOME BIOL, V2; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kaufman PJ L.R., 1990, FINDING GROUPS DATA; Longabaugh WJR, 2005, DEV BIOL, V283, P1, DOI 10.1016/j.ydbio.2005.04.023; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Nachman I, 2004, BIOINFORMATICS, V20, P248, DOI 10.1093/bioinformatics/bth941; Reiss DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-280; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Rogers S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; Wasserman S., 1994, SOCIAL NETWORK ANAL; Weitzman Jonathan B, 2004, J Biol, V3, P19, DOI 10.1186/jbiol18	32	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1717	10.1371/journal.pone.0001717	http://dx.doi.org/10.1371/journal.pone.0001717			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320038	Green Published, gold, Green Submitted			2022-12-25	WOS:000260586600013
J	Loukin, S; Zhou, XL; Kung, C; Saimi, Y				Loukin, Stephen; Zhou, Xinliang; Kung, Ching; Saimi, Yoshiro			A genome-wide survey suggests an osmoprotective role for vacuolar Ca2+ release in cell wall-compromised yeast	FASEB JOURNAL			English	Article						Saccharomyces cerevisiae; Yvc1; TRPY1; transient receptor potential ion channel; CCH1; calcineurin	SIGNAL-TRANSDUCTION PATHWAY; SACCHAROMYCES-CEREVISIAE; INTEGRITY PATHWAY; ANCHORED PROTEINS; HYPERTONIC SHOCK; PLASMA-MEMBRANE; HYPOTONIC SHOCK; ION-CHANNEL; GENE; CALCINEURIN	In yeast, osmotic upshock causes a release of vacuolar Ca2+ through the mechanosensitive transient receptor potential channel, Yvc1. We screened the collection of 4810 yeast gene deletants twice for alterations in this response in an attempt to find elements that regulate the amount of vacuolar Ca2+ or the Yvc1 channel. Severe overresponders and underresponders to upshock were further scrutinized for their calcium content with Ca-45 and their Yvc1 electrophysiological activities under patch-clamp. The severe underresponders have lower calcium content but no change in Yvc1 activity. The strong overresponders, most of which are deleted of genes involved in cell wall metabolism, have higher calcium content. Wall mutations are known to up-regulate Ca2+ -calcineurin-dependent genes. It appears that stress on the cell wall induces Ca2+ accumulation, adaptively anticipating the need in defense or repair against future stress, including osmotic stress.	[Loukin, Stephen; Zhou, Xinliang; Kung, Ching; Saimi, Yoshiro] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Kung, Ching] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Loukin, S (corresponding author), Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA.	shloukin@wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047856] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 47856, GM54867] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Batiza AF, 1996, J BIOL CHEM, V271, P23357, DOI 10.1074/jbc.271.38.23357; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Benachour A, 1999, J BIOL CHEM, V274, P15251, DOI 10.1074/jbc.274.21.15251; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cunningham KW, 1996, MOL CELL BIOL, V16, P2226; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; EILAM Y, 1985, J GEN MICROBIOL, V131, P623; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; Fujita M, 2006, MOL BIOL CELL, V17, P5253, DOI 10.1091/mbc.E06-08-0715; GARRETTENGELE P, 1995, MOL CELL BIOL, V15, P4103; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GUSTIN MC, 1988, SCIENCE, V242, P762, DOI 10.1126/science.2460920; Hamada K, 1998, MOL GEN GENET, V258, P53, DOI 10.1007/s004380050706; HOFMANN M, 1994, EUR J BIOCHEM, V221, P741, DOI 10.1111/j.1432-1033.1994.tb18787.x; HONG Z, 1994, MOL CELL BIOL, V14, P1017, DOI 10.1128/MCB.14.2.1017; Kanzaki M, 1999, SCIENCE, V285, P882, DOI 10.1126/science.285.5429.882; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1111/j.1574-6976.2002.tb00613.x; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Lesage G, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-8; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Loukin SH, 2007, FASEB J, V21, P1813, DOI 10.1096/fj.06-7898com; Martin-Yken H, 2003, MOL MICROBIOL, V49, P23, DOI 10.1046/j.1365-2958.2003.03541.x; Matsumoto TK, 2002, J BIOL CHEM, V277, P33075, DOI 10.1074/jbc.M205037200; Miseta A, 1999, FEBS LETT, V451, P132, DOI 10.1016/S0014-5793(99)00519-0; Nass R, 1999, MICROBIOL-SGM, V145, P3221, DOI 10.1099/00221287-145-11-3221; Palmer CP, 2005, BIOCHEM J, V387, P211, DOI 10.1042/BJ20041710; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Zhao C, 1998, MOL CELL BIOL, V18, P1013, DOI 10.1128/MCB.18.2.1013; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100	36	11	11	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2008	22	7					2405	2415		10.1096/fj.07-101410	http://dx.doi.org/10.1096/fj.07-101410			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18323404				2022-12-25	WOS:000257292500032
J	Chen, D; Yu, ZY; Zhu, ZY; Lopez, CD				Chen, Dexi; Yu, Zhiyong; Zhu, Zhiyi; Lopez, Charles D.			E2F1 regulates the base excision repair gene XRCC1 and promotes DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; TRANSCRIPTION FACTOR; DIFFERENTIAL REGULATION; IONIZING-RADIATION; PROSTATE CARCINOMA; PROTEIN-KINASE; DAMAGE REPAIR; TARGET GENES; P53; EXPRESSION	The E2F1 transcription factor activates S-phase-promoting genes, mediates apoptosis, and stimulates DNA repair through incompletely understood mechanisms. XRCC1 (x-ray repair cross-complementing group 1) protein is important for efficient single strand break/base excision repair. Although both damage and proliferative signals increase XRCC1 levels, the mechanisms regulating XRCC1 transcription remain unclear. To study these upstream mechanisms, the XRCC1 promoter was cloned into a luciferase reporter. Ectopic expression of wild-type E2F1, but not an inactive mutant E2F1(132E), activated the XRCC1 promoter-luciferase reporter, and deletion of predicted E2F1 binding sites in the promoter attenuated E2F1-induced activation. Endogenous XRCC1 expression increased in cells conditionally expressing wild-type, but not mutant E2F1, and methyl methanesulfonate-induced DNA damage stimulated XRCC1 expression in E2F1(+/+) but not E2F1(-/-) mouse embryo fibroblasts (MEFs). Additionally, E2F1(-/-) MEFs displayed attenuated DNA repair after methyl methanesulfonate-induced damage compared with E2F1(+/+) MEFs. Moreover, Chinese hamster ovary cells with mutant XRCC1 (EM9) were more sensitive to E2F1-induced apoptosis compared with Chinese hamster ovary cells with wild-type XRCC1 (AA8). These results provide new mechanistic insight into the role of the E2F pathway in maintaining genomic stability.	[Chen, Dexi; Yu, Zhiyong; Zhu, Zhiyi; Lopez, Charles D.] Oregon Hlth & Sci Univ, Dept Med, Div Hematol & Med Oncol, Portland, OR 97239 USA	Oregon Health & Science University	Lopez, CD (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Div Hematol & Med Oncol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lopezc@ohsu.edu			NCI NIH HHS [CA 104997] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA104997] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adimoolam S, 2003, DNA REPAIR, V2, P947, DOI 10.1016/S1568-7864(03)00087-9; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bell LA, 2004, CELL DEATH DIFFER, V11, P137, DOI 10.1038/sj.cdd.4401324; Berton TR, 2005, ONCOGENE, V24, P2449, DOI 10.1038/sj.onc.1208462; Bindra RS, 2005, CANCER RES, V65, P11597, DOI 10.1158/0008-5472.CAN-05-2119; Blattner C, 1999, MOL CELL BIOL, V19, P3704; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Brem R, 2005, NUCLEIC ACIDS RES, V33, P2512, DOI 10.1093/nar/gki543; Caldecott KW, 2001, BIOESSAYS, V23, P447, DOI 10.1002/bies.1063; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Campalans A, 2005, DNA REPAIR, V4, P826, DOI 10.1016/j.dnarep.2005.04.014; CANTONI O, 1987, CHEM-BIOL INTERACT, V63, P29, DOI 10.1016/0009-2797(87)90102-5; Chen D, 2005, CELL DEATH DIFFER, V12, P358, DOI 10.1038/sj.cdd.4401536; Chen J, 1997, J NEUROCHEM, V69, P232; CHURCHILL ME, 1991, PHOTOCHEM PHOTOBIOL, V53, P229, DOI 10.1111/j.1751-1097.1991.tb03927.x; Collis SJ, 2003, CANCER RES, V63, P1550; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dong ZW, 2006, NUCLEIC ACIDS RES, V34, P5721, DOI 10.1093/nar/gkl705; Dynlacht BD, 2005, CELL DEATH DIFFER, V12, P313, DOI 10.1038/sj.cdd.4401612; Fan JS, 2004, NUCLEIC ACIDS RES, V32, P2193, DOI 10.1093/nar/gkh556; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; Iwanaga R, 2004, ONCOGENE, V23, P8581, DOI 10.1038/sj.onc.1207976; Ladiges WC, 2006, ONCOGENE, V25, P1612, DOI 10.1038/sj.onc.1209370; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Levy N, 2006, NUCLEIC ACIDS RES, V34, P32, DOI 10.1093/nar/gkj409; Lin WC, 2001, GENE DEV, V15, P1833; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Luo H, 2004, MOL CELL BIOL, V24, P8356, DOI 10.1128/MCB.24.19.8356-8365.2004; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Moore DJ, 2000, P NATL ACAD SCI USA, V97, P13649, DOI 10.1073/pnas.250477597; Nakada D, 2003, NUCLEIC ACIDS RES, V31, P1715, DOI 10.1093/nar/gkg252; Offer H, 1999, FEBS LETT, V450, P197, DOI 10.1016/S0014-5793(99)00505-0; Pediconi N, 2003, NAT CELL BIOL, V5, P552, DOI 10.1038/ncb998; Pickering MT, 2006, ONCOGENE, V25, P746, DOI 10.1038/sj.onc.1209103; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Prost S, 2007, ONCOGENE, V26, P3572, DOI 10.1038/sj.onc.1210151; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sears RC, 2002, J BIOL CHEM, V277, P11617, DOI 10.1074/jbc.R100063200; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Seo YR, 2002, ONCOGENE, V21, P731, DOI 10.1038/sj.onc.1205129; Shen NR, 1998, NUCLEIC ACIDS RES, V26, P1032, DOI 10.1093/nar/26.4.1032; SHUNG B, 1994, MUTAT RES, V307, P43, DOI 10.1016/0027-5107(94)90276-3; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Speit G, 1999, METH MOL B, V113, P203; Stevens C, 2004, DNA REPAIR, V3, P1071, DOI 10.1016/j.dnarep.2004.03.034; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; Taylor RM, 2002, MOL CELL BIOL, V22, P2556, DOI 10.1128/MCB.22.8.2556-2563.2002; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; THOMPSON LH, 1982, MUTAT RES, V95, P427, DOI 10.1016/0027-5107(82)90276-7; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; TIMARCHI JM, 2002, NAT REV MOL CELL BIO, V3, P11; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; WALSH MJ, 1995, J BIOL CHEM, V270, P5289, DOI 10.1074/jbc.270.10.5289; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; WINKONKAL N, 2003, NAT CELL BIOL, V5, P655; Yacoub A, 2003, RADIAT RES, V159, P439, DOI 10.1667/0033-7587(2003)159[0439:EGFAIR]2.0.CO;2; Yacoub A, 2001, INT J RADIAT BIOL, V77, P1067, DOI 10.1080/09553000110069317; Yamasaki L, 1996, CELL, V85, P537, DOI 10.1016/S0092-8674(00)81254-4; Youn CK, 2005, NAT CELL BIOL, V7, P137, DOI 10.1038/ncb1215; ZDZIENICKA MZ, 1992, MUTAGENESIS, V7, P265, DOI 10.1093/mutage/7.4.265; Zhou JM, 2001, EMBO J, V20, P914, DOI 10.1093/emboj/20.4.914; Zhu ZY, 2005, J BIOL CHEM, V280, P34473, DOI 10.1074/jbc.M503736200	75	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15381	15389		10.1074/jbc.M710296200	http://dx.doi.org/10.1074/jbc.M710296200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18348985	hybrid, Green Published			2022-12-25	WOS:000256232000056
J	Nie, C; Tian, CH; Zhao, LX; Petit, PX; Mehrpour, M; Chen, Q				Nie, Chunlai; Tian, Changhai; Zhao, Lixia; Petit, Patrice Xavier; Mehrpour, Maryam; Chen, Quan			Cysteine 62 of Bax is critical for its conformational activation and its proapoptotic activity in response to H2O2-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; MITOCHONDRIAL DYSFUNCTION; CELL-DEATH; CASPASE ACTIVATION; HYDROGEN-PEROXIDE; ARSENIC TRIOXIDE; NITRIC-OXIDE; TRANSLOCATION; PHOSPHORYLATION; DIMERIZATION	Bax is activated and translocated onto mitochondria to mediate cytochrome c release and apoptosis. The molecular mechanisms of Bax activation during apoptosis remain a subject of debate. We addressed the question of whether reactive oxygen species could directly activate Bax for its subsequent translocation and apoptosis. Using the SW480 human colon adenocarcinoma cell line stably expressing Bax fused to GFP, we showed that H2O2 induces Bax conformational change, mitochondrial translocation, and subsequent oligomerization at mitochondria. We found that H2O2-induced Bax activation is dependent on the conserved cysteine residue 62 of Bax. Mutation of cysteine 6, but not cysteine 126, to serine or alanine abolished its activation by H2O2 but not other death stimuli, both in SW480 and Bax-deficient HCT116 cells, whereas wild type Bax sensitizes these cells to apoptosis. Cysteines of Bax could chemically react with H2O2. Mutation of Bax BH3 domain in the presence of cysteine 62 also abolished Bax proapoptotic activity. We conclude that reactive oxygen species could be a direct signal for Bax activation by reacting with cysteine residues. Our results identify a critical role of cysteine 62 in oxidative stress-induced Bax activation and subsequent apoptosis.	[Nie, Chunlai; Tian, Changhai; Zhao, Lixia; Mehrpour, Maryam; Chen, Quan] Chinese Acad Med Sci, Joint Lab Apoptosis & Canc Biol, State Key Lab Biomembrane & Membrane Biotechnol, Inst Zool, Tianjin 300071, Peoples R China; [Nie, Chunlai; Tian, Changhai; Zhao, Lixia; Mehrpour, Maryam; Chen, Quan] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Petit, Patrice Xavier] Univ Paris 05, Inst Cochin, CNRS UMR 8104,INSERM U567, Dept Genet & Dev,Team Canc Apoptosis & Mitochondr, F-75014 Paris, France; [Mehrpour, Maryam] Univ Paris 11, Fac Pharm, INSERM U756, F-92296 Chatenay Malabry, France	Chinese Academy of Medical Sciences - Peking Union Medical College; Nankai University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Mehrpour, M (corresponding author), Chinese Acad Sci, Lab Apoptosis & Canc Biol, IOZ, Beijing 100101, Peoples R China.	mehrpour@ioz.ac.cn	Mehrpour, Maryam/D-8640-2017; Petit, Patrice X./A-3692-2009; Tian, Changhai/AAD-4856-2019; Petit, patrice/AAF-6774-2020	Petit, Patrice X./0000-0002-5038-9101; Chen, Quan/0000-0001-7539-8728				Ahmad KA, 2004, CANCER RES, V64, P7867, DOI 10.1158/0008-5472.CAN-04-0648; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Chandra D, 2005, J BIOL CHEM, V280, P19051, DOI 10.1074/jbc.M501391200; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; Chen Q, 2000, CELL DEATH DIFFER, V7, P227, DOI 10.1038/sj.cdd.4400629; Chen Q, 1997, J BIOL CHEM, V272, P14532, DOI 10.1074/jbc.272.23.14532; Croteau DL, 1997, J BIOL CHEM, V272, P27338, DOI 10.1074/jbc.272.43.27338; D'Alessio M, 2005, FASEB J, V19, P1504, DOI 10.1096/fj.04-3329fje; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Heimlich G, 2004, BIOCHEM J, V378, P247, DOI 10.1042/BJ20031152; Jezek P, 2005, INT J BIOCHEM CELL B, V37, P2478, DOI 10.1016/j.biocel.2005.05.013; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Li DC, 2004, CANCER SCI, V95, P644, DOI 10.1111/j.1349-7006.2004.tb03323.x; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Trojan J, 2004, INT J COLORECTAL DIS, V19, P538, DOI 10.1007/s00384-004-0597-1; Wang XD, 2001, GENE DEV, V15, P2922; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zha HB, 1996, MOL CELL BIOL, V16, P6494; Zheng YH, 2005, ONCOGENE, V24, P3339, DOI 10.1038/sj.onc.1208484; Zheng YH, 2004, ONCOGENE, V23, P1239, DOI 10.1038/sj.onc.1207205; Zhou H, 2007, ONCOGENE, V26, P7092, DOI 10.1038/sj.onc.1210517	36	85	92	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15359	15369		10.1074/jbc.M800847200	http://dx.doi.org/10.1074/jbc.M800847200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18344566	Green Published, hybrid			2022-12-25	WOS:000256232000054
J	Ishida, H; Huang, H; Yamniuk, AP; Takaya, Y; Vogel, HJ				Ishida, Hiroaki; Huang, Hao; Yamniuk, Aaron P.; Takaya, Yoshiaki; Vogel, Hans J.			The solution structures of two soybean calmodulin isoforms provide a structural basis for their selective target activation properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; PLANT CALMODULIN; NITRIC-OXIDE; BACKBONE DYNAMICS; BINDING PROTEINS; CHEMICAL-SHIFT; NMR; CALCIUM; DOMAIN; RELAXATION	The intracellular calcium ion is one of the most important secondary messengers in eukaryotic cells. Ca2+ signals are translated into physiological responses by EF-hand calcium-binding proteins such as calmodulin (CaM). Multiple CaM isoforms occur in plant cells, whereas only a single CaM protein is found in animals. Soybean CaM isoform 1 (sCaM1) shares 90% amino acid sequence identity with animal CaM (aCaM), whereas sCaM4 is only 78% identical. These two sCaM isoforms have distinct target-enzyme activation properties and physiological functions. sCaM4 is highly expressed during the self-defense reaction of the plant and activates the enzyme nitric-oxide synthase (NOS), whereas sCaM1 is incapable of activating NOS. The mechanism of selective target activation by plant CaM isoforms is poorly understood. We have determined high resolution NMR solution structures of Ca2+-sCaM1 and -sCaM4. These were compared with previously determined Ca2+-aCaM structures. For the N-lobe of the protein, the solution structures of Ca2+-sCaM1, -sCaM4, and -aCaM all closely resemble each other. However, despite the high sequence identity with aCaM, the C-lobe of Ca2+-sCaM1 has a more open conformation and consequently a larger hydrophobic target-protein binding pocket than Ca2+-aCaM or -sCaM4, the presence of which was further confirmed through biophysical measurements. The single Val-144 -> Met substitution in the C-lobe of Ca2+-sCaM1, which restores its ability to activate NOS, alters the structure of the C-lobe to a more closed conformation resembling Ca2+-aCaM and -sCaM4. The relationships between the structural differences in the two Ca2+-sCaM isoforms and their selective target activation properties are discussed.	[Ishida, Hiroaki; Huang, Hao; Yamniuk, Aaron P.; Takaya, Yoshiaki; Vogel, Hans J.] Univ Calgary, Dept Biol Sci, Struct Biol Res Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Vogel, HJ (corresponding author), Univ Calgary, Dept Biol Sci, Struct Biol Res Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	vogel@ucalgary.ca						BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bonvin AMJJ, 2005, CURR OPIN CHEM BIOL, V9, P501, DOI 10.1016/j.cbpa.2005.08.011; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chou JJ, 2001, NAT STRUCT BIOL, V8, P990, DOI 10.1038/nsb1101-990; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Heo WD, 1999, P NATL ACAD SCI USA, V96, P766, DOI 10.1073/pnas.96.2.766; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Jee JunGoo, 2003, Journal of Structural and Functional Genomics, V4, P179, DOI 10.1023/A:1026122726574; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Kondo R, 1999, J BIOL CHEM, V274, P36213, DOI 10.1074/jbc.274.51.36213; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kretsinger RH, 1996, NAT STRUCT BIOL, V3, P12, DOI 10.1038/nsb0196-12; Krueger JK, 2001, J BIOL CHEM, V276, P4535, DOI 10.1074/jbc.C000857200; LAPORTE DC, 1980, BIOCHEMISTRY-US, V19, P3814, DOI 10.1021/bi00557a025; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee SH, 1997, J BIOL CHEM, V272, P9252, DOI 10.1074/jbc.272.14.9252; LEE SH, 1995, J BIOL CHEM, V270, P21806, DOI 10.1074/jbc.270.37.21806; Lee SH, 2000, BIOCHEM J, V350, P299, DOI 10.1042/0264-6021:3500299; Lee SH, 1999, BBA-PROTEIN STRUCT M, V1433, P56, DOI 10.1016/S0167-4838(99)00149-1; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Van Lierop JE, 2002, J BIOL CHEM, V277, P6550, DOI 10.1074/jbc.M111404200; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Yamniuk AP, 2005, BIOCHEMISTRY-US, V44, P3101, DOI 10.1021/bi047770y; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yamniuk AP, 2004, J BIOL CHEM, V279, P7698, DOI 10.1074/jbc.M310763200; Yuan T, 1999, PROTEIN SCI, V8, P113; Zielinski RE, 2002, PLANTA, V214, P446, DOI 10.1007/s004250100636; Zielinski RE, 1998, ANNU REV PLANT PHYS, V49, P697, DOI 10.1146/annurev.arplant.49.1.697; Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908	46	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14619	14628		10.1074/jbc.M801398200	http://dx.doi.org/10.1074/jbc.M801398200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18347016	hybrid			2022-12-25	WOS:000255941400050
J	van der Weerden, NL; Lay, FT; Anderson, MA				van der Weerden, Nicole L.; Lay, Fung T.; Anderson, Marilyn A.			The plant defensin, NaD1, enters the cytoplasm of Fusarium oxysporum hyphae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAHLIA DAHLIA-MERCKII; ANTIMICROBIAL PEPTIDES; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; ANTIFUNGAL ACTIVITY; GAMMA-PUROTHIONINS; PROTEIN; ARABIDOPSIS; MEMBRANE; MECHANISMS	The plant defensin, NaD1, from the flowers of Nicotiana alata displays potent antifungal activity against a variety of agronomically important filamentous fungi including Fusarium oxysporum f. sp. vasinfectum (Fov). To understand the mechanism of this antifungal activity, the effect of NaD1 on Fov fungal membranes and the location of NaD1 in treated hyphae was examined using various fluorescence techniques. NaD1 permeabilized fungal plasma membranes via the formation of an aperture with an internal diameter of between 14 and 22 A. NaD1 bound to the cell walls of all treated hyphae and entered several hyphae, resulting in granulation of the cytoplasm and cell death. These results suggest that the activity of antifungal plant defensins may not be restricted to the hyphal membrane and that they enter cells and affect intracellular targets.	[van der Weerden, Nicole L.; Lay, Fung T.; Anderson, Marilyn A.] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia	La Trobe University	Anderson, MA (corresponding author), La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia.	M.Anderson@latrobe.edu.Au	van der Weerden, Nicole L/C-3705-2014; Anderson, Marilyn A/A-4259-2012; Lay, Fung T/A-9043-2010	Anderson, Marilyn A/0000-0002-8257-5128; Lay, Fung T/0000-0002-3101-3782				Aerts AM, 2007, J MOL MICROB BIOTECH, V13, P243, DOI 10.1159/000104753; BLOCH C, 1991, FEBS LETT, V279, P101, DOI 10.1016/0014-5793(91)80261-Z; BOMAN HG, 1993, INFECT IMMUN, V61, P2978, DOI 10.1128/IAI.61.7.2978-2984.1993; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; COLILLA FJ, 1990, FEBS LETT, V270, P191, DOI 10.1016/0014-5793(90)81265-P; Dickinson H G, 1998, Symp Soc Exp Biol, V51, P51; Hoover DM, 2003, ANTIMICROB AGENTS CH, V47, P2804, DOI 10.1128/AAC.47.9.2804-2809.2003; Ibeas JI, 2000, PLANT J, V23, P375, DOI 10.1046/j.1365-313x.2000.00792.x; Janssen BJC, 2003, BIOCHEMISTRY-US, V42, P8214, DOI 10.1021/bi034379o; Ladokhin AS, 1997, BIOPHYS J, V72, P1762, DOI 10.1016/S0006-3495(97)78822-2; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lay FT, 2003, PLANT PHYSIOL, V131, P1283, DOI 10.1104/pp.102.016626; Li XWS, 2003, J BIOL CHEM, V278, P28553, DOI 10.1074/jbc.M300680200; Lobo DS, 2007, BIOCHEMISTRY-US, V46, P987, DOI 10.1021/bi061441j; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; McPhee JB, 2005, J PEPT SCI, V11, P677, DOI 10.1002/psc.704; Mirouze M, 2006, PLANT J, V47, P329, DOI 10.1111/j.1365-313X.2006.02788.x; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Salzman RA, 2004, MOL PLANT MICROBE IN, V17, P780, DOI 10.1094/MPMI.2004.17.7.780; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Silverstein KAT, 2006, CURR OPIN PLANT BIOL, V9, P142, DOI 10.1016/j.pbi.2006.01.002; Spelbrink RG, 2004, PLANT PHYSIOL, V135, P2055, DOI 10.1104/pp.104.040873; Thevissen K, 2000, P NATL ACAD SCI USA, V97, P9531, DOI 10.1073/pnas.160077797; Thevissen K, 2003, PEPTIDES, V24, P1705, DOI 10.1016/j.peptides.2003.09.014; Thevissen K, 2004, J BIOL CHEM, V279, P3900, DOI 10.1074/jbc.M311165200; Thevissen K, 2003, FEMS MICROBIOL LETT, V226, P169, DOI 10.1016/S0378-1097(03)00590-1; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Vylkova S, 2006, ANTIMICROB AGENTS CH, V50, P324, DOI 10.1128/AAC.50.1.324-331.2006; Wilson IW, 2005, PLANT CELL PHYSIOL, V46, P1190, DOI 10.1093/pcp/pci128; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200	33	142	155	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14445	14452		10.1074/jbc.M709867200	http://dx.doi.org/10.1074/jbc.M709867200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18339623	hybrid			2022-12-25	WOS:000255941400031
J	Shah, C; Yang, G; Lee, I; Bielawski, J; Hannun, YA; Samad, F				Shah, Charmi; Yang, Guang; Lee, Ian; Bielawski, Jacek; Hannun, Yusuf A.; Samad, Fahumiya			Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; PLASMA SPHINGOLIPID METABOLISM; INSULIN-RESISTANCE; ADIPOSE-TISSUE; SKELETAL-MUSCLE; OBESITY; RAT; INDUCTION; INFLAMMATION; EXPRESSION	Obesity increases the risk for metabolic and cardiovascular disease, and adipose tissue plays a central role in this process. Ceramide, the key intermediate of sphingolipid metabolism, also contributes to obesity-related disorders. We show that a high fat diet increased ceramide levels in the adipose tissues and plasma in C57BL/6J mice via a mechanism that involves an increase in gene expression of enzymes mediating ceramide generation through the de novo pathway (e. g. serine palmitoyltransferase) and via the hydrolysis of sphingomyelin (acid sphingomyelinase and neutral sphingomyelinase). Although the induction of total ceramide in response to the high fat diet was modest, dramatic increases were observed for C16, C18, and C18:1 ceramides. Next, we investigated the relationship of ceramide to plasminogen activator inhibitor-1 (PAI-1), the primary inhibitor of plasminogen activation and another key player in obesity. PAI-1 is consistently elevated in obesity and thought to contribute to increased artherothrombotic events and more recently to obesity-mediated insulin resistance. Interestingly, the changes in ceramide were attenuated in mice lacking PAI-1. Mechanistically, mice lacking PAI-1 were protected from dietinduced increase in serine palmitoyltransferase, acid sphingomyelinase, and neutral sphingomyelinase mRNA, providing a mechanistic link for decreased ceramide in PAI-1(-/-) mice. The decreases in plasma free fatty acids and adipose tumor necrosis factor-alpha in PAI-1(-/-) mice may have additionally contributed indirectly to improvements in ceramide profile in these mice. This study has identified a novel link between sphingolipid metabolism and PAI-1 and also suggests that ceramide may be an intermediary molecule linking elevated PAI-1 to insulin resistance.	[Shah, Charmi; Yang, Guang; Lee, Ian; Samad, Fahumiya] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA; [Bielawski, Jacek; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Torrey Pines Institute for Molecular Studies, California; Medical University of South Carolina	Samad, F (corresponding author), Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA.	fsamad@tpims.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071146] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL071146] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Auge N, 2004, CIRCULATION, V110, P571, DOI 10.1161/01.CIR.0000136995.83451.1D; Auge N, 2000, PROG LIPID RES, V39, P207, DOI 10.1016/S0163-7827(00)00007-2; Axelsson J, 2005, J RENAL NUTR, V15, P131, DOI 10.1053/j.jrn.2004.09.034; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; De Taeye B, 2005, CURR OPIN PHARMACOL, V5, P149, DOI 10.1016/j.coph.2005.01.007; Deng G, 2001, J CELL PHYSIOL, V189, P23, DOI 10.1002/jcp.1133; Dobrzyn A, 2002, AM J PHYSIOL-ENDOC M, V282, pE277, DOI 10.1152/ajpendo.00151.2001; FEARNS C, 1995, VASCULAR CONTROL HEM, P207; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Juhan-Vague I, 2003, J THROMB HAEMOST, V1, P1575, DOI 10.1046/j.1538-7836.2003.00279.x; Kimura M, 2000, J NEUROSCI RES, V62, P781, DOI 10.1002/1097-4547(20001215)62:6<781::AID-JNR4>3.3.CO;2-N; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Li HG, 2002, CIRCULATION, V106, P2250, DOI 10.1161/01.CIR.0000035650.05921.50; Li ZQ, 2005, BBA-MOL CELL BIOL L, V1735, P130, DOI 10.1016/j.bbalip.2005.05.004; Lijnen HR, 2003, ARTERIOSCL THROM VAS, V23, P78, DOI 10.1161/01.ATV.0000044457.60665.DD; Lopez-Alemany R, 2003, EUR J BIOCHEM, V270, P814, DOI 10.1046/j.1432-1033.2003.03453.x; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Marathe S, 2000, ARTERIOSCL THROM VAS, V20, P2607, DOI 10.1161/01.ATV.20.12.2607; MEGIDISH T, 1995, BIOCHEM BIOPH RES CO, V216, P739, DOI 10.1006/bbrc.1995.2684; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mitchinson MJ, 1996, CURR OPIN LIPIDOL, V7, P324, DOI 10.1097/00041433-199610000-00011; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Morange PE, 2000, ARTERIOSCL THROM VAS, V20, P1150, DOI 10.1161/01.ATV.20.4.1150; Pandey M, 2005, FASEB J, V19, P1317, DOI 10.1096/fj.04-3459fje; Pandey M, 2003, AM J PATHOL, V162, P933, DOI 10.1016/S0002-9440(10)63888-6; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Samad F, 1997, THROMB HAEMOSTASIS, V78, P652; Samad F, 1996, J CLIN INVEST, V97, P37, DOI 10.1172/JCI118404; Samad F, 1996, MOL MED, V2, P568, DOI 10.1007/BF03401641; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schafer K, 2001, FASEB J, V15, P1840, DOI 10.1096/fj.00-0750fje; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; TURINSKY J, 1990, J BIOL CHEM, V265, P16880; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Zendzian-Piotrowska M, 2006, J PHYSIOL PHARMACOL, V57, P101	53	110	111	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13538	13548		10.1074/jbc.M709950200	http://dx.doi.org/10.1074/jbc.M709950200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359942	Green Published, hybrid			2022-12-25	WOS:000255728200007
J	Drover, VA; Nguyen, DV; Bastie, CC; Darlington, YF; Abumrad, NA; Pessin, JE; London, E; Sahoo, D; Phillips, MC				Drover, Victor A.; Nguyen, David V.; Bastie, Claire C.; Darlington, Yolanda F.; Abumrad, Nada A.; Pessin, Jeffrey E.; London, Erwin; Sahoo, Daisy; Phillips, Michael C.			CD36 mediates both cellular uptake of very long chain fatty acids and their intestinal absorption in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; B SCAVENGER RECEPTOR; SR-BI; CHOLESTEROL ABSORPTION; LIPID ABSORPTION; SERUM-ALBUMIN; TRANSPORT; LOCALIZATION; CELLS; ADRENOLEUKODYSTROPHY	The intestine has an extraordinary capacity for fatty acid ( FA) absorption. Numerous candidates for a protein-mediated mechanism of dietary FA absorption have been proposed, but firm evidence for this process has remained elusive. Here we show that the scavenger receptor CD36 is required both for the uptake of very long chain FAs (VLCFAs) in cultured cells and the absorption of dietary VLCFAs in mice. We found that the fraction of CD36-dependent saturated fatty acid association/ absorption in these model systems is proportional to the FA chain length and specific for fatty acids and fatty alcohols containing very long saturated acyl chains. Moreover, intestinal VLCFA absorption is completely abolished in CD36-null mice fed a high fat diet, illustrating that the predominant mechanism for VLCFA absorption is CD36-dependent. Together, these findings represent the first direct evidence for protein-facilitated FA absorption in the intestine and identify a novel therapeutic target for the treatment of diseases characterized by elevated VLCFA levels.	[Drover, Victor A.; Bastie, Claire C.; Darlington, Yolanda F.; Pessin, Jeffrey E.; Sahoo, Daisy] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Nguyen, David V.; Phillips, Michael C.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, GI Nutr Div, Philadelphia, PA 19104 USA; [Abumrad, Nada A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Washington University (WUSTL)	Drover, VA (corresponding author), H4880 Hlth Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53089 USA.	victor.drover@mcw.edu		Bastie, Claire/0000-0001-8178-4748; Phillips, Michael/0000-0002-7147-8007	NHLBI NIH HHS [HL63768, HL22633] Funding Source: Medline; NIDDK NIH HHS [P30 DK056341-08, DK060022, P30 DK056341, P30 DK056341-07] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633, R01HL063768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R01DK060022] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Calvo D, 1998, J LIPID RES, V39, P777; Chen M, 2001, AM J PHYSIOL-ENDOC M, V281, pE916, DOI 10.1152/ajpendo.2001.281.5.E916; Choi JK, 2002, J LIPID RES, V43, P1000, DOI 10.1194/jlr.M200041-JLR200; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Connelly MA, 2001, BIOCHEMISTRY-US, V40, P5249, DOI 10.1021/bi002825r; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; FIELDS M, 1963, NATURE, V198, P994, DOI 10.1038/198994b0; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Goudriaan JR, 2002, MOL CELL BIOCHEM, V239, P199, DOI 10.1023/A:1020575412789; Hamilton JA, 1998, J LIPID RES, V39, P467; HO JK, 1995, J CLIN INVEST, V96, P1455, DOI 10.1172/JCI118182; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; JOHNSON WJ, 1986, J BIOL CHEM, V261, P5766; Kamp F, 2006, PROSTAG LEUKOTR ESS, V75, P149, DOI 10.1016/j.plefa.2006.05.003; Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253, DOI 10.1177/002215540104901007; Moser HW, 1997, BRAIN, V120, P1485, DOI 10.1093/brain/120.8.1485; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Out R, 2004, J BIOL CHEM, V279, P18401, DOI 10.1074/jbc.M401170200; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Sane AT, 2006, J LIPID RES, V47, P2112, DOI 10.1194/jlr.M600174-JLR200; van Bennekum A, 2005, BIOCHEMISTRY-US, V44, P4517, DOI 10.1021/bi0484320; Werder M, 2001, BIOCHEMISTRY-US, V40, P11643, DOI 10.1021/bi0109820; Zhang FL, 1996, BIOCHEMISTRY-US, V35, P16055, DOI 10.1021/bi961685b; Zhang XQ, 2003, LAB INVEST, V83, P317, DOI 10.1097/01.LAB.0000059923.67198.BA	30	104	108	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13108	13115		10.1074/jbc.M708086200	http://dx.doi.org/10.1074/jbc.M708086200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18332148	hybrid, Green Published			2022-12-25	WOS:000255499800049
J	Gushiken, FC; Patel, V; Liu, Y; Pradhan, S; Bergeron, AL; Peng, Y; Vijayan, KV				Gushiken, Francisca C.; Patel, Vimal; Liu, Yan; Pradhan, Subhashree; Bergeron, Angela L.; Peng, Yuandong; Vijayan, K. Vinod			Protein phosphatase 2A negatively regulates integrin alpha(IIb)beta(3) signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; CYTOPLASMIC DOMAIN; CELL-MIGRATION; OKADAIC ACID; ACTIVATION; KINASE; PHOSPHORYLATION; PLATELETS; ADHESION; GROWTH	Integrin alpha(IIb)beta(3) activation is critical for platelet physiology and is controlled by signal transduction through kinases and phosphatases. Compared with kinases, a role for phosphatases in platelet integrin alpha(IIb)beta(3) signaling is less understood. We report that the catalytic subunit of protein phosphatase 2A (PP2Ac) associates constitutively with the integrin alpha(IIb)beta(3) in resting platelets and in human embryonal kidney 293 cells expressing alpha(IIb)beta(3). The membrane proximal KVGFFKR sequence within the cytoplasmic domain of integrin alpha(IIb) is sufficient to support a direct interaction with PP2Ac. Fibrinogen binding to alpha(IIb)beta(3) during platelet adhesion decreased integrin-associated PP2A activity and increased the phosphorylation of a PP2A substrate, vasodilator associated phosphoprotein. Overexpression of PP2Ac(alpha) in 293 cells decreased alpha(IIb)beta(3)-mediated adhesion to immobilized fibrinogen. Conversely, small interference RNA mediated knockdown of endogenous PP2Ac alpha expression in 293 cells, enhanced extracellular signal-regulated kinase (ERK1/2) and p38 activation, and accelerated alpha(IIb)beta(3) adhesion to fibrinogen and von Willebrand factor. Inhibition of ERK1/2, but not p38 activation, abolished the increased adhesiveness of PP2Ac(alpha)-depleted 293 cells to fibrinogen. Furthermore, knockdown of PP2Ac(alpha) expression in bone marrow-derived murine megakaryocytes increased soluble fibrinogen binding induced by protease-activated receptor 4-activating peptide. These studies demonstrate that PP2Ac(alpha) can negatively regulate integrin alpha(IIb)beta(3) signaling by suppressing the ERK1/2 signaling pathway.	[Gushiken, Francisca C.; Patel, Vimal; Liu, Yan; Pradhan, Subhashree; Bergeron, Angela L.; Peng, Yuandong; Vijayan, K. Vinod] Baylor Coll Med, Thrombosis Res Sect, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Vijayan, KV (corresponding author), Baylor Coll Med, Thrombosis Res Sect, Dept Med, 1 Baylor Plaza,BCM 286,N1319, Houston, TX 77030 USA.	vvijayan@bcm.tmc.edu			NHLBI NIH HHS [R01 HL081613, R01 HL081613-02, HL0816013, T-32HL072754] Funding Source: Medline; PHS HHS [0435017N] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081613, T32HL072754] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arias-Salgado EG, 2005, J CELL BIOL, V170, P837, DOI 10.1083/jcb.200503125; Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200; Brunton VG, 2001, NEOPLASIA, V3, P215, DOI 10.1038/sj.neo.7900149; Buensuceso CS, 2005, J BIOL CHEM, V280, P644, DOI 10.1074/jbc.M410229200; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; HIGASHIHARA M, 1992, FEBS LETT, V307, P206, DOI 10.1016/0014-5793(92)80768-C; HOYT CH, 1995, BIOCHEMISTRY-US, V34, P9565, DOI 10.1021/bi00029a033; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; KHEWGOODALL Y, 1988, FEBS LETT, V238, P265, DOI 10.1016/0014-5793(88)80493-9; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Larkin D, 2004, J BIOL CHEM, V279, P27286, DOI 10.1074/jbc.M402159200; Lerea KM, 1999, J BIOL CHEM, V274, P1914, DOI 10.1074/jbc.274.4.1914; LEREA KM, 2006, BIOCHIM BIOPHYS ACTA, V1773, P185; Li ZY, 2006, BLOOD, V107, P965, DOI 10.1182/blood-2005-03-1308; Mazharian A, 2007, J BIOL CHEM, V282, P5478, DOI 10.1074/jbc.M609881200; McCluskey A, 2002, J MED CHEM, V45, P1151, DOI 10.1021/jm010066k; Mutz D, 2006, J NEUROSCI RES, V84, P1759, DOI 10.1002/jnr.21078; Naik UP, 2003, BLOOD, V102, P1355, DOI 10.1182/blood-2003-02-0591; NISHIKAWA M, 1994, CELL SIGNAL, V6, P59, DOI 10.1016/0898-6568(94)90061-2; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Rita M, 2003, INT J CANCER, V103, P38, DOI 10.1002/ijc.10772; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shiraga M, 1999, J CELL BIOL, V147, P1419, DOI 10.1083/jcb.147.7.1419; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Vijayan KV, 2004, J BIOL CHEM, V279, P33039, DOI 10.1074/jbc.C400239200; Vijayan KV, 2003, J BIOL CHEM, V278, P3860, DOI 10.1074/jbc.M208680200; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Young MRI, 2002, INT J CANCER, V100, P276, DOI 10.1002/ijc.10491; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131; ZHU XY, 1995, MOL BIOL CELL, V6, P273, DOI 10.1091/mbc.6.3.273	36	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12862	12869		10.1074/jbc.M708804200	http://dx.doi.org/10.1074/jbc.M708804200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18334487	hybrid, Green Published			2022-12-25	WOS:000255499800022
J	Lane, DJR; Lawen, A				Lane, Darius J. R.; Lawen, Alfons			Non-transferrin iron reduction and uptake are regulated by transmembrane ascorbate cycling in K562 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERRIC CITRATE UPTAKE; VITAMIN-C TRANSPORT; BOUND IRON; FERRIREDUCTASE ACTIVITY; DEHYDROASCORBIC ACID; STEAP PROTEINS; HEPATOMA-CELLS; NONHEME-IRON; METABOLISM; PLASMA	K562 erythroleukemia cells import non-transferrin-bound iron (NTBI) by an incompletely understood process that requires initial iron reduction. The mechanism of NTBI ferrir-eduction remains unknown but probably involves transplasma membrane electron transport. We here provide evidence for a novel mechanism of NTBI reduction and uptake by K562 cells that utilizes transplasma membrane ascorbate cycling. Incubation of cells with dehydroascorbic acid, but not ascorbate, resulted in (i) accumulation of intracellular ascorbate that was blocked by the glucose transporter inhibitor, cytochalasin B, and (ii) subsequent release of micromolar concentrations of ascorbate into the externalmedium via a route that was sensitive to the anion channel inhibitor, 4,4'-diisothiocyanatostilbene-2,2'-disulfonate. Ascorbate-deficient control cells demonstrated low levels of ferric citrate reduction. However, incubation of the cells with dehydroascorbic acid resulted in a dose-dependent stimulation of both iron reduction and uptake from radiolabeled [Fe-55] ferric citrate. This stimulation was abrogated by ascorbate oxidase treatment, suggesting dependence on direct chemical reduction by ascorbate. These results support a novel model of NTBI reduction and uptake by K562 cells in which uptake is preceded by reduction of iron by extracellular ascorbate, the latter of which is subsequently regenerated by transplasma membrane ascorbate cycling.	[Lane, Darius J. R.; Lawen, Alfons] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Melbourne, Vic 3800, Australia	Monash University	Lawen, A (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Bldg 13D,100 Wellington Rd, Melbourne, Vic 3800, Australia.	alfons.lawen@med.monash.edu.au	Lawen, Alfons/A-6598-2008	Lawen, Alfons/0000-0001-6553-9945; Lane, Darius/0000-0001-8725-6903				AKOMPONG T, 1995, J BIOL CHEM, V270, P20937, DOI 10.1074/jbc.270.36.20937; Anderson GJ, 2001, IUBMB LIFE, V51, P11, DOI 10.1080/15216540152035000; Baker E, 1998, BBA-GEN SUBJECTS, V1380, P21, DOI 10.1016/S0304-4165(97)00120-7; Breuer W, 2000, TRANSFUS SCI, V23, P185, DOI 10.1016/S0955-3886(00)00087-4; Brunner-Dopper L, 1998, ANAL BIOCHEM, V261, P128, DOI 10.1006/abio.1998.2712; Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271; CRANE FL, 1985, BIOCHIM BIOPHYS ACTA, V811, P233, DOI 10.1016/0304-4173(85)90013-8; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; Davis KA, 2006, BRIT J PHARMACOL, V147, P131, DOI 10.1038/sj.bjp.0706492; DeSilva DM, 1996, PHYSIOL REV, V76, P31, DOI 10.1152/physrev.1996.76.1.31; DOREY C, 1993, BRIT J NUTR, V70, P157, DOI 10.1079/BJN19930113; Dringen R, 2007, NEUROCHEM RES, V32, P1884, DOI 10.1007/s11064-007-9375-0; Duarte TL, 2007, FREE RADICAL BIO MED, V43, P1165, DOI 10.1016/j.freeradbiomed.2007.07.017; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Fidler MC, 2004, AM J CLIN NUTR, V79, P99; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Ghio AJ, 2003, AM J RESP CELL MOL, V29, P653, DOI 10.1165/rcmb.2003-0070OC; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; Gutierrez JA, 1998, J CELL PHYSIOL, V177, P585, DOI 10.1002/(SICI)1097-4652(199812)177:4<585::AID-JCP9>3.3.CO;2-P; HAN O, 1995, J NUTR, V125, P1291; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HOFFMAN KE, 1991, AM J CLIN NUTR, V54, pS1188, DOI 10.1093/ajcn/54.6.1188s; INMAN RS, 1993, J BIOL CHEM, V268, P8521; INMAN RS, 1994, BIOCHEMISTRY-US, V33, P11850, DOI 10.1021/bi00205a022; JORDAN I, 1994, BIOCHEM J, V302, P875, DOI 10.1042/bj3020875; Jung CH, 1998, ARCH BIOCHEM BIOPHYS, V355, P9, DOI 10.1006/abbi.1998.0713; KAPLAN J, 1991, J BIOL CHEM, V266, P2997; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; Konigsberger LC, 2000, J INORG BIOCHEM, V78, P175, DOI 10.1016/S0162-0134(99)00222-6; Konya C, 2006, BRIT J PHARMACOL, V147, P125, DOI 10.1038/sj.bjp.0706494; Kovar J, 2006, BLOOD CELL MOL DIS, V37, P95, DOI 10.1016/j.bcmd.2006.06.004; Laggner H, 1999, EUR J BIOCHEM, V262, P659, DOI 10.1046/j.1432-1327.1999.00403.x; Lane DJR, 2008, ANAL BIOCHEM, V373, P287, DOI 10.1016/j.ab.2007.09.009; Liang WJ, 2001, MOL MEMBR BIOL, V18, P87, DOI 10.1080/09687680120706; May JM, 2006, NEUROCHEM RES, V31, P785, DOI 10.1007/s11064-006-9077-z; May JM, 1999, BIOCHEM PHARMACOL, V57, P1275, DOI 10.1016/S0006-2952(99)00040-4; Musilkova J, 2001, BBA-BIOMEMBRANES, V1514, P117, DOI 10.1016/S0005-2736(01)00367-4; Ngkeekwong FC, 1997, BIOCHEM J, V324, P225, DOI 10.1042/bj3240225; Nualart FJ, 2003, J BIOL CHEM, V278, P10128, DOI 10.1074/jbc.M210686200; Oakhill JS, 2008, BBA-BIOENERGETICS, V1777, P260, DOI 10.1016/j.bbabio.2007.12.001; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Rumsey SC, 1998, J NUTR BIOCHEM, V9, P116, DOI 10.1016/S0955-2863(98)00002-3; SAVINI I, 2007, IN PRESS AMINO ACIDS; Schweinzer E, 1996, CELL BIOCHEM FUNCT, V14, P27, DOI 10.1002/(SICI)1099-0844(199603)14:1<27::AID-CBF635>3.3.CO;2-P; STURROCK A, 1990, J BIOL CHEM, V265, P3139; Su D, 2006, FEBS J, V273, P3722, DOI 10.1111/j.1742-4658.2006.05381.x; Su D, 2006, J BIOL CHEM, V281, P39852, DOI 10.1074/jbc.M606543200; Takeda A, 2002, NEUROCHEM INT, V41, P223, DOI 10.1016/S0197-0186(02)00023-2; TOTH I, 1995, J BIOL CHEM, V270, P2846, DOI 10.1074/jbc.270.6.2846; Trinder D, 1998, AM J PHYSIOL-GASTR L, V275, pG279, DOI 10.1152/ajpgi.1998.275.2.G279; Upston JM, 1999, BIOCHEM J, V342, P49, DOI 10.1042/0264-6021:3420049; Van Duijn MM, 1998, J BIOL CHEM, V273, P13415, DOI 10.1074/jbc.273.22.13415; Verrijt CEH, 1998, PLACENTA, V19, P525, DOI 10.1016/S0143-4004(98)91046-3; WATKINS D, 1983, BIOCHEM J, V214, P465, DOI 10.1042/bj2140465; Wilson JX, 2005, ANNU REV NUTR, V25, P105, DOI 10.1146/annurev.nutr.25.050304.092647; Wilson JX, 2000, BRAIN RES, V858, P61, DOI 10.1016/S0006-8993(99)02433-6	59	44	47	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12701	12708		10.1074/jbc.M800713200	http://dx.doi.org/10.1074/jbc.M800713200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18347019	hybrid			2022-12-25	WOS:000255499800005
J	Palazuelos, J; Davoust, N; Julien, B; Hatterer, E; Aguado, T; Mechoulam, R; Benito, C; Romero, J; Silva, A; Guzman, M; Nataf, S; Galve-Roperh, I				Palazuelos, Javier; Davoust, Nathalie; Julien, Boris; Hatterer, Eric; Aguado, Tania; Mechoulam, Raphael; Benito, Cristina; Romero, Julian; Silva, Augusto; Guzman, Manuel; Nataf, Serge; Galve-Roperh, Ismael			The CB2 cannabinoid receptor controls myeloid progenitor trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS; ENDOCANNABINOID SYSTEM; MICROGLIAL CELLS; MURINE MODEL; SPASTICITY; BRAIN; INFLAMMATION; DIFFERENTIATION; INVOLVEMENT; MODULATION	Cannabinoids are potential agents for the development of therapeutic strategies against multiple sclerosis. Here we analyzed the role of the peripheral CB2 cannabinoid receptor in the control of myeloid progenitor cell trafficking toward the inflamed spinal cord and their contribution to microglial activation in an animal model of multiple sclerosis ( experimental autoimmune encephalomyelitis, EAE). CB2 receptor knock-out mice showed an exacerbated clinical score of the disease when compared with their wild-type littermates, and this occurred in concert with extended axonal loss, T-lymphocyte (CD4(+)) infiltration, and microglial ( CD11b(+)) activation. Immature bone marrow-derived CD34(+) myeloid progenitor cells, which play a role in neuroinflammatory pathologies, were shown to express CB2 receptors and to be abundantly recruited toward the spinal cords of CB2 knock-out EAE mice. Bone marrow-derived cell transfer experiments further evidenced the increased contribution of these cells to microglial replenishment in the spinal cords of CB2-deficient animals. In line with these observations, selective pharmacological CB2 activation markedly reduced EAE symptoms, axonal loss, and microglial activation. CB2 receptor manipulation altered the expression pattern of different chemokines (CCL2, CCL3, CCL5) and their receptors (CCR1, CCR2), thus providing a mechanistic explanation for its role in myeloid progenitor recruitment during neuroinflammation. These findings demonstrate the protective role of CB2 receptors in EAE pathology; provide evidence for a new site of CB2 receptor action, namely the targeting of myeloid progenitor trafficking and its contribution to microglial activation; and support the potential use of non-psychoactive CB2 agonists in therapeutic strategies for multiple sclerosis and other neuroinflammatory disorders.	[Palazuelos, Javier; Julien, Boris; Aguado, Tania; Guzman, Manuel; Galve-Roperh, Ismael] Univ Complutense, Dept Biochem & Mol Biol 1, Sch Biol, E-28040 Madrid, Spain; [Palazuelos, Javier; Julien, Boris; Aguado, Tania; Guzman, Manuel; Galve-Roperh, Ismael] Univ Complutense, CIBERNED, E-28040 Madrid, Spain; [Davoust, Nathalie; Hatterer, Eric; Nataf, Serge] Fac Med Laennec, Inst Federatif Rech Neurosci Lyon, INSERM, U433, F-69372 Lyon, France; [Mechoulam, Raphael] Hebrew Univ Jerusalem, Sch Pharm, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel; [Benito, Cristina; Romero, Julian] Fdn Hosp Alcorcon, Lab Apoyo Invest, Madrid 28922, Spain; [Silva, Augusto] CSIC, CIB, Madrid 28040, Spain	Complutense University of Madrid; CIBERNED; Complutense University of Madrid; Institut National de la Sante et de la Recherche Medicale (Inserm); Hebrew University of Jerusalem; Alcorcon Foundation University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Galve-Roperh, I (corresponding author), Univ Complutense, Dept Biochem & Mol Biol 1, Sch Biol, E-28040 Madrid, Spain.	igr@quim.ucm.es	PAREDES, JULIAN ROMERO/F-4772-2016; Galve-Roperh, Ismael/AAG-2369-2020; Davoust, Nathalie/S-5676-2017; Aguado, Tania/AAE-3972-2019; AGUADO SANCHEZ, TANIA/ABD-6975-2021; PALAZUELOS, JAVIER/AAD-7313-2020; Julien, Boris/E-2374-2012; PALAZUELOS, JAVIER/D-1211-2013	PAREDES, JULIAN ROMERO/0000-0002-2897-606X; AGUADO SANCHEZ, TANIA/0000-0003-4339-0443; PALAZUELOS, JAVIER/0000-0002-0409-1398; Guzman, Manuel/0000-0001-7475-118X				Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Arevalo-Martin A, 2003, J NEUROSCI, V23, P2511; Asheuer M, 2004, P NATL ACAD SCI USA, V101, P3557, DOI 10.1073/pnas.0306431101; Babcock AA, 2003, J NEUROSCI, V23, P7922; Baker D, 2000, NATURE, V404, P84, DOI 10.1038/35003583; Benito C, 2007, J NEUROSCI, V27, P2396, DOI 10.1523/JNEUROSCI.4814-06.2007; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cabranes A, 2005, NEUROBIOL DIS, V20, P207, DOI 10.1016/j.nbd.2005.03.002; Carayon P, 1998, BLOOD, V92, P3605, DOI 10.1182/blood.V92.10.3605.422k05_3605_3615; Carrier EJ, 2004, MOL PHARMACOL, V65, P999, DOI 10.1124/mol.65.4.999; Collin C, 2007, EUR J NEUROL, V14, P290, DOI 10.1111/j.1468-1331.2006.01639.x; Croxford JL, 2008, J NEUROIMMUNOL, V193, P120, DOI 10.1016/j.jneuroim.2007.10.024; Croxford JL, 2003, J CLIN INVEST, V111, P1231, DOI 10.1172/JCI200317652; Davoust N, 2006, FASEB J, V20, P2081, DOI 10.1096/fj.05-5593com; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Docagne F, 2007, MOL CELL NEUROSCI, V34, P551, DOI 10.1016/j.mcn.2006.12.005; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Fernandez-Ruiz J, 2007, TRENDS PHARMACOL SCI, V28, P39, DOI 10.1016/j.tips.2006.11.001; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hanus L, 1999, P NATL ACAD SCI USA, V96, P14228, DOI 10.1073/pnas.96.25.14228; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Jackson SJ, 2005, NEUROSCIENCE, V134, P261, DOI 10.1016/j.neuroscience.2005.02.045; Jorda MA, 2004, BLOOD, V104, P526, DOI 10.1182/blood-2003-12-4257; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; MECHOULAM R, 2002, SCI STKE, V129, pE5; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Montecucco F, 2008, AM J PHYSIOL-HEART C, V294, pH1145, DOI 10.1152/ajpheart.01328.2007; Nataf S, 2000, J IMMUNOL, V165, P5867, DOI 10.4049/jimmunol.165.10.5867; Ortega-Gutierrez S, 2005, FASEB J, V19, P1338, DOI 10.1096/fj.04-2464fje; Palazuelos J, 2006, FASEB J, V20, P2405, DOI 10.1096/fj.06-6164fje; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pryce G, 2007, BRIT J PHARMACOL, V150, P519, DOI 10.1038/sj.bjp.0707003; Pryce G, 2005, TRENDS NEUROSCI, V28, P272, DOI 10.1016/j.tins.2005.03.006; Servet-Delprat Christine, 2002, BMC Immunol, V3, P15, DOI 10.1186/1471-2172-3-15; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Vallieres L, 2003, J NEUROSCI, V23, P5197; Wade DT, 2006, MULT SCLER J, V12, P639, DOI 10.1177/1352458505070618; Walter L, 2004, BRIT J PHARMACOL, V141, P775, DOI 10.1038/sj.bjp.0705667; Witting A, 2006, P NATL ACAD SCI USA, V103, P6362, DOI 10.1073/pnas.0510418103; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12; Zajicek JP, 2005, J NEUROL NEUROSUR PS, V76, P1664, DOI 10.1136/jnnp.2005.070136; Zhang J, 2007, J NEUROSCI, V27, P12396, DOI 10.1523/JNEUROSCI.3016-07.2007	46	132	139	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13320	13329		10.1074/jbc.M707960200	http://dx.doi.org/10.1074/jbc.M707960200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18334483	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000255499800072
J	Gonzales, ML; Mellman, DL; Anderson, RA				Gonzales, Michael L.; Mellman, David L.; Anderson, Richard A.			CKI alpha is associated with and phosphorylates Star-PAP and is also required for expression of select Star-PAP target messenger RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-I; PHOSPHATIDYLINOSITOL PHOSPHATE KINASES; POLY(A) POLYMERASE; HEME OXYGENASE-1; FAMILY; POLYADENYLATION; EUKARYOTES; MECHANISM	We have recently identified Star-PAP, a nuclear poly( A) polymerase that associates with phosphatidylinositol-4-phosphate 5-kinase I alpha (PIPKI alpha) and is required for the expression of a specific subset of mRNAs. Star-PAP activity is directly modulated by the PIPKI alpha product phosphatidylinositol 4,5-bisphosphate (PI-4,5-P-2), linking nuclear phosphoinositide signaling to gene expression. Here, we show that PI-4,5-P-2-dependent protein kinase activity is also a part of the Star-PAP protein complex. We identify the PI-4,5- P-2-sensitive casein kinase I alpha (CKI alpha) as a protein kinase responsible for this activity and further show that CKI alpha is capable of directly phosphorylating Star-PAP. Both CKI alpha and PIPKI alpha are required for the synthesis of some but not all Star-PAP target mRNA, and like Star-PAP, CKI alpha is associated with these messages in vivo. Taken together, these data indicate that CKI alpha, PIPKI alpha, and Star-PAP function together to modulate the production of specific Star-PAP messages. The Star-PAP complex therefore represents a location where multiple signaling pathways converge to regulate the expression of specific mRNAs.	[Gonzales, Michael L.; Mellman, David L.; Anderson, Richard A.] Univ Wisconsin, Dept Pharmacol, Mol & Cellular Pharmacol Training Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Anderson, RA (corresponding author), Univ Wisconsin, Dept Pharmacol, Mol & Cellular Pharmacol Training Program, 1300 Univ Ave,Rm 3750 MSC, Madison, WI 53706 USA.	raanders@wisc.edu		Anderson, Richard/0000-0001-6265-8359	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051968, R01GM114386] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051968, R01 GM114386] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; BAZENET CE, 1990, J BIOL CHEM, V265, P7369; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Budd DC, 2000, J BIOL CHEM, V275, P19667, DOI 10.1074/jbc.M000492200; Colgan DF, 1996, NATURE, V384, P282, DOI 10.1038/384282a0; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Gonzales ML, 2006, J CELL BIOCHEM, V97, P252, DOI 10.1002/jcb.20655; Gross SD, 1999, J CELL SCI, V112, P2647; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; HUANG S, 1991, Genes and Development, V5, P2288, DOI 10.1101/gad.5.12a.2288; HUMPHREY T, 1987, EMBO J, V6, P4159, DOI 10.1002/j.1460-2075.1987.tb02762.x; Keum YS, 2006, PHARM RES, V23, P2586, DOI 10.1007/s11095-006-9094-2; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Takahashi T, 2004, CURR MED CHEM, V11, P1545, DOI 10.2174/0929867043365080; WAHLE E, 1991, EMBO J, V10, P4251, DOI 10.1002/j.1460-2075.1991.tb05003.x; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao WQ, 1998, MOL CELL BIOL, V18, P5010, DOI 10.1128/MCB.18.9.5010	26	39	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12665	12673		10.1074/jbc.M800656200	http://dx.doi.org/10.1074/jbc.M800656200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18305108	Green Published, hybrid			2022-12-25	WOS:000255340000083
J	Hazelbaker, D; Azaro, MA; Landy, A				Hazelbaker, Dane; Azaro, Marco A.; Landy, Arthur			A biotin interference assay highlights two different asymmetric interaction profiles for lambda integrase arm-type binding sites in integrative versus excisive recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-LAMBDA; DNA-BINDING; ATT-SITE; CRYSTAL-STRUCTURE; SINGLE-BASE; HOST FACTOR; PROTEIN; DIRECTIONALITY; COMPLEX; XIS	The site-specific recombinase integrase encoded by bacteriophage lambda promotes integration and excision of the viral chromosome into and out of its Escherichia coli host chromosome through a Holliday junction recombination intermediate. This intermediate contains an integrase tetramer bound via its catalytic carboxyl-terminal domains to the four "core-type" sites of the Holliday junction DNA and via its amino-terminal domains to distal "arm-type" sites. The two classes of integrase binding sites are brought into close proximity by an ensemble of accessory proteins that bind and bend the intervening DNA. We have used a biotin interference assay that probes the requirement for major groove protein binding at specified DNA loci in conjunction with DNA protection, gel mobility shift, and genetic experiments to test several predictions of the models derived from the x-ray crystal structures of minimized and symmetrized surrogates of recombination intermediates lacking the accessory proteins and their cognate DNA targets. Our data do not support the predictions of "non-canonical" DNA targets for the N-domain of integrase, and they indicate that the complexes used for x-ray crystallography are more appropriate for modeling excisive rather than integrative recombination intermediates. We suggest that the difference in the asymmetric interaction profiles of the N-domains and arm-type sites in integrative versus excisive recombinogenic complexes reflects the regulation of recombination, whereas the asymmetry of these patterns within each reaction contributes to directionality.	[Hazelbaker, Dane; Landy, Arthur] Brown Univ, Dept Biochem Mol Biol & Cellular Biol, Providence, RI 02912 USA; [Azaro, Marco A.] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA	Brown University; Rutgers State University New Brunswick	Landy, A (corresponding author), 185 Meeting St, Providence, RI 02912 USA.	Arthur_Landy@brown.edu			NIGMS NIH HHS [R01 GM033928, R01 GM062723, GM62723, R01 GM033928-23, R01 GM062723-31, GM33928] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062723, R01GM033928] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbani MA, 2007, P NATL ACAD SCI USA, V104, P2109, DOI 10.1073/pnas.0607820104; ABREMSKI K, 1982, J BIOL CHEM, V257, P9658; Aihara H, 2003, MOL CELL, V12, P187, DOI 10.1016/S1097-2765(03)00268-5; Akamatsu Y, 1998, MOL CELL BIOL, V18, P4670, DOI 10.1128/MCB.18.8.4670; Azaro MA., 2002, MOBILE DNA-UK, P118, DOI DOI 10.1128/9781555817954.CH7; BAUER CE, 1986, J MOL BIOL, V192, P513, DOI 10.1016/0022-2836(86)90273-1; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Boldt JL, 2007, NUCLEIC ACIDS RES, V35, P716, DOI 10.1093/nar/gkl1078; Boldt JL, 2004, J BIOL CHEM, V279, P3472, DOI 10.1074/jbc.M309361200; BUSHMAN W, 1984, CELL, V39, P699, DOI 10.1016/0092-8674(84)90477-X; BUSHMAN W, 1985, SCIENCE, V230, P906, DOI 10.1126/science.2932798; CAMPBELL AM, 1962, ADV GENET, V11, P101; Cassell G, 2000, J MOL BIOL, V299, P1193, DOI 10.1006/jmbi.2000.3828; Daniels DS, 2004, NAT STRUCT MOL BIOL, V11, P714, DOI 10.1038/nsmb791; DEVARGAS LM, 1991, P NATL ACAD SCI USA, V88, P588, DOI 10.1073/pnas.88.2.588; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Ghosh K, 2005, J BIOL CHEM, V280, P8290, DOI 10.1074/jbc.M411668200; GOPALAKRISHNAN V, 1994, J BIOL CHEM, V269, P21123; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; HSU PL, 1984, NATURE, V311, P721, DOI 10.1038/311721a0; KIM S, 1992, SCIENCE, V256, P198, DOI 10.1126/science.1533056; KIM SH, 1990, CELL, V63, P773, DOI 10.1016/0092-8674(90)90143-3; Klemm M, 2000, J MOL BIOL, V299, P1203, DOI 10.1006/jmbi.2000.3829; KOSTREWA D, 1991, NATURE, V349, P178, DOI 10.1038/349178a0; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; LANDY A, 1977, SCIENCE, V197, P1147, DOI 10.1126/science.331474; Lynch TW, 2003, J MOL BIOL, V330, P493, DOI 10.1016/S0022-2836(03)00529-1; Maxam A M, 1980, Methods Enzymol, V65, P499; MIZUUCHI K, 1980, COLD SPRING HARB SYM, V45, P429; Nash H, 1996, ESCHERICHIA COLI SAL, P2363; NASH HA, 1981, J BIOL CHEM, V256, P9246; NASH HA, 1974, NATURE, V247, P543, DOI 10.1038/247543a0; NUMRYCH TE, 1992, EMBO J, V11, P3797, DOI 10.1002/j.1460-2075.1992.tb05465.x; NUMRYCH TE, 1990, NUCLEIC ACIDS RES, V18, P3953, DOI 10.1093/nar/18.13.3953; Nunes-Duby SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/nar/26.2.391; NUNESDUBY SE, 1995, J MOL BIOL, V253, P228, DOI 10.1006/jmbi.1995.0548; NUNESDUBY SE, 1989, CELL, V59, P197, DOI 10.1016/0092-8674(89)90881-7; Pan CQ, 1996, J MOL BIOL, V264, P675, DOI 10.1006/jmbi.1996.0669; Papagiannis CV, 2007, J MOL BIOL, V367, P328, DOI 10.1016/j.jmb.2006.12.071; Radman-Livaja M, 2006, CURR OPIN STRUC BIOL, V16, P42, DOI 10.1016/j.sbi.2005.12.003; Radman-Livaja M, 2005, P NATL ACAD SCI USA, V102, P3913, DOI 10.1073/pnas.0500844102; Radman-Livaja M, 2003, MOL CELL, V11, P783, DOI 10.1016/S1097-2765(03)00111-4; RADMANLIVAJA M, 2003, THESIS BROWN U; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; RICHET E, 1986, CELL, V46, P1011, DOI 10.1016/0092-8674(86)90700-2; ROSS W, 1982, P NATL ACAD SCI-BIOL, V79, P7724, DOI 10.1073/pnas.79.24.7724; Sam MD, 2004, J MOL BIOL, V338, P229, DOI 10.1016/j.jmb.2004.02.053; Sam MD, 2002, J MOL BIOL, V324, P791, DOI 10.1016/S0022-2836(02)01150-6; Sarkar D, 2002, J MOL BIOL, V324, P775, DOI 10.1016/S0022-2836(02)01199-3; Sarkar D, 2001, EMBO J, V20, P1203, DOI 10.1093/emboj/20.5.1203; Sun XM, 2006, MOL CELL, V24, P569, DOI 10.1016/j.molcel.2006.10.006; TELSER J, 1989, J AM CHEM SOC, V111, P6966, DOI 10.1021/ja00200a011; THOMPSON JF, 1987, J MOL BIOL, V195, P481, DOI 10.1016/0022-2836(87)90177-X; THOMPSON JF, 1987, CELL, V50, P901, DOI 10.1016/0092-8674(87)90516-2; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; THOMPSON JF, 1986, J BACTERIOL, V168, P1343, DOI 10.1128/jb.168.3.1343-1351.1986; Tirumalai RS, 1997, P NATL ACAD SCI USA, V94, P6104, DOI 10.1073/pnas.94.12.6104; TULLIUS TD, 1989, ANNU REV BIOPHYS BIO, V18, P213, DOI 10.1146/annurev.bb.18.060189.001241; Van Duyne G.D., 2002, MOBILE DNA, VII, P93; Van Duyne GD, 2005, CURR BIOL, V15, pR658, DOI 10.1016/j.cub.2005.08.031; Warren D, 2005, MOL MICROBIOL, V55, P1104, DOI 10.1111/j.1365-2958.2004.04447.x; WINOTO A, 1986, J MOL BIOL, V192, P677, DOI 10.1016/0022-2836(86)90286-X; Wojciak JM, 2002, P NATL ACAD SCI USA, V99, P3434, DOI 10.1073/pnas.052017999	63	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12402	12414		10.1074/jbc.M800544200	http://dx.doi.org/10.1074/jbc.M800544200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319248	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000255340000057
J	Kayama, H; Ramirez-Carrozzi, VR; Yamamoto, M; Mizutani, T; Kuwata, H; Iba, H; Matsumoto, M; Honda, K; Smale, ST; Takeda, K				Kayama, Hisako; Ramirez-Carrozzi, Vladimir R.; Yamamoto, Masahiro; Mizutani, Taketoshi; Kuwata, Hirotaka; Iba, Hideo; Matsumoto, Makoto; Honda, Kenya; Smale, Stephen T.; Takeda, Kiyoshi			Class-specific regulation of pro-inflammatory genes by MyD88 pathways and I kappa B zeta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCIBLE NUCLEAR-PROTEIN; NEGATIVE REGULATION; REMODELING COMPLEXES; IMMUNE-RESPONSES; ACTIVE GENES; HISTONE H3; T-CELLS; CHROMATIN; TRANSCRIPTION; INDUCTION	Toll-like receptors trigger the induction of primary response genes via MyD88-mediated activation of NF-kappa B and other transcription factors. These factors then act in concert with primary response gene products to induce secondary response genes. Although the MyD88 pathway is important for the expression of both primary and secondary response genes, we show that the recruitment of NF-kappa B, RNA polymerase, and the TATA-binding protein is MyD88-dependent only at secondary response genes. This selective dependence correlates with the fact that MyD88 is required for nucleosome remodeling and histone H3K4 trimethylation at secondary response promoters, whereas rapidly induced primary response promoters are assembled into poised MyD88-independent chromatin structures. At a subset of secondary response promoters, I kappa B zeta was identified as a selective regulator of H3K4 trimethylation and preinitiation complex assembly after nucleosome remodeling. These mechanistic distinctions advance our understanding of the diverse molecular cascades that underlie the differential regulation of pro-inflammatory genes.	[Ramirez-Carrozzi, Vladimir R.; Smale, Stephen T.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, HHMI, Los Angeles, CA 90095 USA; [Kayama, Hisako; Yamamoto, Masahiro; Honda, Kenya; Takeda, Kiyoshi] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Lab Immune Regulat, Suita, Osaka 5650871, Japan; [Kayama, Hisako; Kuwata, Hirotaka; Matsumoto, Makoto; Takeda, Kiyoshi] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 8128582, Japan; [Mizutani, Taketoshi; Iba, Hideo] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Host Parasite Interact, Tokyo 1088639, Japan	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Osaka University; Kyushu University; University of Tokyo	Smale, ST (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, HHMI, 6525 MRL,675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	smale@mednet.ucla.edu; ktakeda@ongene.med.osaka-u.ac.jp	Kuwata, Hiro/N-2023-2019; Takeda, Kiyoshi/C-9331-2009	Kuwata, Hiro/0000-0002-5023-1777; Takeda, Kiyoshi/0000-0002-1778-6332	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; DINARELLO CA, 1991, J INFECT DIS, V163, P1177, DOI 10.1093/infdis/163.6.1177; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Kuwata H, 2006, IMMUNITY, V24, P41, DOI 10.1016/j.immuni.2005.11.004; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mostoslavsky R, 2003, NAT IMMUNOL, V4, P603, DOI 10.1038/ni0703-603; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Natoli G, 2006, FEBS LETT, V580, P2843, DOI 10.1016/j.febslet.2006.02.072; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Zhang XW, 2001, BRIT J PHARMACOL, V133, P413, DOI 10.1038/sj.bjp.0704087; Zhou L, 2004, MOL CELL BIOL, V24, P2385, DOI 10.1128/MCB.24.6.2385-2396.2004	41	76	77	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12468	12477		10.1074/jbc.M709965200	http://dx.doi.org/10.1074/jbc.M709965200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319258	hybrid			2022-12-25	WOS:000255340000063
J	Wang, T; Craig, EA				Wang, Tao; Craig, Elizabeth A.			Binding of yeast frataxin to the scaffold for Fe-S cluster biogenesis, Isu	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-BINDING; FRIEDREICHS-ATAXIA; 2FE-2S CLUSTERS; PROTEIN; HOMOLOG; ISD11; BIOSYNTHESIS; DONOR; YFH1P	Friedreich ataxia is caused by reduced activity of frataxin, a conserved iron-binding protein of the mitochondrial matrix, thought to supply iron for formation of Fe-S clusters on the scaffold protein Isu. Frataxin binds Isu in an iron-dependent manner in vitro. However, the biological relevance of this interaction and whether in vivo the interaction between frataxin and Isu is mediated by adaptor proteins is a matter of debate. Here, we report that alterations of conserved, surface-exposed residues of yeast frataxin, which have deleterious effects on cell growth, impair Fe-S cluster biogenesis and interaction with Isu while altering neither iron binding nor oligomerization. Our results support the idea that the surface of the beta-sheet, adjacent to the acidic, iron binding ridge, is important for interaction of Yfh1 with the Fe-S cluster scaffold and point to a critical role for frataxin in Fe-S cluster biogenesis.	[Wang, Tao; Craig, Elizabeth A.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Craig, EA (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	ecraig@wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027870] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM27870] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; Andrew AJ, 2006, J BIOL CHEM, V281, P14580, DOI 10.1074/jbc.M600842200; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Parvin R, 1969, METHODS ENZYMOL, P16; Puccio H, 2000, HUM MOL GENET, V9, P887, DOI 10.1093/hmg/9.6.887; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Voisine C, 2001, P NATL ACAD SCI USA, V98, P1483, DOI 10.1073/pnas.98.4.1483; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; Zuhlke CH, 2004, EUR J HUM GENET, V12, P979, DOI 10.1038/sj.ejhg.5201257	29	77	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12674	12679		10.1074/jbc.M800399200	http://dx.doi.org/10.1074/jbc.M800399200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319250	hybrid, Green Published			2022-12-25	WOS:000255340000084
J	Tatematsu, K; Yoshimoto, N; Okajima, T; Tanizawa, K; Kuroda, S				Tatematsu, Kenji; Yoshimoto, Nobuo; Okajima, Toshihide; Tanizawa, Katsuyuki; Kuroda, Shun'ichi			Identification of ubiquitin ligase activity of RBCK1 and its inhibition by splice variant RBCK2 and protein kinase C beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOIMMUNE REGULATOR PROTEIN; RING-FINGER; PARKINSONS-DISEASE; MOLECULAR-CLONING; BINDING; PHOSPHORYLATION; INTERACTS; FAMILY; DEGRADATION; ACTIVATION	We previously identified a RING-IBR protein, RBCK1, as a protein kinase C (PKC) beta- and zeta-interacting protein, and its splice variant, RBCK2, lacking the C-terminal half including the RING-IBR domain. RBCK1 has been shown to function as a transcriptional activator whose nuclear translocation is prevented by interaction with the cytoplasmic RBCK2. We here demonstrate that RBCK1, like many other RING proteins, also possesses a ubiquitin ligase (E3) activity and that its E3 activity is inhibited by interaction with RBCK2. Moreover, RBCK1 has been found to undergo efficient phosphorylation by PKC beta. The phosphorylated RBCK1 shows no self-ubiquitination activity in vitro. Overexpression of PKC beta leads to significant increases in the amounts of intracellular RBCK1, presumably suppressing the proteasomal degradation of RBCK1 through self-ubiquitination, whereas coexpression with PKC beta, PKC epsilon, and PKC zeta shows no or little effect on the intracellular amount of RBCK1. Taken together, the E3 activity of RBCK1 is controlled by two distinct manners, interaction with RBCK2 and phosphorylation by PKC beta. It is possible that other RING proteins, such as Parkin, BRCA1, and RNF8, having the E3 activity, are also down-regulated by interaction with their RING-lacking splice variants and/or phosphorylation by protein kinases.	[Tatematsu, Kenji; Yoshimoto, Nobuo; Okajima, Toshihide; Tanizawa, Katsuyuki; Kuroda, Shun'ichi] Osaka Univ, Inst Sci & Ind Res, Dept Struct Mol Biol, Osaka 5670047, Japan	Osaka University	Tatematsu, K (corresponding author), Osaka Univ, Inst Sci & Ind Res, Dept Struct Mol Biol, Osaka 5670047, Japan.	kenji44@sanken.osaka-u.ac.jp		Okajima, Toshihide/0000-0003-1733-9580				Akiyoshi H, 2004, J BIOL CHEM, V279, P33984, DOI 10.1074/jbc.M400702200; CIECHANOVER A, 1994, J BIOL CHEM, V269, P9582; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Iwata M, 2005, BIOCHEM BIOPH RES CO, V327, P1105, DOI 10.1016/j.bbrc.2004.12.128; KIM HY, 1995, J BIOL CHEM, V270, P4983, DOI 10.1074/jbc.270.10.4983; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Kumar PG, 2001, J BIOL CHEM, V276, P41357, DOI 10.1074/jbc.M104898200; Kuroda S, 1996, J BIOL CHEM, V271, P31029, DOI 10.1074/jbc.271.49.31029; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Los GV, 2007, METH MOL B, V356, P195; Louria-Hayon I, 2003, J BIOL CHEM, V278, P33134, DOI 10.1074/jbc.M301264200; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Marteijn JAF, 2005, BLOOD, V106, P4114, DOI 10.1182/blood-2005-04-1450; Martinez-Noel G, 1999, FEBS LETT, V454, P257, DOI 10.1016/S0014-5793(99)00823-6; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; Niwa J, 2001, BIOCHEM BIOPH RES CO, V281, P706, DOI 10.1006/bbrc.2001.4414; Pitkanen J, 2001, J BIOL CHEM, V276, P19597, DOI 10.1074/jbc.M008322200; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Tatematsu K, 1998, BIOCHEM BIOPH RES CO, V247, P392, DOI 10.1006/bbrc.1998.8795; Tatematsu K, 2005, J BIOL CHEM, V280, P22937, DOI 10.1074/jbc.M413476200; Thomson AM, 2000, J BIOL CHEM, V275, P31609, DOI 10.1074/jbc.M002354200; Tokunaga C, 1998, BIOCHEM BIOPH RES CO, V244, P353, DOI 10.1006/bbrc.1998.8270; Tokunaga C, 1998, FEBS LETT, V435, P11, DOI 10.1016/S0014-5793(98)01029-1; Wei XL, 2003, J BIOL CHEM, V278, P29288, DOI 10.1074/jbc.M212215200; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Yang C, 2006, MOL CELL, V21, P135, DOI 10.1016/j.molcel.2005.11.014; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; Yoshimoto N, 2005, BIOCHEM BIOPH RES CO, V335, P550, DOI 10.1016/j.bbrc.2005.07.104; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	48	22	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11575	11585		10.1074/jbc.M706961200	http://dx.doi.org/10.1074/jbc.M706961200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303026	hybrid			2022-12-25	WOS:000255067400058
J	Rollins, SM; Peppercorn, A; Young, JS; Drysdale, M; Baresch, A; Bikowski, MV; Ashford, DA; Quinn, CP; Handfield, M; Hillman, JD; Lyons, CR; Koehler, TM; Calderwood, SB; Ryan, ET				Rollins, Sean M.; Peppercorn, Amanda; Young, John S.; Drysdale, Melissa; Baresch, Andrea; Bikowski, Margaret V.; Ashford, David A.; Quinn, Conrad P.; Handfield, Martin; Hillman, Jeffrey D.; Lyons, C. Rick; Koehler, Theresa M.; Calderwood, Stephen B.; Ryan, Edward T.			Application of In Vivo Induced Antigen Technology (IVIAT) to Bacillus anthracis	PLOS ONE			English	Article								In vivo induced antigen technology (IVIAT) is an immuno-screening technique that identifies bacterial antigens expressed during infection and not during standard in vitro culturing conditions. We applied IVIAT to Bacillus anthracis and identified PagA, seven members of a N-acetylmuramoyl-L-alanine amidase autolysin family, three P60 family lipoproteins, two transporters, spore cortex lytic protein SleB, a penicillin binding protein, a putative prophage holin, respiratory nitrate reductase NarG, and three proteins of unknown function. Using quantitative real-time PCR comparing RNA isolated from in vitro cultured B. anthracis to RNA isolated from BALB/c mice infected with virulent Ames strain B. anthracis, we confirmed induced expression in vivo for a subset of B. anthracis genes identified by IVIAT, including L-alanine amidases BA3767, BA4073, and amiA (pXO2-42); the bacteriophage holin gene BA4074; and pagA (pXO1-110). The exogenous addition of two purified putative autolysins identified by IVIAT, N-acetylmuramoyl-L-alanine amidases BA0485 and BA2446, to vegetative B. anthracis cell suspensions induced a species-specific change in bacterial morphology and reduction in viable bacterial cells. Many of the proteins identified in our screen are predicted to affect peptidoglycan re-modeling, and our results support significant cell wall structural remodeling activity during B. anthracis infection. Identification of L-alanine amidases with B. anthracis specificity may suggest new potential therapeutic targets.	[Rollins, Sean M.; Peppercorn, Amanda; Young, John S.; Baresch, Andrea; Bikowski, Margaret V.; Calderwood, Stephen B.; Ryan, Edward T.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Drysdale, Melissa; Lyons, C. Rick] Univ New Mexico Hlth Sci Ctr, Albuquerque, NM USA; [Drysdale, Melissa; Koehler, Theresa M.] Univ Texas Med Sch Houston, Dept Microbiol & Mol Genet, Houston, TX USA; [Ashford, David A.] USDA, APHIS, Sao Paulo, Brazil; [Quinn, Conrad P.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Handfield, Martin] Univ Florida, Coll Dentist, Ctr Mol Microbiol, Dept Oral Biol, Gainesville, FL USA; [Hillman, Jeffrey D.] Oragenics Inc, Alachua, FL USA; [Calderwood, Stephen B.] Harvard Med Sch, Dept Microbiol & Mol Genet, Boston, MA USA; [Calderwood, Stephen B.; Ryan, Edward T.] Harvard Med Sch, Dept Med, Boston, MA USA; [Ryan, Edward T.] Harvard Sch Public Hlth, Dept Immunol & Infect Dis, Boston, MA USA	Harvard University; Massachusetts General Hospital; University of New Mexico; University of New Mexico's Health Sciences Center; University of Texas System; University of Texas Health Science Center Houston; Centers for Disease Control & Prevention - USA; State University System of Florida; University of Florida; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Rollins, SM (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	srollins1@partners.org	Young, John/ABG-2132-2020	Young, John/0000-0001-7801-9017; Rollins, Sean/0000-0002-3724-1989	New England Regional Center of Excellence/Biodefense and Emerging Infectious Disease Career Development Award [U54 AI057159];  [AI053442];  [N01-A1-40053];  [T32 AI07061];  [DE13523];  [U54 AI057156];  [AI33537]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033537, U54AI057156, R29AI033537, U54AI057159, T32AI007061, R21AI053442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013523] Funding Source: NIH RePORTER	New England Regional Center of Excellence/Biodefense and Emerging Infectious Disease Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by AI053442 and N01-A1-40053 (ETR); U54 AI057159 (SBC); T32 AI07061 (AP), a New England Regional Center of Excellence/Biodefense and Emerging Infectious Disease Career Development Award U54 AI057159 (SMR), DE13523 (MH), U54 AI057156 (TMK and CRL) and AI33537 (TMK).	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Antelmann H, 2005, PROTEOMICS, V5, P3684, DOI 10.1002/pmic.200401218; Bourgogne A, 2003, INFECT IMMUN, V71, P2736, DOI 10.1128/IAI.71.5.2736-2743.2003; Chirakkal H, 2002, MICROBIOL-SGM, V148, P2383, DOI 10.1099/00221287-148-8-2383; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Chitlaru T, 2006, J BACTERIOL, V188, P3551, DOI 10.1128/JB.188.10.3551-3571.2006; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Deb DK, 2002, TUBERCULOSIS, V82, P175, DOI 10.1054/tube.2002.0337; Drysdale M, 2004, J BACTERIOL, V186, P307, DOI 10.1128/JB.186.2.307-315.2004; DRYSDALE M, 2007, INFECT IMMUN; ETIENNETOUMELIN I, 1995, J BACTERIOL, V177, P614, DOI 10.1128/jb.177.3.614-620.1995; Fisher N, 2006, J BACTERIOL, V188, P1301, DOI 10.1128/JB.188.4.1301-1309.2006; FOSTER SJ, 1992, J BACTERIOL, V174, P464, DOI 10.1128/jb.174.2.464-470.1992; Fouet A, 1999, J APPL MICROBIOL, V87, P251, DOI 10.1046/j.1365-2672.1999.00882.x; Friedlander AM, 2002, CURR TOP MICROBIOL, V271, P33; Gao LY, 2006, INFECT IMMUN, V74, P1757, DOI 10.1128/IAI.74.3.1757-1767.2006; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gat O, 2006, INFECT IMMUN, V74, P3987, DOI 10.1128/IAI.00174-06; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Handfield M, 2000, TRENDS MICROBIOL, V8, P336, DOI 10.1016/S0966-842X(00)01775-3; Handfield Martin, 2006, Infectious Disorders - Drug Targets, V6, P327, DOI 10.2174/187152606778249908; Hang L, 2003, P NATL ACAD SCI USA, V100, P8508, DOI 10.1073/pnas.1431769100; Harris JB, 2006, INFECT IMMUN, V74, P5161, DOI 10.1128/IAI.00488-06; Ishikawa S, 1998, J BACTERIOL, V180, P2549, DOI 10.1128/JB.180.9.2549-2555.1998; John M, 2005, INFECT IMMUN, V73, P2665, DOI 10.1128/IAI.73.5.2665-2679.2005; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; Koehler TM, 2002, CURR TOP MICROBIOL, V271, P143; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; LaRocque RC, 2005, INFECT IMMUN, V73, P4488, DOI 10.1128/IAI.73.8.4488-4493.2005; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; Mesnage S, 2002, J BACTERIOL, V184, P331, DOI 10.1128/JB.184.1.331-334.2002; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Moriyama R, 1996, J BACTERIOL, V178, P5330, DOI 10.1128/jb.178.17.5330-5332.1996; Moriyama R, 1996, J BACTERIOL, V178, P6059, DOI 10.1128/jb.178.20.6059-6063.1996; PEZARD C, 1993, J GEN MICROBIOL, V139, P2459, DOI 10.1099/00221287-139-10-2459; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Rollins SM, 2005, CELL MICROBIOL, V7, P1, DOI 10.1111/j.1462-5822.2004.00477.x; Saile E, 2002, J BACTERIOL, V184, P370, DOI 10.1128/JB.184.2.370-380.2002; Salim KY, 2005, INFECT IMMUN, V73, P6026, DOI 10.1128/IAI.73.9.6026-6038.2005; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; STERNE M, 1939, J VET SCI ANIM IND, V13, P307; Tinsley E, 2004, J BACTERIOL, V186, P2717, DOI 10.1128/JB.186.9.2717-2723.2004; Weber I, 2000, MOL MICROBIOL, V35, P1017, DOI 10.1046/j.1365-2958.2000.01794.x; Wei YP, 2004, J BACTERIOL, V186, P258, DOI 10.1128/JB.186.1.258-261.2004; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; WUENSCHER MD, 1993, J BACTERIOL, V175, P3491, DOI 10.1128/jb.175.11.3491-3501.1993; Yoong P, 2006, J BACTERIOL, V188, P2711, DOI 10.1128/JB.188.7.2711-2714.2006; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; YOUNG R, 1995, FEMS MICROBIOL REV, V17, P191, DOI 10.1016/0168-6445(94)00079-4	54	25	29	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1824	10.1371/journal.pone.0001824	http://dx.doi.org/10.1371/journal.pone.0001824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350160	gold, Green Submitted, Green Published			2022-12-25	WOS:000260762300026
J	Sreenivasan, R; Cai, MN; Bartfai, R; Wang, XG; Christoffels, A; Orban, L				Sreenivasan, Rajini; Cai, Minnie; Bartfai, Richard; Wang, Xingang; Christoffels, Alan; Orban, Laszlo			Transcriptomic Analyses Reveal Novel Genes with Sexually Dimorphic Expression in the Zebrafish Gonad and Brain	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; SEX-DIFFERENTIATION; MICROARRAY ANALYSIS; MAMMALIAN SEPTIN; CDNA MICROARRAY; RAINBOW-TROUT; PROTEIN; OVARY; TESTIS; AROMATASE	Background: Our knowledge on zebrafish reproduction is very limited. We generated a gonad-derived cDNA microarray from zebrafish and used it to analyze large-scale gene expression profiles in adult gonads and other organs. Methodology/Principal Findings: We have identified 116638 gonad-derived zebrafish expressed sequence tags (ESTs), 21% of which were isolated in our lab. Following in silico normalization, we constructed a gonad-derived microarray comprising 6370 unique, full-length cDNAs from differentiating and adult gonads. Labeled targets from adult gonad, brain, kidney and 'rest-of-body' from both sexes were hybridized onto the microarray. Our analyses revealed 1366, 881 and 656 differentially expressed transcripts (34.7% novel) that showed highest expression in ovary, testis and both gonads respectively. Hierarchical clustering showed correlation of the two gonadal transcriptomes and their similarities to those of the brains. In addition, we have identified 276 genes showing sexually dimorphic expression both between the brains and between the gonads. By in situ hybridization, we showed that the gonadal transcripts with the strongest array signal intensities were germline-expressed. We found that five members of the GTP-binding septin gene family, from which only one member (septin 4) has previously been implicated in reproduction in mice, were all strongly expressed in the gonads. Conclusions/Significance: We have generated a gonad-derived zebrafish cDNA microarray and demonstrated its usefulness in identifying genes with sexually dimorphic co-expression in both the gonads and the brains. We have also provided the first evidence of large-scale differential gene expression between female and male brains of a teleost. Our microarray would be useful for studying gonad development, differentiation and function not only in zebrafish but also in related teleosts via cross-species hybridizations. Since several genes have been shown to play similar roles in gonadogenesis in zebrafish and other vertebrates, our array may even provide information on genetic disorders affecting gonadal phenotypes and fertility in mammals.	[Sreenivasan, Rajini; Cai, Minnie; Bartfai, Richard; Wang, Xingang; Orban, Laszlo] Temasek Life Sci Lab, Reprod Genom Grp, Singapore, Singapore; [Wang, Xingang; Orban, Laszlo] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Christoffels, Alan] Temasek Life Sci Lab, Singapore, Singapore; [Christoffels, Alan] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Orban, L (corresponding author), Temasek Life Sci Lab, Reprod Genom Grp, Singapore, Singapore.	laszlo@tll.org.sg	Bartfai, Richard/E-2083-2012; Sreenivasan, Rajini/G-6930-2019; Orbán, László/A-3030-2009; Christoffels, Alan/C-3269-2014	Bartfai, Richard/0000-0002-8460-6477; Sreenivasan, Rajini/0000-0002-6357-5392; Orbán, László/0000-0001-5435-5948; Christoffels, Alan/0000-0002-0420-2916	Temasek Life Sciences Laboratory [fellowships]; Department of Biological Sciences of the National University of Singapore [fellowships]	Temasek Life Sciences Laboratory(National University of Singapore); Department of Biological Sciences of the National University of Singapore(National University of Singapore)	This work was supported by fellowships from Temasek Life Sciences Laboratory and the Department of Biological Sciences of the National University of Singapore as well as by internal research grants from Temasek Life Sciences Laboratory.	Amatruda JF, 2002, CANCER CELL, V1, P229, DOI 10.1016/S1535-6108(02)00052-1; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; Arnold AP, 2004, NAT REV NEUROSCI, V5, P701, DOI 10.1038/nrn1494; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beier DR, 1998, GENOME RES, V8, P9, DOI 10.1101/gr.8.1.9; Blaser S, 2003, GENE, V312, P313, DOI 10.1016/S0378-1119(03)00635-8; Bollig F, 2006, DEV DYNAM, V235, P554, DOI 10.1002/dvdy.20645; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Chiang EFL, 2001, MOL BIOL EVOL, V18, P542, DOI 10.1093/oxfordjournals.molbev.a003833; Davies W, 2006, BRAIN RES, V1126, P36, DOI 10.1016/j.brainres.2006.09.105; Dennis C, 2004, NATURE, V427, P390, DOI 10.1038/427390a; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; di Clemente N, 2003, MOL CELL ENDOCRINOL, V211, P9, DOI 10.1016/j.mce.2003.09.005; DICLEMENTE N, 1992, DEVELOPMENT, V114, P721; Diehl F, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e38; Dodd A, 2000, HUM MOL GENET, V9, P2443, DOI 10.1093/hmg/9.16.2443; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Elhasid R, 2004, ONCOGENE, V23, P5468, DOI 10.1038/sj.onc.1207725; Ensslin M, 1998, BIOL REPROD, V58, P1057, DOI 10.1095/biolreprod58.4.1057; FRANCIS RC, 1993, P NATL ACAD SCI USA, V90, P10673, DOI 10.1073/pnas.90.22.10673; FRANCIS RC, 1992, Q REV BIOL, V67, P1, DOI 10.1086/417445; Gahr M, 2003, P NATL ACAD SCI USA, V100, P7959, DOI 10.1073/pnas.1335934100; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Giuili G, 1997, DEVELOPMENT, V124, P1799; Greenbaum MP, 2007, DEV BIOL, V305, P389, DOI 10.1016/j.ydbio.2007.02.025; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Guo J, 2003, CYTOGENET GENOME RES, V103, P58, DOI 10.1159/000076290; Guo JH, 2005, CYTOGENET GENOME RES, V111, P107, DOI 10.1159/000086378; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Hanai N, 2004, FEBS LETT, V568, P83, DOI 10.1016/j.febslet.2004.05.030; Herrera L, 2005, DEV BIOL, V279, P271, DOI 10.1016/j.ydbio.2004.11.029; Hsia N, 2004, BIOL REPROD, V70, P448, DOI 10.1095/biolreprod.103.021493; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Josso N, 2001, MOL CELL ENDOCRINOL, V179, P25, DOI 10.1016/S0303-7207(01)00467-1; Kinoshita M, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-236; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Larisch S, 2000, NAT CELL BIOL, V2, P915, DOI 10.1038/35046566; Li Y, 2004, COMP FUNCT GENOM, V5, P403, DOI 10.1002/cfg.418; Liao J, 1997, BIOTECHNIQUES, V23, P368, DOI 10.2144/97233bm03; Liu SJ, 2000, J STEROID BIOCHEM, V75, P291, DOI 10.1016/S0960-0760(00)00186-2; Liu XJ, 2006, BIOL REPROD, V74, P1016, DOI 10.1095/biolreprod.105.049403; Lo J, 2003, GENOME RES, V13, P455, DOI 10.1101/gr.885403; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x; Mold DE, 2001, MOL REPROD DEV, V58, P4, DOI 10.1002/1098-2795(200101)58:1&lt;4::AID-MRD2&gt;3.0.CO;2-P; Montagna C, 2003, CANCER RES, V63, P2179; Munday PL, 2006, TRENDS ECOL EVOL, V21, P89, DOI 10.1016/j.tree.2005.10.020; MUNSTERBERG A, 1991, DEVELOPMENT, V113, P613; ORBAN L, 2008, GENOME MAPP IN PRESS; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; Petrunkina AM, 2003, REPRODUCTION, V125, P377, DOI 10.1530/reprod/125.3.377; PICARD JY, 1986, P NATL ACAD SCI USA, V83, P5464, DOI 10.1073/pnas.83.15.5464; Rebrikov DV, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e90; Rey R, 2003, MOL CELL ENDOCRINOL, V211, P21, DOI 10.1016/j.mce.2003.09.007; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Santos EM, 2007, PHYSIOL GENOMICS, V30, P111, DOI 10.1152/physiolgenomics.00284.2006; Scott M, 2005, ONCOGENE, V24, P4688, DOI 10.1038/sj.onc.1208574; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; STRAHLE U, 1994, TRENDS GENET, V10, P75, DOI 10.1016/0168-9525(94)90221-6; TAKAHASHI H, 1977, Bulletin of the Faculty of Fisheries Hokkaido University, V28, P57; Ton C, 2002, BIOCHEM BIOPH RES CO, V296, P1134, DOI 10.1016/S0006-291X(02)02010-7; Uchida D, 2002, J EXP BIOL, V205, P711; van der Ven K, 2005, COMP BIOCHEM PHYS B, V141, P408, DOI 10.1016/j.cbpc.2005.05.004; von Hofsten J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-63; von Hofsten J, 2005, DEV DYNAM, V233, P595, DOI 10.1002/dvdy.20335; von Schalburg KR, 2005, BIOL REPROD, V72, P687, DOI 10.1095/biolreprod.104.034967; Wang H, 1999, BBA-GENE STRUCT EXPR, V1446, P156, DOI 10.1016/S0167-4781(99)00066-4; Wang XG, 2007, DEV DYNAM, V236, P1329, DOI 10.1002/dvdy.21129; Wang XG, 2007, J FISH BIOL, V70, P33, DOI 10.1111/j.1095-8649.2007.01363.x; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Wassarman PM, 2004, CYTOGENET GENOME RES, V105, P228, DOI 10.1159/000078193; Weltzien FA, 2004, COMP BIOCHEM PHYS A, V137, P447, DOI 10.1016/j.cbpb.2003.11.007; Wixon J, 2000, YEAST, V17, P225, DOI 10.1002/1097-0061(20000930)17:3&lt;225::AID-YEA34&gt;3.0.CO;2-5; Xu M, 2001, INT J BIOCHEM CELL B, V33, P1172, DOI 10.1016/S1357-2725(01)00089-9; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	85	88	91	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1791	10.1371/journal.pone.0001791	http://dx.doi.org/10.1371/journal.pone.0001791			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335061	Green Published, Green Submitted, gold			2022-12-25	WOS:000260723000042
J	Huang, J; Gan, Q; Han, LM; Li, J; Zhang, H; Sun, Y; Zhang, ZY; Tong, TJ				Huang, Jing; Gan, Qini; Han, Limin; Li, Jian; Zhang, Hai; Sun, Ying; Zhang, Zongyu; Tong, Tanjun			SIRT1 Overexpression Antagonizes Cellular Senescence with Activated ERK/S6k1 Signaling in Human Diploid Fibroblasts	PLOS ONE			English	Article								Sir2, a NAD-dependent deacetylase, modulates lifespan in yeasts, worms and flies. The SIRT1, mammalian homologue of Sir2, regulates signaling for favoring survival in stress. But whether SIRT1 has the function to influence cell viability and senescence under non-stressed conditions in human diploid fibroblasts is far from unknown. Our data showed that enforced SIRT1 expression promoted cell proliferation and antagonized cellular senescence with the characteristic features of delayed Senescence-Associated beta-galactosidase (SA-beta-gal) staining, reduced Senescence-Associated Heterochromatic Foci (SAHF) formation and G1 phase arrest, increased cell growth rate and extended cellular lifespan in human fibroblasts, while dominant-negative SIRT1 allele (H363Y) did not significantly affect cell growth and senescence but displayed a bit decreased lifespan.. Western blot results showed that SIRT1 reduced the expression of p16(INK4A) and promoted phosphorylation of Rb. Our data also exposed that overexpression of SIRT1 was accompanied by enhanced activation of ERK and S6K1 signaling. These effects were mimicked in both WI38 cells and 2BS cells by concentration-dependent resveratrol, a SIRT1 activator. It was noted that treatment of SIRT1-.transfected cells with Rapamycin, a mTOR inhibitor, reduced the phosphorylation of S6K1 and the expression of Id1, implying that SIRT1-induced phosphorylation of S6K1 may be partly for the decreased expression of p16(INK4A) and promoted phosphorylation of Rb in 2BS. It was also observed that the expression of SIRT1 and phosphorylation of ERK and S6K1 was declined in senescent 2BS. These findings suggested that SIRT1-promoted cell proliferation and antagonized cellular senescence in human diploid fibroblasts may be, in part, via the activation of ERK/S6K1 signaling.	[Huang, Jing; Gan, Qini; Han, Limin; Li, Jian; Zhang, Hai; Sun, Ying; Zhang, Zongyu; Tong, Tanjun] Peking Univ, Res Ctr Aging, Beijing 100871, Peoples R China; [Huang, Jing; Gan, Qini; Han, Limin; Li, Jian; Zhang, Hai; Sun, Ying; Zhang, Zongyu; Tong, Tanjun] Peking Univ Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing, Peoples R China	Peking University; Peking University	Huang, J (corresponding author), Peking Univ, Res Ctr Aging, Beijing 100871, Peoples R China.	tztong@bjmu.edu.cn	Li, Jian/N-7001-2014		National Basic Research Programs of China [2007CB507400]; National Natural Science Foundation of China [3050082, 30671064]; National Post doctoral Foundation of China	National Basic Research Programs of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Post doctoral Foundation of China(China Postdoctoral Science Foundation)	This work was supported by grants from the National Basic Research Programs of China (No. 2007CB507400), the National Natural Science Foundation of China (No.3050082 and No.30671064), and the National Post doctoral Foundation of China.	Arvisais EW, 2006, J BIOL CHEM, V281, P26904, DOI 10.1074/jbc.M605371200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Duan JM, 2001, J BIOL CHEM, V276, P48325, DOI 10.1074/jbc.M104814200; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Gan LX, 2005, BIOCHEM BIOPH RES CO, V337, P1092, DOI 10.1016/j.bbrc.2005.09.169; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Gerasimovskaya EV, 2005, J BIOL CHEM, V280, P1838, DOI 10.1074/jbc.M409466200; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hidayat S, 2003, BIOCHEM BIOPH RES CO, V301, P417, DOI 10.1016/S0006-291X(02)03052-8; Hutter E, 2002, EXP GERONTOL, V37, P1165, DOI 10.1016/S0531-5565(02)00136-5; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kamel C, 2006, AGING CELL, V5, P81, DOI 10.1111/j.1474-9726.2006.00191.x; Kobayashi Y, 2006, ONCOGENE, V25, P512, DOI 10.1038/sj.onc.1209072; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lorenzini A, 2005, MECH AGEING DEV, V126, P1130, DOI 10.1016/j.mad.2005.05.004; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Munro J, 2004, EXP CELL RES, V295, P525, DOI 10.1016/j.yexcr.2004.01.017; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Raffetto Joseph D, 2006, Vasc Endovascular Surg, V40, P59, DOI 10.1177/153857440604000108; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Shay J W, 2001, Novartis Found Symp, V235, P116; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Thomas G, 2002, BIOL RES, V35, P305, DOI 10.4067/S0716-97602002000200022; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Zhang H, 2000, EXP CELL RES, V259, P284, DOI 10.1006/excr.2000.4965; Zheng WJ, 2004, J BIOL CHEM, V279, P31524, DOI 10.1074/jbc.M400365200	45	147	155	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1710	10.1371/journal.pone.0001710	http://dx.doi.org/10.1371/journal.pone.0001710			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320031	Green Submitted, gold, Green Published			2022-12-25	WOS:000260586600006
J	Kajava, AV; Anisimova, M; Peeters, N				Kajava, Andrey V.; Anisimova, Maria; Peeters, Nemo			Origin and Evolution of GALA-LRR, a New Member of the CC-LRR Subfamily: From Plants to Bacteria?	PLOS ONE			English	Article							AMINO-ACID SITES; LEUCINE-RICH REPEAT; PATHOGEN RALSTONIA-SOLANACEARUM; LIKELIHOOD-RATIO TEST; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; EFFECTOR PROTEINS; UBIQUITIN LIGASE; SECRETION SYSTEM; COMPLEX	The phytopathogenic bacterium Ralstonia solanacearum encodes type III effectors, called GALA proteins, which contain F-box and LRR domains. The GALA LRRs do not perfectly fit any of the previously described LRR subfamilies. By applying protein sequence analysis and structural prediction, we clarify this ambiguous case of LRR classification and assign GALA-LRRs to CC-LRR subfamily. We demonstrate that side-by-side packing of LRRs in the 3D structures may control the limits of repeat variability within the LRR subfamilies during evolution. The LRR packing can be used as a criterion, complementing the repeat sequences, to classify newly identified LRR domains. Our phylogenetic analysis of F-box domains proposes the lateral gene transfer of bacterial GALA proteins from host plants. We also present an evolutionary scenario which can explain the transformation of the original plant LRRs into slightly different bacterial LRRs. The examination of the selective evolutionary pressure acting on GALA proteins suggests that the convex side of their horse-shoe shaped LRR domains is more prone to positive selection than the concave side, and we therefore hypothesize that the convex surface might be the site of protein binding relevant to the adaptor function of the F-box GALA proteins. This conclusion provides a strong background for further functional studies aimed at determining the role of these type III effectors in the virulence of R. solanacearum.	[Kajava, Andrey V.] Univ Montpellier I, CNRS, Ctr Rech Biochim Macromol, Montpellier, France; [Anisimova, Maria] Swiss Fed Inst Technol, Inst Comp Sci, Zurich, Switzerland; [Anisimova, Maria] Swiss Inst Bioinformat, Lausanne, Switzerland; [Peeters, Nemo] INRA CNRS, UMR 441 2594, Lab Interactions Plantes Microorganismes, Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Kajava, AV (corresponding author), Univ Montpellier I, CNRS, Ctr Rech Biochim Macromol, Montpellier, France.	andrey.kajava@crbm.cnrs.fr	Kajava, Andrey V/E-1107-2014; Peeters, Nemo/R-5834-2019; Peeters, Nemo M/A-2488-2012	Kajava, Andrey V/0000-0002-2342-6886; Peeters, Nemo/0000-0002-1802-0769; Peeters, Nemo M/0000-0002-1802-0769; Anisimova, Maria/0000-0001-8145-7966	BBSRC (UK); ETH, Zurich;  [2007 ANR jeune-chercheur (FR) grant]	BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ETH, Zurich(ETH Zurich); 	MA was supported by the BBSRC (UK) grant to Prof Ziheng Yang and, at finalizing stage of this study, by the ETH, Zurich. This work is partly supported by a 2007 ANR jeune-chercheur (FR) grant to NP.	Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Angot A, 2006, P NATL ACAD SCI USA, V103, P14620, DOI 10.1073/pnas.0509393103; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; BUARD J, 1994, EMBO J, V13, P3203, DOI 10.1002/j.1460-2075.1994.tb06619.x; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Cunnac S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/j.1365-2958.2004.04118.x; DAYRINGER HE, 1986, J MOL GRAPHICS, V4, P82; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Fegan M., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P449; Gabriel DW, 2006, MOL PLANT MICROBE IN, V19, P69, DOI 10.1094/MPMI-19-0069; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Guidot A, 2007, J BACTERIOL, V189, P377, DOI 10.1128/JB.00999-06; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hirt RP, 2002, MOL BIOCHEM PARASIT, V125, P195, DOI 10.1016/S0166-6851(02)00211-6; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Hubber A, 2004, MOL MICROBIOL, V54, P561, DOI 10.1111/j.1365-2958.2004.04292.x; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V26, P282; Lupas A, 1997, MOL BIOL REP, V24, P125, DOI 10.1023/A:1006803512761; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Mercier A, 2007, RES MICROBIOL, V158, P537, DOI 10.1016/j.resmic.2007.05.003; Mukaihara T, 2004, MOL MICROBIOL, V54, P863, DOI 10.1111/j.1365-2958.2004.04328.x; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schrammeijer B, 2001, CURR BIOL, V11, P258, DOI 10.1016/S0960-9822(01)00069-0; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	46	36	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1694	10.1371/journal.pone.0001694	http://dx.doi.org/10.1371/journal.pone.0001694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301771	Green Published, gold, Green Submitted			2022-12-25	WOS:000260586500038
J	Fleury, L; Gerus, M; Lavigne, AC; Richard-Foy, H; Bystricky, K				Fleury, L.; Gerus, M.; Lavigne, A. C.; Richard-Foy, H.; Bystricky, K.			Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells	ONCOGENE			English	Article						breast cancer; chromatin; ER alpha; PR; methylation	BONE MORPHOGENETIC PROTEIN-6; HISTONE DEACETYLASE INHIBITION; DNA METHYLATION; PROGESTERONE-RECEPTOR; PROSTATE-CANCER; COPY NUMBER; ALPHA; BINDING; PROGRESSION; PROMOTER	In breast cancer, approximately one-third of tumors express neither the estrogen receptor ( ER alpha) nor estrogen-regulated genes such as the progesterone receptor gene ( PR). Our study provides new insights into the mechanism allowing hormone-activated expression of ER alpha target genes silenced in ER alpha-negative mammary tumor cells. In cell lines derived from ER alpha-negative MDA-MB231 cells, stable expression of different levels of ER alpha from a transgene did not result in transcription of PR. A quantitative comparative analysis demonstrates that inhibiting DNA methyltransferases using 5-aza-2 '-deoxycytidine or specific disruption of DNMT1 by small interfering RNAs and treatment with the histone-deacetylase inhibitor trichostatin A enabled ER alpha-mediated hormone-dependent expression of endogenous PR. We show that demethylation of a CpG island located in the first exon of PR was a prerequisite for ER alpha binding to these regulatorysequences. Although not a general requirement, DNA demethylation is also necessary for derepression of a subset of ER alpha target genes involved in tumorigenesis. PR transcription did not subsist 4 days after removal of the DNA methyltransferase blocking agents, suggesting that hormone-induced expression of ER alpha target genes in ER alpha-negative tumor cells is transient. Our observations support a model where an epigenetic mark confers stable silencing by precluding ER alpha access to promoters.	[Fleury, L.; Gerus, M.; Lavigne, A. C.; Richard-Foy, H.; Bystricky, K.] Univ Toulouse, Lab Biol Mol Eucaryote, IBCG, F-31062 Toulouse, Midi Pyrenees, France; [Fleury, L.; Gerus, M.; Lavigne, A. C.; Richard-Foy, H.; Bystricky, K.] CNRS, UMR 5099, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Bystricky, K (corresponding author), Univ Toulouse, Lab Biol Mol Eucaryote, IBCG, 118 Route Narbonne, F-31062 Toulouse, Midi Pyrenees, France.	kerstin@ibcg.biotoul.fr	Bystricky, Kerstin/AAA-3003-2020; Lavigne, Anne-Claire/O-8805-2015; BYSTRICKY, Kerstin/B-8670-2009	Bystricky, Kerstin/0000-0001-6717-3721; BYSTRICKY, Kerstin/0000-0001-6717-3721				Ahram M, 2002, MOL CARCINOGEN, V33, P9, DOI 10.1002/mc.10019; Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Balleine RL, 2000, GENE CHROMOSOME CANC, V29, P48, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1005>3.0.CO;2-O; Baron S, 2007, J BIOL CHEM, V282, P11732, DOI 10.1074/jbc.M610079200; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Dobosy JR, 2001, CELL MOL LIFE SCI, V58, P721, DOI 10.1007/PL00000895; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Giamarchi C, 1999, ONCOGENE, V18, P533, DOI 10.1038/sj.onc.1202317; GOODFELLOW PJ, 1995, J NATL CANCER I, V87, P1515, DOI 10.1093/jnci/87.20.1515; Hamdy FC, 1997, CANCER RES, V57, P4427; Heikinheimo AK, 1999, CANCER RES, V59, P5815; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lacroix M, 2004, ENDOCR-RELAT CANCER, V11, P497, DOI 10.1677/erc.1.00758; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lande-Diner L, 2007, J BIOL CHEM, V282, P12194, DOI 10.1074/jbc.M607838200; Lazennec G, 1999, MOL ENDOCRINOL, V13, P969, DOI 10.1210/me.13.6.969; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Lopez-Serra L, 2006, CANCER RES, V66, P8342, DOI 10.1158/0008-5472.CAN-06-1932; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Momparler RL, 2003, ONCOGENE, V22, P6479, DOI 10.1038/sj.onc.1206774; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; OTTAVIANO YL, 1994, CANCER RES, V54, P2552; Petz LN, 2004, J STEROID BIOCHEM, V88, P113, DOI 10.1016/j.jsbmb.2003.11.008; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; ROODI N, 1995, JNCI-J NATL CANCER I, V87, P446, DOI 10.1093/jnci/87.6.446; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Rubin MA, 2004, CANCER RES, V64, P3814, DOI 10.1158/0008-5472.CAN-03-3881; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Suzuki M, 2004, CANCER RES, V64, P3137, DOI 10.1158/0008-5472.CAN-03-3046; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; TOUITOU I, 1991, J STEROID BIOCHEM, V40, P231, DOI 10.1016/0960-0760(91)90187-A; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Yang XW, 2001, CANCER RES, V61, P7025; Zhang M, 2007, J STEROID BIOCHEM, V105, P91, DOI 10.1016/j.jsbmb.2007.01.002	46	21	22	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 3	2008	27	29					4075	4085		10.1038/onc.2008.41	http://dx.doi.org/10.1038/onc.2008.41			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	321RV	18317449				2022-12-25	WOS:000257325100007
J	Scapa, EF; Pocai, A; Wu, MK; Gutierrez-Juarez, R; Glenz, L; Kanno, K; Li, H; Biddinger, S; Jelicks, LA; Rossetti, L; Cohen, DE				Scapa, Erez F.; Pocai, Alessandro; Wu, Michele K.; Gutierrez-Juarez, Roger; Glenz, Lauren; Kanno, Keishi; Li, Hua; Biddinger, Sudha; Jelicks, Linda A.; Rossetti, Luciano; Cohen, David E.			Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2	FASEB JOURNAL			English	Article						fatty acid; triglyceride; glucose; respiratory quotient; phospholipid	STEAROYL-COA DESATURASE-1; FATTY-ACID TRANSPORT; DIET-INDUCED OBESITY; CHOLESTEROL-METABOLISM; LIPID-METABOLISM; ADIPOSE-TISSUE; DEFICIENT MICE; START DOMAIN; WEIGHT-LOSS; LIVER	Phosphatidylcholine transfer protein (PC-TP, also known as StarD2) is a highly specific intracellular lipid binding protein with accentuated expression in oxidative tissues. Here we show that decreased plasma concentrations of glucose and free fatty acids in fasting PC-TP-deficient (Pctp(-/-)) mice are attributable to increased hepatic insulin sensitivity. In hyperinsulinemic-euglycemic clamp studies, Pctp(-/-) mice exhibited profound reductions in hepatic glucose production, gluconeogenesis, glycogenolysis, and glucose cycling. These changes were explained in part by the lack of PC-TP expression in liver per se and in part by marked alterations in body fat composition. Reduced respiratory quotients in Pctp(-/-) mice were indicative of preferential fatty acid utilization for energy production in oxidative tissues. In the setting of decreased hepatic fatty acid synthesis, increased clearance rates of dietary triglycerides and increased hepatic triglyceride production rates reflected higher turnover in Pctp(-/-) mice. Collectively, these data support a key biological role for PC-TP in the regulation of energy substrate utilization.	[Scapa, Erez F.; Wu, Michele K.; Glenz, Lauren; Kanno, Keishi; Cohen, David E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol,Dept Med, Boston, MA 02115 USA; [Pocai, Alessandro; Gutierrez-Juarez, Roger; Rossetti, Luciano] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Pocai, Alessandro; Gutierrez-Juarez, Roger; Rossetti, Luciano] Albert Einstein Coll Med, Diabet Res Ctr, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Li, Hua; Jelicks, Linda A.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10467 USA; [Biddinger, Sudha] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA; [Cohen, David E.] Harvard Massachusetts Inst Technol, Div Hlth & Sci & Technol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University	Cohen, DE (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol,Dept Med, 75 Francis St, Boston, MA 02115 USA.	dcohen@partners.org	Jelicks, Linda/L-9740-2019	Jelicks, Linda/0000-0002-6438-1792	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056626, R37DK048873, R01DK048873, R29DK048873] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [DK-56626, R01 DK056626, DK-48873, R37 DK048873] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Baez JM, 2005, BIOCHEM J, V388, P57, DOI 10.1042/BJ20041899; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; de Brouwer APM, 2002, EXP CELL RES, V274, P100, DOI 10.1006/excr.2001.5460; Dolley G, 2007, ATHEROSCLEROSIS, V195, P297, DOI 10.1016/j.atherosclerosis.2007.01.002; Geijtenbeek TBH, 1996, BIOCHEM J, V316, P49; Gibbons Geoffrey F., 1994, Current Opinion in Lipidology, V5, P191, DOI 10.1097/00041433-199405030-00006; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Gutierrez-Juarez R, 2006, J CLIN INVEST, V116, P1686, DOI 10.1172/JCI26991; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hyogo H, 2002, J BIOL CHEM, V277, P34117, DOI 10.1074/jbc.M203912200; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Ilany J, 2006, P NATL ACAD SCI USA, V103, P4481, DOI 10.1073/pnas.0511246103; Kanno K, 2007, J BIOL CHEM, V282, P30728, DOI 10.1074/jbc.M703745200; Kanno K, 2007, BBA-MOL CELL BIOL L, V1771, P654, DOI 10.1016/j.bbalip.2007.04.003; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Neufeld D S, 1997, Methods Mol Biol, V75, P145; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Okamoto H, 2005, J CLIN INVEST, V115, P1314, DOI 10.1172/JCI200523096; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Riachi M, 2004, CAN J PHYSIOL PHARM, V82, P1075, DOI [10.1139/y04-117, 10.1139/Y04-117]; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; Roy S, 2005, HEPATOLOGY, V41, P887, DOI 10.1002/hep.20643; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; SHIMADA M, 2000, GEOMECH RES SER, V2, P1; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; van Helvoort A, 1999, P NATL ACAD SCI USA, V96, P11501, DOI 10.1073/pnas.96.20.11501; VanPatten S, 2004, BIOCHEM J, V379, P229, DOI 10.1042/BJ20040134; Wang WJ, 2006, J LIPID RES, V47, P2400, DOI 10.1194/jlr.M600277-JLR200; Wu MK, 2005, J LIPID RES, V46, P422, DOI 10.1194/jlr.M400387-JLR200; Wu MK, 2005, AM J PHYSIOL-GASTR L, V289, pG1067, DOI 10.1152/ajpgi.00194.2005; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006	48	31	32	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUL	2008	22	7					2579	2590		10.1096/fj.07-105395	http://dx.doi.org/10.1096/fj.07-105395			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18347010				2022-12-25	WOS:000257292500049
J	Bright, NJ; Carling, D; Thornton, C				Bright, Nicola J.; Carling, David; Thornton, Claire			Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-SUPPRESSOR; NEURONAL POLARIZATION; UPSTREAM KINASE; SAD KINASES; LKB1; UBIQUITIN; BETA; STIMULATION; INTERACT	Brain-specific kinases 1 and 2 (BRSK1/2) are AMP-activated protein kinase (AMPK)-related kinases that are highly expressed in mammalian forebrain. Studies using transgenic animal models have implicated a role for these kinases in the establishment of neuronal polarity. BRSK1 and BRSK2 are activated by phosphorylation of a threonine residue in the T-loop activation segment of the kinase domain. In vitro studies have demonstrated that LKB1, an upstream kinase in the AMPK cascade, can catalyze this phosphorylation. However, to date, a detailed comparative analysis of the molecular regulation of BRSK1/2 has not been undertaken. Here we present evidence that excludes another upstream kinase in the AMPK cascade, Ca2+/calmodulin-dependent protein kinase kinase beta, from a role in activating BRSK1/2. We show that equivalent mutations in the ubiquitin-associated domains of the BRSK isoforms produce differential effects on the activation of BRSK1 and BRSK2. Contrary to previous reports, activation of cAMP-dependent protein kinase does not affect BRSK1 or BRSK2 activity in mammalian cells. Furthermore, stimuli that activate AMPK had no effect on BRSK1/2. Finally, we provide evidence suggesting that protein phosphatase 2C is a likely candidate for catalyzing the dephosphorylation and inactivation of BRSK1/2.	[Bright, Nicola J.; Carling, David; Thornton, Claire] MRC, Ctr Clin Sci, Cellular Stress Grp, London W12 0NN, England		Carling, D (corresponding author), MRC, Ctr Clin Sci, Cellular Stress Grp, Du Cane Rd, London W12 0NN, England.	dcarling@imperial.ac.uk; claire.thornton@imperial.ac.uk	Thornton, Claire/AAF-7481-2019; Carling, David/F-1943-2014	Thornton, Claire/0000-0001-7676-3272; Carling, David/0000-0002-2316-1830	Medical Research Council [MC_U120027537] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Guo ZK, 2006, BIOCHEM BIOPH RES CO, V347, P867, DOI 10.1016/j.bbrc.2006.06.178; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jaleel M, 2006, BIOCHEM J, V394, P545, DOI 10.1042/BJ20051844; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marley AE, 1996, BIOCHEM J, V320, P801, DOI 10.1042/bj3200801; Milburn CC, 2004, NAT STRUCT MOL BIOL, V11, P193, DOI 10.1038/nsmb716; Murphy JM, 2007, P NATL ACAD SCI USA, V104, P14336, DOI 10.1073/pnas.0703012104; Ross H, 2002, BIOCHEM J, V366, P977, DOI 10.1042/BJ20020786; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Wang JW, 2007, J NEUROSCI, V27, P574, DOI 10.1523/JNEUROSCI.5094-06.2007; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005	36	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					14946	14954		10.1074/jbc.M710381200	http://dx.doi.org/10.1074/jbc.M710381200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18339622	Green Published, hybrid			2022-12-25	WOS:000256232000006
J	Klutts, JS; Doering, TL				Klutts, J. Stacey; Doering, Tamara L.			Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans plays a direct role in the synthesis of capsule polysaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT STRAINS; O-ACETYLATION; GLUCURONOXYLOMANNAN; GALACTOXYLOMANNAN; ABSENCE; FAMILY	The opportunistic yeast Cryptococcus neoformans causes serious disease in humans and expresses a prominent polysaccharide capsule that is required for its virulence. Little is known about how this capsule is synthesized. We previously identified a beta 1,2-xylosyltransferase (Cxt1p) with in vitro enzymatic activity appropriate for involvement in capsule synthesis. Here, we investigate C. neoformans strains in which the corresponding gene has been deleted (cxt1 Delta). Loss of CXT1 does not affect in vitro growth of the mutant cells or the general morphology of their capsules. However, NMR structural analysis of the two main capsule polysaccharides, glucuronoxylomannan (GXM) and galactoxylomannan (GalXM), showed that both were missing beta 1,2-xylose residues. There was an similar to 30% reduction in the abundance of this residue in GXM in mutant compared with wild-type strains, and mutant GalXM was almost completely devoid of beta 1,2-linked xylose. The GalXM from the mutant strain was also missing a beta 1,3- linked xylose residue. Furthermore, deletion of CXT1 led to attenuation of cryptococcal growth in a mouse model of infection, suggesting that the affected xylose residues are important for normal host-pathogen interactions. Cxt1p is the first glycosyltransferase with a defined role in C. neoformans capsule biosynthesis, and cxt1 Delta is the only strain identified to date with structural alterations of the capsule polysaccharide GalXM.	[Klutts, J. Stacey; Doering, Tamara L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Klutts, J. Stacey] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Doering, TL (corresponding author), 660 S Euclid Ave,Campus Box 8230, St Louis, MO 63110 USA.	doering@wustl.edu		Klutts, James/0000-0003-3788-1940	NIGMS NIH HHS [R01 GM071007, R01 GM 071007, F32 GM072341, F32 GM 072341] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071007, F32GM072341] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2004, CURRENT PROTOCOLS MO; ASHWELL G, 1957, METHOD ENZYMOL, V3, P73, DOI 10.1016/S0076-6879(57)03350-9; Brandt S, 2003, CLIN DIAGN LAB IMMUN, V10, P903, DOI 10.1128/CDLI.10.5.903-909.2003; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; Cherniak R, 1998, CLIN DIAGN LAB IMMUN, V5, P146; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; ECKERT TF, 1987, INFECT IMMUN, V55, P1895, DOI 10.1128/IAI.55.8.1895-1899.1987; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Gutierrez ALS, 2007, GLYCOBIOLOGY, V17, p1C, DOI 10.1093/glycob/cwm030; Heise N, 2002, GLYCOBIOLOGY, V12, P409, DOI 10.1093/glycob/cwf053; Janbon G, 2001, MOL MICROBIOL, V42, P453, DOI 10.1046/j.1365-2958.2001.02651.x; Klutts JS, 2007, J BIOL CHEM, V282, P17890, DOI 10.1074/jbc.M701941200; Klutts JS, 2006, FEMS YEAST RES, V6, P499, DOI 10.1111/j.1567-1364.2006.00054.x; Kozel TR, 2003, INFECT IMMUN, V71, P2868, DOI 10.1128/IAI.71.5.2868-2875.2003; KWONCHUNG KJ, 1986, EUKARYOT CELL, V2, P655; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; McFadden DC, 2006, J BIOL CHEM, V281, P1868, DOI 10.1074/jbc.M509465200; Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x; Moyrand F, 2007, MOL MICROBIOL, V64, P771, DOI 10.1111/j.1365-2958.2007.05695.x; Nelson RT, 2001, GENETICS, V157, P935; OWUOR E, 2007, GLYCOBIOLOGY, V17, P1183; Pericolini E, 2006, CELL MICROBIOL, V8, P267, DOI 10.1111/j.1462-5822.2005.00619.x; Pierini LM, 2001, MOL MICROBIOL, V41, P105, DOI 10.1046/j.1365-2958.2001.02504.x; Sheng SQ, 1997, CARBOHYD RES, V301, P33, DOI 10.1016/S0008-6215(97)00084-0; Sommer U, 2003, J BIOL CHEM, V278, P47724, DOI 10.1074/jbc.M307223200; SPIROPULU C, 1989, INFECT IMMUN, V57, P3240, DOI 10.1128/IAI.57.10.3240-3242.1989; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; Vecchiarelli A, 2005, CURR MOL MED, V5, P413, DOI 10.2174/1566524054022585; Yan Z, 2002, J CLIN MICROBIOL, V40, P965, DOI 10.1128/JCM.40.3.965-972.2002; YORK WS, 1986, METHOD ENZYMOL, V118, P3	32	43	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14327	14334		10.1074/jbc.M708927200	http://dx.doi.org/10.1074/jbc.M708927200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18347023	Green Published, hybrid			2022-12-25	WOS:000255941400019
J	Nahle, Z; Hsieh, M; Pietka, T; Coburn, CT; Grimaldi, PA; Zhang, MQ; Das, D; Abumrad, NA				Nahle, Zaher; Hsieh, Michael; Pietka, Terri; Coburn, Chris T.; Grimaldi, Paul A.; Zhang, Michael Q.; Das, Debopriya; Abumrad, Nada A.			CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-DELTA; FATTY-ACID UPTAKE; TRANSCRIPTION FACTOR FOXO1; PYRUVATE-DEHYDROGENASE COMPLEX; HUMAN SKELETAL-MUSCLE; GENE-EXPRESSION; CELL-CYCLE; INSULIN-RESISTANCE; LIPID-METABOLISM; PROTEIN-KINASE	The transcription factor FoxO1 contributes to the metabolic adaptation to fasting by suppressing muscle oxidation of glucose, sparing it for glucose-dependent tissues. Previously, we reported that FoxO1 activation in C2C12 muscle cells recruits the fatty acid translocase CD36 to the plasma membrane and increases fatty acid uptake and oxidation. This, together with FoxO1 induction of lipoprotein lipase, would promote the reliance on fatty acid utilization characteristic of the fasted muscle. Here, we show that CD36-mediated fatty acid uptake, in turn, up-regulates protein levels and activity of FoxO1 as well as its target PDK4, the negative regulator of glucose oxidation. Increased fatty acid flux or enforced CD36 expression in C2C12 cells is sufficient to induce FoxO1 and PDK4, whereas CD36 knockdown has opposite effects. In vivo, CD36 loss blunts fasting induction of FoxO1 and PDK4 and the associated suppression of glucose oxidation. Importantly, CD36-dependent regulation of FoxO1 is mediated by the nuclear receptor PPAR delta/beta. Loss of PPAR delta/beta phenocopies CD36 deficiency in blunting fasting induction of muscle FoxO1 and PDK4 in vivo. Expression of PPAR delta/beta in C2C12 cells, like that of CD36, robustly induces FoxO1 and suppresses glucose oxidation, whereas co-expression of a dominant negative PPAR delta/beta compromises FoxO1 induction. Finally, several PPRE sites were identified in the FoxO1 promoter, which was responsive to PPAR delta/beta. Agonists of PPAR delta/beta were sufficient to confer responsiveness and transactivate the heterologous FoxO1 promoter but not in the presence of dominant negative PPAR delta/beta. Taken together, our findings suggest that CD36-dependent FA activation of PPAR delta/beta results in the transcriptional regulation of FoxO1 as well as PDK4, recently shown to be a direct PPAR delta/beta target. FoxO1 in turn can regulate CD36, lipoprotein lipase, and PDK4, reinforcing the action of PPAR delta/beta to increase muscle reliance on FA. The findings could have implications in the chronic abnormalities of fatty acid metabolism associated with obesity and diabetes.	[Nahle, Zaher; Hsieh, Michael; Pietka, Terri; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Coburn, Chris T.] Western Carolina Univ, Dept Biol, Cullowhee, NC 28723 USA; [Grimaldi, Paul A.] Univ Nice Sophia Antipolis, INSERM, Ctr Biochim, U636,UFR Sci, F-06108 Nice, France; [Zhang, Michael Q.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Das, Debopriya] Ernest O Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94270 USA	Washington University (WUSTL); University of North Carolina; Western Carolina University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Cold Spring Harbor Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Nahle, Z (corresponding author), Washington Univ, Sch Med, Dept Med, Campus Box 8031, St Louis, MO 63110 USA.	znahle@im.wustl.edu			NIDDK NIH HHS [P30 DK056341, P30 DK056341-07, P30 DK056341-08, DK 56351, DK 33301] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, P30DK056341] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aguilar PS, 2006, MOL MICROBIOL, V62, P1507, DOI 10.1111/j.1365-2958.2006.05484.x; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bastie C, 2000, J BIOL CHEM, V275, P38768, DOI 10.1074/jbc.M006450200; Bastie CC, 2005, J BIOL CHEM, V280, P14222, DOI 10.1074/jbc.M413625200; Bastie CC, 2004, DIABETES, V53, P2209, DOI 10.2337/diabetes.53.9.2209; Bonen A, 2003, ACTA PHYSIOL SCAND, V178, P347, DOI 10.1046/j.1365-201X.2003.01157.x; Bonen A, 2006, ESSAYS BIOCHEM, V42, P47, DOI 10.1042/bse0420047; Chabowski A, 2006, AM J PHYSIOL-ENDOC M, V291, pE675, DOI 10.1152/ajpendo.00096.2006; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Constantin D, 2007, J PHYSIOL-LONDON, V583, P381, DOI 10.1113/jphysiol.2007.135459; Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; Degenhardt T, 2007, J MOL BIOL, V372, P341, DOI 10.1016/j.jmb.2007.06.091; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dyck DJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE600, DOI 10.1152/ajpendo.2001.281.3.E600; Farmer SR, 2003, MOL CELL, V11, P6, DOI 10.1016/S1097-2765(03)00003-0; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Furnsinn C, 2007, DIABETOLOGIA, V50, P8, DOI 10.1007/s00125-006-0492-0; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; GREENWALT DE, 1995, J CLIN INVEST, V96, P1382, DOI 10.1172/JCI118173; Grimaldi PA, 2007, BBA-MOL CELL BIOL L, V1771, P983, DOI 10.1016/j.bbalip.2007.02.006; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Heron-Milhavet L, 2004, ENDOCRINOLOGY, V145, P4667, DOI 10.1210/en.2003-1543; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Holst D, 2003, EXP CELL RES, V288, P168, DOI 10.1016/S0014-4827(03)00179-4; Holst D, 2003, BBA-MOL CELL BIOL L, V1633, P43, DOI 10.1016/S1388-1981(03)00071-4; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Kamei Y, 2003, FEBS LETT, V536, P232, DOI 10.1016/S0014-5793(03)00062-0; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kelley DE, 2002, ANNU REV NUTR, V22, P325, DOI 10.1146/annurev.nutr.22.010402.102912; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V282, pE491, DOI 10.1152/ajpendo.00419.2001; Luiken JJFP, 2001, J BIOL CHEM, V276, P40567, DOI 10.1074/jbc.M100052200; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Matsumoto M, 2005, CELL METAB, V1, P215, DOI 10.1016/j.cmet.2005.03.008; Moller DE, 2003, INT J OBESITY, V27, pS17, DOI 10.1038/sj.ijo.0802494; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Nahle Z, 2004, CURR OPIN CLIN NUTR, V7, P397, DOI 10.1097/01.mco.0000134360.30911.bb; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nakae J, 2001, BIOCHEMISTRY-US, V40, P11768, DOI 10.1021/bi015532m; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Palanivel R, 2005, FEBS LETT, V579, P5049, DOI 10.1016/j.febslet.2005.08.011; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Puig O, 2006, CELL CYCLE, V5, P503, DOI 10.4161/cc.5.5.2501; Puigserver P, 2005, INT J OBESITY, V29, P5; Sidossis LS, 1996, J CLIN INVEST, V98, P2244, DOI 10.1172/JCI119034; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sugden MC, 2001, BIOCHEM SOC T, V29, P272, DOI 10.1042/0300-5127:0290272; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Thewke D, 2000, BIOCHEM BIOPH RES CO, V273, P1, DOI 10.1006/bbrc.2000.2826; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Voss MD, 2005, DIABETOLOGIA, V48, P2622, DOI 10.1007/s00125-005-0025-2; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wolkenhauer O, 2005, FEBS LETT, V579, P1846, DOI 10.1016/j.febslet.2005.02.008; Xuan ZY, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r72; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	79	88	91	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14317	14326		10.1074/jbc.M706478200	http://dx.doi.org/10.1074/jbc.M706478200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18308721	hybrid, Green Published			2022-12-25	WOS:000255941400018
J	Desai, B; Ma, T; Chellaiah, MA				Desai, Bhavik; Ma, Tao; Chellaiah, Meenakshi A.			Invadopodia and matrix degradation, a new property of prostate cancer cells during migration and invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; BONE-RESORPTION; EXTRACELLULAR-MATRIX; BREAST-CANCER; TRANSFORMED FIBROBLASTS; ACTIN POLYMERIZATION; PODOSOME FORMATION; ENDOTHELIAL-CELLS; MMP-9 EXPRESSION; IN-VITRO	The present study demonstrated that invadopodia are associated with invasion by degradation of matrix in prostate cancer cells PC3. To find out the presence of invadopodia in PC3 cells, we performed a few comparative analyses with osteoclasts, which utilize podosomes for migration. Our investigations indeed demonstrated that invadopodia are comparable to podosomes in the localization of Wiskott-Aldrich syndrome protein (WASP)/matrix metalloproteinase-9 and the degradation of matrix. Invadopodia are different from podosomes in the localization of actin/vinculin, distribution during migration, and the mode of degradation of extracellular matrix. Invadopodia enable polarized invasion of PC3 cells into the gelatin matrix in a time-dependent manner. Gelatin degradation was confined within the periphery of the cell. Osteoclasts demonstrated directional migration with extensive degradation of matrix underneath and around the osteoclasts. A pathway of degradation of matrix representing a migratory track was observed due to the rearrangement of podosomes as rosettes or clusters at the leading edge. Reducing the matrix metalloproteinase-9 levels by RNA interference inhibited the degradation of matrix but not the formation of podosomes or invadopodia. Competition experiments with TAT-fused WASP peptides suggest that actin polymerization and formation of invadopodia involve the WASP-Arp2/3 complex pathway. Moreover, PC3 cells overexpressing osteopontin (OPN) displayed an increase in the number of invadopodia and gelatinolytic activity as compared with PC3 cells and PC3 cells expressing mutant OPN in integrin-binding domain and null for OPN. Thus, we conclude that OPN/integrin alpha v beta 3 signaling participates in the process of migration and invasion of PC3 cells through regulating processes essential for the formation and function of invadopodia.	[Desai, Bhavik; Ma, Tao; Chellaiah, Meenakshi A.] Univ Maryland, Sch Dent, Dept Biomed Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Chellaiah, MA (corresponding author), Univ Maryland, Sch Dent, Dept Biomed Sci, 7th Floor, S,650 W Baltimore St, Baltimore, MD 21201 USA.	mchellaiah@umaryland.edu			NIAMS NIH HHS [AR46292] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046292, R56AR046292] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abecassis I, 2003, EXP CELL RES, V291, P363, DOI 10.1016/j.yexcr.2003.08.006; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Biswas RS, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-19; Bowden ET, 2001, METHOD CELL BIOL, V63, P613; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Burgstaller G, 2005, AM J PHYSIOL-HEART C, V288, pH3001, DOI 10.1152/ajpheart.01002.2004; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Calle Y, 2004, BLOOD, V103, P3552, DOI 10.1182/blood-2003-04-1259; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chellaiah M, 1996, MOL BIOL CELL, V7, P743, DOI 10.1091/mbc.7.5.743; Chellaiah MA, 2005, J BIOL CHEM, V280, P32930, DOI 10.1074/jbc.M500154200; Chellaiah MA, 2000, J BIOL CHEM, V275, P11993, DOI 10.1074/jbc.275.16.11993; Chellaiah MA, 2007, J BIOL CHEM, V282, P10104, DOI 10.1074/jbc.M608957200; Chen WT, 1996, ENZYME PROTEIN, V49, P59, DOI 10.1159/000468616; Collin O, 2006, J CELL SCI, V119, P1914, DOI 10.1242/jcs.02838; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; Courtneidge SA, 2005, COLD SH Q B, V70, P167, DOI 10.1101/sqb.2005.70.014; Desai B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-18; Festuccia C, 1998, INT J CANCER, V75, P418, DOI 10.1002/(SICI)1097-0215(19980130)75:3<418::AID-IJC16>3.0.CO;2-4; Gimona M, 2008, SEMIN CANCER BIOL, V18, P23, DOI 10.1016/j.semcancer.2007.08.005; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Goto T, 2002, J BONE MINER METAB, V20, P98, DOI 10.1007/s007740200013; Incorvaia L, 2007, ANTICANCER RES, V27, P1519; Ishibashi O, 2006, LIFE SCI, V79, P1657, DOI 10.1016/j.lfs.2006.05.024; KANEHISA J, 1990, BONE, V11, P287, DOI 10.1016/8756-3282(90)90082-A; Kelly T, 1998, CLIN EXP METASTAS, V16, P501, DOI 10.1023/A:1006538200886; KIEFER MC, 1989, NUCLEIC ACIDS RES, V17, P3306, DOI 10.1093/nar/17.8.3306; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Low JA, 1996, CLIN CANCER RES, V2, P1207; MARCHISIO PC, 1987, EXP CELL RES, V169, P202, DOI 10.1016/0014-4827(87)90238-2; Mizutani K, 2002, CANCER RES, V62, P669; Moreau V, 2006, EUR J CELL BIOL, V85, P319, DOI 10.1016/j.ejcb.2005.09.009; Mueller SC, 1999, J BIOL CHEM, V274, P24947, DOI 10.1074/jbc.274.35.24947; Nakahara H, 1998, J BIOL CHEM, V273, P9, DOI 10.1074/jbc.273.1.9; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; Samanna V, 2007, J CELL PHYSIOL, V213, P710, DOI 10.1002/jcp.21137; Sossey-Alaoui K, 2005, EXP CELL RES, V308, P135, DOI 10.1016/j.yexcr.2005.04.011; Thalmann GN, 1999, CLIN CANCER RES, V5, P2271; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; Yamaguchi H, 2006, EUR J CELL BIOL, V85, P213, DOI 10.1016/j.ejcb.2005.10.004; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Zambonin Z.A., 1989, CONNECT TISSUE RES, V20, P143	44	60	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13856	13866		10.1074/jbc.M709401200	http://dx.doi.org/10.1074/jbc.M709401200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18337256	Green Published, hybrid			2022-12-25	WOS:000255728200039
J	Esquerra, RM; Jensen, RA; Bhaskaran, S; Pillsbury, ML; Mendoza, JL; Lintner, BW; Kliger, DS; Goldbeck, RA				Esquerra, Raymond M.; Jensen, Russell A.; Bhaskaran, Shyam; Pillsbury, Marlisa L.; Mendoza, Juan L.; Lintner, Benjamin W.; Kliger, David S.; Goldbeck, Robert A.			The pH dependence of heme pocket hydration and ligand rebinding kinetics in photodissociated carbonmonoxymyoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM-WHALE MYOGLOBIN; DISTAL HISTIDINE; RESONANCE RAMAN; CARBON-MONOXIDE; CRYSTAL-STRUCTURES; BINDING; CO; RELAXATION; HEMOGLOBIN; RESOLUTION	We monitored the occupancy of a functionally important non-coordinated water molecule in the distal heme pocket of sperm whale myoglobin over the pH range 4.3-9.4. Water occupancy was assessed by using time-resolved spectroscopy to detect the perturbation of the heme visible band absorption spectrum caused by water entry after CO photodissociation (Goldbeck, R. A., Bhaskaran, S., Ortega, C., Mendoza, J. L., Olson, J. S., Soman, J., Kliger, D. S., and Esquerra, R. M. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 1254-1259). We found that the water occupancy observed during the time interval between ligand photolysis and diffusive recombination decreased by nearly 20% as the pH was lowered below 6. This decrease accounted for most of the concomitant increase in the observed CO bimolecular recombination rate constant, as the lower water occupancy presented a smaller kinetic barrier to CO entry into the pocket at lower pH. These results were consistent with a model in which the distal histidine, which stabilizes the water molecule within the distal pocket by accepting a hydrogen bond, tends to swing out of the pocket upon protonation and destabilize the water occupancy at low pH. Extrapolation of this model to lower pH suggests that the additional increase in ligand association rate constant observed previously in stopped-flow studies at pH 3 may also be due in part to reduced distal water occupancy concomitant with further His(64) protonation and coupled protein conformational change.	[Esquerra, Raymond M.; Jensen, Russell A.; Bhaskaran, Shyam; Pillsbury, Marlisa L.; Mendoza, Juan L.; Lintner, Benjamin W.] San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA; [Kliger, David S.; Goldbeck, Robert A.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	California State University System; San Francisco State University; University of California System; University of California Santa Cruz	Esquerra, RM (corresponding author), San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA.	esquerra@sfsu.edu; goldbeck@chemistry.ucsc.edu		Mendoza, Juan/0000-0001-6972-7476	NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD000262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM052588, T34GM008574] Funding Source: NIH RePORTER; NIBIB NIH HHS [EB02056] Funding Source: Medline; NIGMS NIH HHS [GM52588, 5T34 GM08574] Funding Source: Medline; NIMHD NIH HHS [P20 MD000262] Funding Source: Medline	NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		ANSARI A, 1987, BIOPHYS CHEM, V26, P337, DOI 10.1016/0301-4622(87)80034-0; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; BARBOY N, 1987, BIOCHEMISTRY-US, V26, P3240, DOI 10.1021/bi00385a046; BASHFORD D, 1993, BIOCHEMISTRY-US, V32, P8045, DOI 10.1021/bi00082a027; Bonaventura C, 1999, J BIOL CHEM, V274, P8686, DOI 10.1074/jbc.274.13.8686; BONAVENTURA C, 1991, J BIOL CHEM, V266, P23033; CANNON J, 1976, J AM CHEM SOC, V98, P3395, DOI 10.1021/ja00427a069; Cao WX, 2001, BIOCHEMISTRY-US, V40, P5728, DOI 10.1021/bi010067e; CARVER TE, 1992, J BIOL CHEM, V267, P14443; CASE DA, 1979, J MOL BIOL, V132, P343, DOI 10.1016/0022-2836(79)90265-1; CHANCE B, 1966, J MOL BIOL, V17, P525, DOI 10.1016/S0022-2836(66)80162-6; COCCO MJ, 1992, BIOCHEMISTRY-US, V31, P6481, DOI 10.1021/bi00143a018; COLETTA M, 1985, J BIOL CHEM, V260, P4151; Dantsker D, 2004, J BIOL CHEM, V279, P38844, DOI 10.1074/jbc.M401513200; Dantsker D, 2005, BBA-PROTEINS PROTEOM, V1749, P234, DOI 10.1016/j.bbapap.2005.04.002; De Angelis F, 2005, J PHYS CHEM B, V109, P3065, DOI 10.1021/jp0451851; DOSTER W, 1982, BIOCHEMISTRY-US, V21, P4831, DOI 10.1021/bi00263a001; EGEBERG KD, 1990, J BIOL CHEM, V265, P11788; Esquerra RM, 1998, BIOCHEMISTRY-US, V37, P17527, DOI 10.1021/bi9814437; FERMI G, 1984, J MOL BIOL, V175, P159, DOI 10.1016/0022-2836(84)90472-8; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; FUCHSMAN WH, 1979, BIOCHEMISTRY-US, V18, P1309, DOI 10.1021/bi00574a030; GEIBEL J, 1975, J AM CHEM SOC, V97, P5924, DOI 10.1021/ja00853a053; GIACOMETTI GM, 1977, J BIOL CHEM, V252, P7447; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Goldbeck R. A., 2001, ENCY CHEM PHYS PHYS, P2637; GOLDBECK RA, 1993, METHOD ENZYMOL, V226, P147, DOI 10.1016/0076-6879(93)26009-X; Goldbeck RA, 2006, P NATL ACAD SCI USA, V103, P1254, DOI 10.1073/pnas.0507840103; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; JOHNSON KA, 1989, J MOL BIOL, V207, P459, DOI 10.1016/0022-2836(89)90269-6; KURIYAN J, 1986, J MOL BIOL, V192, P133, DOI 10.1016/0022-2836(86)90470-5; LAMBRIGHT DG, 1989, J MOL BIOL, V207, P289, DOI 10.1016/0022-2836(89)90456-7; MORIKIS D, 1989, BIOCHEMISTRY-US, V28, P4791, DOI 10.1021/bi00437a041; Muller JD, 1999, BIOPHYS J, V77, P1036, DOI 10.1016/S0006-3495(99)76954-7; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; PERUTZ MF, 1989, TRENDS BIOCHEM SCI, V14, P42, DOI 10.1016/0968-0004(89)90039-X; Peterson ES, 1997, BIOCHEMISTRY-US, V36, P13110, DOI 10.1021/bi971156n; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; RAMSDEN J, 1989, BIOCHEMISTRY-US, V28, P3125, DOI 10.1021/bi00434a001; RINGE D, 1984, BIOCHEMISTRY-US, V23, P2, DOI 10.1021/bi00296a001; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; SAGE JT, 1991, BIOCHEMISTRY-US, V30, P1227, DOI 10.1021/bi00219a010; SAGE JT, 1991, BIOCHEMISTRY-US, V30, P1237, DOI 10.1021/bi00219a011; Schotte F, 2004, J STRUCT BIOL, V147, P235, DOI 10.1016/j.jsb.2004.06.009; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Spiro TG, 2001, ACCOUNTS CHEM RES, V34, P137, DOI 10.1021/ar000108j; Spiro TG, 2001, CURR OPIN CHEM BIOL, V5, P715, DOI 10.1016/S1367-5931(01)00271-X; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; Tang Q, 1997, BIOSPECTROSCOPY, V3, P17, DOI 10.1002/(SICI)1520-6343(1997)3:1<17::AID-BSPY2>3.3.CO;2-P; TIAN WD, 1993, J MOL BIOL, V233, P155, DOI 10.1006/jmbi.1993.1491; TIAN WD, 1992, PHYS REV LETT, V68, P408, DOI 10.1103/PhysRevLett.68.408; TRAYLOR TG, 1983, J BIOL CHEM, V258, P2147; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123	55	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14165	14175		10.1074/jbc.M709710200	http://dx.doi.org/10.1074/jbc.M709710200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359768	Green Published, hybrid			2022-12-25	WOS:000255728200070
J	Malki, A; Le, HT; Milles, S; Kern, R; Caldas, T; Abdallah, J; Richarme, G				Malki, Abderrahim; Le, Hai-Tuong; Milles, Sigrid; Kern, Renee; Caldas, Teresa; Abdallah, Jad; Richarme, Gilbert			Solubilization of protein aggregates by the acid stress chaperones HdeA and HdeB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; ESCHERICHIA-COLI; PERIPLASMIC PROTEIN; HELICOBACTER-PYLORI; COMPETENT STATE; DNAK CHAPERONE; PH; DISAGGREGATION; RESISTANCE; HSP26	The acid stress chaperones HdeA and HdeB of Escherichia coli prevent the aggregation of periplasmic proteins at acidic pH. We show in this report that they also form mixed aggregates with proteins that have failed to be solubilized at acidic pH and allow their subsequent solubilization at neutral pH. HdeA, HdeB, and HdeA and HdeB together display an increasing efficiency for the solubilization of protein aggregates at pH 3. They are less efficient for the solubilization of aggregates at pH 2, whereas HdeB is the most efficient. Increasing amounts of periplasmic proteins draw increasing amounts of chaperone into pellets, suggesting that chaperones co-aggregate with their substrate proteins. We observed a decrease in the size of protein aggregates in the presence of HdeA and HdeB, from very high molecular mass aggregates to 100-5000-kDa species. Moreover, a marked decrease in the exposed hydrophobicity of aggregated proteins in the presence of HdeA and HdeB was revealed by 1,1'-bis(4-anilino) naphtalene-5,5'-disulfonic acid binding experiments. In vivo, during the recovery at neutral pH of acid stressed bacterial cells, HdeA and HdeB allow the solubilization and renaturation of protein aggregates, including those formed by the maltose receptor MalE, the oligopeptide receptor OppA, and the histidine receptor HisJ. Thus, HdeA and HdeB not only help to maintain proteins in a soluble state during acid treatment, as previously reported, but also assist, both in vitro and in vivo, in the solubilization at neutral pH of mixed protein-chaperone aggregates formed at acidic pH, by decreasing the size of protein aggregates and the exposed hydrophobicity of aggregated proteins.	[Malki, Abderrahim; Le, Hai-Tuong; Milles, Sigrid; Kern, Renee; Caldas, Teresa; Abdallah, Jad; Richarme, Gilbert] Univ Paris 07, Inst Jacques Monod, Stress Mol Lab, F-75005 Paris, France	UDICE-French Research Universities; Universite Paris Cite	Richarme, G (corresponding author), Univ Paris 07, Inst Jacques Monod, Stress Mol Lab, 2 Pl Jussieu, F-75005 Paris, France.	richarme@ccr.jussieu.fr	Abdallah, Jad/AAD-3595-2020	Abdallah, Jad/0000-0001-5267-4953				Arie JP, 2006, MOL MICROBIOL, V62, P427, DOI 10.1111/j.1365-2958.2006.05394.x; Booth IR, 2002, ANTON LEEUW INT J G, V81, P33, DOI 10.1023/A:1020565206835; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; De Angelis M, 2004, PROTEOMICS, V4, P106, DOI 10.1002/pmic.200300497; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; DUGAY AR, 2004, BIOCHIM BIOPHYS ACTA, V1694, P121; FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2005, J BIOL CHEM, V280, P23861, DOI 10.1074/jbc.M502697200; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Jiao WW, 2005, BIOCHEM BIOPH RES CO, V335, P227, DOI 10.1016/j.bbrc.2005.07.065; Kern R, 2007, J BACTERIOL, V189, P603, DOI 10.1128/JB.01522-06; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; LAEMMLI UK, 1972, NATURE, V227, P680; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; Lim EM, 2000, ELECTROPHORESIS, V21, P2557, DOI 10.1002/1522-2683(20000701)21:12&lt;2557::AID-ELPS2557&gt;3.0.CO;2-B; Liu Y, 2004, BIOCHEM BIOPH RES CO, V316, P795, DOI 10.1016/j.bbrc.2004.02.125; Malki A, 2003, BIOCHEM BIOPH RES CO, V301, P430, DOI 10.1016/S0006-291X(02)03053-X; Matuszewska M, 2005, J BIOL CHEM, V280, P12292, DOI 10.1074/jbc.M412706200; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V742, P16, DOI 10.1016/0167-4838(83)90353-9; Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946; SEALE JW, 1995, BIOCHEMISTRY-US, V34, P7443, DOI 10.1021/bi00022a018; Small PLC, 1998, TRENDS MICROBIOL, V6, P214, DOI 10.1016/S0966-842X(98)01285-2; THOMPSON SA, 1995, INFECT IMMUN, V63, P2185, DOI 10.1128/IAI.63.6.2185-2193.1995; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; Yohannes E, 2004, J BACTERIOL, V186, P192, DOI 10.1128/JB.186.1.192-199.2004	34	55	61	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13679	13687		10.1074/jbc.M800869200	http://dx.doi.org/10.1074/jbc.M800869200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359765	hybrid			2022-12-25	WOS:000255728200019
J	Bachhuber, T; Almaca, J; Aldehni, F; Mehta, A; Amaral, MD; Schreiber, R; Kunzelmann, K				Bachhuber, Tanja; Almaca, Joana; Aldehni, Fadi; Mehta, Anil; Amaral, Margarida D.; Schreiber, Rainer; Kunzelmann, Karl			Regulation of the epithelial Na+ channel by the protein kinase CK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CELL-SURFACE EXPRESSION; SODIUM-CHANNEL; OPEN PROBABILITY; DOWN-REGULATION; ALPHA-SUBUNIT; BETA-SUBUNIT; PHOSPHORYLATION; ENAC; SERUM	CK2 is a ubiquitous, pleiotropic, and constitutively active Ser/Thr protein kinase that controls protein expression, cell signaling, and ion channel activity. Phosphorylation sites for CK2 are located in the C terminus of both beta- and gamma- subunits of the epithelial Na+ channel ( ENaC). We examined the role of CK2 on the regulation of both endogenous ENaC in native murine epithelia and in Xenopus oocytes expressing rENaC. In Ussing chamber experiments with mouse airways, colon, and cultured M1-collecting duct cells, amiloride-sensitive Na+ transport was inhibited dose-dependently by the selective CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB). In oocytes, ENaC currents were also inhibited by TBB and by the structurally unrelated inhibitors heparin and poly(E:Y). Expression of a trimeric channel lacking both CK2 sites (alpha beta(S631A)gamma(T599A)) produced a largely attenuated amiloride-sensitive whole cell conductance and rendered the mutant channel insensitive to CK2. In Xenopus oocytes, CK2 was translocated to the cell membrane upon expression of wt-ENaC but not of (alpha beta(S631A)gamma(T599A)-ENaC. Phosphorylation by CK2 is essential for ENaC activation, and to a lesser degree, it also controls membrane expression of alpha beta gamma-ENaC. Channels lacking the Nedd4-2 binding motif in beta-ENaC(R561X, Y618A) no longer required the CK2 site for channel activity and siRNA-knockdown of Nedd4-2 eliminated the effects of TBB. This implies a role for CK2 in inhibiting the Nedd4-2 pathway. We propose that the C terminus of beta-ENaC is targeted by this essential, conserved pleiotropic kinase that directs its constitutive activity toward many cellular protein complexes.	[Bachhuber, Tanja; Almaca, Joana; Aldehni, Fadi; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Mehta, Anil; Amaral, Margarida D.] Univ Dundee, Ninewells Hosp, Dept Maternal & Child Hlth Sci, Dundee DD1 9SY, Scotland; [Almaca, Joana] Univ Lisbon, Fac Ciencias, P-1749016 Lisbon, Portugal; [Amaral, Margarida D.] Natl Inst Hlth, Ctr Human Genet, P-1649016 Lisbon, Portugal	University of Regensburg; University of Dundee; Universidade de Lisboa	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	uqkkunze@mailbox.uq.edu.au	Amaral, Margarida D/E-5748-2012	Amaral, Margarida D/0000-0002-0828-8630; Kunzelmann, Karl/0000-0002-4583-7037; Almaca, Joana/0000-0002-9316-712X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Awayda MS, 1996, J GEN PHYSIOL, V108, P49, DOI 10.1085/jgp.108.1.49; Bachhuber T, 2005, J BIOL CHEM, V280, P31587, DOI 10.1074/jbc.M504347200; Becchetti A, 2002, AM J PHYSIOL-RENAL, V283, pF1030, DOI 10.1152/ajprenal.00011.2002; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Cai YQ, 2004, J BIOL CHEM, V279, P19987, DOI 10.1074/jbc.M312031200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Dinudom A, 2004, P NATL ACAD SCI USA, V101, P11886, DOI 10.1073/pnas.0402178101; Falin RA, 2007, J GEN PHYSIOL, V130, P313, DOI 10.1085/jgp.200709775; Feldman RD, 2002, MOL PHARMACOL, V61, P707, DOI 10.1124/mol.61.4.707; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Hu JH, 2006, MOL BIOL CELL, V17, P2200, DOI 10.1091/mbc.E05-10-0935; Kimura T, 2003, NEUROSCI RES, V46, P105, DOI 10.1016/S0168-0102(03)00038-5; Kunzelmann K, 2000, PFLUG ARCH EUR J PHY, V440, P193, DOI 10.1007/s004240000255; MEGGIO F, 1994, BIOCHEMISTRY-US, V33, P4336, DOI 10.1021/bi00180a030; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Rajamanickam J, 2007, J NEUROCHEM, V102, P858, DOI 10.1111/j.1471-4159.2007.04585.x; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Shi HK, 2002, EUR J BIOCHEM, V269, P4551, DOI 10.1046/j.1432-1033.2002.03154.x; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Treharne KJ, 2007, J BIOL CHEM, V282, P10804, DOI 10.1074/jbc.M610956200; Yan WS, 2007, AM J PHYSIOL-RENAL, V293, pF868, DOI 10.1152/ajprenal.00194.2007; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200	26	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13225	13232		10.1074/jbc.M704532200	http://dx.doi.org/10.1074/jbc.M704532200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308722	Green Published, hybrid			2022-12-25	WOS:000255499800062
J	He, DY; Ron, D				He, Dao-Yao; Ron, Dorit			Glial cell line-derived neurotrophic factor reverses ethanol-mediated increases in tyrosine hydroxylase immunoreactivity via altering the activity of heat shock protein 90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK-PROTEIN 90; GLUCOCORTICOID-RESPONSIVE ELEMENT; NIGROSTRIATAL DOPAMINE SYSTEM; HSP90 MOLECULAR CHAPERONE; ANTI-ADDICTION DRUG; GENE-EXPRESSION; NOREPINEPHRINE BIOSYNTHESIS; PROMOTER REGION; BINDING-SITE; GDNF	We previously found that glial cell line-derived neurotrophic factor (GDNF) in the midbrain ventral tegmental area (VTA) negatively regulates alcohol drinking (He, D. Y., McGough, N. N., Ravindranathan, A., Jeanblanc, J., Logrip, M. L., Phamluong, K., Janak, P. H., and Ron, D. (2005) J. Neurosci. 25, 619 628). Several studies suggest a role for GDNF in the regulation of tyrosine hydroxylase (TH) levels in the midbrain (Georgievska, B., Kirik, D., and Bjorklund, A. (2004) J. Neurosci. 24, 6437 6445). Up-regulation of TH levels has been reported as a hallmark of biochemical adaptations to in vivo chronic exposure to drugs of abuse, including ethanol (Ortiz, J., Fitzgerald, L. W., Charlton, M., Lane, S., Trevisan, L., Guitart, X., Shoemaker, W., Duman, R. S., and Nestler, E. J. (1995) Synapse 21, 289 -298). We hypothesized that GDNF plays an important role in regulating prolonged ethanol-mediated increases in TH protein levels. Using the SH-SY5Y dopaminergic-like cell line, we found that the increase in TH levels in the presence of ethanol required the activation of the cAMP/PKA pathway and was reversed by GDNF. Ethanol treatment did not alter the mRNA level or protein translation of TH, but enhanced the stability of the protein that was decreased by GDNF. Interestingly, we observed that ethanol treatment resulted in an increase in TH association with the chaperone heat shock protein (HSP90) that was mediated by the cAMP/PKA pathway and inhibited by GDNF. Taken together, these data suggest that prolonged ethanol exposure leads to increased association of TH and HSP90 via the cAMP/ PKA pathway, resulting in the stabilization and subsequent accumulation of TH. GDNF reverses this ethanol-mediated adaptation by inhibiting the interaction of TH with HSP90.	[He, Dao-Yao] Univ Calif San Francisco, Ernest Gallo Res Ctr, Emeryville, CA 94608 USA; [Ron, Dorit] Univ Calif San Francisco, Dept Neurol, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	Ron, D (corresponding author), 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	dorit.ron@ucsf.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014366] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA014366-02] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BEITNERJOHNSON D, 1991, J NEUROCHEM, V57, P344, DOI 10.1111/j.1471-4159.1991.tb02133.x; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bobrovskaya L, 2007, CELL SIGNAL, V19, P1141, DOI 10.1016/j.cellsig.2006.12.006; Borba JC, 2005, DEV BRAIN RES, V156, P193, DOI 10.1016/j.devbrainres.2005.02.016; CAPPENDIJK SLT, 1993, EUR J PHARMACOL, V241, P261, DOI 10.1016/0014-2999(93)90212-Z; Cass WA, 1996, J NEUROSCI, V16, P8132; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; GAHN LG, 1995, BIOCHEMISTRY-US, V34, P252, DOI 10.1021/bi00001a030; Georgievska B, 2004, J NEUROSCI, V24, P6437, DOI 10.1523/JNEUROSCI.1122-04.2004; Green-Sadan T, 2005, EXP NEUROL, V194, P97, DOI 10.1016/j.expneurol.2005.01.020; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Gueorguiev VD, 2006, J BIOL CHEM, V281, P10188, DOI 10.1074/jbc.M513806200; Hadden MK, 2006, CURR TOP MED CHEM, V6, P1173; Hagerty T, 2001, J NEUROCHEM, V78, P1379, DOI 10.1046/j.1471-4159.2001.00521.x; Hagerty T, 2001, J NEUROCHEM, V76, P825, DOI 10.1046/j.1471-4159.2001.00072.x; Haile CN, 2001, SYNAPSE, V41, P179, DOI 10.1002/syn.1073; He DY, 2006, FASEB J, V20, P2420, DOI 10.1096/fj.06-6394fje; He DY, 2005, J NEUROSCI, V25, P619, DOI 10.1523/JNEUROSCI.3959-04.2005; Jeong H, 2006, J NEUROCHEM, V98, P386, DOI 10.1111/j.1471-4159.2006.03866.x; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kumer SC, 1996, J NEUROCHEM, V67, P443; LAZAR MA, 1981, J NEUROCHEM, V36, P677, DOI 10.1111/j.1471-4159.1981.tb01641.x; Lei HT, 2007, J BIOL CHEM, V282, P9364, DOI 10.1074/jbc.M608985200; LEVITT M, 1965, J PHARMACOL EXP THER, V148, P1; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Mailliard WS, 2004, PHARMACOL THERAPEUT, V101, P39, DOI 10.1016/j.pharmthera.2003.10.002; Mash DC, 1998, ANN NY ACAD SCI, V844, P274, DOI 10.1111/j.1749-6632.1998.tb08242.x; Messer CJ, 2000, NEURON, V26, P247, DOI 10.1016/S0896-6273(00)81154-X; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; Ochel HJ, 2001, CELL STRESS CHAPERON, V6, P105, DOI 10.1379/1466-1268(2001)006<0105:GTPOAC>2.0.CO;2; ORTIZ J, 1995, SYNAPSE, V21, P289, DOI 10.1002/syn.890210403; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Piech-Dumas KM, 2001, J NEUROCHEM, V76, P1376, DOI 10.1046/j.1471-4159.2001.00127.x; POPIK P, 1995, PHARMACOL REV, V47, P235; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; REZVANI AH, 1995, PHARMACOL BIOCHEM BE, V52, P615, DOI 10.1016/0091-3057(95)00152-M; Roe DF, 2004, MOL BRAIN RES, V120, P91, DOI 10.1016/j.molbrainres.2003.09.019; RON D, 2005, SCI STKE, pRE14; Ronca F, 1999, J BIOL CHEM, V274, P18128, DOI 10.1074/jbc.274.25.18128; Rosenblad C, 2003, EUR J NEUROSCI, V17, P260, DOI 10.1046/j.1460-9568.2003.02456.x; Royo M, 2005, ARCH BIOCHEM BIOPHYS, V434, P266, DOI 10.1016/j.abb.2004.11.007; Sajadi A, 2005, J NEUROCHEM, V93, P1482, DOI 10.1111/j.1471-4159.2005.03139.x; Schmidt EF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-07-j0003.2001; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; SERSHEN H, 1994, PHARMACOL BIOCHEM BE, V47, P13, DOI 10.1016/0091-3057(94)90105-8; SORG BA, 1993, J PHARMACOL EXP THER, V266, P424; Suzuki T, 2004, BIOCHEM BIOPH RES CO, V315, P389, DOI 10.1016/j.bbrc.2004.01.068; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Toska K, 2002, J NEUROCHEM, V83, P775, DOI 10.1046/j.1471-4159.2002.01172.x; Vanhoose AM, 2006, J NEUROSCI, V26, P1138, DOI 10.1523/JNEUROSCI.3572-05.2006; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Xiao L, 2007, CURR MED CHEM, V14, P223, DOI 10.2174/092986707779313372; Xu RY, 1998, J NEUROCHEM, V70, P1383, DOI 10.1046/j.1471-4159.1998.70041383.x; Yoshimura R, 2004, MOL BRAIN RES, V126, P188, DOI 10.1016/j.molbrainres.2004.04.007; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9	63	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12811	12818		10.1074/jbc.M706216200	http://dx.doi.org/10.1074/jbc.M706216200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18343820	Green Published, hybrid			2022-12-25	WOS:000255499800017
J	Reid, BN; Ables, GP; Otlivanchik, OA; Schoiswohl, G; Zechner, R; Blaner, WS; Goldberg, IJ; Schwabe, RF; Chua, SC; Huang, LS				Reid, Brendan N.; Ables, Gene P.; Otlivanchik, Oleg A.; Schoiswohl, Gabriele; Zechner, Rudolf; Blaner, William S.; Goldberg, Ira J.; Schwabe, Robert F.; Chua, Streamson C., Jr.; Huang, Li-Shin			Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MOUSE STRAINS; LIVER-DISEASE; OB/OB MICE; GENE-EXPRESSION; DIABETIC MICE; PPAR-ALPHA; APO-B; TISSUE; OBESE; METABOLISM	Hepatic steatosis is often associated with insulin resistance and obesity and can lead to steatohepatitis and cirrhosis. In this study, we have demonstrated that hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL), two enzymes critical for lipolysis in adipose tissues, also contribute to lipolysis in the liver and can mobilize hepatic triglycerides in vivo and in vitro. Adenoviral overexpression of HSL and/or ATGL reduced liver triglycerides by 40 - 60% in both ob/ob mice and mice with high fat diet-induced obesity. However, these enzymes did not affect fasting plasma triglyceride and free fatty acid levels or triglyceride and apolipoprotein B secretion rates. Plasma 3-beta-hydroxybutyrate levels were increased 3 - 5 days after infection in both HSL- and ATGL-overexpressing male mice, suggesting an increase in beta-oxidation. Expression of genes involved in fatty acid transport and synthesis, lipid storage, and mitochondrial bioenergetics was unchanged. Mechanistic studies in oleate-supplemented McA-RH7777 cells with adenoviral overexpression of HSL or ATGL showed that reduced cellular triglycerides could be attributed to increases in beta-oxidation as well as direct release of free fatty acids into the medium. In summary, hepatic overexpression of HSL or ATGL can promote fatty acid oxidation, stimulate direct release of free fatty acid, and ameliorate hepatic steatosis. This study suggests a direct functional role for both HSL and ATGL in hepatic lipid homeostasis and identifies these enzymes as potential therapeutic targets for ameliorating hepatic steatosis associated with insulin resistance and obesity.	[Reid, Brendan N.; Ables, Gene P.; Otlivanchik, Oleg A.; Blaner, William S.; Goldberg, Ira J.; Schwabe, Robert F.; Huang, Li-Shin] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Schoiswohl, Gabriele; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Chua, Streamson C., Jr.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Columbia University; University of Graz; Yeshiva University; Albert Einstein College of Medicine	Huang, LS (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, 630 W 168th St,P&S 9-503, New York, NY 10032 USA.	lh99@columbia.edu	Schwabe, Robert/AAY-6506-2021	Zechner, Rudolf/0000-0001-5483-1182; Schoiswohl, Gabriele/0000-0002-7346-2834	NHLBI NIH HHS [R01 HL062583, HL45095, HL007343, HL73029, R01 HL045095, HL62583, R01 HL073029] Funding Source: Medline; NIDDK NIH HHS [DK063306, DK079221] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062583, R37HL045095, R01HL045095, R01HL073029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063306, R01DK079221] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 3002, Z 136] Funding Source: researchfish	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Augustus AS, 2006, J BIOL CHEM, V281, P8716, DOI 10.1074/jbc.M509890200; Baffy G, 2005, FRONT BIOSCI-LANDMRK, V10, P2082, DOI 10.2741/1683; Boelsterli UA, 2002, BIOCHEM PHARMACOL, V63, P1, DOI 10.1016/S0006-2952(01)00817-6; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chua S, 2002, DIABETOLOGIA, V45, P976, DOI 10.1007/s00125-002-0880-z; Ferrante AW, 2001, DIABETES, V50, P2268, DOI 10.2337/diabetes.50.10.2268; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Goldberg IJ, 2006, GASTROENTEROLOGY, V130, P1343, DOI 10.1053/j.gastro.2006.02.040; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Ko C, 2003, J LIPID RES, V44, P1946, DOI 10.1194/jlr.M300172-JLR200; Koteish A, 2001, SEMIN LIVER DIS, V21, P89, DOI 10.1055/s-2001-12932; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lewin TM, 2005, AM J PHYSIOL-ENDOC M, V288, pE835, DOI 10.1152/ajpendo.00300.2004; Liang JJ, 2004, J BIOL CHEM, V279, P44938, DOI 10.1074/jbc.M408507200; Lin HZ, 2000, NAT MED, V6, P998, DOI 10.1038/79697; Lutchman G, 2006, CLIN GASTROENTEROL H, V4, P1048, DOI 10.1016/j.cgh.2006.05.005; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; MEMON RA, 1994, HORM METAB RES, V26, P85, DOI 10.1055/s-2007-1000778; Memon RA, 1999, DIABETES, V48, P121, DOI 10.2337/diabetes.48.1.121; Pease RJ, 1999, BIOCHEM J, V341, P453, DOI 10.1042/0264-6021:3410453; Portincasa P, 2006, CURR MED CHEM, V13, P2889, DOI 10.2174/092986706778521878; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Suzuki J, 2001, AM J PHYSIOL-ENDOC M, V281, pE857, DOI 10.1152/ajpendo.2001.281.4.E857; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Voyiaziakis E, 1999, J LIPID RES, V40, P2004; Wei SH, 1997, J BIOL CHEM, V272, P14159, DOI 10.1074/jbc.272.22.14159; Wiegman CH, 2003, DIABETES, V52, P1081, DOI 10.2337/diabetes.52.5.1081; YEAMAN SJ, 1994, ADV ENZYME REGUL, V34, P355, DOI 10.1016/0065-2571(94)90022-1; Youssef Wael, 2002, Semin Gastrointest Dis, V13, P17; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	43	232	246	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13087	13099		10.1074/jbc.M800533200	http://dx.doi.org/10.1074/jbc.M800533200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337240	Green Published, hybrid			2022-12-25	WOS:000255499800047
J	Majumdar, A; Muniandy, PA; Liu, J; Liu, JI; Liu, ST; Cuenoud, B; Seidman, MM				Majumdar, Alokes; Muniandy, Parameswary A.; Liu, Jia; Liu, Ji-Ian; Liu, Su-ting; Cuenoud, Bernard; Seidman, Michael M.			Targeted gene knock in and sequence modulation mediated by a psoralen-linked triplex-forming oligonucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; NUCLEOTIDE EXCISION-REPAIR; INTERSTRAND CROSS-LINK; INDUCED HOMOLOGOUS RECOMBINATION; SISTER-CHROMATID EXCHANGE; MAMMALIAN-CELLS; 2'-O-(2-AMINOETHYL) RESIDUES; DIRECTED REPAIR; HELIX FORMATION; UV-RADIATION	Information from exogenous donor DNA can be introduced into the genome via homology-directed repair (HDR) pathways. These pathways are stimulated by double strand breaks and by DNA damage such as interstrand cross-links. We have employed triple helix-forming oligonucleotides linked to psoralen (pso-TFO) to introduce a DNA interstrand cross-link at a specific site in the genome of living mammalian cells. Co-introduction of duplex DNA with target region homology resulted in precise knock in of the donor at frequencies 2-3 orders of magnitude greater than with donor alone. Knock-in was eliminated in cells deficient in ERCC1-XPF, which is involved in recombinational pathways as well as cross-link repair. Separately, single strand oligonucleotide donors (SSO) were co-introduced with the pso-TFO. These were 10-fold more active than the duplex knock-in donor. SSO efficacy was further elevated in cells deficient in ERCC1-XPF, in contrast to the duplex donor. Resected single strand ends have been implicated as critical intermediates in sequence modulation by SSO, as well as duplex donor knock in. We asked whether there would be a competition between the donor species for these ends if both were present with the pso-TFO. The frequency of duplex donor knock in was unaffected by a 100-fold molar excess of the SSO. The same result was obtained when the homing endonuclease I-SceI was used to initiate HDR at the target site. We conclude that the entry of double strand breaks into distinct HDR pathways is controlled by factors other than the nucleic acid partners in those pathways.	[Majumdar, Alokes; Muniandy, Parameswary A.; Liu, Jia; Liu, Ji-Ian; Liu, Su-ting; Seidman, Michael M.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Cuenoud, Bernard] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Novartis	Seidman, MM (corresponding author), NIA, Lab Mol Gerontol, NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	seidmanm@grc.nia.nih.gov			Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000747, ZIAAG000747] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aarts M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl896; Adair GM, 1998, SOMAT CELL MOLEC GEN, V24, P91, DOI 10.1023/B:SCAM.0000007112.62928.d8; Adair GR, 2000, EMBO J, V19, P5552, DOI 10.1093/emboj/19.20.5552; Al-Minawi AZ, 2008, NUCLEIC ACIDS RES, V36, P1, DOI 10.1093/nar/gkm888; Becker NA, 1999, ANTISENSE NUCLEIC A, V9, P313, DOI 10.1089/oli.1.1999.9.313; Bessho T, 2003, J BIOL CHEM, V278, P5250, DOI 10.1074/jbc.M212323200; Cao J, 1997, MUTAT RES-FUND MOL M, V374, P233, DOI 10.1016/S0027-5107(96)00237-0; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; Chin JY, 2007, FRONT BIOSCI-LANDMRK, V12, P4288, DOI 10.2741/2388; CORTES F, 1991, EXP CELL RES, V196, P127, DOI 10.1016/0014-4827(91)90464-6; Couedel C, 2004, GENE DEV, V18, P1293, DOI 10.1101/gad.1209204; Cuenoud B, 1998, ANGEW CHEM INT EDIT, V37, P1288, DOI 10.1002/(SICI)1521-3773(19980518)37:9<1288::AID-ANIE1288>3.0.CO;2-U; De Semir D, 2003, OLIGONUCLEOTIDES, V13, P261, DOI 10.1089/154545703322460630; Dronkert MLG, 2000, MOL CELL BIOL, V20, P3147, DOI 10.1128/MCB.20.9.3147-3156.2000; Durant ST, 2006, MOL CELL BIOL, V26, P6047, DOI 10.1128/MCB.00444-06; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Faruqi AF, 1996, MOL CELL BIOL, V16, P6820; FELSENFELD G, 1957, J AM CHEM SOC, V79, P2023, DOI 10.1021/ja01565a074; Fisher LA, 2008, J BIOL CHEM, V283, P1275, DOI 10.1074/jbc.M708072200; Honma M, 2007, DNA REPAIR, V6, P781, DOI 10.1016/j.dnarep.2007.01.004; Jonnalagadda VS, 2005, DNA REPAIR, V4, P594, DOI 10.1016/j.dnarep.2005.02.002; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lin YF, 1999, MOL CELL BIOL, V19, P8353; Lin YF, 2001, GENETICS, V158, P1665; Ma YM, 2005, CELL CYCLE, V4, P1193, DOI 10.4161/cc.4.9.1977; Majumdar A, 2003, J BIOL CHEM, V278, P11072, DOI 10.1074/jbc.M211837200; Majumdar A, 1998, NAT GENET, V20, P212, DOI 10.1038/2530; Maurisse R, 2006, OLIGONUCLEOTIDES, V16, P375, DOI 10.1089/oli.2006.16.375; Motycka TA, 2004, J BIOL CHEM, V279, P13634, DOI 10.1074/jbc.M313779200; Niedernhofer LJ, 2001, EMBO J, V20, P6540, DOI 10.1093/emboj/20.22.6540; Olsen PA, 2005, J GENE MED, V7, P1534, DOI 10.1002/jgm.804; Olsen PA, 2003, GENE THER, V10, P1830, DOI 10.1038/sj.gt.3302079; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Porteus MH, 2006, MOL THER, V13, P438, DOI 10.1016/j.ymthe.2005.08.003; Puri N, 2004, BIOCHEMISTRY-US, V43, P1343, DOI 10.1021/bi035808l; Puri N, 2002, BIOCHEMISTRY-US, V41, P7716, DOI 10.1021/bi025734y; Radecke F, 2006, MOL THER, V14, P798, DOI 10.1016/j.ymthe.2006.06.008; Richards S, 2005, NUCLEIC ACIDS RES, V33, P5382, DOI 10.1093/nar/gki851; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Richardson C, 1999, METH MOL B, V113, P453; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; Rolig RL, 1997, MUTAGENESIS, V12, P277, DOI 10.1093/mutage/12.4.277; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Saffran WA, 2004, J BIOL CHEM, V279, P36462, DOI 10.1074/jbc.M402323200; Sargent RG, 2000, NUCLEIC ACIDS RES, V28, P3771, DOI 10.1093/nar/28.19.3771; Sargent RG, 1997, P NATL ACAD SCI USA, V94, P13122, DOI 10.1073/pnas.94.24.13122; Sarkar S, 2006, EMBO J, V25, P1285, DOI 10.1038/sj.emboj.7600993; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; SAWAI M, 1990, EXP CELL RES, V187, P4, DOI 10.1016/0014-4827(90)90108-M; Seidman MM, 2003, J CLIN INVEST, V112, P487, DOI 10.1172/JCI200319552; Shen X, 2006, J BIOL CHEM, V281, P13869, DOI 10.1074/jbc.C600071200; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; TSUJIMURA T, 1990, P NATL ACAD SCI USA, V87, P1566, DOI 10.1073/pnas.87.4.1566; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Varga T, 2005, DNA REPAIR, V4, P1038, DOI 10.1016/j.dnarep.2005.05.004; Vasquez KM, 2001, P NATL ACAD SCI USA, V98, P8403, DOI 10.1073/pnas.111009698; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2	63	31	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11244	11252		10.1074/jbc.M800607200	http://dx.doi.org/10.1074/jbc.M800607200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303025	Green Published, hybrid			2022-12-25	WOS:000255067400020
J	Dahlgren, A; Lundmark, P; Axelsson, T; Lind, L; Syvanen, AC				Dahlgren, Andreas; Lundmark, Per; Axelsson, Tomas; Lind, Lars; Syvanen, Ann-Christine			Association of the Estrogen Receptor 1 (ESR1) Gene with Body Height in Adult Males from Two Swedish Population Cohorts	PLOS ONE			English	Article								Human body height is a complex genetic trait with high heritability. We performed an association study of 17 candidate genes for height in the Uppsala Longitudinal Study of Adult Men (ULSAM) that consists of 1153 elderly men of age 70 born in the central region of Sweden. First we genotyped a panel of 137 single nucleotide polymorphism (SNPs) evenly distributed across the candidate genes in the ULSAM cohort. We identified 4 SNPs in the estrogen receptor gene (ESR1) on chromosome 6q25.1 with suggestive signals of association (p<0.05) with standing body height. This result was followed up by genotyping the same 25 SNPs in the ESR1 gene as in ULSAM in a second population cohort, the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) cohort that consist of 507 males and 509 females of age 70 from the same geographical region as ULSAM. One SNP, rs2179922 located in intron 4 of ESR1 showed and association signal (p = 0.0056) in the male samples from the PIVUS cohort. Homozygote carriers of the G-allele of the SNP rs2179922 were on average 0.90 cm taller than individuals with the two other genotypes at this SNP in the ULSAM cohort and 2.3 cm taller in the PIVUS cohort. No association was observed for the females in the PIVUS cohort.	[Dahlgren, Andreas; Lundmark, Per; Axelsson, Tomas; Syvanen, Ann-Christine] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lind, Lars] Uppsala Univ Hosp, Dept Med Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital	Dahlgren, A (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	Ann-Christine.Syvanen@medsci.uu.se			Swedish Research Council; Knut and Alice Wallenberg Foundation; Uppsala University Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Uppsala University Hospital	The study was supported by research grants from the Swedish Research Council, the Knut and Alice Wallenberg Foundation and from Uppsala University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BELL PA, 2002, BIOTECHNIQUES S, V70, P7476; Deng HW, 2002, AM J MED GENET, V113, P29, DOI 10.1002/ajmg.10742; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Hedstrand H, 1975, Ups J Med Sci Suppl, V19, P1; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; Khosla S, 2002, J CLIN ENDOCR METAB, V87, P1443, DOI 10.1210/jc.87.4.1443; Khosla S, 2002, CLIN ENDOCRINOL, V56, P291, DOI 10.1046/j.1365-2265.2002.01428.x; LEHRER S, 1994, HORM METAB RES, V26, P486, DOI 10.1055/s-2007-1001739; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Liu YZ, 2004, ANN HUM GENET, V68, P472, DOI 10.1046/j.1529-8817.2003.00117.x; Lorentzon M, 1999, J CLIN ENDOCR METAB, V84, P4597, DOI 10.1210/jc.84.12.4597; Perola M, 2001, AM J HUM GENET, V69, P117, DOI 10.1086/321286; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; R Development Core Team, 2006, R LANG ENV STAT COMP; Sammalisto S, 2005, J MED GENET, V42, P932, DOI 10.1136/jmg.2005.031278; Schuit SCE, 2004, J CLIN ENDOCR METAB, V89, P303, DOI 10.1210/jc.2003-031095; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Visscher PM, 2007, AM J HUM GENET, V81, P1104, DOI 10.1086/522934; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Willemsen G, 2004, EUR J HUM GENET, V12, P820, DOI 10.1038/sj.ejhg.5201229; Wu XD, 2003, EUR J HUM GENET, V11, P271, DOI 10.1038/sj.ejhg.5200952; Xu JF, 2002, AM J HUM GENET, V71, P646, DOI 10.1086/342216	24	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1807	10.1371/journal.pone.0001807	http://dx.doi.org/10.1371/journal.pone.0001807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350145	gold, Green Published, Green Submitted			2022-12-25	WOS:000260762300011
J	Gupta, S; Hopner, S; Rupp, B; Gunther, S; Dickhaut, K; Agarwal, N; Cardoso, MC; Kuhne, R; Wiesmuller, KH; Jung, G; Falk, K; Rotzschke, O				Gupta, Shashank; Hoepner, Sabine; Rupp, Bernd; Guenther, Sebastian; Dickhaut, Katharina; Agarwal, Noopur; Cardoso, M. Cristina; Kuehne, Ronald; Wiesmueller, Karl-Heinz; Jung, Guenther; Falk, Kirsten; Roetzschke, Olaf			Anchor Side Chains of Short Peptide Fragments Trigger Ligand-Exchange of Class II MHC Molecules	PLOS ONE			English	Article								Class II MHC molecules display peptides on the cell surface for the surveillance by CD4+ T cells. To ensure that these ligands accurately reflect the content of the intracellular MHC loading compartment, a complex processing pathway has evolved that delivers only stable peptide/MHC complexes to the surface. As additional safeguard, MHC molecules quickly acquire a 'non-receptive' state once they have lost their ligand. Here we show now that amino acid side chains of short peptides can bypass these safety mechanisms by triggering the reversible ligand-exchange. The catalytic activity of dipeptides such as Tyr-Arg was stereo-specific and could be enhanced by modifications addressing the conserved H-bond network near the P1 pocket of the MHC molecule. It affected both antigen-loading and ligand-release and strictly correlated with reported anchor preferences of P1, the specific target site for the catalytic side chain of the dipeptide. The effect was evident also in CD4+ T cell assays, where the allele-selective influence of the dipeptides translated into increased sensitivities of the antigen-specific immune response. Molecular dynamic calculations support the hypothesis that occupation of P1 prevents the 'closure' of the empty peptide binding site into the non-receptive state. During antigen-processing and -presentation P1 may therefore function as important "sensor'' for peptide-load. While it regulates maturation and trafficking of the complex, on the cell surface, short protein fragments present in blood or lymph could utilize this mechanism to alter the ligand composition on antigen presenting cells in a catalytic way.	[Gupta, Shashank; Hoepner, Sabine; Guenther, Sebastian; Dickhaut, Katharina; Agarwal, Noopur; Cardoso, M. Cristina; Falk, Kirsten; Roetzschke, Olaf] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Rupp, Bernd; Kuehne, Ronald] Leibniz Inst Mol Pharmacol FMP, Berlin, Germany; [Dickhaut, Katharina] Charite, Berlin, Germany; [Wiesmueller, Karl-Heinz; Jung, Guenther] Univ Tubingen, Tubingen, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen	Gupta, S (corresponding author), Max Delbruck Ctr Mol Med MDC, Berlin, Germany.	falk@mdc-berlin.de; roetzsch@mdc-berlin.de	Cardoso, M. Cristina/F-5215-2011; Guenther, Sebastian/GON-7207-2022; Roetzschke, Olaf/GXH-0012-2022	Guenther, Sebastian/0000-0002-7329-6653; Rupp, Bernd/0000-0001-9447-9638	BMBF [network grant MHCenhancer]; EC; MDC	BMBF(Federal Ministry of Education & Research (BMBF)); EC(European CommissionEuropean Commission Joint Research Centre); MDC	B. Rupp, R. Kuhne, G. Jung, O. Rotzschke and K. Falk were supported by the BMBF-sponsored network grant MHCenhancer (www.MHCenhancer.de). S. Gupta was supported by the EC-funded Marie-Curie Research Training Network (MC-RTN) Drugs for therapy. S. Hopner and S. Gunther were supported by grants awarded by MDC Ph.D. stipend programs.	Chen QY, 2004, P NATL ACAD SCI USA, V101, P9363, DOI 10.1073/pnas.0403271101; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Falk K, 2000, EUR J IMMUNOL, V30, P3012, DOI 10.1002/1521-4141(200010)30:10<3012::AID-IMMU3012>3.0.CO;2-Q; Falk K, 2002, J BIOL CHEM, V277, P2709, DOI 10.1074/jbc.M109098200; Fleckenstein B, 1996, EUR J BIOCHEM, V240, P71, DOI 10.1111/j.1432-1033.1996.0071h.x; Fourneau JM, 2004, J IMMUNOL METHODS, V285, P253, DOI 10.1016/j.jim.2003.11.011; Grotenbreg GM, 2007, J BIOL CHEM, V282, P21425, DOI 10.1074/jbc.M702844200; Hochweller K, 2006, CURR MOL MED, V6, P631, DOI 10.2174/156652406778194982; Hopner S, 2006, J BIOL CHEM, V281, P38535, DOI 10.1074/jbc.M606437200; HUMPHREY W, 1996, J MOL GRAPHICS, V14; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; KROPSHOFER H, 1995, SCIENCE, V270, P1357, DOI 10.1126/science.270.5240.1357; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; LAMB JR, 1982, NATURE, V300, P66, DOI 10.1038/300066a0; Marin-Esteban V, 2004, J BIOL CHEM, V279, P50684, DOI 10.1074/jbc.M407598200; Marin-Esteban V, 2003, J AUTOIMMUN, V20, P63, DOI 10.1016/S0896-8411(02)00107-5; Narayan K, 2007, NAT IMMUNOL, V8, P92, DOI 10.1038/ni1414; Natarajan SK, 1999, J IMMUNOL, V162, P4030; Natarajan SK, 1999, J IMMUNOL, V162, P3463; ONG B, 1991, P NATL ACAD SCI USA, V88, P7343, DOI 10.1073/pnas.88.16.7343; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; RAMMENSEE HG, 1997, MHC LIGANDS PEPTIDE; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Rosloniec EF, 1997, J EXP MED, V185, P1113, DOI 10.1084/jem.185.6.1113; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15050, DOI 10.1073/pnas.96.26.15050; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Stern LJ, 2006, CURR OPIN IMMUNOL, V18, P64, DOI 10.1016/j.coi.2005.11.005; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vergelli M, 1997, EUR J IMMUNOL, V27, P941, DOI 10.1002/eji.1830270421; Watts C, 2001, CURR OPIN IMMUNOL, V13, P26, DOI 10.1016/S0952-7915(00)00177-1; Xu M, 2001, SCAND J IMMUNOL, V54, P39, DOI 10.1046/j.1365-3083.2001.00964.x	38	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1814	10.1371/journal.pone.0001814	http://dx.doi.org/10.1371/journal.pone.0001814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350151	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000260762300017
J	Aguas, R; White, LJ; Snow, RW; Gomes, MGM				Aguas, Ricardo; White, Lisa J.; Snow, Robert W.; Gomes, M. Gabriela M.			Prospects for Malaria Eradication in Sub-Saharan Africa	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; TRANSMISSION DYNAMICS; ACQUIRED-IMMUNITY; INOCULATION RATE; DISEASE; MANIFESTATIONS; CONSEQUENCES; EPIDEMIOLOGY; ENDEMICITY; INTENSITY	Background: A characteristic of Plasmodium falciparum infections is the gradual acquisition of clinical immunity resulting from repeated exposures to the parasite. While the molecular basis of protection against clinical malaria remains unresolved, its effects on epidemiological patterns are well recognized. Accumulating epidemiological data constitute a valuable resource that must be intensively explored and interpreted as to effectively inform control planning. Methodology/Principal Finding: Here we apply a mathematical model to clinical data from eight endemic regions in sub-Saharan Africa. The model provides a quantitative framework within which differences in age distribution of clinical disease are assessed in terms of the parameters underlying transmission. The shorter infectious periods estimated for clinical infections induce a regime of bistability of endemic and malaria-free states in regions of mesoendemic transmission. The two epidemiological states are separated by a threshold that provides a convenient measure for intervention design. Scenarios of eradication and resurgence are simulated. Conclusions/Significance: In regions that support mesoendemic transmission, intervention success depends critically on reducing prevalence below a threshold which separates endemic and malaria-free regimes.	[Aguas, Ricardo; Gomes, M. Gabriela M.] Gulbenkian Inst Sci, Oeiras, Portugal; [White, Lisa J.] Univ Warwick, Dept Biol Sci, Ecol & Epidemiol Grp, Coventry, W Midlands, England; [Snow, Robert W.] Kenya Govt Med Res Ctr, Ctr Geographic Med, Malaria Public Hlth & Epidemiol Grp, Nairobi, Kenya; [Snow, Robert W.] Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford, England; [Gomes, M. Gabriela M.] Univ Lisbon, Ctr Matematica Aplicacoes Fundamentais, Lisbon, Portugal	University of Warwick; Kenya Medical Research Institute; University of Oxford; Universidade de Lisboa	Aguas, R (corresponding author), Gulbenkian Inst Sci, Oeiras, Portugal.	ggomes@igc.gulbenkian.pt	Snow, Robert William/AFR-1436-2022; White, Lisa/AAC-9396-2020; Gomes, Gabriela/H-7218-2014	Snow, Robert William/0000-0003-3725-6088; White, Lisa/0000-0002-6523-185X; Gomes, Gabriela/0000-0002-1454-4979	Portuguese Research Council-FCT [SFRH/BD/23900/2005]; European Commission [MEXT-CT-2004-14338]; Wellcome Trust [061584]	Portuguese Research Council-FCT(Portuguese Foundation for Science and Technology); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission)	Funded by the Portuguese Research Council-FCT (grant SFRH/BD/23900/2005), the European Commission (grant MEXT-CT-2004-14338), and the Wellcome Trust (grant 061584). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguas R, 2006, LANCET INFECT DIS, V6, P112, DOI 10.1016/S1473-3099(06)70384-X; Bull PC, 2002, TRENDS MICROBIOL, V10, P55, DOI 10.1016/S0966-842X(01)02278-8; Coleman PG, 2001, LANCET, V357, P1284, DOI 10.1016/S0140-6736(00)04410-X; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010020; Dushoff J, 1996, J THEOR BIOL, V180, P181, DOI 10.1006/jtbi.1996.0094; Freeman J, 1999, AM J TROP MED HYG, V60, P774, DOI 10.4269/ajtmh.1999.60.774; Gouagna LC, 2004, PARASITOLOGY, V128, P235, DOI 10.1017/S003118200300444X; Gramiccia G., 1988, Malaria: principles and practice of malariology. Volume 2., P1335; Gu WD, 2003, ACTA TROP, V86, P71, DOI 10.1016/S0001-706X(03)00020-2; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; HALLORAN ME, 1992, PARASITOL TODAY, V8, P77, DOI 10.1016/0169-4758(92)90240-3; Hviid L, 2004, PARASITE IMMUNOL, V26, P477, DOI 10.1111/j.0141-9838.2004.00733.x; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Medley GF, 2001, NAT MED, V7, P619, DOI 10.1038/87953; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Molineaux L, 1980, THE GARKI PROJECT; Mueller I, 2005, AM J TROP MED HYG, V72, P554, DOI 10.4269/ajtmh.2005.72.554; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; Smith T, 2006, AM J TROP MED HYG, V75, P56, DOI 10.4269/ajtmh.2006.75.56; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Snow RW, 1998, BRIT MED BULL, V54, P293, DOI 10.1093/oxfordjournals.bmb.a011689; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SNOW RW, 1999, B WORLD HEALTH ORGAN, P77; *UN, 2005, POP RES ENV DEV 2005; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; White LJ, 2005, EPIDEMIOL INFECT, V133, P279, DOI 10.1017/S0950268804003450	36	58	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1767	10.1371/journal.pone.0001767	http://dx.doi.org/10.1371/journal.pone.0001767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335042	Green Published, gold, Green Submitted			2022-12-25	WOS:000260723000021
J	Grant, SFA; Li, MY; Bradfield, JP; Kim, CE; Annaiah, K; Santa, E; Glessner, JT; Casalunovo, T; Frackelton, EC; Otieno, FG; Shaner, JL; Smith, RM; Imielinski, M; Eckert, AW; Chiavacci, RM; Berkowitz, RI; Hakonarson, H				Grant, Struan F. A.; Li, Mingyao; Bradfield, Jonathan P.; Kim, Cecilia E.; Annaiah, Kiran; Santa, Erin; Glessner, Joseph T.; Casalunovo, Tracy; Frackelton, Edward C.; Otieno, F. George; Shaner, Julie L.; Smith, Ryan M.; Imielinski, Marcin; Eckert, Andrew W.; Chiavacci, Rosetta M.; Berkowitz, Robert I.; Hakonarson, Hakon			Association Analysis of the FTO Gene with Obesity in Children of Caucasian and African Ancestry Reveals a Common Tagging SNP	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FACTOR-H POLYMORPHISM; CHILDHOOD PREDICTORS; INSULIN-RESISTANCE; ADULT; OVERWEIGHT; VARIANTS; RISK; ADOLESCENTS; TWIN	Recently an association was demonstrated between the single nucleotide polymorphism (SNP), rs9939609, within the FTO locus and obesity as a consequence of a genome wide association (GWA) study of type 2 diabetes in adults. We examined the effects of two perfect surrogates for this SNP plus 11 other SNPs at this locus with respect to our childhood obesity cohort, consisting of both Caucasians and African Americans (AA). Utilizing data from our ongoing GWA study in our cohort of 418 Caucasian obese children (BMI >= 95th percentile), 2,270 Caucasian controls (BMI<95th percentile), 578 AA obese children and 1,424 AA controls, we investigated the association of the previously reported variation at the FTO locus with the childhood form of this disease in both ethnicities. The minor allele frequencies (MAF) of rs8050136 and rs3751812 (perfect surrogates for rs9939609 i.e. both r(2) = 1) in the Caucasian cases were 0.448 and 0.443 respectively while they were 0.391 and 0.386 in Caucasian controls respectively, yielding for both an odds ratio (OR) of 1.27 (95% CI 1.08-1.47; P = 0.0022). Furthermore, the MAFs of rs8050136 and rs3751812 in the AA cases were 0.449 and 0.115 respectively while they were 0.436 and 0.090 in AA controls respectively, yielding an OR of 1.05 (95% CI 0.91-1.21; P = 0.49) and of 1.31 (95% CI 1.050-1.643; P = 0.017) respectively. Investigating all 13 SNPs present on the Illumina HumanHap550 BeadChip in this region of linkage disequilibrium, rs3751812 was the only SNP conferring significant risk in AA. We have therefore replicated and refined the association in an AA cohort and distilled a tag-SNP, rs3751812, which captures the ancestral origin of the actual mutation. As such, variants in the FTO gene confer a similar magnitude of risk of obesity to children as to their adult counterparts and appear to have a global impact.	[Grant, Struan F. A.; Bradfield, Jonathan P.; Kim, Cecilia E.; Annaiah, Kiran; Santa, Erin; Glessner, Joseph T.; Casalunovo, Tracy; Frackelton, Edward C.; Otieno, F. George; Shaner, Julie L.; Smith, Ryan M.; Imielinski, Marcin; Eckert, Andrew W.; Chiavacci, Rosetta M.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet, Philadelphia, PA USA; [Grant, Struan F. A.; Hakonarson, Hakon] Univ Pennsylvania, Sch Med, Dept Pediat, Philadelphia, PA USA; [Li, Mingyao] Univ Pennsylvania, Dept Biostat & Epidemiol, Philadelphia, PA USA; [Berkowitz, Robert I.] Univ Pennsylvania, Sch Med, Dept Psychiat, Weight & Eating Disorders Program, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Grant, SFA (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA.	grants@chop.edu; hakonarson@chop.edu		Glessner, Joseph/0000-0001-5131-2811	Children's Hospital of Philadelphia	Children's Hospital of Philadelphia	This research was financially supported by the Children's Hospital of Philadelphia.	[Anonymous], 1985, Ann Intern Med, V103, P147; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; BORJESON M, 1976, ACTA PAEDIATR SCAND, V65, P279, DOI 10.1111/j.1651-2227.1976.tb04887.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Dietz WH, 1998, PEDIATRICS, V101, P518; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Farooqi IS, 2005, INT J OBESITY, V29, P1149, DOI 10.1038/sj.ijo.0803056; Flodmark CE, 2004, INT J OBESITY, V28, P1189, DOI 10.1038/sj.ijo.0802787; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563; GERKEN T, 2007, OBESITY ASS FTO GENE; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hebebrand J, 2003, Obes Rev, V4, P139; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; KNOWLER WC, 1990, DIABETES METAB REV, V6, P1, DOI 10.1002/dmr.5610060101; Koplan JP, 2005, J AM DIET ASSOC, V105, P131, DOI 10.1016/j.jada.2004.11.023; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lyon HN, 2005, AM J CLIN NUTR, V82, p215S, DOI 10.1093/ajcn/82.1.215S; Must A, 2003, NUTR REV, V61, P139, DOI 10.1301/nr.2003.apr.139-142; Nicklas TA, 2001, J AM COLL NUTR, V20, P599, DOI 10.1080/07315724.2001.10719064; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Patterson M, 2005, PLOS BIOL, V3, P1511, DOI 10.1371/journal.pbio.0030327; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Troiano RP, 1998, PEDIATRICS, V101, P497; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; ZEGGINI E, 2006, DIABETOLOGIA; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; ZIMMET P, 1990, DIABETES METAB REV, V6, P91, DOI 10.1002/dmr.5610060203	48	158	166	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1746	10.1371/journal.pone.0001746	http://dx.doi.org/10.1371/journal.pone.0001746			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335027	Green Submitted, Green Published, gold			2022-12-25	WOS:000260723000001
J	Sadlish, H; Rampelt, H; Shorter, J; Wegrzyn, RD; Andreasson, C; Lindquist, S; Bukau, B				Sadlish, Heather; Rampelt, Heike; Shorter, James; Wegrzyn, Renee D.; Andreasson, Claes; Lindquist, Susan; Bukau, Bernd			Hsp110 Chaperones Regulate Prion Formation and Propagation in S-cerevisiae by Two Discrete Activities	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTORS; DE-NOVO APPEARANCE; PSI+ PRION; CYTOSOLIC HSP70; YEAST; TOXICITY; PSI(+); HSP40; SSE1; SSB	The cytosolic chaperone network of Saccharomyces cerevisiae is intimately associated with the emergence and maintenance of prion traits. Recently, the Hsp110 protein, Sse1, has been identified as a nucleotide exchange factor (NEF) for both cytosolic Hsp70 chaperone family members, Ssa1 and Ssb1. We have investigated the role of Sse1 in the de novo formation and propagation of [PSI+], the prion form of the translation termination factor, Sup35. As observed by others, we find that Sse1 is essential for efficient prion propagation. Our results suggest that the NEF activity is required for maintaining sufficient levels of substrate-free Ssa1. However, Sse1 exhibits an additional NEF-independent activity; it stimulates in vitro nucleation of Sup35NM, the prion domain of Sup35. We also observe that high levels of Sse1, but not of an unrelated NEF, very potently inhibit Hsp104-mediated curing of [PSI+]. Taken together, these results suggest a chaperone-like activity of Sse1 that assists in stabilization of early folding intermediates of the Sup35 prion conformation. This activity is not essential for prion formation under conditions of Sup35 overproduction, however, it may be relevant for spontaneous [PSI+] formation as well as for protection of the prion trait upon physiological Hsp104 induction.	[Sadlish, Heather; Rampelt, Heike; Wegrzyn, Renee D.; Andreasson, Claes; Bukau, Bernd] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany; [Shorter, James] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA USA; [Lindquist, Susan] Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Pennsylvania; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Sadlish, H (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany.	bukau@zmbh.uni-heidelberg.de	Shorter, James/E-8207-2011; Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533; Rampelt, Heike/0000-0002-5458-5652; Bukau, Bernd/0000-0003-0521-7199; Andreasson, Claes/0000-0001-8948-0685	Boehringer Ingelheim Fonds [scholarship]; EMBO [fellowship]; American Heart Association [Scientist Development Grant]; Fonds der Chemischen Industrie; Sonderforschungsbereich 638	Boehringer Ingelheim Fonds(Boehringer Ingelheim); EMBO(European Molecular Biology Organization (EMBO)); American Heart Association(American Heart Association); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Sonderforschungsbereich 638(German Research Foundation (DFG))	This work was supported by a scholarship of the Boehringer Ingelheim Fonds (to H.R.), an EMBO fellowship (to C.A.), an American Heart Association Scientist Development Grant (to J.S.), as well as by grants from the Fonds der Chemischen Industrie and the Sonderforschungsbereich 638 (to B.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Chacinska A, 2001, CURR GENET, V39, P62, DOI 10.1007/s002940000180; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Chernoff YO, 2001, MUTAT RES-REV MUTAT, V488, P39, DOI 10.1016/S1383-5742(00)00060-0; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Jones G, 2004, MOL CELL BIOL, V24, P3928, DOI 10.1128/MCB.24.9.3928-3937.2004; Jones GW, 2003, MOL GENET GENOMICS, V269, P304, DOI 10.1007/s00438-003-0838-y; Jones GW, 2003, GENETICS, V163, P495; Jung G, 2000, GENETICS, V156, P559; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200	44	58	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1763	10.1371/journal.pone.0001763	http://dx.doi.org/10.1371/journal.pone.0001763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335038	Green Published, gold			2022-12-25	WOS:000260723000017
J	Rossi, S; De Capua, A; Pasqualetti, P; Ulivelli, M; Fadiga, L; Falzarano, V; Bartalini, S; Passero, S; Nuti, D; Rossini, PM				Rossi, Simone; De Capua, Alberto; Pasqualetti, Patrizio; Ulivelli, Monica; Fadiga, Luciano; Falzarano, Vincenzo; Bartalini, Sabina; Passero, Stefano; Nuti, Daniele; Rossini, Paolo M.			Distinct Olfactory Cross-Modal Effects on the Human Motor System	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICOSPINAL EXCITABILITY MODULATION; HAND MUSCLES; FACILITATION; ACTIVATION; POTENTIALS; HEARING; IMAGERY; EMPATHY; OUTPUT	Background: Converging evidence indicates that action observation and action-related sounds activate cross-modally the human motor system. Since olfaction, the most ancestral sense, may have behavioural consequences on human activities, we causally investigated by transcranial magnetic stimulation (TMS) whether food odour could additionally facilitate the human motor system during the observation of grasping objects with alimentary valence, and the degree of specificity of these effects. Methodology/Principal Findings: In a repeated-measure block design, carried out on 24 healthy individuals participating to three different experiments, we show that sniffing alimentary odorants immediately increases the motor potentials evoked in hand muscles by TMS of the motor cortex. This effect was odorant-specific and was absent when subjects were presented with odorants including a potentially noxious trigeminal component. The smell-induced corticospinal facilitation of hand muscles during observation of grasping was an additive effect which superimposed to that induced by the mere observation of grasping actions for food or non-food objects. The odour-induced motor facilitation took place only in case of congruence between the sniffed odour and the observed grasped food, and specifically involved the muscle acting as prime mover for hand/fingers shaping in the observed action. Conclusions/Significance: Complex olfactory cross-modal effects on the human corticospinal system are physiologically demonstrable. They are odorant-specific and, depending on the experimental context, muscle- and action-specific as well. This finding implies potential new diagnostic and rehabilitative applications.	[Rossi, Simone; Ulivelli, Monica; Bartalini, Sabina; Passero, Stefano] Univ Siena, Dipartimento Neurosci, Sez Neurol, I-53100 Siena, Italy; [De Capua, Alberto; Falzarano, Vincenzo] Univ Siena, Dipartimento Neurosci, Siena, Italy; [Pasqualetti, Patrizio] Isola Tiberina, AFaR Fatebenefratelli Ass Res, Med Stat & Informat Technol, Rome, Italy; [Pasqualetti, Patrizio; Rossini, Paolo M.] Fatebenefratelli Isola Tiberina, AFaR Dipartimento Neurosci, Rome, Italy; [Pasqualetti, Patrizio; Nuti, Daniele; Rossini, Paolo M.] Casa di Cura San Raffaele Cassino, IRCCS San Raffaele Pisana, Rome, Italy; [Fadiga, Luciano] Univ Ferrara, Dipartimento Sci Biomed, Sezione Fisiologia Umana, Ferrara, Italy; [Rossini, Paolo M.] Univ Campus Biomed, Clin Neurol, Rome, Italy; [Fadiga, Luciano] Italian Inst Technol, Genoa, Italy	University of Siena; University of Siena; IRCCS San Raffaele Pisana; University of Ferrara; University Campus Bio-Medico - Rome Italy; Istituto Italiano di Tecnologia - IIT	Rossi, S (corresponding author), Univ Siena, Dipartimento Neurosci, Sez Neurol, Via Laterina 8, I-53100 Siena, Italy.	Rossisimo@unisi.it	Fadiga, Luciano/AAC-7404-2022; Rossini, Paolo M./D-4994-2013; Ulivelli, Monica/K-7270-2016; Pasqualetti, Patrizio/D-4496-2013; Rossi, Simone/AAC-6067-2022	Rossini, Paolo M./0000-0003-2665-534X; Ulivelli, Monica/0000-0003-3463-6341; Pasqualetti, Patrizio/0000-0001-5560-1979; Rossi, Simone/0000-0001-6697-9459; fadiga, luciano/0000-0001-5691-5080				Abbruzzese G, 1996, EXP BRAIN RES, V111, P465; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Aziz-Zadeh L, 2004, EUR J NEUROSCI, V19, P2609, DOI 10.1111/j.0953-816X.2004.03348.x; Bensafi M, 2003, NAT NEUROSCI, V6, P1142, DOI 10.1038/nn1145; Castiello U, 2006, CHEM SENSES, V31, P665, DOI 10.1093/chemse/bjl007; CHENG Y, 2006, CER CORTEX; Clark S, 2004, NEUROPSYCHOLOGIA, V42, P105, DOI 10.1016/S0028-3932(03)00144-1; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fadiga L, 1999, NEUROPSYCHOLOGIA, V37, P147; Ferrari PF, 2005, BEHAV BRAIN RES, V161, P95, DOI 10.1016/j.bbr.2005.01.009; Filippi MM, 2000, BRAIN RES, V881, P159, DOI 10.1016/S0006-8993(00)02837-7; Fontanini A, 2006, TRENDS NEUROSCI, V29, P429, DOI 10.1016/j.tins.2006.06.013; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Herz RS, 2004, NEUROPSYCHOLOGIA, V42, P371, DOI 10.1016/j.neuropsychologia.2003.08.009; Herz RS, 1998, ANN NY ACAD SCI, V855, P670, DOI 10.1111/j.1749-6632.1998.tb10643.x; Hummel T, 2005, CHEM SENSES, V30, pI205, DOI 10.1093/chemse/bjh186; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Le Pera D, 2001, CLIN NEUROPHYSIOL, V112, P1633, DOI 10.1016/S1388-2457(01)00631-9; LEMON RN, 1995, J NEUROSCI, V15, P6145; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; Nielsen JF, 1996, J CLIN NEUROPHYSIOL, V13, P423, DOI 10.1097/00004691-199609000-00005; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Rizzolatti G, 1998, NOVART FDN SYMP, V218, P81; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rossi S, 2004, TRENDS COGN SCI, V8, P273, DOI 10.1016/j.tics.2004.04.012; Rossi S, 1998, NEUROIMAGE, V8, P163, DOI 10.1006/nimg.1998.0352; Rossi S, 1998, NEUROSCI LETT, V243, P147, DOI 10.1016/S0304-3940(98)00088-3; Rossini PM, 2007, NEUROLOGY, V68, P484, DOI 10.1212/01.wnl.0000250268.13789.b2; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rossini PM, 1999, CEREB CORTEX, V9, P161, DOI 10.1093/cercor/9.2.161; ROTHMAN KJ, EPIDEMIOLOGY INTRO; Royet JP, 2000, J NEUROSCI, V20, P7752; Savic I, 2002, HUM BRAIN MAPP, V17, P17, DOI 10.1002/hbm.10045; Savic I, 2002, CURR OPIN NEUROBIOL, V12, P455, DOI 10.1016/S0959-4388(02)00346-X; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Spence C, 2001, Q J EXP PSYCHOL-A, V54, P775, DOI 10.1080/02724980042000480; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0; Zucco GM, 2003, EUR PSYCHOL, V8, P77, DOI 10.1027//1016-9040.8.2.77	49	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1702	10.1371/journal.pone.0001702	http://dx.doi.org/10.1371/journal.pone.0001702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XS	18301777	Green Published, Green Submitted, gold			2022-12-25	WOS:000260586500046
J	Gangloff, M; Murali, A; Xiong, J; Arnot, CJ; Weber, AN; Sandercock, AM; Robinson, CV; Sarisky, R; Holzenburg, A; Kao, C; Gay, NJ				Gangloff, Monique; Murali, Ayaluru; Xiong, Jin; Arnot, Christopher J.; Weber, Alexander N.; Sandercock, Alan M.; Robinson, Carol V.; Sarisky, Robert; Holzenburg, Andreas; Kao, Cheng; Gay, Nicholas J.			Structural insight into the mechanism of activation of the Toll receptor by the dimeric ligand Spatzle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; CRYSTAL-STRUCTURE; PROTEIN; COMPLEX; BINDING; ORIGIN; DOMAIN; IONS	The Drosophila Toll receptor, which functions in both embryonic patterning and innate immunity to fungi and Gram-positive bacteria, is activated by a dimeric cytokine ligand, Spatzle (Spz). Previous studies have suggested that one Spz cross-links two Toll receptor molecules to form an activated complex. Here we report electron microscopy structures of the Toll ectodomain in the absence and presence of Spz. Contrary to expectations, Spz does not directly cross-link two Toll ectodomains. Instead, Spz binding at the N-terminal end of Toll predominantly induces the formation of a 2: 2 complex, with two sites of interaction between the ectodomain chains, one located near to the N terminus of the solenoid and the other between the C-terminal juxtamembrane sequences. Moreover, Toll undergoes a ligand-induced conformational change, becoming more tightly curved than in the apo form. The unexpected 2: 2 complex was confirmed by mass spectrometry under native conditions. These results suggest that activation of Toll is an allosteric mechanism induced by an end-on binding mode of its ligand Spz.	[Kao, Cheng] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Xiong, Jin] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Holzenburg, Andreas] Texas A&M Univ, Microscopy & Imaging Ctr, College Stn, TX 77843 USA; [Gangloff, Monique; Arnot, Christopher J.; Weber, Alexander N.; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Sandercock, Alan M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Sarisky, Robert] Centocor Res & Dev Inc, Discovery Res, Radnor, PA 19087 USA; [Weber, Alexander N.] Deutsches Krebsforschungzentrum, Angewandte Tumovirrol, Div F120, Lab 2 206, D-69120 Heidelberg, Germany	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Cambridge; University of Cambridge; Johnson & Johnson; Johnson & Johnson USA	Kao, C (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	ckao@tamu.edu; njg11@mole.bio.cam.ac.uk	Murali, Ayaluru/G-3401-2014	Murali, Ayaluru/0000-0001-6406-6840; Gangloff, Monique/0000-0001-6131-0115; robinson, carol/0000-0001-7829-5505; Weber, Alexander/0000-0002-8627-7056	Medical Research Council [G0400007, G1000133] Funding Source: Medline; MRC [G0400007] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Chernushevich IV, 2004, ANAL CHEM, V76, P1754, DOI 10.1021/ac035406j; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; DeLotto Y, 2001, MOL GEN GENET, V264, P643, DOI 10.1007/s004380000350; Felitsyn N, 2002, INT J MASS SPECTROM, V219, P39, DOI 10.1016/S1387-3806(02)00588-2; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hu XD, 2004, P NATL ACAD SCI USA, V101, P9369, DOI 10.1073/pnas.0307062101; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jurchen JC, 2003, J AM CHEM SOC, V125, P2817, DOI 10.1021/ja0211508; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mizuguchi K, 1998, TRENDS BIOCHEM SCI, V23, P239, DOI 10.1016/S0968-0004(98)01216-X; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; ROBINSON RC, 1995, BIOCHEMISTRY-US, V34, P4139, DOI 10.1021/bi00013a001; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; VAKSER IA, 1995, PROTEIN ENG, V8, P371, DOI 10.1093/protein/8.4.371; Weber ANR, 2007, J BIOL CHEM, V282, P13522, DOI 10.1074/jbc.M700068200; Weber ANR, 2005, J BIOL CHEM, V280, P22793, DOI 10.1074/jbc.M502074200; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Zhou HY, 2005, PROTEINS, V61, P152, DOI 10.1002/prot.20732	40	52	54	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14629	14635		10.1074/jbc.M800112200	http://dx.doi.org/10.1074/jbc.M800112200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18347020	hybrid			2022-12-25	WOS:000255941400051
J	Misra, S; Obeid, LM; Hannun, YA; Minamisawa, S; Berger, FG; Markwald, RR; Toole, BP; Ghatak, S				Misra, Suniti; Obeid, Lina M.; Hannun, Yusuf A.; Minamisawa, Susumu; Berger, Franklin G.; Markwald, Roger R.; Toole, Bryan P.; Ghatak, Shibnath			Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; COLORECTAL-CANCER; BETA-CATENIN; MESENCHYMAL-TRANSITION; PROSTATE-CANCER; CYCLOOXYGENASE-2 EXPRESSION; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; CD44 EXPRESSION; IN-VITRO	Hyaluronan is a major component of the pericellular matrix surrounding tumor cells, including colon carcinomas. Elevated cycooxygenase-2 levels have been implicated in several malignant properties of colon cancer. We now show for the first time a strong link between hyaluronan-CD44 interaction and cyclooxygenase-2 in colon cancer cells. First, we have shown that increased expression of hyaluronan synthase-2 induces malignant cell properties, including increased proliferation, anchorage-independent growth, and epithelial-mesenchymal transition in HIEC6 cells. Second, constitutive hyaluronan-CD44 interaction stimulates a signaling pathway involving ErbB2, phosphoinositide 3-kinase/AKT, beta-catenin, and cyclooxygenase-2/prostaglandin E-2 in HCA7 colon carcinoma cells. Third, the HA/CD44-activated ErbB2 --> phosphoinositide 3-kinase/ AKT --> beta-catenin pathway stimulates cell survival/cell proliferation through COX-2 induction in hyaluronan-overexpressing HIEC6 cells and in HCA7 cells. Fourth, perturbation of hyaluronan-CD44 interaction by hyaluronan oligomers or CD44-silencing RNA decreases cyclooxygenase-2 expression and enzyme activity, and inhibition of cyclooxygenase-2 decreases hyaluronan production suggesting the possibility of an amplifying positive feedback loop between hyaluronan and cyclooxygenase-2. We conclude that hyaluronan is an important endogenous regulator of colon cancer cell survival properties and that cyclooxygenase-2 is a major mediator of these hyaluronan-induced effects. Defining hyaluronan-dependent cyclooxygenase-2/prostaglandin E-2-associated signaling pathways will provide a platform for developing novel therapeutic approaches for colon cancer.	[Misra, Suniti; Markwald, Roger R.; Toole, Bryan P.; Ghatak, Shibnath] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Hosp, Div Gen Internal Med, Charleston, SC 29401 USA; [Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Berger, Franklin G.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Minamisawa, Susumu] Yokohama City Univ, Dept Physiol, Yokohama, Kanagawa 2360004, Japan	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Yokohama City University	Misra, S (corresponding author), Med Univ S Carolina, Dept Cell Biol & Anat, 171 Ashley Ave, Charleston, SC 29425 USA.	misra@musc.edu		obeid, lina/0000-0002-0734-0847; Minamisawa, Susumu/0000-0003-4728-2116	NCI NIH HHS [CA 082867, R01 CA 87584, CA 073839] Funding Source: Medline; NCRR NIH HHS [P20 RR 017698, P20 RR 016434] Funding Source: Medline; NIGMS NIH HHS [GM 062887] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073839, R01CA087584, R01CA082867] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016434, P20RR017698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anttila MA, 2000, CANCER RES, V60, P150; Bates RC, 2005, CELL CYCLE, V4, P1350, DOI 10.4161/cc.4.10.2053; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Castellone MD, 2006, CANCER RES, V66, P11085, DOI 10.1158/0008-5472.CAN-06-2233; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chen QZ, 2004, J UROLOGY, V172, P2153, DOI 10.1097/01.ju.0000143440.08760.3a; Crew TE, 2000, CARCINOGENESIS, V21, P69, DOI 10.1093/carcin/21.1.69; Dale TC, 1998, BIOCHEM J, V329, P209; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Dohadwala M, 2001, J BIOL CHEM, V276, P20809, DOI 10.1074/jbc.C100140200; Du JG, 2005, NEOPLASIA, V7, P761, DOI 10.1593/neo.04652; Edward M, 2005, CARCINOGENESIS, V26, P1215, DOI 10.1093/carcin/bgi064; Edward M, 2001, BRIT J DERMATOL, V144, P465, DOI 10.1046/j.1365-2133.2001.04069.x; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; FUKAZAWA H, 1995, ANAL BIOCHEM, V228, P83, DOI 10.1006/abio.1995.1318; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Gordon LB, 2003, HUM GENET, V113, P178, DOI 10.1007/s00439-003-0958-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V332, P433, DOI 10.1016/j.bbrc.2005.04.143; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; KIM H, 1994, ARCH BIOCHEM BIOPHYS, V310, P504, DOI 10.1006/abbi.1994.1199; Kim HR, 2004, CANCER RES, V64, P4569, DOI 10.1158/0008-5472.CAN-04-0202; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kosunen A, 2004, ORAL ONCOL, V40, P257, DOI 10.1016/j.oraloncology.2003.08.004; Kovar JL, 2006, AM J PATHOL, V169, P1415, DOI 10.2353/ajpath.2006.060324; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Laurich C, 2004, J SURG RES, V122, P70, DOI 10.1016/j.jss.2004.05.018; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Lesley J, 2000, J BIOL CHEM, V275, P26967; Liebner S, 2004, J CELL BIOL, V166, P359, DOI 10.1083/jcb.200403050; Lipponen P, 2001, EUR J CANCER, V37, P849, DOI 10.1016/S0959-8049(00)00448-2; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Lopez JI, 2005, CANCER RES, V65, P6755, DOI 10.1158/0008-5472.CAN-05-0863; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Marieb EA, 2004, CANCER RES, V64, P1229, DOI 10.1158/0008-5472.CAN-03-2832; MARKWALD RR, 1978, DEV BIOL, V62, P292, DOI 10.1016/0012-1606(78)90218-X; Milinkovic M, 2004, BLOOD, V103, P740, DOI 10.1182/blood-2003-05-1500; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Murphy JF, 2005, FASEB J, V19, P446, DOI 10.1096/fj.03-1376fje; Okada H, 1996, INT J CANCER, V66, P255, DOI 10.1002/(SICI)1097-0215(19960410)66:2<255::AID-IJC20>3.0.CO;2-A; OSHEROV N, 1993, J BIOL CHEM, V268, P11134; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Ropponen KM, 1998, SCAND J GASTROENTERO, V33, P301; SCHAEFFER WI, 1976, CANCER LETT, V1, P259; Shao JY, 2000, J BIOL CHEM, V275, P33951, DOI 10.1074/jbc.M002324200; Sheng HM, 2000, J BIOL CHEM, V275, P6628, DOI 10.1074/jbc.275.9.6628; Simpson MA, 2006, AM J PATHOL, V169, P247, DOI 10.2353/ajpath.2006.060032; Spicer AP, 1996, J BIOL CHEM, V271, P23400, DOI 10.1074/jbc.271.38.23400; Takahashi K, 1995, ONCOGENE, V11, P2223; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; UNDERHILL CB, 1983, J BIOL CHEM, V258, P8086; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wu R, 2005, CLIN CANCER RES, V11, P6155, DOI 10.1158/1078-0432.CCR-04-2664; Yoshida M, 2000, J BIOL CHEM, V275, P497, DOI 10.1074/jbc.275.1.497	73	78	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14335	14344		10.1074/jbc.M703811200	http://dx.doi.org/10.1074/jbc.M703811200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18326857	hybrid, Green Published			2022-12-25	WOS:000255941400020
J	Smith, J; Su, X; El-Maghrabi, R; Stahl, PD; Abumrad, NA				Smith, Jill; Su, Xiong; El-Maghrabi, Raafat; Stahl, Philip D.; Abumrad, Nada A.			Opposite regulation of CD36 ubiquitination by fatty acids and insulin - Effects on fatty acid uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOCYTE MEMBRANE-PROTEIN; SKELETAL-MUSCLE; CELLULAR REDISTRIBUTION; RECEPTOR; TRANSPORT; DEGRADATION; HEART; METABOLISM; EXPRESSION; OXIDATION	FAT/CD36 is a membrane scavenger receptor that facilitates long chain fatty acid uptake by muscle. Acute increases in membrane CD36 and fatty acid uptake have been reported in response to insulin and contraction. In this study we have explored protein ubiquitination as one potential mechanism for the regulation of CD36 level. CD36 expressed in Chinese hamster ovary (CHO) or HEK 293 cells was found to be polyubiquitinated via a process involving both lysines 48 and 63 of ubiquitin. Using CHO cells expressing the insulin receptor (CHO/hIR) and CD36, it is shown that addition of insulin (100 nM, 10 and 30 min) significantly reduced CD36 ubiquitination. In contrast, ubiquitination was strongly enhanced by fatty acids (200 mu M palmitate or oleate, 2 h). Similarly, endogenous CD36 in C2C12 myotubes was ubiquitinated, and this was enhanced by oleic acid treatment, which also reduced total CD36 protein in cell lysates. Insulin reduced CD36 ubiquitination, increased CD36 protein, and inhibited the opposite effects of fatty acids on both parameters. These changes were paralleled by changes in fatty acid uptake, which could be blocked by the CD36 inhibitor sulfosuccinimidyl oleate. Mutation of the two lysine residues in the carboxyl-terminal tail of CD36 markedly attenuated ubiquitination of the protein expressed in CHO cells and was associated with increased CD36 level and enhanced oleate uptake and incorporation into triglycerides. In conclusion, fatty acids and insulin induce opposite alterations in CD36 ubiquitination, modulating CD36 level and fatty acid uptake. Altered CD36 turnover may contribute to abnormal fatty acid uptake in the insulin-resistant muscle.	[Smith, Jill; Su, Xiong; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Su, Xiong; Stahl, Philip D.; Abumrad, Nada A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [El-Maghrabi, Raafat] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Washington University (WUSTL); Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Abumrad, NA (corresponding author), Washington Univ, Sch Med, Dept Med, Ctr Human Nutr, St Louis, MO 63110 USA.	nabumrad@im.wustl.edu	Stahl, Philip/D-6315-2012		NHLBI NIH HHS [T32 HL-007275] Funding Source: Medline; NIDDK NIH HHS [R01DK 33301, P30 DK056341, P30 DK056341-07, DK56351, P30 DK056341-08] Funding Source: Medline; NIGMS NIH HHS [2R01GM42259] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033301, P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042259] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Bastie CC, 2005, J BIOL CHEM, V280, P14222, DOI 10.1074/jbc.M413625200; Bastie CC, 2004, DIABETES, V53, P2209, DOI 10.2337/diabetes.53.9.2209; Bonen A, 2000, J BIOL CHEM, V275, P14501, DOI 10.1074/jbc.275.19.14501; Bonen A, 2003, ACTA PHYSIOL SCAND, V178, P347, DOI 10.1046/j.1365-201X.2003.01157.x; Chen D, 1996, J BIOL CHEM, V271, P6328, DOI 10.1074/jbc.271.11.6328; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012; Glatz JFC, 2006, CARDIOVASC DRUG THER, V20, P471, DOI 10.1007/s10557-006-0582-8; Glatz JFC, 2001, J MOL NEUROSCI, V16, P123, DOI 10.1385/JMN:16:2-3:123; GREENWALT DE, 1995, J CLIN INVEST, V96, P1382, DOI 10.1172/JCI118173; Grimaldi PA, 2001, CURR OPIN CLIN NUTR, V4, P433, DOI 10.1097/00075197-200109000-00015; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; HARMON CM, 1992, BIOCHEM SOC T, V20, P811, DOI 10.1042/bst0200811; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Irie H, 2003, P NATL ACAD SCI USA, V100, P6819, DOI 10.1073/pnas.1132094100; Liang CP, 2004, J CLIN INVEST, V113, P764, DOI [10.1172/JCI200419528, 10.1172/JCI19528]; LOVEGREGORY L, 2008, IN PRESS HUM MOL GEN; Luiken JJFP, 2002, DIABETES, V51, P3113, DOI 10.2337/diabetes.51.10.3113; Luiken JJFP, 2001, J BIOL CHEM, V276, P40567, DOI 10.1074/jbc.M100052200; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Muoio DM, 2007, APPL PHYSIOL NUTR ME, V32, P874, DOI 10.1139/H07-083; Nahle Z, 2008, J BIOL CHEM, V283, P14317, DOI 10.1074/jbc.M706478200; Nicholson AC, 2004, VASC PHARMACOL, V41, P139, DOI 10.1016/j.vph.2004.08.003; Osanai T, 2007, CIRC RES, V100, P1106, DOI 10.1161/01.RES.0000266975.34924.b1; Palanivel R, 2005, FEBS LETT, V579, P5049, DOI 10.1016/j.febslet.2005.08.011; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Steinberg GR, 2002, J BIOL CHEM, V277, P8854, DOI 10.1074/jbc.M107683200; Su X, 2004, BIOCHEMISTRY-US, V43, P5033, DOI 10.1021/bi035867z; Su X, 2007, J BIOL CHEM, V282, P21278, DOI 10.1074/jbc.M703725200; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Tao NB, 1996, J BIOL CHEM, V271, P22315, DOI 10.1074/jbc.271.37.22315; Xia XF, 2004, J BIOL CHEM, V279, P44931, DOI 10.1074/jbc.M400969200; Yamashita S, 2007, MOL CELL BIOCHEM, V299, P19, DOI 10.1007/s11010-005-9031-4; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Zhang ZG, 2004, MOL PHARMACOL, V66, P395, DOI 10.1124/mol.104.001966; Zhou Q, 2007, ENDOCRINOLOGY, V148, P5696, DOI 10.1210/en.2007-0183	48	73	76	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13578	13585		10.1074/jbc.M800008200	http://dx.doi.org/10.1074/jbc.M800008200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353783	hybrid, Green Published			2022-12-25	WOS:000255728200011
J	Barbas, A; Matos, RG; Amblar, M; Lopez-Vinas, E; Gomez-Puertas, P; Arraiano, CM				Barbas, Ana; Matos, Rute G.; Amblar, Monica; Lopez-Vinas, Eduardo; Gomez-Puertas, Paulino; Arraiano, Cecilia M.			New insights into the mechanism of RNA degradation by ribonuclease II - Identification of the residue responsible for setting the RNase II end product	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ESCHERICHIA-COLI; EXOSOME; COMPLEX; EXPRESSION; DECAY; SPECIFICITY; SUBUNIT; CELLS	RNase II is a key exoribonuclease involved in the maturation, turnover, and quality control of RNA. RNase II homologues are components of the exosome, a complex of exoribonucleases. The structure of RNase II unraveled crucial aspects of the mechanism of RNA degradation. Here we show that mutations in highly conserved residues at the active site affect the activity of the enzyme. Moreover, we have identified the residue that is responsible for setting the end product of RNase II. In addition, we present for the first time the models of two members of the RNase II family, RNase R from Escherichia coli and human Rrp44, also called Dis3. Our findings improve the present model for RNA degradation by the RNase II family of enzymes.	[Barbas, Ana; Matos, Rute G.; Amblar, Monica; Arraiano, Cecilia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Lopez-Vinas, Eduardo; Gomez-Puertas, Paulino] Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; [Lopez-Vinas, Eduardo; Gomez-Puertas, Paulino] Inst Salud Carlos III, CIBER Obn, Madrid 28049, Spain	Universidade Nova de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Arraiano, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Apartado 127, P-2781901 Oeiras, Portugal.	cecilia@itqb.unl.pt	Amblar, Monica/E-2366-2016; López-Viñas, Eduardo/AAT-1124-2021; Matos, Rute/J-4983-2013; Amblar, 2405/C-3941-2011; Gomez-Puertas, Paulino/G-8821-2014	Amblar, Monica/0000-0003-3530-615X; Gomez-Puertas, Paulino/0000-0003-3131-729X; Arraiano, Cecilia/0000-0003-1934-9301; Barbas, Ana/0000-0002-6245-8549; Matos Luis, Rute/0000-0002-9788-7562				ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Amblar M, 2005, FEBS J, V272, P363, DOI 10.1111/j.1742-4658.2004.04477.x; Amblar M, 2007, RNA, V13, P317, DOI 10.1261/rna.220407; Amblar M, 2006, J MOL BIOL, V360, P921, DOI 10.1016/j.jmb.2006.05.043; Andrade JM, 2006, MOL MICROBIOL, V60, P219, DOI 10.1111/j.1365-2958.2006.05092.x; Bollenbach TJ, 2005, NUCLEIC ACIDS RES, V33, P2751, DOI 10.1093/nar/gki576; Cairrao F, 2006, BIOCHEM BIOPH RES CO, V343, P731, DOI 10.1016/j.bbrc.2006.03.040; Cairrao F, 2005, DEV DYNAM, V232, P733, DOI 10.1002/dvdy.20269; Cairrao F, 2001, MOL MICROBIOL, V276, P19172; CANNISTRARO VJ, 1994, J MOL BIOL, V243, P930, DOI 10.1006/jmbi.1994.1693; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CASE DA, 2004, AMBER, V8; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Grossman D, 2006, NAT STRUCT MOL BIOL, V13, P760, DOI 10.1038/nsmb0906-760; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Lim JT, 1997, CANCER RES, V57, P921; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; McVey CE, 2006, ACTA CRYSTALLOGR F, V62, P684, DOI 10.1107/S1744309106021506; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Zilhao R, 1996, MOL MICROBIOL, V20, P1033, DOI 10.1111/j.1365-2958.1996.tb02544.x; ZILHAO R, 1995, FEMS MICROBIOL LETT, V130, P237; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	32	39	41	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13070	13076		10.1074/jbc.M709989200	http://dx.doi.org/10.1074/jbc.M709989200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337246	hybrid			2022-12-25	WOS:000255499800045
J	Callejas-Valera, JL; Guinea-Viniegra, J; Ramirez-Castillejo, C; Recio, JA; Galan-Moya, E; Martinez, N; Rojas, JM; Cajal, SR; Sanchez-Prieto, R				Callejas-Valera, Juan L.; Guinea-Viniegra, Juan; Ramirez-Castillejo, Carmen; Recio, Juan A.; Galan-Moya, Eva; Martinez, Natalia; Rojas, Jose M.; Ramon y Cajal, Santiago; Sanchez-Prieto, Ricardo			E1a gene expression blocks the ERK1/2 signaling pathway by promoting nuclear localization and MKP up-regulation - Implication in v-H-Ras-induced senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INDUCED PREMATURE SENESCENCE; ONCOGENE-INDUCED SENESCENCE; MAP KINASE; CYTOPLASMIC SEQUESTRATION; PHYSIOLOGICAL FUNCTIONS; ADENOVIRAL E1A; PHOSPHATASE 2A; PEA-15; PROLIFERATION	In response to oncogenic signals, cells have developed safe mechanisms to avoid transformation through activation of a senescence program. Upon v-H-Ras overexpression, normal cells undergo senescence through several cellular processes, including activation of the ERK1/2 pathway. Interestingly, the E1a gene from adenovirus 5 has been shown to rescue cells from senescence by a yet unknown mechanism. We investigated whether E1a was able to interfere with the ERK1/ 2 signaling pathway to rescue cells from v-H-Ras-mediated senescence. Our results show that, E1a overexpression blocks v-H-Ras-mediated ERK1/ 2 activation by two different and concomitant mechanisms. E1a through its ability to interfere with PKB/Akt activation induces the down-regulation of the PEA15 protein, an ERK1/ 2 nuclear export factor, leading to nuclear accumulation of ERK1/2. In addition to this, we show that E1a increases the expression of the inducible ERK1/ 2 nuclear phosphatases (MAPK phosphatases) MKP1/DUSP1 and DUSP5, which leads to ERK1/ 2 dephosphorylation. We confirmed our observations in the human normal diploid fibroblasts IMR90, in which we could also show that an E1a mutant, unable to bind retinoblastoma protein (pRb), cannot rescue cells from v-H-Ras-induced senescence. In conclusion, E1a is able to rescue from Ras-induced senescence by affecting ERK1/ 2 localization and phosphorylation.	[Callejas-Valera, Juan L.; Guinea-Viniegra, Juan; Ramirez-Castillejo, Carmen; Galan-Moya, Eva; Sanchez-Prieto, Ricardo] Univ Castilla La Mancha, Fac Med, Ctr Reg Invest Biomed, Albacete 02006, Spain; [Recio, Juan A.; Martinez, Natalia; Rojas, Jose M.] Univ Vall Hebron, Inst Recerca Vall Hebron Hosp, Programa Oncol Med, Barcelona 08035, Spain; [Martinez, Natalia; Rojas, Jose M.] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Biol Celular, Madrid 28220, Spain; [Ramon y Cajal, Santiago] Hosp Univ Vall Hebron, Serv Anat Patol, Barcelona 08035, Spain	Universidad de Castilla-La Mancha; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Hospital Universitari Vall d'Hebron	Sanchez-Prieto, R (corresponding author), Univ Castilla La Mancha, Fac Med, Ctr Reg Invest Biomed, Albacete 02006, Spain.	ricardo.sanchez@uclm.es	Galan-Moya, Eva M/I-2912-2015; Rojas, José M/D-3718-2018; Ramirez-Castillejo, Carmen/S-7276-2019; Sanchez-Prieto, Ricardo/B-6877-2008; Ramon y Cajal, Santiago/H-4955-2016; Sanchez-Prieto, Ricardo/AAY-4271-2021; Prieto, Ricardo/AAZ-7221-2021; Rojas, José M./AAA-3354-2021	Galan-Moya, Eva M/0000-0001-5758-7592; Rojas, José M/0000-0002-5383-3482; Ramirez-Castillejo, Carmen/0000-0002-1877-3381; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Ramon y Cajal, Santiago/0000-0002-3867-1390; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Rojas, José M./0000-0002-7547-2825; Recio, Juan Angel/0000-0002-7320-3832				Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Bartholomeusz C, 2006, ONCOGENE, V25, P79, DOI 10.1038/sj.onc.1209014; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Deng QD, 2005, CANCER RES, V65, P8298, DOI 10.1158/0008-5472.CAN-05-0054; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Ferbeyre G, 2000, GENE DEV, V14, P2015; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Frisch SM, 2002, NAT REV MOL CELL BIO, V3, P441, DOI 10.1038/nrm827; Gaumont-Leclerc MF, 2004, J BIOL CHEM, V279, P46802, DOI 10.1074/jbc.M403893200; Gervais M, 2006, MOL BIOL CELL, V17, P3940, DOI 10.1091/mbc.E06-06-0501; Glading A, 2007, CANCER RES, V67, P1536, DOI 10.1158/0008-5472.CAN-06-1378; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Liao Y, 2004, CANCER RES, V64, P5938, DOI 10.1158/0008-5472.CAN-04-1533; Liao Y, 2003, MOL CELL BIOL, V23, P6836, DOI 10.1128/MCB.23.19.6836-6848.2003; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Malumbres M, 2000, MOL CELL BIOL, V20, P2915, DOI 10.1128/MCB.20.8.2915-2925.2000; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mason DX, 2006, CARCINOGENESIS, V27, P350, DOI 10.1093/carcin/bgi264; Minamino T, 2004, CELL CYCLE, V3, P449; MYMRYK JS, 1994, ONCOGENE, V9, P1187; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Renault-Mihara F, 2006, MOL BIOL CELL, V17, P5141, DOI 10.1091/mbc.E05-11-1072; Renganathan H, 2005, BIOCHEM J, V390, P729, DOI 10.1042/BJ20050378; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; SANCHEZPRIETO R, 1995, INT J CANCER, V60, P235; Sang NL, 2002, FRONT BIOSCI, V7, pD407, DOI 10.2741/sang; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Torres C, 2003, EXP CELL RES, V290, P195, DOI 10.1016/S0014-4827(03)00309-4; Trencia A, 2003, MOL CELL BIOL, V23, P4511, DOI 10.1128/MCB.23.13.4511-4521.2003; Tresini M, 2007, J BIOL CHEM, V282, P4136, DOI 10.1074/jbc.M604955200; Viniegra JG, 2002, ONCOGENE, V21, P7131, DOI 10.1038/sj.onc.1205934; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002	37	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13450	13458		10.1074/jbc.M709230200	http://dx.doi.org/10.1074/jbc.M709230200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18316372	hybrid			2022-12-25	WOS:000255499800084
J	Dusa, A; Staerk, J; Elliott, J; Pecquet, C; Poirel, HA; Johnston, JA; Constantinescu, SN				Dusa, Alexandra; Staerk, Judith; Elliott, Joanne; Pecquet, Christian; Poirel, Helene A.; Johnston, James A.; Constantinescu, Stefan N.			Substitution of pseudokinase domain residue Val-617 by large non-polar amino acids causes activation of JAK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR SURFACE EXPRESSION; PROTEIN-TYROSINE KINASES; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE DISORDERS; ERYTHROPOIETIN RECEPTOR; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; SOCS3 DEGRADATION; CYTOKINE RECEPTOR; MUTATION	Explaining the uniqueness of the acquired somatic JAK2 V617F mutation, which is present in more than 95% of polycythemia vera patients, has been a challenge. The V617F mutation in the pseudokinase domain of JAK2 renders the unmutated kinase domain constitutively active. We have performed random mutagenesis at position 617 of JAK2 and tested each of the 20 possible amino acids for ability to induce constitutive signaling in Ba/F3 cells expressing the erythropoietin receptor. Four JAK2 mutants, V617W, V617M, V617I, and V617L, were able to induce cytokine independence and constitutive downstream signaling. Only V617W induced a level of constitutive activation comparable with V617F. Also, only V617W stabilized tyrosine-phosphorylated suppressor of cytokine signaling 3 ( SOCS3), a mechanism by which JAK2 V617F overcomes inhibition by SOCS3. The V617W mutant induced a myeloproliferative disease in mice, mainly characterized by erythrocytosis and megakaryocytic proliferation. Although JAK2 V617W would predictably be pathogenic in humans, the substitution of the Val codon, GTC, by TTG, the codon for Trp, would require three base pair changes, and thus it is unlikely to occur. We discuss how the predicted conformations of the activated JAK2 mutants can lead to better screening assays for novel small molecule inhibitors.	[Dusa, Alexandra; Staerk, Judith; Pecquet, Christian; Constantinescu, Stefan N.] Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Dusa, Alexandra; Staerk, Judith; Pecquet, Christian; Constantinescu, Stefan N.] Univ Catholique Louvain, Duve Inst, B-1200 Brussels, Belgium; [Elliott, Joanne; Johnston, James A.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Infect & Immun Grp, Belfast BT7 1NN, Antrim, North Ireland; [Poirel, Helene A.] Univ Catholique Louvain, Ctr Human Genet, Clin Univ St Luc, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Queens University Belfast; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Constantinescu, SN (corresponding author), Ave Hippocrate 74,UCL 75-4, B-1200 Brussels, Belgium.	stefan.constantinescu@bru.licr.org	Constantinescu, Stefan N/E-5277-2012	Staerk, Judith/0000-0001-8698-6998; Constantinescu, Stefan N./0000-0002-8599-2699; Christian, Pecquet/0000-0002-8623-3483				Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Dumoutier L, 2000, P NATL ACAD SCI USA, V97, P10144, DOI 10.1073/pnas.170291697; Eyckerman S, 1999, EUR CYTOKINE NETW, V10, P549; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Gordon H, 1936, AM J PATHOL, V12, P545; Haan S, 2003, J BIOL CHEM, V278, P31972, DOI 10.1074/jbc.M303170200; HARPUR AG, 1992, ONCOGENE, V7, P1347; Hookham MB, 2007, BLOOD, V109, P4924, DOI 10.1182/blood-2006-08-039735; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Johnston JA, 2004, J LEUKOCYTE BIOL, V75, P743, DOI 10.1189/jlb.1003507; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Lu XH, 2008, J BIOL CHEM, V283, P5258, DOI 10.1074/jbc.M707125200; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Radtke S, 2005, J BIOL CHEM, V280, P25760, DOI 10.1074/jbc.M500822200; Radtke S, 2002, J BIOL CHEM, V277, P11297, DOI 10.1074/jbc.M100822200; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; Sotiropoulos A, 1996, MOL ENDOCRINOL, V10, P998, DOI 10.1210/me.10.8.998; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; Yoshimura A, 2005, ARTHRITIS RES THER, V7, P100, DOI 10.1186/ar1741; Zapata JM, 1998, J BIOL CHEM, V273, P6916, DOI 10.1074/jbc.273.12.6916; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	32	50	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12941	12948		10.1074/jbc.M709302200	http://dx.doi.org/10.1074/jbc.M709302200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326042	hybrid			2022-12-25	WOS:000255499800031
J	Masuda, J; Usui, R; Maru, Y				Masuda, Junko; Usui, Ryosuke; Maru, Yoshiro			Fibronectin type I repeat is a nonactivating ligand for EphA1 and inhibits ATF3-dependent angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; PROTEIN; ATF3; INTEGRIN; ADHESION; FAMILY; VIVO; PROGRESSION	ATF3 stimulated promoter activity of EphA1 by 3.4-fold in ATF3-dependent angiogenesis in vitro. Although tyrosine kinase activation of EphA1 was dispensable, binding of EphA1 to fibronectin through its type I repeat played an essential role in the angiogenesis. Recombinant proteins containing fibronectin 10th to 12th type I repeat (I10-12) but not I 12 could inhibit the angiogenesis in vitro by competitively targeting EphA1 with the full-length fibronectin. However, I 12 acquired a higher affinity toward EphA2 with K-d 18 nM and inhibited vascular endothelial growth factor-dependent angiogenic invasion in a Matrigel plug assay.	[Masuda, Junko; Usui, Ryosuke; Maru, Yoshiro] Tokyo Womens Med Univ, Dept Pharmacol, Shinjuku Ku, Tokyo 1628666, Japan	Tokyo Women's Medical University	Maru, Y (corresponding author), Tokyo Womens Med Univ, Dept Pharmacol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ymaru@research.twmu.ac.jp						Allen-Jennings AE, 2001, J BIOL CHEM, V276, P29507, DOI 10.1074/jbc.M100986200; Ambesi A, 2005, CANCER RES, V65, P148; Ameri K, 2007, ONCOGENE, V26, P284, DOI 10.1038/sj.onc.1209781; Baldwin C, 2006, AM J PHYSIOL-RENAL, V291, pF960, DOI 10.1152/ajprenal.00020.2006; Bin Fang W, 2005, ONCOGENE, V24, P7859, DOI 10.1038/sj.onc.1208937; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; Brantley-Sieders DM, 2005, FASEB J, V19, P1884, DOI 10.1096/fj.05-4038fje; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Cheng N, 2002, MOL CANCER RES, V1, P2; Cheng N, 2002, CYTOKINE GROWTH F R, V13, P75, DOI 10.1016/S1359-6101(01)00031-4; Dobrzanski P, 2004, CANCER RES, V64, P910, DOI 10.1158/0008-5472.CAN-3430-2; Dohn M, 2001, ONCOGENE, V20, P6503, DOI 10.1038/sj.onc.1204816; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gurniak CB, 1996, ONCOGENE, V13, P777; Halloran MC, 2006, CURR OPIN CELL BIOL, V18, P533, DOI 10.1016/j.ceb.2006.08.010; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Ingham KC, 2004, J BIOL CHEM, V279, P42945, DOI 10.1074/jbc.M406984200; Ivanov AI, 2005, PHYSIOL GENOMICS, V21, P152, DOI 10.1152/physiolgenomics.00043.2004; Kertesz N, 2006, BLOOD, V107, P2330, DOI 10.1182/blood-2005-04-1655; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Makogonenko E, 2007, BIOCHEMISTRY-US, V46, P5418, DOI 10.1021/bi7001373; Mallory JC, 2005, MOL PHARMACOL, V68, P1747, DOI 10.1124/mol.105.016519; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Maru Y, 1998, J CELL PHYSIOL, V176, P223, DOI 10.1002/(SICI)1097-4652(199808)176:2<223::AID-JCP1>3.0.CO;2-Q; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Ojima T, 2006, AM J PATHOL, V168, P331, DOI 10.2353/ajpath.2006.050435; Okamoto A, 2006, MOL CELL BIOL, V26, P1087, DOI 10.1128/MCB.26.3.1087-1097.2006; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Rostagno AA, 1999, BIOCHEM J, V338, P375, DOI 10.1042/0264-6021:3380375; Takeda N, 1999, P NATL ACAD SCI USA, V96, P203, DOI 10.1073/pnas.96.1.203; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620; Zhou RP, 1998, PHARMACOL THERAPEUT, V77, P151, DOI 10.1016/S0163-7258(97)00112-5	38	10	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13148	13155		10.1074/jbc.M702164200	http://dx.doi.org/10.1074/jbc.M702164200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18308734	hybrid			2022-12-25	WOS:000255499800054
J	Fusco, AJ; Savinova, OV; Talwar, R; Kearns, JD; Hoffmann, A; Ghosh, G				Fusco, Amanda J.; Savinova, Olga V.; Talwar, Rashmi; Kearns, Jeffrey D.; Hoffmann, Alexander; Ghosh, Gourisankar			Stabilization of RelB requires multidomain interactions with p100/p52	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IKK-ALPHA; TRANSCRIPTIONAL ACTIVITY; PROTEASOMAL DEGRADATION; NF-KAPPA-B2 P100; SIGNALING MODULE; ACTIVATION; MICE; PHOSPHORYLATION; RESPONSES	The NF-kappa B family member RelB has many properties not shared by other family members such as restricted subunit association and lack of regulation by the classical I kappa B proteins. We show that the protein level of RelB is significantly reduced in the absence of p100 and reduced even more when both p100 and p105 are absent. RelB stabilizes itself by directly interacting with p100, p105, and their processed products. However, RelB forms complexes with its partners using different interaction modes. Although the C-terminal ankyrin repeat domain of p105 is not involved in the RelB-p105 complex formation, all domains and flexible regions of each protein are engaged in the RelB-p100 complex. In several respects the RelB-p52 and RelB-p100 complexes are unique in the NF-kappa B family. The N-terminal domain of p100/p52 interacts with RelB but not RelA. The transcriptional activation domain of RelB, but not RelA, directly interacts with the processing region of p100. These unique protein-protein contacts explain why RelB prefers p52 as its dimeric partner for transcriptional activity and is retained in the cytoplasm as an inhibited complex by p100. This association-mediated stabilization of RelB implies a possible role for RelB in the processing of p100 into p52.	[Fusco, Amanda J.; Savinova, Olga V.; Talwar, Rashmi; Kearns, Jeffrey D.; Hoffmann, Alexander; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Kearns, Jeffrey D.; Hoffmann, Alexander] Univ Calif San Diego, Signaling Syst Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Ghosh, G (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	gghosh@ucsd.edu						Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Fong A, 2002, J BIOL CHEM, V277, P22111, DOI 10.1074/jbc.C200151200; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huang DB, 2005, STRUCTURE, V13, P1365, DOI 10.1016/j.str.2005.06.018; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; LERNBECHER T, 1994, EMBO J, V13, P4060, DOI 10.1002/j.1460-2075.1994.tb06723.x; Malek S, 1998, J BIOL CHEM, V273, P25427, DOI 10.1074/jbc.273.39.25427; Marienfeld R, 2001, ONCOGENE, V20, P8142, DOI 10.1038/sj.onc.1204884; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; MOORTHY AK, 2007, J MOL BIOL; RUBEN SM, 1992, GENE DEV, V6, P745, DOI 10.1101/gad.6.5.745; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; TOLEDANO MB, 1993, MOL CELL BIOL, V13, P852, DOI 10.1128/MCB.13.2.852; Vogel CFA, 2007, MOL ENDOCRINOL, V21, P2941, DOI 10.1210/me.2007-0211; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3	33	52	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12324	12332		10.1074/jbc.M707898200	http://dx.doi.org/10.1074/jbc.M707898200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321863	Green Published, hybrid			2022-12-25	WOS:000255340000049
J	Zaun, HC; Shrier, A; Orlowski, J				Zaun, Hans C.; Shrier, Alvin; Orlowski, John			Calcineurin B homologous protein 3 promotes the Biosynthetic maturation, cell surface stability, and optimal transport of the Na+/H+ exchanger NHE1 isoform	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAND CA2+-BINDING PROTEIN; NA-H EXCHANGE; EVOLUTIONARY ORIGINS; DEPENDENT ACTIVATION; ESSENTIAL COFACTOR; PH REGULATION; BINDING-SITE; KINASE; TESCALCIN; GENE	Calcineurin B homologous protein (CHP) 1 and 2 are Ca2+-binding proteins that modulate several cellular processes, including cytoplasmic pH by positively regulating plasma membranetype Na+/H+ exchangers ( NHEs). Recently another CHP-related protein, termed tescalcin or CHP3, was also shown to interact with the ubiquitous NHE1 isoform, but seemingly suppressed its activity. However, the precise physical and functional nature of this association was not examined in detail. In this study, biochemical and cellular studies were undertaken to further delineate this relationship. Glutathione S-transferase NHE1 fusion protein pulldown assays revealed that full-length CHP3 binds directly to the proximal juxtamembrane C-terminal region (amino acids 505-571) of rat NHE1 in the same region that binds CHP1 and CHP2. The interaction was further validated by coimmunoprecipitation and coimmunolocalization experiments using full-length CHP3 and wild-type NHE1 in transfected Chinese hamster ovary AP-1 cells. Simultaneous mutation of four hydrophobic residues within this region ((FLDHLL535)-F-530) to either Ala, Gln, or Arg (FL-A, FL-Q,or FL-R)abrogated this interaction both in vitro and in intact cells. The NHE1 mutants were sorted properly to the cell surface but showed markedly reduced (FL-A) or minimal (FL-R and FL-Q) activity. Interestingly, and contrary to an earlier finding, ectopic coexpression of CHP3 up-regulated the cell surface activity of wild-type NHE1. This stimulation was not observed with the CHP3 binding-defective mutants. Mechanistically, overexpression of CHP3 did not alter the H+ sensitivity of wild-type NHE1 but rather promoted its biosynthetic maturation and half-life at the cell surface, thereby increasing the steady-state abundance of functional NHE1 protein.	[Zaun, Hans C.; Shrier, Alvin; Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University	Orlowski, J (corresponding author), McGill Univ, Dept Physiol, McIntyre Med Sci Bldg,3655 Promenade Sir William, Montreal, PQ H3G 1Y6, Canada.	john.orlowski@mcgill.ca		Orlowski, John/0000-0001-7371-175X				Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622; Andrade J, 2004, MOL BIOL CELL, V15, P481, DOI 10.1091/mbc.E03-07-0500; Barroso MR, 1996, J BIOL CHEM, V271, P10183, DOI 10.1074/jbc.271.17.10183; Ben Ammar Y, 2006, EMBO J, V25, P2315, DOI 10.1038/sj.emboj.7601145; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Bobulescu IA, 2005, CURR OPIN NEPHROL HY, V14, P485, DOI 10.1097/01.mnh.0000174146.52915.5d; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Cuello F, 2007, MOL PHARMACOL, V71, P799, DOI 10.1124/mol.106.029900; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Di Sole F, 2004, J BIOL CHEM, V279, P2962, DOI 10.1074/jbc.M306838200; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Inoue H, 2003, BIOL PHARM BULL, V26, P148, DOI 10.1248/bpb.26.148; Jin Q, 2007, IN VIVO, V21, P593; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; Konstantinidis D, 2006, CELL PHYSIOL BIOCHEM, V18, P211, DOI 10.1159/000097668; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Lehoux S, 2001, J BIOL CHEM, V276, P15794, DOI 10.1074/jbc.M100410200; Levay K, 2007, J CLIN INVEST, V117, P2672, DOI 10.1172/JCI27465; Li XJ, 2003, BIOCHEMISTRY-US, V42, P7448, DOI 10.1021/bi027143d; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; Mailander J, 2001, FEBS LETT, V507, P331, DOI 10.1016/S0014-5793(01)02986-6; Malo ME, 2007, J BIOL CHEM, V282, P6292, DOI 10.1074/jbc.M611073200; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; Matsushita M, 2007, AM J PHYSIOL-CELL PH, V293, pC246, DOI 10.1152/ajpcell.00464.2006; Meima ME, 2007, CURR OPIN NEPHROL HY, V16, P365, DOI 10.1097/MNH.0b013e3281bd888d; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; Misik AJ, 2005, BIOCHEMISTRY-US, V44, P5842, DOI 10.1021/bi047659s; Nakamura N, 2002, J BIOCHEM, V132, P483, DOI 10.1093/oxfordjournals.jbchem.a003246; Naoe Y, 2005, J BIOL CHEM, V280, P32372, DOI 10.1074/jbc.M503390200; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Pang TX, 2004, BIOCHEMISTRY-US, V43, P3628, DOI 10.1021/bi0360004; Pang TX, 2002, J BIOL CHEM, V277, P43771, DOI 10.1074/jbc.M208313200; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Perera EM, 2001, ENDOCRINOLOGY, V142, P455, DOI 10.1210/en.142.1.455; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shrode LD, 1998, AM J PHYSIOL-CELL PH, V275, pC431, DOI 10.1152/ajpcell.1998.275.2.C431; Snabaitis AK, 2006, J BIOL CHEM, V281, P20252, DOI 10.1074/jbc.M600268200; Stock C, 2006, ACTA PHYSIOL, V187, P149, DOI 10.1111/j.1748-1716.2006.01543.x; Sun HY, 2004, EUR J PHARMACOL, V486, P121, DOI 10.1016/j.ejphar.2003.12.016; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Wu KL, 2003, AM J PHYSIOL-RENAL, V284, pF829, DOI 10.1152/ajprenal.00314.2002; Xiang MH, 2007, P NATL ACAD SCI USA, V104, P18677, DOI 10.1073/pnas.0707120104; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200	54	47	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12456	12467		10.1074/jbc.M800267200	http://dx.doi.org/10.1074/jbc.M800267200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321853	hybrid, Green Published			2022-12-25	WOS:000255340000062
J	Canals, M; Milligan, G				Canals, Meritxell; Milligan, Graeme			Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed mu opioid receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; INVERSE AGONISM; CROSS-TALK; CONCURRENT STIMULATION; BETA-ARRESTINS; ACTIVATION; LOCALIZATION; ENDOCYTOSIS; INHIBITION; IDENTIFICATION	The human mu opioid receptor was expressed stably in Flp-In T-REx HEK293 cells. Occupancy by the agonist DAMGO (Tyr-D-Ala-Gly-N-methyl-Phe-Gly-ol) resulted in phosphorylation of the ERK1/2 MAP kinases, which was blocked by the opioid antagonist naloxone but not the cannabinoid CB1 receptor inverse agonist SR141716A. Expression of the human cannabinoid CB1 receptor in these cells from the inducible Flp-In T-REx locus did not alter expression levels of the mu opioid receptor. This allowed the cannabinoid CB1 agonist WIN55212-2 to stimulate ERK1/2 phosphorylation but resulted in a large reduction in the capacity of DAMGO to activate these kinases. Although lacking affinity for the mu opioid receptor, co-addition of SR141716A caused recovery of the effectiveness of DAMGO. In contrast co-addition of the CB1 receptor neutral antagonist O-2050 did not. Induction of the CB1 receptor also resulted in an increase of basal [S-35] guanosine 5'-3-O-(thio) triphosphate (GTP gamma S) binding and thereby a greatly reduced capacity of DAMGO to further stimulate [S-35] GTP gamma S binding. CB1 inverse agonists attenuated basal [S-35] GTP gamma S binding and restored the capacity of DAMGO to stimulate. Flp-In T-REx HEK293 cells were generated, which express the human mu opioid receptor constitutively and harbor a modified D163N cannabinoid CB1 receptor that lacks constitutive activity. Induction of expression of the modified cannabinoid CB1 receptor did not limit DAMGO-mediated ERK1/2 MAP kinase phosphorylation and did not allow SR141716A to enhance the function of DAMGO. These data indicate that it is the constitutive activity inherent in the cannabinoid CB1 receptor that reduces the capacity of co-expressed mu opioid receptor to function.	[Canals, Meritxell; Milligan, Graeme] Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Milligan, G (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Mol Pharmacol Grp, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	g.milligan@bio.gla.ac.uk	Milligan, Graeme/F-9426-2011	Milligan, Graeme/0000-0002-6946-3519; Canals, Meritxell/0000-0002-7942-5006	MRC [G9811527] Funding Source: UKRI; Medical Research Council [G9811527] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abadji V, 1999, J NEUROCHEM, V72, P2032, DOI 10.1046/j.1471-4159.1999.0722032.x; ADIE EJ, 1992, BIOCHEM J, V285, P529, DOI 10.1042/bj2850529; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Bidlack Jean M., 2003, V237, P135; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Bosier B, 2007, TRENDS PHARMACOL SCI, V28, P438, DOI 10.1016/j.tips.2007.06.001; Burt AR, 1996, BIOCHEM J, V320, P227, DOI 10.1042/bj3200227; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; CHILDERS SR, 1992, ANN NY ACAD SCI, V654, P33, DOI 10.1111/j.1749-6632.1992.tb25954.x; Christie MJ, 2006, BRIT J PHARMACOL, V148, P385, DOI 10.1038/sj.bjp.0706756; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Fraile-Ramos A, 2003, TRAFFIC, V4, P243, DOI 10.1034/j.1600-0854.2003.00079.x; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Gardner A, 2006, EUR J PHARMACOL, V530, P103, DOI 10.1016/j.ejphar.2005.11.032; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Glass M, 1997, J NEUROSCI, V17, P5327, DOI 10.1523/jneurosci.17-14-05327.1997; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Hilairet S, 2003, J BIOL CHEM, V278, P23731, DOI 10.1074/jbc.M212369200; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; HOWLETT AC, 1995, ANNU REV PHARMACOL, V35, P607, DOI 10.1146/annurev.pharmtox.35.1.607; Hur EM, 2002, CELL SIGNAL, V14, P397, DOI 10.1016/S0898-6568(01)00258-3; Kearn CS, 2005, MOL PHARMACOL, V67, P1697, DOI 10.1124/mol.104.006882; Kenakin T, 2004, MOL PHARMACOL, V65, P2, DOI 10.1124/mol.65.1.2; Lane JR, 2007, MOL PHARMACOL, V71, P1349, DOI 10.1124/mol.106.032722; LANE JR, 2008, IN PRESS FASEB J; Leterrier C, 2006, J NEUROSCI, V26, P3141, DOI 10.1523/JNEUROSCI.5437-05.2006; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Macey TA, 2006, J BIOL CHEM, V281, P34515, DOI 10.1074/jbc.M604278200; MacLennan SJ, 1998, BRIT J PHARMACOL, V124, P619, DOI 10.1038/sj.bjp.0701915; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; Merkouris M, 1997, J NEUROCHEM, V69, P2115; Milasta S, 2006, MOL PHARMACOL, V69, P479, DOI 10.1124/mol.105.018788; MILLIGAN G, 1994, METHOD ENZYMOL, V237, P268; Milligan G, 2003, LIFE SCI, V74, P181, DOI 10.1016/j.lfs.2003.09.005; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Milligan G, 2006, DRUG DISCOV TODAY, V11, P541, DOI 10.1016/j.drudis.2006.04.007; MITCHELL FM, 1993, BIOCHEM J, V293, P495, DOI 10.1042/bj2930495; MULLANEY I, 1990, J NEUROCHEM, V55, P1890, DOI 10.1111/j.1471-4159.1990.tb05773.x; Navarro M, 2001, J NEUROSCI, V21, P5344, DOI 10.1523/JNEUROSCI.21-14-05344.2001; Nie JJ, 2001, J NEUROSCI, V21, P8758, DOI 10.1523/JNEUROSCI.21-22-08758.2001; Parra S, 2007, CURR OPIN PHARMACOL, V7, P146, DOI 10.1016/j.coph.2006.10.005; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Pickel VM, 2004, NEUROSCIENCE, V127, P101, DOI 10.1016/j.neuroscience.2004.05.015; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Reisine T, 1996, ANN NY ACAD SCI, V780, P168, DOI 10.1111/j.1749-6632.1996.tb15121.x; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Roche JP, 1999, MOL PHARMACOL, V56, P611, DOI 10.1124/mol.56.3.611; Rodriguez JJ, 2001, J NEUROSCI, V21, P823, DOI 10.1523/JNEUROSCI.21-03-00823.2001; Rosenkilde MM, 2001, ONCOGENE, V20, P1582, DOI 10.1038/sj.onc.1204191; Salim S, 2007, J PHARMACOL EXP THER, V321, P51, DOI 10.1124/jpet.106.116921; Salio C, 2001, NEUROREPORT, V12, P3689, DOI 10.1097/00001756-200112040-00017; Schoffelmeer ANM, 2006, NEUROPHARMACOLOGY, V51, P773, DOI 10.1016/j.neuropharm.2006.05.019; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Solinas M, 2005, NEUROPSYCHOPHARMACOL, V30, P2035, DOI 10.1038/sj.npp.1300720; Tanda G, 1997, SCIENCE, V276, P2048, DOI 10.1126/science.276.5321.2048; Tao Q, 1998, J PHARMACOL EXP THER, V285, P651; Turu G, 2007, J BIOL CHEM, V282, P7753, DOI 10.1074/jbc.C600318200; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vischer HF, 2007, ERNST SCHERING FOUND, V2, P187, DOI 10.1007/2789_2006_009; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940	63	72	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11424	11434		10.1074/jbc.M710300200	http://dx.doi.org/10.1074/jbc.M710300200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18319252	hybrid			2022-12-25	WOS:000255067400040
J	Geisler, C; Aumiller, JJ; Jarvis, DL				Geisler, Christoph; Aumiller, Jared J.; Jarvis, Donald L.			A fused lobes gene encodes the processing beta-N-acetylglucosaminidase in Sf9 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; INSECT CELLS; MOLECULAR-CLONING; HEXOSAMINIDASE; EXPRESSION; SEQUENCE; GLYCOSYLTRANSFERASES; GLYCOSYLATION; PREDICTION; DROSOPHILA	Man alpha 6( Man alpha 3) Man beta 4GlcNAc beta 4GlcNAc-R is the core structure of the major processed protein N-glycans produced by insect cells. Ultimately, this paucimannose type structure is produced by an unusual beta-N-acetylglucosaminidase, which removes the terminal N-acetylglucosamine residue from the upstream intermediate, Man alpha 6(GlcNAc beta 2Man alpha 3) Man beta 4GlcNAc beta 4GlcNAc-R. Because the N-glycan processing pathways leading to the production of this intermediate are probably identical in insects and higher eukaryotes, the presence or absence of this specific, processing beta-N-acetylglucosaminidase is a key factor distinguishing the processing pathways in these two different types of organisms. Recent studies have shown that the fused lobes (fdl) gene encodes the specific, processing beta-N-acetylglucosaminidase of Drosophila melanogaster. However, there are conflicting reports on the identity of the gene encoding this enzyme in the lepidopteran insect, Spodoptera frugiperda. One has suggested that a gene alternatively designated SfGlcNAcase-3 or SfHex encodes this function, whereas another has suggested that this gene encodes a broad-spectrum beta-N-acetylglucosaminidase that functions in glycan and chitin degradation. In this study we resolved this conflict by molecularly cloning an S. frugiperda fdl ortholog (Sf-fdl) and demonstrating that it encodes a product with the substrate specificity expected of the processing beta-N-acetylglucosaminidase. Moreover, we showed that the endogenous levels of specific, processing beta-N-acetylglucosaminidase activity were significantly reduced in S. frugiperda cells engineered to express a double-stranded RNA derived from the Sf-fdl gene. These results indicate that Sf-fdl encodes the specific, processing beta-N-acetylglucosaminidase of S. frugiperda and validate our previous suggestion that the broad-spectrum beta-N-acetylglucosaminidase encoded by the SfGlcNAcase-3/SfHex gene is more likely to be involved in N-glycan and/or chitin degradation.	[Geisler, Christoph; Aumiller, Jared J.; Jarvis, Donald L.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Wyoming	Jarvis, DL (corresponding author), Univ Wyoming, Dept Mol Biol, Mol Biol Dept 3944,1000 E Univ Ave, Laramie, WY 82071 USA.	DLJarvis@uwyo.edu		Jarvis, Donald/0000-0002-8104-7155	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049734] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM049734, R01 GM49734] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; ALTMANN F, 1993, GLYCOBIOLOGY, V3, P619, DOI 10.1093/glycob/3.6.619; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Aumiller JJ, 2006, PROTEIN EXPRES PURIF, V47, P571, DOI 10.1016/j.pep.2005.11.026; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; FIELD MC, 1995, GLYCOBIOLOGY, V5, P463, DOI 10.1093/glycob/5.5.463; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Harrison Robert L., 2007, V388, P299; Innis MA, 1990, PCR PROTOCOLS GUIDE; Jarvis DL, 1996, PROTEIN EXPRES PURIF, V8, P191, DOI 10.1006/prep.1996.0092; JARVIS DL, 1997, BACULOVIRUSES, P389; KITTS PA, 1993, BIOTECHNIQUES, V14, P810; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023; Marz L., 1995, GLYCOPROTEINS, P543; MYEROWITZ R, 1985, P NATL ACAD SCI USA, V82, P7830, DOI 10.1073/pnas.82.23.7830; ODOWD BF, 1985, P NATL ACAD SCI USA, V82, P1184, DOI 10.1073/pnas.82.4.1184; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Summers MD, 1987, TEXAS AGR EXPT STATI; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomiya N, 2006, J BIOL CHEM, V281, P19545, DOI 10.1074/jbc.M603312200; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wagner R, 1996, J VIROL, V70, P4103, DOI 10.1128/JVI.70.6.4103-4109.1996; Zhang WL, 2003, BIOCHEM J, V372, P53, DOI 10.1042/BJ20021931	32	64	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11330	11339		10.1074/jbc.M710279200	http://dx.doi.org/10.1074/jbc.M710279200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303021	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000255067400029
J	Nagao, K; Taniyama, Y; Kietzmann, T; Doi, T; Komuro, I; Morishita, R				Nagao, Kaori; Taniyama, Yoshiaki; Kietzmann, Thomas; Doi, Takefumi; Komuro, Issei; Morishita, Ryuichi			HIF-1 alpha signaling upstream of NKX2.5 is required for cardiac development in xenopus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; HEART DEVELOPMENT; FACTOR 1-ALPHA; EMBRYOS LACKING; SMOOTH-MUSCLE; CARDIOVASCULAR-SYSTEM; PROGENITOR CELLS; VERTEBRATE HEART; HIF-ALPHA; PROTEIN	HIF-1 alpha is originally identified as a transcription factor that activates gene expression in response to hypoxia. In metazoans, HIF-1 alpha functions as a master regulator of oxygen homeostasis and regulates adaptive responses to change in oxygen tension during embryogenesis, tissue ischemia, and tumorigenesis. Because Hif-1 alpha-deficient mice exhibit a number of developmental defects, the precise role of HIF-1 alpha in early cardiac morphogenesis has been uncertain. Therefore, to clarify the role of HIF-1 alpha in heart development, we investigated the effect of knockdown of HIF-1 alpha in Xenopus embryos using antisense morpholino oligonucleotide microinjection techniques. Knockdown of HIF-1 alpha resulted in defects of cardiogenesis. Whole mount in situ hybridization for cardiac troponin I (cTnI) showed the two separated populations of cardiomyocytes, which is indicative of cardia bifida, in HIF-1 alpha-depleted embryos. Furthermore, the depletion of HIF-1 alpha led to the reduction in cTnI expression, suggesting the correlation between HIF-1 alpha and cardiac differentiation. We further examined the expression of several heart markers, nkx2.5, gata4, tbx5, bmp4, hand1, and hand2 in HIF-1 alpha-depleted embryos. Among them, the expression of nkx2.5 was significantly reduced. Luciferase reporter assay using the Nkx2.5 promoter showed that knockdown of HIF-1 alpha decreased its promoter activity. The cardiac abnormality in the HIF-1 alpha-depleted embryo was restored with co-injection of nkx2.5 mRNA. Collectively, these findings reveal that HIF-1 alpha-regulated nkx2.5 expression is required for heart development in Xenopus.	[Nagao, Kaori; Taniyama, Yoshiaki; Morishita, Ryuichi] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka 5650871, Japan; [Doi, Takefumi; Komuro, Issei] Osaka Univ, Grad Sch Med, Dept Pharmacol, Suita, Osaka 5650871, Japan; [Kietzmann, Thomas; Komuro, Issei] Univ Kaiserslautern, Dept Biochem, D-67663 Kaiserslautern, Germany; [Doi, Takefumi; Komuro, Issei] Chiba Univ, Grad Sch Med, Dept Cardiovasc Sci & Med, Chiba 2608670, Japan	Osaka University; Osaka University; University of Kaiserslautern; Chiba University	Morishita, R (corresponding author), Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	morishit@cgt.med.osaka-u.ac.jp		Kietzmann, Thomas/0000-0003-0242-8636				Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; BODMER R, 1993, DEVELOPMENT, V118, P719; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; DALE L, 1987, DEVELOPMENT, V99, P527; Fu YC, 1998, DEVELOPMENT, V125, P4439; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Grow MW, 1998, DEV BIOL, V204, P187, DOI 10.1006/dbio.1998.9080; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Iraha F, 2002, DEV GROWTH DIFFER, V44, P395; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Koibuchi N, 2006, BIOCHEM BIOPH RES CO, V344, P339, DOI 10.1016/j.bbrc.2006.03.140; Lacaud G, 2001, ANN NY ACAD SCI, V938, P96; Liberatore CM, 2002, DEV BIOL, V244, P243, DOI 10.1006/dbio.2002.0604; Lien CL, 1999, DEVELOPMENT, V126, P75; Lien CL, 2002, DEV BIOL, V244, P257, DOI 10.1006/dbio.2002.0603; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mohun T, 1997, CURR OPIN GENET DEV, V7, P628, DOI 10.1016/S0959-437X(97)80010-X; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pereira T, 2003, J BIOL CHEM, V278, P6816, DOI 10.1074/jbc.M209297200; Peterkin T, 2003, EMBO J, V22, P4260, DOI 10.1093/emboj/cdg400; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Ramirez-Bergeron DL, 2001, STEM CELLS, V19, P279, DOI 10.1634/stemcells.19-4-279; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Saga Y, 1999, DEVELOPMENT, V126, P3437; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schoenwolf GC, 1995, CELL MOL BIOL RES, V41, P233; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Searcy RD, 1998, DEVELOPMENT, V125, P4461; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Shi YQ, 2000, DEV BIOL, V224, P226, DOI 10.1006/dbio.2000.9802; Sparrow DB, 2000, DEV BIOL, V227, P65, DOI 10.1006/dbio.2000.9891; Takahashi T, 2001, BIOCHEM BIOPH RES CO, V281, P1057, DOI 10.1006/bbrc.2001.4463; Tanaka M, 1999, DEVELOPMENT, V126, P1269; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Walters MJ, 2001, MECH DEVELOP, V100, P263, DOI 10.1016/S0925-4773(00)00535-9; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028	53	32	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11841	11849		10.1074/jbc.M702563200	http://dx.doi.org/10.1074/jbc.M702563200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18303027	hybrid			2022-12-25	WOS:000255067400083
J	Wooldridge, AA; Fortner, CN; Lontay, B; Akimoto, T; Neppl, RL; Facemire, C; Datto, MB; Kwon, A; McCook, E; Li, P; Wang, S; Thresher, RJ; Miller, SE; Perriard, JC; Gavin, TP; Hickner, RC; Coffman, TM; Somlyo, AV; Yan, Z; Haystead, TAJ				Wooldridge, Anne A.; Fortner, Christopher N.; Lontay, Beata; Akimoto, Takayuki; Neppl, Ronald L.; Facemire, Carie; Datto, Michael B.; Kwon, Ashley; McCook, Everett; Li, Ping; Wang, Shiliang; Thresher, Randy J.; Miller, Sara E.; Perriard, Jean-Claude; Gavin, Timothy P.; Hickner, Robert C.; Coffman, Thomas M.; Somlyo, Avril V.; Yan, Zhen; Haystead, Timothy A. J.			Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; DEFICIENT MICE; CGMP KINASE; MYOSIN; PHOSPHORYLATION; PHOSPHATASE; CONTRACTILITY; ADAPTATION; STRESS	In vivo protein kinases A and G (PKA and PKG) coordinately phosphorylate a broad range of substrates to mediate their various physiological effects. The functions of many of these substrates have yet to be defined genetically. Herein we show a role for smoothelin-like protein 1 (SMTNL1), a novel in vivo target of PKG/PKA, in mediating vascular adaptations to exercise. Aortas from smtnl1(-/-) mice exhibited strikingly enhanced vasorelaxation before exercise, similar in extent to that achieved after endurance training of wild-type littermates. Additionally, contractile responses to alpha-adrenergic agonists were greatly attenuated. Immunological studies showed SMTNL1 is expressed in smooth muscle and type 2a striated muscle fibers. Consistent with a role in adaptations to exercise, smtnl1(-/-) mice also exhibited increased type 2a fibers before training and better performance after forced endurance training compared smtnl1(-/-) mice. Furthermore, exercise was found to reduce expression of SMTNL1, particularly in female mice. In both muscle types, SMTNL1 is phosphorylated at Ser-301 in response to adrenergic signals. In vitro SMTNL1 suppresses myosin phosphatase activity through a substrate-directed effect, which is relieved by Ser-301 phosphorylation. Our findings suggest roles for SMTNL1 in cGMP/cAMP-mediated adaptations to exercise through mechanisms involving direct modulation of contractile activity.	[Wooldridge, Anne A.; Fortner, Christopher N.; Lontay, Beata; Kwon, Ashley; McCook, Everett; Haystead, Timothy A. J.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; [Akimoto, Takayuki; Facemire, Carie; Li, Ping; Coffman, Thomas M.; Yan, Zhen] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Datto, Michael B.; Miller, Sara E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Neppl, Ronald L.; Somlyo, Avril V.] Univ Virginia, Dept Mol Physiol, Charlottesville, VA 22908 USA; [Wang, Shiliang; Thresher, Randy J.] Univ N Carolina, Anim Models Core Facil, Chapel Hill, NC 27599 USA; [Perriard, Jean-Claude] ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Gavin, Timothy P.; Hickner, Robert C.] E Carolina Univ, Dept Exercise & Sport Sci, Greenville, NC 27878 USA	Duke University; Duke University; Duke University; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of North Carolina; East Carolina University	Haystead, TAJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol, Med Ctr Box 3813,C11P LSRC Res Dr, Durham, NC 27710 USA.	hayst001@mc.duke.edu	Neppl, Ronald L/AAW-1257-2020; Akimoto, Takayuki/H-6704-2012	Neppl, Ronald L/0000-0003-1497-6058; Akimoto, Takayuki/0000-0002-8874-7779; hickner, Robert/0000-0002-2683-1617; Yan, Zhen/0000-0002-4826-9813	NHLBI NIH HHS [5 R01 HL078795-04] Funding Source: Medline; NIAMS NIH HHS [R01 AR050429] Funding Source: Medline; NIDDK NIH HHS [DK065954-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065954, R56DK065954] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Boo YC, 2006, EXP MOL MED, V38, P453, DOI 10.1038/emm.2006.53; Borman MA, 2004, FEBS LETT, V573, P207, DOI 10.1016/j.febslet.2004.08.002; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Geiselhoringer A, 2004, EMBO J, V23, P4222, DOI 10.1038/sj.emboj.7600440; Haubold KW, 2003, J APPL PHYSIOL, V95, P1617, DOI 10.1152/japplphysiol.00408.2003; Kojda G, 2005, CARDIOVASC RES, V67, P187, DOI 10.1016/j.cardiores.2005.04.032; Lincoln TM, 2007, CIRC RES, V100, P10, DOI 10.1161/01.RES.0000255894.25293.82; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Niessen P, 2005, GASTROENTEROLOGY, V129, P1592, DOI 10.1053/j.gastro.2005.08.018; Pannirselvam M, 2003, BRIT J PHARMACOL, V140, P701, DOI 10.1038/sj.bjp.0705476; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; PLOURDE G, 1993, J APPL PHYSIOL, V74, P1641, DOI 10.1152/jappl.1993.74.4.1641; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Sakamoto K, 2002, J APPL PHYSIOL, V93, P369, DOI 10.1152/japplphysiol.00167.2002; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Somlyo AV, 2004, PHILOS T R SOC B, V359, P1921, DOI 10.1098/rstb.2004.1562; Szczesna D, 2002, J APPL PHYSIOL, V92, P1661, DOI 10.1152/japplphysiol.00858.2001; Wooldridge AA, 2004, J BIOL CHEM, V279, P34496, DOI 10.1074/jbc.M405957200	21	29	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11850	11859		10.1074/jbc.M708628200	http://dx.doi.org/10.1074/jbc.M708628200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18310078	hybrid, Green Published			2022-12-25	WOS:000255067400084
J	Yoshida, KI; Yamaguchi, M; Morinaga, T; Kinehara, M; Ikeuchi, M; Ashida, H; Fujita, Y				Yoshida, Ken-Ichi; Yamaguchi, Masanori; Morinaga, Tetsuro; Kinehara, Masaki; Ikeuchi, Maya; Ashida, Hitoshi; Fujita, Yasutaro			myo-inositol catabolism in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYO-INOSITOL DEGRADATION; AEROBACTER-AEROGENES; ESCHERICHIA-COLI; 2-DEOXY-5-KETO-D-GLUCONIC ACID; MOLECULAR-CLONING; GENE; IDENTIFICATION; PATHWAY; DEHYDROGENASE; EXPRESSION	The iolABCDEFGHIJ operon of Bacillus subtilis is responsible for myo-inositol catabolism involving multiple and stepwise reactions. Previous studies demonstrated that IolG and IolE are the enzymes for the first and second reactions, namely dehydrogenation of myo-inositol to give 2-keto-myo-inositol and the subsequent dehydration to 3D-(3,5/4)-trihydroxycyclohexane1,2- dione. In the present studies the third reaction was shown to be the hydrolysis of 3D-(3,5/4)-trihydroxycyclohexane-1,2-dione catalyzed by IolD to yield 5-deoxy-D-glucuronic acid. The fourth reaction was the isomerization of 5-deoxy-D-glucuronic acid by IolB to produce 2-deoxy-5-keto-D-gluconic acid. Next, in the fifth reaction 2-deoxy-5-keto-D-gluconic acid was phosphorylated by IolC kinase to yield 2-deoxy-5-keto-D-gluconic acid 6-phosphate. IolR is known as the repressor controlling transcription of the iol operon. In this reaction 2-deoxy-5-keto-D-gluconic acid 6-phosphate appeared to be the intermediate acting as inducer by antagonizing DNA binding of IolR. Finally, IolJ turned out to be the specific aldolase for the sixth reaction, the cleavage of 2-deoxy-5-keto-D-gluconic acid 6-phosphate into dihydroxyacetone phosphate and malonic semialdehyde. The former is a known glycolytic intermediate, and the latter was previously shown to be converted to acetyl-CoA and CO2 by a reaction catalyzed by IolA. The net result of the inositol catabolic pathway in B. subtilis is, thus, the conversion of myo-inositol to an equimolar mixture of dihydroxyacetone phosphate, acetyl-CoA, and CO2.	[Yoshida, Ken-Ichi; Morinaga, Tetsuro; Kinehara, Masaki; Ikeuchi, Maya; Ashida, Hitoshi] Kobe Univ, Dept Agrobiosci, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Yamaguchi, Masanori] Hokko Chem Ind Co Ltd, Cent Res Labs, Atsugi, Kanagawa 2430023, Japan; [Fujita, Yasutaro] Fukuyama Univ, Dept Biotechnol, Fac Life Sci & Biotechnol, Fukuyama, Hiroshima 7290292, Japan	Kobe University; Fukuyama University	Yoshida, KI (corresponding author), Kobe Univ, Dept Agrobiosci, Grad Sch Agr Sci, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	kenyoshi@kobe-u.ac.jp	Yoshida, Ken-ichi/R-8863-2016	Yoshida, Ken-ichi/0000-0002-3383-4664				ANDERSON WA, 1971, J BIOL CHEM, V246, P5653; ANDERSON WA, 1971, J BIOL CHEM, V246, P5662; BERMAN T, 1966, J BIOL CHEM, V241, P807; BERMAN T, 1966, J BIOL CHEM, V241, P800; FUJITA Y, 1981, J BACTERIOL, V145, P760, DOI 10.1128/JB.145.2.760-767.1981; Fujita Y, 1998, J BACTERIOL, V180, P4309, DOI 10.1128/JB.180.16.4309-4313.1998; FUJITA Y, 1983, J BACTERIOL, V154, P864, DOI 10.1128/JB.154.2.864-869.1983; FUJITA Y, 1991, GENE, V108, P121; Galbraith MP, 1998, MICROBIOL-SGM, V144, P2915, DOI 10.1099/00221287-144-10-2915; Jiang GQ, 2001, J BACTERIOL, V183, P2595, DOI 10.1128/JB.183.8.2595-2604.2001; KAEMPFER RO, 1967, J MOL BIOL, V27, P453, DOI 10.1016/0022-2836(67)90051-4; Krings E, 2006, J BACTERIOL, V188, P8054, DOI 10.1128/JB.00935-06; Morinaga T, 2006, BIOSCI BIOTECH BIOCH, V70, P1913, DOI 10.1271/bbb.60084; Nakano M, 1999, J BIOL CHEM, V274, P23185, DOI 10.1074/jbc.274.33.23185; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; POOLE PS, 1994, MICROBIOL-SGM, V140, P2787, DOI 10.1099/00221287-140-10-2787; Sambrook J, 2001, MOL CLONING LAB MANU; Stines-Chaumeil C, 2006, BIOCHEM J, V395, P107, DOI 10.1042/BJ20051525; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; VANROOIJEN RJ, 1990, J BIOL CHEM, V265, P18499; VIDALLEI.M, 1973, BIOCHIM BIOPHYS ACTA, V293, P295, DOI 10.1016/0005-2744(73)90337-9; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yebra MJ, 2007, APPL ENVIRON MICROB, V73, P3850, DOI 10.1128/AEM.00243-07; Yoshida K, 2006, APPL ENVIRON MICROB, V72, P1310, DOI 10.1128/AEM.72.2.1310-1315.2006; Yoshida KI, 2004, MICROBIOL-SGM, V150, P571, DOI 10.1099/mic.0.26768-0; Yoshida KI, 1997, J BACTERIOL, V179, P4591, DOI 10.1128/jb.179.14.4591-4598.1997; Yoshida KI, 2002, J BACTERIOL, V184, P983, DOI 10.1128/jb.184.4.983-991.2002; Yoshida KI, 1999, J MOL BIOL, V285, P917, DOI 10.1006/jmbi.1998.2398	28	87	94	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10415	10424		10.1074/jbc.M708043200	http://dx.doi.org/10.1074/jbc.M708043200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18310071	hybrid			2022-12-25	WOS:000254894700022
J	Lin, CY; Fang, J; Xu, XL; Zhao, T; Cheng, JA; Tu, JM; Ye, GY; Shen, ZC				Lin, Chaoyang; Fang, Jun; Xu, Xiaoli; Zhao, Te; Cheng, Jiaan; Tu, Juming; Ye, Gongyin; Shen, Zhicheng			A Built-In Strategy for Containment of Transgenic Plants: Creation of Selectively Terminable Transgenic Rice	PLOS ONE			English	Article							MATERNAL INHERITANCE; CYTOCHROMES P450; ORYZA-SATIVA; RED RICE; GENE; TRANSFORMATION; RESISTANCE; EXPRESSION; PROTEINS; FLOW	Plant transgenic technology has been widely utilized for engineering crops for trait improvements and for production of high value proteins such as pharmaceuticals. However, the unintended spreading of commercial transgenic crops by pollination and seed dispersal is a major concern for environmental and food safety. Simple and reliable containment strategies for transgenes are highly desirable. Here we report a novel method for creating selectively terminable transgenic rice. In this method, the gene(s) of interest is tagged with a RNA interference cassette, which specifically suppresses the expression of the bentazon detoxification enzyme CYP81A6 and thus renders transgenic rice to be sensitive to bentazon, a herbicide used for rice weed control. We generated transgenic rice plants by this method using a new glyphosate resistant 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) gene from Pesudomonas putida as the gene of interest, and demonstrated that these transgenic rice plants were highly sensitive to bentazon but tolerant to glyphosate, which is exactly the opposite of conventional rice. Field trial of these transgenic rice plants further confirmed that they can be selectively killed at 100% by one spray of bentazon at a regular dose used for conventional rice weed control. Furthermore, we found that the terminable transgenic rice created in this study shows no difference in growth, development and yield compared to its non-transgenic control. Therefore, this method of creating transgenic rice constitutes a novel strategy of transgene containment, which appears simple, reliable and inexpensive for implementation.	[Lin, Chaoyang; Fang, Jun; Xu, Xiaoli; Zhao, Te; Cheng, Jiaan; Ye, Gongyin; Shen, Zhicheng] Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310027, Peoples R China; [Tu, Juming] Zhejiang Univ, Inst Crop Sci, Hangzhou, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University	Shen, ZC (corresponding author), Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310027, Peoples R China.	zcshen@zju.edu.cn			National Basic Research and Development Program of China [2007CB109202]; Department of Science and Technology of Zhejiang Province [2006C12092]; IRT Program of the Ministry of Education of China [IRT 0535]	National Basic Research and Development Program of China(National Basic Research Program of China); Department of Science and Technology of Zhejiang Province; IRT Program of the Ministry of Education of China(Ministry of Education, China)	This study was supported by the National Basic Research and Development Program of China (2007CB109202), the Department of Science and Technology of Zhejiang Province (2006C12092) and by the IRT Program of the Ministry of Education of China (IRT 0535).	CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Daniell H, 2002, NAT BIOTECHNOL, V20, P581, DOI 10.1038/nbt0602-581; Daniell H, 2001, TRENDS PLANT SCI, V6, P219, DOI 10.1016/S1360-1385(01)01922-7; Daniell H, 2007, P NATL ACAD SCI USA, V104, P6879, DOI 10.1073/pnas.0702219104; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Forthoffer N, 2001, EUR J DRUG METAB PH, V26, P9, DOI 10.1007/BF03190370; Fox JL, 2003, NAT BIOTECHNOL, V21, P3, DOI 10.1038/nbt0103-3b; Gealy DR, 2003, WEED TECHNOL, V17, P627, DOI 10.1614/WT02-100; Gealy DR, 2002, WEED SCI, V50, P333, DOI 10.1614/0043-1745(2002)050[0333:IORRRA]2.0.CO;2; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hood EE, 1999, ADV EXP MED BIOL, V464, P127; Khan MS, 1999, NAT BIOTECHNOL, V17, P910, DOI 10.1038/12907; Kumar S, 2004, PLANT MOL BIOL, V56, P203, DOI 10.1007/s11103-004-2907-y; Kumar S, 2004, PLANT PHYSIOL, V136, P2843, DOI 10.1104/pp.104.045187; Kuvshinov V, 2004, PLANT SCI, V167, P173, DOI 10.1016/j.plantsci.2004.03.018; Kuvshinov V, 2001, PLANT SCI, V160, P517, DOI 10.1016/S0168-9452(00)00414-3; Lamb SB, 1998, FEBS LETT, V431, P343, DOI 10.1016/S0014-5793(98)00771-6; Larrick JW, 2001, CURR OPIN BIOTECH, V12, P411, DOI 10.1016/S0958-1669(00)00236-6; Lee D, 2006, TRENDS BIOTECHNOL, V24, P109, DOI 10.1016/j.tibtech.2006.01.006; MARIANI C, 1990, NATURE, V347, P737, DOI 10.1038/347737a0; MEDGYESY P, 1986, MOL GEN GENET, V204, P195, DOI 10.1007/BF00425497; Morant M, 2003, CURR OPIN BIOTECH, V14, P151, DOI 10.1016/S0958-1669(03)00024-7; Pan G, 2006, PLANT MOL BIOL, V61, P933, DOI 10.1007/s11103-006-0058-z; Pedroncelli R, 2007, NATURE, V445, P132; Siminszky B, 1999, P NATL ACAD SCI USA, V96, P1750, DOI 10.1073/pnas.96.4.1750; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Werck-Reichhart D, 2000, TRENDS PLANT SCI, V5, P116, DOI 10.1016/S1360-1385(00)01567-3; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61	28	40	51	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1818	10.1371/journal.pone.0001818	http://dx.doi.org/10.1371/journal.pone.0001818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350155	gold, Green Published, Green Submitted			2022-12-25	WOS:000260762300021
J	Ryan, PL; Young, JAT				Ryan, Patricia L.; Young, John A. T.			Evidence against a Human Cell-Specific Role for LRP6 in Anthrax Toxin Entry	PLOS ONE			English	Article								The role of the cellular protein LRP6 in anthrax toxin entry is controversial. Previous studies showed that LRP6 was important for efficient intoxication of human M2182 prostate carcinoma cells but other studies performed with cells from gene-knockout mice demonstrated no role for either LRP6 or the related LRP5 protein in anthrax toxin entry. One possible explanation for this discrepancy is that LRP6 may be important for anthrax toxin entry into human, but not mouse, cells. To test this idea we have investigated the effect of knocking down LRP6 or LRP5 expression with siRNAs in human HeLa cells. We show here that efficient knockdown of either LRP6, LRP5, or both proteins has no influence on the kinetics of anthrax lethal toxin entry or MEK1 substrate cleavage in these cells. These data argue against a human-specific role for LRP6 in anthrax toxin entry and suggest instead that involvement of this protein may be restricted to certain cell types independently of their species of origin.	[Ryan, Patricia L.; Young, John A. T.] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA; [Ryan, Patricia L.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA USA	Salk Institute; University of California System; University of California San Diego	Ryan, PL (corresponding author), Salk Inst Biol Studies, Infect Dis Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jyoung@salk.edu		Young, John/0000-0003-1824-2561	NIH [AI48489]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048489] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI48489.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Beauregard KE, 2000, CELL MICROBIOL, V2, P251, DOI 10.1046/j.1462-5822.2000.00052.x; Blanke SR, 1996, P NATL ACAD SCI USA, V93, P8437, DOI 10.1073/pnas.93.16.8437; Boll W, 2004, EUR J CELL BIOL, V83, P281, DOI 10.1078/0171-9335-00373; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; MILNE JC, 1994, J BIOL CHEM, V269, P20607; OBRIEN J, 1985, INFECT IMMUN, V47, P306, DOI 10.1128/IAI.47.1.306-310.1985; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Young JJ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030027	24	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1817	10.1371/journal.pone.0001817	http://dx.doi.org/10.1371/journal.pone.0001817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350154	Green Published, gold, Green Submitted			2022-12-25	WOS:000260762300020
J	Zhao, Z; Taylor, WD; Styner, M; Steffens, DC; Krishnan, KRR; MacFall, JR				Zhao, Zheen; Taylor, Warren D.; Styner, Martin; Steffens, David C.; Krishnan, K. Ranga R.; MacFall, James R.			Hippocampus Shape Analysis and Late-Life Depression	PLOS ONE			English	Article							GERIATRIC DEPRESSION; ALZHEIMERS-DISEASE; RISK-FACTOR; VOLUME; DEMENTIA; HISTORY; ABNORMALITIES; AMYGDALA; ILLNESS; ONSET	Major depression in the elderly is associated with brain structural changes and vascular lesions. Changes in the subcortical regions of the limbic system have also been noted. Studies examining hippocampus volumetric differences in depression have shown variable results, possibly due to any volume differences being secondary to local shape changes rather than differences in the overall volume. Shape analysis offers the potential to detect such changes. The present study applied spherical harmonic (SPHARM) shape analysis to the left and right hippocampi of 61 elderly subjects with major depression and 43 non-depressed elderly subjects. Statistical models controlling for age, sex, and total cerebral volume showed a significant reduction in depressed compared with control subjects in the left hippocampus (F-1,F-103 = 5.26; p = 0.0240) but not right hippocampus volume (F-1,F-103 = 0.41; p = 0.5213). Shape analysis showed significant differences in the mid-body of the left (but not the right) hippocampus between depressed and controls. When the depressed group was dichotomized into those whose depression was remitted at time of imaging and those who were unremitted, the shape comparison showed remitted subjects to be indistinguishable from controls (both sides) while the unremitted subjects differed in the midbody and the lateral side near the head. Hippocampal volume showed no difference between controls and remitted subjects but nonremitted subjects had significantly smaller left hippocampal volumes with no significant group differences in the right hippocampus. These findings may provide support to other reports of neurogenic effects of antidepressants and their relation to successful treatment for depressive symptoms.	[Zhao, Zheen; Taylor, Warren D.; MacFall, James R.] Duke Univ, Med Ctr, Neuropsychiat Imaging Res Lab, Durham, NC 27706 USA; [MacFall, James R.] Duke Univ, Dept Biomed Engn, Durham, NC USA; [MacFall, James R.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC USA; [Zhao, Zheen; Taylor, Warren D.; Steffens, David C.; Krishnan, K. Ranga R.] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC USA; [Styner, Martin] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA; [Krishnan, K. Ranga R.] Duke NUS Grad Med Sch Singapore, Singapore, Singapore	Duke University; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; National University of Singapore	Zhao, Z (corresponding author), Duke Univ, Med Ctr, Neuropsychiat Imaging Res Lab, Durham, NC 27706 USA.	kurt.zhao@duke.edu	Styner, Martin/AAS-9949-2020; Taylor, Warren D/J-3687-2014	Styner, Martin/0000-0002-8747-5118; 	NIMH [K23 MH65939, RR-00030-S42, P50 MH60451, 5U24RR021382]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382, M01RR000030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH065939, P50MH060451] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by NIMH grants K23 MH65939, RR-00030-S42, P50 MH60451 and 5U24RR021382 (Biomedical Informatics Research Network).	Ashtari M, 1999, PSYCHOL MED, V29, P629, DOI 10.1017/S0033291799008405; AXELSON DA, 1993, PSYCHIAT RES, V47, P163, DOI 10.1016/0165-1781(93)90046-J; Bell-McGinty S, 2002, AM J PSYCHIAT, V159, P1424, DOI 10.1176/appi.ajp.159.8.1424; Beyer JL, 2004, AM J GERIAT PSYCHIAT, V12, P613, DOI 10.1176/appi.ajgp.12.6.613; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Caetano SC, 2004, PSYCHIAT RES-NEUROIM, V132, P141, DOI 10.1016/j.psychresns.2004.08.002; Chen PJ, 1999, ARCH GEN PSYCHIAT, V56, P261, DOI 10.1001/archpsyc.56.3.261; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frodl T, 2002, AM J PSYCHIAT, V159, P1112, DOI 10.1176/appi.ajp.159.7.1112; Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753; Hawley CJ, 2002, J AFFECT DISORDERS, V72, P177, DOI 10.1016/S0165-0327(01)00451-7; Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197; Hickie IB, 2007, J AFFECT DISORDERS, V98, P137, DOI 10.1016/j.jad.2006.07.010; Hsieh MH, 2002, INT J GERIATR PSYCH, V17, P519, DOI 10.1002/gps.611; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Janssen J, 2007, J NEUROL NEUROSUR PS, V78, P638, DOI 10.1136/jnnp.2006.098087; JORM AF, 1991, INT J EPIDEMIOL, V20, pS43, DOI 10.1093/ije/20.Supplement_2.S43; KRISHNAN KRR, 1993, J GERIATR PSYCH NEUR, V6, P39, DOI 10.1177/002383099300600107; KRISHNAN KRR, 1991, J NEUROPSYCH CLIN N, V3, P387; Lee JM, 2004, NEUROIMAGE, V22, P831, DOI 10.1016/j.neuroimage.2004.02.004; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; McHugh TL, 2007, CLIN NEUROPSYCHOL, V21, P130, DOI 10.1080/13854040601064534; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; O'Brien JT, 2004, AM J PSYCHIAT, V161, P2081, DOI 10.1176/appi.ajp.161.11.2081; Olin JT, 2002, AM J GERIAT PSYCHIAT, V10, P125; Pantel J, 1997, J AFFECT DISORDERS, V42, P69, DOI 10.1016/S0165-0327(96)00105-X; Posener JA, 2003, AM J PSYCHIAT, V160, P83, DOI 10.1176/appi.ajp.160.1.83; Rapp MA, 2006, ARCH GEN PSYCHIAT, V63, P161, DOI 10.1001/archpsyc.63.2.161; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Scher AI, 2007, NEUROIMAGE, V36, P8, DOI 10.1016/j.neuroimage.2006.12.036; Shah PJ, 1998, BRIT J PSYCHIAT, V172, P527, DOI 10.1192/bjp.172.6.527; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; SPECK CE, 1995, EPIDEMIOLOGY, V6, P366, DOI 10.1097/00001648-199507000-00006; Steffens David C, 2002, Psychopharmacol Bull, V36, P58; Steffens DC, 2000, BIOL PSYCHIAT, V48, P301, DOI 10.1016/S0006-3223(00)00829-5; Steffens DC, 2002, AM J GERIAT PSYCHIAT, V10, P62, DOI 10.1176/appi.ajgp.10.1.62; Styner M, 2003, MED IMAGE ANAL, V7, P207, DOI 10.1016/S1361-8415(02)00110-X; Styner M., 2006, INSIGHT J; Taki Y, 2005, J AFFECT DISORDERS, V88, P313, DOI 10.1016/j.jad.2005.08.003; Taylor WD, 2005, ARCH GEN PSYCHIAT, V62, P537, DOI 10.1001/archpsyc.62.5.537; Vakili K, 2000, BIOL PSYCHIAT, V47, P1087, DOI 10.1016/S0006-3223(99)00296-6; Vythilingam M, 2003, BIOL PSYCHIAT, V54, P744, DOI 10.1016/S0006-3223(02)01908-X; Wang L, 2003, NEUROIMAGE, V20, P667, DOI 10.1016/S1053-8119(03)00361-6; Wang L, 2001, NEUROIMAGE, V14, P531, DOI 10.1006/nimg.2001.0830; Wang L, 2007, IEEE T MED IMAGING, V26, P462, DOI 10.1109/TMI.2006.887380	46	68	73	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1837	10.1371/journal.pone.0001837	http://dx.doi.org/10.1371/journal.pone.0001837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370KY	18350172	Green Published, gold			2022-12-25	WOS:000260762300038
J	Morris, GAJ; Ikumapayi, UN; Antonio, M; Howie, SRC; Adegbola, RA				Morris, Gerard A. J.; Ikumapayi, Usman N.; Antonio, Martin; Howie, Stephen R. C.; Adegbola, Richard A.			A Novel Campylobacter jejuni Sequence Type from a Culture-Negative Patient in The Gambia	PLOS ONE			English	Article							PNEUMONIA; CLONES; BLOOD	The introduction of molecular diagnostic methods is crucial for improved understanding of the aetiology and epidemiology of bacterial infections in communities in resource poor settings. A blood sample from a 7 month old patient diagnosed with malaria in 2001 in a Gambian outpatient clinic was reported as culture negative after it was subjected to traditional bacterial culture protocols. We re-addressed the analysis of the blood sample from this case more recently (after 6.5 years in archival storage) in pilot work establishing 16S rRNA PCR in our molecular laboratory. Initial 16S rRNA PCR results confirmed the presence of bacterial DNA in the sample. 16S rRNA sequence analysis identified the organism as Campylobacter spp. In light of the molecular evidence we successfully grew the organism using appropriate culture conditions and subsequently biochemically confirmed that the isolate was Campylobacter jejuni. PCR and DNA sequencing of a set of seven C. jejuni housekeeping genes and in silico Multilocus Sequence Typing (MLST) analysis revealed that the isolate exhibits a novel sequence type (ST) of C. jejuni (ST 2928) and belongs to ST-443 clonal complex. This study demonstrates the potential for molecular tools to enhance the diagnosis of bacterial infections, which remain a major killer globally, not least in children in the developing world. Improvements in diagnostics are needed, and will be important not only for sick individuals but also for populations, where better measures of disease burden will contribute significantly to the improvement of public health policy.	[Morris, Gerard A. J.; Ikumapayi, Usman N.; Antonio, Martin; Howie, Stephen R. C.; Adegbola, Richard A.] MRC Labs, Bacterial Dis Programme, Fajara, Gambia	MRC Laboratory Molecular Biology	Morris, GAJ (corresponding author), MRC Labs, Bacterial Dis Programme, Fajara, Gambia.	gmorris@mrc.gm			Medical Research Council United Kingdom; MRC [MC_U190088478, MC_U190081991, MC_U190074190] Funding Source: UKRI; Medical Research Council [MC_U190081991, MC_U190088478, MC_U190074190] Funding Source: researchfish	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was mainly supported by funding from Medical Research Council United Kingdom. The MRC UK was not directly involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, nor in the preparation, review, or approval of the manuscript.	BLASER MJ, 1995, MANDELL DOUGLAS BENN; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Duim B, 2003, J CLIN MICROBIOL, V41, P5593, DOI 10.1128/JCM.41.12.5593-5597.2003; Fenollar F, 2007, INT J ANTIMICROB AG, V30, pS7, DOI 10.1016/j.ijantimicag.2007.06.024; Manning G, 2003, APPL ENVIRON MICROB, V69, P6370, DOI 10.1128/AEM.69.11.6370-6379.2003; McLaughlin RW, 2002, J CLIN MICROBIOL, V40, P4771, DOI 10.1128/JCM.40.12.4771-4775.2002; Miller RL, 2007, AM J EVAL, V28, P7, DOI 10.1177/1098214006298057; Mulholland EK, 2005, NEW ENGL J MED, V352, P75, DOI 10.1056/NEJMe048306; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nikkari S, 2001, J CLIN MICROBIOL, V39, P1956, DOI 10.1128/JCM.39.5.1956-1959.2001; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Rao MR, 2001, AM J EPIDEMIOL, V154, P166, DOI 10.1093/aje/154.2.166; Scott JAG, 1999, CHEST, V116, P1716, DOI 10.1378/chest.116.6.1716; Wassenaar TM, 2000, APPL ENVIRON MICROB, V66, P1, DOI 10.1128/AEM.66.1.1-9.2000; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	25	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1773	10.1371/journal.pone.0001773	http://dx.doi.org/10.1371/journal.pone.0001773			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335047	gold, Green Published, Green Submitted			2022-12-25	WOS:000260723000026
J	Uzochukwu, BSC; Onwujekwe, EO; Onoka, CA; Ughasoro, MD				Uzochukwu, Benjamin S. C.; Onwujekwe, Emmanuel O.; Onoka, Chima A.; Ughasoro, Maduka D.			Rural-Urban Differences in Maternal Responses to Childhood Fever in South East Nigeria	PLOS ONE			English	Article							MALARIA MORBIDITY; SEEKING BEHAVIOR; HOME TREATMENT; BURKINA-FASO; CHILDREN; DISTRICT; KNOWLEDGE; MANAGEMENT; COMMUNITY; DIAGNOSIS	Background: Childhood fevers due to malaria remain a major cause of morbidity and mortality among under-five children in Nigeria. The degree of vulnerability perceived by mothers will affect their perception of the severity and threat of their child's fever and the patterns of health care use. This study was undertaken to compare maternal responses to childhood fever in urban and rural areas of Enugu, south east Nigeria. Methodology/Principal Findings: Data was collected with pre-tested interviewer-administered questionnaires from 276 and 124 urban and rural households respectively. In each household, only one woman aged 15-49 years who had lived in each of the urban and rural communities for at least one year and had at least one child less than 5 years old was interviewed. Malaria was mentioned as the commonest cause of childhood fevers. Rural mothers were more likely to recognize danger signs and symptoms than urban mothers. Rural mothers use more of informal than formal health services, and there is more home management of the fever with urban than rural mothers. Chloroquine, ACT, SP and Paracetamol are the main drugs given at home for childhood fevers, but the rural mothers were more likely to use leftover drugs from previous treatment to treat the fevers than urban mothers. The urban respondents were also more likely to use a preventive measure. Urban mothers sought actions faster than rural mothers and the total cost of treatment was also higher in urban areas. Conclusions/Significance: Both urban and rural mothers are aware that malaria is the major cause of childhood fevers. Although rural mothers recognize childhood fever and danger signs better than urban mothers, the urban mothers' responses to fever seem to be better than that for rural mothers. These responses and differences may be important for geographical targeting by policy makers for malaria interventions.	[Uzochukwu, Benjamin S. C.] Univ Nigeria, Coll Med, Dept Community Med, Enugu, Nigeria; [Onwujekwe, Emmanuel O.] Univ Nigeria, Coll Med, Dept Hlth Administrat & Management, Enugu, Nigeria; [Onoka, Chima A.] Univ Nigeria Teach Hosp, Dept Community Med, Enugu, Nigeria; [Ughasoro, Maduka D.] Univ Nigeria Teach Hosp, Dept Paediat, Enugu, Nigeria	University of Nigeria; University of Nigeria; University of Nigeria; University of Nigeria	Uzochukwu, BSC (corresponding author), Univ Nigeria, Coll Med, Dept Community Med, Enugu, Nigeria.	bscuzochukwu@yahoo.com	Onwujekwe, Obinna/O-6232-2014	Onwujekwe, Obinna/0000-0002-1214-4285; Onoka, Chima/0000-0002-3328-1887				ADETUNJI JA, 1991, SOC SCI MED, V32, P1379, DOI 10.1016/0277-9536(91)90198-L; Adikwu MU, 1996, HEALTH POLICY PLANN, V11, P202, DOI 10.1093/heapol/11.2.202; AGYEPONG IA, 1994, ACTA TROP, V58, P317, DOI 10.1016/0001-706X(94)90025-6; Akogun OB, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-13; BAUDON D, 1985, T ROY SOC TROP MED H, V79, P283, DOI 10.1016/0035-9203(85)90361-X; Baume C, 2000, SOC SCI MED, V51, P1491, DOI 10.1016/S0277-9536(00)00049-6; Brieger WR, 2004, HEALTH POLICY PLANN, V19, P177, DOI 10.1093/heapol/czh021; BRIEGER WR, 2002, AFRICAN J MED MED SC, V30, P7; BRODY JE, 1993, NY TIMES, P20; Brugha R, 2002, HLTH POLICY PLAN, V13, P103; Buor D, 2003, INT J HEALTH PLAN M, V18, P293, DOI 10.1002/hpm.729; CHANDRASHEKHAR T, 2006, BMC INT HEALTH HUM R, V6, P7, DOI DOI 10.1186/1472-698X-6-7; DEMING MS, 1989, B WORLD HEALTH ORGAN, V67, P695; DNELLI M, 2005, URBAN MALARIA AFRICA; ERHUN OO, 2001, J HLTH POPULATION DE, V4, P23; ERHUN WO, 1992, NIGERIAN J PHARM, V23, P13; Fawole O I, 2001, West Afr J Med, V20, P152; *FED MIN HLTH, 2001, STRAT PLAN ROLL BACK; *FED REP NIG, 2003, NIG DEM HLTH SURV; Federal Ministry of Health, 2005, ANN REP FED MIN HLTH; Feyisetan B J, 1997, Health Transit Rev, V7, P221; Fotso J, 2006, INT J EQUITY HEALTH, V5; GENTON B, 1994, T ROY SOC TROP MED H, V88, P537, DOI 10.1016/0035-9203(94)90152-X; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; GLIK DC, 1989, J HLTH SOCIAL BEHAV, V30, P426; Hamel MJ, 2001, B WORLD HEALTH ORGAN, V79, P1014; HANSON K, 2004, EC MALARIA CONTROL I; HASIBEDER G, 1988, THEOR POPUL BIOL, V33, P31, DOI 10.1016/0040-5809(88)90003-2; IWEZE EA, 1987, URBAN POOR NIGERIA, P317; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Kelly L, 1996, J Pediatr Health Care, V10, P167, DOI 10.1016/S0891-5245(96)90040-1; KLINKENBERG E, 2004, AM J TROP MED HYG; Krantz C, 2001, Pediatr Nurs, V27, P567; LEVY J, 2001, PEDIAT NURSING, V27, P567; LISA C, 2004, 176 INT FOOD POL RES; Molyneux CS, 1999, TROP MED INT HEALTH, V4, P836, DOI 10.1046/j.1365-3156.1999.00489.x; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; *MVCU, 2000, PREV MAL MORB MORT E; Njama D, 2003, TROP MED INT HEALTH, V8, P685, DOI 10.1046/j.1365-3156.2003.01060.x; Nyamongo IK, 2002, SOC SCI MED, V54, P377, DOI 10.1016/S0277-9536(01)00036-3; Oguonu T, 2005, PUBLIC HEALTH, V119, P409, DOI 10.1016/j.puhe.2004.05.008; OKEKE TA, 2006, NIGERIAN COMMUNITY M, V5, P97; Onwujekwe O, 2004, ACTA TROP, V91, P101, DOI 10.1016/j.actatropica.2004.03.005; Onwujekwe Obinna, 2005, Health Policy, V71, P383, DOI 10.1016/j.healthpol.2004.06.006; ONWUJEKWE OE, 2003, J COLL MED, V8, P20; Ruel Marie, 1998, 51 INT FOOD POL RES; Ruel MT, 2001, NESTLE NUTR WORKS SE, V47, P123; Salako LA, 2001, J TROP PEDIATRICS, V47, P230, DOI 10.1093/tropej/47.4.230; *STAT MIN HLTH EN, 2000, DEM PROF EN STAT; STEIN CM, 1988, TROP GEOGR MED, V40, P264; TABIBZADEH I, 1989, SPOTLIGHT CITIES IMP; TANNER M, 1995, ACTION RES URBAN HEA; Tarimo DS, 2000, TROP MED INT HEALTH, V5, P179, DOI 10.1046/j.1365-3156.2000.00537.x; Thera MA, 2000, TROP MED INT HEALTH, V5, P876, DOI 10.1046/j.1365-3156.2000.00652.x; Uzochukwu Benjamin Sc, 2004, Int J Equity Health, V3, P6, DOI 10.1186/1475-9276-3-6; VanderStuyft P, 1996, TROP MED INT HEALTH, V1, P161	56	42	42	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1788	10.1371/journal.pone.0001788	http://dx.doi.org/10.1371/journal.pone.0001788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369VW	18335058	Green Published, gold, Green Submitted			2022-12-25	WOS:000260723000039
J	Paruchuri, V; Prasad, A; McHugh, K; Bhat, HK; Polyak, K; Ganju, RK				Paruchuri, Vikram; Prasad, Anil; McHugh, Kevin; Bhat, Hari K.; Polyak, Kornelia; Ganju, Ramesh K.			S100A7-Downregulation Inhibits Epidermal Growth Factor-Induced Signaling in Breast Cancer Cells and Blocks Osteoclast Formation	PLOS ONE			English	Article							PSORIASIN S100A7 EXPRESSION; CARCINOMA IN-SITU; FACTOR RECEPTOR; C-SRC; BONE METASTASES; EGF RECEPTOR; PROTEIN; ACTIVATION; IDENTIFICATION; HER2	S100A7 is a small calcium binding protein, which has been shown to be differentially expressed in psoriatic skin lesions, as well as in squamous cell tumors of the skin, lung and breast. Although its expression has been correlated to HER+ high-grade tumors and to a high risk of progression, the molecular mechanisms of these S100A7-mediated tumorigenic effects are not well known. Here, we showed for the first time that epidermal growth factor (EGF) induces S100A7 expression in both MCF-7 and MDA-MB-468 cell lines. We also observed a decrease in EGF-directed migration in shRNA-downregulated MDA-MB-468 cell lines. Furthermore, our signaling studies revealed that EGF induced simultaneous EGF receptor phosphorylation at Tyr1173 and HER2 phosphorylation at Tyr1248 in S100A7-downregulated cell lines as compared to the vector-transfected controls. In addition, reduced phosphorylation of Src at tyrosine 416 and p-SHP2 at tyrosine 542 was observed in these downregulated cell lines. Further studies revealed that S100A7-downregulated cells had reduced angiogenesis in vivo based on matrigel plug assays. Our results also showed decreased tumor-induced osteoclastic resorption in an intra-tibial bone injection model involving SCID mice. S100A7-downregulated cells had decreased osteoclast number and size as compared to the vector controls, and this decrease was associated with variations in IL-8 expression in in vitro cell cultures. This is a novel report on the role of S100A7 in EGF-induced signaling in breast cancer cells and in osteoclast formation.	[Paruchuri, Vikram; Prasad, Anil; Ganju, Ramesh K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med, Boston, MA 02215 USA; [McHugh, Kevin] Beth Israel Deaconess Med Ctr, Harvard Med Sch, Div Rheumatol, Boston, MA USA; [Bhat, Hari K.] Columbia Univ, Mailman Sch Public Hlth, Dept Environmental Hlth Sci, New York, NY USA; [Polyak, Kornelia] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Columbia University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Ganju, RK (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Expt Med, Boston, MA 02215 USA.	ramesh.ganju@osumc.edu			National Institutes of Health [CA109527]; Susan G. Komen Breast Cancer Foundation; Department of Defense Award [W81XWH-05-1-0465]; NATIONAL CANCER INSTITUTE [R01CA109527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Department of Defense Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research is supported in part by a grant from the National Institutes of Health CA109527, Susan G. Komen Breast Cancer Foundation, and the Department of Defense Award # W81XWH-05-1-0465 to RKG.	Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Alowami Salem, 2003, BMC Dermatol, V3, P1, DOI 10.1186/1471-5945-3-1; Angelucci A, 2006, ENDOCR-RELAT CANCER, V13, P197, DOI 10.1677/erc.1.01100; Bendre M, 2003, CLIN ORTHOP RELAT R, pS39, DOI 10.1097/01.blo.0000093844.72468.f4; Bendre MS, 2002, CANCER RES, V62, P5571; BERTICS PJ, 1988, J BIOL CHEM, V263, P3610; Brandt BH, 1999, FASEB J, V13, P1939, DOI 10.1096/fasebj.13.14.1939; Bryborn M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-118; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.3.CO;2-T; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; Chelouche-Lev D, 2004, EUR J CANCER, V40, P2509, DOI 10.1016/j.ejca.2004.05.024; DiGiovanna MP, 2005, J CLIN ONCOL, V23, P1152, DOI 10.1200/JCO.2005.09.055; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Emberley ED, 2005, CANCER RES, V65, P5696, DOI 10.1158/0008-5472.CAN-04-3927; Emberley ED, 2003, CLIN CANCER RES, V9, P2627; Emberley ED, 2003, CANCER RES, V63, P1954; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Harvey HA, 1997, CANCER-AM CANCER SOC, V80, P1646, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1646::AID-CNCR14>3.0.CO;2-#; HENNIPMAN A, 1989, CANCER RES, V49, P516; Hudelist G, 2006, INT J CANCER, V118, P1126, DOI 10.1002/ijc.21492; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kakonen SM, 2003, CANCER-AM CANCER SOC, V97, P834, DOI 10.1002/cncr.11132; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; KHAZAIE K, 1993, CANCER METAST REV, V12, P255, DOI 10.1007/BF00665957; Klos KS, 2006, CANCER RES, V66, P2028, DOI 10.1158/0008-5472.CAN-04-4559; Krop I, 2005, CANCER RES, V65, P11326, DOI 10.1158/0008-5472.CAN-05-1523; LIU E, 1992, ONCOGENE, V7, P1027; Lombardo CR, 1995, BIOCHEMISTRY-US, V34, P16456, DOI 10.1021/bi00050a029; Lotz M, 2003, J SURG RES, V109, P123, DOI 10.1016/S0022-4804(02)00100-2; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Moubayed N, 2007, J CANCER RES CLIN, V133, P253, DOI 10.1007/s00432-006-0164-y; Ostergaard M, 1997, CANCER RES, V57, P4111; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; Pederson L, 1999, CANCER RES, V59, P5849; Porter D, 2003, MOL CANCER RES, V1, P362; RADINSKY R, 1995, CLIN CANCER RES, V1, P19; Silva AR, 2006, INT J SURG PATHOL, V14, P268, DOI 10.1177/1066896906290820; Roodman GD, 2001, J CLIN ONCOL, V19, P3562, DOI 10.1200/JCO.2001.19.15.3562; Singh B, 2006, J SURG RES, V134, P44, DOI 10.1016/j.jss.2006.03.018; Vogl G, 2006, APPL IMMUNOHISTO M M, V14, P138, DOI 10.1097/01.pai.0000168591.58721.a6; Webb M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-17; Weber KL, 2003, CANCER RES, V63, P2940; Wilson GR, 2006, BRIT J CANCER, V95, P1410, DOI 10.1038/sj.bjc.6603444; YONEDA T, 1994, BREAST CANCER RES TR, V32, P73, DOI 10.1007/BF00666208	46	34	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1741	10.1371/journal.pone.0001741	http://dx.doi.org/10.1371/journal.pone.0001741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320059	Green Published, Green Submitted, gold			2022-12-25	WOS:000260586600036
J	Drago, I; Giacomello, M; Pizzo, P; Pozzan, T				Drago, Ilaria; Giacomello, Marta; Pizzo, Paola; Pozzan, Tullio			Calcium dynamics in the peroxisomal lumen of living cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING SIGNAL-1; BETA-OXIDATION; CA2+; PH; HOMEOSTASIS; PROTEINS	We here describe the generation of novel, green fluorescent protein-based Ca2+ indicators targeted to the peroxisome lumen. We show that (i) the Ca2+ concentration of peroxisomes in living cells at rest is similar to that of the cytosol; ( ii) increases in cytosolic Ca2+ concentration ( elicited by either Ca2+ mobilization from stores or Ca2+ influx through plasma membrane Ca2+ channels) are followed by a slow rise in intraperoxisomal [ Ca2+]; ( iii) Ca2+ influx into peroxisomes is driven neither by an ATP-dependent pump nor by membrane potential nor by a H+(Na+) gradient. The peroxisomal membrane appears to play a low pass filter role, preventing the organelle from taking up shortlasting cytosolic Ca2+ transients but allowing equilibration of the peroxisomal luminal [Ca2+] with that of the cytosol during prolonged Ca2+ increases. Thus, peroxisomes appear to be an additional cytosolic Ca2+ buffer, but their influx and efflux mechanisms are unlike those of any other cellular organelle.	[Drago, Ilaria; Giacomello, Marta; Pizzo, Paola; Pozzan, Tullio] Univ Padua, CNR, Inst Neurosci, Dept Biomed Sci, I-35121 Padua, Italy; [Pozzan, Tullio] Venetian Inst Mol Med, I-35121 Padua, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Padua; Veneto Institute Molecular Medicine	Pozzan, T (corresponding author), Univ Padua, CNR, Inst Neurosci, Dept Biomed Sci, Viale G Colombo 3, I-35121 Padua, Italy.	tullio.pozzan@unipd.it	drago, ilaria/I-3014-2017; Pizzo, Paola/T-4874-2018; GIACOMELLO, MARTA/HGB-1486-2022; Marta, Giacomello/B-6308-2013	Pizzo, Paola/0000-0001-6077-3265; Giacomello, Marta/0000-0002-0290-6602	Telethon [1226] Funding Source: Medline	Telethon(Fondazione Telethon)		Dansen TB, 2000, NAT CELL BIOL, V2, P51, DOI 10.1038/71375; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Jankowski A, 2001, J BIOL CHEM, V276, P48748, DOI 10.1074/jbc.M109003200; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Lasorsa FM, 2004, BIOCHEM J, V381, P581, DOI 10.1042/BJ20040856; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Pizzo P, 1997, J CELL BIOL, V136, P355, DOI 10.1083/jcb.136.2.355; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rudolf R, 2006, J CELL BIOL, V173, P187, DOI 10.1083/jcb.200601160; SCHLEGEL W, 1987, NATURE, V329, P719, DOI 10.1038/329719a0; Shimozawa N, 2007, J INHERIT METAB DIS, V30, P193, DOI 10.1007/s10545-007-0516-z; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; van Roermund CWT, 2004, J CELL SCI, V117, P4231, DOI 10.1242/jcs.01305; WATERHAM HR, 1990, FEBS LETT, V262, P17, DOI 10.1016/0014-5793(90)80142-6; Weber FE, 1997, P NATL ACAD SCI USA, V94, P8509, DOI 10.1073/pnas.94.16.8509; Yang T, 2002, P NATL ACAD SCI USA, V99, P4097, DOI 10.1073/pnas.052564899	21	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14384	14390		10.1074/jbc.M800600200	http://dx.doi.org/10.1074/jbc.M800600200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18362140	hybrid			2022-12-25	WOS:000255941400025
J	Bailey, KM; Liu, J				Bailey, Kelly M.; Liu, Jun			Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; RESISTANT CANCER-CELLS; ROUS-SARCOMA VIRUS; GROWTH-FACTOR-BETA; TYROSINE PHOSPHORYLATION; DOWN-REGULATION; BREAST-CANCER; E-CADHERIN; TGF-BETA; SIGNAL-TRANSDUCTION	Emerging evidence has shown that caveolin-1 is up-regulated in a number of metastatic cancers and can influence various aspects of cell migration. However, in general, the role of caveolin-1 in cancer progression is poorly understood. In the present study, we examined alterations in caveolin-1 expression during epithelial-to-mesenchymal transition (EMT) and the ability of caveolin-1 to alter cancer cell adhesion, an aspect of cell motility. We employed two EMT cell models, the human embryonic carcinoma cell line NT2/D1, and TGF-beta 1-treated NMuMG cells, which are derived from normal mouse mammary epithelia. Caveolin-1 expression was substantially upregulated in both cell lines following the induction of EMT and was preceded by increased activation of focal adhesion kinase (FAK) and Src, two known tyrosine kinases involved in EMT. We hypothesized that caveolin-1 expression could be influenced by increased FAK phosphorylation, to which Src is a known contributor. Examination of FAK(+/+) and FAK(+/+) mouse embryonic fibroblasts revealed that in cells devoid of FAK, caveolin-1 expression is strikingly diminished. Using FAK and superFAK constructs and the novel FAK inhibitor PF-228, we were able to demonstrate that indeed, FAK can regulate caveolin-1 expression. We also found that Src can contribute to increases in caveolin-1 expression, however, only in the presence of FAK. From the culmination of this data and our functional analyses, we conclude that caveolin-1 expression can be up-regulated during EMT, and further, once expressed, caveolin-1 can greatly influence cancer cell adhesion.	[Liu, Jun] W Virginia Univ, Hlth Sci Ctr, Dept Physiol & Pharmacol, Morgantown, WV 26506 USA	West Virginia University	Liu, J (corresponding author), W Virginia Univ, Hlth Sci Ctr, Dept Physiol & Pharmacol, POB 9229, Morgantown, WV 26506 USA.	junliu@hsc.wvu.edu		Bailey, Kelly/0000-0003-3925-3243	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NCRR NIH HHS [RR016440] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDREWS PW, 1982, INT J CANCER, V29, P523, DOI 10.1002/ijc.2910290507; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; ANDREWS PW, 1984, LAB INVEST, V50, P147; [Anonymous], MEMBRANE MICRODOMAIN; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Beardsley A, 2005, J BIOL CHEM, V280, P3541, DOI 10.1074/jbc.M409040200; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; Duran C, 2001, INT J CANCER, V93, P324, DOI 10.1002/ijc.1355; Earley S, 2006, BIOCHEM BIOPH RES CO, V350, P405, DOI 10.1016/j.bbrc.2006.09.056; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Engelman JA, 1998, FEBS LETT, V436, P403, DOI 10.1016/S0014-5793(98)01134-X; Fielding CJ, 1997, P NATL ACAD SCI USA, V94, P3753, DOI 10.1073/pnas.94.8.3753; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Gabarra-Niecko V, 2002, BIOCHEM J, V365, P591, DOI 10.1042/BJ20020065; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; GLENNEY JR, 1989, J BIOL CHEM, V264, P20163; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hauck CR, 2002, EMBO J, V21, P6289, DOI 10.1093/emboj/cdf631; Hayashi K, 2001, CANCER RES, V61, P2361; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; Lavie Y, 2001, ADV DRUG DELIVER REV, V49, P317, DOI 10.1016/S0169-409X(01)00144-2; Lee H, 2001, J BIOL CHEM, V276, P35150, DOI 10.1074/jbc.M104530200; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; LEE VMY, 1986, J NEUROSCI, V6, P514; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nakamura K, 2001, ONCOGENE, V20, P2626, DOI 10.1038/sj.onc.1204359; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; Owen JD, 1999, MOL CELL BIOL, V19, P4806; Parat MO, 2003, MOL BIOL CELL, V14, P3156, DOI 10.1091/mbc.e02-11-0761; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Podar K, 2004, CANCER RES, V64, P7500, DOI 10.1158/0008-5472.CAN-04-0124; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251; Rajjayabun PH, 2001, UROLOGY, V58, P811, DOI 10.1016/S0090-4295(01)01337-1; Ravid D, 2006, ADV ENZYME REGUL, V46, P163, DOI 10.1016/j.advenzreg.2006.01.022; Razani B, 2001, BIOCHEM SOC T, V29, P494, DOI 10.1042/BST0290494; Robson EJD, 2006, DIFFERENTIATION, V74, P254, DOI 10.1111/j.1432-0436.2006.00075.x; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Salatino M, 2006, ONCOGENE, V25, P7723, DOI 10.1038/sj.onc.1209757; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Slack JK, 2001, ONCOGENE, V20, P1152, DOI 10.1038/sj.onc.1204208; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0; Sun XH, 2007, J BIOL CHEM, V282, P7232, DOI 10.1074/jbc.M607396200; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yang G, 1998, CLIN CANCER RES, V4, P1873; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	75	82	91	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13714	13724		10.1074/jbc.M709329200	http://dx.doi.org/10.1074/jbc.M709329200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18332144	Green Published, hybrid			2022-12-25	WOS:000255728200023
J	Kim, KJ; Park, MC; Choi, SJ; Oh, YS; Choi, EC; Cho, HJ; Kim, MH; Kim, SH; Kim, DW; Kim, S; Kang, BS				Kim, Kyung-Jin; Park, Min Chul; Choi, So Jung; Oh, Young Sun; Choi, Eung-Chil; Cho, Hyo Je; Kim, Myung Hee; Kim, Soo-Hyun; Kim, Dong Wook; Kim, Sunghoon; Kang, Beom Sik			Determination of three-dimensional structure and residues of the novel tumor suppressor AIMP3/p18 required for the interaction with ATM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; CRYSTAL-STRUCTURE; COMPLEX-FORMATION; PROTEIN; DOMAIN; P43; COFACTOR; IDENTIFICATION; TRANSLATION; ACTIVATION	Although AIMP3/p18 is normally associated with the multi-tRNA synthetase complex via its specific interaction with methionyl-tRNA synthetase, it also works as a tumor suppressor by interacting with ATM, the upstream kinase of p53. To understand the molecular interactions of AIMP3 and the mechanisms involved, we determined the crystal structure of AIMP3 at 2.0-angstrom resolution and identified its potential sites of interaction with ATM. AIMP3 contains two distinct domains linked by a 7-amino acid (Lys(57)-Ser(63)) peptide, which contains a 310 helix. The 56-amino acid N-terminal domain consists of two helices into which three antiparallel beta strands are inserted, and the 111-amino acid C-terminal domain contains a bundle of five helices (Thr(64)-Tyr(152)) followed by a coiled region (Pro(153)-Leu(169)). Structural analyses revealed homologous proteins such as yeast glutamyl-tRNA synthetase, Arc1p, EF1B gamma, and glutathione S-transferase and suggested two potential molecular binding sites. Moreover, mutations at the C-terminal putative binding site abolished the interaction between AIMP3 and ATM and the ability of AIMP3 to activate p53. Thus, this work identified the two potential molecular interaction sites of AIMP3 and determined the residues critical for its tumor-suppressive activity through the interaction with ATM.	[Park, Min Chul; Choi, So Jung; Oh, Young Sun; Choi, Eung-Chil; Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Ctr Med Prot Network & Syst Biol, Seoul 151742, South Korea; [Kim, Kyung-Jin] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790784, South Korea; [Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Kim, Soo-Hyun; Kim, Dong Wook] Catholic Univ, Coll Med, St Marys Hosp, Div Hematol, Seoul 150713, South Korea; [Cho, Hyo Je; Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital; Kyungpook National University	Kim, S (corresponding author), Seoul Natl Univ, Coll Pharm, Ctr Med Prot Network & Syst Biol, Kwanak Ro 599, Seoul 151742, South Korea.	sungkim@snu.ac.kr; bskang2@knu.ac.kr	Kim, Sunghoon/AAE-8314-2020					Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Cheong HK, 2003, INT J BIOCHEM CELL B, V35, P1548, DOI 10.1016/S1357-2725(03)00070-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han JM, 2006, J BIOL CHEM, V281, P38663, DOI 10.1074/jbc.M605211200; Hansen AM, 2005, J BIOL CHEM, V280, P17380, DOI 10.1074/jbc.M501444200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jeong EJ, 2000, BIOCHEMISTRY-US, V39, P15775, DOI 10.1021/bi001393h; Jeppesen MG, 2003, J BIOL CHEM, V278, P47190, DOI 10.1074/jbc.M306630200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Kim E, 2006, J IMMUNOL, V176, P256, DOI 10.4049/jimmunol.176.1.256; Kim MJ, 2003, NAT GENET, V34, P330, DOI 10.1038/ng1182; Kim Y, 2000, J BIOL CHEM, V275, P27062; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; Neuefeind T, 1997, J MOL BIOL, V274, P446, DOI 10.1006/jmbi.1997.1402; Nishida M, 1998, J MOL BIOL, V281, P135, DOI 10.1006/jmbi.1998.1927; Oakley AJ, 2001, PROTEIN SCI, V10, P2176, DOI 10.1110/ps.21201; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Park BJ, 2006, CANCER RES, V66, P6913, DOI 10.1158/0008-5472.CAN-05-3740; Park SG, 2006, P NATL ACAD SCI USA, V103, P14913, DOI 10.1073/pnas.0602045103; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Park SG, 2005, AM J PATHOL, V166, P387, DOI 10.1016/S0002-9440(10)62262-6; Park SG, 2002, J BIOL CHEM, V277, P45243, DOI 10.1074/jbc.M207934200; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Renault L, 2001, EMBO J, V20, P570, DOI 10.1093/emboj/20.3.570; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Simader H, 2006, ACTA CRYSTALLOGR D, V62, P1510, DOI 10.1107/S0907444906039850; Simader H, 2006, NUCLEIC ACIDS RES, V34, P3968, DOI 10.1093/nar/gkl560; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898	39	32	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14032	14040		10.1074/jbc.M800859200	http://dx.doi.org/10.1074/jbc.M800859200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18343821	hybrid			2022-12-25	WOS:000255728200057
J	Lopez-Pajares, V; Kim, MM; Yuan, ZM				Lopez-Pajares, Vanessa; Kim, Mihee M.; Yuan, Zhi-Min			Phosphorylation of MDMX mediated by Akt leads to stabilization and induces 14-3-3 binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; LIGASE ACTIVITY; P53 UBIQUITINATION; CANCER-THERAPY; DEGRADATION; HDMX; PROTEIN; AMPLIFICATION; ATM; CONTRIBUTES	The critical tumor suppressor p53 is mutated or functionally inactivated in nearly all cancers. We have shown previously that the MDM2-MDMX complex functions as an integral unit in targeting p53 for degradation. Here we identify the small protein 14-3-3 as a binding partner of MDMX, which binds at the C terminus (Ser367) in a phosphorylation-dependent manner. Importantly, we demonstrate that the serine/threonine kinase Akt mediates phosphorylation of MDMX at Ser367. This phosphorylation leads to stabilization of MDMX and consequent stabilization of MDM2. Previous studies have shown that Akt phosphorylates and stabilizes MDM2. Our data suggest that stabilization of MDMX by Akt may be an alternative mechanism by which Akt up-regulates MDM2 protein levels and exerts its oncogenic effects on p53 in tumor cells.	[Lopez-Pajares, Vanessa; Kim, Mihee M.; Yuan, Zhi-Min] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Yuan, ZM (corresponding author), 665 Huntington Ave Bldg 1-507, Boston, MA 02215 USA.	zyuan@hsph.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA085679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007155] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA85679-02] Funding Source: Medline; NIEHS NIH HHS [T32ES07155] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Badciong JC, 2002, J BIOL CHEM, V277, P49668, DOI 10.1074/jbc.M208593200; Basu S, 2003, CELL CYCLE, V2, P69, DOI 10.4161/cc.2.2.303; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Finch RA, 2002, CANCER RES, V62, P3221; Gentiletti F, 2002, ONCOGENE, V21, P867, DOI 10.1038/sj.onc.1205137; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Gu JJ, 2000, MOL CELL BIOL, V20, P1243, DOI 10.1128/MCB.20.4.1243-1253.2000; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Milne D, 2004, FEBS LETT, V577, P270, DOI 10.1016/j.febslet.2004.09.081; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Ramos YFM, 2001, CANCER RES, V61, P1839; Riemenschneider MJ, 1999, CANCER RES, V59, P6091; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Singh RK, 2007, J BIOL CHEM, V282, P10901, DOI 10.1074/jbc.M610879200; Stad R, 2000, J BIOL CHEM, V275, P28039; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	48	53	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13707	13713		10.1074/jbc.M710030200	http://dx.doi.org/10.1074/jbc.M710030200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18356162	hybrid, Green Published			2022-12-25	WOS:000255728200022
J	Malla, N; Berg, E; Uhlin-Hansen, L; Winberg, JO				Malla, Nabin; Berg, Eli; Uhlin-Hansen, Lars; Winberg, Jan-Olof			Interaction of pro-matrix metalloproteinase-9/proteoglycan heteromer with gelatin and collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; EPIDERMOLYSIS-BULLOSA SIMPLEX; HUMAN NEUTROPHIL GELATINASE; FIBRONECTIN-LIKE DOMAIN; IV COLLAGENASE; EXTRACELLULAR-MATRIX; FUNCTIONAL-ANALYSIS; BINDING-PROPERTIES; ENDOTHELIAL-CELLS; COMPLEX-FORMATION	Previously we have shown that THP-1 cells synthesize matrix metalloproteinase-9 (MMP-9) where a fraction of the enzyme is strongly linked to a proteoglycan ( PG) core protein. In the present work we show that these pro-MMP-9 center dot PG heteromers have different biochemical properties compared with the monomeric form of pro-MMP-9. In these heteromers, the fibronectin II-like domain in the catalytic site of the enzyme is hidden, and the fibronectin II-like-mediated binding to gelatin and collagen is prevented. However, a fraction of the pro-MMP-9 center dot PG heteromers interacted with gelatin and collagen. This interaction was not through the chondroitin sulfate (CS) part of the PG molecule but, rather, through a region in the PG core protein, a new site induced by the interaction of pro-MMP-9 and the PG core protein, or a non-CS glycosaminoglycan part of the PG molecule. The interaction between pro-MMP-9 center dot PG heteromers and gelatin was weaker than the interaction between pro-MMP-9 and gelatin. In contrast, collagen I bound to pro-MMP-9 center dot PG heteromers and pro-MMP-9 with approximately the same affinity. Removal of CS chains from the PG part of the heteromers did not affect the binding to gelatin and collagen. Although the identity of the PG core protein is not known, this does not have any impact on the described biochemical properties of the heteromer or its pro-MMP-9 component. It is also shown that a small fraction of the PG, which is not a part of the pro-MMP-9 center dot PG heteromer, can bind gelatin. As for the pro-MMP-9 center dot PG heteromers, this was independent of the CS chains. The structure that mediates the binding of free PG to gelatin is different from the corresponding structure in the pro-MMP-9 center dot PG heteromer, because they were eluted from gelatin-Sepharose columns under totally different conditions. Although only a small amount of pro-MMP-9 center dot PG heteromer is formed, the heteromer may have fundamental physiological importance, because only catalytic amounts of the enzyme are required to digest physiological targets.	[Malla, Nabin; Berg, Eli; Winberg, Jan-Olof] Univ Tromso, Inst Med Biol, Dept Med Biochem, N-9037 Tromso, Norway; [Uhlin-Hansen, Lars] Univ Tromso, Inst Med Biol, Dept Pathol, N-9037 Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Winberg, JO (corresponding author), Univ Tromso, Inst Med Biol, Dept Med Biochem, MH Bldg, N-9037 Tromso, Norway.	janow@fagmed.uit.no						ALLAN JA, 1995, BIOCHEM J, V309, P299, DOI 10.1042/bj3090299; CARRINO DA, 1991, BIOCHEM INT, V24, P485; CARSON DD, 1992, DEV BIOL, V149, P307, DOI 10.1016/0012-1606(92)90286-P; Cattaruzza S, 2006, MACROMOL BIOSCI, V6, P667, DOI 10.1002/mabi.200600100; Cawston TE, 2006, BEST PRACT RES CL RH, V20, P983, DOI 10.1016/j.berh.2006.06.007; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; CRABBE T, 1993, EUR J BIOCHEM, V218, P431, DOI 10.1111/j.1432-1033.1993.tb18393.x; EDWARDS IJ, 1995, ARTERIOSCL THROM VAS, V15, P400, DOI 10.1161/01.ATV.15.3.400; Flannery CR, 2006, FRONT BIOSCI-LANDMRK, V11, P544, DOI 10.2741/1818; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; HASCALL VC, 1994, METHOD ENZYMOL, V230, P390; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kolkenbrock H, 1996, BIOL CHEM, V377, P529, DOI 10.1515/bchm3.1996.377.7-8.529; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; LYON M, 1991, BIOCHEM J, V273, P415, DOI 10.1042/bj2730415; LYONS JG, 1991, BIOCHEMISTRY-US, V30, P1449, DOI 10.1021/bi00220a001; Makatsori E, 2003, ANTICANCER RES, V23, P3303; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; MURPHY G, 1994, J BIOL CHEM, V269, P6632; MURPHY G, 1995, METHOD ENZYMOL, V248, P470; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; O'Farrell TJ, 1998, ARCH BIOCHEM BIOPHYS, V354, P24, DOI 10.1006/abbi.1998.0662; OKAYAMA M, 1973, J BIOCHEM-TOKYO, V74, P1069; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Oynebraten I, 2000, J LEUKOCYTE BIOL, V67, P183, DOI 10.1002/jlb.67.2.183; POURMOTABBED T, 1994, ANN NY ACAD SCI, V732, P372, DOI 10.1111/j.1749-6632.1994.tb24757.x; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; RUOSLAHTI E, 1980, BIOCHIM BIOPHYS ACTA, V631, P350, DOI 10.1016/0304-4165(80)90308-6; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Shipley JM, 1996, J BIOL CHEM, V271, P4335; SMITH RL, 1988, ARCH BIOCHEM BIOPHYS, V266, P181, DOI 10.1016/0003-9861(88)90248-2; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Strongin AY, 2006, CANCER METAST REV, V25, P87, DOI 10.1007/s10555-006-7892-y; STRONGIN AY, 1993, KIDNEY INT, V43, P158, DOI 10.1038/ki.1993.26; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; ToyamaSorimachi N, 1997, J BIOL CHEM, V272, P26714, DOI 10.1074/jbc.272.42.26714; TRIEBEL S, 1992, FEBS LETT, V314, P386, DOI 10.1016/0014-5793(92)81511-J; Tschesche H, 2001, EUR J BIOCHEM, V268, P1918, DOI 10.1046/j.1432-1327.2001.02066.x; UHLINHANSEN L, 1993, BLOOD, V82, P2880; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Wallon UM, 1997, J BIOL CHEM, V272, P7473, DOI 10.1074/jbc.272.11.7473; WINBERG JO, 1992, BIOCHEM GENET, V30, P401, DOI 10.1007/BF00569330; WINBERG JO, 1986, J INVEST DERMATOL, V87, P326, DOI 10.1111/1523-1747.ep12524396; Winberg JO, 2003, EUR J BIOCHEM, V270, P3996, DOI 10.1046/j.1432-1033.2003.03788.x; Winberg JO, 2000, J MOL BIOL, V304, P669, DOI 10.1006/jmbi.2000.4235; Xu XP, 2005, BIOCHEM J, V392, P127, DOI 10.1042/BJ20050650; Xu XP, 2004, MATRIX BIOL, V23, P171, DOI 10.1016/j.matbio.2004.05.002; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183; Zhou J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-25	54	29	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13652	13665		10.1074/jbc.M709140200	http://dx.doi.org/10.1074/jbc.M709140200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359769	hybrid			2022-12-25	WOS:000255728200017
J	Singh, P; Wang, BL; Maeda, T; Palczewski, K; Tesmer, JJG				Singh, Puja; Wang, Benlian; Maeda, Tadao; Palczewski, Krzysztof; Tesmer, John J. G.			Structures of rhodopsin kinase in different ligand states reveal key elements involved in G protein-coupled receptor kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; TERMINAL TAIL; OGUCHI FORM; PHOSPHORYLATION; SITES; ROD; IDENTIFICATION; PEPTIDE; GENE; ISOPRENYLATION	G protein-coupled receptor (GPCR) kinases (GRKs) phosphorylate activated heptahelical receptors, leading to their uncoupling from G proteins. Here we report six crystal structures of rhodopsin kinase (GRK1), revealing not only three distinct nucleotide-binding states of a GRK but also two key structural elements believed to be involved in the recognition of activated GPCRs. The first is the C-terminal extension of the kinase domain, which was observed in all nucleotide-bound GRK1 structures. The second is residues 5-30 of the N terminus, observed in one of the GRK1 center dot(Mg2+)(2)center dot ATP structures. The N terminus was also clearly phosphorylated, leading to the identification of two novel phosphorylation sites by mass spectral analysis. Co-localization of the N terminus and the C-terminal extension near the hinge of the kinase domain suggests that activated GPCRs stimulate kinase activity by binding to this region to facilitate full closure of the kinase domain.	[Singh, Puja; Tesmer, John J. G.] Univ Michigan, Dept Pharmacol, Inst Life Sci, Ann Arbor, MI 48109 USA; [Singh, Puja] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Maeda, Tadao; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Wang, Benlian] Case Western Reserve Univ, Sch Med, Ctr Prote & Mass Spectrometry, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Austin; Case Western Reserve University; Case Western Reserve University	Tesmer, JJG (corresponding author), Univ Michigan, Dept Pharmacol, Inst Life Sci, Ann Arbor, MI 48109 USA.	johntesmer@umich.edu	Singh, Puja/M-9548-2014	Tesmer, John/0000-0003-1125-3727	NCI NIH HHS [Y1-CO-1020] Funding Source: Medline; NEI NIH HHS [P30 EY011373, P30-EY11373, R01 EY008061-22, R01 EY008061, EY 08061, P30 EY011373-129005] Funding Source: Medline; NHLBI NIH HHS [HL071818] Funding Source: Medline; NIGMS NIH HHS [Y1-GM-1104] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY011373, R29EY008061, R01EY008061] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akamine P, 2003, J MOL BIOL, V327, P159, DOI 10.1016/S0022-2836(02)01446-8; Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Batkin M, 2000, BIOCHEMISTRY-US, V39, P5366, DOI 10.1021/bi000153z; BINDER BM, 1990, J BIOL CHEM, V265, P15333; BUCZYLKO J, 1991, P NATL ACAD SCI USA, V88, P2568, DOI 10.1073/pnas.88.6.2568; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P328, DOI 10.1073/pnas.95.1.328; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; FOWLES C, 1988, FEBS LETT, V238, P56, DOI 10.1016/0014-5793(88)80224-2; Hayashi T, 2007, OPHTHALMOLOGY, V114, P134, DOI 10.1016/j.ophtha.2006.05.069; Hemmer W, 1997, J BIOL CHEM, V272, P16946, DOI 10.1074/jbc.272.27.16946; Higgins MK, 2006, J BIOL CHEM, V281, P19426, DOI 10.1074/jbc.M602203200; INGLESE J, 1992, J BIOL CHEM, V267, P1422; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KELLEHER DJ, 1990, J BIOL CHEM, V265, P2632; Khani SC, 1998, P NATL ACAD SCI USA, V95, P2824, DOI 10.1073/pnas.95.6.2824; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levay K, 1998, BIOCHEMISTRY-US, V37, P13650, DOI 10.1021/bi980998z; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lodowski DT, 2005, BIOCHEMISTRY-US, V44, P6958, DOI 10.1021/bi050119q; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Noble B, 2003, J BIOL CHEM, V278, P47466, DOI 10.1074/jbc.M308257200; Nowakowski J, 2002, STRUCTURE, V10, P1659, DOI 10.1016/S0969-2126(02)00907-3; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; OTWINOSKI Z, 1993, P CCP4 STUD WEEK DAT; PALCZEWSKI K, 1989, BIOCHEMISTRY-US, V28, P8764, DOI 10.1021/bi00448a013; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; PALCZEWSKI K, 1988, BIOCHEMISTRY-US, V27, P2306, DOI 10.1021/bi00407a010; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; PALCZEWSKI K, 1992, J BIOL CHEM, V267, P18991; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 1999, J BIOL CHEM, V274, P29381, DOI 10.1074/jbc.274.41.29381; Shi GW, 2005, J BIOL CHEM, V280, P41184, DOI 10.1074/jbc.M506935200; SHI W, 1995, J BIOL CHEM, V270, P2112, DOI 10.1074/jbc.270.5.2112; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Yu QM, 1999, J NEUROCHEM, V73, P1222, DOI 10.1046/j.1471-4159.1999.0731222.x; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	50	80	82	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14053	14062		10.1074/jbc.M708974200	http://dx.doi.org/10.1074/jbc.M708974200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18339619	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000255728200059
J	Valentine, WJ; Fells, JI; Perygin, DH; Mujahid, S; Yokoyama, K; Fujiwara, Y; Tsukahara, R; Van Brocklyn, JR; Parrill, AL; Tigyi, G				Valentine, William J.; Fells, James I.; Perygin, Donna H.; Mujahid, Sana; Yokoyama, Kazuaki; Fujiwara, Yuko; Tsukahara, Ryoko; Van Brocklyn, James R.; Parrill, Abby L.; Tigyi, Gabor			Subtype-specific residues involved in ligand activation of the endothelial differentiation gene family lysophosphatidic acid receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; LYSOPHOSPHOLIPID RECEPTORS; CELLULAR-RESPONSES; MOLECULAR-CLONING; PPAR-GAMMA; IDENTIFICATION; OVARIAN; PROLIFERATION; SPHINGOSINE-1-PHOSPHATE; RECOGNITION	Lysophosphatidic acid (LPA) is a ligand for three endothelial differentiation gene family G protein-coupled receptors, LPA(1-3). We performed computational modeling-guided mutagenesis of conserved residues in transmembrane domains 3, 4, 5, and 7 of LPA(1-3) predicted to interact with the glycerophosphate motif of LPA C18:1. The mutants were expressed in RH7777 cells, and the efficacy (E-max) and potency (EC50) of LPA-elicited Ca2+ transients were measured. Mutation to alanine of R3.28 universally decreased both the efficacy and potency in LPA(1-3) and eliminated strong ionic interactions in the modeled LPA complexes. The alanine mutation at Q3.29 decreased modeled interactions and activation in LPA(1) and LPA(2) more than in LPA(3). The mutation W4.64A had no effect on activation and modeled LPA interaction of LPA(1) and LPA(2) but reduced the activation and modeled interactions of LPA(3). The R5.38A mutant of LPA(2) and R5.38N mutant of LPA(3) showed diminished activation by LPA; however, in LPA(1) the D5.38A mutation did not, and mutation to arginine enhanced receptor activation. In LPA(2), K7.36A decreased the potency of LPA; in LPA(1) this same mutation increased the E-max. In LPA(3), R7.36A had almost no effect on receptor activation; however, the mutation K7.35A increased the EC50 in response to LPA 10-fold. In LPA(1-3), the mutation Q3.29E caused a modest increase in EC50 in response to LPA but caused the LPA receptors to become more responsive to sphingosine 1-phosphate (S1P). Surprisingly micromolar concentrations of S1P activated the wild type LPA(2) and LPA(3) receptors, indicating that S1P may function as a weak agonist of endothelial differentiation gene family LPA receptors.	[Valentine, William J.; Mujahid, Sana; Yokoyama, Kazuaki; Fujiwara, Yuko; Tsukahara, Ryoko; Tigyi, Gabor] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Fells, James I.; Perygin, Donna H.; Parrill, Abby L.] Univ Memphis, Dept Chem, Memphis, TN 38152 USA; [Fells, James I.; Perygin, Donna H.; Parrill, Abby L.] Univ Memphis, Computat Res Mat Inst, Memphis, TN 38152 USA; [Van Brocklyn, James R.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Memphis; University System of Ohio; Ohio State University	Tigyi, G (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	gtigyi@physio1.utmem.edu	Van Brocklyn, Jim/A-9733-2010	Parrill, Abby/0000-0003-1658-8497	NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061469, T32HL007641, R01HL084007] Funding Source: NIH RePORTER; NCI NIH HHS [CA921160, R01 CA092160] Funding Source: Medline; NHLBI NIH HHS [R01 HL061469, R01 HL084007, HL61469, HL07641-19, T32 HL007641, HL084007] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		An SZ, 1998, MOL PHARMACOL, V54, P881, DOI 10.1124/mol.54.5.881; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; An SZ, 1999, MOL PHARMACOL, V55, P787; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Durgam GG, 2005, J MED CHEM, V48, P4919, DOI 10.1021/jm049609r; Fischer DJ, 1998, MOL PHARMACOL, V54, P979, DOI 10.1124/mol.54.6.979; Fischer DJ, 2001, MOL PHARMACOL, V60, P776; Fujiwara Y, 2005, J BIOL CHEM, V280, P35038, DOI 10.1074/jbc.M504351200; Fujiwara Y, 2007, J BIOL CHEM, V282, P2374, DOI 10.1074/jbc.M609648200; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Goetzl EJ, 1999, CANCER RES, V59, P4732; Gueguen G, 1999, BIOCHEMISTRY-US, V38, P8440, DOI 10.1021/bi9816756; Guo R, 2006, ENDOCRINOLOGY, V147, P4883, DOI 10.1210/en.2005-1635; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hama K, 2002, FEBS LETT, V523, P187, DOI 10.1016/S0014-5793(02)02976-9; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Heringdorf DMZ, 2004, J CELL BIOCHEM, V92, P937, DOI 10.1002/jcb.20107; Heringdorf DMZ, 2003, FEBS LETT, V554, P443, DOI 10.1016/S0014-5793(03)01219-5; Holdsworth Gill, 2004, BMC Biochemistry, V5, P1, DOI 10.1186/1471-2091-5-12; Im DS, 2000, MOL PHARMACOL, V57, P753, DOI 10.1124/mol.57.4.753; Inagaki Y, 2005, BIOCHEM J, V389, P187, DOI 10.1042/BJ20050046; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Jiang XT, 2006, J LIPID RES, V47, P1865, DOI 10.1194/jlr.D600012-JLR200; Karliner JS, 2002, BBA-MOL CELL BIOL L, V1582, P216, DOI 10.1016/S1388-1981(02)00174-9; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee MJ, 1998, J BIOL CHEM, V273, P22105, DOI 10.1074/jbc.273.34.22105; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Motohashi K, 2000, FEBS LETT, V468, P189, DOI 10.1016/S0014-5793(00)01222-9; Naor MM, 2007, J MOL GRAPH MODEL, V26, P519, DOI 10.1016/j.jmgm.2007.03.004; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Parrill AL, 2000, ANN NY ACAD SCI, V905, P330; Qi C, 1998, J CELL PHYSIOL, V174, P261, DOI 10.1002/(SICI)1097-4652(199802)174:2<261::AID-JCP13>3.0.CO;2-F; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Rhee MH, 2000, J NEUROCHEM, V75, P2485, DOI 10.1046/j.1471-4159.2000.0752485.x; Sardar VM, 2002, BBA-MOL CELL BIOL L, V1582, P309, DOI 10.1016/S1388-1981(02)00185-3; Schwartz BM, 2001, GYNECOL ONCOL, V81, P291, DOI 10.1006/gyno.2001.6124; Sliva D, 2000, BIOCHEM BIOPH RES CO, V268, P471, DOI 10.1006/bbrc.2000.2111; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; XU Y, 1995, BIOCHEM J, V309, P933, DOI 10.1042/bj3090933; Xu Y, 1995, CLIN CANCER RES, V1, P1223; Yatomi Y, 1997, J BIOL CHEM, V272, P5291, DOI 10.1074/jbc.272.8.5291; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619	51	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12175	12187		10.1074/jbc.M708847200	http://dx.doi.org/10.1074/jbc.M708847200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18316373	Green Published, hybrid			2022-12-25	WOS:000255340000034
J	de Pina, MZ; Vazquez-Meza, H; Pardo, JP; Rendon, JL; Villalobos-Molina, R; Riveros-Rosas, H; Pina, E				Zentella de Pina, Martha; Vazquez-Meza, Hector; Pardo, Juan Pablo; Rendon, Juan Luis; Villalobos-Molina, Rafael; Riveros-Rosas, Hector; Pina, Enrique			Signaling the signal, cyclic AMP-dependent protein kinase inhibition by insulin-formed H2O2 and reactivation by thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; DISULFIDE BOND FORMATION; RII-BETA-SUBUNIT; II REGULATORY SUBUNITS; HYDROGEN-PEROXIDE; CATALYTIC SUBUNIT; RAT ADIPOCYTES; SEQUENCE ALIGNMENT; INDUCED ACTIVATION; 3T3-L1 ADIPOCYTES	Catecholamines in adipose tissue promote lipolysis via cAMP, whereas insulin stimulates lipogenesis. Here we show that H2O2 generated by insulin in rat adipocytes impaired cAMP- mediated amplification cascade of lipolysis. These micromolar concentrations of H2O2 added before cAMP suppressed cAMP activation of type II beta cyclic AMP-dependent protein kinase (PKA) holoenzyme, prevented hormone-sensitive lipase translocation from cytosol to storage droplets, and inhibited lipolysis. Similarly, H2O2 impaired activation of type II alpha PKA holoenzyme from bovine heart and from that reconstituted with regulatory II alpha and catalytic alpha subunits. H2O2 was ineffective (a) if these PKA holoenzymes were preincubated with cAMP, (b) if added to the catalytic alpha subunit, which is active independently of cAMP activation, and (c) if the catalytic alpha subunit was substituted by its C199A mutant in the reconstituted holoenzyme. H2O2 inhibition of PKA activation remained after H2O2 elimination by gel filtration but was reverted with dithiothreitol or with thioredoxin reductase plus thioredoxin. Electrophoresis of holoenzyme in SDS gels showed separation of catalytic and regulatory subunits after cAMP incubation but a single band after H2O2 incubation. These data strongly suggest that H2O2 promotes the formation of an intersubunit disulfide bond, impairing cAMP-dependent PKA activation. Phylogenetic analysis showed that Cys-97 is conserved only in type II regulatory subunits and not in type I regulatory subunits; hence, the redox regulation mechanism described is restricted to type II PKA-expressing tissues. In conclusion, phylogenetic analysis results, selective chemical behavior, and the privileged position in holoenzyme lead us to suggest that Cys-97 in regulatory II alpha or II beta subunits is the residue forming the disulfide bond with Cys- 199 in the PKA catalytic alpha subunit. A new molecular point for cross-talk among heterologous signal transduction pathways is demonstrated.	[Zentella de Pina, Martha; Vazquez-Meza, Hector; Pardo, Juan Pablo; Rendon, Juan Luis; Riveros-Rosas, Hector; Pina, Enrique] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Villalobos-Molina, Rafael] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Unidad Biomed, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Pina, E (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Apartado Postal 70159, Mexico City 04510, DF, Mexico.	epgarza@servidor.unam.mx	Riveros-Rosas, Hector/B-6607-2008; Riveros-Rosas, Hector/ABD-6638-2020	Riveros-Rosas, Hector/0000-0003-0194-2537; Riveros-Rosas, Hector/0000-0003-0194-2537; Pina, Enrique/0000-0003-2436-9956; Vazquez-Meza, Hector/0000-0002-8312-3115				ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Blaschke RJ, 2000, GENOMICS, V64, P187, DOI 10.1006/geno.2000.6116; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Burns LL, 2003, BIOCHEMISTRY-US, V42, P5754, DOI 10.1021/bi0265729; Burton KA, 1997, P NATL ACAD SCI USA, V94, P11067, DOI 10.1073/pnas.94.20.11067; Burton KA, 1999, J BIOL CHEM, V274, P24131, DOI 10.1074/jbc.274.34.24131; Chaudhry A, 2002, AM J PHYSIOL-CELL PH, V282, pC205, DOI 10.1152/ajpcell.2002.282.1.C205; Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Clifford GM, 2000, J BIOL CHEM, V275, P5011, DOI 10.1074/jbc.275.7.5011; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; DAME JB, 1980, BIOCHEMISTRY-US, V19, P2931, DOI 10.1021/bi00554a018; Dwivedi Y, 2002, J PHARMACOL EXP THER, V301, P197, DOI 10.1124/jpet.301.1.197; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FIRST EA, 1984, J BIOL CHEM, V259, P4011; FIRST EA, 1988, J BIOL CHEM, V263, P5176; GAGELMANN M, 1980, P NATL ACAD SCI-BIOL, V77, P2492, DOI 10.1073/pnas.77.5.2492; Gaudiot N, 2000, AM J PHYSIOL-CELL PH, V279, pC1603, DOI 10.1152/ajpcell.2000.279.5.C1603; HOLM C, 1988, NUCLEIC ACIDS RES, V16, P9879, DOI 10.1093/nar/16.20.9879; Holm C, 1997, METHOD ENZYMOL, V286, P45; HONNOR RC, 1985, J BIOL CHEM, V260, P5122; Humphries KM, 2007, J BIOL CHEM, V282, P22072, DOI 10.1074/jbc.M702582200; Humphries KM, 2005, J BIOL CHEM, V280, P2750, DOI 10.1074/jbc.M410242200; Humphries KM, 2002, J BIOL CHEM, V277, P43505, DOI 10.1074/jbc.M207088200; Hupfeld CJ, 2003, P NATL ACAD SCI USA, V100, P161, DOI 10.1073/pnas.0235674100; KRIEGERBRAUER HI, 1992, J CLIN INVEST, V89, P1006, DOI 10.1172/JCI115641; KriegerBrauer HI, 1997, J BIOL CHEM, V272, P10135; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Linke K, 2003, ANTIOXID REDOX SIGN, V5, P425, DOI 10.1089/152308603768295168; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; MARGOLIASH E, 1960, BIOCHEM J, V74, P349, DOI 10.1042/bj0740349; Mueller S, 2002, BIOCHEM J, V363, P483, DOI 10.1042/0264-6021:3630483; MUKHERJEE SP, 1980, BIOCHEM PHARMACOL, V29, P1239; NELSON NC, 1983, J BIOL CHEM, V258, P981; Newhall KJ, 2005, MOL ENDOCRINOL, V19, P982, DOI 10.1210/me.2004-0343; Niedner RH, 2006, PROTEINS, V63, P78, DOI 10.1002/prot.20825; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; Powis G, 2001, ANNU REV PHARMACOL, V41, P261, DOI 10.1146/annurev.pharmtox.41.1.261; Raynaud F, 1997, FREE RADICAL BIO MED, V22, P623, DOI 10.1016/S0891-5849(96)00353-X; Rigobello MP, 2005, FREE RADICAL RES, V39, P687, DOI 10.1080/10715760500135391; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schreyer SA, 2001, DIABETES, V50, P2555, DOI 10.2337/diabetes.50.11.2555; SHOWERS MO, 1986, J BIOL CHEM, V261, P6288; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; SLICE LW, 1989, J BIOL CHEM, V264, P20940; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; TAKIO K, 1982, P NATL ACAD SCI-BIOL, V79, P2544, DOI 10.1073/pnas.79.8.2544; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; TAYLOR WM, 1979, BIOCHEM J, V178, P381, DOI 10.1042/bj1780381; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turner SM, 2003, AM J PHYSIOL-ENDOC M, V285, pE790, DOI 10.1152/ajpendo.00402.2002; Vigil D, 2004, J MOL BIOL, V337, P1183, DOI 10.1016/j.jmb.2004.02.028; Visentin V, 2003, EUR J PHARMACOL, V466, P235, DOI 10.1016/S0014-2999(03)01562-0; Warnick G R, 1986, Methods Enzymol, V129, P101; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Zentella de Pina M., 2007, Autonomic & Autacoid Pharmacology, V27, P85; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; ZHAO J, 1988, J BIOL CHEM, V273, P30448; Zmuda-Trzebiatowska E, 2007, CELL SIGNAL, V19, P81, DOI 10.1016/j.cellsig.2006.05.024	69	37	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12373	12386		10.1074/jbc.M706832200	http://dx.doi.org/10.1074/jbc.M706832200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326045	hybrid			2022-12-25	WOS:000255340000054
J	Kliebenstein, DJ				Kliebenstein, Daniel J.			A Role for Gene Duplication and Natural Variation of Gene Expression in the Evolution of Metabolism	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GLUCOSINOLATE BIOSYNTHESIS; SECONDARY METABOLITES; INSECT RESISTANCE; GIBBERELLIC-ACID; DIVERSITY; PATHWAY; DIVERSIFICATION; DIVERGENCE; HYDROLYSIS	Background: Most eukaryotic genomes have undergone whole genome duplications during their evolutionary history. Recent studies have shown that the function of these duplicated genes can diverge from the ancestral gene via neo-or sub-functionalization within single genotypes. An additional possibility is that gene duplicates may also undergo partitioning of function among different genotypes of a species leading to genetic differentiation. Finally, the ability of gene duplicates to diverge may be limited by their biological function. Methodology/Principal Findings: To test these hypotheses, I estimated the impact of gene duplication and metabolic function upon intraspecific gene expression variation of segmental and tandem duplicated genes within Arabidopsis thaliana. In all instances, the younger tandem duplicated genes showed higher intraspecific gene expression variation than the average Arabidopsis gene. Surprisingly, the older segmental duplicates also showed evidence of elevated intraspecific gene expression variation albeit typically lower than for the tandem duplicates. The specific biological function of the gene as defined by metabolic pathway also modulated the level of intraspecific gene expression variation. The major energy metabolism and biosynthetic pathways showed decreased variation, suggesting that they are constrained in their ability to accumulate gene expression variation. In contrast, a major herbivory defense pathway showed significantly elevated intraspecific variation suggesting that it may be under pressure to maintain and/or generate diversity in response to fluctuating insect herbivory pressures. Conclusion: These data show that intraspecific variation in gene expression is facilitated by an interaction of gene duplication and biological activity. Further, this plays a role in controlling diversity of plant metabolism.	[Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Kliebenstein, DJ (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	Kliebenstein@ucdavis.edu		Kliebenstein, Daniel/0000-0001-5759-3175	NSF [0642481]	NSF(National Science Foundation (NSF))	Funding for this project was obtained by NSF grant DBI#0642481 to DJK.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Benderoth M, 2006, P NATL ACAD SCI USA, V103, P9118, DOI 10.1073/pnas.0601738103; BENEDETTI CE, 1995, PLANT PHYSIOL, V109, P567, DOI 10.1104/pp.109.2.567; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Burow M, 2006, FEBS J, V273, P2432, DOI 10.1111/j.1742-4658.2006.05252.x; CASNEUF T, 2006, GENOME BIOL, V7; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; D'Auria JC, 2005, CURR OPIN PLANT BIOL, V8, P308, DOI 10.1016/j.pbi.2005.03.012; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Ehrenreich IM, 2006, AM J BOT, V93, P953, DOI 10.3732/ajb.93.7.953; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Espiritu DJD, 2001, TOXICON, V39, P1899, DOI 10.1016/S0041-0101(01)00175-1; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; GANKO EW, 2007, MOL BIOL EVOL, DOI DOI 10.1093/MOLBEV/MSM1158; Grubb CD, 2004, PLANT J, V40, P893, DOI 10.1111/j.1365-313X.2004.02261.x; Grun S, 2005, PHYTOCHEMISTRY, V66, P1264, DOI 10.1016/j.phytochem.2005.01.024; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Ha M, 2007, TRENDS GENET, V23, P162, DOI 10.1016/j.tig.2007.02.005; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen BG, 2007, PLANT J, V50, P902, DOI 10.1111/j.1365-313X.2007.03101.x; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Hansen CH, 2001, J BIOL CHEM, V276, P11078, DOI 10.1074/jbc.M010123200; Hemm MR, 2003, PLANT CELL, V15, P179, DOI 10.1105/tpc.006544; KALISZ S, 2007, VARIATION CONSTRAINT; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim SY, 2007, J PLANT BIOL, V50, P117, DOI 10.1007/BF03030619; Klein M, 2006, FEBS J, V273, P122, DOI 10.1111/j.1742-4658.2005.05048.x; Kliebenstein DJ, 2006, GENETICS, V172, P1179, DOI 10.1534/genetics.105.049353; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kliebenstein DJ, 2004, PLANT CELL ENVIRON, V27, P675, DOI 10.1111/j.1365-3040.2004.01180.x; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Kliebenstein DJ, 2001, GENETICS, V159, P359; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; KORVES TM, 2007, FIELD AM NATURALIST, V169, pE141; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; LANGRIDGE J, 1957, NATURE, V180, P36, DOI 10.1038/180036a0; Lankau RA, 2007, SCIENCE, V317, P1561, DOI 10.1126/science.1147455; Lankau RA, 2007, NEW PHYTOL, V175, P176, DOI 10.1111/j.1469-8137.2007.02090.x; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; Micheals SD, 1999, DEV GENET, V25, P194, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;194::AID-DVG2&gt;3.0.CO;2-2; Mikkelsen MD, 2004, PLANT J, V37, P770, DOI 10.1111/j.1365-313X.2004.02002.x; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Mithen R, 1996, ENTOMOL EXP APPL, V80, P202, DOI 10.1007/BF00194757; MITHEN R, 1995, SOC EXP BIOL SEMIN S, V56, P261; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Noel L, 1999, PLANT CELL, V11, P2099, DOI 10.1105/tpc.11.11.2099; Ober D, 2005, TRENDS PLANT SCI, V10, P444, DOI 10.1016/j.tplants.2005.07.007; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Scarcelli N, 2007, P NATL ACAD SCI USA, V104, P16986, DOI 10.1073/pnas.0708209104; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schuster J, 2006, PLANT CELL, V18, P2664, DOI 10.1105/tpc.105.039339; Schwenk K, 2003, KEYWORDS CONCEPTS EV, P52; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Textor S, 2004, PLANTA, V218, P1026, DOI 10.1007/s00425-003-1184-3; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; van Leeuwen H, 2007, PLANT CELL, V19, P2099, DOI 10.1105/tpc.107.050641; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; WALSH JB, 1995, GENETICS, V139, P421; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Zhang JM, 2002, PHYSIOL PLANTARUM, V115, P25, DOI 10.1034/j.1399-3054.2002.1150103.x; Zhang PF, 2005, PLANT PHYSIOL, V138, P27, DOI 10.1104/pp.105.060376; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419	86	80	80	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1838	10.1371/journal.pone.0001838	http://dx.doi.org/10.1371/journal.pone.0001838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350173	Green Published, Green Submitted, gold			2022-12-25	WOS:000260762300039
J	Russell, JH; Keiler, KC				Russell, Jay H.; Keiler, Kenneth C.			Screen for Localized Proteins in Caulobacter crescentus	PLOS ONE			English	Article								Precise localization of individual proteins is required for processes such as motility, chemotaxis, cell-cycle progression, and cell division in bacteria, but the number of proteins that are localized in bacterial species is not known. A screen based on transposon mutagenesis and fluorescence activated cell sorting was devised to identify large numbers of localized proteins, and employed in Caulobacter crescentus. From a sample of the clones isolated in the screen, eleven proteins with no previously characterized localization in C. crescentus were identified, including six hypothetical proteins. The localized hypothetical proteins included one protein that was localized in a helix-like structure, and two proteins for which the localization changed as a function of the cell cycle, suggesting that complex three-dimensional patterns and cell cycle-dependent localization are likely to be common in bacteria. Other mutants produced localized fusion proteins even though the transposon has inserted near the 59 end of a gene, demonstrating that short peptides can contain sufficient information to localize bacterial proteins. The screen described here could be used in most bacterial species.	[Russell, Jay H.; Keiler, Kenneth C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Russell, JH (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	kkeiler@psu.edu		Keiler, Kenneth/0000-0001-8753-335X	NIGMS [GM068720]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068720] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS grant GM068720. The funders played no role in any aspect of the research or manuscript.	Addinall SG, 1996, MOL MICROBIOL, V22, P231, DOI 10.1046/j.1365-2958.1996.00100.x; ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825; Ausmees N, 2003, ANNU REV MICROBIOL, V57, P225, DOI 10.1146/annurev.micro.57.030502.091006; Awram P, 1998, J BACTERIOL, V180, P3062, DOI 10.1128/JB.180.12.3062-3069.1998; Bingle WH, 2000, J BACTERIOL, V182, P3298, DOI 10.1128/JB.182.11.3298-3301.2000; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; EDWARDS P, 1991, J BACTERIOL, V173, P5568, DOI 10.1128/jb.173.17.5568-5572.1991; ELY B, 1991, METHOD ENZYMOL, V204, P372; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Jacobs-Wagner C, 2004, MOL MICROBIOL, V51, P7, DOI 10.1046/j.1365-2958.2003.03828.x; Keiler KC, 2003, J BACTERIOL, V185, P573, DOI 10.1128/JB.185.2.573-580.2003; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; MADDOCK JR, 1993, SCIENCE, V259, P1717; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; OCHMAN H, 1988, GENETICS, V120, P621; Russell JH, 2007, J BACTERIOL, V189, P7581, DOI 10.1128/JB.00981-07; Ryan KR, 2003, ANNU REV BIOCHEM, V72, P367, DOI 10.1146/annurev.biochem.72.121801.161824; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; Shih YL, 2006, MICROBIOL MOL BIOL R, V70, P729, DOI 10.1128/MMBR.00017-06; Shiomi D, 2005, J BACTERIOL, V187, P7647, DOI 10.1128/JB.187.22.7647-7654.2005; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Wu JG, 1996, BIOCHEMISTRY-US, V35, P4984, DOI 10.1021/bi9530189	34	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1756	10.1371/journal.pone.0001756	http://dx.doi.org/10.1371/journal.pone.0001756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335033	Green Published, Green Submitted, gold			2022-12-25	WOS:000260723000010
J	Sockman, KW				Sockman, Keith W.			Ovulation Order Mediates a Trade-Off between Pre-Hatching and Post-Hatching Viability in an Altricial Bird	PLOS ONE			English	Article							BROOD REDUCTION; EGG-VIABILITY; CLUTCH SIZE; ADAPTIVE SIGNIFICANCE; SIBLING COMPETITION; SEX-RATIOS; ASYNCHRONY; CONSTRAINT; ANDROGENS; FAILURE	Simultaneously dependent siblings often compete for parentally provided resources. This competition may lead to mortality, the probability of which may be a function, in part, of the individual offspring's production order. In birds, serial ovulation followed by hatching asynchrony of simultaneous dependents leads to differences in post-hatching survival that largely depend on ovulation (laying) order. This has led to the widespread assumption that early-laid eggs are of greater value and therefore should possess different maternally manipulated characteristics than later-laid eggs. However, this perspective ignores the potential effect of laying order on pre-hatching viability, an effect which some studies suggest should offset the effect of laying order on post-hatching viability. I examined the relationship between laying order and hatching and fledging probability in wild, free-living Lincoln's sparrows (Melospiza lincolnii). In broods with complete hatching success, first-laid and therefore first-hatched offspring had the highest probability of fledging, and fledging probability declined with increasing laying order. However, first-laid eggs were less likely than later-laid eggs to hatch. This effect of laying order on pre-hatching viability seemed to offset that on post-hatching viability, and, consistently, maternal investment in egg size varied little if at all with respect to laying order. These results suggest that ovulation order mediates a trade-off between pre-hatching and post-hatching viability and should encourage a re-evaluation of the solitary role postembryonic survival often plays when researchers make assumptions about the value of propagules based on the order in which they are produced.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Sockman, KW (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	kws@unc.edu			R.J. Reynolds fund [U.N.C. Award]	R.J. Reynolds fund	A U.N.C. Award from the R.J. Reynolds fund to K.W.S. provided financial support. The funder of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat JA, 2001, IBIS, V143, P17, DOI 10.1111/j.1474-919X.2001.tb04165.x; Ammon E. M., 1995, BIRDS N AM; AMUNDSEN T, 1988, J ANIM ECOL, V57, P329, DOI 10.2307/4909; ARNOLD TW, 1987, AM NAT, V130, P643, DOI 10.1086/284736; Badyaev AV, 2002, SCIENCE, V295, P316, DOI 10.1126/science.1066651; BORTOLOTTI GR, 1986, AM NAT, V127, P495, DOI 10.1086/284498; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Cabezas-Diaz S, 2007, ARDEA, V95, P55, DOI 10.5253/078.095.0106; Cicero C, 1997, GREAT BASIN NAT, V57, P104; CLARK AB, 1981, Q REV BIOL, V56, P253, DOI 10.1086/412316; CODERO PJ, 1999, J AVIAN BIOL, V30, P103; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; Cooper CB, 2005, ECOLOGY, V86, P2018, DOI 10.1890/03-8028; Cordero PJ, 1999, J AVIAN BIOL, V30, P103, DOI 10.2307/3677249; EVANS RM, 1990, WILSON BULL, V102, P684; Godard RD, 2007, J AVIAN BIOL, V38, P709, DOI 10.1111/j.0908-8857.2007.04052.x; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; HOYT DF, 1979, AUK, V96, P73; Krackow S, 2001, BEHAV ECOL SOCIOBIOL, V50, P293, DOI 10.1007/s002650100366; Lack D., 1954, P343; MAGRATH RD, 1990, BIOL REV, V65, P587, DOI 10.1111/j.1469-185X.1990.tb01239.x; Mock D. W., 1997, EVOLUTION SIBLING RI, P464; Mock DW, 1998, ANIM BEHAV, V56, P1, DOI 10.1006/anbe.1998.0842; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Monaghan P, 1998, P ROY SOC B-BIOL SCI, V265, P1731, DOI 10.1098/rspb.1998.0495; Morton Martin L., 2002, Studies in Avian Biology, V24, P1; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; PIJANOWSKI BC, 1992, AM NAT, V139, P1270, DOI 10.1086/285386; Potti J, 1996, CONDOR, V98, P328, DOI 10.2307/1369151; POUGH FH, 2005, VERTEBRATE LIFE, P684; PULLIAINEN E, 1994, ORNIS FENNICA, V71, P109; RABEHESKETH S, 2005, MULTILEVEL LONGITUDI, P317; Romanoff A. L., 1949, AVIAN EGG; Royle NJ, 2001, BEHAV ECOL, V12, P381, DOI 10.1093/beheco/12.4.381; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; Smiseth PT, 2007, ECOLOGY, V88, P3174, DOI 10.1890/06-1992.1; Sockman KW, 2006, BIOL REV, V81, P629, DOI 10.1017/S1464793106007147; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; SOCKMAN KW, 2007, BEHAV ECOLOGY SOCIOB; Stenning MJ, 1996, TRENDS ECOL EVOL, V11, P243, DOI 10.1016/0169-5347(96)10030-6; Stoleson Scott H., 1995, Current Ornithology, V12, P191; Stoleson SH, 1999, J ANIM ECOL, V68, P951, DOI 10.1046/j.1365-2656.1999.00342.x; VEIGA JP, 1992, AM NAT, V139, P669, DOI 10.1086/285351	44	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1785	10.1371/journal.pone.0001785	http://dx.doi.org/10.1371/journal.pone.0001785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335056	Green Submitted, gold, Green Published			2022-12-25	WOS:000260723000037
J	Akesson, M; Bensch, S; Hasselquist, D; Tarka, M; Hansson, B				Akesson, Mikael; Bensch, Staffan; Hasselquist, Dennis; Tarka, Maja; Hansson, Bengt			Estimating Heritabilities and Genetic Correlations: Comparing the 'Animal Model' with Parent-Offspring Regression Using Data from a Natural Population	PLOS ONE			English	Article								Quantitative genetic parameters are nowadays more frequently estimated with restricted maximum likelihood using the 'animal model' than with traditional methods such as parent-offspring regressions. These methods have however rarely been evaluated using equivalent data sets. We compare heritabilities and genetic correlations from animal model and parent-offspring analyses, respectively, using data on eight morphological traits in the great reed warbler (Acrocephalus arundinaceus). Animal models were run using either mean trait values or individual repeated measurements to be able to separate between effects of including more extended pedigree information and effects of replicated sampling from the same individuals. We show that the inclusion of more pedigree information by the use of mean traits animal models had limited effect on the standard error and magnitude of heritabilities. In contrast, the use of repeated measures animal model generally had a positive effect on the sampling accuracy and resulted in lower heritabilities; the latter due to lower additive variance and higher phenotypic variance. For most trait combinations, both animal model methods gave genetic correlations that were lower than the parent-offspring estimates, whereas the standard errors were lower only for the mean traits animal model. We conclude that differences in heritabilities between the animal model and parent-offspring regressions were mostly due to the inclusion of individual replicates to the animal model rather than the inclusion of more extended pedigree information. Genetic correlations were, on the other hand, primarily affected by the inclusion of more pedigree information. This study is to our knowledge the most comprehensive empirical evaluation of the performance of the animal model in relation to parent-offspring regressions in a wild population. Our conclusions should be valuable for reconciliation of data obtained in earlier studies as well as for future meta-analyses utilizing estimates from both traditional methods and the animal model.	[Akesson, Mikael; Bensch, Staffan; Hasselquist, Dennis; Tarka, Maja; Hansson, Bengt] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden	Lund University	Akesson, M (corresponding author), Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden.	mikael.akesson@zooekol.lu.se	Hasselquist, Dennis/M-5223-2014; Hansson, Bengt/L-8874-2013; Åkesson, Mikael/K-5370-2014; Tarka, Maja/L-8065-2013	Hasselquist, Dennis/0000-0002-0056-6616; Hansson, Bengt/0000-0001-6694-8169; Tarka, Maja/0000-0001-9651-1101	Swedish Research Council; Swedish Council for Environment; Agricultural Sciences and Spatial Planning (FORMAS); National Swedish Environment Protection Board; Carl Tryggers stiftelse; Royal Swedish Academy of Science; Ahlstrand and Hierta-Retzius Foundations; Lunds Djurskyddsfond; Magn Bergvalls Stiftelse; National Geographic Society; Crafoordska Stiftelsen	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Environment; Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); National Swedish Environment Protection Board; Carl Tryggers stiftelse; Royal Swedish Academy of Science; Ahlstrand and Hierta-Retzius Foundations; Lunds Djurskyddsfond; Magn Bergvalls Stiftelse; National Geographic Society(National Geographic Society); Crafoordska Stiftelsen	The work was supported by grants from the Swedish Research Council (VR), the Swedish Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), the National Swedish Environment Protection Board, the Carl Tryggers stiftelse, the Royal Swedish Academy of Science (J.A. Ahlstrand and Hierta-Retzius Foundations), the Lunds Djurskyddsfond, the Magn Bergvalls Stiftelse, the National Geographic Society and the Crafoordska Stiftelsen	Akesson M, 2007, J AVIAN BIOL, V38, P58, DOI 10.1111/j.2006.0908-8857.03669.x; Arlt D, 2004, BEHAVIOUR, V141, P863, DOI 10.1163/1568539042265699; Becker W. A, 1984, MANUAL QUANTITATIVE; BENSCH S, 1991, J ANIM ECOL, V60, P857, DOI 10.2307/5418; Bensch S, 1998, EVOLUTION, V52, P877, DOI 10.1111/j.1558-5646.1998.tb03712.x; BROWN GH, 1969, BIOMETRICS, V25, P63, DOI 10.2307/2528678; Coltman DW, 2005, EVOLUTION, V59, P1372; Cramp S., 1992, HDB BIRDS EUROPE MID; Falconer D. S, 1996, INTRO QUANTITATIVE G; Galton F, 1889, NATURAL INHERITANCE, P1; Gilmour A., 2006, ASREML USER GUIDE RE; GRANT PR, 1983, PROC R SOC SER B-BIO, V220, P219, DOI 10.1098/rspb.1983.0096; Hansson B, 2004, EVOLUTION, V58, P870; Hansson B, 2000, MOL ECOL, V9, P1529, DOI 10.1046/j.1365-294x.2000.01028.x; Hansson B, 2004, EVOLUTION, V58, P2546, DOI 10.1111/j.0014-3820.2004.tb00883.x; HANSSON B, 2004, BIOL LETT, V271, P290; HASSELQUIST D, 1995, OIKOS, V72, P173, DOI 10.2307/3546219; HASSELQUIST D, 1995, BEHAV ECOL, V6, P27, DOI 10.1093/beheco/6.1.27; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; Helbig AJ, 1999, MOL PHYLOGENET EVOL, V11, P246, DOI 10.1006/mpev.1998.0571; HOULE D, 1992, GENETICS, V130, P195; Jensen H, 2003, J EVOLUTION BIOL, V16, P1296, DOI 10.1046/j.1420-9101.2003.00614.x; KNOTT SA, 1995, FUNCT ECOL, V9, P122, DOI 10.2307/2390099; Kruuk LEB, 2007, J EVOLUTION BIOL, V20, P1890, DOI 10.1111/j.1420-9101.2007.01377.x; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; LANDE R, 1989, GENETICS, V122, P915; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Lynch M., 1998, GENETICS ANAL QUANTI; MacColl ADC, 2003, EVOLUTION, V57, P2191; Merila J, 2001, CURR ORNITHOL, V16, P179; MERILA J, 1993, J EVOLUTION BIOL, V6, P375, DOI 10.1046/j.1420-9101.1993.6030375.x; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; PRICE T, 1992, TRENDS ECOL EVOL, V7, P307, DOI 10.1016/0169-5347(92)90229-5; Provine WB., 2001, ORIGINS THEORETICAL; Reale D, 1999, HEREDITY, V83, P526, DOI 10.1038/sj.hdy.6885430; REEVE ECR, 1955, BIOMETRICS, V11, P357, DOI 10.2307/3001774; ROBERTSON A, 1959, BIOMETRICS, V15, P469, DOI 10.2307/2527750; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Sheldon BC, 2003, EVOLUTION, V57, P406; Sokal R. R., 2012, BIOMETRY; SPSS Inc, 2005, SPSS 14 0 WIND; Svensson L., 1992, IDENTIFICATION GUIDE; VANVLECK LD, 1961, BIOMETRICS, V17, P359, DOI 10.2307/2527831; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Windig JJ, 1997, J EVOLUTION BIOL, V10, P853, DOI 10.1007/s000360050058	46	64	67	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1739	10.1371/journal.pone.0001739	http://dx.doi.org/10.1371/journal.pone.0001739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320057	Green Published, gold, Green Submitted			2022-12-25	WOS:000260586600034
J	Kurt, S; Deutscher, A; Crook, JM; Ohl, FW; Budinger, E; Moeller, CK; Scheich, H; Schulze, H				Kurt, Simone; Deutscher, Anke; Crook, John M.; Ohl, Frank W.; Budinger, Eike; Moeller, Christoph K.; Scheich, Henning; Schulze, Holger			Auditory Cortical Contrast Enhancing by Global Winner-Take-All Inhibitory Interactions	PLOS ONE			English	Article								Brains decompose the world into discrete objects of perception, thereby facing the problem of how to segregate and selectively address similar objects that are concurrently present in a scene. Theoretical models propose that this could be achieved by neuronal implementations of so-called winner-take-all algorithms where neuronal representations of objects or object features interact in a competitive manner. Here we present evidence for the existence of such a mechanism in an animal species. We present electrophysiological, neuropharmacological and neuroanatomical data which suggest a novel view of the role of GABA(A)-mediated inhibition in primary auditory cortex (AI), where intracortical GABA(A)-mediated inhibition operates on a global scale within a circular map of sound periodicity representation in AI, with functionally inhibitory projections of similar effect from any location throughout the whole map. These interactions could underlie the proposed competitive ''winner-take-all'' algorithm to support object segregation, e.g., segregation of different speakers in cocktail-party situations.	[Kurt, Simone; Deutscher, Anke; Ohl, Frank W.; Budinger, Eike; Moeller, Christoph K.; Scheich, Henning; Schulze, Holger] Leibniz Inst Neurobiol, Magdeburg, Germany; [Kurt, Simone] Univ Ulm, Inst Neurobiol, Ulm, Germany; [Crook, John M.] Newcastle Univ, Sch Biol, Div Psychol, Newcastle Upon Tyne, Tyne & Wear, England; [Budinger, Eike] Otto von Guericke Univ, Clin Neurol II, Magdeburg, Germany; [Schulze, Holger] Univ Erlangen Nurnberg, Expt Otorhinolaryngol, Erlangen, Germany	Leibniz Institut fur Neurobiologie (LIN); Ulm University; Newcastle University - UK; Otto von Guericke University; University of Erlangen Nuremberg	Kurt, S (corresponding author), Leibniz Inst Neurobiol, Magdeburg, Germany.	Holger.Schulze@uk-erlangen.de	Kurt, Simone/I-2927-2012	Kurt, Simone/0000-0002-1820-2597; Budinger, Eike/0000-0003-2420-8159	DFG [SFB-TR 31]; German Ministry of Education and Research [0311891]	DFG(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study presents data that were collected in our laboratory over a period of several years. It cumulates results of a number of experiments that were supported by different institutions: The interaction experiment was supported by the VolkswagenStiftung (I/77 356). The microiontophoretic experiments were supported by the Deutsche Forschungsgemeinschaft (DFG; SCHU 1272/2-1,2). The anatomical studies were supported by the DFG (SFB-TR 31, cooperation between projects A2 and A3). Dr. Ohl was supported by the BMBF (German Ministry of Education and Research; grant BioFuture 0311891).	Budinger E, 2006, NEUROSCIENCE, V143, P1065, DOI 10.1016/j.neuroscience.2006.08.035; Budinger E, 2000, EUR J NEUROSCI, V12, P2425, DOI 10.1046/j.1460-9568.2000.00142.x; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; Chen QC, 2000, HEARING RES, V150, P161, DOI 10.1016/S0378-5955(00)00197-0; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Deutscher A, 2006, NEUROREPORT, V17, P853, DOI 10.1097/01.wnr.0000221837.20255.62; Fabri M, 2004, NEUROSCIENCE, V123, P557, DOI 10.1016/j.neuroscience.2003.09.011; Fay RR, 1998, HEARING RES, V120, P69, DOI 10.1016/S0378-5955(98)00058-6; Foeller E, 2001, JARO, V2, P279; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Kurt S, 2006, HEARING RES, V212, P224, DOI 10.1016/j.heares.2005.12.002; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lewis JE, 1998, NATURE, V391, P76, DOI 10.1038/34172; MOLLER C, 2007, ASS RES OT 30 MIDW R; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Porrill J, 1999, NATURE, V397, P63, DOI 10.1038/16244; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; SCHEICH H, 2005, 23 PROBLEMS SYSTEM N, P343; Scheich H, 2007, HEARING RES, V229, P213, DOI 10.1016/j.heares.2007.01.025; Schul J, 2006, NEUROSCIENCE, V138, P1, DOI 10.1016/j.neuroscience.2005.11.023; Schulze H, 2002, EUR J NEUROSCI, V15, P1077, DOI 10.1046/j.1460-9568.2002.01935.x; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; SHAMMA SA, 1985, HEARING RES, V19, P1, DOI 10.1016/0378-5955(85)90094-2; Standage DI, 2005, NEURAL NETWORKS, V18, P620, DOI 10.1016/j.neunet.2005.06.015; SUTTER ML, 1991, J NEUROPHYSIOL, V65, P1207, DOI 10.1152/jn.1991.65.5.1207; Sutter ML, 1999, J NEUROPHYSIOL, V82, P2358, DOI 10.1152/jn.1999.82.5.2358; Tomioka R, 2005, EUR J NEUROSCI, V21, P1587, DOI 10.1111/j.1460-9568.2005.03989.x; VONDERMALSBURG C, 1986, BIOL CYBERN, V54, P29, DOI 10.1007/BF00337113; Wang J, 2000, NEUROREPORT, V11, P1137, DOI 10.1097/00001756-200004070-00045; Wang JA, 2002, BRAIN RES, V944, P219, DOI 10.1016/S0006-8993(02)02926-8; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116	33	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1735	10.1371/journal.pone.0001735	http://dx.doi.org/10.1371/journal.pone.0001735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320054	Green Submitted, gold, Green Published			2022-12-25	WOS:000260586600030
J	Aghi, M; Visted, T; DePinho, RA; Chiocca, EA				Aghi, M.; Visted, T.; DePinho, R. A.; Chiocca, E. A.			Oncolytic herpes virus with defective ICP6 specifically replicates in quiescent cells with homozygous genetic mutations in p16	ONCOGENE			English	Article						oncolytic virus; gene therapy; glioma; brain tumor; mechanism of replication; tumor-suppressor gene	RIBONUCLEOTIDE REDUCTASE; GLIOBLASTOMA-MULTIFORME; HUMAN GLIOMAS; THERAPY; CANCER; PATHWAY; DELETION; KINASE; MUTANT; PERMISSIVENESS	Oncolytic herpes simplex viruses (HSVs), in clinical trials for the treatment of malignant gliomas, are assumed to be selective for tumor cells because their replication is strongly attenuated in quiescent cells, but not in cycling cells. Oncolytic selectivity is thought to occur because mutations in viral ICP6 (encoding a viral ribonucleotide reductase function) and/or gamma 34.5 function are respectively complemented by mammalian ribonucleotide reductase and GADD34, whose genes are expressed in cycling cells. However, it is estimated that only 5-15% of malignant glioma cells are in mitosis at any one time. Therefore, effective replication of HSV oncolytic viruses might be limited to a subpopulation of tumor cells, since at any one time the majority of tumor cells would not be cycling. However, we report that an HSV with defective ICP6 function replicates in quiescent cultured murine embryonic fibroblasts obtained from mice with homozygous p16 deletions. Furthermore, intracranial inoculation of this virus into the brains of p16-/- mice provides evidence of viral replication that does not occur when the virus is injected into the brains of wild-type mice. These approaches provide in vitro and in vivo evidence that ICP6-negative HSVs are 'molecularly targeted,' because they replicate in quiescent tumor cells carrying specific oncogene deletions, independent of cell cycle status.	[Chiocca, E. A.] Ohio State Univ, Dept Neurosurg, Med Ctr, Dardinger Lab Neurooncol & Neurosci, Columbus, OH 43210 USA; [Chiocca, E. A.] Ohio State Univ, James Comprehens Canc Ctr, Med Ctr, Columbus, OH 43210 USA; [Aghi, M.; Visted, T.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [DePinho, R. A.] Harvard Univ, Sch Med,Belfer Inst Innovat Canc Sci, Dana Farber Canc Inst,Ctr Appl Canc sci, Dept Med Oncol & Med Genet, Boston, MA 02115 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Chiocca, EA (corresponding author), Ohio State Univ, Dept Neurosurg, Med Ctr, Dardinger Lab Neurooncol & Neurosci, Wiseman Hall,400 W 10th Ave, Columbus, OH 43210 USA.	EA.Chiocca@osumc.edu		DePinho, Ronald/0000-0002-5625-577X	NATIONAL CANCER INSTITUTE [P01CA069246, P01CA095616, R01CA084628, R01CA085139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041571] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA084628, R01 CA85139, R01 CA085139, P01 CA69246, R01 CA084628, P01 CA069246, P01 CA095616] Funding Source: Medline; NINDS NIH HHS [R01 NS41571, R01 NS041571] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aghi M, 2005, ONCOGENE, V24, P7802, DOI 10.1038/sj.onc.1209037; Burns KL, 1998, J NEUROPATH EXP NEUR, V57, P122, DOI 10.1097/00005072-199802000-00003; Costello JF, 1996, CANCER RES, V56, P2405; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Farassati F, 2001, NAT CELL BIOL, V3, P745, DOI 10.1038/35087061; Finney D.J., 1971, PROBIT ANAL; Fu XP, 2006, MOL THER, V13, P882, DOI 10.1016/j.ymthe.2006.02.007; GOLDSTEIN DJ, 1988, VIROLOGY, V166, P41, DOI 10.1016/0042-6822(88)90144-4; GrayBablin J, 1997, CANCER RES, V57, P604; HOSHINO T, 1989, J NEUROSURG, V71, P335, DOI 10.3171/jns.1989.71.3.0335; Ikeda K, 1999, NAT MED, V5, P881, DOI 10.1038/11320; Jiang H, 2005, NEOPLASIA, V7, P48, DOI 10.1593/neo.04391; Kamiryo T, 2002, J NEUROSURG, V96, P815, DOI 10.3171/jns.2002.96.5.0815; Kirn D, 2001, NAT MED, V7, P781, DOI 10.1038/89901; Komata T, 2000, GENE THER, V7, P2071, DOI 10.1038/sj.gt.3301327; McCart JA, 2001, CANCER RES, V61, P8751; Nakamura M, 1998, Brain Tumor Pathol, V15, P83, DOI 10.1007/BF02478888; Nakamura T, 2005, NAT BIOTECHNOL, V23, P209, DOI 10.1038/nbt1060; Norman KL, 2004, P NATL ACAD SCI USA, V101, P11099, DOI 10.1073/pnas.0404310101; O'Shea CC, 2005, CANCER CELL, V8, P61, DOI 10.1016/j.ccr.2005.06.009; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ono Y, 1996, J NEUROPATH EXP NEUR, V55, P1026, DOI 10.1097/00005072-199655100-00002; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Smith KD, 2006, J VIROL, V80, P1110, DOI 10.1128/JVI.80.3.1110-1120.2006; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Ueki K, 1996, CANCER RES, V56, P150; Wang CC, 2006, CANCER RES, V66, P6756, DOI 10.1158/0008-5472.CAN-06-0185; Watanabe T, 2001, ACTA NEUROPATHOL, V101, P185; Wein LM, 2003, CANCER RES, V63, P1317; Wurdinger T, 2005, GENE THER, V12, P1394, DOI 10.1038/sj.gt.3302535; Yoon SS, 1999, J GASTROINTEST SURG, V3, P34, DOI 10.1016/S1091-255X(99)80005-5	31	63	70	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2008	27	30					4249	4254		10.1038/onc.2008.53	http://dx.doi.org/10.1038/onc.2008.53			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	324DB	18345032	Green Published, Bronze, Green Submitted			2022-12-25	WOS:000257496800012
J	Wagstaff, KM; Fan, JY; De Jesus, MA; Tremethick, DJ; Jans, DA				Wagstaff, Kylie M.; Fan, Jun Y.; De Jesus, Michelle A.; Tremethick, David J.; Jans, David A.			Efficient gene delivery using reconstituted chromatin enhanced for nuclear targeting	FASEB JOURNAL			English	Article						gene therapy; histone; protein transduction; NLS	CELL-PENETRATING PEPTIDES; HIV-1 TAT PROTEIN; LOCALIZATION SEQUENCES; MAMMALIAN-CELLS; PLASMID DNA; IMPORT; TRANSPORT; HISTONES; TRANSDUCTION; RECOGNITION	Nonviral gene delivery is hampered by difficulties associated with transporting negatively charged DNA through the cell membrane and, more importantly, the nuclear envelope of target cells. Here we show for the first time that chromatin reconstituted with histone H2B proteins optimized for nuclear targeting can be used as an efficient means to deliver DNA to the nucleus of intact living mammalian cells, resulting in high levels of transgene expression that were similar to 6-fold more than those achieved by commercial liposomal preparations. The high efficiency is due in part to DNA condensation and protection against degradation in the reconstituted chromatin, as well as its ability to interact with high affinity with the importin proteins of the cellular nuclear import machinery. "Chromofection," gene delivery by protein transduction using chromatin enhanced for nuclear targeting represents an efficient means to deliver DNA to a wide variety of cell types, with the potential to treat complex genetic disorders.	[Wagstaff, Kylie M.; De Jesus, Michelle A.; Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Nucl Signalling Lab, Clayton, VIC 3800, Australia; [Jans, David A.] Monash Univ, Australian Res Council, Ctr Excellence Biotechnol & Dev, Clayton, VIC 3800, Australia; [Fan, Jun Y.; Tremethick, David J.] Australian Natl Univ, John Curtin Sch Med Res, Chromatin Transcript & Regulat Lab, Canberra, ACT 2601, Australia	Monash University; Monash University; Australian National University; John Curtin School of Medical Research	Jans, DA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Nucl Signalling Lab, Clayton, VIC 3800, Australia.	david.jans@med.monash.edu.au		Jans, David/0000-0001-5115-4745; Wagstaff, Kylie/0000-0003-4791-1410; Tremethick, David/0000-0001-5274-8078				Baake M, 2001, J CELL BIOCHEM, V81, P333, DOI 10.1002/1097-4644(20010501)81:2<333::AID-JCB1048>3.3.CO;2-4; Balicki D, 1997, MOL MED, V3, P782, DOI 10.1007/BF03401715; Balicki D, 2000, P NATL ACAD SCI USA, V97, P11500, DOI 10.1073/pnas.210382997; Balicki D, 2002, P NATL ACAD SCI USA, V99, P7467, DOI 10.1073/pnas.102168299; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Bao YH, 2004, EMBO J, V23, P3314, DOI 10.1038/sj.emboj.7600316; CAPECCHI MR, 1980, CELL, V22, P479, DOI 10.1016/0092-8674(80)90358-X; Chan CK, 2001, GENE THER, V8, P166, DOI 10.1038/sj.gt.3301366; Demirhan I, 1998, J Hum Virol, V1, P430; DOWTY ME, 1995, P NATL ACAD SCI USA, V92, P4572, DOI 10.1073/pnas.92.10.4572; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Hariton-Gazal E, 2003, J CELL SCI, V116, P4577, DOI 10.1242/jcs.00757; Hashida H, 2004, BRIT J CANCER, V90, P1252, DOI 10.1038/sj.bjc.6601680; Hubner S, 1999, J BIOL CHEM, V274, P22610, DOI 10.1074/jbc.274.32.22610; Ignatovich IA, 2003, J BIOL CHEM, V278, P42625, DOI 10.1074/jbc.M301431200; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Jarver P, 2004, DRUG DISCOV TODAY, V9, P395, DOI 10.1016/S1359-6446(04)03042-9; Johnson-Saliba M, 2000, FEBS LETT, V467, P169, DOI 10.1016/S0014-5793(00)01142-X; Langer T, 2000, HISTOCHEM CELL BIOL, V113, P455; Lundberg P, 2003, J MOL RECOGNIT, V16, P227, DOI 10.1002/jmr.630; Morris MC, 2000, CURR OPIN BIOTECH, V11, P461, DOI 10.1016/S0958-1669(00)00128-2; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pollard H, 2001, J GENE MED, V3, P153, DOI 10.1002/jgm.160; Pollard H, 1998, J BIOL CHEM, V273, P7507, DOI 10.1074/jbc.273.13.7507; Quimby BB, 2001, CELL MOL LIFE SCI, V58, P1766, DOI 10.1007/PL00000816; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; Rosenbluh J, 2004, BBA-BIOMEMBRANES, V1664, P230, DOI 10.1016/j.bbamem.2004.06.003; van der Aa MAEM, 2006, PHARM RES-DORDR, V23, P447, DOI 10.1007/s11095-005-9445-4; WAGNER E, 1991, BIOCONJUGATE CHEM, V2, P226, DOI 10.1021/bc00010a006; Wagstaff KM, 2006, CURR MED CHEM, V13, P1371, DOI 10.2174/092986706776872871; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Wagstaff KM, 2005, J FLUORESC, V15, P469, DOI 10.1007/s10895-005-2819-5; Wagstaff KM, 2007, MOL THER, V15, P721, DOI 10.1038/sj.mt.6300093; Xiao CY, 1997, J BIOL CHEM, V272, P22191, DOI 10.1074/jbc.272.35.22191; ZABNER J, 1995, J BIOL CHEM, V270, P18997, DOI 10.1074/jbc.270.32.18997	42	32	32	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2008	22	7					2232	2242		10.1096/fj.07-099911	http://dx.doi.org/10.1096/fj.07-099911			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18356302				2022-12-25	WOS:000257292500016
J	Erlandson, KJ; Or, E; Osborne, AR; Rapoport, TA				Erlandson, Karl J.; Or, Eran; Osborne, Andrew R.; Rapoport, Tom A.			Analysis of polypeptide movement in the SecY channel during SecA-mediated protein translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREPROTEIN TRANSLOCASE; ESCHERICHIA-COLI; CYTOPLASMIC MEMBRANE; STEPWISE MOVEMENT; DISULFIDE BRIDGE; ER MEMBRANE; DOMAIN; CYCLE	In bacteria most secretory proteins are transported across the plasma membrane by the interplay of the ATPase SecA with the translocation channel formed by the SecY complex; SecA uses cycles of ATP hydrolysis to "push" consecutive segments of a polypeptide substrate through the channel. Here we have addressed the mechanism of this process by following the fate of stalled translocation intermediates. These were generated by using a polypeptide substrate containing a bulky disulfide-bonded loop, thus preventing the final residues from passing through the channel. Protease protection experiments showed that the intermediates were stable in the presence of ATP and could complete translocation once the block was removed. The translocation intermediate was also stable when SecA associated with ATP gamma S, a poorly hydrolyzable ATP analog, or ADP plus AlF4, which mimics the transition state during ATP hydrolysis. In contrast, when SecA was in its ADP-bound state, the translocating polypeptide moved back into the cytosol, as indicated by the disappearance of the protected fragment. Backsliding was not significantly altered by deletion of the plug domain, a short helix in the center of the SecY channel, but it was slowed down when changes were introduced into the pore ring, the constriction of the hourglass-shaped channel. In all cases, backsliding was significantly slower than forward translocation. Together, these data suggest that SecA binds the polypeptide chain in its ATP state and releases it in the ADP state. The channel itself does not bind the polypeptide chain but provides "friction" that minimizes backsliding when ADP-bound SecA resets to "grab" the next segment of the substrate.	[Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM052586, R01 GM052586-13] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Collinson I, 2001, EMBO J, V20, P2462, DOI 10.1093/emboj/20.10.2462; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Gumbart J, 2006, BIOPHYS J, V90, P2356, DOI 10.1529/biophysj.105.075291; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Karamanou S, 1999, MOL MICROBIOL, V34, P1133, DOI 10.1046/j.1365-2958.1999.01686.x; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Sato K, 1997, J BIOL CHEM, V272, P5880, DOI 10.1074/jbc.272.9.5880; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804; TANI K, 1990, J BIOL CHEM, V265, P17341; Tomkiewicz D, 2007, FEBS LETT, V581, P2820, DOI 10.1016/j.febslet.2007.04.015; Tomkiewicz D, 2006, J BIOL CHEM, V281, P15709, DOI 10.1074/jbc.M600205200; Uchida K, 1995, J BIOL CHEM, V270, P30862, DOI 10.1074/jbc.270.52.30862; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van Voorst F, 2000, FEBS LETT, V486, P57, DOI 10.1016/S0014-5793(00)02209-2	26	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					15709	15715		10.1074/jbc.M710356200	http://dx.doi.org/10.1074/jbc.M710356200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18359943	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000256332500026
J	Congdon, EE; Kim, S; Bonchak, J; Songrug, T; Matzavinos, A; Kuret, J				Congdon, Erin E.; Kim, Sohee; Bonchak, Jonathan; Songrug, Tanakorn; Matzavinos, Anastasios; Kuret, Jeff			Nucleation-dependent tau filament formation - The importance of dimerization and an estimation of elementary rate constants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; FULL-LENGTH TAU; ALZHEIMERS-DISEASE; PROTEIN-TAU; IN-VITRO; ELECTRON-MICROSCOPY; AGGREGATION; KINETICS; ACTIN; PHOSPHORYLATION	Filamentous inclusions composed of the microtubule-associated protein tau are found in Alzheimer disease and other tauopathic neurodegenerative diseases, but the mechanisms underlying their formation from full-length protein monomer under physiological conditions are unclear. To address this issue, the fibrillization of recombinant full-length four-repeat human tau was examined in vitro as a function of time and submicromolar tau concentrations using electron microscopy assay methods and a small-molecule inducer of aggregation, thiazine red. Data were then fit to a simple homogeneous nucleation model with rate constant constraints established from filament dissociation rate, critical concentration, and mass-per-unit length measurements. The model was then tested by comparing the predicted time-dependent evolution of length distributions to experimental data. Results indicated that once assembly-competent conformations were attained, the rate-limiting step in the fibrillization pathway was tau dimer formation. Filament elongation then proceeded by addition of tau monomers to nascent filament ends. Filaments isolated at reaction plateau contained similar to 2 tau protomers/beta-strand spacing on the basis of mass-per-unit length measurements. The model suggests four key steps in the aggregation pathway that must be surmounted for tau filaments to form in disease.	[Congdon, Erin E.; Kim, Sohee; Bonchak, Jonathan; Songrug, Tanakorn; Kuret, Jeff] Ohio State Univ, Ctr Mol Neurobiol, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Matzavinos, Anastasios] Ohio State Univ, Dept Math, Math Biosci Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kuret, J (corresponding author), Ohio State Univ, Ctr Mol Neurobiol, Dept Mol & Cellular Biochem, 1060 Carmack Rd, Columbus, OH 43210 USA.	kuret.3@osu.edu		Congdon, Erin/0000-0001-8322-6176; Matzavinos, Anastasios/0000-0003-0491-7329	NIA NIH HHS [AG14452] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG014452] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200; Ahn JS, 2005, CHEM BIOL, V12, P811, DOI 10.1016/j.chembiol.2005.05.011; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Bandyopadhyay B, 2007, J BIOL CHEM, V282, P16454, DOI 10.1074/jbc.M700192200; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; BRIEHL RW, 1990, J MOL BIOL, V211, P693, DOI 10.1016/0022-2836(90)90070-3; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Carlson SW, 2007, BIOCHEMISTRY-US, V46, P8838, DOI 10.1021/bi700403a; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chang E, 2008, ANAL BIOCHEM, V373, P330, DOI 10.1016/j.ab.2007.09.015; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Dehmelt L, 2005, GENOME BIOL, V6; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Flyvbjerg H, 1997, PHYS REV E, V56, P7083, DOI 10.1103/PhysRevE.56.7083; Flyvbjerg H, 1996, P NATL ACAD SCI USA, V93, P5975, DOI 10.1073/pnas.93.12.5975; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Galvan M, 2001, J ALZHEIMERS DIS, V3, P417, DOI 10.3233/JAD-2001-3409; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; GOLDSTEIN RF, 1986, BIOPHYS J, V50, P583, DOI 10.1016/S0006-3495(86)83498-1; GomezIsla T, 1996, J NEUROSCI, V16, P4491; GRAY EG, 1987, NEUROPATH APPL NEURO, V13, P91, DOI 10.1111/j.1365-2990.1987.tb00174.x; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Hu JF, 2007, J STAT PHYS, V128, P111, DOI 10.1007/s10955-006-9204-x; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Ignatova Z, 2005, BIOCHEMISTRY-US, V44, P7266, DOI 10.1021/bi047404e; KHATOON S, 1994, FEBS LETT, V351, P80, DOI 10.1016/0014-5793(94)00829-9; Kim YS, 2003, J BIOL CHEM, V278, P10842, DOI 10.1074/jbc.M212540200; King ME, 1999, BIOCHEMISTRY-US, V38, P14851, DOI 10.1021/bi9911839; King ME, 2001, AM J PATHOL, V158, P1481, DOI 10.1016/S0002-9440(10)64099-0; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; Ko LW, 2002, J MOL NEUROSCI, V19, P311; KRISTOFFERSON D, 1980, J BIOL CHEM, V255, P8567; Ksiezak-Reding H, 2005, MICROSC RES TECHNIQ, V67, P126, DOI 10.1002/jemt.20188; Kuret J, 2005, BBA-MOL BASIS DIS, V1739, P167, DOI 10.1016/j.bbadis.2004.06.016; Kuret Jeff, 2008, P289; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Makrides V, 2004, P NATL ACAD SCI USA, V101, P6746, DOI 10.1073/pnas.0400992101; Makrides V, 2003, J BIOL CHEM, V278, P33298, DOI 10.1074/jbc.M305207200; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; Necula M, 2005, BIOCHEMISTRY-US, V44, P10227, DOI 10.1021/bi050387o; Necula M, 2005, FEBS LETT, V579, P1453, DOI 10.1016/j.febslet.2005.01.047; Necula M, 2004, ANAL BIOCHEM, V329, P238, DOI 10.1016/j.ab.2004.02.023; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; OOSAWA F, 1975, THERMODYNAMICS POLYM, P51; Paudel HK, 1997, J BIOL CHEM, V272, P1777; Perez M, 1996, J NEUROCHEM, V67, P1183; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Reynolds MR, 2005, BIOCHEMISTRY-US, V44, P1690, DOI 10.1021/bi047982v; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; Sept D, 1999, BIOPHYS J, V77, P2911, DOI 10.1016/S0006-3495(99)77124-9; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Timasheff S. N., 1981, PROTEIN PROTEIN INTE, P315; Tsemekhman K, 2007, PROTEIN SCI, V16, P761, DOI 10.1110/ps.062609607; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; WEGNER A, 1975, BIOPHYS CHEM, V3, P215, DOI 10.1016/0301-4622(75)80013-5; Wilson DM, 1997, AM J PATHOL, V150, P2181; WISCHIK CM, 1985, J CELL BIOL, V100, P1905, DOI 10.1083/jcb.100.6.1905; Xu SH, 2007, AMYLOID, V14, P119, DOI 10.1080/13506120701260059; Zhao DH, 2003, ORG BIOMOL CHEM, V1, P3471, DOI 10.1039/b308788c; Zhu XW, 2004, LANCET NEUROL, V3, P219, DOI 10.1016/S1474-4422(04)00707-0	82	87	90	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13806	13816		10.1074/jbc.M800247200	http://dx.doi.org/10.1074/jbc.M800247200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18359772	Green Published, hybrid			2022-12-25	WOS:000255728200033
J	Schulze, H; Dose, M; Korpal, M; Meyer, I; Italiano, JE; Shivdasani, RA				Schulze, Harald; Dose, Marei; Korpal, Manav; Meyer, Imke; Italiano, Joseph E., Jr.; Shivdasani, Ramesh A.			RanBP10 is a cytoplasmic guanine nucleotide exchange factor that modulates noncentrosomal microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NF-E2; GAMMA-TUBULIN COMPLEXES; XENOPUS EGG EXTRACTS; NUCLEAR-PORE COMPLEX; SMALL GTPASE RAN; STRUCTURAL INSIGHTS; BLOOD-PLATELETS; BINDING PROTEIN; BETA-1 TUBULIN; IMPORTIN-BETA	Microtubule spindle assembly in mitosis is stimulated by Ran.GTP, which is generated along condensed chromosomes by the guanine nucleotide exchange factor (GEF) RCC1. This relationship suggests that similar activities might modulate other microtubule structures. Interphase microtubules usually extend from the centrosome, although noncentrosomal microtubules function in some differentiated cells, including megakaryocytes. In these cells, platelet biogenesis requires massive mobilization of microtubules in the cell periphery, where they form proplatelets, the immediate precursors of platelets, in the apparent absence of centrioles. Here we identify a cytoplasmic Ran-binding protein, RanBP10, as a factor that binds beta-tubulin and associates with megakaryocyte microtubules. Unexpectedly, RanBP10 harbors GEF activity toward Ran. A point mutation in the candidate GEF domain abolishes exchange activity, and our results implicate RanBP10 as a localized cytoplasmic Ran-GEF. RNA interference-mediated loss of RanBP10 in cultured megakaryocytes disrupts microtubule organization. These results lead us to propose that spatiotemporally restricted generation of cytoplasmic Ran.GTP may influence organization of the specialized microtubules required in thrombopoiesis and that RanBP10 might serve as a molecular link between Ran and noncentrosomal microtubules.	[Schulze, Harald; Dose, Marei; Korpal, Manav; Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Schulze, Harald; Italiano, Joseph E., Jr.; Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Italiano, Joseph E., Jr.; Shivdasani, Ramesh A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Meyer, Imke] Charite Univ Med Berlin, Dept Pediat, D-10017 Berlin, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schulze, H (corresponding author), Labor Padiatr Mol Biol, Ziegelstr 5-9, D-10098 Berlin, Germany.	harald.schulze@charite.de; ramesh_shivdasani@dfci.harvard.edu		Dose, Marei/0000-0001-5394-9779	NHLBI NIH HHS [R01HL63143] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063143] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Cheng L, 2002, MOL CELL BIOL, V22, P6895, DOI 10.1128/MCB.22.19.6895-6905.2002; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Keating TJ, 1999, BIOL CELL, V91, P321, DOI 10.1016/S0248-4900(99)80093-8; KIRKPATRICK D, 1994, GENETICS, V137, P381; KLEBE C, 1993, BIOCHEMISTRY-US, V32, P11923, DOI 10.1021/bi00095a023; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Lecine P, 2000, BLOOD, V96, P1366, DOI 10.1182/blood.V96.4.1366.h8001366_1366_1373; Lecine P, 1998, J BIOL CHEM, V273, P7572, DOI 10.1074/jbc.273.13.7572; LEWIS SA, 1987, CELL, V49, P539, DOI 10.1016/0092-8674(87)90456-9; Li HY, 2004, GENE DEV, V18, P512, DOI 10.1101/gad.1177304; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Moritz M, 2001, CURR OPIN STRUC BIOL, V11, P174, DOI 10.1016/S0959-440X(00)00187-1; MOSKWINTARKHANOV MI, 1978, TSITOLOGIYA+, V20, P1436; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nagata Y, 1997, J CELL BIOL, V139, P449, DOI 10.1083/jcb.139.2.449; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; Nicolas FJ, 2001, J CELL SCI, V114, P3013; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Nogales E, 2001, ANNU REV BIOPH BIOM, V30, P397, DOI 10.1146/annurev.biophys.30.1.397; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Patel SR, 2005, BLOOD, V106, P4076, DOI 10.1182/blood-2005-06-2204; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; RADLEY JM, 1980, BLOOD, V56, P996; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schiebel E, 2000, CURR OPIN CELL BIOL, V12, P113, DOI 10.1016/S0955-0674(99)00064-2; Schulze H, 2004, BLOOD, V104, P3949, DOI 10.1182/blood-2004-03-1179; Schwer HD, 2001, CURR BIOL, V11, P579, DOI 10.1016/S0960-9822(01)00153-1; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Steggerda SM, 2000, J BIOL CHEM, V275, P23175, DOI 10.1074/jbc.C000252200; Urbani L, 1999, CURR BIOL, V9, pR315, DOI 10.1016/S0960-9822(99)80201-2; WANG D, 1986, J CELL BIOL, V103, P1903, DOI 10.1083/jcb.103.5.1903; Wang DK, 2004, BIOCHEM BIOPH RES CO, V313, P320, DOI 10.1016/j.bbrc.2003.11.124; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Wells CD, 2001, J BIOL CHEM, V276, P28897, DOI 10.1074/jbc.M102913200; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	55	44	50	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14109	14119		10.1074/jbc.M709397200	http://dx.doi.org/10.1074/jbc.M709397200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18347012	hybrid, Green Published			2022-12-25	WOS:000255728200065
J	Townsend, TA; Wrana, JL; Davis, GE; Barnett, JV				Townsend, Todd A.; Wrana, Jeffrey L.; Davis, George E.; Barnett, Joey V.			Transforming growth factor-beta-stimulated endocardial cell transformation is dependent on Par6c regulation of RhoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSFORMATION; CONGENITAL HEART-DISEASE; CARDIAC-VALVE FORMATION; VASCULAR HOMEOSTASIS; ENDOTHELIAL-CELLS; RECEPTOR SYSTEM; EXPRESSION; ACTIVATION; MIGRATION; GTPASES	Valvular heart disease due to congenital abnormalities or pathology is a major cause of mortality and morbidity. Understanding the cellular processes and molecules that regulate valve formation and remodeling is required to develop effective therapies. In the developing heart, epithelial-mesenchymal transformation (EMT) in a subpopulation of endocardial cells in the atrioventricular cushion (AVC) is an important step in valve formation. Transforming growth factor-beta(TGF beta) has been shown to be an important regulator of AVC endocardial cell EMT in vitro and mesenchymal cell differentiation in vivo. Recently Par6c (Par6) has been shown to function downstream of TGF beta to recruit Smurf1, an E3 ubiquitin ligase, which targets RhoA for degradation to control apical-basal polarity and tight junction dissolution. We tested the hypothesis that Par6 functions in a pathway that regulates endocardial cell EMT. Here we show that the Type I TGF beta receptor ALK5 is required for endocardial cell EMT. Overexpression of dominant negative Par6 inhibits EMT in AVC endocardial cells, whereas overexpression of wild-type Par6 in normally non-transforming ventricular endocardial cells results in EMT. Overexpression of Smurf1 in ventricular endocardial cells induces EMT. Decreasing RhoA activity using dominant negative RhoA or small interfering RNA in ventricular endocardial cells also increases EMT, whereas overexpression of constitutively active RhoA in AVC endothelial cells blocks EMT. Manipulation of Rac1 or Cdc42 activity is without effect. These data demonstrate a functional role for Par6/Smurf1/RhoA in regulating EMT in endocardial cells.	[Townsend, Todd A.; Barnett, Joey V.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Wrana, Jeffrey L.] Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M56 1X5, Canada; [Davis, George E.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65212 USA	Vanderbilt University; University of Toronto; University of Missouri System; University of Missouri Columbia	Barnett, JV (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Rm 476 RRB,220 Pierce Ave, Nashville, TN 37232 USA.	joey.barnett@vanderbilt.edu	Wrana, Jeffrey/F-8857-2013		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007628] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL52922, R01 HL052922-10, R01 HL052922] Funding Source: Medline; NIGMS NIH HHS [GM007628] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		American Heart Association, 2008, HEART STROK STAT UPD; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bakin AV, 2002, J CELL SCI, V115, P3193; Barnett Joey V., 2003, Birth Defects Research, V69, P58, DOI 10.1002/bdrc.10006; Bayless KJ, 2002, J CELL SCI, V115, P1123; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; BERNANKE DH, 1982, DEV BIOL, V91, P235, DOI 10.1016/0012-1606(82)90030-6; Bhowmick NA, 2003, P NATL ACAD SCI USA, V100, P15548, DOI 10.1073/pnas.2536483100; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Bose R, 2006, CURR OPIN CELL BIOL, V18, P206, DOI 10.1016/j.ceb.2006.02.005; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Brown CB, 1996, DEV BIOL, V174, P248, DOI 10.1006/dbio.1996.0070; Bryan B, 2005, FEBS LETT, V579, P1015, DOI 10.1016/j.febslet.2004.12.074; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Compton LA, 2007, CIRC RES, V101, P784, DOI 10.1161/CIRCRESAHA.107.152082; Connolly HM, 1997, NEW ENGL J MED, V337, P581, DOI 10.1056/NEJM199708283370901; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Dejana E, 2001, THROMB HAEMOSTASIS, V86, P308; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desgrosellier JS, 2005, DEV BIOL, V280, P201, DOI 10.1016/j.ydbio.2004.12.037; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; GALLOWAY AC, 1999, SCHWARTZS PRINCIPLES, P845; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HOFFMAN JIE, 1990, PEDIATR CLIN N AM, V37, P25; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kaarbo M, 2003, DEV DYNAM, V227, P35, DOI 10.1002/dvdy.10283; KELLER BRADLY B, 1998, HURSTS HEART ARTERIE, P195; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Masszi A, 2003, AM J PHYSIOL-RENAL, V284, pF911, DOI 10.1152/ajprenal.00183.2002; Mercado-Pimentel ME, 2007, DEV BIOL, V304, P420, DOI 10.1016/j.ydbio.2006.12.038; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; ROBIOLIO PA, 1995, CIRCULATION, V92, P790, DOI 10.1161/01.CIR.92.4.790; Sadler TW, 1985, LANGMANS MED EMBRYOL, P168; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sakabe M, 2006, DEV DYNAM, V235, P94, DOI 10.1002/dvdy.20648; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Storey NM, 2002, CURR BIOL, V12, P27, DOI 10.1016/S0960-9822(01)00625-X; Sugi Y, 2004, DEV BIOL, V269, P505, DOI 10.1016/j.ydbio.2004.01.045; Tavares ALP, 2006, DEV DYNAM, V235, P1589, DOI 10.1002/dvdy.20771; Amerongen GPV, 2007, ARTERIOSCL THROM VAS, V27, P2332, DOI 10.1161/ATVBAHA.107.152322; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wang GY, 2005, J BONE MINER RES, V20, P1022, DOI 10.1359/JBMR.050113; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; Ward SM, 2002, J MOL CELL CARDIOL, V34, P1217, DOI 10.1006/jmcc.2002.7023; Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Wojciak-Stothard B, 2001, J CELL SCI, V114, P1343; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Zhao ZY, 2004, DEV BIOL, V275, P183, DOI 10.1016/j.ydbio.2004.08.002	62	46	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13834	13841		10.1074/jbc.M710607200	http://dx.doi.org/10.1074/jbc.M710607200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18343818	hybrid, Green Published			2022-12-25	WOS:000255728200036
J	Lu, ZL; Liu, W; Huang, HZ; He, Y; Han, Y; Rui, YN; Wang, YH; Li, QX; Ruan, K; Ye, ZY; Low, BC; Meng, AM; Lin, SC				Lu, Zailian; Liu, Wei; Huang, Huizhe; He, Ying; Han, Ying; Rui, Yanning; Wang, Yanhai; Li, Qinxi; Ruan, Ka; Ye, Zhiyun; Low, Boon Chuan; Meng, Anming; Lin, Sheng-Cai			Protein encoded by the Axin(Fu) allele effectively down-regulates wnt signaling but exerts a dominant negative effect on c-jun n-terminal kinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; AXIS FORMATION; FUSED LOCUS; PATHWAY; MOUSE; JNK; DOMAINS; COMPLEX; GENE; NEURECTODERM	Axin plays an architectural role in many important signaling pathways that control various aspects of development and tumorigenesis, including the Wnt, transforming growth factor-beta, MAP kinase pathways, as well as p53 activation cascades. It is encoded by the mouse Fused (Fu) locus; the Axin(Fu) allele is caused by insertion of an IAP transposon. Axin(Fu/Fu) mice display varying phenotypes ranging from embryonic lethality to relatively normal adulthood with kinky tails. However, the protein product(s) has not been identified or characterized. In the present study, we conducted immunoprecipitation using brain extracts from the Axin(Fu) mice with specific antibodies against different regions of Axin and found that a truncated Axin containing amino acids 1-596 (designated as Axin(Fu-NT)) and the full-length complement of Axin (Axin(WT)) can both be generated from the AxinFu allele. When tested for functionality changes, Axin(Fu-NT) was found to abolish Axin-mediated activation of JNK, which plays a critical role in dorsoventral patterning. Together with a proteomics approach, we found that Axin(Fu-NT) contains a previously uncharacterized dimerization domain and can form a heterodimeric interaction with Axin(WT). TheAxin(Fu-NT)/Axin(WT) is not conducive to JNK activation, providing a molecular explanation for the dominant negative effect of Axin(Fu-NT) on JNK activation by wild-type Axin. Importantly, Axin(Fu-NT) exhibits no difference in the inhibition of Wnt signaling compared with Axin(WT) as determined by reporter gene assays, interaction with key Wnt regulators, and expression of Wnt marker genes in zebrafish embryos, suggesting that altered JNK signaling contributes, at least in part, to the developmental defects seen in Axin(Fu) mice.	[Lu, Zailian; Huang, Huizhe; He, Ying; Han, Ying; Rui, Yanning; Wang, Yanhai; Li, Qinxi; Ruan, Ka; Ye, Zhiyun; Lin, Sheng-Cai] Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China; [Liu, Wei] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; [Meng, Anming] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Low, Boon Chuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117609, Singapore	Xiamen University; Hong Kong University of Science & Technology; Tsinghua University; National University of Singapore	Lin, SC (corresponding author), Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China.	linsc@xmu.edu.cn	Li, QX/G-4669-2010; Lin, SC/G-4666-2010; Low, Boon Chuan/AAU-7685-2021; Low, Boon Chuan/H-8049-2012; Meng, Anming/A-4785-2012	Low, Boon Chuan/0000-0003-0756-096X; Low, Boon Chuan/0000-0003-0756-096X; Rui, Yanning/0000-0002-4482-5579				Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; DUNN LC, 1956, GENETICS, V41, P344; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Fekany K, 1999, DEVELOPMENT, V126, P1427; Flood WD, 2001, HEREDITY, V87, P146, DOI 10.1046/j.1365-2540.2001.00868.x; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; GLUECKSOHNSCHOENHEIMER S, 1949, J EXP ZOOL, V110, P47, DOI 10.1002/jez.1401100105; GREENSPAN RJ, 1986, P NATL ACAD SCI USA, V83, P4413, DOI 10.1073/pnas.83.12.4413; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; JACOBSCOHEN RJ, 1984, GENET RES, V43, P43, DOI 10.1017/S0016672300025702; JOLY JS, 1993, DEVELOPMENT, V119, P1261; Kelly C, 2000, DEVELOPMENT, V127, P3899; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Luo W, 2003, J BIOL CHEM, V278, P37451, DOI 10.1074/jbc.M305277200; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PERRY WL, 1995, GENETICS, V141, P321; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Reed SC, 1937, GENETICS, V22, P1; Rui YN, 2007, DEV CELL, V13, P268, DOI 10.1016/j.devcel.2007.07.006; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Takebayashi-Suzuki K, 2003, DEVELOPMENT, V130, P3929, DOI 10.1242/dev.00615; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; THISSE C, 1994, DEV BIOL, V164, P420, DOI 10.1006/dbio.1994.1212; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Vasicek TJ, 1997, GENETICS, V147, P777; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Weaver C, 2004, DEVELOPMENT, V131, P3491, DOI 10.1242/dev.01284; WEAVER CR, 2002, CURR OPIN GENE DEV, V12, P14; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247; Zhang Y, 2001, J BIOL CHEM, V276, P32152, DOI 10.1074/jbc.M104451200; Zhang Y, 2000, J BIOL CHEM, V275, P25008, DOI 10.1074/jbc.M002491200; Zhao J, 2003, EMBO J, V22, P6078, DOI 10.1093/emboj/cdg593	41	5	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13132	13139		10.1074/jbc.M710595200	http://dx.doi.org/10.1074/jbc.M710595200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18316368	hybrid			2022-12-25	WOS:000255499800052
J	Bartoszewski, R; Rab, A; Twitty, G; Stevenson, L; Fortenberry, J; Piotrowski, A; Dumanski, JP; Bebok, Z				Bartoszewski, Rafal; Rab, Andras; Twitty, George; Stevenson, Lauren; Fortenberry, James; Piotrowski, Arkadiusz; Dumanski, Jan P.; Bebok, Zsuzsa			The mechanism of cystic fibrosis transmembrane conductance regulator transcriptional repression during the unfolded protein response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SMALL-MOLECULE CORRECTORS; AIRWAY EPITHELIAL-CELLS; ER STRESS; MESSENGER-RNA; INHIBITORS INDUCE; CHLORIDE CHANNEL; DELTA-F508 CFTR; GENE-EXPRESSION; CPG ISLANDS	The unfolded protein response (UPR) aids cellular recovery by increasing the capacity and decreasing the protein load of the endoplasmic reticulum (ER). Although the main pathways of the UPR are known, the mechanisms of UPR-associated transcriptional repression have not been explored in mammalian cells. Previous studies indicate that endogenous cystic fibrosis transmembrane conductance regulator (CFTR) mRNA levels and protein maturation efficiency decrease when the UPR is activated. In the present study, we demonstrate that inhibition of CFTR expression under ER stress leads to reduced cAMP-activated chloride secretion in epithelial monolayers, an indication of diminished CFTR function. Moreover, ER stress and the UPR obliterate endogenous Delta F508 CFTR mRNA expression in CFPAC-1 cells without affecting recombinant Delta F508 CFTR mRNA levels or mRNA half-life. These results emphasize that transcriptional repression of CFTR under ER stress, in concert with decreased CFTR maturation efficiency, leads to diminished function. Using human CFTR promoter reporter constructs, we confined the ER stress-associated CFTR transcriptional repression to the minimal promoter. Chromatin immunoprecipitation assays established the binding of the UPR-activated ATF6 transcription factor to this region during ER stress, which links the repression to the UPR. Methylation-specific PCR (MSP) revealed hypermethylation of CpG sites inside and in the vicinity of the MAZ transcription factor binding region of CFTR, demonstrating methylation-dependent repression. Using pharmacological inhibitors, we show that both DNA methylation and histone deacetylation contribute to CFTR transcriptional inhibition. These studies provide novel insight into the mechanism of gene repression during the mammalian UPR.	[Bartoszewski, Rafal; Rab, Andras; Twitty, George; Stevenson, Lauren; Bebok, Zsuzsa] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Piotrowski, Arkadiusz; Dumanski, Jan P.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Fortenberry, James] Univ Alabama Birmingham, Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bebok, Z (corresponding author), Univ Alabama Birmingham, Dept Cell Biol, 1918 Univ Blvd,MCLM 760, Birmingham, AL 35294 USA.	bebok@uab.edu	Bartoszewski, Rafal A/D-6311-2011; Rab, András/AAR-7804-2021; Piotrowski, Arkadiusz/A-5484-2010; Rab, Andras/AAI-9402-2021	Bartoszewski, Rafal A/0000-0002-2864-6757; Rab, András/0000-0003-2154-0017; Piotrowski, Arkadiusz/0000-0002-0823-0607; Dumanski, Jan Piotr/0000-0002-1489-1452				AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; Akiba Y, 2005, AM J PHYSIOL-GASTR L, V289, pG753, DOI 10.1152/ajpgi.00130.2005; Amaral MD, 2005, PEDIATR PULM, V39, P479, DOI 10.1002/ppul.20168; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bates E, 2007, J CYST FIBROS, V6, P351, DOI 10.1016/j.jcf.2007.01.001; Baudouin-Legros M, 2005, AM J PHYSIOL-CELL PH, V289, pC1240, DOI 10.1152/ajpcell.00595.2004; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bebok Z, 1998, AM J PHYSIOL-CELL PH, V275, pC599, DOI 10.1152/ajpcell.1998.275.2.C599; Bebok Z, 2002, J BIOL CHEM, V277, P43041, DOI 10.1074/jbc.M203154200; Bebok Z, 2001, AM J PHYSIOL-CELL PH, V280, pC135, DOI 10.1152/ajpcell.2001.280.1.C135; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; BRAUN ME, 2006, PEDIATR PULM, V29, P236; Cantin AM, 2006, AM J PHYSIOL-CELL PH, V290, pC262, DOI 10.1152/ajpcell.00070.2005; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Chaabane C, 2006, BIOCHEM BIOPH RES CO, V345, P1377, DOI 10.1016/j.bbrc.2006.05.054; Chen L, 2006, J BIOL CHEM, V281, P9190, DOI 10.1074/jbc.M513231200; CHOU JL, 1991, J BIOL CHEM, V266, P24471; CLIFF WH, 1992, AM J PHYSIOL, V262, pC1154, DOI 10.1152/ajpcell.1992.262.5.C1154; DOERFLER W, 1989, CELL BIOPHYS, V15, P21, DOI 10.1007/BF02991576; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; El-Osta A, 2002, MOL CELL BIOL, V22, P1844, DOI 10.1128/MCB.22.6.1844-1857.2002; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; HARROLD S, 1991, ANAL BIOCHEM, V198, P19, DOI 10.1016/0003-2697(91)90500-S; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hong M, 2004, J CELL BIOCHEM, V92, P723, DOI 10.1002/jcb.20118; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kawane T, 2001, BIOCHEM BIOPH RES CO, V287, P313, DOI 10.1006/bbrc.2001.5586; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; Kimata Y, 2006, GENES CELLS, V11, P59, DOI 10.1111/j.1365-2443.2005.00921.x; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Latchman DS, 1996, INT J BIOCHEM CELL B, V28, P965, DOI 10.1016/1357-2725(96)00039-8; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Li S, 1999, J BIOL CHEM, V274, P7803, DOI 10.1074/jbc.274.12.7803; Matthews RP, 1996, J BIOL CHEM, V271, P31869, DOI 10.1074/jbc.271.50.31869; McCarthy VA, 2005, PEDIATR PULM, V40, P1, DOI 10.1002/ppul.20199; MEEHAN R, 1992, J CELL SCI, P9; Mehta A, 2005, PEDIATR PULM, V39, P292, DOI 10.1002/ppul.20147; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Nadanaka S, 2004, MOL BIOL CELL, V15, P2537, DOI 10.1091/mbc.E03-09-0693; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; Nozell S, 2004, J BIOL CHEM, V279, P38577, DOI 10.1074/jbc.M403738200; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Paz MF, 2003, HUM MOL GENET, V12, P2209, DOI 10.1093/hmg/ddg226; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Piotrowski A, 2006, GENE CHROMOSOME CANC, V45, P656, DOI 10.1002/gcc.20331; Quivy V, 2004, CLONING STEM CELLS, V6, P140, DOI 10.1089/1536230041372454; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Rajesh D, 2003, J BIOL CHEM, V278, P35968, DOI 10.1074/jbc.M303280200; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Ratjen F, 2006, PAEDIATR RESPIR REV, V7, pS70, DOI 10.1016/j.prrv.2006.04.170; Rene C, 2005, NUCLEIC ACIDS RES, V33, P5271, DOI 10.1093/nar/gki837; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Rodriguez BAT, 2005, BIOCHEM CELL BIOL, V83, P525, DOI 10.1139/O05-055; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Rowe SM, 2006, CURR OPIN PEDIATR, V18, P604, DOI 10.1097/MOP.0b013e3280109b90; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Song J, 2001, J BIOL CHEM, V276, P19897, DOI 10.1074/jbc.M010658200; Taddei A, 2004, FEBS LETT, V558, P52, DOI 10.1016/S0014-5793(04)00011-0; Thuerauf DJ, 2004, J BIOL CHEM, V279, P21078, DOI 10.1074/jbc.M400713200; van der Deen M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-59; Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200; Verkman AS, 2004, CURR OPIN NEPHROL HY, V13, P563, DOI 10.1097/00041552-200409000-00013; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Xue X, 2005, J BIOL CHEM, V280, P33917, DOI 10.1074/jbc.M505818200; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zeng LF, 2004, EMBO J, V23, P950, DOI 10.1038/sj.emboj.7600106; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	84	59	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12154	12165		10.1074/jbc.M707610200	http://dx.doi.org/10.1074/jbc.M707610200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319256	hybrid			2022-12-25	WOS:000255340000032
J	Moya-Garcia, AA; Ruiz-Pernia, J; Marti, S; Sanchez-Jimenez, F; Tunon, I				Moya-Garcia, Aurelio A.; Ruiz-Pernia, Javier; Marti, Sergio; Sanchez-Jimenez, Francisca; Tunon, Inaki			Analysis of the decarboxylation step in mammalian histidine decarboxylase - A computational study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DECARBOXYLASE; CATECHOL O-METHYLTRANSFERASE; SITE-DIRECTED MUTAGENESIS; POTENTIAL-ENERGY SURFACE; TRANSITION-STATE; HISTAMINE; ENZYMES; CATALYSIS; STABILIZATION; CONFORMATION	We report a hybrid quantum mechanics/molecular mechanics theoretical study on the reaction mechanism of mammalian histidine decarboxylase that allows us to obtain valuable insights on the structure of the cofactor-substrate adduct ( external aldimine) in the active site of rat histidine decarboxylase. By means of molecular dynamics simulations, we traced the potential of mean force corresponding to the decarboxylation reaction of the adduct both in the active site of the enzyme and in aqueous solution. By comparing this process in both media, we have identified the key electrostatic interactions that explain the lowering of the free energy barrier in the enzyme. Our analysis also offers a validation of Dunathan's hypothesis (Dunathan, H. (1966) Proc. Natl. Acad. Sci. U. S. A. 55, 712-716) regarding the role of stereoelectronic effects in the enzymatic decarboxylation process.	[Ruiz-Pernia, Javier; Tunon, Inaki] Univ Valencia, Dept Quim Fis, E-46100 Valencia, Spain; [Moya-Garcia, Aurelio A.; Sanchez-Jimenez, Francisca] Univ Malaga, Dept Biol Mol & Bioquim, Procel Lab, E-29071 Malaga, Spain; [Marti, Sergio] Univ Jaume 1, Dept Quim Fis & Analit, Castellon de La Plana 12071, Spain	University of Valencia; Universidad de Malaga; Universitat Jaume I	Tunon, I (corresponding author), Univ Valencia, Dept Quim Fis, E-46100 Valencia, Spain.	Tunon@uv.es	Martí, Sergio/G-7844-2015; Pernia, Jose Javier Ruiz/L-9863-2014; Tunon, Inaki/F-7973-2012; Ruiz-Pernía, José Javier/AAT-2917-2021; Moya-García, Aurelio/AAA-3429-2020; Jiménez, Francisca María Sánchez/H-2513-2015	Martí, Sergio/0000-0002-1087-7143; Tunon, Inaki/0000-0002-6995-1838; Ruiz-Pernía, José Javier/0000-0002-4640-0419; Jiménez, Francisca María Sánchez/0000-0002-4958-6060; Moya Garcia, Aurelio/0000-0002-0567-0949				AULD DS, 1967, J AM CHEM SOC, V89, P2098, DOI 10.1021/ja00985a022; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Bruice TC, 2002, ACCOUNTS CHEM RES, V35, P139, DOI 10.1021/ar0001665; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; Chiu W, 2005, STRUCTURE, V13, P363, DOI 10.1016/j.str.2004.12.016; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Ferrer S, 2005, J CHEM THEORY COMPUT, V1, P750, DOI 10.1021/ct050016l; Fitzpatrick LA, 2003, P NATL ACAD SCI USA, V100, P6027, DOI 10.1073/pnas.0934373100; Fleming JV, 2004, BIOCHEM J, V381, P769, DOI 10.1042/BJ20031553; Fleming JV, 2004, BIOCHEM J, V379, P253, DOI 10.1042/BJ20031525; Furuta K, 2007, J BIOL CHEM, V282, P13438, DOI 10.1074/jbc.M609943200; Gao JL, 2002, ANNU REV PHYS CHEM, V53, P467, DOI 10.1146/annurev.physchem.53.091301.150114; GAO JL, 1991, J AM CHEM SOC, V113, P7796, DOI 10.1021/ja00020a070; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; HAYASHI H, 1993, BIOCHEMISTRY-US, V32, P812, DOI 10.1021/bi00054a011; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Ishii S, 1998, PROTEIN SCI, V7, P1802, DOI 10.1002/pro.5560070816; JANSONIUS JN, 1984, BIOCHEM SOC T, V12, P424, DOI 10.1042/bst0120424; KAMATH AV, 1991, J BIOL CHEM, V266, P9432; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martinez-de-Albeniz FJ, 2004, INT J GAME THEORY, V33, P107, DOI 10.1007/s001820400188; Matsuda N, 2004, J BIOCHEM, V135, P33, DOI 10.1093/jb/mvh004; Medina MA, 2003, CRIT REV BIOCHEM MOL, V38, P23, DOI 10.1080/713609209; Moya-Garcia AA, 2005, BIOESSAYS, V27, P57, DOI 10.1002/bies.20174; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Olmo M, 2002, J BIOCHEM, V132, P433, DOI 10.1093/oxfordjournals.jbchem.a003240; Olsson MHM, 2006, CHEM REV, V106, P1737, DOI 10.1021/cr040427e; Panula P, 2000, SEMIN CANCER BIOL, V10, P11, DOI 10.1006/scbi.2000.0302; Parsons ME, 2006, BRIT J PHARMACOL, V147, pS127, DOI 10.1038/sj.bjp.0706440; Pos Z, 2005, CANCER RES, V65, P4458, DOI 10.1158/0008-5472.CAN-05-0011; Poulsen TD, 2003, J PHYS CHEM B, V107, P9567, DOI 10.1021/jp030107j; Poupon A, 1999, PROTEINS, V37, P191, DOI 10.1002/(SICI)1097-0134(19991101)37:2<191::AID-PROT5>3.0.CO;2-4; Roca M, 2006, J PHYS CHEM A, V110, P503, DOI 10.1021/jp0520953; Roca M, 2005, J AM CHEM SOC, V127, P10648, DOI 10.1021/ja051503d; Rodriguez-Caso C, 2003, EUR J BIOCHEM, V270, P4376, DOI 10.1046/j.1432-1033.2003.03834.x; Rodriguez-Caso C, 2003, CELL MOL LIFE SCI, V60, P1760, DOI 10.1007/s00018-003-3135-3; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; Schneider E, 2002, TRENDS IMMUNOL, V23, P255, DOI 10.1016/S1471-4906(02)02215-9; Schubert ML, 2005, CURR OPIN GASTROEN, V21, P636, DOI 10.1097/01.mog.0000181713.89281.14; Siaterli MZ, 2003, NEUROCHEM RES, V28, P797, DOI 10.1023/A:1023246620276; TANASE S, 1985, J BIOL CHEM, V260, P6738; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Warshel A, 1998, J BIOL CHEM, V273, P27035, DOI 10.1074/jbc.273.42.27035; Warshel A, 2000, BIOCHEMISTRY-US, V39, P14728, DOI 10.1021/bi000987h; Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797	51	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12393	12401		10.1074/jbc.M707434200	http://dx.doi.org/10.1074/jbc.M707434200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18310073	hybrid			2022-12-25	WOS:000255340000056
J	Fukushima, T; Kitajima, T; Yamaguchi, H; Ouyang, Q; Furuhata, K; Yamamoto, H; Shida, T; Sekiguchi, J				Fukushima, Tatsuya; Kitajima, Toshihiko; Yamaguchi, Hiroyuki; Ouyang, Qin; Furuhata, Kazumi; Yamamoto, Hiroki; Shida, Toshio; Sekiguchi, Junichi			Identification and characterization of novel cell wall hydrolase CwIT - A two-domain autolysin exhibiting N-acetylmuramidase and DL-endopeptidase activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE LYTIC TRANSGLYCOSYLASE; BACILLUS-SUBTILIS 168; EGG-WHITE LYSOZYME; GOOSE LYSOZYME; GENE-PRODUCT; PEPTIDOGLYCAN; ELEMENT; PLAYS; SEPARATION; SEQUENCE	A cell wall hydrolase homologue, Bacillus subtilis YddH (renamed CwlT), was determined to be a novel cell wall lytic enzyme. The cwlT gene is located in the region of an integrative and conjugative element (ICEBs1), and a cwlT-lacZ fusion experiment revealed the significant expression when mitomycin C was added to the culture. Judging from the Pfam data base, CwlT (cell wall lytic enzyme T (Two-catalytic domains)) has two hydrolase domains that exhibit high amino acid sequence similarity to DL-endopeptidases and relatively low similarity to lytic transglycosylases at the C and N termini, respectively. The purified C-terminal domain of CwlT (CwlT-C-His) could hydrolyze the linkage of D-gamma-glutamyl-meso-diaminopimelic acid in B. subtilis peptidoglycan, suggesting that the C-terminal domain acts as a DL-endopeptidase. On the other hand, the purified N-terminal domain (CwlT-N-His) could also hydrolyze the peptidoglycan of B. subtilis. However, on reverse-phase HPLC and mass spectrometry (MS) and MS-MS analyses of the reaction products by CwlT-N-His, this domain was determined to act as an N-acetylmuramidase and not a lytic transglycosylase. Moreover, the site-directed mutagenesis analysis revealed that Glu-87 and Asp-94 are sites related with the cell wall lytic activity. Because the amino acid sequence of the N-terminal domain of CwlT exhibits low similarity compared with those of the soluble lytic transglycosylase and muramidase (goose lysozyme), this domain represents "a new category of cell wall hydrolases.".	[Fukushima, Tatsuya; Kitajima, Toshihiko; Yamaguchi, Hiroyuki; Ouyang, Qin; Furuhata, Kazumi; Yamamoto, Hiroki; Shida, Toshio; Sekiguchi, Junichi] Shinshu Univ, Dept Biosci & Text Technol, Interdisciplinary Grad Sch Sci & Technol, Nagano 3868567, Japan; [Sekiguchi, Junichi] Shinshu Univ, Div Gene Res, Dept Life Sci, Res Ctr Human & Environm Sci, Nagano 3868567, Japan	Shinshu University; Shinshu University	Sekiguchi, J (corresponding author), Shinshu Univ, Dept Biosci & Text Technol, Interdisciplinary Grad Sch Sci & Technol, 3-15-1 Tokida, Nagano 3868567, Japan.	jsekigu@shinshu-u.ac.jp	Sekiguchi, Junichi/F-9963-2010; Kitajima, Toshihiko/K-2894-2013; Kitajima, Toshihiko/D-2463-2016	Kitajima, Toshihiko/0000-0002-0202-5282; Kitajima, Toshihiko/0000-0001-9677-5086				ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Auchtung JM, 2005, P NATL ACAD SCI USA, V102, P12554, DOI 10.1073/pnas.0505835102; Beaber JW, 2002, J BACTERIOL, V184, P4259, DOI 10.1128/JB.184.15.4259-4269.2002; Boltner D, 2002, J BACTERIOL, V184, P5158, DOI 10.1128/JB.184.18.5158-5169.2002; Burrus V, 2002, PLASMID, V48, P77, DOI 10.1016/S0147-619X(02)00102-6; DEHART HP, 1995, APPL ENVIRON MICROB, V61, P1475, DOI 10.1128/AEM.61.4.1475-1479.1995; ENGEL H, 1991, J BACTERIOL, V173, P6773, DOI 10.1128/jb.173.21.6773-6782.1991; FEIN JE, 1976, J BACTERIOL, V127, P1427, DOI 10.1128/JB.127.3.1427-1442.1976; Foster S.J., 2002, BACILLUS SUBTILIS IT, P21; FRANKE AE, 1981, J BACTERIOL, V145, P494, DOI 10.1128/JB.145.1.494-502.1981; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; Fukushima T, 2002, J BACTERIOL, V184, P6007, DOI 10.1128/JB.184.21.6007-6015.2002; Fukushima T, 2007, MOL GENET GENOMICS, V278, P371, DOI 10.1007/s00438-007-0255-8; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; GREEN F, 1989, ANAL BIOCHEM, V182, P197, DOI 10.1016/0003-2697(89)90578-2; GRUTTER MG, 1983, NATURE, V303, P828, DOI 10.1038/303828a0; Kawamura S, 2006, J BIOCHEM, V140, P75, DOI 10.1093/jb/mvj125; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; LECLERC D, 1989, CAN J MICROBIOL, V35, P749, DOI 10.1139/m89-125; MALCOLM BA, 1989, P NATL ACAD SCI USA, V86, P133, DOI 10.1073/pnas.86.1.133; Matsumura I, 1996, BIOCHEMISTRY-US, V35, P1881, DOI 10.1021/bi951671q; Nugroho FA, 1999, J BACTERIOL, V181, P6230, DOI 10.1128/JB.181.20.6230-6237.1999; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Roberts AP, 2001, MICROBIOL-SGM, V147, P1243, DOI 10.1099/00221287-147-5-1243; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Shida T, 2001, J BIOL CHEM, V276, P28140, DOI 10.1074/jbc.M103903200; SHIMOTSU H, 1986, J BACTERIOL, V168, P380, DOI 10.1128/jb.168.1.380-388.1986; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Suzuki T, 2003, J BACTERIOL, V185, P2379, DOI 10.1128/JB.185.7.2379-2382.2003; THUNNISSEN AMWH, 1995, PROTEINS, V22, P245, DOI 10.1002/prot.340220305; THUNNISSEN AMWH, 1994, NATURE, V367, P750, DOI 10.1038/367750a0; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Yamaguchi H, 2004, J BIOSCI BIOENG, V98, P174, DOI 10.1263/jbb.98.174	39	35	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11117	11125		10.1074/jbc.M706626200	http://dx.doi.org/10.1074/jbc.M706626200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18305117	hybrid			2022-12-25	WOS:000255067400007
J	Furukohri, A; Goodman, MF; Maki, H				Furukohri, Asako; Goodman, Myron F.; Maki, Hisaji			A dynamic polymerase exchange with Escherichia coli DNA polymerase IV replacing DNA polymerase III on the sliding clamp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION FORK; BETA-CLAMP; LEADING-STRAND; IN-VIVO; POL-IV; PROCESSIVITY; HOLOENZYME; MUTAGENESIS; MECHANISM; MUTATIONS	An assay that measures synchronized, processive DNA replication by Escherichia coli DNA polymerase III holoenzyme was used to reveal replacement of pol III by the specialized lesion bypass DNA polymerase IV when the replicative polymerase is stalled. When idled replication is restarted, a rapid burst of pol III-catalyzed synthesis accompanied by similar to 7-kb full-length products is strongly inhibited by the presence of pol IV. The production of slower-forming, shorter length DNA reflects a rapid takeover of DNA synthesis by pol IV. Here we demonstrate that pol IV rapidly (<15s) obstructs the stable interaction between pol III* and the beta clamp (the lifetime of the complex is > 5 min), causing the removal of pol III* from template DNA. We propose that the rapid replacement of pol III* on the beta clamp with pol IV is mediated by two processes, an interaction between pol IV and the beta clamp and a separate interaction between pol IV and pol III*. This newly discovered property of pol IV facilitates a dynamic exchange between the two free polymerases at the primer terminus. Our study suggests a model in which the interaction between pol III* and the beta clamp is mediated by pol IV to ensure that DNA replication proceeds with minimal interruption.	[Furukohri, Asako; Maki, Hisaji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Mol Biol, Nara 6300192, Japan; [Goodman, Myron F.] Univ So Calif, Dept Biol Sci & Chem, Los Angeles, CA 90089 USA	Nara Institute of Science & Technology; University of Southern California	Maki, H (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Mol Biol, Nara 6300192, Japan.	maki@bs.naist.jp			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM021422] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES012259] Funding Source: Medline; NIGMS NIH HHS [R37GM21422] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; Dohrmann PR, 2005, J MOL BIOL, V350, P228, DOI 10.1016/j.jmb.2005.04.065; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Higuchi K, 2003, GENES CELLS, V8, P437, DOI 10.1046/j.1365-2443.2003.00646.x; Indiani C, 2005, MOL CELL, V19, P805, DOI 10.1016/j.molcel.2005.08.011; Jarosz DF, 2007, TRENDS MICROBIOL, V15, P70, DOI 10.1016/j.tim.2006.12.004; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Kim SR, 2001, MOL GENET GENOMICS, V266, P207; Kobayashi S, 2002, J BIOL CHEM, V277, P34198, DOI 10.1074/jbc.M204826200; Langston LD, 2006, MOL CELL, V23, P155, DOI 10.1016/j.molcel.2006.05.034; Lehmann AR, 2006, DNA REPAIR, V5, P1495, DOI 10.1016/j.dnarep.2006.07.002; Lenne-Samuel N, 2002, EMBO REP, V3, P45, DOI 10.1093/embo-reports/kvf007; Leu FP, 2003, MOL CELL, V11, P315, DOI 10.1016/S1097-2765(03)00042-X; Li XJ, 2000, J BIOL CHEM, V275, P34757, DOI 10.1074/jbc.M006556200; MAKI S, 1988, J BIOL CHEM, V263, P6561; Maul RW, 2007, MOL MICROBIOL, V65, P811, DOI 10.1111/j.1365-2958.2007.05828.x; McHenry CS, 2003, MOL MICROBIOL, V49, P1157, DOI 10.1046/j.1365-2958.2003.03645.x; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; NORRIS D, 1990, BIOCHEMISTRY-US, V29, P7911, DOI 10.1021/bi00486a019; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; STUKENBERG PT, 1994, CELL, V78, P877, DOI 10.1016/S0092-8674(94)90662-9; STUKENBERG PT, 1991, J BIOL CHEM, V266, P11328; Sugaya Y, 2002, GENES CELLS, V7, P385, DOI 10.1046/j.1365-2443.2002.00527.x; Tippin B, 2004, TRENDS MICROBIOL, V12, P288, DOI 10.1016/j.tim.2004.04.004; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Wagner J, 2000, EMBO REP, V1, P484; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101	32	66	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11260	11269		10.1074/jbc.M709689200	http://dx.doi.org/10.1074/jbc.M709689200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18308729	Green Published, hybrid			2022-12-25	WOS:000255067400022
J	Mlotshwa, S; Pruss, GJ; Peragine, A; Endres, MW; Li, JJ; Chen, XM; Poethig, RS; Bowman, LH; Vance, V				Mlotshwa, Sizolwenkosi; Pruss, Gail J.; Peragine, Angela; Endres, Matthew W.; Li, Junjie; Chen, Xuemei; Poethig, R. Scott; Bowman, Lewis H.; Vance, Vicki			DICER-LIKE2 Plays a Primary Role in Transitive Silencing of Transgenes in Arabidopsis	PLOS ONE			English	Article								Dicer-like (DCL) enzymes play a pivotal role in RNA silencing in plants, processing the long double-stranded RNA (dsRNA) that triggers silencing into the primary short interfering RNAs (siRNAs) that mediate it. The siRNA population can be augmented and silencing amplified via transitivity, an RNA-dependent RNA polymerase (RDR)-dependent pathway that uses the target RNA as substrate to generate secondary siRNAs. Here we report that Arabidopsis DCL2-but not DCL4-is required for transitivity in cell-autonomous, post-transcriptional silencing of transgenes. An insertion mutation in DCL2 blocked sense transgene-induced silencing and eliminated accumulation of the associated RDR-dependent siRNAs. In hairpin transgene-induced silencing, the dcl2 mutation likewise eliminated accumulation of secondary siRNAs and blocked transitive silencing, but did not block silencing mediated by primary siRNAs. Strikingly, in all cases, the dcl2 mutation eliminated accumulation of all secondary siRNAs, including those generated by other DCL enzymes. In contrast, mutations in DCL4 promoted a dramatic shift to transitive silencing in the case of the hairpin transgene and enhanced silencing induced by the sense transgene. Suppression of hairpin and sense transgene silencing by the P1/HC-Pro and P38 viral suppressors was associated with elimination of secondary siRNA accumulation, but the suppressors did not block processing of the stem of the hairpin transcript into primary siRNAs. Thus, these viral suppressors resemble the dcl2 mutation in their effects on siRNA biogenesis. We conclude that DCL2 plays an essential, as opposed to redundant, role in transitive silencing of transgenes and may play a more important role in silencing of viruses than currently thought.	[Mlotshwa, Sizolwenkosi; Pruss, Gail J.; Endres, Matthew W.; Bowman, Lewis H.; Vance, Vicki] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Peragine, Angela; Poethig, R. Scott] Univ Pennsylvania, Dept Biol, Philadelphia, PA USA; [Li, Junjie; Chen, Xuemei] Univ Calif Riverside, Inst Integrat Genome Biol, Dept Bot & Plant Sci, Riverside, CA USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Pennsylvania; University of California System; University of California Riverside	Mlotshwa, S (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	vance@biol.sc.edu	Poethig, R. Scott/J-7009-2015	Poethig, R. Scott/0000-0001-6592-5862; Chen, Xuemei/0000-0002-5209-1157	NIH [GM6101401, R01 GM051893, GM61146, MCB-0718029]; NSF [0501760, 0646540, GM61146, MCB-0718029]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051893, R01GM061014, R01GM061146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grant GM6101401 and NSF Grants 0501760 and 0646540 to V.V. and L.H.B., NIH Grant R01 GM051893 to R.S.P., and NIH and NSF Grants GM61146 and MCB-0718029 to X.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Boutet S, 2003, CURR BIOL, V13, P843, DOI 10.1016/S0960-9822(03)00293-8; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Finnegan EJ, 2003, CURR BIOL, V13, P236, DOI 10.1016/S0960-9822(03)00010-1; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; Mallory AC, 2001, PLANT CELL, V13, P571, DOI 10.1105/tpc.13.3.571; Matzke M, 2004, BBA-GENE STRUCT EXPR, V1677, P129, DOI 10.1016/j.bbaexp.2003.10.015; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Mette MF, 2001, CURR BIOL, V11, P1119, DOI 10.1016/S0960-9822(01)00315-3; Mlotshwa S, 2005, PLANT CELL, V17, P2873, DOI 10.1105/tpc.105.036608; Mlotshwa S, 2006, PLANT MOL BIOL, V61, P781, DOI 10.1007/s11103-006-0049-0; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Smith LM, 2007, PLANT CELL, V19, P1507, DOI 10.1105/tpc.107.051540; VANCE VB, 1988, J BIOL CHEM, V263, P1476; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	56	120	126	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1755	10.1371/journal.pone.0001755	http://dx.doi.org/10.1371/journal.pone.0001755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335032	gold, Green Published, Green Submitted			2022-12-25	WOS:000260723000009
J	Wright, GA; Kottcamp, SM; Thomson, MGA				Wright, Geraldine A.; Kottcamp, Sonya M.; Thomson, Mitchell G. A.			Generalization Mediates Sensitivity to Complex Odor Features in the Honeybee	PLOS ONE			English	Article							APIS-MELLIFERA; STIMULUS GENERALIZATION; OLFACTORY SYSTEM; SIGNAL EVOLUTION; ANTENNAL LOBE; INTENSITY; DISCRIMINATION; FLOWERS; REPRESENTATION; THRESHOLDS	Animals use odors as signals for mate, kin, and food recognition, a strategy which appears ubiquitous and successful despite the high intrinsic variability of naturally-occurring odor quantities. Stimulus generalization, or the ability to decide that two objects, though readily distinguishable, are similar enough to afford the same consequence [1], could help animals adjust to variation in odor signals without losing sensitivity to key inter-stimulus differences. The present study was designed to investigate whether an animal's ability to generalize learned associations to novel odors can be influenced by the nature of the associated outcome. We use a classical conditioning paradigm for studying olfactory learning in honeybees [2] to show that honeybees conditioned on either a fixed- or variable-proportion binary odor mixture generalize learned responses to novel proportions of the same mixture even when inter-odor differences are substantial. We also show that the resulting olfactory generalization gradients depend critically on both the nature of the stimulus-reward paradigm and the intrinsic variability of the conditioned stimulus. The reward dependency we observe must be cognitive rather than perceptual in nature, and we argue that outcome-dependent generalization is necessary for maintaining sensitivity to inter-odor differences in complex olfactory scenes.	[Wright, Geraldine A.; Thomson, Mitchell G. A.] Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England; [Kottcamp, Sonya M.] Ohio State Univ, Rothenbuhler Honeybee Lab, Columbus, OH USA	Newcastle University - UK; University System of Ohio; Ohio State University	Wright, GA (corresponding author), Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England.	jeri.wright@ncl.ac.uk			NSF [0112050]; NIH NCRR [9 R01 RR1466]	NSF(National Science Foundation (NSF)); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by an NSF grant awarded to the Mathematical Biosciences Institute (agreement no. 0112050) and by an NIH NCRR (9 R01 RR1466) award held by Brian H. Smith.	Ayasse M, 2000, EVOLUTION, V54, P1995, DOI 10.1111/j.0014-3820.2000.tb01243.x; Bhagavan S, 1997, PHYSIOL BEHAV, V61, P107, DOI 10.1016/S0031-9384(96)00357-5; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BLOUGH DS, 1967, SCIENCE, V158, P940, DOI 10.1126/science.158.3803.940; Blough DS, 2001, BEHAV PROCESS, V54, P127, DOI 10.1016/S0376-6357(01)00154-1; Chittka L., 2001, ANIMAL BEHAV FLORAL; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; Deisig N, 2006, EUR J NEUROSCI, V24, P1161, DOI 10.1111/j.1460-9568.2006.04959.x; Ditzen M, 2003, CHEM SENSES, V28, P781, DOI 10.1093/chemse/bjg070; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; FOSTER DH, 1991, PSYCHOL BULL, V109, P152, DOI 10.1037/0033-2909.109.1.152; Green DM, 1966, SIGNAL DETECTION THE; HEINEMAN.EG, 1969, J EXP PSYCHOL, V80, P215, DOI 10.1037/h0027309; Helsper JPFG, 1998, PLANTA, V207, P88, DOI 10.1007/s004250050459; Kim HJ, 2000, J CHROMATOGR A, V902, P389, DOI 10.1016/S0021-9673(00)00863-3; Lynn SK, 2005, EVOLUTION, V59, P1300, DOI 10.1111/j.0014-3820.2005.tb01780.x; Mant J, 2005, EVOLUTION, V59, P1449, DOI 10.1111/j.0014-3820.2005.tb01795.x; Martin J, 2007, BIOL LETTERS, V3, P125, DOI 10.1098/rsbl.2006.0589; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Miklas N, 2000, J CHEM ECOL, V26, P2473, DOI 10.1023/A:1005517410299; Moore PJ, 1997, NATURE, V389, P25, DOI 10.1038/37888; Penn D, 1998, TRENDS ECOL EVOL, V13, P391, DOI 10.1016/S0169-5347(98)01473-6; Sachse S, 2003, EUR J NEUROSCI, V18, P2119, DOI 10.1046/j.1460-9568.2003.02931.x; Schiestl FP, 2005, NATURWISSENSCHAFTEN, V92, P255, DOI 10.1007/s00114-005-0636-y; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; ten Cate C, 2007, TRENDS ECOL EVOL, V22, P380, DOI 10.1016/j.tree.2007.03.006; Wright GA, 2005, P ROY SOC B-BIOL SCI, V272, P2417, DOI 10.1098/rspb.2005.3252; Wright GA, 2005, J COMP PHYSIOL A, V191, P105, DOI 10.1007/s00359-004-0576-6; Wright GA, 2004, CHEM SENSES, V29, P127, DOI 10.1093/chemse/bjh016; WRIGHT GA, 2005, RECENT ADV PHYTOCHEM, P191	32	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1704	10.1371/journal.pone.0001704	http://dx.doi.org/10.1371/journal.pone.0001704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XS	18301779	gold, Green Published, Green Submitted			2022-12-25	WOS:000260586500048
J	Xiong, MM; Arnett, FC; Guo, XJ; Xiong, H; Zhou, XD				Xiong, Momiao; Arnett, Frank C.; Guo, Xinjian; Xiong, Hao; Zhou, Xiaodong			Differential Dynamic Properties of Scleroderma Fibroblasts in Response to Perturbation of Environmental Stimuli	PLOS ONE			English	Article							GENETIC REGULATORY NETWORKS; SYSTEMS BIOLOGY; MAXIMUM-LIKELIHOOD; BAYESIAN NETWORKS; EXPRESSION DATA; ROBUSTNESS; ACTIVATION; STABILITY; SCLEROSIS; SILICA	Diseases are believed to arise from dysregulation of biological systems (pathways) perturbed by environmental triggers. Biological systems as a whole are not just the sum of their components, rather ever-changing, complex and dynamic systems over time in response to internal and external perturbation. In the past, biologists have mainly focused on studying either functions of isolated genes or steady-states of small biological pathways. However, it is systems dynamics that play an essential role in giving rise to cellular function/dysfunction which cause diseases, such as growth, differentiation, division and apoptosis. Biological phenomena of the entire organism are not only determined by steady-state characteristics of the biological systems, but also by intrinsic dynamic properties of biological systems, including stability, transient-response, and controllability, which determine how the systems maintain their functions and performance under a broad range of random internal and external perturbations. As a proof of principle, we examine signal transduction pathways and genetic regulatory pathways as biological systems. We employ widely used state-space equations in systems science to model biological systems, and use expectation-maximization (EM) algorithms and Kalman filter to estimate the parameters in the models. We apply the developed state-space models to human fibroblasts obtained from the autoimmune fibrosing disease, scleroderma, and then perform dynamic analysis of partial TGF-beta pathway in both normal and scleroderma fibroblasts stimulated by silica. We find that TGF-beta pathway under perturbation of silica shows significant differences in dynamic properties between normal and scleroderma fibroblasts. Our findings may open a new avenue in exploring the functions of cells and mechanism operative in disease development.	[Xiong, Momiao] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA; [Arnett, Frank C.; Guo, Xinjian; Zhou, Xiaodong] Univ Texas Hlth Sci Ctr Houston, Med Sch, Div Rheumatol & Clin Immunogenet, Houston, TX USA; [Xiong, Hao] Texas A&M Univ, Dept Comp Sci, College Stn, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station	Xiong, MM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Houston, TX USA.	xiaodong.zhou@uth.tmc.edu			NIH/NIAMS Center of Research Translation (CORT) in Scleroderma [1 P50 AR054144, 5RO3AR050517-02]; NIH/NCRR Center for Clinical and Translational Sciences [1UL1 RR 024148, M01RR002558]; University of Texas Health Science Center at Houston CreFF; Department of the Army, Medical Research Acquisition Activity [PR064803]; Scleroderma Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002558, UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054144, R03AR050517] Funding Source: NIH RePORTER	NIH/NIAMS Center of Research Translation (CORT) in Scleroderma(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NCRR Center for Clinical and Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Health Science Center at Houston CreFF; Department of the Army, Medical Research Acquisition Activity; Scleroderma Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by UTHSC-H grants from NIH/NIAMS Center of Research Translation (CORT) in Scleroderma (1 P50 AR054144) (F.C.A) and 5RO3AR050517-02 (X.Z.), NIH/NCRR Center for Clinical and Translational Sciences (Houston CTSA Program) (1UL1 RR 024148), NIH PHS NCRR GCRC grant M01RR002558, University of Texas Health Science Center at Houston CreFF (X.Z.), Department of the Army, Medical Research Acquisition Activity: PR064803 (X.Z) and the Scleroderma Foundation (X.Z.).	Akutsu T, 1999, Pac Symp Biocomput, P17; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Arcangeli G, 2001, SCI TOTAL ENVIRON, V270, P135, DOI 10.1016/S0048-9697(00)00781-6; Assmus HE, 2006, EXPERT REV MOL DIAGN, V6, P891, DOI 10.1586/14737159.6.6.891; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Beal MJ, 2005, BIOINFORMATICS, V21, P349, DOI 10.1093/bioinformatics/bti014; Binder B, 2002, MOL BIOL REP, V29, P51, DOI 10.1023/A:1020302318189; CABRAL AR, 1994, REV INVEST CLIN, V46, P257; Chen LN, 2002, IEEE T CIRCUITS-I, V49, P602, DOI 10.1109/TCSI.2002.1001949; CLAMAN HN, 1991, ARTHRITIS RHEUM, V34, P1495; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dojer N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-249; Gerriets JE, 1996, BBA-MOL BASIS DIS, V1316, P121, DOI 10.1016/0925-4439(96)00019-1; Gibson S, 2005, AUTOMATICA, V41, P1667, DOI 10.1016/j.automatica.2005.05.008; Herrero J, 2004, NUCLEIC ACIDS RES, V32, pW485, DOI 10.1093/nar/gkh421; JIMENEZ SA, 1986, BIOCHEM J, V237, P837, DOI 10.1042/bj2370837; Jinnin M, 2006, BIOCHEM BIOPH RES CO, V343, P904, DOI 10.1016/j.bbrc.2006.03.037; Kailath T., 1999, LINEAR ESTIMATION; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kim KA, 2002, TOXICOL LETT, V135, P185, DOI 10.1016/S0378-4274(02)00237-0; Kremling A, 2007, J BIOTECHNOL, V129, P329, DOI 10.1016/j.jbiotec.2007.02.009; LEROY EC, 1988, J RHEUMATOL, V15, P202; LEROY EC, 1974, J CLIN INVEST, V54, P880, DOI 10.1172/JCI107827; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Martins NC, 2006, IEEE T AUTOMAT CONTR, V51, P438, DOI 10.1109/TAC.2006.871940; Nachman I, 2004, BIOINFORMATICS, V20, P248, DOI 10.1093/bioinformatics/bth941; Ogata K., 1998, SYSTEM DYNAMICS, VVol. 3; Pan Y, 2007, BIOINFORMATICS, V23, pI367, DOI 10.1093/bioinformatics/btm228; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; RANGEL C, 2001, P 2 INT C SYST BIOL, P248; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Vinson DR, 2000, J PROCESS CONTR, V10, P185, DOI 10.1016/S0959-1524(99)00045-1; VOIT EO, 2007, UNDERSTANDING MODELI; Wei YM, 2003, APPL MATH COMPUT, V145, P45, DOI 10.1016/S0096-3003(02)00437-X; Werhli AV, 2007, STAT APPL GENET MOL, V6; Wolkenhauer O, 2005, MOL BIOSYST, V1, P14, DOI 10.1039/b502088n; Wolkenhauer O, 2005, FEBS LETT, V579, P1846, DOI 10.1016/j.febslet.2005.02.008; Xiong MA, 2005, FEBS LETT, V579, P5325, DOI 10.1016/j.febslet.2005.08.058; Zhou XD, 2006, ARTHRITIS RHEUM, V54, P3885, DOI 10.1002/art.22249	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1693	10.1371/journal.pone.0001693	http://dx.doi.org/10.1371/journal.pone.0001693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XS	18301770	Green Submitted, gold, Green Published			2022-12-25	WOS:000260586500037
J	Park, J; Will, C; Martin, B; Gullotti, L; Friedrichs, N; Buettner, R; Schneider, H; Ludwig, S; Wixler, V				Park, Jung; Will, Carola; Martin, Bernd; Gullotti, Lucia; Friedrichs, Nicolaus; Buettner, Reinhard; Schneider, Holm; Ludwig, Stephan; Wixler, Viktor			Deficiency in the LIM-only protein FHL2 impairs assembly of extracellular matrix proteins	FASEB JOURNAL			English	Article						fibronectin; integrin-mediated ERK activation; focal adhesions; cytoskeleton	SMOOTH MUSCLE ACTIN; FOCAL ADHESION KINASE; FIBRONECTIN MATRIX; MAP KINASE; TRANSCRIPTIONAL COACTIVATOR; INTEGRIN ACTIVATION; STRESS FIBERS; BETA-CATENIN; ALPHA; CELLS	We have described the scaffolding protein FHL2 as a component of focal adhesion structures, to which it is recruited via binding to both alpha- or beta-integrin subunits. Using mesenchymal stem cells from wild-type and FHL2-knockout mice, we show here that inactivation of FHL2 leads to impaired assembly of extracellular matrix proteins on the cell surface and to impaired bundling of focal adhesions. Both altered properties can be restored by reexpression of recombinant FHL2 protein in FHL2-null cells. Molecular analysis of integrin-mediated signaling revealed a higher phosphorylation of FAK at tyrosine 925 in FHL2-knockout cells compared to their wild-type counterpart. Consequently, the activation of the mitogenic kinase ERK was more pronounced in knockout cells on cell adhesion. The growth factor-induced activation of ERK, however, was not altered. The perturbed organization of extracellular matrix on FHL2-null cells was improved when the increased activation of MAPK was inhibited. Our findings point to a role of FHL2 in bundling of focal adhesion structures, in integrin-mediated ERK activation, and subsequently in proper allocation of matrix proteins on the cell surface.	[Will, Carola; Ludwig, Stephan; Wixler, Viktor] Munster Univ Hosp, Inst Mol Virol, Sch Med, D-48149 Munster, Germany; [Park, Jung] Univ Erlangen Nurnberg, Dept Expt Med 1, Erlangen, Germany; [Martin, Bernd] Goethe Univ Frankfurt, Sch Med, Dept Gynecol & Obstet, Frankfurt, Germany; [Gullotti, Lucia; Friedrichs, Nicolaus; Buettner, Reinhard] Univ Hosp, Sch Med, Inst Pathol, Bonn, Germany; [Schneider, Holm] Med Univ Innsbruck, Dept Pediat, Innsbruck, Austria	University of Munster; University of Erlangen Nuremberg; Goethe University Frankfurt; University of Bonn; Medical University of Innsbruck	Wixler, V (corresponding author), Munster Univ Hosp, Inst Mol Virol, Sch Med, Von Esmarch Str 56, D-48149 Munster, Germany.	vwixler@uni-muenster.de		Ludwig, Stephan/0000-0003-4490-3052				Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Barros JC, 2005, J CELL SCI, V118, P1663, DOI 10.1242/jcs.02308; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Brenner KA, 2000, ONCOGENE, V19, P3156, DOI 10.1038/sj.onc.1203626; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; Chu PH, 2000, MOL CELL BIOL, V20, P7460, DOI 10.1128/MCB.20.20.7460-7462.2000; Clark K, 2005, J CELL SCI, V118, P291, DOI 10.1242/jcs.01623; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; deHart GW, 2004, CELL MOTIL CYTOSKEL, V57, P107, DOI 10.1002/cm.10161; Friedrichs N, 2005, MODERN PATHOL, V18, P431, DOI 10.1038/modpathol.3800292; Gabriel B, 2004, ANTICANCER RES, V24, P921; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; GOSPODAROWICZ D, 1980, P NATL ACAD SCI-BIOL, V77, P4094, DOI 10.1073/pnas.77.7.4094; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hughes PE, 2002, MOL BIOL CELL, V13, P2256, DOI 10.1091/mbc.01-10-0480; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Ilic D, 2004, J CELL SCI, V117, P177, DOI 10.1242/jcs.00845; Ilic D, 1996, EXP CELL RES, V222, P298, DOI 10.1006/excr.1996.0038; ILLC D, 1995, NATURE, V377, P539; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kong YF, 2001, CIRCULATION, V103, P2731; Lai CF, 2006, J BONE MINER RES, V21, P17, DOI 10.1359/JBMR.050915; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Morlon A, 2003, P NATL ACAD SCI USA, V100, P3977, DOI 10.1073/pnas.0735923100; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; Park J, 2006, J GENE MED, V8, P112, DOI 10.1002/jgm.826; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Samson T, 2004, J BIOL CHEM, V279, P28641, DOI 10.1074/jbc.M312894200; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Sechler JL, 1996, CELL ADHES COMMUN, V4, P413, DOI 10.3109/15419069709004458; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5; TROPPMAIR J, 1994, J BIOL CHEM, V269, P7030; Wang JX, 2006, EXP CELL RES, V312, P205, DOI 10.1016/j.yexcr.2005.11.004; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Wixler V, 2000, J BIOL CHEM, V275, P33669, DOI 10.1074/jbc.M002519200; Wixler V, 1996, FEBS LETT, V385, P131, DOI 10.1016/0014-5793(96)00363-8; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001; Yatomi Y, 2000, BLOOD, V96, P3431; Zamir E, 2001, J CELL SCI, V114, P3583	52	28	28	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2008	22	7					2508	2520		10.1096/fj.07-095521	http://dx.doi.org/10.1096/fj.07-095521			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	321GK	18356303				2022-12-25	WOS:000257292500042
J	Schlehe, JS; Lutz, AK; Pilsl, A; Lammermann, K; Grgur, K; Henn, IH; Tatzelt, J; Winklhofer, KF				Schlehe, Julia S.; Lutz, A. Kathrin; Pilsl, Anna; Laemmermann, Kerstin; Grgur, Katja; Henn, Iris H.; Tatzelt, Joerg; Winklhofer, Konstanze F.			Aberrant folding of pathogenic Parkin mutants - Aggregation versus degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; LOSS-OF-FUNCTION; PROTECTIVE FUNCTION; OXIDATIVE STRESS; S-NITROSYLATION; PRION PROTEIN; CELL-DEATH; DISEASE; MUTATIONS; LOCALIZATION	Loss-of-function mutations in the Parkin gene (PARK2) are responsible for the majority of autosomal recessive Parkinson disease. A growing body of evidence indicates that misfolding and aggregation of Parkin is a major mechanism of Parkin inactivation, accounting for the loss-of-function phenotype of various pathogenic Parkin mutants. Remarkably, wild-type Parkin is also prone to misfolding under certain cellular conditions, suggesting a more general role of Parkin in the pathogenesis of Parkinson disease. We now show that misfolding of Parkin can lead to two phenotypes: the formation of detergent-insoluble, aggregated Parkin, or destabilization of Parkin resulting in an accelerated proteasomal degradation. By combining two pathogenic Parkin mutations, we could demonstrate that destabilization of Parkin is dominant over the formation of detergent-insoluble Parkin aggregates. Furthermore, a comparative analysis with HHARI, an E3 ubiquitin ligase with an RBR domain highly homologous to that of Parkin, revealed that folding of Parkin is specifically dependent on the integrity of the C-terminal domain, but not on the presence of a putative PDZ-binding motif at the extreme C terminus.	[Schlehe, Julia S.; Lutz, A. Kathrin; Pilsl, Anna; Laemmermann, Kerstin; Grgur, Katja; Henn, Iris H.; Tatzelt, Joerg; Winklhofer, Konstanze F.] Univ Munich, Adolf Butenandt Inst, Dept Biochem Neurobiochem, D-80336 Munich, Germany	University of Munich	Winklhofer, KF (corresponding author), Univ Munich, Adolf Butenandt Inst, Dept Biochem Neurobiochem, Schillerstr 44, D-80336 Munich, Germany.	Konstanze.Winklhofer@med.uni-muenchen.de	Mueller-Rischart, Anne Kathrin/L-3219-2017	Winklhofer, Konstanze/0000-0002-7256-8231; Tatzelt, Jorg/0000-0001-5017-5528				Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Cookson MR, 2003, HUM MOL GENET, V12, P2957, DOI 10.1093/hmg/ddg328; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Gu WJ, 2003, NEUROBIOL DIS, V14, P357, DOI 10.1016/j.nbd.2003.08.011; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Henn IH, 2007, J NEUROSCI, V27, P1868, DOI 10.1523/JNEUROSCI.5537-06.2007; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Jensen LD, 2006, NEUROREPORT, V17, P1205, DOI 10.1097/01.wnr.0000230511.63220.e3; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; Kubo S, 2001, J NEUROCHEM, V78, P42, DOI 10.1046/j.1471-4159.2001.00364.x; Kyratzi E, 2007, J NEUROCHEM, V102, P1292, DOI 10.1111/j.1471-4159.2007.04620.x; LaVoie MJ, 2007, J NEUROCHEM, V103, P2354, DOI 10.1111/j.1471-4159.2007.04911.x; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Muqit MMK, 2004, HUM MOL GENET, V13, P117, DOI 10.1093/hmg/ddh012; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Rambold AS, 2006, MOL BIOL CELL, V17, P3356, DOI 10.1091/mbc.E06-01-0083; Safadi SS, 2007, BIOCHEMISTRY-US, V46, P14162, DOI 10.1021/bi7016969; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Stichel CC, 2000, EUR J NEUROSCI, V12, P4181, DOI 10.1111/j.1460-9568.2000.01314.x; Tatzelt J, 1996, EMBO J, V15, P6363, DOI 10.1002/j.1460-2075.1996.tb01027.x; Wang C, 2005, HUM MOL GENET, V14, P3885, DOI 10.1093/hmg/ddi413; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; Winklhofer KF, 2003, J BIOL CHEM, V278, P47199, DOI 10.1074/jbc.M306769200; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Winklhofer KF, 2007, EXPERT OPIN THER TAR, V11, P1543, DOI 10.1517/14728222.11.12.1543; Wong ESP, 2007, J BIOL CHEM, V282, P12310, DOI 10.1074/jbc.M609466200; Wood-Kaczmar A, 2006, TRENDS MOL MED, V12, P521, DOI 10.1016/j.molmed.2006.09.007; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	38	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13771	13779		10.1074/jbc.M707494200	http://dx.doi.org/10.1074/jbc.M707494200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18362144	hybrid			2022-12-25	WOS:000255728200029
J	Stahl, M; Uemura, K; Ge, CH; Shi, SL; Tashima, Y; Stanley, P				Stahl, Mark; Uemura, Kazuhide; Ge, Changhui; Shi, Shaolin; Tashima, Yuko; Stanley, Pamela			Roles of Pofut1 and O-fucose in mammalian notch signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-MANNOSE 4,6-DEHYDRATASE; LIGAND-BINDING DOMAIN; FACTOR-LIKE REPEATS; PROTEIN O-FUCOSYL-TRANSFERASE-1; CONGENITAL DISORDER; MOLECULAR-CLONING; DROSOPHILA-MELANOGASTER; GLYCOSYLATION MUTANTS; LINKED GLYCOSYLATION; RECEPTOR ACTIVATION	Mammalian Notch receptors contain 29-36 epidermal growth factor (EGF)-like repeats that may be modified by protein O-fucosyltransferase 1 (Pofut1), an essential component of the canonical Notch signaling pathway. The Drosophila orthologue Ofut1 is proposed to function as both a chaperone required for stable cell surface expression of Notch and a protein O-fucosyltransferase. Here we investigate these dual roles of Pofut1 in relation to endogenous Notch receptors of Chinese hamster ovary and murine embryonic stem (ES) cells. We show that fucosylation-deficient Lec13 Chinese hamster ovary cells have wild type levels of Pofut1 and cell surface Notch receptors. Nevertheless, they have reduced binding of Notch ligands and low levels of Delta1- and Jagged1-induced Notch signaling. Exogenous fucose but not galactose rescues both ligand binding and Notch signaling. Murine ES cells lacking Pofut1 also have wild type levels of cell surface Notch receptors. However, Pofut1(-/-) ES cells do not bind Notch ligands or exhibit Notch signaling. Although overexpression of fucosyltransferase-defective Pofut1 R245A in Pofut1(-/-) cells partially rescues ligand binding and Notch signaling, this effect is not specific. The same rescue is achieved by an unrelated, inactive, endoplasmic reticulum glucosidase. Therefore, mammalian Notch receptors require Pofut1 for the generation of optimally functional Notch receptors, but, in contrast to Drosophila, Pofut1 is not required for stable cell surface expression of Notch. Importantly, we also show that, under certain circumstances, mammalian Notch receptors are capable of signaling in the absence of Pofut1 and O-fucose.	[Stahl, Mark; Uemura, Kazuhide; Ge, Changhui; Shi, Shaolin; Tashima, Yuko; Stanley, Pamela] Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Stanley, P (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	stanley@aecom.yu.edu		Shi, Shaolin/0000-0003-2297-6496; Stahl, Mark/0000-0002-6885-1106; Stanley, Pamela/0000-0001-5704-3747	NATIONAL CANCER INSTITUTE [R01CA095022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NCI NIH HHS [CA 95022] Funding Source: Medline; NIGMS NIH HHS [T32 GM07288] Funding Source: Medline; PHS HHS [P01 13330] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ACAR M, 2008, J CELL, V132, P247; Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Anderson AC, 2005, J IMMUNOL, V174, P890, DOI 10.4049/jimmunol.174.2.890; Arboleda-Velasquez JF, 2005, HUM MOL GENET, V14, P1631, DOI 10.1093/hmg/ddi171; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Cordle J, 2008, J BIOL CHEM, V283, P11785, DOI 10.1074/jbc.M708424200; Duan ZJ, 2004, MOL CELL BIOL, V24, P58, DOI 10.1128/MCB.24.1.58-70.2004; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; Hellbusch CC, 2007, J BIOL CHEM, V282, P10762, DOI 10.1074/jbc.M700314200; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hong Y, 2004, J BIOL CHEM, V279, P49894, DOI 10.1074/jbc.M410121200; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Ishikawa HO, 2005, P NATL ACAD SCI USA, V102, P18532, DOI 10.1073/pnas.0504115102; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Kanda Y, 2007, J BIOTECHNOL, V130, P300, DOI 10.1016/j.jbiotec.2007.04.025; Kopan R, 2002, J CELL SCI, V115, P1095; Lee JH, 2001, J BIOL CHEM, V276, P13924, DOI 10.1074/jbc.M010046200; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Loriol C, 2006, GLYCOBIOLOGY, V16, P736, DOI 10.1093/glycob/cwj124; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Ohyama C, 1998, J BIOL CHEM, V273, P14582, DOI 10.1074/jbc.273.23.14582; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; OKAJIMA T, 2008, IN PRESS J BIOCH TOK; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Oyama T, 2007, P NATL ACAD SCI USA, V104, P9764, DOI 10.1073/pnas.0700240104; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; RIPKA J, 1986, ARCH BIOCHEM BIOPHYS, V249, P533, DOI 10.1016/0003-9861(86)90031-7; Roos C, 2002, J BIOL CHEM, V277, P3168, DOI 10.1074/jbc.m107927200; Sasaki N, 2007, GENES CELLS, V12, P89, DOI 10.1111/j.1365-2443.2007.01037.x; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shi SL, 2007, J BIOL CHEM, V282, P20133, DOI 10.1074/jbc.M702593200; Shi SL, 2005, MOL CELL BIOL, V25, P9503, DOI 10.1128/MCB.25.21.9503-9508.2005; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Shimizu K, 1999, J BIOL CHEM, V274, P32961, DOI 10.1074/jbc.274.46.32961; Smith PL, 2002, J CELL BIOL, V158, P801, DOI 10.1083/jcb.200203125; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Strobl LJ, 1997, IMMUNOBIOLOGY, V198, P299, DOI 10.1016/S0171-2985(97)80050-2; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Tsukamoto H, 2002, ANAT REC, V267, P7, DOI 10.1002/ar.10070; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Vodovar Nicolas, 2008, J Biol, V7, P7, DOI 10.1186/jbiol68; Walker BK, 1998, BIOCHEM BIOPH RES CO, V250, P264, DOI 10.1006/bbrc.1998.9304; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Wu LZ, 2004, SEMIN CANCER BIOL, V14, P348, DOI 10.1016/j.semcancer.2004.04.014; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614	69	133	138	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13638	13651		10.1074/jbc.M802027200	http://dx.doi.org/10.1074/jbc.M802027200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18347015	Green Published, hybrid			2022-12-25	WOS:000255728200016
J	Wang, SY; Assmann, SM; Fedoroff, NV				Wang, Shiyu; Assmann, Sarah M.; Fedoroff, Nina V.			Characterization of the Arabidopsis heterotrimeric G protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVING PLANT-CELLS; ALPHA-SUBUNIT GPA1; G-BETA-GAMMA; PLASMA-MEMBRANE; SEED-GERMINATION; BINDING PROTEIN; FLUORESCENT PROTEINS; DISEASE RESISTANCE; ACTIVATION; INTERACTS	We have used fluorescence resonance energy transfer and co-immunoprecipitation to analyze the interactions among the alpha, beta, and gamma 1 subunits of the Arabidopsis heterotrimeric G protein. Using cyan and yellow fluorescent protein fusion constructs, we show that overexpressed G(gamma 1) localizes to protoplast membranes, but G beta exhibits membrane localization only when the G gamma(1) protein is co-overexpressed. Overexpressed G alpha shows membrane localization unaccompanied by overexpression of either G beta or G gamma(1). We detect fluorescence resonance energy transfer between G beta and G gamma(1) in the absence of G alpha overexpression and between G alpha and G gamma(1) but only when all three subunits are co-overexpressed. Both G alpha and G beta are associated with large macromolecular complexes of similar to 700 kDa in the plasma membrane. G alpha is present in both large complexes and as free G alpha in plasma membranes from wild type plants. In plants homozygous for a null allele of the G beta gene, G alpha is associated with smaller complexes in the 200-400-kDa range, indicating that its presence in the large complex depends on association with G beta gamma. Activation of the G alpha subunit with guanosine 5'-3-O-(thio)triphosphate (GTP gamma S) results in partial dissociation of G alpha from the complex. Hydrogen peroxide (H2O2) promotes extensive dissociation of the G alpha complex but does not interfere with binding of GTP gamma S to purified recombinant G alpha, suggesting that reactive oxygen species affect the stability of the large complex but not the activity of G alpha itself.	[Wang, Shiyu; Assmann, Sarah M.; Fedoroff, Nina V.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Wang, Shiyu; Fedoroff, Nina V.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Fedoroff, Nina V.] Santa Fe Inst, Santa Fe, NM 87501 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; The Santa Fe Institute	Fedoroff, NV (corresponding author), Penn State Univ, Dept Biol, 219 Wartik Lab, University Pk, PA 16802 USA.	nvf1@psu.edu						Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; BASBOA O, 1987, INDIAN J BIOCHEM BIO, V24, P24; BOWLER C, 1994, GENE DEV, V8, P2188, DOI 10.1101/gad.8.18.2188; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chen JG, 2004, PLANT PHYSIOL, V135, P907, DOI 10.1104/pp.104.038992; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Diaspro A, 2005, Q REV BIOPHYS, V38, P97, DOI 10.1017/S0033583505004129; Fedoroff N, 2006, ANN BOT-LONDON, V98, P289, DOI 10.1093/aob/mcl128; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Gadella TWJ, 1999, TRENDS PLANT SCI, V4, P287, DOI 10.1016/S1360-1385(99)01426-0; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Huang J, 2006, PLANT CELL, V18, P1226, DOI 10.1105/tpc.105.037259; Immink RGH, 2002, P NATL ACAD SCI USA, V99, P2416, DOI 10.1073/pnas.042677699; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Kato C, 2004, PLANT J, V38, P320, DOI 10.1111/j.1365-313X.2004.02046.x; Kato N, 2002, PLANT PHYSIOL, V129, P931, DOI 10.1104/pp.005496; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lapik YR, 2003, PLANT CELL, V15, P1578, DOI 10.1105/tpc.011890; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; Nishida M, 2002, J BIOL CHEM, V277, P9036, DOI 10.1074/jbc.M107392200; Obrdlik P, 2000, FEBS LETT, V476, P208, DOI 10.1016/S0014-5793(00)01706-3; Okamoto H, 2001, PLANT CELL, V13, P1639, DOI 10.1105/tpc.13.7.1639; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; Rivas S, 2002, PLANT CELL, V14, P689, DOI [10.1105/tpc.010357, 10.​1105/​tpc.​010357]; Ruiz-Velasco V, 2001, J PHYSIOL-LONDON, V537, P679; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SERRANO R, 1984, BIOCHEM BIOPH RES CO, V121, P735, DOI 10.1016/0006-291X(84)90243-2; Shah K, 2002, GENE DEV, V16, P1707, DOI 10.1101/gad.220402; Suharsono U, 2002, P NATL ACAD SCI USA, V99, P13307, DOI 10.1073/pnas.192244099; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; THOMSON LJ, 1993, PLANT PHYSIOL, V102, P553, DOI 10.1104/pp.102.2.553; Trusov Y, 2006, PLANT PHYSIOL, V140, P210, DOI 10.1104/pp.105.069625; Trusov Y, 2007, PLANT CELL, V19, P1235, DOI 10.1105/tpc.107.050096; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2002, PLANT PHYSIOL, V129, P897, DOI 10.1104/pp.005017; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Wang HX, 2006, MOL BIOL CELL, V17, P4257, DOI 10.1091/mbc.E06-01-0046; Wang SY, 2007, P NATL ACAD SCI USA, V104, P3817, DOI 10.1073/pnas.0611735104; Wang XQ, 2001, SCIENCE, V292, P2070, DOI 10.1126/science.1059046; Warpeha KM, 2006, PLANT PHYSIOL, V140, P844, DOI 10.1104/pp.105.071282; WARPEHA KMF, 1991, P NATL ACAD SCI USA, V88, P8925, DOI 10.1073/pnas.88.20.8925; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Weiss CA, 1997, FEBS LETT, V407, P361, DOI 10.1016/S0014-5793(97)00378-5; WU WH, 1994, P NATL ACAD SCI USA, V91, P6310, DOI 10.1073/pnas.91.14.6310; Xu XH, 2005, MOL BIOL CELL, V16, P676, DOI 10.1091/mbc.E04-07-0544; Yan F, 1998, PLANT PHYSIOL, V117, P311, DOI 10.1104/pp.117.1.311; Zeng Q, 2007, PLANT PHYSIOL, V143, P1119, DOI 10.1104/pp.106.093583; Zhao J, 2004, J BIOL CHEM, V279, P1794, DOI 10.1074/jbc.M309529200	64	51	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13913	13922		10.1074/jbc.M801376200	http://dx.doi.org/10.1074/jbc.M801376200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18326491	hybrid			2022-12-25	WOS:000255728200045
J	Dang, Y; Siew, LM; Zheng, YH				Dang, Ying; Siew, Lai Mun; Zheng, Yong-Hui			APOBEC3G is degraded by the proteasomal pathway in a vif-dependent manner without being polyubiquitylated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; E3 UBIQUITIN LIGASE; HIV-1 VIF; INDEPENDENT DEGRADATION; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G; SOCS-BOX; PROTEIN; RESIDUES; COMPLEX	Although the covalent attachment of a polyubiquitin is the prevailing paradigm for entry into proteasomes, accumulating evidence suggests that poorly defined ubiquitin-free pathways also degrade proteins. The cytidine deaminase APOBEC3G (A3G) potently inhibits human immunodeficiency virus type 1 replication by disrupting viral reverse transcription. However, human immunodeficiency virus type 1 produces a viral infectivity factor (Vif) to destroy this antiretroviral protein. It was shown that Vif binds to both A3G and a Cullin 5 ubiquitin-protein isopeptide ligase. It is currently accepted that this enzyme polyubiquitylates A3G on lysine residues, resulting in its degradation by proteasomes. Here, we find that A3G without ubiquitylation is still degraded by proteasomes in a Vif-dependent manner. We further show that Vif is polyubiquitylated and that this event could be critical for A3G proteasomal degradation. Thus, A3G is degraded by a novel pathway that might involve ubiquitylation of one protein and then targets a second binding partner for proteasomal entry and degradation. We propose that instead of triggering A3G polyubiquitylation, polyubiquitylated Vif might serve as a vehicle to transport A3G into proteasomes for degradation.	[Dang, Ying; Siew, Lai Mun; Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University	Zheng, YH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, 2215 Biomed & Phys Sci, E Lansing, MI 48824 USA.	zhengyo@msu.edu	Zheng, Yong-Hui/AAP-4492-2021	Zheng, Yong-Hui/0000-0002-1098-7385	NIAID NIH HHS [AI063344, R01 AI063944-02, R01 AI063944, K02 AI080225] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063944, K02AI080225] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akari H, 2004, J BIOL CHEM, V279, P12355, DOI 10.1074/jbc.M312426200; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Flick K, 2004, NAT CELL BIOL, V6, P634, DOI 10.1038/ncb1143; GONCALVES J, 1995, J VIROL, V69, P7196, DOI 10.1128/JVI.69.11.7196-7204.1995; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; HOYT MA, 2007, PROTEIN DEGRADATIO, V4, P107; Kalejta RF, 2003, P NATL ACAD SCI USA, V100, P3263, DOI 10.1073/pnas.0538058100; Kao Sandra, 2004, Retrovirology, V1, P27, DOI 10.1186/1742-4690-1-27; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Madani N, 2002, J VIROL, V76, P11133, DOI 10.1128/JVI.76.21.11133-11138.2002; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Pena MMO, 2006, BIOCHEM J, V394, P355, DOI 10.1042/BJ20051479; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1997, J VIROL, V71, P5259, DOI 10.1128/JVI.71.7.5259-5267.1997; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Verma R, 2000, CELL, V101, P341, DOI 10.1016/S0092-8674(00)80843-0; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Xiao ZX, 2006, VIROLOGY, V349, P290, DOI 10.1016/j.virol.2006.02.002; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	33	47	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13124	13131		10.1074/jbc.M708728200	http://dx.doi.org/10.1074/jbc.M708728200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326044	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000255499800051
J	Hwang, SO; Boswell, SA; Seo, JS; Lee, SW				Hwang, Sun Ok; Boswell, Sarah A.; Seo, Jeong-Sun; Lee, Sam W.			Novel oxidative stress-responsive gene ERS25 functions as a regulator of the heat-shock and cell death response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; COPII-COATED VESICLES; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; QUALITY-CONTROL; TARGETED GENE; P24 PROTEINS; FACTOR-I; TRANSPORT	Members of the yeast p24 family, including Emp24p and Erv25p, exist as heteromeric complexes that have been proposed to cycle between the endoplasmic reticulum ( ER) and Golgi compartments. The specific functions and sites of action of p24 proteins are still unknown. Here we identified a human homolog of the yeast p24 family of proteins, named ERS25 ( endoplasmic reticulum stress-response protein 25), and investigated its role in stress response. ERS25 is predicted to have an ER localization signal peptide, a GOLD ( Golgi dynamics) domain, which is found in several eukaryotic Golgi and lipid-trafficking proteins, a coiled- coil region, and a transmembrane domain. We demonstrate that ERS25 is localized to the ER and is induced by ER-specific stress, heat shock, and oxidative stress. The selective induction of ERS25 by brefeldin A, but not tunicamycin, implicates the involvement of ERS25 in protein trafficking between the ER and the Golgi. Small interfering RNA-mediated inhibition of ERS25 results in a significant decrease in apoptosis as well as a reduction of reactive oxygen species induced by oxidative stress. Moreover, ERS25 depletion results in a significant increase in the levels of the ER chaperone HSP70 in response to heat-shock stress through increased levels of HSF-1. We also found that inhibition of ERS25 induction in response to heat shock enhanced the binding of HSP70 to Apaf-1, which is likely to interfere in stress-mediated apoptosis. Together, the data presented here demonstrate that ERS25 may play a critical role in regulation of heat-shock response and apoptosis.	[Hwang, Sun Ok; Boswell, Sarah A.; Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Hwang, Sun Ok; Boswell, Sarah A.; Lee, Sam W.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Seo, Jeong-Sun] Seoul Natl Univ, Coll Med, Inst Med Res Council, ILCHUN Mol Med,Dept Biochem & Mol Biol, Seoul 110799, South Korea	Harvard University; Massachusetts General Hospital; Harvard University; Seoul National University (SNU)	Lee, SW (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Bldg 149,13th St, Charlestown, MA 02129 USA.	sam.lee@cbrc2.mgh.harvard.edu	Seo, Jeong-Sun/J-2763-2012	Boswell, Sarah/0000-0002-3118-3378	NATIONAL CANCER INSTITUTE [R01CA127247, R01CA097216, R01CA078356] Funding Source: NIH RePORTER; NCI NIH HHS [CA80058, CA078356, CA127247, CA097216] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anantharaman V, 2002, GENOME BIOL, V3; Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19; Bannykh SI, 1998, TRENDS CELL BIOL, V8, P21, DOI 10.1016/S0962-8924(97)01184-7; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Belden WJ, 2001, J BIOL CHEM, V276, P43040, DOI 10.1074/jbc.M108113200; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Blum R, 1999, J CELL SCI, V112, P537; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Carney GE, 2004, BIOL CELL, V96, P271, DOI 10.1016/j.biolcel.2004.01.004; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Gommel D, 1999, FEBS LETT, V447, P179, DOI 10.1016/S0014-5793(99)00246-X; HAND JW, 1979, INT J RADIAT BIOL, V35, P521, DOI 10.1080/09553007914550631; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; KING IA, 1981, BIOCHEM J, V198, P331, DOI 10.1042/bj1980331; KROEGER PE, 1993, MOL CELL BIOL, V13, P3370, DOI 10.1128/MCB.13.6.3370; LANDRY J, 1982, CANCER RES, V42, P2457; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; LI GC, 1991, P NATL ACAD SCI USA, V88, P1681, DOI 10.1073/pnas.88.5.1681; LI GC, 1982, P NATL ACAD SCI-BIOL, V79, P3218, DOI 10.1073/pnas.79.10.3218; Li WX, 1996, RADIAT RES, V145, P324, DOI 10.2307/3578988; MORGAN WD, 1987, MOL CELL BIOL, V7, P1129, DOI 10.1128/MCB.7.3.1129; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Samali A, 1998, CELL STRESS CHAPERON, V3, P228, DOI 10.1054/csac.1998.0129; Samali A, 1996, EXP CELL RES, V223, P163, DOI 10.1006/excr.1996.0070; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; Stavridi ES, 2004, GENE DEV, V18, P241, DOI 10.1101/gad.1181704; Strating JRPM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000704; STROUS GJ, 1993, J BIOL CHEM, V268, P2341; SUBJECK JR, 1982, BRIT J CANCER, V45, P127; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; WEI YQ, 1995, CANCER IMMUNOL IMMUN, V40, P73, DOI 10.1007/s002620050146; Wen CH, 1999, J CELL BIOL, V145, P1165, DOI 10.1083/jcb.145.6.1165	46	13	16	6	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13063	13069		10.1074/jbc.M709656200	http://dx.doi.org/10.1074/jbc.M709656200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326488	hybrid, Green Published			2022-12-25	WOS:000255499800044
J	Iyer, RR; Pohlhaus, TJ; Chen, S; Hura, GL; Dzantiev, L; Beese, LS; Modrich, P				Iyer, Ravi R.; Pohlhaus, Timothy J.; Chen, Sihong; Hura, Gregory L.; Dzantiev, Leonid; Beese, Lorena S.; Modrich, Paul			The MutS alpha-proliferating cell nuclear antigen interaction in human DNA mismatch repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; RAY SOLUTION SCATTERING; BIOLOGICAL MACROMOLECULES; RECOGNITION COMPLEX; PCNA; PROTEINS; SYSTEM; ASSOCIATION; EXPRESSION; RESOLUTION	We have examined the interaction parameters, conformation, and functional significance of the human MutS alpha center dot proliferating cell nuclear antigen ( PCNA) complex in mismatch repair. The two proteins associate with a 1: 1 stoichiometry and a K-D of 0.7 mu M in the absence or presence of heteroduplex DNA. PCNA does not influence the affinity of MutS alpha for a mismatch, and mismatch-bound MutS alpha binds PCNA. Small angle x-ray scattering studies have established the molecular parameters of the complex, which are consistent with an elongated conformation in which the two proteins associate in an end-to-end fashion in a manner that does not involve an extended unstructured tether, as has been proposed for yeast MutS alpha and PCNA ( Shell, S. S., Putnam, C. D., and Kolodner, R. D. (2007) Mol. Cell 26, 565 578). MutS alpha variants lacking the PCNA interaction motif are functional in 3 '- or 5 '- directed mismatch- provoked excision, but display a partial defect in 5 '- directed mismatch repair. This finding is consistent with the modest mutability conferred by inactivation of the MutS alpha PCNA interaction motif and suggests that interaction of the replication clamp with other repair protein(s) accounts for the essential role of PCNA in MutS alpha-dependent mismatch repair.	[Iyer, Ravi R.; Pohlhaus, Timothy J.; Chen, Sihong; Dzantiev, Leonid; Beese, Lorena S.; Modrich, Paul] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Iyer, Ravi R.; Chen, Sihong; Dzantiev, Leonid; Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Hura, Gregory L.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Duke University; Duke University; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Modrich, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	modrich@biochem.duke.edu	beese, lorena/G-4993-2010; Classen, Scott/AAY-8176-2020	Modrich, Paul/0000-0001-8708-9885; Hura, Greg/0000-0003-0501-8464	NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA092584-070005, P01 CA092584, P01 CA92584] Funding Source: Medline; NIGMS NIH HHS [R01 GM45190, R01 GM045190, R01 GM045190-18] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ackers G K, 1973, Methods Enzymol, V27, P441; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Dynlacht BD, 1997, METHOD ENZYMOL, V283, P230; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Guinier A., 1955, SMALL ANGLE SCATTERI; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; KELMAN Z, 1995, GENE, V166, P177, DOI 10.1016/0378-1119(95)00556-7; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KRATKY O, 1963, PROG BIOPHYS MOL BIO, V13, P105, DOI 10.1016/S0079-6107(63)80015-2; Lau PJ, 2003, J BIOL CHEM, V278, P14, DOI 10.1074/jbc.C200627200; Lee SD, 2006, J MOL BIOL, V355, P175, DOI 10.1016/j.jmb.2005.10.059; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2005, STRUCTURE, V13, P169, DOI 10.1016/j.str.2005.01.001; Nielsen FC, 2004, ONCOGENE, V23, P1457, DOI 10.1038/sj.onc.1207265; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; ZHANG P, 1995, BIOCHEMISTRY-US, V34, P10703, DOI 10.1021/bi00034a002	44	35	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13310	13319		10.1074/jbc.M800606200	http://dx.doi.org/10.1074/jbc.M800606200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18326858	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000255499800071
J	Ramsay, AJ; Dong, Y; Hunt, ML; Linn, M; Samaratunga, H; Clements, JA; Hooper, JD				Ramsay, Andrew J.; Dong, Ying; Hunt, Melanie L.; Linn, Mayla; Samaratunga, Hemamali; Clements, Judith A.; Hooper, John D.			Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARRESTIN-DEPENDENT ENDOCYTOSIS; HUMAN PROSTATIC-CARCINOMA; HUMAN TISSUE KALLIKREIN-4; BREAST-CANCER CELLS; THROMBIN RECEPTOR; SERINE-PROTEASE; MOLECULAR-CLONING; PLASMINOGEN-ACTIVATOR; EPITHELIAL-CELLS; GENE FAMILY	Kallikrein-related peptidase 4 (KLK4) is one of the 15 members of the human KLK family and a trypsin-like, prostate cancer-associated serine protease. Signaling initiated by trypsin-like serine proteases are transduced across the plasma membrane primarily by members of the protease-activated receptor (PAR) family of G protein-coupled receptors. Here we show, using Ca2+ flux assays, that KLK4 signals via both PAR-1 and PAR-2 but not via PAR-4. Dose-response analysis over the enzyme concentration range 0.1-1000 nM indicated that KLK4-induced Ca2+ mobilization via PAR-1 is more potent than via PAR-2, whereas KLK4 displayed greater efficacy via the latter PAR. We confirmed the specificity of KLK4 signaling via PAR-2 using in vitro protease cleavage assays and anti-phospho-ERK1/2/total ERK1/2 Western blot analysis of PAR-2-overexpressing and small interfering RNA-mediated receptor knockdown cell lines. Consistently, confocal microscopy analyses indicated that KLK4 initiates loss of PAR-2 from the cell surface and receptor internalization. Immunohistochemical analysis indicated the co-expression of agonist and PAR-2 in primary prostate cancer and bone metastases, suggesting that KLK4 signaling via this receptor will have pathological relevance. These data provide insight into KLK4-mediated cell signaling and suggest that signals induced by this enzyme via PARs may be important in prostate cancer.	[Ramsay, Andrew J.; Dong, Ying; Hunt, Melanie L.; Linn, Mayla; Clements, Judith A.; Hooper, John D.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [Samaratunga, Hemamali] Dept Anat Pathol, Taringa, Qld 4068, Australia	Queensland University of Technology (QUT)	Hooper, JD (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Corner Musk Ave & Blamey St, Kelvin Grove, Qld 4059, Australia.	jd.hooper@qut.edu.au	Hooper, John/C-1481-2016; Dong, Ying/C-3511-2012; Hooper, John/B-4153-2011; Samaratunga, Hemamali M L/D-1559-2013	Hooper, John/0000-0003-1054-8486; Samaratunga, Hemamali M L/0000-0001-5796-1791; Clements, Judith/0000-0001-6026-1964				Abraham LA, 2000, BONE, V26, P7, DOI 10.1016/S8756-3282(99)00237-9; Abraham LA, 1999, J BONE MINER RES, V14, P1320, DOI 10.1359/jbmr.1999.14.8.1320; Abraham LA, 1998, J BONE MINER RES, V13, P818, DOI 10.1359/jbmr.1998.13.5.818; Afar DEH, 2001, CANCER RES, V61, P1686; Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Angelo PF, 2006, J BIOL CHEM, V281, P3116, DOI 10.1074/jbc.M510096200; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Beaufort N, 2006, BIOL CHEM, V387, P217, DOI 10.1515/BC.2006.029; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Black PC, 2007, PROSTATE, V67, P743, DOI 10.1002/pros.20503; Bohm SK, 1996, J BIOL CHEM, V271, P22003; Bohm SK, 1996, BIOCHEM J, V314, P1009; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Chay CH, 2002, UROLOGY, V60, P760, DOI 10.1016/S0090-4295(02)01969-6; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Darrow AL, 1996, THROMB HAEMOSTASIS, V76, P860; Davidson B, 2005, AM J CLIN PATHOL, V123, P360, DOI 10.1309/PTBB5BPCKX8K9V69; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Day CH, 2002, ONCOGENE, V21, P7114, DOI 10.1038/sj.onc.1205786; Debela M, 2006, J MOL BIOL, V362, P1094, DOI 10.1016/j.jmb.2006.08.003; Debela M, 2006, J BIOL CHEM, V281, P25678, DOI 10.1074/jbc.M602372200; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dong Y, 2005, ENDOCR-RELAT CANCER, V12, P875, DOI 10.1677/erc.1.01062; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Gao J, 2007, PROSTATE, V67, P348, DOI 10.1002/pros.20465; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Greenberg DL, 2003, BIOCHEMISTRY-US, V42, P702, DOI 10.1021/bi027100x; Hart PS, 2004, J MED GENET, V41, P545, DOI 10.1136/jmg.2003.017657; Harvey TJ, 2000, J BIOL CHEM, V275, P37397, DOI 10.1074/jbc.M004525200; Harvey Tracey J, 2003, Methods Mol Med, V81, P241; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Hooper JD, 2003, BIOCHEM J, V373, P689, DOI 10.1042/BJ20030390; Hooper JD, 1999, CANCER RES, V59, P3199; Hooper JD, 2001, GENOMICS, V73, P117, DOI 10.1006/geno.2000.6490; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; JAMESON GW, 1973, BIOCHEM J, V131, P107, DOI 10.1042/bj1310107; Jenkins Alison L., 1993, Journal of Biological Chemistry, V268, P21432; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kaushal V, 2006, PROSTATE, V66, P273, DOI 10.1002/pros.20326; Klokk TI, 2007, CANCER RES, V67, P5221, DOI 10.1158/0008-5472.CAN-06-4728; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Matsumura M, 2005, PROSTATE, V62, P1, DOI 10.1002/pros.20101; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Morris DR, 2006, CANCER RES, V66, P307, DOI 10.1158/0008-5472.CAN-05-1735; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Nelson PS, 1999, P NATL ACAD SCI USA, V96, P3114, DOI 10.1073/pnas.96.6.3114; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Obiezu CV, 2006, BIOL CHEM, V387, P749, DOI 10.1515/BC.2006.094; Oikonomopoulou K, 2006, J BIOL CHEM, V281, P32095, DOI 10.1074/jbc.M513138200; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Prezas P, 2006, BIOL CHEM, V387, P807, DOI 10.1515/BC.2006.102; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Shaffer DR, 2003, LANCET ONCOL, V4, P407, DOI 10.1016/S1470-2045(03)01138-0; Smith R, 2004, J BONE MINER RES, V19, P507, DOI 10.1359/JBMR.0301248; Smith R, 2000, FEBS LETT, V484, P285, DOI 10.1016/S0014-5793(00)02146-3; Stefansson K, 2008, J INVEST DERMATOL, V128, P18, DOI 10.1038/sj.jid.5700965; Stephenson SA, 1999, J BIOL CHEM, V274, P23210, DOI 10.1074/jbc.274.33.23210; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Sun J, 2003, BIOCHEMISTRY-US, V42, P892, DOI 10.1021/bi026878f; Takayama TK, 2001, BIOCHEMISTRY-US, V40, P15341, DOI 10.1021/bi015775e; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Titus B, 2005, CRIT REV EUKAR GENE, V15, P103, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i2.20; Vesey DA, 2007, NEPHROLOGY, V12, P36, DOI 10.1111/j.1440-1797.2006.00746.x; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; VOURETCRAVIARI V, 1995, J BIOL CHEM, V270, P8367, DOI 10.1074/jbc.270.14.8367; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Webber MM, 1996, PROSTATE, V29, P386, DOI 10.1002/(SICI)1097-0045(199612)29:6<386::AID-PROS7>3.0.CO;2-6; Wilson S, 2005, BIOCHEM J, V388, P967, DOI 10.1042/BJ20041066; WILSON S, 2004, PROSTATE, V9999, P1; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Ye XC, 2007, FRONT BIOSCI, V12, P3273, DOI 10.2741/2311; Yousef GM, 1999, CANCER RES, V59, P4252; Zaichick V. Ye., 1997, International Urology and Nephrology, V29, P565, DOI 10.1007/BF02552202; Zaichick V. Ye, 1996, International Urology and Nephrology, V28, P687, DOI 10.1007/BF02552165	86	121	121	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12293	12304		10.1074/jbc.M709493200	http://dx.doi.org/10.1074/jbc.M709493200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18308730	hybrid, Green Published			2022-12-25	WOS:000255340000046
J	Huang, Y; Wu, M; Li, HY				Huang, Yafen; Wu, Mian; Li, Hoi-Yeung			Tumor suppressor ARF promotes non-classic proteasome-independent polyubiquitination of COMMD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53-INDEPENDENT FUNCTIONS; NUCLEOLAR LOCALIZATION; UBIQUITIN LIGASE; HUMAN P14(ARF); GENE; DEGRADATION; PATHWAYS; MURR1; MDM2; P53	Although the tumor suppressor ARF is generally accepted for its essential role in activating the p53 pathway, its p53-independent function has also been proposed. Here, we report that ARF associates with COMMD1 and promotes Lys(63)-mediated polyubiquitination of COMMD1 in a p53-independent manner. We found that ARF interacts with COMMD1 in vivo. Deletion analysis of ARF suggested that the N-terminal amino acids 15-45 are important for its interaction with COMMD1. In addition, we found that endogenous ARF redistributes from the nucleolus to the nucleoplasm and interacts with COMMD1 when DNA is damaged by actinomycin D. Interestingly, we found that ARF promotes the polyubiquitination of COMMD1 through Lys(63) of ubiquitin but not the polyubiquitination of Lys(48), which does not target COMMD1 for proteasome-dependent proteolysis. Moreover, ARF mutants lacking the domain interacting with COMMD1 did not promote COMMD1 polyubiquitination, indicating that physical association is a prerequisite condition for the polyubiquitination process. Together, these data suggest that the ability to promote Lys(63)-mediated polyubiquitination of COMMD1 is a novel property of ARF independent of p53.	[Huang, Yafen; Li, Hoi-Yeung] Nanyang Technol Univ, Coll Sci, Sch Biol Sci, Div Mol & Cell Biol, Singapore 637551, Singapore; [Wu, Mian] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, HY (corresponding author), Nanyang Technol Univ, Coll Sci, Sch Biol Sci, Div Mol & Cell Biol, Singapore 637551, Singapore.	hyli@ntu.edu.sg		Wu, Mian/0000-0002-2714-0500; Li, Hoi Yeung/0000-0002-8603-1953				Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burstein E, 2004, EMBO J, V23, P244, DOI 10.1038/sj.emboj.7600031; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Chin L, 1998, TRENDS BIOCHEM SCI, V23, P291, DOI 10.1016/S0968-0004(98)01236-5; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; Fatyol K, 2001, J BIOL CHEM, V276, P28421, DOI 10.1074/jbc.M102847200; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Karayan L, 2001, ONCOGENE, V20, P836, DOI 10.1038/sj.onc.1204170; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Lindstrom MS, 2000, EXP CELL RES, V256, P400, DOI 10.1006/excr.2000.4854; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; QUELLE DE, 1995, CELL, V83, P993; Rizos H, 2000, ONCOGENE, V19, P2978, DOI 10.1038/sj.onc.1203629; Rizos H, 2005, CELL CYCLE, V4, P597, DOI 10.4161/cc.4.4.1588; Rizos H, 2007, CELL CYCLE, V6, P1741, DOI 10.4161/cc.6.14.4428; Rodway H, 2004, ONCOGENE, V23, P6186, DOI 10.1038/sj.onc.1207854; Saporita AJ, 2007, CURR MED CHEM, V14, P1815; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Tago K, 2005, P NATL ACAD SCI USA, V102, P7689, DOI 10.1073/pnas.0502978102; Weber JD, 2000, MOL CELL BIOL, V20, P2517, DOI 10.1128/MCB.20.7.2517-2528.2000; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Woods YL, 2004, J BIOL CHEM, V279, P50157, DOI 10.1074/jbc.M405414200; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	33	17	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11453	11460		10.1074/jbc.M708544200	http://dx.doi.org/10.1074/jbc.M708544200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18305112	hybrid			2022-12-25	WOS:000255067400043
J	Torok, ME; Chau, TTH; Mai, PP; Phong, ND; Dung, NT; Van Chuong, L; Lee, SJ; Caws, M; de Jong, MD; Hien, TT; Farrar, JJ				Torok, M. Estee; Chau, Tran Thi Hong; Mai, Pham Phuong; Phong, Nguyen Duy; Dung, Nguyen Thi; Van Chuong, Ly; Lee, Sue J.; Caws, M.; de Jong, Menno D.; Hien, Tran Tinh; Farrar, Jeremy J.			Clinical and Microbiological Features of HIV-Associated Tuberculous Meningitis in Vietnamese Adults	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; DRUG SENSITIVITY; INFECTION; OUTCOMES; THERAPY; ERA	Methods: The aim of this prospective, observational cohort study was to determine the clinical and microbiological features, outcome, and baseline variables predictive of death, in Vietnamese adults with HIV-associated tuberculous meningitis (TBM). 58 patients were admitted to the Hospital for Tropical Diseases in Ho Chi Minh City and underwent routine clinical and laboratory assessments. Treatment was with standard antituberculous therapy and adjunctive dexamethasone; antiretroviral therapy was not routinely available. Patients were followed up until the end of TB treatment or death. Results: The median symptom duration was 11 days (range 2-90 days), 21.8% had a past history of TB, and 41.4% had severe (grade 3) TBM. The median CD4 count was 32 cells/mm(3). CSF findings were as follows: median leucocyte count 438610 9 cells/l (63% neutrophils), 69% smear positive and 87.9% culture positive. TB drug resistance rates were high (13% mono-resistance 32.6% poly-resistance 8.7% multidrug resistance). 17% patients developed further AIDS-defining illnesses. 67.2% died (median time to death 20 days). Three baseline variables were predictive of death by multivariate analysis: increased TBM grade [adjusted hazard ratio (AHR) 1.73, 95% CI 1.08-2.76, p = 0.02], lower serum sodium (AHR 0.93, 95% CI 0.89 to 0.98, p = 0.002) and decreased CSF lymphocyte percentage (AHR 0.98, 95% CI 0.97 to 0.99, p = 0.003). Conclusions: HIV-associated TBM is devastating disease with a dismal prognosis. CSF findings included CSF neutrophil predominance, high rates of smear and culture positivity, and high rates of antituberculous drug resistance. Three baseline variables were independently associated with death: increased TBM grade; low serum sodium and decreased CSF lymphocyte percentage.	[Torok, M. Estee; Caws, M.; de Jong, Menno D.; Farrar, Jeremy J.] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Chau, Tran Thi Hong; Mai, Pham Phuong; Phong, Nguyen Duy; Dung, Nguyen Thi; Van Chuong, Ly; Hien, Tran Tinh] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Lee, Sue J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Torok, M. Estee; Caws, M.; de Jong, Menno D.; Farrar, Jeremy J.] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England	University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Torok, ME (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam.	etorok@oucru.org	Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X; Torok, Mili Estee/0000-0001-9098-8590; Caws, Maxine/0000-0002-9109-350X	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	This study was funded by the Wellcome Trust, UK. The funding source had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Azuaje C, 2006, ENFERM INFEC MICR CL, V24, P245, DOI 10.1016/S0213-005X(06)73770-3; BERENGUER J, 1992, NEW ENGL J MED, V326, P668, DOI 10.1056/NEJM199203053261004; Burman WJ, 1997, AM J RESP CRIT CARE, V155, P321, DOI 10.1164/ajrccm.155.1.9001331; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; DUBE MP, 1992, AM J MED, V93, P520, DOI 10.1016/0002-9343(92)90579-Z; Enberg G Margarita, 2006, Rev. chil. infectol., V23, P134; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Garg RK, 1999, POSTGRAD MED J, V75, P133, DOI 10.1136/pgmj.75.881.133; Girgis NI, 1998, AM J TROP MED HYG, V58, P28, DOI 10.4269/ajtmh.1998.58.28; Hirsch HH, 2004, CLIN INFECT DIS, V38, P1159, DOI 10.1086/383034; Hosoglu S, 2002, INT J TUBERC LUNG D, V6, P64; KARANDE S, 2005, HIV INDIAN J PEDIAT, V72, P755; Karstaedt AS, 1998, QJM-INT J MED, V91, P743, DOI 10.1093/qjmed/91.11.743; Katrak SM, 2000, J NEUROL SCI, V181, P118, DOI 10.1016/S0022-510X(00)00440-8; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; MARSHALL G, 1948, LANCET, V254, P582; Martinez M, 2006, J CLIN MICROBIOL, V44, P2967, DOI 10.1128/JCM.00754-06; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Nolan CM, 2005, AM J RESP CRIT CARE, V172, P1169, DOI 10.1164/rccm.2508001; Ormerod P, 1998, THORAX, V53, P536; Schutte CM, 2001, INFECTION, V29, P213, DOI 10.1007/s15010-001-1198-3; Shelburne Samuel A. III, 2003, AIDS Reviews, V5, P67; Shin SS, 2006, INT J TUBERC LUNG D, V10, P402; Simmons CP, 2006, J IMMUNOL, V176, P2007, DOI 10.4049/jimmunol.176.3.2007; Stoll Matthias, 2003, Curr Infect Dis Rep, V5, P266, DOI 10.1007/s11908-003-0083-x; Thwaites GE, 2005, J INFECT DIS, V192, P2134, DOI 10.1086/498220; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2005, J INFECT DIS, V192, P79, DOI 10.1086/430616; Thwaites GE, 2002, INT J TUBERC LUNG D, V6, P865; Thwaites GE, 2005, LANCET NEUROL, V4, P160, DOI 10.1016/S1474-4422(05)01013-6; TOROK ME, 2005, PRACTICAL NEUROLOGY, V5, P334; UNAIDS, 2006, AIDS EP UPD, P1; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; *WHO, 2003, WHOGDSTB2003313; World Health Organization, 2006, WHOHTMTB2006362; Yechoor VK, 1996, ARCH INTERN MED, V156, P1710, DOI 10.1001/archinte.156.15.1710	42	66	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1772	10.1371/journal.pone.0001772	http://dx.doi.org/10.1371/journal.pone.0001772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350135	gold, Green Published, Green Submitted			2022-12-25	WOS:000260762300001
J	Garvin, P; Nilsson, L; Carstensen, J; Jonasson, L; Kristenson, M				Garvin, Peter; Nilsson, Lennart; Carstensen, John; Jonasson, Lena; Kristenson, Margareta			Circulating Matrix Metalloproteinase-9 Is Associated with Cardiovascular Risk Factors in a Middle-Aged Normal Population	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; MATRIX METALLOPROTEINASES; TNF-ALPHA; ATHEROSCLEROTIC LESIONS; MYOCARDIAL-INFARCTION; MONONUCLEAR-CELLS; OXIDATIVE STRESS; 92-KD GELATINASE; PLASMA	Background: Elevated levels of circulating matrix metalloproteinase-9 (MMP-9) have been demonstrated in patients with established coronary artery disease (CAD). The aim of this study was to analyse levels of MMP-9 in a population free from symptomatic CAD and investigate their associations with cardiovascular (CV) risk factors, including C-reactive protein (CRP). Methods: A cross-sectional study was performed in a population based random sample aged 45-69 (n = 345, 50% women). MMP-9 levels were measured in EDTA-plasma using an ELISA-method. CV risk factors were measured using questionnaires and standard laboratory methods. Results: Plasma MMP-9 was detectable in all participants, mean 38.9 ng/mL (SD 22.1 ng/mL). Among individuals without reported symptomatic CAD a positive association (p<0.001) was seen, for both men and women, of MMP-9 levels regarding total risk load of eight CV risk factors i.e. blood pressure, dyslipidemia, diabetes, obesity, smoking, alcohol intake, physical activity and fruit and vegetable intake. The association was significant also after adjustment for CRP, and was not driven by a single risk factor alone. In regression models adjusted for age, sex, smoking, alcohol intake and CRP, elevated MMP-9 levels were independently positively associated with systolic blood pressure (p = 0.037), smoking (p<0.001), alcohol intake (p = 0.003) and CRP (p<0.001). The correlation coefficient between MMP-9 and CRP was r = 0.24 (p<0.001). Conclusions: In a population without reported symptomatic CAD, MMP-9 levels were associated with total CV risk load as well as with single risk factors. This was found also after adjustment for CRP.	[Garvin, Peter; Kristenson, Margareta] Linkoping Univ, Dept Med & Hlth Sci, Div Community Med, Linkoping, Sweden; [Nilsson, Lennart; Jonasson, Lena] Linkoping Univ, Dept Med & Hlth Sci, Div Cardiol, Linkoping, Sweden; [Carstensen, John] Linkoping Univ, Dept Med & Hlth Sci, Div Hlth & Soc, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Garvin, P (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Div Community Med, Linkoping, Sweden.	peter.garvin@ihs.liu.se		Carstensen, John/0000-0003-2256-8089; Garvin, Peter/0000-0001-7429-0889	Swedish Research Council [2004-1881]; Swedish Heart and Lung Foundation [20040530]; Linkoping University; County of Ostergotland	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Linkoping University; County of Ostergotland	Grants from the Swedish Research Council (2004-1881), the Swedish Heart and Lung Foundation (20040530), from Linkoping University and the County of Ostergotland via the two joint strategic programmes CIRC, Cardiovascular Inflammation Research Centre and Health and Society, respectively. All grants received after application, where specifying the design of the study. Apart from the scientific review, none of the funders have had any role in the design, implementation, interpretation of the data or writing of the manuscript.	Aljada A, 2001, J CLIN ENDOCR METAB, V86, P5988, DOI 10.1210/jc.86.12.5988; BERK BC, 1990, AM J CARDIOL, V65, P168, DOI 10.1016/0002-9149(90)90079-G; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; BROWN DL, 1995, CIRCULATION, V91, P2125, DOI 10.1161/01.CIR.91.8.2125; Derosa G, 2007, HEART VESSELS, V22, P361, DOI 10.1007/s00380-007-0989-6; Eriksson JS, 2020, SCAND J MED SCI SPOR, V30, P370, DOI 10.1111/sms.13581; Evans J, 2007, EUR J VASC ENDOVASC, V34, P302, DOI 10.1016/j.ejvs.2007.04.011; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gerlach RF, 2007, CLIN BIOCHEM, V40, P119, DOI 10.1016/j.clinbiochem.2006.10.007; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HAVERKATE F, 1995, THROMB HAEMOSTASIS, V73, P561; Hollman G, 2007, EUR J CARDIOVASC NUR; Holven KB, 2006, STROKE, V37, P1731, DOI 10.1161/01.STR.0000226465.84561.cb; Kalela A, 2000, EUR J CLIN INVEST, V30, P99; Kameda K, 2003, EUR HEART J, V24, P2180, DOI 10.1016/j.ehj.2003.09.022; Kameda K, 2006, CIRC J, V70, P673, DOI 10.1253/circj.70.673; Khani BR, 2004, J NUTR, V134, P1541, DOI 10.1093/jn/134.6.1541; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Loftus IM, 2000, STROKE, V31, P40, DOI 10.1161/01.STR.31.1.40; Newby AC, 2006, CURR OPIN LIPIDOL, V17, P556, DOI 10.1097/01.mol.0000245262.48258.b4; Nikkari ST, 1996, AM J PATHOL, V149, P1427; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Orbe J, 2003, ATHEROSCLEROSIS, V170, P269, DOI 10.1016/S0021-9150(03)00251-X; Potier M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1237, DOI 10.1152/ajpendo.00451.2002; Potier M, 2001, J AM SOC NEPHROL, V12, P241, DOI 10.1681/ASN.V122241; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rouy D, 2005, ANAL BIOCHEM, V338, P294, DOI 10.1016/j.ab.2004.10.052; Saren P, 1996, J IMMUNOL, V157, P4159; Sillanaukee P, 2002, EUR J CLIN INVEST, V32, P225, DOI 10.1046/j.1365-2362.2002.00975.x; Siwik DA, 2001, AM J PHYSIOL-CELL PH, V280, pC53, DOI 10.1152/ajpcell.2001.280.1.C53; Sundstrom J, 2004, CIRCULATION, V109, P2850, DOI 10.1161/01.CIR.0000129318.79570.84; Tayebjee MH, 2005, CURR MED CHEM, V12, P917, DOI 10.2174/0929867053507270; Tayebjee MH, 2004, AM J HYPERTENS, V17, P764, DOI 10.1016/j.amjhyper.2004.05.019; Turner NA, 2007, J MOL CELL CARDIOL, V43, P168, DOI 10.1016/j.yjmcc.2007.05.006; Wagner DR, 2006, J CARD FAIL, V12, P66, DOI 10.1016/j.cardfail.2005.08.002; Wright JL, 2007, AM J PHYSIOL-LUNG C, V292, pL125, DOI 10.1152/ajplung.00539.2005; Yasmin, 2005, ARTERIOSCL THROM VAS, V25, P372, DOI 10.1161/01.ATV.0000151373.33830.41	40	58	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1774	10.1371/journal.pone.0001774	http://dx.doi.org/10.1371/journal.pone.0001774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335048	gold, Green Published, Green Submitted			2022-12-25	WOS:000260723000027
J	Crevel, G; Bennett, D; Cotterill, S				Crevel, Gilles; Bennett, Dorothy; Cotterill, Sue			The Human TPR Protein TTC4 Is a Putative Hsp90 Co-Chaperone Which Interacts with CDC6 and Shows Alterations in Transformed Cells	PLOS ONE			English	Article								Background: The human TTC4 protein is a TPR (tetratricopeptide repeat) motif-containing protein. The gene was originally identified as being localized in a genomic region linked to breast cancer and subsequent studies on melanoma cell lines revealed point mutations in the TTC4 protein that may be associated with the progression of malignant melanoma. Methodology/Principle Findings: Here we show that TTC4 is a nucleoplasmic protein which interacts with HSP90 and HSP70, and also with the replication protein CDC6. It has significant structural and functional similarities with a previously characterised Drosophila protein Dpit47. We show that TTC4 protein levels are raised in malignant melanoma cell lines compared to melanocytes. We also see increased TTC4 expression in a variety of tumour lines derived from other tissues. In addition we show that TTC4 proteins bearing some of the mutations previously identified from patient samples lose their interaction with the CDC6 protein. Conclusions/Significance: Based on these results and our previous work with the Drosophila Dpit47 protein we suggest that TTC4 is an HSP90 co-chaperone protein which forms a link between HSP90 chaperone activity and DNA replication. We further suggest that the loss of the interaction with CDC6 or with additional client proteins could provide one route through which TTC4 could influence malignant development of cells.	[Crevel, Gilles; Bennett, Dorothy; Cotterill, Sue] St George Hosp, Sch Med, Dept Basic Med Sci, London, England	St Georges University London	Crevel, G (corresponding author), St George Hosp, Sch Med, Dept Basic Med Sci, Cranmer Terrace, London, England.	s.cotterill@sghms.ac.uk	Bennett, Dorothy C/C-2418-2008	Bennett, Dorothy C/0000-0002-3639-7527	AICR	AICR	AICR	Beliakoff J, 2004, ANTI-CANCER DRUG, V15, P651, DOI 10.1097/01.cad.0000136876.11928.be; BENNETT DC, 1985, J CELL SCI, V77, P167; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Clay-Farrace L, 2003, EMBO J, V22, P704, DOI 10.1093/emboj/cdg046; Crevel G, 2005, J CELL SCI, V118, P2451, DOI 10.1242/jcs.02361; Crevel G, 2001, J CELL SCI, V114, P2015; Crevel G, 2001, NUCLEIC ACIDS RES, V29, P4834, DOI 10.1093/nar/29.23.4834; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dmitriev RI, 2007, BIOCHEM BIOPH RES CO, V355, P1051, DOI 10.1016/j.bbrc.2007.02.073; Dolinski KJ, 1998, MOL CELL BIOL, V18, P7344, DOI 10.1128/MCB.18.12.7344; Franzen B, 1996, BRIT J CANCER, V74, P1632, DOI 10.1038/bjc.1996.600; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Hey Y, 2000, CYTOGENET CELL GENET, V88, P272, DOI 10.1159/000015536; Irwin N, 2002, J INVEST DERMATOL, V119, P186, DOI 10.1046/j.1523-1747.2002.18181.x; Konieczny I, 1999, GENET ENG P, V21, P95; Lee YM, 2001, BIOCHEM J, V360, P549, DOI 10.1042/0264-6021:3600549; Liu JS, 1998, J BIOL CHEM, V273, P30704, DOI 10.1074/jbc.273.46.30704; Loop T, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-24; Marsh JA, 1998, MOL CELL BIOL, V18, P7353, DOI 10.1128/MCB.18.12.7353; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Moir RD, 2004, ADV PROTEIN CHEM, V67, P93; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Poetsch M, 2000, ONCOGENE, V19, P5817, DOI 10.1038/sj.onc.1203961; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Russell LC, 1999, J BIOL CHEM, V274, P20060, DOI 10.1074/jbc.274.29.20060; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SMITH RL, 1995, GENE DEV, V9, P2903, DOI 10.1101/gad.9.23.2903; Su GF, 1999, GENOMICS, V55, P157, DOI 10.1006/geno.1998.5633; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	33	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e0001737	10.1371/journal.pone.0001737	http://dx.doi.org/10.1371/journal.pone.0001737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320024	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000260586600032
J	Liu, XY; Pavlovsky, AG; Viola, RE				Liu, Xuying; Pavlovsky, Alexander G.; Viola, Ronald E.			The structural basis for allosteric inhibition of a threonine-sensitive aspartokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOSERINE DEHYDROGENASE-I; COMPLETE GENOME SEQUENCE; AMINO-ACID BIOSYNTHESIS; ESCHERICHIA-COLI K12; ASPARTATE KINASE; IDENTIFICATION; EQUILIBRIUM; PROTEINS; ENZYMES	The commitment step to the aspartate pathway of amino acid biosynthesis is the phosphorylation of aspartic acid catalyzed by aspartokinase (AK). Most microorganisms and plants have multiple forms of this enzyme, and many of these isofunctional enzymes are subject to feedback regulation by the end products of the pathway. However, the archeal species Methanococcus jannaschii has only a single, monofunctional form of AK. The substrate L-aspartate binds to this recombinant enzyme in two different orientations, providing the first structural evidence supporting the relaxed regiospecificity previously observed with several alternative substrates of Escherichia coli AK (Angeles, T. S., Hunsley, J. R., and Viola, R. E. (1992) Biochemistry 31, 799-805). Binding of the nucleotide substrate triggers significant domain movements that result in a more compact quaternary structure. In contrast, the highly cooperative binding of the allosteric regulator L-threonine to multiple sites on this dimer of dimers leads to an open enzyme structure. A comparison of these structures supports a mechanism for allosteric regulation in which the domain movements induced by threonine binding causes displacement of the substrates from the enzyme, resulting in a relaxed, inactive conformation.	[Liu, Xuying; Pavlovsky, Alexander G.] Univ Toledo, Dept Chem, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Viola, RE (corresponding author), Univ Toledo, Dept Chem, 2801 W Bancroft St, Toledo, OH 43606 USA.	ron.viola@utoledo.edu	Viola, Ronald/C-5904-2011; liu, xuying/G-7258-2012					ANGELES TS, 1992, BIOCHEMISTRY-US, V31, P799, DOI 10.1021/bi00118a023; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; BEARER CF, 1978, BIOCHEMISTRY-US, V17, P3523, DOI 10.1021/bi00610a016; BEARER CF, 1978, BIOCHEMISTRY-US, V17, P3512, DOI 10.1021/bi00610a014; Bono H, 1998, GENOME RES, V8, P203, DOI 10.1101/gr.8.3.203; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faehnle CR, 2006, ACTA CRYSTALLOGR F, V62, P962, DOI 10.1107/S1744309106038279; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HECK HD, 1972, BIOCHEMISTRY-US, V11, P4421, DOI 10.1021/bi00774a001; JANIN J, 1969, EUR J BIOCHEM, V11, P520, DOI 10.1111/j.1432-1033.1969.tb00804.x; JANIN J, 1969, EUR J BIOCHEM, V11, P530, DOI 10.1111/j.1432-1033.1969.tb00805.x; JANIN J, 1974, FEBS LETT, V45, P318, DOI 10.1016/0014-5793(74)80870-7; Keng YF, 1996, ARCH BIOCHEM BIOPHYS, V335, P73, DOI 10.1006/abbi.1996.0483; Kotaka M, 2006, J BIOL CHEM, V281, P31544, DOI 10.1074/jbc.M605886200; Lyon GJ, 2004, PEPTIDES, V25, P1389, DOI 10.1016/j.peptides.2003.11.026; Mas-Droux C, 2006, PLANT CELL, V18, P1681, DOI 10.1105/tpc.105.040451; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paris S, 2003, J BIOL CHEM, V278, P5361, DOI 10.1074/jbc.M207379200; Ragkousi K, 2003, J BACTERIOL, V185, P2315, DOI 10.1128/JB.185.7.2315-2329.2003; Roberts CJ, 1995, NUCLEIC ACIDS RES, V23, P4818, DOI 10.1093/nar/23.23.4818; Somerville R. L., 1983, AMINO ACIDS BIOSYNTH, P147; TILAK A, 1976, EUR J BIOCHEM, V69, P249, DOI 10.1111/j.1432-1033.1976.tb10880.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Heijenoort J, 2001, NAT PROD REP, V18, P503, DOI 10.1039/a804532a; VICKERS LP, 1978, J BIOL CHEM, V253, P2155; Viola RE, 2001, ACCOUNTS CHEM RES, V34, P339, DOI 10.1021/ar000057q	30	21	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					16216	16225		10.1074/jbc.M800760200	http://dx.doi.org/10.1074/jbc.M800760200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18334478	Green Published, hybrid			2022-12-25	WOS:000256332500080
J	Shankar, E; Sivaprasad, U; Basu, A				Shankar, E.; Sivaprasad, U.; Basu, A.			Protein kinase C epsilon confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53	ONCOGENE			English	Article						Akt; Bid; p53; PKC epsilon; TRAIL	BREAST-CANCER CELLS; CASPASE ACTIVATION; INDUCED APOPTOSIS; DEATH RECEPTORS; MDM2; PHOSPHORYLATION; UBIQUITINATION; PROMOTES; GENE; DEGRADATION	Protein kinase C epsilon (PKC epsilon) acts as an antiapoptotic protein and inhibits tumor necrosis factor-alpha (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in MCF-7 breast cancer cells. Members of the TNF receptor superfamily trigger apoptosis independent of the tumor suppressor protein p53, which primarily affects DNA damage-induced apoptosis. We have previously shown that PKCe acts upstream of Akt to inhibit receptor-initiated cell death. Since Akt can regulate p53, we have examined the involvement of p53 in PKC epsilon-mediated TRAIL resistance. Overexpression of PKCe in MCF-7 cells (MCF-7/PKC epsilon) caused a decrease in p53 and an increase in human homolog of murine double minute 2 (Hdm2) and phospho-Hdm2. Depletion of p53 by siRNA attenuated, whereas depletion of Hdm2 enhanced TRAIL-mediated apoptosis. Knockdown of Akt decreased Hdm2 phosphorylation, increased p53 level and potentiated TRAIL-induced cell death. Depletion of PKCe from MCF-7 cells caused an increase in p53, whereas knockdown of p53 caused a decrease in Bid mRNA. Depletion of Akt from MCF-7/PKCe cells resulted in an increase in p53 and Bid. These results suggest that PKCe mediates TRAIL resistance by Akt-mediated phosphorylation of Hdm2 resulting in suppression of p53 expression and down-regulation of Bid in MCF-7 breast cancer cells.	[Shankar, E.; Sivaprasad, U.; Basu, A.] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA; [Shankar, E.; Basu, A.] Univ N Texas, Hlth Sci Ctr, Inst Canc Res, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Basu, A (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	abasu@hsc.unt.edu	Shankar, Eswar/E-5139-2015	Shankar, Eswar/0000-0001-8968-838X; Basu, Alakananda/0000-0002-1656-0788	NATIONAL CANCER INSTITUTE [R01CA071727] Funding Source: NIH RePORTER; NCI NIH HHS [CA71727] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Basu A, 2002, J BIOL CHEM, V277, P41850, DOI 10.1074/jbc.M205997200; Basu A, 1999, BIOCHEMISTRY-US, V38, P4245, DOI 10.1021/bi982854q; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Ehrhardt H, 2008, ONCOGENE, V27, P783, DOI 10.1038/sj.onc.1210666; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; LIU X, 2004, CANCER RES, V83, P5078; Lu DM, 2004, INT J ONCOL, V25, P671; Lu DM, 2006, J BIOL CHEM, V281, P22799, DOI 10.1074/jbc.M603390200; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Toole A, 2001, BIOCHEM J, V359, P119, DOI 10.1042/0264-6021:3590119; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Rozan LM, 2007, CELL DEATH DIFFER, V14, P3, DOI 10.1038/sj.cdd.4402058; Rudner J, 2005, ONCOGENE, V24, P130, DOI 10.1038/sj.onc.1208191; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Sivaprasad U, 2007, CELL DEATH DIFFER, V14, P851, DOI 10.1038/sj.cdd.4402077; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Weber HO, 2005, ONCOGENE, V24, P1965, DOI 10.1038/sj.onc.1208389; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; ZAUBERMAN A, 1993, EMBO J, V12, P2799, DOI 10.1002/j.1460-2075.1993.tb05941.x; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	40	39	40	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2008	27	28					3957	3966		10.1038/onc.2008.39	http://dx.doi.org/10.1038/onc.2008.39			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	318JZ	18317451				2022-12-25	WOS:000257089000007
J	Younes, A; Lyashkov, AE; Graham, D; Sheydina, A; Volkova, MV; Mitsak, M; Vinogradova, TM; Lukyanenko, YO; Li, Y; Ruknudin, AM; Boheler, KR; van Eyk, J; Lakatta, EG				Younes, Antoine; Lyashkov, Alexey E.; Graham, David; Sheydina, Anna; Volkova, Maria V.; Mitsak, Megan; Vinogradova, Tatiana M.; Lukyanenko, Yevgeniya O.; Li, Yue; Ruknudin, Abdul M.; Boheler, Kenneth R.; van Eyk, Jennifer; Lakatta, Edward G.			Ca2+-stimulated basal adenylyl cyclase activity localization in membrane lipid microdomains of cardiac sinoatrial nodal pacemaker cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHODIESTERASE ACTIVITY; DIASTOLIC DEPOLARIZATION; RYANODINE RECEPTOR; TRANSGENIC MICE; SIGNALING COMPONENTS; DIRECTED EXPRESSION; PLASMA-MEMBRANE; CA2+ RELEASES; BEATING RATE; CYCLIC-AMP	Spontaneous, rhythmic subsarcolemmal local Ca2+ releases driven by cAMP- mediated, protein kinase A (PKA)- dependent phosphorylation are crucial for normal pacemaker function of sinoatrial nodal cells (SANC). Because local Ca2+ releases occur beneath the cell surface membrane, near to where adenylyl cyclases (ACs) reside, we hypothesized that the dual Ca2+ and cAMP/ PKA regulatory components of automaticity are coupled via Ca2+ activation of AC activity within membrane microdomains. Here we show by quantitative reverse transcriptase PCR that SANC express Ca2+-activated AC isoforms 1 and 8, in addition to AC type 2, 5, and 6 transcripts. Immunolabeling of cell fractions, isolated by sucrose gradient ultracentrifugation, confirmed that ACs localize to membrane lipid microdomains. AC activity within these lipid microdomains is activated by Ca2+ over the entire physiological Ca2+ range. In intact SANC, the high basal AC activity produces a high level of cAMP that is further elevated by phosphodiesterase inhibition. cAMP and cAMP- mediated PKA- dependent activation of ion channels and Ca2+ cycling proteins drive sarcoplasmic reticulum Ca2+ releases, which, in turn, activate ACs. This feed forward "fail safe" system, kept in check by a high basal phosphodiesterase activity, is central to the generation of normal rhythmic, spontaneous action potentials by pacemaker cells.	[Younes, Antoine; Lyashkov, Alexey E.; Sheydina, Anna; Volkova, Maria V.; Vinogradova, Tatiana M.; Lukyanenko, Yevgeniya O.; Li, Yue; Ruknudin, Abdul M.; Boheler, Kenneth R.; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Graham, David; Mitsak, Megan; van Eyk, Jennifer] Johns Hopkins Univ, Dept Med, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Lakatta, EG (corresponding author), NIA, Cardiovasc Sci Lab, Gerontol Res Ctr, Intramural Res Program,NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	lakattae@mail.nih.gov	Lakatta, Edward G/AAL-1447-2020; Vinogradova, Tatiana/AAU-5793-2020	Lakatta, Edward/0000-0002-4772-0035	Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [P01 HL077180-040001, P01 HL077180-030001, P01 HL077180-020001, P01 HL077180-010001, P01 HL077180] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000259, ZIAAG000258, ZIAAG000260] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Barbuti A, 2004, CIRC RES, V94, P1325, DOI 10.1161/01.RES.0000127621.54132.AE; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Bogdanov KY, 2006, CIRC RES, V99, P979, DOI 10.1161/01.RES.0000247933.66532.0b; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Bossuyt J, 2002, FEBS LETT, V511, P113, DOI 10.1016/S0014-5793(01)03323-3; Bucchi A, 2002, J GEN PHYSIOL, V120, P1, DOI 10.1085/jgp.20028593; CALI JJ, 1994, J BIOL CHEM, V269, P12190; DiFrancesco D, 2005, CURR MED RES OPIN, V21, P1115, DOI 10.1185/030079905X50543; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Georget M, 2003, FASEB J, V17, P1380, DOI 10.1096/fj.02-0784com; Georget M, 2002, FASEB J, V16, P1636, DOI 10.1096/fj.02-0292fje; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Herrmann S, 2007, EMBO J, V26, P4423, DOI 10.1038/sj.emboj.7601868; Ilangumaran S, 1996, ANAL BIOCHEM, V235, P49, DOI 10.1006/abio.1996.0090; Ju YK, 2007, CIRC RES, V100, P1605, DOI 10.1161/CIRCRESAHA.107.152181; Lipskaia L, 2000, CIRC RES, V86, P795, DOI 10.1161/01.RES.86.7.795; Liu LJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1550, DOI 10.1152/ajpcell.00555.2002; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; Lyashkov AE, 2007, CIRC RES, V100, P1723, DOI 10.1161/CIRCRESAHA.107.153676; Maltsev VA, 2004, BIOPHYS J, V86, P2596, DOI 10.1016/S0006-3495(04)74314-3; Maltsev VA, 2006, J PHARMACOL SCI, V100, P338, DOI 10.1254/jphs.CR0060018; MASSONPEVET M, 1979, CIRC RES, V45, P621, DOI 10.1161/01.RES.45.5.621; Mattick P, 2007, J PHYSIOL-LONDON, V582, P1195, DOI 10.1113/jphysiol.2007.133439; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Sanders L, 2006, J PHYSIOL-LONDON, V571, P639, DOI 10.1113/jphysiol.2005.100305; Schwencke C, 1999, MOL ENDOCRINOL, V13, P1061, DOI 10.1210/me.13.7.1061; Scriven DRL, 2005, BIOPHYS J, V89, P1893, DOI 10.1529/biophysj.105.064212; Stieber J, 2006, MOL PHARMACOL, V69, P1328, DOI 10.1124/mol.105.020701; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Swaney JS, 2006, J BIOL CHEM, V281, P17173, DOI 10.1074/jbc.M513097200; TARASOVA YS, 2006, EMBRYONIC STEM CELLS; TAUSSIG R, 1995, J BIOL CHEM, V270, P1, DOI 10.1074/jbc.270.1.1; TOBISE K, 1994, CIRC RES, V74, P596, DOI 10.1161/01.RES.74.4.596; Vinogradova TM, 2008, CIRC RES, V102, P761, DOI 10.1161/CIRCRESAHA.107.161679; Vinogradova TM, 2000, CIRC RES, V87, P760, DOI 10.1161/01.RES.87.9.760; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Vinogradova TM, 2004, CIRC RES, V94, P802, DOI 10.1161/01.RES.0000122045.55331.0F; Vinogradova TM, 2002, CIRC RES, V90, P73, DOI 10.1161/hh0102.102271; VINOGRADOVA TM, 2006, BIOPHYS J, V90, pA155; Zaccolo M, 2003, TRENDS NEUROSCI, V26, P53, DOI 10.1016/S0166-2236(02)00017-6	45	76	79	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14461	14468		10.1074/jbc.M707540200	http://dx.doi.org/10.1074/jbc.M707540200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18356168	Green Published, hybrid			2022-12-25	WOS:000255941400033
J	Joly, N; Burrows, PC; Buck, M				Joly, Nicolas; Burrows, Patricia C.; Buck, Martin			An intramolecular route for coupling ATPase activity in AAA(+) proteins for transcription activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEINS; PROMOTER DNA COMPLEX; ESCHERICHIA-COLI; FUNCTIONAL DOMAINS; ALUMINUM FLUORIDE; PLUS ATPASES; MECHANISM; PSPF; SIGMA(54); SIGMA-54	AAA(+) proteins ( ATPases associated with various cellular activities) contribute to many cellular processes and typically function as higher order oligomers permitting the coordination of nucleotide hydrolysis for functional output, which leads to substrate remodeling. The precise mechanisms that enable the relay of nucleotide hydrolysis to their specific functional outputs are largely unknown. Here we use PspF, a specialized AAA(+) protein required for enhancer-dependent transcription activation in Escherichia coli, as a model system to address this question. We demonstrate that a conserved asparagine is involved in internal organization of the oligomeric ring, regulation of ATPase activity by "trans" factors, and optimizing substrate remodeling. We provide evidence that the spatial relationship between the asparagine residue and the Walker B motif is one key element in the conformational signaling pathway that leads to substrate remodeling. Such functional organization most likely applies to other AAA(+) proteins, including Ltag ( simian virus 40), Rep40 (Adeno-associated virus-2), and p97 (Mus musculus) in which the asparagine to Walker B motif relationship is conserved.	[Joly, Nicolas; Burrows, Patricia C.; Buck, Martin] Imperial Coll London, Div Biol, London SW7 2AZ, England	Imperial College London	Buck, M (corresponding author), Imperial Coll London, Div Biol, London SW7 2AZ, England.	m.buck@imperial.ac.uk	Joly, Nicolas/H-6851-2018	Joly, Nicolas/0000-0003-2731-3827	BBSRC [BB/G001278/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G001278/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bordes P, 2003, P NATL ACAD SCI USA, V100, P2278, DOI 10.1073/pnas.0537525100; Bordes P, 2004, MOL MICROBIOL, V54, P489, DOI 10.1111/j.1365-2958.2004.04280.x; Burrows PC, 2008, J MOL BIOL, V375, P43, DOI 10.1016/j.jmb.2007.10.045; Burrows PC, 2004, EMBO J, V23, P4253, DOI 10.1038/sj.emboj.7600406; Cannon WV, 2000, NAT STRUCT BIOL, V7, P594; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Chen BY, 2007, STRUCTURE, V15, P429, DOI 10.1016/j.str.2007.02.007; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Elderkin S, 2002, J MOL BIOL, V320, P23, DOI 10.1016/S0022-2836(02)00404-7; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Joly N, 2008, J MOL BIOL, V375, P1206, DOI 10.1016/j.jmb.2007.11.050; Joly N, 2007, MOL MICROBIOL, V66, P583, DOI 10.1111/j.1365-2958.2007.05901.x; Joly N, 2006, J BIOL CHEM, V281, P34997, DOI 10.1074/jbc.M606628200; Jovanovic G, 1999, J MOL BIOL, V285, P469, DOI 10.1006/jmbi.1998.2263; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Krzywda S, 2002, STRUCTURE, V10, P1073, DOI 10.1016/S0969-2126(02)00806-7; Lin YC, 2005, NAT STRUCT MOL BIOL, V12, P603, DOI 10.1038/nsmb949; Lloyd LJ, 2004, J BIOL CHEM, V279, P55707, DOI 10.1074/jbc.M408994200; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; MAYER AN, 1995, GENE, V153, P1, DOI 10.1016/0378-1119(94)00752-E; MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; Rappas M, 2006, J MOL BIOL, V357, P481, DOI 10.1016/j.jmb.2005.12.052; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Rappas M, 2007, CURR OPIN STRUC BIOL, V17, P110, DOI 10.1016/j.sbi.2006.11.002; SASSEDWIGHT S, 1990, CELL, V62, P945, DOI 10.1016/0092-8674(90)90269-K; SASSEDWIGHT S, 1988, P NATL ACAD SCI USA, V85, P8934, DOI 10.1073/pnas.85.23.8934; Schumacher J, 2004, J MOL BIOL, V338, P863, DOI 10.1016/j.jmb.2004.02.071; Schumacher J, 2006, J STRUCT BIOL, V156, P190, DOI 10.1016/j.jsb.2006.01.006; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; Tucker PA, 2007, CURR OPIN STRUC BIOL, V17, P641, DOI 10.1016/j.sbi.2007.09.012; Wigneshweplaraj SR, 2005, PROG NUCLEIC ACID RE, V79, P339, DOI 10.1016/S0079-6603(04)79007-8; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x	37	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13725	13735		10.1074/jbc.M800801200	http://dx.doi.org/10.1074/jbc.M800801200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18326037	hybrid			2022-12-25	WOS:000255728200024
J	Brazier, MW; Davies, P; Player, E; Marken, F; Viles, JH; Brown, DR				Brazier, Marcus W.; Davies, Paul; Player, Esmie; Marken, Frank; Viles, John H.; Brown, David R.			Manganese binding to the prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-ION BINDING; FULL-LENGTH; COPPER-BINDING; RESISTANT PRION; HIGH-AFFINITY; SCRAPIE; COORDINATION; RECOMBINANT; GENERATION; CONVERSION	There is considerable evidence that the prion protein binds copper. However, there have also been suggestions that prion protein (PrP) binds manganese. We used isothermal titration calorimetry to identify the manganese binding sites in wild-type mouse PrP. The protein showed two manganese binding sites with affinities that would bind manganese at concentrations of 63 and 200 mu M at pH 5.5. This indicates that PrP binds manganese with affinity similar to other known manganese-binding proteins. Further study indicated that the main manganese binding site is associated with His-95 in the so-called "fifth site" normally associated with copper binding. Additionally, it was shown that occupancy by copper does not prevent manganese binding. Under these conditions, manganese binding resulted in an altered conformation of PrP, displacement of copper, and altered redox chemistry of the metal-protein complex. Cyclic voltammetric measurements suggested a complex redox chemistry involving manganese bound to PrP, whereas copper-bound PrP was able to undergo fully reversible electron cycling. Additionally, manganese binding to PrP converted it to a form able to catalyze aggregation of metal-free PrP. These results further support the notion that manganese binding could cause a conformation change in PrP and trigger changes in the protein similar to those associated with prion disease.	[Brazier, Marcus W.; Davies, Paul; Player, Esmie; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Marken, Frank] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England; [Viles, John H.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of Bath; University of Bath; University of London	Brown, DR (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssdrb@bath.ac.uk	Marken, Frank/H-7674-2014; Marken, Frank/AAG-3210-2020	Marken, Frank/0000-0003-3177-4562; Marken, Frank/0000-0003-3177-4562; Davies, Paul/0000-0001-8022-2719	Biotechnology and Biological Sciences Research Council [BB/D005027/1] Funding Source: Medline; BBSRC [BB/D005027/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abdelraheim SR, 2006, INT J BIOCHEM CELL B, V38, P1429, DOI 10.1016/j.biocel.2006.02.007; Bellini P, 2006, BIOCHEMISTRY-US, V45, P2686, DOI 10.1021/bi052081n; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Brown DR, 2000, EMBO J, V19, P1180, DOI 10.1093/emboj/19.6.1180; Brown DR, 2001, TRENDS NEUROSCI, V24, P85, DOI 10.1016/S0166-2236(00)01689-1; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 2004, J INORG BIOCHEM, V98, P133, DOI 10.1016/j.jinorgbio.2003.09.006; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; Cui T, 2003, EUR J BIOCHEM, V270, P3368, DOI 10.1046/j.1432-1033.2003.03717.x; del Pino P, 2007, EUR BIOPHYS J BIOPHY, V36, P239, DOI 10.1007/s00249-006-0124-0; Deloncle R, 2006, NEUROTOXICOLOGY, V27, P437, DOI 10.1016/j.neuro.2006.01.003; DESMET J, 1988, BIOCHIM BIOPHYS ACTA, V957, P411, DOI 10.1016/0167-4838(88)90232-4; Erikson KM, 2006, NEUROTOXICOLOGY, V27, P125, DOI 10.1016/j.neuro.2005.07.003; Gaggelli E, 2005, J AM CHEM SOC, V127, P996, DOI 10.1021/ja045958z; Garnett AP, 2003, J BIOL CHEM, V278, P6795, DOI 10.1074/jbc.M209280200; Garrick MD, 2006, BIOL RES, V39, P79, DOI 10.4067/S0716-97602006000100009; Giese A, 2004, BIOCHEM BIOPH RES CO, V320, P1240, DOI 10.1016/j.bbrc.2004.06.075; Hesketh S, 2007, J ANIM SCI, V85, P1596, DOI 10.2527/jas.2006-714; Hijazi N, 2003, BRAIN RES, V993, P192, DOI 10.1016/j.brainres.2003.09.014; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; Horton TE, 1998, BIOCHEMISTRY-US, V37, P18094, DOI 10.1021/bi981425p; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jones CE, 2005, J MOL BIOL, V346, P1393, DOI 10.1016/j.jmb.2004.12.043; Jose TJ, 1999, J BIOL INORG CHEM, V4, P814, DOI 10.1007/s007750050355; Kim NH, 2005, FASEB J, V19, P783, DOI 10.1096/fj.04-2117fje; Kramer ML, 2001, J BIOL CHEM, V276, P16711, DOI 10.1074/jbc.M006554200; Lekishvili T, 2004, EXP NEUROL, V190, P233, DOI 10.1016/j.expneurol.2004.07.002; Mauk MR, 1998, BIOCHEMISTRY-US, V37, P6767, DOI 10.1021/bi972932u; McKenzie D, 1998, J BIOL CHEM, V273, P25545, DOI 10.1074/jbc.273.40.25545; Mizuno K, 2004, J BIOL CHEM, V279, P27339, DOI 10.1074/jbc.M400813200; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Ragnarsdottir KV, 2006, J GEOCHEM EXPLOR, V88, P228, DOI 10.1016/j.gexplo.2005.08.046; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Semin BK, 2006, BBA-BIOENERGETICS, V1757, P189, DOI 10.1016/j.bbabio.2006.02.001; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Thackray AM, 2002, BIOCHEM J, V362, P253, DOI 10.1042/0264-6021:3620253; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Treiber C, 2007, J BIOL INORG CHEM, V12, P711, DOI 10.1007/s00775-007-0220-3; Treiber C, 2006, BIOCHEMISTRY-US, V45, P6674, DOI 10.1021/bi060244h; Tsenkova RN, 2004, BIOCHEM BIOPH RES CO, V325, P1005, DOI 10.1016/j.bbrc.2004.10.135; UPPINGTON KM, 2008, IN PRESS J NEUROCHEM; Walter ED, 2006, BIOCHEMISTRY-US, V45, P13083, DOI 10.1021/bi060948r; Wong BS, 2001, J NEUROCHEM, V78, P1400, DOI 10.1046/j.1471-4159.2001.00522.x; Zhu F, 2008, BIOCHEMISTRY-US, V47, P2510, DOI 10.1021/bi7022893	51	84	84	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12831	12839		10.1074/jbc.M709820200	http://dx.doi.org/10.1074/jbc.M709820200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18332141	hybrid			2022-12-25	WOS:000255499800019
J	Suzuki, R; Wada, J; Katayama, T; Fushinobu, S; Wakagi, T; Shoun, H; Sugimoto, H; Tanaka, A; Kumagai, H; Ashida, H; Kitaoka, M; Yamamoto, K				Suzuki, Ryuichiro; Wada, Jun; Katayama, Takane; Fushinobu, Shinya; Wakagi, Takayoshi; Shoun, Hirofumi; Sugimoto, Hayuki; Tanaka, Akiyoshi; Kumagai, Hidehiko; Ashida, Hisashi; Kitaoka, Motomitsu; Yamamoto, Kenji			Structural and thermodynamic analyses of solute-binding protein from Bifidobacterium longum specific for core 1 disaccharide and lacto-N-biose I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; GLYCOSIDE HYDROLASE FAMILY; T-ANTIGEN DISACCHARIDE; X-RAY-ANALYSIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; HUMAN-MILK; ACTIVE-TRANSPORT; PEANUT LECTIN; L-ARABINOSE	Recently, a gene cluster involving a phosphorylase specific for lacto-N-biose I (LNB; Gal beta 1-3GlcNAc) and galacto-N-biose (GNB; Gal beta 1-3GalNAc) has been found in Bifidobacterium longum. We showed that the solute-binding protein of a putative ATP-binding cassette-type transporter encoded in the cluster crystallizes only in the presence of LNB or GNB, and therefore we named it GNB/LNB-binding protein (GL-BP). Isothermal titration calorimetry measurements revealed that GL-BP specifically binds LNB and GNB with K-d values of 0.087 and 0.010 mu M, respectively, and the binding process is enthalpy-driven. The crystal structures of GL-BP complexed with LNB, GNB, and lacto-N-tetraose ( Gal beta 1-3GlcNAc beta 1-3Gal beta 1-4Glc) were determined. The interactions between GL-BP and the disaccharide ligands mainly occurred through water-mediated hydrogen bonds. In comparison with the LNB complex, one additional hydrogen bond was found in the GNB complex. These structural characteristics of ligand binding are in agreement with the thermodynamic properties. The overall structure of GL-BP was similar to that of maltose-binding protein; however, the mode of ligand binding and the thermodynamic properties of these proteins were significantly different.	[Suzuki, Ryuichiro; Fushinobu, Shinya; Wakagi, Takayoshi; Shoun, Hirofumi] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Wada, Jun; Ashida, Hisashi; Yamamoto, Kenji] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Wada, Jun; Katayama, Takane; Kumagai, Hidehiko] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Sugimoto, Hayuki; Tanaka, Akiyoshi] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; [Kitaoka, Motomitsu] Natl Food Res Inst, Tsukuba, Ibaraki 3058642, Japan	University of Tokyo; Kyoto University; Ishikawa Prefecture University; Mie University; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Wada, J (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Kitaoka, Motomitsu/R-1536-2019; Fushinobu, Shinya/E-4987-2011; Wakagi, Takayoshi/AAJ-4145-2021; Ashida, Hisashi/HCI-0293-2022	Kitaoka, Motomitsu/0000-0002-0083-1838; Fushinobu, Shinya/0000-0003-1346-6435; Ashida, Hisashi/0000-0001-5844-4075; Katayama, Takane/0000-0003-4009-7874; Sugimoto, Hayuki/0000-0002-0171-7631				Adhikari P, 2001, J BIOL CHEM, V276, P40734, DOI 10.1074/jbc.M103040200; [Anonymous], BIOCH PHYSL BIFIDOBA; BENNO Y, 1984, MICROBIOL IMMUNOL, V28, P975, DOI 10.1111/j.1348-0421.1984.tb00754.x; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Bruns CM, 1997, NAT STRUCT BIOL, V4, P919, DOI 10.1038/nsb1197-919; Campobasso N, 1998, BIOCHEMISTRY-US, V37, P15981, DOI 10.1021/bi981673l; Carrizo ME, 2005, J BIOL CHEM, V280, P10614, DOI 10.1074/jbc.M411989200; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; Daranas AH, 2004, J AM CHEM SOC, V126, P11870, DOI 10.1021/ja048054m; Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erney RM, 2000, J PEDIATR GASTR NUTR, V30, P181, DOI 10.1097/00005176-200002000-00016; Evdokimov AG, 2001, J MOL BIOL, V305, P891, DOI 10.1006/jmbi.2000.4202; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; FUKADA H, 1983, J BIOL CHEM, V258, P3193; GIBSON GR, 1995, GASTROENTEROLOGY, V108, P975, DOI 10.1016/0016-5085(95)90192-2; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; HAEUWFIEVRE S, 1993, EUR J BIOCHEM, V215, P361, DOI 10.1111/j.1432-1033.1993.tb18042.x; HE JJ, 1993, PROTEIN SCI, V2, P1643, DOI 10.1002/pro.5560021010; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HOSKINS LC, 1985, J CLIN INVEST, V75, P944, DOI 10.1172/JCI111795; Hu YL, 1997, NAT STRUCT BIOL, V4, P703, DOI 10.1038/nsb0997-703; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jeyaprakash AA, 2002, J MOL BIOL, V321, P637, DOI 10.1016/S0022-2836(02)00674-5; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kobata A, 1978, Methods Enzymol, V50, P216, DOI 10.1016/0076-6879(78)50023-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; LANDICK R, 1982, MEMBRANES TRANSPORT, P81; LARSON G, 1988, J BIOL CHEM, V263, P10790; Lee X, 1998, J BIOL CHEM, V273, P6312, DOI 10.1074/jbc.273.11.6312; Lopez-Lucendo MF, 2004, J MOL BIOL, V343, P957, DOI 10.1016/j.jmb.2004.08.078; MacRaild CA, 2007, J MOL BIOL, V368, P822, DOI 10.1016/j.jmb.2007.02.055; MAGNANI JL, 1983, CANCER RES, V43, P5489; Martin-Pastor M, 2000, BIOCHEMISTRY-US, V39, P4674, DOI 10.1021/bi992050q; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Natchiar SK, 2004, ACTA CRYSTALLOGR D, V60, P211, DOI 10.1107/S090744490302849X; Newburg D, 1995, HDB MILK COMPOSITION, P273; NEWMAN RA, 1979, J NATL CANCER I, V63, P1339; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parche S, 2007, J MOL MICROB BIOTECH, V12, P9, DOI 10.1159/000096455; PEREGO M, 1991, MOL MICROBIOL, V5, P173, DOI 10.1111/j.1365-2958.1991.tb01838.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; QUIOCHO FA, 1977, J BIOL CHEM, V252, P5142; Ravishankar R, 1997, CURR SCI INDIA, V72, P855; ROTIMI VO, 1981, J MED MICROBIOL, V14, P51, DOI 10.1099/00222615-14-1-51; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Schafer K, 2004, J MOL BIOL, V335, P261, DOI 10.1016/j.jmb.2003.10.042; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; SHARFF AJ, 1993, BIOCHEMISTRY-US, V32, P10553, DOI 10.1021/bi00091a004; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Springer G F, 1990, Immunol Ser, V53, P587; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Sugiyama S, 1996, PROTEIN SCI, V5, P1984, DOI 10.1002/pro.5560051004; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomson J, 1998, BIOPHYS CHEM, V70, P101, DOI 10.1016/S0301-4622(97)00113-0; Tonozuka T, 2007, FEBS J, V274, P2109, DOI 10.1111/j.1742-4658.2007.05753.x; Transue TR, 1997, NAT STRUCT BIOL, V4, P779, DOI 10.1038/nsb1097-779; VandenAkker F, 1996, PROTEIN SCI, V5, P1184; Wada J, 2007, ACTA CRYSTALLOGR F, V63, P751, DOI 10.1107/S1744309107036263; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; Wu HC, 1996, ESCHERICHIA COLI SAL, V1, P1005	76	88	90	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13165	13173		10.1074/jbc.M709777200	http://dx.doi.org/10.1074/jbc.M709777200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18332142	hybrid			2022-12-25	WOS:000255499800056
J	Liu, HY; Collins, QF; Moukdar, F; Zhuo, DG; Han, JM; Hong, T; Collins, S; Cao, WH				Liu, Hui-Yu; Collins, Qu Fan; Moukdar, Fatiha; Zhuo, Degen; Han, Jianmin; Hong, Tao; Collins, Sheila; Cao, Wenhong			Suppression of hepatic glucose production by human neutrophil alpha-defensins through a signaling pathway distinct from insulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR FOXO1; METABOLIC CONTROL; SKELETAL-MUSCLE; MAP KINASE; C-SRC; GLUCONEOGENESIS; RESISTANCE; EXPRESSION; HEPATOCYTES	In this study, we tested the hypothesis that human neutrophil alpha-defensins (HNPs) inhibit hepatic glucose production through a signaling pathway distinct from insulin. The effect of HNP-1 on fasting blood glucose levels and the expression of hepatic gluconeogenic genes was first examined. Using hyperinsuline-miceuglycemic clamps, we determined the effect of HNP-1 on endogenous glucose production, hepatic expression of key gluconeogenic genes and glucose uptake in skeletal muscle in Zucker diabetic fatty rats. In isolated primary hepatocytes, we studied the effect of HNP-1 and -2 on glucose production, expression of gluconeogenic genes, and phosphorylation of Akt, c-Src, and FoxO1. Our results show that HNP-1 reduced blood glucose levels of both normal mice and Zucker diabetic fatty rats predominantly through suppression of hepatic glucose production. HNPs inhibited glycogenolysis and gluconeogenesis in isolated hepatocytes. HNPs also suppressed expression of key gluconeogenic genes including phosphoenoylpyruvate carboxyl kinase and glucose-6-phosphatase. To investigate the mechanism, we found that HNPs stimulated phosphorylation of Akt and FoxO1 without activating IRS1. Nevertheless, HNPs activated c-Src. Blockade of c-Src activity with either a chemical inhibitor PP2 or an alternative inhibitor CSK prevented the inhibitory effect of HNPs on gluconeogenesis. Together, our results support the hypothesis that HNPs can suppress hepatic glucose production through an intracellular mechanism distinct from the classical insulin signaling pathway.	[Liu, Hui-Yu; Collins, Qu Fan; Moukdar, Fatiha; Zhuo, Degen; Han, Jianmin; Hong, Tao; Collins, Sheila; Cao, Wenhong] Hamner Inst Hlth Sci, Div Translat Biol, Res Triangle Pk, NC 27709 USA; [Collins, Sheila] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Collins, Sheila; Cao, Wenhong] Duke Univ, Med Ctr, Dept Med Endocrinol, Durham, NC 27710 USA	The Hamner Institutes for Health Sciences; Duke University; Duke University	Cao, WH (corresponding author), Hamner Inst Hlth Sci, Div Translat Biol, 6 Davis Dr, Res Triangle Pk, NC 27709 USA.	wcao@thehamner.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK076039-01A2, R01 DK076039, R01DK076039] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aarbiou J, 2002, J LEUKOCYTE BIOL, V72, P167; Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; ARDAWI MSM, 1989, J LAB CLIN MED, V114, P579; Berasi SP, 2006, J BIOL CHEM, V281, P27167, DOI 10.1074/jbc.M602416200; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Chakravarty K, 2007, NUTR REV, V65, pS47, DOI [10.1111/j.1753-4887.2007.tb00328.x, 10.1301/nr.2007.jun.S47-S56]; Chavakis T, 2004, FASEB J, V18, P1306, DOI 10.1096/fj.03-1009fje; Cherrington AD, 2002, DIABETES, V51, pS103, DOI 10.2337/diabetes.51.2007.S103; Chong YP, 2005, GROWTH FACTORS, V23, P233, DOI 10.1080/08977190500178877; Choudhury GG, 2006, CELL SIGNAL, V18, P1854, DOI 10.1016/j.cellsig.2006.02.003; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; DEVASCONCELOS PRL, 1987, CLIN SCI, V72, P683, DOI 10.1042/cs0720683; Diaz B, 2001, LIFE SCI, V68, P2925, DOI 10.1016/S0024-3205(01)01087-6; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Froy O, 2007, MOL IMMUNOL, V44, P796, DOI 10.1016/j.molimm.2006.04.009; Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0; Giovambattista A, 2000, NEUROIMMUNOMODULAT, V7, P92, DOI 10.1159/000026426; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hiratsuka T, 2001, NEPHRON, V88, P65, DOI 10.1159/000045961; Jin CJ, 2007, J NUTR, V137, P339, DOI 10.1093/jn/137.2.339; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kaneto H, 2007, CURR MOL MED, V7, P674, DOI 10.2174/156652407782564408; KENISON DC, 1991, AM J VET RES, V52, P1320; Kim JK, 2003, DIABETES, V52, P1311, DOI 10.2337/diabetes.52.6.1311; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Liu YJ, 2005, DIABETES, V54, P32, DOI 10.2337/diabetes.54.1.32; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; PANYUTICH AV, 1993, J LAB CLIN MED, V122, P202; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; ROMIJN JA, 1990, J ENDOCRINOL INVEST, V13, P743, DOI 10.1007/BF03349613; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SHIOMI K, 1993, BIOCHEM BIOPH RES CO, V195, P1336, DOI 10.1006/bbrc.1993.2190; Syeda F, 2008, J CELL PHYSIOL, V214, P820, DOI 10.1002/jcp.21279; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Warmuth M, 2003, CURR PHARM DESIGN, V9, P2043, DOI 10.2174/1381612033454126; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65	48	23	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12056	12063		10.1074/jbc.M801033200	http://dx.doi.org/10.1074/jbc.M801033200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18347011	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000255340000021
J	Narayana, Y; Balaji, KN				Narayana, Yeddula; Balaji, Kithiganahalli Narayanaswamy			NOTCH1 up-regulation and signaling involved in Mycobacterium bovis BCG-induced SOCS3 expression in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; KAPPA-B ACTIVITY; IFN-GAMMA; NONPATHOGENIC MYCOBACTERIA; MAMMALIAN TARGET; TNF-ALPHA; T-CELLS; TUBERCULOSIS; PATHWAY; SUPPRESSOR	Suppressor of cytokine signaling ( SOCS) 3 is a critical negative regulator of cytokine signaling and is induced by Mycobacterium bovis Bacille Calmette-Guerin ( M. bovis BCG) in mouse macrophages. However, little is known about the early receptor proximal signaling mechanisms underlying mycobacteria-mediated induction of SOCS3. We demonstrate here for the first time that M. bovis BCG up-regulates NOTCH1 and activates the NOTCH1 signaling pathway, leading to the expression of SOCS3. We show that perturbing Notch signaling in infected macrophages results in the marked reduction in the expression of SOCS3. Furthermore, enforced expression of the Notch1 intracellular domain in RAW 264.7 macrophages induces the expression of SOCS3, which can be further potentiated by M. bovis BCG. The perturbation of Toll-like receptor (TLR) 2 signaling resulted in marked reduction in SOCS3 levels and expression of the NOTCH1 target gene, Hes1. The down-regulation of MyD88 resulted in a significant decrease in SOCS3 expression, implicating the role of the TLR2-MyD88 axis in M. bovis BCG-triggered signaling. However, the SOCS3 inducing ability of M. bovis BCG remains unaltered also upon infection of macrophages from TLR4-defective C3H/HeJ mice. More importantly, signaling perturbation data suggest the involvement of crosstalk among members of the phosphoinositide 3-kinase and mitogen-activated protein kinase cascades with NOTCH1 signaling in SOCS3 expression. Furthermore, SOCS3 expression requires the NOTCH1-mediated recruitment of Suppressor of Hairless (CSL) and nuclear factor-kappa B to the Socs3 promoter. Overall, these results implicate NOTCH1 signaling during inducible expression of SOCS3 following infection of macrophages with an intracellular bacillus-like M. bovis BCG.	[Narayana, Yeddula; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Balaji, KN (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in	Yeddula, Narayana/H-4893-2011					Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Balcewicz-Sablinska MK, 1998, J IMMUNOL, V161, P2636; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Barolo S, 2000, CELL, V103, P957, DOI 10.1016/S0092-8674(00)00198-7; Beltan E, 2000, MICROB PATHOGENESIS, V28, P313, DOI 10.1006/mpat.1999.0345; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1936, DOI 10.1073/pnas.0510710103; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cassatella MA, 1999, BLOOD, V94, P2880, DOI 10.1182/blood.V94.8.2880.420k31_2880_2889; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; EHEBAUER M, 2006, SCI STKE, pCM7, DOI DOI 10.1126/STKE.3642006CM7; FALCONE V, 1994, FEMS IMMUNOL MED MIC, V8, P225, DOI 10.1016/0928-8244(94)90054-X; Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Imai K, 2003, FEMS IMMUNOL MED MIC, V39, P173, DOI 10.1016/S0928-8244(03)00231-1; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Jonsson JI, 2001, EUR J IMMUNOL, V31, P3240, DOI 10.1002/1521-4141(200111)31:11<3240::AID-IMMU3240>3.0.CO;2-E; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; Kaufmann SHE, 2005, NEW ENGL J MED, V353, P2423, DOI 10.1056/NEJMp058131; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Lasunskaia EB, 2006, J LEUKOCYTE BIOL, V80, P1480, DOI 10.1189/jlb.0106066; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Matsuno K, 1998, NAT GENET, V19, P74, DOI 10.1038/ng0598-74; Mckenzie G, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-10; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Nagabhushanam V, 2003, J IMMUNOL, V171, P4750, DOI 10.4049/jimmunol.171.9.4750; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Oswald F, 1998, MOL CELL BIOL, V18, P2077, DOI 10.1128/MCB.18.4.2077; Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; Reiling N, 2001, J IMMUNOL, V167, P3339, DOI 10.4049/jimmunol.167.6.3339; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Sands WA, 2006, MOL CELL BIOL, V26, P6333, DOI 10.1128/MCB.00207-06; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Shin HM, 2006, EMBO J, V25, P129, DOI 10.1038/sj.emboj.7600902; Sommer U, 2005, J BIOL CHEM, V280, P31478, DOI 10.1074/jbc.M506008200; Stoiber D, 1999, J IMMUNOL, V163, P2640; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206; WHO, 2007, WHOHTMTB2007376; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Yang CS, 2006, CELL MICROBIOL, V8, P1158, DOI 10.1111/j.1462-5822.2006.00699.x; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshimura A, 2003, CURR OPIN IMMUNOL, V15, P704, DOI 10.1016/j.coi.2003.09.004; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zlobin A., 2000, Current Pharmaceutical Biotechnology, V1, P83, DOI 10.2174/1389201003379013	59	77	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12501	12511		10.1074/jbc.M709960200	http://dx.doi.org/10.1074/jbc.M709960200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18332140	hybrid			2022-12-25	WOS:000255340000066
J	Frankild, S; de Boer, RJ; Lund, O; Nielsen, M; Kesmir, C				Frankild, Sune; de Boer, Rob J.; Lund, Ole; Nielsen, Morten; Kesmir, Can			Amino Acid Similarity Accounts for T Cell Cross-Reactivity and for "Holes" in the T Cell Repertoire	PLOS ONE			English	Article								Background: Cytotoxic T cell (CTL) cross-reactivity is believed to play a pivotal role in generating immune responses but the extent and mechanisms of CTL cross-reactivity remain largely unknown. Several studies suggest that CTL clones can recognize highly diverse peptides, some sharing no obvious sequence identity. The emerging realization in the field is that T cell receptors (TcR) recognize multiple distinct ligands. Principal Findings: First, we analyzed peptide scans of the HIV epitope SLFNTVATL (SFL9) and found that TCR specificity is position dependent and that biochemically similar amino acid substitutions do not drastically affect recognition. Inspired by this, we developed a general model of TCR peptide recognition using amino acid similarity matrices and found that such a model was able to predict the cross-reactivity of a diverse set of CTL epitopes. With this model, we were able to demonstrate that seemingly distinct T cell epitopes, i.e., ones with low sequence identity, are in fact more biochemically similar than expected. Additionally, an analysis of HIV immunogenicity data with our model showed that CTLs have the tendency to respond mostly to peptides that do not resemble self-antigens. Conclusions: T cell cross-reactivity can thus, to an extent greater than earlier appreciated, be explained by amino acid similarity. The results presented in this paper will help resolving some of the long-lasting discussions in the field of T cell cross-reactivity.	[Frankild, Sune; Lund, Ole; Nielsen, Morten] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [de Boer, Rob J.; Kesmir, Can] Univ Utrecht, Theoret Biol Bioinformat, Utrecht, Netherlands; [Kesmir, Can] Univ Utrecht, Academ Biomed Ctr, Utrecht, Netherlands	Technical University of Denmark; Utrecht University; Utrecht University	Frankild, S (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	mniel@cbs.dtu.dk	Kesmir, Can/B-9410-2011; Nielsen, Morten/E-7754-2011; de Boer, Rob/B-6050-2011; Nielsen, Morten/AAL-8700-2020; Lund, Ole/F-4437-2014	Nielsen, Morten/0000-0001-7885-4311; de Boer, Rob/0000-0002-2130-691X; Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Pletscher-Frankild, Sune/0000-0002-7745-193X	NIAID [HHSN266200400083C]	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID Contract no. HHSN266200400083C. The principal funding recipient was Prof. Ole Lund (Technical University of Denmark).	Arden B, 1998, CURR OPIN IMMUNOL, V10, P74, DOI 10.1016/S0952-7915(98)80035-6; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806; CASANOVA JL, 1993, IMMUNOL TODAY, V14, P391, DOI 10.1016/0167-5699(93)90140-G; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Hemmer B, 1998, J IMMUNOL, V160, P3631; Hohn H, 2003, EUR J IMMUNOL, V33, P1613, DOI 10.1002/eji.200323480; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Kim SK, 2005, J EXP MED, V201, P523, DOI 10.1084/jem.20041337; KULKARNI AB, 1993, J VIROL, V67, P4086, DOI 10.1128/JVI.67.7.4086-4092.1993; La Rosa C, 2001, BLOOD, V97, P1776; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Lauemoller S L, 2000, Rev Immunogenet, V2, P477; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Nilges K, 2003, J VIROL, V77, P5464, DOI 10.1128/JVI.77.9.5464-5474.2003; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rolland M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000823; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; SHANNON CE, 1948, BELL SYSTEM TECH J, V27; Spaulding AC, 1999, J VIROL, V73, P398, DOI 10.1128/JVI.73.1.398-403.1999; Tangri S, 2001, J EXP MED, V194, P833, DOI 10.1084/jem.194.6.833; Van Epps HL, 1999, J VIROL, V73, P5301, DOI 10.1128/JVI.73.7.5301-5308.1999; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; Welsh RM, 2004, ANNU REV IMMUNOL, V22, P711, DOI 10.1146/annurev.immunol.22.012703.104527; Wong CP, 2006, J IMMUNOL, V176, P1637, DOI 10.4049/jimmunol.176.3.1637; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zivny J, 1999, J IMMUNOL, V163, P2754	38	80	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1831	10.1371/journal.pone.0001831	http://dx.doi.org/10.1371/journal.pone.0001831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350167	Green Submitted, gold, Green Published			2022-12-25	WOS:000260762300033
J	Rosado, A; Zanella, F; Garcia, B; Carnero, A; Link, WG				Rosado, Aranzazu; Zanella, Fabian; Garcia, Beatriz; Carnero, Amancio; Link, Wolfgang			A Dual-Color Fluorescence-Based Platform to Identify Selective Inhibitors of Akt Signaling	PLOS ONE			English	Article								Background: Inhibition of Akt signaling is considered one of the most promising therapeutic strategies for many cancers. However, rational target-orientated approaches to cell based drug screens for anti-cancer agents have historically been compromised by the notorious absence of suitable control cells. Methodology/Principal Findings: In order to address this fundamental problem, we have developed BaFiso, a live-cell screening platform to identify specific inhibitors of this pathway. BaFiso relies on the co-culture of isogenic cell lines that have been engineered to sustain interleukin-3 independent survival of the parental Ba/F3 cells, and that are individually tagged with different fluorescent proteins. Whilst in the first of these two lines cell survival in the absence of IL-3 is dependent on the expression of activated Akt, the cells expressing constitutively-activated Stat5 signaling display IL-3 independent growth and survival in an Akt-independent manner. Small molecules can then be screened in these lines to identify inhibitors that rescue IL-3 dependence. Conclusions/Significance: BaFiso measures differential cell survival using multiparametric live cell imaging and permits selective inhibitors of Akt signaling to be identified. BaFiso is a platform technology suitable for the identification of small molecule inhibitors of IL-3 mediated survival signaling.	[Rosado, Aranzazu; Zanella, Fabian; Garcia, Beatriz; Carnero, Amancio; Link, Wolfgang] Ctr Nacl Investigaciones Oncol CNIO, Expt Therapeut Program, Madrid, Spain		Rosado, A (corresponding author), Ctr Nacl Investigaciones Oncol CNIO, Expt Therapeut Program, Madrid, Spain.	wlink@cnio.es	IBIS, CANCER/P-3323-2015; Link, Wolfgang/F-4435-2012	Link, Wolfgang/0000-0002-3340-5165; Carnero, Amancio/0000-0003-4357-3979; Rosado Diez, Aranzazu/0000-0002-3362-2450	Spanish MCyT [BIO2002-00197]; Spanish MEC [BIO2006-02432]; Marie Curie Fellowship	Spanish MCyT(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Spanish MEC(Spanish Government); Marie Curie Fellowship(European Commission)	This work was supported by a grant from the Spanish MCyT (BIO2002-00197) and the Spanish MEC (project BIO2006-02432). F.Z. is the recipient of a Marie Curie Fellowship.	Balis FM, 2002, J NATL CANCER I, V94, P78, DOI 10.1093/jnci/94.2.78; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Carnero A, 2000, NUCLEIC ACIDS RES, V28, P2234, DOI 10.1093/nar/28.11.2234; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; delPeso L, 1997, SCIENCE, V278, P687; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Gibbs JB, 2000, SCIENCE, V287, P1969, DOI 10.1126/science.287.5460.1969; Hoover RR, 2001, ONCOGENE, V20, P5826, DOI 10.1038/sj.onc.1204549; Komander D, 2003, BIOCHEM J, V375, P255, DOI 10.1042/BJ20031119; Leverrier Y, 1999, CELL DEATH DIFFER, V6, P290, DOI 10.1038/sj.cdd.4400492; Link W, 2005, J CELL BIOCHEM, V95, P979, DOI 10.1002/jcb.20479; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; Zanella F, 2007, ASSAY DRUG DEV TECHN, V5, P333, DOI 10.1089/adt.2007.058; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	23	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1823	10.1371/journal.pone.0001823	http://dx.doi.org/10.1371/journal.pone.0001823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350159	Green Published, gold			2022-12-25	WOS:000260762300025
J	Fonteneau, E; van der Lely, HKJ				Fonteneau, Elisabeth; van der Lely, Heather K. J.			Electrical Brain Responses in Language-Impaired Children Reveal Grammar-Specific Deficits	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ELECTROPHYSIOLOGICAL EVIDENCE; SYNTACTIC ANALYSIS; VIOLATIONS; COMPLEXITY; FACULTY; REPAIR	Background: Scientific and public fascination with human language have included intensive scrutiny of language disorders as a new window onto the biological foundations of language and its evolutionary origins. Specific language impairment (SLI), which affects over 7% of children, is one such disorder. SLI has received robust scientific attention, in part because of its recent linkage to a specific gene and loci on chromosomes and in part because of the prevailing question regarding the scope of its language impairment: Does the disorder impact the general ability to segment and process language or a specific ability to compute grammar? Here we provide novel electrophysiological data showing a domain-specific deficit within the grammar of language that has been hitherto undetectable through behavioural data alone. Methods and Findings: We presented participants with Grammatical(G)-SLI, age-matched controls, and younger child and adult controls, with questions containing syntactic violations and sentences containing semantic violations. Electrophysiological brain responses revealed a selective impairment to only neural circuitry that is specific to grammatical processing in G-SLI. Furthermore, the participants with G-SLI appeared to be partially compensating for their syntactic deficit by using neural circuitry associated with semantic processing and all non-grammar-specific and low-level auditory neural responses were normal. Conclusions: The findings indicate that grammatical neural circuitry underlying language is a developmentally unique system in the functional architecture of the brain, and this complex higher cognitive system can be selectively impaired. The findings advance fundamental understanding about how cognitive systems develop and all human language is represented and processed in the brain.	[Fonteneau, Elisabeth; van der Lely, Heather K. J.] UCL, UCL Ctr Dev Language Disorders & Cognit Neurosci, London, England	University of London; University College London	Fonteneau, E (corresponding author), UCL, UCL Ctr Dev Language Disorders & Cognit Neurosci, London, England.	h.vanderlely@ucl.ac.uk			Wellcome Trust University Award [063713]	Wellcome Trust University Award(Wellcome Trust)	This research and both authors were supported by a Wellcome Trust University Award (Grant No: 063713) to Heather van der Lely.	Ainsworth-Darnell K, 1998, J MEM LANG, V38, P112, DOI 10.1006/jmla.1997.2537; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; Dunn L. M., 1997, BRIT PICTURE VOCABUL; Friederici AD, 2002, J PSYCHOLINGUIST RES, V31, P45, DOI 10.1023/A:1014376204525; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Hagoort P, 2003, P NATL ACAD SCI USA, V100, P4340, DOI 10.1073/pnas.0230613100; Hagoort P., 1999, NEUROCOGNITION LANGU, P273, DOI DOI 10.1093/ACPROF:OSO/9780198507932.001.0001; Hahne A, 2004, J COGNITIVE NEUROSCI, V16, P1302, DOI 10.1162/0898929041920504; Hahne A, 2002, COGNITIVE BRAIN RES, V13, P339, DOI 10.1016/S0926-6410(01)00127-6; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Joanisse MF, 1998, TRENDS COGN SCI, V2, P240, DOI 10.1016/S1364-6613(98)01186-3; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Leonard L.B., 1998, CHILDREN SPECIFIC LA; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Montgomery JW, 2002, APPL PSYCHOLINGUIST, V23, P447, DOI 10.1017/S0142716402003077; Munte TF, 1998, NEUROPSYCHOLOGIA, V36, P217, DOI 10.1016/S0028-3932(97)00119-X; Oberecker R, 2005, J COGNITIVE NEUROSCI, V17, P1667, DOI 10.1162/089892905774597236; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004; Raven J. C., 1986, MANUAL RAVENS PROGRE; Thomas M, 2002, BEHAV BRAIN SCI, V25, P727, DOI 10.1017/S0140525X02000134; THOMAS M, 2002, BEHAV BRAIN SCI, V25, P750; van der Lely HKJ, 1998, CURR BIOL, V8, P1253, DOI 10.1016/S0960-9822(07)00534-9; van der Lely HKJ, 2004, COGNITION, V94, P167, DOI 10.1016/j.cognition.2004.01.003; van der Lely HKJ, 2005, TRENDS COGN SCI, V9, P53, DOI 10.1016/j.tics.2004.12.002; VanderLely HKJ, 1996, BRAIN LANG, V52, P484, DOI 10.1006/brln.1996.0026	27	52	52	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1832	10.1371/journal.pone.0001832	http://dx.doi.org/10.1371/journal.pone.0001832			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	369VW	18347740	Green Published, gold, Green Submitted			2022-12-25	WOS:000260723000048
J	Hennige, AM; Staiger, H; Wicke, C; Machicao, F; Fritsche, A; Haring, HU; Stefan, N				Hennige, Anita M.; Staiger, Harald; Wicke, Corinna; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Stefan, Norbert			Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ALPHA(2)-HEREMANS-SCHMID GLYCOPROTEIN/FETUIN-A; CORONARY-HEART-DISEASE; BETA-CELL FUNCTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; ADIPOSE-TISSUE; HUMAN PREADIPOCYTES; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION	Background: The secreted liver protein fetuin-A (AHSG) is up-regulated in hepatic steatosis and the metabolic syndrome. These states are strongly associated with low-grade inflammation and hypoadiponectinemia. We, therefore, hypothesized that fetuin-A may play a role in the regulation of cytokine expression, the modulation of adipose tissue expression and plasma concentration of the insulin-sensitizing and atheroprotective adipokine adiponectin. Methodology and Principal Findings: Human monocytic THP1 cells and human in vitro differenttiated adipocytes as well as C57BL/6 mice were treated with fetuin-A. mRNA expression of the genes encoding inflammatory cytokines and the adipokine adiponectin (ADIPOQ) was assessed by real-time RT-PCR. In 122 subjects, plasma levels of fetuin-A, adiponectin and, in a subgroup, the multimeric forms of adiponectin were determined. Fetuin-A treatment induced TNF and IL1B mRNA expression in THP1 cells (p<0.05). Treatment of mice with fetuin-A, analogously, resulted in a marked increase in adipose tissue Tnf mRNA as well as Il6 expression (27- and 174-fold, respectively). These effects were accompanied by a decrease in adipose tissue Adipoq mRNA expression and lower circulating adiponectin levels (p< 0.05, both). Furthermore, fetuin-A repressed ADIPOQ mRNA expression of human in vitro differentiated adipocytes (p<0.02) and induced inflammatory cytokine expression. In humans in plasma, fetuin-A correlated positively with high-sensitivity C-reactive protein, a marker of subclinical inflammation (r = 0.26, p = 0.01), and negatively with total- (r = -0.28, p = 0.02) and, particularly, high molecular weight adiponectin (r = -0.36, p = 0.01). Conclusions and Significance: We provide novel evidence that the secreted liver protein fetuin-A induces low-grade inflammation and represses adiponectin production in animals and in humans. These data suggest an important role of fatty liver in the pathophysiology of insulin resistance and atherosclerosis.	[Hennige, Anita M.; Staiger, Harald; Machicao, Fausto; Fritsche, Andreas; Haering, Hans-Ulrich; Stefan, Norbert] Univ Tubingen, Dept Internal Med, Div Endocrinol Nephrol Vasc Dis & Clin Chem, D-7400 Tubingen, Germany; [Wicke, Corinna] Univ Tubingen, Dept Gen, Visceral & Transplant Surg, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hennige, AM (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Nephrol Vasc Dis & Clin Chem, D-7400 Tubingen, Germany.	norbert.stefan@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014	Staiger, Harald/0000-0002-9507-5333; Stefan, Norbert/0000-0002-2186-9595	Deutsche Forschungsgemeinschaft [KFO 114, HE 3653/3-1]; FP6 EUGENE2 [LSHM-CT-2004-512013]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FP6 EUGENE2	The study was partially supported grants from the Deutsche Forschungsgemeinschaft(KFO 114 and HE 3653/3-1) and the European Community's frame program FP6 EUGENE2 (LSHM-CT-2004-512013). The funders had a limited influence on the design of the study but no influence on the conduct of the study, on the collection, analysis, and interpretation of the data, and on the preparation, review, or approval of the manuscript.	AUBERGER P, 1989, CELL, V58, P631, DOI 10.1016/0092-8674(89)90098-6; BACHA F, DIABETES CARE, V27, P547; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Chan Dick C, 2004, Am J Cardiovasc Drugs, V4, P227, DOI 10.2165/00129784-200404040-00004; Dahlman I, 2004, DIABETOLOGIA, V47, P1974, DOI 10.1007/s00125-004-1556-7; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; DZIEGIELEWSKA KM, 1990, J BIOL CHEM, V265, P4354; Fasshauer M, 2003, BIOCHEM BIOPH RES CO, V301, P1045, DOI 10.1016/S0006-291X(03)00090-1; Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307; Fisher FM, 2005, DIABETOLOGIA, V48, P1084, DOI 10.1007/s00125-005-1758-7; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Iglseder B, 2005, STROKE, V36, P2577, DOI 10.1161/01.STR.0000190834.00284.fd; Ix JH, 2006, CIRCULATION, V113, P1760, DOI 10.1161/CIRCULATIONAHA.105.588723; Jahnen-Dechent W, 2001, Z Kardiol, V90 Suppl 3, P47; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kappes A, 2000, HORM METAB RES, V32, P548, DOI 10.1055/s-2007-978684; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Lam Karen S L, 2005, Curr Diab Rep, V5, P254, DOI 10.1007/s11892-005-0019-y; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lihn AS, 2003, AM J PHYSIOL-ENDOC M, V285, pE1072, DOI 10.1152/ajpendo.00206.2003; Lin X, 1998, LIFE SCI, V63, P145, DOI 10.1016/S0024-3205(98)00250-1; LYLES JM, 1993, J NEUROSCI RES, V34, P273, DOI 10.1002/jnr.490340304; Mathews ST, 1997, LIFE SCI, V61, P1583, DOI 10.1016/S0024-3205(97)00737-6; Mathews ST, 2000, MOL CELL ENDOCRINOL, V164, P87, DOI 10.1016/S0303-7207(00)00237-9; Mathews ST, 2002, DIABETES, V51, P2450, DOI 10.2337/diabetes.51.8.2450; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mori K, 2006, DIABETES CARE, V29, P468, DOI 10.2337/diacare.29.02.06.dc05-1484; Mori K, 2007, CLIN ENDOCRINOL, V66, P246, DOI 10.1111/j.1365-2265.2006.02716.x; Pedersen KO, 1944, NATURE, V154, P575, DOI 10.1038/154575a0; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Pollin TI, 2005, DIABETES, V54, P268, DOI 10.2337/diabetes.54.1.268; RAUTH G, 1992, EUR J BIOCHEM, V204, P523, DOI 10.1111/j.1432-1033.1992.tb16663.x; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Rothenbacher D, 2005, EUR HEART J, V26, P1640, DOI 10.1093/eurheartj/ehi340; Ruminy P, 2001, INFLAMM RES, V50, P383, DOI 10.1007/PL00000260; Santoliquido A, 2005, Eur Rev Med Pharmacol Sci, V9, P269; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schling P, 1999, INT J OBESITY, V23, P336, DOI 10.1038/sj.ijo.0800821; SCHMIDT W, 1990, J BIOL CHEM, V265, P15489; Schulze MB, 2005, DIABETES, V54, P534, DOI 10.2337/diabetes.54.2.534; Siddiq A, 2005, DIABETES, V54, P2477, DOI 10.2337/diabetes.54.8.2477; Sopasakis VR, 2004, OBES RES, V12, P454, DOI 10.1038/oby.2004.51; SRINIVAS PR, 1993, MOL ENDOCRINOL, V7, P1445, DOI 10.1210/me.7.11.1445; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Tschritter O, 2003, DIABETES, V52, P239, DOI 10.2337/diabetes.52.2.239; VIONNET N, AM J HUM GENET, V67, P1470; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	54	219	225	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1765	10.1371/journal.pone.0001765	http://dx.doi.org/10.1371/journal.pone.0001765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335040	gold, Green Published, Green Submitted			2022-12-25	WOS:000260723000019
J	MacDonald, BT; Yokota, C; Tamai, K; Zeng, X; He, X				MacDonald, Bryan T.; Yokota, Chika; Tamai, Keiko; Zeng, Xin; He, Xi			Wnt signal amplification via activity, cooperativity, and regulation of multiple intracellular PPPSP motifs in the wnt co-receptor LRP6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-5; MUTATION; PHOSPHORYLATION; INITIATION; MECHANISM; DENSITY; DISEASE; AXIN	Low density lipoprotein receptor-related protein 6 (LRP6) and its homologue LRP5 serve as Wnt co-receptors that are essential for the Wnt/beta-catenin pathway. Wnt activation of LRP6 leads to recruitment of the scaffolding protein Axin and inhibition of Axin-mediated phosphorylation/destruction of beta-catenin. We showed that five conserved PPPSP motifs in the LRP6 intracellular domain are required for LRP6 function, and mutation of these motifs together abolishes LRP6 signaling activity. We further showed that Wnt induces the phosphorylation of a prototypic PPPSP motif, which provides a docking site for Axin and is sufficient to transfer signaling activity to a heterologous receptor. However, the activity, regulation, and functionality of multiple PPPSP motifs in LRP6 have not been characterized. Here we provide a comprehensive analysis of all five PPPSP motifs in LRP6. We define the core amino acid residues of a prototypic PPPSP motif via alanine scanning mutagenesis and demonstrate that each of the five PPPSP motifs exhibits signaling and Axin binding activity in isolation. We generated two novel phosphorylation-specific antibodies to additional PPPSP motifs and show that Wnt induces phosphorylation of these motifs in the endogenous LRP6 through glycogen synthase kinase 3. Finally, we uncover the critical cooperativity of PPPSP motifs in the full-length LRP6 by demonstrating that LRP6 mutants lacking a single PPPSP motif display compromised function, whereas LRP6 mutants lacking two of the five PPPSP motifs are mostly inactive. This cooperativity appears to reflect the ability of PPPSP motifs to promote the phosphorylation of one another and to interact with Axin synergistically. These results establish the critical role and a common phosphorylation/activation mechanism for the PPPSP motifs in LRP6 and suggest that the conserved multiplicity and cooperativity of the PPPSP motifs represents a built-in amplifier for Wnt signaling by the LRP6 family of receptors.	[MacDonald, Bryan T.; Yokota, Chika; Tamai, Keiko; Zeng, Xin; He, Xi] Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp Boston, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	He, X (corresponding author), Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp Boston, 320 Longwood Ave,Enders 461, Boston, MA 02115 USA.	xi.he@childrens.harvard.edu			NIGMS NIH HHS [R01 GM74241, F32 GM073357] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM073357, R01GM074241] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baig-Lewis S, 2007, DEV BIOL, V306, P94, DOI 10.1016/j.ydbio.2007.03.005; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Kato Y, 1999, J NEUROSCI, V19, P9364; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; MCGREW LL, 1995, DEV BIOL, V172, P337, DOI 10.1006/dbio.1995.0027; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Wolf J, 2008, FEBS LETT, V582, P255, DOI 10.1016/j.febslet.2007.12.013; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	22	72	80	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2008	283	23					16115	16123		10.1074/jbc.M800327200	http://dx.doi.org/10.1074/jbc.M800327200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	307QD	18362152	Green Published, hybrid			2022-12-25	WOS:000256332500070
J	Bazirgan, OA; Hampton, RY				Bazirgan, Omar A.; Hampton, Randolph Y.			Cue1p is an activator of Ubc7p E2 activity in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; ENDOPLASMIC-RETICULUM DEGRADATION; ER-ASSOCIATED DEGRADATION; HMG-COA REDUCTASE; MEMBRANE-PROTEIN; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; LIGASE COMPLEX; REGULATED DEGRADATION; POLYUBIQUITIN CHAINS; OVERLAP EXTENSION	Ubc7p is a ubiquitin-conjugating enzyme (E2) that functions with endoplasmic reticulum (ER)-resident ubiquitin ligases (E3s) to promote endoplasmic reticulum-associated degradation (ERAD). Ubc7p only functions in ERAD if bound to the ER surface by Cue1p, a membrane-anchored ER protein. The role of Cue1p was thought to involve passive concentration of Ubc7p at the surface of the ER. However, our biochemical studies of Ubc7p suggested that Cue1p may, in addition, stimulate Ubc7p E2 activity. We have tested this idea and found it to be true both in vitro and in vivo. Ubc7p bound to the soluble domain of Cue1p showed strongly enhanced in vitro ubiquitination activity, both in the presence and absence of E3. Cue1p also enhanced Ubc7p function in vivo, and this activation was separable from the established ER-anchoring role of Cue1p. Finally, we tested in vivo activation of Ubc7p by Cue1p in an assay independent of the ER membrane and ERAD. A chimeric E2 linking Ubc7p to the Cdc34p/Ubc3p localization domain complemented the cdc34-2 TS phenotype, and co-expression of the soluble Cue1p domain enhanced complementation by this chimeric Ubc7p E2. These studies reveal a previously unobserved stimulation of Ubc7p E2 activity by Cue1p that is critical for full ERAD and that functions independently of the well known Cue1p anchoring function. Moreover, it suggests a previously unappreciated mode for regulation of E2s by Cue1p-like interacting partners.	[Bazirgan, Omar A.; Hampton, Randolph Y.] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@biomail.ucsd.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051996] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07240, GM51996-06] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen PL, 2005, J CELL BIOL, V170, P745, DOI 10.1083/jcb.200502113; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bazirgan OA, 2006, J BIOL CHEM, V281, P38989, DOI 10.1074/jbc.M608174200; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Cronin SR, 1999, METHOD ENZYMOL, V302, P58, DOI 10.1016/S0076-6879(99)02010-8; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; GOSINK MM, 1995, P NATL ACAD SCI USA, V92, P9117, DOI 10.1073/pnas.92.20.9117; Hampton RY, 1997, P NATL ACAD SCI USA, V94, P12944, DOI 10.1073/pnas.94.24.12944; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; JONES RB, 2002, INT J COMP PSYCHOL, V15, P1; Koller A, 1999, J CELL BIOL, V146, P99, DOI 10.1083/jcb.146.1.99; KOLMAN CJ, 1992, EMBO J, V11, P3081, DOI 10.1002/j.1460-2075.1992.tb05380.x; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Mori S, 1997, EUR J BIOCHEM, V247, P1190, DOI 10.1111/j.1432-1033.1997.01190.x; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2006, MOL CELL, V24, P523, DOI 10.1016/j.molcel.2006.10.010; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Ptak C, 2001, MOL CELL BIOL, V21, P6537, DOI 10.1128/MCB.21.19.6537-6548.2001; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Sommer T, 1997, FASEB J, V11, P1227, DOI 10.1096/fasebj.11.14.9409541; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; VanDemark AP, 2002, CURR OPIN STRUC BIOL, V12, P822, DOI 10.1016/S0959-440X(02)00389-5; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697	56	50	50	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12797	12810		10.1074/jbc.M801122200	http://dx.doi.org/10.1074/jbc.M801122200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18321851	Green Published, hybrid			2022-12-25	WOS:000255499800016
J	Moore, KJ; Angevine, CM; Vincent, OD; Schwem, BE; Fillingame, RH				Moore, Kyle J.; Angevine, Christine M.; Vincent, Owen D.; Schwem, Brian E.; Fillingame, Robert H.			The cytoplasmic loops of subunit a of Escherichia coli ATP synthase may participate in the proton translocating mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTIONS; AQUEOUS ACCESS PATHWAYS; CROSS-LINKING; POTASSIUM CHANNEL; ROTARY MOTOR; C-SUBUNITS; MEMBRANE; RING; F-0; TRANSPORTER	Subunit a plays a key role in promoting H+ transport and the coupled rotary motion of the subunit c ring in F1F0-ATP synthase. H+ binding and release occur at Asp-61 in the middle of the second transmembrane helix (TMH) of F-0 subunit c. H+ are thought to reach Asp-61 via aqueous pathways mapping to the surfaces of TMHs 2 - 5 of subunit a based upon the chemical reactivity of Cys substituted into these helices. Here we substituted Cys into loops connecting TMHs 1 and 2 ( loop 1 - 2) and TMHs 3 and 4 ( loop 3 - 4). A large segment of loop 3 - 4 extending from loop residue 192 loop to residue 203 in TMH4 at the lipid bilayer surface proved to be very sensitive to inhibition by Ag+. Cys-161 and - 165 at the other end of the loop bordering TMH3 were also sensitive to inhibition by Ag+. Further Cys substitutions in residues 86 and 93 in the middle of the 1 - 2 loop proved to be Ag+-sensitive. We next asked whether the regions of Ag+-sensitive residues clustered together near the surface of the membrane by combining Cys substitutions from two domains and testing for cross-linking. Cys-161 and - 165 in loop 3 - 4 were found to cross-link with Cys-202, - 203, or - 205, which extend into TMH4 from the cytoplasm. Further Cys at residues 86 and 93 in loop 1 - 2 were found to cross-link with Cys-195 in loop 3 - 4. We conclude that the Ag+-sensitive regions of loops 1 - 2 and 3 - 4 may pack in a single domain that packs at the ends of TMHs 3 and 4. We suggest that the Ag+- sensitive domain may be involved in gating H+ release at the cytoplasmic side of the aqueous access channel extending through F-0.	[Moore, Kyle J.; Angevine, Christine M.; Vincent, Owen D.; Schwem, Brian E.; Fillingame, Robert H.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	rhfillin@wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23105] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Barik S, 1996, Methods Mol Biol, V57, P203; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREEN GAM, 1986, J BIOL CHEM, V261, P1680; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; COX GB, 1986, BIOCHIM BIOPHYS ACTA, V849, P62, DOI 10.1016/0005-2728(86)90096-4; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dmitriev OY, 2004, J BIOMOL NMR, V29, P439, DOI 10.1023/B:JNMR.0000032519.14221.20; Dmitriev OY, 1999, P NATL ACAD SCI USA, V96, P7785, DOI 10.1073/pnas.96.14.7785; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fillingame RH, 2000, BBA-BIOENERGETICS, V1458, P387, DOI 10.1016/S0005-2728(00)00089-X; FILLINGAME RH, 1991, J BIOL CHEM, V266, P20934; FILLINGAME RH, 1975, J BACTERIOL, V124, P870, DOI 10.1128/JB.124.2.870-883.1975; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; FRAGA D, 1994, J BIOL CHEM, V269, P2562; GALINIS M, 1989, FEBS LETT, V249, P333; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; HERMOLIN J, 1995, J BIOL CHEM, V270, P2815, DOI 10.1074/jbc.270.6.2815; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; JOHN UP, 1986, FEBS LETT, V207, P79, DOI 10.1016/0014-5793(86)80016-3; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li J, 2002, P NATL ACAD SCI USA, V99, P11605, DOI 10.1073/pnas.192439299; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; LU Q, 1995, SCIENCE, V268, P304, DOI 10.1126/science.7716526; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; NAGLEY P, 1986, FEBS LETT, V195, P159, DOI 10.1016/0014-5793(86)80152-1; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; RAY MK, 1988, BIOCHIM BIOPHYS ACTA, V951, P213, DOI 10.1016/0167-4781(88)90042-5; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; von Glehn M, 1972, FEBS Lett, V20, P267, DOI 10.1016/0014-5793(72)80083-8; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zhang D, 2003, J BIOL CHEM, V278, P12319, DOI 10.1074/jbc.M212413200	53	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13044	13052		10.1074/jbc.M800900200	http://dx.doi.org/10.1074/jbc.M800900200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18337242	Green Published, hybrid			2022-12-25	WOS:000255499800042
J	Pratt, G; Rechsteiner, M				Pratt, Gregory; Rechsteiner, Martin			Proteasomes cleave at multiple sites within polyglutamine tracts - Activation by PA28 gamma(K188E)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUNTINGTONS-DISEASE; REG-GAMMA; NEURODEGENERATIVE DISEASES; TRINUCLEOTIDE REPEAT; PROTEIN AGGREGATION; MOUSE MODEL; CELL-DEATH; SYSTEM; IMPAIRMENT; TOXICITY	Eukaryotic proteasomes have been reported to cleave only once within polyglutamine tracts and then only after the N-terminal glutamine ( Venkatraman, P., Wetzel, R., Tanaka, M., Nukina, N., and Goldberg, A. L. ( 2004) Mol. Cell 14, 95-104). We have obtained results that directly conflict with that report. In the presence of the proteasome activator PA28 gamma(K188E) human red cell proteasomes progressively degraded fluorescein-GGQ(10)RR or fluorescein-HPHQ(10)RR into small fragments as shown by size exclusion chromatography and mass spectrometry. MALDI-TOF mass spectrometry revealed that proteolytic products arose from cleavage after every glutamine in fluorescein-HPHQ(10)RR, and mass accuracy rules out deamidation of glutamine to glutamic acid as an explanation for peptide degradation. Moreover, degradation cannot be attributed to a contaminating protease because peptide hydrolysis was completely blocked by the proteasome-specific inhibitors, lactacystin and epoxomicin. We conclude that proteasomes cleave repetitively anywhere within a stretch of ten glutamine residues. Thus our results cast doubt on the idea that mammalian proteasomes cannot degrade glutamine-expanded regions within pathogenic polyQ-expanded proteins, such as Huntingtin.	[Pratt, Gregory; Rechsteiner, Martin] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Rechsteiner, M (corresponding author), 15 N Med Dr E Rm 4100, Salt Lake City, UT 84112 USA.	marty@biochem.utah.edu			NINDS NIH HHS [NS042892] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042892] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bett JS, 2006, HUM MOL GENET, V15, P33, DOI 10.1093/hmg/ddi423; Borrell-Pages M, 2006, CELL MOL LIFE SCI, V63, P2642, DOI 10.1007/s00018-006-6242-0; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; de Cristofaro T, 2000, BIOCHEM BIOPH RES CO, V272, P816, DOI 10.1006/bbrc.2000.2843; Di Prospero NA, 2005, NAT REV GENET, V6, P756, DOI 10.1038/nrg1690; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Goellner GM, 2003, INT J BIOCHEM CELL B, V35, P562, DOI 10.1016/S1357-2725(02)00388-6; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Harris JL, 2001, CHEM BIOL, V8, P1131, DOI 10.1016/S1074-5521(01)00080-1; Helmlinger D, 2006, TRENDS GENET, V22, P562, DOI 10.1016/j.tig.2006.07.010; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Klein FAC, 2007, J MOL BIOL, V371, P235, DOI 10.1016/j.jmb.2007.05.028; Li J, 2001, EMBO J, V20, P3359, DOI 10.1093/emboj/20.13.3359; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Martin-Aparicio E, 2001, J NEUROSCI, V21, P8772, DOI 10.1523/JNEUROSCI.21-22-08772.2001; Morfini G, 2005, TRENDS MOL MED, V11, P64, DOI 10.1016/j.molmed.2004.12.002; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paulson HL, 2000, P NATL ACAD SCI USA, V97, P12957, DOI 10.1073/pnas.210395797; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; Rechsteiner M, 2000, BIOCHEM J, V345, P1, DOI 10.1042/0264-6021:3450001; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Weydt P, 2006, EXPERT OPIN THER TAR, V10, P505, DOI 10.1517/14728222.10.4.505; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076	41	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					12919	12925		10.1074/jbc.M709347200	http://dx.doi.org/10.1074/jbc.M709347200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18343811	hybrid, Green Published			2022-12-25	WOS:000255499800028
J	Dadsetan, S; Zakharova, L; Molinski, TF; Fomina, AF				Dadsetan, Sepehr; Zakharova, Liudmila; Molinski, Tadeusz F.; Fomina, Alla F.			Store-operated Ca2(+) influx causes Ca2(+) release from the intracellular Ca2(+) channels that is required for T cell activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CAPACITATIVE CALCIUM-ENTRY; SARCOPLASMIC-RETICULUM VESICLES; TYPE-3 RYANODINE RECEPTOR; CYCLIC ADP-RIBOSE; CA2+ ENTRY; PLASMA-MEMBRANE; LYMPHOCYTE-ACTIVATION; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION	The precise control of many T cell functions relies on cytosolic Ca2(+) dynamics that is shaped by the Ca2(+) release from the intracellular store and extracellular Ca2(+) influx. The Ca2(+) influx activated following T cell receptor (TCR)-mediated store depletion is considered to be a major mechanism for sustained elevation in cytosolic Ca2(+) concentration ([ Ca2(+)](i)) necessary for T cell activation, whereas the role of intracellular Ca2(+) release channels is believed to be minor. We found, however, that in Jurkat T cells [Ca2(+)] i elevation observed upon activation of the store-operated Ca2(+) entry (SOCE) by passive store depletion with cyclopiazonic acid, a reversible blocker of sarco-endoplasmic reticulum Ca2(+)-ATPase, inversely correlated with store refilling. This indicated that intracellular Ca2(+) release channels were activated in parallel with SOCE and contributed to global [ Ca2(+)] i elevation. Pretreating cells with (-)- xestospongin C (10 mu M) or ryanodine (400 mu M), the antagonists of inositol 1,4,5-trisphosphate receptor (IP3R) or ryanodine receptor (RyR), respectively, facilitated store refilling and significantly reduced [Ca2(+)] i elevation evoked by the passive store depletion or TCR ligation. Although the Ca2(+) release from the IP3R can be activated by TCR stimulation, the Ca2(+) release from the RyR was not inducible via TCR engagement and was exclusively activated by the SOCE. We also established that inhibition of IP3R or RyR down-regulated T cell proliferation and T-cell growth factor interleukin 2 production. These studies revealed a new aspect of [Ca2(+)]i signaling in T cells, that is SOCE-dependent Ca2(+) release via IP3R and/or RyR, and identified the IP3R and RyR as potential targets for manipulation of Ca2+-dependent functions of T lymphocytes.	[Dadsetan, Sepehr; Zakharova, Liudmila; Fomina, Alla F.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Molinski, Tadeusz F.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California Davis; University of California System; University of California San Diego	Fomina, AF (corresponding author), 4138 Tupper Hall,1 Shields Ave, Davis, CA 95616 USA.	affomina@ucdavis.edu	Molinski, Tadeusz F/P-2125-2018					Bergling S, 1998, CELL CALCIUM, V23, P251, DOI 10.1016/S0143-4160(98)90123-3; Berridge MJ, 1997, CRIT REV IMMUNOL, V17, P155, DOI 10.1615/CritRevImmunol.v17.i2.30; BYRON KL, 1992, J BIOL CHEM, V267, P108; CHIESI M, 1981, ARCH BIOCHEM BIOPHYS, V208, P586, DOI 10.1016/0003-9861(81)90547-6; CHIESI M, 1980, BIOCHEMISTRY-US, V19, P2912, DOI 10.1021/bi00554a015; Conrad DM, 2004, J CELL BIOCHEM, V92, P387, DOI 10.1002/jcb.20064; Dadsetan S, 2005, J BIOL CHEM, V280, P16377, DOI 10.1074/jbc.M501202200; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; DUPUIS G, 1988, J LEUKOCYTE BIOL, V43, P238, DOI 10.1002/jlb.43.3.238; Fanger CM, 2000, J IMMUNOL, V164, P1153, DOI 10.4049/jimmunol.164.3.1153; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; HAKAMATA Y, 1994, FEBS LETT, V352, P206, DOI 10.1016/0014-5793(94)00955-4; HARNICK DJ, 1995, J BIOL CHEM, V270, P2833, DOI 10.1074/jbc.270.6.2833; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; Hosoi E, 2001, J IMMUNOL, V167, P4887, DOI 10.4049/jimmunol.167.9.4887; JAYARAMAN T, 1995, P NATL ACAD SCI USA, V92, P6007, DOI 10.1073/pnas.92.13.6007; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; Kunerth S, 2004, J CELL SCI, V117, P2141, DOI 10.1242/jcs.01063; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma JJ, 2003, CELL CALCIUM, V33, P375, DOI 10.1016/S0143-4160(03)00050-2; Ma JJ, 2003, FRONT BIOSCI-LANDMRK, V8, pD242, DOI 10.2741/977; MISSIAEN L, 1990, J PHYSIOL-LONDON, V427, P171, DOI 10.1113/jphysiol.1990.sp018166; Mogami H, 1997, CELL, V88, P49, DOI 10.1016/S0092-8674(00)81857-7; Moon SS, 2002, J NAT PROD, V65, P249, DOI 10.1021/np010427z; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 1999, BIOESSAYS, V21, P38; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Schwarzmann N, 2002, J BIOL CHEM, V277, P50636, DOI 10.1074/jbc.M209061200; SUGIYAMA T, 1994, FEBS LETT, V354, P149, DOI 10.1016/0014-5793(94)01099-4; TAKEMURA H, 1989, BIOCHEM J, V258, P409, DOI 10.1042/bj2580409; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yao J, 2004, J BIOL CHEM, V279, P21511, DOI 10.1074/jbc.M314028200; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813; Zucchi R, 1997, PHARMACOL REV, V49, P1	47	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12512	12519		10.1074/jbc.M709330200	http://dx.doi.org/10.1074/jbc.M709330200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18316371	hybrid			2022-12-25	WOS:000255340000067
J	Mardones, P; Medina, JF; Elferink, RPJO				Mardones, Pablo; Medina, Juan F.; Elferink, Ronald P. J. Oude			Activation of cyclic AMP signaling in Ae2-deficient mouse fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; AE2 ANION-EXCHANGER; CYTOPLASMIC DOMAIN; GENETIC-DISEASES; INTRACELLULAR PH; SPLICE VARIANTS; C-FOS; CAMP; TRANSCRIPTION; EXPRESSION	Anion exchanger 2 (AE2, SLC4A2) is a ubiquitously expressed membrane solute carrier that regulates intracellular pH (pH(i)) by exchanging cytosolic bicarbonate for extracellular chloride. We used fibroblasts from Ae2-deficient (Ae2(a,b)(-/-)) mice to study the effects of an alkaline shift in resting intracellular pH (pH(i)) on the activation of cAMP signaling and gene expression. Ae2(a,b)(-/-) fibroblasts show increased pH(i) (by 0.22 +/- 0.03 unit) compared with wild type cells at extracellular pH (pH(o)) 7.4 and 37 degrees C. This shift in resting pHi is associated with an up-regulation of bicarbonate-activated soluble adenylyl cyclase expression, increased cAMP production, Creb phosphorylation, inducible cAMP early repressor 1 mRNA expression, and impaired activation of c-Fos transcription by forskolin. These results highlight the importance of bicarbonate transport via Ae2 in maintaining pHi homeostasis in cultured mouse fibroblasts and unveil the role of cAMP in the cellular response to chronic alkalization, which putatively includes an inducible cAMP early repressor 1-mediated attenuation of phosphorylated Creb activity.	[Mardones, Pablo; Elferink, Ronald P. J. Oude] Univ Amsterdam, Acad Med Ctr, Ctr Liver, NL-1105 BK Amsterdam, Netherlands; [Medina, Juan F.] Univ Navarra, Univ Hosp, Sch Med, Ctr Appl Med Res,Div Gene Therapy & Hepatol, E-31008 Pamplona, Spain	University of Amsterdam; Academic Medical Center Amsterdam; University of Navarra	Elferink, RPJO (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Liver, S1-162,Meibergdreef 69-71, NL-1105 BK Amsterdam, Netherlands.	r.p.oude-elferink@amc.uva.nl	Mardones, Pablo/ABG-3418-2021; Mardones Hiche, Pablo/B-8544-2009					Alper SL, 2002, ANNU REV PHYSIOL, V64, P899, DOI 10.1146/annurev.physiol.64.092801.141759; Baker JG, 2004, MOL PHARMACOL, V65, P986, DOI 10.1124/mol.65.4.986; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Behr R, 2001, INT J ANDROL, V24, P126, DOI 10.1046/j.1365-2605.2001.00277.x; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Bumke MA, 2003, PROTEOMICS, V3, P675, DOI 10.1002/pmic.200300395; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Cooper DMF, 2006, TRENDS PHARMACOL SCI, V27, P426, DOI 10.1016/j.tips.2006.06.002; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Don J, 2002, MOL CELL ENDOCRINOL, V187, P115, DOI 10.1016/S0303-7207(01)00696-7; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Foulkes NS, 1997, BIOL CELL, V89, P487, DOI 10.1016/S0248-4900(98)80004-X; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jaiswal BS, 2001, J BIOL CHEM, V276, P31698, DOI 10.1074/jbc.M011698200; Kurschat CE, 2006, J BIOL CHEM, V281, P1885, DOI 10.1074/jbc.M509734200; Lamas M, 1996, PHILOS T R SOC B, V351, P561, DOI 10.1098/rstb.1996.0055; Lecanda J, 2000, BIOCHEM BIOPH RES CO, V276, P117, DOI 10.1006/bbrc.2000.3439; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Medina JF, 2003, P NATL ACAD SCI USA, V100, P15847, DOI 10.1073/pnas.2536127100; Medina JF, 2000, BIOCHEM BIOPH RES CO, V267, P228, DOI 10.1006/bbrc.1999.1951; Misund K, 2007, J CELL BIOCHEM, V101, P1532, DOI 10.1002/jcb.21267; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; PETRONINI PG, 1995, J CELL PHYSIOL, V162, P322, DOI 10.1002/jcp.1041620304; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Recalde S, 2006, AM J PATHOL, V169, P165, DOI 10.2353/ajpath.2006.051096; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Steigedal TS, 2007, AM J PHYSIOL-GASTR L, V292, pG1062, DOI 10.1152/ajpgi.00287.2006; Sterling D, 1999, BIOCHEM J, V344, P221, DOI 10.1042/0264-6021:3440221; Stewart AK, 2001, AM J PHYSIOL-CELL PH, V281, pC1344, DOI 10.1152/ajpcell.2001.281.4.C1344; Sun Xing Cai, 2004, BMC Physiol, V4, P8, DOI 10.1186/1472-6793-4-8; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje; Zippin JH, 2001, TRENDS ENDOCRIN MET, V12, P366, DOI 10.1016/S1043-2760(01)00454-4	44	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12146	12153		10.1074/jbc.M710590200	http://dx.doi.org/10.1074/jbc.M710590200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18319251	hybrid			2022-12-25	WOS:000255340000031
J	Tsumoto, K; Yokota, A; Tanaka, Y; Ui, M; Tsumuraya, T; Fujii, I; Kumagai, I; Nagumo, Y; Oguri, H; Inoue, M; Hirama, M				Tsumoto, Kouhei; Yokota, Akiko; Tanaka, Yoshikazu; Ui, Mihoko; Tsumuraya, Takeshi; Fujii, Ikuo; Kumagai, Izumi; Nagumo, Yoko; Oguri, Hiroki; Inoue, Masayuki; Hirama, Masahiro			Critical contribution of aromatic rings to specific recognition of polyether rings - The case of ciguatoxin CTX3C-ABC and its specific antibody 1C49	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTODEXTRIN-BINDING PROTEIN; ALANINE-SCANNING MUTAGENESIS; CATION-PI INTERACTIONS; CHAIN FV FRAGMENT; SANDWICH IMMUNOASSAY; PTYCHODISCUS-BREVIS; STEPWISE DIALYSIS; MASS-SPECTROMETRY; INCLUSION-BODIES; MARINE TOXINS	To address how proteins recognize polyether toxin compounds, we focused on the interaction between the ABC ring compound of ciguatoxin 3C and its specific antibody, 1C49. Surface plasmon resonance analyses indicated that Escherichia coli-expressed variable domain fragments (Fv) of 1C49 had the high affinity constants and slow dissociation constants typical of antigen-antibody interactions. Linear van't Hoff analyses suggested that the interaction is enthalpy-driven. We resolved the crystal structure of 1C49 Fv bound to ABC ring compound of ciguatoxin 3C at a resolution of 1.7 angstrom. The binding pocket of the antibody had many aromatic rings and bound the antigen by shape complementarity typical of hapten-antibody interactions. Three hydrogen bonds and many van der Waals interactions were present. We mutated several residues of the antibody to Ala, and we used surface plasmon resonance to analyze the interactions between the mutated antibodies and the antigen. This analysis identified Tyr-91 and Trp-96 in the light chain as hot spots for the interaction, and other residues made incremental contributions by conferring enthalpic advantages and reducing the dissociation rate constant. Systematic mutation of Tyr-91 indicated that CH-pi and pi-pi interactions between the aromatic ring at this site and the antigen made substantial contributions to the association, and van der Waals interactions inhibited dissociation, suggesting that aromaticity and bulkiness are critical for the specific recognition of polyether compounds by proteins.	[Tsumoto, Kouhei; Tanaka, Yoshikazu; Ui, Mihoko] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan; [Yokota, Akiko; Kumagai, Izumi] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan; [Tsumuraya, Takeshi; Fujii, Ikuo] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5998570, Japan; [Nagumo, Yoko; Oguri, Hiroki; Inoue, Masayuki; Hirama, Masahiro] Tohoku Univ, Grad Sch Sci, Dept Chem, Sendai, Miyagi 9808578, Japan; [Nagumo, Yoko; Oguri, Hiroki; Inoue, Masayuki; Hirama, Masahiro] Japan Sci & Technol Agcy, SORST, Sendai, Miyagi 9808578, Japan	University of Tokyo; Tohoku University; Osaka Metropolitan University; Tohoku University; Japan Science & Technology Agency (JST)	Tsumoto, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan.	tsumoto@k.u-tokyo.ac.jp	Oguri, Hiroki/F-9541-2015; Oguri, Hiroki/AAV-2045-2020; Oguri, Hiroki/B-7366-2014; Tsumuraya, Takeshi/W-1080-2019	Oguri, Hiroki/0000-0001-8007-1631; Oguri, Hiroki/0000-0001-8007-1631; Tsumuraya, Takeshi/0000-0001-8979-2160				Almagro JC, 2004, J MOL RECOGNIT, V17, P132, DOI 10.1002/jmr.659; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchbinder JL, 1998, J MOL BIOL, V282, P1033, DOI 10.1006/jmbi.1998.2025; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Daranas AH, 2004, CHEM REC, V4, P1, DOI 10.1002/tcr.10072; Dechraoui MY, 1999, TOXICON, V37, P125, DOI 10.1016/S0041-0101(98)00169-X; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Evdokimov AG, 2001, J MOL BIOL, V305, P891, DOI 10.1006/jmbi.2000.4202; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Fields BA, 1996, BIOCHEMISTRY-US, V35, P15494, DOI 10.1021/bi961709e; Heine A, 1998, SCIENCE, V279, P1934, DOI 10.1126/science.279.5358.1934; Hirama M, 2005, CHEM REC, V5, P240, DOI 10.1002/tcr.20049; JEFFREY PD, 1993, P NATL ACAD SCI USA, V90, P10310, DOI 10.1073/pnas.90.21.10310; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Kabat EA, 1991, SEQUENCES PROTEINS I; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Lang S, 2000, BIOCHEMISTRY-US, V39, P15674, DOI 10.1021/bi000838z; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEWIS RJ, 1993, TOXICON, V31, P1333, DOI 10.1016/0041-0101(93)90407-A; Lewis RJ, 1997, TOXICON, V35, P159, DOI 10.1016/S0041-0101(96)00132-8; Lewis RJ, 1999, ANAL CHEM, V71, P247, DOI 10.1021/ac980598h; Lewis RJ, 2001, TOXICON, V39, P97, DOI 10.1016/S0041-0101(00)00161-6; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Lim K, 1998, J BIOL CHEM, V273, P28576, DOI 10.1074/jbc.273.44.28576; LIN YY, 1981, J AM CHEM SOC, V103, P6773, DOI 10.1021/ja00412a053; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Makabe K, 2005, BIOCHEM BIOPH RES CO, V328, P98, DOI 10.1016/j.bbrc.2004.12.141; MANGER RL, 1995, J AOAC INT, V78, P521; Mecozzi S, 1996, P NATL ACAD SCI USA, V93, P10566, DOI 10.1073/pnas.93.20.10566; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; MURATA M, 1989, J AM CHEM SOC, V111, P8929, DOI 10.1021/ja00206a032; Nagumo Y, 2004, J IMMUNOL METHODS, V289, P137, DOI 10.1016/j.jim.2004.04.003; Oguri H, 2003, J AM CHEM SOC, V125, P7608, DOI 10.1021/ja034990a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pons J, 1999, PROTEIN SCI, V8, P958, DOI 10.1110/ps.8.5.958; SCHEUER PJ, 1967, SCIENCE, V155, P1267, DOI 10.1126/science.155.3767.1267; SCHEUER PJ, 1994, TETRAHEDRON, V50, P3, DOI 10.1016/S0040-4020(01)80733-X; SHIMIZU Y, 1983, NATURE, V302, P212, DOI 10.1038/302212a0; SHIMIZU Y, 1986, J AM CHEM SOC, V108, P514, DOI 10.1021/ja00263a031; Shiroishi M, 2007, J BIOL CHEM, V282, P6783, DOI 10.1074/jbc.M605197200; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Sundberg EJ, 2000, BIOCHEMISTRY-US, V39, P15375, DOI 10.1021/bi000704l; Takahashi H, 1996, TETRAHEDRON LETT, V37, P7087, DOI 10.1016/0040-4039(96)01580-8; TRONRUD DE, 1987, SCIENCE, V235, P571, DOI 10.1126/science.3810156; TSUMOTO K, 1995, J BIOL CHEM, V270, P18551, DOI 10.1074/jbc.270.31.18551; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6; Tsumuraya T, 2006, TOXICON, V48, P287, DOI 10.1016/j.toxicon.2006.05.014; Ulrich HD, 1997, NATURE, V389, P271, DOI 10.1038/38470; Umetsu M, 2003, J BIOL CHEM, V278, P8979, DOI 10.1074/jbc.M212247200; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965; YASUMOTO T, 1995, J AOAC INT, V78, P574; Yasumoto T, 2001, CHEM REC, V1, P228, DOI 10.1002/tcr.1010; Yasumoto T, 2000, J AM CHEM SOC, V122, P4988, DOI 10.1021/ja9944204	59	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12259	12266		10.1074/jbc.M710553200	http://dx.doi.org/10.1074/jbc.M710553200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18326040	hybrid			2022-12-25	WOS:000255340000042
J	Xiao, ZS; Zhang, SQ; Magenheimer, BS; Luo, JM; Quarles, LD				Xiao, Zhousheng; Zhang, Shiqin; Magenheimer, Brenda S.; Luo, Junming; Quarles, L. Darryl			Polycystin-1 regulates skeletogenesis through stimulation of the osteoblast-specific transcription factor RUNX2-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY CILIUM; NUCLEAR-FACTOR; INTRAFLAGELLAR TRANSPORT; GROWTH-PLATE; CLEIDOCRANIAL DYSPLASIA; TARGETED DISRUPTION; EPITHELIAL-CELLS; BONE-FORMATION; C-TERMINUS; GENE	Polycystin-1 (PC1) may play an important role in skeletogenesis through regulation of the bone-specific transcription factor Runx2-II. In the current study we found that PC1 co-localizes with the calcium channel polycystin-2 (PC2) in primary cilia of MC3T3-E1 osteoblasts. To establish the role of Runx2-II in mediating PC1 effects on bone, we crossed heterozygous Pkd1(m1Bei) and Runx2-II mice to create double heterozygous mice (Pkd1(+/m1Bei)/Runx2-II+/-) deficient in both PC1 and Runx2-II. Pkd1(+/m1Bei)/Runx2-II+/- mice exhibited additive reductions in Runx2-II expression that was associated with impaired endochondral bone development, defective osteoblast-mediated bone formation, and osteopenia. In addition, we found that basal intracellular calcium levels were reduced in homozygous Pkd1m1Bei osteoblasts. In contrast, overexpression of a PC1 C-tail construct increased intracellular calcium and selectively stimulated Runx2-II P1 promoter activity in osteoblasts through a calcium-dependent mechanism. Site-directed mutagenesis of critical amino acids in the coiled-coil domain of PC1 required for coupling to PC2 abolished PC1-mediated Runx2-II P1 promoter activity. Additional promoter analysis mapped the PC1-responsive region to the "osteoblast-specific" enhancer element between -420 and -350 bp that contains NFI and AP-1 binding sites. Chromatin immunoprecipitation assays confirmed the calcium-dependent binding of NFI to this region. These findings indicate that PC1 regulates osteoblast function through intracellular calcium-dependent control of Runx2-II expression. The overall function of the primary cilium-polycystin complex may be to sense and transduce environmental clues into signals regulating osteoblast differentiation and bone development.	[Xiao, Zhousheng; Zhang, Shiqin; Magenheimer, Brenda S.; Luo, Junming; Quarles, L. Darryl] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Quarles, LD (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, MS 3018,3901 Rainbow Blvd,6018 Wahl Hall E, Kansas City, KS 66160 USA.	dquarles@kumc.edu		Quarles, L. Darryl/0000-0002-5082-7896	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057301, R01DK083303] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01-AR049712] Funding Source: Medline; NIDDK NIH HHS [P50-DK057301, R01 DK083303] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alevizopoulos A, 1997, J BIOL CHEM, V272, P23597, DOI 10.1074/jbc.272.38.23597; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Chauvet V, 2004, J CLIN INVEST, V114, P1433, DOI 10.1172/JCI200421753; Christensen ST, 2007, SCIENCE, V317, P330, DOI 10.1126/science.1146180; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Delmas P, 2004, BIOCHEM BIOPH RES CO, V322, P1374, DOI 10.1016/j.bbrc.2004.08.044; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; FEDERMAN M, 1974, CALC TISS RES, V17, P81, DOI 10.1007/BF02547216; Ferrari S, 2004, J BIOL CHEM, V279, P55520, DOI 10.1074/jbc.M410346200; Forman JR, 2005, J MOL BIOL, V349, P861, DOI 10.1016/j.jmb.2005.04.008; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Geng L, 2000, BBA-MOL BASIS DIS, V1535, P21, DOI 10.1016/S0925-4439(00)00079-X; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hebbar PB, 2003, MOL CELL BIOL, V23, P887, DOI 10.1128/MCB.23.3.887-898.2003; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; Karreth F, 2004, DEVELOPMENT, V131, P5717, DOI 10.1242/dev.01414; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Le NH, 2004, J BIOL CHEM, V279, P27472, DOI 10.1074/jbc.M312183200; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Manzati E, 2005, EXP CELL RES, V304, P391, DOI 10.1016/j.yexcr.2004.10.023; Mukhopadhyay SS, 2001, MOL CELL BIOL, V21, P6859, DOI 10.1128/MCB.21.20.6859-6869.2001; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Nims N, 2003, BIOCHEMISTRY-US, V42, P13035, DOI 10.1021/bi035074c; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; Puri S, 2004, J BIOL CHEM, V279, P55455, DOI 10.1074/jbc.M402905200; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Song B, 2007, DEV BIOL, V305, P202, DOI 10.1016/j.ydbio.2007.02.003; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; Takaoki Muneo, 2004, Biol Sci Space, V18, P181; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Uchihashi T, 2007, BONE, V41, P1025, DOI 10.1016/j.bone.2007.08.028; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Vandorpe DH, 2001, J BIOL CHEM, V276, P4093, DOI 10.1074/jbc.M006252200; Wang W, 2007, J NEUROSCI, V27, P6115, DOI 10.1523/JNEUROSCI.0180-07.2007; Whitfield JF, 2003, J CELL BIOCHEM, V89, P233, DOI 10.1002/jcb.10509; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Xiao ZS, 1999, J CELL BIOCHEM, V74, P596, DOI 10.1002/(SICI)1097-4644(19990915)74:4<596::AID-JCB9>3.0.CO;2-F; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; Zambotti A, 2002, J BIOL CHEM, V277, P41497, DOI 10.1074/jbc.M204271200; Zhu ED, 2008, J BIOL CHEM, V283, P7361, DOI 10.1074/jbc.M703304200	59	52	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12624	12634		10.1074/jbc.M710407200	http://dx.doi.org/10.1074/jbc.M710407200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18321855	Green Published, hybrid			2022-12-25	WOS:000255340000079
J	Bisson, GP; Gaolathe, T; Gross, R; Rollins, C; Bellamy, S; Mogorosi, M; Avalos, A; Friedman, H; Dickinson, D; Frank, I; Ndwapi, N				Bisson, Gregory P.; Gaolathe, Tendani; Gross, Robert; Rollins, Caitlin; Bellamy, Scarlett; Mogorosi, Mpho; Avalos, Ava; Friedman, Harvey; Dickinson, Diana; Frank, Ian; Ndwapi, Ndwapi			Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; FOLLOW-UP; MORTALITY; OUTCOMES; EXPERIENCE; PROGRAM; AFRICA	Background: Monitoring the effectiveness of global antiretroviral therapy scale-up efforts in resource-limited settings is a global health priority, but is complicated by high rates of losses to follow-up after treatment initiation. Determining definitive outcomes of these lost patients, and the effects of losses to follow-up on estimates of survival and risk factors for death after HAART, are key to monitoring the effectiveness of global HAART scale-up efforts. Methodology/Principal Findings: A cohort study comparing clinical outcomes and risk factors for death after HAART initiation as reported before and after tracing of patients lost to follow-up was conducted in Botswana's National Antiretroviral Therapy Program. 410 HIV-infected adults consecutively presenting for HAART were evaluated. The main outcome measures were death or loss to follow-up within the first year after HAART initiation. Of 68 patients initially categorized as lost, over half (58.8%) were confirmed dead after tracing. Patient tracing resulted in reporting of significantly lower survival rates when death was used as the outcome and losses to follow-up were censored [1-year Kaplan Meier survival estimate 0.92 (95% confidence interval, 0.88-0.94 before tracing and 0.83 (95% confidence interval, 0.79-0.86) after tracing, log rank P<0.001]. In addition, a significantly increased risk of death after HAART among men [adjusted hazard ratio 1.74 (95% confidence interval, 1.05-2.87)] would have been missed had patients not been traced [adjusted hazard ratio 1.41 (95% confidence interval, 0.65-3.05)]. Conclusions/Significance: Due to high rates of death among patients lost to follow-up after HAART, survival rates may be inaccurate and important risk factors for death may be missed if patients are not actively traced. Patient tracing and uniform reporting of outcomes after HAART are needed to enable accurate monitoring of global HAART scale-up efforts.	[Bisson, Gregory P.; Gross, Robert; Rollins, Caitlin; Bellamy, Scarlett; Friedman, Harvey; Frank, Ian] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Gaolathe, Tendani; Ndwapi, Ndwapi] Botswana Harvard Sch Public Hlth AIDS Initiative, Partnership HIV Res & Ed, Gaborone, Botswana; [Mogorosi, Mpho; Avalos, Ava] Princess Marina Hosp, Infect Dis Care Clin, Gaborone, Botswana; [Dickinson, Diana] Independence Surg, Gaborone, Botswana	University of Pennsylvania	Bisson, GP (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.	gregbisson@mac.com		Bellamy, Scarlett/0000-0002-2906-4046	National Institutes of Health [P30-AI45008]; PENN AIDS Clinical Trials Unit [U01-AI32783]; Career Development Awards [K23AI058881, K08MH01584]; Agency for Healthcare Research and Quality (AHRQ) Centers for Education and Research on Therapeutics [HS10399]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008, K23AI058881, U01AI032783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PENN AIDS Clinical Trials Unit; Career Development Awards; Agency for Healthcare Research and Quality (AHRQ) Centers for Education and Research on Therapeutics(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful for the support of the National Institutes of Health which supported this research through the University of Pennsylvania Center for AIDS Research International, Developmental and Clinical Cores (P30-AI45008) the PENN AIDS Clinical Trials Unit (U01-AI32783), Career Development Awards K23AI058881 (GB) and K08MH01584 (RG), and an Agency for Healthcare Research and Quality (AHRQ) Centers for Education and Research on Therapeutics cooperative agreement (HS10399).	Anglaret X, 2004, JAIDS-J ACQ IMM DEF, V35, P320, DOI 10.1097/00126334-200403010-00015; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Djomand G, 2003, AIDS, V17, pS5, DOI 10.1097/00002030-200317003-00002; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; GAMMINO VBG, 2007, NATL TUBERCULOSIS PR; GUIARD S, 2004, TRICAM MEDICOECONOMI; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hosseinipour Mina C, 2006, J Int Assoc Physicians AIDS Care (Chic), V5, P103, DOI 10.1177/1545109706288722; Lanoy E, 2006, J CLIN EPIDEMIOL, V59, P829, DOI 10.1016/j.jclinepi.2005.11.024; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Macharia DK, 2003, AIDS, V17, P938, DOI 10.1097/00002030-200304110-00028; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; ROTHMAN KJ, 2008, MODERN EPIDEMIOLOGY; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; UNAIDS, 2006, REP GLOB AIDS EP; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; *WHO, 2006, SCAL ANT THER RES LT; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	28	96	97	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1725	10.1371/journal.pone.0001725	http://dx.doi.org/10.1371/journal.pone.0001725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320045	Green Submitted, Green Published, gold			2022-12-25	WOS:000260586600021
J	Plyusnin, I; Evans, AR; Karme, A; Gionis, A; Jernvall, J				Plyusnin, Ilya; Evans, Alistair R.; Karme, Aleksis; Gionis, Aristides; Jernvall, Jukka			Automated 3D Phenotype Analysis Using Data Mining	PLOS ONE			English	Article							TOPOGRAPHY; MORPHOLOGY; EVOLUTION	The ability to analyze and classify three-dimensional (3D) biological morphology has lagged behind the analysis of other biological data types such as gene sequences. Here, we introduce the techniques of data mining to the study of 3D biological shapes to bring the analyses of phenomes closer to the efficiency of studying genomes. We compiled five training sets of highly variable morphologies of mammalian teeth from the MorphoBrowser database. Samples were labeled either by dietary class or by conventional dental types (e.g. carnassial, selenodont). We automatically extracted a multitude of topological attributes using Geographic Information Systems (GIS)-like procedures that were then used in several combinations of feature selection schemes and probabilistic classification models to build and optimize classifiers for predicting the labels of the training sets. In terms of classification accuracy, computational time and size of the feature sets used, non-repeated best-first search combined with 1-nearest neighbor classifier was the best approach. However, several other classification models combined with the same searching scheme proved practical. The current study represents a first step in the automatic analysis of 3D phenotypes, which will be increasingly valuable with the future increase in 3D morphology and phenomics databases.	[Plyusnin, Ilya; Evans, Alistair R.; Jernvall, Jukka] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Karme, Aleksis] Univ Helsinki, Dept Geol, Helsinki, Finland; [Gionis, Aristides] Yahoo Res Barcelona, Barcelona, Spain	University of Helsinki; University of Helsinki	Plyusnin, I (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	ipljusni@cc.hut.fi	Gionis, Aristides/G-2225-2013; Evans, Alistair R/D-4239-2011	Gionis, Aristides/0000-0002-5211-112X; Evans, Alistair R/0000-0002-4078-4693	Academy of Finland	Academy of Finland(Academy of Finland)	This study was supported by the Academy of Finland	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1023/A:1022689900470; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BUTLER PM, 1983, J BIOL BUCCALE, V11, P285; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Evans AR, 2001, J MICROSC-OXFORD, V204, P108, DOI 10.1046/j.1365-2818.2001.00939.x; Evans G, 2005, INTEGR COMP BIOL, V45, P1129; Evans G, 2006, J VERTEBR PALEONTOL, V26, p59A; Funkhouser T, 2005, COMMUN ACM, V48, P58, DOI 10.1145/1064830.1064859; Hand D., 2001, ADAP COMP MACH LEARN; Hillson S., 2005, TEETH; Jernvall J, 1996, SCIENCE, V274, P1489, DOI 10.1126/science.274.5292.1489; JERNVALL J, 1999, PALAEONTOLOGIA ELECT, V2; JOHN HG, 1995, 11 C UNC ART INT SAN, P338; KAY RF, 1985, ANNU REV ANTHROPOL, V14, P315, DOI 10.1146/annurev.an.14.100185.001531; KAY RF, 1975, AM J PHYS ANTHROPOL, V43, P195, DOI 10.1002/ajpa.1330430207; Levoy M, 2000, COMP GRAPH, P131, DOI 10.1145/344779.344849; Lucas P., 2004, DENT FUNCTIONAL MORP; NOWAK MR, 1999, WALKERS MAMMALS WORL; Osada R, 2002, ACM T GRAPHIC, V21, P807, DOI 10.1145/571647.571648; Osborn, 1907, EVOLUTION MAMMALIAN, P48; Quinlan JR., 1993, C45 PROGRAMS MACHINE; RAUP DAVID M., 1966, J PALEONTOL, V40, P1178; REED DNO, 1997, AM J PHYS ANTHR S, V24, P113; Regli WC, 2000, COMPUT AIDED DESIGN, V32, P119, DOI 10.1016/S0010-4485(99)00095-0; Salazar-Ciudad I, 2004, EVOL DEV, V6, P6, DOI 10.1111/j.1525-142X.2004.04002.x; STRAIT SG, 1993, J MAMMAL, V74, P391, DOI 10.2307/1382395; Strait S, 2006, J VERTEBR PALEONTOL, V26, p129A; Tangelder JWH, 2004, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SHAPE MODELING AND APPLICATIONS, P145, DOI 10.1109/SMI.2004.1314502; Ungar P, 2004, J HUM EVOL, V46, P605, DOI 10.1016/j.jhevol.2004.03.004; Witten I. H., 2005, DATA MINING PRACTICA; Zuccotti LF, 1998, AM J PHYS ANTHROPOL, V107, P137, DOI 10.1002/(SICI)1096-8644(199809)107:1<137::AID-AJPA11>3.0.CO;2-1	32	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1742	10.1371/journal.pone.0001742	http://dx.doi.org/10.1371/journal.pone.0001742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XT	18320060	Green Published, gold			2022-12-25	WOS:000260586600037
J	Cohen, L; Lipstein, N; Karbat, I; Ilan, N; Gilles, N; Kahn, R; Gordon, D; Gurevitz, M				Cohen, Lior; Lipstein, Noa; Karbat, Izhar; Ilan, Nitza; Gilles, Nicolas; Kahn, Roy; Gordon, Dalia; Gurevitz, Michael			Miniaturization of scorpion beta-toxins uncovers a putative ancestral surface of interaction with voltage-gated sodium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; ALLOSTERIC INTERACTIONS; FUNCTIONAL SURFACE; RECEPTOR-SITES; INSECT CONTROL; NA+ CHANNELS; ION CHANNELS; BINDING; BREVETOXIN; NEUROTOXINS	The bioactive surface of scorpion beta-toxins that interact with receptor site-4 at voltage-gated sodium channels is constituted of residues of the conserved beta alpha beta beta core and the C-tail. In an attempt to evaluate the extent by which residues of the toxin core contribute to bioactivity, the anti-insect and anti-mammalian beta-toxins Bj-xtrIT and Css4 were truncated at their N and C termini, resulting in miniature peptides composed essentially of the core secondary structure motives. The truncated beta-toxins (Delta Delta Bj-xtrIT and Delta Delta Css4) were non-toxic and did not compete with the parental toxins on binding at receptor site-4. Surprisingly, Delta Delta Bj-xtrIT and Delta Delta Css4 were capable of modulating in an allosteric manner the binding and effects of site-3 scorpion alpha-toxins in a way reminiscent of that of brevetoxins, which bind at receptor site-5. While reducing the binding and effect of the scorpion alpha-toxin Lqh2 at mammalian sodium channels, they enhanced the binding and effect of Lqh alpha IT at insect sodium channels. Co-application of Delta Delta Bj-xtrIT or Delta Delta Css4 with brevetoxin abolished the brevetoxin effect, although they did not compete in binding. These results denote a novel surface at Delta Delta Bj-xtrIT and Delta Delta Css4 capable of interaction with sodium channels at a site other than sites 3,4, or 5, which prior to the truncation was masked by the bioactive surface that interacts with receptor site-4. The disclosure of this hidden surface at both beta-toxins may be viewed as an exercise in "reverse evolution," providing a clue as to their evolution from a smaller ancestor of similar scaffold.	[Cohen, Lior; Lipstein, Noa; Karbat, Izhar; Ilan, Nitza; Kahn, Roy; Gordon, Dalia; Gurevitz, Michael] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel; [Gilles, Nicolas] CE Saclay, Dept Ingn & Etud Prot, Commissariat Energie Atom, F-91191 Gif Sur Yvette, France	Tel Aviv University; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Gordon, D (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel.	dgordon@post.tau.ac.il; mamgur@post.tau.ac.il		Lipstein, Noa/0000-0002-0755-5899	NINDS NIH HHS [1U01 NS 058039-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS058039] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Baden DG, 2005, ENVIRON HEALTH PERSP, V113, P621, DOI 10.1289/ehp.7499; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; Bourdelais AJ, 2004, CELL MOL NEUROBIOL, V24, P553, DOI 10.1023/B:CEMN.0000023629.81595.09; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Cestele S, 1998, J NEUROCHEM, V70, P1217; Cestele S, 1996, J BIOL CHEM, V271, P18329, DOI 10.1074/jbc.271.31.18329; CESTELE S, 1995, J BIOL CHEM, V270, P15153, DOI 10.1074/jbc.270.25.15153; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2004, J BIOL CHEM, V279, P8206, DOI 10.1074/jbc.M307531200; Cohen L, 2007, MOL PHARMACOL, V72, P1220, DOI 10.1124/mol.107.039057; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; Cohen L, 2006, FASEB J, V20, P1933, DOI 10.1096/fj.05-5545fje; Froy O, 1998, FASEB J, V12, P1793, DOI 10.1096/fasebj.12.15.1793; Froy O, 1999, J BIOL CHEM, V274, P5769, DOI 10.1074/jbc.274.9.5769; Gilles N, 2003, FEBS LETT, V540, P81, DOI 10.1016/S0014-5793(03)00226-6; Gilles N, 2001, BIOCHEMISTRY-US, V40, P14576, DOI 10.1021/bi010973r; Gilles N, 2000, J NEUROCHEM, V75, P1735, DOI 10.1046/j.1471-4159.2000.0751735.x; GORDON D, 1993, FEBS LETT, V315, P125, DOI 10.1016/0014-5793(93)81147-R; Gordon D, 1996, J BIOL CHEM, V271, P8034, DOI 10.1074/jbc.271.14.8034; Gordon D, 1997, TOXINS SIGNAL TRANSD, P119; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Gurevitz M, 2001, FASEB J, V15, P1201, DOI 10.1096/fj.00-0571hyp; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; Karbat I, 2004, FASEB J, V18, P683, DOI 10.1096/fj.03-0733com; Karbat I, 2007, J MOL BIOL, V366, P586, DOI 10.1016/j.jmb.2006.10.085; Leipold E, 2006, MOL PHARMACOL, V70, P340, DOI 10.1124/mol.106.024034; Martin-Eauclaire M. F., 1995, Handbook of neurotoxicology., P683; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Oren DA, 1998, STRUCTURE, V6, P1095, DOI 10.1016/S0969-2126(98)00111-7; Pimenta AMC, 2001, RAPID COMMUN MASS SP, V15, P1562, DOI 10.1002/rcm.415; Pintar A, 1999, J MOL BIOL, V287, P359, DOI 10.1006/jmbi.1999.2611; Purkerson-Parker SL, 2000, CHEM BIOL, V7, P385, DOI 10.1016/S1074-5521(00)00119-8; Shichor I, 2002, J NEUROSCI, V22, P4364, DOI 10.1523/JNEUROSCI.22-11-04364.2002; Tedford HW, 2004, TOXICON, V43, P601, DOI 10.1016/j.toxicon.2004.02.010; TRAINER VL, 1994, J BIOL CHEM, V269, P19904	39	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15169	15176		10.1074/jbc.M801229200	http://dx.doi.org/10.1074/jbc.M801229200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18339620	hybrid, Green Published			2022-12-25	WOS:000256232000033
J	Srimathi, T; Robbins, SL; Dubas, RL; Chang, H; Cheng, H; Roder, H; Park, YC				Srimathi, Thiagarajan; Robbins, Sheila L.; Dubas, Rachel L.; Chang, Helen; Cheng, Hong; Roder, Heinrich; Park, Young Chul			Mapping of POP1-binding site on pyrin domain of ASC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATE CASPASE-1; ONLY PROTEIN-2; INFLAMMASOME; REGULATOR; OLIGOMERIZATION; CRYOPYRIN/NALP3; PREDICTION; APOPTOSIS; COMPLEX	Apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) is an essential adaptor protein in the formation of a multiprotein complex that activates procaspase-1. ASC is also known as a modulator of NF-kappa B activation pathways. ASC has a bipartite domain structure, consisting of an N-terminal pyrin domain (PYD) and a C-terminal caspase-recruitment domain. The PYD of ASC (ASC_PYD) is known to interact with various PYD-containing intracellular danger signal sensors and PYD-only proteins. Using purified proteins, we characterized the in vitro interaction of ASC_ PYD with PYD-only protein 1 (POP1). POP1 specifically interacts with ASC_ PYD with a dissociation constant of 4.08 +/- 0.52 mu M but does not interact with Cryopyrin. NMR and mutagenesis experiments show that a negative electrostatic potential surface patch (EPSP) on ASC_PYD, consisting of the first (H1) and fourth (H4) helices, is essential in the interaction with POP1. A positive EPSP on POP1, consisting of the second (H2) and third (H3) helices, is a counterpart of this interaction. The interaction between ASC PYD and POP1 is similar to the interaction between caspase recruitment domains of Apaf-1 and pro-caspase-9. In addition, we present evidence that conformational changes at the long loop of ASC_PYD between the H2 and H3 helices can affect its interaction with POP1. Based on our observations, we propose that the positive EPSP of ASC_PYD, including the H2 and H3 helices, maybe the binding site for Cryopyrin, and the interaction with Cryopyrin may induce the dissociation of POP1 from ASC_PYD.	[Srimathi, Thiagarajan; Robbins, Sheila L.; Dubas, Rachel L.; Chang, Helen; Cheng, Hong; Roder, Heinrich; Park, Young Chul] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Park, YC (corresponding author), 333 Cottman Ave, Philadelphia, PA 19111 USA.	Young.Park@fccc.edu	Roder, Heinrich/B-3455-2009	Roder, Heinrich/0000-0003-1860-2491				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; DOFLEUTNER A, 2007, VIRUS GENES, V35, P685; Dorfleutner A, 2007, INFECT IMMUN, V75, P1484, DOI 10.1128/IAI.01315-06; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Hiller S, 2003, STRUCTURE, V11, P1199, DOI 10.1016/j.str.2003.08.009; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; McConnell BB, 2004, APOPTOSIS, V9, P5, DOI 10.1023/B:APPT.0000012117.32430.0c; McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987; Moriya M, 2005, BIOCHEMISTRY-US, V44, P575, DOI 10.1021/bi048374i; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stehlik C, 2003, BIOCHEM J, V373, P101, DOI 10.1042/BJ20030304; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	36	39	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15390	15398		10.1074/jbc.M801589200	http://dx.doi.org/10.1074/jbc.M801589200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18362139	hybrid, Green Published			2022-12-25	WOS:000256232000057
J	Shanmugam, M; Hernandez, N				Shanmugam, Mayilvahanan; Hernandez, Nouria			Mitotic functions for SNAP45, a subunit of the small nuclear RNA-activating protein complex SNAP(c)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; POLYMERASES II; BRCA1-DEPENDENT UBIQUITINATION; SNRNA TRANSCRIPTION; DNA-REPLICATION; CELL-CYCLE; CENTROSOME; PROMOTER; GENES; BRCA1	The small nuclear RNA-activating protein complex SNAP(c) is required for transcription of small nuclear RNA genes and binds to a proximal sequence element in their promoters. SNAP(c) contains five types of subunits stably associated with each other. Here we show that one of these polypeptides, SNAP45, also known as PTF delta, localizes to centrosomes during parts of mitosis, as well as to the spindle midzone during anaphase and the mid-body during telophase. Consistent with localization to these mitotic structures, both down- and up-regulation of SNAP45 lead to a G(2)/M arrest with cells displaying abnormal mitotic structures. In contrast, down- regulation of SNAP190, another SNAPc subunit, leads to an accumulation of cells with a G(0)/G(1) DNA content. These results are consistent with the proposal that SNAP45 plays two roles in the cell, one as a subunit of the transcription factor SNAPc and another as a factor required for proper mitotic progression.	[Hernandez, Nouria] Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, CH-1015 Lausanne, Switzerland; [Shanmugam, Mayilvahanan] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Lausanne; Cold Spring Harbor Laboratory	Hernandez, N (corresponding author), Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, Genopode Bldg,Quartier Sorge, CH-1015 Lausanne, Switzerland.	Nouria.Hernandez@unil.ch		Hernandez, Nouria/0000-0003-1465-4585	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM 38810] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038810] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Borgne A, 1999, J BIOL CHEM, V274, P11977, DOI 10.1074/jbc.274.17.11977; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; COMPTON DA, 1992, J CELL BIOL, V116, P1395, DOI 10.1083/jcb.116.6.1395; Emran F, 2006, GENE, V377, P96, DOI 10.1016/j.gene.2006.03.012; Grant PA, 1998, TRENDS CELL BIOL, V8, P193, DOI 10.1016/S0962-8924(98)01263-X; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Henry RW, 1998, COLD SPRING HARB SYM, V63, P111, DOI 10.1101/sqb.1998.63.111; Henry RW, 1998, GENE DEV, V12, P2664, DOI 10.1101/gad.12.17.2664; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Li C, 2004, MOL CELL BIOL, V24, P1897, DOI 10.1128/MCB.24.5.1897-1906.2004; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Ma B, 2001, J BIOL CHEM, V276, P5027, DOI 10.1074/jbc.M009301200; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Mittal V, 1999, GENE DEV, V13, P1807, DOI 10.1101/gad.13.14.1807; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Ohtani M, 2005, PLANT J, V43, P479, DOI 10.1111/j.1365-313X.2005.02469.x; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Pombo A, 1998, EMBO J, V17, P1768, DOI 10.1093/emboj/17.6.1768; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; RUPPERT S, 1993, NATURE, V362, P175, DOI 10.1038/362175a0; Sadowski CL, 1996, P NATL ACAD SCI USA, V93, P4289, DOI 10.1073/pnas.93.9.4289; Sankaran S, 2006, CANCER RES, V66, P4100, DOI 10.1158/0008-5472.CAN-05-4430; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; YANG CH, 1992, J CELL BIOL, V116, P1303, DOI 10.1083/jcb.116.6.1303; Yoon JB, 1996, MOL CELL BIOL, V16, P1; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	37	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2008	283	21					14845	14856		10.1074/jbc.M800833200	http://dx.doi.org/10.1074/jbc.M800833200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302BL	18356157	Green Published, hybrid			2022-12-25	WOS:000255941400072
J	Angelini, S; Gerez, C; Ollagnier-de Choudens, S; Sanakis, Y; Fontecave, M; Barras, F; Py, B				Angelini, Sandra; Gerez, Catherine; Ollagnier-de Choudens, Sandrine; Sanakis, Yiannis; Fontecave, Marc; Barras, Frederic; Py, Beatrice			NfuA, a new factor required for maturing Fe/S proteins in Escherichia coli under oxidative stress and iron starvation conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR CLUSTER; CYSTEINE DESULFURASE; SCAFFOLD PROTEIN; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; AZOTOBACTER-VINELANDII; CRYSTAL-STRUCTURE; 2FE-2S CLUSTER; NIFU PROTEIN; BIOGENESIS	Iron/sulfur (Fe/S) proteins are central to the functioning of cells in both prokaryotes and eukaryotes. Here, we show that the yhgI gene, which we renamed nfuA, encodes a two-domain protein that is required for Fe/S biogenesis in Escherichia coli. The N-terminal domain resembles the so-called Fe/S A-type scaffold but, curiously, has lost the functionally important Cys residues. The C-terminal domain shares sequence identity with Nfu proteins. Mossbauer and UV-visible spectroscopic analyses revealed that, upon reconstitution, NfuA binds a [4Fe-4S] cluster. Moreover, NfuA can transfer this cluster to apo-aconitase. Mutagenesis studies indicated that the N-and C-terminal domains are important for NfuA function in vivo. Similarly, the functional importance of Cys residues present in the Nfu-like domain was demonstrated in vivo by introducing Cys-->Ser mutations. In vivo investigations revealed that the nfuA gene is important for E. coli to sustain oxidative stress and iron starvation. Also, combining nfuA with either isc or suf mutations led to additive phenotypic deficiencies, indicating that NfuA is a bona fide new player in Isc-and Suf-dependent Fe/S biogenesis pathways. Taken together, these data demonstrate that NfuA intervenes in the maturation of apoproteins in E. coli, allowing them to acquire Fe/S clusters. By taking into account results from numerous previous transcriptomic studies that had suggested a link between NfuA and protein misfolding, we discuss the possibility that NfuA could act as a scaffold/chaperone for damaged Fe/S proteins.	[Angelini, Sandra; Barras, Frederic; Py, Beatrice] CNRS, Chim Bacterienne Lab, UPR 9043, F-13402 Marseille 20, France; [Barras, Frederic; Py, Beatrice] Univ Aix Marseille 2, F-13009 Marseille, France; [Gerez, Catherine; Ollagnier-de Choudens, Sandrine; Fontecave, Marc] CNRS, UMR 5249, Lab Chim & Biol Met, F-38054 Grenoble, France; [Gerez, Catherine; Ollagnier-de Choudens, Sandrine; Fontecave, Marc] CEA, Lab Chim & Biol Met, F-38054 Grenoble, France; [Gerez, Catherine; Ollagnier-de Choudens, Sandrine; Fontecave, Marc] Univ Grenoble 1, F-38054 Grenoble, France; [Sanakis, Yiannis] NCSR Demokritos, Inst Mat Sci, Athens 15310, Greece	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); National Centre of Scientific Research "Demokritos"	Py, B (corresponding author), CNRS, Chim Bacterienne Lab, UPR 9043, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	py@ibsm.cnrs-mrs.fr		Barras, Frederic/0000-0003-3458-2574; Angelini, Sandra/0000-0002-8671-8018; Ollagnier de Choudens, Sandrine/0000-0002-0080-6659				Agar JN, 2000, J BIOL INORG CHEM, V5, P167, DOI 10.1007/s007750050361; Balasubramanian R, 2006, J BACTERIOL, V188, P3182, DOI 10.1128/JB.188.9.3182-3191.2006; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Bandyopadhyay S, 2008, J BIOL CHEM, V283, P14092, DOI 10.1074/jbc.M709161200; Barras F, 2005, ADV MICROB PHYSIOL, V50, P41, DOI 10.1016/S0065-2911(05)50002-X; Bilder PW, 2004, BIOCHEMISTRY-US, V43, P133, DOI 10.1021/bi035440s; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cupp-Vickery JR, 2004, J MOL BIOL, V338, P127, DOI 10.1016/j.jmb.2004.02.027; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; Dos Santos PC, 2004, J BIOL CHEM, V279, P19705, DOI 10.1074/jbc.M400278200; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; FU WG, 1994, BIOCHEMISTRY-US, V33, P13455, DOI 10.1021/bi00249a034; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Hwang DM, 1996, J MOL EVOL, V43, P536, DOI 10.1007/PL00006114; IUCHI S, 2004, ZINC FINGER PROTEINS; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; Lesley SA, 2002, PROTEIN ENG, V15, P153, DOI 10.1093/protein/15.2.153; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; Mihara H, 2000, J BIOCHEM-TOKYO, V127, P559, DOI 10.1093/oxfordjournals.jbchem.a022641; Morimoto K, 2006, J MOL BIOL, V360, P117, DOI 10.1016/j.jmb.2006.04.067; Nachin L, 2001, MOL MICROBIOL, V39, P960, DOI 10.1046/j.1365-2958.2001.02288.x; Nishio K, 2000, J BIOL CHEM, V275, P22615, DOI 10.1074/jbc.C000279200; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Porco A, 1998, J BASIC MICROB, V38, P395, DOI 10.1002/(SICI)1521-4028(199811)38:5/6<395::AID-JOBM395>3.3.CO;2-Z; Rubio LM, 2005, J BACTERIOL, V187, P405, DOI 10.1128/JB.187.2.405-414.2005; Saio T, 2007, J BIOCHEM, V142, P113, DOI 10.1093/jb/mvm120; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Shaw KJ, 2003, J MOL MICROB BIOTECH, V5, P105, DOI 10.1159/000069981; Smith AD, 2005, BIOCHEMISTRY-US, V44, P12955, DOI 10.1021/bi051257i; Tamarit J, 2000, J BIOL CHEM, V275, P15669, DOI 10.1074/jbc.275.21.15669; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Tong WH, 2003, P NATL ACAD SCI USA, V100, P9762, DOI 10.1073/pnas.1732541100; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Yuvaniyama P, 2000, P NATL ACAD SCI USA, V97, P599, DOI 10.1073/pnas.97.2.599; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754	44	109	111	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					14084	14091		10.1074/jbc.M709405200	http://dx.doi.org/10.1074/jbc.M709405200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18339628	hybrid			2022-12-25	WOS:000255728200062
J	Cheung, J; Bingman, CA; Reyngold, M; Hendrickson, WA; Waldburger, CD				Cheung, Jonah; Bingman, Craig A.; Reyngold, Marsha; Hendrickson, Wayne A.; Waldburger, Carey D.			Crystal structure of a functional dimer of the PhoQ sensor domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; PROTEIN STRUCTURES; DISTANCE MATRICES; HISTIDINE KINASES; SIGNAL-DETECTION; PAS DOMAIN; MG2+; CRYSTALLOGRAPHY	The PhoP-PhoQ two-component system is a well studied bacterial signaling system that regulates virulence and stress response. Catalytic activity of the histidine kinase sensor protein PhoQ is activated by low extracellular concentrations of divalent cations such as Mg2+, and subsequently the response regulator PhoP is activated in turn through a classic phosphotransfer pathway that is typical in such systems. The PhoQ sensor domains of enteric bacteria contain an acidic cluster of residues (EDDDDAE) that has been implicated in direct binding to divalent cations. We have determined crystal structures of the wildtype Escherichia coli PhoQ periplasmic sensor domain and of a mutant variant in which the acidic cluster was neutralized to conservative uncharged residues (QNNNNAQ). The PhoQ domain structure is similar to that of DcuS and CitA sensor domains, and this PhoQ-DcuS-CitA (PDC) sensor fold is seen to be distinct from the superficially similar PAS domain fold. Analysis of the wild-type structure reveals a dimer that allows for the formation of a salt bridge across the dimer interface between Arg-50' and Asp-179 and with nickel ions bound to aspartate residues in the acidic cluster. The physiological importance of the salt bridge to in vivo PhoQ function has been confirmed by mutagenesis. The mutant structure has an alternative, non-physiological dimeric association.	[Cheung, Jonah; Bingman, Craig A.; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Reyngold, Marsha; Waldburger, Carey D.] Columbia Univ, Dept Microbiol, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Waldburger, CD (corresponding author), William Paterson Univ, Dept Biol, Wayne, NJ 07470 USA.	WaldburgerC@wpunj.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034102, R37GM034102] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [AI41566] Funding Source: Medline; NIGMS NIH HHS [GM34102] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Dutta R, 1999, MOL MICROBIOL, V34, P633, DOI 10.1046/j.1365-2958.1999.01646.x; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Genick UK, 1997, SCIENCE, V275, P1471, DOI 10.1126/science.275.5305.1471; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; HENDRICKSON WA, 1979, ACTA CRYSTALLOGR A, V35, P158, DOI 10.1107/S0567739479000279; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaspar S, 1999, MOL MICROBIOL, V33, P858, DOI 10.1046/j.1365-2958.1999.01536.x; KLEYWEGT GJ, 1994, CCP4 ESF EACBM NEWSL, V31, P9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lesley JA, 2001, J BIOL CHEM, V276, P30827, DOI 10.1074/jbc.M104262200; Minagawa S, 2005, BIOSCI BIOTECH BIOCH, V69, P1281, DOI 10.1271/bbb.69.1281; Monsieurs P, 2005, J MOL EVOL, V60, P462, DOI 10.1007/s00239-004-0212-7; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Razeto A, 2004, J MOL BIOL, V336, P319, DOI 10.1016/j.jmb.2003.12.057; Regelmann AG, 2002, J BACTERIOL, V184, P5468, DOI 10.1128/JB.184.19.5468-5478.2002; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Sanowar S, 2005, BIOCHEM J, V390, P769, DOI 10.1042/BJ20050060; Schneider TR, 2000, ACTA CRYSTALLOGR D, V56, P714, DOI 10.1107/S0907444900003723; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Vescovi EG, 1997, J BIOL CHEM, V272, P1440, DOI 10.1074/jbc.272.3.1440; Waldburger CD, 1996, J BIOL CHEM, V271, P26630, DOI 10.1074/jbc.271.43.26630; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; WOLANIN PM, 2002, GENOME BIOL; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	44	71	73	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13762	13770		10.1074/jbc.M710592200	http://dx.doi.org/10.1074/jbc.M710592200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18348979	hybrid, Green Published			2022-12-25	WOS:000255728200028
J	Lu, XD; Kovalev, GI; Chang, H; Kallin, E; Knudsen, G; Xia, L; Mishra, N; Ruiz, P; Li, E; Su, LS; Zhang, Y				Lu, Xiangdong; Kovalev, Grigoriy I.; Chang, Hua; Kallin, Eric; Knudsen, Geoffrey; Xia, Li; Mishra, Nilamadhab; Ruiz, Phillip; Li, En; Su, Lishan; Zhang, Yi			Inactivation of NuRD component Mta2 causes abnormal T cell activation and lupus-like autoimmune disease in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; GENE-EXPRESSION; COMPLEX; DIFFERENTIATION; MBD3; OVEREXPRESSION; METHYLATION; METASTASIS; CARCINOMAS; MI-2/NURD	Dynamic changes in chromatin structure through ATP-dependent remodeling and covalent modifications on histones play important roles in transcription regulation. Among the many chromatin modifiers identified, the NuRD (nucleosome remodeling histone deacetylase) complex is unique because it possesses both nucleosome remodeling and histone deacetylase activities. To understand the biological function of the NuRD complex, we generated a knock-out mouse model of the Mta2 (metastasis-associated protein 2) gene, which encodes a NuRD-specific component. Mta2 null mice exhibited partial embryonic lethality. The surviving mice developed lupus-like autoimmune symptoms including skin lesions, bodyweight loss, glomerulonephritis, liver inflammation, and production of autoantibodies. Transplantation of bone marrow cells from Mta2 null mice recapitulated some of the symptoms including skin lesion and bodyweight loss in the recipient mice. Mta2 null T lymphocytes showed normal development but hyperproliferation upon stimulation, which correlates with hyperinduction of interleukin (IL)-2, IL-4, and interferon (IFN)-gamma. T cell hyperproliferation, but not other autoimmune symptoms, was observed in T cell-specific Mta2 knock-out mice. Mta2 null T cells produced more IL-4 and IFN-gamma under Th2 activation conditions, but normal levels of IL-4 and IFN-gamma under Th1 activation conditions. Furthermore, we found that IL-4 is a direct target gene of Mta2. Our study suggests that Mta2/NuRD is involved in modulating IL-4 and IFN-gamma expression in T cell immune responses, and gene expression in non-T cells plays an important role in controlling autoimmunity.	[Kovalev, Grigoriy I.; Knudsen, Geoffrey; Su, Lishan] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Lu, Xiangdong; Kallin, Eric; Xia, Li; Zhang, Yi] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Lu, Xiangdong; Kallin, Eric; Xia, Li; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Chang, Hua; Li, En] Novartis Inst Biomed Res Inc, Models Dis Ctr, Cambridge, MA 02139 USA; [Mishra, Nilamadhab] Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; [Ruiz, Phillip] Univ Miami, Dept Pathol, Miami, FL 33136 USA	University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Novartis; Wake Forest University; University of Miami	Su, LS (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	lsu@med.unc.edu	Kovalev, Grigoriy/V-8768-2018	Zhang, Yi/0000-0002-2789-0811; Kovalev, Grigoriy/0000-0003-4346-3585	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL072240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI048407, R01AI077454, R01AI048407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063067] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [HL72240] Funding Source: Medline; NIAID NIH HHS [R01 AI077454, AI48407] Funding Source: Medline; NIGMS NIH HHS [GM63067] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Feng Q, 2003, CURR TOP MICROBIOL, V274, P269; Feng Q, 2001, GENE DEV, V15, P827; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; KANAUCHI H, 1991, J INVEST DERMATOL, V96, P478, DOI 10.1111/1523-1747.ep12470176; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kovalev GI, 2001, J IMMUNOL, V167, P3285, DOI 10.4049/jimmunol.167.6.3285; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lomvardas S, 2002, CELL, V110, P261, DOI 10.1016/S0092-8674(02)00822-X; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; ROUBINIAN JR, 1978, J EXP MED, V147, P1568, DOI 10.1084/jem.147.6.1568; Salvador JM, 2002, IMMUNITY, V16, P499, DOI 10.1016/S1074-7613(02)00302-3; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; Toh Y, 1997, INT J CANCER, V74, P459, DOI 10.1002/(SICI)1097-0215(19970822)74:4<459::AID-IJC18>3.3.CO;2-H; Toh Y, 1999, BRIT J CANCER, V79, P1723, DOI 10.1038/sj.bjc.6690274; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	37	43	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2008	283	20					13825	13833		10.1074/jbc.M801275200	http://dx.doi.org/10.1074/jbc.M801275200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	299AM	18353770	Green Published, hybrid			2022-12-25	WOS:000255728200035
J	Gou, DM; Mishra, A; Weng, TT; Su, LJ; Chintagari, NR; Wang, ZX; Zhang, HH; Gao, L; Wang, PC; Stricker, HM; Liu, L				Gou, Deming; Mishra, Amarjit; Weng, Tingting; Su, Lijing; Chintagari, Narendranath Reddy; Wang, Zhixin; Zhang, Honghao; Gao, Li; Wang, Pengcheng; Stricker, Heidi M.; Liu, Lin			Annexin A2 interactions with Rab14 in alveolar type II cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG SURFACTANT SECRETION; BINDING PROTEIN; LAMELLAR BODY; ENDOTHELIAL-CELLS; MEMBRANE-FUSION; PLASMA-MEMBRANE; IN-VITRO; RAT LUNG; EXOCYTOSIS; TETRAMER	Annexin A2, a calcium-dependent phospholipid-binding protein, is abundantly expressed in alveolar type II cells where it plays a role in lung surfactant secretion. Nevertheless, little is known about the details of its cellular pathways. To identify annexin A2-regulated or associated proteins, we silenced endogenous annexin A2 expression in rat alveolar type II cells by RNA interference and assessed the change of the cellular transcriptome by DNA microarray analysis. The loss of annexin A2 resulted in the change of 61 genes. Thirteen of the selected genes (11 down- regulated and 2 up-regulated genes) were validated by real time quantitative PCR. When the loss of rat annexin A2 was rescued by overexpressing EGFP-tagged human annexin A2, six of seven selected targets returned to their normal expression level, indicating that these genes are indeed annexin A2-associated targets. One of the targets, Rab14, co-immunoprecipitated with annexin A2. Rab14 also co-localized in part with annexin A2 and lamellar bodies in alveolar type II cells. The silencing of Rab14 resulted in a decrease in surfactant secretion, suggesting that Rab14 may play a role in surfactant secretion.	[Gou, Deming; Mishra, Amarjit; Weng, Tingting; Su, Lijing; Chintagari, Narendranath Reddy; Wang, Zhixin; Zhang, Honghao; Gao, Li; Wang, Pengcheng; Stricker, Heidi M.; Liu, Lin] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Liu, L (corresponding author), Oklahoma State Univ, Dept Physiol Sci, 264 McElroy Hall, Stillwater, OK 74078 USA.	lin.liu@okstate.edu	wang, zhixin/GZH-2500-2022; MISHRA, AMARJIT/I-4928-2019; MISHRA, AMARJIT/D-7504-2016	MISHRA, AMARJIT/0000-0002-3777-0338; MISHRA, AMARJIT/0000-0002-3777-0338; Zhang, Honghao/0000-0002-2338-6992	NHLBI NIH HHS [R01 HL-083188, R01 HL083188, R01 HL-071628, R01 HL052146, R01 HL-052146, R01 HL071628] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083188, R01HL052146, R01HL071628] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALI SM, 1989, NATURE, V340, P313, DOI 10.1038/340313a0; Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; Benli M, 1996, EMBO J, V15, P6460, DOI 10.1002/j.1460-2075.1996.tb01037.x; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Chattopadhyay S, 2003, J BIOL CHEM, V278, P39675, DOI 10.1074/jbc.M212594200; Chen ZM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-47; Chen ZM, 2005, PHYSIOL GENOMICS, V21, P284, DOI 10.1152/physiolgenomics.00236.2004; Chintagari NR, 2006, AM J RESP CELL MOL, V34, P677, DOI 10.1165/rcmb.2005-0418OC; Dietl P, 2005, ANNU REV PHYSIOL, V67, P595, DOI 10.1146/annurev.physiol.67.040403.102553; DOBBS LG, 1986, AM REV RESPIR DIS, V134, P141; Eberhard DA, 2001, J CELL SCI, V114, P3155; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Filipenko NR, 2004, J BIOL CHEM, V279, P8723, DOI 10.1074/jbc.M311951200; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gou D, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh129; GOU D, 2004, ANNEXINS, V1, P31; Gou DM, 2007, J GENE MED, V9, P751, DOI 10.1002/jgm.1080; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; Haller T, 1999, AM J PHYSIOL-LUNG C, V277, pL893, DOI 10.1152/ajplung.1999.277.5.L893; HUBAISHY I, 1995, BIOCHEMISTRY-US, V34, P14527, DOI 10.1021/bi00044a031; Ichimura H, 2006, AM J PHYSIOL-LUNG C, V291, pL596, DOI 10.1152/ajplung.00036.2006; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; KARASIK A, 1988, J BIOL CHEM, V263, P11862; Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Liu L, 1996, AM J PHYSIOL-LUNG C, V270, pL668, DOI 10.1152/ajplung.1996.270.4.L668; Liu L, 1999, CELL SIGNAL, V11, P317, DOI 10.1016/S0898-6568(98)00047-3; Liu L, 2002, EUR J BIOCHEM, V269, P4277, DOI 10.1046/j.1432-1033.2002.03118.x; Liu L, 1997, ARCH BIOCHEM BIOPHYS, V342, P322, DOI 10.1006/abbi.1997.0140; Mason RJ, 2002, AM J PHYSIOL-LUNG C, V282, pL249, DOI 10.1152/ajplung.00027.2001; Nilius B, 1996, J BIOL CHEM, V271, P30631, DOI 10.1074/jbc.271.48.30631; Osanai K, 2005, BIOL CHEM, V386, P143, DOI 10.1515/BC.2005.018; Osanai K, 2001, AM J PATHOL, V158, P1665, DOI 10.1016/S0002-9440(10)64122-3; Ren MD, 1996, P NATL ACAD SCI USA, V93, P5151, DOI 10.1073/pnas.93.10.5151; Rowan WH, 2002, BIOCHEMISTRY-US, V41, P1409, DOI 10.1021/bi0119767; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; van Weeren L, 2004, AM J RESP CELL MOL, V30, P288, DOI 10.1165/rcmb.2003-0264OC; Yaekura K, 2003, J BIOL CHEM, V278, P9715, DOI 10.1074/jbc.M211352200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	47	22	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 9	2008	283	19					13156	13164		10.1074/jbc.M801532200	http://dx.doi.org/10.1074/jbc.M801532200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	295UQ	18332131	Green Published, hybrid			2022-12-25	WOS:000255499800055
J	Yoshida, Y; Yang, J; Peaker, PE; Kato, H; Bush, CA; Cisar, JO				Yoshida, Yasuo; Yang, Jinghua; Peaker, Paule-Esther; Kato, Hirohisa; Bush, C. Allen; Cisar, John O.			Molecular and antigenic characterization of a Streptococcus oralis coaggregation receptor polysaccharide by carbohydrate engineering in Streptococcus gordonii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE POLYSACCHARIDE; VIRIDANS GROUP STREPTOCOCCI; CAPSULAR POLYSACCHARIDE; GENETIC-TRANSFORMATION; ACTINOMYCES-VISCOSUS; WALL POLYSACCHARIDES; FUNCTIONAL-ANALYSIS; BIOSYNTHESIS; COMPETENCE; IDENTIFICATION	The coaggregation receptor polysaccharides (RPS) of Streptococcus oralis and related species are recognized by lectin-like adhesins on other members of the oral biofilm community and by RPS-specific antibodies. The former interactions involve beta-GalNAc or beta-Gal containing host-like motifs in the oligosaccharide repeating units of these polysaccharides, whereas the latter involves features of these molecules that are immunogenic. In the present investigation, the molecular and corresponding structural basis for the serotype specificity of S. oralis ATCC 10557 RPS was determined by engineering the production of this polysaccharide in transformable Streptococcus gordonii 38. This involved the systematic replacement of genes in the rps cluster of strain 38 with different but related genes from S. oralis 10557 and structural characterization of the resulting polysaccharides. The results identify four unique genes in the rps cluster of strain 10557. These include wefI for an alpha-Gal transferase, wefJ for a GalNAc-1-phosphotransferase that has a unique acceptor specificity, wefK for an acetyl transferase that acts at two positions in the hexasaccharide repeating unit, and a novel wzy associated with the beta 1-3 linkage between these units. The serotype specificity of engineered polysaccharides correlated with the wefI-dependent presence of alpha-Gal in these molecules rather than with partial O-acetylation or with the linkage between repeating units. The findings illustrate a direct approach for defining the molecular basis of polysaccharide structure and antigenicity.	[Yoshida, Yasuo; Yang, Jinghua; Cisar, John O.] NIH, NIDCR, Oral Infect & Immun Branch, Bethesda, MD 20892 USA; [Yoshida, Yasuo; Kato, Hirohisa] Iwate Med Univ, Sch Dent, Dept Dent Pharmacol, Morioka, Iwate 0208505, Japan; [Peaker, Paule-Esther; Bush, C. Allen] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Iwate Medical University; University System of Maryland; University of Maryland Baltimore County	Cisar, JO (corresponding author), NIH, NIDCR, Oral Infect & Immun Branch, Bldg 30,Rm 3A-301,30 Convent Dr, Bethesda, MD 20892 USA.	john.cisar@nih.gov			NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000672] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ABEYGUNAWARDANA C, 1990, BIOCHEMISTRY-US, V29, P234, DOI 10.1021/bi00453a032; ABEYGUNAWARDANA C, 1991, BIOCHEMISTRY-US, V30, P8568, DOI 10.1021/bi00099a012; ABEYGUNAWARDANA C, 1991, BIOCHEMISTRY-US, V30, P6528, DOI 10.1021/bi00240a025; ABEYGUNAWARDANA C, 1989, CARBOHYD RES, V191, P279, DOI 10.1016/0008-6215(89)85071-2; Abeygunawardana C, 1993, ADV BIOPHYSICAL CHEM, V3, P199; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; BRIDGE PD, 1983, J GEN MICROBIOL, V129, P565; CASSELS FJ, 1995, J IND MICROBIOL, V15, P176, DOI 10.1007/BF01569823; Cisar JO, 1997, INFECT IMMUN, V65, P5035, DOI 10.1128/IAI.65.12.5035-5041.1997; CISAR JO, 1995, GLYCOBIOLOGY, V5, P655, DOI 10.1093/glycob/5.7.655; CISAR JO, 1979, INFECT IMMUN, V24, P742, DOI 10.1128/IAI.24.3.742-752.1979; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; GLUSHKA J, 1992, BIOCHEMISTRY-US, V31, P10741, DOI 10.1021/bi00159a014; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; HAWLEY RJ, 1980, ANTIMICROB AGENTS CH, V17, P372, DOI 10.1128/AAC.17.3.372; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HSU SD, 1994, MICROB ECOL HEALTH D, V7, P125, DOI 10.3109/08910609409141342; Jiang SM, 2001, INFECT IMMUN, V69, P1244, DOI 10.1128/IAI.69.3.1244-1255.2001; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; Kolkman MAB, 1997, J BIOL CHEM, V272, P19502, DOI 10.1074/jbc.272.31.19502; LEBLANC DJ, 1992, PLASMID, V28, P130, DOI 10.1016/0147-619X(92)90044-B; Lee MS, 1999, J BACTERIOL, V181, P5004, DOI 10.1128/JB.181.16.5004-5016.1999; Lunsford RD, 1996, J BACTERIOL, V178, P5831, DOI 10.1128/jb.178.19.5831-5835.1996; MCINTIRE FC, 1988, J BACTERIOL, V170, P2229, DOI 10.1128/jb.170.5.2229-2235.1988; Morona JK, 1999, J BACTERIOL, V181, P5355, DOI 10.1128/JB.181.17.5355-5364.1999; OCHMAN H, 1988, GENETICS, V120, P621; ORSKOV F, 1979, J EXP MED, V149, P669, DOI 10.1084/jem.149.3.669; Palmer RJ, 2003, J BACTERIOL, V185, P3400, DOI 10.1128/JB.185.11.3400-3409.2003; Palmer RJ, 2001, INFECT IMMUN, V69, P5794, DOI 10.1128/IAI.69.9.5794-5804.2001; REDDY GP, 1994, GLYCOBIOLOGY, V4, P183, DOI 10.1093/glycob/4.2.183; SLAUCH JM, 1995, INFECT IMMUN, V63, P437, DOI 10.1128/IAI.63.2.437-441.1995; Takahashi Y, 2002, ORAL MICROBIOL IMMUN, V17, P257, DOI 10.1034/j.1399-302X.2002.170409.x; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; WHITE JC, 1946, J BACTERIOL, V51, P717, DOI 10.1128/JB.51.6.717-722.1946; Xu DQ, 2003, J BACTERIOL, V185, P5419, DOI 10.1128/JB.185.18.5419-5430.2003; Yoshida Y, 2005, MOL MICROBIOL, V58, P244, DOI 10.1111/j.1365-2958.2005.04820.x; Yoshida Y, 2006, J BACTERIOL, V188, P4125, DOI 10.1128/JB.01843-05	39	27	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12654	12664		10.1074/jbc.M801412200	http://dx.doi.org/10.1074/jbc.M801412200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18303023	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000255340000082
J	Huen, MSY; Sy, SMH; van Deursen, JM; Chen, JJ				Huen, Michael S. Y.; Sy, Shirley M. -H.; van Deursen, Jan M.; Chen, Junjie			Direct interaction between SET8 and proliferating cell nuclear antigen couples H4-K20 methylation with DNA replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H4; STRUCTURAL BASIS; GENE-EXPRESSION; S-PHASE; METHYLTRANSFERASE; CHROMATIN; TRIMETHYLATION; PR-SET7; L3MBTL1; HETEROCHROMATIN	Chromatin endowed by histone modifications governs chromatin structure, which in turn represents a means to regulate cellular processes, including transcription and heterochromatin formation. Recent evidence revealed a plethora of enzymes that catalyze specific histone modifications for epigenetic maintenance, and dysregulation of which contributes to tumorigenesis and developmental defects. The histone methyltransferase SET8 (also known as Pr-Set7) was previously reported to monomethylate Lys(20) of histone H4. However, the temporal and spatial control of SET8 activity remains elusive. Here, we provide evidence to support that SET8 monomethylates Lys(20) of histone H4 during S phase by tethering to proliferating cell nuclear antigen via a putative proliferating cell nuclear antigen-interacting protein box. In addition, we show that SET8 function is required for S phase progression. Finally, deletion of SET8 in mice causes embryonic lethality, suggesting that SET8 plays an important role in mammalian embryogenesis.	[Huen, Michael S. Y.; Sy, Shirley M. -H.; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA; [van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Pediat, Rochester, MN 55905 USA	Yale University; Mayo Clinic	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, 333 Cedar St, New Haven, CT 06520 USA.	junjie.chen@yale.edu	Huen, Michael Shing Yan/E-9862-2010	Huen, Michael Shing-Yan/0000-0003-1774-2425; Sy, Ming Hui/0000-0002-2731-6692	NATIONAL CANCER INSTITUTE [R01CA100109, P50CA116201] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA100109, R01 CA100109-07, CA100109] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yin YL, 2005, J BIOL CHEM, V280, P30025, DOI 10.1074/jbc.M501691200	33	104	106	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11073	11077		10.1074/jbc.C700242200	http://dx.doi.org/10.1074/jbc.C700242200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18319261	Green Published, hybrid			2022-12-25	WOS:000255067400002
J	Morgan, OW; Rodrigues, B; Elston, T; Verlander, NQ; Brown, DFJ; Brazier, J; Reacher, M				Morgan, Oliver W.; Rodrigues, Boaventura; Elston, Tony; Verlander, Neville Q.; Brown, Derek F. J.; Brazier, Jonathan; Reacher, Mark			Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study	PLOS ONE			English	Article							NORTH-AMERICA; DISEASE; EPIDEMIC; STRAIN; DIARRHEA; OUTBREAKS	Background: Clostridium difficile is a leading infectious cause of health care associated diarrhoea. Several industrialised countries have reported increased C. difficile infections and outbreaks, which have been attributed to the emergent PCR ribotype 027 strain. Methods and Findings: We conducted a case-case study to compare severity of C. difficile disease for patients with 027 versus non-027 ribotypes. We retrospectively collected clinical information about 123/136 patients with C. difficile infections admitted to hospitals in the East of England region in 2006 and from whom stool isolates were cultured and ribotyped as part of an earlier national survey. We defined severe C. difficile disease as having one or more of shock, paralytic ileus, pseudo membranous colitis or toxic megacolon. Patient median age was 83 years old (range 3 to 98, interquartile range 75 to 89), 86% were prescribed antibiotics in the eight weeks before illness onset, 41% had ribotype 027 and 30-day all cause mortality during hospital admission was 21%. Severe disease occurred in 24% (95% CI 13% to 37%) and 17% (95% CI 9% to 27%) of patients with PCR ribotype 027 and non-027 ribotypes respectively. In a multivariable model, ribotype 027 was not associated with severe disease after adjusting for sex, discharge from hospital prior to 60 days of current admission, gastroenteritis on admission, number of initiator antibiotics for C. difficile disease, and hospital where the patient was admitted. Conclusions: Our study found no evidence to support previous assertions that ribotype 027 is more virulent than other PCR ribotypes. This finding raises questions about the contribution of this strain to the recent increase in C. difficile disease throughout North America and Europe.	[Morgan, Oliver W.; Reacher, Mark] E England Reg Epidemiol Unit, Hlth Protect Agcy, Cambridge, England; [Rodrigues, Boaventura] Eastern Deanery Public Hlth Train Scheme, Cambridge, England; [Elston, Tony] Essex Rivers NHS Trust, Colchester, Essex, England; [Verlander, Neville Q.] Ctr Infect, Statist, Model & Bioinformat Dept, Hlth Protect Agcy, London, England; [Brown, Derek F. J.] Addenbrookes Hosp, Clin Microbiol & Public Hlth Lab, Hlth Protect Agcy, Cambridge, England; [Brazier, Jonathan] Univ Hosp Wales, Natl Public Hlth Serv, Anaerobe Reference Lab, Cardiff, S Glam, Wales	Health Protection Agency; Health Protection Agency; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Health Protection Agency; University of Cambridge; Cardiff University	Morgan, OW (corresponding author), E England Reg Epidemiol Unit, Hlth Protect Agcy, Cambridge, England.	omorgan@bigfoot.com	Reacher, Mark/Y-6979-2018	Reacher, Mark/0000-0001-6871-7903				[Anonymous], 2007, Health Stat Q, P71; Archibald LK, 2004, J INFECT DIS, V189, P1585, DOI 10.1086/383045; Barbut F, 2007, INFECT CONT HOSP EP, V28, P131, DOI 10.1086/511794; Bartlett JG, 2005, NEW ENGL J MED, V353, P2503, DOI 10.1056/NEJMe058221; Bartlett JG, 2006, ANN INTERN MED, V145, P758, DOI 10.7326/0003-4819-145-10-200611210-00008; Beaulieu M, 2006, CLIN INFECT DIS, V42, P725, DOI 10.1086/500264; BRAZIER J, 2007, EUROSURVEILLANCE, V12; Goorhuis A, 2007, CLIN INFECT DIS, V45, P695, DOI 10.1086/520984; Hubert B, 2007, CLIN INFECT DIS, V44, P238, DOI 10.1086/510391; Kazakova SV, 2006, ARCH INTERN MED, V166, P2518, DOI 10.1001/archinte.166.22.2518; KUIJPER E, 2007, EURO SURVEILL, V12; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; Lauritsen J, EPIDATA DATA ENTRY D; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; McCarthy N, 1999, INT J EPIDEMIOL, V28, P764, DOI 10.1093/ije/28.4.764; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Musher DM, 2006, NEW ENGL J MED, V354, P1199; REDELINGS M, 2007, EMERG INFECT DIS; Rupnik M, 2001, MICROBIOL-UK, V147, P439, DOI 10.1099/00221287-147-2-439; *STATACORP, 2006, STAT STAT SOFTW REL; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Valiquette L, 2007, CLIN INFECT DIS, V45, pS112, DOI 10.1086/519258; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X	26	88	90	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1812	10.1371/journal.pone.0001812	http://dx.doi.org/10.1371/journal.pone.0001812			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350149	gold, Green Published, Green Submitted			2022-12-25	WOS:000260762300015
J	Kim, J; Lee, JH; Iyer, VR				Kim, Jonghwan; Lee, Ji-hoon; Iyer, Vishwanath R.			Global Identification of Myc Target Genes Reveals Its Direct Role in Mitochondrial Biogenesis and Its E-Box Usage In Vivo	PLOS ONE			English	Article								The Myc oncoprotein is a transcription factor involved in a variety of human cancers. Overexpression of Myc is associated with malignant transformation. In normal cells, Myc is induced by mitotic signals, and in turn, it regulates the expression of downstream target genes. Although diverse roles of Myc have been predicted from many previous studies, detailed functions of Myc targets are still unclear. By combining chromatin immunoprecipitation (ChIP) and promoter microarrays, we identified a total of 1469 Myc direct target genes, the majority of which are novel, in HeLa cells and human primary fibroblasts. We observed dramatic changes of Myc occupancy at its target promoters in foreskin fibroblasts in response to serum stimulation. Among the targets of Myc, 107 were nuclear encoded genes involved in mitochondrial biogenesis. Genes with important roles in mitochondrial replication and biogenesis, such as POLG, POLG2, and NRF1 were identified as direct targets of Myc, confirming a direct role for Myc in regulating mitochondrial biogenesis. Analysis of target promoter sequences revealed a strong preference for Myc occupancy at promoters containing one of several described consensus sequences, CACGTG, in vivo. This study thus sheds light on the transcriptional regulatory networks mediated by Myc in vivo.	[Kim, Jonghwan; Lee, Ji-hoon; Iyer, Vishwanath R.] Univ Texas Austin, Inst Cell & Mol Biol, Ctr Systems & Synthet Biol, Sect Mol Genet & Microbiol, Austin, TX USA	University of Texas System; University of Texas Austin	Kim, J (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Ctr Systems & Synthet Biol, Sect Mol Genet & Microbiol, Austin, TX USA.	vishy@mail.utexas.edu	Kim, Jonghwan/AAR-2815-2021	Kim, Jonghwan/0000-0002-9919-9843	NIH; NSF; US Army	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); US Army(United States Department of DefenseUnited States Army)	This work was supported in part by grants from the NIH, NSF, and the US Army.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BLACKWOOD EM, 1991, COLD SPRING HARB SYM, V56, P109; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bolton EC, 2003, GENOME RES, V13, P254, DOI 10.1101/gr.612203; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Gu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r42; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Izumi H, 2001, J CELL SCI, V114, P1533; James L, 2002, P NATL ACAD SCI USA, V99, P10429, DOI 10.1073/pnas.162369299; Kim JW, 2005, NAT METHODS, V2, P47, DOI 10.1038/NMETH726; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Morrish F, 2003, GENE DEV, V17, P240, DOI 10.1101/gad.1032503; Morrish F, 2003, CELL CYCLE, V2, P11, DOI 10.4161/cc.2.1.275; Nesbit CE, 2000, ONCOGENE, V19, P3200, DOI 10.1038/sj.onc.1203636; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; WICK M, 1994, J CELL SCI, V107, P227; Winkles JA, 1998, PROG NUCLEIC ACID RE, V58, P41; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	45	157	163	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1798	10.1371/journal.pone.0001798	http://dx.doi.org/10.1371/journal.pone.0001798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335064	Green Published, gold, Green Submitted			2022-12-25	WOS:000260723000046
J	Tamaki, T; Akatsuka, A; Okada, Y; Uchiyama, Y; Tono, K; Wada, M; Hoshi, A; Iwaguro, H; Iwasaki, H; Oyamada, A; Asahara, T				Tamaki, Tetsuro; Akatsuka, Akira; Okada, Yoshinori; Uchiyama, Yoshiyasu; Tono, Kayoko; Wada, Mika; Hoshi, Akio; Iwaguro, Hideki; Iwasaki, Hiroto; Oyamada, Akira; Asahara, Takayuki			Cardiomyocyte Formation by Skeletal Muscle-Derived Multi-Myogenic Stem Cells after Transplantation into Infarcted Myocardium	PLOS ONE			English	Article							CELLULAR CARDIOMYOPLASTY; INTERSTITIAL SPACES; CARDIAC-MUSCLE; PAX7; DIFFERENTIATION; PERFORMANCE; MYOBLASTS; RENEWAL; REPAIR; HEART	Background: Cellular cardiomyoplasty for myocardial infarction has been developed using various cell types. However, complete differentiation and/or trans-differentiation into cardiomyocytes have never occurred in these transplant studies, whereas functional contributions were reported. Methods and Results: Skeletal muscle interstitium-derived CD34(+)/CD45(-) (Sk-34) cells were purified from green fluorescent protein transgenic mice by flowcytometory. Cardiac differentiation of Sk-34 cells was examined by in vitro clonal culture and co-culture with embryonic cardiomyocytes, and in vivo transplantation into a nude rat myocardial infarction (MI) model (left ventricle). Lower relative expression of cardiomyogenic transcription factors, such as GATA-4, Nkx2-5, Isl-1, Mef2 and Hand2, was seen in clonal cell culture. However, vigorous expression of these factors was seen on co-culture with embryonic cardiomyocytes, together with formation of gap-junctions and synchronous contraction following sphere-like colony formation. At 4 weeks after transplantation of freshly isolated Sk-34 cells, donor cells exhibited typical cardiomyocyte structure with formation of gap-junctions, as well as intercalated discs and desmosomes, between donor and recipient and/or donor and donor cells. Fluorescence in situ hybridization (FISH) analysis detecting the rat and mouse genomic DNA and immunoelectron microscopy using anti-GFP revealed donor-derived cells. Transplanted Sk-34 cells were incorporated into infarcted portions of recipient muscles and contributed to cardiac reconstitution. Significant improvement in left ventricular function, as evaluated by transthoracic echocardiography and micro-tip conductance catheter, was also observed. Conclusions and Significance: Skeletal muscle-derived multipotent Sk-34 cells that can give rise to skeletal and smooth muscle cells as reported previously, also give rise to cardiac muscle cells as multi-myogenic stem cells, and thus are a potential source for practical cellular cardiomyoplasty.	[Tamaki, Tetsuro; Akatsuka, Akira; Okada, Yoshinori; Uchiyama, Yoshiyasu; Tono, Kayoko; Hoshi, Akio] Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, Kanagawa 2591100, Japan; [Tamaki, Tetsuro; Tono, Kayoko; Wada, Mika; Iwaguro, Hideki; Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med, Div Basic Clin Sci, Isehara, Kanagawa, Japan; [Akatsuka, Akira; Okada, Yoshinori] Tokai Univ, Sch Med, Teach & Res Support Ctr, Isehara, Kanagawa, Japan; [Uchiyama, Yoshiyasu] Tokai Univ, Sch Med, Dept Orthoped, Div Surg, Isehara, Kanagawa, Japan; [Hoshi, Akio] Tokai Univ, Sch Med, Dept Urol, Div Surg, Isehara, Kanagawa, Japan; [Iwasaki, Hiroto; Oyamada, Akira; Asahara, Takayuki] Stem Cell Translat Res, RIKEN Ctr Dev Biol, Kobe Inst Biomed Res & Innovat, Kobe, Hyogo, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Tokai University; Institute for Biomedical Research & Innovation (IBRI); RIKEN	Tamaki, T (corresponding author), Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, Kanagawa 2591100, Japan.	tamaki@is.icc.u-tokai.ac.jp	Tamaki, Tetsuro/I-2615-2019	Tamaki, Tetsuro/0000-0002-9071-049X	New Energy and Industrial Technology Development Organization of Japan; Tokai University Research aid	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Tokai University Research aid	This work was supported by a Grant from the New Energy and Industrial Technology Development Organization of Japan (T.T.), and Tokai University Research aid (T.T.).	Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Chiu RCJ, 2004, INT J CARDIOL, V95, pS3, DOI 10.1016/S0167-5273(04)90001-0; CHIU RCJ, 1995, ANN THORAC SURG, V60, P12; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Edelman GM, 1993, TOPOBIOLOGY INTRO MO; Ghostine S, 2002, CIRCULATION, V106, pI131, DOI 10.1161/01.cir.0000032889.55215.f1; Grounds MD, 2002, J HISTOCHEM CYTOCHEM, V50, P589, DOI 10.1177/002215540205000501; Horackova M, 2004, AM J PHYSIOL-HEART C, V287, pH1599, DOI 10.1152/ajpheart.00965.2003; Hutcheson KA, 2000, CELL TRANSPLANT, V9, P359, DOI 10.1177/096368970000900307; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Kao RL, 1989, PHYSIOLOGIST, V32, P220; Marelli D, 1992, Cell Transplant, V1, P383; Murry CE, 2002, J CARD FAIL, V8, pS532, DOI 10.1054/jcaf.2002.129268; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Pouzet B, 2000, CIRCULATION, V102, P210; Reinecke H, 1999, CIRCULATION, V100, P193, DOI 10.1161/01.CIR.100.2.193; Reinecke H, 2000, J CELL BIOL, V149, P731, DOI 10.1083/jcb.149.3.731; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Scorsin M, 1997, CIRCULATION, V96, P188; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Tamaki T, 2005, CIRCULATION, V112, P2857, DOI 10.1161/CIRCULATIONAHA.105.554832; Tamaki T, 2003, EXP CELL RES, V291, P83, DOI 10.1016/S0014-4827(03)00376-8; Tamaki T, 2002, J HISTOCHEM CYTOCHEM, V50, P1097, DOI 10.1177/002215540205000812; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tamaki T, 2007, HISTOCHEM CELL BIOL, V128, P349, DOI 10.1007/s00418-007-0331-5; Tamaki T, 2007, STEM CELLS, V25, P2283, DOI 10.1634/stemcells.2006-0746; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Winitsky SO, 2005, PLOS BIOL, V3, P662, DOI 10.1371/journal.pbio.0030087	35	35	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1789	10.1371/journal.pone.0001789	http://dx.doi.org/10.1371/journal.pone.0001789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18335059	Green Published, gold, Green Submitted			2022-12-25	WOS:000260723000040
J	Diniz, JAP; dos Santos, ZA; Braga, MAG; Dias, ALB; da Silva, DEA; Medeiros, DBD; Barros, VLRD; Chiang, JO; Zoghbi, KED; Quaresma, JAS; Takiya, CM; Neto, VM; de Souza, W; Vasconcelos, PFD; Diniz, CWP				Picanco Diniz, Jose Antonio; dos Santos, Zaire Alves; Galvao Braga, Marcio Augusto; Barros Dias, Adila Liliane; Andrade da Silva, Daisy Elaine; de Almeida Medeiros, Daniele Barbosa; Reis de Souza Barros, Vera Lucia; Chiang, Jannifer Oliveira; de Freitas Zoghbi, Kendra Eyllen; Simoes Quaresma, Juarez Antonio; Takiya, Christina Maeda; Neto, Vivaldo Moura; de Souza, Wanderley; da Costa Vasconcelos, Pedro Fernando; Picanco Diniz, Cristovam Wanderley			Early and Late Pathogenic Events of Newborn Mice Encephalitis Experimentally Induced by Itacaiunas and Curionopolis Bracorhabdoviruses Infection	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; MOUSE HEPATITIS-VIRUS; INTRANASAL INOCULATION; JAPANESE-ENCEPHALITIS; NERVOUS-SYSTEM; CELL-CULTURES; RABIES VIRUS; T-CELLS; BRAIN; RHABDOVIRUSES	In previous reports we proposed a new genus for Rhabdoviridae and described neurotropic preference and gross neuropathology in newborn albino Swiss mice after Curionopolis and Itacaiunas infections. In the present report a time-course study of experimental encephalitis induced by Itacaiunas and Curionopolis virus was conducted both in vivo and in vitro to investigate cellular targets and the sequence of neuroinvasion. We also investigate, after intranasal inoculation, clinical signs, histopathology and apoptosis in correlation with viral immunolabeling at different time points. Curionopolis and Itacaiunas viral antigens were first detected in the parenchyma of olfactory pathways at 2 and 3 days post-inoculation (dpi) and the first clinical signs were observed at 4 and 8 dpi, respectively. After Curionopolis infection, the mortality rate was 100% between 5 and 6 dpi, and 35% between 8 and 15 dpi after Itacaiunas infection. We identified CNS mice cell types both in vivo and in vitro and the temporal sequence of neuroanatomical olfactory areas infected by Itacaiunas and Curionopolis virus. Distinct virulences were reflected in the neuropathological changes including TUNEL immunolabeling and cytopathic effects, more intense and precocious after intracerebral or in vitro inoculations of Curionopolis than after Itacaiunas virus. In vitro studies revealed neuronal but not astrocyte or microglial cytopathic effects at 2 dpi, with monolayer destruction occurring at 5 and 7 dpi with Curionopolis and Itacaiunas virus, respectively. Ultrastructural changes included virus budding associated with interstitial and perivascular edema, endothelial hypertrophy, a reduced and/or collapsed small vessel luminal area, thickening of the capillary basement membrane, and presence of phagocytosed apoptotic bodies. Glial cells with viral budding similar to oligodendrocytes were infected with Itacaiunas virus but not with Curionopolis virus. Thus, Curionopolis and Itacaiunas viruses share many pathological and clinical features present in other rhabdoviruses but distinct virulence and glial targets in newborn albino Swiss mice brain.	[Picanco Diniz, Jose Antonio; Barros Dias, Adila Liliane; Andrade da Silva, Daisy Elaine; de Almeida Medeiros, Daniele Barbosa; Reis de Souza Barros, Vera Lucia; Chiang, Jannifer Oliveira; de Freitas Zoghbi, Kendra Eyllen; da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas, Belem, Para, Brazil; [dos Santos, Zaire Alves; Galvao Braga, Marcio Augusto; Simoes Quaresma, Juarez Antonio; Picanco Diniz, Cristovam Wanderley] Univ Fed Para, Belem, Para, Brazil; [Takiya, Christina Maeda; Neto, Vivaldo Moura; de Souza, Wanderley] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil	Instituto Evandro Chagas; Universidade Federal do Para; Universidade Federal do Rio de Janeiro	Diniz, JAP (corresponding author), Inst Evandro Chagas, Belem, Para, Brazil.	pedrovasconcelos@iec.pa.gov.br	Neurociencia, Inct/I-1011-2013; Vasconcelos, Pedro/AAH-3142-2019; Takiya, Christina/AAU-5959-2021; Quaresma, Juarez AS/M-4190-2014; Moura-Neto, VIVALDO/V-9913-2019; QUARESMA, JUAREZ ANTONIO SIMOES/F-8390-2012; Diniz, Cristovam W.P./G-1474-2010	Takiya, Christina/0000-0002-8019-628X; Quaresma, Juarez AS/0000-0002-6267-9966; Moura-Neto, VIVALDO/0000-0002-6266-043X; QUARESMA, JUAREZ ANTONIO SIMOES/0000-0002-6267-9966; Diniz, Cristovam W.P./0000-0001-6611-6880	CNPq [300460/2005-8, 484511/2007-6]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was partially supported by CNPq (processes 300460/2005-8 and 484511/2007-6).	Anlar B, 2001, J CHILD NEUROL, V16, P895, DOI 10.1177/088307380101601206; BABIC N, 1994, VIROLOGY, V204, P616, DOI 10.1006/viro.1994.1576; Barber GN, 2005, ONCOGENE, V24, P7710, DOI 10.1038/sj.onc.1209042; BARNETT EM, 1993, VIROLOGY, V194, P185, DOI 10.1006/viro.1993.1248; BARTHOLD SW, 1987, VIRUS RES, V7, P225, DOI 10.1016/0168-1702(87)90030-X; Beaty BJ, 1989, DIAGNOSTIC PROCEDURE, P797; Buki A, 2000, J NEUROSCI, V20, P2825; CHAN WL, 1989, J NEUROIMMUNOL, V23, P195, DOI 10.1016/0165-5728(89)90051-9; CHARLES PC, 1995, VIROLOGY, V208, P662, DOI 10.1006/viro.1995.1197; Crotty S, 2002, J GEN VIROL, V83, P1707, DOI 10.1099/0022-1317-83-7-1707; da Rosa APAT, 2002, EMERG INFECT DIS, V8, P614, DOI 10.3201/eid0806.010384; DALCANTO MC, 1976, LAB INVEST, V35, P515; Diniz JAP, 2006, ARCH VIROL, V151, P2519, DOI 10.1007/s00705-006-0812-1; Dobler G, 1996, ARCH VIROL, P33; Elena SF, 2005, J VIROL, V79, P11555, DOI 10.1128/JVI.79.18.11555-11558.2005; ESIRI MM, 1984, J NEUROL SCI, V64, P213, DOI 10.1016/0022-510X(84)90039-X; Fazakerley JK, 2006, NEUROPATH APPL NEURO, V32, P397, DOI 10.1111/j.1365-2990.2006.00739.x; Fazakerley JK, 2004, ARCH VIROL, P179; FORGER JM, 1991, J VIROL, V65, P4950, DOI 10.1128/JVI.65.9.4950-4958.1991; Fu ZF, 2005, CURR TOP MICROBIOL, V292, P1; Fu ZF, 2005, J NEUROVIROL, V11, P101, DOI 10.1080/13550280590900445; German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008; Gomes-Leal W, 2006, ACTA TROP, V97, P126, DOI 10.1016/j.actatropica.2005.09.006; GRIFFIN DE, 1995, SPRINGER SEMIN IMMUN, V17, P121; GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158; HEPLER PK, 1980, J CELL BIOL, V86, P490, DOI 10.1083/jcb.86.2.490; HUNEYCUTT BS, 1994, BRAIN RES, V635, P81, DOI 10.1016/0006-8993(94)91426-5; Hunsperger EA, 2006, J NEUROVIROL, V12, P129, DOI 10.1080/13550280600758341; Iwasaki T, 2004, ARCH VIROL, V149, P1139, DOI 10.1007/s00705-003-0271-x; Jackson AC, 2001, J MED VIROL, V65, P614, DOI 10.1002/jmv.2080; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Khuth ST, 2005, J NEUROCHEM, V94, P1580, DOI 10.1111/j.1471-4159.2005.03309.x; Khuth ST, 2001, J VIROL, V75, P8268, DOI 10.1128/JVI.75.17.8268-8282.2001; Komatsu T, 1999, NITRIC OXIDE-BIOL CH, V3, P327, DOI 10.1006/niox.1999.0237; LAFAY F, 1991, VIROLOGY, V183, P320, DOI 10.1016/0042-6822(91)90145-2; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lima FRS, 2001, J NEUROSCI, V21, P2028, DOI 10.1523/JNEUROSCI.21-06-02028.2001; LUNDH B, 1987, NEUROPATH APPL NEURO, V13, P111, DOI 10.1111/j.1365-2990.1987.tb00175.x; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; Maslin CLV, 2005, CURR HIV RES, V3, P303, DOI 10.2174/157016205774370401; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MURPHY FA, 1973, LAB INVEST, V28, P361; PLAKHOV IV, 1995, VIROLOGY, V209, P257, DOI 10.1006/viro.1995.1252; Reiss CS, 1998, ANN NY ACAD SCI, V855, P751, DOI 10.1111/j.1749-6632.1998.tb10655.x; Rempel JD, 2004, VIROLOGY, V318, P381, DOI 10.1016/j.virol.2003.09.023; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Saha S, 2006, J GEN VIROL, V87, P3285, DOI 10.1099/vir.0.82107-0; SOILUHANNINEN M, 1994, J VIROL, V68, P6291; SoiluHanninen M, 1997, J NEUROVIROL, V3, P350, DOI 10.3109/13550289709030749; Travassos da Rosa Amelia P.A., 2001, American Journal of Tropical Medicine and Hygiene, V64, P93; Van der Poel WHM, 2000, ARCH VIROL, V145, P1919, DOI 10.1007/s007050070066; Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100	55	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2008	3	3							e1733	10.1371/journal.pone.0001733	http://dx.doi.org/10.1371/journal.pone.0001733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	367XT	18320052	gold, Green Published, Green Submitted			2022-12-25	WOS:000260586600028
J	Sligte, IG; Scholte, HS; Lamme, VAF				Sligte, Ilja G.; Scholte, H. Steven; Lamme, Victor A. F.			Are There Multiple Visual Short-Term Memory Stores?	PLOS ONE			English	Article							WORKING-MEMORY; DISTINCT MODES; ICONIC MEMORY; INFORMATION; STORAGE; ATTENTION; FIGURE; CAPACITY; REPRESENTATIONS; FEATURES	Background: Classic work on visual short-term memory (VSTM) suggests that people store a limited amount of items for subsequent report. However, when human observers are cued to shift attention to one item in VSTM during retention, it seems as if there is a much larger representation, which keeps additional items in a more fragile VSTM store. Thus far, it is not clear whether the capacity of this fragile VSTM store indeed exceeds the traditional capacity limits of VSTM. The current experiments address this issue and explore the capacity, stability, and duration of fragile VSTM representations. Methodology/Principal Findings: We presented cues in a change-detection task either just after off-set of the memory array (iconic-cue), 1,000 ms after off-set of the memory array (retro-cue) or after on-set of the probe array (post-cue). We observed three stages in visual information processing 1) iconic memory with unlimited capacity, 2) a four seconds lasting fragile VSTM store with a capacity that is at least a factor of two higher than 3) the robust and capacity-limited form of VSTM. Iconic memory seemed to depend on the strength of the positive after-image resulting from the memory display and was virtually absent under conditions of isoluminance or when intervening light masks were presented. This suggests that iconic memory is driven by prolonged retinal activation beyond stimulus duration. Fragile VSTM representations were not affected by light masks, but were completely overwritten by irrelevant pattern masks that spatially overlapped the memory array. Conclusions/Significance: We find that immediately after a stimulus has disappeared from view, subjects can still access information from iconic memory because they can see an after-image of the display. After that period, human observers can still access a substantial, but somewhat more limited amount of information from a high-capacity, but fragile VSTM that is overwritten when new items are presented to the eyes. What is left after that is the traditional VSTM store, with a limit of about four objects. We conclude that human observers store more sustained representations than is evident from standard change detection tasks and that these representations can be accessed at will.	[Sligte, Ilja G.; Scholte, H. Steven; Lamme, Victor A. F.] Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, Amsterdam, Netherlands; [Lamme, Victor A. F.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Sligte, IG (corresponding author), Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, Amsterdam, Netherlands.	I.G.Sligte@uva.nl	Scholte, H.Steven/ABD-1737-2020	Scholte, H.Steven/0000-0002-9839-1788				ADELSON EH, 1978, SCIENCE, V201, P544, DOI 10.1126/science.663675; Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Block N, 2005, TRENDS COGN SCI, V9, P46, DOI 10.1016/j.tics.2004.12.006; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; DICK AO, 1969, J EXP PSYCHOL, V82, P279, DOI 10.1037/h0028147; Eng HY, 2005, PSYCHON B REV, V12, P1127, DOI 10.3758/BF03206454; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; IRWIN DE, 1991, COGNITIVE PSYCHOL, V23, P420, DOI 10.1016/0010-0285(91)90015-G; Irwin DE, 1996, CURR DIR PSYCHOL SCI, V5, P94, DOI 10.1111/1467-8721.ep10772833; Jiang YH, 2004, PERCEPT PSYCHOPHYS, V66, P446, DOI 10.3758/BF03194892; Jiang YH, 2000, J EXP PSYCHOL LEARN, V26, P683, DOI 10.1037/0278-7393.26.3.683; Jolij J, 2005, P NATL ACAD SCI USA, V102, P10747, DOI 10.1073/pnas.0500834102; Lamme VAF, 2003, TRENDS COGN SCI, V7, P12, DOI 10.1016/S1364-6613(02)00013-X; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lamme VAF, 2006, TRENDS COGN SCI, V10, P494, DOI 10.1016/j.tics.2006.09.001; Landman R, 2004, PSYCHON B REV, V11, P254, DOI 10.3758/BF03196567; Landman R, 2003, VISION RES, V43, P149, DOI 10.1016/S0042-6989(02)00402-9; Lepsien J, 2005, NEUROIMAGE, V26, P733, DOI 10.1016/j.neuroimage.2005.02.026; Lepsien J, 2007, CEREB CORTEX, V17, P2072, DOI 10.1093/cercor/bhl116; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; MAKOVSKI T, J EXPT PSYC IN PRESS; Makovski T, 2007, PSYCHON B REV, V14, P1072, DOI 10.3758/BF03193093; Matsukura M, 2007, PERCEPT PSYCHOPHYS, V69, P1422, DOI 10.3758/BF03192957; MCRAE K, 1987, PSYCHOL RES-PSYCH FO, V49, P221, DOI 10.1007/BF00309030; MEWHORT DJK, 1981, MEM COGNITION, V9, P50, DOI 10.3758/BF03196951; Olsson H, 2005, P NATL ACAD SCI USA, V102, P8776, DOI 10.1073/pnas.0500810102; PARR WV, 1992, B PSYCHONOMIC SOC, V30, P369; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; TOWNSEND VM, 1973, J EXP PSYCHOL, V98, P113, DOI 10.1037/h0034309; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92	39	301	304	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2008	3	2							e1699	10.1371/journal.pone.0001699	http://dx.doi.org/10.1371/journal.pone.0001699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	367XS	18301775	gold, Green Submitted, Green Published			2022-12-25	WOS:000260586500043
J	Kao, CY; Kim, C; Huang, F; Wu, R				Kao, Cheng-Yuan; Kim, Christy; Huang, Fei; Wu, Reen			Requirements for two proximal NF-kappa B binding sites and I kappa B-zeta in IL-17A-induced human beta-defensin 2 expression by conducting airway epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED TRANSCRIPTIONAL REGULATION; KLEBSIELLA-PNEUMONIAE INFECTION; COLONY-STIMULATING FACTOR; NEUTROPHIL RECRUITMENT; GENE-EXPRESSION; UP-REGULATION; T-CELL; INTERLEUKIN-17 FAMILY; ADAPTIVE IMMUNITY; BETA-DEFENSINS	Among a panel of 21 cytokines (IL-1 alpha, -1 beta, -2-13, and -15-18; interferon-gamma granulocyte-macrophage colony-stimulating factor; and tumor necrosis factor a), we have recently observed that IL-17A is the most potent inducer for human P-defensin 2 (hBD-2) in conducting airway epithelial cells (Kao, C. Y., Chen, Y., Thai, P., Wachi, S., Huang, F., Kim, C., Harper, R. W., and Wu, R. (2004) J. Immunol. 173,3482-3491). The molecular basis of this regulation is not known. In this study, we demonstrated a coordinated degradation of inhibitory kappa B (I kappa B)-alpha followed by a nuclear translocation of p50 and p65 NF-kappa B subunits and their binding to NF-kappa B sites of hBD-2 promoter region. With site-directed mutagenesis, we demonstrated the requirement of two proximal NF-kappa B binding sites (p kappa B1, -205 to -186; p kappa B2, -596 to -572) but not the distal site (d kappa B, -2193 to -2182) in supporting IL-17A-induced hBD-2 promoter activity. These results are consistent with the data of the chromatin immunoprecipitation assay, which showed enhanced p50 binding to these p kappa B sites but not the d kappa B site in cells after IL-17A treatment. We also found that the NF-kappa B binding cofactor, I kappa B-zeta, was up-regulated by IL-17A, and the knockdown of I kappa B-zeta significantly diminished the IL-17A-induced hBD-2 expression. This is the first demonstration of the involvement of two proximal NF-kappa B sites and I kappa B-zeta in the regulation of hBD-2 by IL-17A, two important genes responsible for host defense.	[Wu, Reen] Univ Calif Davis, Ctr Comparat Resp Biol & Med, Genome & Biomed Sci Facil, Davis, CA 95616 USA	University of California System; University of California Davis	Wu, R (corresponding author), Univ Calif Davis, Ctr Comparat Resp Biol & Med, Genome & Biomed Sci Facil, Suite 6523,451 Hlth Sci Dr, Davis, CA 95616 USA.	rwu@ucdavis.edu	Macheroux, Peter/AAB-5157-2019; KAO, CHENG-YUAN/A-7531-2010	Macheroux, Peter/0000-0002-0242-454X; KAO, CHENG-YUAN/0000-0003-0946-9270	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077902, R01HL077315, R01HL035635, R37HL035635] Funding Source: NIH RePORTER; Austrian Science Fund FWF [W 901] Funding Source: Medline; NHLBI NIH HHS [HL 077902, HL 35635, HL 077315] Funding Source: Medline; NIEHS NIH HHS [ES 00628] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Becker MN, 2000, J BIOL CHEM, V275, P29731, DOI 10.1074/jbc.M000184200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Duits LA, 2003, FEMS IMMUNOL MED MIC, V38, P59, DOI 10.1016/S0928-8244(03)00106-8; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayot F, 2006, J THEOR BIOL, V240, P583, DOI 10.1016/j.jtbi.2005.10.018; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hoshino H, 1999, AM J RESP CRIT CARE, V159, P1423, DOI 10.1164/ajrccm.159.5.9806008; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Jang BC, 2004, BIOCHEM BIOPH RES CO, V320, P1026, DOI 10.1016/j.bbrc.2004.06.049; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kawaguchi M, 2001, J ALLERGY CLIN IMMUN, V108, P804, DOI 10.1067/mai.2001.119027; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kolls JK, 2003, AM J RESP CELL MOL, V28, P9, DOI 10.1165/rcmb.2002-0255PS; Krisanaprakornkit S, 2002, J IMMUNOL, V168, P316, DOI 10.4049/jimmunol.168.1.316; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Liao F, 1999, J IMMUNOL, V162, P186; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Liu LD, 2003, J IMMUNOL, V170, P575, DOI 10.4049/jimmunol.170.1.575; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Ogushi K, 2001, J BIOL CHEM, V276, P30521, DOI 10.1074/jbc.M011618200; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Tsutsumi-Ishii Y, 2002, J LEUKOCYTE BIOL, V71, P154; Uehara N, 2003, J MED MICROBIOL, V52, P41, DOI 10.1099/jmm.0.04985-0; Wada A, 2001, CELL MICROBIOL, V3, P115, DOI 10.1046/j.1462-5822.2001.00096.x; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; YANKASKAS JR, 1993, AM J PHYSIOL, V264, pC1219, DOI 10.1152/ajpcell.1993.264.5.C1219; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424	51	70	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					15309	15318		10.1074/jbc.M708289200	http://dx.doi.org/10.1074/jbc.M708289200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18362142	hybrid, Green Published			2022-12-25	WOS:000256232000049
